PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lai, IL; Lin, TP; Yao, YL; Lin, CY; Hsieh, MJ; Yang, WM				Lai, I-Lu; Lin, Tung-Ping; Yao, Ya-Li; Lin, Ching-Yi; Hsieh, Mei-Ju; Yang, Wen-Ming			Histone Deacetylase 10 Relieves Repression on the Melanogenic Program by Maintaining the Deacetylation Status of Repressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAARDENBURG-SYNDROME; TRANSCRIPTION FACTOR; IN-VIVO; PAX3; GENES; ACETYLATION; EXPRESSION; PROTEIN; HDAC10; MICROPHTHALMIA	HDAC10 belongs to the class II histone deacetylase family; however, its functions remain enigmatic. We report here that the HDAC10 protein complex contained deacetylated chaperone protein hsc70, and HDAC10 relieved repression of melanogenesis by decreasing the repressional activity of two transcriptional regulators, paired box protein 3 (Pax3) and KRAB-associated protein 1 (KAP1). HDAC10 physically interacted with Pax3 and KAP1 in a ternary complex and maintained Pax3 and KAP1 in a deacetylated state. Deacetylated Pax3 and KAP1 derepressed promoters of microphthalmia-associated transcription factor (MITF) and melanocyte-specific tyrosinase-related protein 1 and 2 (TRP-1 and TRP-2), three genes of the melanogenesis cascade, in a trichostatin A-sensitive manner. Co-occupancy of melanogenic promoters by HDAC10, Pax3, and KAP1 only happened in cells of the melanocyte lineage, and KAP1 facilitated nuclear enrichment of HDAC10. Finally, cellular melanin content correlated directly with the expression level and activity of HDAC10. Our results not only show that HDAC10 regulates melanogenesis but also demonstrate that the transcriptional activities of Pax3 and KAP1 are intimately linked to their acetylation status.	[Lai, I-Lu; Lin, Tung-Ping; Hsieh, Mei-Ju; Yang, Wen-Ming] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Yao, Ya-Li; Lin, Ching-Yi] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Yao, Ya-Li; Lin, Ching-Yi] Asia Univ, Dept Bioinformat, Taichung 41354, Taiwan	National Chung Hsing University; Asia University Taiwan; Asia University Taiwan	Yang, WM (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.	yangwm@mail.nchu.edu.tw		Yang, Wen-Ming/0000-0002-5871-5979	National Health Research Institutes [NHRI-9212SI]; National Science Council [NSC96-2311-B-005-006-MY3, NSC95-2311-B-468-001-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-9212SI (to W.- M. Y.) and by National Science Council Grants NSC96-2311-B-005-006-MY3 (to W.- M. Y.) and NSC95-2311-B-468-001-MY3 (to Y.- L. Y.).	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hsieh MJ, 2006, BIOCHEM BIOPH RES CO, V349, P573, DOI 10.1016/j.bbrc.2006.08.064; Jepsen K, 2002, J CELL SCI, V115, P689; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Mayanil CSK, 2006, J BIOL CHEM, V281, P24544, DOI 10.1074/jbc.M512449200; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Oka M, 1996, J INVEST DERMATOL, V106, P377, DOI 10.1111/1523-1747.ep12343168; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Tachibana M, 1999, J INVEST DERM SYMP P, V4, P126, DOI 10.1038/sj.jidsp.5640195; Tong JJ, 2002, NUCLEIC ACIDS RES, V30, P1114, DOI 10.1093/nar/30.5.1114; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	37	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7187	7196		10.1074/jbc.M109.061861	http://dx.doi.org/10.1074/jbc.M109.061861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20032463	hybrid, Green Published			2022-12-27	WOS:000275415600032
J	Yang, YJ; Cimen, HY; Han, MJ; Shi, T; Deng, JH; Koc, H; Palacios, OM; Montier, L; Bai, YD; Tong, Q; Koc, EC				Yang, Yongjie; Cimen, Huseyin; Han, Min-Joon; Shi, Tong; Deng, Jian-Hong; Koc, Hasan; Palacios, Orsolya M.; Montier, Laura; Bai, Yidong; Tong, Qiang; Koc, Emine C.			NAD(+)-dependent Deacetylase SIRT3 Regulates Mitochondrial Protein Synthesis by Deacetylation of the Ribosomal Protein MRPL10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SMALL-SUBUNIT; IDENTIFICATION; HOMOLOG; ACETYLATION; GENE; BINDING; SITES; STALK; RNA	A member of the sirtuin family of NAD(+)-dependent deacetylases, SIRT3, is located in mammalian mitochondria and is important for regulation of mitochondrial metabolism, cell survival, and longevity. In this study, MRPL10 (mitochondrial ribosomal protein L10) was identified as the major acetylated protein in the mitochondrial ribosome. Ribosome-associated SIRT3 was found to be responsible for deacetylation of MRPL10 in an NAD(+)-dependent manner. We mapped the acetylated Lys residues by tandem mass spectrometry and determined the role of these residues in acetylation of MRPL10 by site-directed mutagenesis. Furthermore, we observed that the increased acetylation of MRPL10 led to an increase in translational activity of mitochondrial ribosomes in Sirt3(-/-) mice. In a similar manner, ectopic expression and knockdown of SIRT3 in C2C12 cells resulted in the suppression and enhancement of mitochondrial protein synthesis, respectively. Our findings constitute the first evidence for the regulation of mitochondrial protein synthesis by the reversible acetylation of the mitochondrial ribosome and characterize MRPL10 as a novel substrate of the NAD(+)-dependent deacetylase, SIRT3.	[Yang, Yongjie; Shi, Tong; Palacios, Orsolya M.; Tong, Qiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Cimen, Huseyin; Han, Min-Joon; Koc, Hasan; Koc, Emine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Deng, Jian-Hong; Montier, Laura; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Health San Antonio	Tong, Q (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, 1100 Bates St,Rm 5076, Houston, TX 77030 USA.	qtong@bcm.edu; eck12@psu.edu	Bai, Yidong/A-4959-2012; Montier, Laura/AAA-2031-2021; Cimen, Huseyin/H-7272-2012	Cimen, Huseyin/0000-0003-0801-3554	National Institutes of Health [R01AG025223, R01DK075978, R01GM071034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG025223 ( to Y. B.), R01DK075978 ( to Q. T.), and R01GM071034 ( to E. C. K.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Chintharlapalli SR, 2005, J CELL BIOCHEM, V94, P611, DOI 10.1002/jcb.20292; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004; Hunter SE, 2004, BIOCHEMISTRY-US, V43, P6917, DOI 10.1021/bi036068j; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JACKSON PJ, 1986, BIOCHEM J, V235, P577, DOI 10.1042/bj2350577; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Landry J, 2003, METHODS, V31, P33, DOI 10.1016/S1046-2023(03)00085-9; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Miller JL, 2009, J PROTEOME RES, V8, P4789, DOI 10.1021/pr9004844; O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shao ZH, 2003, PHARMACOL RES, V47, P463, DOI 10.1016/S1043-6618(03)00041-0; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Soung GY, 2009, J PROTEOME RES, V8, P3390, DOI 10.1021/pr900042e; Spremulli Linda L, 2007, Methods Mol Biol, V372, P265, DOI 10.1007/978-1-59745-365-3_19; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Woriax VL, 1997, BBA-GENE STRUCT EXPR, V1352, P91, DOI 10.1016/S0167-4781(97)00002-X; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zanotto E, 2008, BBA-MOL CELL RES, V1783, P2352, DOI 10.1016/j.bbamcr.2008.08.001; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	50	121	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7417	7429		10.1074/jbc.M109.053421	http://dx.doi.org/10.1074/jbc.M109.053421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042612	Green Published, hybrid			2022-12-27	WOS:000275415600054
J	Owens, L; Simanski, S; Squire, C; Smith, A; Cartzendafner, J; Cavett, V; Busby, JC; Sato, T; Ayad, NG				Owens, Laura; Simanski, Scott; Squire, Christopher; Smith, Anthony; Cartzendafner, Jeff; Cavett, Valerie; Busby, Jennifer Caldwell; Sato, Trey; Ayad, Nagi G.			Activation Domain-dependent Degradation of Somatic Wee1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE OSCILLATOR; MITOTIC ENTRY; S PHASE; DNA; PHOSPHORYLATION; INHIBITION; G1; IDENTIFICATION; CHECKPOINT; P27(KIP1)	Cell cycle progression is dependent upon coordinate regulation of kinase and proteolytic pathways. Inhibitors of cell cycle transitions are degraded to allow progression into the subsequent cell cycle phase. For example, the tyrosine kinase and Cdk1 inhibitor Wee1 is degraded during G(2) and mitosis to allow mitotic progression. Previous studies suggested that the N terminus of Wee1 directs Wee1 destruction. Using a chemical mutagenesis strategy, we report that multiple regions of Wee1 control its destruction. Most notably, we find that the activation domain of the Wee1 kinase is also required for its degradation. Mutations in this domain inhibit Wee1 degradation in somatic cell extracts and in cells without affecting the overall Wee1 structure or kinase activity. More broadly, these findings suggest that kinase activation domains may be previously unappreciated sites of recognition by the ubiquitin proteasome pathway.	[Ayad, Nagi G.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Cartzendafner, Jeff; Cavett, Valerie; Busby, Jennifer Caldwell] Scripps Florida, Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Squire, Christopher] Univ Auckland, Sch Biol Sci, Auckland 1001, New Zealand; [Squire, Christopher] Univ Auckland, Ctr Mol Biodiscovery, Auckland 1001, New Zealand; [Sato, Trey] Scripps Florida, Scripps Res Inst, Dept Biochem, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida; Scripps Research Institute; State University System of Florida; University of Florida; University of Auckland; University of Auckland; Scripps Research Institute; State University System of Florida; University of Florida	Ayad, NG (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	nayad@scripps.edu		Squire, Christopher/0000-0001-9212-0461; Simanski, Scott/0000-0002-7594-5952	National Institutes of Health [1 R21 NS056991-01]; Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 NS056991-01. This work was also supported by a Landenberger Foundation grant (to N.G.A.).	Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Ayad NG, 2005, METHOD ENZYMOL, V399, P404, DOI 10.1016/S0076-6879(05)99028-9; COREY RB, 1953, REV SCI INSTRUM, V24, P621, DOI 10.1063/1.1770803; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; LI C, 2009, MOL CELL BIOL, V1, P116; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Murakami MS, 2004, DEVELOPMENT, V131, P571, DOI 10.1242/dev.00971; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Smith A, 2007, CELL CYCLE, V6, P2795, DOI 10.4161/cc.6.22.4919; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; TESSMAN I, 1964, J MOL BIOL, V9, P352, DOI 10.1016/S0022-2836(64)80212-6; Tominaga Y, 2006, INT J BIOL SCI, V2, P161; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047	29	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6761	6769		10.1074/jbc.M109.093237	http://dx.doi.org/10.1074/jbc.M109.093237			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038582	Green Published, hybrid			2022-12-27	WOS:000275367500079
J	Allam, H; Ali, N				Allam, Heba; Ali, Naushad			Initiation Factor eIF2-independent Mode of c-Src mRNA Translation Occurs via an Internal Ribosome Entry Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C; MEDIATED TRANSLATION; VIRUS-RNA; EUKARYOTIC TRANSLATION; PROTEIN-SYNTHESIS; TYROSINE KINASES; PROSTATE-CANCER; CARCINOMA CELLS; CULTURED-CELLS; BREAST-CANCER	Overexpression and activation of the c-Src protein have been linked to the development of a wide variety of cancers. The molecular mechanism(s) of c-Src overexpression in cancer cells is not clear. We report here an internal ribosome entry site (IRES) in the c-Src mRNA that is constituted by both 5'-noncoding and -coding regions. The inhibition of cap-dependent translation by m(7)GDP in the cell-free translation system or induction of endoplasmic reticulum stress in hepatoma-derived cells resulted in stimulation of the c-Src IRES activities. Sucrose density gradient analyses revealed formation of a stable binary complex between the c-Src IRES and purified HeLa 40 S ribosomal subunit in the absence of initiation factors. We further demonstrate eIF2-independent assembly of 80 S initiation complex on the c-Src IRES. These features of the c-Src IRES appear to be reminiscent of that of hepatitis C virus-like IRESs and translation initiation in prokaryotes. Transfection studies and genetic analysis revealed that the c-Src IRES permitted initiation at the authentic AUG351, which is also used for conventional translation initiation of the c-Src mRNA. Our studies unveiled a novel regulatory mechanism of c-Src synthesis mediated by an IRES element, which exhibits enhanced activity during cellular stress and is likely to cause c-Src overexpression during oncogenesis and metastasis.	[Allam, Heba; Ali, Naushad] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	University of Denver	Ali, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Digest Dis & Nutr, 975 NE 10th St,BRC W 1268A, Oklahoma City, OK 73104 USA.	naushad-ali@ouhsc.edu	Allam, Heba/AAC-9226-2019	Allam, Heba/0000-0003-3053-8066; Ali, Naushad/0000-0002-0058-7396	National Institutes of Health [R03AI063046]; Egyptian Student Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Egyptian Student Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03AI063046 (to N. A.).r Recipient of an Egyptian Student Fellowship.	Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Barton DJ, 1996, METHOD ENZYMOL, V275, P35; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bonham K, 2000, J BIOL CHEM, V275, P37604, DOI 10.1074/jbc.M004882200; BONHAM K, 1993, ONCOGENE, V8, P1973; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Chao TSO, 1997, CANCER RES, V57, P3168; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Collier AJ, 1998, J GEN VIROL, V79, P2359, DOI 10.1099/0022-1317-79-10-2359; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Giaccone G, 2008, ANN ONCOL, V19, P1219, DOI 10.1093/annonc/mdn048; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Horn S, 2003, ONCOGENE, V22, P7170, DOI 10.1038/sj.onc.1206856; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kentsis A, 2005, RNA, V11, P1762, DOI 10.1261/rna.2238705; Kozak M, 2007, GENE, V403, P194, DOI 10.1016/j.gene.2007.08.017; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Le SY, 1997, NUCLEIC ACIDS RES, V25, P362, DOI 10.1093/nar/25.2.362; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Murray KE, 2001, RNA, V7, P1126, DOI 10.1017/S1355838201010044; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Seal R, 2005, NUCLEIC ACIDS RES, V33, P376, DOI 10.1093/nar/gki169; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Serrels B, 2009, CARCINOGENESIS, V30, P249, DOI 10.1093/carcin/bgn278; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Soto Rifo R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm682; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; WANG CY, 1993, J VIROL, V67, P3338, DOI 10.1128/JVI.67.6.3338-3344.1993; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; Yamamoto N, 2006, J CELL SCI, V119, P4623, DOI 10.1242/jcs.03236; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5713	5725		10.1074/jbc.M109.029462	http://dx.doi.org/10.1074/jbc.M109.029462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028973	hybrid, Green Published			2022-12-27	WOS:000275327200064
J	Fan, YH; Yu, Y; Shi, Y; Sun, WJ; Xie, M; Ge, NL; Mao, RF; Chang, A; Xu, GF; Schneider, MD; Zhang, H; Fu, SB; Qin, J; Yang, JH				Fan, Yihui; Yu, Yang; Shi, Yi; Sun, Wenjing; Xie, Min; Ge, Ningling; Mao, Renfang; Chang, Alex; Xu, Gufeng; Schneider, Michael D.; Zhang, Hong; Fu, Songbin; Qin, Jun; Yang, Jianhua			Lysine 63-linked Polyubiquitination of TAK1 at Lysine 158 Is Required for Tumor Necrosis Factor alpha- and Interleukin-1 beta-induced IKK/NF-kappa B and JNK/AP-1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-DEPENDENT KINASE; BETA SIGNAL-TRANSDUCTION; LYS63-LINKED POLYUBIQUITINATION; LIVER DEGENERATION; DEFICIENT MICE; IL-1; PROTEIN; PHOSPHORYLATION; PATHWAY; BINDING	Transforming growth factor-beta-activated kinase 1 (TAK1) plays an essential role in the tumor necrosis factor alpha (TNF alpha)- and interleukin-1 beta (IL-1 beta)-induced I kappa B kinase (IKK)/nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK)/activator protein 1 (AP-1) activation. Here we report that TNF alpha and IL-1 beta induce Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue within the kinase domain. Tumor necrosis factor receptor-associated factors 2 and 6 (TRAF2 and -6) act as the ubiquitin E3 ligases to mediate Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue in vivo and in vitro. Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue is required for TAK1-mediated IKK complex recruitment. Reconstitution of TAK1-deficient mouse embryo fibroblast cells with TAK1 wild type or a TAK1 mutant containing a K158R mutation revealed the importance of this site in TNF alpha and IL-1 beta-mediated IKK/NF-kappa B and JNK/AP-1 activation as well as IL-6 gene expression. Our findings demonstrate that Lys(63)-linked polyubiquitination of TAK1 at Lys(158) is essential for its own kinase activation and its ability to mediate its downstream signal transduction pathways in response to TNF alpha and IL-1 beta stimulation.	[Yang, Jianhua] Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Fan, Yihui; Yu, Yang; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Mao, Renfang; Zhang, Hong] Baylor Coll Med, Dept Pathol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shi, Yi; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Xie, Min; Schneider, Michael D.] Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; [Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Baylor College of Medicine; Texas Children's Cancer Center; Harbin Medical University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Imperial College London	Yang, JH (corresponding author), Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Texas Childrens Canc Ctr, 1 Baylor Plaza,BCM320,6621 Fannin St,MC3-3320, Houston, TX 77030 USA.	jianhuay@bcm.edu	Shi, Yi/P-7972-2018	Shi, Yi/0000-0002-2761-8324; Xie, Min/0000-0002-2967-3490; Schneider, Michael/0000-0001-9645-1938	National Institutes of Health; NCI [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; Virginia and L. E. Simmons Family Foundation; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant 1R21CA106513-01A2 (to J.Y.). This work was also supported by American Cancer Society Grant RSG-06-070-01-TBE (to J.Y.) and a grant from the Virginia and L. E. Simmons Family Foundation Collaborative Research Fund (to J.Y.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Carter RS, 2005, J BIOL CHEM, V280, P43272, DOI 10.1074/jbc.M508656200; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Thiefes A, 2006, EMBO REP, V7, P838, DOI 10.1038/sj.embor.7400754; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	51	124	129	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5347	5360		10.1074/jbc.M109.076976	http://dx.doi.org/10.1074/jbc.M109.076976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20038579	Green Published, hybrid			2022-12-27	WOS:000275327200028
J	Ng, Y; Ramm, G; James, DE				Ng, Yvonne; Ramm, Georg; James, David E.			Dissecting the Mechanism of Insulin Resistance Using a Novel Heterodimerization Strategy to Activate Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN-KINASE-B; 3T3-L1 ADIPOCYTES; RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; 3-KINASE PATHWAY; SKELETAL-MUSCLE; PHOSPHORYLATION; GROWTH; CELLS; MICE	Insulin resistance can occur in response to many different external insults, including chronic exposure to insulin itself as well as other agonists such as dexamethasone. It is generally thought that such defects arise due to a defect(s) at an early stage in the insulin signaling cascade. One model suggests that this involves activation of the mammalian target of rapamycin/S6 kinase pathway, which inactivates insulin receptor substrate via Ser/Thr phosphorylation. However, we have recently shown that insulin receptor substrate is not a major node for insulin resistance defects. To explore the mechanism of insulin resistance, we have developed a novel system to activate Akt independently of its upstream effectors as well as other insulin-responsive pathways such as mitogen-activated protein kinase. 3T3-L1 adipocytes were rendered insulin-resistant either with chronic insulin or dexamethasone treatment, but conditional activation of Akt2 stimulated hemagglutinin-tagged glucose transporter 4 translocation to the same extent in these insulin-resistant and control cells. However, addition of insulin to cells in which Akt was conditionally activated resulted in a reversion to the insulin-resistant state, indicating a feedforward inhibitory mechanism activated by insulin itself. This effect was overcome with wortmannin, implicating a role for phosphatidylinositol 3-kinase in this inhibitory process. We conclude that in chronic insulin- and dexamethasone-treated cells, acute activation with insulin itself is required to activate a feedforward inhibitory pathway likely emanating from phosphatidylinositol 3-kinase that converges on a target downstream of Akt to cause insulin resistance.	[Ng, Yvonne; Ramm, Georg] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [Ng, Yvonne; James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Ramm, Georg] Monash Univ, Sch Biomed Sci, Melbourne, Vic 3800, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Monash University		d.james@garvan.org.au		Ramm, Georg/0000-0003-3596-2288; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia.	Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Chen GL, 2004, J BIOL CHEM, V279, P39705, DOI 10.1074/jbc.C400171200; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li MJ, 2005, METH MOL B, V309, P261; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Tremblay F, 2001, J BIOL CHEM, V276, P38052; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Whiteman EL, 2003, ENDOCRINOLOGY, V144, P3811, DOI 10.1210/en.2003-0480; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	36	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5232	5239		10.1074/jbc.M109.060632	http://dx.doi.org/10.1074/jbc.M109.060632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022950	hybrid, Green Published			2022-12-27	WOS:000275327200016
J	Yao, HW; Hwang, JW; Moscat, J; Diaz-Meco, MT; Leitges, M; Kishore, N; Li, X; Rahman, I				Yao, Hongwei; Hwang, Jae-Woong; Moscat, Jorge; Diaz-Meco, Maria T.; Leitges, Michael; Kishore, Nandini; Li, Xiong; Rahman, Irfan			Protein Kinase C zeta Mediates Cigarette Smoke/Aldehyde- and Lipopolysaccharide-induced Lung Inflammation and Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; HUMAN ALVEOLAR MACROPHAGES; PKC-ZETA; PHOSPHATIDYLINOSITOL 3-KINASE; EPITHELIAL-CELLS; GENE-EXPRESSION; MOUSE LUNG; IKK-ALPHA	Atypical protein kinase C (PKC) zeta is an important regulator of inflammation through activation of the nuclear factor-kappa B (NF-kappa B) pathway. Chromatin remodeling on pro-inflammatory genes plays a pivotal role in cigarette smoke (CS)- and lipopolysaccharide (LPS)-induced abnormal lung inflammation. However, the signaling mechanism whereby chromatin remodeling occurs in CS-and LPS-induced lung inflammation is not known. We hypothesized that PKC zeta is an important regulator of chromatin remodeling, and down-regulation of PKC zeta ameliorates lung inflammation by CS and LPS exposures. We determined the role and molecular mechanism of PKC zeta in abnormal lung inflammatory response to CS and LPS exposures in PKC zeta-deficient (PKC zeta(-/-)) and wild-type mice. Lung inflammatory response was decreased in PKC zeta(-/-) mice compared with WT mice exposed to CS and LPS. Moreover, inhibition of PKC zeta by a specific pharmacological PKC zeta inhibitor attenuated CS extract-, reactive aldehydes (present in CS)-, and LPS-mediated pro-inflammatory mediator release from macrophages. The mechanism underlying these findings is associated with decreased RelA/p65 phosphorylation (Ser311) and translocation of the RelA/p65 subunit of NF-kappa B into the nucleus. Furthermore, CS/reactive aldehydes and LPS exposures led to activation and translocation of PKC zeta into the nucleus where it forms a complex with CREB-binding protein (CBP) and acetylated RelA/p65 causing histone phosphorylation and acetylation on promoters of pro-inflammatory genes. Taken together, these data suggest that PKC zeta plays an important role in CS/aldehyde-and LPS-induced lung inflammation through acetylation of RelA/p65 and histone modifications via CBP. These data provide new insights into the molecular mechanisms underlying the pathogenesis of chronic inflammatory lung diseases.	[Yao, Hongwei; Hwang, Jae-Woong; Rahman, Irfan] Univ Rochester, Med Ctr, Lung Biol & Dis Program, Dept Environm Med, Rochester, NY 14642 USA; [Moscat, Jorge; Diaz-Meco, Maria T.; Leitges, Michael] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45237 USA; [Kishore, Nandini; Li, Xiong] Pfizer Res Labs, Dept Biol Sci, St Louis, MO 63167 USA	University of Rochester; University System of Ohio; University of Cincinnati; Pfizer	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Lung Biol & Dis Program, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Leitges, Michael/AAN-1953-2021; Yao, Hongwei/G-6444-2010	Leitges, Michael/0000-0003-4203-6995; Diaz-Meco, Maria/0000-0003-0147-0998	NIEHS Environmental Health Science Center [R01-HL085613, R01-HL097751, P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097751, R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIEHS Environmental Health Science Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL085613 and R01-HL097751 and Grant P30-ES01247 from the NIEHS Environmental Health Science Center.	BARNES PJ, 2004, J COPD, V1, P59; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Calcerrada MC, 2002, FEBS LETT, V514, P361, DOI 10.1016/S0014-5793(02)02401-8; Carnevali S, 1998, AM J PHYSIOL-LUNG C, V274, pL591, DOI 10.1152/ajplung.1998.274.4.L591; Chakrabarti S, 2008, MICROCIRCULATION, V15, P555, DOI 10.1080/10739680801949732; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cockerill PN, 1996, CELL GROWTH DIFFER, V7, P917; Corradi M, 2003, AM J RESP CRIT CARE, V167, P1380, DOI 10.1164/rccm.200210-1253OC; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; Dallot E, 2005, BIOCHIMIE, V87, P513, DOI 10.1016/j.biochi.2005.02.009; de Kozak Y, 2007, AM J PATHOL, V170, P1241, DOI 10.2353/ajpath.2007.060236; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Engdahl R, 2007, BIOCHEM BIOPH RES CO, V359, P88, DOI 10.1016/j.bbrc.2007.05.057; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Garrett S, 2008, INFLAMMATION, V31, P235, DOI 10.1007/s10753-008-9070-6; Guo H, 2009, J LEUKOCYTE BIOL, V85, P911, DOI 10.1189/jlb.0708429; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Koch A, 2004, AM J RESP CELL MOL, V30, P342, DOI 10.1165/rcmb.2003-0122OC; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Lapperre TS, 2007, CHEST, V131, P53, DOI 10.1378/chest.06-0796; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Marchisio M, 2005, J CELL PHYSIOL, V205, P32, DOI 10.1002/jcp.20364; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Mauderly JL, 2004, TOXICOL SCI, V81, P280, DOI 10.1093/toxsci/kfh203; Monick MM, 2000, J IMMUNOL, V165, P4632, DOI 10.4049/jimmunol.165.8.4632; Monick MM, 1999, J IMMUNOL, V162, P3005; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Neri LM, 1999, FASEB J, V13, P2299, DOI 10.1096/fasebj.13.15.2299; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Savkovic SD, 2003, AM J PHYSIOL-CELL PH, V285, pC512, DOI 10.1152/ajpcell.00444.2002; Sethi JM, 2000, CLIN CHEST MED, V21, P67, DOI 10.1016/S0272-5231(05)70008-3; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; Syed DN, 2007, ONCOGENE, V26, P673, DOI 10.1038/sj.onc.1209829; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; van Houwelingen AH, 2008, FASEB J, V22, P3403, DOI 10.1096/fj.07-096230; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Xin MG, 2007, J BIOL CHEM, V282, P21268, DOI 10.1074/jbc.M701613200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	76	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5405	5416		10.1074/jbc.M109.041418	http://dx.doi.org/10.1074/jbc.M109.041418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007975	Green Published, hybrid			2022-12-27	WOS:000275327200034
J	Zhang, H; Verkman, AS				Zhang, Hua; Verkman, A. S.			Aquaporin-1 Tunes Pain Perception by Interaction with Na(v)1.8 Na+ Channels in Dorsal Root Ganglion Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOCICEPTIVE SENSORY NEURONS; WATER CHANNELS; INFLAMMATORY PAIN; SLOW INACTIVATION; SODIUM-CHANNELS; DRG NEURONS; DEPENDENT INHIBITION; FUNCTIONAL-ANALYSIS; ACTION-POTENTIALS; TRANSGENIC MICE	Aquaporin-1 (AQP1) water channels are expressed in the plasma membrane of dorsal root ganglion (DRG) neurons. We found reduced osmotic water permeability in freshly isolated DRG neurons from AQP1(-/-) versus AQP1(-/-) mice. Behavioral studies showed greatly reduced thermal inflammatory pain perception in AQP1(-/-) mice evoked by bradykinin, prostaglandin E-2, and capsaicin as well as reduced cold pain perception. Patch clamp of freshly isolated DRG neurons showed reduced action potential firing in response to current injections. Single action potentials after pulse current injections showed reduced maximum inward current, suggesting impaired Na(v)1.8 Na+ function. Whole-cell Na(v)1.8 Na+ currents in Na(v)1.8-expressing ND7-23 cells showed slowed frequency-dependent inactivation after AQP1 transfection. Immunoprecipitation studies showed AQP1-Na(v)1.8 Na+ interaction, which was verified in live cells by single-particle tracking of quantum dot-labeled AQP1. Our results implicate the involvement of AQP1 in DRG neurons for the perception of inflammatory thermal pain and cold pain, whose molecular basis is accounted for, in part, by reduced Na(v)1.8-dependent membrane Na+ current. AQP1 is, thus, a novel target for pain management.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [DK35124, EY13574, EB00415, DK86125, DK72517, HL73856]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, RC1DK086125, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK35124, EY13574, EB00415, DK86125, DK72517, and HL73856. This work was also supported by a grant from the Guthy-Jackson Charitable Foundation.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Blair NT, 2002, J NEUROSCI, V22, P10277; Blair NT, 2003, J NEUROSCI, V23, P10338; Chahine M, 2005, TRENDS PHARMACOL SCI, V26, P496, DOI 10.1016/j.tips.2005.08.002; Choi JS, 2007, J NEUROPHYSIOL, V97, P1258, DOI 10.1152/jn.01033.2006; Choi JS, 2006, J NEUROPHYSIOL, V96, P97, DOI 10.1152/jn.00854.2005; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Foulkes T, 2007, CHANNELS, V1, P154, DOI 10.4161/chan.4692; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KOSTYUK PG, 1977, NATURE, V267, P70, DOI 10.1038/267070a0; Lariviere RC, 2002, J NEUROCHEM, V81, P525, DOI 10.1046/j.1471-4159.2002.00853.x; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Liu CJ, 2005, MOL CELL NEUROSCI, V28, P636, DOI 10.1016/j.mcn.2004.11.007; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; QUANDT FN, 1988, MOL PHARMACOL, V34, P557; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Solenov EI, 2002, J NEUROSCI METH, V113, P85, DOI 10.1016/S0165-0270(01)00481-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	50	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5896	5906		10.1074/jbc.M109.090233	http://dx.doi.org/10.1074/jbc.M109.090233			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018876	Green Published, hybrid			2022-12-27	WOS:000275327200080
J	Graham, JR; Tullai, JW; Cooper, GM				Graham, Julie R.; Tullai, John W.; Cooper, Geoffrey M.			GSK-3 Represses Growth Factor-inducible Genes by Inhibiting NF-kappa B in Quiescent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FACTOR-BINDING SITES; PHOSPHATIDYLINOSITOL 3-KINASE; IKK-BETA; TRANSCRIPTION; ACTIVATION; SURVIVAL; APOPTOSIS; INSULIN; P65	GSK-3 is active in the absence of growth factor stimulation and generally acts to induce apoptosis or inhibit cell proliferation. We previously identified a subset of growth factor-inducible genes that can also be induced in quiescent T98G cells solely by inhibition of GSK-3 in the absence of growth factor stimulation. Computational predictions verified by chromatin immunoprecipitation assays identified NF-kappa B binding sites in the upstream regions of 75% of the genes regulated by GSK-3. p50 bound to most of these sites in quiescent cells, and for one-third of the genes, binding of p65 to the predicted sites increased upon inhibition of GSK-3. The functional role of p65 in gene induction following inhibition of GSK-3 was demonstrated by RNA interference experiments. Furthermore, inhibition of GSK-3 in quiescent cells resulted in activation of I kappa B kinase, leading to phosphorylation and degradation of I kappa B alpha and nuclear translocation of p65 and p50. Taken together, these results indicate that the high levels of GSK-3 activity in quiescent cells repress gene expression by negatively regulating NF-kappa B through inhibition of I kappa B kinase. This inhibition of NF-kappa B is consistent with the role of GSK-3 in the induction of apoptosis or cell cycle arrest in cells deprived of growth factors.	[Graham, Julie R.; Cooper, Geoffrey M.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA USA; [Tullai, John W.; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA USA	Boston University; Boston University	Cooper, GM (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [R01 CA18689]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA18689.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hurel SJ, 1996, BIOCHEM J, V320, P871, DOI 10.1042/bj3200871; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Sauer T, 2006, BIOINFORMATICS, V22, P430, DOI 10.1093/bioinformatics/bti819; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	48	26	26	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4472	4480		10.1074/jbc.M109.053785	http://dx.doi.org/10.1074/jbc.M109.053785			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018891	Green Published, hybrid			2022-12-27	WOS:000275274800025
J	He, YX; Huang, L; Xue, YY; Fei, X; Teng, YB; Rubin-Pitel, SB; Zhao, HM; Zhou, CZ				He, Yong-Xing; Huang, Liang; Xue, Yanyan; Fei, Xue; Teng, Yan-Bin; Rubin-Pitel, Sheryl B.; Zhao, Huimin; Zhou, Cong-Zhao			Crystal Structure and Computational Analyses Provide Insights into the Catalytic Mechanism of 2,4-Diacetylphloroglucinol Hydrolase PhlG from Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC 2,4-DIACETYLPHLOROGLUCINOL; BIOLOGICAL-CONTROL; BINDING; FOLD; SUPPRESSION; VALIDATION; RESISTANCE; PATHOGENS; SEQUENCE; PROTEIN	2,4-Diacetylphloroglucinol hydrolase PhlG from Pseudomonas fluorescens catalyzes hydrolytic carbon-carbon (C-C) bond cleavage of the antibiotic 2,4-diacetylphloroglucinol to form monoacetylphloroglucinol, a rare class of reactions in chemistry and biochemistry. To investigate the catalytic mechanism of this enzyme, we determined the three-dimensional structure of PhlG at 2.0 angstrom resolution using x-ray crystallography and MAD methods. The overall structure includes a small N-terminal domain mainly involved in dimerization and a C-terminal domain of Bet v1-like fold, which distinguishes PhlG from the classical alpha/beta-fold hydrolases. A dumbbell-shaped substrate access tunnel was identified to connect a narrow interior amphiphilic pocket to the exterior solvent. The tunnel is likely to undergo a significant conformational change upon substrate binding to the active site. Structural analysis coupled with computational docking studies, site-directed mutagenesis, and enzyme activity analysis revealed that cleavage of the 2,4-diacetylphloroglucinol C-C bond proceeds via nucleophilic attack by a water molecule, which is coordinated by a zinc ion. In addition, residues Tyr(121), Tyr(229), and Asn(132), which are predicted to be hydrogen-bonded to the hydroxyl groups and unhydrolyzed acetyl group, can finely tune and position the bound substrate in a reactive orientation. Taken together, these results revealed the active sites and zinc-dependent hydrolytic mechanism of PhlG and explained its substrate specificity as well.	[Rubin-Pitel, Sheryl B.; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [He, Yong-Xing; Huang, Liang; Xue, Yanyan; Fei, Xue; Teng, Yan-Bin; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [He, Yong-Xing; Huang, Liang; Xue, Yanyan; Fei, Xue; Teng, Yan-Bin; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhao, HM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011	Zhou, Cong-Zhao/0000-0002-6881-7151; Fei, Xue/0000-0003-3378-7447				Abbas A, 2004, MICROBIOL-SGM, V150, P2443, DOI 10.1099/mic.0.27033-0; Abbas A, 2002, J BACTERIOL, V184, P3008, DOI 10.1128/JB.184.11.3008-3016.2002; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; Bottiglieri M, 2006, APPL ENVIRON MICROB, V72, P418, DOI 10.1128/AEM.72.1.418-427.2006; BROADBENT D, 1976, PHYTOCHEMISTRY, V15, P1785, DOI 10.1016/S0031-9422(00)97487-9; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Delany I, 2000, MICROBIOL-UK, V146, P537, DOI 10.1099/00221287-146-2-537; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grogan G, 2005, BIOCHEM J, V388, P721, DOI 10.1042/BJ20042038; Grogan G, 2002, J MOL CATAL B-ENZYM, V19, P73, DOI 10.1016/S1381-1177(02)00153-4; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Hermann JC, 2006, ORG BIOMOL CHEM, V4, P206, DOI 10.1039/b512969a; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; KEEL C, 1990, SYMBIOSIS, V9, P327; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liu SP, 2008, P NATL ACAD SCI USA, V105, P13309, DOI 10.1073/pnas.0708850105; Makinen M W, 1984, Adv Inorg Biochem, V6, P1; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Schleberger C, 2007, J MOL BIOL, V367, P409, DOI 10.1016/j.jmb.2006.12.068; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schoefer L, 2004, APPL ENVIRON MICROB, V70, P6131, DOI 10.1128/AEM.70.10.6131-6137.2004; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822	46	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4603	4611		10.1074/jbc.M109.044180	http://dx.doi.org/10.1074/jbc.M109.044180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018877	hybrid, Green Published			2022-12-27	WOS:000275274800038
J	Zhao, ML; Zhang, NY; Zurawel, A; Hansen, KC; Liu, CW				Zhao, Minglian; Zhang, Nan-Yan; Zurawel, Ashley; Hansen, Kirk C.; Liu, Chang-Wei			Degradation of Some Polyubiquitinated Proteins Requires an Intrinsic Proteasomal Binding Element in the Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; REGULATORY PARTICLE; TRANSCRIPTION FACTOR; 20S PROTEASOME; ATP BINDING; RECOGNITION; DEUBIQUITINATION; TRANSLOCATION; ASSOCIATION; MECHANISM	Lysine 48-linked polyubiquitin chains usually target proteins for 26 S proteasomal degradation; however, this modification is not a warrant for destruction. Here, we found that efficient degradation of a physiological substrate UbcH10 requires not only an exogenous polyubiquitin chain modification but also its unstructured N-terminal region. Interestingly, the unstructured N-terminal region of UbcH10 directly binds the 19 S regulatory complex of the 26 S proteasome, and it mediates the initiation of substrate translocation. To promote ubiquitin-dependent degradation of the folded domains of UbcH10, its N-terminal region can be displaced by exogenous proteasomal binding elements. Moreover, the unstructured N-terminal region can initiate substrate translocation even when UbcH10 is artificially cyclized without a free terminus. Polyubiquitinated circular UbcH10 is completely degraded by the 26 S proteasome. Accordingly, we propose that degradation of some polyubiquitinated proteins requires two binding interactions: a polyubiquitin chain and an intrinsic proteasomal binding element in the substrates (likely an unstructured region); moreover, the intrinsic proteasomal binding element initiates substrate translocation regardless of its location in the substrates.	[Zhao, Minglian; Zhang, Nan-Yan; Liu, Chang-Wei] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Zurawel, Ashley; Hansen, Kirk C.] Univ Colorado, Denver Sch Med, Prote Core Facil, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, CW (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, POB 6511,Mail Stop 8101,12801 E 17th Ave, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu			American Heart Association; Basil O'Conner Starter Scholar Research Award; American Cancer Society	American Heart Association(American Heart Association); Basil O'Conner Starter Scholar Research Award(March of Dimes); American Cancer Society(American Cancer Society)	This work was supported by grants from the American Heart Association, the Basil O'Conner Starter Scholar Research Award, and the American Cancer Society (to C.-W.L.).	Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoskins JR, 2002, ADV PROTEIN CHEM, V59, P413; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kwok SC, 2003, J BIOL CHEM, V278, P35248, DOI 10.1074/jbc.M305306200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	43	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4771	4780		10.1074/jbc.M109.060095	http://dx.doi.org/10.1074/jbc.M109.060095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007692	Green Published, hybrid			2022-12-27	WOS:000275274800055
J	Han, JX; Clement, JM; Li, J; King, A; Ng, S; Jaworski, JG				Han, Jixiang; Clement, Joel M.; Li, Jia; King, Andrew; Ng, Shirley; Jaworski, Jan G.			The Cytochrome P450 CYP86A22 Is a Fatty Acyl-CoA omega-Hydroxylase Essential for Estolide Synthesis in the Stigma of Petunia hybrida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; ARABIDOPSIS-THALIANA; NICOTIANA-TABACUM; HIGHER-PLANTS; ACID; LIPIDS; GENE; EXPRESSION; POLLEN; P450	The stigmatic estolide is a lipid-based polyester constituting the major component of exudate in solanaceous plants. Although the exudate is believed to play important roles in the pollination process, the biosynthetic pathway of stigmatic estolide, including genes encoding the key enzymes, remains unknown. Here we report the cloning and characterization of the cytochrome P450 gene CYP86A22, which encodes a fatty acyl-CoA omega-hydroxylase involved in estolide biosynthesis in the stigma of Petunia hybrida. A CYP86A22 cDNA was isolated from a developing stigma cDNA library, and the corresponding gene was shown to express predominantly in the developing stigma. Among six P450 genes isolated from this library, only CYP86A22 was implicated in omega-hydroxylation following RNA interference (RNAi)-mediated suppression. Unlike wild-type plants in which omega-hydroxy fatty acids (mainly in the form of 18-hydroxy oleic acid and 18-hydroxy linoleic acid) compose 96% of total stigma fatty acids, the omega-hydroxy fatty acids were essentially absent in the stigmas from 18 of 46 CYP86A22-RNAi transgenic plants and had varying levels of suppression in the remaining 28 plants. Furthermore, lipids in the 18 CYP86A22-RNAi stigmas were predominantly triacylglycerols and diacylglycerols instead of the estolides, which characterize the wild-type stigma. Analyses of recombinant CYP86A22 conclusively demonstrated that this P450 is a omega-hydroxylase with a substrate preference for both saturated and unsaturated acyl-CoAs rather than free fatty acids. We conclude that the cytochrome P450 enzyme CYP86A22 is the key fatty acyl-CoA omega-hydroxylase essential for the production of omega-hydroxy fatty acids and the biosynthesis of triacylglycerol-/diacylglycerol-based estolide polyesters in the petunia stigma.	[Han, Jixiang; Clement, Joel M.; Li, Jia; King, Andrew; Ng, Shirley; Jaworski, Jan G.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Jaworski, JG (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	jjaworski@danforthcenter.org	King, Andrew/A-9887-2011; Jaworski, Jan/N-2255-2014	King, Andrew/0000-0002-2388-6081; Jaworski, Jan/0000-0003-3309-4915	National Science Foundation [DBI-0521250]	National Science Foundation(National Science Foundation (NSF))	This work was funded by Dow Chemical Co.(Midland, MI) and Dow AgroSciences LLC (Indianapolis, IN). The 4000 Q-TRAP system was supported by the National Science Foundation (Grant DBI-0521250).	Benveniste I, 1998, BIOCHEM BIOPH RES CO, V243, P688, DOI 10.1006/bbrc.1998.8156; BENVENISTE I, 1982, PLANT PHYSIOL, V70, P122, DOI 10.1104/pp.70.1.122; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Christie W. W., 2003, LIPID ANAL, P91; CRESTI M, 1986, AM J BOT, V73, P1713, DOI 10.2307/2444237; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; HlousekRadojcic A, 1995, PLANT J, V8, P803, DOI 10.1046/j.1365-313X.1995.8060803.x; Holcapek M, 2003, J CHROMATOGR A, V1010, P195, DOI 10.1016/S0021-9673(03)01030-6; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson EF, 1996, FASEB J, V10, P1241, DOI 10.1096/fasebj.10.11.8836037; KANDASAMY MK, 1987, ANN BOT-LONDON, V60, P427, DOI 10.1093/oxfordjournals.aob.a087464; King A, 2007, PLANTA, V226, P381, DOI 10.1007/s00425-007-0489-z; KOIWAI A, 1988, PHYTOCHEMISTRY, V27, P2827, DOI 10.1016/0031-9422(88)80671-X; KOLATTUKUDY PE, 1974, LIPIDS, V9, P682, DOI 10.1007/BF02532176; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; KONAR RN, 1966, PLANTA, V71, P372, DOI 10.1007/BF00396322; KONAR RN, 1966, PLANTA, V71, P356, DOI 10.1007/BF00396321; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Le Bouquin R, 2001, EUR J BIOCHEM, V268, P3083, DOI 10.1046/j.1432-1327.2001.02207.x; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; MACKENZIE CJ, 1990, AM J BOT, V77, P1111, DOI 10.2307/2444621; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; MARTIN FW, 1969, AM J BOT, V56, P1023, DOI 10.2307/2440924; MATSUZAKI T, 1983, AGR BIOL CHEM TOKYO, V47, P77, DOI 10.1080/00021369.1983.10865578; MATSUZAKI T, 1986, AGR BIOL CHEM TOKYO, V50, P1581, DOI 10.1080/00021369.1986.10867599; MATSUZAKI T, 1983, PLANT CELL PHYSIOL, V24, P207, DOI 10.1093/pcp/24.2.207; MIZUTANI M, 1998, PLANT PHYSIOL, V357, P367; NAWRATH C, 2002, BIOPOLYMERS CUTIN SU, P1; Okita RT, 2001, CURR DRUG METAB, V2, P265; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rupasinghe SG, 2007, PROTEINS, V68, P279, DOI 10.1002/prot.21335; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; SEGHEZZI W, 1991, GENE, V106, P51, DOI 10.1016/0378-1119(91)90565-S; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 1998, BIOCHEM J, V332, P583, DOI 10.1042/bj3320583; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Wolters-Arts M, 2002, PLANT CELL ENVIRON, V25, P513, DOI 10.1046/j.1365-3040.2002.00827.x; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Xiao FM, 2004, EMBO J, V23, P2903, DOI 10.1038/sj.emboj.7600290; Zimmer T, 1996, BIOCHEM BIOPH RES CO, V224, P784, DOI 10.1006/bbrc.1996.1100	45	22	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3986	3996		10.1074/jbc.M109.050765	http://dx.doi.org/10.1074/jbc.M109.050765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940120	Green Published, hybrid			2022-12-27	WOS:000275254000052
J	Heikkinen, PT; Nummela, M; Leivonen, SK; Westermarck, J; Hill, CS; Kahari, VM; Jaakkola, PM				Heikkinen, Pekka T.; Nummela, Marika; Leivonen, Suvi-Katri; Westermarck, Jukka; Hill, Caroline S.; Kahari, Veli-Matti; Jaakkola, Panu M.			Hypoxia-activated Smad3-specific Dephosphorylation by PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; FACTOR GENE-EXPRESSION; FACTOR-BETA PATHWAYS; TGF-BETA; SERINE/THREONINE PHOSPHATASES; PROLYL HYDROXYLATION; OKADAIC ACID; HIF-ALPHA; GROWTH; SMAD3	The transforming growth factor-beta (TGF-beta) maintains epithelial homeostasis and suppresses early tumor formation, but paradoxically at later stages of tumor progression, TGF-beta promotes malignancy. TGF-beta activates phosphorylation of Smad2 and -3 effectors. Smad2 and -3 are known to have different functions, but differential regulation of their phosphorylation has not been described. Here we show that upon hypoxia, the TGF-beta-induced phosphorylation of Smad3 was inhibited, although Smad2 remained phosphorylated. The inhibition of Smad3 phosphorylation was not due to TGF-beta receptor inactivation. We show that Smad3 was dephosphorylated by PP2A (protein phosphatase 2A) specifically under hypoxic conditions. The hypoxic Smad3 dephosphorylation required intact expression of the essential scaffold component PR65 of PP2A. PP2A physically interacted with Smad3 that occurred only in hypoxia. Accordingly, Smad3-associated PP2A activity was found under hypoxic conditions. Hypoxia attenuated the nuclear accumulation of TGF-beta-induced Smad3 but did not affect Smad2. Moreover, the influence of TGF-beta on a set of Smad3-activated genes was attenuated by hypoxia, and this was reversed by chemical PP2A inhibition. Our data demonstrate the existence of a Smad3-specific phosphatase and identify a novel role for PP2A. Moreover, our data implicate a novel mechanism by which hypoxia regulates growth factor responses.	[Jaakkola, Panu M.] Turku Univ, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Jaakkola, Panu M.] Abo Akad Univ, FI-20520 Turku, Finland; [Heikkinen, Pekka T.] Turku Univ, Sch Biol Sci, FI-20520 Turku, Finland; [Leivonen, Suvi-Katri; Kahari, Veli-Matti] Turku Univ, Med Res Labs, FI-20520 Turku, Finland; [Westermarck, Jukka] Tampere Univ, Inst Med Technol, FI-33014 Tampere, Finland; [Westermarck, Jukka] Tampere Univ, Univ Hosp, FI-33014 Tampere, Finland; [Hill, Caroline S.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Kahari, Veli-Matti] Univ Turku, Dept Dermatol, FI-20520 Turku, Finland; [Jaakkola, Panu M.] Turku Univ Hosp, Dept Radiotherapy & Oncol, FI-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Cancer Research UK; University of Turku; University of Turku	Jaakkola, PM (corresponding author), Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	panjaa@utu.fi	Westermarck, Jukka/AAL-6464-2020; Leivonen, Suvi-Katri/AAK-3096-2021; Kähäri, Veli-Matti/E-5144-2011; Jaakkola, Panu M/B-4355-2012; Kahari, Veli-Matti/T-4925-2019	Westermarck, Jukka/0000-0001-7478-3018; Kähäri, Veli-Matti/0000-0003-2421-9368; Kahari, Veli-Matti/0000-0003-2421-9368; Hill, Caroline/0000-0002-8632-0480; Heikkinen, Marika/0000-0002-3287-4437; Leivonen, Suvi-Katri/0000-0003-3224-0757; Jaakkola, Panu/0000-0002-2365-4985	Academy of Finland [200779, 210282, 8212695]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Finnish Cancer Research Foundation; Turku University [13336, 13031]; Cancer Foundation Finland sr [100104] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Finnish Cancer Research Foundation; Turku University; Cancer Foundation Finland sr	The work was supported by Academy of Finland Grants 200779, 210282, and 8212695, the Sigrid Juselius Foundation, the Emil Aaltonen Foundation, the Finnish Cancer Research Foundation, and Turku University Hospital Grants EVO 13336 and 13031.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Fernandez JJ, 2002, CURR MED CHEM, V9, P229, DOI 10.2174/0929867023371247; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; KOKABU S, 2010, J BONE MINE IN PRESS; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Leivonen SK, 2002, J BIOL CHEM, V277, P46338, DOI 10.1074/jbc.M206535200; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Li JJ, 2008, NEUROSCIENCE, V156, P662, DOI 10.1016/j.neuroscience.2008.07.061; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Moustakas A, 2001, J CELL SCI, V114, P4359; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Scheid A, 2002, FASEB J, V16, P411, DOI 10.1096/fj.01-0496fje; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wykoff CC, 2000, CANCER RES, V60, P7075; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	48	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3740	3749		10.1074/jbc.M109.042978	http://dx.doi.org/10.1074/jbc.M109.042978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951945	Green Published, hybrid			2022-12-27	WOS:000275254000026
J	Brailoiu, E; Hooper, R; Cai, XJ; Brailoiu, GC; Keebler, MV; Dun, NJ; Marchant, JS; Patel, S				Brailoiu, Eugen; Hooper, Robert; Cai, Xinjiang; Brailoiu, G. Cristina; Keebler, Michael V.; Dun, Nae J.; Marchant, Jonathan S.; Patel, Sandip			An Ancestral Deuterostome Family of Two-pore Channels Mediates Nicotinic Acid Adenine Dinucleotide Phosphate-dependent Calcium Release from Acidic Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; MOBILIZES CALCIUM; CA2+ RELEASE; NAADP; RECEPTORS; MESSENGERS; STORES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent and widespread calcium-mobilizing messenger, the properties of which have been most extensively described in sea urchin eggs. The molecular basis for calcium release by NAADP, however, is not clear and subject to controversy. Recent studies have provided evidence that members of the two-pore channel (TPC) family in mammals are the long sought after target channels for NAADP. Here, we show that the TPC3 gene, which has yet to be functionally characterized, is present throughout the deuterostome lineage but is a pseudogene in humans and other primates. We report the molecular cloning of the complete ancestral TPC gene family from the sea urchin and demonstrate that all three isoforms localize to acidic organelles to mediate NAADP-dependent calcium release. Our data highlight the functional divergence of this novel gene family during deuterostome evolution and provide further evidence that NAADP mediates calcium release from acidic stores through activation of TPCs.	[Hooper, Robert; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Brailoiu, Eugen; Brailoiu, G. Cristina; Dun, Nae J.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Cai, Xinjiang] Duke Univ, Div Cardiol, Dept Med, Med Ctr, Durham, NC 27710 USA; [Keebler, Michael V.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Duke University; University of Minnesota System; University of Minnesota Twin Cities	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Marchant, Jonathan/Q-5484-2019; MARCHANT, Jonathan/B-8051-2009; Cai, Xinjiang/F-4843-2010; Patel, Sandip/O-9591-2015	Marchant, Jonathan/0000-0001-6592-0877; MARCHANT, Jonathan/0000-0001-6592-0877; Cai, Xinjiang/0000-0001-8933-7133; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [GM088790, HL 090804, HL 090804-01A2S109]; Biotechnology and Biological Sciences Research Council [BB/D018110/1, BB/G013721/1]; American Heart Association Fellowship Award [0625403U]; BBSRC [BB/D018110/1, BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); American Heart Association Fellowship Award(American Heart Association); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM088790 (to J. S. M.), HL 090804 (to E. B.), and HL 090804-01A2S109 (to E. B.). This work was also supported by Biotechnology and Biological Sciences Research Council Grants BB/D018110/1 and BB/G013721/1 (to S. P.) and American Heart Association Fellowship Award 0625403U (to X. C.).	Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chini EN, 1996, BIOCHEM J, V316, P709, DOI 10.1042/bj3160709; Churamani D, 2006, BIOCHEM J, V397, P313, DOI 10.1042/BJ20060179; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; ZHANG F, 2008, J CELL MOL IN PRESS; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	22	96	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2897	10.1074/jbc.C109.081943	http://dx.doi.org/10.1074/jbc.C109.081943			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940116	hybrid, Green Published			2022-12-27	WOS:000273829000003
J	Lee, J; Kim, KY; Lee, J; Paik, YK				Lee, Jeeyong; Kim, Kwang-Youl; Lee, Jihyun; Paik, Young-Ki			Regulation of Dauer Formation by O-GlcNAcylation in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR; INSULIN-RESISTANCE; PHOSPHORYLATION DYNAMICS; GLYCOSYLATION; METABOLISM; ACTIVATION; EXPRESSION; LONGEVITY; GLCNACASE; PROTEINS	Modification of proteins at serine or threonine residues with N-acetylglucosamine, termed O-GlcNAcylation, plays an important role in most eukaryotic cells. To understand the molecular mechanism by which O-GlcNAcylation regulates the entry of Caenorhabditis elegans into the non-aging dauer state, we performed proteomic studies using two mutant strains: the O-GlcNAc transferase-deficient ogt-1(ok430) strain and the O-GlcNAcase-defective oga-1(ok1207) strain. In the presence of the dauer pheromone daumone, ogt-1 showed suppression of dauer formation, whereas oga-1 exhibited enhancement of dauer formation. Consistent with these findings, treatment of wild-type N2 worms with low concentrations of daumone and the O-GlcNAcase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate (PUGNAc) enhanced dauer formation, which was dependent on intact O-GlcNAcylation metabolism. We also found that the treatment of daumone enhanced O-GlcNAcylation in vivo. Seven proteins, identified by coupled two-dimensional electrophoresis/liquid chromatography-mass spectroscopy (LC-MS) analysis, were differentially expressed in oga-1(ok1207) worms compared with wild-type N2 worms. The identities of these proteins suggest that O-GlcNAcylation influences stress resistance, protein folding, and mitochondrial function. Using O-GlcNAc labeling with fluorescent dye combined with two-dimensional electrophoresis/LC-MS analysis, we also identified five proteins that were differentially O-GlcNAcylated during dauer formation. Analysis of these candidate O-GlcNAcylated proteins suggests that O-GlcNAcylation may regulate cytoskeleton modifications and protein turnover during dauer formation.	[Paik, Young-Ki] Yonsei Univ, Coll Life Sci & Biotechnol, World Class Univ Program, Dept Biochem & Biomed Sci, Seoul 120749, South Korea; Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University	Paik, YK (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, World Class Univ Program, Dept Biochem & Biomed Sci, Rm 423,Ind Univ Res Bldg,134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		kim, kwangyoul/0000-0001-8667-3369	Korea Forest Service [S110707L0501501]; Ministry of Education, Science and Technology [R31-2008-000-10086-0]; Ministry of Health and Welfare of the Republic of Korea [A030003]	Korea Forest Service(Korea Forest Service); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Forest Science and Technology Project Grant S110707L0501501 (to Y.-K. P.) from the Korea Forest Service; the World Class University (WCU) Program from the National Research Foundation of Korea, funded by Grant R31-2008-000-10086-0 from the Ministry of Education, Science and Technology; and Grant A030003 from the Korea Health 21 R&D Project, Ministry of Health and Welfare of the Republic of Korea (to Y.-K. P.).	Antebi A, 1998, DEVELOPMENT, V125, P1191; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BRENNER S, 1974, GENETICS, V77, P71; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562; Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Cooper G. M., 2004, CELL MOL APPROACH, P436; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee HJ, 2008, PROTEOMICS, V8, P3371, DOI 10.1002/pmic.200800111; Lee HJ, 2008, PROTEOMICS, V8, P2168, DOI 10.1002/pmic.200701022; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MILLER DJ, 1993, DEVELOPMENT, V118, P1279; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, C ELEGANS, P739; SCHMIDT RE, 1981, DIABETES, V30, P416, DOI 10.2337/diabetes.30.5.416; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wolf M, 2008, J CELL PHYSIOL, V214, P721, DOI 10.1002/jcp.21269	41	27	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2930	10.1074/jbc.M109.022665	http://dx.doi.org/10.1074/jbc.M109.022665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940149	Green Published, hybrid			2022-12-27	WOS:000273829000007
J	Christgen, M; Geffers, R; Ballmaier, M; Christgen, H; Poczkaj, J; Krech, T; Kreipe, H; Lehmann, U				Christgen, Matthias; Geffers, Robert; Ballmaier, Matthias; Christgen, Henriette; Poczkaj, Janette; Krech, Till; Kreipe, Hans; Lehmann, Ulrich			Down-regulation of the Fetal Stem Cell Factor SOX17 by H33342 A MECHANISM RESPONSIBLE FOR DIFFERENTIAL GENE EXPRESSION IN BREAST CANCER SIDE POPULATION CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POPULATION CELLS; STEM/PROGENITOR CELLS; CARCINOMA; IDENTIFICATION; JAG1; PHENOTYPE; SURVIVAL; PATHWAY; EFFLUX; LINES	Human solid tumors contain rare cancer side population (SP) cells, which expel the fluorescent dye Hoechst 33342 (H33342) and display cancer stem cell characteristics. Transcriptional profiling of cancer SP cells isolated by H33342 fluorescence analysis is a newly emerging approach to discover cancer stem cell markers and aberrant differentiation pathways. Using Affymetrix expression microarrays and quantitative reverse transcription-PCR, we investigated differential gene expression between SP and non-SP (NSP) cells isolated from human mammary carcinoma cell lines. A total of 136 genes were up-regulated in breast cancer SP relative to NSP cells, one of which was the fetal stem cell factor and Wnt/beta-catenin signaling pathway target SOX17. Strikingly, we discovered that SOX17 was down-regulated by H33342 in a dose-dependent manner. In SP cells, which expel H33342, down-regulation of SOX17 was less pronounced than in NSP cells, which retain H33342. As a result of this, SOX17 displayed a 10-20-fold overexpression in cancer SP relative to NSP cells. Similar results were obtained for further stemness-related genes, namely EPC1 and SPRY1. These findings establish a previously unidentified gene-regulatory impact of H33342 as a novel mechanism responsible for differential gene expression in cancer SP cells. This has significant implications for the future interpretation of cancer SP cells.	[Christgen, Matthias; Christgen, Henriette; Poczkaj, Janette; Krech, Till; Kreipe, Hans; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany; [Ballmaier, Matthias] Hannover Med Sch, Cell Sorting Core Facil, D-30625 Hannover, Germany; [Geffers, Robert] Helmholtz Ctr, Dept Cell Biol, D-38124 Braunschweig, Germany	Hannover Medical School; Hannover Medical School	Christgen, M (corresponding author), Hannover Med Sch, Inst Pathol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	christgen.matthias@MH-Hannover.de	Ballmaier, Matthias/J-4175-2014	Ballmaier, Matthias/0000-0002-1352-5995				Behbod F, 2006, STEM CELLS, V24, P1065, DOI 10.1634/stemcells.2005-0375; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; CAMARGO FD, 2004, HDB STEM CELLS, P329; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Decraene C, 2005, PHYSIOL GENOMICS, V23, P132, DOI 10.1152/physiolgenomics.00141.2004; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Du YC, 2009, GASTROENTEROLOGY, V137, P1346, DOI 10.1053/j.gastro.2009.06.041; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; FRIED J, 1982, CYTOMETRY, V3, P42, DOI 10.1002/cyto.990030110; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Liang SX, 2005, PHYSIOL GENOMICS, V23, P172, DOI 10.1152/physiolgenomics.00059.2005; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Simon R, 2004, DESIGN ANAL DNA MICR; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	41	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6412	6418		10.1074/jbc.M109.082941	http://dx.doi.org/10.1074/jbc.M109.082941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040597	Green Published, hybrid			2022-12-27	WOS:000275367500045
J	Geoghegan, JA; Ganesh, VK; Smeds, E; Liang, XW; Hook, M; Foster, TJ				Geoghegan, Joan A.; Ganesh, Vannakambadi K.; Smeds, Emanuel; Liang, Xiaowen; Hook, Magnus; Foster, Timothy J.			Molecular Characterization of the Interaction of Staphylococcal Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) ClfA and Fbl with Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR-A; BINDING MSCRAMM; LIGAND-BINDING; EXPERIMENTAL ENDOCARDITIS; AUREUS; PROTEIN; LUGDUNENSIS; IDENTIFICATION; IMMUNOGLOBULIN; PATHOGENESIS	The ligand-binding domain of Fbl (the fibrinogen binding protein from Staphylococcus lugdunensis) shares 60% sequence identity with ClfA (clumping factor A) of Staphylococcus aureus. Recombinant Fbl corresponding to the minimum fibrinogenbinding region (subdomains N2N3) was compared with ClfA for binding to fibrinogen. Fbl and ClfA had very similar affinities for fibrinogen by surface plasmon resonance. The binding site for Fbl in fibrinogen was localized to the extreme C terminus of the fibrinogen gamma-chain at the same site recognized by ClfA. Isothermal titration calorimetry showed that Fbl and ClfA had very similar affinities for a peptide mimicking the C-terminal segment of the fibrinogen gamma-chain. The peptide also inhibited binding of Fbl and ClfA to fibrinogen. Aseries of substituted gamma-chain variant peptides behaved very similarly when used to inhibit ClfA and Fbl binding to immobilized fibrinogen. Both ClfA and Fbl bound to bovine fibrinogen with a lower affinity compared with human fibrinogen and did not bind detectably to ovine fibrinogen. The structure of the N2N3 subdomains of Fbl in complex with the fibrinogen gamma-chain peptide was modeled based on the crystal structure of the N2N3 subdomains of the ClfA-gamma-chain peptide complex. Residues in the putative binding trench likely to be involved in fibrinogen binding were identified. Fbl variant proteins with alanine substitutions in key residues had reduced affinities for fibrinogen. Thus Fbl and ClfA bind the same site in fibrinogen by similar mechanisms.	[Geoghegan, Joan A.; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland; [Ganesh, Vannakambadi K.; Smeds, Emanuel; Liang, Xiaowen; Hook, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA	Trinity College Dublin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Foster, TJ (corresponding author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland.	tfoster@tcd.ie		Liang, Xiaowen/0000-0002-6174-2951; Geoghegan, Joan/0000-0002-3788-0668	National Institutes of Health [AI20624]; Health Research Board of Ireland project; Science Foundation Ireland Programme Investigator; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R56AI020624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Board of Ireland project; Science Foundation Ireland Programme Investigator(Science Foundation Ireland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI20624 (to M.H.). This work was also supported by a Health Research Board of Ireland project grant and a Science Foundation Ireland Programme Investigator grant (to T.J F.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; CARSON MJ, 1997, J MOL GRAPHICS, V5, P103; Deivanayagam CCS, 1999, ACTA CRYSTALLOGR D, V55, P554, DOI 10.1107/S0907444998012426; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Mitchell J, 2004, MICROBIOL-SGM, V150, P3831, DOI 10.1099/mic.0.27337-0; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Nilsson M, 2004, FEMS MICROBIOL LETT, V241, P87, DOI 10.1016/j.femsle.2004.10.008; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863	26	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6208	6216		10.1074/jbc.M109.062208	http://dx.doi.org/10.1074/jbc.M109.062208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20007717	Green Published, hybrid			2022-12-27	WOS:000275367500025
J	Gout, E; Garlatti, V; Smith, DF; Lacroix, M; Dumestre-Perard, C; Lunardi, T; Martin, L; Cesbron, JY; Arlaud, GJ; Gaboriaud, C; Thielens, NM				Gout, Evelyne; Garlatti, Virginie; Smith, David F.; Lacroix, Monique; Dumestre-Perard, Chantal; Lunardi, Thomas; Martin, Lydie; Cesbron, Jean-Yves; Arlaud, Gerard J.; Gaboriaud, Christine; Thielens, Nicole M.			Carbohydrate Recognition Properties of Human Ficolins GLYCAN ARRAY SCREENING REVEALS THE SIALIC ACID BINDING SPECIFICITY OF M-FICOLIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE COMPLEXES; N-ACETYLNEURAMINIC ACID; CRYSTAL-STRUCTURE; INNATE IMMUNITY; HAKATA ANTIGEN; LECTIN PATHWAY; CELL-SURFACE; H-FICOLIN; PATTERN; IDENTIFICATION	Ficolins are oligomeric innate immune recognition proteins consisting of a collagen-like region and a fibrinogen-like recognition domain that bind to pathogen- and apoptotic cell-associated molecular patterns. To investigate their carbohydrate binding specificities, serum-derived L-ficolin and recombinant H- and M-ficolins were fluorescently labeled, and their carbohydrate binding ability was analyzed by glycan array screening. L-ficolin preferentially recognized disulfated N-acetyllactosamine and tri- and tetrasaccharides containing terminal galactose or N-acetylglucosamine. Binding was sensitive to the position and orientation of the bond between N-acetyllactosamine and the adjacent carbohydrate. No significant binding of H- ficolin to any of the 377 glycans probed could be detected, providing further evidence for its poor lectin activity. M-ficolin bound preferentially to 9-O-acetylated 2-6-linked sialic acid derivatives and to various glycans containing sialic acid engaged in a 2-3 linkage. To further investigate the structural basis of sialic acid recognition by M-ficolin, point mutants were produced in which three residues of the fibrinogen domain were replaced by their counterparts in L-ficolin. Mutations G221F and A256V inhibited binding to the 9-O-acetylated sialic acid derivatives, whereas Y271F abolished interaction with all sialic acid-containing glycans. The crystal structure of the Y271F mutant fibrinogen domain was solved, showing that the mutation does not alter the structure of the ligand binding pocket. These analyses reveal novel ficolin ligands such as sulfated N-acetyllactosamine (L-ficolin) and gangliosides (M-ficolin) and provide precise insights into the sialic acid binding specificity of M-ficolin, emphasizing the essential role of Tyr(271) in this respect.	[Gout, Evelyne; Lacroix, Monique; Lunardi, Thomas; Arlaud, Gerard J.; Thielens, Nicole M.] Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,CEA,Lab Enzymol, F-38027 Grenoble 1, France; [Garlatti, Virginie; Martin, Lydie; Gaboriaud, Christine] Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,CEA,Lab Cristal, F-38027 Grenoble 1, France; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dumestre-Perard, Chantal; Cesbron, Jean-Yves] Univ Grenoble 1, CNRS, UMR 5163, Lab Adaptat & Pathogenie Microorganismes, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Emory University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Thielens, NM (corresponding author), Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,CEA,Lab Enzymol, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	nicole.thielens@ibs.fr	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; gaboriaud, christine/0000-0001-5308-0516	Commissariat a l'Energie Atomique; CNRS; Universite Joseph Fourier; Grenoble; Agence Nationale de la Recherche [ANR-05-MIME-023-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; Grenoble(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commissariat a l'Energie Atomique, the CNRS, the Universite Joseph Fourier, Grenoble, and Agence Nationale de la Recherche Grant ANR-05-MIME-023-01.	Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; Aoyagi Y, 2008, INFECT IMMUN, V76, P179, DOI 10.1128/IAI.00837-07; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fraser DA, 2008, CURR DRUG TARGETS, V9, P113, DOI 10.2174/138945008783502476; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garlatti V, 2010, J INNATE IMMUN, V2, P17, DOI 10.1159/000233475; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Harumiya S, 1996, J BIOCHEM-TOKYO, V120, P745; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Honore C, 2008, MOL IMMUNOL, V45, P4134, DOI 10.1016/j.molimm.2008.08.117; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Krarup A, 2008, IMMUNOL LETT, V118, P152, DOI 10.1016/j.imlet.2008.03.014; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu JH, 1996, BIOCHEM J, V313, P473, DOI 10.1042/bj3130473; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohashi T, 2004, J BIOL CHEM, V279, P6534, DOI 10.1074/jbc.M310555200; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; Rodrigues ML, 1997, INFECT IMMUN, V65, P4937, DOI 10.1128/IAI.65.12.4937-4942.1997; SAHU A, 1993, MOL IMMUNOL, V30, P679, DOI 10.1016/0161-5890(93)90079-Q; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sinha D, 2000, TRENDS GLYCOSCI GLYC, V12, P17, DOI 10.4052/tigg.12.17; Soares RMA, 2000, BBA-GEN SUBJECTS, V1474, P262, DOI 10.1016/S0304-4165(00)00003-9; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2009, BIOCHEM J, V417, P485, DOI 10.1042/BJ20081640; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; WITTENBORN T, 2010, J INNATE IM IN PRESS; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06; Zacho RM, 2008, MOL IMMUNOL, V45, P4135, DOI 10.1016/j.molimm.2008.08.118	58	89	91	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6612	6622		10.1074/jbc.M109.065854	http://dx.doi.org/10.1074/jbc.M109.065854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032467	hybrid, Green Published			2022-12-27	WOS:000275367500066
J	Li, M; Aliotta, JM; Asara, JM; Wu, Q; Dooner, MS; Tucker, LD; Wells, A; Quesenberry, PJ; Ramratnam, B				Li, Ming; Aliotta, Jason M.; Asara, John M.; Wu, Qian; Dooner, Mark S.; Tucker, Lynne D.; Wells, Alan; Quesenberry, Peter J.; Ramratnam, Bharat			Intercellular Transfer of Proteins as Identified by Stable Isotope Labeling of Amino Acids in Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; EMBRYONIC STEM-CELLS; REPRESSES E-CADHERIN; GENE-EXPRESSION; TUMOR-CELLS; DEACETYLASE COMPLEX; PROTEOMIC APPROACH; BREAST-CANCER	We tracked the extracellular fate of proteins of pulmonary origin using the technique of stable isotope labeling of amino acids in cell culture (SILAC) in cell-impermeable Transwell culture systems. We find that irradiation to murine lung and lung-derived cells induces their release of proteins that are capable of entering neighboring cells, including primary murine bone marrow cells as well as prostate cancer and hematopoietic cell lines. The functional classification of transferred proteins was broad and included transcription factors, mediators of basic cellular processes and components of the nucleosome remodeling and deacetylase complex, including metastasis associated protein 3 and retinoblastoma-binding protein 7. In further analysis we find that retinoblastoma-binding protein 7 is a transcriptional activator of E-cadherin and that its intercellular transfer leads to decreased gene expression of downstream targets such as N-cadherin and vimentin. SILAC-generated data sets offer a valuable tool to identify and validate potential paracrine networks that may impact relevant biologic processes associated with phenotypic and genotypic signatures of health and disease.	[Ramratnam, Bharat] Brown Univ, Dept Med, Div Infect Dis, Lab Retrovirol,Warren Alpert Med Sch, Providence, RI 02903 USA; [Aliotta, Jason M.; Dooner, Mark S.; Quesenberry, Peter J.] Brown Univ, Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, Providence, RI 02903 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Wu, Qian; Wells, Alan] Pittsburgh Vet Adm Med Ctr, Dept Pathol, Pittsburgh, PA 15219 USA; [Wu, Qian; Wells, Alan] Univ Pittsburgh, Pittsburgh, PA 15219 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramratnam, B (corresponding author), Brown Univ, Dept Med, Div Infect Dis, Lab Retrovirol,Warren Alpert Med Sch, 55 Claverick St, Providence, RI 02903 USA.	BRamratnam@lifespan.org		Wells, Alan/0000-0002-1637-8150; Dooner, Mark/0000-0003-0653-6562	National Institutes of Health [P20RR025179]; Lifespan/Brown/Tufts Center for AIDS Research [P30AI042853]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103726, K08HL086868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Brown/Tufts Center for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR025179 and by Lifespan/Brown/Tufts Center for AIDS Research Grant P30AI042853 for assay support.	Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Gioia Magda, 2009, V539, P131, DOI 10.1007/978-1-60327-003-8_8; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajra KM, 2002, CANCER RES, V62, P1613; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; Ibarrola N, 2003, ANAL CHEM, V75, P6043, DOI 10.1021/ac034931f; JACOB L, 1987, P NATL ACAD SCI USA, V84, P1361, DOI 10.1073/pnas.84.5.1361; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Thakur A, 2007, MOL CANCER RES, V5, P171, DOI 10.1158/1541-7786.MCR-06-0071; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	49	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6285	6297		10.1074/jbc.M109.057943	http://dx.doi.org/10.1074/jbc.M109.057943			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026604	Green Published, hybrid			2022-12-27	WOS:000275367500033
J	Whelan, SA; Dias, WB; Thiruneelakantapillai, L; Lane, MD; Hart, GW				Whelan, Stephen A.; Dias, Wagner B.; Thiruneelakantapillai, Lakshmanan; Lane, M. Daniel; Hart, Gerald W.			Regulation of Insulin Receptor Substrate 1 (IRS-1)/AKT Kinase-mediated Insulin Signaling by O-Linked beta-N-Acetylglucosamine in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GLCNAC TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; PHOSPHATIDYLINOSITOL 3-KINASE; NUCLEOCYTOPLASMIC PROTEIN; DEPENDENT PHOSPHORYLATION; FULL ACTIVATION; TERMINAL DOMAIN; AKT ACTIVATION; OKADAIC ACID	Increased O-linked beta-N-acetylglucosamine (O-GlcNAc) is associated with insulin resistance in muscle and adipocytes. Upon insulin treatment of insulin-responsive adipocytes, O-GlcNAcylation of several proteins is increased. Key insulin signaling proteins, including IRS-1, IRS-2, and PDK1, are substrates for OGT, suggesting potential O-GlcNAc control points within the pathway. To elucidate the roles of O-GlcNAc in dampening insulin signaling (Vosseller, K., Wells, L., Lane, M. D., and Hart, G. W. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 5313-5318), we focused on the pathway upstream of AKT. Increasing O-GlcNAc in 3T3-L1 adipocytes decreases phosphoinositide 3-kinase (PI3K) interactions with both IRS-1 and IRS-2. Elevated O-GlcNAc also reduces phosphorylation of the PI3K p85 binding motifs (YXXM) of IRS-1 and results in a concomitant reduction in tyrosine phosphorylation of (YXXM)-X-608 in IRS-1, one of the two main PI3K p85 binding motifs. Additionally, insulin signaling stimulates the interaction of OGT with PDK1. We conclude that one of the steps at which O-GlcNAc contributes to insulin resistance is by inhibiting phosphorylation at the (YXXM)-X-608 PI3K p85 binding motif in IRS-1 and possibly at PDK1 as well.	[Whelan, Stephen A.; Dias, Wagner B.; Thiruneelakantapillai, Lakshmanan; Lane, M. Daniel; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Whelan, Stephen A/I-9502-2012; Dias, Wagner/B-1401-2016	Whelan, Stephen A/0000-0002-4740-0795; Dias, Wagner/0000-0002-8378-8846; Whelan, Stephen A/0000-0002-5439-6501; Hart, Gerald/0000-0001-7812-4351	National Institutes of Health (NIH) [DK61671, N01-HV-28180]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant DK61671 and NIH Contract N01-HV-28180. G. W. H. receives a share of royalty received by the university on sales of the CTD 110.6 antibody. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict of interest policies.	Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; LIMA FB, 1991, ENDOCRINOLOGY, V128, P2415, DOI 10.1210/endo-128-5-2415; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tao GZ, 2006, BIOCHEM BIOPH RES CO, V351, P708, DOI 10.1016/j.bbrc.2006.10.092; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	58	117	120	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5204	5211		10.1074/jbc.M109.077818	http://dx.doi.org/10.1074/jbc.M109.077818			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018868	hybrid, Green Published			2022-12-27	WOS:000275327200013
J	Chiu, FY; Chen, YR; Tu, SL				Chiu, Fang-Yi; Chen, Yu-Rong; Tu, Shih-Long			Electrostatic Interaction of Phytochromobilin Synthase and Ferredoxin for Biosynthesis of Phytochrome Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; GLUTAMATE SYNTHASE; 2FE-2S FERREDOXIN; NITRITE REDUCTASE; SULFITE REDUCTASE; OXIDOREDUCTASE; COMPLEX; ARABIDOPSIS; PHYCOCYANOBILIN; BINDING	In plants, phytochromobilin synthase (HY2) synthesize the open chain tetrapyrrole chromophore for light-sensing phytochromes. It catalyzes the double bond reduction of a heme-derived tetrapyrrole intermediate biliverdin IX alpha (BV) at the A-ring diene system. HY2 is a member of ferredoxin-dependent bilin reductases (FDBRs), which require ferredoxins (Fds) as the electron donors for double bond reductions. In this study, we investigated the interaction mechanism of FDBRs and Fds by using HY2 and Fd from Arabidopsis thaliana as model proteins. We found that one of the six Arabidopsis Fds, AtFd2, was the preferred electron donor for HY2. HY2 and AtFd2 formed a heterodimeric complex that was stabilized by chemical cross-linking. Surface-charged residues on HY2 and AtFd2 were important in the protein-protein interaction as well as BV reduction activity of HY2. These surface residues are close to the iron-sulfur center of Fd and the HY2 active site, implying that the interaction promotes direct electron transfer from the Fd to HY2-bound BV. In addition, the C12 propionate group of BV is important for HY2-catalyzed BV reduction. A possible role for this functional group is to mediate the electron transfer by interacting directly with AtFd2. Together, our biochemical data suggest a docking mechanism for HY2: BV and AtFd2.	[Chiu, Fang-Yi; Chen, Yu-Rong; Tu, Shih-Long] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tu, SL (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	tsl@gate.sinica.edu.tw	Tu, Shih-Long/ABF-5446-2021	Tu, Shih-Long/0000-0001-9436-278X	National Science Council [96-2311-B-001-019-MY2]; Academia Sinica of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taiwan(Academia Sinica - Taiwan)	This work was supported by Grant 96-2311-B-001-019-MY2 ( to S.-L. T.) from the National Science Council and the Summit Team Project from Academia Sinica of Taiwan.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; BEALE SI, 1991, J BIOL CHEM, V266, P22328; Binda C, 1998, ACTA CRYSTALLOGR D, V54, P1353, DOI 10.1107/S0907444998005137; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; Dose MM, 1997, PLANT PHYSIOL, V114, P1047, DOI 10.1104/pp.114.3.1047; ELICH TD, 1989, J BIOL CHEM, V264, P183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg N.F., 2003, PORPHYRIN HDB CHLORO; Garcia-Sanchez MI, 2000, J BIOL INORG CHEM, V5, P713, DOI 10.1007/s007750000160; GarciaSanchez MI, 1997, EUR J BIOCHEM, V250, P364, DOI 10.1111/j.1432-1033.1997.0364a.x; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hanke GT, 2005, PLANT CELL ENVIRON, V28, P1146, DOI 10.1111/j.1365-3040.2005.01352.x; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; HUISMAN JG, 1978, BIOCHEM BIOPH RES CO, V82, P1121, DOI 10.1016/0006-291X(78)90303-0; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P17680, DOI 10.1021/bi981718i; McDowell MT, 2001, PLANT PHYSIOL, V126, P1546, DOI 10.1104/pp.126.4.1546; Okada K, 2009, FEBS LETT, V583, P1251, DOI 10.1016/j.febslet.2009.03.052; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; SCHLUCHTER WM, 1994, CHARACTERIZATION PHO; Sevrioukova IF, 2005, J MOL BIOL, V347, P607, DOI 10.1016/j.jmb.2005.01.047; Tu SL, 2008, J BIOL CHEM, V283, P27555, DOI 10.1074/jbc.M803761200; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Yonekura-Sakakibara K, 2000, PLANT PHYSIOL, V122, P887, DOI 10.1104/pp.122.3.887; ZANETTI G, 1988, BIOCHEMISTRY-US, V27, P3753, DOI 10.1021/bi00410a035; ZANETTI G, 1984, J BIOL CHEM, V259, P6153	33	12	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5056	5065		10.1074/jbc.M109.075747	http://dx.doi.org/10.1074/jbc.M109.075747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996315	Green Published, hybrid			2022-12-27	WOS:000275274800081
J	Del Cid, N; Jeffery, E; Rizvi, SM; Stamper, E; Peters, LR; Brown, WC; Provoda, C; Raghavan, M				Del Cid, Natasha; Jeffery, Elise; Rizvi, Syed Monem; Stamper, Ericca; Peters, Larry Robert; Brown, William Clay; Provoda, Chester; Raghavan, Malini			Modes of Calreticulin Recruitment to the Major Histocompatibility Complex Class I Assembly Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; PEPTIDE-LOADING COMPLEX; CHAPERONE CALRETICULIN; MOLECULAR CHAPERONE; MUTATIONAL ANALYSIS; LISTERIOLYSIN-O; REDOX ACTIVITY; ERP57; TAPASIN; CALNEXIN	Major histocompatibility complex (MHC) class I molecules are ligands for T-cell receptors of CD8(+) T cells and inhibitory receptors of natural killer cells. Assembly of the heavy chain, light chain, and peptide components of MHC class I molecules occurs in the endoplasmic reticulum (ER). Specific assembly factors and generic ER chaperones, collectively called the MHC class I peptide loading complex (PLC), are required for MHC class I assembly. Calreticulin has an important role within the PLC and induces MHC class I cell surface expression, but the interactions and mechanisms involved are incompletely understood. We show that interactions with the thiol oxidoreductase ERp57 and substrate glycans are important for the recruitment of calreticulin into the PLC and for its functional activities in MHC class I assembly. The glycan and ERp57 binding sites of calreticulin contribute directly or indirectly to complexes between calreticulin and the MHC class I assembly factor tapasin and are important for maintaining steady-state levels of both tapasin and MHC class I heavy chains. A number of destabilizing conditions and mutations induce generic polypeptide binding sites on calreticulin and contribute to calreticulin-mediated suppression of misfolded protein aggregation in vitro. We show that generic polypeptide binding sites per se are insufficient for stable recruitment of calreticulin to PLC substrates in cells. However, such binding sites could contribute to substrate stabilization in a step that follows the glycan and ERp57-dependent recruitment of calreticulin to the PLC.	[Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Del Cid, Natasha; Peters, Larry Robert] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Brown, William Clay] Univ Michigan, Struct Biol Ctr, Ann Arbor, MI 48109 USA; [Provoda, Chester] Univ Michigan, Ctr Drug Targeting, Ann Arbor, MI 48109 USA; [Provoda, Chester] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu		Stamper, Ericca/0000-0003-2230-7911	University of Michigan Diabetes Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R01AI066131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	University of Michigan Diabetes Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Drs. Marek Michalak and Tim Elliott for providing calreticulin-deficient K42 cells and to Drs. Ted Hansen and Jon Yewdell for antibodies used in these studies. We thank James Delproposto of the University of Michigan high throughput protein laboratory for assistance with expression of recombinant truncated proteins, the University of Michigan DNA sequencing core for DNA sequence data, the University of Michigan Hybridoma Core for ascites production, the University of Michigan Microarray core for Sypro Orange binding analyses, and the University of Michigan Diabetes Research and Training Center for financial support. We thank Ramkumar Nandkumar and Kalpana Krishnaswamy (Metaome) for assistance with supplemental Fig. S1, and Ben Schwartz, Rachael Sturtevant, and Laura Weiser for assistance with the project.	Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Gopalakrishnapai J, 2006, BIOCHEM BIOPH RES CO, V351, P14, DOI 10.1016/j.bbrc.2006.09.164; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Harris MR, 1998, J IMMUNOL, V160, P5404; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Malawski GA, 2006, PROTEIN SCI, V15, P2718, DOI 10.1110/ps.062491906; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Silvennoinen L, 2004, J BIOL CHEM, V279, P13607, DOI 10.1074/jbc.M313054200; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Thammavongsa V, 2009, IMMUNOGENETICS, V61, P703, DOI 10.1007/s00251-009-0399-2; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VANPARIJS L, 2009, IMMUNITY, V30, P611; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	40	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4520	4535		10.1074/jbc.M109.085407	http://dx.doi.org/10.1074/jbc.M109.085407			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959473	Green Published, hybrid			2022-12-27	WOS:000275274800029
J	Kemp, MG; Mason, AC; Carreira, A; Reardon, JT; Haring, SJ; Borgstahl, GEO; Kowalczykowski, SC; Sancar, A; Wold, MS				Kemp, Michael G.; Mason, Aaron C.; Carreira, Aura; Reardon, Joyce T.; Haring, Stuart J.; Borgstahl, Gloria E. O.; Kowalczykowski, Stephen C.; Sancar, Aziz; Wold, Marc S.			An Alternative Form of Replication Protein A Expressed in Normal Human Tissues Supports DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; BINDING-PROTEIN; PHYSICAL INTERACTION; COMPLEX-FORMATION; DAMAGED DNA; RPA; RAD51; XPA; RECOGNITION	Replication protein A (RPA) is a heterotrimeric protein complex required for a large number of DNA metabolic processes, including DNA replication and repair. An alternative form of RPA (aRPA) has been described in which the RPA2 subunit (the 32-kDa subunit of RPA and product of the RPA2 gene) of canonical RPA is replaced by a homologous subunit, RPA4. The normal function of aRPA is not known; however, previous studies have shown that it does not support DNA replication in vitro or S-phase progression in vivo. In this work, we show that the RPA4 gene is expressed in normal human tissues and that its expression is decreased in cancerous tissues. To determine whether aRPA plays a role in cellular physiology, we investigated its role in DNA repair. aRPA interacted with both Rad52 and Rad51 and stimulated Rad51 strand exchange. We also showed that, by using a reconstituted reaction, aRPA can support the dual incision/excision reaction of nucleotide excision repair. aRPA is less efficient in nucleotide excision repair than canonical RPA, showing reduced interactions with the repair factor XPA and no stimulation of XPF-ERCC1 endonuclease activity. In contrast, aRPA exhibits higher affinity for damaged DNA than canonical RPA, which may explain its ability to substitute for RPA in the excision step of nucleotide excision repair. Our findings provide the first direct evidence for the function of aRPA in human DNA metabolism and support a model for aRPA functioning in chromosome maintenance functions in nonproliferating cells.	[Mason, Aaron C.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Kemp, Michael G.; Reardon, Joyce T.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Kemp, Michael G.; Sancar, Aziz] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Haring, Stuart J.] N Dakota State Univ, Dept Chem & Mol Biol, Fargo, ND 58105 USA; [Borgstahl, Gloria E. O.] Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA	University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Davis; University of California System; University of California Davis; North Dakota State University Fargo; University of Nebraska System; University of Nebraska Medical Center	Wold, MS (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Haring, Stuart/E-7481-2012; Borgstahl, Gloria/AAZ-4114-2020; Wold, Marc/F-5806-2010; Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745; Wold, Marc/0000-0002-4580-1624; Carreira, Aura/0000-0001-5489-4343	National Institutes of Health Research [GM32833, GM62653, GM44721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM032833, R01GM062653, R01GM044721] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants GM32833 (to A. S.), GM62653 (to S. C. K.), and GM44721 (to M. S. W.).	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; LI L, 1995, MOL CELL BIOL, V15, P5396; Mason AC, 2009, J BIOL CHEM, V284, P5324, DOI 10.1074/jbc.M808963200; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Stigger E, 1998, J BIOL CHEM, V273, P9337, DOI 10.1074/jbc.273.15.9337; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tomkiel JE, 2002, CLIN CANCER RES, V8, P752; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wang M, 2000, BIOCHEMISTRY-US, V39, P6433, DOI 10.1021/bi000472q; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	53	20	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4788	4797		10.1074/jbc.M109.079418	http://dx.doi.org/10.1074/jbc.M109.079418			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996105	Green Published, hybrid			2022-12-27	WOS:000275274800057
J	Wang, XS; Zhang, SJ; Zhang, JH; Huang, XJ; Xu, C; Wang, WW; Liu, ZJ; Wu, JH; Shi, Y				Wang, Xingsheng; Zhang, Shaojie; Zhang, Jiahai; Huang, Xiaojuan; Xu, Chao; Wang, Weiwei; Liu, Zhijun; Wu, Jihui; Shi, Yunyu			A Large Intrinsically Disordered Region in SKIP and Its Disorder-Order Transition Induced by PPIL1 Binding Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; D-MEDIATED TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CIRCULAR-DICHROISM; BACKBONE DYNAMICS; SPLICING FACTORS; GENE-EXPRESSION; CHEMICAL-SHIFTS; SPLICEOSOME; INTERACTS	Intrinsically disordered proteins or protein regions play an important role in fundamental biological processes. During spliceosome activation, a large structural rearrangement occurs. The Prp19 complex and related factors are involved in the catalytic activation of the spliceosome. Recent mass spectrometric analyses have shown that Ski interaction protein (SKIP) and peptidylprolyl isomerase-like protein 1 (PPIL1) are Prp19-related factors that constitute the spliceosome B, B*, and C complexes. Here, we report that a highly flexible region of SKIP (SKIPN, residues 59-129) is intrinsically disordered. Upon binding to PPIL1, SKIPN undergoes a disorder-order transition. A highly conserved fragment of SKIP (residues 59-79) called the PPIL1-binding fragment (PBF) was sufficient to bind PPIL1. The structure of PBF.PPIL1 complex, solved by NMR, shows that PBF exhibits an ordered structure and interacts with PPIL1 through electrostatic and hydrophobic interactions. Three subfragments in the PBF (residues 59-67, 68-73, and 74-79) show hook-like backbone structure, and interactions between these subfragments are necessary for PBF.PPIL1 complex formation. PPIL1 is a cyclophilin family protein. It is recruited by SKIP into the spliceosome by a region other than the peptidylprolyl isomerase active site. This enables the active site of PPIL1 to remain open in the complex and still function as a peptidylprolyl cis/trans-isomerase or molecular chaperon to facilitate the folding of other proteins in the spliceosomes. The large disordered region in SKIP provides an interaction platform. Its disorder-order transition, induced by PPIL1 binding, may adapt the requirement for a large structural rearrangement occurred in the activation of spliceosome.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Xu, Chao/G-3885-2010	Xu, Chao/0000-0003-0444-7080; Wang, Weiwei/0000-0002-0215-9467	Chinese National Fundamental Research [2006CB806507, 2006CB910201, 2002CB713806, 2006AA02A315]; Chinese National Natural Science Foundation [30121001, 30570361, 30830031]	Chinese National Fundamental Research; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Fundamental Research Project (Grants 2006CB806507, 2006CB910201, 2002CB713806, and 2006AA02A315) and the Chinese National Natural Science Foundation (Grants 30121001, 30570361, and 30830031).	AIYAR A, 1993, BIOTECHNIQUES, V14, P366; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Ambrozkova M, 2001, BIOCHEM BIOPH RES CO, V284, P1148, DOI 10.1006/bbrc.2001.5108; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bourquin JP, 1997, NUCLEIC ACIDS RES, V25, P2055, DOI 10.1093/nar/25.11.2055; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIEHL BE, 1991, GENETICS, V127, P287; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Jung JW, 2005, J BIOCHEM MOL BIOL, V38, P550; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; MacDonald PN, 2004, J STEROID BIOCHEM, V89-90, P179, DOI 10.1016/j.jsbmb.2004.03.097; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Mesa A, 2008, FEBS LETT, V582, P2345, DOI 10.1016/j.febslet.2008.06.006; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Nagai K, 2004, BIOCHEM BIOPH RES CO, V316, P512, DOI 10.1016/j.bbrc.2004.02.077; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Reidt U, 2003, J MOL BIOL, V331, P45, DOI 10.1016/S0022-2836(03)00684-3; Romero P, 1998, Pac Symp Biocomput, P437; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Skruzny M, 2001, BBA-GENE STRUCT EXPR, V1521, P146, DOI 10.1016/S0167-4781(01)00301-3; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200	53	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4951	4963		10.1074/jbc.M109.087528	http://dx.doi.org/10.1074/jbc.M109.087528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007319	Green Published, hybrid			2022-12-27	WOS:000275274800072
J	Guo, JP; Shu, SK; Esposito, NN; Coppola, D; Koomen, JM; Cheng, JQ				Guo, Jian-Ping; Shu, Shao-Kun; Esposito, Nicole N.; Coppola, Domenico; Koomen, John M.; Cheng, Jin Q.			IKK epsilon Phosphorylation of Estrogen Receptor alpha Ser-167 and Contribution to Tamoxifen Resistance in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 EXPRESSION; KAPPA-B ACTIVATION; CELL-PROLIFERATION; ENDOCRINE-THERAPY; GENE ACTIVATION; PROTEIN-KINASE; ALPHA; COMPLEX; TRANSCRIPTION; PATHWAY	IKK epsilon has recently been identified as a breast cancer oncogene. Elevated levels of IKK epsilon are associated with cell survival and growth. Here, we show that IKK epsilon interacts with and phosphorylates estrogen receptor alpha (ER alpha) on serine 167 in vitro and in vivo. As a result, IKK epsilon induces ER alpha transactivation activity and enhances ER alpha binding to DNA. Cyclin D1, a major target of ER alpha, is transcriptionally up-regulated by IKK epsilon in a phospho-ER alpha-Ser-167-dependent manner. Further, overexpression of IKK epsilon induces tamoxifen resistance, whereas knockdown of IKK epsilon sensitizes cells to tamoxifen-induced cell death. These data suggest that ER alpha is a bona fide substrate of IKK epsilon and IKK epsilon plays an important role in tamoxifen resistance. Thus, IKK epsilon represents a critical therapeutic target in breast cancer.	[Guo, Jian-Ping; Shu, Shao-Kun; Koomen, John M.; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Esposito, Nicole N.; Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Koomen, JM (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	john.koomen@moffitt.org; jin.cheng@moffitt.org	Koomen, John/D-1844-2013		National Institutes of Health [CA137041]; Department of Defense [W81XWH-08-2-0101]; Bankhead-Coley Grant [09BB-05]; US Army Medical Research and Materiel Command [DAMD17-02-20051]; National Cancer Institute [P30-CA076292]; Moffitt Foundation; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley Grant; US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant CA137041 from the National Institutes of Health. This work was also supported by the Department of Defense Grant W81XWH-08-2-0101 and Bankhead-Coley Grant 09BB-05 (to J.Q.C.).; We thank Bin Fang and Victoria Izumi for completing the analysis of in vitro phosphorylation of ER alpha by IKK epsilon. We are grateful for the Tissue Procurement, Proteomics, DNA Sequence, and Flow Cytometry Core Facilities at H. Lee Moffitt Cancer Center for providing cancer specimens, sequencing, and FACS analysis. The Moffitt Proteomics Facility is supported by the US Army Medical Research and Materiel Command under Award No. DAMD17-02-20051 for a National Functional Genomics Center, the National Cancer Institute under Award No. P30-CA076292 as a Cancer Center Support Grant, and the Moffitt Foundation.	ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; GIERTHY JF, 1991, J CELL BIOCHEM, V45, P177, DOI 10.1002/jcb.240450209; Guo JP, 2009, AM J PATHOL, V175, P324, DOI 10.2353/ajpath.2009.080767; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Keen JC, 2006, IMMUNOLOGY, V117, P29, DOI 10.1111/j.1365-2567.2005.02260.x; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Massarweh S, 2006, ENDOCR-RELAT CANCER, V13, pS15, DOI 10.1677/erc.1.01273; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pichon MF, 1996, BRIT J CANCER, V73, P1545, DOI 10.1038/bjc.1996.291; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sun M, 2001, CANCER RES, V61, P5985; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yamashita H, 2005, BREAST CANCER RES, V7, pR753, DOI 10.1186/bcr1285; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	36	48	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3676	3684		10.1074/jbc.M109.078212	http://dx.doi.org/10.1074/jbc.M109.078212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940156	Green Published, hybrid			2022-12-27	WOS:000275254000019
J	Choe, KS; Ujhelly, O; Wontakal, SN; Skoultchi, AI				Choe, Kevin S.; Ujhelly, Olga; Wontakal, Sandeep N.; Skoultchi, Arthur I.			PU.1 Directly Regulates cdk6 Gene Expression, Linking the Cell Proliferation and Differentiation Programs in Erythroid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; CYCLIN-DEPENDENT KINASES; TERMINAL DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; C-MYC; DEREGULATED EXPRESSION; C/EBP-ALPHA; GATA-1; MACROPHAGE; BINDING	Cell proliferation and differentiation are highly coordinated processes during normal development. Most leukemia cells are blocked from undergoing terminal differentiation and also exhibit uncontrolled proliferation. Dysregulated expression of transcription factor PU.1 is strongly associated with Friend virus-induced erythroleukemia. PU.1 inhibits erythroid differentiation by binding to and inhibiting GATA-1. PU.1 also may be involved in controlling proliferation of erythroid cells. We reported previously that the G(1) phase-specific cyclin-dependent kinase 6 (CDK6) also blocks erythroid differentiation. We now report that PU.1 directly stimulates transcription of the cdk6 gene in both normal erythroid progenitors and erythroleukemia cells, as well as in macrophages. We propose that PU.1 coordinates proliferation and differentiation in immature erythroid cells by inhibiting the GATA-1-mediated gene expression program and also by regulating expression of genes that control progression through the G(1) phase of the cell cycle, the period during which the decision to differentiate is made.	[Choe, Kevin S.; Ujhelly, Olga; Wontakal, Sandeep N.; Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Skoultchi, AI (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	arthur.skoultchi@einstein.yu.edu			National Institutes of Health [HL078381, 5T32GM07288]; National Cancer Institute Cancer Center [2P30CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant HL078381.; Supported by National Institutes of Health Medical Scientist Training Program Grant 5T32GM07288.; Supported by National Cancer Institute Cancer Center Grant 2P30CA13330.	Atar O, 2005, BIOCHEM BIOPH RES CO, V329, P1288, DOI 10.1016/j.bbrc.2005.02.109; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Carotta S, 2004, BLOOD, V104, P1873, DOI 10.1182/blood-2004-02-0570; CARROLL M, 1995, P NATL ACAD SCI USA, V92, P2869, DOI 10.1073/pnas.92.7.2869; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Choe KS, 2003, CANCER RES, V63, P6363; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dolznig H, 2004, METH MOLEC MED, V105, P323; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Fisher RC, 2004, LEUKEMIA RES, V28, P83, DOI 10.1016/S0145-2126(03)00178-4; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Matushansky I, 2000, BLOOD, V96, P2755, DOI 10.1182/blood.V96.8.2755.h8002755_2755_2764; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; Migliaccio AR, 2005, ANN NY ACAD SCI, V1044, P142, DOI 10.1196/annals.1349.019; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Papetti M, 2007, MOL CANCER RES, V5, P1053, DOI 10.1158/1541-7786.MCR-07-0145; Pesu M, 2003, EUR J IMMUNOL, V33, P1727, DOI 10.1002/eji.200323680; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Zeng WL, 2000, J CELL BIOCHEM, V78, P519, DOI 10.1002/1097-4644(20000915)78:4<519::AID-JCB1>3.0.CO;2-V; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	48	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3044	10.1074/jbc.M109.077727	http://dx.doi.org/10.1074/jbc.M109.077727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955566	Green Published, hybrid			2022-12-27	WOS:000273829000020
J	Yego, ECK; Mohr, S				Yego, E. Chepchumba K.; Mohr, Susanne			siah-1 Protein Is Necessary for High Glucose-induced Glyceraldehyde-3-phosphate Dehydrogenase Nuclear Accumulation and Cell Death in Muller Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GLIAL-CELLS; UBIQUITIN LIGASE; PROTEASOME PATHWAY; DIABETIC-RETINOPATHY; INDUCED APOPTOSIS; ELEVATED GLUCOSE; ALPHA-SYNUCLEIN; RAT RETINA; SINA GENE; DEGRADATION	The translocation and accumulation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the nucleus has closely been associated with cell death induction. However, the mechanism of this process has not been completely understood. The E3 ubiquitin ligase siah-1 (seven in absentia homolog 1) has recently been identified as a potential shuttle protein to transport GAPDH from the cytosol to the nucleus. Previously, we have demonstrated that elevated glucose levels induce GAPDH nuclear accumulation in retinal Muller cells. Therefore, this study investigated the role of siah-1 in high glucose-induced GAPDH nuclear translocation and subsequent cell death in retinal Muller cells. High glucose significantly increased siah-1 expression within 12 h. Under hyperglycemic conditions, siah-1 formed a complex with GAPDH and was predominantly localized in the nucleus of Muller cells. siah-1 knockdown using 50 nM siah-1 small interfering RNA significantly decreased high glucose-induced GAPDH nuclear accumulation at 24 h by 43.8 +/- 4.0%. Further, knockdown of siah-1 prevented high glucose-induced cell death of Muller cells potentially by inhibiting p53 phosphorylation consistent with previous observations, indicating that nuclear GAPDH induces cell death via p53 activation. Therefore, inhibition of GAPDH nuclear translocation and accumulation by targeting siah-1 promotes Muller cell survival under hyperglycemic conditions.	[Mohr, Susanne] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Yego, E. Chepchumba K.; Mohr, Susanne] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Michigan State University; Case Western Reserve University	Mohr, S (corresponding author), Michigan State Univ, Dept Physiol, 3175 Biomed Phys Sci, E Lansing, MI 48824 USA.	mohrs@msu.edu			National Institutes of Health [2T32EY007157, 1F31EY018075, EY-014380, EY-017206]; Visual Science Research Center Core [2P30EY011373]; American Diabetes Association [7-06-RA-95]; NATIONAL EYE INSTITUTE [F31EY018075, R01EY017206, R03EY014380, T32EY007157, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Visual Science Research Center Core; American Diabetes Association(American Diabetes Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Training Grants 2T32EY007157 and 1F31EY018075 (to E.Y.) and Research Grants: EY-014380 and EY-017206 (to S.M.). This work was also supported by Visual Science Research Center Core Grant 2P30EY011373 (to E.Y. and S. M.) and by American Diabetes Association Grant 7-06-RA-95 (to S.M.).	Adachi-Uehara N, 2006, EXP EYE RES, V83, P849, DOI 10.1016/j.exer.2006.04.012; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Cahuana GM, 2004, EXP CELL RES, V293, P22, DOI 10.1016/j.yexcr.2003.10.004; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Chuang DM, 1996, NAT MED, V2, P609, DOI 10.1038/nm0696-609; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Distler C, 1996, VISION RES, V36, P2381, DOI 10.1016/0042-6989(96)00005-3; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du ZX, 2007, ENDOCRINOLOGY, V148, P4352, DOI 10.1210/en.2006-1511; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Fukuba H, 2007, BIOCHEM BIOPH RES CO, V353, P324, DOI 10.1016/j.bbrc.2006.12.051; Germani A, 2003, ONCOGENE, V22, P8845, DOI 10.1038/sj.onc.1206994; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Groenman F, 2007, J HISTOCHEM CYTOCHEM, V55, P355, DOI 10.1369/jhc.6A7129.2006; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Kannan R, 1999, EXP EYE RES, V68, P609, DOI 10.1006/exer.1998.0639; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Kodama R, 2005, GENES CELLS, V10, P1211, DOI 10.1111/j.1365-2443.2005.00911.x; Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; MOHR S, 2000, ASS RES VIS OPHTH AN; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Podesta F, 2000, AM J PATHOL, V156, P1025, DOI 10.1016/S0002-9440(10)64970-X; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; PURO DG, 1991, J NEUROSCI, V11, P1873; REICHENBACH A, 1993, J CHEM NEUROANAT, V6, P201, DOI 10.1016/0891-0618(93)90042-3; Sarthy V P, 2000, Arch Soc Esp Oftalmol, V75, P367; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; Schutte M, 1998, NEUROSCI LETT, V246, P53, DOI 10.1016/S0304-3940(98)00229-8; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sugiyama T, 2004, INVEST OPHTH VIS SCI, V45, P1026, DOI 10.1167/iovs.03-1062; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Ward MM, 2005, DIABETOLOGIA, V48, P351, DOI 10.1007/s00125-004-1639-5; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Xi X, 2005, BIOCHEM BIOPH RES CO, V326, P548, DOI 10.1016/j.bbrc.2004.11.064; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082	65	43	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3181	3190		10.1074/jbc.M109.083907	http://dx.doi.org/10.1074/jbc.M109.083907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940145	Green Published, hybrid			2022-12-27	WOS:000273829000033
J	Mascanfroni, ID; Montesinos, MD; Alamino, VA; Susperreguy, S; Nicola, JP; Ilarregui, JM; Masini-Repiso, AM; Rabinovich, GA; Pellizas, CG				Mascanfroni, Ivan D.; del Mar Montesinos, Maria; Alamino, Vanina A.; Susperreguy, Sebastian; Nicola, Juan P.; Ilarregui, Juan M.; Masini-Repiso, Ana M.; Rabinovich, Gabriel A.; Pellizas, Claudia G.			Nuclear Factor (NF)-kappa B-dependent Thyroid Hormone Receptor beta(1) Expression Controls Dendritic Cell Function via Akt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NONGENOMIC ACTIONS; ACTIVATION; PROTEIN; KINASE; IMMUNOPRECIPITATION; PATHWAY; GENE; MECHANISMS; MATURATION	Despite considerable progress in our understanding of the interplay between immune and endocrine systems, the role of thyroid hormones and their receptors in the control of adaptive immunity is still uncertain. Here, we investigated the role of thyroid hormone receptor (TR) beta(1) signaling in modulating dendritic cell (DC) physiology and the intracellular mechanisms underlying these immunoregulatory effects. Exposure of DCs to triiodothyronine (T-3) resulted in a rapid and sustained increase in Akt phosphorylation independently of phosphatidylinositol 3-kinase activation, which was essential for supporting T-3-induced DC maturation and interleukin (IL)-12 production. This effect was dependent on intact TR beta(1) signaling as small interfering RNA-mediated silencing of TR beta(1) expression prevented T-3-induced DC maturation and IL-12 secretion as well as Akt activation and I kappa B-epsilon degradation. In turn, T-3 up-regulated TR beta(1) expression through mechanisms involving NF-kappa B, suggesting an autocrine regulatory loop to control hormone-dependent TR beta(1) signaling. These findings were confirmed by chromatin immunoprecipitation analysis, which disclosed a new functional NF-kappa B consensus site in the promoter region of the TRB1 gene. Thus, a T-3-induced NF-kappa B-dependent mechanism controls TR beta(1) expression, which in turn signals DCs to promote maturation and function via an Akt-dependent but PI3K-independent pathway. These results underscore a novel unrecognized target that regulates DC maturation and function with critical implications in immunopathology at the crossroads of the immune-endocrine circuits.	[Mascanfroni, Ivan D.; del Mar Montesinos, Maria; Alamino, Vanina A.; Susperreguy, Sebastian; Nicola, Juan P.; Masini-Repiso, Ana M.; Pellizas, Claudia G.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Consejo Nacl Invest Cient & Tecn,Ctr Invest Bioqu, RA-5000 Cordoba, Argentina; [Ilarregui, Juan M.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Pellizas, CG (corresponding author), Ciudad Univ, RA-5000 Cordoba, Argentina.	claudia@fcq.unc.edu.ar	Pellizas, Claudia Gabriela/U-5241-2019	Ilarregui, Juan Martin/0000-0002-6871-6764	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-5325]; Agencia Nacional de Promocion Ciencia y Tecnica [PICT 2005-33139, 2006-603]; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba; Cancer Research Institute; Fundacion Sales	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Ciencia y Tecnica(ANPCyT); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Cancer Research Institute; Fundacion Sales	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP-5325 (to C. G. P.), Agencia Nacional de Promocion Ciencia y Tecnica Grants PICT 2005-33139 (to A. M. M.) and 2006-603 (to G. A. R.), and grants from Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (to C. G. P.), Cancer Research Institute (to G. A. R.), and Fundacion Sales (to G. A. R.).	Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Davis PJ, 2008, STEROIDS, V73, P1013, DOI 10.1016/j.steroids.2007.12.030; Davis PJ, 2008, FRONT NEUROENDOCRIN, V29, P211, DOI 10.1016/j.yfrne.2007.09.003; Dhodapkar MV, 2008, CELL DEATH DIFFER, V15, P39, DOI 10.1038/sj.cdd.4402247; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; HODIN RA, 1990, J CLIN INVEST, V85, P101, DOI 10.1172/JCI114398; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; ISSEMANN I, 1991, J STEROID BIOCHEM, V40, P263, DOI 10.1016/0960-0760(91)90191-7; Kemenade LVV, 2007, GEN COMP ENDOCR, V152, P352, DOI 10.1016/j.ygcen.2007.05.025; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Klecha AJ, 2006, J ENDOCRINOL, V189, P45, DOI 10.1677/joe.1.06137; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Lam QLK, 2007, J BIOL CHEM, V282, P27587, DOI 10.1074/jbc.M704579200; Lei J, 2008, AM J PHYSIOL-LUNG C, V294, pL749, DOI 10.1152/ajplung.00335.2007; Mascanfroni I, 2008, FASEB J, V22, P1032, DOI 10.1096/fj.07-8652com; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Refetoff S, 2007, BEST PRACT RES CL EN, V21, P277, DOI 10.1016/j.beem.2007.03.005; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Storey NM, 2006, P NATL ACAD SCI USA, V103, P5197, DOI 10.1073/pnas.0600089103; Straw AD, 2003, J IMMUNOL, V170, P727, DOI 10.4049/jimmunol.170.2.727; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; WOOD WM, 1994, MOL ENDOCRINOL, V8, P1605, DOI 10.1210/me.8.12.1605; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang TY, 2007, J IMMUNOL, V178, P2517, DOI 10.4049/jimmunol.178.4.2517	43	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9569	9582		10.1074/jbc.M109.071241	http://dx.doi.org/10.1074/jbc.M109.071241			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20018842	Green Published, hybrid			2022-12-27	WOS:000276165900030
J	Coe, H; Jung, J; Groenendyk, J; Prins, D; Michalak, M				Coe, Helen; Jung, Joanna; Groenendyk, Jody; Prins, Daniel; Michalak, Marek			ERp57 Modulates STAT3 Signaling from the Lumen of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; GLUCOSE-REGULATED PROTEIN-58; CALCIUM-BINDING; SARCOPLASMIC-RETICULUM; GENE-EXPRESSION; QUALITY-CONTROL; CALRETICULIN; CHAPERONE; CELL; CALNEXIN	ERp57 is an endoplasmic reticulum (ER) resident thiol disulfide oxidoreductase. Using the gene trap technique, we created a ERp57-deficient mouse model. Targeted deletion of the Pdia3 gene, which encodes ERp57, in mice is embryonic lethal at embryonic day (E) 13.5. beta-Galactosidase reporter gene analysis revealed that ERp57 is expressed early on during blastocyst formation with the highest expression in the inner cell mass. In early stages of mouse embryonic development (E11.5) there is a relatively low level of expression of ERp57. As the embryos developed, ERp57 became highly expressed in both the brain and the lungs (E15.5 and E18.5). The absence of ERp57 has no impact on ER morphology; expression of ER-associated chaperones and folding enzymes, ER stress, or apoptosis. ERp57 has been reported to interact with STAT3 (signal transducer and activator of transcription)-DNA complexes. We show here that STAT3 dependent signaling is increased in the absence of ERp57 and this can be rescued by expression of ER-targeted ER p57 but not by cytoplasmic- targeted protein, indicating that ERp57 affects STAT3 signaling from the lumen of the ER. ERp57 effects on STAT3 signaling are enhanced by ER luminal complex formation between ERp57 and calreticulin. In conclusion, we show that ERp57 deficiency in mouse is embryonic lethal at E13.5 and ERp57-dependent modulation of STAT3 signaling may contribute to this phenotype.	[Coe, Helen; Michalak, Marek] Univ Alberta, Dept Pediat, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Michalak, M (corresponding author), Univ Alberta, Dept Pediat, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada.	marek.michalak@ualberta.ca			Canadian Institutes of Health Research [MOP-15291]; Heart and Stroke Foundation of Alberta; Alberta Heritage Foundation for Medical Research; Heart and Stroke Foundation of Canada Membrane Protein; Cardiovascular Disease Training Program; Alberta Heritage Foundation for Medical Research Summer Studentship; Canadian Institutes of Health Research Frederick Banting; Charles Best Canada Graduate Scholarship Master's Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Heart and Stroke Foundation of Canada Membrane Protein(Heart & Stroke Foundation of Canada); Cardiovascular Disease Training Program; Alberta Heritage Foundation for Medical Research Summer Studentship; Canadian Institutes of Health Research Frederick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship Master's Award	This work was supported in part by Canadian Institutes of Health Research Grant MOP-15291, the Heart and Stroke Foundation of Alberta, and the Alberta Heritage Foundation for Medical Research.; <SUP>1</SUP>Recipients of studentship awards from the Alberta Heritage Foundation for Medical Research.; <SUP>2</SUP>Supported by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada Membrane Protein and the Cardiovascular Disease Training Program.; <SUP>3</SUP>Supported by an Alberta Heritage Foundation for Medical Research Summer Studentship and the Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award.	ALTIERI F, 1993, BIOCHEM BIOPH RES CO, V194, P992, DOI 10.1006/bbrc.1993.1919; Alvarez C, 1999, EUR J CELL BIOL, V78, P1; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chung YH, 2004, J VIROL, V78, P6489, DOI 10.1128/JVI.78.12.6489-6497.2004; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Eufemi M, 2004, BIOCHEM BIOPH RES CO, V323, P1306, DOI 10.1016/j.bbrc.2004.09.009; Ferraro A, 1999, J CELL BIOCHEM, V72, P528, DOI 10.1002/(SICI)1097-4644(19990315)72:4<528::AID-JCB8>3.0.CO;2-V; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Ghassemifar MR, 2003, MOL HUM REPROD, V9, P245, DOI 10.1093/molehr/gag033; Grillo C, 2002, BIOCHEM BIOPH RES CO, V295, P67, DOI 10.1016/S0006-291X(02)00634-4; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kita K, 2006, FEBS LETT, V580, P199, DOI 10.1016/j.febslet.2005.11.074; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; Lucero HA, 1998, J BIOL CHEM, V273, P9857, DOI 10.1074/jbc.273.16.9857; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; MAZZARELLA RA, 1994, ARCH BIOCHEM BIOPHYS, V308, P454, DOI 10.1006/abbi.1994.1064; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MILNER RE, 1991, BIOCHIM BIOPHYS ACTA, V1063, P120, DOI 10.1016/0005-2736(91)90361-B; Muhlenkamp CR, 1998, TOXICOL APPL PHARM, V148, P101, DOI 10.1006/taap.1997.8323; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Reddy RK, 2002, CANCER RES, V62, P7207; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Wyse B, 2002, AM J PHYSIOL-RENAL, V282, pF424, DOI 10.1152/ajprenal.0028.2001; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	60	85	88	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6725	6738		10.1074/jbc.M109.054015	http://dx.doi.org/10.1074/jbc.M109.054015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022947	Green Published, hybrid			2022-12-27	WOS:000275367500076
J	De Groot, CO; Jelesarov, I; Damberger, FF; Bjelic, S; Scharer, MA; Bhavesh, NS; Grigoriev, I; Buey, RM; Wuthrich, K; Capitani, G; Akhmanova, A; Steinmetz, MO				De Groot, Christian O.; Jelesarov, Ilian; Damberger, Fred F.; Bjelic, Sasa; Schaerer, Martin A.; Bhavesh, Neel S.; Grigoriev, Ilia; Buey, Ruben M.; Wuethrich, Kurt; Capitani, Guido; Akhmanova, Anna; Steinmetz, Michel O.			Molecular Insights into Mammalian End-binding Protein Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS-END; CAP-GLY DOMAINS; HYDROGEN-EXCHANGE; IN-VITRO; EB1; DYNAMICS; TRACKING; APC; PLASTICITY; STABILITY	Microtubule plus-end tracking proteins (+TIPs) are involved in many microtubule-based processes. End binding (EB) proteins constitute a highly conserved family of +TIPs. They play a pivotal role in regulating microtubule dynamics and in the recruitment of diverse +TIPs to growing microtubule plus ends. Here we used a combination of methods to investigate the dimerization properties of the three human EB proteins EB1, EB2, and EB3. Based on Forster resonance energy transfer, we demonstrate that the C-terminal dimerization domains of EBs (EBc) can readily exchange their chains in solution. We further document that EB1c and EB3c preferentially form heterodimers, whereas EB2c does not participate significantly in the formation of heterotypic complexes. Measurements of the reaction thermodynamics and kinetics, homology modeling, and mutagenesis provide details of the molecular determinants of homo-versus heterodimer formation of EBc domains. Fluorescence spectroscopy and nuclear magnetic resonance studies in the presence of the cytoskeleton-associated protein-glycine-rich domains of either CLIP-170 or p150(glued) or of a fragment derived from the adenomatous polyposis coli tumor suppressor protein show that chain exchange of EBc domains can be controlled by binding partners. Extension of these studies of the EBc domains to full-length EBs demonstrate that heterodimer formation between EB1 and EB3, but not between EB2 and the other two EBs, occurs both in vitro and in cells as revealed by live cell imaging. Together, our data provide molecular insights for rationalizing the dominant negative control by C-terminal EB domains and form a basis for understanding the functional role of heterotypic chain exchange by EBs in cells.	[De Groot, Christian O.; Bjelic, Sasa; Schaerer, Martin A.; Buey, Ruben M.; Capitani, Guido; Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Jelesarov, Ilian] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Damberger, Fred F.; Bhavesh, Neel S.; Wuethrich, Kurt] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Grigoriev, Ilia; Akhmanova, Anna] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Wuethrich, Kurt] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; Scripps Research Institute; Scripps Research Institute	Steinmetz, MO (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	michel.steinmetz@psi.ch	Akhmanova, Anna S/B-8896-2011; Martinez-Buey, Ruben/K-4296-2014; Bjelic, Sasa/G-6849-2011; Bhavesh, Neel Sarovar/F-3127-2015; Steinmetz, Michel O/AAA-3349-2022; Bjelic, Sasa/N-1348-2019; Damberger, Fred F/A-8938-2011	Akhmanova, Anna S/0000-0002-9048-8614; Martinez-Buey, Ruben/0000-0003-1263-0221; Bjelic, Sasa/0000-0002-9805-3201; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Steinmetz, Michel O/0000-0001-6157-3687; Bjelic, Sasa/0000-0002-9805-3201; Damberger, Fred F/0000-0002-8457-3409; Wuthrich, Kurt/0000-0001-8739-6965	Swiss National Science Foundation; Netherlands Organization for Scientific Research NWO-ALW-VICI; ZonMW-TOP; Federation of European Biochemical Societies; NCCR Structural Biology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research NWO-ALW-VICI(Netherlands Organization for Scientific Research (NWO)); ZonMW-TOP; Federation of European Biochemical Societies; NCCR Structural Biology(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (to M. O. S. and I. J.), by Netherlands Organization for Scientific Research NWO-ALW-VICI and ZonMW-TOP grants (to A. A.), by a Federation of European Biochemical Societies fellowship (to R. M. B.), and by the Swiss National Science Foundation and the ETH Zurich through the NCCR Structural Biology (to I. J. and K. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Ban R, 2009, J BIOL CHEM, V284, P28367, DOI 10.1074/jbc.M109.000273; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; DeLano W.L, PYMOL MOL GRAPHICS S; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Keller R., 2004, COMPUTER AIDED RESON, V1; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kronja I, 2009, MOL BIOL CELL, V20, P2684, DOI 10.1091/mbc.E08-10-1051; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WAGNER G, 1979, J MOL BIOL, V134, P75, DOI 10.1016/0022-2836(79)90414-5; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	51	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5802	5814		10.1074/jbc.M109.068130	http://dx.doi.org/10.1074/jbc.M109.068130			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20008324	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000275327200071
J	Cai, Y; Jin, JJ; Swanson, SK; Cole, MD; Choi, SH; Florens, L; Washburn, MP; Conaway, JW; Conaway, RC				Cai, Yong; Jin, Jingji; Swanson, Selene K.; Cole, Michael D.; Choi, Seung Hyuk; Florens, Laurence; Washburn, Michael P.; Conaway, Joan W.; Conaway, Ronald C.			Subunit Composition and Substrate Specificity of a MOF-containing Histone Acetyltransferase Distinct from the Male-specific Lethal (MSL) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; PROTEIN IDENTIFICATION TECHNOLOGY; DOSAGE COMPENSATION; PROTEOMIC ANALYSIS; TRANSCRIPTION; DROSOPHILA; INO80; ACETYLATION; H4; ACTIVATION	Human MOF (MYST1), a member of the MYST (Moz-Ybf2/Sas3-Sas2-Tip60) family of histone acetyltransferases (HATs), is the human ortholog of the Drosophila males absent on the first (MOF) protein. MOF is the catalytic subunit of the male-specific lethal (MSL) HAT complex, which plays a key role in dosage compensation in the fly and is responsible for a large fraction of histone H4 lysine 16 (H4K16) acetylation in vivo. MOF was recently reported to be a component of a second HAT complex, designated the non-specific lethal (NSL) complex (Mendjan, S., Taipale, M., Kind, J., Holz, H., Gebhardt, P., Schelder, M., Vermeulen, M., Buscaino, A., Duncan, K., Mueller, J., Wilm, M., Stunnenberg, H. G., Saumweber, H., and Akhtar, A. (2006) Mol. Cell 21, 811-823). Here we report an analysis of the subunit composition and substrate specificity of the NSL complex. Proteomic analyses of complexes purified through multiple candidate subunits reveal that NSL is composed of nine subunits. Two of its subunits, WD repeat domain 5 (WDR5) and host cell factor 1 (HCF1), are shared with members of the MLL/SET family of histone H3 lysine 4 (H3K4) methyltransferase complexes, and a third subunit, MCRS1, is shared with the human INO80 chromatin-remodeling complex. In addition, we show that assembly of the MOF HAT into MSL or NSL complexes controls its substrate specificity. Although MSL-associated MOF acetylates nucleosomal histone H4 almost exclusively on lysine 16, NSL-associated MOF exhibits a relaxed specificity and also acetylates nucleosomal histone H4 on lysines 5 and 8.	[Cai, Yong; Jin, Jingji; Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Cole, Michael D.; Choi, Seung Hyuk] Dartmouth Med Sch, Dept Pharmacol, Hanover, NH 03756 USA; [Cole, Michael D.; Choi, Seung Hyuk] Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Dartmouth College; Dartmouth College; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org		Conaway, Joan/0000-0002-2786-0663; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	NIGMS, National Institutes of Health [R37 GM41628]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R01CA055248, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant R37 GM41628 from the NIGMS, National Institutes of Health Grant (to R. C. C.), and by funds from the Stowers Institute for Medical Research.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Owen-Hughes T, 1999, METH MOL B, V119, P319; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	38	162	177	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4268	4272		10.1074/jbc.C109.087981	http://dx.doi.org/10.1074/jbc.C109.087981			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018852	Green Published, hybrid			2022-12-27	WOS:000275274800002
J	Desai, LP; White, SR; Waters, CM				Desai, Leena P.; White, Steven R.; Waters, Christopher M.			Cyclic Mechanical Stretch Decreases Cell Migration by Inhibiting Phosphatidylinositol 3-Kinase-and Focal Adhesion Kinase-mediated JNK1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; PLECKSTRIN HOMOLOGY DOMAIN; WOUND CLOSURE; IN-VITRO; PHOSPHOINOSITIDE 3-KINASE; BASEMENT-MEMBRANE; DNA-SYNTHESIS; SEVERE ASTHMA	Epithelial cell migration during wound healing requires coordinated signaling pathways that direct polarization of the leading and trailing ends of the cells, cytoskeletal organization, and remodeling of focal adhesions. These inherently mechanical processes are disrupted by cyclic stretch (CS), but the specific signaling molecules involved in this disruption are not well understood. In this study, we demonstrate that inhibition of phosphatidylinositol 3-kinase (PI3K) or expression of a dominant-negative form of PI3K caused inhibition of airway epithelial cell wound closure. CS caused a sustained decrease in activation of PI3K and inhibited wound healing. Expression of constitutively active PI3K stimulated translocation of Tiam1 to the membrane, increased Rac1 activity, and increased wound healing of airway epithelial cells. Increased Rac1 activity resulted in increased phosphorylation of JNK1. PI3K activation was not regulated by association with focal adhesion kinase. Restoration of efficient cell migration during CS required coexpression of constitutively active PI3K, focal adhesion kinase, and JIP3.	[Desai, Leena P.; Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn, Memphis, TN 38163 USA; [White, Steven R.] Univ Chicago, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago	Waters, CM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave,426 Nash, Memphis, TN 38163 USA.	cwaters2@uthsc.edu	Waters, Christopher/V-2759-2019		National Institutes of Health [HL-094366, HL-080417]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094366, R01HL080417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-094366 (to C. M. W.) and HL-080417 (to S. R. W.).	Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; Baba Y, 2008, BRIT J CANCER, V98, P974, DOI 10.1038/sj.bjc.6604252; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Chartier NT, 2006, J CELL SCI, V119, P31, DOI 10.1242/jcs.02698; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chu HW, 1998, AM J RESP CRIT CARE, V158, P1936, DOI 10.1164/ajrccm.158.6.9712073; Coon M, 2002, J CELL BIOCHEM, V84, P655, DOI 10.1002/jcb.10078; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Desai LP, 2008, AM J PHYSIOL-LUNG C, V295, pL958, DOI 10.1152/ajplung.90218.2008; Desai LP, 2009, AM J PHYSIOL-LUNG C, V297, pL520, DOI 10.1152/ajplung.00076.2009; Desai LP, 2004, AM J PHYSIOL-LUNG C, V287, pL1134, DOI 10.1152/ajplung.00022.2004; El-Assal ON, 2005, GASTROENTEROLOGY, V129, P609, DOI 10.1053/j.gastro.2005.05.054; ERJEFALT JS, 1995, CELL TISSUE RES, V281, P305, DOI 10.1007/BF00583399; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hammerschmidt S, 2007, AM J RESP CELL MOL, V37, P699, DOI 10.1165/rcmb.2006-0429OC; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Ikeda M, 1999, BIOCHEM BIOPH RES CO, V257, P668, DOI 10.1006/bbrc.1999.0532; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Kallergi G, 2003, EXP CELL RES, V288, P94, DOI 10.1016/S0014-4827(03)00210-6; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Kodama K, 2005, INT J CANCER, V116, P876, DOI 10.1002/ijc.21136; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; RICKARD KA, 1993, AM J RESP CELL MOL, V8, P63, DOI 10.1165/ajrcmb/8.1.63; ROCHE WR, 1989, LANCET, V1, P520; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Savla U, 2004, J APPL PHYSIOL, V96, P566, DOI 10.1152/japplphysiol.00510.2003; Savla U, 1998, AM J PHYSIOL-LUNG C, V274, pL883, DOI 10.1152/ajplung.1998.274.6.L883; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Song JJ, 2005, J BIOL CHEM, V280, P26845, DOI 10.1074/jbc.M502318200; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Tetreault MP, 2008, J CELL PHYSIOL, V214, P545, DOI 10.1002/jcp.21239; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Tscharntke M, 2005, FASEB J, V19, P1836, DOI 10.1096/fj.04-3327fje; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; White SR, 1999, AM J RESP CELL MOL, V20, P787, DOI 10.1165/ajrcmb.20.4.3318; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P4277, DOI 10.1167/iovs.04-0119; Zhang Y, 1999, INVEST OPHTH VIS SCI, V40, P2819; Zou L, 2004, SHOCK, V22, P453, DOI 10.1097/01.shk.0000142255.15759.de	76	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4511	4519		10.1074/jbc.M109.084335	http://dx.doi.org/10.1074/jbc.M109.084335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018857	Green Published, hybrid			2022-12-27	WOS:000275274800028
J	Gros, Y; Schuldiner, S				Gros, Yael; Schuldiner, Shimon			Directed Evolution Reveals Hidden Properties of VMAT, a Neurotransmitter Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER; SACCHAROMYCES-CEREVISIAE; SUBSTRATE RECOGNITION; CHROMAFFIN GRANULE; AMINE TRANSPORTER; MULTIDRUG TRANSPORTERS; TETRABENAZINE BINDING; RESIDUES CONTRIBUTE; LIGAND RECOGNITION; RESERPINE BINDING	The vesicular neurotransmitter transporter VMAT2 is responsible for the transport of monoamines into synaptic and storage vesicles. VMAT2 is the target of many psychoactive drugs and is essential for proper neurotransmission and survival. Here we describe a new expression system in Saccharomyces cerevisiae that takes advantage of the polyspecificity of VMAT2. Expression of rVMAT2 confers resistance to acriflavine and to the parkinsonian toxin 1-methyl-4-phenylpyridinium (MPP+) by their removal into the yeast vacuole. This expression system allowed identification of a new substrate, acriflavine, and isolation of mutants with modified affinity to tetrabenazine (TBZ), a non-competitive inhibitor of VMAT2 that is used in the treatment of various movement disorders including Tourette syndrome and Huntington chorea. Whereas one type of mutant obtained displayed decreased affinity to TBZ, a second type showed only a slight decrease in the affinity to TBZ, displayed a higher K-m to the neurotransmitter serotonin, but conferred increased resistance to acriflavine and MPP+. A protein where both types of mutations were combined (with only three amino acid replacements) lost most of the properties of the neurotransmitter transporter (TBZ-insensitive, no transport of neurotransmitter) but displayed enhanced resistance to the above toxicants. The work described here shows that in the case of rVMAT2, loss of traits acquired in evolution of function (such as serotonin transport and TBZ binding) bring about an improvement in older functions such as resistance to toxic compounds. A process that has taken millions of years of evolution can be reversed by three mutations.	[Gros, Yael; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	National Institutes of Health [NS16708]; Center for Innovation in Membrane Protein Production [P50 GM73210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Innovation in Membrane Protein Production; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grant NS16708 from the National Institutes of Health. This work was also supported by The Center for Innovation in Membrane Protein Production (P50 GM73210).	Adam Y, 2008, AM J PHYSIOL-CELL PH, V294, pC1004, DOI 10.1152/ajpcell.00348.2007; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; DARCHEN F, 1989, BIOCHEMISTRY-US, V28, P1692, DOI 10.1021/bi00430a040; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Eiden LE, 2000, FASEB J, V14, P2396, DOI 10.1096/fj.00-0817rev; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Erickson JD, 2000, FASEB J, V14, P2450, DOI 10.1096/fj.00-0206rev; Finn JP, 1998, J BIOL CHEM, V273, P3943, DOI 10.1074/jbc.273.7.3943; Finn JP, 1997, J BIOL CHEM, V272, P16301, DOI 10.1074/jbc.272.26.16301; FREIS ED, 1954, NEW ENGL J MED, V251, P1006, DOI 10.1056/NEJM195412162512504; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; GUTHRIE C, 1991, METHOD ENZYMOL, pR17; Kenney Christopher, 2006, Expert Rev Neurother, V6, P7, DOI 10.1586/14737175.6.1.7; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; MERICKEL A, 1995, NEUROPHARMACOLOGY, V34, P1543, DOI 10.1016/0028-3908(95)00148-Y; PETER D, 1994, J BIOL CHEM, V269, P7231; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; SCHERMAN D, 1984, MOL PHARMACOL, V25, P113; SCHERMAN D, 1983, P NATL ACAD SCI-BIOL, V80, P584, DOI 10.1073/pnas.80.2.584; SCHULDINER S, 1993, MOL PHARMACOL, V44, P1227; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; SteinerMordoch S, 1996, J BIOL CHEM, V271, P13048, DOI 10.1074/jbc.271.22.13048; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; STITZEL RE, 1976, PHARMACOL REV, V28, P179; Thiriot DS, 2001, J BIOL CHEM, V276, P27304, DOI 10.1074/jbc.M103947200; Vardy E, 2005, J BACTERIOL, V187, P7518, DOI 10.1128/JB.187.21.7518-7525.2005; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6; Yelin R, 2001, BBA-BIOMEMBRANES, V1510, P426, DOI 10.1016/S0005-2736(00)00374-6; Yelin R, 1999, J BACTERIOL, V181, P949, DOI 10.1128/JB.181.3.949-956.1999; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	39	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5076	5084		10.1074/jbc.M109.081216	http://dx.doi.org/10.1074/jbc.M109.081216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007701	Green Published, hybrid			2022-12-27	WOS:000275274800083
J	Naganuma, T; Nomura, N; Yao, M; Mochizuki, M; Uchiumi, T; Tanaka, I				Naganuma, Takao; Nomura, Naoko; Yao, Min; Mochizuki, Masahiro; Uchiumi, Toshio; Tanaka, Isao			Structural Basis for Translation Factor Recruitment to the Eukaryotic/Archaeal Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ASSOCIATED CENTER; ESCHERICHIA-COLI RIBOSOMES; ELONGATION-FACTOR-G; C-TERMINAL DOMAIN; PROTEIN L7/L12; P2 PROTEINS; FACTOR-BINDING; STALK; P1; REFINEMENT	The archaeal ribosomal stalk complex has been shown to have an apparently conserved functional structure with eukaryotic pentameric stalk complex; it provides access to eukaryotic elongation factors at levels comparable to that of the eukaryotic stalk. The crystal structure of the archaeal heptameric (P0(P1)(2)(P1)(2)(P1)(2)) stalk complex shows that the rRNA anchor protein P0 consists of an N-terminal rRNA-anchoring domain followed by three separated spine helices on which three P1 dimers bind. Based on the structure, we have generated P0 mutants depleted of any binding site(s) for P1 dimer(s). Factor-dependent GTPase assay of such mutants suggested that the first P1 dimer has higher activity than the others. Furthermore, we constructed a model of the archaeal 50 S with stalk complex by superposing the rRNA-anchoring domain of P0 on the archaeal 50 S. This model indicates that the C termini of P1 dimers where translation factors bind are all localized to the region between the stalk base of the 50 S and P0 spine helices. Together with the mutational experiments we infer that the functional significance of multiple copies of P1 is in creating a factor pool within a limited space near the stalk base of the ribosome.	[Naganuma, Takao; Mochizuki, Masahiro; Uchiumi, Toshio] Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; [Naganuma, Takao; Nomura, Naoko; Yao, Min; Tanaka, Isao] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Niigata University; Hokkaido University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Ikarashi 2,Machi 8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp; tanaka@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011	yao, min/0000-0003-1687-5904	National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Grants-in-Aid for Scientific Research [20247007] Funding Source: KAKEN	National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan and the Naito Foundation (to T. U.).	Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Briceno V, 2009, INT J BIOCHEM CELL B, V41, P1315, DOI 10.1016/j.biocel.2008.11.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Guarinos E, 2001, J BIOL CHEM, V276, P32474, DOI 10.1074/jbc.M103229200; Gudkov AT, 1997, FEBS LETT, V407, P253, DOI 10.1016/S0014-5793(97)00361-X; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Iwasaki K, 1979, Methods Enzymol, V60, P657; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Lalioti VS, 2002, MOL MICROBIOL, V46, P719, DOI 10.1046/j.1365-2958.2002.03179.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIAO DQ, 1994, J MOL EVOL, V38, P405, DOI 10.1007/BF00163157; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; Maki Y, 2007, J BIOL CHEM, V282, P32827, DOI 10.1074/jbc.M705412200; Moller W., 1986, STRUCTURE FUNCTION G, P309; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; Nomura T, 2006, BIOCHEM J, V396, P565, DOI 10.1042/BJ20060038; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; Santos C, 2004, ANTIMICROB AGENTS CH, V48, P2930, DOI 10.1128/AAC.48.8.2930-2936.2004; Sanyal SC, 2000, CURR OPIN STRUC BIOL, V10, P633, DOI 10.1016/S0959-440X(00)00143-3; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Traut RR, 1995, BIOCHEM CELL BIOL, V73, P949, DOI 10.1139/o95-102; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; ZHONG DG, 1993, BIOTECHNIQUES, V15, P874	48	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4747	4756		10.1074/jbc.M109.068098	http://dx.doi.org/10.1074/jbc.M109.068098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007716	Green Published, hybrid			2022-12-27	WOS:000275274800053
J	Jung, YS; Cai, ML; Clore, GM				Jung, Young-Sang; Cai, Mengli; Clore, G. Marius			Solution Structure of the IIA(Chitobiose)-IIBChitobiose Complex of the N,N '-Diacetylchitobiose Branch of the Escherichia coli Phosphotransferase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; RESIDUAL DIPOLAR COUPLINGS; MANNITOL TRANSPORTER IIMANNITOL; PHOSPHOCARRIER PROTEIN HPR; N-TERMINAL DOMAIN; MACROMOLECULAR STRUCTURE DETERMINATION; POTATO CARBOXYPEPTIDASE INHIBITOR; MOLECULAR-STRUCTURE DETERMINATION; CYTOPLASMIC B-DOMAIN; ENZYME-I	The solution structure of the IIA-IIB complex of the N,N '-diacetylchitobiose (Chb) transporter of the Escherichia coli phosphotransferase system has been solved by NMR. The active site His-89 of IIA(Chb) was mutated to Glu to mimic the phosphorylated state and the active site Cys-10 of IIBChb was substituted by serine to prevent intermolecular disulfide bond formation. Binding is weak with a K-D of similar to 1.3mM. The two complementary interaction surfaces are largely hydrophobic, with the protruding active site loop (residues 9-16) of IIBChb buried deep within the active site cleft formed at the interface of two adjacent subunits of the IIA(Chb) trimer. The central hydrophobic portion of the interface is surrounded by a ring of polar and charged residues that provide a relatively small number of electrostatic intermolecular interactions that serve to correctly align the two proteins. The conformation of the active site loop in unphosphorylated IIBChb is inconsistent with the formation of a phosphoryl transition state intermediate because of steric hindrance, especially from the methyl group of Ala-12 of IIBChb. Phosphorylation of IIBChb is accompanied by a conformational change within the active site loop such that its path from residues 11-13 follows a mirror-like image relative to that in the unphosphorylated state. This involves a transition of the phi/psi angles of Gly-13 from the right to left alpha-helical region, as well as smaller changes in the backbone torsion angles of Ala-12 and Met-14. The resulting active site conformation is fully compatible with the formation of the His-89-P-Cys-10 phosphoryl transition state without necessitating any change in relative translation or orientation of the two proteins within the complex.	[Jung, Young-Sang; Cai, Mengli; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm B1-301, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Jung, Young-Sang/H-1169-2011; Clore, G Marius/L-2546-2018; Jung, Young-Sang/L-5068-2013	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Jung, Young-Sang/0000-0003-0817-0664	NIDDK; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of NIDDK, National Institutes of Health and the Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G. M. C.).	AB E, 1997, PROTEIN SCI, V6, P304; AB E, 2001, J MOL BIOL, V308, P993, DOI 10.1006/jmbi.2001.4623; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Eberstadt M, 1996, BIOCHEMISTRY-US, V35, P11286, DOI 10.1021/bi960492l; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; HERZBERG O, 1992, P NATL ACAD SCI USA, V89, P2499, DOI 10.1073/pnas.89.6.2499; Hu J, 2008, J BIOL CHEM, V283, P11024, DOI 10.1074/jbc.M800312200; JIA ZC, 1993, J BIOL CHEM, V268, P22490; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALBITZER HR, 1993, EUR J BIOCHEM, V216, P205, DOI 10.1111/j.1432-1033.1993.tb18134.x; Keyhani NO, 2000, J BIOL CHEM, V275, P33102, DOI 10.1074/jbc.M001045200; Keyhani NO, 2000, J BIOL CHEM, V275, P33091, DOI 10.1074/jbc.M001044200; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 1997, P NATL ACAD SCI USA, V94, P14367, DOI 10.1073/pnas.94.26.14367; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; LIAO DI, 1991, BIOCHEMISTRY-US, V30, P9583, DOI 10.1021/bi00104a004; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Ortega-Roldan JL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp211; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Oberholzer AE, 2009, J BIOL CHEM, V284, P33169, DOI 10.1074/jbc.M109.057612; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Schwieters CD, 2008, J PHYS CHEM B, V112, P6070, DOI 10.1021/jp076244o; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; Suh JY, 2005, J MOL BIOL, V353, P1129, DOI 10.1016/j.jmb.2005.09.033; Tang C, 2005, J BIOL CHEM, V280, P11770, DOI 10.1074/jbc.M414300200; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; vanMontfort RLM, 1997, STRUCTURE, V5, P217, DOI 10.1016/S0969-2126(97)00180-9; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; WITTEKIND M, 1992, PROTEIN SCI, V1, P1363, DOI 10.1002/pro.5560011016; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006	80	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4173	4184		10.1074/jbc.M109.080937	http://dx.doi.org/10.1074/jbc.M109.080937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959833	Green Published, hybrid			2022-12-27	WOS:000275254000069
J	Leffler, J; Herbert, AP; Norstrom, E; Schmidt, CQ; Barlow, PN; Blom, AM; Martin, M				Leffler, Jonatan; Herbert, Andrew P.; Norstrom, Eva; Schmidt, Christoph Q.; Barlow, Paul N.; Blom, Anna M.; Martin, Myriam			Annexin-II, DNA, and Histones Serve as Factor H Ligands on the Surface of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY COMPLEMENT ACTIVATION; CYTOSOLIC PHOSPHOLIPASE A(2); BINDING LECTIN ENGAGEMENT; HEMOLYTIC-UREMIC SYNDROME; DISEASE-ASSOCIATED FORM; DEPENDENT PROTEIN-S; C4B-BINDING PROTEIN; NECROTIC CELLS; ALTERNATIVE PATHWAY; MACULAR DEGENERATION	Apoptotic cells are opsonized by complement components such as C1q and C3b, which increases their susceptibility to phagocytosis. Soluble complement inhibitors such as factor H (fH) also recognize apoptotic cells to minimize the pro-inflammatory effects of downstream complement activation. We used four radiolabeled protein constructs that span different regions of the 20 complement control protein (CCP) modules that make up fH and found that fragments comprising CCPs 6-8, CCPs 8-15, and CCPs 19-20 but not CCPs 1-4, bound to apoptotic Jurkat T cells. There are four possible ligand types on apoptotic cells that could recruit fH: proteins, carbohydrates, lipids, and DNA. We found that CCPs 6-8 of fH bind to annexin-II, a trypsin-insensitive protein that becomes exposed on surfaces of apoptotic cells. The second ligand of fH, which interacts with CCPs 6-8 and 19-20, is DNA. Confocal microscopy showed co-localization of fH with antibodies specific for DNA. fH also binds to histones devoid of DNA, and CCPs 1-4, 6-8, and 8-15 mediate this interaction. Treatment of apoptotic cells with neuraminidase, chondroitinase, heparitinase, and heparinase did not change fH binding. Treatment of apoptotic cells with phospholipase A(2) dramatically increased both binding of fH and cell-surface DNA. We also excluded the possibility that fH interacts with lysophospholipids using surface plasmon resonance and flow cytometry with lipid-coated beads. Identification of annexin-II as one of the fH ligands on apoptotic cells together with the fact that autoantibodies against annexin-II are found in systemic lupus erythematosus provides further insight into understanding the pathogenesis of this disease.	[Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Med Prot Chem,Wallenberg Lab, S-20502 Malmo, Sweden; [Herbert, Andrew P.; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Edinburgh Biol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland	Lund University; Skane University Hospital; University of Edinburgh	Blom, AM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Med Prot Chem,Wallenberg Lab, Entrance 46,Floor 4, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Leffler, Jonatan/A-8748-2018; Herbert, Andrew P/C-4755-2008; Blom, Anna/B-9607-2009; Leffler, Jonatan/D-4630-2011; Herbert, Andy P/F-6693-2010; Barlow, Paul N/G-2853-2011; Blom, Anna/AFS-7369-2022	Leffler, Jonatan/0000-0001-5674-8462; Herbert, Andrew P/0000-0002-4549-6965; Blom, Anna/0000-0002-1348-1734; Leffler, Jonatan/0000-0001-5674-8462; Herbert, Andy P/0000-0002-4549-6965; Martin, Myriam/0000-0003-1526-8678	Swedish Research Council; Swedish Foundation for Strategic Research; Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary; Knut; Alice Wallenberg; IngaBritt; Arne Lundberg; University Hospital in Malmo; Wellcome Trust; MRC [G0001089] Funding Source: UKRI; Medical Research Council [G0001089] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary; Knut; Alice Wallenberg(Knut & Alice Wallenberg Foundation); IngaBritt; Arne Lundberg; University Hospital in Malmo; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, and IngaBritt and Arne Lundberg, and research grants from the University Hospital in Malmo. Work in Edinburgh was supported by the Wellcome Trust.	Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; COLEMAN K, 2008, 22 INT COMPL WORKSH, P411; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Fadeel B, 2003, CELL MOL LIFE SCI, V60, P2575, DOI 10.1007/s00018-003-3145-1; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Hinkovska-Galcheva V, 1998, BLOOD, V91, P4761, DOI 10.1182/blood.V91.12.4761.412k24_4761_4769; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Jones AL, 2005, J BIOL CHEM, V280, P35733, DOI 10.1074/jbc.M504384200; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Lehmann PV, 1996, NEPHROL DIAL TRANSPL, V11, P953; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Oslakovic C, 2009, J BIOL CHEM, V284, P5896, DOI 10.1074/jbc.M807286200; PULIDO R, 1989, J IMMUNOL, V143, P1930; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Salle V, 2008, J CLIN IMMUNOL, V28, P291, DOI 10.1007/s10875-008-9188-1; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Wissing D, 1997, P NATL ACAD SCI USA, V94, P5073, DOI 10.1073/pnas.94.10.5073; WOODIN AM, 1966, BIOCHEM J, V99, P493, DOI 10.1042/bj0990493; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613	51	50	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3766	3776		10.1074/jbc.M109.045427	http://dx.doi.org/10.1074/jbc.M109.045427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951950	Green Published, hybrid			2022-12-27	WOS:000275254000029
J	Samuvel, DJ; Sundararaj, KP; Li, YC; Lopes-Virella, MF; Huang, Y				Samuvel, Devadoss J.; Sundararaj, Kamala P.; Li, Yanchun; Lopes-Virella, Maria F.; Huang, Yan			Adipocyte-Mononuclear Cell Interaction, Toll-like Receptor 4 Activation, and High Glucose Synergistically Up-regulate Osteopontin Expression via an Interleukin 6-mediated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-GRADE INFLAMMATION; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; HUMAN MONOCYTES; DISEASE; FIBROBLASTS; CYTOKINE; ADHESION	Although it has been reported that osteopontin, a matrix glycoprotein and proinflammatory cytokine, mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance, it remains unclear how osteopontin is up-regulated in adipose tissue in obese humans and animals. In this study, we incubated U937 mononuclear cells with adipocytes in a transwell system and studied how cell interaction regulated osteopontin expression. Results showed that coculture of U937 cells with adipocytes led to a marked increase in osteopontin production when compared with that released by independent cultures of U937 cells. Moreover, lipopolysaccharide or palmitic acid-induced TLR4 activation and high glucose further augmented the coculture-stimulated osteopontin secretion. Similar observations were made in the coculture of human primary monocytes and adipocytes. Real time PCR studies showed that coculture of U937 cells and adipocytes increased osteopontin mRNA in U937 cells, but not adipocytes, suggesting that adipocyte-derived soluble factor may stimulate osteopontin expression by U937 cells. In our studies to explore the underlying mechanism, we found that the neutralizing antibodies against interleukin (IL)-6 or IL-6 small interfering RNA transfection in adipocytes effectively inhibited coculture-stimulated osteopontin expression, suggesting that IL-6 released by adipocytes plays an essential role in the coculture-stimulated osteopontin expression by U937 cells. In conclusion, this study has demonstrated that cell interaction, TLR4 activation, and high glucose up-regulate osteopontin expression, and adipocyte-derived IL-6 played a major role in the up-regulation.	[Lopes-Virella, Maria F.; Huang, Yan] Med Univ S Carolina, Dept Med, Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Samuvel, Devadoss J.; Sundararaj, Kamala P.; Li, Yanchun; Lopes-Virella, Maria F.; Huang, Yan] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Huang, Y (corresponding author), 114 Doughty St, Charleston, SC 29403 USA.	huangyan@musc.edu	li, yan/GTI-4638-2022		National Institutes of Health [DE16353]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grant DE16353 (to Y.H.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to Y.H.).	Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Caceres-Cortes JR, 2008, ANTI-CANCER AGENT ME, V8, P717, DOI 10.2174/187152008785914752; Cammisotto PG, 2003, AM J PHYSIOL-ENDOC M, V285, pE521, DOI 10.1152/ajpendo.00052.2003; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim S, 2008, J LIPID RES, V49, P2571, DOI 10.1194/jlr.M800112-JLR200; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kitahara K, 2003, ENDOCRINOLOGY, V144, P2132, DOI 10.1210/en.2002-220996; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Naldini A, 2006, J IMMUNOL, V177, P4267, DOI 10.4049/jimmunol.177.7.4267; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Ohmori R, 2003, ATHEROSCLEROSIS, V170, P333, DOI 10.1016/S0021-9150(03)00298-3; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Serlin DM, 2006, J CELL BIOCHEM, V97, P519, DOI 10.1002/jcb.20661; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Syed MA, 2002, DIABETES NUTR METAB, V15, P68; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305	33	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3916	3927		10.1074/jbc.M109.033951	http://dx.doi.org/10.1074/jbc.M109.033951			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007708	Green Published, hybrid			2022-12-27	WOS:000275254000045
J	Krudysz-Amblo, J; Jennings, ME; Mann, KG; Butenas, S				Krudysz-Amblo, Jolanta; Jennings, Mark E., II; Mann, Kenneth G.; Butenas, Saulius			Carbohydrates and Activity of Natural and Recombinant Tissue Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC CHARACTERIZATION; FACTOR PROCOAGULANT ACTIVITY; FACTOR PATHWAY INHIBITOR; HUMAN FACTOR-VIIA; HUMAN FACTOR-IX; ANTITHROMBIN-III; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATION PEPTIDE; FACTOR-X; LC MS	The effect of glycosylation on tissue factor (TF) activity was evaluated, and site-specific glycosylation of full-length recombinant TF (rTF) and that of natural TF from human placenta (pTF) were studied by liquid chromatography-tandem mass spectrometry. The amidolytic activity of the TF.factor VIIa (FVIIa) complex toward a fluorogenic substrate showed that the catalytic efficiency (V-max) of the complex increased in the order rTF(1-243) (Escherichia coli) < rTF(1-263) (Sf9 insect cells) < pTF for the glycosylated and deglycosylated forms. Substrate hydrolysis was unaltered by deglycosylation. In FXase, the K-m of FX for rTF(1-263)-FVIIa remained unchanged after deglycosylation, whereas the k(cat) decreased slightly. A pronounced decrease, 4-fold, in k(cat) was observed for pTF.FVIIa upon deglycosylation, whereas the K-m was minimally altered. The parameters of FX activation by both rTF(1-263D)-FVIIa and pTF(D)-FVIIa were identical and similar to those for rTF(1-243)-FVIIa. In conclusion, carbohydrates significantly influence the activity of TF proteins. Carbohydrate analysis revealed glycosylation on asparagines 11, 124, and 137 in both rTF1-263 and pTF. The carbohydrates of rTF(1-263) contain high mannose, hybrid, and fucosylated glycans. Natural pTF contains no high mannose glycans but is modified with hybrid, highly fucosylated, and sialylated sugars.	Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Jennings, Mark E., II] Univ Vermont, Dept Med Cardiol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Butenas, S (corresponding author), Univ Vermont, Dept Biochem, 208 S Pk Dr,Rm 235A, Colchester, VT 05446 USA.	sbutenas@uvm.edu			National Institutes of Health [P01HL46703]; National Center for Research Resources [P20RR16462]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL46703 (Project 2). This work was presented in part at the XXII Congress of the International Society on Thrombosis and Haemostasis, July 11-16, 2009, Boston, MA.; We thank Dr. Dwight E. Matthews for helpful analysis and discussion. The LC/MS instrumentation and the materials used for LC/MS analysis were provided by support made possible by Vermont Genetics Network Grant P20RR16462 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources, a component of the National Institutes of Health.	AGARWALA KL, 1994, BIOCHEMISTRY-US, V33, P5167, DOI 10.1021/bi00183a021; Ashline D, 2005, ANAL CHEM, V77, P6250, DOI 10.1021/ac050724z; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; BONA R, 1987, THROMB RES, V48, P487, DOI 10.1016/0049-3848(87)90405-1; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; BUTENAS S, 1993, BIOCHEMISTRY-US, V32, P6531, DOI 10.1021/bi00077a006; BUTENAS S, 1994, BIOCHEMISTRY-US, V33, P3449, DOI 10.1021/bi00177a039; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Dietzen DJ, 2004, BLOOD, V103, P3038, DOI 10.1182/blood-2003-07-2399; Dorfleutner A, 2003, BLOOD, V102, P3998, DOI 10.1182/blood-2003-04-1149; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Egorina EM, 2008, THROMB RES, V122, P831, DOI 10.1016/j.thromres.2007.11.004; Fenaille F, 2008, GLYCOCONJUGATE J, V25, P827, DOI 10.1007/s10719-008-9143-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; GUZZETTA AW, 1993, ANAL CHEM, V65, P2953, DOI 10.1021/ac00069a004; HANSEN L, 1988, J BIOL CHEM, V263, P15713; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; Harvey DJ, 1997, J MASS SPECTROM, V32, P167, DOI 10.1002/(SICI)1096-9888(199702)32:2<167::AID-JMS472>3.0.CO;2-Q; HUDDLESTON MJ, 1993, ANAL CHEM, V65, P877, DOI 10.1021/ac00055a009; Iacob RE, 2008, J AM SOC MASS SPECTR, V19, P428, DOI 10.1016/j.jasms.2007.11.022; Irungu J, 2008, J AM SOC MASS SPECTR, V19, P1209, DOI 10.1016/j.jasms.2008.05.010; Jiang H, 2004, J AM SOC MASS SPECTR, V15, P750, DOI 10.1016/j.jasms.2004.01.009; Klammer AA, 2006, J PROTEOME RES, V5, P695, DOI 10.1021/pr050315j; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; LAWSON JH, 1992, J BIOL CHEM, V267, P4834; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; MARTIN DMA, 1995, FASEB J, V9, P852, DOI 10.1096/fasebj.9.10.7615155; Mody RS, 1997, BIOCHEMISTRY-US, V36, P7869, DOI 10.1021/bi9701235; Mori Y, 2009, J THROMB HAEMOST, V7, P111, DOI 10.1111/j.1538-7836.2008.03222.x; Munzert E, 1997, BIOTECHNOL BIOENG, V56, P441, DOI 10.1002/(SICI)1097-0290(19971120)56:4<441::AID-BIT9>3.0.CO;2-O; Osterud B, 2000, THROMB HAEMOSTASIS, V83, P861, DOI 10.1055/s-0037-1613934; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; PABORSKY LR, 1991, J BIOL CHEM, V266, P21911; PABORSKY LR, 1990, THROMB RES, V60, P367, DOI 10.1016/0049-3848(90)90219-3; Parhami-Seren B, 2006, J THROMB HAEMOST, V4, P1747, DOI 10.1111/j.1538-7836.2006.02000.x; Pendurthi UR, 2007, BLOOD, V110, P3900, DOI 10.1182/blood-2007-07-101469; Peter-Katalinic J, 2005, METHOD ENZYMOL, V405, P139, DOI 10.1016/S0076-6879(05)05007-X; PETERSON CB, 1985, J BIOL CHEM, V260, P610; PITLICK FA, 1975, J CLIN INVEST, V55, P175, DOI 10.1172/JCI107908; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; REHEMTULLA A, 1991, J BIOL CHEM, V266, P10294; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; REINHOLD VN, 1995, ANAL CHEM, V67, P1772, DOI 10.1021/ac00107a005; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; SCHULLEK JR, 1994, J BIOL CHEM, V269, P19399; SHANDS JW, 1985, BLOOD, V65, P169; Silveira JR, 2002, BIOCHEMISTRY-US, V41, P1672, DOI 10.1021/bi011304g; SPICER EK, 1987, P NATL ACAD SCI USA, V84, P5148, DOI 10.1073/pnas.84.15.5148; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; TOOMEY JR, 1991, J BIOL CHEM, V266, P19198; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Valmu L, 2006, GLYCOBIOLOGY, V16, P1207, DOI 10.1093/glycob/cwl034; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; VANDENBESSELAAR AMHP, 1984, THROMB HAEMOSTASIS, V52, P192; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Wang YH, 2006, BIOTECHNOL PROGR, V22, P873, DOI 10.1021/bp060005l; WAXMAN E, 1992, BIOCHEMISTRY-US, V31, P3998, DOI 10.1021/bi00131a015; Weiskopf AS, 1998, ANAL CHEM, V70, P4441, DOI 10.1021/ac980289r; Wuhrer M, 2005, ANAL CHEM, V77, P886, DOI 10.1021/ac048619x; Yang L, 2009, J THROMB HAEMOST, V7, P1696, DOI 10.1111/j.1538-7836.2009.03578.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	70	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3371	3382		10.1074/jbc.M109.055178	http://dx.doi.org/10.1074/jbc.M109.055178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955571	Green Published, hybrid			2022-12-27	WOS:000273829000052
J	Vicent, GP; Zaurin, R; Nacht, AS; Font-Mateu, J; Le Dily, F; Beato, M				Pablo Vicent, Guillermo; Zaurin, Roser; Silvina Nacht, A.; Font-Mateu, Jofre; Le Dily, Francois; Beato, Miguel			Nuclear Factor 1 Synergizes with Progesterone Receptor on the Mouse Mammary Tumor Virus Promoter Wrapped around a Histone H3/H4 Tetramer by Facilitating Access to the Central Hormone-responsive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; YEAST SWI/SNF COMPLEX; MMTV PROMOTER; TRANSCRIPTIONAL ACTIVATION; REGULATORY ELEMENT; H1 PHOSPHORYLATION; BAF COMPLEX; CROSS-TALK; IN-VIVO; NUCLEOSOME	Steroid hormones induce transcription of their responsive genes by complex mechanisms including synergism between the hormone receptors and other transcription factors. On the mouse mammary tumor virus (MMTV) promoter progesterone induction is mediated by the reciprocal synergism between progesterone receptor (PR) and the ubiquitous transcription factor nuclear factor 1 (NF1). PR binding mediates ATP-dependent displacement of histone H2A and H2B, enabling NF1 access to its target site. In minichromosomes assembled in vitro NF1 binding facilitates access of PR to the hormone-responsive elements (HREs) by precluding reforming of the histone octamer, but the function of NF1 in living cells remains unclear. Here we show that depleting NF1 by small interfering RNAs or mutating the NF1-binding site significantly compromises transcription of the MMTV promoter. The central HREs 2 and 3 are not needed for ATP-dependent H2A/H2B displacement or NF1 binding but are critical for full PR binding and MMTV transactivation. We found that NF1 binding to the MMTV promoter on a H3/H4 histone tetramer particle exposes the central HREs and facilitates their binding by PR, suggesting a possible mechanism for the reciprocal synergism between PR and NF1.	[Pablo Vicent, Guillermo; Zaurin, Roser; Silvina Nacht, A.; Font-Mateu, Jofre; Le Dily, Francois; Beato, Miguel] Univ Pompeu Fabra, Ctr Regulacio Genom, E-08003 Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Vicent, GP (corresponding author), Univ Pompeu Fabra, Ctr Regulacio Genom, Parc Recerca Biomed,Dr Aiguader 88, E-08003 Barcelona, Spain.	guillermo.vicent@crg.es; miguel.beato@crg.es	Vicent, Guillermo P./K-5432-2015; Beato, Miguel/B-5564-2015; Le Dily, François/J-9448-2015; Le Dily, François/GNH-3646-2022; Font-Mateu, Jofre/AAE-9801-2019; Font-Mateu, Jofre/K-5492-2015	Vicent, Guillermo P./0000-0002-0554-2226; Beato, Miguel/0000-0002-2878-2222; Le Dily, François/0000-0002-8324-7927; Le Dily, François/0000-0002-8324-7927; Font-Mateu, Jofre/0000-0001-9983-9647	Department d'Innovacio Universitat i Empresa, Ministerio de Ciencia e Innovacion [BMC 200302902, CSD2006-00049]; Fondo de Investigacion Sanitaria, [PI0411605, CP04/00087]; European Union	Department d'Innovacio Universitat i Empresa, Ministerio de Ciencia e Innovacion; Fondo de Investigacion Sanitaria,(Instituto de Salud Carlos III); European Union(European Commission)	This work was supported by grants from the Department d'Innovacio Universitat i Empresa, Ministerio de Ciencia e Innovacion Grant BMC 200302902, Consolider (CSD2006-00049), and Fondo de Investigacion Sanitaria Grant PI0411605 and CP04/00087, as well as by European Union Integrated Project HEROIC.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bhattacharjee RN, 2006, VIROLOGY, V346, P1, DOI 10.1016/j.virol.2005.12.034; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Boyer LA, 2000, J BIOL CHEM, V275, P11545, DOI 10.1074/jbc.275.16.11545; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, GENE DEV, V10, P2131, DOI 10.1101/gad.10.17.2131; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Candau R, 1996, J STEROID BIOCHEM, V57, P19, DOI 10.1016/0960-0760(96)00262-2; CHALEPAKIS G, 1988, CELL, V53, P371, DOI 10.1016/0092-8674(88)90157-2; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Eisfeld K, 1997, NUCLEIC ACIDS RES, V25, P3733, DOI 10.1093/nar/25.18.3733; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Logie C, 1999, METHOD ENZYMOL, V304, P726; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; SCHEIDEREIT C, 1984, P NATL ACAD SCI-BIOL, V81, P3029, DOI 10.1073/pnas.81.10.3029; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Spangenberg C, 1998, J MOL BIOL, V278, P725, DOI 10.1006/jmbi.1998.1718; Strutt H, 1999, METH MOL B, V119, P455; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Venditti P, 1998, NUCLEIC ACIDS RES, V26, P3657, DOI 10.1093/nar/26.16.3657; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Vicent GP, 2002, J STEROID BIOCHEM, V83, P15, DOI 10.1016/S0960-0760(02)00253-4; Vicent GP, 2002, J MOL BIOL, V324, P501, DOI 10.1016/S0022-2836(02)01101-4; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Yang CY, 2007, XENOTRANSPLANTATION, V14, P547; Zhao LH, 2005, ACTA BIOCH BIOPH SIN, V37, P440, DOI 10.1111/j.1745-7270.2005.00061.x	48	20	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2622	2631		10.1074/jbc.M109.060848	http://dx.doi.org/10.1074/jbc.M109.060848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940123	hybrid, Green Published			2022-12-27	WOS:000273697800041
J	Artavanis-Tsakonas, K; Weihofen, WA; Antos, JM; Coleman, BI; Comeaux, CA; Duraisingh, MT; Gaudet, R; Ploegh, HL				Artavanis-Tsakonas, Katerina; Weihofen, Wilhelm A.; Antos, John M.; Coleman, Bradley I.; Comeaux, Christy A.; Duraisingh, Manoj T.; Gaudet, Rachelle; Ploegh, Hidde L.			Characterization and Structural Studies of the Plasmodium falciparum Ubiquitin and Nedd8 Hydrolase UCHL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HYDROLASES; DEUBIQUITINATING ENZYMES; MALARIA PARASITES; FUNCTIONAL PROTEOMICS; DECONJUGATING ENZYMES; MOLECULAR-DYNAMICS; SPECIFICITY; SUBSTRATE; UCH-L3; INHIBITORS	Like their human hosts, Plasmodium falciparum parasites rely on the ubiquitin-proteasome system for survival. We previously identified PfUCHL3, a deubiquitinating enzyme, and here we characterize its activity and changes in active site architecture upon binding to ubiquitin. We find strong evidence that PfUCHL3 is essential to parasite survival. The crystal structures of both PfUCHL3 alone and in complex with the ubiquitin-based suicide substrate UbVME suggest a rather rigid active site crossover loop that likely plays a role in restricting the size of ubiquitin adduct substrates. Molecular dynamics simulations of the structures and a model of the PfUCHL3-PfNedd8 complex allowed the identification of shared key interactions of ubiquitin and PfNedd8 with PfUCHL3, explaining the dual specificity of this enzyme. Distinct differences observed in ubiquitin binding between PfUCHL3 and its human counterpart make it likely that the parasitic DUB can be selectively targeted while leaving the human enzyme unaffected.	[Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weihofen, Wilhelm A.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Coleman, Bradley I.; Comeaux, Christy A.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr,Rm 361, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X; Coleman, Bradley/0000-0003-4217-508X	National Institutes of Health [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephen Harrison, David Fidock, Rich Eastman, Max Popp, and Marcos Sotomayor for helpful discussions. Simulations were performed using National Science Foundation TeraGrid resources provided by the National Center for Supercomputing Applications and Texas Advanced Computing Center (TRAC MCB080015), and x-ray data collection was done using the Northeastern Collaborative Access Team beamlines (supported by National Institutes of Health Award RR-15301) at the Advanced Photon Source (supported by United States Department of Energy Contract DE-AC02-06CH11357).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Featherstone C, 1997, MOL MED TODAY, V3, P367; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hooft RWW, 1996, J MOL GRAPHICS, V14, P168, DOI 10.1016/S0263-7855(96)00055-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; MACKERELL J, 1998, ENCY COMPUTATIONAL C, V1, P271; Mermerian AH, 2007, BIOORG MED CHEM LETT, V17, P3729, DOI 10.1016/j.bmcl.2007.04.027; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun Y, 2003, CANCER BIOL THER, V2, P623; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227	39	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6857	6866		10.1074/jbc.M109.072405	http://dx.doi.org/10.1074/jbc.M109.072405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042598	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000275367500088
J	Deng, KW; Gao, Y; Cao, ZX; Graziani, EI; Wood, A; Doherty, P; Walsh, FS				Deng, Kangwen; Gao, Ying; Cao, Zixuan; Graziani, Edmund I.; Wood, Andrew; Doherty, Patrick; Walsh, Frank S.			Overcoming Amino-Nogo-induced Inhibition of Cell Spreading and Neurite Outgrowth by 12-O-Tetradecanoylphorbol-13-acetate-type Tumor Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CHONDROITIN SULFATE PROTEOGLYCANS; MYELIN-ASSOCIATED GLYCOPROTEIN; PHORBOL ESTER; AXONAL REGENERATION; ACTIVATION; RECEPTOR; GROWTH; DOMAIN; GTPASES	The N-terminal domain of NogoA, called amino-Nogo, inhibits axonal outgrowth and cell spreading via a largely unknown mechanism. In the present study, we show that amino-Nogo decreases Rac1 activity and inhibits fibroblast spreading. 12-O-Tetradecanoylphorbol-13-acetate-type tumor promoters, such as phorbol 12-myristate 13-acetate (PMA) and teleocidin, increase Rac1 activity and overcome the amino-Nogo-induced inhibition of cell spreading. The stimulating effect of tumor promoters on cell spreading requires activation of protein kinase D and the subsequent activation of Akt1. Furthermore, we identified Akt1 as a new signaling component of the amino-Nogo pathway. Akt1 phosphorylation is decreased by amino-Nogo. Activation of Akt1 with a cell-permeable peptide, TAT-TCL1, blocks the amino-Nogo inhibition. Finally, we provide evidence that these signaling pathways operate in neurons in addition to fibroblasts. Our results suggest that activation of protein kinase D and Akt1 are approaches to promote axonal regeneration after injury.	[Doherty, Patrick; Walsh, Frank S.] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 9RT, England; [Deng, Kangwen; Gao, Ying; Cao, Zixuan; Wood, Andrew] Pfizer Global Res & Dev, Neurosci Res, Princeton, NJ 08543 USA; [Graziani, Edmund I.] Pfizer Global Res & Dev, Pearl River, NY 10965 USA	University of London; King's College London; Pfizer; Pfizer	Walsh, FS (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 9RT, England.	frank.s.walsh@kcl.ac.uk	Doherty, Patrick/A-8752-2008	Doherty, Patrick/0000-0002-0407-5689				AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Cao ZX, 2010, MOL CELL NEUROSCI, V43, P1, DOI 10.1016/j.mcn.2009.07.008; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Dergham P, 2002, J NEUROSCI, V22, P6570; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; FUJIKI H, 1984, BIOCHEM BIOPH RES CO, V120, P339, DOI 10.1016/0006-291X(84)91259-2; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hasegawa Y, 2004, J NEUROSCI, V24, P6826, DOI 10.1523/JNEUROSCI.1856-04.2004; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiromura M, 2004, J BIOL CHEM, V279, P53407, DOI 10.1074/jbc.M403775200; HSU L, 1984, MUSCLE NERVE, V7, P211, DOI 10.1002/mus.880070305; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kubo Takekazu, 2007, Recent Pat CNS Drug Discov, V2, P173, DOI 10.2174/157488907782411738; LEACH KL, 1983, P NATL ACAD SCI-BIOL, V80, P4208, DOI 10.1073/pnas.80.14.4208; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; McDunn JE, 2008, FASEB J, V22, P561, DOI 10.1096/fj.07-8283com; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Niederost B, 2002, J NEUROSCI, V22, P10368; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Obara Y, 2007, LIFE SCI, V80, P1669, DOI 10.1016/j.lfs.2007.01.057; Oertle T, 2003, J NEUROSCI, V23, P5393; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Rozengurt E, 1995, MUTAT RES-FUND MOL M, V333, P153, DOI 10.1016/0027-5107(95)00141-7; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	46	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6425	6433		10.1074/jbc.M109.071548	http://dx.doi.org/10.1074/jbc.M109.071548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018888	Green Published, hybrid			2022-12-27	WOS:000275367500047
J	Tobisawa, Y; Imai, Y; Fukuda, M; Kawashima, H				Tobisawa, Yuki; Imai, Yasuyuki; Fukuda, Minoru; Kawashima, Hiroto			Sulfation of Colonic Mucins by N-Acetylglucosamine 6-O-Sulfotransferase-2 and Its Protective Function in Experimental Colitis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGANDS; HISTONE DEACETYLASE; HEPARAN-SULFATE; MUC2 MUCIN; SULFOTRANSFERASES; EXPRESSION; ROLES; SPECIFICITIES; LOCALIZATION; RECOGNITION	N-Acetylglucosamine 6-O-sulfotransferase-2 (GlcNAc6ST-2) catalyzes the sulfation of mucin-like glycoproteins, which function as ligands for a lymphocyte homing receptor, L-selectin, in the lymph node high endothelial venules (HEVs). We previously showed that GlcNAc6ST-2 is expressed not only in lymph node HEVs but also in the colonic epithelial cells in mice. Here we investigated the regulatory mechanism and physiological significance of colonic expression of GlcNAc6ST-2 in mice. Treatment of a mouse colonic epithelial cell line with butyrate, a short-chain fatty acid produced by anaerobic bacteria, induced GlcNAc6ST-2 expression in the presence of epidermal growth factor. Administration of butyrate in the drinking water stimulated GlcNAc6ST-2 expression in the mouse intestine, indicating that butyrate could serve as a regulatory molecule for the GlcNAc6ST-2 expression in vivo. Immunohistochemical analysis indicated that the sulfation of colonic mucins was greatly diminished in GlcNAc6ST-2-deficient mice. Liquid chromatography coupled to electrospray ionization tandem mass spectrometry of the colonic-mucin O-glycans from wild-type and GlcNAc6ST-2-deficient mice showed that GlcNAc-6-O-sulfation was the predominant sulfate modification of these mucins, and it was exclusively mediated by GlcNAc6ST-2. After colitis induction by dextran sulfate sodium, significantly more leukocyte infiltration was observed in the colon of GlcNAc6ST-2-deficient mice than in that of wild-type mice, indicating that the sulfation of colonic mucins by GlcNAc6ST-2 has a protective function in experimental colitis. These findings indicate that GlcNAc6ST-2, whose expression is regulated by butyrate, is a major sulfotransferase in the biosynthesis of sulfomucins in the mouse colon, where they serve as a mucosal barrier against colonic inflammation.	[Tobisawa, Yuki; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Tobisawa, Yuki; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Global COE Program, Shizuoka 4228526, Japan; [Fukuda, Minoru] Burnham Inst Med Res, Tumor Microenvironm Program, Canc Res Ctr, La Jolla, CA 92037 USA; [Kawashima, Hiroto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Shizuoka; University of Shizuoka; Sanford Burnham Prebys Medical Discovery Institute; Japan Science & Technology Agency (JST)	Kawashima, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan.	kawashih@u-shizuoka-ken.ac.jp	Tobisawa, Yuki/G-3802-2014; Imai, Yasuyuki/E-8701-2010	Tobisawa, Yuki/0000-0001-8026-9541; Imai, Yasuyuki/0000-0002-8937-0221	National Institutes of Health [P01CA71932]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390023, 20057022]; Takeda Science Foundation; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant P01CA71932 (to M.F.), Grants-in-aid for Scientific Research, Category (B) and Grants-in-aid for Scientific Research on Priority Areas, Dynamics of Extracellular Environments, from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21390023 and 20057022, respectively, to H.K.), and the Takeda Science Foundation (to H.K.).	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; de Graffenried CL, 2003, J BIOL CHEM, V278, P40282, DOI 10.1074/jbc.M304928200; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Honke K, 2004, GLYCOCONJUGATE J, V21, P59, DOI 10.1023/B:GLYC.0000043749.06556.3d; Hurd EA, 2005, GLYCOBIOLOGY, V15, P1002, DOI 10.1093/glycob/cwi089; IRIMURA T, 1991, CANCER RES, V51, P5728; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima H, 2006, BIOL PHARM BULL, V29, P2343, DOI 10.1248/bpb.29.2343; Kawashima H, 2009, J IMMUNOL, V182, P5461, DOI 10.4049/jimmunol.0802327; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Naldi M, 2006, J CHROMATOGR A, V1129, P73, DOI 10.1016/j.chroma.2006.06.100; RAOUF AH, 1992, CLIN SCI, V83, P623, DOI 10.1042/cs0830623; Sanderson IR, 2007, J NUTR, V137, p2557S, DOI 10.1093/jn/137.11.2557S; Seko A, 2002, GLYCOBIOLOGY, V12, P379, DOI 10.1093/glycob/12.6.379; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPICER SS, 1981, J HISTOCHEM CYTOCHEM, V29, P994, DOI 10.1177/29.9.6169762; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Tsuiji H, 1998, BIOCHEM BIOPH RES CO, V253, P374, DOI 10.1006/bbrc.1998.9726; TSUKADA T, 1993, ONCOGENE, V8, P3313; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; YAMORI T, 1987, CANCER RES, V47, P2741; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	46	64	67	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6750	6760		10.1074/jbc.M109.067082	http://dx.doi.org/10.1074/jbc.M109.067082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018871	hybrid, Green Published			2022-12-27	WOS:000275367500078
J	Jerneren, F; Sesma, A; Francheschetti, M; Hamberg, M; Oliw, EH				Jerneren, Fredrik; Sesma, Ane; Francheschetti, Marina; Hamberg, Mats; Oliw, Ernst H.			Gene Deletion of 7,8-Linoleate Diol Synthase of the Rice Blast Fungus STUDIES ON PATHOGENICITY, STEREOCHEMISTRY, AND OXYGENATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNAPORTHE-GRISEA; LINOLEIC-ACID; APPRESSORIUM FORMATION; GAEUMANNOMYCES-GRAMINIS; HYDROPEROXIDE ISOMERASE; ASPERGILLUS-NIDULANS; PLANT INFECTION; MASS-SPECTROMETRY; MAP KINASE; REVEALS	Linoleate diol synthases (LDS) are heme enzymes, which oxygenate 18:2n-6 sequentially to (8R)-hydroperoxylinoleic acid ((8R)-HPODE) and to(5S,8R)-dihydroxy-, (7S,8S)-dihydroxy-, or (8R,11S)-dihydroxylinoleic acids (DiHODE). The genome of the rice blast fungus, Magnaporthe oryzae, contains two genes with homology to LDS. M. oryzae oxidized 18:2n-6 to (8R)-HPODE and to (7S,8S)-DiHODE, (6S,8R)-DiHODE, and (8R,11S)-HODE. Small amounts of 10-hydroxy-(8E,12Z)-octadecadienoic acid and traces of 5,8-DiHODE were also detected by liquid chromatography-mass spectrometry. The contribution of the 7,8-LDS gene to M. oryzae pathogenicity was evaluated by replacement of the catalytic domain with hygromycin and green fluorescent protein variant (SGFP) cassettes. This genetically modified strain Delta 7,8-LDS infected rice leaves and roots and formed appressoria and conidia as the native fungus. The Delta 7,8-LDS mutant had lost the capacity to biosynthesize all the metabolites except small amounts of 8-hydroxylinoleic acid. Studies with stereospecifically deuterated linoleic acids showed that (8R)-HPODE was formed by abstraction of the pro-S hydrogen at C-8 and antarafacial oxygenation, whereas (7S,8S)-DiHODE and (8R,11S)-DiHODE were formed from (8R)-HPODE by suprafacial hydrogen abstraction and oxygenation at C-7 and C-11, respectively. A mac1 suppressor mutant (Delta mac1 sum1-99) of M. oryzae, which shows cAMP-independent protein kinase A activity, oxygenated 18:2n-6 to increased amounts of (10R)-HPODE and (5S,8R)-DiHODE. Expression of the 7,8-LDS gene but not of the second homologue was detected in the suppressor mutant. This suggests that PKA-mediated signaling pathway regulates the dioxygenase and hydroperoxide isomerase activities of M. oryzae.	[Jerneren, Fredrik; Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Sect Biochem Pharmacol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Sesma, Ane; Francheschetti, Marina] John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Uppsala University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Sect Biochem Pharmacol, Biomed Ctr, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	Sesma, Ane/AAF-4796-2021; Sesma, Ane/A-8883-2010	Sesma, Ane/0000-0003-3982-8932; Hamberg, Mats/0000-0002-8910-7810; Oliw, Ernst/0000-0002-7986-8130; Jerneren, Fredrik/0000-0003-0897-7177	Vetenskapsradet Medicin [03X-06523]; The Knut and Alice Wallenberg Foundation [KAW 2004.0123]; The Swedish Research Council for Environmental, Agricultural Sciences [222-2005-1733]; Spatial Planning Project [229-2004833]; The Biotechnology and Biological Sciences Research Council [BB/C520720/1]; Biotechnology and Biological Sciences Research Council [BB/C520720/1] Funding Source: researchfish	Vetenskapsradet Medicin; The Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); The Swedish Research Council for Environmental, Agricultural Sciences; Spatial Planning Project; The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Vetenskapsradet Medicin/Grant 03X-06523 (to E.O.), The Knut and Alice Wallenberg Foundation/Grant KAW 2004.0123 and Formas/Grant 222-2005-1733, The Swedish Research Council for Environmental, Agricultural Sciences, and Spatial Planning Project 229-2004833 (to M.H.), and The Biotechnology and Biological Sciences Research Council Grant BB/C520720/1, United Kingdom (to A.S.).	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; Cannon P. F., 1994, Systema Ascomycetum, V13, P25; Capdevila JH, 1996, J BIOL CHEM, V271, P22663, DOI 10.1074/jbc.271.37.22663; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Cook RJ, 2003, PHYSIOL MOL PLANT P, V62, P73, DOI 10.1016/S0885-5765(03)00042-0; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Cristea M, 2003, LIPIDS, V38, P1275, DOI 10.1007/s11745-003-1189-3; Dagenais TRT, 2008, INFECT IMMUN, V76, P3214, DOI 10.1128/IAI.00009-08; DAVIS LV, 1994, BUILDING WOMENS STRE, P1; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deng JX, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-30; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; HASLBECK F, 1983, BIOCHIM BIOPHYS ACTA, V750, P185, DOI 10.1016/0005-2760(83)90219-9; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Huber SMFE, 2002, MOL GENET GENOMICS, V267, P757, DOI 10.1007/s00438-002-0717-y; JERNEREN F, 2010, BIOCH BIOPH IN PRESS; Kitazume T, 2000, J BIOL CHEM, V275, P39734, DOI 10.1074/jbc.M005617200; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; Oliw EH, 2001, BIOCHEM PHARMACOL, V62, P407, DOI 10.1016/S0006-2952(01)00683-9; Ou SH, 1985, RICE DIS; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Rho HS, 2001, MOL CELLS, V12, P407; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Talbot NJ, 2001, ADV BOT RES, V34, P263, DOI 10.1016/S0065-2296(01)34011-9; TALBOT NJ, 2001, MOL CELLULAR BIOL FI, P25; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Wadman MW, 2005, LIPIDS, V40, P1163, DOI 10.1007/s11745-005-1481-2; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696	50	27	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5308	5316		10.1074/jbc.M109.062810	http://dx.doi.org/10.1074/jbc.M109.062810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20023302	Green Published, hybrid			2022-12-27	WOS:000275327200024
J	Jones, L; Tedrick, K; Baier, A; Logan, MR; Eitzen, G				Jones, Lynden; Tedrick, Kelly; Baier, Alicia; Logan, Michael R.; Eitzen, Gary			Cdc42p Is Activated during Vacuole Membrane Fusion in a Sterol-dependent Subreaction of Priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; ACTIN POLYMERIZATION; GRANULE EXOCYTOSIS; HUMAN NEUTROPHILS; CELL POLARITY; YEAST; TRANSFORMATION; TRAFFICKING; HYDROLYSIS; BINDING	Cdc42p is a Rho GTPase that initiates signaling cascades at spatially defined intracellular sites for many cellular functions. We have previously shown that Cdc42p is localized to the yeast vacuole where it initiates actin polymerization during membrane fusion. Here we examine the activation cycle of Cdc42p during vacuole membrane fusion. Expression of either GTP- or GDP-locked Cdc42p mutants caused several morphological defects including enlarged cells and fragmented vacuoles. Stimulation of multiple rounds of fusion enhanced vacuole fragmentation, suggesting that cycles of Cdc42p activation, involving rounds of GTP binding and hydrolysis, are required to propagate Cdc42p signaling. We developed an assay to directly examine Cdc42p activation based on affinity to a probe derived from the p21-activated kinase effector, Ste20p. Cdc42p was rapidly activated during vacuole membrane fusion, which kinetically coincided with priming subreaction. During priming, Sec18p ATPase activity dissociates SNARE complexes and releases Sec17p, however, priming inhibitors such as Sec17p and Sec18p ligands did not block Cdc42p activation. Therefore, Cdc42p activation seems to be a parallel subreaction of priming, distinct from Sec18p activity. Specific mutants in the ergosterol synthesis pathway block both Sec17p release and Cdc42p activation. Taken together, our results define a novel sterol-dependent subreaction of vacuole priming that activates cycles of Cdc42p activity to facilitate membrane fusion.	[Jones, Lynden; Tedrick, Kelly; Baier, Alicia; Logan, Michael R.; Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, 5-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	gary.eitzen@ualberta.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR).	Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Davis CR, 1998, J BIOL CHEM, V273, P849, DOI 10.1074/jbc.273.2.849; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fidyk N, 2006, BIOCHEMISTRY-US, V45, P7750, DOI 10.1021/bi060365h; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Merz AJ, 2004, P NATL ACAD SCI USA, V101, P11548, DOI 10.1073/pnas.0404583101; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Pruyne D, 2000, J CELL SCI, V113, P365; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Tedrick K, 2004, MOL BIOL CELL, V15, P4609, DOI 10.1091/mbc.E04-03-0194; Vanni C, 2005, CELL CYCLE, V4, P1675, DOI 10.4161/cc.4.11.2170; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007	34	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4298	4306		10.1074/jbc.M109.074609	http://dx.doi.org/10.1074/jbc.M109.074609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007700	Green Published, hybrid			2022-12-27	WOS:000275274800006
J	Sohma, Y; Hua, QX; Liu, M; Phillips, NB; Hu, SQ; Whittaker, J; Whittaker, LJ; Ng, A; Roberts, CT; Arvan, P; Kent, SBH; Weiss, MA				Sohma, Youhei; Hua, Qing-xin; Liu, Ming; Phillips, Nelson B.; Hu, Shi-Quan; Whittaker, Jonathan; Whittaker, Linda J.; Ng, Aubree; Roberts, Charles T., Jr.; Arvan, Peter; Kent, Stephen B. H.; Weiss, Michael A.			Contribution of Residue B5 to the Folding and Function of Insulin and IGF-I CONSTRAINTS AND FINE-TUNING IN THE EVOLUTION OF A PROTEIN FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; 3-DIMENSIONAL SOLUTION STRUCTURE; PANCREATIC TRYPSIN-INHIBITOR; TOTAL CHEMICAL-SYNTHESIS; ENDOPLASMIC-RETICULUM; RECEPTOR-BINDING; BIOLOGICAL-ACTIVITY; DIABETES-MELLITUS; CRYSTAL-STRUCTURE; DISULFIDE BONDS	Proinsulin exhibits a single structure, whereas insulin-like growth factors refold as two disulfide isomers in equilibrium. Native insulin-related growth factor (IGF)-I has canonical cystines (A6-A11, A7-B7, and A20-B19) maintained by IGF-binding proteins; IGF-swap has alternative pairing (A7-A11, A6-B7, and A20-B19) and impaired activity. Studies of mini-domain models suggest that residue B5 (His in insulin and Thr in IGFs) governs the ambiguity or uniqueness of disulfide pairing. Residue B5, a site of mutation in proinsulin causing neonatal diabetes, is thus of broad biophysical interest. Here, we characterize reciprocal B5 substitutions in the two proteins. In insulin, His(B5)-> Thr markedly destabilizes the hormone (Delta Delta G(u) 2.0 +/- 0.2 kcal/mol), impairs chain combination, and blocks cellular secretion of proinsulin. The reciprocal IGF-I substitution Thr(B5)-> His (residue 4) specifies a unique structure with native H-1 NMR signature. Chemical shifts and nuclear Overhauser effects are similar to those of native IGF-I. Whereas wild-type IGF-I undergoes thiol-catalyzed disulfide exchange to yield IGF-swap, His(B5)-IGF-I retains canonical pairing. Chemical denaturation studies indicate that His(B5) does not significantly enhance thermodynamic stability (Delta Delta Gu 0.2 +/- 0.2 kcal/mol), implying that the substitution favors canonical pairing by destabilizing competing folds. Whereas the activity of Thr(B5)-insulin is decreased 5-fold, His(B5)-IGF-I exhibits 2-fold increased affinity for the IGF receptor and augmented post-receptor signaling. We propose that conservation of Thr(B5) in IGF-I, rescued from structural ambiguity by IGF-binding proteins, reflects fine-tuning of signal transduction. In contrast, the conservation of HisB5 in insulin highlights its critical role in insulin biosynthesis.	[Hua, Qing-xin; Phillips, Nelson B.; Hu, Shi-Quan; Whittaker, Jonathan; Whittaker, Linda J.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Sohma, Youhei; Kent, Stephen B. H.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sohma, Youhei; Kent, Stephen B. H.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Liu, Ming; Arvan, Peter] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Ng, Aubree; Roberts, Charles T., Jr.] Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Roberts, Charles T., Jr.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA	Case Western Reserve University; University of Chicago; University of Chicago; University of Michigan System; University of Michigan; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	maw21@case.edu	Roberts, Charles/K-6953-2017	Roberts, Charles/0000-0003-1756-5772	National Institutes of Health [DK48280, R01 DK069764, R01 DK40949]; Department of Energy [DE-FG02-04ER63786]; American Diabetes Association [ADA 1-08-RA-218]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK048280, R01DK040949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK48280 (to P. A.), Department of Energy Grant DE-FG02-04ER63786 (to S. B. H. K.), and National Institutes of Health Grants R01 DK069764 and R01 DK40949 (to M. A. W.). This work was also supported by American Diabetes Association Grant ADA 1-08-RA-218 (to M. A. W.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology and Institute for Biophysical Dynamics at the University of Chicago.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BRYANT C, 1992, BIOCHEMISTRY-US, V31, P5692, DOI 10.1021/bi00140a002; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURKHARDT E, 1994, HUM GENET, V94, P91, DOI 10.1007/BF02272850; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; CREIGHTON T, 1995, PHILOS T ROY SOC B, V348, P5, DOI 10.1098/rstb.1995.0039; Creighton TE, 1997, BIOL CHEM, V378, P731; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Denley A, 2006, ENDOCRINOLOGY, V147, P1029, DOI 10.1210/en.2005-0736; DEVROEDE MA, 1986, DIABETES, V35, P355, DOI 10.2337/diabetes.35.3.355; DeWolf E, 1996, PROTEIN SCI, V5, P2193; DiMarchi RD, 1992, PEPTIDES CHEM BIOL, P26; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P1556, DOI 10.1021/bi011166v; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P10585, DOI 10.1021/bi020165f; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; HEJNAES KR, 1992, PROTEIN ENG, V5, P797, DOI 10.1093/protein/5.8.797; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hober S, 1999, FEBS LETT, V443, P271, DOI 10.1016/S0014-5793(98)01737-2; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang QL, 2007, BIOCHEMISTRY-US, V46, P218, DOI 10.1021/bi0616798; HUDSON P, 1984, EMBO J, V3, P2333, DOI 10.1002/j.1460-2075.1984.tb02135.x; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Johnson ECB, 2007, TETRAHEDRON LETT, V48, P1795, DOI 10.1016/j.tetlet.2007.01.030; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Katugampola S, 2003, TRENDS PHARMACOL SCI, V24, P30, DOI 10.1016/S0165-6147(02)00007-X; Liu AZ, 2007, J MAGN RESON, V186, P319, DOI 10.1016/j.jmr.2007.02.008; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Magee BA, 1999, BIOCHEMISTRY-US, V38, P15863, DOI 10.1021/bi9910070; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; Milner SJ, 1999, BIOTECHNOL BIOENG, V62, P693; NAGATA K, 1995, J MOL BIOL, V253, P749, DOI 10.1006/jmbi.1995.0588; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SATO A, 1992, J BIOCHEM-TOKYO, V111, P529, DOI 10.1093/oxfordjournals.jbchem.a123791; SATO A, 1993, INT J PEPT PROT RES, V41, P433; Sato A, 2000, J PEPT RES, V56, P218, DOI 10.1034/j.1399-3011.2000.00769.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SCHWARZ RT, 1991, BEHRING I MITT, V89, P198; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SMITH MC, 1989, J BIOL CHEM, V264, P9314; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; WEISSMAN JS, 1992, P NATL ACAD SCI USA, V89, P9900, DOI 10.1073/pnas.89.20.9900; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yan H, 2003, PROTEIN SCI, V12, P768, DOI 10.1110/ps.0237203; Yun CH, 2005, BIOCHEM BIOPH RES CO, V326, P52, DOI 10.1016/j.bbrc.2004.10.203; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	108	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5040	5055		10.1074/jbc.M109.062992	http://dx.doi.org/10.1074/jbc.M109.062992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959476	hybrid, Green Published			2022-12-27	WOS:000275274800080
J	Suzuki, S; Zhou, Y; Refaat, A; Takasaki, I; Koizumi, K; Yamaoka, S; Tabuchi, Y; Saiki, I; Sakurai, H				Suzuki, Shunsuke; Zhou, Yue; Refaat, Alaa; Takasaki, Ichiro; Koizumi, Keiichi; Yamaoka, Shoji; Tabuchi, Yoshiaki; Saiki, Ikuo; Sakurai, Hiroaki			Human T Cell Lymphotropic Virus 1 Manipulates Interferon Regulatory Signals by Controlling the TAK1-IRF3 and IRF4 Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; GENE INDUCTION; FACTOR FAMILY; RNA HELICASE; KINASE TAK1; HTLV-1 TAX; RIG-I; ACTIVATION; LEUKEMIA	We previously reported that human T cell lymphotropic virus 1 (HTLV-1) Tax oncoprotein constitutively activates transforming growth factor-beta-activated kinase 1 (TAK1). Here, we established Tax-positive HuT-102 cells stably transfected with a short hairpin RNA vector (HuT-shTAK1 cells) and investigated the physiological function of TAK1. Microarray analysis demonstrated that several interferon (IFN)-inducible genes, including chemokines such as CXCL10 and CCL5, were significantly down-regulated in HuT-shTAK1 cells. In contrast, Tax-mediated constitutive activation of nuclear factor-kappa B (NF-kappa B) was intact in HuT-shTAK1 cells. IFN-regulatory factor 3 (IRF3), a critical transcription factor in innate immunity to viral infection, was constitutively activated in a Tax-dependent manner. Activation of IRF3 and IRF3-dependent gene expressions was dependent on TAK1 and TANK-binding kinase 1 (TBK1). On the other hand, IRF4, another member in the IRF family of transcription factors overexpressed in a Tax-independent manner, negatively regulated TAK1-dependent IRF3 transcriptional activity. Together, HTLV-1 manipulates IFN signaling by regulating both positive and negative IRFs.	[Suzuki, Shunsuke; Zhou, Yue; Refaat, Alaa; Koizumi, Keiichi; Saiki, Ikuo; Sakurai, Hiroaki] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Takasaki, Ichiro; Tabuchi, Yoshiaki] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Toyama 9300194, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan	University of Toyama; University of Toyama; Tokyo Medical & Dental University (TMDU)	Sakurai, H (corresponding author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, 2630 Sugitani, Toyama 9300194, Japan.	hsakurai@inm.u-toyama.ac.jp	Refaat, Alaa/F-3596-2018; Sakurai, Hiroaki/AAE-4294-2019; Koizumi, Keiichi/AAG-6915-2019	Refaat, Alaa/0000-0002-7821-2500; Sakurai, Hiroaki/0000-0003-0657-9570; Zhou, Yue/0000-0002-1335-5703; Tabuchi, Yoshiaki/0000-0002-6007-6176	Ministry of Education, Culture, Sports, Science, and Technology, Japan [C 19590063, 20890078]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Scientific Research (C 19590063), Young Scientists Start-up Grant 20890078, a grant for the Cooperative Link of Unique Science and Technology for Economy Revitalization from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a grant from Takeda Science Foundation.	Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Imaizumi Y, 2001, JPN J CANCER RES, V92, P1284, DOI 10.1111/j.1349-7006.2001.tb02151.x; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Miura H, 2005, EXP CELL RES, V308, P29, DOI 10.1016/j.yexcr.2005.04.005; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Sharma S, 2000, AIDS RES HUM RETROV, V16, P1613, DOI 10.1089/08892220050193047; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Takasaki I, 2007, J CELL BIOCHEM, V102, P1472, DOI 10.1002/jcb.21369; Wu XF, 2007, EMBO REP, V8, P510, DOI 10.1038/sj.embor.7400931; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8; Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	31	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4441	4446		10.1074/jbc.M109.031476	http://dx.doi.org/10.1074/jbc.M109.031476			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19955181	hybrid, Green Published			2022-12-27	WOS:000275274800021
J	Zhang, XJ; Skiba, NP; Cote, RH				Zhang, Xiu-Jun; Skiba, Nikolai P.; Cote, Rick H.			Structural Requirements of the Photoreceptor Phosphodiesterase gamma-Subunit for Inhibition of Rod PDE6 Holoenzyme and for Its Activation by Transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; RETINAL CGMP-PHOSPHODIESTERASE; ALPHA-SUBUNIT; CATALYTIC SUBUNITS; BINDING-SITES; G-PROTEIN; GAF DOMAINS; ALLOSTERIC REGULATION; CARBOXYL-TERMINUS; PURIFICATION	The central enzyme of the visual transduction cascade, cGMP phosphodiesterase (PDE6), is regulated by its gamma-subunit (P gamma), whose inhibitory constraint is released upon binding of activated transducin. It is generally believed that the last four or five C-terminal amino acid residues of P gamma are responsible for blocking catalysis. In this paper, we showed that the last 10 C-terminal residues (P gamma 78-87) are the minimum required to completely block catalysis. The kinetic mechanism of inhibition by the P gamma C terminus depends on which substrate is undergoing catalysis. We also discovered a second mechanism of P gamma inhibition that does not require this C-terminal region and that is capable of inhibiting up to 80% of the maximal cGMP hydrolytic rate. Furthermore, amino acids 63-70 and/or the intact alpha 2 helix of P gamma stabilize binding of C-terminal P gamma peptides by 100-fold. When PDE6 catalytic subunits were reconstituted with portions of the P gamma molecule and tested for activation by transducin, we found that the C-terminal region (P gamma 63-87) by itself could not be displaced but that transducin could relieve inhibition of certain P gamma truncation mutants. Our results are consistent with two distinct mechanisms of P gamma inhibition of PDE6. One involves direct interaction of the C-terminal residues with the catalytic site. A second regulatory mechanism may involve binding of other regions of P gamma to the catalytic domain, thereby allosterically reducing the catalytic rate. Transducin activation of PDE6 appears to require interaction with both the C terminus and other regions of P gamma to effectively relieve its inhibitory constraint.	[Zhang, Xiu-Jun; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Skiba, Nikolai P.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	University System Of New Hampshire; University of New Hampshire; Duke University	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798]; NATIONAL EYE INSTITUTE [P30EY005722, R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN NG, 1992, EUR J BIOCHEM, V208, P659, DOI 10.1111/j.1432-1033.1992.tb17232.x; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote R. H., 2008, VISUAL TRANSDUCTION, P141; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, MOL PHARMACOL, V55, P508; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Farber DB, 2003, FRONT BIOSCI, V8, pS666, DOI 10.2741/1111; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Jungbauer A, 2001, J CLIN LIGAND ASSAY, V24, P270; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; LIPKIN VM, 1993, BIOCHIM BIOPHYS ACTA, V1176, P250, DOI 10.1016/0167-4889(93)90052-Q; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Moussaif M, 2006, J NEUROSCI, V26, P6863, DOI 10.1523/JNEUROSCI.1322-06.2006; Muradov KG, 2000, J BIOL CHEM, V275, P6969, DOI 10.1074/jbc.275.10.6969; Natochin M, 1996, J BIOL CHEM, V271, P19964, DOI 10.1074/jbc.271.33.19964; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pentia Dana C., 2005, V307, P125; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Salchow DJ, 1999, INVEST OPHTH VIS SCI, V40, P3262; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tsang SH, 2002, VISION RES, V42, P439, DOI 10.1016/S0042-6989(01)00213-9; Tsang SH, 2001, BIOCHEM J, V353, P467, DOI 10.1042/0264-6021:3530467; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Wensel Theodore G., 2005, V307, P289; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	54	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4455	4463		10.1074/jbc.M109.057406	http://dx.doi.org/10.1074/jbc.M109.057406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948718	Green Published, hybrid			2022-12-27	WOS:000275274800023
J	Behrendt, M; Polaina, J; Naim, HY				Behrendt, Marc; Polaina, Julio; Naim, Hassan Y.			Structural Hierarchy of Regulatory Elements in the Folding and Transport of an Intestinal Multidomain Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTASE-PHLORHIZIN HYDROLASE; BETA-GLUCOSIDASE; PHLORIZIN HYDROLASE; INTRACELLULAR-TRANSPORT; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; MEMBRANE; ENZYME; EXPRESSION; BIOSYNTHESIS	Human intestinal lactase-phlorizin hydrolase, LPH, encompasses four homologous domains, which presumably have evolved from two subsequent duplications of one ancestral gene. The profragment, LPH alpha, comprises homologous domains I and II and functions as an intramolecular chaperone in the context of the brush-border LPH beta region of LPH. Here, we analyze the inter-relationship between homologous domains III and IV of LPH beta and their implication in the overall structure, function, and trafficking of LPH. In silico analyses revealed potential domain boundaries for these domains as a basis for loop-out mutagenesis and construction of deletion or individual domain forms of LPH. Removal of domain IV, which contains lactase, results in a diminished phlorizin hydrolase activity, lack of dimerization in the endoplasmic reticulum (ER), but accelerated transport kinetics from the ER to the Golgi apparatus. By contrast, deletion of domain III, which harbors phlorizin hydrolase, generates a malfolded protein that is blocked in the ER. Interestingly, homologous domain III is transport-competent per se and sorted to the apical membrane in polarized Madin-Darby canine kidney cells. Nevertheless, it neither dimerizes nor acquires complete phlorizin hydrolase activity. Our data present a hierarchical model of LPH in which the homologous domain III constitutes (i) a fully autonomous core domain within LPH and (ii) another intramolecular chaperone besides the profragment LPH alpha. Nevertheless, the regulation of the trafficking kinetics and activity of domain III and entire LPH including elevation of the enzymatic activities require the correct dimerization of LPH in the ER, an event that is accomplished by the non-autonomous domain IV.	[Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany; [Polaina, Julio] Univ Valencia, CSIC, Inst Agroquim & Tecnol Alimentos, E-46100 Valencia, Spain	University of Veterinary Medicine Hannover, Foundation; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.	Hassan.Naim@tiho-hannover.de	Polaina, Julio/H-4498-2012	Polaina, Julio/0000-0001-9912-0640	German Research Foundation Deutsche Forschungsgemeinschaft [Na 331/1-5]; Sonderforschungsbereich [621]	German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation Deutsche Forschungsgemeinschaft (Grant Na 331/1-5) and Sonderforschungsbereich (Grant 621) (to H. Y. N.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Behrendt M, 2009, GASTROENTEROLOGY, V136, P2295, DOI 10.1053/j.gastro.2009.01.041; BULLER HA, 1990, ANNU REV MED, V41, P141; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; DANIELSEN EM, 1984, BIOCHEM BIOPH RES CO, V122, P82; DIGEON B, 1986, Digestive Diseases, V4, P139, DOI 10.1159/000171144; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Jacob R, 1996, EUR J BIOCHEM, V236, P789, DOI 10.1111/j.1432-1033.1996.t01-1-00789.x; Jacob R, 2000, J BIOL CHEM, V275, P10630, DOI 10.1074/jbc.275.14.10630; Jacob R, 2002, J BIOL CHEM, V277, P8217, DOI 10.1074/jbc.M111500200; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; JACOB R, 1994, J BIOL CHEM, V269, P2712; MAIURI L, 1991, GASTROENTEROLOGY, V100, P359, DOI 10.1016/0016-5085(91)90203-W; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NAIM HY, 1991, J BIOL CHEM, V266, P12313; NAIM HY, 1994, J BIOL CHEM, V269, P26933; Naim HY, 1996, EUR J CELL BIOL, V70, P198; Naim HY, 2001, HISTOL HISTOPATHOL, V16, P553, DOI 10.14670/HH-16.553; Nijikken Y, 2007, FEBS LETT, V581, P1514, DOI 10.1016/j.febslet.2007.03.009; OBERHOLZER T, 1993, FEBS LETT, V333, P127, DOI 10.1016/0014-5793(93)80389-C; Ouwendijk J, 1998, J BIOL CHEM, V273, P6650, DOI 10.1074/jbc.273.12.6650; Panzer P, 1998, J BIOL CHEM, V273, P13861, DOI 10.1074/jbc.273.22.13861; PHILLIPS T, 1978, P NUTR SOC, V37, pA24; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; STEINER DF, 1984, J CELL BIOCHEM, V24, P121, DOI 10.1002/jcb.240240204; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657; Wuthrich M, 1996, ARCH BIOCHEM BIOPHYS, V336, P27, DOI 10.1006/abbi.1996.0528; YEH KY, 1991, AM J PHYSIOL, V260, pG379, DOI 10.1152/ajpgi.1991.260.3.G379; Zecca L, 1998, FEBS LETT, V435, P225, DOI 10.1016/S0014-5793(98)01076-X	38	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4143	4152		10.1074/jbc.M109.060780	http://dx.doi.org/10.1074/jbc.M109.060780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955176	Green Published, hybrid			2022-12-27	WOS:000275254000066
J	Irie, K; Kitagawa, K; Nagura, H; Imai, T; Shimomura, T; Fujiyoshi, Y				Irie, Katsumasa; Kitagawa, Kazuya; Nagura, Hitoshi; Imai, Tomoya; Shimomura, Takushi; Fujiyoshi, Yoshinori			Comparative Study of the Gating Motif and C-type Inactivation in Prokaryotic Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; SHAKER K-CHANNELS; ALKALIPHILIC BACILLUS; POTASSIUM CHANNEL; SP-NOV.; PORE; SPECTROSCOPY; CHEMOTAXIS; ACTIVATION; MOTILITY	Prokaryotic voltage-gated sodium channels (Na(V)s) are homotetramers and are thought to inactivate through a single mechanism, named C-type inactivation. Here we report the voltage dependence and inactivation rate of the NaChBac channel from Bacillus halodurans, the first identified prokaryotic Na-V, as well as of three new homologues cloned from Bacillus licheniformis (Na(V)BacL), Shewanella putrefaciens (Na(V)SheP), and Roseobacter denitrificans (Na(V)RosD). We found that, although activated by a lower membrane potential, Na(V)BacL inactivates as slowly as NaChBac. Na(V)SheP and Na(V)RosD inactivate faster than NaChBac. Mutational analysis of helix S6 showed that residues corresponding to the "glycine hinge" and "PXP motif" in voltage-gated potassium channels are not obligatory for channel gating in these prokaryotic Na(V)s, but mutations in the regions changed the inactivation rates. Mutation of the region corresponding to the glycine hinge in Na(V)BacL (A214G), Na(V)SheP (A216G), and NaChBac (G219A) accelerated inactivation in these channels, whereas mutation of glycine to alanine in the lower part of helix S6 in NaChBac (G229A), Na(V)BacL (G224A), and Na(V)RosD (G217A) reduced the inactivation rate. These results imply that activation gating in prokaryotic Na(V)s does not require gating motifs and that the residues of helix S6 affect C-type inactivation rates in these channels.	[Irie, Katsumasa; Kitagawa, Kazuya; Nagura, Hitoshi; Shimomura, Takushi; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Irie, Katsumasa] Japan Biol Informat Consortium, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Tomoya] Kyoto Univ, RISH, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Fujiyoshi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Irie, Katsumasa/D-7332-2013; 今井, 友也/M-1834-2019; Fujiyoshi, Yoshinori/E-5989-2012	Irie, Katsumasa/0000-0002-8178-1552; 今井, 友也/0000-0001-7026-0287; Fujiyoshi, Yoshinori/0000-0002-8070-1493	Japan New Energy and Industrial Technology Development Organization	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grants-in-Aid for Specially Promoted Research and the Japan New Energy and Industrial Technology Development Organization.	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Choudhary M, 2007, J BACTERIOL, V189, P1914, DOI 10.1128/JB.01498-06; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fujinami S, 2007, MICROBIOL-SGM, V153, P4027, DOI 10.1099/mic.0.2007/012070-0; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humbelin M, 2002, GENE, V297, P129, DOI 10.1016/S0378-1119(02)00877-6; Ito M, 2004, MOL MICROBIOL, V53, P1035, DOI 10.1111/j.1365-2958.2004.04173.x; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; LALIK PH, 1993, AM J PHYSIOL, V264, pC803, DOI 10.1152/ajpcell.1993.264.4.C803; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; McEvoy MM, 1997, CURR OPIN STRUC BIOL, V7, P793, DOI 10.1016/S0959-440X(97)80148-0; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Nurani G, 2008, BIOCHEMISTRY-US, V47, P8114, DOI 10.1021/bi800645w; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Strompl C, 2003, INT J SYST EVOL MICR, V53, P1901, DOI 10.1099/ijs.0.02635-0; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P1263, DOI 10.1099/ijs.0.03006-0; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Ziemke F, 1998, INT J SYST BACTERIOL, V48, P179, DOI 10.1099/00207713-48-1-179	41	51	52	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3685	3694		10.1074/jbc.M109.057455	http://dx.doi.org/10.1074/jbc.M109.057455			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959480	Green Published, hybrid			2022-12-27	WOS:000275254000020
J	Mayoral, R; Valverde, AM; Izquierdo, CL; Gonzalez-Rodriguez, A; Bosca, L; Martin-Sanz, P				Mayoral, Rafael; Valverde, Angela M.; Llorente Izquierdo, Cristina; Gonzalez-Rodriguez, Agueda; Bosca, Lisardo; Martin-Sanz, Paloma			Impairment of Transforming Growth Factor beta Signaling in Caveolin-1-deficient Hepatocytes ROLE IN LIVER REGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD PROTEINS; ONCOGENIC TRANSFORMATION; HEPATOCELLULAR-CARCINOMA; FIBROBLAST CELLS; RAT HEPATOCYTES; HEPATIC CELLS; EXPRESSION; RECEPTOR; SNON; SKI	Caveolin-1 (Cav-1) is the main structural protein of caveolae and plays an important role in various cellular processes such as vesicular transport, cholesterol homeostasis, and signal transduction pathways. The expression and functional role of Cav-1 have been reported in liver and in hepatocyte cell lines, in human cirrhotic liver, and in hepatocellular carcinomas. Previous studies demonstrated that Cav-1 was dispensable for liver regeneration, because Cav-1(-/-) animals survived and fully regenerated liver function and size after partial hepatectomy. In this study, we have investigated the mechanisms by which the lack of Cav-1 accelerates liver regeneration after partial hepatectomy. The data show that transforming growth factor beta (TGF-beta) signaling is impaired in regenerating liver of Cav-1(-/-) mice and in hepatocytes derived from these animals. TGF-beta receptors I and II do not colocalize in the same membrane fraction in the hepatocytes derived from Cav-1(-/-) mice, as Smad2/3 signaling decreased in the absence of Cav-1 at the time that the transcriptional corepressor SnoN accumulates. Accordingly, the expression of TGF-beta target genes, such as plasminogen activator inhibitor-1, is decreased due to the presence of the high levels of SnoN. Moreover, hepatocyte growth factor inhibited TGF-beta signaling in the absence of Cav-1 by increasing SnoN expression. Taken together, these data might help to unravel why Cav-1-deficient mice exhibit an accelerated liver regeneration after partial hepatectomy and add new insights on the molecular mechanisms controlling the initial commitment to hepatocyte proliferation.	[Mayoral, Rafael; Valverde, Angela M.; Llorente Izquierdo, Cristina; Gonzalez-Rodriguez, Agueda; Bosca, Lisardo; Martin-Sanz, Paloma] CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Mayoral, Rafael; Bosca, Lisardo; Martin-Sanz, Paloma] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona 08036, Spain; [Valverde, Angela M.; Gonzalez-Rodriguez, Agueda] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Martin-Sanz, P (corresponding author), CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	pmartins@iib.uam.es	González-Rodróguez, Águeda/D-7651-2012; Bosca, Lisardo/A-2059-2008; Martín-Sanz, Paloma/K-1303-2014; Mayoral Monibas, Rafael/B-3563-2013	González-Rodróguez, Águeda/0000-0001-6559-0847; Bosca, Lisardo/0000-0002-0253-5469; Mayoral Monibas, Rafael/0000-0002-6645-7172	MICINN [SAF2007-60551, BFU2008-02161]; Comunidad de Madrid [S-BIO-0283/2006]; FIS-RECAVA [RD06/0014/0025]; Instituto de Salud Carlos III	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); FIS-RECAVA; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Grants SAF2007-60551 and BFU2008-02161 from MICINN, S-BIO-0283/2006 from Comunidad de Madrid, and FIS-RECAVA RD06/0014/0025. Red tematica Enfermedades Cardiovasculares, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, and Centro de Investigacion Biome dica en Red de Diabetes y Enfermedades Metabolicas Asociadas are funded by the Instituto de Salud Carlos III.	Bouzahzah B, 2000, CANCER RES, V60, P4531; Calvo M, 2001, HEPATOLOGY, V33, P1259, DOI 10.1053/jhep.2001.23937; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kim S, 2008, CELL SIGNAL, V20, P1313, DOI 10.1016/j.cellsig.2008.02.020; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Lee EK, 2007, BIOCHEM BIOPH RES CO, V359, P385, DOI 10.1016/j.bbrc.2007.05.121; Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003; Longerich T, 2004, VIRCHOWS ARCH, V445, P589, DOI 10.1007/s00428-004-1118-x; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; Martin-Sanz P, 1998, BRIT J PHARMACOL, V125, P1313, DOI 10.1038/sj.bjp.0702196; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nishikawa Y, 1998, J CELL PHYSIOL, V176, P612, DOI 10.1002/(SICI)1097-4652(199809)176:3<612::AID-JCP18>3.0.CO;2-0; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; STAVNEZER E, 1986, J VIROL, V57, P1073, DOI 10.1128/JVI.57.3.1073-1083.1986; Tan RY, 2007, J AM SOC NEPHROL, V18, P2340, DOI 10.1681/ASN.2007010128; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Wang SJ, 2008, IUBMB LIFE, V60, P693, DOI 10.1002/iub.104; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yerian LM, 2004, AM J SURG PATHOL, V28, P357, DOI 10.1097/00000478-200403000-00008; Yokomori H, 2002, LIVER, V22, P150, DOI 10.1034/j.1600-0676.2002.01588.x; Zhang F, 2003, CANCER RES, V63, P5005; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	44	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3633	3642		10.1074/jbc.M109.072900	http://dx.doi.org/10.1074/jbc.M109.072900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19966340	Green Published, hybrid			2022-12-27	WOS:000275254000015
J	Fujimoto, Y; Shiraki, T; Horiuchi, Y; Waku, T; Shigenaga, A; Otaka, A; Ikura, T; Igarashi, K; Aimoto, S; Tate, S; Morikawa, K				Fujimoto, Yoshito; Shiraki, Takuma; Horiuchi, Yuji; Waku, Tsuyoshi; Shigenaga, Akira; Otaka, Akira; Ikura, Tsuyoshi; Igarashi, Kazuhiko; Aimoto, Saburo; Tate, Shin-ichi; Morikawa, Kosuke			Proline cis/trans-Isomerase Pin1 Regulates Peroxisome Proliferator-activated Receptor gamma Activity through the Direct Binding to the Activation Function-1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; PROTEIN AP2; PHOSPHORYLATION; GENE; DIFFERENTIATION; INHIBITION; EXPRESSION; ADIPOGENESIS; METABOLISM; LIGANDS	The important roles of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) are widely accepted in various biological processes as well as metabolic diseases. Despite the worldwide quest for pharmaceutical manipulation of PPAR gamma activity through the ligand-binding domain, very little information about the activation mechanism of the N-terminal activation function-1 (AF-1) domain. Here, we demonstrate the molecular and structural basis of the phosphorylation-dependent regulation of PPAR gamma activity by a peptidyl-prolyl isomerase, Pin1. Pin1 interacts with the phosphorylated AF-1 domain, thereby inhibiting the polyubiquitination of PPAR gamma. The interaction and inhibition are dependent upon the WW domain of Pin1 but are independent of peptidyl-prolyl cis/trans-isomerase activity. Gene knockdown experiments revealed that Pin1 inhibits the PPAR gamma-dependent gene expression in THP-1 macrophage-like cells. Thus, our results suggest that Pin1 regulates macrophage function through the direct binding to the phosphorylated AF-1 domain of PPAR gamma.	[Fujimoto, Yoshito; Shiraki, Takuma; Waku, Tsuyoshi; Morikawa, Kosuke] Osaka Univ, Open Labs Adv Biosci & Biotechnol, Takara Bio Endowed Div, Dept Biomol Recognit,Inst Prot Res, Osaka 5650874, Japan; [Shiraki, Takuma; Ikura, Tsuyoshi; Igarashi, Kazuhiko] Tohoku Univ, Dept Biochem, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Horiuchi, Yuji; Tate, Shin-ichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Shigenaga, Akira; Otaka, Akira] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708505, Japan; [Shigenaga, Akira; Otaka, Akira] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Aimoto, Saburo] Osaka Univ, Inst Prot Res, Div Prot Chem, Lab Prot Organ Chem, Suita, Osaka 5650871, Japan	Osaka University; Tohoku University; Hiroshima University; Tokushima University; Tokushima University; Osaka University	Shiraki, T (corresponding author), Osaka Univ, Open Labs Adv Biosci & Biotechnol, Takara Bio Endowed Div, Dept Biomol Recognit,Inst Prot Res, 6-2-3 Furuedai, Osaka 5650874, Japan.	tshiraki@m.tains.tohoku.ac.jp; morikako@protein.osaka-u.ac.jp	Fujimoto, Yukari/M-7282-2014; Tate, Shin-ichi/E-3057-2015	Fujimoto, Yukari/0000-0001-5320-3192; Tate, Shin-ichi/0000-0002-5556-7712; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Society for the Promotion of Science [18GS0316]; Grants-in-Aid for Scientific Research [21390031] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a donation from Takara Bio, Inc. and by a Grant-in-aid for Creative Scientific Research Program (18GS0316) from the Japan Society for the Promotion of Science.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bluher M, 2003, EXP CLIN ENDOCR DIAB, V111, P85, DOI 10.1055/s-2003-39235; Cavanagh John, 1996, P410; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glass CK, 2000, GENE DEV, V14, P121; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Siegrist R, 2007, HELV CHIM ACTA, V90, P217, DOI 10.1002/hlca.200790028; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; Smet C, 2005, FEBS LETT, V579, P4159, DOI 10.1016/j.febslet.2005.06.048; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044	30	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3126	3132		10.1074/jbc.M109.055095	http://dx.doi.org/10.1074/jbc.M109.055095			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996102	Green Published, hybrid			2022-12-27	WOS:000273829000028
J	Bi, WZ; Xiao, L; Jia, YF; Wu, JB; Xie, Q; Ren, J; Ji, GJ; Yuan, ZQ				Bi, Wenzhi; Xiao, Lei; Jia, Yunfeng; Wu, Junbing; Xie, Qi; Ren, Jian; Ji, Guangju; Yuan, Zengqiang			c-Jun N-terminal Kinase Enhances MST1-mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; CELL-DEATH MACHINERY; PROMOTES APOPTOSIS; JNK PHOSPHORYLATION; STERILE-20 KINASE; HISTONE H2B; MST1 KINASE; ACTIVATION; CASPASE; PATHWAY	Protein kinases play an important role in the maintenance of homeostasis between cell survival and apoptosis. Deregulation of these kinases leads to various pathological manifestations, such as cancer and neurodegenerative diseases. The MST1 encodes a serine/threonine kinase that is activated upon apoptotic stimulation, which in turn phosphorylates its downstream targets, Histone H2B and FOXO. However, the upstream regulators of MST1 kinase have been poorly studied. In this study, we report that JNK (c-Jun N-terminal kinase) phosphorylates MST1 at serine 82, which leads to the enhancement of MST1 activation. Accordingly, the activation of MST1 phosphorylates FOXO3 at serine 207 and promotes cell death. The inhibition of JNK kinase per se attenuates MST1 activity and nuclear translocation as well as MST1-induced apoptosis. We also find the S82A (serine mutated to alanine) diminishes MST1 activation and its effect on the FOXO transcription activity. Collectively, these findings define the novel feedback regulation of MST1 kinase activation by its putative substrate, JNK, with implication for our understanding of the signaling mechanism during cell death.	[Xiao, Lei; Wu, Junbing; Xie, Qi; Ren, Jian; Ji, Guangju; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bi, Wenzhi] Chinese Peoples Liberat Army Gen Hosp, Clin Div Surg, Dept Orthoped, Beijing 100853, Peoples R China; [Jia, Yunfeng] Chinese PLA 306 Hosp, Dept Neurosurg, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese People's Liberation Army General Hospital	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	gj28@ibp.ac.cn; zqyuan@ibp.ac.cn	Xiao, Lei/I-3655-2017; xiao, Lei/J-4217-2017; Yuan, Zengqiang/G-5245-2017	Ji, Guangju/0000-0001-8626-3490; Xie, Qi/0000-0002-2370-2078	National Science Foundation of China [30870792]; Ministry of Science and Technology of China [973-2009CB918704]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Science Foundation of China (30870792) and the Ministry of Science and Technology of China (973-2009CB918704).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2008, CURR MOL MED, V8, P313, DOI 10.2174/156652408784533805; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Wang P, 2007, NEUROSCI LETT, V415, P248, DOI 10.1016/j.neulet.2007.01.050; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200	30	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6259	6264		10.1074/jbc.M109.038570	http://dx.doi.org/10.1074/jbc.M109.038570			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028971	hybrid, Green Published			2022-12-27	WOS:000275367500030
J	Pafundo, DE; Alvarez, CL; Krumschnabel, G; Schwarzbaum, PJ				Pafundo, Diego E.; Alvarez, Cora L.; Krumschnabel, Gerhard; Schwarzbaum, Pablo J.			A Volume Regulatory Response Can Be Triggered by Nucleosides in Human Erythrocytes, a Perfect Osmometer No Longer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; ECTO-ATPASE ACTIVITY; ANION-EXCHANGER; GOLDFISH HEPATOCYTES; ADENOSINE RECEPTORS; ADENINE-NUCLEOTIDES; TRANSPORT-SYSTEMS; EPITHELIAL-CELLS; ION-TRANSPORT; RELEASE	Human erythrocytes have been regarded as perfect osmometers, which swell or shrink as dictated by their osmotic environment. In contrast, in most other cells, swelling elicits a regulatory volume decrease (RVD) modulated by the activation of purinic and pyrimidinic receptors (P receptors). For human erythrocytes this modulation has not been tested, and we thus investigated whether P receptor activation can induce RVD in these cells. Further, because ectonucleotidases may scavenge ATP or ADP or act as a source for extracellular adenosine and therefore modulate P receptor activation and RVD, we also determined their activity in intact erythrocytes. We found relatively low ectoATPase but significant ectoADPase and ectoAMPase activities. When erythrocytes were exposed to hypotonic medium alone, they swelled as expected for an osmometric response and showed no RVD. Activation of P2 receptors by exogenous ATP or ADP did not trigger RVD, whereas P1 agonists adenosine and adenosine-5'-N-ethylcarboxamide induced significant RVD. The effect of adenosine-5'-N-ethylcarboxamide was dose-dependent (maximal RVD of 27%; apparent K-1/2 of 1.6 +/- 1.7 mu M). The RVD induced by adenosine was blocked 80% with the non-selective P1 antagonist 8-(p-sulfophenyl theophylline) or the P1-A(2B) inhibitor MRS1754, but not by inhibitors of P1 subtypes A(1), A(2A), and A(3). In addition, forskolin (an inducer of intracellular cAMP formation) could mimic the effect of adenosine, supporting the idea of P1-A(2B) receptor activation. In conclusion, we report a novel P1-A(2B) receptor-mediated RVD activation in mature human erthrocytes and thus indicate that these long held perfect osmometers are not so perfect after all.	[Pafundo, Diego E.; Alvarez, Cora L.; Schwarzbaum, Pablo J.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina; [Krumschnabel, Gerhard] Innsbruck Med Univ, Div Dev Immunol, Bioctr, A-6020 Innsbruck, Austria	University of Buenos Aires; Medical University of Innsbruck	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, Junin 956 C1113AAD, RA-1113 Buenos Aires, DF, Argentina.	pablos@qb.ffyb.uba.ar	Krumschnabel, Gerhard/E-3694-2010	Krumschnabel, Gerhard/0000-0003-0804-1248; Pafundo, Diego/0000-0002-2535-9111; schwarzbaum, pablo/0000-0002-5176-089X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires and Agencia Nacional de Promocion Cientifica y Tecnologica [1432]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires and Agencia Nacional de Promocion Cientifica y Tecnologica	This work was supported in part by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Universidad de Buenos Aires and Agencia Nacional de Promocion Cientifica y Tecnologica (Grant 1432) of Argentina.	Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; BIENZLE U, 1977, CLIN CHIM ACTA, V76, P183, DOI 10.1016/0009-8981(77)90094-8; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Brugnara C, 1997, Curr Opin Hematol, V4, P122; CALA PM, 1977, J GEN PHYSIOL, V69, P537, DOI 10.1085/jgp.69.5.537; CANESSA M, 1990, J MEMBRANE BIOL, V116, P107, DOI 10.1007/BF01868669; CANESSA M, 1991, HEMATOL ONCOL CLIN N, V5, P495, DOI 10.1016/S0889-8588(18)30427-1; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; COLMAN RW, 1990, FASEB J, V4, P1425, DOI 10.1096/fasebj.4.5.2407587; FUGELLI K, 1986, J PHYSIOL-LONDON, V374, P245, DOI 10.1113/jphysiol.1986.sp016077; GARCIAROMEU F, 1991, J PHYSIOL-LONDON, V440, P547, DOI 10.1113/jphysiol.1991.sp018724; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Guest GM, 1942, J CLIN INVEST, V21, P257, DOI 10.1172/JCI101297; GUEST MM, 1947, AM J PHYSIOL, V150, P471, DOI 10.1152/ajplegacy.1947.150.3.471; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Gusev G P, 1997, Membr Cell Biol, V11, P305; HAAS M, 1989, AM J PHYSIOL, V256, pC265, DOI 10.1152/ajpcell.1989.256.2.C265; Hamann S, 2005, J PHYSIOL-LONDON, V568, P123, DOI 10.1113/jphysiol.2005.093526; Hategan A, 2003, BIOPHYS J, V85, P2746, DOI 10.1016/S0006-3495(03)74697-9; Heptinstall S, 2005, J THROMB HAEMOST, V3, P2331, DOI 10.1111/j.1538-7836.2005.01489.x; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jindal HK, 1996, BLOOD, V88, P1479, DOI 10.1182/blood.V88.4.1479.bloodjournal8841479; JOINER CH, 2005, ASH ANN M, V106, P2321; KADLUBOWSKI M, 1977, BRIT J HAEMATOL, V37, P111; Kim HD, 1996, AM J PHYSIOL-CELL PH, V270, pC86, DOI 10.1152/ajpcell.1996.270.1.C86; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LAUF PK, 1983, AM J PHYSIOL, V245, pC445, DOI 10.1152/ajpcell.1983.245.5.C445; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Light DB, 2001, J MEMBRANE BIOL, V182, P193, DOI 10.1007/s0023201-0043-z; Light DB, 1999, AM J PHYSIOL-CELL PH, V277, pC480, DOI 10.1152/ajpcell.1999.277.3.C480; LINDERKAMP O, 1982, BLOOD, V59, P1121; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LUTHJE J, 1989, KLIN WOCHENSCHR, V67, P317, DOI 10.1007/BF01741386; MACEY RI, 1988, AM J PHYSIOL, V254, pC669, DOI 10.1152/ajpcell.1988.254.5.C669; Mairbaurl H, 2000, AM J PHYSIOL-CELL PH, V279, pC1621, DOI 10.1152/ajpcell.2000.279.5.C1621; MEL HC, 1977, BLOOD, V49, P1001; Musante L, 1999, J BIOL CHEM, V274, P11701, DOI 10.1074/jbc.274.17.11701; Musch MW, 2008, AM J PHYSIOL-REG I, V294, pR1657, DOI 10.1152/ajpregu.00837.2007; ONEILL WC, 1989, AM J PHYSIOL, V256, pC858, DOI 10.1152/ajpcell.1989.256.4.C858; Pafundo DE, 2004, AM J PHYSIOL-REG I, V287, pR833, DOI 10.1152/ajpregu.00199.2004; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; PONDER E, 1951, J GEN PHYSIOL, V34, P567, DOI 10.1085/jgp.34.5.567; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Schwarzbaum PJ, 1998, AM J PHYSIOL-REG I, V274, pR1031, DOI 10.1152/ajpregu.1998.274.4.R1031; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; SOHN DH, 1991, J CELL PHYSIOL, V146, P318, DOI 10.1002/jcp.1041460217; Sprague RS, 2009, PHARMACOL REP, V61, P183, DOI 10.1016/S1734-1140(09)70020-9; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; WILEY JS, 1979, BRIT J HAEMATOL, V41, P133, DOI 10.1111/j.1365-2141.1979.tb03689.x; Wurm A, 2009, MOL VIS, V15, P1858	60	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6134	6144		10.1074/jbc.M109.078246	http://dx.doi.org/10.1074/jbc.M109.078246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040601	hybrid, Green Published			2022-12-27	WOS:000275367500017
J	Spanova, M; Czabany, T; Zellnig, G; Leitner, E; Hapala, I; Daum, G				Spanova, Miroslava; Czabany, Tibor; Zellnig, Guenther; Leitner, Erich; Hapala, Ivan; Daum, Guenther			Effect of Lipid Particle Biogenesis on the Subcellular Distribution of Squalene in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROLS; BIOSYNTHESIS; LOCALIZATION; ACCUMULATION; EPOXIDASE; REDUCTASE; MUTANTS; PROTON; OXYGEN	Squalene belongs to the group of isoprenoids and is a precursor for the synthesis of sterols, steroids, and ubiquinons. In the yeast Saccharomyces cerevisiae, the amount of squalene can be increased by variation of growth conditions or by genetic manipulation. In this report, we show that a hem1 Delta mutant accumulated a large amount of squalene, which was stored almost exclusively in cytoplasmic lipid particles/droplets. Interestingly, a strain bearing a hem1 Delta deletion in a dga1 Delta lro1 Delta are1 Delta are2 Delta quadruple mutant background (QMhem1 Delta), which is devoid of the classical storage lipids, triacylglycerols and steryl esters, and lacks lipid particles, accumulated squalene at similar amounts as the hem1 Delta mutant in a wild type background. In QMhem1 Delta, however, increased amounts of squalene were found in cellular membranes, especially in microsomes. The fact that QMhem1 Delta did not form lipid particles indicated that accumulation of squalene solely was not sufficient to initiate proliferation of lipid particles. Most importantly, these results also demonstrated that (i) squalene was not lipotoxic under the conditions tested, and (ii) organelle membranes in yeast can accommodate relatively large quantities of this non-polar lipid without compromising cellular functions. In summary, localization of squalene as described here can be regarded as an unconventional example of non-polar lipid storage in cellular membranes.	[Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Leitner, Erich] Graz Univ Technol, Inst Analyt Chem & Food Technol, A-8010 Graz, Austria; [Zellnig, Guenther] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria; [Hapala, Ivan] Slovak Acad Sci, Inst Anim Biochem & Genet, Ivanka Pri Dunaji 90028, Slovakia	Graz University of Technology; Graz University of Technology; University of Graz; Slovak Academy of Sciences	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at	Leitner, Erich/AAG-8826-2021; Hapala, Ivan/ABB-5807-2021	Czabany, Tibor/0000-0003-1754-6723; Leitner, Erich/0000-0003-2520-2111	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich [18857, W901-B05]; Slovak Agency for Science and Technology Project [APVV-0681-07, VEGA2/7135/27]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich(Austrian Science Fund (FWF)); Slovak Agency for Science and Technology Project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich Projects 18857 and W901-B05 (to G. D.) and by Slovak Agency for Science and Technology Project APVV-0681-07 and Grant VEGA2/7135/27 (to I. H.).	ANDREASEN AA, 1954, J CELL COMPAR PHYSL, V43, P271, DOI 10.1002/jcp.1030430303; ANDREASEN AA, 1953, J CELL COMPAR PHYSL, V41, P23, DOI 10.1002/jcp.1030410103; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; BARD M, 1974, BIOCHEM BIOPH RES CO, V56, P324, DOI 10.1016/0006-291X(74)90845-6; BARD M, 1993, LIPIDS, V28, P963, DOI 10.1007/BF02537115; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Desai KN, 1996, CANCER LETT, V101, P93, DOI 10.1016/0304-3835(96)04122-5; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; Ferreira T, 2004, BIOCHEM J, V378, P899, DOI 10.1042/BJ20031064; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HAID A, 1983, METHOD ENZYMOL, V96, P192; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Hauss T, 2002, BBA-BIOENERGETICS, V1556, P149, DOI 10.1016/S0005-2728(02)00346-8; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; IKEKAWA T, 1986, YAKUGAKU ZASSHI, V106, P578, DOI 10.1248/yakushi1947.106.7_578; IVASHKEVICH S P, 1981, Biokhimiya, V46, P1420; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; KALB VF, 1986, GENE, V45, P237, DOI 10.1016/0378-1119(86)90021-1; Ko TF, 2002, J AGR FOOD CHEM, V50, P5343, DOI 10.1021/jf0203500; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; LAEMMLI UK, 1970, NATURE, V227, P685; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LOHNER K, 1993, BIOCHIM BIOPHYS ACTA, V1152, P69, DOI 10.1016/0005-2736(93)90232-O; LORENZ RT, 1989, J BACTERIOL, V171, P6169, DOI 10.1128/jb.171.11.6169-6173.1989; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Quail M A, 1996, Methods Mol Biol, V53, P123; Qureshi AA, 1996, J NUTR, V126, P1972; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; Rissmann R, 2008, BBA-BIOMEMBRANES, V1778, P2350, DOI 10.1016/j.bbamem.2008.06.017; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; STAMELLOS KD, 1993, J BIOL CHEM, V268, P12825; Valachovic M, 2002, FEMS MICROBIOL LETT, V206, P121, DOI 10.1016/S0378-1097(01)00529-8; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	44	56	58	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6127	6133		10.1074/jbc.M109.074229	http://dx.doi.org/10.1074/jbc.M109.074229			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032462	Green Published, hybrid			2022-12-27	WOS:000275367500016
J	Pankiv, S; Lamark, T; Bruun, JA; Overvatn, A; Bjorkoy, G; Johansen, T				Pankiv, Serhiy; Lamark, Trond; Bruun, Jack-Ansgar; Overvatn, Aud; Bjorkoy, Geir; Johansen, Terje			Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-INDEPENDENT LIGAND; SIGNALING ADAPTER P62; A170 STRESS-PROTEIN; KAPPA-B ACTIVATION; BINDING-PROTEIN; LOCALIZATION SIGNALS; SELECTIVE AUTOPHAGY; EXPORT SIGNALS; KINASE-C; SUBCELLULAR-LOCALIZATION	p62, also known as sequestosome1 (SQSTM1), A170, or ZIP, is a multifunctional protein implicated in several signal transduction pathways. p62 is induced by various forms of cellular stress, is degraded by autophagy, and acts as a cargo receptor for autophagic degradation of ubiquitinated targets. It is also suggested to shuttle ubiquitinated proteins for proteasomal degradation. p62 is commonly found in cytosolic protein inclusions in patients with protein aggregopathies, it is up-regulated in several forms of human tumors, and mutations in the gene are linked to classical adult onset Paget disease of the bone. To this end, p62 has generally been considered to be a cytosolic protein, and little attention has been paid to possible nuclear roles of this protein. Here, we present evidence that p62 shuttles continuously between nuclear and cytosolic compartments at a high rate. The protein is also found in nuclear promyelocytic leukemia bodies. We show that p62 contains two nuclear localization signals and a nuclear export signal. Our data suggest that the nucleocytoplasmic shuttling of p62 is modulated by phosphorylations at or near the most important nuclear localization signal, NLS2. The aggregation of p62 in cytosolic bodies also regulates the transport of p62 between the compartments. We found p62 to be essential for accumulation of polyubiquitinated proteins in promyelocytic leukemia bodies upon inhibition of nuclear protein export. Furthermore, p62 contributed to the assembly of proteasome-containing degradative compartments in the vicinity of nuclear aggregates containing polyglutamine-expanded Ataxin1Q84 and to the degradation of Ataxin1Q84.	[Pankiv, Serhiy; Lamark, Trond; Bruun, Jack-Ansgar; Overvatn, Aud; Bjorkoy, Geir; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Bjorkoy, Geir] Univ Coll Sor Trondelag, Dept Biosci, N-7006 Trondheim, Norway	UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU)	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Pankiv, Serhiy/0000-0001-7953-2445; Lamark, Trond/0000-0001-6338-3342; Bruun, Jack-Ansgar/0000-0003-0614-2790; Bjorkoy, Geir/0000-0003-0031-8361	Top Research Programme; Norwegian Research Council; Norwegian Cancer Society; Blix Foundation	Top Research Programme; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Blix Foundation	This work was supported in part by grants from the Top Research Programme and the FUGE Programme of the Norwegian Research Council, the Norwegian Cancer Society, and the Blix Foundation (to T. J.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen M, 2008, J CELL BIOL, V180, P697, DOI 10.1083/jcb.200708131; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hinton CV, 2007, EXP CELL RES, V313, P1735, DOI 10.1016/j.yexcr.2007.03.008; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nilsen T, 2007, J BIOL CHEM, V282, P26245, DOI 10.1074/jbc.M611234200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pikkarainen M, 2008, J NEUROPATH EXP NEUR, V67, P280, DOI 10.1097/NEN.0b013e31816a1da2; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sudo T, 2000, BIOCHEM BIOPH RES CO, V269, P521, DOI 10.1006/bbrc.2000.2333; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Yanagawa T, 1997, BIOCHEM BIOPH RES CO, V241, P157, DOI 10.1006/bbrc.1997.7783; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	66	170	177	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5941	5953		10.1074/jbc.M109.039925	http://dx.doi.org/10.1074/jbc.M109.039925			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018885	Green Published, hybrid			2022-12-27	WOS:000275327200084
J	Suzuki, N; Yamamoto, K				Suzuki, Noriko; Yamamoto, Kazuo			Molecular Cloning of Pigeon UDP-galactose:beta-D-Galactoside alpha 1,4-Galactosyltransferase and UDP-galactose:beta-D-Galactoside beta 1,4-Galactosyltransferase, Two Novel Enzymes Catalyzing the Formation of Gal alpha 1-4Gal beta 1-4Gal beta 1-4GlcNAc Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED DOMAIN DATABASE; STRUCTURAL-ANALYSIS; OVIDUCAL MUCINS; EGG-WHITE; N-GLYCANS; CARBOHYDRATE CHAINS; UNFERTILIZED EGGS; FERTILIZED-EGGS; SHIGA TOXIN; GLYCOPROTEINS	We previously found that pigeon IgG possesses unique N-glycan structures that contain the Gal alpha 1-4Gal beta 1-4Gal beta 1-4GlcNAc sequence at their nonreducing termini. This sequence is most likely produced by putative alpha 1,4- and beta 1,4-galactosyltransferases (GalTs), which are responsible for the biosynthesis of the Gal alpha 1-4Gal and Gal beta 1-4Gal sequences on the N-glycans, respectively. Because no such glycan structures have been found in mammalian glycoproteins, the biosynthetic enzymes that produce these glycans are likely to have distinct substrate specificities from the known mammalian GalTs. To study these enzymes, we cloned the pigeon liver cDNAs encoding alpha 4GalT and beta 4GalT by expression cloning and characterized these enzymes using the recombinant proteins. The deduced amino acid sequence of pigeon alpha 4GalT has 58.2% identity to human beta 4GalT and 68.0 and 66.6% identity to putative alpha 4GalTs from chicken and zebra finch, respectively. Unlike human and putative chicken alpha 4GalTs, which possess globotriosylceramide synthase activity, pigeon alpha 4GalT preferred to catalyze formation of the Gal alpha 1-4Gal sequence on glycoproteins. In contrast, the sequence of pigeon beta 4GalT revealed a type II transmembrane protein consisting of 438 amino acid residues, with no significant homology to the glycosyltransferases so far identified from mammals and chicken. However, hypothetical proteins from zebra finch (78.8% identity), frogs (58.9-60.4%), zebrafish (37.1-43.0%), and spotted green pufferfish (43.3%) were similar to pigeon beta 4GalT, suggesting that the pigeon beta 4GalT gene was inherited from the common ancestors of these vertebrates. The sequence analysis revealed that pigeon beta 4GalT and its homologs form a new family of glycosyltransferases.	[Suzuki, Noriko; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of Tokyo	Suzuki, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	nrsuzuki@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [18770081]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 18770081 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Bouhours D, 2000, GLYCOBIOLOGY, V10, P857, DOI 10.1093/glycob/10.9.857; Brown S, 2008, NATURE, V453, P138, DOI 10.1038/453138a; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Coppin A, 2003, BIOCHIMIE, V85, P53, DOI 10.1016/S0300-9084(03)00021-X; Coppin A, 1999, EUR J BIOCHEM, V266, P94, DOI 10.1046/j.1432-1327.1999.00823.x; COSSEY A, 1979, EUR J BIOCHEM, V98, P53, DOI 10.1111/j.1432-1033.1979.tb13159.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Florea D, 2002, BIOCHIMIE, V84, P611, DOI 10.1016/S0300-9084(02)01432-3; Fujii Y, 2005, GLYCOBIOLOGY, V15, P1257, DOI 10.1093/glycob/cwj015; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GARRED O, 1995, J BIOL CHEM, V270, P10817; Guerardel Y, 2006, GLYCOBIOLOGY, V16, P244, DOI 10.1093/glycob/cwj062; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; INOUE S, 1989, J BIOL CHEM, V264, P18520; Iwamura K, 2003, J BIOL CHEM, V278, P44429, DOI 10.1074/jbc.M301609200; IWASAKI M, 1992, J BIOL CHEM, V267, P24287; IWASAKI M, 1984, BIOCHEMISTRY-US, V23, P305, DOI 10.1021/bi00297a020; Iwasaki M., 1985, GLYCOCONJUGATE J, V2, P209, DOI [10.1007/BF01049269, DOI 10.1007/BF01049269]; JOHNSON JR, 1994, AM J MED SCI, V307, P335, DOI 10.1097/00000441-199405000-00004; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Khoo KH, 1997, MOL BIOCHEM PARASIT, V86, P237, DOI 10.1016/S0166-6851(97)00036-4; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Maes E, 1997, GLYCOCONJUGATE J, V14, P127, DOI 10.1023/A:1018577302255; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Moriguchi K, 2007, J BIOCHEM, V142, P213, DOI 10.1093/jb/mvm128; Mourad R, 2001, EUR J BIOCHEM, V268, P1990, DOI 10.1046/j.1432-1327.2001.02071.x; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SHIMAMURA M, 1983, BIOCHEMISTRY-US, V22, P959, DOI 10.1021/bi00273a039; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SLOMIANY A, 1974, J BIOL CHEM, V249, P1225; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Suzuki N, 2006, BBA-GEN SUBJECTS, V1760, P538, DOI 10.1016/j.bbagen.2005.10.005; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Suzuki N, 2003, J BIOL CHEM, V278, P46293, DOI 10.1074/jbc.M307132200; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Taguchi T, 1996, EUR J BIOCHEM, V238, P357, DOI 10.1111/j.1432-1033.1996.0357z.x; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; TAGUCHI T, 1994, J BIOL CHEM, V269, P8762; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650; [No title captured]; [No title captured]; [No title captured]	50	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5178	5187		10.1074/jbc.M109.018663	http://dx.doi.org/10.1074/jbc.M109.018663			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19959475	Green Published, hybrid			2022-12-27	WOS:000275327200010
J	Essabbani, A; Margottin-Goguet, F; Chiocchia, G				Essabbani, Abdellatif; Margottin-Goguet, Florence; Chiocchia, Gilles			Identification of Clusterin Domain Involved in NF-kappa B Pathway Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; CELL-DEATH; BETA-TRCP; RHEUMATOID-ARTHRITIS; PROTEIN; APOPTOSIS; CANCER; DEGRADATION; EXPRESSION	Clusterin (CLU) is a ubiquitous protein that has been implicated in tumorigenesis, apoptosis, inflammation, and cell proliferation. We and others have previously shown that CLU is an inhibitor of the NF-kappa B pathway. However, the exact form of CLU and the region(s) of CLU involved in this effect were unknown. Using newly generated molecular constructs encoding for CLU and various regions of the molecule, we demonstrated that the presecretory form of CLU (psCLU) form bears the NF-kappa B regulatory activity. Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involvedinI kappa B-alpha degradation. These homologies were localized in the disulfide constraint region of CLU. We generated a specific molecular construct of this region, named Delta CLU, and showed that it has the same NF-kappa B regulatory activity as CLU. Neither the alpha-chain nor the beta-chain of CLU had any NF-kappa B regulatory activity. Furthermore, we showed that following tumor necrosis factor-alpha stimulation of transfected cells, we could co-immunoprecipitate phospho-I kappa B-alpha with Delta CLU. Moreover, we showed that Delta CLU could localize both in the cytoplasm and in the nucleus. These results demonstrate the identification of a new CLU activity site involved in NF-kappa B pathway regulation.	[Chiocchia, Gilles] INSERM, Inst Cochin, U567, Dept Immunol & Hematol, F-75014 Paris, France; [Essabbani, Abdellatif; Margottin-Goguet, Florence; Chiocchia, Gilles] Univ Paris 05, CNRS, UMR 8104, F-75014 Paris, France; [Chiocchia, Gilles] Hop Ambroise Pare, Serv Rhumatol, F-92100 Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Chiocchia, G (corresponding author), INSERM, Inst Cochin, U567, Dept Immunol & Hematol, Pavillon Hardy A 1Er Etage,27 Rue Faubourg St Jac, F-75014 Paris, France.	gilles.chiocchia@inserm.fr	Margottin-Goguet, Florence/F-9272-2013; CHIOCCHIA, Gilles R/F-6287-2013	Margottin-Goguet, Florence/0000-0002-3124-6690; CHIOCCHIA, Gilles R/0000-0001-9973-0940	Societe Francaise de Rhumatologie (SFR); Fondation Arthritis Courtin; Association pour la Recherche contre le Cancer	Societe Francaise de Rhumatologie (SFR); Fondation Arthritis Courtin; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by a grant from the Societe Francaise de Rhumatologie (SFR) and Fondation Arthritis Courtin.; Supported by SFR and Association pour la Recherche contre le Cancer.	Chen XD, 2003, P NATL ACAD SCI USA, V100, P9530, DOI 10.1073/pnas.1233633100; CHOI NH, 1990, INT IMMUNOL, V2, P413, DOI 10.1093/intimm/2.5.413; CHOI NH, 1989, MOL IMMUNOL, V26, P835; Devauchelle V, 2004, GENES IMMUN, V5, P597, DOI 10.1038/sj.gene.6364132; Devauchelle V, 2006, J IMMUNOL, V177, P6471, DOI 10.4049/jimmunol.177.9.6471; DUVERGER E, 1995, J CELL SCI, V108, P1325; Evrard-Todeschi N, 2008, J CHEM INF MODEL, V48, P2350, DOI 10.1021/ci800248u; FRENCH LE, 1994, J CLIN INVEST, V93, P877, DOI 10.1172/JCI117043; Gilmore TD, 1996, ONCOGENE, V13, P1367; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kaisman-Elbaz T, 2009, J CELL PHYSIOL, V220, P222, DOI 10.1002/jcp.21754; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Markopoulou S, 2009, FEBS J, V276, P4208, DOI 10.1111/j.1742-4658.2009.07093.x; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Savkovic V, 2007, BIOCHEM BIOPH RES CO, V356, P431, DOI 10.1016/j.bbrc.2007.02.148; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	24	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4273	4277		10.1074/jbc.C109.057133	http://dx.doi.org/10.1074/jbc.C109.057133			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20028970	hybrid, Green Published			2022-12-27	WOS:000275274800003
J	Hou, ZJ; Cherian, C; Drews, J; Wu, JM; Matherly, LH				Hou, Zhanjun; Cherian, Christina; Drews, Joseph; Wu, Jianmei; Matherly, Larry H.			Identification of the Minimal Functional Unit of the Homo-oligomeric Human Reduced Folate Carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; NHAA NA+/H+ ANTIPORTER; MEMBRANE-TRANSPORT; ESCHERICHIA-COLI; OLIGOMERIC STRUCTURE; ACCESSIBILITY METHODS; CELLS; METHOTREXATE; COTRANSPORTER; LOCALIZATION	The reduced folate carrier (RFC) is the major transport system for folates in mammals. We previously demonstrated the existence of human RFC (hRFC) homo-oligomers and established the importance of these higher order structures to intracellular trafficking and carrier function. In this report, we examined the operational significance of hRFC oligomerization and the minimal functional unit for transport. In negative dominance experiments, multimeric transporters composed of different ratios of active (either wild type (WT) or cysteine-less (CLFL)) and inactive (either inherently inactive (Y281L and R373A) due to mutation, or resulting from inactivation of the Y126C mutant by (2-sulfonatoethyl) methanethiosulfonate (MTSES)) hRFC monomers were expressed in hRFC-null HeLa (R5) cells, and residual WT or CLFL activity was measured. In either case, residual transport activity with increasing levels of inactive mutant correlated linearly with the fraction of WT or CLFL hRFC in plasma membranes. When active covalent hRFC dimers, generated by fusing CLFL and Y126C monomers, were expressed in R5 cells and treated with MTSES, transport activity of the CLFL-CLFL dimer was unaffected, whereas Y126C-Y126C was potently (64%) inhibited; heterodimeric CLFL-Y126C and Y126C-CLFL were only partly (27 and 23%, respectively) inhibited by MTSES. In contrast to Y126C-Y126C, trans-stimulation of methotrexate uptake by intracellular folates for Y126C-CLFL and CLFL-Y126C was nominally affected by MTSES. Collectively, these results strongly support the notion that each hRFC monomer comprises a single translocation pathway for anionic folate substrates and functions independently of other monomers (i.e. despite an oligomeric structure, hRFC functions as a monomer).	[Hou, Zhanjun; Cherian, Christina; Drews, Joseph; Wu, Jianmei; Matherly, Larry H.] Wayne State Univ, Sch Med, Dev Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Grad Program Canc Biol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Matherly, LH (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	matherly@kci.wayne.edu	/S-1117-2019		National Institutes of Health, NCI [CA53535]; NATIONAL CANCER INSTITUTE [R01CA053535] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA53535.	Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bossi E, 2007, AM J PHYSIOL-CELL PH, V292, pC1379, DOI 10.1152/ajpcell.00473.2006; Cao W, 2003, BIOCHEM J, V374, P27, DOI 10.1042/BJ20030301; Drori S, 2000, EUR J BIOCHEM, V267, P690, DOI 10.1046/j.1432-1327.2000.01049.x; EMERICK MC, 1993, J BIOL CHEM, V268, P23455; FRY DW, 1982, J BIOL CHEM, V257, P1890; Geertsma ER, 2005, J MOL BIOL, V350, P102, DOI 10.1016/j.jmb.2005.04.047; GOLDMAN ID, 1971, BIOCHIM BIOPHYS ACTA, V233, P624, DOI 10.1016/0005-2736(71)90162-3; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Hou ZJ, 2009, J BIOL CHEM, V284, P3285, DOI 10.1074/jbc.M807206200; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kitayama S, 1999, J BIOL CHEM, V274, P10731, DOI 10.1074/jbc.274.16.10731; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loo TW, 2005, J BIOENERG BIOMEMBR, V37, P501, DOI 10.1007/s10863-005-9499-3; LOO TW, 1994, J BIOL CHEM, V269, P28683; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly Larry H., 2004, Current Pharmacogenomics, V2, P287, DOI 10.2174/1570160043377547; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Wong SC, 1999, J BIOL CHEM, V274, P10388, DOI 10.1074/jbc.274.15.10388; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946	42	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4732	4740		10.1074/jbc.M109.086033	http://dx.doi.org/10.1074/jbc.M109.086033			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018840	Green Published, hybrid			2022-12-27	WOS:000275274800051
J	Juranic, N; Atanasova, E; Filoteo, AG; Macura, S; Prendergast, FG; Penniston, JT; Strehler, EE				Juranic, Nenad; Atanasova, Elena; Filoteo, Adelaida G.; Macura, Slobodan; Prendergast, Franklyn G.; Penniston, John T.; Strehler, Emanuel E.			Calmodulin Wraps around Its Binding Domain in the Plasma Membrane Ca2+ Pump Anchored by a Novel 18-1 Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; TARGET RECOGNITION; PEPTIDE COMPLEX; MULTIDIMENSIONAL NMR; CRYSTAL-STRUCTURE; CALCIUM-BINDING; ISOFORM 4B; KINASE; ACTIVATION; PROTEINS	Using solution NMR spectroscopy, we obtained the structure of Ca2+-calmodulin (holoCaM) in complex with peptide C28 from the binding domain of the plasma membrane Ca2+-ATPase (PMCA) pump isoform 4b. This provides the first atomic resolution insight into the binding mode of holoCaM to the full-length binding domain of PMCA. Structural comparison of the previously determined holoCaM.C20 complex with this holoCaM.C28 complex supports the idea that the initial binding step is represented by (holoCaM.C20) and the final bound complex by (holoCaM.C28). This affirms the existing multi-step kinetic model of PMCA4b activation by CaM. The complex exhibits a new binding motif in which holoCaM is wrapped around helical C28 peptide using two anchoring residues from the peptide at relative positions 18 and 1. The anchors correspond to Phe-1110 and Trp-1093, respectively, in full-length PMCA4b, and the peptide and CaM are oriented in an anti-parallel manner. This is a greater sequence distance between anchors than in any of the known holoCaM complexes with a helical peptide. Analysis of the geometry of holoCaM-peptide binding for the cases where the target peptide adopts an alpha(D)-helix with its anchors buried in the main hydrophobic pockets of the two CaM lobes establishes that only relative sequential positions of 10, 14, 17, and 18 are allowed for the second anchor.	[Juranic, Nenad; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Prendergast, Franklyn G.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Penniston, John T.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Mayo Clinic; Mayo Clinic; Harvard University; Massachusetts General Hospital	Juranic, N (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	juranic.nenad@mayo.edu			National Institutes of Health [NS51769]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769. Portions of this work have been presented in abstract form at the Keystone Conference on Frontiers of NMR in Biology, February 15-20, 2009 in Santa Fe, NM.	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BAX A, 1994, METHOD ENZYMOL, V239, P79; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; COX JA, 1985, J BIOL CHEM, V260, P2527; DEGRADO WF, 1985, J CELL BIOCHEM, V29, P83, DOI 10.1002/jcb.240290204; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; GUERINI D, 1984, J BIOL CHEM, V259, P5172; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KATAOKA M, 1991, BIOCHEMISTRY-US, V30, P6247, DOI 10.1021/bi00239a024; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P14117, DOI 10.1021/bi9950894; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P3936, DOI 10.1021/bi9821263; Neal S, 2006, MAGN RESON CHEM, V44, pS158, DOI 10.1002/mrc.1832; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Permi P, 2000, J BIOMOL NMR, V17, P43, DOI 10.1023/A:1008372624615; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Scheschonka A, 2008, J BIOL CHEM, V283, P5577, DOI 10.1074/jbc.M709505200; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Slaughter BD, 2007, BIOCHEMISTRY-US, V46, P4045, DOI 10.1021/bi602481u; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Sun HY, 2000, J BIOL CHEM, V275, P1731, DOI 10.1074/jbc.275.3.1731; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VERMA AK, 1988, J BIOL CHEM, V263, P14152; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682	45	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4015	4024		10.1074/jbc.M109.060491	http://dx.doi.org/10.1074/jbc.M109.060491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996092	Green Published, hybrid			2022-12-27	WOS:000275254000055
J	Luo, WB; Zhong, J; Chang, R; Hu, HX; Pandey, A; Semenza, GL				Luo, Weibo; Zhong, Jun; Chang, Ryan; Hu, Hongxia; Pandey, Akhilesh; Semenza, Gregg L.			Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1 alpha but Not HIF-2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; CANCER-THERAPY; CELL-CULTURE; AMINO-ACIDS; HIF-ALPHA; HIF-1-ALPHA; EXPRESSION; BINDING; PROMOTES; PATHWAY	Hypoxia-inducible factors (HIFs) are transcription factors that mediate adaptive responses to reduced oxygen availability. HIF-alpha subunits are stabilized under conditions of acute hypoxia. However, prolonged hypoxia leads to decay of HIF-1 alpha but not HIF-2 alpha protein levels by unknown mechanisms. Here, we identify Hsp70 and CHIP (carboxyl terminus of Hsc70-interacting protein) as HIF-1 alpha-interacting proteins. Hsp70, through recruiting the ubiquitin ligase CHIP, promotes the ubiquitination and proteasomal degradation of HIF-1 alpha but not HIF-2 alpha, thereby inhibiting HIF-1-dependent gene expression. Disruption of Hsp70-CHIP interaction blocks HIF-1 alpha degradation mediated by Hsp70 and CHIP. Inhibition of Hsp70 or CHIP synthesis by RNA interference increases protein levels of HIF-1 alpha but not HIF-2 alpha and attenuates the decay of HIF-1 alpha levels during prolonged hypoxia. Thus, Hsp70- and CHIP-dependent ubiquitination represents a molecular mechanism by which prolonged hypoxia selectively reduces the levels of HIF-1 alpha but not HIF-2 alpha protein.	[Luo, Weibo; Chang, Ryan; Hu, Hongxia; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; [Luo, Weibo; Chang, Ryan; Hu, Hongxia; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Zhong, Jun; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), 733 N Broadway,Ste 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Hu, Hongxia/Q-7765-2016; Pandey, Akhilesh/B-4127-2009; 高, 雨莉/HGU-8187-2022; Zhong, Jun/D-1662-2010	Pandey, Akhilesh/0000-0001-9943-6127; Zhong, Jun/0000-0003-3148-4143; Luo, Weibo/0000-0002-1992-0320	NHLBI [N01-HV28180, U54 RR020839]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-HV28180 from NHLBI and Roadmap Grant U54 RR020839.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cui Y, 2002, BLOOD, V99, P399, DOI 10.1182/blood.V99.2.399; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	37	164	173	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3651	3663		10.1074/jbc.M109.068577	http://dx.doi.org/10.1074/jbc.M109.068577			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940151	Green Published, hybrid			2022-12-27	WOS:000275254000017
J	Xie, JZ; Yin, HF; Nichols, TD; Yoder, JA; Horowitz, JM				Xie, Jianzhen; Yin, Haifeng; Nichols, Teresa D.; Yoder, Jeffrey A.; Horowitz, Jonathan M.			Sp2 Is a Maternally Inherited Transcription Factor Required for Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEINS; SP-FAMILY MEMBERS; MICE LACKING; DNA-BINDING; SEGMENTATION GENE; LIMB OUTGROWTH; CELL-GROWTH; RB PROTEIN; WILD-TYPE; EXPRESSION	The Sp family of transcription factors is required for the expression of cell cycle- and developmentally regulated genes, and the deregulated expression of a handful of family members is associated with human tumorigenesis. Sp2 is a relatively poorly characterized member of the Sp family that, although widely expressed, exhibits little or no DNA binding or transcriptional activity in human and mouse cell lines. To begin to address the role(s) played by Sp2 in early metazoan development we have cloned and characterized Sp2 from zebrafish (Danio rerio). We report that 1) the intron/exon organization and amino acid sequence of zebrafish Sp2 is closely conserved with its mammalian orthologues, 2) zebrafish Sp2 weakly stimulates an Sp-dependent promoter in vitro and associates with the nuclear matrix in a DNA-independent fashion, 3) zebrafish Sp2 is inherited as a maternal transcript, is transcribed in zebrafish embryos and adult tissues, and is required for completion of gastrulation, and 4) zebrafish lines carrying transgenes regulated by the Sp2 promoter recapitulate patterns of endogenous Sp2 expression.	[Horowitz, Jonathan M.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27606 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Horowitz, JM (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, 4700 Hillsborough St, Raleigh, NC 27606 USA.	jon_horowitz@ncsu.edu	Yin, Haifeng/E-8787-2012; Yoder, Jeffrey A./I-5329-2019	Yoder, Jeffrey A./0000-0002-6083-1311	National Institutes of Health [GM065405, CA105313]; Jimmy V-NCSU Cancer Therapeutics Training Program; NATIONAL CANCER INSTITUTE [R01CA105313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jimmy V-NCSU Cancer Therapeutics Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065405 and CA105313 (to J.M.H.). This work was also supported by the Jimmy V-NCSU Cancer Therapeutics Training Program.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; Griesel G, 2006, DEVELOPMENT, V133, P1779, DOI 10.1242/dev.02326; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hertveldt V, 2008, DEV DYNAM, V237, P883, DOI 10.1002/dvdy.21355; Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kawakami Y, 2004, DEVELOPMENT, V131, P4763, DOI 10.1242/dev.01331; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Moorefield KS, 2004, J BIOL CHEM, V279, P13911, DOI 10.1074/jbc.M313589200; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Penberthy WT, 2004, DEV BIOL, V275, P225, DOI 10.1016/j.ydbio.2004.08.007; Phan D, 2004, CANCER RES, V64, P3072, DOI 10.1158/0008-5472.CAN-03-3730; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Prince VE, 1998, DEVELOPMENT, V125, P393; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHI YG, 1995, CHEM BIOL, V2, P83, DOI 10.1016/1074-5521(95)90280-5; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Sun ZH, 2006, DEV DYNAM, V235, P2999, DOI 10.1002/dvdy.20945; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tallafuss A, 2001, DEVELOPMENT, V128, P4021; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Treichel D, 2001, MECH DEVELOP, V101, P175, DOI 10.1016/S0925-4773(00)00544-X; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; van Loo PF, 2003, BLOOD, V102, P858, DOI 10.1182/blood-2002-06-1848; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WIMMER EA, 1993, NATURE, V366, P690, DOI 10.1038/366690a0; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593	50	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4153	4164		10.1074/jbc.M109.078881	http://dx.doi.org/10.1074/jbc.M109.078881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959469	hybrid, Green Published			2022-12-27	WOS:000275254000067
J	Brull, F; Mensink, RP; van den Hurk, K; Duijvestijn, A; Plat, J				Brull, Florence; Mensink, Ronald P.; van den Hurk, Karin; Duijvestijn, Adriaan; Plat, Jogchum			TLR2 Activation Is Essential to Induce a Th1 Shift in Human Peripheral Blood Mononuclear Cells by Plant Stanols and Plant Sterols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTORS; REGULATORY T-CELLS; IMMUNE-RESPONSE; BETA-SITOSTEROL; TH1/TH2 BALANCE; CYTOKINE; DISEASE; PHYTOSTEROLS; MICE; TARGET	Plant sterols may induce a Th1 shift in humans. However, whether plant stanols have similar effects as well as the underlying mechanism are unknown. We have now shown that ( like sitosterol) sitostanol, both 4-desmethylsterols, induces a Th1 shift when added in vitro at physiological concentrations to human PBMCs. This conclusion was based on a higher IFN gamma production, with no change in the production of IL-4 and IL-10. alpha-Amyrin, a 4.4-dimethylsterol, had comparable effects. Because 4.4-dimethylsterols cannot activate transcription factor LXR, this finding indicates that LXR activation was not involved. Sitosterol and sitostanol did not alter the production of IL-12 and IL-18 in PBMCs as well as in monocyte-derived U937 cells, suggesting that plant sterols directly affect T-helper cells, without activating APCs. However, in PBMCs treated with a TLR2 blocker (T2.5), IFN gamma production was completely inhibited, whereas blocking TLR4 with HTA125 had no such effect. To confirm these findings, PBMCs from TLR2(-/-) mice were cultured in the presence of sitosterol and sitostanol. In these cells, no Th1 shift was observed. Our results, therefore, indicate that TLR2 activation is essential to induce a Th1 shift in human PBMCs by plant stanols and plant sterols.	[Brull, Florence; Mensink, Ronald P.; van den Hurk, Karin; Plat, Jogchum] Maastricht Univ, Dept Human Biol, NL-6229 ER Maastricht, Netherlands; [Brull, Florence; Mensink, Ronald P.; van den Hurk, Karin; Plat, Jogchum] Maastricht Univ, Sch Nutr Toxicol & Metab NUTRIM, NL-6229 ER Maastricht, Netherlands; [Duijvestijn, Adriaan] Maastricht Univ, Dept Immunol, NL-6229 ER Maastricht, Netherlands; [Duijvestijn, Adriaan] Maastricht Univ, Sch Cardiovasc Dis CARIM, NL-6229 ER Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Plat, J (corresponding author), POB 616, NL-6200 MD Maastricht, Netherlands.	j.plat@hb.unimaas.nl						Albers R, 2005, BRIT J NUTR, V94, P452, DOI 10.1079/BJN20051469; Awad AB, 2004, PROSTAG LEUKOTR ESS, V70, P511, DOI 10.1016/j.plefa.2003.11.005; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Bouic PJD, 2001, CURR OPIN CLIN NUTR, V4, P471, DOI 10.1097/00075197-200111000-00001; Bouic PJD, 1996, INT J IMMUNOPHARMACO, V18, P693, DOI 10.1016/S0192-0561(97)85551-8; Bouic PJD, 2002, DRUG DISCOV TODAY, V7, P775, DOI 10.1016/S1359-6446(02)02343-7; Breytenbach U, 2001, CELL BIOL INT, V25, P43, DOI 10.1006/cbir.2000.0676; Calpe-Berdiel L, 2007, ATHEROSCLEROSIS, V195, P210, DOI 10.1016/j.atherosclerosis.2006.11.042; Calpe-Berdiel L, 2007, LIFE SCI, V80, P1951, DOI 10.1016/j.lfs.2007.02.032; Chan YM, 2006, NUTR REV, V64, P385, DOI [10.1301/nr.2006.sept.385-402, 10.1111/j.1753-4887.2006.tb00224.x]; Desai F, 2009, INT IMMUNOPHARMACOL, V9, P153, DOI 10.1016/j.intimp.2008.10.019; Eigenmann PA, 2008, CLIN EXP IMMUNOL, V151, P546, DOI 10.1111/j.1365-2249.2007.03582.x; Fransen HP, 2007, J NUTR, V137, P1301, DOI 10.1093/jn/137.5.1301; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kew S, 2004, AM J CLIN NUTR, V79, P674; Kidd Parris, 2003, Altern Med Rev, V8, P223; Lee JH, 2007, VACCINE, V25, P3834, DOI 10.1016/j.vaccine.2007.01.108; Lesourd B, 2006, P NUTR SOC, V65, P319, DOI 10.1079/PNS2006507; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; Moghadasian MH, 2000, LIFE SCI, V67, P605, DOI 10.1016/S0024-3205(00)00665-2; Nashed B, 2005, J NUTR, V135, P2438, DOI 10.1093/jn/135.10.2438; Naumann E, 2003, J NUTR, V133, P2741, DOI 10.1093/jn/133.9.2741; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; Normen AL, 2001, AM J CLIN NUTR, V74, P141; O'Garra A, 2003, NAT IMMUNOL, V4, P304, DOI 10.1038/ni0403-304; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ostlund RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE911, DOI 10.1152/ajpendo.00328.2001; Plat J, 2001, NUTR METAB CARDIOVAS, V11, P31; Plat J, 2005, J LIPID RES, V46, P2468, DOI 10.1194/jlr.M500272-JLR200; Plat J, 2005, CURR OPIN LIPIDOL, V16, P31, DOI 10.1097/00041433-200502000-00007; ROITT I, 2000, IMMUNOLOGIE; Sato M, 1999, IMMUNOL LETT, V70, P29, DOI 10.1016/S0165-2478(99)00122-4; Shearer GM, 1998, AIDS RES HUM RETROV, V14, pS149; Sutmuller R, 2007, ANN RHEUM DIS, V66, P91, DOI 10.1136/ard.2007.078535; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tammi A, 2001, J NUTR, V131, P1942, DOI 10.1093/jn/131.7.1942; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weststrate JA, 1998, EUR J CLIN NUTR, V52, P334, DOI 10.1038/sj.ejcn.1600559; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Zhang P, 2005, J NUTR, V135, P1745, DOI 10.1093/jn/135.7.1745	44	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2951	10.1074/jbc.M109.036343	http://dx.doi.org/10.1074/jbc.M109.036343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948716	hybrid, Green Published			2022-12-27	WOS:000273829000009
J	Daniels, R; Mellroth, P; Bernsel, A; Neiers, F; Normark, S; von Heijne, G; Henriques-Normark, B				Daniels, Robert; Mellroth, Peter; Bernsel, Andreas; Neiers, Fabrice; Normark, Staffan; von Heijne, Gunnar; Henriques-Normark, Birgitta			Disulfide Bond Formation and Cysteine Exclusion in Gram-positive Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS DSBA; ESCHERICHIA-COLI; PROTEIN SECRETION; BETA-LACTAMASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; CYTOPLASMIC MEMBRANE; SIGNAL PEPTIDES; OXIDOREDUCTASES	Most secretion pathways in bacteria and eukaryotic cells are challenged by the requirement for their substrate proteins to mature after they traverse a membrane barrier and enter a reactive oxidizing environment. For Gram-positive bacteria, the mechanisms that protect their exported proteins from misoxidation during their post-translocation maturation are poorly understood. To address this, we separated numerous bacterial species according to their tolerance for oxygen and divided their proteomes based on the predicted subcellular localization of their proteins. We then applied a previously established computational approach that utilizes cysteine incorporation patterns in proteins as an indicator of enzymatic systems that may exist in each species. The Sec-dependent exported proteins from aerobic Gram-positive Actinobacteria were found to encode cysteines in an even-biased pattern indicative of a functional disulfide bond formation system. In contrast, aerobic Gram-positive Firmicutes favor the exclusion of cysteines from both their cytoplasmic proteins and their substantially longer exported proteins. Supporting these findings, we show that Firmicutes, but not Actinobacteria, tolerate growth in reductant. We further demonstrate that the actinobacterium Corynebacterium glutamicum possesses disulfide-bonded proteins and two dimeric Dsb-like enzymes that can efficiently catalyze the formation of disulfide bonds. Our results suggest that cysteine exclusion is an important adaptive strategy against the challenges presented by oxidative environments.	[Bernsel, Andreas; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Daniels, Robert; Mellroth, Peter; Neiers, Fabrice; Normark, Staffan; Henriques-Normark, Birgitta] Swedish Inst Infect Dis Control, S-17182 Solna, Sweden	Stockholm University; Karolinska Institutet; Swedish Institute for Infectious Disease Control	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, Svante Arrhenius Vag 16, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se; birgitta.henriques@smi.se	von Heijne, Gunnar/AAH-9389-2019; Neiers, Fabrice/AAM-1637-2021; von Heijne, Gunnar/F-5576-2011	Neiers, Fabrice/0000-0002-8965-4929; von Heijne, Gunnar/0000-0002-4490-8569; Mellroth, Peter/0000-0002-3518-1054; daniels, Robert/0000-0002-5988-2920	Wenner-Gren Foundation; Swedish Research Council; Torsten and Ragnar Soderbergs Foundation; Swedish Royal Academy of Sciences; Swedish Foundation for Strategic Research	Wenner-Gren Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderbergs Foundation; Swedish Royal Academy of Sciences; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by a postdoctoral fellowship from the Wenner-Gren Foundation (to R.D.) and the Swedish Research Council, the Torsten and Ragnar Soderbergs Foundation, the Swedish Royal Academy of Sciences, and the Swedish Foundation for Strategic Research.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bolhuis A, 1999, J BIOL CHEM, V274, P24531, DOI 10.1074/jbc.274.35.24531; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; Kouwen TRHM, 2009, TRENDS MICROBIOL, V17, P6, DOI 10.1016/j.tim.2008.10.003; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lim D, 2001, BIOCHEMISTRY-US, V40, P395, DOI 10.1021/bi001653v; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Mallick P, 2002, P NATL ACAD SCI USA, V99, P9679, DOI 10.1073/pnas.142310499; Matias VRF, 2007, MOL MICROBIOL, V64, P195, DOI 10.1111/j.1365-2958.2007.05634.x; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	62	68	68	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3300	3309		10.1074/jbc.M109.081398	http://dx.doi.org/10.1074/jbc.M109.081398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940132	Green Published, hybrid			2022-12-27	WOS:000273829000045
J	Walker, VE; Wong, MJH; Atanasiu, R; Hantouche, C; Young, JC; Shrier, A				Walker, Valerie E.; Wong, Michael J. H.; Atanasiu, Roxana; Hantouche, Christine; Young, Jason C.; Shrier, Alvin			Hsp40 Chaperones Promote Degradation of the hERG Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-PROTEASOME PATHWAY; INHERITED CARDIAC-ARRHYTHMIA; MOLECULAR CHAPERONES; QUALITY-CONTROL; CYSTIC-FIBROSIS; HEAT-SHOCK; HSP70 CHAPERONES; PROTEIN	Loss of function mutations in the hERG (human ether-ago-go related gene or KCNH2) potassium channel underlie the proarrhythmic cardiac long QT syndrome type 2. Most often this is a consequence of defective trafficking of hERG mutants to the cell surface, with channel retention and degradation at the endoplasmic reticulum. Here, we identify the Hsp40 type 1 chaperones DJA1 (DNAJA1/Hdj2) and DJA2 (DNAJA2) as key modulators of hERG degradation. Overexpression of the DJAs reduces hERG trafficking efficiency, an effect eliminated by the proteasomal inhibitor lactacystin or with DJA mutants lacking their J domains essential for Hsc70/Hsp70 activation. Both DJA1 and DJA2 cause a decrease in the amount of hERG complexed with Hsc70, indicating a preferential degradation of the complex. Similar effects were observed with the E3 ubiquitin ligase CHIP. Both the DJAs and CHIP reduce hERG stability and act differentially on folding intermediates of hERG and the disease-related trafficking mutant G601S. We propose a novel role for the DJA proteins in regulating degradation and suggest that they act at a critical point in secretory pathway quality control.	[Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Wong, Michael J. H.; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University		jason.young2@mcgill.ca; alvin.shrier@mcgill.ca			Canadian Institutes of Health Research [MOP-86589, MOP-68825]; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by Canadian Institutes of Health Research Grants MOP-86589 and MOP-68825 and by the Canadian Foundation for Innovation.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rajamani S, 2002, CIRCULATION, V105, P2830, DOI 10.1161/01.CIR.0000019513.50928.74; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	55	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3319	3329		10.1074/jbc.M109.024000	http://dx.doi.org/10.1074/jbc.M109.024000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940115	Green Published, hybrid			2022-12-27	WOS:000273829000047
J	Zee, BM; Levin, RS; Xu, B; LeRoy, G; Wingreen, NS; Garcia, BA				Zee, Barry M.; Levin, Rebecca S.; Xu, Bo; LeRoy, Gary; Wingreen, Ned S.; Garcia, Benjamin A.			In Vivo Residue-specific Histone Methylation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; KINETIC MECHANISM; H3 LYSINE-9; CHROMATIN; IDENTIFICATION; TRANSCRIPTION; ACETYLATION; ACTIVATION; PATTERNS; STATES	Methylation of specific histone residues is capable of both gene activation and silencing. Despite vast work on the function of methylation, most studies either present a static snapshot of methylation or fail to assign kinetic information to specific residues. Using liquid chromatography-tandem mass spectrometry on a high-resolution mass spectrometer and heavy methyl-SILAC labeling, we studied site-specific histone lysine and arginine methylation dynamics. The detection of labeled intermediates within a methylation state revealed that mono-, di-, and trimethylated residues generally have progressively slower rates of formation. Furthermore, methylations associated with active genes have faster rates than methylations associated with silent genes. Finally, the presence of both an active and silencing mark on the same peptide results in a slower rate of methylation than the presence of either mark alone. Here we show that quantitative proteomic approaches such as this can determine the dynamics of multiple methylated residues, an understudied portion of histone biology.	[Zee, Barry M.; Xu, Bo; LeRoy, Gary; Wingreen, Ned S.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Levin, Rebecca S.; Garcia, Benjamin A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Garcia, BA (corresponding author), Princeton Univ, Dept Mol Biol, 415 Schultz Lab, Princeton, NJ 08544 USA.	bagarcia@princeton.edu		Zee, Barry/0000-0002-3123-8375	Princeton University; National Science Foundation [CBET-0941143]; Waters Corporation	Princeton University(Princeton University); National Science Foundation(National Science Foundation (NSF)); Waters Corporation	This work was supported by Princeton University, the National Science Foundation Grant CBET-0941143, and an American Society for Mass Spectrometry research award sponsored by the Waters Corporation (to B.A.G.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyne MT, 2009, J PROTEOME RES, V8, P374, DOI 10.1021/pr800635m; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; DJONDJUROV LP, 1983, BIOCHEMISTRY-US, V22, P4095; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; FODOR BD, 2009, GENE DEV, V20, P1557; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lan F, 2009, SCI CHINA SER C, V52, P311, DOI 10.1007/s11427-009-0054-z; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; SCHARF AN, 2009, NUCLEIC ACIDS RES, P1; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; THOMAS G, 1975, EUR J BIOCHEM, V51, P609, DOI 10.1111/j.1432-1033.1975.tb03963.x; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WATERBORG JH, 1993, J BIOL CHEM, V268, P4918; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	49	189	194	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3341	3350		10.1074/jbc.M109.063784	http://dx.doi.org/10.1074/jbc.M109.063784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940157	Green Published, hybrid			2022-12-27	WOS:000273829000049
J	Meng, JM; Lien, E; Golenbock, DT				Meng, Jianmin; Lien, Egil; Golenbock, Douglas T.			MD-2-mediated Ionic Interactions between Lipid A and TLR4 Are Essential for Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED DOCKING; HUMAN MD-2; LIPOPOLYSACCHARIDE; COMPLEX; MALARIA; VACCINE; SEPSIS	Lipopolysaccharide (LPS) activates innate immune responses through TLR4.MD-2. LPS binds to the MD-2 hydrophobic pocket and bridges the dimerization of two TLR4.MD-2 complexes to activate intracellular signaling. However, exactly how lipid A, the endotoxic moiety of LPS, activates myeloid lineage cells remains unknown. Lipid IVA, a tetra-acylated lipid A precursor, has been used widely as a model for lipid A activation. For unknown reasons, lipid IVA activates proinflammatory responses in rodent cells but inhibits the activity of LPS in human cells. Using stable TLR4-expressing cell lines and purified monomeric MD-2, as well as MD-2-deficient bone marrow-derived macrophages, we found that both mouse TLR4 and mouse MD-2 are required for lipid IVA activation. Computational studies suggested that unique ionic interactions exist between lipid IVA and TLR4 at the dimerization interface in the mouse complex only. The negatively charged 4'-phosphate on lipid IVA interacts with two positively charged residues on the opposing mouse, but not human, TLR4 (Lys(367) and Arg(434)) at the dimerization interface. When replaced with their negatively charged human counterparts Glu(369) and Gln(436), mouse TLR4 was no longer responsive to lipid IVA. In contrast, human TLR4 gained lipid IVA responsiveness when ionic interactions were enabled by charge reversal at the dimerization interface, defining the basis of lipid IVA species specificity. Thus, using lipid IVA as a selective lipid A agonist, we successfully decoupled and coupled two sequential events required for intracellular signaling: receptor engagement and dimerization, underscoring the functional role of ionic interactions in receptor activation.	[Meng, Jianmin; Lien, Egil; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	egil.lien@umassmed.edu; douglas.golenbock@umassmed.edu			National Institutes of Health [GM54060, AI057588]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075318, R01AI057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060, R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54060 (to D. T. G.) and AI057588 ( to E. L.).	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fujimoto Yukari, 2005, J Endotoxin Res, V11, P341, DOI 10.1179/096805105X76841; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOMMA JY, 1990, ADV EXP MED BIOL, V256, P101; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Moitessier N, 2004, J MED CHEM, V47, P4178, DOI 10.1021/jm0311386; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; PARK BS, 2009, NATURE; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; RIETSCHEL ET, 1987, EUR J BIOCHEM, V169, P27, DOI 10.1111/j.1432-1033.1987.tb13576.x; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	37	73	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8695	8702		10.1074/jbc.M109.075127	http://dx.doi.org/10.1074/jbc.M109.075127			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20018893	Green Published, hybrid			2022-12-27	WOS:000275553700022
J	Woodard, GE; Lopez, JJ; Jardin, I; Salido, GM; Rosado, JA				Woodard, Geoffrey E.; Lopez, Jose J.; Jardin, Isaac; Salido, Gines M.; Rosado, Juan A.			TRPC3 Regulates Agonist-stimulated Ca2+ Mobilization by Mediating the Interaction between Type I Inositol 1,4,5-Trisphosphate Receptor, RACK1, and Orai1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; STORE DEPLETION; CALCIUM-ENTRY; CHANNELS; STIM1; ACTIVATION; COMPLEX; CRAC; PROTEINS; RELEASE	There is a body of evidence suggesting that Ca2+ handling proteins assemble into signaling complexes required for a fine regulation of Ca2+ signals, events that regulate a variety of critical cellular processes. Canonical transient receptor potential (TRPC) and Orai proteins have both been proposed to form Ca2+-permeable channels mediating Ca2+ entry upon agonist stimulation. A number of studies have demonstrated that inositol 1,4,5-trisphosphate receptors (IP(3)Rs) interact with plasma membrane TRPC channels; however, at present there is no evidence supporting the interaction between Orai proteins and IP(3)Rs. Here we report that treatment with thapsigargin or cellular agonists results in association of Orai1 with types I and II IP(3)Rs. In addition, we have found that TRPC3, RACK1 (receptor for activated protein kinase C-1), and STIM1 (stromal interaction molecule 1) interact with Orai1 upon stimulation with agonists. TRPC3 expression silencing prevented both the interaction of Orai1 with TRPC3 and, more interestingly, the association of Orai1 with the type I IP3R, but not with the type II IP3R, thus suggesting that TRPC3 selectively mediates interaction between Orai1 and type I IP3R. In addition, TRPC3 expression silencing attenuated ATP- and CCh-stimulated interaction between RACK1 and the type I IP3R, as well as Ca2+ release and entry. In conclusion, our results indicate that agonist stimulation results in the formation of an Orai1-STIM1-TRPC3-RACK1-type I IP3R complex, where TRPC3 plays a central role. This Ca2+ signaling complex might be important for both agonist-induced Ca2+ release and entry.	[Lopez, Jose J.; Jardin, Isaac; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Cell Physiol Res Grp, Dept Physiol, Caceres 10071, Spain; [Woodard, Geoffrey E.] NIDDK, NIH, Bethesda, MD 20892 USA	Universidad de Extremadura; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rosado, JA (corresponding author), Univ Extremadura, Cell Physiol Res Grp, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Woodard, Geoffrey/A-8608-2009; Salido, Gines M/A-4292-2009; Lopez, Jose J/F-4602-2016; Jardin, Isaac/E-8310-2016; Rosado, Juan A/H-3488-2015	Salido, Gines M/0000-0002-8687-2445; Lopez, Jose J/0000-0002-5234-1478; Jardin, Isaac/0000-0003-4575-8264; Rosado, Juan A/0000-0002-9749-2325	Spanish Ministry of Science and Innovation [BFI2007-60104]; National Institutes of Health; Direccion General de Investigation (DGI) [BES-2005-6899, BFU2007-60104]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Investigation (DGI)	This work was supported by Spanish Ministry of Science and Innovation Grant BFI2007-60104. This work was authored, in whole or in part, by National Institutes of Health staff.; <SUP>1</SUP>Supported by Direccion General de Investigation (DGI) fellowship BES-2005-6899.; <SUP>2</SUP>Supported by DGI fellowship BFU2007-60104.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Groschner K, 2005, N-S ARCH PHARMACOL, V371, P251, DOI 10.1007/s00210-005-1054-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, CELL SIGNAL, V20, P737, DOI 10.1016/j.cellsig.2007.12.010; Jardin I, 2009, BIOCHEM J, V420, P267, DOI 10.1042/BJ20082179; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; MANDERS EMM, 1992, J CELL SCI, V103, P857; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Putney James W Jr, 2004, Novartis Found Symp, V258, P123; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Shuttleworth TJ, 2007, CELL CALCIUM, V42, P183, DOI 10.1016/j.ceca.2007.01.012; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Soboloff J., 2007, V179, P575; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tai K, 2008, EUR J PHARMACOL, V583, P135, DOI 10.1016/j.ejphar.2008.01.007; THASTRUP O, 1987, BIOCHEM BIOPH RES CO, V142, P654, DOI 10.1016/0006-291X(87)91464-1; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Woo JS, 2008, BIOCHEM J, V411, P399, DOI [10.1042/BJ20071504, 10.1042/bj20071504]; Woodard GE, 2008, AM J PHYSIOL-CELL PH, V294, pC1323, DOI 10.1152/ajpcell.00071.2008; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zubov AI, 1999, J BIOL CHEM, V274, P25983, DOI 10.1074/jbc.274.37.25983	60	62	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8045	8053		10.1074/jbc.M109.033605	http://dx.doi.org/10.1074/jbc.M109.033605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20022948	Green Published, hybrid			2022-12-27	WOS:000275413800022
J	Fan, YJ; Dickman, KG; Zong, WX				Fan, Yongjun; Dickman, Kathleen G.; Zong, Wei-Xing			Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDEPENDENT SURVIVAL; CANCER-CELLS; FATTY-ACID; IN-VIVO; MITOCHONDRIAL BIOGENESIS; GLUCOSE-METABOLISM; TUMOR-CELLS; GROWTH; EXPRESSION; HEXOKINASE	The high glucose consumption of tumor cells even in an oxygen-rich environment, referred to as the Warburg effect, has been noted as a nearly universal biochemical characteristic of cancer cells. Targeting the glycolysis pathway has been explored as an anti-cancer therapeutic strategy to eradicate cancer based on this fundamental biochemical property of cancer cells. Oncoproteins such as Akt and c-Myc regulate cell metabolism. Accumulating studies have uncovered various molecular mechanisms by which oncoproteins affect cellular metabolism, raising a concern as to whether targeting glycolysis will be equally effective in treating cancers arising from different oncogenic activities. Here, we established a dual-regulatable FL5.12 pre-B cell line in which myristoylated Akt is expressed under the control of doxycycline, and c-Myc, fused to the hormone-binding domain of the human estrogen receptor, is activated by 4-hydroxytamoxifen. Using this system, we directly compared the effect of these oncoproteins on cell metabolism in an isogenic background. Activation of either Akt or c-Myc leads to the Warburg effect as indicated by increased cellular glucose uptake, glycolysis, and lactate generation. When cells are treated with glycolysis inhibitors, Akt sensitizes cells to apoptosis, whereas c-Myc does not. In contrast, c-Myc but not Akt sensitizes cells to the inhibition of mitochondrial function. This is correlated with enhanced mitochondrial activities in c-Myc cells. Hence, although both Akt and c-Myc promote aerobic glycolysis, they differentially affect mitochondrial functions and render cells susceptible to the perturbation of cellular metabolic programs.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Dickman, Kathleen G.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook		wzong@notes.cc.sunysb.edu			NCI [CA129536, CA098092]; Susan Komen for the Cure [KG081538]; Long Island League Against Cancer; NATIONAL CANCER INSTITUTE [R01CA129536, K01CA098092] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Long Island League Against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129536 and CA098092 from NCI. This work was also supported by Susan Komen for the Cure Grant KG081538 and Long Island League Against Cancer.	Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Birnbaum MJ, 2004, DEV CELL, V7, P781, DOI 10.1016/j.devcel.2004.11.016; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Dickman KG, 2000, AM J PHYSIOL-GASTR L, V279, pG757, DOI 10.1152/ajpgi.2000.279.4.G757; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Gogvadze V, 2009, SEMIN CANCER BIOL, V19, P57, DOI 10.1016/j.semcancer.2008.11.007; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lewis BC, 2000, CANCER RES, V60, P6178; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wechatekar K, 2005, CLIN RADIOL, V60, P1143, DOI 10.1016/j.crad.2005.05.018; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu RH, 2005, CANCER RES, V65, P613; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	52	95	98	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7324	7333		10.1074/jbc.M109.035584	http://dx.doi.org/10.1074/jbc.M109.035584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20018866	Green Published, hybrid			2022-12-27	WOS:000275415600044
J	Bushman, JD; Gay, JW; Tewson, P; Stanley, CA; Shyng, SL				Bushman, Jeremy D.; Gay, Joel W.; Tewson, Paul; Stanley, Charles A.; Shyng, Show-Ling			Characterization and Functional Restoration of a Potassium Channel Kir6.2 Pore Mutation Identified in Congenital Hyperinsulinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; INSULIN-SECRETION; INWARD RECTIFICATION; MOLECULAR-BASIS; SUBUNITS; GLYCINE; DISEASE; STABILIZATION; STOICHIOMETRY; MECHANISM	The inwardly rectifying potassium channel Kir6.2 assembles with sulfonylurea receptor 1 to form the ATP-sensitive potassium (K-ATP) channels that regulate insulin secretion in pancreatic beta-cells. Mutations in K-ATP channels underlie insulin secretion disease. Here, we report the characterization of a heterozygous missense Kir6.2 mutation, G156R, identified in congenital hyperinsulinism. Homomeric mutant channels reconstituted in COS cells show similar surface expression as wild-type channels but fail to conduct potassium currents. The mutated glycine is in the pore-lining transmembrane helix of Kir6.2; an equivalent glycine in other potassium channels has been proposed to serve as a hinge to allow helix bending during gating. We found that mutation of an adjacent asparagine, Asn-160, to aspartate, which converts the channel from a weak to a strong inward rectifier, on the G156R background restored ion conduction in the mutant channel. Unlike N160D channels, however, G156R/N160D channels are not blocked by intracellular polyamines at positive membrane potential and exhibit wildtype- like nucleotide sensitivities, suggesting the aspartate introduced at position 160 interacts with arginine at 156 to restore ion conduction and gating. Using tandem Kir6.2 tetramers containing G156R and/or N160D in designated positions, we show that one mutant subunit in the tetramer is insufficient to abolish conductance and that G156R and N160D can interact in the same or adjacent subunits to restore conduction. We conclude that the glycine at 156 is not essential for K-ATP channel gating and that the Kir6.2 gating defect caused by the G156R mutation could be rescued by manipulating chemical interactions between pore residues.	[Bushman, Jeremy D.; Gay, Joel W.; Tewson, Paul; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA	Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health [R01DK066485, F31NS065688, R01DK56268]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056268, R01DK066485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK066485 (to S.-L.S.), F31NS065688 (to J.D.B.), and R01DK56268 (to C.A.S.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2001, RECENT PROG HORM RES, V56, P47, DOI 10.1210/rp.56.1.47; Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Glaser B, 2000, SEMIN PERINATOL, V24, P150, DOI 10.1053/sp.2000.6365; Haider S, 2007, BIOCHEMISTRY-US, V46, P3643, DOI 10.1021/bi062210f; HILLE B, 2001, ION CHANNELS EXCITAB, P150; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1995, BIOCHEMISTRY-US, V34, P13133, DOI 10.1021/bi00040a026; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798	45	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6012	6023		10.1074/jbc.M109.085860	http://dx.doi.org/10.1074/jbc.M109.085860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032456	hybrid, Green Published			2022-12-27	WOS:000275367500004
J	Yamamoto, S; Inoue, K; Murata, T; Kamigaso, S; Yasujima, T; Maeda, JY; Yoshida, Y; Ohta, KY; Yuasa, H				Yamamoto, Syunsuke; Inoue, Katsuhisa; Murata, Tomoaki; Kamigaso, Syunsuke; Yasujima, Tomoya; Maeda, Jun-ya; Yoshida, Yukihiro; Ohta, Kin-ya; Yuasa, Hiroaki			Identification and Functional Characterization of the First Nucleobase Transporter in Mammals IMPLICATION IN THE SPECIES DIFFERENCE IN THE INTESTINAL ABSORPTION MECHANISM OF NUCLEOBASES AND THEIR ANALOGS BETWEEN HIGHER PRIMATES AND OTHER MAMMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; ACID-XANTHINE PERMEASE; RAT SMALL-INTESTINE; PURINE-RICH FOODS; ASPERGILLUS-NIDULANS; URIC-ACID; MOLECULAR CHARACTERIZATION; EVOLUTIONARY IMPLICATIONS; URATE OXIDASE; NUCLEOSIDE	Nucleobases are important compounds that constitute nucleosides and nucleic acids. Although it has long been suggested that specific transporters are involved in their intestinal absorption and uptake in other tissues, none of their molecular entities have been identified in mammals to date. Here we describe identification of rat Slc23a4 as the first sodium-dependent nucleobase transporter (rSNBT1). The mRNA of rSNBT1 was expressed highly and only in the small intestine. When transiently expressed in HEK293 cells, rSNBT1 could transport uracil most efficiently. The transport of uracil mediated by rSNBT1 was sodium-dependent and saturable with a Michaelis constant of 21.2 mu M. Thymine, guanine, hypoxanthine, and xanthine were also transported, but adenine was not. It was also suggested by studies of the inhibitory effect on rSNBT1-mediated uracil transport that several nucleobase analogs such as 5-fluorouracil are recognized by rSNBT1, but cytosine and nucleosides are not or only poorly recognized. Furthermore, rSNBT1 fused with green fluorescent protein was mainly localized at the apical membrane, when stably expressed in polarized Madin-Darby canine kidney II cells. These characteristics of rSNBT1 were almost fully in agreement with those of the carrier-mediated transport system involved in intestinal uracil uptake. Therefore, it is likely that rSNBT1 is its molecular entity or at least in part responsible for that. It was also found that the gene orthologous to the rSNBT1 gene is genetically defective in humans. This may have a biological and evolutional meaning in the transport and metabolism of nucleobases. The present study provides novel insights into the specific transport and metabolism of nucleobases and their analogs for therapeutic use.	[Yamamoto, Syunsuke; Inoue, Katsuhisa; Murata, Tomoaki; Kamigaso, Syunsuke; Yasujima, Tomoya; Maeda, Jun-ya; Yoshida, Yukihiro; Ohta, Kin-ya; Yuasa, Hiroaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Nagoya, Aichi 4678603, Japan	Nagoya City University	Inoue, K (corresponding author), 3-1 Tanabe Dori,Mizuho Ku, Nagoya, Aichi 4678603, Japan.	kinoue@phar.nagoya-cu.ac.jp	Yuasa, Hiroaki/AGW-4587-2022	Yuasa, Hiroaki/0000-0001-8349-6694; Yamamoto, Syunsuke/0000-0002-0257-1216	Ministry of Education, Culture, Sports, Science and Technology, Japan; Nagoya City University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagoya City University	This work was supported in part by a grant-in-aid for young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a grant-in-aid for research in Nagoya City University.	ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Argyrou E, 2001, PLANT CELL, V13, P953, DOI 10.1105/tpc.13.4.953; Baker SD, 1996, J CLIN ONCOL, V14, P3085, DOI 10.1200/JCO.1996.14.12.3085; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BRONK JR, 1987, J PHYSIOL-LONDON, V382, P475, DOI 10.1113/jphysiol.1987.sp016379; Burchmore RJS, 2003, J BIOL CHEM, V278, P23502, DOI 10.1074/jbc.M301252200; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CLIFFORD AJ, 1976, J NUTR, V106, P428, DOI 10.1093/jn/106.3.428; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cropp CD, 2008, MOL PHARMACOL, V73, P1151, DOI 10.1124/mol.107.043117; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; DIALLINAS G, 1989, GENETICS, V122, P341; DIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215, DOI 10.2165/00003088-198916040-00002; Faaland CA, 1998, BBA-GENE STRUCT EXPR, V1442, P353, DOI 10.1016/S0167-4781(98)00151-1; Gillissen B, 2000, PLANT CELL, V12, P291, DOI 10.1105/tpc.12.2.291; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Govindarajan R, 2007, AM J PHYSIOL-REG I, V293, pR1809, DOI 10.1152/ajpregu.00293.2007; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; GRIFFITH DA, 1994, BIOCHEM J, V303, P901, DOI 10.1042/bj3030901; GRIFFITH DA, 1993, J BIOL CHEM, V268, P20085; GUIMARAES MJ, 1995, DEVELOPMENT, V121, P3335; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOHAMEDALI KA, 1993, J BIOL CHEM, V268, P23728; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Moriwaki Y, 1999, HISTOL HISTOPATHOL, V14, P1321, DOI 10.14670/HH-14.1321; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Ohta KY, 2006, DRUG METAB DISPOS, V34, P1868, DOI 10.1124/dmd.106.010876; Ortiz D, 2007, MOL MICROBIOL, V64, P1228, DOI 10.1111/j.1365-2958.2007.05730.x; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; Theisinger A, 2003, J COMP PHYSIOL B, V173, P165, DOI 10.1007/s00360-002-0324-6; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Valdes R, 2000, GASTROENTEROLOGY, V119, P1623, DOI 10.1053/gast.2000.20183; WASHINGTON CB, 1995, J BIOL CHEM, V270, P22816, DOI 10.1074/jbc.270.39.22816; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; WITTE DP, 1991, J CELL BIOL, V115, P179, DOI 10.1083/jcb.115.1.179; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yuasa H, 1996, BIOL PHARM BULL, V19, P94; ZOLLNER N, 1982, P NUTR SOC, V41, P329, DOI 10.1079/PNS19820048	52	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6522	6531		10.1074/jbc.M109.032961	http://dx.doi.org/10.1074/jbc.M109.032961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042597	hybrid, Green Published			2022-12-27	WOS:000275367500057
J	Bardswell, SC; Cuello, F; Rowland, AJ; Sadayappan, S; Robbins, J; Gautel, M; Walker, JW; Kentish, JC; Avkiran, M				Bardswell, Sonya C.; Cuello, Friederike; Rowland, Alexandra J.; Sadayappan, Sakthivel; Robbins, Jeffrey; Gautel, Mathias; Walker, Jeffery W.; Kentish, Jonathan C.; Avkiran, Metin			Distinct Sarcomeric Substrates Are Responsible for Protein Kinase D-mediated Regulation of Cardiac Myofilament Ca2+ Sensitivity and Cross-bridge Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-BINDING; TROPONIN-I; C PHOSPHORYLATION; VENTRICULAR MYOCYTES; A PHOSPHORYLATION; ATPASE ACTIVITY; MYOCARDIUM; CONTRACTION; VELOCITY; MUSCLE	Protein kinase D (PKD), a serine/threonine kinase with emerging cardiovascular functions, phosphorylates cardiac troponin I (cTnI) at Ser(22)/Ser(23), reduces myofilament Ca2+ sensitivity, and accelerates cross-bridge cycle kinetics. Whether PKD regulates cardiac myofilament function entirely through cTnI phosphorylation at Ser(22)/Ser(23) remains to be established. To determine the role of cTnI phosphorylation at Ser(22)/Ser(23) in PKD-mediated regulation of cardiac myofilament function, we used transgenic mice that express cTnI in which Ser(22)/Ser(23) are substituted by nonphosphorylatable Ala (cTnI-Ala(2)). In skinned myocardium from wild-type (WT) mice, PKD-increased cTnI phosphorylation at Ser(22)/Ser(23) and decreased the Ca2+ sensitivity of force. In contrast, PKD had no effect on the Ca2+ sensitivity of force in myocardium from cTnI-Ala(2) mice, in which Ser(22)/Ser(23) were unavailable for phosphorylation. Surprisingly, PKD accelerated cross-bridge cycle kinetics similarly in myocardium from WT and cTnI-Ala(2) mice. Because cardiac myosin-binding protein C (cMyBP-C) phosphorylation underlies cAMP-dependent protein kinase (PKA)-mediated acceleration of cross-bridge cycle kinetics, we explored whether PKD phosphorylates cMyBP-C at its PKA sites, using recombinant C1C2 fragments with or without site-specific Ser/Ala substitutions. Kinase assays confirmed that PKA phosphorylates Ser(273), Ser(282), and Ser(302), and revealed that PKD phosphorylates only Ser(302). Furthermore, PKD phosphorylated Ser(302) selectively and to a similar extent in native cMyBP-C of skinned myocardium from WT and cTnI-Ala(2) mice, and this phosphorylation occurred throughout the C-zones of sarcomeric A-bands. In conclusion, PKD reduces myofilament Ca2+ sensitivity through cTnI phosphorylation at Ser(22)/Ser(23) but accelerates cross-bridge cycle kinetics by a distinct mechanism. PKD phosphorylates cMyBP-C at Ser(302), which may mediate the latter effect.	[Avkiran, Metin] St Thomas Hosp, Rayne Inst, Kings Coll London, Div Cardiovasc, London SE1 7EH, England; [Sadayappan, Sakthivel; Robbins, Jeffrey] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Walker, Jeffery W.] Univ Arizona, Mol Cardiovasc Res Program, Tucson, AZ 85724 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cincinnati Children's Hospital Medical Center; University of Arizona	Avkiran, M (corresponding author), St Thomas Hosp, Rayne Inst, Kings Coll London, Div Cardiovasc, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk	Gautel, Mathias/AAB-9860-2019; Cuello, Friederike/A-9642-2016	Sadayappan, Sakthivel/0000-0003-2006-7678; Gautel, Mathias/0000-0003-4027-9803; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation [PG/07/056/23150]; King's British Heart Foundation Centre of Research Excellence; Medical Research Council [G0001112, G0600251] Funding Source: researchfish; MRC [G0001112, G0600251] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); King's British Heart Foundation Centre of Research Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Project Grant PG/07/056/23150 and in part by the King's British Heart Foundation Centre of Research Excellence.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GE Y, 2009, P NATL ACAD SCI US; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2007, J MOL CELL CARDIOL, V43, P686, DOI 10.1016/j.yjmcc.2007.09.013; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; HOFMANN PA, 1994, CIRC RES, V74, P718, DOI 10.1161/01.RES.74.4.718; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kulikovskaya I, 2007, J GEN PHYSIOL, V129, P419, DOI 10.1085/jgp.200609714; McDonald KS, 1998, J PHYSIOL-LONDON, V511, P519, DOI 10.1111/j.1469-7793.1998.519bh.x; MESSERLI JM, 1993, HISTOCHEMISTRY, V100, P193, DOI 10.1007/BF00269092; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; SCHWINGER RHG, 1994, CIRC RES, V74, P959, DOI 10.1161/01.RES.74.5.959; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004	38	85	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5674	5682		10.1074/jbc.M109.066456	http://dx.doi.org/10.1074/jbc.M109.066456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018870	Green Published, hybrid			2022-12-27	WOS:000275327200060
J	Dang, YK; Green, BR				Dang, Yunkun; Green, Beverley R.			Long Transcripts from Dinoflagellate Chloroplast Minicircles Suggest "Rolling Circle" Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERIVATIVE-CONTAINING PLASTIDS; TRANSFER-RNA GENES; MESSENGER-RNA; AMPHIDINIUM-OPERCULATUM; CERATIUM-HORRIDUM; SEPARATE ORIGINS; RIBOSOMAL-RNA; GAPDH GENE; GENOME; DNA	The chloroplast genome of a dinoflagellate consists of a group of small circular DNA molecules (minicircles), most of which carry a single gene. With RT-PCR, primer extension, and Northern analyses, we show that the entire minicircle is transcribed and that some minicircles can produce RNAs larger than themselves. Using an RNA ligase-mediated rapid amplification of cDNA ends method, we were able to detect large processed precursors that are generated by endonucleolytic cleavage of an even longer molecule. This cleavage produces the mature mRNA 3'-end and at the same time the 5'-end of the precursor. The tRNAs encoded by the petD and psbE minicircles appear to be processed in the same way. We propose a "rolling circle" model for chloroplast transcription in which transcription would proceed continuously around the minicircular DNA to produce transcripts larger than the minicircle itself. These transcripts would be further processed into discrete mature mRNAs and tRNAs.	[Dang, Yunkun; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Green, BR (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	brgreen@interchange.ubc.ca	Green, Beverley R./AAJ-5199-2021	Green, Beverley R./0000-0002-4021-9387	Natural Sciences and Engineering Research Council of Canada [54688]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 54688.	Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Barbrook AC, 2000, MOL GEN GENET, V263, P152, DOI 10.1007/s004380050042; Barbrook AC, 2001, MOL GENET GENOMICS, V266, P632, DOI 10.1007/s004380100582; Barbrook AC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-297; Bensing BA, 1996, P NATL ACAD SCI USA, V93, P7794, DOI 10.1073/pnas.93.15.7794; Canino G, 2009, PLANT PHYSIOL, V150, P1494, DOI 10.1104/pp.109.137950; Ceballos-Chavez M, 2005, J BIOL CHEM, V280, P33461, DOI 10.1074/jbc.M504691200; Dang Y, 2009, GENE, V442, P73, DOI 10.1016/j.gene.2009.04.006; DAUBENDIEK SL, 1995, J AM CHEM SOC, V117, P7818, DOI 10.1021/ja00134a032; Diegelman AM, 1998, NUCLEIC ACIDS RES, V26, P3235, DOI 10.1093/nar/26.13.3235; GRAHAM LE, 2000, ALGAE, P198; Green BR, 2004, PROTIST, V155, P23, DOI 10.1078/1434461000161; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hayes R, 1996, EMBO J, V15, P1132, DOI 10.1002/j.1460-2075.1996.tb00451.x; Herrin DL, 2004, PHOTOSYNTH RES, V82, P301, DOI 10.1007/s11120-004-2741-8; Hiller RG, 2001, FEBS LETT, V505, P449, DOI 10.1016/S0014-5793(01)02871-X; HOHFELD I, 1992, J PHYCOL, V28, P82, DOI 10.1111/j.0022-3646.1992.00082.x; Laatsch T, 2004, MOL BIOL EVOL, V21, P1318, DOI 10.1093/molbev/msh127; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Leung SK, 2009, NUCLEIC ACIDS RES, V37, P1991, DOI 10.1093/nar/gkp063; Monde RA, 2000, BIOCHIMIE, V82, P573, DOI 10.1016/S0300-9084(00)00606-4; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Nelson MJ, 2007, GENE, V392, P291, DOI 10.1016/j.gene.2007.01.018; Nelson MJ, 2005, GENE, V358, P102, DOI 10.1016/j.gene.2005.05.024; Nisbet RER, 2008, PROTIST, V159, P31, DOI 10.1016/j.protis.2007.07.002; Sambrook J., 2002, MOL CLONING LAB MANU; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Swiatecka-Hagenbruch M, 2007, MOL GENET GENOMICS, V277, P725, DOI 10.1007/s00438-007-0222-4; Takishita K, 2005, PHYCOLOGIA, V44, P26, DOI 10.2216/0031-8884(2005)44[26:POTPGC]2.0.CO;2; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; WESTHOFF P, 1988, EUR J BIOCHEM, V171, P551, DOI 10.1111/j.1432-1033.1988.tb13824.x; Zauner S, 2004, FEBS LETT, V577, P535, DOI 10.1016/j.febslet.2004.10.060; Zhang ZD, 2002, MOL BIOL EVOL, V19, P489, DOI 10.1093/oxfordjournals.molbev.a004104; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099	38	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5196	5203		10.1074/jbc.M109.058545	http://dx.doi.org/10.1074/jbc.M109.058545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19948728	Green Published, hybrid			2022-12-27	WOS:000275327200012
J	Kim, JH; Kim, K; Jin, HM; Song, I; Youn, BU; Lee, SH; Choi, Y; Kim, N				Kim, Jung Ha; Kim, Kabsun; Jin, Hye Mi; Song, Insun; Youn, Bang Ung; Lee, Seoung-Hoon; Choi, Yongwon; Kim, Nacksung			Negative Feedback Control of Osteoclast Formation through Ubiquitin-mediated Down-regulation of NFATc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS C1; NUCLEAR-FACTOR; CBL-B; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; RECEPTOR; DIFFERENTIATION; BONE; ACTIVATION; PROTEINS	The regulation of NFATc1 expression is important for osteoclast differentiation and function. Herein, we demonstrate that macrophage-colony-stimulating factor induces NFATc1 degradation via Cbl proteins in a Src kinase-dependent manner. NFATc1 proteins are ubiquitinated and rapidly degraded during late stage osteoclastogenesis, and this degradation is mediated by Cbl-b and c-Cbl ubiquitin ligases in a Src-dependent manner. In addition, NFATc1 interacts endogenously with c-Src, c-Cbl, and Cbl-b in osteoclasts. Overexpression of c-Src induces down-regulation of NFATc1, and depletion of Cbl proteins blocks NFATc1 degradation during late stage osteoclastogenesis. Taken together, our data provide a negative regulatory mechanism by which macrophage-colony-stimulating factor activates Src family kinases and Cbl proteins, and subsequently, induces NFATc1 degradation during osteoclast differentiation.	[Kim, Nacksung] Chonnam Natl Univ, Sch Med, Natl Res Lab Regulat Bone Metab & Dis, Med Res Ctr Gene Regulat,Res Inst Med Sci,Dept Ph, Kwangju 501746, South Korea; [Lee, Seoung-Hoon] Wonkwang Univ, Sch Dent, Dept Oral Microbiol & Immunol, Iksan 570749, South Korea; [Lee, Seoung-Hoon; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Chonnam National University; Wonkwang University; University of Pennsylvania	Kim, N (corresponding author), Chonnam Natl Univ, Sch Med, Natl Res Lab Regulat Bone Metab & Dis, Med Res Ctr Gene Regulat,Res Inst Med Sci,Dept Ph, Hak Dong 5, Kwangju 501746, South Korea.	nacksung@chonnam.ac.kr			National Institutes of Health [AR053843, DE19381]; Medical Research Center for Gene Regulation at Chonnam National University, Korean government [R0A-2007-000-20025-0, R13-2002-013-03001-0]; Brain Korea 21 Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Center for Gene Regulation at Chonnam National University, Korean government(Korean Government); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053843 and DE19381 ( to Y.C.). This work was also supported in part by the Korea Science and Engineering Foundation National Research Laboratory Program grant funded by the Korean government Grant R0A-2007-000-20025-0 and Grant R13-2002-013-03001-0 from the Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation at Chonnam National University and by a grant from the Brain Korea 21 Project ( to J.H.K. and K. K.).	Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rangachari M, 2004, CURR OPIN PHARMACOL, V4, P415, DOI 10.1016/j.coph.2004.03.007; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200	38	37	38	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5224	5231		10.1074/jbc.M109.042812	http://dx.doi.org/10.1074/jbc.M109.042812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20037154	Green Published, hybrid			2022-12-27	WOS:000275327200015
J	Liu, YY; Fang, YA; Shao, HB; Lindsey-Boltz, L; Sancar, A; Modrich, P				Liu, Yiyong; Fang, Yanan; Shao, Hongbing; Lindsey-Boltz, Laura; Sancar, Aziz; Modrich, Paul			Interactions of Human Mismatch Repair Proteins MutS alpha and MutL alpha with Proteins of the ATR-Chk1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRO-N-NITROSOGUANIDINE; CELL-CYCLE ARREST; DNA-DAMAGE; IN-VITRO; CHECKPOINT KINASE; NUCLEAR EXTRACTS; ATR KINASE; TOPBP1; O-6-METHYLGUANINE; RECONSTITUTION	At clinically relevant doses, chemotherapeutic SN1 DNA methylating agents induce an ATR-mediated checkpoint response in human cells that is dependent on functional MutS alpha and MutL alpha. Deficiency of either mismatch repair activity renders cells highly resistant to this class of drug, but the mechanisms linking mismatch repair to checkpoint activation have remained elusive. In this study we have systematically examined the interactions of human MutS alpha and MutL alpha with proteins of the ATR-Chk1 pathway using both nuclear extracts and purified proteins. Using nuclear co-immunoprecipitation, we have detected interaction of MutS alpha with ATR, TopBP1, Claspin, and Chk1 and interaction of MutL alpha with TopBP1 and Claspin. We were unable to detect interaction of MutS alpha or MutL alpha with Rad17, Rad9, or replication protein A in the extract system. Use of purified proteins confirmed direct interaction of MutS alpha with ATR, TopBP1, and Chk1 and of MutL alpha with TopBP1. MutS alpha Claspin and MutL alpha-Claspin interactions were not demonstrable with purified proteins, suggesting that extract interactions are indirect or depend on post-translational modification. Use of a modified chromatin immunoprecipitation assay showed that proliferating cell nuclear antigen, ATR, TopBP1, and Chk1 are recruited to chromatin in a MutL alpha- and MutS alpha-dependent fashion after N-methyl-N'-nitro-N-nitrosoguanidine treatment. However, chromatin enrichment of replication protein A, Claspin, Rad17-RFC, and Rad9-Rad1-Hus1 was not detected in these experiments. Although our failure to observe enrichment of the latter activities could be due to sensitivity limitations, these observations may indicate a novel mechanism for ATR activation.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Liu, Yiyong; Fang, Yanan; Shao, Hongbing; Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lindsey-Boltz, Laura; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Duke University; Duke University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine		modrich@biochem.duke.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194; Fang, Yanan/0000-0002-1112-9569; Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [GM45190, GM32833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM45190 (to P. M.) and GM32833 (to A. S.).	Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Beardsley DI, 2005, MOL PHARMACOL, V68, P1049, DOI 10.1124/mol.105.013888; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ceccotti S, 1996, CURR BIOL, V6, P1528, DOI 10.1016/S0960-9822(96)00758-0; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Edelmann W, 2000, CANCER RES, V60, P803; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iams K, 2002, J BIOL CHEM, V277, P30805, DOI 10.1074/jbc.M200846200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Klapacz J, 2009, P NATL ACAD SCI USA, V106, P576, DOI 10.1073/pnas.0811991106; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; LAEMMLI UK, 1970, NATURE, V227, P685; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Longley MJ, 1997, J BIOL CHEM, V272, P10917; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Quaresima B, 2006, HUM MUTAT, V27, P715, DOI 10.1002/humu.9427; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Szadkowski M, 2005, CANCER RES, V65, P4525, DOI 10.1158/0008-5472.CAN-05-0080; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wang Y, 2000, GENE DEV, V14, P927; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	61	56	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5974	5982		10.1074/jbc.M109.076109	http://dx.doi.org/10.1074/jbc.M109.076109			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20029092	Green Published, hybrid			2022-12-27	WOS:000275327200087
J	Musset, B; Capasso, M; Cherny, VV; Morgan, D; Bhamrah, M; Dyer, MJS; DeCoursey, TE				Musset, Boris; Capasso, Melania; Cherny, Vladimir V.; Morgan, Deri; Bhamrah, Mandeep; Dyer, Martin J. S.; DeCoursey, Thomas E.			Identification of Thr(29) as a Critical Phosphorylation Site That Activates the Human Proton Channel Hvcn1 in Leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDASE-RELATED PROTON; NADPH OXIDASE; HUMAN-NEUTROPHILS; ELECTRON CURRENTS; VOLTAGE-DEPENDENCE; H+ CHANNEL; EOSINOPHILS; PH; CONDUCTANCE; PHAGOCYTES	Voltage-gated proton channels and NADPH oxidase function cooperatively in phagocytes during the respiratory burst, when reactive oxygen species are produced to kill microbial invaders. Agents that activate NADPH oxidase also enhance proton channel gating profoundly, facilitating its roles in charge compensation and pH(i) regulation. The "enhanced gating mode" appears to reflect protein kinase C (PKC) phosphorylation. Here we examine two candidates for PKC-delta phosphorylation sites in the human voltage-gated proton channel, H(V)1 (Hvcn1), Thr(29) and Ser(97), both in the intracellular N terminus. Channel phosphorylation was reduced in single mutants S97A or T29A, and further in the double mutant T29A/S97A, by an in vitro kinase assay with PKC-delta. Enhanced gating was evaluated by expressing wild-type (WT) or mutant H(V)1 channels in LK35.2 cells, a B cell hybridoma. Stimulation by phorbol myristate acetate enhanced WT channel gating, and this effect was reversed by treatment with the PKC inhibitor GF109203X. The single mutant T29A or double mutant T29A/S97A failed to respond to phorbol myristate acetate or GF109203X. In contrast, the S97A mutant responded like cells transfected with WT H(V)1. We conclude that under these conditions, direct phosphorylation of the proton channel molecule at Thr(29) is primarily responsible for the enhancement of proton channel gating. This phosphorylation is crucial to activation of the proton conductance during the respiratory burst in phagocytes.	[Musset, Boris; Cherny, Vladimir V.; Morgan, Deri] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Capasso, Melania; Bhamrah, Mandeep; Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	Rush University; University of Leicester	DeCoursey, TE (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, 1750 W Harrison, Chicago, IL 60612 USA.	tdecours@rush.edu	DeCoursey, Thomas/A-6820-2009; Musset, Boris/J-2520-2013; Musset, Boris/AAD-4158-2022; Dyer, Martin/F-2691-2014	DeCoursey, Thomas/0000-0002-4263-180X; Musset, Boris/0000-0001-8242-8817; Musset, Boris/0000-0001-8242-8817; Capasso, Melania/0000-0001-8659-9867; Dyer, Martin/0000-0002-5033-2236	National Institutes of Health Research through the NHLBI [HL61437]; Philip Morris USA Inc.; Philip Morris International; MRC, United Kingdom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER; Medical Research Council [MC_U132670597] Funding Source: researchfish; MRC [MC_U132670597] Funding Source: UKRI	National Institutes of Health Research through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Philip Morris USA Inc.; Philip Morris International; MRC, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL61437 through the NHLBI. This work was also supported by grants from Prof. Dr. Adolf Schmidtmann-Stiftung, Philip Morris USA Inc. and Philip Morris International, and the MRC, United Kingdom.	Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; CAPASSO M, 2010, NAT IMMUNOL IN PRESS; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; CHVAPIL M, 1977, INFECT IMMUN, V16, P367, DOI 10.1128/IAI.16.1.367-373.1977; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Femling JK, 2006, J GEN PHYSIOL, V127, P659, DOI 10.1085/jgp.200609504; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; He R, 2004, J IMMUNOL, V173, P7462, DOI 10.4049/jimmunol.173.12.7462; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1995, J BIOL CHEM, V270, P5909, DOI 10.1074/jbc.270.11.5909; KAPUS A, 1992, BIOCHEM J, V281, P697, DOI 10.1042/bj2810697; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Morgan D, 2003, J PHYSIOL-LONDON, V550, P447, DOI 10.1113/jphysiol.2003.041525; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murphy R, 2006, BBA-BIOENERGETICS, V1757, P996, DOI 10.1016/j.bbabio.2006.01.005; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Musset B, 2009, BIOPHYS J, V96, p667A, DOI 10.1016/j.bpj.2008.12.3528; Musset B, 2009, FEBS LETT, V583, P7, DOI 10.1016/j.febslet.2008.12.005; NANDA A, 1991, P NATL ACAD SCI USA, V88, P10816, DOI 10.1073/pnas.88.23.10816; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Petheo GL, 2005, BIOCHEM J, V388, P485, DOI 10.1042/BJ20041889; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; SIMCHOWITZ L, 1990, J BIOL CHEM, V265, P13449; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284	37	51	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5117	5121		10.1074/jbc.C109.082727	http://dx.doi.org/10.1074/jbc.C109.082727			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20037153	Green Published, hybrid			2022-12-27	WOS:000275327200001
J	Saxena, M; Abhyankar, M; Bastia, D				Saxena, Mukesh; Abhyankar, Mayuresh; Bastia, Deepak			Replication Initiation at a Distance DETERMINATION OF THE CIS- AND TRANS-ACTING ELEMENTS OF REPLICATION ORIGIN alpha OF PLASMID R6K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; R-PLASMID RSF1040; ESCHERICHIA-COLI; DNA-REPLICATION; IN-VIVO; PURIFIED PROTEINS; COPY NUMBER; R6K DNA; GAMMA; PRIMASE	Plasmid R6K, which contains 3 replication origins called alpha, gamma, and beta, is a favorable system to investigate the molecular mechanism(s) of action at a distance, i.e. replication initiation at a considerable distance from the primary initiator protein binding sites (iterons). The centrally located gamma origin contains 7 iterons that bind to the plasmid-encoded initiator protein, pi. Ori alpha, located at a distance of similar to 4 kb from gamma, contains a single iteron that does not directly bind to pi but is believed to access the protein by pi-mediated alpha-gamma iteron-iteron interaction that loops out the intervening similar to 3.7 kb of DNA. Although the cis-acting components and the trans-acting proteins required for ori gamma function have been analyzed in detail, such information was lacking for ori alpha. Here, we have identified both the sequence elements located at alpha and those at gamma, that together promoted alpha activity. The data support the conclusion that besides the single iteron, a neighboring DNA primase recognition element called G site is essential for alpha-directed plasmid maintenance. Sequences preceding the iteron and immediately following the G site, although not absolutely necessary, appear to play a role in efficient plasmid maintenance. In addition, while both dnaA1 and dnaA2 boxes that bind to DnaA protein and are located at gamma were essential for alpha activity, only dnaA2 was required for initiation at gamma. Mutations in the AT-rich region of gamma also abolished alpha function. These results are consistent with the interpretation that a protein-DNA complex consisting of pi and DnaA forms at gamma and activates alpha at a distance by DNA looping.	[Saxena, Mukesh; Abhyankar, Mayuresh; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	bastia@musc.edu			NIAID [RO1GM049264]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM049264 from the NIAID (to D. B.).	Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; Abhyankar MM, 2003, J BIOL CHEM, V278, P45476, DOI 10.1074/jbc.M308516200; Avila P, 1996, J MOL BIOL, V261, P135, DOI 10.1006/jmbi.1996.0447; BOUCHE JP, 1978, J BIOL CHEM, V253, P765; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CROSA JH, 1978, J MOL BIOL, V124, P443, DOI 10.1016/0022-2836(78)90181-X; CROSA JH, 1980, J BIOL CHEM, V255, P1075; CROSA JH, 1976, J BACTERIOL, V126, P454, DOI 10.1128/JB.126.1.454-466.1976; Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73; de Laat W, 2007, CURR OPIN CELL BIOL, V19, P317, DOI 10.1016/j.ceb.2007.04.004; FILUTOWICZ M, 1988, NUCLEIC ACIDS RES, V16, P3829, DOI 10.1093/nar/16.9.3829; FLASHNER Y, 1990, P NATL ACAD SCI USA, V87, P9123, DOI 10.1073/pnas.87.23.9123; Flashner Y, 1996, MOL MICROBIOL, V19, P985, DOI 10.1046/j.1365-2958.1996.428960.x; GERMINO J, 1983, CELL, V34, P125, DOI 10.1016/0092-8674(83)90142-3; Gondor A, 2009, NAT REV GENET, V10, P269, DOI 10.1038/nrg2555; INUZUKA N, 1980, J BIOL CHEM, V255, P1071; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KELLEY WL, 1991, J BIOL CHEM, V266, P15924; KELLEY WL, 1992, NEW BIOL, V4, P569; KELLEY WL, 1992, P NATL ACAD SCI USA, V89, P5078, DOI 10.1073/pnas.89.11.5078; KOLTER R, 1978, PLASMID, V1, P571, DOI 10.1016/0147-619X(78)90014-8; Kornberg A., 1992, DNA REPLICATION; KUBOTA Y, 1993, GENE, V126, P9; LOBELL RB, 1991, J MOL BIOL, V218, P45, DOI 10.1016/0022-2836(91)90872-4; Loscha K, 2004, PROTEIN EXPRES PURIF, V33, P304, DOI 10.1016/j.pep.2003.10.001; LOVETT MA, 1975, P NATL ACAD SCI USA, V72, P2905, DOI 10.1073/pnas.72.8.2905; Lu YB, 1998, EMBO J, V17, P5192, DOI 10.1093/emboj/17.17.5192; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; MACALLISTER TW, 1991, J BIOL CHEM, V266, P16056; MASAI H, 1990, J BIOL CHEM, V265, P15124; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; Park K, 2001, J MOL BIOL, V310, P69, DOI 10.1006/jmbi.2001.4741; Pritchard AE, 1996, J BIOL CHEM, V271, P10291, DOI 10.1074/jbc.271.17.10291; PTASHNE M, 2004, GENETIC SWITCH; ROWEN L, 1978, J BIOL CHEM, V253, P758; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SHAFFERMAN A, 1987, MOL GEN GENET, V208, P263, DOI 10.1007/BF00330452; Sharma R, 2001, EMBO J, V20, P4577, DOI 10.1093/emboj/20.16.4577; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; SIMS J, 1980, P NATL ACAD SCI-BIOL, V77, P900, DOI 10.1073/pnas.77.2.900; STAYTON MM, 1983, J BIOL CHEM, V258, P3205; Swan MK, 2006, P NATL ACAD SCI USA, V103, P18481, DOI 10.1073/pnas.0609046103; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	51	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5705	5712		10.1074/jbc.M109.067348	http://dx.doi.org/10.1074/jbc.M109.067348			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018882	Green Published, hybrid			2022-12-27	WOS:000275327200063
J	Tsai, AC; Pan, SL; Sun, HL; Wang, CY; Peng, CY; Wang, SW; Chang, YL; Kuo, SC; Lee, KH; Teng, CM				Tsai, An-Chi; Pan, Shiow-Lin; Sun, Hui-Lung; Wang, Chih-Ya; Peng, Chieh-Yu; Wang, Shih-Wei; Chang, Ya-Ling; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Teng, Che-Ming			CHM-1, a New Vascular Targeting Agent, Induces Apoptosis of Human Umbilical Vein Endothelial Cells via p53-mediated Death Receptor 5 Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMITOTIC ANTITUMOR AGENTS; IN-VITRO; TUBULIN POLYMERIZATION; DISRUPTING AGENTS; GENE-EXPRESSION; GROWTH-FACTOR; DNA-DAMAGE; ANGIOGENESIS; ACTIVATION; CANCER	CHM-1 (2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone) has been identified as a potent antitumor agent in human hepatocellular carcinoma; however, its role in tumor angiogenesis is unclear. This study investigated the effects of CHM-1 and the mechanisms by which it exerts its antiangiogenic and vascular disrupting properties. Using a xenograft model antitumor assay, we found that CHM-1 significantly inhibits tumor growth and microvessel formation. Flow cytometry, immunofluorescence microscopy, and cell death enzyme-linked immunosorbent assay kit revealed that CHM-1 inhibits growth of human umbilical vein endothelial cells (HUVEC) by induction of apoptotic cell death in a concentration-dependent manner. CHM-1 also suppresses HUVEC migration and capillary-like tube formation. We were able to correlate CHM-1-induced apoptosis in HUVEC with the cleavage of procaspase-3, -7, and -8, as well as with the cleavage of poly(ADP-ribose) polymerase by Western blotting assay. Such sensitization was achieved through up-regulation of death receptor 5 (DR5) but not DR4 or Fas. CHM-1 was also capable of increasing the expression level of p53, and most importantly, the induction of DR5 by CHM-1 was abolished by p53 small interfering RNA. Taken together, the results of this study indicate that CHM-1 exhibits vascular targeting activity associated with the induction of DR5-mediated endothelial cell apoptosis through p53 up-regulation, which suggests its potential as an antivascular and antitumor therapeutic agent.	[Tsai, An-Chi; Pan, Shiow-Lin; Sun, Hui-Lung; Wang, Chih-Ya; Peng, Chieh-Yu; Wang, Shih-Wei; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Inst Pharmacol, Coll Med, Taipei 10051, Taiwan; [Pan, Shiow-Lin] Taipei Med Univ, Grad Inst Pharmacol, Taipei 10051, Taiwan; [Kuo, Sheng-Chu] China Med Univ, Grad Inst Pharmaceut Chem, Taichung 40402, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	National Taiwan University; Taipei Medical University; China Medical University Taiwan; University of North Carolina; University of North Carolina Chapel Hill	Pan, SL (corresponding author), Natl Taiwan Univ, Inst Pharmacol, Coll Med, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan.	psl0826@ms13.hinet.net; cmteng@ntu.edu.tw	Pan, Shiow-Lin/C-1372-2010; Wang, Shih-Wei/AAH-1967-2020	Wang, Shih-Wei/0000-0001-7522-6352; WANG, CHIH-YUAN/0000-0002-6742-3935; TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan [96-2628-B002-109-MY3, 96-2321-B-002-031-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Research Grants 96-2628-B002-109-MY3 and 96-2321-B-002-031-MY2.	Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Cao L, 2006, TRANSPL P, V38, P2207, DOI 10.1016/j.transproceed.2006.06.014; Chen TH, 2008, CLIN CANCER RES, V14, P4250, DOI 10.1158/1078-0432.CCR-07-4578; Chen YC, 2007, BIOCHEM PHARMACOL, V74, P10, DOI 10.1016/j.bcp.2007.03.015; Cooney MM, 2006, NAT CLIN PRACT ONCOL, V3, P682, DOI 10.1038/ncponc0663; Dimmeler S, 2000, CIRC RES, V87, P434; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Ferlin MG, 2005, J MED CHEM, V48, P3417, DOI 10.1021/jm049387x; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2008, J BIOL CHEM, V283, P30273, DOI 10.1074/jbc.M804196200; Hsu SC, 2009, J ORTHOP RES, V27, P1637, DOI 10.1002/jor.20937; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; KUO SC, 1993, J MED CHEM, V36, P1146, DOI 10.1021/jm00061a005; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; LI L, 1994, J MED CHEM, V37, P1126, DOI 10.1021/jm00034a010; Lippert JW, 2007, BIOORGAN MED CHEM, V15, P605, DOI 10.1016/j.bmc.2006.10.020; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Meng FY, 2008, CANCER CHEMOTH PHARM, V61, P953, DOI 10.1007/s00280-007-0549-x; Pasquier E, 2004, MOL CANCER THER, V3, P1301; Peng CY, 2008, CANCER LETT, V263, P114, DOI 10.1016/j.canlet.2007.12.028; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Sakamaki K, 2004, CURR NEUROVASC RES, V1, P305, DOI 10.2174/1567202043362072; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Sheikh MS, 1998, CANCER RES, V58, P1593; SIEGEL RM, 2002, CURRENT PROTOCOLS CY; Taatjes DJ, 2008, HISTOCHEM CELL BIOL, V129, P33, DOI 10.1007/s00418-007-0356-9; Tas F, 2008, CANCER CHEMOTH PHARM, V61, P721, DOI 10.1007/s00280-007-0526-4; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang SW, 2008, MOL CANCER THER, V7, P350, DOI 10.1158/1535-7163.MCT-07-2000; Wang SW, 2007, CANCER LETT, V257, P87, DOI 10.1016/j.canlet.2007.07.002; Wu GS, 2000, ADV EXP MED BIOL, V465, P143; Xia Y, 1998, J MED CHEM, V41, P1155, DOI 10.1021/jm9707479; Xia Y, 2001, J MED CHEM, V44, P3932, DOI 10.1021/jm0101085	43	24	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5497	5506		10.1074/jbc.M109.036277	http://dx.doi.org/10.1074/jbc.M109.036277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007968	Green Published, hybrid			2022-12-27	WOS:000275327200043
J	Fujii, M; Kanematsu, T; Ishibashi, H; Fukami, K; Takenawa, T; Nakayama, KI; Moss, SJ; Nabekura, J; Hirata, M				Fujii, Makoto; Kanematsu, Takashi; Ishibashi, Hitoshi; Fukami, Kiyoko; Takenawa, Tadaomi; Nakayama, Keiichi I.; Moss, Stephen J.; Nabekura, Junichi; Hirata, Masato			Phospholipase C-related but Catalytically Inactive Protein Is Required for Insulin-induced Cell Surface Expression of gamma-Aminobutyric Acid Type A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE BINDING-PROTEIN; INHIBITORY SYNAPTIC-TRANSMISSION; CLATHRIN AP2 ADAPTER; GABA(A) RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT BINDING; ANCHORING PROTEIN; BETA SUBUNITS; BREFELDIN-A; RAT-BRAIN	The gamma-aminobutyric acid type A (GABA(A)) receptors play a pivotal role in fast synaptic inhibition in the central nervous system. One of the key factors for determining synaptic strength is the number of receptors on the postsynaptic membrane, which is maintained by the balance between cell surface insertion and endocytosis of the receptors. In this study, we investigated whether phospholipase C-related but catalytically inactive protein (PRIP) is involved in insulin-induced GABA(A) receptor insertion. Insulin potentiated the GABA-induced Cl- current (I-GABA) by about 30% in wild-type neurons, but not in PRIP1 and PRIP2 double-knock-out (DKO) neurons, suggesting that PRIP is involved in insulin-induced potentiation. The phosphorylation level of the GABA(A) receptor beta-subunit was increased by about 30% in the wild-type neurons but not in the mutant neurons, which were similar to the changes observed in I-GABA. We also revealed that PRIP recruited active Akt to the GABA(A) receptors by forming a ternary complex under insulin stimulation. The disruption of the binding between PRIP and the GABA(A) receptor beta-subunit by PRIP interference peptide attenuated the insulin potentiation of I-GABA. Taken together, these results suggest that PRIP is involved in insulin-induced GABA(A) receptor insertion by recruiting active Akt to the receptor complex.	[Fujii, Makoto; Kanematsu, Takashi; Hirata, Masato] Kyushu Univ, Lab Mol & Cellular Biochem, Fac Dent Sci, Fukuoka 8128582, Japan; [Fujii, Makoto; Kanematsu, Takashi; Hirata, Masato] Kyushu Univ, Stn Collaborat Res, Fukuoka 8128582, Japan; [Ishibashi, Hitoshi; Nabekura, Junichi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Kyushu University; Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo University of Pharmacy & Life Sciences; Kobe University; Kyushu University; Tufts University	Hirata, M (corresponding author), Kyushu Univ, Lab Mol & Cellular Biochem, Fac Dent Sci, Fukuoka 8128582, Japan.	hirata1@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute for Physiological Sciences; Japan Diabetes Foundation; Pharmacological Research Foundation, Tokyo; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS)); Japan Diabetes Foundation; Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. F., T. K., and M. H.), the Cooperative Study Program of the National Institute for Physiological Sciences (to T. K., J. N., and M. H.), the Japan Diabetes Foundation (to T. K.), and the Pharmacological Research Foundation, Tokyo (to T. K.).; Research Fellow supported by the Japan Society for the Promotion of Science.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Coyle JE, 2003, NEUROSCIENTIST, V9, P205, DOI 10.1177/1073858403009003013; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fujii M, 2005, J BIOL CHEM, V280, P1156, DOI 10.1074/jbc.M412006200; Goto H, 2005, MOL CELL NEUROSCI, V30, P197, DOI 10.1016/j.mcn.2005.07.006; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kittler JT, 2008, P NATL ACAD SCI USA, V105, P3616, DOI 10.1073/pnas.0707920105; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Matsuda M, 1998, NEUROSCI LETT, V257, P97, DOI 10.1016/S0304-3940(98)00810-6; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Mielke JG, 2005, J NEUROCHEM, V92, P103, DOI 10.1111/j.1471-4159.2004.02841.x; Mizoguchi Y, 2003, J PHYSIOL-LONDON, V548, P703, DOI 10.1113/jphysiol.2003.038935; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Smith KR, 2008, NEUROPHARMACOLOGY, V55, P844, DOI 10.1016/j.neuropharm.2008.06.072; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Vetiska SM, 2007, NEUROPHARMACOLOGY, V52, P146, DOI 10.1016/j.neuropharm.2006.06.023; Vicini S, 2004, PHARMACOL THERAPEUT, V103, P109, DOI 10.1016/j.pharmthera.2004.06.001; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200	50	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4837	4846		10.1074/jbc.M109.070045	http://dx.doi.org/10.1074/jbc.M109.070045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996098	hybrid, Green Published			2022-12-27	WOS:000275274800062
J	Korsgren, C; Peters, LL; Lux, SE				Korsgren, Catherine; Peters, Luanne L.; Lux, Samuel E.			Protein 4.2 Binds to the Carboxyl-terminal EF-hands of Erythroid alpha-Spectrin in a Calcium- and Calmodulin-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; MEMBRANE SKELETON; HEREDITARY SPHEROCYTOSIS; CYTOPLASMIC DOMAIN; ANION TRANSPORT; BETA-SPECTRIN; ACTIN-BINDING; BAND-3; ANKYRIN; COMPLEX	Spectrin and protein 4.1 cross-link F-actin protofilaments into a network called the membrane skeleton. Actin and 4.1 bind to one end of beta-spectrin. The adjacent end of alpha-spectrin, called the EF-domain, is calmodulin-like, with calcium-dependent and calcium-independent EF-hands. It has no known function. However, the sph(1J)/sph(1J) mouse has very fragile red cells and lacks the last 13 amino acids in the EF-domain, suggesting the domain is critical for skeletal integrity. Using pulldown binding assays, we find the alpha-spectrin EF-domain either alone or incorporated into a mini-spectrin binds native and recombinant protein 4.2 at a previously identified region of 4.2 (G(3) peptide). Native 4.2 binds with an affinity comparable with other membrane skeletal interactions (K-d = 0.30 mu M). EF-domains bearing the sph(1J) mutation are inactive. Binding of protein 4.2 to band 3 (K-d = 0.45 mu M) does not interfere with the spectrin-4.2 interaction. Spectrin-4.2 binding is amplified by micromolar concentrations of Ca2+ (but not Mg2+) by three to five times. Calmodulin also binds to the EF-domain (K-d = 17 mu M), and Ca2+-calmodulin blocks Ca2+-dependent binding of protein 4.2 but not Ca2+-independent binding. The data suggest that protein 4.2 is located near protein 4.1 at the spectrin-actin junctions. Because proteins 4.1 and 4.2 also bind to band 3, the erythrocyte anion channel, we suggest that one or both of these proteins cause a portion of band 3 to localize near the spectrin-actin junctions and provide another point of attachment between the membrane skeleton and the lipid bilayer.	[Lux, Samuel E.] Harvard Univ, Dept Med, Childrens Hosp, Div Hematol Oncol,Sch Med, Boston, MA 02115 USA; [Korsgren, Catherine; Lux, Samuel E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Peters, Luanne L.; Lux, Samuel E.] Jackson Lab, Bar Harbor, ME 04609 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jackson Laboratory	Lux, SE (corresponding author), Harvard Univ, Dept Med, Childrens Hosp, Div Hematol Oncol,Sch Med, HU260-1,300 Longwood Ave, Boston, MA 02115 USA.	lux@enders.tch.harvard.edu		Peters, Luanne/0000-0002-0784-0534	National Institutes of Health [RO1 HL081608, RO1 HL088468]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081608, R01HL088468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL081608 (to S. E. L.) and RO1 HL088468 (to L. L. P.).	An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Begg GE, 2000, J BIOL CHEM, V275, P3279, DOI 10.1074/jbc.275.5.3279; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BERGLUND A, 1986, FEBS LETT, V201, P306, DOI 10.1016/0014-5793(86)80629-9; Bhattacharyya R, 1999, BIOCHEM J, V340, P505, DOI 10.1042/0264-6021:3400505; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; BURGER D, 1984, BIOCHEMISTRY-US, V23, P1966, DOI 10.1021/bi00304a013; BURNS NR, 1985, BIOCHEMISTRY-US, V24, P3070, DOI 10.1021/bi00333a040; Calderon-Salinas JV, 1999, HUM EXP TOXICOL, V18, P327, DOI 10.1191/096032799678840138; Cherry R J, 1981, Prog Clin Biol Res, V51, P59; COUSIN JL, 1979, J MEMBRANE BIOL, V46, P125, DOI 10.1007/BF01961377; Dahl KN, 2004, BLOOD, V103, P1131, DOI 10.1182/blood-2003-04-1331; Dahl KN, 2003, BLOOD, V101, P1194, DOI 10.1182/blood-2002-04-1187; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; FERREIRA HG, 1976, NATURE, V259, P47, DOI 10.1038/259047a0; FRIEDRICHS B, 1989, EUR J CELL BIOL, V48, P121; FUNDER J, 1978, J GEN PHYSIOL, V71, P721, DOI 10.1085/jgp.71.6.721; Galluzzi L, 1999, BLOOD, V93, P2421, DOI 10.1182/blood.V93.7.2421; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; GHANEM A, 1990, BRIT J HAEMATOL, V75, P414, DOI 10.1111/j.1365-2141.1990.tb04357.x; GILLIGAN DM, 1993, SEMIN HEMATOL, V30, P74; Golan DE, 1996, BIOPHYS J, V70, P1534, DOI 10.1016/S0006-3495(96)79717-5; GRACE RF, 2009, NATHAN OSKIS HEMATOL, V1, P659; HALESTRAP AP, 1976, BIOCHEM J, V156, P193, DOI 10.1042/bj1560193; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HARGREAVES WR, 1980, J BIOL CHEM, V255, P1965; Harper SL, 2001, BIOCHEMISTRY-US, V40, P9935, DOI 10.1021/bi0107795; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; IDEGUCHI H, 1990, BRIT J HAEMATOL, V74, P347, DOI 10.1111/j.1365-2141.1990.tb02594.x; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; KORSGREN C, 1988, J BIOL CHEM, V263, P10212; Li XL, 1996, J BIOL CHEM, V271, P15695, DOI 10.1074/jbc.271.26.15695; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LUNDBERG S, 1992, BIOCHEMISTRY-US, V31, P5665, DOI 10.1021/bi00139a034; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1979, SEMIN HEMATOL, V16, P21; MACARA IG, 1981, BIOCHEMISTRY-US, V20, P5095, DOI 10.1021/bi00521a001; Mandal D, 2002, BIOCHEM J, V364, P841, DOI 10.1042/BJ20020195; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; OREAR EA, 1981, AM J HEMATOL, V11, P283, DOI 10.1002/ajh.2830110309; Pei XH, 2007, J BIOL CHEM, V282, P26754, DOI 10.1074/jbc.M701612200; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Peters LL, 1999, J CLIN INVEST, V103, P1527, DOI 10.1172/JCI5766; RISINGER MA, 1992, J BIOL CHEM, V267, P5680; RYBICKI AC, 1995, BLOOD, V86, P3583, DOI 10.1182/blood.V86.9.3583.bloodjournal8693583; SAHR KE, 1990, J BIOL CHEM, V265, P4434; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; SATO Y, 1986, BIOCHIM BIOPHYS ACTA, V856, P11, DOI 10.1016/0005-2736(86)90003-9; SAVVIDES P, 1993, BLOOD, V82, P2953; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SHIP S, 1977, J MEMBRANE BIOL, V33, P311, DOI 10.1007/BF01869522; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; SIMONS TJB, 1982, J MEMBRANE BIOL, V66, P235, DOI 10.1007/BF01868498; STROMQVIST M, 1988, BIOCHEMISTRY-US, V27, P1104, DOI 10.1021/bi00404a004; Su Y, 2006, MOL CELL BIOCHEM, V289, P159, DOI 10.1007/s11010-006-9159-x; Taylor AM, 1999, BIOCHEMISTRY-US, V38, P11172, DOI 10.1021/bi990618p; Toye AM, 2005, BLOOD, V105, P4088, DOI 10.1182/blood-2004-05-1895; TRAVE G, 1995, EMBO J, V14, P4922, DOI 10.1002/j.1460-2075.1995.tb00175.x; TRAVE G, 1995, EUR J BIOCHEM, V227, P35, DOI 10.1111/j.1432-1033.1995.tb20357.x; URSITTI JA, 1991, CELL MOTIL CYTOSKEL, V19, P227, DOI 10.1002/cm.970190402; Van Dort HM, 1998, J BIOL CHEM, V273, P14819, DOI 10.1074/jbc.273.24.14819; Wandersee NJ, 2003, BLOOD, V101, P325, DOI 10.1182/blood-2002-01-0113; WIETH JO, 1979, J PHYSIOL-LONDON, V294, P521, DOI 10.1113/jphysiol.1979.sp012944; WILEY JS, 1977, J CLIN INVEST, V59, P1113, DOI 10.1172/JCI108735; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; Workman RF, 1998, J BIOL CHEM, V273, P6171, DOI 10.1074/jbc.273.11.6171; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966	83	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4757	4770		10.1074/jbc.M109.056200	http://dx.doi.org/10.1074/jbc.M109.056200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007969	Green Published, hybrid			2022-12-27	WOS:000275274800054
J	Ogundare, M; Theofilopoulos, S; Lockhart, A; Hall, LJ; Arenas, E; Sjovall, J; Brenton, AG; Wang, YQ; Griffiths, WJ				Ogundare, Michael; Theofilopoulos, Spyridon; Lockhart, Andrew; Hall, Leslie J.; Arenas, Ernest; Sjovall, Jan; Brenton, A. Gareth; Wang, Yuqin; Griffiths, William J.			Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; CDNA CLONING; CHOLESTEROL HOMEOSTASIS; ELECTROSPRAY-IONIZATION; 7-ALPHA-HYDROXY-3-OXO-4-CHOLESTENOIC ACID; ALZHEIMERS-DISEASE; RAT-BRAIN; OXYSTEROLS; IDENTIFICATION; 24S-HYDROXYCHOLESTEROL	In this study we have profiled the free sterol content of cerebrospinal fluid by a combination of charge tagging and liquid chromatography-tandem mass spectrometry. Surprisingly, the most abundant cholesterol metabolites were found to be C-27 and C-24 intermediates of the bile acid biosynthetic pathways with structures corresponding to 7 alpha-hydroxy-3-oxocholest-4-en-26- oic acid (7.170 +/- 2.826 ng/ml, mean +/- S. D., six subjects), 3 beta-hydroxycholest-5-en-26-oic acid (0.416 +/- 0.193 ng/ml), 7 alpha,x-dihydroxy-3-oxocholest-4-en-26-oic acid (1.330 +/- 0.543 ng/ml), and 7 alpha-hydroxy-3-oxochol-4-en-24-oic acid (0.172 +/- k0.085 ng/ml), and the C-26 sterol 7 alpha-hydroxy-26-norcholest-4ene- 3,x-dione (0.204 +/- 0.083 ng/ml), where x is an oxygen atom either on the CD rings or more likely on the C-17 side chain. The ability of intermediates of the bile acid biosynthetic pathways to activate the liver X receptors (LXRs) and the farnesoid X receptor was also evaluated. The acidic cholesterol metabolites 3 beta-hydroxycholest-5-en-26-oic acid and 3 beta,7 alpha-dihydroxycholest-5- en-26-oic acid were found to activate LXR in a luciferase assay, but the major metabolite identified in this study, i.e. 7 alpha-hydroxy-3-oxocholest-4-en-26-oic acid, was not an LXR ligand. 7 alpha-Hydroxy-3-oxocholest-4-en-26-oic acid is formed from 3 beta,7 alpha-dihydroxycholest-5-en-26-oic acid in a reaction catalyzed by 3 beta-hydroxy-Delta(5)-C-27-steroid dehydrogenase (HSD3B7), which may thus represent a deactivation pathway of LXR ligands in brain. Significantly, LXR activation has been found to reduce the symptoms of Alzheimer disease (Fan, J., Donkin, J., and Wellington C. (2009) Biofactors 35, 239-248); thus, cholesterol metabolites may play an important role in the etiology of Alzheimer disease.	[Ogundare, Michael; Brenton, A. Gareth; Wang, Yuqin; Griffiths, William J.] Swansea Univ, Inst Mass Spectrometry, Sch Med, Swansea SA2 8PP, W Glam, Wales; [Theofilopoulos, Spyridon; Arenas, Ernest; Sjovall, Jan] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lockhart, Andrew] Addenbrookes Hosp, GlaxoSmithKline R&D China, Cambridge CB2 2GG, England; [Hall, Leslie J.] GlaxoSmithKline, Strateg & External Alliances Genet, Res Triangle Pk, NC 27709 USA	Swansea University; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge; GlaxoSmithKline	Griffiths, WJ (corresponding author), Swansea Univ, Inst Mass Spectrometry, Sch Med, Grove Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	w.j.griffiths@swansea.ac.uk	Theofilopoulos, Spyridon/B-2075-2015; Arenas, Ernest/AAO-5231-2020; Theofilopoulos, Spyridon/E-1508-2011; Griffiths, William/N-4641-2016	Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Griffiths, William/0000-0002-4129-6616; wang, yuqin/0000-0002-3063-3066	United Kingdom Research Councils, Biotechnology and Biological Sciences Research Council [BBC5157712, BBC5113561]; Engineering and Physical Sciences Research Council [EP/F014341/1]; EPSRC [EP/F014341/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515771/2, BB/C511356/1] Funding Source: researchfish	United Kingdom Research Councils, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Research Councils, Biotechnology and Biological Sciences Research Council Grants BBC5157712 and BBC5113561, and Engineering and Physical Sciences Research Council Grant EP/F014341/1.	Alvelius G, 2001, J LIPID RES, V42, P1571; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AXELSON M, 1988, J LIPID RES, V29, P629; Baumgart E, 1996, P NATL ACAD SCI USA, V93, P13748, DOI 10.1073/pnas.93.24.13748; Berger J, 1998, FEBS LETT, V425, P305, DOI 10.1016/S0014-5793(98)00255-5; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bjorkhem I, 2001, J BIOL CHEM, V276, P37004, DOI 10.1074/jbc.M103828200; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bun-ya M, 1998, J BIOCHEM-TOKYO, V123, P347; Cowan DA, 2008, STEROIDS, V73, P621, DOI 10.1016/j.steroids.2008.01.026; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Ebner MJ, 2006, ENDOCRINOLOGY, V147, P179, DOI 10.1210/en.2005-1065; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Ferdinandusse S, 2009, J LIPID RES, V50, P2139, DOI 10.1194/jlr.R900009-JLR200; Fine JM, 2008, J CHEM ECOL, V34, P1259, DOI 10.1007/s10886-008-9535-y; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Furster C, 1996, J BIOL CHEM, V271, P20903, DOI 10.1074/jbc.271.34.20903; Gilardi F, 2009, NEUROSCIENCE, V164, P530, DOI 10.1016/j.neuroscience.2009.08.003; Griffiths WJ, 2008, J PROTEOME RES, V7, P3602, DOI 10.1021/pr8001639; Griffiths WJ, 2010, J LIPID RES, V51, P23, DOI 10.1194/jlr.R001941-JLR200; Griffiths WJ, 2009, J CHROMATOGR B, V877, P2778, DOI 10.1016/j.jchromb.2009.05.017; Griffiths WJ, 2006, J AM SOC MASS SPECTR, V17, P341, DOI 10.1016/j.jasms.2005.10.012; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Higashi T, 2007, CHEM PHARM BULL, V55, P662, DOI 10.1248/cpb.55.662; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ikeda H, 2003, LAB INVEST, V83, P349, DOI 10.1097/01.LAB.0000059933.35157.40; Itoh M, 2000, BRAIN RES, V858, P40, DOI 10.1016/S0006-8993(99)02423-3; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KARLAGANIS G, 1984, J LIPID RES, V25, P693; KARLAGANIS G, 1981, J STEROID BIOCHEM, V14, P341, DOI 10.1016/0022-4731(81)90152-7; Karu K, 2007, J LIPID RES, V48, P976, DOI 10.1194/jlr.M600497-JLR200; Kirk JM, 2006, RAPID COMMUN MASS SP, V20, P1247, DOI 10.1002/rcm.2442; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Leoni V, 2006, NEUROSCI LETT, V397, P83, DOI 10.1016/j.neulet.2005.11.046; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Leoni V, 2009, SCAND J CLIN LAB INV, V69, P22, DOI 10.1080/00365510802651858; LI WM, 1995, J GEN PHYSIOL, V105, P569, DOI 10.1085/jgp.105.5.569; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Liu SY, 2003, ANAL CHEM, V75, P5835, DOI 10.1021/ac0346297; Lutjohann D, 2006, ACTA NEUROL SCAND, V114, P33, DOI 10.1111/j.1600-0404.2006.00683.x; Lund E, 1996, ARTERIOSCL THROM VAS, V16, P208, DOI 10.1161/01.ATV.16.2.208; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mano N, 2004, J LIPID RES, V45, P1741, DOI 10.1194/jlr.M400157-JLR200; Mano N, 2004, J LIPID RES, V45, P295, DOI 10.1194/jlr.M300369-JLR200; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; Meng LJ, 1997, J LIPID RES, V38, P926; MICKAN H, 1972, STEROIDS, V19, P659, DOI 10.1016/S0039-128X(72)80031-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; NAGATA K, 1992, BIOCHIM BIOPHYS ACTA, V1126, P229; Nagata Kazuya, 1995, Neurologia Medico-Chirurgica, V35, P294, DOI 10.2176/nmc.35.294; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ruan BF, 2001, J LIPID RES, V42, P799; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Schonknecht P, 2002, NEUROSCI LETT, V324, P83, DOI 10.1016/S0304-3940(02)00164-7; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SEEDORF U, 1991, J BIOL CHEM, V266, P630; Shafaati M, 2009, BIOCHEM BIOPH RES CO, V378, P689, DOI 10.1016/j.bbrc.2008.11.103; Siciliano M, 1986, Quad Sclavo Diagn, V22, P355; Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Wang YQ, 2008, J PROTEOME RES, V7, P1606, DOI 10.1021/pr7006076; Wang YQ, 2009, MOL BIOSYST, V5, P529, DOI 10.1039/b819502a; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Woo HK, 2009, RAPID COMMUN MASS SP, V23, P1849, DOI 10.1002/rcm.4076; Yang Y, 1997, BIOMED CHROMATOGR, V11, P240, DOI 10.1002/(SICI)1099-0801(199707)11:4<240::AID-BMC686>3.0.CO;2-6; YURI M, 1993, CHEM PHARM BULL, V41, P1327; Zhang J, 1997, BIOCHEM J, V322, P175, DOI 10.1042/bj3220175	77	87	90	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4666	4679		10.1074/jbc.M109.086678	http://dx.doi.org/10.1074/jbc.M109.086678			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996111	Green Published, hybrid			2022-12-27	WOS:000275274800045
J	Srikanth, S; Jung, HJ; Ribalet, B; Gwack, Y				Srikanth, Sonal; Jung, Hea-Jin; Ribalet, Bernard; Gwack, Yousang			The Intracellular Loop of Orai1 Plays a Central Role in Fast Inactivation of Ca2+ Release-activated Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; CRAC CHANNELS; CA(V)1.2 CHANNELS; CALCIUM-CHANNEL; PLASMA-MEMBRANE; STORE; STIM1; ENTRY; SENSOR; BLOCK	Store-operated Ca2+ entry (SOCE) due to activation of Ca2+ release-activated Ca2+ (CRAC) channels leads to sustained elevation of cytoplasmic Ca2+ and activation of lymphocytes. CRAC channels consisting of four pore-forming Orai1 subunits are activated by STIM1, an endoplasmic reticulum Ca2+ sensor that senses intracellular store depletion and migrates to plasma membrane proximal regions to mediate SOCE. One of the fundamental properties of CRAC channels is their Ca2+-dependent fast inactivation. To identify the domains of Orai1 involved in fast inactivation, we have mutated residues in the Orai1 intracellular loop linking transmembrane segment II to III. Mutation of four residues, (VSNV154)-S-151, at the center of the loop (MutA) abrogated fast inactivation, leading to increased SOCE as well as higher CRAC currents. Point mutation analysis identified five key amino acids, (NVHNL157)-V-153, that increased SOCE in Orai1 null murine embryonic fibroblasts. Expression or direct application of a peptide comprising the entire intracellular loop or the sequence (NVHNL157)-V-153 blocked CRAC currents from both wild type (WT) and MutA Orai1. A peptide incorporating the MutA mutations had no blocking effect. Concatenated Orai1 constructs with four MutA monomers exhibited high CRAC currents lacking fast inactivation. Reintroduction of a single WT monomer (MutA-MutA-MutA-WT) was sufficient to fully restore fast inactivation, suggesting that only a single intracellular loop can block the channel. These data suggest that the intracellular loop of Orai1 acts as an inactivation particle, which is stabilized in the ion permeation pathway by the (NVHNL157)-V-153 residues. These results along with recent reports support a model in which the N terminus and the selectivity filter of Orai1 as well as STIM1 act in concert to regulate the movement of the intracellular loop and evoke fast inactivation.	[Ribalet, Bernard] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ribalet, Bernard] Univ Calif Los Angeles, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Ribalet, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 53-364 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bribalet@mednet.ucla.edu; ygwack@mednet.ucla.edu			National Institutes of Health [AI083432]; Cancer Research Coordinating Committee (University of California); American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Coordinating Committee (University of California)(University of California System); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083432. This work was also supported by a grant from the Cancer Research Coordinating Committee (University of California) ( to Y.G.) and a fellowship from the American Heart Association ( to S. S.).	Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; Babich O, 2007, J GEN PHYSIOL, V129, P461, DOI 10.1085/jgp.200709733; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	46	63	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5066	5075		10.1074/jbc.M109.072736	http://dx.doi.org/10.1074/jbc.M109.072736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007711	Green Published, hybrid			2022-12-27	WOS:000275274800082
J	Takagi, S; Nakajima, M; Kida, K; Yamaura, Y; Fukami, T; Yokoi, T				Takagi, Shingo; Nakajima, Miki; Kida, Katsuhiko; Yamaura, Yu; Fukami, Tatsuki; Yokoi, Tsuyoshi			MicroRNAs Regulate Human Hepatocyte Nuclear Factor 4 alpha, Modulating the Expression of Metabolic Enzymes and Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACIDS; GENE-EXPRESSION; APOPTOSIS; LIVER; NUCLEAR-FACTOR-4-ALPHA; TRANSACTIVATION; TRANSCRIPTION; CHOLESTASIS; REPRESSION; PROMOTER	Hepatocyte nuclear factor (HNF) 4 alpha is a key transcription factor regulating endo/xenobiotic-metabolizing enzymes and transporters. We investigated whether microRNAs are involved in the regulation of human HNF4 alpha. Potential recognition elements for miR-24 (MRE24) were identified in the coding region and the 3'-untranslated region (3'-UTR), and those for miR-34a (MRE34a) were identified in the 3'-UTR in HNF4 alpha mRNA. The HNF4 alpha protein level in HepG2 cells was markedly decreased by the overexpression of miR-24 and miR-34a. The HNF4 alpha mRNA level was significantly decreased by the overexpression of miR-24 but not by miR-34a. In luciferase analyses in HEK293 cells, the reporter activity of plasmid containing the 3'-UTR of HNF4 alpha was significantly decreased by miR-34a. The reporter activity of plasmid containing the HNF4 alpha coding region downstream of the luciferase gene was significantly decreased by miR24. These results suggest that the MRE24 in the coding region and MRE34a in the 3'-UTR are functional in the negative regulation by mRNA degradation and translational repression, respectively. The down-regulation of HNF4 alpha by these microRNAs resulted in the decrease of various target genes such as cytochrome P450 7A1 and 8B1 as well as morphological changes and the decrease of the S phase population in HepG2 cells. We also clarified that the expressions of miR-24 and miR-34a were regulated by protein kinase C/mitogen-activated protein kinase and reactive oxygen species pathways, respectively. In conclusion, we found that human HNF4 alpha was down-regulated by miR-24 and miR-34a, the expression of which are regulated by cellular stress, affecting the metabolism and cellular biology.	[Takagi, Shingo; Nakajima, Miki; Kida, Katsuhiko; Yamaura, Yu; Fukami, Tatsuki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yokoi, T (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	yokoi, tsuyoshi/I-7115-2014; Nakajima, Miki/C-3990-2015; Fukami, Tatsuki/C-8907-2015	Fukami, Tatsuki/0000-0003-2416-5988; Yokoi, Tsuyoshi/0000-0002-3239-2817	Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [21390174] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research (B) from the Japan Society for the Promotion of Science and in part by a Health and Labor Science Research Grant from the Ministry of Health, Labor and Welfare of Japan.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Day CP, 2002, GUT, V50, P585, DOI 10.1136/gut.50.5.585; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Geier A, 2005, HEPATOLOGY, V41, P470, DOI 10.1002/hep.20594; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kubitz R, 2004, J BIOL CHEM, V279, P10323, DOI 10.1074/jbc.M306242200; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Popowski K, 2005, MOL PHARMACOL, V67, P1629, DOI 10.1124/mol.104.010223; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Stanger BZ, 2008, DIABETES, V57, P1461, DOI 10.2337/db08-0454; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; YUE HY, 2009, GUT IN PRESS	34	127	135	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4415	4422		10.1074/jbc.M109.085431	http://dx.doi.org/10.1074/jbc.M109.085431			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018894	Green Published, hybrid			2022-12-27	WOS:000275274800018
J	Tsutsui, K; Manabe, R; Yamada, T; Nakano, I; Oguri, Y; Keene, DR; Sengle, G; Sakai, LY; Sekiguchi, K				Tsutsui, Ko; Manabe, Ri-ichiroh; Yamada, Tomiko; Nakano, Itsuko; Oguri, Yasuko; Keene, Douglas R.; Sengle, Gerhard; Sakai, Lynn Y.; Sekiguchi, Kiyotoshi			ADAMTSL-6 Is a Novel Extracellular Matrix Protein That Binds to Fibrillin-1 and Promotes Fibrillin-1 Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; PROTEOLYTIC ACTIVITIES; MICROFIBRILS; GLYCOPROTEIN; ORGANIZATION; DEPOSITION; DOMAIN; SITES; GENE	ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs)-like (ADAMTSL) proteins, a subgroup of the ADAMTS superfamily, share several domains with ADAMTS proteinases, including thrombospondin type I repeats, a cysteine-rich domain, and an ADAMTS spacer, but lack a catalytic domain. We identified two new members of ADAMTSL proteins, ADAMTSL-6 alpha and -6 alpha, that differ in their N-terminal amino acid sequences but have common C-terminal regions. When transfected into MG63 osteosarcoma cells, both isoforms were secreted and deposited into pericellular matrices, although ADAMTSL-6 alpha, in contrast to -6 beta, was barely detectable in the conditioned medium. Immunolabeling at the light and electron microscopic levels showed their close association with fibrillin-1-rich microfibrils in elastic connective tissues. Surface plasmon resonance analyses demonstrated that ADAMTSL-6 beta binds to the N-terminal half of fibrillin-1 with a dissociation constant of similar to 80 nM. When MG63 cells were transfected or exogenously supplemented with ADAMTSL-6, fibrillin-1 matrix assembly was promoted in the early but not the late stage of the assembly process. Furthermore, ADAMTSL-6 transgenic mice exhibited excessive fibrillin-1 fibril formation in tissues where ADAMTSL-6 was overexpressed. All together, these results indicated that ADAMTSL-6 is a novel microfibril-associated protein that binds directly to fibrillin-1 and promotes fibrillin-1 matrix assembly.	[Tsutsui, Ko; Manabe, Ri-ichiroh; Nakano, Itsuko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Tsutsui, Ko; Manabe, Ri-ichiroh; Yamada, Tomiko; Nakano, Itsuko; Oguri, Yasuko; Sekiguchi, Kiyotoshi] Aichi Med Univ, Japan Sci & Technol Agcy, Sekiguchi Biomatrix Signaling Project, Aichi 4801195, Japan; [Keene, Douglas R.; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Osaka University; Aichi Medical University; Japan Science & Technology Agency (JST); Oregon Health & Science University; Oregon Health & Science University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp		Tsutsui, Ko/0000-0003-0729-5975	National Institutes of Health [P01AR049698]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [17082005, 20370046]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AR049698 (to L. Y. S.). This work was also supported by Grants-in-aid for Scientific Research 17082005 and 20370046 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from the Shriners Hospitals for Children (to D. R. K. and to L. Y. S.).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Ashworth JL, 1999, J CELL SCI, V112, P3549; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Buchner DA, 2003, GENE, V307, P23, DOI 10.1016/S0378-1119(03)00423-2; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Dzamba BJ, 2001, J INVEST DERMATOL, V117, P1612, DOI 10.1046/j.0022-202x.2001.01588.x; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Faivre L, 2002, HUM GENET, V110, P366, DOI 10.1007/s00439-002-0689-3; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; GODFREY M, 1995, AM J PATHOL, V146, P1414; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Handford PA, 2000, MATRIX BIOL, V19, P457, DOI 10.1016/S0945-053X(00)00100-1; Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kielty CM, 2002, J CELL SCI, V115, P2817; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Trask TM, 1999, BIOCHEM J, V340, P693, DOI 10.1042/0264-6021:3400693; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161	60	69	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4870	4882		10.1074/jbc.M109.076919	http://dx.doi.org/10.1074/jbc.M109.076919			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19940141	Green Published, hybrid			2022-12-27	WOS:000275274800065
J	van de Wijngaart, DJ; Molier, M; Lusher, SJ; Hersmus, R; Jenster, G; Trapman, J; Dubbink, HJ				van de Wijngaart, Dennis J.; Molier, Michel; Lusher, Scott J.; Hersmus, Remko; Jenster, Guido; Trapman, Jan; Dubbink, Hendrikus J.			Systematic Structure-Function Analysis of Androgen Receptor Leu(701) Mutants Explains the Properties of the Prostate Cancer Mutant L701H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; NUCLEAR RECEPTOR; GENE-MUTATIONS; THERAPEUTIC IMPLICATIONS; MOLECULAR-MECHANISMS; LXXLL MOTIFS; FXXLF; INSENSITIVITY; BICALUTAMIDE; RECOGNITION	One mechanism of prostate tumors for escape from androgen ablation therapies is mutation of the androgen receptor (AR). We investigated the unique properties of the ARL701H mutant, which is strongly stimulated by cortisol, by a systematic structure-function analysis. Most amino acid substitutions at position 701 did not affect AR activation by 5 alpha-dihydrotestosterone. Further analysis of the AR Leu(701) variants showed that AR L701M and AR L701Q, like AR L701H, had changed ligand responsiveness. AR L701M was strongly activated by progesterone but not by cortisol, whereas the opposite was observed for AR L701Q and AR L701H. Next, we analyzed a panel of structurally related steroids to study which of the OH groups at positions 11 beta, 17 alpha, and 21, which discriminate cortisol from progesterone, underlie the differential responses to both hormones. The results showed that the 17 alpha-OH group was essential for activation of AR L701H and AR L701Q, whereas its absence was important for activation of AR L701M. Modeling indicated a conserved H-bonding network involving the steroidal 17 alpha-OH group, His(701) or Gln(701), and the backbone of Ser(778). This network is absent in Leu701 and in other mutants. A hydrophobic leucine or methionine at position 701 is unfavorable for the 17 alpha-OH group. Our results indicate that the specific amino acid residue at position 701, its interaction with the backbone of Ser778, and the steroidal 17 alpha-hydroxyl group of the ligand are all important for the distinct transcriptional responses to progesterone and cortisol of AR mutants, including the prostate cancer mutant L701H.	[van de Wijngaart, Dennis J.; Molier, Michel; Hersmus, Remko; Trapman, Jan; Dubbink, Hendrikus J.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, NL-3000 CA Rotterdam, Netherlands; [van de Wijngaart, Dennis J.; Jenster, Guido] Erasmus MC, Josephine Nefkens Inst, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [Lusher, Scott J.] Schering Plough Corp, Mol Design & Informat, NL-5340 BH Oss, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Merck & Company	Dubbink, HJ (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	h.dubbink@erasmusmc.nl	Hersmus, Remko/AAE-9953-2019	Hersmus, Remko/0000-0001-5250-3572	Dutch Cancer Society [DDHK2001-2402]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Grant DDHK2001-2402 from the Dutch Cancer Society.	Ahmed SF, 2000, J CLIN ENDOCR METAB, V85, P658, DOI 10.1210/jc.85.2.658; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Brinkmann AO, 2001, MOL CELL ENDOCRINOL, V179, P105, DOI 10.1016/S0303-7207(01)00466-X; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; Chavez B, 2001, CLIN GENET, V59, P185, DOI 10.1034/j.1399-0004.2001.590307.x; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Hara T, 2003, CANCER RES, V63, P149; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krishnan AV, 2002, ENDOCRINOLOGY, V143, P1889, DOI 10.1210/en.143.5.1889; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcelli M, 2000, CANCER RES, V60, P944; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; Poujol N, 2000, J BIOL CHEM, V275, P24022, DOI 10.1074/jbc.M001999200; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Steketee K, 2002, EUR J BIOCHEM, V269, P5780, DOI 10.1046/j.1432-1033.2002.03276.x; SUZUKI H, 1993, J STEROID BIOCHEM, V46, P759, DOI 10.1016/0960-0760(93)90316-O; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Trapman J, 2001, EUR J CANCER, V37, pS119; van de Wijngaart DJ, 2006, J BIOL CHEM, V281, P19407, DOI 10.1074/jbc.M602567200; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Watanabe M, 1997, JPN J CLIN ONCOL, V27, P389, DOI 10.1093/jjco/27.6.389; Zhao XY, 1999, J UROLOGY, V162, P2192, DOI 10.1016/S0022-5347(05)68158-X; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	44	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5097	5105		10.1074/jbc.M109.039958	http://dx.doi.org/10.1074/jbc.M109.039958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007693	Green Published, hybrid			2022-12-27	WOS:000275274800085
J	Liu, YW; Huang, HD; Zhou, BO; Wang, SS; Hu, YX; Li, X; Liu, JP; Zang, JY; Niu, LW; Wu, JH; Zhou, JQ; Teng, MK; Shi, YY				Liu, Yiwei; Huang, Hongda; Zhou, Bo O.; Wang, Shan-Shan; Hu, Yingxia; Li, Xu; Liu, Jianping; Zang, Jianye; Niu, Liwen; Wu, Jihui; Zhou, Jin-Qiu; Teng, Maikun; Shi, Yunyu			Structural Analysis of Rtt106p Reveals a DNA Binding Role Required for Heterochromatin Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE CHAPERONE ACTIVITY; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; MAMMALIAN-CELLS; CHROMATIN; PROTEIN; YEAST; FACT; INHERITANCE	Rtt106p is a Saccharomyces cerevisiae histone chaperone with roles in heterochromatin silencing and nucleosome assembly. The molecular mechanism by which Rtt106p engages in chromatin dynamics remains unclear. Here, we report the 2.5 angstrom crystal structure of the core domain of Rtt106p, which adopts an unusual "double pleckstrin homology" domain architecture that represents a novel structural mode for histone chaperones. A histone H3-H4-binding region and a novel double-stranded DNA-binding region have been identified. Mutagenesis studies reveal that the histone and DNA binding activities of Rtt106p are involved in Sir protein-mediated heterochromatin formation. Our results uncover the structural basis of the diverse functions of Rtt106p and provide new insights into its cellular roles.	[Niu, Liwen; Wu, Jihui; Teng, Maikun; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Niu, Liwen; Wu, Jihui; Teng, Maikun; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhou, Bo O.; Wang, Shan-Shan; Zhou, Jin-Qiu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Teng, MK (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	mkteng@ustc.edu.cn; yyshi@ustc.edu.cn	Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009; Zang, Jianye/E-5228-2013	Shi, Yunyu/0000-0002-1348-4759; Li, Xu/0000-0001-5221-0817	Chinese National Fundamental Research Project [2006CB806500, 2006CB910200]; Chinese National Natural Science Foundation [30670426, 30830031]; National High-Tech RD Program [2006AA02A315, 2006AA02A318]; Chinese Academy of Sciences [KSCX2-YW-R-60]; Chinese Ministry of Education [20070358025]	Chinese National Fundamental Research Project; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High-Tech RD Program(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by Chinese National Fundamental Research Project Grants 2006CB806500 and 2006CB910200, Chinese National Natural Science Foundation Grants 30670426 and 30830031, National High-Tech R&D Program Grants 2006AA02A315 and 2006AA02A318, Chinese Academy of Sciences Grant KSCX2-YW-R-60, and Chinese Ministry of Education Grant 20070358025.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CY, 2005, NUCLEIC ACIDS RES, V33, P430, DOI 10.1093/nar/gki191; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; ISHIMI Y, 1984, EUR J BIOCHEM, V142, P431, DOI 10.1111/j.1432-1033.1984.tb08305.x; ISHIMI Y, 1983, J BIOCHEM-TOKYO, V94, P735, DOI 10.1093/oxfordjournals.jbchem.a134414; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Monson EK, 1997, P NATL ACAD SCI USA, V94, P13081, DOI 10.1073/pnas.94.24.13081; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scholes DT, 2001, GENETICS, V159, P1449; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200	49	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4251	4262		10.1074/jbc.M109.055996	http://dx.doi.org/10.1074/jbc.M109.055996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007951	Green Published, hybrid			2022-12-27	WOS:000275254000077
J	Kumphune, S; Bassi, R; Jacquet, S; Sicard, P; Clark, JE; Verma, S; Avkiran, M; O'Keefe, SJ; Marber, MS				Kumphune, Sarawut; Bassi, Rekha; Jacquet, Sebastien; Sicard, Pierre; Clark, James E.; Verma, Sharwari; Avkiran, Metin; O'Keefe, Stephen J.; Marber, Michael S.			A Chemical Genetic Approach Reveals That p38 alpha MAPK Activation by Diphosphorylation Aggravates Myocardial Infarction and Is Prevented by the Direct Binding of SB203580	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; IN-VIVO; LOOP AUTOPHOSPHORYLATION; INDEPENDENT ACTIVATION; SUBSTRATE-SPECIFICITY; ISCHEMIA-REPERFUSION; PHOSPHORYLATION; INHIBITORS; MYOCYTES; INJURY	The use of nonselective pharmacological inhibitors has resulted in controversy regarding the mechanism and consequences of p38 activation during myocardial infarction. Classic p38 inhibitors such as SB203580 rely on a critical "gatekeeper" threonine residue for binding. We addressed these controversies by using mice in which the p38 alpha alleles were targeted to cause substitution of the gatekeeper residue and resistance to inhibition. In homozygous drug-resistant compared with wildtype hearts, SB203580 failed to inhibit the activating phosphorylation of p38 or to reduce the infarction caused by myocardial ischemia. However, BIRB796, a p38 inhibitor not reliant on the gatekeeper for binding, similarly reduced p38-activating phosphorylation and infarction in both wild-type and knock-in mice, thereby excluding a nonspecific inhibitor-dependent phenotype resulting from the targeting strategy. Furthermore, the activation during myocardial ischemia involved phosphorylation of both the threonine and tyrosine residues in the activation loop of p38 despite the phosphorylation of the threonine alone being sufficient to create the epitope for dual phosphospecific antibody binding. Finally, SB203580 failed to reduce infarction in heterozygous drug-resistant hearts, suggesting that near complete inhibition of p38 alpha kinase activity is necessary to elicit protection. These results indicate that, during myocardial ischemia, p38 alpha (i) is the dominant-active p38 isoform, (ii) contributes to infarction, (iii) is responsible for the cardioprotective effect of SB203580, and (iv) is activated by a mechanism consistent with autodiphosphorylation despite this necessitating the phosphorylation of a tyrosine residue by an archetypal serine/threonine kinase.	[Kumphune, Sarawut; Bassi, Rekha; Jacquet, Sebastien; Sicard, Pierre; Clark, James E.; Verma, Sharwari; Avkiran, Metin; Marber, Michael S.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, Rayne Inst, London SE1 7EH, England; [Kumphune, Sarawut; Bassi, Rekha; Jacquet, Sebastien; Sicard, Pierre; Clark, James E.; Verma, Sharwari; Avkiran, Metin; Marber, Michael S.] St Thomas Hosp, London SE1 7EH, England; [O'Keefe, Stephen J.] Merck Res Labs, Dept Immunol, Rahway, NJ 07065 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Merck & Company	Marber, MS (corresponding author), Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, Rayne Inst, London SE1 7EH, England.	mike.marber@kcl.ac.uk	Sicard, Pierre/N-7310-2018; Sicard, Pierre/B-1637-2010; marber, michael/AAW-7916-2021; Clark, James/H-7786-2019; Kumphune, Sarawut/AAH-9060-2019; KUMPHUNE, SARAWUT/AAA-9278-2021	Sicard, Pierre/0000-0001-5837-3916; Sicard, Pierre/0000-0001-8100-9792; KUMPHUNE, SARAWUT/0000-0003-4940-7103; Avkiran, Metin/0000-0003-2392-6343; Marber, Michael/0000-0002-3463-7128; Clark, James/0000-0001-7574-2162	Royal Thai Government scholarship and Medical Research Council [G0802033]; British Heart Foundation [07/073/23432]; MRC [G0802033] Funding Source: UKRI; Medical Research Council [G0802033] Funding Source: researchfish	Royal Thai Government scholarship and Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Royal Thai Government scholarship (to S. K.) and by Medical Research Council Project Grant G0802033 and British Heart Foundation Project Grant 07/073/23432.	Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Clark JE, 2007, PHARMACOL THERAPEUT, V116, P192, DOI 10.1016/j.pharmthera.2007.06.013; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hart SL, 1997, GENE THER, V4, P1225, DOI 10.1038/sj.gt.3300513; Jacquet S, 2008, J BIOL CHEM, V283, P11964, DOI 10.1074/jbc.M707750200; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Otsu K, 2003, BIOCHEM BIOPH RES CO, V302, P56, DOI 10.1016/S0006-291X(03)00096-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200	25	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2968	10.1074/jbc.M109.079228	http://dx.doi.org/10.1074/jbc.M109.079228			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996096	Green Published, hybrid			2022-12-27	WOS:000273829000011
J	Kobayashi, K; Kato, K; Sugi, T; Takemae, H; Pandey, K; Gong, HY; Tohya, Y; Akashi, H				Kobayashi, Kyousuke; Kato, Kentaro; Sugi, Tatsuki; Takemae, Hitoshi; Pandey, Kishor; Gong, Haiyan; Tohya, Yukinobu; Akashi, Hiroomi			Plasmodium falciparum BAEBL Binds to Heparan Sulfate Proteoglycans on the Human Erythrocyte Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; RED-BLOOD-CELLS; MEMBRANE PROTEIN-1 PFEMP1; MALARIA PARASITE; RECEPTOR SPECIFICITY; PSEUDORABIES VIRUS; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; GLYCOPHORIN-C; INVASION	Erythrocyte invasion is critical to the pathogenesis and survival of the malarial parasite, Plasmodium falciparum. This process is partly mediated by proteins that belong to the Duffy binding-like family, which are expressed on the merozoite surface. One of these proteins, BAEBL (also known as EBA-140), is thought to bind to glycophorin C in a sialic acid-dependent manner. In this report, by the binding assay between recombinant BAEBL protein and enzyme-treated erythrocytes, we show that the binding of BAEBL to erythrocytes is mediated primarily by sialic acid and partially through heparan sulfate (HS). Because BAEBL binds to several kinds of HS proteoglycans or purified HS, the BAEBL-HS binding was found to be independent of the HS proteoglycan peptide backbone and the presence of sialic acid moieties. Furthermore, both the sialic acid-and HS-dependent binding were disrupted by the addition of soluble heparin. This inhibition may be the result of binding between BAEBL and heparin. Invasion assays demonstrated that HS-dependent binding was related to the efficiency of merozoite invasion. These results suggest that HS functions as a factor that promotes the binding of BAEBL and merozoite invasion. Moreover, these findings may explain the invasion inhibition mechanisms observed following the addition of heparin and other sulfated glycoconjugates.	[Kobayashi, Kyousuke; Kato, Kentaro; Sugi, Tatsuki; Takemae, Hitoshi; Pandey, Kishor; Gong, Haiyan; Tohya, Yukinobu; Akashi, Hiroomi] Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Kato, K (corresponding author), Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akkato@mail.ecc.u-tokyo.ac.jp	Sugi, Tatsuki/A-9110-2012; Takemae, Hitoshi/AEP-5503-2022	Kobayashi, Kyousuke/0000-0001-5501-8396	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bio-Oriented Technology Research Advancement Institution	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution	This work was supported by a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Bio-Oriented Technology Research Advancement Institution.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Akhouri RR, 2004, BIOCHEM J, V379, P815, DOI 10.1042/BJ20031500; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BUTCHER GA, 1988, T ROY SOC TROP MED H, V82, P558, DOI 10.1016/0035-9203(88)90504-4; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Clark DL, 1997, GLYCOCONJUGATE J, V14, P473, DOI 10.1023/A:1018551518610; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Crandall IE, 2007, BIOCHEM PHARMACOL, V73, P632, DOI 10.1016/j.bcp.2006.10.030; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Drzeniek Z, 1999, BLOOD, V93, P2884; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Flynn SJ, 1996, J VIROL, V70, P1355, DOI 10.1128/JVI.70.3.1355-1364.1996; GALLAGHER JT, 1985, BIOCHEM J, V230, P665, DOI 10.1042/bj2300665; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; HORIO T, 1995, THEORY PRACTICE ENZY, P436; Kaneko O, 1999, EXP PARASITOL, V93, P116, DOI 10.1006/expr.1999.4441; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kato K, 2001, J GEN VIROL, V82, P1457, DOI 10.1099/0022-1317-82-6-1457; Kisilevsky R, 2002, ANTIMICROB AGENTS CH, V46, P2619, DOI 10.1128/AAC.46.8.2619-2626.2002; Kobayashi K, 2009, ANAL BIOCHEM, V389, P80, DOI 10.1016/j.ab.2009.03.008; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; KULANE A, 1992, AM J TROP MED HYG, V46, P589, DOI 10.4269/ajtmh.1992.46.589; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Onishi M, 1996, EXP HEMATOL, V24, P324; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pasvol G, 2003, TRENDS PARASITOL, V19, P430, DOI 10.1016/j.pt.2003.08.005; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trybala E, 1998, J BIOL CHEM, V273, P5047, DOI 10.1074/jbc.273.9.5047; Vogt AM, 2004, BIOCHEM J, V381, P593, DOI 10.1042/BJ20040762; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; Xiao LH, 1996, INFECT IMMUN, V64, P1373, DOI 10.1128/IAI.64.4.1373-1378.1996; Yoon M, 2003, J VIROL, V77, P9221, DOI 10.1128/JVI.77.17.9221-9231.2003	54	38	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1716	1725		10.1074/jbc.M109.021576	http://dx.doi.org/10.1074/jbc.M109.021576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19940142	Green Published, hybrid			2022-12-27	WOS:000273429100017
J	Won, EY; Cha, K; Byun, JS; Kim, DU; Shin, S; Ahn, B; Kim, YH; Rice, AJ; Walz, T; Kwon, BS; Cho, HS				Won, Eun-Young; Cha, Kiweon; Byun, Jung-Sue; Kim, Dong-Uk; Shin, Sumi; Ahn, Byungchan; Kim, Young Ho; Rice, Amanda J.; Walz, Thomas; Kwon, Byoung S.; Cho, Hyun-Soo			The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CELL-ACTIVATION; TNF; STIMULATION; RECOGNITION; RESOLUTION; SOFTWARE; COMPLEX; FAMILY; DOMAIN	Binding of the 4-1BB ligand (4-1BBL) to its receptor, 4-1BB, provides the T lymphocyte with co-stimulatory signals for survival, proliferation, and differentiation. Importantly, the 4-1BB4-1BBL pathway is a well known target for anti-cancer immunotherapy. Here we present the 2.3-A crystal structure of the extracellular domain of human 4-1BBL. The ectodomain forms a homotrimer with an extended, three-bladed propeller structure that differs from trimers formed by other members of the tumor necrosis factor (TNF) superfamily. Based on the 4-1BBL structure, we modeled its complex with 4-1BB, which was consistent with images obtained by electron microscopy, and verified the binding site by site-directed mutagenesis. This structural information will facilitate the development of immunotherapeutics targeting 4-1BB.	[Shin, Sumi; Kim, Young Ho; Kwon, Byoung S.] Natl Canc Ctr, Div Cell & Immunobiol, Goyang 410769, Gyonggi Do, South Korea; [Shin, Sumi; Kim, Young Ho; Kwon, Byoung S.] Natl Canc Ctr, R&D Ctr Canc Therapeut, Goyang 410769, Gyonggi Do, South Korea; [Won, Eun-Young; Byun, Jung-Sue; Kim, Dong-Uk; Cho, Hyun-Soo] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Cha, Kiweon; Cho, Hyun-Soo] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 70042, South Korea; [Ahn, Byungchan] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Rice, Amanda J.; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Yonsei University; Kyungpook National University; University of Ulsan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kwon, BS (corresponding author), Natl Canc Ctr, Div Cell & Immunobiol, Goyang 410769, Gyonggi Do, South Korea.	bskwon@ncc.re.kr; hscho8@yonsei.ac.kr		Walz, Thomas/0000-0003-2606-2835	National Institutes of Health [GM62580]; Korea Research Foundation [KRF-2006-005-J04502, KRF-2008-313-C00745, KRF-C00040, KRF-2005-201-E00008, KRF-2005-084E00001]; Korea Science and Engineering Foundation; Arthritis Foundation Innovative Research Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Arthritis Foundation Innovative Research Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62580. This work was also supported by Korea Research Foundation Grants KRF-2006-005-J04502 and KRF-2008-313-C00745 (to H.-S. C.), KRF-C00040 (to K. C.), and KRF-2005-201-E00008 and KRF-2005-084E00001 (to B. S. K.); by the SRC Fund from the Korea Science and Engineering Foundation; and by the Arthritis Foundation Innovative Research Award (to B. S. K.).	Arens R, 2004, J IMMUNOL, V173, P3901, DOI 10.4049/jimmunol.173.6.3901; ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byun JS, 2006, ACTA CRYSTALLOGR F, V62, P23, DOI 10.1107/S1744309105039242; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOH CR, 1991, PROTEIN ENG, V4, P785; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SMITH CS, 1994, J IMMUNOL, V153, P3997; Soellner L, 2007, CELL SIGNAL, V19, P1899, DOI 10.1016/j.cellsig.2007.04.014; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; YAMAGISHI J, 1990, PROTEIN ENG, V3, P713, DOI 10.1093/protein/3.8.713; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343	40	42	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9202	9210		10.1074/jbc.M109.084442	http://dx.doi.org/10.1074/jbc.M109.084442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20032458	Green Published, hybrid			2022-12-27	WOS:000275553700069
J	Sato, Y; Probst, HC; Tatsumi, R; Ikeuchi, Y; Neuberger, MS; Rada, C				Sato, Yusuke; Probst, Hans Christian; Tatsumi, Ryuichi; Ikeuchi, Yoshihide; Neuberger, Michael S.; Rada, Cristina			Deficiency in APOBEC2 Leads to a Shift in Muscle Fiber Type, Diminished Body Mass, and Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA DEAMINASE DOMAIN; CYTIDINE DEAMINASE; SKELETAL-MUSCLE; AID/APOBEC FAMILY; CRYSTAL-STRUCTURE; PURIFICATION; RAT; AID	The apoB RNA-editing enzyme, catalytic polypeptide-like (APOBEC) family of proteins includes APOBEC1, APOBEC3, and activation-induced deaminase, all of which are zinc-dependent cytidine deaminases active on polynucleotides and involved in RNA editing or DNA mutation. In contrast, the biochemical and physiological functions of APOBEC2, a muscle-specific member of the family, are unknown, although it has been speculated, like APOBEC1, to be an RNA-editing enzyme. Here, we show that, although expressed widely in striated muscle (with levels peaking late during myoblast differentiation), APOBEC2 is preferentially associated with slow-twitch muscle, with its abundance being considerably greater in soleus compared with gastrocnemius muscle and, within soleus muscle, in slow as opposed to fast muscle fibers. Its abundance also decreases following muscle denervation. We further show that APOBEC2-deficient mice harbor a markedly increased ratio of slow to fast fibers in soleus muscle and exhibit an similar to 15-20% reduction in body mass from birth onwards, with elderly mutant animals revealing clear histological evidence of a mild myopathy. Thus, APOBEC2 is essential for normal muscle development and maintenance of fiber-type ratios; although its molecular function remains to be identified, biochemical analyses do not especially argue for any role in RNA editing.	Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Agr, Higashi Ku, Fukuoka 8128581, Japan; [Probst, Hans Christian; Neuberger, Michael S.; Rada, Cristina] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Kyushu University; MRC Laboratory Molecular Biology		ikeuchiy@agr.kyushu-u.ac.jp; msn@mrc-lmb.cam.ac.uk		PROBST, Hans Christian/0000-0002-7926-0651	Human Frontier Science Program; MRC [MC_U105178806] Funding Source: UKRI; Medical Research Council [MC_U105178806] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a fellowship from the Human Frontier Science Program. Present address: Inst. of Immunology, Johannes Gutenberg-Universitat Mainz, 55131 Mainz, Germany.	Agbulut O, 2009, AM J PHYSIOL-CELL PH, V296, pC205, DOI 10.1152/ajpcell.00408.2008; Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; MIDRIO M, 1992, PFLUG ARCH EUR J PHY, V420, P446, DOI 10.1007/BF00374618; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; NAVARATNAM N, 1993, P NATL ACAD SCI USA, V90, P222, DOI 10.1073/pnas.90.1.222; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; NWOYE L, 1982, AM J PHYSIOL, V242, pR401, DOI 10.1152/ajpregu.1982.242.3.R401; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; TAKEKURA H, 1987, J MUSCLE RES CELL M, V8, P342, DOI 10.1007/BF01568890; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x	31	83	86	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7111	7118		10.1074/jbc.M109.052977	http://dx.doi.org/10.1074/jbc.M109.052977			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022958	Green Published, hybrid			2022-12-27	WOS:000275415600024
J	Xi, G; Shen, XC; Clemmons, DR				Xi, Gang; Shen, Xinchun; Clemmons, David R.			p66(shc) Inhibits Insulin-like Growth Factor-I Signaling via Direct Binding to Src through Its Polyproline and Src Homology 2 Domains, Resulting in Impairment of Src Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FAMILY TYROSINE KINASES; OXIDATIVE STRESS; PROTEIN-KINASE; C-SRC; ADAPTER PROTEIN; INDUCED APOPTOSIS; FACTOR RECEPTOR; BREAST-CANCER; 3T3-L1 CELLS	p66(shc) is increased in response to cell stress, and these increases regulate growth factor actions. These studies were conducted to determine how p66(shc) alters IGF-I-stimulated Src activation, leading to decreased IGF-I actions. Our results show that p66(shc) binds to Src through a polyproline sequence motif contained in the CH2 domain, a unique domain in p66(shc), and IGF-I stimulates this interaction. Disruption of this interaction using a synthetic peptide containing the p66(shc) polyproline domain or expression of a p66(shc) mutant containing substitutions for the proline residues (P47A/P48A/P50A) resulted in enhanced Src kinase activity, p52(shc) phosphorylation, MAPK activation, and cell proliferation in response to IGF-I. To determine the mechanism of inhibition, the full-length CH2 domain and intact p66(shc) were tested for their ability to directly inhibit Src kinase activation in vitro. The CH2 domain peptide was clearly inhibitory, but full-length p66(shc) had a greater effect. Deletion of the C-terminal Src homology 2 domain in p66(shc) reduced its ability to inhibit Src kinase activation. These findings demonstrate that p66(shc) utilizes a novel mechanism for modulating Src kinase activation and that this interaction is mediated through both its collagen homologous region 2 and Src homology 2 domains.	[Clemmons, David R.] Univ N Carolina, Div Endocrinol, Dept Med, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, Dept Med, Sch Med, CB 7170,5030 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu	Xi, Gang/C-1498-2011		National Institutes of Health [HL56850, AG02331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56850 and AG02331.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Alper O, 2005, CURR PHARM DESIGN, V11, P1119, DOI 10.2174/1381612053507576; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boney CM, 2001, CELL GROWTH DIFFER, V12, P379; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Campbell M, 2005, CIRC RES, V96, P197, DOI 10.1161/01.RES.0000152966.88353.9d; Campbell M, 2003, DIABETES, V52, P519, DOI 10.2337/diabetes.52.2.519; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chen Y, 1998, GROWTH HORM IGF RES, V8, P299, DOI 10.1016/S1096-6374(98)80125-1; Chintapalli J, 2007, AM J PHYSIOL-RENAL, V292, pF523, DOI 10.1152/ajprenal.00215.2006; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Cui QL, 2005, J BIOL CHEM, V280, P8918, DOI 10.1074/jbc.M414267200; Favetta LA, 2004, EXP CELL RES, V299, P36, DOI 10.1016/j.yexcr.2004.05.009; Favetta LA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-132; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller EC, 2007, INVEST OPHTH VIS SCI, V48, P3878, DOI 10.1167/iovs.07-0014; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Ruiz E, 2006, DIABETES, V55, P1243, DOI 10.2337/db05-0949; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sasaoka T, 2001, ENDOCRINOLOGY, V142, P5226, DOI 10.1210/en.142.12.5226; Sato K, 1997, BIOCHEM BIOPH RES CO, V240, P399, DOI 10.1006/bbrc.1997.7667; Schulte RJ, 2003, BIOCHEMISTRY-US, V42, P9424, DOI 10.1021/bi034519u; Sekimoto H, 2005, MOL ENDOCRINOL, V19, P1859, DOI 10.1210/me.2004-0481; Shigematsu S, 1999, ENDOCR J, V46, pS59; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang S, 2005, AM J PHYSIOL-RENAL, V289, pF1144, DOI 10.1152/ajprenal.00094.2005; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047	54	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6937	6951		10.1074/jbc.M109.069872	http://dx.doi.org/10.1074/jbc.M109.069872			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048152	Green Published, hybrid			2022-12-27	WOS:000275415600007
J	Yu, Q; Kuzmiak, H; Olsen, L; Kulkarni, A; Fink, E; Zou, YF; Bi, X				Yu, Qun; Kuzmiak, Holly; Olsen, Lars; Kulkarni, Ajit; Fink, Emma; Zou, Yanfei; Bi, Xin			Saccharomyces cerevisiae Esc2p Interacts with Sir2p through a Small Ubiquitin-like Modifier (SUMO)-binding Motif and Regulates Transcriptionally Silent Chromatin in a Locus-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE LENGTH REGULATION; CELL-CYCLE PROGRESSION; PROTEIN SUMOYLATION; RENT COMPLEX; YEAST; DNA; DOMAIN; RDNA; HMR; HETEROCHROMATIN	Saccharomyces cerevisiae Esc2p is a member of a conserved family of proteins that contain small ubiquitin-like modifier (SUMO)-like domains. It has been implicated in transcriptional silencing and shown to interact with the silencing protein Sir2p in a two-hybrid analysis. However, little is known about how Esc2p regulates the structure of silent chromatin. We demonstrate here that ESC2 differentially regulates silent chromatin at telomeric, rDNA, and HM loci. Specifically, ESC2 is required for efficient telomeric silencing and Sir2p association with telomeric silent chromatin and for silencing and maintenance of silent chromatin structure at rDNA. On the other hand, ESC2 negatively regulates silencing at HML and HMR and destabilizes HML silent chromatin without affecting Sir2p association with chromatin. We present evidence that Esc2p is associated with both transcriptionally silent and active loci in the genome, and the abundance of Esc2p is not correlated with the chromatin state at a particular locus. Using affinity pull-down analyses, we show that Esc2p and Sir2p interact in vivo, and recombinant Esc2p and Sir2p interact directly. Moreover, we dissect Esc2p and identify a putative SUMO-binding motif that is necessary and sufficient for interacting with Sir2p and SUMO and is required for the function of Esc2p in transcriptional silencing.	[Yu, Qun; Kuzmiak, Holly; Olsen, Lars; Kulkarni, Ajit; Fink, Emma; Zou, Yanfei; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu			National Institutes of Health [GM62484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62484 ( to X. B.).	Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Chiu YH, 2003, GENETICS, V165, P115; Cuperus G, 2002, GENETICS, V162, P633; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hickman M, 2007, J MOL BIOL, V367, P1246, DOI 10.1016/j.jmb.2007.01.044; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; James P, 1996, GENETICS, V144, P1425; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Lustig AJ, 1996, MOL CELL BIOL, V16, P2483; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Raffa GD, 2006, J BIOL CHEM, V281, P27973, DOI 10.1074/jbc.M601943200; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shore D, 1997, BIOL CHEM, V378, P591; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smolikov S, 2004, P NATL ACAD SCI USA, V101, P1656, DOI 10.1073/pnas.0307796100; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Yu Q, 2009, J BIOL CHEM, V284, P740, DOI 10.1074/jbc.M806274200; Zou YF, 2006, GENETICS, V174, P203, DOI 10.1534/genetics.106.055525	55	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7525	7536		10.1074/jbc.M109.016360	http://dx.doi.org/10.1074/jbc.M109.016360			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048165	Green Published, hybrid			2022-12-27	WOS:000275415600064
J	Arcemisbehere, L; Sen, T; Boudier, L; Balestre, MN; Gaibelet, G; Detouillon, E; Orcel, H; Mendre, C; Rahmeh, R; Granier, S; Vives, C; Fieschi, F; Damian, M; Durroux, T; Baneres, JL; Mouillac, B				Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Vives, Corinne; Fieschi, Franck; Damian, Marjorie; Durroux, Thierry; Baneres, Jean-Louis; Mouillac, Bernard			Leukotriene BLT2 Receptor Monomers Activate the G(i2) GTP-binding Protein More Efficiently than Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; AMINO-ACID-SEQUENCE; COUPLED RECEPTORS; B-4 RECEPTOR; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; GPCR FUNCTION; RHODOPSIN; PURIFICATION; TRANSDUCIN	Accumulating evidence indicates that G protein-coupled receptors can assemble as dimers/oligomers but the role of this phenomenon in G protein coupling and signaling is not yet clear. We have used the purified leukotriene B-4 receptor BLT2 as a model to investigate the capacity of receptor monomers and dimers to activate the adenylyl cyclase inhibitory G(i2) protein. For this, we overexpressed the recombinant receptor as inclusion bodies in the Escherichia coli prokaryotic system, using a human alpha(5) integrin as a fusion partner. This strategy allowed the BLT2 as well as several other G protein-coupled receptors from different families to be produced and purified in large amounts. The BLT2 receptor was then successfully refolded to its native state, as measured by high-affinity LTB4 binding in the presence of the purified G protein G alpha(i2). The receptor dimer, in which the two protomers displayed a well defined parallel orientation as assessed by fluorescence resonance energy transfer, was then separated from the monomer. Using two methods of receptor-catalyzed guanosine 5'-3-O-(thio) triphosphate binding assay, we clearly demonstrated that monomeric BLT2 stimulates the purified G alpha(i2)beta(1)gamma(2) protein more efficiently than the dimer. These data suggest that assembly of two BLT2 protomers into a dimer results in the reduced ability to signal.	[Mouillac, Bernard] IGF, Dept Mol Pharmacol, CNRS, UMR 5203, F-34094 Montpellier, France; [Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Durroux, Thierry; Mouillac, Bernard] INSERM, U661, Montpellier, France; [Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Durroux, Thierry; Mouillac, Bernard] Univ Montpellier I, F-34094 Montpellier, France; [Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Durroux, Thierry; Mouillac, Bernard] Univ Montpellier 2, F-34094 Montpellier, France; [Vives, Corinne; Fieschi, Franck] CEA, CNRS, UMR 5075, Inst Biol Struct JP Ebel,Lab Prot Membranaires, Grenoble, France; [Vives, Corinne; Fieschi, Franck] Univ Grenoble 1, F-38027 Grenoble 1, France; Fac Pharm Montpellier, Inst Biomol Max Mousseron, CNRS, UMR 5247, Montpellier, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier I, F-34093 Montpellier 05, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier 2, F-34093 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Mouillac, B (corresponding author), IGF, Dept Mol Pharmacol, CNRS, UMR 5203, 141 Rue Cardonille, F-34094 Montpellier, France.	Bernard.Mouillac@igf.cnrs.fr	MOUILLAC, Bernard/M-3896-2014; Granier, Sebastien/J-1089-2016; Fieschi, Franck/W-2748-2019	MOUILLAC, Bernard/0000-0002-3906-8673; Baneres, jean-louis/0000-0001-7078-1285; FIESCHI, Franck/0000-0003-1194-8107; Rahmeh, Rita/0000-0001-5118-3650; Durroux, Thierry/0000-0003-1091-6066	INSERM; CNRS; European community [LSHB-CT-2003-503337]; ANRS Foundation [AC14]; French Ministry of Research [ACI BCMS 328]; National Agency of Research [ANR 06-BLAN-0087]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); European community(European Commission); ANRS Foundation(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); National Agency of Research(French National Research Agency (ANR))	This work was supported in part by INSERM, CNRS, European community Grant LSHB-CT-2003-503337, ANRS Foundation Grant AC14, French Ministry of Research Grant ACI BCMS 328, and National Agency of Research Grant ANR 06-BLAN-0087.	Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Baneres JL, 1998, J BIOL CHEM, V273, P24744, DOI 10.1074/jbc.273.38.24744; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Jager M, 2006, PROTEIN SCI, V15, P640, DOI 10.1110/ps.051851506; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Mouillac B, 2002, PROG BRAIN RES, V139, P163; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Poudrel JM, 1999, J MED CHEM, V42, P5289, DOI 10.1021/jm9910573; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sabirsh A, 2005, J LIPID RES, V46, P1339, DOI 10.1194/jlr.D500005-JLR200; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tan CA, 1997, PROTEIN EXPRES PURIF, V10, P365, DOI 10.1006/prep.1997.0756; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; TSO JY, 1982, J BIOL CHEM, V257, P3525; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443; WYMAN J, 1990, BINDING LINKAGE FUNC, P33; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168	49	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6337	6347		10.1074/jbc.M109.083477	http://dx.doi.org/10.1074/jbc.M109.083477			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026606	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-27	WOS:000275367500038
J	Kitazume, S; Imamaki, R; Ogawa, K; Komi, Y; Futakawa, S; Kojima, S; Hashimoto, Y; Marth, JD; Paulson, JC; Taniguchi, N				Kitazume, Shinobu; Imamaki, Rie; Ogawa, Kazuko; Komi, Yusuke; Futakawa, Satoshi; Kojima, Soichi; Hashimoto, Yasuhiro; Marth, Jamey D.; Paulson, James C.; Taniguchi, Naoyuki			alpha 2,6-Sialic Acid on Platelet Endothelial Cell Adhesion Molecule (PECAM) Regulates Its Homophilic Interactions and Downstream Antiapoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC ACIDS; CD22 LIGANDS; APOPTOSIS; GLYCANS; SIALYLTRANSFERASE; ANGIOGENESIS; TRANSDUCTION; SIALYLATION; ENDOCYTOSIS; ACTIVATION	Antiangiogenesis therapies are now part of the standard repertoire of cancer therapies, but the mechanisms for the proliferation and survival of endothelial cells are not fully understood. Although endothelial cells are covered with a glycocalyx, little is known about how endothelial glycosylation regulates endothelial functions. Here, we show that alpha 2,6-sialic acid is necessary for the cell-surface residency of platelet endothelial cell adhesion molecule ( PECAM), a member of the immunoglobulin superfamily that plays multiple roles in cell adhesion, mechanical stress sensing, antiapoptosis, and angiogenesis. As a possible underlying mechanism, we found that the homophilic interactions of PECAM in endothelial cells were dependent on alpha 2,6-sialic acid. We also found that the absence of alpha 2,6-sialic acid down-regulated the tyrosine phosphorylation of PECAM and recruitment of Src homology 2 domain-containing protein-tyrosine phosphatase 2 and rendered the cells more prone to mitochondrion-dependent apoptosis, as evaluated using PECAM-deficient endothelial cells. The present findings open up a new possibility that modulation of glycosylation could be one of the promising strategies for regulating angiogenesis.	[Kitazume, Shinobu; Imamaki, Rie; Ogawa, Kazuko; Taniguchi, Naoyuki] RIKEN Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Komi, Yusuke; Kojima, Soichi] RIKEN Adv Sci Inst, Mol Ligand Biol Res Team, Wako, Saitama 3510198, Japan; [Futakawa, Satoshi; Hashimoto, Yasuhiro] Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan; [Marth, Jamey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Marth, Jamey D.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Taniguchi, Naoyuki] Osaka Univ, Microbial Dis Res Inst, Dept Dis Glyc Lab, Osaka 565871, Japan	RIKEN; RIKEN; Fukushima Medical University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Osaka University	Taniguchi, N (corresponding author), RIKEN Adv Sci Inst, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani@sanken.osaka-u.ac.jp	Kojima, Soichi/N-7104-2015; Paulson, James/AAG-3565-2019; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Kojima, Soichi/0000-0002-5252-1612; Taniguchi, Naoyuki/0000-0001-5889-5968	National Institutes of Health [HL57345]; Systems Glycobiology Research Project; RIKEN; Japan Foundation for Applied Enzymology; Yamada Science Foundation; Ministry of Education, Science, Sports and Culture of Japan [18570141]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Glycobiology Research Project; RIKEN; Japan Foundation for Applied Enzymology; Yamada Science Foundation; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 (to J. M.). This work was also supported by grants from the Systems Glycobiology Research Project (to N. T.), the Chemical Genomics Research Project from RIKEN (to S. Kojima), Japan Foundation for Applied Enzymology (to S. Kitazume), Yamada Science Foundation (to S. Kitazume), and Grant 18570141 from the Ministry of Education, Science, Sports and Culture of Japan (to S. Kitazume).	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bird IN, 1999, J CELL SCI, V112, P1989; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Noble KE, 1999, J IMMUNOL, V162, P1376; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	34	85	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6515	6521		10.1074/jbc.M109.073106	http://dx.doi.org/10.1074/jbc.M109.073106			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048157	Green Published, hybrid			2022-12-27	WOS:000275367500056
J	Paik, JC; Wang, B; Liu, K; Lue, JK; Lin, WC				Paik, Jason C.; Wang, Bing; Liu, Kang; Lue, Jerry K.; Lin, Weei-Chin			Regulation of E2F1-induced Apoptosis by the Nucleolar Protein RRP1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DNA-DAMAGE; RIBOSOMAL-PROTEINS; CELL-CYCLE; C-MYC; DIFFERENTIAL REGULATION; RETINOBLASTOMA PROTEIN; GENE-TRANSCRIPTION; HISTONE CHAPERONE; E2F1	Regulation of the E2F family of transcription factors is important in control of cellular proliferation; dysregulation of the E2Fs is a hallmark of many cancers. One member of the E2F family, E2F1, also has the paradoxical ability to induce apoptosis; however, the mechanisms underlying this selectivity are not fully understood. We now identify a nucleolar protein, RRP1B, as an E2F1-specific transcriptional target. We characterize the RRP1B promoter and demonstrate its selective response to E2F1. Consistent with the activation of E2F1 activity upon DNA damage, RRP1B is induced by several DNA-damaging agents. Importantly, RRP1B is required for the expression of certain E2F1 proapoptotic target genes and the induction of apoptosis by DNA-damaging agents. This activity is mediated in part by complex formation between RRP1B and E2F1 on selective E2F1 target gene promoters. Interaction between RRP1B and E2F1 can be found inside the nucleolus and diffuse nucleoplasmic punctates. Thus, E2F1 makes use of its transcriptional target RRP1B to activate other genes directly involved in apoptosis. Our data also suggest an underappreciated role for nucleolar proteins in transcriptional regulation.	Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Paik, Jason C.; Lin, Weei-Chin] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lin, WC (corresponding author), 1 Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.tmc.edu		Paik, Jason/0000-0002-9075-4679	National Institutes of Health [T32 GM008361, CA100857]; Department of Defense Breast Cancer Research Program [W81XWH-09-1-0338, W81XWH-06-1-0708]; NATIONAL CANCER INSTITUTE [R01CA100857, R01CA138641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM008361 (to J.C.P.) and CA100857 (to W.-C. L.). This work was also supported by Department of Defense Breast Cancer Research Program Grants W81XWH-09-1-0338 (to W.-C. L.) and W81XWH-06-1-0708 (to J.C.P.). This work is submitted in partial fulfillment of the requirements for the UAB Cell Biology Graduate Program (J. C. P.).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Ayrault O, 2004, ONCOGENE, V23, P8097, DOI 10.1038/sj.onc.1207968; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Burke Emily, 2003, Methods Mol Biol, V226, P525; Chiu CM, 2002, J BIOL CHEM, V277, P39102, DOI 10.1074/jbc.M205915200; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2009, J BIOL CHEM, V284, P28660, DOI 10.1074/jbc.M109.023457; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Datta A, 2005, MOL CELL BIOL, V25, P8024, DOI 10.1128/MCB.25.18.8024-8036.2005; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; FABIAN GR, 1987, J BACTERIOL, V169, P1571, DOI 10.1128/jb.169.4.1571-1578.1987; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grinstein E, 2006, J BIOL CHEM, V281, P22223, DOI 10.1074/jbc.M513335200; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hauck L, 2002, MOL CELL BIOL, V22, P2147, DOI 10.1128/MCB.22.7.2147-2158.2002; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huddleson JP, 2006, J BIOL CHEM, V281, P15121, DOI 10.1074/jbc.M513406200; Hunt KK, 1997, CANCER RES, V57, P4722; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kel-Margoulis OV, 2000, NUCLEIC ACIDS RES, V28, P311, DOI 10.1093/nar/28.1.311; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim H, 2006, NEURON, V49, P707, DOI 10.1016/j.neuron.2006.01.035; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Leotoing L, 2008, ONCOGENE, V27, P2858, DOI 10.1038/sj.onc.1210942; LI Y, 1994, MOL CELL BIOL, V14, P1861, DOI 10.1128/MCB.14.3.1861; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Lin WC, 2001, GENE DEV, V15, P1833; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Masumi A, 2006, ONCOGENE, V25, P5113, DOI 10.1038/sj.onc.1209522; Meng RD, 1999, INT J ONCOL, V14, P5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Pruschy M, 1999, CELL GROWTH DIFFER, V10, P141; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Samuel S, 2008, MOL CARCINOGEN, V47, P34, DOI 10.1002/mc.20358; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Savino TM, 1999, J CELL SCI, V112, P1889; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Zou YL, 2008, J BIOL CHEM, V283, P5728, DOI 10.1074/jbc.M709932200	74	21	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6348	6363		10.1074/jbc.M109.072074	http://dx.doi.org/10.1074/jbc.M109.072074			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040599	Green Published, hybrid			2022-12-27	WOS:000275367500039
J	Dahlman, JM; Bakkar, N; He, W; Guttridge, DC				Dahlman, Jason M.; Bakkar, Nadine; He, Wei; Guttridge, Denis C.			NF-kappa B Functions in Stromal Fibroblasts to Regulate Early Postnatal Muscle Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; MYOBLAST FUSION; TRANSCRIPTION FACTORS; EMBRYONIC LETHALITY; SKELETAL MYOGENESIS; SIGNALING PATHWAY; CELL ACTIVATION; MEMBRANE-FUSION; IKK-ALPHA	Classical NF-kappa B activity functions as an inhibitor of the skeletal muscle myogenic program. Recent findings reveal that even in newborn RelA/p65(-/-) mice, myofiber numbers are increased over that of wild type mice, suggesting that NF-kappa B may be a contributing factor in early postnatal skeletal muscle development. Here we show that in addition to p65 deficiency, repression of NF-kappa B with the I kappa B alpha-SR transdominant inhibitor or with muscle-specific deletion of IKK beta resulted in similar increases in total fiber numbers as well as an up-regulation of myogenic gene products. Upon further characterization of early postnatal muscle, we observed that NF-kappa B activity progressively declines within the first few weeks of development. At birth, the majority of this activity is compartmentalized to muscle fibers, but by neonatal day 8 NF-kappa B activity from the myofibers diminishes, and instead, stromal fibroblasts become the main cellular compartment within the muscle that contains active NF-kappa B. We find that NF-kappa B functions in these fibroblasts to regulate inducible nitric-oxide synthase expression, which we show is important for myoblast fusion during the growth and maturation process of skeletal muscle. Together, these data broaden our understanding of NF-kappa B during development by showing that in addition to its role as a negative regulator of myogenesis, NF-kappa B also regulates nitric-oxide synthase expression within stromal fibroblasts to stimulate myoblast fusion and muscle hypertrophy.	[Guttridge, Denis C.] Ohio State Univ, Coll Med, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Dahlman, Jason M.; Guttridge, Denis C.] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [He, Wei; Guttridge, Denis C.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Guttridge, Denis C.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Guttridge, DC (corresponding author), Ohio State Univ, Coll Med, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, 460 W 12th Ave,Biomed Res Tower 910, Columbus, OH 43210 USA.	denis.guttridge@osumc.edu	Core, Vector/CAF-4832-2022; He, Wei/J-6275-2016	Guttridge, Denis/0000-0002-7276-6609	National Institutes of Health [R01AR052787]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR052787 (to D. C. G.).	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Delfini MC, 2000, DEVELOPMENT, V127, P5213; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; JOHNSON SE, 1990, EXP CELL RES, V187, P250, DOI 10.1016/0014-4827(90)90088-R; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Lee KH, 1997, BIOCHEM J, V324, P237, DOI 10.1042/bj3240237; LEE KH, 1994, J BIOL CHEM, V269, P14371; Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Long JHD, 2006, J MUSCLE RES CELL M, V27, P577, DOI 10.1007/s10974-006-9078-1; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SOULET L, 1994, MOL REPROD DEV, V39, P49, DOI 10.1002/mrd.1080390109; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wozniak AC, 2007, DEV DYNAM, V236, P240, DOI 10.1002/dvdy.21012; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630	54	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5479	5487		10.1074/jbc.M109.075606	http://dx.doi.org/10.1074/jbc.M109.075606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018862	hybrid, Green Published			2022-12-27	WOS:000275327200041
J	Falk, S; Ravaud, S; Koch, J; Sinning, I				Falk, Sebastian; Ravaud, Stephanie; Koch, Joachim; Sinning, Irmgard			The C Terminus of the Alb3 Membrane Insertase Recruits cpSRP43 to the Thylakoid Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; YIDC/OXA/ALB3 FAMILY; CYTOCHROME-OXIDASE; PERIPLASMIC DOMAIN; PROTEIN INSERTION; CRYSTAL-STRUCTURE; SRP-RECEPTOR; BINDING; YIDC; BIOGENESIS	The YidC/Oxa1/Alb3 family of membrane proteins controls the insertion and assembly of membrane proteins in bacteria, mitochondria, and chloroplasts. Here we describe the molecular mechanisms underlying the interaction of Alb3 with the chloroplast signal recognition particle (cpSRP). The Alb3 C-terminal domain (A3CT) is intrinsically disordered and recruits cpSRP to the thylakoid membrane by a coupled binding and folding mechanism. Two conserved, positively charged motifs reminiscent of chromodomain interaction motifs in histone tails are identified in A3CT that are essential for the Alb3-cpSRP43 interaction. They are absent in the C-terminal domain of Alb4, which therefore does not interact with cpSRP43. Chromodomain 2 in cpSRP43 appears as a central binding platform that can interact simultaneously with A3CT and cpSRP54. The observed negative cooperativity of the two binding events provides the first insights into cargo release at the thylakoid membrane. Taken together, our data show how Alb3 participates in cpSRP-dependent membrane targeting, and our data provide a molecular explanation why Alb4 cannot compensate for the loss of Alb3. Oxa1 and YidC utilize their positively charged, C-terminal domains for ribosome interaction in co-translational targeting. Alb3 is adapted for the chloroplast-specific Alb3-cpSRP43 interaction in post-translational targeting by extending the spectrum of chromodomain interactions.	Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany; [Koch, Joachim] Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Germany	Ruprecht Karls University Heidelberg; Octapharma		irmi.sinning@bzh.uni-heidelberg.de	Falk, Sebastian/AAG-9706-2019; Ravaud, Stephanie/I-4059-2015; Falk, Sebastian/T-4796-2017	Falk, Sebastian/0000-0001-7848-4621; Ravaud, Stephanie/0000-0001-5867-0785; Falk, Sebastian/0000-0001-7848-4621	Collaborative Research [SFB 638, FOR 967]; Deutsche Forschungsgemeinschaft [GRK1188]; German-Israeli-Foundation	Collaborative Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli-Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Collaborative Research Grants SFB 638 and FOR 967) and Grant GRK1188 from the Deutsche Forschungsgemeinschaft and by the German-Israeli-Foundation (to I. S.).	Amin P, 1999, PLANT PHYSIOL, V121, P61, DOI 10.1104/pp.121.1.61; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DeLano W.L, PYMOL MOL GRAPHICS S; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eissenberg JC, 2001, GENE, V275, P19, DOI 10.1016/S0378-1119(01)00628-X; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; GROVES MR, 2002, SPRING LAB MAN, P83; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kathir KM, 2008, J MOL BIOL, V381, P49, DOI 10.1016/j.jmb.2008.05.065; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Klostermann E, 2002, BIOCHEM J, V368, P777, DOI 10.1042/BJ20021291; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2007, BIOL CHEM, V388, P907, DOI 10.1515/BC.2007.111; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718; Zeev-Ben-Mordehai T, 2003, BIOPOLYMERS, V68, P395, DOI 10.1002/bip.10287; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	59	74	77	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5954	5962		10.1074/jbc.M109.084996	http://dx.doi.org/10.1074/jbc.M109.084996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018841	Green Published, hybrid			2022-12-27	WOS:000275327200085
J	Marfil, V; Moya, M; Pierreux, CE; Castell, JV; Lemaigre, FP; Real, FX; Bort, R				Marfil, Vanessa; Moya, Marta; Pierreux, Christophe E.; Castell, Jose V.; Lemaigre, Frederic P.; Real, Francisco X.; Bort, Roque			Interaction between Hhex and SOX13 Modulates Wnt/TCF Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENE HEX; TRANSCRIPTION FACTOR; BETA-CATENIN; HOMEODOMAIN PROTEIN; DNA-BINDING; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; LIVER BUD; EXPRESSION; DIFFERENTIATION	Fine-tuning of the Wnt/TCF pathway is crucial for multiple embryological processes, including liver development. Here we describe how the interaction between Hhex (hematopoietically expressed homeobox) and SOX13 (SRY-related high mobility group box transcription factor 13), modulates Wnt/TCF pathway activity. Hhex is a homeodomain factor expressed in multiple endoderm-derived tissues, like the liver, where it is essential for proper development. The pleiotropic expression of Hhex during embryonic development and its dual role as a transcriptional repressor and activator suggest the presence of different tissue-specific partners capable of modulating its activity and function. While searching for developmentally regulated Hhex partners, we set up a yeast two-hybrid screening using an E9.5-10.5 mouse embryo library and the N-terminal domain of Hhex as bait. Among the putative protein interactors, we selected SOX13 for further characterization. We found that SOX13 interacts directly with full-length Hhex, and we delineated the interaction domains within the two proteins. SOX13 is known to repress Wnt/TCF signaling by interacting with TCF1. We show that Hhex is able to block the SOX13-dependent repression of Wnt/TCF activity by displacing SOX13 from the SOX13.TCF1 complex. Moreover, Hhex de-repressed the Wnt/TCF pathway in the ventral foregut endoderm of cultured mouse embryos electroporated with a SOX13-expressing plasmid. We conclude that the interaction between Hhex and SOX13 may contribute to control Wnt/TCF signaling in the early embryo.	[Marfil, Vanessa] Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, Barcelona 08003, Spain; [Moya, Marta; Castell, Jose V.; Bort, Roque] Hosp Univ Fe, Ctr Invest, Unidad Hepatol Expt, Valencia 46009, Spain; [Pierreux, Christophe E.; Lemaigre, Frederic P.] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Real, Francisco X.] Ctr Nacl Invest Oncol, Mol Pathol Programme, Epithelial Carcinogenesis Grp, E-28029 Madrid, Spain	Pompeu Fabra University; Universite Catholique Louvain	Bort, R (corresponding author), Ctr Invest Fe, Avda Campanar 21, Valencia 46009, Spain.	bort_ber@gva.es	Arribas, Francisco X Real/H-5275-2015; Castell, Jose V/I-9529-2016; Bort, Roque/Y-5466-2019	Arribas, Francisco X Real/0000-0001-9501-498X; Castell, Jose V/0000-0003-1179-6430; Bort, Roque/0000-0002-7285-0536; Lemaigre, Frederic/0000-0002-3609-434X	Spanish Ministry of Science [SAF-64414]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Supported by Spanish Ministry of Science Grant SAF-64414.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; Bischof J, 2004, DEV BIOL, V276, P552, DOI 10.1016/j.ydbio.2004.09.035; Bogue CW, 2000, DEV DYNAM, V219, P84, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5; Bogue CW, 2003, P NATL ACAD SCI USA, V100, P556, DOI 10.1073/pnas.0236979100; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Brickman JM, 2000, DEVELOPMENT, V127, P2303; Cong R, 2006, BIOCHEM BIOPH RES CO, V346, P535, DOI 10.1016/j.bbrc.2006.05.153; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; Denson LA, 2000, AM J PHYSIOL-GASTR L, V279, pG347, DOI 10.1152/ajpgi.2000.279.2.G347; Fagotto F, 1997, DEVELOPMENT, V124, P453; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOMEZFOIX AM, 1992, J BIOL CHEM, V267, P25129; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kasamatsu S, 2004, J BIOCHEM, V135, P217, DOI 10.1093/jb/mvh025; Kasimiotis H, 2000, DIABETES, V49, P555, DOI 10.2337/diabetes.49.4.555; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Obinata A, 2002, DEV GROWTH DIFFER, V44, P281; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pierreux CE, 2004, J BIOL CHEM, V279, P51298, DOI 10.1074/jbc.M409038200; Pierreux CE, 2005, J PANCREAS, V6, P128; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Roose J, 1999, GENOMICS, V57, P301, DOI 10.1006/geno.1999.5779; Roose J, 1998, NUCLEIC ACIDS RES, V26, P469, DOI 10.1093/nar/26.2.469; Schaefer LK, 2001, J BIOL CHEM, V276, P43074, DOI 10.1074/jbc.M102552200; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tanaka T, 1999, BIOCHEM J, V339, P111, DOI 10.1042/0264-6021:3390111; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Topcu Z, 1999, ONCOGENE, V18, P7091, DOI 10.1038/sj.onc.1203201; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Wang Y, 2006, J HISTOCHEM CYTOCHEM, V54, P1327, DOI 10.1369/jhc.6A6923.2006; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Zamparini AL, 2006, DEVELOPMENT, V133, P3709, DOI 10.1242/dev.02516	63	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5726	5737		10.1074/jbc.M109.046649	http://dx.doi.org/10.1074/jbc.M109.046649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028982	Green Published, hybrid			2022-12-27	WOS:000275327200065
J	Obermair, GJ; Schlick, B; Di Biase, V; Subramanyam, P; Gebhart, M; Baumgartner, S; Flucher, BE				Obermair, Gerald J.; Schlick, Bettina; Di Biase, Valentina; Subramanyam, Prakash; Gebhart, Mathias; Baumgartner, Sabine; Flucher, Bernhard E.			Reciprocal Interactions Regulate Targeting of Calcium Channel beta Subunits and Membrane Expression of alpha(1) Subunits in Cultured Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CA2+ CHANNELS; I-II-LINKER; SKELETAL-MUSCLE; FUNCTIONAL EXPRESSION; DENDRITIC SPINES; BRAIN; IDENTIFICATION; CA(V)1.2; CLONING; COMPLEX	Auxiliary beta subunits modulate current properties and mediate the functional membrane expression of voltage-gated Ca2+ channels in heterologous cells. In brain, all four beta isoforms are widely expressed, yet little is known about their specific roles in neuronal functions. Here, we investigated the expression and targeting properties of beta subunits and their role in membrane expression of Ca(V)1.2 alpha(1) subunits in cultured hippocampal neurons. Quantitative reverse transcription-PCR showed equal expression, and immunofluorescence showed a similar distribution of all endogenous beta subunits throughout dendrites and axons. High resolution microscopy of hippocampal neurons transfected with six different V5 epitope-tagged beta subunits demonstrated that all beta subunits were able to accumulate in synaptic terminals and to colocalize with postsynaptic Ca(V)1.2, thus indicating a great promiscuity in alpha(1)-beta interactions. In contrast, restricted axonal targeting of beta(1) and weak colocalization of beta(4b) with Ca(V)1.2 indicated isoform-specific differences in local channel complex formation. Membrane expression of external hemagglutinin epitope-tagged Ca(V)1.2 was strongly enhanced by all beta subunits in an isoform-specific manner. Conversely, mutating the alpha-interaction domain of Ca(V)1.2 (W440A) abolished membrane expression and targeting into dendritic spines. This demonstrates that in neurons the interaction of a beta subunit with the alpha-interaction domain is absolutely essential for membrane expression of alpha(1) subunits, as well as for the subcellular localization of beta subunits, which by themselves possess little or no targeting properties.	[Obermair, Gerald J.; Schlick, Bettina; Di Biase, Valentina; Subramanyam, Prakash; Baumgartner, Sabine; Flucher, Bernhard E.] Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Gebhart, Mathias] Univ Innsbruck, Dept Pharmacol & Toxicol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck	Obermair, GJ (corresponding author), Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria.	Gerald.Obermair@i-med.ac.at; bernhard.e.flucher@i-med.ac.at	Di Biase, Valentina/AFE-2569-2022; , Gerald/AAD-3183-2020; Di Biase, Valentina/T-3714-2017; Di Biase, Valentina/AFT-6986-2022; Di Biase, Valentina/AAE-9529-2022	Di Biase, Valentina/0000-0002-3292-6516; Di Biase, Valentina/0000-0002-3292-6516; Di Biase, Valentina/0000-0002-3292-6516; Flucher, Bernhard/0000-0002-5255-4705	Austrian National Bank [P17806-B05, P17807-B05, P20059-B05, P20670, W1101-B12]; Tyrolean Science Fund	Austrian National Bank; Tyrolean Science Fund	This work was supported by grants from the Austrian Science Fund and the Austrian National Bank Grants P17806-B05, P17807-B05, P20059-B05, P20670, and W1101-B12, and the Tyrolean Science Fund (to G. J. O.).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Butcher AJ, 2006, J PHYSIOL-LONDON, V574, P387, DOI 10.1113/jphysiol.2006.109744; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOENERG BIOMEMBR, V30, P377, DOI 10.1023/A:1021941706726; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Di Biase V, 2009, J NEUROSCI METH, V176, P78, DOI 10.1016/j.jneumeth.2008.08.025; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Goslin K., 1998, CULTURING NERVE CELL, P339; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Ludwig A, 1997, J NEUROSCI, V17, P1339; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neuhuber B, 1998, P NATL ACAD SCI USA, V95, P5015, DOI 10.1073/pnas.95.9.5015; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Subramanyam P, 2009, CHANNELS, V3, P343, DOI 10.4161/chan.3.5.9696; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANAKA O, 1995, BRAIN RES MOL BRAIN, V30, P1, DOI DOI 10.1016/0169-328X(94)00265-G; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Watschinger K, 2008, CHANNELS, V2, P461, DOI 10.4161/chan.2.6.6793; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, NEUROPHARMACOLOGY, V32, P1127, DOI 10.1016/0028-3908(93)90007-P; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Xie M, 2007, J CELL BIOL, V178, P489, DOI 10.1083/jcb.200702072	70	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5776	5791		10.1074/jbc.M109.044271	http://dx.doi.org/10.1074/jbc.M109.044271			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996312	Green Published, hybrid			2022-12-27	WOS:000275327200069
J	Tatsumi, K; Sou, YS; Tada, N; Nakamura, E; Iemura, S; Natsume, T; Kang, SH; Chung, CH; Kasahara, M; Kominami, E; Yamamoto, M; Tanaka, K; Komatsu, M				Tatsumi, Kanako; Sou, Yu-shin; Tada, Norihiro; Nakamura, Eri; Iemura, Shun-ichiro; Natsume, Tohru; Kang, Sung Hwan; Chung, Chin Ha; Kasahara, Masanori; Kominami, Eiki; Yamamoto, Masayuki; Tanaka, Keiji; Komatsu, Masaaki			A Novel Type of E3 Ligase for the Ufm1 Conjugation System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; GENE-ACTIVATION; UBIQUITIN; UBIQUITIN-FOLD-MODIFIER-1; TRANSLATION; INHIBITION; REGULATORS; PATHWAYS; FAMILY; MOUSE	The ubiquitin fold modifier 1 (Ufm1) is the most recently discovered ubiquitin-like modifier whose conjugation (ufmylation) system is conserved in multicellular organisms. Ufm1 is known to covalently attach with cellular protein(s) via a specific E1-activating enzyme (Uba5) and an E2-conjugating enzyme (Ufc1), but its E3-ligating enzyme(s) as well as the target protein(s) remain unknown. Herein, we report both a novel E3 ligase for Ufm1, designated Ufl1, and an Ufm1-specific substrate ligated by Ufl1, C20orf116. Ufm1 was covalently conjugated with C20orf116. Although Ufl1 has no obvious sequence homology to any other known E3s for ubiquitin and ubiquitin-like modifiers, the C20orf116.Ufm1 formation was greatly accelerated by Ufl1. The C20orf116.Ufm1 conjugate was cleaved by Ufm1-specific proteases, implying the reversibility of ufmylation. The conjugation was abundant in the liver and lungs of Ufm1-transgenic mice, fractionated into membrane fraction, and impaired in Uba5 knock-out cells. Intriguingly, immunological analysis revealed localizations of Ufl1 and C20orf116 mainly to the endoplasmic reticulum. Our results provide novel insights into the Ufm1 system involved in cellular regulation of multicellular organisms.	[Tatsumi, Kanako; Sou, Yu-shin; Tanaka, Keiji; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan; [Tatsumi, Kanako; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Tada, Norihiro; Nakamura, Eri] Juntendo Univ, Sch Med, Res Inst Dis, Div Genome Res,Old Age Grad Sch Med,Bunkyo Ku, Tokyo 1138421, Japan; [Sou, Yu-shin; Kominami, Eiki; Komatsu, Masaaki] Juntendo Univ, Sch Med, Res Inst Dis, Old Age Grad Sch Med,Dept Biochem,Bunkyo Ku, Tokyo 1138421, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Kohtoh Ku, Tokyo 1350064, Japan; [Kang, Sung Hwan; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Aoba Ku, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; [Komatsu, Masaaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Juntendo University; Juntendo University; National Institute of Advanced Industrial Science & Technology (AIST); Seoul National University (SNU); Hokkaido University; Tohoku University; Japan Science & Technology Agency (JST)	Komatsu, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan.	komatsu-ms@igakuken.or.jp	Yamamoto, Masayuki/A-4873-2010; Natsume, Tohru/M-7627-2018; Kasahara, Masanori/G-7651-2011; Komatsu, Masaaki/B-8321-2011	Yamamoto, Masayuki/0000-0002-9073-9436; Natsume, Tohru/0000-0002-1510-2582; Komatsu, Masaaki/0000-0001-7672-7722; Sou, Yu-shin/0000-0002-7219-9106	Japan Science and Technology Agency; Ministry of Education, Science and Culture of Japan; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the Japan Science and Technology Agency (to M. K.); the Ministry of Education, Science and Culture of Japan (to M. K. and K. T.); and New Energy and Industrial Technology Development Organization (to T.N.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; LEE GH, 1995, AM J PATHOL, V147, P1811; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449	32	130	139	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5417	5427		10.1074/jbc.M109.036814	http://dx.doi.org/10.1074/jbc.M109.036814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018847	Green Published, hybrid			2022-12-27	WOS:000275327200035
J	Khattar, E; Kumar, V				Khattar, Ekta; Kumar, Vijay			Mitogenic Regulation of p27(Kip1) Gene Is Mediated by AP-1 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; CELL-CYCLE; C-FOS; HEPATOCELLULAR-CARCINOMA; ACTIVATOR PROTEIN-1; INHIBITOR P27(KIP1); CDK INHIBITOR; EXPRESSION; PROMOTER; PROLIFERATION	The abundance of cyclin-dependent kinase inhibitor p27(Kip1) during the cell cycle determines whether cells will proliferate or become quiescent. Although the post-translational regulation of p27(Kip1) is well established, its transcriptional regulation is poorly understood. Here, we report that mitogenic stimulation of quiescent HEK293 and Huh7 cells showed a rapid decline in the levels of p27(Kip1) transcript by 2.4 +/- 0.1-fold. Inhibition of the p27(Kip1) gene in response to mitogens involved transcriptional down-regulation and required newly synthesized protein( s). Mutation of the AP-1 element at position -469 in the human p27(Kip1) promoter abrogated the effect of mitogens. The recruitment of the AP-1 complex to the p27(Kip1) promoter was confirmed by in vitro DNA binding and chromatin immunoprecipitation studies. Reporter gene analysis combined with enforced expression of Jun/Fos proteins suggested the involvement of Jun/Fos heterodimer in the transrepression process. Both MAPK and phosphatidylinositol 3-kinase signaling pathways appeared to mediate p27(Kip1) transcription. Furthermore, hepatitis B virus X protein-mediated down-regulation of p27(Kip1) in a transgenic environment correlated with an increase in c-Fos levels, reiterating the physiological relevance of AP-1 in the transcriptional regulation of p27(Kip1). Collectively, our studies present the first evidence demonstrating the role of the AP-1 complex in transcriptional down-regulation of the p27(Kip1) gene following mitogenic stimulation.	[Khattar, Ekta; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, POB 10504,Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in	Khattar, Ekta/AAE-7597-2020		International Centre for Genetic Engineering and Biotechnology, New Delhi, India	International Centre for Genetic Engineering and Biotechnology, New Delhi, India	This work was supported in part by a core grant of the International Centre for Genetic Engineering and Biotechnology, New Delhi, India.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bagui TK, 2009, CELL CYCLE, V8, P115, DOI 10.4161/cc.8.1.7527; Chassot AA, 2007, ONCOGENE, V26, P5772, DOI 10.1038/sj.onc.1210386; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Coleman J, 2001, BMC Mol Biol, V2, P12, DOI 10.1186/1471-2199-2-12; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Guller M, 2008, WORLD J GASTROENTERO, V14, P6339, DOI 10.3748/wjg.14.6339; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; HATTORI M, 1993, AM J PHYSIOL, V264, pG95, DOI 10.1152/ajpgi.1993.264.1.G95; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Karla N, 2004, J BIOL CHEM, V279, P25313, DOI 10.1074/jbc.M400932200; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Liu YC, 1998, FEBS LETT, V441, P200, DOI 10.1016/S0014-5793(98)01549-X; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Minami S, 1997, FEBS LETT, V411, P1, DOI 10.1016/S0014-5793(97)00660-1; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ponzielli R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn735; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Williamson EA, 2002, ONCOGENE, V21, P3199, DOI 10.1038/sj.onc.1205461; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yuen MF, 2001, CANCER, V91, P106, DOI 10.1002/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2	41	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4554	4561		10.1074/jbc.M109.029280	http://dx.doi.org/10.1074/jbc.M109.029280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959471	Green Published, hybrid			2022-12-27	WOS:000275274800032
J	Luo, Y; Pollard, JW; Casadevall, A				Luo, Yong; Pollard, Jeffrey W.; Casadevall, Arturo			Fc gamma Receptor Cross-linking Stimulates Cell Proliferation of Macrophages via the ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PERITONEAL EXUDATE CELLS; CATALYTIC SUBUNIT P34(PSK-J3)/CDK4; INDUCED GRANULOMA-FORMATION; MEDIATED PHAGOCYTOSIS; MURINE MACROPHAGES; BLOOD MONOCYTES; IN-VITRO; TYROSINE PHOSPHORYLATION; CRYPTOCOCCUS-NEOFORMANS	Macrophage proliferation can be stimulated by phagocytosis and by cross-linking of Fc gamma receptors (Fc gamma R). In this study, we investigated the role of Fc gamma R and the signaling cascades that link Fc gamma R activation to cell cycle progression. This effect was mediated by the activating Fc gamma R, including Fc gamma RI and III, via their Fc gamma subunit. Further investigation revealed that the cell cycle machinery was activated by Fc gamma R cross-linking through downstream signaling events. Specifically, we identified the extracellular signal-regulated kinase (ERK) signaling pathway as a mediator of signals from Fc gamma R activation to cyclin D1 expression, because cyclin D1 expression associated with Fc gamma R cross-linking was attenuated by specific inhibitors of the ERK1/2 signaling pathway, PD98059 and U0126 and the spleen tyrosine kinase (Syk) inhibitor, Piceatannol. Our findings establish a link between the ERK activation and cell cycle signaling pathways, thus providing a causal mechanism by which Fc gamma R activation produces a mitogenic effect that stimulates macrophage proliferation. Macrophage mitosis following Fc gamma R activation could potentially affect the outcome of macrophage interactions with intracellular pathogens. In addition, our results suggest the possibility of new treatment options for certain infectious diseases, chronic inflammatory diseases, and leukemias based on interference with Fc gamma R-stimulated macrophage cell proliferation.	[Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave,Forch 411, Bronx, NY 10461 USA.	arturo.casadevall@einstein.yu.edu			National Institutes of Health [AI033142, AI033774, AI052733, HL059842]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030280] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA089617, R01CA131270, T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R01AI033774, R37AI033142, U54AI057158, R01AI052733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI033142, AI033774, AI052733, and HL059842.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; Blom AB, 1999, CYTOKINE, V11, P1046, DOI 10.1006/cyto.1999.0503; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CANNON GJ, 1992, J CELL SCI, V101, P907; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Chen B, 2003, MOL ENDOCRINOL, V17, P1368, DOI 10.1210/me.2003-0036; Chen YC, 2006, WORLD J GASTROENTERO, V12, P5972, DOI 10.3748/wjg.v12.i37.5972; Cote-Velez MJA, 1999, IMMUNOL LETT, V67, P251, DOI 10.1016/S0165-2478(99)00021-8; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; DEBAKKER JM, 1985, J SUBMICR CYTOL PATH, V17, P133; DEFRANCO AL, 1982, J EXP MED, V155, P1523, DOI 10.1084/jem.155.5.1523; DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DURDEN DL, 1995, J IMMUNOL, V154, P4039; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FORBES IJ, 1966, J IMMUNOL, V96, P734; GANDOUR DM, 1983, J IMMUNOL, V130, P1108; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; GOLD MR, 1995, INT REV CYTOL, V157, P181, DOI 10.1016/S0074-7696(08)62159-2; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Karimi K, 1998, INFLAMMATION, V22, P67, DOI 10.1023/A:1022347808042; Kortylewski M, 2001, BIOCHEM J, V357, P297, DOI 10.1042/0264-6021:3570297; Krasinskas AM, 1998, AM J CLIN PATHOL, V110, P797; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; LIN HS, 1974, J CELL PHYSIOL, V83, P369, DOI 10.1002/jcp.1040830307; LIN HS, 1973, NATURE-NEW BIOL, V243, P176, DOI 10.1038/newbio243176a0; Luo Y, 2005, J IMMUNOL, V174, P7226, DOI 10.4049/jimmunol.174.11.7226; Luo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003219; Marsh CB, 1999, J IMMUNOL, V162, P6217; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MIMS CA, 1964, BRIT J EXP PATHOL, V45, P37; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; MURCH AR, 1981, J PATHOL, V133, P177, DOI 10.1002/path.1711330302; NAITO M, 1991, LAB INVEST, V64, P664; Naito M, 1997, MOL REPROD DEV, V46, P85; Nelson MB, 2001, NEOPLASIA, V3, P115, DOI 10.1038/sj.neo.7900140; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Reid S, 1996, MOL IMMUNOL, V33, P1139, DOI 10.1016/S0161-5890(96)00065-X; REIKVAM A, 1976, ACTA PATH MICRO IM C, V84, P161; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; RIDLEY MJ, 1982, J PATHOL, V136, P59, DOI 10.1002/path.1711360106; Rose DM, 1997, BIOCHEM BIOPH RES CO, V238, P256, DOI 10.1006/bbrc.1997.7271; Rose DM, 1997, J IMMUNOL, V158, P3433; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; SAWYER RT, 1982, LAB INVEST, V46, P165; SCOTT CS, 1983, J CLIN PATHOL, V36, P555, DOI 10.1136/jcp.36.5.555; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; STEWART CC, 1975, J EXP MED, V141, P1114, DOI 10.1084/jem.141.5.1114; TAKEMURA R, 1986, J CELL BIOL, V102, P55, DOI 10.1083/jcb.102.1.55; Tanguay DA, 1996, J IMMUNOL, V156, P539; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; TSITSIKOV EN, 1995, INT IMMUNOL, V7, P1665, DOI 10.1093/intimm/7.10.1665; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vadiveloo PK, 1999, J LEUKOCYTE BIOL, V66, P579, DOI 10.1002/jlb.66.4.579; VANDERZEIJST BAM, 1978, J EXP MED, V147, P1253, DOI 10.1084/jem.147.4.1253; VIDRIALES MB, 1995, BRIT J HAEMATOL, V89, P342, DOI 10.1111/j.1365-2141.1995.tb03310.x; Voigt H, 1999, CELL MICROBIOL, V1, P195, DOI 10.1046/j.1462-5822.1999.00021.x; WALKER WS, 1988, CELL IMMUNOL, V111, P492, DOI 10.1016/0008-8749(88)90112-8; WESTERMANN J, 1989, J LEUKOCYTE BIOL, V46, P263, DOI 10.1002/jlb.46.3.263; YAMADA M, 1990, J LEUKOCYTE BIOL, V47, P195, DOI 10.1002/jlb.47.3.195; YUAN RR, 1995, J IMMUNOL, V154, P1810	72	29	29	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4232	4242		10.1074/jbc.M109.037168	http://dx.doi.org/10.1074/jbc.M109.037168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996316	hybrid, Green Published			2022-12-27	WOS:000275254000075
J	Okada, T; Tomita, T; Wulandari, AP; Kuzuyama, T; Nishiyama, M				Okada, Takuya; Tomita, Takeo; Wulandari, Asri P.; Kuzuyama, Tomohisa; Nishiyama, Makoto			Mechanism of Substrate Recognition and Insight into Feedback Inhibition of Homocitrate Synthase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ISOPROPYLMALATE SYNTHASE; LYSINE BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; LEPTOSPIRA-INTERROGANS; CITRAMALATE SYNTHASE; REGULATORY MECHANISM; AMINOADIPATE PATHWAY; CRYSTAL-STRUCTURE; MOLECULAR-BASIS	Homocitrate synthase (HCS) catalyzes aldol-type condensation of acetyl coenzyme A (acetyl-CoA) and alpha-ketoglutarate (alpha-KG) to synthesize homocitrate (HC), which is the first and committed step in the lysine biosynthetic pathway through alpha-aminoadipate. As known in most enzymes catalyzing the first reactions in amino acid biosynthetic pathways, HCS is regulated via feedback inhibition by the end product, lysine. Here, we determined the crystal structures of HCS from Thermus thermophilus complexed with alpha-KG, HC, or lysine. In the HC complex, the C1-carboxyl group of HC, which is derived from acetyl-CoA, is hydrogen-bonded with His-292* from another subunit (indicated by the asterisk), indicating direct involvement of this residue in the catalytic mechanism of HCS. The crystal structure of HCS complexed with lysine showed that lysine is bound to the active site with rearrangement of amino acid residues in the substrate-binding site, which accounts for the competitive inhibition by lysine with alpha-KG. Comparison between the structures suggests that His-72, which is conserved in lysine-sensitive HCSs and binds the C5-carboxyl group of alpha-KG, serves as a switch for the conformational change. Replacement of His-72 by leucine made HCS resistant to lysine inhibition, demonstrating the regulatory role of this conserved residue.	[Okada, Takuya; Tomita, Takeo; Wulandari, Asri P.; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Nishiyama, Makoto] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan	University of Tokyo; RIKEN	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Kuzuyama, Tomohisa/0000-0002-7221-5858; Nishiyama, Makoto/0000-0001-8143-8052	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nagase Science and Technology Foundation; Asahi Glass Foundation; Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagase Science and Technology Foundation; Asahi Glass Foundation; Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from the Nagase Science and Technology Foundation, from the Asahi Glass Foundation, and from the Charitable Trust Araki Medical and Biochemistry Memorial Research Promotion Fund. This work was performed with approval from the Photon Factory Program Advisory Committee (Proposals 2007G530 and 2009G540).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2005, J BIOL CHEM, V280, P31633, DOI 10.1074/jbc.M502847200; BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; Broquist HP., 1971, METHODS ENZYMOL, V17B, P112; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; Cavalieri D, 1999, MOL GEN GENET, V261, P152, DOI 10.1007/s004380050952; CHATTERJEE SP, 1994, PLANT MOL BIOL, V26, P285, DOI 10.1007/BF00039539; *COMP COLL PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; de Carvalho LPS, 2005, J AM CHEM SOC, V127, P10004, DOI 10.1021/ja052513h; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; de Carvalho LPS, 2009, BIOCHEMISTRY-US, V48, P1996, DOI 10.1021/bi801707t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; HADLER HI, 1963, BIOCHEMISTRY-US, V2, P954, DOI 10.1021/bi00905a010; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LUENGO JM, 1980, J BACTERIOL, V144, P869, DOI 10.1128/JB.144.3.869-876.1980; Ma J, 2008, BIOCHEM J, V415, P45, DOI 10.1042/BJ20080242; MCLEAN PA, 1981, NATURE, V292, P655, DOI 10.1038/292655a0; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki J, 2002, FEBS LETT, V512, P269, DOI 10.1016/S0014-5793(02)02290-1; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian JH, 2008, BIOCHEMISTRY-US, V47, P6851, DOI 10.1021/bi800087k; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Tsubouchi T, 2005, J BIOL CHEM, V280, P18511, DOI 10.1074/jbc.M414456200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Zhang P, 2009, BIOCHEM J, V421, P133, DOI 10.1042/BJ20090336	42	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4195	4205		10.1074/jbc.M109.086330	http://dx.doi.org/10.1074/jbc.M109.086330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996101	hybrid, Green Published			2022-12-27	WOS:000275254000071
J	Saxena, G; Chen, JQ; Shalev, A				Saxena, Geetu; Chen, Junqin; Shalev, Anath			Intracellular Shuttling and Mitochondrial Function of Thioredoxin-interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATING KINASE-1; BETA-CELL APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; MAMMALIAN THIOREDOXIN; CARDIAC-HYPERTROPHY; GLUCOSE TOXICITY; BINDING-PROTEINS; REDOX REGULATION; IMPORTIN-ALPHA	The thioredoxin-interacting protein TXNIP is a ubiquitously expressed redox protein that promotes apoptosis. Recently, we found that TXNIP deficiency protects against type 1 and 2 diabetes by inhibiting beta cell apoptosis and maintaining pancreatic beta cell mass, indicating that TXNIP plays a key role in beta cell biology. However, very little is known about the intracellular localization and function of TXNIP, and although TXNIP has been thought to be a cytoplasmic protein, our immunohistochemistry studies in beta cells surprisingly revealed a nuclear TXNIP localization, suggesting that TXNIP may shuttle within the cell. Using immunohistochemistry/confocal imaging and cell fractionation/co-immunoprecipitation, we found that, under physiological conditions, TXNIP is localized primarily in the nucleus of pancreatic beta cells, whereas oxidative stress leads to TXNIP shuttling into the mitochondria. In mitochondria, TXNIP binds to and oxidizes Trx2, thereby reducing Trx2 binding to ASK1 and allowing for ASK1 phosphorylation/activation, resulting in induction of the mitochondrial pathway of apoptosis with cytochrome c release and caspase-3 cleavage. TXNIP overexpression and Trx2 (but not cytosolic Trx1) silencing mimic these effects. Thus, we discovered that TXNIP shuttles between subcellular compartments in response to oxidative stress and identified a novel redox-sensitive mitochondrial TXNIP-Trx2-ASK1 signaling cascade.	[Shalev, Anath] Univ Wisconsin, Dept Med, Clin Sci Ctr H4 526, Madison, WI 53792 USA; William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Shalev, A (corresponding author), Univ Wisconsin, Dept Med, Clin Sci Ctr H4 526, 600 Highland Ave, Madison, WI 53792 USA.	as7@medicine.wisc.edu			National Institutes of Health [R01DK-078752]; NIDDK [R21HL-089205]; NHLBI; American Diabetes Association [7-07-CD-22]; Juvenile Diabetes Research Foundation [1-2007-790]; William S. Middleton Memorial Veterans Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); William S. Middleton Memorial Veterans Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK-078752 from NIDDK and R21HL-089205 from NHLBI (to A. S.). This work was also supported by American Diabetes Association Grant 7-07-CD-22 and Juvenile Diabetes Research Foundation Grant 1-2007-790) (to A. S.) and is the result of work supported by resources and use of facilities at the William S. Middleton Memorial Veterans Hospital (Madison, WI).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Cheng Davis W., 2006, Archives of Physiology and Biochemistry, V112, P189, DOI 10.1080/13813450601093518; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Dutta KK, 2005, LAB INVEST, V85, P798, DOI 10.1038/labinvest.3700280; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Liang MY, 2007, ARTERIOSCL THROM VAS, V27, P77, DOI 10.1161/01.ATV.0000251006.54632.bb; Lim PLK, 2008, TOXICOL SCI, V101, P341, DOI 10.1093/toxsci/kfm273; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yodoi J, 2002, BIOL CHEM, V383, P585, DOI 10.1515/BC.2002.060; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	43	198	204	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3997	4005		10.1074/jbc.M109.034421	http://dx.doi.org/10.1074/jbc.M109.034421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959470	Green Published, hybrid			2022-12-27	WOS:000275254000053
J	Tada, H; Okano, HJ; Takagi, H; Shibata, S; Yao, I; Matsumoto, M; Saiga, T; Nakayama, KI; Kashima, H; Takahashi, T; Setou, M; Okano, H				Tada, Hirobumi; Okano, Hirotaka James; Takagi, Hiroshi; Shibata, Shinsuke; Yao, Ikuko; Matsumoto, Masaki; Saiga, Toru; Nakayama, Keiichi I.; Kashima, Haruo; Takahashi, Takuya; Setou, Mitsutoshi; Okano, Hideyuki			Fbxo45, a Novel Ubiquitin Ligase, Regulates Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; F-BOX PROTEIN; CELL-CYCLE; SYNAPTOPHYSIN DEGRADATION; NEUROTRANSMITTER RELEASE; NEURONAL DEVELOPMENT; MESSENGER-RNA; MAMMALIAN CNS; C-ELEGANS; SYSTEM	Neurons communicate with each other through synapses. To establish the precise yet flexible connections that make up neural networks in the brain, continuous synaptic modulation is required. The ubiquitin-proteasome system of protein degradation is one of the critical mechanisms that underlie this process, playing crucial roles in the regulation of synaptic structure and function. We identified a novel ubiquitin ligase, Fbxo45, that functions at synapses. Fbxo45 is evolutionarily conserved and selectively expressed in the nervous system. We demonstrated that the knockdown of Fbxo45 in primary cultured hippocampal neurons resulted in a greater frequency of miniature excitatory postsynaptic currents. We also found that Fbxo45 induces the degradation of a synaptic vesicle-priming factor, Munc13-1. We propose that Fbxo45 plays an important role in the regulation of neurotransmission by modulating Munc13-1 at the synapse.	[Okano, Hirotaka James] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608502, Japan; [Tada, Hirobumi; Okano, Hideyuki] Keio Univ, Sch Med, Bridgestone Lab Dev & Regenerat Neurobiol, Tokyo 1608502, Japan; [Kashima, Haruo] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608502, Japan; [Tada, Hirobumi; Takahashi, Takuya] Yokohama City Univ, Sch Med, Dept Physiol, Kanagawa 2360004, Japan; [Okano, Hirotaka James; Okano, Hideyuki] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan; [Matsumoto, Masaki; Saiga, Toru; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Takagi, Hiroshi; Yao, Ikuko; Setou, Mitsutoshi] Mitsubishi Kagaku Inst, Life Sci Setou Grp, Lab Mol Gerontol, Tokyo 1948511, Japan; [Matsumoto, Masaki; Saiga, Toru; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan	Keio University; Keio University; Keio University; Yokohama City University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyushu University; Hamamatsu University School of Medicine	Okano, HJ (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608502, Japan.	hjokano@sc.itc.keio.ac.jp; setou@hama-med.ac.jp; hidokano@sc.itc.keio.ac.jp	Okano, Hideyuki/I-7584-2019; Tada, Hirobumi/ABB-7665-2020; Shibata, Shinsuke/AAM-6620-2020	Okano, Hirotaka James/0000-0003-4611-7098; Matsumoto, Masaki/0000-0002-6987-0288	Solution-oriented Research for Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science; Keio University; grant-in-aid for Scientific Research on Priority Areas; WAKATE S and SENTAN	Solution-oriented Research for Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; grant-in-aid for Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); WAKATE S and SENTAN	This work was supported by grants from Solution-oriented Research for Science and Technology, the Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to Hideyuki Okano) and by grants from Japan Society for the Promotion of Science, the Keio University grant-in-aid for Encouragement of Young Medical Scientists (to H. Tada), a grant-in-aid for Scientific Research on Priority Areas (to H. J. Okano), WAKATE S and SENTAN (to M. S.), and a grant-in-aid for the Global COE program (to Keio University) from the MEXT, Japan.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Deak F, 2009, J NEUROSCI, V29, P8639, DOI 10.1523/JNEUROSCI.0898-09.2009; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fukaya M, 2008, EUR J NEUROSCI, V28, P1744, DOI 10.1111/j.1460-9568.2008.06495.x; Haas KF, 2008, BBA-GENE REGUL MECH, V1779, P495, DOI 10.1016/j.bbagrm.2007.12.010; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Hennou S, 2003, EUR J NEUROSCI, V18, P811, DOI 10.1046/j.1460-9568.2003.02812.x; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; PICKART CM, 2001, ANNU REV BIOCHEM, V503, P533; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 1999, J BIOL CHEM, V274, P11889, DOI 10.1074/jbc.274.17.11889; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Yoshida K, 2005, ONCOL REP, V14, P531; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	55	61	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3840	3849		10.1074/jbc.M109.046284	http://dx.doi.org/10.1074/jbc.M109.046284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996097	Green Published, hybrid			2022-12-27	WOS:000275254000037
J	Zhang, WJ; Urban, A; Mihara, H; Leimkuhler, S; Kurihara, T; Esaki, N				Zhang, Wanjiao; Urban, Alexander; Mihara, Hisaaki; Leimkuehler, Silke; Kurihara, Tatsuo; Esaki, Nobuyoshi			IscS Functions as a Primary Sulfur-donating Enzyme by Interacting Specifically with MoeB and MoaD in the Biosynthesis of Molybdopterin in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; MOLYBDENUM COFACTOR BIOSYNTHESIS; IN-VITRO BIOSYNTHESIS; CYSTEINE DESULFURASE; TRANSFER-RNA; SELENOCYSTEINE LYASE; STRUCTURAL-CHARACTERIZATION; UBIQUITIN ACTIVATION; GENE CLONING; MECHANISM	The persulfide sulfur formed on an active site cysteine residue of pyridoxal 5'-phosphate-dependent cysteine desulfurases is subsequently incorporated into the biosynthetic pathways of a variety of sulfur-containing cofactors and thionucleosides. In molybdenum cofactor biosynthesis, MoeB activates the C terminus of the MoaD subunit of molybdopterin (MPT) synthase to form MoaD-adenylate, which is subsequently converted to a thiocarboxylate for the generation of the dithiolene group of MPT. It has been shown that three cysteine desulfurases (CsdA, SufS, and IscS) of Escherichia coli can transfer sulfur from L-cysteine to the thiocarboxylate of MoaD in vitro. Here, we demonstrate by surface plasmon resonance analyses that IscS, but not CsdA or SufS, interacts with MoeB and MoaD. MoeB and MoaD can stimulate the IscS activity up to 1.6-fold. Analysis of the sulfuration level of MoaD isolated from strains defective in cysteine desulfurases shows a largely decreased sulfuration level of the protein in an iscS deletion strain but not in a csdA/sufS deletion strain. We also show that another iscS deletion strain of E. coli accumulates compound Z, a direct oxidation product of the immediate precursor of MPT, to the same extent as an MPT synthase-deficient strain. In contrast, analysis of the content of compound Z in Delta csdA and Delta sufS strains revealed no such accumulation. These findings indicate that IscS is the primary physiological sulfur-donating enzyme for the generation of the thiocarboxylate of MPT synthase in MPT biosynthesis.	[Zhang, Wanjiao; Kurihara, Tatsuo; Esaki, Nobuyoshi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Mihara, Hisaaki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Inst Sci & Engn, Shiga 5258577, Japan; [Urban, Alexander; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	Kyoto University; Ritsumeikan University; University of Potsdam	Esaki, N (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	esakin@scl.kyoto-u.ac.jp	Mihara, Hisaaki/F-2172-2010	Mihara, Hisaaki/0000-0002-5153-4403; Leimkuhler, Silke/0000-0003-3238-2122	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17370037]; Japan Society for the Promotion of Science [18780073]; Deutsche Forschungsgemeinschaft [LE1171/5]; Fonds der Chemischen Industrie	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by a Grant-in-aid for Scientific Research on Priority Areas (B) 17370037 (to N. E.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Grant-in-aid for Encouragement of Young Scientists 18780073 (to H. M.) from the Japan Society for the Promotion of Science, by the National Project on Protein Structural and Functional Analyses, by a Grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21st Century COE on Kyoto University Alliance for Chemistry), and by Deutsche Forschungsgemeinschaft Grant LE1171/5, and the Fonds der Chemischen Industrie (to S. L.).	Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Fonknechten N, 2009, J BACTERIOL, V191, P3162, DOI 10.1128/JB.01777-08; Hille R, 1998, FEMS MICROBIOL REV, V22, P489; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JOHNSON JL, 1989, J BIOL CHEM, V264, P13440; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kambampati R, 1999, BIOCHEMISTRY-US, V38, P16561, DOI 10.1021/bi991119r; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; KLUGER R, 1987, CHEM REV, V87, P863, DOI 10.1021/cr00081a001; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kurihara T, 2003, BBA-PROTEINS PROTEOM, V1647, P303, DOI 10.1016/S1570-9639(03)00078-5; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Leimkuhler S, 2001, J BIOL CHEM, V276, P1837, DOI 10.1074/jbc.M007304200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; RAMABHADRAN TV, 1976, J BACTERIOL, V128, P671, DOI 10.1128/JB.128.2.671-672.1976; ROGERS KC, 1995, BIOCHIMIE, V77, P66, DOI 10.1016/0300-9084(96)88106-5; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; SEN GC, 1976, NUCLEIC ACIDS RES, V3, P523, DOI 10.1093/nar/3.3.523; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905	49	51	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2302	2308		10.1074/jbc.M109.082172	http://dx.doi.org/10.1074/jbc.M109.082172			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19946146	Green Published, hybrid			2022-12-27	WOS:000273697800009
J	Rangaraju, S; Khoo, KK; Feng, ZP; Crossley, G; Nugent, D; Khaytin, I; Chi, V; Pham, C; Calabresi, P; Pennington, MW; Norton, RS; Chandy, KG				Rangaraju, Srikant; Khoo, Keith K.; Feng, Zhi-Ping; Crossley, George; Nugent, Daniel; Khaytin, Ilya; Chi, Victor; Pham, Cory; Calabresi, Peter; Pennington, Michael W.; Norton, Raymond S.; Chandy, K. George			Potassium Channel Modulation by a Toxin Domain in Matrix Metalloprotease 23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SECRETORY PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; GENE-EXPRESSION PROFILE; CRYSTAL-STRUCTURE; SNAKE-VENOM; SEA-ANEMONE; NMR-SPECTROSCOPY; ION CHANNELS; K+ CHANNEL; SHK TOXIN	Peptide toxins found in a wide array of venoms block K+ channels, causing profound physiological and pathological effects. Here we describe the first functional K+ channel-blocking toxin domain in a mammalian protein. MMP23 (matrix metalloprotease 23) contains a domain (MMP23(TxD)) that is evolutionarily related to peptide toxins from sea anemones. MMP23(TxD) shows close structural similarity to the sea anemone toxins BgK and ShK. Moreover, this domain blocks K+ channels in the nanomolar to low micromolar range (Kv1.6 > Kv1.3 > Kv1.1 = Kv3.2 > Kv1.4, in decreasing order of potency) while sparing other K+ channels (Kv1.2, Kv1.5, Kv1.7, and KCa3.1). Full-length MMP23 suppresses K+ channels by co-localizing with and trapping MMP23(TxD)-sensitive channels in the ER. Our results provide clues to the structure and function of the vast family of proteins that contain domains related to sea anemone toxins. Evolutionary pressure to maintain a channel-modulatory function may contribute to the conservation of this domain throughout the plant and animal kingdoms.	[Chandy, K. George] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Rangaraju, Srikant; Chi, Victor; Pham, Cory; Chandy, K. George] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Khoo, Keith K.; Feng, Zhi-Ping; Norton, Raymond S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Khoo, Keith K.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Crossley, George; Nugent, Daniel; Khaytin, Ilya; Pennington, Michael W.] Bachem Biosci Inc, King Of Prussia, PA 19406 USA; [Calabresi, Peter] Johns Hopkins Univ, Sch Med, Dept Neurol Neurosurg, Baltimore, MD 21287 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Walter & Eliza Hall Institute; University of Melbourne; Johns Hopkins University	Chandy, KG (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 291 JISH, Irvine, CA 92697 USA.	gchandy@uci.edu	Calabresi, Peter A./AAF-2288-2019; Khoo, Keith/G-5010-2016; RANGARAJU, SRIKANT/Q-1924-2018	Khoo, Keith/0000-0002-3334-6564; pennington, michael/0000-0001-5446-3447; Norton, Raymond/0000-0001-8893-0584; RANGARAJU, SRIKANT/0000-0003-2765-1500	National Institutes of Health [NS-048252, NS041435]; National Health and Medical Research Council Independent Research Institutes Infrastructure [361646]; Victorian State Government Operational Infrastructure Support grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS099474, R37NS041435, R01NS041435, R01NS048252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Independent Research Institutes Infrastructure; Victorian State Government Operational Infrastructure Support grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-048252 (to K. G. C. and M. W. P.) and NS041435 (to P. C. and K. G. C.). This work was also supported by National Health and Medical Research Council Independent Research Institutes Infrastructure Support Schemes Grant 361646 (to R.S.N.) and a Victorian State Government Operational Infrastructure Support grant (to R.S.N.).	AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Alessandri-Haber N, 1999, J BIOL CHEM, V274, P35653, DOI 10.1074/jbc.274.50.35653; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Clancy BM, 2003, BONE, V33, P46, DOI 10.1016/S8756-3282(03)00116-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Cousin X, 1998, J BIOL CHEM, V273, P9812, DOI 10.1074/jbc.273.16.9812; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; FARACO J, 1995, GENOMICS, V25, P630, DOI 10.1016/0888-7543(95)80004-6; Fortunato SJ, 2002, J ASSIST REPROD GEN, V19, P483, DOI 10.1023/A:1020362519981; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Gilquin B, 2002, J BIOL CHEM, V277, P37406, DOI 10.1074/jbc.M206205200; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; INOUE S, 1991, FEBS LETT, V279, P38, DOI 10.1016/0014-5793(91)80244-W; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438; KOCHVA E, 1993, TOXICON, V31, P541, DOI 10.1016/0041-0101(93)90111-U; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Ohnishi J, 2001, MOL ENDOCRINOL, V15, P747, DOI 10.1210/me.15.5.747; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pan TL, 1998, DEV GENES EVOL, V208, P259, DOI 10.1007/s004270050180; Pei DQ, 2000, J BIOL CHEM, V275, P33988, DOI 10.1074/jbc.M006493200; Pei DQ, 1999, FEBS LETT, V457, P262, DOI 10.1016/S0014-5793(99)01046-7; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Suzuki N, 2005, ACTA CRYSTALLOGR F, V61, P750, DOI 10.1107/S1744309105020439; Tsang SW, 2007, DEV BIOL, V312, P353, DOI 10.1016/j.ydbio.2007.09.037; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Vacher H, 2007, FASEB J, V21, P906, DOI 10.1096/fj.06-7229com; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Wang F, 2006, BIOCHEM BIOPH RES CO, V351, P443, DOI 10.1016/j.bbrc.2006.10.067; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Yan L, 2000, DEVELOPMENT, V127, P129; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724; Zhu J, 2001, J BIOL CHEM, V276, P39419, DOI 10.1074/jbc.M107399200	66	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9124	9136		10.1074/jbc.M109.071266	http://dx.doi.org/10.1074/jbc.M109.071266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	19965868	hybrid, Green Published			2022-12-27	WOS:000275553700062
J	Bargagna-Mohan, P; Paranthan, RR; Hamza, A; Dimova, N; Trucchi, B; Srinivasan, C; Elliott, GI; Zhan, CG; Lau, DL; Zhu, HY; Kasahara, K; Inagaki, M; Cambi, F; Mohan, R				Bargagna-Mohan, Paola; Paranthan, Riya R.; Hamza, Adel; Dimova, Neviana; Trucchi, Beatrice; Srinivasan, Cidambi; Elliott, Gregory I.; Zhan, Chang-Guo; Lau, Daniel L.; Zhu, Haiyan; Kasahara, Kousuke; Inagaki, Masaki; Cambi, Franca; Mohan, Royce			Withaferin A Targets Intermediate Filaments Glial Fibrillary Acidic Protein and Vimentin in a Model of Retinal Gliosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE DEFICIENT; MULLER CELLS; GFAP; PHOSPHORYLATION; ASTROCYTES; DYNAMICS; INJURY; PROLIFERATION; CYTOSKELETAL; INHIBITION	Gliosis is a biological process that occurs during injury repair in the central nervous system and is characterized by the overexpression of the intermediate filaments (IFs) glial fibrillary acidic protein (GFAP) and vimentin. A common thread in many retinal diseases is reactive Muller cell gliosis, an untreatable condition that leads to tissue scarring and even blindness. Here, we demonstrate that the vimentin-targeting small molecule withaferin A (WFA) is a novel chemical probe of GFAP. Using molecular modeling studies that build on the x-ray crystal structure of tetrameric vimentin rod 2B domain we reveal that the WFA binding site is conserved in the corresponding domain of tetrameric GFAP. Consequently, we demonstrate that WFA covalently binds soluble recombinant tetrameric human GFAP at cysteine 294. In cultured primary astrocytes, WFA binds to and down-regulates soluble vimentin and GFAP expression to cause cell cycle G(0)/G(1) arrest. Exploiting a chemical injury model that overexpresses vimentin and GFAP in retinal Muller glia, we demonstrate that systemic delivery of WFA down-regulates soluble vimentin and GFAP expression in mouse retinas. This pharmacological knockdown of soluble IFs results in the impairment of GFAP filament assembly and inhibition of cell proliferative response in Muller glia. We further show that a more severe GFAP filament assembly deficit manifests in vimentin-deficient mice, which is partly rescued by WFA. These findings illustrate WFA as a chemical probe of type III IFs and illuminate this class of with anolide as a potential treatment for diverse gliosis-dependent central nervous system traumatic injury conditions and diseases, and for orphan IF-dependent pathologies.	[Hamza, Adel; Elliott, Gregory I.; Zhan, Chang-Guo; Mohan, Royce] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Dimova, Neviana; Zhu, Haiyan; Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Srinivasan, Cidambi] Univ Kentucky, Dept Stat, Lexington, KY 40536 USA; [Elliott, Gregory I.] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA; [Lau, Daniel L.] Univ Kentucky, Dept Elect & Comp Engn, Lexington, KY 40536 USA; Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Kasahara, Kousuke; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Aichi Cancer Center	Mohan, R (corresponding author), Lab Chem Biol & Drug Discovery, 166 HSRB,1095 VA Dr, Lexington, KY 40536 USA.	Royce.Mohan@uky.edu	zhu, xueqiong/U-1320-2019; Inagaki, Masaki/B-9920-2016; Lau, Daniel L/O-5169-2014	Lau, Daniel L/0000-0003-1377-4622	National Institutes of Health [R21 NS053593, R01 EY0167821, R01 DA013930, R01 DA025100, R01 DA021416, R01NS053905]; Kentucky Science and Technology Corporation [KSTC-144-401-07-020]; Kentucky Science and Engineering Foundation [KSEF-578-RDE-005]; Research to Prevent Blindness, Inc.; European Leukodystrophy Association Foundation; NATIONAL EYE INSTITUTE [R01EY016782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905, R21NS053593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021416, R01DA025100, R01DA013930] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [19057010] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Science and Technology Corporation; Kentucky Science and Engineering Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); European Leukodystrophy Association Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS053593, R01 EY0167821, R01 DA013930, R01 DA025100, and R01 DA021416 (C.-G.Z.), and R01NS053905, the Fight for Sight, Inc., Grant KSTC-144-401-07-020 from the Kentucky Science and Technology Corporation and KSEF-578-RDE-005 from the Kentucky Science and Engineering Foundation (to R.M.), and additionally by a Challenge Grant from Research to Prevent Blindness, Inc. and a grant from the European Leukodystrophy Association Foundation (to F.C.).	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166; DAHL D, 1982, J HISTOCHEM CYTOCHEM, V30, P207, DOI 10.1177/30.3.7037941; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Eckes B, 2000, J CELL SCI, V113, P2455; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; FRANKE WW, 1979, J CELL BIOL, V81, P570, DOI 10.1083/jcb.81.3.570; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Galou M, 1996, J CELL BIOL, V133, P853, DOI 10.1083/jcb.133.4.853; Gillard BK, 1998, EXP CELL RES, V242, P561, DOI 10.1006/excr.1998.4126; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Huang Z, 2002, MOL CELL NEUROSCI, V19, P250, DOI 10.1006/mcne.2001.1077; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; KOUKLIS PD, 1992, J CELL SCI, V102, P31; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; MALLOCH GDA, 1987, J NEUROCHEM, V48, P299, DOI 10.1111/j.1471-4159.1987.tb13162.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Mignot C, 2007, EXP CELL RES, V313, P2766, DOI 10.1016/j.yexcr.2007.04.035; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Moromizato Y, 2000, AM J PATHOL, V157, P1277, DOI 10.1016/S0002-9440(10)64643-3; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Spurny R, 2008, EXP CELL RES, V314, P3570, DOI 10.1016/j.yexcr.2008.09.012; Tackenberg MA, 2009, MOL VIS, V15, P1886; Takemura M, 2002, J NEUROSCI, V22, P6972; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; TRAUB P, 1994, BIOESSAYS, V16, P349, DOI 10.1002/bies.950160510; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039	67	51	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7657	7669		10.1074/jbc.M109.093765	http://dx.doi.org/10.1074/jbc.M109.093765			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048155	hybrid, Green Published			2022-12-27	WOS:000275415600076
J	Choi, YB; Son, M; Park, M; Shin, J; Yun, Y				Choi, Young Bong; Son, Myoungsun; Park, Mijin; Shin, Jaekyoon; Yun, Yungdae			SOCS-6 Negatively Regulates T Cell Activation through Targeting p56(lck) to Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SRC-FAMILY KINASES; SH2 DOMAIN; IMMUNOLOGICAL SYNAPSE; TYROSINE PHOSPHORYLATION; UBIQUITIN LIGASES; INSULIN-RECEPTOR; ADAPTER PROTEIN; LCK ACTIVITY; BOX MOTIF	The T cell-specific tyrosine kinase, p56(lck), plays crucial roles in T cell receptor (TCR)-mediated T cell activation. Here, we report that SOCS-6 (suppressor of cytokine signaling-6) is a negative regulator of p56(lck). SOCS-6 was identified as a protein binding to the kinase domain of p56(lck) through yeast two-hybrid screening. SOCS-6 bound specifically to p56(lck) (F505), which mimics the active form of p56(lck), but not to wild type p56(lck). In Jurkat T cells, SOCS-6 binding to p56(lck) was detected 1-2 h after TCR stimulation. Confocal microscopy showed that upon APC-T cell conjugation, SOCS-6 was recruited to the immunological synapse and colocalized with the active form of p56(lck). SOCS-6 promoted p56(lck) ubiquitination and its subsequent targeting to the proteasome. Moreover, SOCS-6 overexpression led to repression of TCR-dependent interleukin-2 promoter activity. These results establish that SOCS-6 acts as a negative regulator of T cell activation by promoting ubiquitin-dependent proteolysis.	[Yun, Yungdae] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Choi, Young Bong; Shin, Jaekyoon] Sungkyunkwan Univ, Mol Cell Biol Lab, Sch Med, Suwon 440746, Kyonggi Do, South Korea; [Choi, Young Bong; Shin, Jaekyoon] Samsung Biomed Res Inst, Suwon 440746, Kyonggi Do, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU)	Yun, Y (corresponding author), Ewha Womans Univ, Dept Life Sci, 11-1 Daehyundong, Seoul 120750, South Korea.	YUNYUNG@ewha.ac.kr	Choi, Young Bong/J-4317-2019	Choi, Young Bong/0000-0002-2523-1441	National Research Foundation [KRF-2006-C00308, 2006-2002689, 2009-0060399]; Ministry of Education, Science, and Technology, Korea [2006-08367]; Brain Korea 21 Project	National Research Foundation; Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported in part by National Research Foundation Grants KRF-2006-C00308, 2006-2002689, and 2009-0060399 and KBRDG Initiative Research Program Grant 2006-08367 from the Ministry of Education, Science, and Technology, Korea.; Supported by the Brain Korea 21 Project.	Ahn E, 2006, BLOOD, V107, P1521, DOI 10.1182/blood-2005-05-1859; Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Banerjee A, 2002, J IMMUNOL, V168, P4277, DOI 10.4049/jimmunol.168.9.4277; Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi YB, 1999, J IMMUNOL, V163, P5242; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Jury EC, 2003, ARTHRITIS RHEUM-US, V48, P1343, DOI 10.1002/art.10978; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nervi S, 2000, J IMMUNOL, V165, P5874, DOI 10.4049/jimmunol.165.10.5874; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park D, 2001, MOL CELLS, V12, P244; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; RUDD CE, 1989, IMMUNOL REV, V111, P225, DOI 10.1111/j.1600-065X.1989.tb00548.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wiedemann A, 2005, IMMUNOL LETT, V98, P57, DOI 10.1016/j.imlet.2004.10.014; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yorgin PD, 2000, J IMMUNOL, V164, P2915, DOI 10.4049/jimmunol.164.6.2915; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	48	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7271	7280		10.1074/jbc.M109.073726	http://dx.doi.org/10.1074/jbc.M109.073726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20007709	hybrid, Green Published			2022-12-27	WOS:000275415600039
J	Bailly-Maitre, B; Belgardt, BF; Jordan, SD; Coornaert, B; von Freyend, MJ; Kleinridders, A; Mauer, J; Cuddy, M; Kress, CL; Willmes, D; Essig, M; Hampel, B; Protzer, U; Reed, JC; Bruning, JC				Bailly-Maitre, Beatrice; Belgardt, Bengt F.; Jordan, Sabine D.; Coornaert, Beatrice; von Freyend, Miriam John; Kleinridders, Andre; Mauer, Jan; Cuddy, Michael; Kress, Christina L.; Willmes, Diana; Essig, Manuela; Hampel, Brigitte; Protzer, Ulrike; Reed, John C.; Bruening, Jens C.			Hepatic Bax Inhibitor-1 Inhibits IRE1 alpha and Protects from Obesity-associated Insulin Resistance and Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE; KINASE-B; APOPTOSIS; MICE; IRE1; BI-1	The unfolded protein response (UPR) or endoplasmic reticulum (ER) stress response is a physiological process enabling cells to cope with altered protein synthesis demands. However, under conditions of obesity, prolonged activation of the UPR has been shown to have deteriorating effects on different metabolic pathways. Here we identify Bax inhibitor-1 (BI-1), an evolutionary conserved ER-membrane protein, as a novel modulator of the obesity-associated alteration of the UPR. BI-1 partially inhibits the UPR by interacting with IRE1 alpha and inhibiting IRE1 alpha endonuclease activity as seen on the splicing of the transcription factor Xbp-1. Because we observed a down-regulation of BI-1 expression in liver and muscle of genetically obese ob/ob and db/db mice as well as in mice with diet-induced obesity in vivo, we investigated the effect of restoring BI-1 expression on metabolic processes in these mice. Importantly, BI-1 overexpression by adenoviral gene transfer dramatically improved glucose metabolism in both standard diet-fed mice as well as in mice with diet-induced obesity and, critically, reversed hyperglycemia in db/db mice. This improvement in whole body glucose metabolism and insulin sensitivity was due to dramatically reduced gluconeogenesis as shown by reduction of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase expression. Taken together, these results identify BI-1 as a critical regulator of ER stress responses in the development of obesity associated insulin resistance and provide proof of concept evidence that gene transfer-mediated elevations in hepatic BI-1 may represent a promising approach for the treatment of type 2 diabetes.	[Bailly-Maitre, Beatrice; Belgardt, Bengt F.; Jordan, Sabine D.; Coornaert, Beatrice; Kleinridders, Andre; Mauer, Jan; Willmes, Diana; Essig, Manuela; Hampel, Brigitte; Bruening, Jens C.] Univ Cologne, Dept Internal Med 2, Dept Mouse Genet & Metab, Inst Genet,Ctr Mol Med Cologne,Univ Hosp Cologne, D-50674 Cologne, Germany; [Bailly-Maitre, Beatrice; Belgardt, Bengt F.; Jordan, Sabine D.; Coornaert, Beatrice; Kleinridders, Andre; Mauer, Jan; Willmes, Diana; Essig, Manuela; Hampel, Brigitte; Bruening, Jens C.] Max Planck Inst Biol Ageing, D-50674 Cologne, Germany; [Bailly-Maitre, Beatrice; Cuddy, Michael; Kress, Christina L.; Reed, John C.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [von Freyend, Miriam John; Protzer, Ulrike] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Mol Infectiol Ctr Mol Med Cologne, D-50935 Cologne, Germany; [von Freyend, Miriam John] Univ Hosp Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [von Freyend, Miriam John] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Protzer, Ulrike] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, D-81675 Munich, Germany	University of Cologne; Max Planck Society; Sanford Burnham Prebys Medical Discovery Institute; University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Bruning, JC (corresponding author), Univ Cologne, Dept Internal Med 2, Dept Mouse Genet & Metab, Inst Genet,Ctr Mol Med Cologne,Univ Hosp Cologne, D-50674 Cologne, Germany.	jens.bruening@uni-koeln.de	Longo, Kenneth A/A-5631-2010; Protzer, Ulrike/D-5915-2015	Protzer, Ulrike/0000-0002-9421-1911; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Kleinridders, Andre/0000-0002-4248-6366; Bailly-Maitre, Beatrice/0000-0002-8389-8498; Mauer, Jan/0000-0002-0189-5876	National Institutes of Health [AG15393]; Cologne Cluster of Excellence on Cellular Stress Responses in Agingassociated Diseases; Center of Molecular Medicine Cologne [TV A1]; European Community 7th Framework Programme [FP7/2007-2013, 201608]; German Research Foundation (Deutsche Forschungsgemeinschaft) [1492/7-1, SFB 612 (TP B16), SFB 670 (TP 17)]; Californian Breast Cancer Research Program; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cologne Cluster of Excellence on Cellular Stress Responses in Agingassociated Diseases; Center of Molecular Medicine Cologne; European Community 7th Framework Programme(European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Californian Breast Cancer Research Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15393 (to J.C.R.). This work was also supported by funding from the Cologne Cluster of Excellence on Cellular Stress Responses in Agingassociated Diseases and grants from the Center of Molecular Medicine Cologne (TV A1; to J.C.B.), European Community 7th Framework Programme (FP7/2007-2013) Grant 201608, acronym " TOBI" (to J.C.B.), German Research Foundation (Deutsche Forschungsgemeinschaft) Grants 1492/7-1, SFB 612 (TP B16), and SFB 670 (TP 17), and the Californian Breast Cancer Research Program.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshiuchi K, 2008, BIOCHEM BIOPH RES CO, V366, P545, DOI 10.1016/j.bbrc.2007.11.182	37	81	87	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6198	6207		10.1074/jbc.M109.056648	http://dx.doi.org/10.1074/jbc.M109.056648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	19996103	Green Published, hybrid			2022-12-27	WOS:000275367500024
J	Bleicken, S; Classen, M; Padmavathi, PVL; Ishikawa, T; Zeth, K; Steinhoff, HJ; Bordignon, E				Bleicken, Stephanie; Classen, Mirjam; Padmavathi, Pulagam V. L.; Ishikawa, Takashi; Zeth, Kornelius; Steinhoff, Heinz-Juergen; Bordignon, Enrica			Molecular Details of Bax Activation, Oligomerization, and Membrane Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; OUTER MITOCHONDRIAL-MEMBRANE; CELL-DEATH; CONFORMATIONAL-CHANGES; PEPTIDE COMPLEX; PORE FORMATION; BCL-2 FAMILY; BH3 DOMAINS; APOPTOSIS; PROTEIN	Bax and Bid are pro-apoptotic members of the Bcl-2 protein family. Upon cleavage by caspase-8, Bid activates Bax. Activated Bax inserts into the mitochondrial outer membrane forming oligomers which lead to membrane poration, release of cytochrome c, and apoptosis. The detailed mechanism of Bax activation and the topology and composition of the oligomers are still under debate. Here molecular details of Bax activation and oligomerization were obtained by application of several biophysical techniques, including atomic force microscopy, cryoelectron microscopy, and particularly electron paramagnetic resonance (EPR) spectroscopy performed on spin-labeled Bax. Incubation with detergents, reconstitution, and Bid-triggered insertion into liposomes were found to be effective in inducing Bax oligomerization. Bid was shown to activate Bax independently of the stoichiometric ratio, suggesting that Bid has a catalytic function and that the interaction with Bax is transient. The formation of a stable dimerization interface involving two Bcl-2 homology 3 (BH3) domains was found to be the nucleation event for Bax homo-oligomerization. Based on intermolecular distance determined by EPR, a model of six adjacent Bax molecules in the oligomer is presented where the hydrophobic hairpins ( helices alpha 5 and alpha 6) are equally spaced in the membrane and the two BH3 domains are in close vicinity in the dimer interface, separated by > 5 nm from the next BH3 pairs.	[Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Ishikawa, Takashi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Padmavathi, Pulagam V. L.; Steinhoff, Heinz-Juergen] Univ Osnabruck, Dept Phys, D-49069 Osnabruck, Germany; [Bleicken, Stephanie] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Classen, Mirjam] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University Osnabruck; Max Planck Society; Max Planck Society	Bordignon, E (corresponding author), ETH, Phys Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch	Ishikawa, Takashi/E-5023-2017; Pulagam, Lakshmi/E-8166-2012; Steinhoff, Heinz-Juergen/H-3791-2014	Ishikawa, Takashi/0000-0002-1976-7477; Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Pamulapati, Padmavathi/0000-0001-5294-137X; Bleicken, Stephanie/0000-0002-4789-0974; Bordignon, Enrica/0000-0003-2450-5161	Deutsche Forschungsgemeinschaft [ZE522-4/1]; Volkswagenstiftung [I-80842]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft via Research Grant ZE522-4/1 (to S. B. and K. Z.) and by Volkswagenstiftung I-80842 ( to H.-J. S.).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Beier C, 2006, BIOPHYS J, V91, P2647, DOI 10.1529/biophysj.105.080051; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; Bordignon E, 2007, BIOL MAGN RESON, V27, P129; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Cartron PF, 2004, FEBS LETT, V578, P41, DOI 10.1016/j.febslet.2004.10.080; Cartron PF, 2004, J BIOL CHEM, V279, P11503, DOI 10.1074/jbc.M311922200; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DeLano W.L, PYMOL MOL GRAPHICS S; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gao G, 2000, J CELL BIOCHEM, V80, P53; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liang HJ, 2007, P NATL ACAD SCI USA, V104, P8212, DOI 10.1073/pnas.0702336104; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Sanders CR, 2006, MAGN RESON CHEM, V44, pS24, DOI 10.1002/mrc.1816; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	59	140	141	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6636	6647		10.1074/jbc.M109.081539	http://dx.doi.org/10.1074/jbc.M109.081539			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20008353	hybrid, Green Published			2022-12-27	WOS:000275367500068
J	Knoblach, B; Rachubinski, RA				Knoblach, Barbara; Rachubinski, Richard A.			Phosphorylation-dependent Activation of Peroxisome Proliferator Protein PEX11 Controls Peroxisome Abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; YARROWIA-LIPOLYTICA; DIVISION; YEAST; BIOGENESIS; TRANSCRIPTION; INHERITANCE; EXPRESSION	Peroxisomes are dynamic organelles that divide continuously in growing cell cultures and expand extensively in lipid-rich medium. Peroxisome population control is achieved in part by Pex11p-dependent regulation of peroxisome size and number. Although the production of Pex11p in yeast is tightly linked to peroxisome biogenesis by transcriptional regulation of the PEX11 gene, it remains unclear if and how Pex11p activity could be modulated by rapid signaling. We report the reversible phosphorylation of Saccharomyces cerevisiae Pex11p in response to nutritional cues and delineate a mechanism for phosphorylation-dependent activation of Pex11p through the analysis of phosphomimicking mutants. Peroxisomal phenotypes in the PEX11-A and PEX11-D strains expressing constitutively dephosphorylated and phosphorylated forms of Pex11p resemble those of PEX11 gene knock-out and overexpression mutants, although PEX11 transcript and Pex11 protein levels remain unchanged. We demonstrate functional inequality and differences in subcellular localization of the Pex11p forms. Pex11Dp promotes peroxisome fragmentation when reexpressed in cells containing induced peroxisomes. Pex11p translocates between endoplasmic reticulum and peroxisomes in a phosphorylation-dependent manner, whereas Pex11Ap and Pex11Dp are impaired in trafficking and constitutively associated with mature and proliferating peroxisomes, respectively. Overexpression of cyclin-dependent kinase Pho85p results in hyperphosphorylation of Pex11p and peroxisome proliferation. This study provides the first evidence for control of peroxisome dynamics by phosphorylation-dependent regulation of a peroxin.	[Knoblach, Barbara; Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Rachubinski, RA (corresponding author), Univ Alberta, Dept Cell Biol, MSB 5-14, Edmonton, AB T6G 2H7, Canada.	rick.rachubinski@ualberta.ca	Knoblach, Barbara/B-9454-2009		Canadian Institutes of Health Research [15131]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 15131.	Barnett P, 2000, TRENDS BIOCHEM SCI, V25, P227, DOI 10.1016/S0968-0004(00)01579-6; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rout MP, 2008, J CELL BIOL, V181, P185, DOI 10.1083/jcb.200803126; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Schekman R, 2005, CELL, V122, P1, DOI 10.1016/j.cell.2005.06.033; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tabak HF, 2008, CURR OPIN CELL BIOL, V20, P393, DOI 10.1016/j.ceb.2008.05.008; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tedrick K, 2004, MOL BIOL CELL, V15, P4609, DOI 10.1091/mbc.E04-03-0194; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Titorenko VI, 2006, J CELL BIOL, V174, P11, DOI 10.1083/jcb.200604036; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042	43	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6670	6680		10.1074/jbc.M109.094805	http://dx.doi.org/10.1074/jbc.M109.094805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028986	hybrid, Green Published			2022-12-27	WOS:000275367500071
J	Kruse, T; Gehl, C; Geisler, M; Lehrke, M; Ringel, P; Hallier, S; Hansch, R; Mendel, RR				Kruse, Tobias; Gehl, Christian; Geisler, Mirco; Lehrke, Markus; Ringel, Phillip; Hallier, Stephan; Haensch, Robert; Mendel, Ralf R.			Identification and Biochemical Characterization of Molybdenum Cofactor-binding Proteins from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; NITRATE REDUCTASE; ESCHERICHIA-COLI; CARRIER PROTEIN; MOLYBDOPTERIN; INSERTION; BIOSYNTHESIS; ENZYMES; INVOLVEMENT; ALIGNMENT	The molybdenum cofactor (Moco) forms part of the catalytic center in all eukaryotic molybdenum enzymes and is synthesized in a highly conserved pathway. Among eukaryotes, very little is known about the processes taking place subsequent to Moco biosynthesis, i.e. Moco transfer, allocation, and insertion into molybdenum enzymes. In the model plant Arabidopsis thaliana, we identified a novel protein family consisting of nine members that after recombinant expression are able to bind Moco with K-D values in the low micromolar range and are therefore named Moco-binding proteins (MoBP). For two of the nine proteins atomic structures are available in the Protein Data Bank. Surprisingly, both crystal structures lack electron density for the C terminus, which may indicate a high flexibility of this part of the protein. C-terminal truncated MoBPs showed significantly decreased Moco binding stoichiometries. Experiments where the MoBP C termini were exchanged among MoBPs converted a weak Moco-binding MoBP into a strong binding MoBP, thus indicating that the MoBP C terminus, which is encoded by a separate exon, is involved in Moco binding. MoBPs were able to enhance Moco transfer to apo-nitrate reductase in the Mocofree Neurospora crassa mutant nit-1. Furthermore, we show that the MoBPs are localized in the cytosol and undergo protein-protein contact with both the Moco donor protein Cnx1 and the Moco acceptor protein nitrate reductase under in vivo conditions, thus indicating for the MoBPs a function in Arabidopsis cellular Moco distribution.	[Kruse, Tobias; Gehl, Christian; Geisler, Mirco; Lehrke, Markus; Ringel, Phillip; Hallier, Stephan; Haensch, Robert; Mendel, Ralf R.] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Mendel, RR (corresponding author), Humboldt St 1, D-38106 Braunschweig, Germany.	r.mendel@tu-bs.de		Hansch, Robert/0000-0003-1310-8419	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ataya FS, 2003, J BIOL CHEM, V278, P10885, DOI 10.1074/jbc.M211320200; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhat RA, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-12; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeon WB, 2006, PROTEINS, V65, P1051, DOI 10.1002/prot.21166; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PHAN APH, 1982, ANAL BIOCHEM, V120, P193, DOI 10.1016/0003-2697(82)90336-0; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Witte CP, 1998, FEBS LETT, V431, P205, DOI 10.1016/S0014-5793(98)00756-X	30	40	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6623	6635		10.1074/jbc.M109.060640	http://dx.doi.org/10.1074/jbc.M109.060640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040598	hybrid, Green Published			2022-12-27	WOS:000275367500067
J	Kyriazis, GA; Belal, C; Madan, M; Taylor, DG; Wang, J; Wei, ZL; Pattisapu, JV; Chan, SL				Kyriazis, George A.; Belal, Cherine; Madan, Meenu; Taylor, David G.; Wang, Jang; Wei, Zelan; Pattisapu, Jogi V.; Chan, Sic L.			Stress-induced Switch in Numb Isoforms Enhances Notch-dependent Expression of Subtype-specific Transient Receptor Potential Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; AMYLOID PRECURSOR PROTEIN; STORE-OPERATED CHANNELS; MAMMALIAN NUMB; PTB DOMAIN; CELL FATE; FACTOR WITHDRAWAL; CORTICAL-NEURONS; BETA-PEPTIDE; CA2+ ENTRY	The Notch signaling pathway plays an essential role in the regulation of cell specification by controlling differentiation, proliferation, and apoptosis. Numb is an intrinsic regulator of the Notch pathway and exists in four alternative splice variants that differ in the length of their phosphotyrosine-binding domain (PTB) and proline-rich region domains. The physiological relevance of the existence of the Numb splice variants and their exact regulation are still poorly understood. We previously reported that Numb switches from isoforms containing the insertion in PTB to isoforms lacking this insertion in neuronal cells subjected to trophic factor withdrawal (TFW). The functional relevance of the TFW-induced switch in Numb isoforms is not known. Here we provide evidence that the TFW-induced switch in Numb isoforms regulates Notch signaling strength and Notch target gene expression. PC12 cells stably overexpressing Numbisoforms lacking the PTB insertion exhibited higher basal Notch activity and Notch-dependent transcription of the transient receptor potential channel 6 (TRPC6) when compared with those overexpressing Numb isoforms with the PTB insertion. The differential regulation of TRPC6 expression is correlated with perturbed calcium signaling and increased neuronal vulnerability to TFW-induced death. Pharmacological inhibition of the Notch pathway or knockdown of TRPC6 function ameliorates the adverse effects caused by the TFW-induced switch in Numb isoforms. Taken together, our results indicate that Notch and Numb interaction may influence the sensitivity of neuronal cells to injurious stimuli by modulating calcium-dependent apoptotic signaling cascades.	[Kyriazis, George A.; Belal, Cherine; Madan, Meenu; Taylor, David G.; Wei, Zelan; Pattisapu, Jogi V.; Chan, Sic L.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Wang, Jang] Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care Med, Baltimore, MD 21224 USA	State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins Medicine	Chan, SL (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	schan@mail.ucf.edu		Kyriazis, George/0000-0001-9514-3482	University of Central Florida	University of Central Florida	This work was supported by start-up funds from the University of Central Florida.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Baba A, 2003, J NEUROSCI, V23, P7737; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Bouron A, 2005, DEV BRAIN RES, V159, P64, DOI 10.1016/j.devbrainres.2005.07.001; Brechard S, 2008, CELL CALCIUM, V44, P492, DOI 10.1016/j.ceca.2008.03.002; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chan SL, 2002, NEUROMOL MED, V1, P55; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo Q, 1997, J NEUROSCI, V17, P4212; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jafar-Nejad H, 2002, DEV CELL, V3, P155, DOI 10.1016/S1534-5807(02)00228-9; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lai EC, 2002, EMBO REP, V3, P840, DOI 10.1093/embo-reports/kvf170; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Munaron L, 2004, J CELL MOL MED, V8, P161, DOI 10.1111/j.1582-4934.2004.tb00271.x; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pedersen WA, 2002, J NEUROCHEM, V82, P976, DOI 10.1046/j.1471-4159.2002.01036.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tesfai Y, 2001, BIOCHEM J, V358, P717, DOI 10.1042/0264-6021:3580717; Tu P, 2009, J NEUROCHEM, V108, P126, DOI 10.1111/j.1471-4159.2008.05752.x; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	86	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6811	6825		10.1074/jbc.M109.074690	http://dx.doi.org/10.1074/jbc.M109.074690			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038578	Green Published, hybrid			2022-12-27	WOS:000275367500084
J	Zhong, SM; Magnolo, AL; Sundaram, M; Zhou, H; Yao, EF; Di Leo, E; Loria, P; Wang, SA; Bamji-Mirza, M; Wang, LS; McKnight, CJ; Figeys, D; Wang, YW; Tarugi, P; Yao, ZM				Zhong, Shumei; Magnolo, Antonia Lucia; Sundaram, Meenakshi; Zhou, Hu; Yao, Erik F.; Di Leo, Enza; Loria, Paola; Wang, Shuai; Bamji-Mirza, Michelle; Wang, Lisheng; McKnight, C. Jamie; Figeys, Daniel; Wang, Yuwei; Tarugi, Patrizia; Yao, Zemin			Nonsynonymous Mutations within APOB in Human Familial Hypobetalipoproteinemia EVIDENCE FOR FEEDBACK INHIBITION OF LIPOGENESIS AND POSTENDOPLASMIC RETICULUM DEGRADATION OF APOLIPOPROTEIN B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEINS; HUMAN APOLIPOPROTEIN-B; MCA-RH7777 CELLS; ATHEROGENIC LIPOPROTEINS; LIPID RECRUITMENT; QUALITY-CONTROL; AMINO-TERMINUS; BINDING-SITE; SECRETION	Five nontruncating missense APOB mutations, namely A31P, G275S, L324M, G912D, and G945S, were identified in heterozygous carriers of familial hypobetalipoproteinemia (FHBL) in the Italian population. To test that the FHBL phenotype was a result of impaired hepatic secretion of mutant apoB proteins, we performed transfection studies using McA-RH7777 cells stably expressing wild type or mutant forms of human apolipoprotein B-48 (apoB-48). All mutant proteins displayed varied impairment in secretion, with G912D the least affected and A31P barely secreted. Although some A31P was degraded by proteasomes, a significant proportion of it (although inappropriately glycosylated) escaped endoplasmic reticulum (ER) quality control and presented in the Golgi compartment. Degradation of the post-ER A31P was achieved by autophagy. Expression of A31P also decreased secretion of endogenous apoB and triglycerides, yet the impaired lipoprotein secretion did not lead to lipid accumulation in the cells or ER stress. Rather, expression of genes involved in lipogenesis was down-regulated, including liver X receptor alpha, sterol regulator element-binding protein 1c, fatty acid synthase, acetyl-CoA carboxylase 1, stearoyl-CoA desaturase 1, and lipin-1. These results suggest that feedback inhibition of hepatic lipogenesis in conjunction with post-ER degradation of misfolded apoB proteins can contribute to reduce fat accumulation in the FHBL liver.	[Magnolo, Antonia Lucia; Di Leo, Enza; Tarugi, Patrizia] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, I-41100 Modena, Italy; [Zhong, Shumei; Sundaram, Meenakshi; Zhou, Hu; Yao, Erik F.; Wang, Shuai; Bamji-Mirza, Michelle; Wang, Lisheng; Figeys, Daniel; Wang, Yuwei; Yao, Zemin] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [McKnight, C. Jamie] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Loria, Paola] Univ Modena & Reggio Emilia, Dipartimento Med, I-41100 Modena, Italy	Universita di Modena e Reggio Emilia; University of Ottawa; Boston University; Universita di Modena e Reggio Emilia	Tarugi, P (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, Via Campi 287, I-41100 Modena, Italy.	tarugi@unimore.it; zyao@uottawa.ca	Tarugi, Patrizia/D-2179-2015	Tarugi, Patrizia/0000-0001-6864-7853; McKnight, Christopher/0000-0002-3237-0896; Figeys, Daniel/0000-0002-5373-7546	National Institutes of Health [HL-26335]; Heart and Stroke Foundation of Ontario [T-4643]; Genome Canada [2008-OGI-TD-01]; Canadian Institutes of Health Research (CIHR) [MOP-158235]; Telethon Foundation Onlus, Italy [GGP05042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Telethon Foundation Onlus, Italy(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL-26335 (to C.J.M.), Heart and Stroke Foundation of Ontario Grant T-4643 (to Z.Y.), Genome Canada Grant 2008-OGI-TD-01 (to D. F.), Canadian Institutes of Health Research (CIHR) Grant MOP-158235 (to L. W.), and Telethon Foundation Onlus, Italy Grant GGP05042 (to P. T.).	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; BLACKHART BD, 1990, J BIOL CHEM, V265, P8358; BOREN J, 1992, J BIOL CHEM, V267, P9858; Bradbury P, 1999, J BIOL CHEM, V274, P3159, DOI 10.1074/jbc.274.5.3159; Burnett JR, 2007, J BIOL CHEM, V282, P24270, DOI 10.1074/jbc.M702442200; Burnett JR, 2003, J BIOL CHEM, V278, P13442, DOI 10.1074/jbc.M300235200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CHAN L, 1992, J BIOL CHEM, V267, P25621; Chen ZJ, 2002, J BIOL CHEM, V277, P14135, DOI 10.1074/jbc.M200617200; Dashti N, 2007, J BIOL CHEM, V282, P28597, DOI 10.1074/jbc.M700229200; Dejgaard S, 2004, CURR ISSUES MOL BIOL, V6, P29; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Di Leo E, 2007, J MED GENET, V44, P219, DOI 10.1136/jmg.2006.046359; Fasano T, 2007, ARTERIOSCL THROM VAS, V27, P677, DOI 10.1161/01.ATV.0000255311.26383.2f; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Flood C, 2002, J BIOL CHEM, V277, P32228, DOI 10.1074/jbc.M204053200; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Gretch DG, 1996, J BIOL CHEM, V271, P8682, DOI 10.1074/jbc.271.15.8682; Huang XF, 1997, J BIOL CHEM, V272, P31872, DOI 10.1074/jbc.272.50.31872; Hussain MM, 1998, J BIOL CHEM, V273, P25612, DOI 10.1074/jbc.273.40.25612; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jiang ZHG, 2006, BIOCHEMISTRY-US, V45, P11799, DOI 10.1021/bi060600w; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lancellotti S, 2005, J HEPATOL, V43, P188, DOI 10.1016/j.jhep.2005.03.012; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Lin XB, 2006, AM J PHYSIOL-GASTR L, V290, pG1170, DOI 10.1152/ajpgi.00402.2005; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; MCLEOD RS, 1994, J BIOL CHEM, V269, P2852; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Segrest JP, 1999, J LIPID RES, V40, P1401; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Tarugi P, 2001, J LIPID RES, V42, P1552; Tarugi P, 2007, ATHEROSCLEROSIS, V195, pE19, DOI 10.1016/j.atherosclerosis.2007.05.003; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Tran K, 1998, J BIOL CHEM, V273, P7244, DOI 10.1074/jbc.273.13.7244; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; YAO ZM, 1994, BBA-LIPID LIPID MET, V1212, P152, DOI 10.1016/0005-2760(94)90249-6; YAO ZM, 1991, J BIOL CHEM, V266, P3300; Zhou H, 2009, J PROTEOME RES, V8, P556, DOI 10.1021/pr800734r	55	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6453	6464		10.1074/jbc.M109.060467	http://dx.doi.org/10.1074/jbc.M109.060467			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032471	hybrid, Green Published			2022-12-27	WOS:000275367500050
J	Pandya, RK; Partridge, JR; Love, KR; Schwartz, TU; Ploegh, HL				Pandya, Renuka K.; Partridge, James R.; Love, Kerry Routenberg; Schwartz, Thomas U.; Ploegh, Hidde L.			A Structural Element within the HUWE1 HECT Domain Modulates Self-ubiquitination and Substrate Ubiquitination Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE; E3; PROTEINS; DYNAMICS; PROLIFERATION; ARF-BP1/MULE; ACTIVATION; MECHANISMS; STABILITY; APOPTOSIS	E3 ubiquitin ligases catalyze the final step of ubiquitin conjugation and regulate numerous cellular processes. The HECT class of E3 ubiquitin (Ub) ligases directly transfers Ub from bound E2 enzyme to a myriad of substrates. The catalytic domain of HECT Ub ligases has a bilobal architecture that separates the E2 binding region and catalytic site. An important question regarding HECT domain function is the control of ligase activity and specificity. Here we present a functional analysis of the HECT domain of the E3 ligase HUWE1 based on crystal structures and show that a single N-terminal helix significantly stabilizes the HECT domain. We observe that this element modulates HECT domain activity, as measured by self-ubiquitination induced in the absence of this helix, as distinct from its effects on Ub conjugation of substrate Mcl-1. Such subtle changes to the protein may be at the heart of the vast spectrum of substrate specificities displayed by HECT domain E3 ligases.	[Partridge, James R.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pandya, Renuka K.; Love, Kerry Routenberg; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu; ploegh@wi.mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; Pandya, Renuka/0000-0002-7667-607X	National Institutes of Health [F32 AI63854]; United States Department of Defense [W8IXWH-06-1-0789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant Postdoctoral Fellowship F32 AI63854 (to K. R. L.).; Supported by United States Department of Defense Breast Cancer Research Program Award W8IXWH-06-1-0789.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	33	42	47	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5664	5673		10.1074/jbc.M109.051805	http://dx.doi.org/10.1074/jbc.M109.051805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007713	hybrid, Green Published			2022-12-27	WOS:000275327200059
J	Wu, XL; Ge, HF; Lemon, B; Vonderfecht, S; Weiszmann, J; Hecht, R; Gupte, J; Hager, T; Wang, ZL; Lindberg, R; Li, Y				Wu, Xinle; Ge, Hongfei; Lemon, Bryan; Vonderfecht, Steven; Weiszmann, Jennifer; Hecht, Randy; Gupte, Jamila; Hager, Todd; Wang, Zhulun; Lindberg, Richard; Li, Yang			FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC-ACTIVITY; TRANSGENIC MICE; BETA-KLOTHO; FGF19; FIBROBLAST-GROWTH-FACTOR-19; DETERMINES; EXPRESSION; REGULATOR	FGF19 and FGF21, unique members of the fibroblast growth factor (FGF) family, are hormones that regulate glucose, lipid, and energy homeostasis. Increased hepatocyte proliferation and liver tumor formation have also been observed in FGF19 transgenic mice. Here, we report that, in contrast to FGF19, FGF21 does not induce hepatocyte proliferation in vivo. To identify the mechanism for FGF19-induced hepatocyte proliferation, we explored similarities and differences in receptor specificity between FGF19 and FGF21. We find that although both are able to activate FGF receptors (FGFRs) 1c, 2c, and 3c, only FGF19 activates FGFR4, the predominant receptor in the liver. Using a C-terminal truncation mutant of FGF19 and a series of FGF19/FGF21 chimeric molecules, we determined that amino acids residues 38-42 of FGF19 are sufficient to confer both FGFR4 activation and increased hepatocyte proliferation in vivo to FGF21. These data suggest that activation of FGFR4 is the mechanism whereby FGF19 can increase hepatocyte proliferation and induce hepatocellular carcinoma formation.	[Wu, Xinle; Ge, Hongfei; Lemon, Bryan; Weiszmann, Jennifer; Gupte, Jamila; Wang, Zhulun; Lindberg, Richard; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Vonderfecht, Steven; Hecht, Randy; Hager, Todd] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	yangl@amgen.com						Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	18	132	181	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5165	5170		10.1074/jbc.M109.068783	http://dx.doi.org/10.1074/jbc.M109.068783			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018895	Green Published, hybrid			2022-12-27	WOS:000275327200008
J	Iwata, J; Hosokawa, R; Sanchez-Lara, PA; Urata, M; Slavkin, H; Chai, Y				Iwata, Jun-ichi; Hosokawa, Ryoichi; Sanchez-Lara, Pedro A.; Urata, Mark; Slavkin, Harold; Chai, Yang			Transforming Growth Factor-beta Regulates Basal Transcriptional Regulatory Machinery to Control Cell Proliferation and Differentiation in Cranial Neural Crest-derived Osteoprogenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL DEVELOPMENT; RUNX2; TAFS; MICE; CHONDROGENESIS; INACTIVATION; AUTOPHAGY; PROMOTER; SYSTEM; CYCLE	Transforming growth factor-beta(Tgf-beta) signaling is crucial for regulating craniofacial development. Loss of Tgf-beta signaling results in defects in cranial neural crest cells (CNCC), but the mechanism by which Tgf-beta signaling regulates bone formation in CNCC-derived osteogenic cells remains largely unknown. In this study, we discovered that Tgf-beta regulates the basal transcriptional regulatory machinery to control intramembranous bone development. Specifically, basal transcription factor Taf4b is down-regulated in the CNCC-derived intramembranous bone in Tgfbr2(fl/fl); Wnt1-Cre mice. Tgf-beta specifically induces Taf4b expression. Moreover, small interfering RNA knockdown of Taf4b results in decreased cell proliferation and altered osteogenic differentiation in primary mouse embryonic maxillary mesenchymal cells, as seen in Tgfbr2 mutant cells. In addition, we show that Taf1 is decreased at the osteogenic initiation stage in the maxilla of Tgfbr2 mutant mice. Furthermore, small interfering RNA knockdown of Taf4b and Taf1 together in primary mouse embryonic maxillary mesenchymal cells results in up-regulated osteogenic initiator Runx2 expression, with decreased cell proliferation and altered osteogenic differentiation. Our results indicate a critical function of Tgf-beta-mediated basal transcriptional factors in regulating osteogenic cell proliferation and differentiation in CNCC-derived osteoprogenitor cells during intramembranous bone formation.	[Iwata, Jun-ichi; Hosokawa, Ryoichi; Urata, Mark; Slavkin, Harold; Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Sanchez-Lara, Pedro A.; Urata, Mark] Childrens Hosp Los Angeles, Div Plast Surg, Los Angeles, CA 90027 USA	University of Southern California; Children's Hospital Los Angeles	Chai, Y (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu	Sanchez-Lara, Pedro A./AAP-5644-2021; Sanchez-Lara, Pedro/F-6352-2012; Sanchez, Pedro/HHM-5713-2022; Sanchez, Pedro/P-1377-2018	Sanchez-Lara, Pedro A./0000-0003-1181-7828; Sanchez-Lara, Pedro/0000-0002-8027-177X; Sanchez, Pedro/0000-0003-1181-7828; 	NIDCR [DE012711, DE014078, U01 DE020065]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE020065, R01DE014078, R37DE012711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE012711, DE014078, and U01 DE020065 from NIDCR (to Y. C.).	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Davidson I, 2005, CELL CYCLE, V4, P1486, DOI 10.4161/cc.4.11.2120; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hilton TL, 2005, MOL CELL BIOL, V25, P4321, DOI 10.1128/MCB.25.10.4321-4332.2005; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Seo HS, 2009, DEV BIOL, V334, P481, DOI 10.1016/j.ydbio.2009.08.015; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Veenstra GJC, 2001, TRENDS BIOCHEM SCI, V26, P665, DOI 10.1016/S0968-0004(01)01970-3; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015	36	58	59	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4975	4982		10.1074/jbc.M109.035105	http://dx.doi.org/10.1074/jbc.M109.035105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959467	Green Published, hybrid			2022-12-27	WOS:000275274800074
J	Kimura, T; Tomura, H; Sato, K; Ito, M; Matsuoka, I; Im, DS; Kuwabara, A; Mogi, C; Itoh, H; Kurose, H; Murakami, M; Okajima, F				Kimura, Takao; Tomura, Hideaki; Sato, Koichi; Ito, Masaaki; Matsuoka, Isao; Im, Doon-Soon; Kuwabara, Atsushi; Mogi, Chihiro; Itoh, Hiroshi; Kurose, Hitoshi; Murakami, Masami; Okajima, Fumikazu			Mechanism and Role of High Density Lipoprotein-induced Activation of AMP-activated Protein Kinase in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; SPHINGOSINE 1-PHOSPHATE RECEPTORS; OXIDE SYNTHASE PHOSPHORYLATION; INHIBITION; ANGIOGENESIS; MIGRATION; LKB1; ADHESION; MUSCLE; PROLIFERATION	The upstream signaling pathway leading to the activation of AMP-activated protein kinase (AMPK) by high density lipoprotein (HDL) and the role of AMPK in HDL-induced antiatherogenic actions were investigated. Experiments using genetic and pharmacological tools showed that HDL-induced activation of AMPK is dependent on both sphingosine 1-phosphate receptors and scavenger receptor class B type I through calcium/calmodulin dependent protein kinase kinase and, for scavenger receptor class B type I system, additionally serine-threonine kinase LKB1 in human umbilical vein endothelial cells. HDL-induced activation of Akt and endothelial NO synthase, stimulation of migration, and inhibition of monocyte adhesion and adhesion molecule expression were dependent on AMPK activation. The inhibitory role of AMPK in the adhesion molecule expression and monocyte adhesion on endothelium of mouse aorta was confirmed in vivo and ex vivo. On the other hand, stimulation of ERK and proliferation were hardly affected by AMPK knockdown but completely inhibited by an N17Ras, whereas the dominant-negative Ras was ineffective for AMPK activation. In conclusion, dual HDL receptor systems differentially regulate AMPK activity through calcium/calmodulin-dependent protein kinase kinase and/or LKB1. Several HDL-induced antiatherogenic actions are regulated by AMPK, but proliferation-related actions are regulated by Ras rather than AMPK.	[Kimura, Takao; Tomura, Hideaki; Sato, Koichi; Kuwabara, Atsushi; Mogi, Chihiro; Okajima, Fumikazu] Gunma Univ, Lab Signal Transduct, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan; [Kimura, Takao; Kuwabara, Atsushi; Murakami, Masami] Gunma Univ, Grad Sch Med, Dept Clin Lab Med, Maebashi, Gunma 3718511, Japan; [Ito, Masaaki; Matsuoka, Isao] Takasaki Univ Hlth & Welf, Fac Pharm, Pharmacol Lab, Gunma 3700033, Japan; [Im, Doon-Soon] Pusan Natl Univ, Coll Pharm, Pharmacol Lab, Pusan 609735, South Korea; [Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Nara 6300101, Japan; [Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan	Gunma University; Gunma University; Pusan National University; Nara Institute of Science & Technology; Kyushu University	Okajima, F (corresponding author), Gunma Univ, Lab Signal Transduct, Inst Mol & Cellular Regulat, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	fokajima@showa.gunma-u.ac.jp		Matsuoka, Isao/0000-0002-7170-3630; IM, DONG-SOON/0000-0001-8054-8946; Sato, Koichi/0000-0001-7694-4014	Japan Society for the Promotion of Science [20591077, 21390016, 20054003, 20015008, 21591157, 21026004, 21591158, 20790636]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; ONO Medical Research Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ONO Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research 20591077 (to T. K.), 21390016, 20054003, and 20015008 (to F. O.), 21591157 and 21026004 (to H. T.), 21591158 (to K. S.), and 20790636 (to C. M.) from the Japan Society for the Promotion of Science and grants from Global Center of Excellence Program (to K. S. and C. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, ONO Medical Research Foundation (to F. O.), and Takeda Science Foundation (to T. K. and C. M.).	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; CaulinGlaser T, 1997, CIRC RES, V81, P885; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Gaskin FS, 2007, AM J PHYSIOL-HEART C, V292, pH326, DOI 10.1152/ajpheart.00744.2006; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hu ZL, 2008, J BIOL CHEM, V283, P25256, DOI 10.1074/jbc.M802455200; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kimura T, 2006, CELL SIGNAL, V18, P841, DOI 10.1016/j.cellsig.2005.07.011; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kimura T, 2008, J IMMUNOL, V181, P7332, DOI 10.4049/jimmunol.181.10.7332; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Londesborough A, 2008, DEVELOPMENT, V135, P2331, DOI 10.1242/dev.017038; Mineo C, 2006, CARDIOVASC RES, V70, P31, DOI 10.1016/j.cardiores.2006.01.025; Miura S, 2003, ARTERIOSCL THROM VAS, V23, P802, DOI 10.1161/01.ATV.0000066134.79956.58; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Okajima F, 2009, ENDOCR J, V56, P317, DOI 10.1507/endocrj.K08E-228; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pace MC, 1999, AM J PHYSIOL-LUNG C, V277, pL106, DOI 10.1152/ajplung.1999.277.1.L106; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rikitake Y, 2000, ARTERIOSCL THROM VAS, V20, P1006, DOI 10.1161/01.ATV.20.4.1006; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	50	63	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4387	4397		10.1074/jbc.M109.043869	http://dx.doi.org/10.1074/jbc.M109.043869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018878	Green Published, hybrid			2022-12-27	WOS:000275274800015
J	Kotani, T; Iemura, S; Natsume, T; Kawakami, K; Yamashita, M				Kotani, Tomoya; Iemura, Shun-ichiro; Natsume, Tohru; Kawakami, Koichi; Yamashita, Masakane			Mys Protein Regulates Protein Kinase A Activity by Interacting with Regulatory Type I alpha Subunit during Vertebrate Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; SIGNALING PATHWAY; NEURAL-TUBE; NEGATIVE REGULATOR; SPINDLE FORMATION; ZEBRAFISH; CAMP; DROSOPHILA; GENE; INDUCTION	During embryonic development, protein kinase A (PKA) plays a key role in cell fate specification by antagonizing the Hedgehog (Hh) signaling pathway. However, the mechanism by which PKA activity is regulated remains unknown. Here we show that the Misty somites (Mys) protein regulates the level of PKA activity during embryonic development in zebrafish. We isolate PKA regulatory type I alpha subunit (Prkar1a) as a protein interacting with Mys by pulldown assay in HEK293 cells followed by mass spectrometry analysis. We show an interaction between endogenous Mys and Prkar1a in the zebrafish embryo. Mys binds to Prkar1a in its C terminus region, termed PRB domain, and activates PKA in vitro. Conversely, knockdown of Mys in zebrafish embryos results in reduction in PKA activity. We also show that knockdown of Mys induces ectopic activation of Hh target genes in the eyes, neural tube, and somites downstream of Smoothened, a protein essential for transduction of Hh signaling activity. The altered patterning of gene expression is rescued by activation of PKA. Together, our results reveal a molecular mechanism of regulation of PKA activity that is dependent on a protein-protein interaction and demonstrate that PKA activity regulated by Mys is indispensable for negative regulation of the Hh signaling pathway in Hh-responsive cells.	[Kotani, Tomoya; Yamashita, Masakane] Hokkaido Univ, Fac Adv Life Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tsukuba, Ibaraki 1350064, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan; [Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan	Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Kotani, T (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan.	tkotani@sci.hokudai.ac.jp	Yamashita, Masakane/A-4556-2012; Natsume, Tohru/M-7627-2018; Kawakami, Koichi/AAF-1380-2019	Yamashita, Masakane/0000-0002-3696-451X; Natsume, Tohru/0000-0002-1510-2582; Kotani, Tomoya/0000-0003-1930-6635	Inamori and Akiyama Foundations; New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology of Japan; Bio-oriented Technology Research Advancement Institution (BRAIN)	Inamori and Akiyama Foundations; New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution (BRAIN)	This work was supported by grants from Inamori and Akiyama Foundations (to T. K.) and the New Energy and Industrial Technology Development Organization (NEDO) (to T. N.), a grant-in-aid for scientific research on Priority Areas "Systems Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. I. and K. K.), and the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) from Bio-oriented Technology Research Advancement Institution (BRAIN) (to M.Y.).	Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen WB, 2001, DEVELOPMENT, V128, P2385; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Ingham PW, 2008, CURR BIOL, V18, pR238, DOI 10.1016/j.cub.2008.01.050; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kamakari S, 2005, LEUKEMIA RES, V29, P17, DOI 10.1016/j.leukres.2004.04.019; Kotani T, 2005, ZYGOTE, V13, P219, DOI 10.1017/S0967199405003321; Kotani T, 2002, DEV BIOL, V252, P271, DOI 10.1006/dbio.2002.0853; Kotani T, 2001, MOL REPROD DEV, V59, P199, DOI 10.1002/mrd.1023; Kotani T, 2008, DEV BIOL, V316, P383, DOI 10.1016/j.ydbio.2008.01.043; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Ma YF, 2005, J BIOL CHEM, V280, P26011, DOI 10.1074/jbc.M409081200; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Philipp M, 2009, CURR BIOL, V19, pR125, DOI 10.1016/j.cub.2008.12.010; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; SARASWAT LD, 1988, J BIOL CHEM, V263, P18241; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; STRUTT DI, 1995, NATURE, V373, P705, DOI 10.1038/373705a0; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; Varga ZM, 2001, DEVELOPMENT, V128, P3497; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	51	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5106	5116		10.1074/jbc.M109.070995	http://dx.doi.org/10.1074/jbc.M109.070995			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018846	Green Published, hybrid			2022-12-27	WOS:000275274800086
J	Lisa, MN; Hemmingsen, L; Vila, AJ				Lisa, Maria-Natalia; Hemmingsen, Lars; Vila, Alejandro J.			Catalytic Role of the Metal Ion in the Metallo-beta-lactamase GOB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CEREUS; STENOTROPHOMONAS-MALTOPHILIA; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; CHRYSEOBACTERIUM-MENINGOSEPTICUM; SPECTROSCOPIC CHARACTERIZATION; ANGSTROM RESOLUTION; REACTION-MECHANISM; SUBSTRATE-BINDING	Metallo-beta-lactamases (M beta Ls) stand as one of the main mechanisms of bacterial resistance toward carbapenems. The rational design of an inhibitor for M beta Ls has been limited by an incomplete knowledge of their catalytic mechanism and by the structural diversity of their active sites. Here we show that the M beta L GOB from Elizabethkingia meningoseptica is active as a monometallic enzyme by using different divalent transition metal ions as surrogates of the native Zn(II) ion. Of the metal derivatives in which Zn(II) is replaced, Co(II) and Cd(II) give rise to the most active enzymes and are shown to occupy the same binding site as the native ion. However, Zn(II) is the only metal ion capable of stabilizing an anionic intermediate that accumulates during nitrocefin hydrolysis, in which the C-N bond has already been cleaved. This finding demonstrates that the catalytic role of the metal ion in GOB is to stabilize the formation of this intermediate prior to nitrogen protonation. This role may be general to all M beta Ls, whereas nucleophile activation by a Zn(II) ion is not a conserved mechanistic feature.	[Vila, Alejandro J.] Univ Nacl Rosario, Dept Quim Biol, Inst Biol Mol & Celular Rosario, Fac Ciencias Bioquim & Farmaceut,IBR,CONICET UNR, RA-2000 Rosario, Santa Fe, Argentina; [Hemmingsen, Lars] Univ Copenhagen, Dept Basic Sci & Environm, DK-1871 Frederiksberg C, Denmark	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Copenhagen	Vila, AJ (corresponding author), Univ Nacl Rosario, Dept Quim Biol, Inst Biol Mol & Celular Rosario, Fac Ciencias Bioquim & Farmaceut,IBR,CONICET UNR, Suipacha 531,S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.	vila@ibr.gov.ar	Hemmingsen, Lars/A-6780-2015; Hemmingsen, Lars/AAD-1318-2020	Hemmingsen, Lars/0000-0002-1823-3035; Hemmingsen, Lars/0000-0002-1823-3035; Vila, Alejandro/0000-0002-7978-3233; Lisa, Maria-Natalia/0000-0001-9630-8090	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bellais S, 2000, ANTIMICROB AGENTS CH, V44, P1878, DOI 10.1128/AAC.44.7.1878-1886.2000; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; Bertini I, 1984, Adv Inorg Biochem, V6, P71; BERTINI I, 1992, J CHEM SOC DALTON, P1443, DOI 10.1039/dt9920001443; Bounaga S, 1998, BIOCHEM J, V331, P703, DOI 10.1042/bj3310703; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004; COLEMAN JE, 1993, METHOD ENZYMOL, V227, P16; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crawford PA, 2005, BIOCHEMISTRY-US, V44, P5168, DOI 10.1021/bi047463s; Cricco JA, 1999, COORDIN CHEM REV, V190, P519, DOI 10.1016/S0010-8545(99)00113-7; Cricco JA, 1999, CURR PHARM DESIGN, V5, P915; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b; Dal Peraro M, 2004, PROTEINS, V54, P412, DOI 10.1002/prot.10554; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; Damblon C, 2003, J BIOL CHEM, V278, P29240, DOI 10.1074/jbc.M301562200; Diaz N, 2001, J AM CHEM SOC, V123, P9867, DOI 10.1021/ja0113246; Docquier JD, 2004, ANTIMICROB AGENTS CH, V48, P4778, DOI 10.1128/AAC.48.12.4778-4783.2004; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Docquier JD, 2002, ANTIMICROB AGENTS CH, V46, P1823, DOI 10.1128/AAC.46.6.1823-1830.2002; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frere JM, 2005, J ANTIMICROB CHEMOTH, V55, P1051, DOI 10.1093/jac/dki155; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garcia-Saez I, 2003, J BIOL CHEM, V278, P23868, DOI 10.1074/jbc.M301062200; Garcia-Saez I, 2003, J MOL BIOL, V325, P651, DOI 10.1016/S0022-2836(02)01271-8; Garrity JD, 2004, J BIOL CHEM, V279, P920, DOI 10.1074/jbc.M309852200; GETTINS P, 1986, J BIOL CHEM, V261, P5513; Gonzalez JM, 2007, J MOL BIOL, V373, P1141, DOI 10.1016/j.jmb.2007.08.031; Hall BG, 2003, J MOL EVOL, V57, P249, DOI 10.1007/s00239-003-2471-0; HEMMINGSEN L, 1995, BIOCHEMISTRY-US, V34, P7145, DOI 10.1021/bi00021a028; Hemmingsen L, 2004, CHEM REV, V104, P4027, DOI 10.1021/cr030030v; Hemmingsen L, 2004, J BIOL INORG CHEM, V9, P591, DOI 10.1007/s00775-004-0553-0; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Materon IC, 2004, J MOL BIOL, V344, P653, DOI 10.1016/j.jmb.2004.09.074; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Murphy TA, 2006, J MOL BIOL, V357, P890, DOI 10.1016/j.jmb.2006.01.003; Nauton L, 2008, J MOL BIOL, V375, P257, DOI 10.1016/j.jmb.2007.10.036; Olsen L, 2004, J PHYS CHEM B, V108, P17639, DOI 10.1021/jp0482215; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Rasia RM, 2004, J BIOL CHEM, V279, P26046, DOI 10.1074/jbc.M311373200; ROSENBERG RC, 1975, J AM CHEM SOC, V97, P21, DOI 10.1021/ja00834a006; Saavedra MJ, 2003, ANTIMICROB AGENTS CH, V47, P2330, DOI 10.1128/AAC.47.7.2330-2333.2003; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062; Spencer J, 2001, J BIOL CHEM, V276, P33638, DOI 10.1074/jbc.M105550200; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524	68	27	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4570	4577		10.1074/jbc.M109.063743	http://dx.doi.org/10.1074/jbc.M109.063743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007696	Green Published, hybrid			2022-12-27	WOS:000275274800034
J	Tang, T; Zhang, J; Yin, J; Staszkiewicz, J; Gawronska-Kozak, B; Jung, DY; Ko, HJ; Ong, H; Kim, JK; Mynatt, R; Martin, RJ; Keenan, M; Gao, ZG; Ye, JP				Tang, Tianyi; Zhang, Jin; Yin, Jun; Staszkiewicz, Jaroslaw; Gawronska-Kozak, Barbara; Jung, Dae Young; Ko, Hwi Jin; Ong, Helena; Kim, Jason K.; Mynatt, Randy; Martin, Roy J.; Keenan, Michael; Gao, Zhanguo; Ye, Jianping			Uncoupling of Inflammation and Insulin Resistance by NF-kappa B in Transgenic Mice through Elevated Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; PPAR-GAMMA; TNF-ALPHA; TARGETED DISRUPTION; GENE-EXPRESSION; P50 SUBUNIT; FOOD-INTAKE; IKK-BETA; OBESITY	To study the metabolic activity of NF-kappa B, we investigated phenotypes of two different mouse models with elevated NF-kappa B activities. The transcriptional activity of NF-kappa B is enhanced either by overexpression of NF-kappa B p65 (RelA) in aP2-p65 mice or inactivation of NF-kappa Bp50 (NF-kappa B1) through gene knock-out. In these models, energy expenditure was elevated in day and night time without a change in locomotion. The mice were resistant to adulthood obesity and diet-induced obesity without reduction in food intake. The adipose tissue growth and adipogenesis were inhibited by the elevated NF-kappa B activity. Peroxisome proliferator-activator receptor gamma expression was reduced by NF-kappa B at the transcriptional level. The two models exhibited elevated inflammatory cytokines (tumor necrosis factor-alpha and interleukin-6) in adipose tissue and serum. However, insulin sensitivity was not reduced by the inflammation in the mice on a chow diet. On a high fat diet, the mice were protected from insulin resistance. The glucose infusion rate was increased more than 30% in the hyperinsulinemic-euglycemic clamp test. Our data suggest that the transcription factor NF-kappa B promotes energy expenditure and inhibits adipose tissue growth. The two effects lead to prevention of adulthood obesity and dietary obesity. The energy expenditure may lead to disassociation of inflammation with insulin resistance. The study indicates that inflammation may prevent insulin resistance by eliminating lipid accumulation.	[Tang, Tianyi; Zhang, Jin; Yin, Jun; Staszkiewicz, Jaroslaw; Gawronska-Kozak, Barbara; Mynatt, Randy; Martin, Roy J.; Gao, Zhanguo; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Martin, Roy J.; Keenan, Michael] Louisiana State Univ Syst, Louisiana State Univ Ag Ctr, Baton Rouge, LA 70808 USA; [Jung, Dae Young; Ko, Hwi Jin; Ong, Helena; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Gawronska-Kozak, Barbara/A-2980-2017; Mynatt, Randall L/N-1980-2017; Ye, Jianping/N-1998-2017	Gawronska-Kozak, Barbara/0000-0002-2006-8534; Mynatt, Randall L/0000-0003-4399-0019; Ye, Jianping/0000-0003-3875-365X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, R01DK080756, R56DK068036, P30DK072476] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56DK068036-06, 1P30 DK072476, P30 DK072476, R56 DK068036, DK80756, R01 DK080756, DK068036, R01 DK068036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anforth HR, 1998, EUR CYTOKINE NETW, V9, P279; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Gadjeva M, 2004, J IMMUNOL, V173, P5786, DOI 10.4049/jimmunol.173.9.5786; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; KLIR JJ, 1993, AM J PHYSIOL, V265, pR512, DOI 10.1152/ajpregu.1993.265.3.R512; Luheshi GN, 1998, ANN NY ACAD SCI, V856, P83, DOI 10.1111/j.1749-6632.1998.tb08316.x; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Pamir N, 2009, ENDOCRINOLOGY, V150, P4124, DOI 10.1210/en.2009-0137; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Staszkiewicz J, 2008, STEM CELLS, V26, P2666, DOI 10.1634/stemcells.2008-0270; Strasser Florian, 2007, Curr Opin Support Palliat Care, V1, P312, DOI 10.1097/SPC.0b013e3282f3474c; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; von Haehling S, 2002, INT J CARDIOL, V85, P173, DOI 10.1016/S0167-5273(02)00245-0; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Ye JP, 1996, MOL CELL BIOL, V16, P4744; YE JP, 1994, J BIOL CHEM, V269, P25728; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	49	122	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4637	4644		10.1074/jbc.M109.068007	http://dx.doi.org/10.1074/jbc.M109.068007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018865	Green Published, hybrid			2022-12-27	WOS:000275274800042
J	Wang, YJ; Kumar, N; Solt, LA; Richardson, TI; Helvering, LM; Crumbley, C; Garcia-Ordonez, RD; Stayrook, KR; Zhang, X; Novick, S; Chalmers, MJ; Griffin, PR; Burris, TP				Wang, Yongjun; Kumar, Naresh; Solt, Laura A.; Richardson, Timothy I.; Helvering, Leah M.; Crumbley, Christine; Garcia-Ordonez, Ruben D.; Stayrook, Keith R.; Zhang, Xi; Novick, Scott; Chalmers, Michael J.; Griffin, Patrick R.; Burris, Thomas P.			Modulation of Retinoic Acid Receptor-related Orphan Receptor alpha and gamma Activity by 7-Oxygenated Sterol Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; NUCLEAR RECEPTOR; ROR-ALPHA; GENE-EXPRESSION; CIRCADIAN TRANSCRIPTION; BINDING DOMAIN; PPAR-GAMMA; CHOLESTEROL; IDENTIFICATION; METABOLISM	The retinoic acid receptor-related orphan receptors alpha and gamma (ROR alpha(NR1F1) and ROR gamma(NR1F3)) are orphan nuclear receptors and perform critical roles in regulation of development, metabolism, and immune function. Cholesterol and cholesterol sulfate have been suggested to be ROR alpha ligands, but the physiological significance is unclear. To date, no endogenous ROR alpha ligands have been described. Here, we demonstrate that 7-oxygenated sterols function as high affinity ligands for both ROR alpha and ROR gamma by directly binding to their ligand-binding domains (K-i similar to 20 nM), modulating coactivator binding, and suppressing the transcriptional activity of the receptors. One of the 7-oxygenated sterols, 7 alpha-hydroxycholesterol (7 alpha-OHC), serves as a key intermediate in bile acid metabolism, and we show that 7 alpha-OHC modulates the expression of ROR target genes, including Glc-6-Pase and phosphoenolpyruvate carboxykinase, in an ROR-dependent manner. Furthermore, glucose output from hepatocytes is suppressed by 7 alpha-OHC functioning as an ROR alpha/gamma ligand. Thus, ROR alpha and ROR gamma are ligand-regulated members of the NR superfamily and may serve as sensors for 7-oxygenated sterols.	[Wang, Yongjun; Kumar, Naresh; Solt, Laura A.; Crumbley, Christine; Garcia-Ordonez, Ruben D.; Zhang, Xi; Novick, Scott; Chalmers, Michael J.; Griffin, Patrick R.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA; [Richardson, Timothy I.; Helvering, Leah M.; Stayrook, Keith R.] Eli Lilly & Co, Indianapolis, IN 46258 USA	Scripps Research Institute; Eli Lilly	Burris, TP (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [DK080201, NS066417, NS067589, GM084041]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769, U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067589, R21NS066417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080201, NS066417, and NS067589 ( to T. P. B.) and GM084041 ( to P. R. G.).	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; BOSTROM H, 1983, J BIOL CHEM, V258, P5091; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1997, J LIPID RES, V38, P1730; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HAHN C, 1995, J LIPID RES, V36, P2059; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jessup W, 2005, REJUV RES, V8, P9, DOI 10.1089/rej.2005.8.9; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; KUMAR N, 2009, MOL PHARM, V8, P156; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Maeda Y, 2002, STEROIDS, V67, P703, DOI 10.1016/S0039-128X(02)00027-2; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Pascal BD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-156; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schoner BE, 2005, MOL GENET METAB, V85, P318, DOI 10.1016/j.ymgme.2005.04.012; SCHWARTZ MA, 1983, J LIPID RES, V24, P28; Staels B, 2007, DRUGS, V67, P1383, DOI 10.2165/00003495-200767100-00001; Stehlin-Gaon C, 2003, NAT STRUCT BIOL, V10, P820, DOI 10.1038/nsb979; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; TENG JI, 1981, J STEROID BIOCHEM, V14, P569, DOI 10.1016/0022-4731(81)90032-7; UCHIDA K, 1975, LIPIDS, V10, P473, DOI 10.1007/BF02532431; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wamil M, 2008, ENDOCRINOLOGY, V149, P5909, DOI 10.1210/en.2008-0420; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	61	142	180	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5013	5025		10.1074/jbc.M109.080614	http://dx.doi.org/10.1074/jbc.M109.080614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19965867	Green Published, hybrid			2022-12-27	WOS:000275274800078
J	Lev, S; Zeevi, DA; Frumkin, A; Offen-Glasner, V; Bach, G; Minke, B				Lev, Shaya; Zeevi, David A.; Frumkin, Ayala; Offen-Glasner, Vered; Bach, Gideon; Minke, Baruch			Constitutive Activity of the Human TRPML2 Channel Induces Cell Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; CATION CHANNEL; HAIR-CELLS; MUTATIONS; TRAFFICKING; MECHANISM; DEAFNESS; GENE; PH; EXPRESSION	The mucolipin (TRPML) ion channel proteins represent a distinct subfamily of channel proteins within the transient receptor potential (TRP) superfamily of cation channels. Mucolipin 1, 2, and 3 (TRPML1, -2, and -3, respectively) are channel proteins that share high sequence homology with each other and homology in the transmembrane domain with other TRPs. Mutations in the TRPML1 protein are implicated in mucolipidosis type IV, whereas mutations in TRPML3 are found in the varitint-waddler mouse. The properties of the wild type TRPML2 channel are not well known. Here we show functional expression of the wild type human TRPML2 channel (h-TRPML2). The channel is functional at the plasma membrane and characterized by a significant inward rectification similar to other constitutively active TRPML mutant isoforms. The h-TRPML2 channel displays nonselective cation permeability, which is Ca2+-permeable and inhibited by low extracytosolic pH but not Ca2+ regulated. In addition, constitutively active h-TRPML2 leads to cell death by causing Ca2+ overload. Furthermore, we demonstrate by functional mutation analysis that h-TRPML2 shares similar characteristics and structural similarities with other TRPML channels that regulate the channel in a similar manner. Hence, in addition to overall structure, all three TRPML channels also share common modes of regulation.	[Lev, Shaya; Minke, Baruch] Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Lev, Shaya; Minke, Baruch] Hebrew Univ Jerusalem, Fac Med, Kuhne Minerva Ctr Studies Visual Transduct, IL-91120 Jerusalem, Israel; [Zeevi, David A.; Frumkin, Ayala; Offen-Glasner, Vered; Bach, Gideon] Hadassah Hebrew Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Minke, B (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, POB 12272, IL-91120 Jerusalem, Israel.	baruchm@ekmd.huji.ac.il			National Institutes of Health [RO1 EY 03529]; Israel Science Foundation; United States-Israel Binational Science Foundation; Moscona Foundation; Minerva Foundation; Rita Altura foundation; NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Moscona Foundation; Minerva Foundation; Rita Altura foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY 03529 (to B. M.). This work was also supported by the Israel Science Foundation (to B. M. and G. B.), the United States-Israel Binational Science Foundation (to B. M.), the Moscona Foundation (to B. M.), the Minerva Foundation (to B. M.), and the Rita Altura foundation (to G. B.).	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2009, J BIOL CHEM, V284, P32040, DOI 10.1074/jbc.M109.037184; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Lindvall JM, 2005, CELL IMMUNOL, V235, P46, DOI 10.1016/j.cellimm.2005.07.001; Lindvall JM, 2004, EUR J IMMUNOL, V34, P1981, DOI 10.1002/eji.200324051; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Parnas M, 2007, J GEN PHYSIOL, V129, P17, DOI 10.1085/jgp.200609659; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Slaugenhaupt Susan A., 2002, Current Molecular Medicine (Hilversum), V2, P445, DOI 10.2174/1566524023362276; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu XL, 2019, J CELL MOL MED, V23, P7449, DOI 10.1111/jcmm.14613; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	58	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2771	2782		10.1074/jbc.M109.046508	http://dx.doi.org/10.1074/jbc.M109.046508			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940139	Green Published, hybrid			2022-12-27	WOS:000273697800054
J	Dames, SA				Dames, Sonja A.			Structural Basis for the Association of the Redox-sensitive Target of Rapamycin FATC Domain with Membrane-mimetic Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; SUBCELLULAR-LOCALIZATION; 3-DIMENSIONAL STRUCTURE; NMR-SPECTROSCOPY; MTOR PATHWAY; COMPLEX; KINASE; TOR; ACTIVATION	The target of rapamycin (TOR) is a conserved eukaryotic Ser/Thr kinase that regulates cellular growth in response to the nutrient and energy state. TOR signaling plays an important role in the development of diseases such as cancer, obesity, and diabetes and in different redox-sensitive processes (hypoxia, apoptosis, and aging). Because TOR has been detected at different cellular membranes and in the nucleus, its localization may influence the specific signaling readout. To better understand how TOR can associate with different membranes, the lipid-binding properties of the redox-sensitive yeast TOR1 FATC domain (y1fatc) have been characterized by solution NMR spectroscopy. Binding studies with different lipids indicate that y1fatc interacts specifically with a membrane-mimetic environment but appears not to recognize a specific lipid headgroup. In both, the structures of oxidized and reduced micelle-bound y1fatc, residues Ile-2456 to Trp-2470 of the lipid-binding motif form a hydrophobic bulb that has a rim of charged residues. The diffusion constants for both micelle-bound states are consistent with the rotational correlation times from the analysis of the N-15 relaxation data. Based on the K-d values, the oxidized form (K-d similar to 0.31 mM) binds dodecyl phosphocholine micelles slightly tighter than the reduced form (K-d similar to 1.86 mM). Binding studies with y1fatc in which one or both tryptophans (Trp-2466 and Trp-2470) were replaced by alanine suggest that these residues are important for the exact positioning in the membrane and that the other aromatic (His-2462, Tyr-2463, and Phe-2469) and aliphatic residues (Ile-2456, Leu-2459, Ile-2464, and Pro-2468) in the lipid-binding motif contribute significantly to the affinity.	[Dames, Sonja A.] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de		Dames, Sonja/0000-0001-7495-6943	Swiss National Science Foundation [31-109712]; German Research Foundation (Deutsche Forschungsgemeinschaft) [1195/3-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported in part by the Swiss National Science Foundation through a grant (SNF Grant 31-109712) to Stephan Grzesiek and by the German Research Foundation (Deutsche Forschungsgemeinschaft Grant DA 1195/3-1 to S.A.D.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d; Almeida M, 2009, J BIOL CHEM, V284, P27438, DOI 10.1074/jbc.M109.023572; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Begotka BA, 2006, MAGN RESON CHEM, V44, P586, DOI 10.1002/mrc.1793; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; Orfi L, 1998, ANAL CHEM, V70, P1339, DOI 10.1021/ac971011m; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Thevenot C, 2005, COLLOID SURFACE A, V252, P105, DOI 10.1016/j.colsurfa.2004.10.062; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200	58	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7766	7775		10.1074/jbc.M109.058404	http://dx.doi.org/10.1074/jbc.M109.058404			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042596	Green Published, hybrid			2022-12-27	WOS:000275415600084
J	Rauert, H; Wicovsky, A; Muller, N; Siegmund, D; Spindler, V; Waschke, J; Kneitz, C; Wajant, H				Rauert, Hilka; Wicovsky, Andreas; Mueller, Nicole; Siegmund, Daniela; Spindler, Volker; Waschke, Jens; Kneitz, Christian; Wajant, Harald			Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; OSTEOCLAST DIFFERENTIATION; DENDRITIC CELLS; DOWN-REGULATION; CUTTING EDGE; ALPHA; LIGAND; INDUCTION; APOPTOSIS; TRAF2	Tumor necrosis factor (TNF) elicits its biological activities by stimulation of two receptors, TNFR1 and TNFR2, both belonging to the TNF receptor superfamily. Whereas TNFR1-mediated signal transduction has been intensively studied and is understood in detail, especially with respect to activation of the classical NF kappa B pathway, cell death induction, and MAP kinase signaling, TNFR2-associated signal transduction is poorly defined. Here, we demonstrate in various tumor cell lines and primary T-cells that TNFR2, but not TNFR1, induces activation of the alternative NF kappa B pathway. In accord with earlier findings demonstrating that only membrane TNF, but not soluble TNF, properly activates TNFR2, we further show by use of TNFR1- and TNFR2-specific mutants of soluble TNF and membrane TNF that soluble ligand trimers fail to activate the alternative NF kappa B pathway. In accord with the known inhibitory role of TRAF2 in the alternative NF kappa B pathway, TNFR2-, but not TNFR1-specific TNF induced depletion of cytosolic TRAF2. Thus, we identified activation of the alternative NF kappa B pathway as a TNF signaling effect that can be specifically assigned to TNFR2 and membrane TNF.	[Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, D-97070 Wurzburg, Germany; [Kneitz, Christian] Hosp Sudstadt Rostock, Dept Rheumatol & Immunol, Clin Internal Med 2, D-18059 Rostock, Germany; [Spindler, Volker; Waschke, Jens] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Spindler, Volker/G-1704-2019; Wajant, Harald/A-3020-2017	Spindler, Volker/0000-0002-1302-5421; Wajant, Harald/0000-0002-2005-3949; Muller-Sienerth, Nicole/0000-0002-7527-5127	Wyeth BioPharma; Deutsche Forschungsgemeinschaft [B7, Wa 1025/18-1]; IZKF Wurzburg [A-49]	Wyeth BioPharma; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Wurzburg	This work was supported by Wyeth BioPharma (Forschungspreis Rheumatologie 2007), Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 487, Project B7, Clinical Research Unit 216, Project 8, and Grant Wa 1025/18-1), and IZKF Wurzburg ( Project A-49).	Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chandrasekharan UM, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000264129.47500.56; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Declercq W, 1998, J IMMUNOL, V161, P390; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Funk JO, 2000, J IMMUNOL, V165, P4792, DOI 10.4049/jimmunol.165.9.4792; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kim EY, 2004, J IMMUNOL, V173, P4500, DOI 10.4049/jimmunol.173.7.4500; Kim EY, 2001, J IMMUNOL, V167, P6812, DOI 10.4049/jimmunol.167.12.6812; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Muller N, 2008, FEBS J, V275, P2296, DOI 10.1111/j.1742-4658.2008.06382.x; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Takayama K, 1999, J INVEST DERMATOL, V113, P541, DOI 10.1046/j.1523-1747.1999.00629.x; Teh HS, 2000, J IMMUNOL, V165, P4814, DOI 10.4049/jimmunol.165.9.4814; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; VANDENABEELE P, 1995, J IMMUNOL, V154, P2904; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; VERCAMMEN D, 1995, CYTOKINE, V7, P463, DOI 10.1006/cyto.1995.0063; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Weiss T, 1998, J IMMUNOL, V161, P3136; Weiss T, 1997, J IMMUNOL, V158, P2398; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200	56	122	128	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7394	7404		10.1074/jbc.M109.037341	http://dx.doi.org/10.1074/jbc.M109.037341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20038584	Green Published, hybrid			2022-12-27	WOS:000275415600052
J	Yokota, A; Tsumoto, K; Shiroishi, M; Nakanishi, T; Kondo, H; Kumagai, I				Yokota, Akiko; Tsumoto, Kouhei; Shiroishi, Mitsunori; Nakanishi, Takeshi; Kondo, Hidemasa; Kumagai, Izumi			Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTILYSOZYME MONOCLONAL-ANTIBODY; SALT BRIDGE FORMATION; ENTROPIC CONTRIBUTION; STRUCTURAL FEATURES; CRYSTAL-STRUCTURES; WATER-MOLECULES; BINDING-ENERGY; HYDROGEN-BONDS; TYR RESIDUES; SPECIFICITY	Many germ line antibodies have asparagine residues at specific sites to achieve specific antigen recognition. To study the role of asparagine residues in the stabilization of antigen-antibody complexes, we examined the interaction between hen egg white lysozyme (HEL) and the corresponding HyHEL-10 variable domain fragment (Fv). We introduced Ala and Asp substitutions into the Fv side chains of L-Asn-31, L-Asn-32, and L-Asn-92, which interact directly with residues in HEL via hydrogen bonding in the wild-type Fv-HEL complex, and we investigated the interactions between these mutant antibodies and HEL. Isothermal titration calorimetric analysis showed that all the mutations decreased the negative enthalpy change and decreased the association constants of the interaction. Structural analyses showed that the effects of the mutations on the structure of the complex could be compensated for by conformational changes and/or by gains in other interactions. Consequently, the contribution of two hydrogen bonds was minor, and their abolition by mutation resulted in only a slight decrease in the affinity of the antibody for its antigen. By comparison, the other two hydrogen bonds buried at the interfacial area had large enthalpic advantage, despite entropic loss that was perhaps due to stiffening of the interface by the bonds, and were crucial to the strength of the interaction. Deletion of these strong hydrogen bonds could not be compensated for by other structural changes. Our results suggest that asparagine can provide the two functional groups for strong hydrogen bond formation, and their contribution to the antigen-antibody interaction can be attributed to their limited flexibility and accessibility at the complex interface.	[Yokota, Akiko; Tsumoto, Kouhei; Shiroishi, Mitsunori; Nakanishi, Takeshi; Kumagai, Izumi] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Yokota, Akiko] Natl Inst Adv Ind Sci & Technol, Prot Design Res Grp, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan; [Tsumoto, Kouhei] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan; [Kondo, Hidemasa] Natl Inst Adv Ind Sci & Technol, Funct Prot Res Grp, Res Inst Genome Based Biofactory, Sapporo, Hokkaido 0628517, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Tsumoto, K (corresponding author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aoba Yama 6-6-11, Sendai, Miyagi 9808579, Japan.	tsumoto@k.u-tokyo.ac.jp; kmiz@kuma.che.tohoku.ac.jp	Yokota, Akiko/M-1807-2018; Kondo, Hidemasa/M-7465-2018	Yokota, Akiko/0000-0002-5896-9899; Kondo, Hidemasa/0000-0003-2799-1775; Shiroishi, Mitsunori/0000-0002-3133-157X	grants-in-aid for general research	grants-in-aid for general research	This work was supported by grants-in-aid for general research (to K.T. and I.K.).	Aitio O, 2008, J MOL BIOL, V382, P167, DOI 10.1016/j.jmb.2008.07.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTLETT PA, 1987, SCIENCE, V235, P569, DOI 10.1126/science.3810155; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BOHM HJ, 2003, PROTEIN LIGAND INTER, V19, P21; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Desiraju G. R., 2001, WEAK HYDROGEN BOND S, P343; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2984; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goldman ER, 1997, BIOCHEMISTRY-US, V36, P49, DOI 10.1021/bi961769k; Imoto T., 1972, ENZYMES, V7, P665; Jackson RM, 1999, PROTEIN SCI, V8, P603; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABAT EA, 1977, J BIOL CHEM, V252, P6609; KABAT EA, 1976, P NATL ACAD SCI USA, V73, P4471, DOI 10.1073/pnas.73.12.4471; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LADBURY JE, 1994, J MOL BIOL, V238, P669, DOI 10.1006/jmbi.1994.1328; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; LO CL, 1999, J MOL BIOL, V285, P2177; MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; Merk H, 1999, J BIOCHEM, V125, P328, DOI 10.1093/oxfordjournals.jbchem.a022290; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nishimiya Y, 2000, J BIOL CHEM, V275, P12813, DOI 10.1074/jbc.275.17.12813; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; POMES R, 1995, PROTEIN ENG, V8, P663, DOI 10.1093/protein/8.7.663; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Rajpal A, 1998, PROTEIN SCI, V7, P1868, DOI 10.1002/pro.5560070903; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Shiroishi M, 2001, J BIOL CHEM, V276, P23042, DOI 10.1074/jbc.M100480200; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; SMITHGILL SJ, 1991, CURR OPIN BIOTECH, V2, P568, DOI 10.1016/0958-1669(91)90082-G; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l; TORIGOE H, 1995, J BIOL CHEM, V270, P22218, DOI 10.1074/jbc.270.38.22218; TRONRUD DE, 1987, SCIENCE, V235, P571, DOI 10.1126/science.3810156; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; TSUMOTO K, 1994, BIOCHEM BIOPH RES CO, V201, P546, DOI 10.1006/bbrc.1994.1736; Tsumoto K, 1996, J BIOL CHEM, V271, P32612, DOI 10.1074/jbc.271.51.32612; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; UEDA Y, 1993, GENE, V129, P129; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; Wibbenmeyer JA, 1999, J BIOL CHEM, V274, P26838, DOI 10.1074/jbc.274.38.26838; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Yokota A, 2003, J BIOL CHEM, V278, P5410, DOI 10.1074/jbc.M210182200	80	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7686	7696		10.1074/jbc.M109.089623	http://dx.doi.org/10.1074/jbc.M109.089623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20038580	hybrid, Green Published			2022-12-27	WOS:000275415600078
J	Buddai, SK; Layzer, JM; Lu, GM; Rusconi, CP; Sullenger, BA; Monroe, DM; Krishnaswamy, S				Buddai, Sai K.; Layzer, Juliana M.; Lu, Genmin; Rusconi, Christopher P.; Sullenger, Bruce A.; Monroe, Dougald M.; Krishnaswamy, Sriram			An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; HUMAN-FACTOR-X; MACROMOLECULAR SUBSTRATE RECOGNITION; PROPOSED STRUCTURAL MODELS; FACTOR PATHWAY INHIBITOR; EXTRINSIC XASE COMPLEX; FACTOR-VA; BINDING-SITE; EXTINCTION COEFFICIENTS; CRYSTAL-STRUCTURE	The interaction of factor Xa with factor Va on membranes to form prothrombinase profoundly increases the rate of the proteolytic conversion of prothrombin to thrombin. We present the characterization of an RNA aptamer (RNA(11F7t)) selected from a combinatorial library based on its ability to bind factor Xa. We show that RNA(11F7t) inhibits thrombin formation catalyzed by prothrombinase without obscuring the active site of Xa within the enzyme complex. Selective inhibition of protein substrate cleavage arises from the ability of the aptamer to bind to factor Xa and exclude interactions between the proteinase and cofactor within prothrombinase. Competition for enzyme complex assembly results from the binding of RNA(11F7t) to factor Xa with nanomolar affinity in a Ca2+-dependent interaction. RNA(11F7t) binds equivalently to the zymogen factor X as well as derivatives lacking gamma-carboxyglutamic acid residues. We suggest that the ability of RNA(11F7t) to compete for the Xa-Va interaction with surprisingly high affinity likely reflects a significant contribution from its ability to indirectly impact regions of Xa that participate in the proteinase-cofactor interaction. Thus, despite the complexity of the macromolecular interactions that underlie the assembly of prothrombinase, efficient inhibition of enzyme complex assembly and thrombin formation can be achieved by tight binding ligands that target factor Xa in a discrete manner.	[Buddai, Sai K.; Lu, Genmin; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Layzer, Juliana M.; Rusconi, Christopher P.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27705 USA; [Monroe, Dougald M.] Univ N Carolina, Div Hematol & Oncol, Chapel Hill, NC 27599 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Monroe, Dougald/0000-0002-0493-2943	National Institutes of Health [HL-74124, HL-47465, HL-65222, NHLBI0]; Medical Research Foundation of the University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047465, R01HL065222, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation of the University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74124, HL-47465 ( to S. K.), and HL-65222 ( to B. A. S.) (NHLBI0). This work was also supported by the Coagulation Research Trust Fund from the Medical Research Foundation of the University of North Carolina, Chapel Hill ( to D. M. M.).	Adler M, 2000, BIOCHEMISTRY-US, V39, P12534, DOI 10.1021/bi001477q; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; Bauer KA, 2008, CURR OPIN HEMATOL, V15, P509, DOI 10.1097/MOH.0b013e328309ecbc; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington P. R., 1992, DATA REDUCTION ERROR, P141; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Bonifacio GF, 1997, BIOPHYS J, V73, P1532, DOI 10.1016/S0006-3495(97)78185-2; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHATTOPADHYAY A, 1992, J BIOL CHEM, V267, P12323; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; FURIE B, 1992, NEW ENGL J MED, V326, P800; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Greenspan NS, 1999, NAT BIOTECHNOL, V17, P936, DOI 10.1038/13590; Gross PL, 2008, ARTERIOSCL THROM VAS, V28, P380, DOI 10.1161/ATVBAHA.108.162677; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Jeter ML, 2004, FEBS LETT, V568, P10, DOI 10.1016/j.febslet.2004.04.087; Kalafatis M, 2005, CURR OPIN HEMATOL, V12, P141, DOI 10.1097/01.moh.0000155016.30296.90; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; KIM DJ, 1994, BIOTECHNOL LETT, V16, P549, DOI 10.1007/BF00128598; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee AYY, 2003, J INTERN MED, V254, P313, DOI 10.1046/j.1365-2796.2003.01224.x; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PABORSKY LR, 1993, J BIOL CHEM, V268, P20808; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PERSSON E, 1989, J BIOL CHEM, V264, P16897; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; TAYLOR FB, 1991, BLOOD, V78, P364; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; TUCKER MM, 1983, J BIOL CHEM, V258, P1210; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WALKER RK, 1994, J BIOL CHEM, V269, P27441; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495	64	30	30	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5212	5223		10.1074/jbc.M109.049833	http://dx.doi.org/10.1074/jbc.M109.049833			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022942	Green Published, hybrid			2022-12-27	WOS:000275327200014
J	Parke, CL; Wojcik, EJ; Kim, S; Worthylake, DK				Parke, Courtney L.; Wojcik, Edward J.; Kim, Sunyoung; Worthylake, David K.			ATP Hydrolysis in Eg5 Kinesin Involves a Catalytic Two-water Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN MOTOR DOMAIN; PHOSPHATE MONOESTER HYDROLYSIS; X-RAY STRUCTURES; SALT-BRIDGE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SWITCH-II; PROTEINS; RESOLUTION; CRYSTALLOGRAPHY	Motor proteins couple steps in ATP binding and hydrolysis to conformational switching both in and remote from the active site. In our kinesin.AMPPPNP crystal structure, closure of the active site results in structural transformations appropriate for microtubule binding and organizes an orthosteric two-water cluster. We conclude that a proton is shared between the lytic water, positioned for gamma-phosphate attack, and a second water that serves as a general base. To our knowledge, this is the first experimental detection of the catalytic base for any ATPase. Deprotonation of the second water by switch residues likely triggers subsequent large scale structural rearrangements. Therefore, the catalytic base is responsible for initiating nucleophilic attack of ATP and for relaying the positive charge over long distances to initiate mechanotransduction. Coordination of switch movements via sequential proton transfer along paired water clusters may be universal for nucleotide triphosphatases with conserved active sites, such as myosins and G-proteins.	[Parke, Courtney L.; Wojcik, Edward J.; Kim, Sunyoung; Worthylake, David K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kim, S (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [GM066328]; Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066328, R01GM097350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066328 (to E. W.). This work was also supported by funding from Louisiana Board of Regents grants (to D. W. and to S. K.).	Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aqvist J, 1999, CHEM BIOL, V6, pR71, DOI 10.1016/S1074-5521(99)89003-6; Asthagiri D, 2005, P NATL ACAD SCI USA, V102, P6704, DOI 10.1073/pnas.0408071102; Asthagiri D, 2004, P NATL ACAD SCI USA, V101, P7229, DOI 10.1073/pnas.0401696101; Bergmann EM, 1997, J VIROL, V71, P2436, DOI 10.1128/JVI.71.3.2436-2448.1997; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dittrich M, 2005, J BIOENERG BIOMEMBR, V37, P441, DOI 10.1007/s10863-005-9487-7; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; GRANOT J, 1980, BIOCHEMISTRY-US, V19, P3537, DOI 10.1021/bi00556a019; Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hodis E, 2007, TRENDS BIOCHEM SCI, V32, P199, DOI 10.1016/j.tibs.2007.03.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamerlin SCL, 2008, CHEMPHYSCHEM, V9, P1767, DOI 10.1002/cphc.200800356; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kull FJ, 2002, J CELL SCI, V115, P15; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; Li GH, 2004, J PHYS CHEM B, V108, P3342, DOI 10.1021/jp0371783; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Onishi H, 1998, P NATL ACAD SCI USA, V95, P6653, DOI 10.1073/pnas.95.12.6653; Onishi H, 2002, P NATL ACAD SCI USA, V99, P15339, DOI 10.1073/pnas.242604099; Onishi H, 2004, BIOCHEMISTRY-US, V43, P3757, DOI 10.1021/bi040002m; Sagnella DE, 1996, BIOPHYS J, V70, P2043, DOI 10.1016/S0006-3495(96)79773-4; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14232, DOI 10.1021/bi961119g; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Wittinghofer A, 2006, TRENDS BIOCHEM SCI, V31, P20, DOI 10.1016/j.tibs.2005.11.012; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yang Y, 2009, J PHYS CHEM A, V113, P12439, DOI 10.1021/jp902949f	47	109	114	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5859	5867		10.1074/jbc.M109.071233	http://dx.doi.org/10.1074/jbc.M109.071233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018897	Green Published, hybrid			2022-12-27	WOS:000275327200076
J	Weaver, MS; Workman, G; Cardo-Vila, M; Arap, W; Pasqualini, R; Sage, EH				Weaver, Matt S.; Workman, Gail; Cardo-Vila, Marina; Arap, Wadih; Pasqualini, Renata; Sage, E. Helene			Processing of the Matricellular Protein Hevin in Mouse Brain Is Dependent on ADAMTS4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; INTEGRIN-LINKED KINASE; PROTEOLYTIC CLEAVAGE; SPARC; ANGIOGENESIS; EXPRESSION; SC1; CELL; AGGRECANASE-1; PLASTICITY	The matricellular SPARC family member hevin (SPARC-like 1/SPARCL-1/SC1/Mast9) contributes to neural development and alters tumor progression in a range of mammalian models. The distribution of hevin in mouse tissues was reexamined with a novel monoclonal antibody that discriminates between hevin and its ortholog SPARC. We now report proteolysis of hevin in many tissues, with the most extensive processing in the brain. We demonstrate a cleavage site within the hevin sequence for the neural tissue proteinase ADAMTS4. Digestion of hevin by ADAMTS4 in vitro produced fragments similar to those present in brain lysates. Monoclonal antibodies revealed a SPARC-like fragment generated from hevin that was co-localized with ADAMTS4 in vivo. We show that proteolysis of hevin by ADAMTS4 in the mouse cerebellum is important for the normal development of this tissue. In conclusion, we have identified the fragmentation of hevin by ADAMTS4 in the mouse brain and propose that this specific proteolysis is integral to cell morphology and extracellular matrix deposition in the developing brain.	Virginia Mason, Benaroya Res Inst, Hope Heart Program, Seattle, WA 98101 USA; [Cardo-Vila, Marina; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Sage, E. Helene] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle	Sage, EH (corresponding author), 1201 9th Ave, Seattle, WA USA.	hsage@benaroyaresearch.org			National Institutes of Health [GM40711, CA109559]; NATIONAL CANCER INSTITUTE [R01CA109559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM40711 and CA109559.	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brekken RA, 2004, J HISTOCHEM CYTOCHEM, V52, P735, DOI 10.1369/jhc.3A6245.2004; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Ehlen HWA, 2009, J BIOL CHEM, V284, P21545, DOI 10.1074/jbc.M109.016568; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Hu B, 2008, J BIOL CHEM, V283, P24848, DOI 10.1074/jbc.M801433200; IRUELAARISPE ML, 1995, MOL BIOL CELL, V6, P327, DOI 10.1091/mbc.6.3.327; Kang TC, 2002, NEUROCHEM INT, V40, P115, DOI 10.1016/S0197-0186(01)00085-7; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Lively S, 2008, NEUROCHEM RES, V33, P1692, DOI 10.1007/s11064-008-9606-z; Lively S, 2007, NEUROCHEM RES, V32, P65, DOI 10.1007/s11064-006-9226-4; Lively S, 2008, J NEUROCHEM, V107, P1335, DOI 10.1111/j.1471-4159.2008.05696.x; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nguon K, 2005, CEREBELLUM, V4, P112, DOI 10.1080/14734220510007860; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607; Sonnewald U, 2003, NMR BIOMED, V16, P424, DOI 10.1002/nbm.837; Sullivan MM, 2008, WOUND REPAIR REGEN, V16, P310, DOI 10.1111/j.1524-475X.2008.00370.x; Sullivan MM, 2006, J BIOL CHEM, V281, P27621, DOI 10.1074/jbc.M510507200; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058	41	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5868	5877		10.1074/jbc.M109.070318	http://dx.doi.org/10.1074/jbc.M109.070318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018883	hybrid, Green Published			2022-12-27	WOS:000275327200077
J	Samarin, J; Wessel, J; Cicha, I; Kroening, S; Warnecke, C; Goppelt-Struebe, M				Samarin, Jana; Wessel, Julia; Cicha, Iwona; Kroening, Sven; Warnecke, Christina; Goppelt-Struebe, Margarete			FoxO Proteins Mediate Hypoxic Induction of Connective Tissue Growth Factor in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL REGULATION; COMBRETASTATIN A-4; STRESS; AGENT; PROLIFERATION; SPECIFICITY; PHOSPHATASE; HOMEOSTASIS	Hypoxia, a driving force in neovascularization, promotes alterations in gene expression mediated by hypoxia-inducible factor (HIF)-1 alpha. Connective tissue growth factor (CTGF, CCN2) is a modulator of endothelial cell growth and migration, but its regulation by hypoxia is poorly understood. Therefore, we analyzed signaling pathways involved in the regulation of CTGF by hypoxia in endothelial cells. Exposure to low oxygen tension or treatment with the hypoxia-mimetic dimethyloxalyl glycine (DMOG) stabilized HIF-1 alpha and up-regulated CTGF in human umbilical vein endothelial cells and in a murine microvascular endothelial cell line. Induction of CTGF correlated with a HIF-dependent increase in protein and mRNA levels, and nuclear accumulation of the transcription factor FoxO3a. By contrast, gene expression and cellular localization of FoxO1 were not significantly altered by hypoxia. Expression of CTGF was strongly reduced by siRNA silencing of FoxO1 or FoxO3a. Furthermore, nuclear exclusion of FoxO1/3a transcription factors by inhibition of serine/threonine protein phosphatases by okadaic acid inhibited CTGF expression, providing evidence for both FoxO proteins as regulators of CTGF expression. The DMOG-stimulated induction of CTGF was further increased when endothelial cells were co-incubated with transforming growth factor-beta, an activator of Smad signaling. Activation of RhoA-Rho kinase signaling by the microtubule-disrupting drug combretastatin A4 also enhanced the DMOG-induced CTGF expression, thus placing CTGF induction by hypoxia in a network of interacting signaling pathways. Our findings provide evidence that FoxO1, hypoxia-stimulated expression of FoxO3a and its nuclear accumulation are required for the induction of CTGF by hypoxia in endothelial cells.	[Samarin, Jana; Wessel, Julia; Kroening, Sven; Warnecke, Christina; Goppelt-Struebe, Margarete] Univ Hosp Erlangen, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Cicha, Iwona] Univ Hosp Erlangen, Dept Cardiol & Angiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Goppelt-Struebe, M (corresponding author), Univ Hosp Erlangen, Dept Hypertens & Nephrol, Loschgestr 8, D-91054 Erlangen, Germany.	margarete.goppelt-struebe@uk-erlangen.de		Cicha, Iwona/0000-0002-7399-5307; Samarin, Jana/0000-0002-5490-0747	Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	This work was supported by Project D5 from the Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg.	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dark GG, 1997, CANCER RES, V57, P1829; Dawson John F., 1999, Frontiers in Bioscience, V4, pd646, DOI 10.2741/Dawson; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Komorowsky C, 2009, J CELL MOL MED, V13, P2353, DOI 10.1111/j.1582-4934.2009.00674.x; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li ZD, 2005, BIOCHEM BIOPH RES CO, V334, P1049, DOI 10.1016/j.bbrc.2005.07.005; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Paik JH, 2006, BIOCHEM SOC T, V34, P731, DOI 10.1042/BST0340731; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papanicolaou KN, 2008, CIRC RES, V102, P16, DOI 10.1161/CIRCRESAHA.107.164186; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Samarin J, 2009, J CELL COMMUN SIGNAL, V3, P79, DOI 10.1007/s12079-009-0055-5; Samarin J, 2009, MOL CANCER RES, V7, P180, DOI 10.1158/1541-7786.MCR-08-0292; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shimo T, 2001, CANCER LETT, V174, P57, DOI 10.1016/S0304-3835(01)00683-8; Truttmann AC, 2004, NEUROSCIENCE, V127, P355, DOI 10.1016/j.neuroscience.2004.05.033; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Woods A, 2009, OSTEOARTHR CARTILAGE, V17, P406, DOI 10.1016/j.joca.2008.07.002; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200	43	30	35	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4328	4336		10.1074/jbc.M109.049650	http://dx.doi.org/10.1074/jbc.M109.049650			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018872	hybrid, Green Published			2022-12-27	WOS:000275274800009
J	Chadli, A; Felts, SJ; Wang, Q; Sullivan, WP; Botuyan, MV; Fauq, A; Ramirez-Alvarado, M; Mer, G				Chadli, Ahmed; Felts, Sara J.; Wang, Qin; Sullivan, William P.; Botuyan, Maria Victoria; Fauq, Abdul; Ramirez-Alvarado, Marina; Mer, Georges			Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; HEAT-SHOCK; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; TRITERPENE CELASTROL; AMYLOID FIBRILS; NUDE-MICE; PROTEIN; COMPLEX; CANCER	Hsp90 is an ATP-dependent molecular chaperone. The best characterized inhibitors of Hsp90 target its ATP binding pocket, causing nonselective degradation of Hsp90 client proteins. Here, we show that the small molecule celastrol inhibits the Hsp90 chaperoning machinery by inactivating the co-chaperone p23, resulting in a more selective destabilization of steroid receptors compared with kinase clients. Our in vitro and in vivo results demonstrate that celastrol disrupts p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils. This study reveals a unique inhibition mechanism of p23 by a small molecule that could be exploited in the dissection of protein fibrillization processes as well as in the therapeutics of steroid receptor-dependent diseases.	[Chadli, Ahmed] Med Coll Georgia, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA 30912 USA; [Felts, Sara J.; Sullivan, William P.; Botuyan, Maria Victoria; Ramirez-Alvarado, Marina; Mer, Georges] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Fauq, Abdul] Mayo Clin, Coll Med, Organ Chem Lab, Jacksonville, FL 32224 USA	University System of Georgia; Augusta University; Mayo Clinic; Mayo Clinic	Chadli, A (corresponding author), Med Coll Georgia, Ctr Mol Chaperone Radiobiol & Canc Virol, 1410 Laney Walker Blvd,CN 3151, Augusta, GA 30912 USA.	achadli@mcg.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; Ramirez-Alvarado, Marina/0000-0003-2325-6773	National Institutes of Health [GM071514, CA109449]; Mayo Foundation; American Heart Association [06-30077N]; NATIONAL CANCER INSTITUTE [R01CA109449, R01CA132878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071514 (to M. R.- A.) and CA109449 (to G. M.). This work was also supported by the Mayo Foundation (to M. R.- A.) and the American Heart Association Grant 06-30077N (to M. R.- A.).	Abbas S, 2007, CLIN CANCER RES, V13, P6769, DOI 10.1158/1078-0432.CCR-07-1536; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Felts SJ, 2007, CELL STRESS CHAPERON, V12, P353, DOI 10.1379/CSC-299.1; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Johnson J, 1996, J STEROID BIOCHEM, V56, P31, DOI 10.1016/0960-0760(95)00221-9; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484	46	71	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4224	4231		10.1074/jbc.M109.081018	http://dx.doi.org/10.1074/jbc.M109.081018			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996313	Green Published, hybrid			2022-12-27	WOS:000275254000074
J	Gastebois, A; Mouyna, I; Simenel, C; Clavaud, C; Coddeville, B; Delepierre, M; Latge, JP; Fontaine, T				Gastebois, Amandine; Mouyna, Isabelle; Simenel, Catherine; Clavaud, Cecile; Coddeville, Bernadette; Delepierre, Muriel; Latge, Jean-Paul; Fontaine, Thierry			Characterization of a New beta(1-3)-Glucan Branching Activity of Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; SACCHAROMYCES-CEREVISIAE; FUNGAL CELL; SPECTROSCOPY; SEQUENCE; ASSAY; ACID; GENE; NMR	A new HPLC method was developed to separate linear from beta(1-6)-branched beta(1-3)-glucooligosaccharides. This methodology has permitted the isolation of the first fungal beta(1-6)/beta(1-3)-glucan branching transglycosidase using a cell wall autolysate of Aspergillus fumigatus (Af). The encoding gene, AfBGT2 is an ortholog of AfBGT1, another transglycosidase of A. fumigatus previously analyzed (Mouyna, I., Hartland, R. P., Fontaine, T., Diaquin, M., Simenel, C., Delepierre, M., Henrissat, B., and Latge, J.P. (1998) Microbiology 144, 3171-3180). Both enzymes release laminaribiose from the reducing end of a beta(1-3)-linked oligosaccharide and transfer the remaining chain to another molecule of the original substrate. The AfBgt1p transfer occurs at C-6 of the non-reducing end group of the acceptor, creating a kinked beta(1-3; 1-6) linear molecule. The AfBgt2p transfer takes place at the C-6 of an internal group of the acceptor, resulting in a beta(1-3)-linked product with a beta(1-6)-linked side branch. The single Afbgt2 mutant and the double Afbgt1/Afbgt2 mutant in A. fumigatus did not display any cell wall phenotype showing that these activities were not responsible for the construction of the branched beta(1-3)-glucans of the cell wall.	[Gastebois, Amandine; Mouyna, Isabelle; Clavaud, Cecile; Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Simenel, Catherine; Delepierre, Muriel] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, CNRS, URA 2185, F-75724 Paris 15, France; [Coddeville, Bernadette] Univ Sci & Tech Lille Flandres Artois, UMR 8576, CNRS, Lab Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Fontaine, T (corresponding author), Inst Pasteur, Unite Aspergillus, 25 Rue Docteur Roux, F-75015 Paris, France.	tfontain@pasteur.fr	Mouyna, Isabelle/O-7697-2018; mouyna, isabelle/F-3578-2011; Fontaine, thierry/Q-2201-2018; Latge, Jean Paul/C-9846-2014; Fontaine, Thierry/F-8227-2011	Mouyna, Isabelle/0000-0003-3140-5927; Fontaine, thierry/0000-0002-8184-789X; 				Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; BEAUVAIS A, 1993, J GEN MICROBIOL, V139, P3071, DOI 10.1099/00221287-139-12-3071; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Bhagwat AA, 1996, J BACTERIOL, V178, P4635, DOI 10.1128/jb.178.15.4635-4642.1996; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DESAI NN, 1983, BIOCHEM J, V211, P273, DOI 10.1042/bj2110273; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2009, CARBOHYD RES, V344, P1960, DOI 10.1016/j.carres.2009.07.012; GIRARDIN H, 1993, J CLIN MICROBIOL, V31, P1547, DOI 10.1128/JCM.31.6.1547-1554.1993; GOLDMAN RC, 1995, EUR J BIOCHEM, V227, P372, DOI 10.1111/j.1432-1033.1995.tb20399.x; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; JOHNSON AR, 1971, ANAL BIOCHEM, V44, P628, DOI 10.1016/0003-2697(71)90252-1; KESSLER H, 1987, J AM CHEM SOC, V109, P607, DOI 10.1021/ja00236a063; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Mattern I.E., 1988, FUNGAL GENET NEWSL, V35, P25, DOI DOI 10.4148/1941-4765.1533; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Receveur-Brechot V, 2006, PROTEINS, V63, P235, DOI 10.1002/prot.20876; S~anchez O, 1996, FUNGAL GENET REP, V43, P21; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; Sestak S, 2004, MICROBIOL-SGM, V150, P3197, DOI 10.1099/mic.0.27293-0; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; Teparic R, 2007, YEAST, V24, P259, DOI 10.1002/yea.1463; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zverlov VV, 1997, MICROBIOL-SGM, V143, P1701, DOI 10.1099/00221287-143-5-1701	40	53	65	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2386	2396		10.1074/jbc.M109.077545	http://dx.doi.org/10.1074/jbc.M109.077545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948732	Green Published, hybrid			2022-12-27	WOS:000273697800019
J	Tsuchimochi, K; Otero, M; Dragomir, CL; Plumb, DA; Zerbini, LF; Libermann, TA; Marcu, KB; Komiya, S; Ijiri, K; Goldring, MB				Tsuchimochi, Kaneyuki; Otero, Miguel; Dragomir, Cecilia L.; Plumb, Darren A.; Zerbini, Luiz F.; Libermann, Towia A.; Marcu, Kenneth B.; Komiya, Setsuro; Ijiri, Kosei; Goldring, Mary B.			GADD45 beta Enhances Col10a1 Transcription via the MTK1/MKK3/6/p38 Axis and Activation of C/EBP beta-TAD4 in Terminally Differentiating Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCHONDRAL BONE-FORMATION; BINDING PROTEIN-ALPHA; P38 MAP KINASE; SIGNAL-TRANSDUCTION PATHWAY; STRESS-INDUCED ACTIVATION; X COLLAGEN GENE; C/EBP-BETA; IN-VIVO; HYPERTROPHIC CHONDROCYTES; DNA-BINDING	GADD45 beta (growth arrest- and DNA damage-inducible) interacts with upstream regulators of the JNK and p38 stress response kinases. Previously, we reported that the hypertrophic zone of the Gadd45 beta(-/-) mouse embryonic growth plate is compressed, and expression of type X collagen (Col10a1) and matrix metalloproteinase 13 (Mmp13) genes is decreased. Herein, we report that GADD45 beta enhances activity of the proximal Col10a1 promoter, which contains evolutionarily conserved AP-1, cAMP-response element, and C/EBP half-sites, in synergism with C/EBP family members, whereas the MMP13 promoter responds to GADD45 beta together with AP-1, ATF, or C/EBP family members. C/EBP beta expression also predominantly co-localizes with GADD45 beta in the embryonic growth plate. Moreover, GADD45 beta enhances C/EBP beta activation via MTK1, MKK3, and MKK6, and dominant-negative p38 alpha apf, but not JNKapf, disrupts the combined trans-activating effect of GADD45 beta and C/EBP beta on the Col10a1 promoter. Importantly, GADD45 beta knockdown prevents p38 phosphorylation while decreasing Col10a1 mRNA levels but does not affect C/EBP beta binding to the Col10a1 promoter in vivo, indicating that GADD45 beta influences the transactivation function of DNA-bound C/EBP beta. In support of this conclusion, we show that the evolutionarily conserved TAD4 domain of C/EBP beta is the target of the GADD45 beta-dependent signaling. Collectively, we have uncovered a novel molecular mechanism linking GADD45 beta via the MTK1/MKK3/6/p38 axis to C/EBP beta-TAD4 activation of Col10a1 transcription in terminally differentiating chondrocytes.	[Tsuchimochi, Kaneyuki; Otero, Miguel; Dragomir, Cecilia L.; Plumb, Darren A.; Goldring, Mary B.] Hosp Special Surg, Weill Cornell Med Coll, Div Res, Lab Cartilage Biol, New York, NY 10021 USA; [Tsuchimochi, Kaneyuki; Komiya, Setsuro; Ijiri, Kosei] Kagoshima Univ, Dept Orthoped Surg, Grad Sch Med & Dent, Kagoshima 8908520, Japan; [Zerbini, Luiz F.; Libermann, Towia A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Genom Ctr, Boston, MA 02115 USA; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Marcu, Kenneth B.] Rizzoli Orthoped Inst, Dept Immunol & Genet, I-40136 Bologna, Italy	Cornell University; Kagoshima University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; IRCCS Istituto Ortopedico Rizzoli	Goldring, MB (corresponding author), Hosp Special Surg, Weill Cornell Med Coll, Div Res, Lab Cartilage Biol, Caspary Res Bldg,5th Floor,535 E 70th St, New York, NY 10021 USA.	goldringm@hss.edu	Libermann, Towia/F-9866-2010; Zerbini, Luiz/B-7720-2015	Zerbini, Luiz/0000-0003-0736-9508; Libermann, Towia/0000-0002-4006-8179	National Institutes of Health [AG022021, CA85467, GM066882]; Department of Defense [PC051217]; Arthritis Foundation; NATIONAL CANCER INSTITUTE [R01CA085467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG022021, R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG022021 (to M. B. G.), CA85467 (to T. A. L.), and GM066882 (to K. B. M.). This work was also supported by Department of Defense Grant PC051217 (to L. F. Z.) and an Arthritis Foundation postdoctoral fellowship (to M. O.).	Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Ambrosino C, 2006, BIOCHEM J, V396, P163, DOI 10.1042/BJ20051502; Aouadi M, 2007, FEBS LETT, V581, P5591, DOI 10.1016/j.febslet.2007.10.064; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bobick Brent E., 2008, Birth Defects Research, V84, P131, DOI 10.1002/bdrc.20126; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chang WZ, 2004, J BIOL CHEM, V279, P42438, DOI 10.1074/jbc.M405549200; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chumakov AM, 2007, BLOOD, V109, P4209, DOI 10.1182/blood-2005-09-031963; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; DERJARD B, 1994, CELL, V76, P1025; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Gebhard S, 2004, MATRIX BIOL, V23, P309, DOI 10.1016/j.matbio.2004.05.010; Gebhard S, 2007, HISTOCHEM CELL BIOL, V127, P183, DOI 10.1007/s00418-006-0236-8; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Massa PE, 2005, J BIOL CHEM, V280, P14057, DOI 10.1074/jbc.M414401200; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Minina E, 2001, DEVELOPMENT, V128, P4523; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Provot S, 2008, MOL CELL BIOL, V28, P344, DOI 10.1128/MCB.00617-07; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; Seto H, 2004, J CLIN INVEST, V113, P718, DOI 10.1172/JCI200419899; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stanton LA, 2007, EXP CELL RES, V313, P146, DOI 10.1016/j.yexcr.2006.09.027; SUTHERLAND JA, 1992, GENE DEV, V6, P1810, DOI 10.1101/gad.6.9.1810; Svensson CI, 2009, ARTHRITIS RHEUM-US, V60, P3229, DOI 10.1002/art.24887; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Vale-Cruz DS, 2008, MECH DEVELOP, V125, P843, DOI 10.1016/j.mod.2008.06.010; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Wu JJ, 2005, MOL CELL BIOL, V25, P4792, DOI 10.1128/MCB.25.11.4792-4803.2005; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi Y, 1998, NUCLEIC ACIDS RES, V26, P3854, DOI 10.1093/nar/26.16.3854; Yang G, 2005, GENESIS, V42, P33, DOI 10.1002/gene.20120; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zheng QP, 2009, J BONE MINER RES, V24, P1022, DOI [10.1359/JBMR.081249, 10.1359/jbmr.081249]; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	81	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8395	8407		10.1074/jbc.M109.038638	http://dx.doi.org/10.1074/jbc.M109.038638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20048163	Green Published, hybrid			2022-12-27	WOS:000275413800055
J	Gao, XL; Chaturvedi, D; Patel, TB				Gao, Xianlong; Chaturvedi, Deepti; Patel, Tarun B.			p90 Ribosomal S6 Kinase 1 (RSK1) and the Catalytic Subunit of Protein Kinase A (PKA) Compete for Binding the Pseudosubstrate Region of PKAR1 alpha ROLE IN THE REGULATION OF PKA AND RSK1 ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-PROLIFERATION; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; CARNEY COMPLEX; SOLUTION NMR; I-ALPHA; PHOSPHORYLATION; ACTIVATION; BAD; ERK	Previously we showed that the inactive form of p90 ribosomal S6 kinase 1 (RSK1) interacts with the regulatory subunit, PKARI alpha, of protein kinase A (PKA), whereas the active RSK1 interacts with the catalytic subunit (PKAc) of PKA. Herein, we demonstrate that the N-terminal kinase domain (NTK) of RSK1 is necessary for interactions with PKARI alpha. Substitution of the activation loop phosphorylation site (Ser-221) in the NTK with the negatively charged Asp residue abrogated the association between RSK1 and PKARI alpha. This explains the lack of an interaction between active RSK1 and PKARI alpha. Full-length RSK1 bound to PKARI alpha with an affinity of 0.8 nM. The NTK domain of RSK1 competed with PKAc for binding to the pseudosubstrate region (amino acids 93-99) of PKARI alpha. Overexpressed RSK1 dissociated PKAc from PKARI alpha, increasing PKAc activity, whereas silencing of RSK1 increased PKAc/PKARI alpha interactions and decreased PKAc activity. Unlike PKAc, which requires Arg-95 and -96 in the pseudosubstrate region of PKARI alpha for their interactions, RSK1/PKARI alpha association requires all four Arg residues (Arg-93-96) in the pseudosubstrate site of PKARI alpha. A peptide (Wt-PS) corresponding to residues 91-99 of PKARI alpha competed for binding of RSK1 with PKARI alpha both in vitro and in intact cells. Furthermore, peptide Wt-PS (but not control peptide Mut-PS), by dissociating RSK1 from PKARI alpha, activated RSK1 in the absence of any growth factors and protected cells from apoptosis. Thus, by competing for binding to the pseudosubstrate region of PKARI alpha, RSK1 regulates PKAc activity in a cAMP-independent manner, and PKARI alpha by associating with RSK1 regulates its activation and its biological functions.	[Gao, Xianlong; Chaturvedi, Deepti; Patel, Tarun B.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM079226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079226.	Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Boucher MJ, 2001, BIOCHEM BIOPH RES CO, V285, P207, DOI 10.1006/bbrc.2001.5147; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Cavet ME, 2003, J BIOL CHEM, V278, P18376, DOI 10.1074/jbc.M208475200; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Clark DE, 2005, CANCER RES, V65, P3108; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Gao XL, 2009, J BIOL CHEM, V284, P33070, DOI 10.1074/jbc.M109.058453; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; SARASWAT LD, 1988, METHOD ENZYMOL, V159, P325; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Smith JA, 2005, CANCER RES, V65, P1027; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8	36	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6970	6979		10.1074/jbc.M109.083642	http://dx.doi.org/10.1074/jbc.M109.083642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048145	Green Published, hybrid			2022-12-27	WOS:000275415600010
J	Stapleton, M; Haq, I; Hunt, DM; Arnvig, KB; Artymiuk, PJ; Buxton, RS; Green, J				Stapleton, Melanie; Haq, Ihtshamul; Hunt, Debbie M.; Arnvig, Kristine B.; Artymiuk, Peter J.; Buxton, Roger S.; Green, Jeffrey			Mycobacterium tuberculosis cAMP Receptor Protein (Rv3676) Differs from the Escherichia coli Paradigm in Its cAMP Binding and DNA Binding Properties and Transcription Activation Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; BOVIS BCG; GENE-EXPRESSION; MACROPHAGES; MUTATIONS; COMPLEX; FAMILY; WHIB; STREPTOMYCES; REGULATOR	The pathogen Mycobacterium tuberculosis produces a burst of cAMP upon infection of macrophages. Bacterial cyclic AMP receptor proteins (CRP) are transcription factors that respond to cAMP by binding at target promoters when cAMP concentrations increase. Rv3676 (CRPMt) is a CRP family protein that regulates expression of genes (rpfA and whiB1) that are potentially involved in M. tuberculosis persistence and/or emergence from the dormant state. Here, the CRPMt homodimer is shown to bind two molecules of cAMP(one per protomer) at non-interacting sites. Furthermore, cAMP binding by CRPMt was relatively weak, entropy driven, and resulted in a relatively small enhancement in DNA binding. Tandem CRPMt-binding sites (CRP1 at -58.5 and CRP2 at -37.5) were identified at the whiB1 promoter (PwhiB1). In vitro transcription reactions showed that CRP1 is an activating site and that CRP2, which was only occupied in the presence of cAMP or at high CRPMt concentrations in the absence of cAMP, is a repressing site. Binding of CRPMt to CRP1 was not essential for open complex formation but was required for transcription activation. Thus, these data suggest that binding of CRPMt to the PwhiB1 CRP1 site activates transcription at a step after open complex formation. In contrast, high cAMP concentrations allowed occupation of both CRP1 and CRP2 sites, resulting in inhibition of open complex formation. Thus, M. tuberculosis CRP has evolved several distinct characteristics, compared with the Escherichia coli CRP paradigm, to allow it to regulate gene expression against a background of high concentrations of cAMP.	[Stapleton, Melanie; Artymiuk, Peter J.; Green, Jeffrey] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Haq, Ihtshamul] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Hunt, Debbie M.; Arnvig, Kristine B.; Buxton, Roger S.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	University of Sheffield; University of Sheffield; MRC National Institute for Medical Research	Green, J (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk		Arnvig, Kristine/0000-0002-6850-2547	Wellcome Trust [078731/Z/05/Z]; Medical Research Council; Medical Research Council [MC_U117585867] Funding Source: researchfish; MRC [MC_U117585867] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust Grant 078731/Z/05/Z and the Medical Research Council.	Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Akhter Y, 2007, INT J MED MICROBIOL, V297, P451, DOI 10.1016/j.ijmm.2007.04.009; Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x; ANGULO J, 1986, J BIOL CHEM, V261, P1315; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2007, INFECT IMMUN, V75, P5509, DOI 10.1128/IAI.00658-07; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1983, J MOL BIOL, V167, P259, DOI 10.1016/S0022-2836(83)80335-0; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Busby Stephen, 1996, P255; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Gazdik MA, 2005, J BACTERIOL, V187, P2681, DOI 10.1128/JB.187.8.2681-2692.2005; GORSHKOVA I, 1995, J BIOL CHEM, V270, P21679, DOI 10.1074/jbc.270.37.21679; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; KIRIN E, 2002, MICROBIOLOGY, V148, P1553; KUBICA G P, 1972, International Journal of Systematic Bacteriology, V22, P99; LODGE J, 1990, FEMS MICROBIOL LETT, V67, P221, DOI 10.1016/0378-1097(90)90199-Z; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; MARSH P, 1986, NUCLEIC ACIDS RES, V14, P3603, DOI 10.1093/nar/14.8.3603; MAXAM AM, 1980, METHOD ENZYMOL, V65, P560; Miller J. H, 1972, EXPT MOL GENETICS; Moore JL, 1996, J BIOL CHEM, V271, P21273, DOI 10.1074/jbc.271.35.21273; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; PADH H, 1976, MICROBIOS, V16, P183; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sambrook J., 2001, MOL CLONING LAB MANU; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SINGH A, 2009, PLOS PATHOG, V8; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Spreadbury CL, 2005, MICROBIOL-SGM, V151, P547, DOI 10.1099/mic.0.27444-0; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	51	60	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7016	7027		10.1074/jbc.M109.047720	http://dx.doi.org/10.1074/jbc.M109.047720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20028978	hybrid, Green Published			2022-12-27	WOS:000275415600015
J	Zhou, XY; Yin, ZA; Guo, XZ; Hajjar, DP; Han, JH				Zhou, Xiaoye; Yin, Zhinan; Guo, Xianzhi; Hajjar, David P.; Han, Jihong			Inhibition of ERK1/2 and Activation of Liver X Receptor Synergistically Induce Macrophage ABCA1 Expression and Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY DISEASE; APOLIPOPROTEIN-E; TANGIER-DISEASE; TARGETED DISRUPTION; SCAVENGER RECEPTORS; HDL CHOLESTEROL; GENE-EXPRESSION; TRANSGENIC MICE	ATP-binding cassette transporter A1 (ABCA1), a molecule mediating free cholesterol efflux from peripheral tissues to apoAI and high density lipoprotein (HDL), inhibits the formation of lipid-laden macrophage/foam cells and the development of atherosclerosis. ERK1/2 are important signaling molecules regulating cellular growth and differentiation. The ERK1/2 signaling pathway is implicated in cardiac development and hypertrophy. However, the role of ERK1/2 in the development of atherosclerosis, particularly in macrophage cholesterol homeostasis, is unknown. In this study, we investigated the effects of ERK1/2 activity on macrophage ABCA1 expression and cholesterol efflux. Compared with a minor effect by inhibition of other kinases, inhibition of ERK1/2 significantly increased macrophage cholesterol efflux to apoAI and HDL. In contrast, activation of ERK1/2 reduced macrophage cholesterol efflux and ABCA1 expression. The increased cholesterol efflux by ERK1/2 inhibitors was associated with the increased ABCA1 levels and the binding of apoAI to cells. The increased ABCA1 by ERK1/2 inhibitors was due to increased ABCA1 mRNA and protein stability. The induction of ABCA1 expression and cholesterol efflux by ERK1/2 inhibitors was concentration-dependent. The mechanism study indicated that activation of liver X receptor (LXR) had little effect on ERK1/2 expression and activation. ERK1/2 inhibitors had no effect on macrophage LXR alpha/beta expression, whereas they did not influence the activation or the inhibition of the ABCA1 promoter by LXR or sterol regulatory element-binding protein (SREBP). However, inhibition of ERK1/2 and activation of LXR synergistically induced macrophage cholesterol efflux and ABCA1 expression. Our data suggest that ERK1/2 activity can play an important role in macrophage cholesterol trafficking.	[Zhou, Xiaoye; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Med Coll, Ctr Vasc Biol, New York, NY 10065 USA; [Zhou, Xiaoye; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10065 USA; [Zhou, Xiaoye; Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Guo, Xianzhi] Nankai Univ, Coll Chem, Tianjin 300071, Peoples R China; [Han, Jihong] Nankai Univ, Minist Educ China, Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Zhou, Xiaoye] Capital Med Univ, Xuanwu Hosp, Dept Neurobiol, Beijing 100053, Peoples R China	Cornell University; Cornell University; Nankai University; Nankai University; Ministry of Education, China; Nankai University; Capital Medical University	Han, JH (corresponding author), Cornell Univ, Weill Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	jhan@med.cornell.edu			National Institutes of Health [P01HL046403]; Julia and Gross Foundation; 973 Basic Research Program of China [2010CB945003]; Natural Science Foundation of China (NSFC) [30971271]; Tianjin Municipal Science and Technology Commission of China [08ZCKFSH04400]; Ministry of Science and Technology of China [2006AA02A408]; National Key Scientific Program of China [2007CB914801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Julia and Gross Foundation; 973 Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Scientific Program of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL046403 (to D. P. H. and J. H.). This work was also supported by the Julia and Gross Foundation (to D. P. H.), a 973 Basic Research Program of China Grant 2010CB945003 (to J. H.), Natural Science Foundation of China (NSFC) Grant 30971271 (to J. H.), the Tianjin Municipal Science and Technology Commission of China (Grant 08ZCKFSH04400 to J. H.), the Ministry of Science and Technology of China (Grant 2006AA02A408 to X. Z.), and the National Key Scientific Program of China (Grant 2007CB914801 to Z. Y.).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Arora S, 2008, DRUG TODAY, V44, P711, DOI 10.1358/dot.2008.44.9.1263999; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BRINTON EA, 1989, J CLIN INVEST, V84, P262, DOI 10.1172/JCI114149; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Huang ZH, 2006, ARTERIOSCL THROM VAS, V26, P157, DOI 10.1161/01.ATV.0000193627.12516.1d; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joyce CW, 2006, J BIOL CHEM, V281, P33053, DOI 10.1074/jbc.M604526200; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200; ZERIVITZ K, 1989, GENE ANAL TECH, V6, P101, DOI 10.1016/0735-0651(89)90016-2; Zhou XY, 2008, J BIOL CHEM, V283, P2129, DOI 10.1074/jbc.M706636200	54	75	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6316	6326		10.1074/jbc.M109.073601	http://dx.doi.org/10.1074/jbc.M109.073601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037141	hybrid, Green Published			2022-12-27	WOS:000275367500036
J	de Late, PL; Pepin, A; Assaf-Vandecasteele, H; Espinasse, C; Nicolas, V; Asselin-Labat, ML; Bertoglio, J; Pallardy, M; Biola-Vidamment, A				de Late, Perle Latre; Pepin, Aurelie; Assaf-Vandecasteele, Hind; Espinasse, Christophe; Nicolas, Valerie; Asselin-Labat, Marie-Liesse; Bertoglio, Jacques; Pallardy, Marc; Biola-Vidamment, Armelle			Glucocorticoid-induced Leucine Zipper (GILZ) Promotes the Nuclear Exclusion of FOXO3 in a Crm1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTECTS T-LYMPHOCYTES; FAS-LIGAND EXPRESSION; INDUCED CELL-DEATH; FACTOR-KAPPA-B; FOXO3A-DEPENDENT REGULATION; OXIDATIVE-STRESS; GENE-EXPRESSION; ACTIVATION; BIM	GILZ (glucocorticoid-induced leucine zipper) is an ubiquitous protein whose expression is induced by glucocorticoids in lymphoid cells. We previously showed that GILZ expression is rapidly induced upon interleukin 2 deprivation in T-cells, protecting cells from apoptosis induced by forkhead box subgroup O3 (FOXO3). The aim of this work is to elucidate the molecular mechanism of FOXO factor inhibition by GILZ. We show in the myeloid cell line HL-60 and the lymphoid CTLL-2 T-cell line that GILZ down-regulates the expression of p27(KIP1) and Bim, two FOXO targets involved in cell cycle regulation and apoptosis, respectively. GILZ inhibits FOXO1, FOXO3, and FOXO4 transcriptional activities measured with natural or synthetic FOXO-responsive promoters in HL-60 cells. This inhibitory effect is independent of protein kinase B and I kappa B kinase phosphorylation sites. GILZ does not hinder FOXO3 DNA-binding activity and does not physically interact with FOXO3. However, using fluorescence microscopy, we observe that GILZ expression provokes a Crm-1-dependent nuclear exclusion of FOXO3 leading to its relocalization to the cytoplasm. Moreover, GILZ exclusive cytoplasmic localization is a prerequisite for FOXO3 inhibition and relocalization. We propose that GILZ is a general inhibitor of FOXO factors acting through an original mechanism by preventing them from reaching target genes within the nucleus.	[de Late, Perle Latre; Pepin, Aurelie; Assaf-Vandecasteele, Hind; Espinasse, Christophe; Asselin-Labat, Marie-Liesse; Bertoglio, Jacques; Pallardy, Marc; Biola-Vidamment, Armelle] Univ Paris 11, Fac Pharm, INSERM, UMR S 749, F-92296 Chatenay Malabry, France; [Nicolas, Valerie] Univ Paris 11, IFR141, ITFM, F-92296 Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Biola-Vidamment, A (corresponding author), Univ Paris 11, Fac Pharm, INSERM, UMR S 749, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	armelle.biola-vidamment@u-psud.fr	Biola-Vidamment, Armelle/B-3735-2014; DE LATE, Perle LATRE/ABA-9692-2020	Biola-Vidamment, Armelle/0000-0003-1113-5851; LATRE DE LATE, Perle/0000-0003-3871-6277				Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Baumann S, 2003, ONCOGENE, V22, P1333, DOI 10.1038/sj.onc.1206126; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Biola A, 2001, MOL ENDOCRINOL, V15, P1062, DOI 10.1210/me.15.7.1062; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chow WA, 2000, J IMMUNOL, V164, P3512, DOI 10.4049/jimmunol.164.7.3512; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Redjimi N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-83; Savickiene J, 2004, ANN NY ACAD SCI, V1030, P569, DOI 10.1196/annals.1329.066; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Xiao S, 2001, EUR J IMMUNOL, V31, P3339, DOI 10.1002/1521-4141(200111)31:11<3339::AID-IMMU3339>3.0.CO;2-U; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353	40	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5594	5605		10.1074/jbc.M109.068346	http://dx.doi.org/10.1074/jbc.M109.068346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018851	Green Published, hybrid			2022-12-27	WOS:000275327200051
J	Ito, K; Katsuma, S; Yamamoto, K; Kadono-Okuda, K; Mita, K; Shimada, T				Ito, Katsuhiko; Katsuma, Susumu; Yamamoto, Kimiko; Kadono-Okuda, Keiko; Mita, Kazuei; Shimada, Toru			Yellow-e Determines the Color Pattern of Larval Head and Tail Spots of the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILES; ROYAL JELLY PROTEINS; DROSOPHILA-YELLOW; FAMILY; CHROMOSOME; HONEYBEE; EBONY	Yellow proteins form a large family in insects. In Drosophila melanogaster, there are 14 yellow genes in the genome. Previous studies have shown that the yellow gene is necessary for normal pigmentation; however, the roles of other yellow genes in body coloration are not known. Here, we provide the first evidence that yellow-e is required for normal body color pattern in insect larvae. In two mutant strains, bts and its allele bts2, of the silkworm Bombyx mori, the larval head cuticle and anal plates are reddish brown instead of the white color found in the wild type. Positional cloning revealed that deletions in the Bombyx homolog of the Drosophila yellow-e gene (Bmyellow-e) were responsible for the bts/bts2 phenotype. Bmyellow-e mRNA was strongly expressed in the trachea, testis, and integument, and expression markedly increased at the molting stages. This profile is quite similar to that of Bmyellow, a regulator of neonatal body color and body markings in Bombyx. Quantitative reverse transcription-PCR analysis showed that Bmyellow-e mRNA was heavily expressed in the integument of the head and tail in which the bts phenotype is observed. The present results suggest that Yellow-e plays a crucial role in the pigmentation process of lepidopteran larvae.	[Ito, Katsuhiko; Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Yamamoto, Kimiko; Kadono-Okuda, Keiko; Mita, Kazuei] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Shimada, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/A-2033-2011; Ito, Katsuhiko/B-8861-2015; Shimada, Toru/AAZ-2703-2021	Shimada, Toru/0000-0002-5791-0000; Ito, Katsuhiko/0000-0003-4464-1734; Shimada, Toru/0000-0002-5791-0000	Ministry of Education, Culture, Sports, Science and Technology [17018007]; MAFF-NIAS; National BioResource Project; Japan Science and Technology Agency, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MAFF-NIAS; National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (17018007), MAFF-NIAS (Agrigenome Research Program), National BioResource Project, and Japan Science and Technology Agency (Professional Program for Agricultural Bioinformatics), Japan.	Abe H, 2005, INSECT MOL BIOL, V14, P339, DOI 10.1111/j.1365-2583.2005.00565.x; Banno Y., 2005, GUIDE SILKWORM MUTAN, P1; CHIKUSHI H, 1960, J SERIC SCI JPN, V29, P278; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; Drapeau MD, 2001, BIOCHEM BIOPH RES CO, V281, P611, DOI 10.1006/bbrc.2001.4391; Eguchi R., 2007, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V76, P159; FUJII H, 1998, GENETICAL STOCKS MUT, P1; Fujii T, 2009, GENES GENET SYST, V84, P147, DOI 10.1266/ggs.84.147; Fujii T, 2008, INSECT BIOCHEM MOLEC, V38, P1072, DOI 10.1016/j.ibmb.2008.03.004; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Han D, 2002, BIOCHEM J, V368, P333; Ito K, 2008, P NATL ACAD SCI USA, V105, P7523, DOI 10.1073/pnas.0711841105; Ito K, 2009, INSECT BIOCHEM MOLEC, V39, P287, DOI 10.1016/j.ibmb.2009.01.005; Maleszka R, 2000, BIOCHEM BIOPH RES CO, V270, P773, DOI 10.1006/bbrc.2000.2506; Meng Y, 2009, GENES CELLS, V14, P129, DOI 10.1111/j.1365-2443.2008.01257.x; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Ote M, 2004, INSECT BIOCHEM MOLEC, V34, P775, DOI 10.1016/j.ibmb.2004.04.002; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21	30	35	40	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5624	5629		10.1074/jbc.M109.035741	http://dx.doi.org/10.1074/jbc.M109.035741			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996320	Green Published, hybrid			2022-12-27	WOS:000275327200054
J	Lowe, JM; Cha, H; Yang, Q; Fornace, AJ				Lowe, Julie M.; Cha, Hyukjin; Yang, Qian; Fornace, Albert J., Jr.			Nuclear Factor-kappa B (NF-kappa B) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZING-RADIATION; INDUCED APOPTOSIS; P38 MAPK; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CELLS; CANCER; P53; TUMORIGENESIS; INHIBITION	The nuclear factor-kappa B (NF-kappa B) family of transcription factors plays a key role in inflammation and augments the initiation, promotion, and progression of cancer. NF-kappa B activation generally leads to transcriptional enhancement of genes important in cell survival and cell growth, which is exploited in cancer cells. In this study, we identify an additional oncogene, PPM1D, which encodes for Wip1, as a transcriptional target of NF-kappa B in breast cancer cells. Inhibition of NF-kappa B or activation of NF-kappa B resulted in decreased or increased Wip1 expression, respectively, at both the mRNA and protein levels. PPM1D promoter activity was positively regulated by NF-kappa B, and this regulation was dependent on the presence of the conserved kappa B site in the PPM1D promoter region. Chromatin immunoprecipitation analysis showed basal binding of the p65 NF-kappa B subunit to the PPM1D promoter region encompassing the kappa B site, which is enhanced after NF-kappa B activation by tumor necrosis factor-kappa. Finally, we show that Wip1 expression is induced in lipopolysaccharide- stimulated mouse splenic B-cells and is required for maximum proliferation. Taken together, these data suggest an additional mechanism by which NF-kappa B may promote tumorigenesis, support the selective use of NF-kappa B inhibitors as chemotherapeutic agents for the treatment of human cancers, and further define a function for Wip1 in inflammation.	[Lowe, Julie M.; Yang, Qian; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Fornace, Albert J., Jr.] Dankook Univ, Cheonan Chungnam 330714, South Korea; [Cha, Hyukjin] Pochon CHA Univ, Coll Med, Cha Stem Cell Inst, Seoul 135081, South Korea	Georgetown University; Dankook University; Pochon Cha University	Fornace, AJ (corresponding author), New Res Bldg,E504,3970 Reservoir Rd NW, Washington, DC 20057 USA.	af294@georgetown.edu	Cha, Hyuk-Jin/AAB-8508-2020; Fornace, Albert/A-7407-2008	Cha, Hyuk-Jin/0000-0001-9277-2662; Fornace, Albert/0000-0001-9695-085X	Ministry of Education, Science and Technology [R31-10069]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was partially supported by Grant R31-10069 (WCU program) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Aravindan N, 2008, CANCER BIOL THER, V7, P569, DOI 10.4161/cbt.7.4.5534; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chen XF, 2002, CANCER RES, V62, P1213; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Doman RK, 1999, J INTERF CYTOK RES, V19, P261, DOI 10.1089/107999099314199; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujioka S, 2004, J BIOL CHEM, V279, P27549, DOI 10.1074/jbc.M313435200; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kong WH, 2009, CANCER BIOL THER, V8, P555, DOI 10.4161/cbt.8.6.7742; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Munshi A, 2004, MOL CANCER THER, V3, P985; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parssinen J, 2008, CANCER GENET CYTOGEN, V182, P33, DOI 10.1016/j.cancergencyto.2007.12.013; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; Tanaka A, 2005, BLOOD, V105, P2324, DOI 10.1182/blood-2004-08-3247; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tsuboi Y, 2009, J NEUROSURG, V110, P594, DOI 10.3171/2008.8.JNS17648; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Yu E, 2007, BREAST CANCER RES TR, V101, P269, DOI 10.1007/s10549-006-9304-y	50	48	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5249	5257		10.1074/jbc.M109.034579	http://dx.doi.org/10.1074/jbc.M109.034579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007970	Green Published, hybrid			2022-12-27	WOS:000275327200018
J	Mazhab-Jafari, MT; Marshall, CB; Smith, M; Gasmi-Seabrook, GMC; Stambolic, V; Rottapel, R; Neel, BG; Ikura, M				Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Smith, Matthew; Gasmi-Seabrook, Genevieve M. C.; Stambolic, Vuk; Rottapel, Robert; Neel, Benjamin G.; Ikura, Mitsuhiko			Real-time NMR Study of Three Small GTPases Reveals That Fluorescent 2 '(3 ')-O-(N-Methylanthraniloyl)-tagged Nucleotides Alter Hydrolysis and Exchange Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS ACTIVATOR SON; GTP HYDROLYSIS; CRYSTAL-STRUCTURE; BINDING PROTEINS; STRUCTURAL BASIS; RHOA; MECHANISM; SEVENLESS; NEUROFIBROMIN; PRODUCT	The Ras family of small GTPases control diverse signaling pathways through a conserved "switch" mechanism, which is turned on by binding of GTP and turned off by GTP hydrolysis to GDP. Full understanding of GTPase switch functions requires reliable, quantitative assays for nucleotide binding and hydrolysis. Fluorescently labeled guanine nucleotides, such as 2'(3')-O-(N-methylanthraniloyl) (mant)-substituted GTP and GDP analogs, have been widely used to investigate the molecular properties of small GTPases, including Ras and Rho. Using a recently developed NMR method, we show that the kinetics of nucleotide hydrolysis and exchange by three small GTPases, alone and in the presence of their cognate GTPase-activating proteins ( GAPs) and guanine nucleotide exchange factors, are affected by the presence of the fluorescent mant moiety. Intrinsic hydrolysis of mantGTP by Ras homolog enriched in brain (Rheb) is similar to 10 times faster than that of GTP, whereas it is 3.4 times slower with RhoA. On the other hand, the mant tag inhibits TSC2GAP-catalyzed GTP hydrolysis by Rheb but promotes p120 RasGAP-catalyzed GTP hydrolysis by H-Ras. Guanine nucleotide exchange factor-catalyzed nucleotide exchange for both H-Ras and RhoA was inhibited by mant-substituted nucleotides, and the degree of inhibition depends highly on the GTPase and whether the assay measures association of mantGTP with, or dissociation of mantGDP from the GTPase. These results indicate that the mant moiety has significant and unpredictable effects on GTPase reaction kinetics and underscore the importance of validating its use in each assay.	[Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Smith, Matthew; Gasmi-Seabrook, Genevieve M. C.; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Rottapel, Robert; Neel, Benjamin G.] Univ Hlth Network, Ontario Canc Inst, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Smith, Matthew; Gasmi-Seabrook, Genevieve M. C.; Stambolic, Vuk; Rottapel, Robert; Neel, Benjamin G.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Smith, Matthew J/AAI-8060-2020; Marshall, Christopher/K-8943-2019	Smith, Matthew J/0000-0003-2896-9350; Marshall, Christopher/0000-0002-7571-5700; Smith, Matthew/0000-0002-9436-2592; Ikura, Mitsuhiko/0000-0002-9524-1303; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877; Rottapel, Robert/0000-0002-6024-5558; Stambolic, Vuk/0000-0001-8853-3239	Cancer Research Society (Canada); United States Department of Defense Tuberous Sclerosis Complex Research	Cancer Research Society (Canada); United States Department of Defense Tuberous Sclerosis Complex Research	This work was supported by grants from the Cancer Research Society (Canada) and a United States Department of Defense Tuberous Sclerosis Complex Research Program Award ( to V. S.).	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Eberth A, 2005, BIOL CHEM, V386, P1105, DOI 10.1515/BC.2005.127; Ford B, 2006, STRUCTURE, V14, P427, DOI 10.1016/j.str.2005.12.010; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Goddard T. D., SPARKY3; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Phillips RA, 2003, BIOCHEMISTRY-US, V42, P3956, DOI 10.1021/bi027316z; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Sacco E, 2006, FEBS LETT, V580, P6322, DOI 10.1016/j.febslet.2006.10.040; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spessard GO, 1998, J CHEM INF COMP SCI, V38, P1250, DOI 10.1021/ci980264t; Tan YC, 2002, ANAL BIOCHEM, V310, P156, DOI 10.1016/S0003-2697(02)00382-2; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447	31	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5132	5136		10.1074/jbc.C109.064766	http://dx.doi.org/10.1074/jbc.C109.064766			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018863	Green Published, hybrid			2022-12-27	WOS:000275327200004
J	Dai, SP; Sodhi, C; Cetin, S; Richardson, W; Branca, M; Neal, MD; Prindle, T; Ma, C; Shapiro, RA; Li, B; Wang, JHC; Hackam, DJ				Dai, Shipan; Sodhi, Chhinder; Cetin, Selma; Richardson, Ward; Branca, Maria; Neal, Matthew D.; Prindle, Thomas; Ma, Congrong; Shapiro, Richard A.; Li, Bin; Wang, James H. -C.; Hackam, David J.			Extracellular High Mobility Group Box-1 (HMGB1) Inhibits Enterocyte Migration via Activation of Toll-like Receptor-4 and Increased Cell-Matrix Adhesiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROTIZING ENTEROCOLITIS; EPITHELIAL RESTITUTION; TRACTION FORCE; PROTEIN; TLR4; PATHOGENESIS; EXPRESSION; MEDIATOR; MICE; HMG-1	Toll-like receptor-4 (TLR4) is the receptor for bacterial lipopolysaccharide, yet it may also respond to a variety of endogenous molecules. Necrotizing enterocolitis (NEC) is the leading cause of death from gastrointestinal disease in newborn infants and is characterized by intestinal mucosal destruction and impaired enterocyte migration due to increased TLR4 signaling on enterocytes. The endogenous ligands for TLR4 that lead to impaired enterocyte migration remain unknown. High mobility group box-1 (HMGB1) is a DNA-binding protein that is released from injured cells during inflammation. We thus hypothesize that extracellular HMGB1 inhibits enterocyte migration via activation of TLR4 and sought to define the pathways involved. We now demonstrate that murine and human NEC are associated with increased intestinal HMGB1 expression, that serum HMGB1 is increased in murine NEC, and that HMGB1 inhibits enterocyte migration in vitro and in vivo in a TLR4-dependent manner. This finding was unique to enterocytes as HMGB1 enhanced migration of inflammatory cells in vitro and in vivo. In seeking to understand the mechanisms involved, TLR4-dependent HMGB1 signaling increased RhoA activation in enterocytes, increased phosphorylation of focal adhesion kinase, and increased phosphorylation of cofilin, resulting in increased stress fibers and focal adhesions. Using single cell force traction microscopy, the net effect of HMGB1 signaling was a TLR4-dependent increase in cell force adhesion, accounting for the impaired enterocyte migration. These findings demonstrate a novel pathway by which TLR4 activation by HMGB1 delays mucosal repair and suggest a novel potential therapeutic target in the amelioration of intestinal inflammatory diseases like NEC.	[Dai, Shipan; Sodhi, Chhinder; Cetin, Selma; Richardson, Ward; Branca, Maria; Neal, Matthew D.; Prindle, Thomas; Ma, Congrong; Hackam, David J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Surg, Pittsburgh, PA 15207 USA; [Dai, Shipan; Sodhi, Chhinder; Richardson, Ward; Neal, Matthew D.; Shapiro, Richard A.; Hackam, David J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15207 USA; [Li, Bin; Wang, James H. -C.] Univ Pittsburgh, Sch Med, Dept Orthoped Surg, Pittsburgh, PA 15207 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hackam, DJ (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Surg, 45th St & Penn Ave, Pittsburgh, PA 15207 USA.	david.hackam@chp.edu	Neal, Matthew/GMW-5601-2022; Li, Bin/B-7802-2012	Neal, Matthew/0000-0001-8931-6236; Hackam, David/0000-0001-5195-8807	National Institutes of Health [R01-GM078238, RO1-DK083752]; Hartwell Foundation, Memphis, TN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation, Memphis, TN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM078238 and RO1-DK083752 ( to D.J.H.) and The Hartwell Foundation, Memphis, TN.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Ngamkitidechakul C, 2002, BIOTECHNIQUES, V33, P1296, DOI 10.2144/02336pt02; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi FG, 2005, GASTROENTEROLOGY, V128, P1012, DOI 10.1053/j.gastro.2005.01.052; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Zamora R, 2005, AM J PHYSIOL-GASTR L, V289, pG643, DOI 10.1152/ajpgi.00067.2005	23	55	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4995	5002		10.1074/jbc.M109.067454	http://dx.doi.org/10.1074/jbc.M109.067454			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007974	Green Published, hybrid			2022-12-27	WOS:000275274800076
J	Ni, J; Waldman, A; Khachigian, LM				Ni, Jun; Waldman, Alla; Khachigian, Levon M.			RETRACTED: c-Jun Regulates Shear- and Injury-inducible Egr-1 Expression, Vein Graft Stenosis after Autologous End-to-Side Transplantation in Rabbits, and Intimal Hyperplasia in Human Saphenous Veins (Retracted article. See vol. 293, pg. 20307, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							SMOOTH-MUSCLE-CELLS; ULTRASOUND FOLLOW-UP; NEOINTIMA FORMATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; METALLOPROTEINASE ACTIVITY; TISSUE INHIBITOR; ELUTING STENTS; BYPASS GRAFTS	Coronary artery bypass graft failure represents an unsolved problem in interventional cardiology and heart surgery. Late occlusion of autologous saphenous vein bypass grafts is a consequence of neointima formation underpinned by smooth muscle cell (SMC) migration and proliferation. Poor long term patency and the lack of pharmacologic agents that prevent graft failure necessitate effective alternative therapies. Our objective here was to evaluate the effect of targeted inhibition of the bZIP transcription factor c-Jun on intimal hyperplasia in human saphenous veins and vein graft stenosis after autologous end-to-side transplantation. DNAzymes targeting c-Jun attenuated intimal hyperplasia in human saphenous vein explants. Adenovirus-forced c-Jun expression stimulated SMC proliferation, proliferating cell nuclear antigen, and MMP-2 expression. c-Jun DNAzymes abrogated Adeno-c-Jun-inducible SMC growth and wound repair and reduced intimal thickening in jugular veins of New Zealand white rabbits 4 weeks after autologous end-to-side transplantation to carotid arteries. Conversely, in a DNAzyme-free setting, Adeno-c-Jun potentiated neointima formation in the veins compared with Adeno-LacZ. Inducible c-Jun expression is ERK1/2- and JNK-dependent but p38-independent. Injury- and shear-inducible c-Jun controls early growth response-1. These data demonstrate that strategies targeting c-Jun may be useful for the prevention of vein graft stenosis. Control of one important shear-responsive transcription factor by another indicates the existence of transcriptional amplification mechanisms that magnify the vascular response to cell injury or stress through inducible transcriptional networks.	[Ni, Jun; Waldman, Alla; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Khachigian, LM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.	L.Khachigian@unsw.edu.au	Khachigian, Levon/AAZ-7458-2020	Khachigian, Levon/0000-0003-3446-0323	National Health and Medical Research Council; Australian Research Council; National Heart Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation(National Heart Foundation of Australia)	This work was supported by grants from the National Health and Medical Research Council, Australian Research Council, and National Heart Foundation.	Berceli SA, 2004, J VASC SURG, V39, P1084, DOI 10.1016/j.jvs.2003.12.031; Campeau L, 1997, NEW ENGL J MED, V336, P153; Cha KS, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.08.003; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Delbridge GJ, 1997, CIRC RES, V81, P282, DOI 10.1161/01.RES.81.2.282; Ehsan A, 2001, J THORAC CARDIOV SUR, V121, P714, DOI 10.1067/mtc.2001.111204; Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225; FAXON DP, 1995, J AM COLL CARDIOL, V25, P362, DOI 10.1016/0735-1097(94)00368-Z; FINGERLE J, 1995, ARTERIOSCL THROM VAS, V15, P1945, DOI 10.1161/01.ATV.15.11.1945; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; George SJ, 1998, GENE THER, V5, P1552, DOI 10.1038/sj.gt.3300764; George SJ, 2000, CIRCULATION, V101, P296, DOI 10.1161/01.CIR.101.3.296; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; GREGORY CR, 1993, TRANSPLANTATION, V55, P1409, DOI 10.1097/00007890-199306000-00037; Gulkarov I, 2009, J SURG RES, V154, P150, DOI 10.1016/j.jss.2008.04.025; Hilker M, 2003, EUR J CARDIO-THORAC, V23, P620, DOI 10.1016/S1010-7940(03)00017-4; Johnson JL, 2001, ARTERIOSCL THROM VAS, V21, P1146, DOI 10.1161/hq0701.092106; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Khachigian LM, 1997, ARTERIOSCL THROM VAS, V17, P2280, DOI 10.1161/01.ATV.17.10.2280; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; Khot UN, 2004, CIRCULATION, V109, P2086, DOI 10.1161/01.CIR.0000127570.20508.5C; Lau GT, 2006, CIRCULATION, V114, pI435, DOI 10.1161/CIRCULATIONAHA.105.001008; Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046; LoGerfo F, 2006, J VASC SURG, V43, P750; Lowe HC, 2002, THROMB HAEMOSTASIS, V87, P134, DOI 10.1055/s-0037-1612956; Lowe HC, 2001, CIRC RES, V89, P670, DOI 10.1161/hh2001.097867; MORISHITA R, 1995, P NATL ACAD SCI USA, V92, P5855, DOI 10.1073/pnas.92.13.5855; Murrell M, 2007, ATHEROSCLEROSIS, V194, P364, DOI 10.1016/j.atherosclerosis.2006.11.016; NABEL EG, 1995, CIRCULATION, V91, P541, DOI 10.1161/01.CIR.91.2.541; Ning W, 2007, AM J RESP CELL MOL, V36, P480, DOI 10.1165/rcmb.2006-0106OC; OHLSTEIN EH, 1993, P NATL ACAD SCI USA, V90, P6189, DOI 10.1073/pnas.90.13.6189; Radke PW, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.003; Rafty LA, 1998, J BIOL CHEM, V273, P5758, DOI 10.1074/jbc.273.10.5758; Sankaranarayanan M, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-14; Santiago FS, 2007, CIRC RES, V101, P146, DOI 10.1161/CIRCRESAHA.106.145235; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Sasseen Brett M., 2001, Journal of Cardiovascular Pharmacology and Therapeutics, V6, P377, DOI 10.1177/107424840100600407; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SOLLOTT SJ, 1995, J CLIN INVEST, V95, P1869, DOI 10.1172/JCI117867; Sousa JE, 2001, CIRCULATION, V103, P192; Sousa JE, 2005, CIRCULATION, V111, P2326, DOI 10.1161/01.CIR.0000164271.01172.1A; Sousa JE, 2003, CIRCULATION, V107, P381, DOI 10.1161/01.CIR.0000051720.59095.6D; Stooker W, 2001, J THORAC CARDIOV SUR, V121, P290, DOI 10.1067/mtc.2001.111656; Sumpio BE, 1998, ARTERIOSCL THROM VAS, V18, P349, DOI 10.1161/01.ATV.18.3.349; Topol EJ, 1998, CIRCULATION, V98, P1802, DOI 10.1161/01.CIR.98.17.1802; Turner NA, 2007, J CARDIOVASC PHARM, V50, P458, DOI 10.1097/FJC.0b013e318123767f; Turner NA, 2007, ATHEROSCLEROSIS, V193, P36, DOI 10.1016/j.atherosclerosis.2006.08.017; Turner NA, 2007, J VASC SURG, V45, P1022, DOI 10.1016/j.jvs.2007.01.061; WANG XL, 1994, CIRCULATION, V89, P1974, DOI 10.1161/01.CIR.89.5.1974; Weissman NJ, 2005, J AM COLL CARDIOL, V45, P1201, DOI 10.1016/j.jacc.2004.10.078; Westerband A, 1997, J VASC SURG, V25, P64, DOI 10.1016/S0741-5214(97)70322-7; Wohrle J, 2001, EUR HEART J, V22, P1808, DOI 10.1053/euhj.2001.2608; Zezina L, 2001, TRANSPL IMMUNOL, V8, P245, DOI 10.1016/S0966-3274(01)00028-4; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120; Zhang GS, 2006, J CELL SCI, V119, P3219, DOI 10.1242/jcs.03059	57	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4038	4048		10.1074/jbc.M109.078345	http://dx.doi.org/10.1074/jbc.M109.078345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940138	Green Published, hybrid			2022-12-27	WOS:000275254000057
J	Price, CE; Driessen, AJM				Price, Claire E.; Driessen, Arnold J. M.			Conserved Negative Charges in the Transmembrane Segments of Subunit K of the NADH:Ubiquinone Oxidoreductase Determine Its Dependence on YidC for Membrane Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; INNER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; PROTEIN INSERTION; F1FO-ATP SYNTHASE; ATP SYNTHASE; NUCLEAR GENE; COMPLEX-I; BIOGENESIS	All members of the Oxa1/Alb3/YidC family have been implicated in the biogenesis of respiratory and energy transducing proteins. In Escherichia coli, YidC functions together with and independently of the Sec system. Although the range of proteins shown to be dependent on YidC continues to increase, the exact role of YidC in insertion remains enigmatic. Here we show that YidC is essential for the insertion of subunit K of the NADH: ubiquinone oxidoreductase and that the dependence is due to the presence of two conserved glutamate residues in the transmembrane segments of subunit K. The results suggest a model in which YidC serves as a membrane chaperone for the insertion of the less hydrophobic, negatively charged transmembrane segments of NuoK.	Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands; Univ Groningen, Kluyver Ctr Genom Ind Fermentat, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Proteomics Centre	Netherlands Proteomics Centre	This work was supported by a grant from the Netherlands Proteomics Centre.	Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Celebi N, 2008, J MOL BIOL, V375, P1282, DOI 10.1016/j.jmb.2007.11.054; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Kol S, 2006, J BIOL CHEM, V281, P29762, DOI 10.1074/jbc.M605317200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Meyer W, 1997, CURR GENET, V31, P401, DOI 10.1007/s002940050222; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Pohlschroder M, 2005, ANNU REV MICROBIOL, V59, P91, DOI 10.1146/annurev.micro.59.030804.121353; Price CE, 2008, J BIOL CHEM, V283, P26921, DOI 10.1074/jbc.M804490200; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Saint-Georges Y, 2001, P NATL ACAD SCI USA, V98, P13814, DOI 10.1073/pnas.251503098; Saller MJ, 2009, J BACTERIOL, V191, P6749, DOI 10.1128/JB.00853-09; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Sellem CH, 2005, GENETICS, V169, P1379, DOI 10.1534/genetics.104.033837; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WACHTER E, 1980, FEBS LETT, V113, P265, DOI 10.1016/0014-5793(80)80606-5; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yu Z, 2008, J BIOL CHEM, V283, P34635, DOI 10.1074/jbc.M804344200	50	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3575	3581		10.1074/jbc.M109.051128	http://dx.doi.org/10.1074/jbc.M109.051128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959836	Green Published, hybrid			2022-12-27	WOS:000275254000008
J	Lewis, EM; Sergeant, S; Ledford, B; Stull, N; Dinauer, MC; Mcphail, LC				Lewis, Eric M.; Sergeant, Susan; Ledford, Bill; Stull, Natalie; Dinauer, Mary C.; Mcphail, Linda C.			Phosphorylation of p22(phox) on Threonine 147 Enhances NADPH Oxidase Activity by Promoting p47(phox) Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL CYTOCHROME-B; TANDEM SH3 DOMAINS; FLAVOCYTOCHROME B(558); RESPIRATORY BURST; REACTIVE OXYGEN; PHORBOL ESTER; LIGHT-CHAIN	NADPH oxidase comprises both cytosolic and membrane-bound subunits, which, when assembled and activated, initiate the transfer of electrons from NADPH to molecular oxygen to form superoxide. This activity, known as the respiratory burst, is extremely important in the innate immune response as indicated by the disorder chronic granulomatous disease. The regulation of this enzyme complex involves protein-protein and protein-lipid interactions as well as phosphorylation events. Previously, our laboratory demonstrated that the small membrane subunit of the oxidase complex, p22(phox), is phosphorylated in neutrophils and that its phosphorylation correlates with NADPH oxidase activity. In this study, we utilized site-directed mutagenesis in a Chinese hamster ovarian cell system to determine the phosphorylation sites within p22(phox). We also explored the mechanism by which p22(phox) phosphorylation affects NADPH oxidase activity. We found that mutation of threonine 147 to alanine inhibited superoxide production in vivo by more than 70%. This mutation also blocked phosphorylation of p22(phox) in vitro by both protein kinase C-alpha and -delta. Moreover, this mutation blocked the p22(phox)-p47(phox) interaction in intact cells. When phosphorylation was mimicked in vivo through mutation of Thr-147 to an aspartyl residue, NADPH oxidase activity was recovered, and the p22(phox)-p47(phox) interaction in the membrane was restored. Maturation of gp91(phox) was not affected by the alanine mutation, and phosphorylation of the cytosolic component p47(phox) still occurred. This study directly implicates threonine 147 of p22(phox) as a critical residue for efficient NADPH oxidase complex formation and resultant enzyme activity.	[Stull, Natalie; Dinauer, Mary C.] Indiana Univ, Sch Med, Riley Hosp Children, Herman B Wells Ctr Pediat Res,Dept Pediat, Indianapolis, IN 46202 USA; Wake Forest Univ, Dept Biochem, Sch Med, Winston Salem, NC 27157 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Wake Forest University		lmcphail@wfubmc.edu	McPhail, Linda C/D-9505-2013	McPhail, Linda C/0000-0002-8670-306X	National Institutes of Health [R01 AI 22564, R01 HL 045635, T32 GM-063485]; March of Dimes Research Foundation [MOD 1-FY02-191]; Wake Forest University Graduate School of Arts and Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Foundation(March of Dimes); Wake Forest University Graduate School of Arts and Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 22564 (to L. C. M.) and R01 HL 045635 (to M. C. D.). This work was also supported by March of Dimes Research Foundation Grant MOD 1-FY02-191 (to L. C. M.).; Supported by National Institutes of Health Training Grant T32 GM-063485 and a graduate fellowship from the Wake Forest University Graduate School of Arts and Sciences.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 2002, J BIOL CHEM, V277, P30368, DOI 10.1074/jbc.M203993200; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; DECHATELET LR, 1976, BLOOD, V47, P545; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; DEMENDEZ I, 1995, BLOOD, V85, P1104, DOI 10.1182/blood.V85.4.1104.bloodjournal8541104; ELLIS JA, 1989, BIOCHEM J, V262, P575, DOI 10.1042/bj2620575; GARCIA RC, 1988, BIOCHEM J, V252, P901, DOI 10.1042/bj2520901; Greaves DR, 2000, MICROBES INFECT, V2, P331, DOI 10.1016/S1286-4579(00)00293-8; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; JESAITIS AJ, 1991, NEW BIOL, V3, P651; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; LETO TL, 1991, J BIOL CHEM, V266, P19812; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; LIGHT DR, 1981, BIOCHEMISTRY-US, V20, P1468, DOI 10.1021/bi00509a010; LU DJ, 1993, BLOOD CELLS, V19, P343; LYNCH RE, 1983, TOP CURR CHEM, V108, P35; McCall C E, 1985, Trans Assoc Am Physicians, V98, P253; MCPHAIL LC, 1993, EUR J HAEMATOL, V51, P294; MCPHAIL LC, 1993, NATURAL IMMUNE SYSTE, P63; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nobuhisa I, 2006, BIOCHEM J, V396, P183, DOI 10.1042/BJ20051899; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; PONTREMOLI S, 1986, ITAL J BIOCHEM, V35, P368; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Reeves EP, 1999, BIOCHEM J, V344, P859, DOI 10.1042/0264-6021:3440859; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Takeya R, 2006, ANTIOXID REDOX SIGN, V8, P1523, DOI 10.1089/ars.2006.8.1523; TAUBER AI, 1982, BLOOD, V60, P333; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121; WIERNIK PH, 1985, MEDIGUIDE ONCOL, V1, P1; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	62	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2959	10.1074/jbc.M109.030643	http://dx.doi.org/10.1074/jbc.M109.030643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948736	Green Published, hybrid			2022-12-27	WOS:000273829000010
J	Adam, AP; Sharenko, AL; Pumiglia, K; Vincent, PA				Adam, Alejandro P.; Sharenko, Amy L.; Pumiglia, Kevin; Vincent, Peter A.			Src-induced Tyrosine Phosphorylation of VE-cadherin Is Not Sufficient to Decrease Barrier Function of Endothelial Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-PERMEABILITY; LEUKOCYTE TRANSMIGRATION; ADHERENS JUNCTIONS; FAMILY KINASES; GROWTH-FACTOR; CELLS; MICE; IDENTIFICATION; P120-CATENIN; ENDOCYTOSIS	Activation of Src family kinases (SFK) and the subsequent phosphorylation of VE-cadherin have been proposed as major regulatory steps leading to increases in vascular permeability in response to inflammatory mediators and growth factors. To investigate Src signaling in the absence of parallel signaling pathways initiated by growth factors or inflammatory mediators, we activated Src and SFKs by expression of dominant negative Csk, expression of constitutively active Src, or knockdown of Csk. Activation of SFK by overexpression of dominant negative Csk induced VE-cadherin phosphorylation at tyrosines 658, 685, and 731. However, dominant negative Csk expression was unable to induce changes in the monolayer permeability. In contrast, expression of constitutively active Src decreased barrier function and promoted VE-cadherin phosphorylation on tyrosines 658 and 731, although the increase in VE-cadherin phosphorylation preceded the increase in permeability by 4-6 h. Csk knockdown induced VE-cadherin phosphorylation at sites 658 and 731 but did not induce a loss in barrier function. Co-immunoprecipitation and immunofluorescence studies suggest that phosphorylation of those sites did not impair VE-cadherin ability to bind p120 and beta-catenin or the ability of these proteins to localize at the plasma membrane. Taken together, our data show that Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to promote an increase in endothelial cell monolayer permeability and suggest that signaling leading to changes in vascular permeability in response to inflammatory mediators or growth factors may require VE-cadherin tyrosine phosphorylation concurrently with other signaling pathways to promote loss of barrier function.	[Adam, Alejandro P.; Sharenko, Amy L.; Vincent, Peter A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Pumiglia, Kevin] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Vincent, PA (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	vincenp@mail.amc.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235; Pumiglia, Kevin/0000-0003-4655-0334	National Institutes of Health [RO1 HL77870]; NATIONAL CANCER INSTITUTE [R01CA081419] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL77870 (to P.A.V.).	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Knezevic II, 2009, J BIOL CHEM, V284, P5381, DOI 10.1074/jbc.M808958200; LAFLAMME SE, 2008, CELL JUNCTIONS ADHES, P169; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Turowski P, 2008, J CELL SCI, V121, P29, DOI 10.1242/jcs.022681; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Zhang Y, 2008, GROWTH FACTORS, V26, P125, DOI 10.1080/08977190802105909	36	97	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7045	7055		10.1074/jbc.M109.079277	http://dx.doi.org/10.1074/jbc.M109.079277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048167	Green Published, hybrid			2022-12-27	WOS:000275415600018
J	Monsey, J; Shen, W; Schlesinger, P; Bose, R				Monsey, John; Shen, Wei; Schlesinger, Paul; Bose, Ron			Her4 and Her2/neu Tyrosine Kinase Domains Dimerize and Activate in a Reconstituted in Vitro System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR SIGNALING COMPLEXES; DEPENDENT PROTEIN-KINASE; EGF RECEPTOR; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; ERBB RECEPTORS; BREAST-CANCER	Her4 (ErbB-4) and Her2/neu (ErbB-2) are receptor-tyrosine kinases belonging to the epidermal growth factor receptor (EGFR) family. Crystal structures of EGFR and Her4 kinase domains demonstrate kinase dimerization and activation through an allosteric mechanism. The kinase domains form an asymmetric dimer, where the C-lobe surface of one monomer contacts the N-lobe of the other monomer. EGFR kinase dimerization and activation in vitro was previously reported using a nickel-chelating lipid-liposome system, and we now apply this system to all other members of the EGFR family. Polyhistidine-tagged Her4, Her2/neu, and Her3 kinase domains are bound to these nickel-liposomes and are brought to high local concentration, mimicking what happens to full-length receptors in vivo following ligand binding. Addition of nickel-liposomes to Her4 kinase domain results in 40-fold activation in kinase activity and marked enhancement of C-terminal tail autophosphorylation. Activation of Her4 shows a sigmoidal dependence on kinase concentration, consistent with a cooperative process requiring kinase dimerization. Her2/neu kinase activity is also activated by nickel-liposomes, and is increased further by heterodimerization with Her3 or Her4. The ability of Her3 and Her4 to heterodimerize and activate other family members is studied in vitro. Her3 kinase domain readily activates Her2/neu but is a poor activator of Her4, which differs from the prediction made by the asymmetric dimer model. Mutation of Her3 residues (ENI954)-E-952 to the corresponding sequence in Her4 enhanced the ability of Her3 to activate Her4, demonstrating that sequence differences on the C-lobe surface influence the heterodimerization and activation of ErbB kinase domains.	Washington Univ, Div Oncol, Dept Med, Sch Med, St Louis, MO 63110 USA; [Schlesinger, Paul; Bose, Ron] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bose, R (corresponding author), 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	rbose@dom.wustl.edu	Schlesinger, Paul H/C-6049-2012		National Institutes of Health [K22CA128951]; NATIONAL CANCER INSTITUTE [K22CA128951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K22CA128951 (NCI Transition Career Development Award, K22) (to R. B.).	ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DeLano W.L, PYMOL MOL GRAPHICS S; Esposito EA, 2008, J BIOMOL SCREEN, V13, P810, DOI 10.1177/1087057108322062; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jan AY, 2000, BIOCHEMISTRY-US, V39, P9786, DOI 10.1021/bi9924922; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Montefusco DJ, 2007, METHOD ENZYMOL, V423, P267, DOI 10.1016/S0076-6879(07)23012-5; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Sun GQ, 1999, BIOCHEMISTRY-US, V38, P5659, DOI 10.1021/bi982793w; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	48	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7035	7044		10.1074/jbc.M109.096032	http://dx.doi.org/10.1074/jbc.M109.096032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022944	Green Published, hybrid			2022-12-27	WOS:000275415600017
J	Shen, Y; Lookene, A; Zhang, L; Olivecrona, G				Shen, Yan; Lookene, Aivar; Zhang, Liyang; Olivecrona, Gunilla			Site-directed Mutagenesis of Apolipoprotein CII to Probe the Role of Its Secondary Structure for Activation of Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; C-II; AMPHIPATHIC HELIX; LIPID-BINDING; HUMAN SERUM; FRAGMENT; LIPOLYSIS	Apolipoprotein CII (apoCII) is a necessary activator for lipoprotein lipase (LPL). We had identified four residues (Tyr-63, Ile-66, Asp-69, and Gln-70), presumably contained in an alpha-helix, as a potential binding site for LPL. We have now used structure prediction, mutagenesis, and functional assays to explore the functional role of the secondary structure in this part of apoCII. First, mutants were generated by replacements with proline residues to disturb the helical structure. Activation by mutant G65P was reduced by 30%, whereas mutant S54P retained activation ability. Mutants V71P and L72P should be located outside the LPL-binding site, but V71P was totally inactive, whereas activation by L72P was reduced by 65%. Insertion of alanine after Tyr-63, changing the position of the putative LPL-binding site in relation to the hydrophobic face of the alpha-helix, also severely impeded the activation ability, and a double mutant (Y63A/I66A) was completely inactive. Next, to investigate the importance of conserved hydrophobic residues in the C-terminal end of apoCII, Phe-67, Val-71, Leu-72, and Leu-75 were exchanged for polar residues. Only F67S showed dramatic loss of function. Finally, fragment 39-62, previously claimed to activate LPL, was found to be completely inactive. Our data support the view that the helical structure close to the C-terminal end of apoCII is important for activation of LPL, probably by placing residues 63, 66, 69, and 70 in an optimal steric position. The structural requirements for the hydrophobic face on the back side of this helix and further out toward the C terminus were less stringent.	[Shen, Yan; Lookene, Aivar; Zhang, Liyang; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Lookene, Aivar] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	Umea University; Tallinn University of Technology	Olivecrona, G (corresponding author), Umea Univ, Dept Med Biosci Physiol Chem, Bldg 6M,3rd Floor, SE-90187 Umea, Sweden.	Gunilla.Olivecrona@medbio.umu.se			Swedish Research Council [12203]; Estonian Science Foundation [6834]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Estonian Science Foundation	This work was supported by Swedish Research Council Grant 12203 and by Estonian Science Foundation Grant 6834.	BALASUBRAMANIAM A, 1986, CHEM PHYS LIPIDS, V39, P341, DOI 10.1016/0009-3084(86)90115-5; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P549, DOI 10.1111/j.1432-1033.1980.tb04602.x; BIER DM, 1970, J LIPID RES, V11, P565; Dahim M, 2001, J LIPID RES, V42, P553; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; KINNUNEN PKJ, 1977, P NATL ACAD SCI USA, V74, P4848, DOI 10.1073/pnas.74.11.4848; KINNUNEN PKJ, 1983, ATHER REV, V11, P65; Lam CW, 2006, CLIN CHIM ACTA, V364, P256, DOI 10.1016/j.cca.2005.07.025; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; LYCKSELL PO, 1992, EUR J BIOCHEM, V205, P223, DOI 10.1111/j.1432-1033.1992.tb16772.x; MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t; MacPhee CE, 1999, ANAL BIOCHEM, V275, P22, DOI 10.1006/abio.1999.4283; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; MENZEL HJ, 1986, J CLIN INVEST, V77, P595, DOI 10.1172/JCI112342; MYKLEBOST O, 1984, J BIOL CHEM, V259, P4401; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; OHMAN A, 1993, EUR BIOPHYS J BIOPHY, V22, P351, DOI 10.1007/BF00213558; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; SEGREST JP, 1992, J LIPID RES, V33, P141; Shen Y, 2000, GENE, V254, P189, DOI 10.1016/S0378-1119(00)00268-7; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; Sparrow J T, 1980, Ann N Y Acad Sci, V348, P187, DOI 10.1111/j.1749-6632.1980.tb21300.x; Storjohann R, 2000, BBA-MOL CELL BIOL L, V1486, P253, DOI 10.1016/S1388-1981(00)00062-7; VAINIO P, 1983, J BIOL CHEM, V258, P5477; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zdunek J, 2003, BIOCHEMISTRY-US, V42, P1872, DOI 10.1021/bi0267184	27	15	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7484	7492		10.1074/jbc.M109.022046	http://dx.doi.org/10.1074/jbc.M109.022046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042600	Green Published, hybrid			2022-12-27	WOS:000275415600060
J	Alberobello, AT; D'Esposito, V; Marasco, D; Doti, N; Ruvo, M; Bianco, R; Tortora, G; Esposito, I; Fiory, F; Miele, C; Beguinot, F; Formisano, P				Alberobello, A. Teresa; D'Esposito, Vittoria; Marasco, Daniela; Doti, Nunzianna; Ruvo, Menotti; Bianco, Roberto; Tortora, Giampaolo; Esposito, Iolanda; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Formisano, Pietro			Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; THERAPEUTIC TARGET; BREAST-CANCER; SOLID TUMORS; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; CARCINOMA CELLS; C-TERMINUS	Insulin-like growth factor-1 (IGF-1) signaling system exerts a broad antiapoptotic function and plays a crucial role in resistance to anticancer therapies. Exposure of MCF-7 breast cancer cells to IGF-1 rapidly and transiently induced tyrosine phosphorylation and activation of phosphoinositide-dependent kinase-1 (PDK1). This was paralleled by Akt/protein kinase B and protein kinase C-zeta phosphorylation, at Thr(308) and Thr(410), respectively. IGF-1 treatment also enhanced PDK1 interaction with IGF-1 receptor (IGF-1R) in intact MCF-7 cells. Pulldown assays revealed that PDK1 bound IGF-1R in vitro and that the region encompassing amino acids 51-359 of PDK1 was necessary for the interaction. Synthetic peptides corresponding to IGF-1R C terminus amino acids 1295-1337 (C43) and to PDK1 amino acids 114-141 reduced in vitro IGF-1R/PDK1 interaction in a concentration-dependent manner. Loading of fluoresceinated-C43 (fluorescein isothiocyanate (FITC)-C43) into MCF-7 cells significantly reduced IGF-1R/PDK1 interaction and phosphorylation of PDK1 substrates. Moreover, FITC-C43 intracellular loading reverted the protective effect of IGF-1 on growth factor deprivation-induced cell death. Finally, the inhibition of IGF-1R/PDK1 interaction and signaling by FITC-C43 was accompanied by 2-fold enhanced killing capacity of cetuximab in human GEO colon adenocarcinoma cells and was sufficient to restore cell death in cetuximab-resistant cell clones. Thus, disruption of PDK1 interaction with IGF-1R reduces IGF-1 survival effects in cancer cells and may enhance cell death by anticancer agents.	[Alberobello, A. Teresa; D'Esposito, Vittoria; Esposito, Iolanda; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Alberobello, A. Teresa; D'Esposito, Vittoria; Esposito, Iolanda; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico II, Ist Endocrinol Oncol Sperimentale, CNR, I-80131 Naples, Italy; [Marasco, Daniela] Univ Naples Federico II, Dipartimento Sci Biol, I-80131 Naples, Italy; [Doti, Nunzianna; Ruvo, Menotti] Univ Naples Federico II, Ist Biostutture & Bioimmagini, CNR, I-80131 Naples, Italy; [Bianco, Roberto; Tortora, Giampaolo] Univ Naples Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II	Formisano, P (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.	fpietro@unina.it	Tortora, Giampaolo/AAA-1252-2019; Marasco, Daniela/H-4848-2015; Doti, Nunzianna/ABC-9948-2020; Tortora, Giampaolo/HGB-6261-2022; D'Esposito, Vittoria/K-7633-2016; Formisano, Pietro/J-4237-2018	Marasco, Daniela/0000-0002-6618-2949; D'Esposito, Vittoria/0000-0002-3675-8062; Formisano, Pietro/0000-0001-7020-6870; Tortora, Giampaolo/0000-0002-1378-4962	European Community FP6 EUGENE2 [LSHM-CT-2004-512013]; FP7 PREPROBEDIA [201681]; European Federation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica [RBRN07BMCT]; Telethon-Italy	European Community FP6 EUGENE2(European Commission); FP7 PREPROBEDIA; European Federation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Telethon-Italy(Fondazione Telethon)	This work was supported by grants from the European Community FP6 EUGENE2 (Grant LSHM-CT-2004-512013) and the FP7 PREPROBEDIA (Grant 201681), the European Federation for the Study of Diabetes, the Associazione Italiana per la Ricerca sul Cancro, and the Ministero dell'Universita e della Ricerca Scientifica (PRIN and FIRB Grants RBRN07BMCT). The financial support of Telethon-Italy is also gratefully acknowledged.	Ahmed N, 2008, BRIT J CANCER, V98, P1415, DOI 10.1038/sj.bjc.6604306; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barnes CJ, 2007, CLIN CANCER RES, V13, P4291, DOI 10.1158/1078-0432.CCR-06-2040; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Dunn SE, 1997, CANCER RES, V57, P2687; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; Formisano P, 1998, J BIOL CHEM, V273, P13197, DOI 10.1074/jbc.273.21.13197; Gallego R, 2009, ENDOCR-RELAT CANCER, V16, P311, DOI 10.1677/ERC-08-0250; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hongo A, 1998, CANCER RES, V58, P2477; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jimeno A, 2008, CANCER CHEMOTH PHARM, V61, P423, DOI 10.1007/s00280-007-0485-9; Jones HE, 2006, ENDOCR-RELAT CANCER, V13, pS45, DOI 10.1677/erc.1.01275; KATO H, 1993, J BIOL CHEM, V268, P2655; KLIP A, 1982, BIOCHIM BIOPHYS ACTA, V687, P265, DOI 10.1016/0005-2736(82)90555-7; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kortmansky J, 2005, J CLIN ONCOL, V23, P1875, DOI 10.1200/JCO.2005.03.116; LeRoith D, 2004, CANCER CELL, V5, P201, DOI 10.1016/S1535-6108(04)00054-6; Liu YM, 1998, CANCER RES, V58, P570; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Reiss K, 1999, J CELL PHYSIOL, V181, P124, DOI 10.1002/(SICI)1097-4652(199910)181:1<124::AID-JCP13>3.0.CO;2-0; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Ryan PD, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.2007-0199; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Samani A A, 2001, Surg Oncol Clin N Am, V10, P289; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; SEYNAEVE CM, 1993, CANCER RES, V53, P2081; SURMACZ E, 1995, EXP CELL RES, V218, P370, DOI 10.1006/excr.1995.1168; Takahari D, 2009, ONCOLOGY-BASEL, V76, P42, DOI 10.1159/000178164; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang Q, 2008, J CLIN INVEST, V118, P2389, DOI 10.1172/JCI36260; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Wu YP, 2003, CANCER RES, V63, P4384; Xie ZH, 2003, CANCER RES, V63, P5370; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	58	19	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6563	6572		10.1074/jbc.M109.097410	http://dx.doi.org/10.1074/jbc.M109.097410			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20044479	Green Published, hybrid			2022-12-27	WOS:000275367500061
J	Sugimoto, S; Yamanaka, K; Nishikori, S; Miyagi, A; Ando, T; Ogura, T				Sugimoto, Shinya; Yamanaka, Kunitoshi; Nishikori, Shingo; Miyagi, Atsushi; Ando, Toshio; Ogura, Teru			AAA(+) Chaperone ClpX Regulates Dynamics of Prokaryotic Cytoskeletal Protein FtsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI FTSZ; ATP-DEPENDENT PROTEASES; N-TERMINAL DOMAIN; CELL-DIVISION; POLYMER DYNAMICS; GTP HYDROLYSIS; IN-VITRO; HSP104; TUBULIN; VISUALIZATION	AAA(+) chaperone ClpX has been suggested to be a modulator of prokaryotic cytoskeletal protein FtsZ, but the details of recognition and remodeling of FtsZ by ClpX are largely unknown. In this study, we have extensively investigated the nature of FtsZ polymers and mechanisms of ClpX-regulated FtsZ polymer dynamics. We found that FtsZ polymerization is inhibited by ClpX in an ATP-independent manner and that the N-terminal domain of ClpX plays a crucial role for the inhibition of FtsZ polymerization. Single molecule analysis with high speed atomic force microscopy directly revealed that FtsZ polymer is in a dynamic equilibrium between polymerization and depolymerization on a time scale of several seconds. ClpX disassembles FtsZ polymers presumably by blocking reassembly of FtsZ. Furthermore, Escherichia coli cells overproducing ClpX and N-terminal domain of ClpX show filamentous morphology with abnormal localization of FtsZ. These data together suggest that ClpX modulates FtsZ polymer dynamics in an ATP-independent fashion, which is achieved by interaction between the N-terminal domain of ClpX and FtsZ monomers or oligomers.	[Sugimoto, Shinya; Yamanaka, Kunitoshi; Nishikori, Shingo; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan; [Miyagi, Atsushi; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Miyagi, Atsushi] Osaka Univ, Inst Prot Res, Takara Bio Endowed Lab, Osaka 5650874, Japan	Kumamoto University; Kanazawa University; Osaka University	Ogura, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ogura@gpo.kumamoto-u.ac.jp	ANDO, Toshio/E-7054-2015	ANDO, Toshio/0000-0001-8819-154X; Ogura, Teru/0000-0003-3784-0970; Sugimoto, Shinya/0000-0002-3114-8513	Japan Society for the Promotion of Science; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, by the Core Research for Evolutional Science and Technology program grant from the Japan Science and Technology Agency, and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matsushita-Ishiodori Y, 2009, GENES CELLS, V14, P925, DOI 10.1111/j.1365-2443.2009.01320.x; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sugimoto S, 2008, MICROBIOL-SGM, V154, P1876, DOI 10.1099/mic.0.2008/017376-0; Sugimoto S, 2007, FEBS LETT, V581, P2993, DOI 10.1016/j.febslet.2007.05.055; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; WOO KM, 1992, J BIOL CHEM, V267, P20429; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	42	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6648	6657		10.1074/jbc.M109.080739	http://dx.doi.org/10.1074/jbc.M109.080739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022957	Green Published, hybrid			2022-12-27	WOS:000275367500069
J	Campbell, S; Hazes, B; Kvansakul, M; Colman, P; Barry, M				Campbell, Stephanie; Hazes, Bart; Kvansakul, Marc; Colman, Peter; Barry, Michele			Vaccinia Virus F1L Interacts with Bak Using Highly Divergent Bcl-2 Homology Domains and Replaces the Function of Mcl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PROAPOPTOTIC PROTEIN BAK; BH3-ONLY PROTEINS; MYXOMA-VIRUS; GRANZYME-B; CELL-DEATH; BLOCKS APOPTOSIS; FOWLPOX VIRUS; E1B 19K; MITOCHONDRIAL-MEMBRANE	The Bcl-2 family regulates induction of apoptosis at the mitochondria. Essential to this regulation are the interactions between Bcl-2 family members, which are mediated by Bcl-2 homology (BH) domains. Vaccinia virus F1L is a unique inhibitor of apoptosis that lacks significant sequence similarity with the Bcl-2 family and does not contain obvious BH domains. Despite this, F1L inhibits cytochrome c release from mitochondria by preventing Bak and Bax activation. Although F1L constitutively interacts with Bak to prevent Bak activation, the precise mechanism of this interaction remains elusive. We have identified highly divergent BH domains in F1L that were verified by the recent crystal structure of F1L (Kvansakul, M., Yang, H., Fairlie, W. D., Czabotar, P. E., Fischer, S. F., Perugini, M. A., Huang, D. C., and Colman, P. M. (2008) Cell Death Differ. 15, 1564-1571). Here we show that F1L required these BH domains to interact with ectopically expressed and endogenous Bak. The interaction between F1L and Bak was conserved across species, and both F1L and the cellular antiapoptotic protein Mcl-1 required the Bak BH3 domain for interaction. Moreover, F1L replaced Mcl-1 during infection, as the Bak.Mcl-1 complex was disrupted during vaccinia virus infection. In contrast to UV irradiation, vaccinia virus infection did not result in rapid degradation of Mcl-1, consistent with our observation that vaccinia virus did not initiate a DNA damage response. Additionally, Mcl-1 expression prevented Bak activation and apoptosis during infection with a proapoptotic vaccinia virus devoid of F1L. Our data suggest that F1L replaces the antiapoptotic activity of Mcl-1 during vaccinia virus infection by interacting with Bak using highly divergent BH domains.	[Campbell, Stephanie; Hazes, Bart; Barry, Michele] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Kvansakul, Marc; Colman, Peter] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	University of Alberta; Walter & Eliza Hall Institute	Barry, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, 621 HMRC, Edmonton, AB T6G 2S2, Canada.	michele.barry@ualberta.ca	Kvansakul, Marc/AAF-2453-2019	Kvansakul, Marc/0000-0003-2639-2498	Canadian Institutes of Health Research; Howard Hughes Medical Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Canadian Institutes of Health Research and the Howard Hughes Medical Institute (to M. B.).	Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Banadyga L, 2007, J VIROL, V81, P11032, DOI 10.1128/JVI.00734-07; Banadyga L, 2009, J VIROL, V83, P7085, DOI 10.1128/JVI.00437-09; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Barry M, 2004, PROG MOL SUBCELL BIO, V36, P19; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; BOYD JM, 1995, ONCOGENE, V11, P1921; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107; Earl PL, 1998, CURRENT PROTOCOLS MO; Everett H, 2000, J EXP MED, V191, P1487, DOI 10.1084/jem.191.9.1487; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Han J, 1996, MOL CELL BIOL, V16, P5857; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Han JH, 1998, ONCOGENE, V17, P2993, DOI 10.1038/sj.onc.1202215; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Khanim F, 1997, J GEN VIROL, V78, P2987, DOI 10.1099/0022-1317-78-11-2987; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Mei YD, 2005, ONCOGENE, V24, P7224, DOI 10.1038/sj.onc.1208873; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Revilla Y, 1997, VIROLOGY, V228, P400, DOI 10.1006/viro.1996.8395; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; STUART D, 1991, J VIROL, V65, P61, DOI 10.1128/JVI.65.1.61-70.1991; Su J, 2006, J VIROL, V80, P1140, DOI 10.1128/JVI.80.3.1140-1151.2006; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tulman ER, 2004, J VIROL, V78, P353, DOI 10.1128/JVI.78.1.353-366.2004; Ulrich E, 1997, GENOMICS, V44, P195, DOI 10.1006/geno.1997.4858; van Buuren N, 2008, J VIROL, V82, P9917, DOI 10.1128/JVI.00953-08; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wang XD, 2001, GENE DEV, V15, P2922; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wasilenko ST, 2001, J VIROL, V75, P11437, DOI 10.1128/JVI.75.23.11437-11448.2001; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	74	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4695	4708		10.1074/jbc.M109.053769	http://dx.doi.org/10.1074/jbc.M109.053769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19955184	hybrid, Green Published			2022-12-27	WOS:000275274800047
J	Parul, D; Palmer, G; Fabian, M				Parul, Dzmitry; Palmer, Graham; Fabian, Marian			Ligand Trapping by Cytochrome c Oxidase IMPLICATIONS FOR GATING AT THE CATALYTIC CENTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; LINKED CONFORMATIONAL-CHANGE; FE(A3)-CU(B) BINUCLEAR SITE; PROTON-PUMPING MECHANISM; BOVINE HEART; CYANIDE BINDING; PARACOCCUS-DENITRIFICANS; INFRARED-SPECTROSCOPY; ESCHERICHIA-COLI; NITRIC-OXIDE	Cytochrome c oxidase is a member of the heme-copper family of oxygen reductases in which electron transfer is linked to the pumping of protons across the membrane. Neither the redox center(s) associated with proton pumping nor the pumping mechanism presumably common to all heme-copper oxidases has been established. A possible conformational coupling between the catalytic center (Fe-a3(3+)-Cu-B(2+)) and a protein site has been identified earlier from ligand binding studies, whereas a structural change initiated by azide binding to the protein has been proposed to facilitate the access of cyanide to the catalytic center of the oxidized bovine enzyme. Here we show that cytochrome oxidase pretreated with a low concentration of azide exhibits a significant increase in the apparent rate of cyanide binding relative to that of free enzyme. However, this increase in rate does not reflect a conformational change enhancing the rapid formation of a Fe-a3(3+)-CN-Cu-B(2+) complex. Instead the cyanide-induced transition of a preformed Fe-a3(3+)-N-3-Cu-B(2+) to the ternary complex of Fe-a3(3+)-N3CuB2+-CN is the most likely reason for the observed acceleration. Significantly, the slow rate of azide release from the ternary complex indicates that cyanide ligated to Cu-B blocks a channel between the catalytic site and the solvent. The results suggest that there is a pathway that originates at Cu-B and that, during catalysis, ligands present at this copper center control access to the iron of heme a(3) from the bulk medium.	[Parul, Dzmitry; Palmer, Graham; Fabian, Marian] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	Fabian, M (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St,MS 140, Houston, TX 77005 USA.	fabian@rice.edu			National Institutes of Health [GM 084348, GM 35649, GM 080575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, R01GM084348, R01GM080575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 084348 (to M. F.), GM 35649 (to John S. Olson), and GM 080575 (to G. P.).	ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; BRUDVIG GW, 1980, BIOCHEMISTRY-US, V19, P5275, DOI 10.1021/bi00564a020; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; DAY EP, 1993, BIOCHEMISTRY-US, V32, P7855, DOI 10.1021/bi00082a003; DYER RB, 1989, J AM CHEM SOC, V111, P7657, DOI 10.1021/ja00201a080; DYER RB, 1991, J AM CHEM SOC, V113, P6276, DOI 10.1021/ja00016a057; DYER RB, 1994, BIOCHEMISTRY-US, V33, P500, DOI 10.1021/bi00168a015; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; Fabian M, 2004, J BIOL CHEM, V279, P16170, DOI 10.1074/jbc.M311834200; FANN YC, 1995, BIOCHEMISTRY-US, V34, P10245, DOI 10.1021/bi00032a019; Fei MJ, 2000, ACTA CRYSTALLOGR D, V56, P529, DOI 10.1107/S0907444900002213; Florens L, 2001, BIOCHEMISTRY-US, V40, P7491, DOI 10.1021/bi0101188; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; HILL BC, 1994, FEBS LETT, V354, P284, DOI 10.1016/0014-5793(94)01140-0; HILL BC, 1983, BIOCHEM J, V215, P57, DOI 10.1042/bj2150057; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kaila VRI, 2009, BBA-BIOENERGETICS, V1787, P1205, DOI 10.1016/j.bbabio.2009.04.008; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; LI WB, 1993, BIOCHEMISTRY-US, V32, P1833, DOI 10.1021/bi00058a018; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Mochizuki M, 2008, BBA-BIOENERGETICS, V1777, pS69, DOI 10.1016/j.bbabio.2008.05.271; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pilet E, 2004, BIOCHEMISTRY-US, V43, P14118, DOI 10.1021/bi0488808; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Puustinen A, 1999, P NATL ACAD SCI USA, V96, P35, DOI 10.1073/pnas.96.1.35; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Riistama S, 1996, BBA-BIOENERGETICS, V1275, P1, DOI 10.1016/0005-2728(96)00040-0; Schmidt B, 2003, P NATL ACAD SCI USA, V100, P15539, DOI 10.1073/pnas.2633243100; Sergio PB, 2004, BBA-BIOENERGETICS, V1655, P353, DOI 10.1016/j.bbabio.2003.06.002; Sharpe MA, 2008, J BIOENERG BIOMEMBR, V40, P541, DOI 10.1007/s10863-008-9182-6; Siegbahn PEM, 2008, J PHYS CHEM A, V112, P12772, DOI 10.1021/jp801635c; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; SOULIMANE T, 1995, EUR J BIOCHEM, V227, P588, DOI 10.1111/j.1432-1033.1995.tb20429.x; STEVENS TH, 1979, P NATL ACAD SCI USA, V76, P3320, DOI 10.1073/pnas.76.7.3320; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; THOMSON AJ, 1985, J INORG BIOCHEM, V23, P187, DOI 10.1016/0162-0134(85)85025-X; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P174, DOI 10.1021/bi00052a023; Tsubaki M, 1996, J BIOL CHEM, V271, P4017; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P164, DOI 10.1021/bi00052a022; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vamvouka M, 1999, J PHYS CHEM B, V103, P3030, DOI 10.1021/jp984589o; VANBUUREN KJ, 1972, BIOCHIM BIOPHYS ACTA, V256, P258, DOI 10.1016/0005-2728(72)90057-6; VYGODINA TV, 1985, BIOL MEMBRANY, V2, P861; WEVER R, 1973, BIOCHIM BIOPHYS ACTA, V325, P1, DOI 10.1016/0005-2728(73)90144-8; Wikstrom M, 2007, BBA-BIOENERGETICS, V1767, P1200, DOI 10.1016/j.bbabio.2007.06.008; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; YOSHIKAWA S, 1990, J BIOL CHEM, V265, P7945; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P9757; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	54	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4536	4543		10.1074/jbc.M109.078618	http://dx.doi.org/10.1074/jbc.M109.078618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20037139	Green Published, hybrid			2022-12-27	WOS:000275274800030
J	Roux, J; Carles, M; Koh, H; Goolaerts, A; Ganter, MT; Chesebro, BB; Howard, M; Houseman, BT; Finkbeiner, W; Shokat, KM; Paquet, AC; Matthay, MA; Pittet, JF				Roux, Jeremie; Carles, Michel; Koh, Hidefumi; Goolaerts, Arnaud; Ganter, Michael T.; Chesebro, Brian B.; Howard, Marybeth; Houseman, Benjamin T.; Finkbeiner, Walter; Shokat, Kevan M.; Paquet, Agnes C.; Matthay, Michael A.; Pittet, Jean-Francois			Transforming Growth Factor beta 1 Inhibits Cystic Fibrosis Transmembrane Conductance Regulator-dependent cAMP-stimulated Alveolar Epithelial Fluid Transport via a Phosphatidylinositol 3-Kinase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG LIQUID CLEARANCE; TGF-BETA; PHOSPHOINOSITIDE 3-KINASE; DECREASES EXPRESSION; HEMORRHAGIC-SHOCK; CFTR EXPRESSION; DOWN-REGULATION; ION-TRANSPORT; CELLS; ACTIVATION	Exogenous or endogenous beta 2-adrenergic receptor agonists enhance alveolar epithelial fluid transport via a cAMP-dependent mechanism that protects the lungs from alveolar flooding in acute lung injury. However, impaired alveolar fluid clearance is present in most of the patients with acute lung injury and is associated with increased mortality, although the mechanisms responsible for this inhibition of the alveolar epithelial fluid transport are not completely understood. Here, we found that transforming growth factor beta 1 (TGF-beta 1), a critical mediator of acute lung injury, inhibits beta(2)-adrenergic receptor agonist-stimulated vectorial fluid and Cl- transport across primary rat and human alveolar epithelial type II cell monolayers. This inhibition is due to a reduction in the cystic fibrosis transmembrane conductance regulator activity and biosynthesis mediated by a phosphatidylinositol 3-kinase (PI3K)-dependent heterologous desensitization and down-regulation of the beta(2)-adrenergic receptors. Consistent with these in vitro results, inhibition of the PI3K pathway or pretreatment with soluble chimeric TGF-beta type II receptor restored beta(2)-adrenergic receptor agonist-stimulated alveolar epithelial fluid transport in an in vivo model of acute lung injury induced by hemorrhagic shock in rats. The results demonstrate a novel role for TGF-beta 1 in impairing the beta-adrenergic agonist-stimulated alveolar fluid clearance in acute lung injury, an effect that could be corrected by using PI3K inhibitors that are safe to use in humans.	[Roux, Jeremie; Carles, Michel; Koh, Hidefumi; Goolaerts, Arnaud; Ganter, Michael T.; Chesebro, Brian B.; Howard, Marybeth; Matthay, Michael A.; Pittet, Jean-Francois] Univ Calif San Francisco, Surg Res Lab, Dept Anesthesia, San Francisco, CA 94110 USA; [Roux, Jeremie; Carles, Michel; Koh, Hidefumi; Goolaerts, Arnaud; Ganter, Michael T.; Chesebro, Brian B.; Howard, Marybeth; Matthay, Michael A.; Pittet, Jean-Francois] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA; [Matthay, Michael A.; Pittet, Jean-Francois] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94110 USA; [Paquet, Agnes C.; Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Finkbeiner, Walter] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94110 USA; [Carles, Michel] Fac Med, INSERM, U895, Cell Death & Survival Team,Equipe AVENIR 3, F-06103 Nice, France; [Carles, Michel] Univ Nice Sophia Antipolis, F-06103 Nice, France; [Carles, Michel] Ctr Hosp Univ, Dept Anesthesie Reanimat, F-06103 Nice, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Roux, J (corresponding author), San Francisco Gen Hosp, Dept Anesthesia, Rm 3C-38,1001 Potrero Ave, San Francisco, CA 94110 USA.	Jeremie.Roux@gmail.com	Carles, Michel/CAH-0065-2022; Roux, Jeremie/A-9746-2013	Roux, Jeremie/0000-0001-5712-8660; CARLES, MICHEL/0000-0001-5485-1511	National Institutes of Health [P50HL074005, HL-51854, HL-51856, T32 GM008440]; American Lung Association Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, R01HL051856, R01HL051854, P50HL074005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50HL074005, Project 4 (to J.-F. P.), HL-51854 and HL-51856 (to M. A. M.), and T32 GM008440 (to J.R.). This work was also supported by a American Lung Association Senior Research Training Fellowship (to J. R.).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Banday AA, 2007, AM J PHYSIOL-RENAL, V293, pF877, DOI 10.1152/ajprenal.00184.2007; BERTHIAUME Y, 1991, J APPL PHYSIOL, V70, P2490, DOI 10.1152/jappl.1991.70.6.2490; BERTHIAUME Y, 1987, J CLIN INVEST, V79, P335, DOI 10.1172/JCI112817; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; El-Haroun H, 2004, CIRC RES, V94, P353, DOI 10.1161/01.RES.0000111801.48626.F4; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Fukuda N, 2000, J APPL PHYSIOL, V89, P672, DOI 10.1152/jappl.2000.89.2.672; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hamacher J, 2002, AM J RESP CRIT CARE, V166, P651, DOI 10.1164/rccm.2109004; Howe K, 2002, AM J PHYSIOL-CELL PH, V283, pC1667, DOI 10.1152/ajpcell.00414.2001; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Hurst V, 1999, AM J PHYSIOL-LUNG C, V276, pL582, DOI 10.1152/ajplung.1999.276.4.L582; Icard P, 1999, AM J PHYSIOL-LUNG C, V277, pL1232, DOI 10.1152/ajplung.1999.277.6.L1232; Jiang X, 2001, J MEMBRANE BIOL, V181, P195, DOI 10.1007/s00232-001-0022-4; Jiang XP, 1998, AM J PHYSIOL-CELL PH, V275, pC1610, DOI 10.1152/ajpcell.1998.275.6.C1610; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lee I, 2005, FASEB J, V19, pA1027; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mak JCW, 2000, N-S ARCH PHARMACOL, V362, P520, DOI 10.1007/s002100000321; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; McAuley DF, 2004, CRIT CARE MED, V32, P1470, DOI 10.1097/01.CCM.0000129489.34416.0E; MCDONALD RA, 1995, P NATL ACAD SCI USA, V92, P7560, DOI 10.1073/pnas.92.16.7560; Modelska K, 1999, AM J PHYSIOL-LUNG C, V276, pL844, DOI 10.1152/ajplung.1999.276.5.L844; Modelska K, 1997, AM J PHYSIOL-LUNG C, V273, pL305, DOI 10.1152/ajplung.1997.273.2.L305; Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC; Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; NOGAMI M, 1994, AM J PHYSIOL, V266, pL187, DOI 10.1152/ajplung.1994.266.2.L187; Norlin A, 1998, AM J PHYSIOL-LUNG C, V274, pL235, DOI 10.1152/ajplung.1998.274.2.L235; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pittet JF, 2001, J IMMUNOL, V166, P6301, DOI 10.4049/jimmunol.166.10.6301; PITTET JF, 1994, J CLIN INVEST, V94, P663, DOI 10.1172/JCI117383; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Roux J, 2005, J BIOL CHEM, V280, P18579, DOI 10.1074/jbc.M410561200; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakuma T, 1997, AM J RESP CRIT CARE, V155, P506, DOI 10.1164/ajrccm.155.2.9032186; Sakuma T, 2001, J APPL PHYSIOL, V90, P10, DOI 10.1152/jappl.2001.90.1.10; Su X, 2006, AM J PHYSIOL-LUNG C, V290, pL769, DOI 10.1152/ajplung.00334.2005; TIBALLI RN, 1995, J CLIN MICROBIOL, V33, P915, DOI 10.1128/JCM.33.4.915-917.1995; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035	54	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4278	4290		10.1074/jbc.M109.036731	http://dx.doi.org/10.1074/jbc.M109.036731			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996317	Green Published, hybrid			2022-12-27	WOS:000275274800004
J	Song, JY; Park, YH; Nemeria, NS; Kale, S; Kakalis, L; Jordan, F				Song, Jaeyoung; Park, Yun-Hee; Nemeria, Natalia S.; Kale, Sachin; Kakalis, Lazaros; Jordan, Frank			Nuclear Magnetic Resonance Evidence for the Role of the Flexible Regions of the E1 Component of the Pyruvate Dehydrogenase Complex from Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ESCHERICHIA-COLI; THIAMIN DIPHOSPHATE; MULTIENZYME COMPLEX; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; REDUCTIVE ACETYLATION; 1',4'-IMINOPYRIMIDINE TAUTOMER; SUBSTRATE; BINDING; RESIDUES	Most bacterial pyruvate dehydrogenase complexes from either Gram-positive or Gram-negative bacteria have E1 components with an alpha(2) homodimeric quaternary structure. In a sequel to our previous publications, we present the first NMR study on the flexible regions of the E1 component from Escherichia coli and its biological relevance. We report sequence-specific NMR assignments for 6 residues in the N-terminal 1-55 region and for a glycine in each of the two mobile active center loops of the E1 component, a 200-kDa homodimer. This was accomplished by using site-specific substitutions and appropriate labeling patterns along with a peptide with the sequence corresponding to the N-terminal 1-35 amino acids of the E1 component. To study the functions of these mobile regions, we also examined the spectra in the presence of (a) a reaction intermediate analog known to affect the mobility of the active center loops, (b) an E2 component construct consisting of a lipoyl domain and peripheral subunit binding domain, and (c) a peptide corresponding to the amino acid sequence of the E2 peripheral subunit binding domain. Deductions from the NMR studies are in excellent agreement with our functional finding, providing a clear indication that the N-terminal region of the E1 interacts with the E2 peripheral subunit binding domain and that this interaction precedes reductive acetylation. The results provide the first structural support to the notion that the N-terminal region of the E1 component of this entire class of bacterial pyruvate dehydrogenase complexes is responsible for binding the E2 component.	[Song, Jaeyoung; Park, Yun-Hee; Nemeria, Natalia S.; Kale, Sachin; Kakalis, Lazaros; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu			NIGMS NIH HHS [R01 GM050380] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050380] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2004, BIOCHEMISTRY-US, V43, P2405, DOI 10.1021/bi030200y; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; BRAUN D, 1994, J AM CHEM SOC, V116, P8466, DOI 10.1021/ja00098a005; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Hengeveld AF, 2002, FEBS LETT, V522, P173, DOI 10.1016/S0014-5793(02)02931-9; Hengeveld AF, 2002, BIOCHEMISTRY-US, V41, P7490, DOI 10.1021/bi012172u; Hong J, 1998, BBA-PROTEIN STRUCT M, V1385, P187, DOI 10.1016/S0167-4838(98)00068-5; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DD, 2008, BIOCHEM J, V409, P357, DOI 10.1042/BJ20071119; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; KALE S, 2007, THESIS RUTGERS U NEW; Kale S, 2008, P NATL ACAD SCI USA, V105, P1158, DOI 10.1073/pnas.0709328105; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; Kale S, 2009, J BIOL CHEM, V284, P33122, DOI 10.1074/jbc.M109.065508; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2002, BIOCHEMISTRY-US, V41, P15459, DOI 10.1021/bi0205909; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Rodriguez JC, 2006, BIOCHEMISTRY-US, V45, P4578, DOI 10.1021/bi0600188; RUSSELL GC, 1992, BIOCHEM J, V287, P611, DOI 10.1042/bj2870611; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; Wallis NG, 1996, J MOL BIOL, V263, P463, DOI 10.1006/jmbi.1996.0589; Wei W, 2003, PROTEIN EXPRES PURIF, V28, P140, DOI 10.1016/S1046-5928(02)00674-5; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	43	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4680	4694		10.1074/jbc.M109.082842	http://dx.doi.org/10.1074/jbc.M109.082842			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996100	hybrid, Green Published			2022-12-27	WOS:000275274800046
J	Porten, E; Seliger, B; Schneider, VA; Woll, S; Stangel, D; Ramseger, R; Kroger, S				Porten, Elmar; Seliger, Beate; Schneider, Verena A.; Woell, Stefan; Stangel, Daniela; Ramseger, Rene; Kroeger, Stephan			The Process-inducing Activity of Transmembrane Agrin Requires Follistatin-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CALCIUM-BINDING PROTEIN; NEOCORTEX IN-VIVO; DENDRITIC FILOPODIA; HIPPOCAMPAL-NEURONS; SYNAPSE FORMATION; DEFICIENT MICE; NEURITE OUTGROWTH; AVIAN RETINA; LIPID RAFTS	Clustering or overexpression of the transmembrane form of the extracellular matrix proteoglycan agrin in neurons results in the formation of numerous highly motile filopodia-like processes extending from axons and dendrites. Here we show that similar processes can be induced by overexpression of transmembrane-agrin in several non-neuronal cell lines. Mapping of the process-inducing activity in neurons and non-neuronal cells demonstrates that the cytoplasmic part of transmembrane agrin is dispensable and that the extracellular region is necessary for process formation. Site-directed mutagenesis reveals an essential role for the loop between beta-sheets 3 and 4 within the Kazal subdomain of the seventh follistatin-like domain of TM-agrin. An aspartic acid residue within this loop is critical for process formation. The seventh follistatin-like domain could be functionally replaced by the first and sixth but not by the eighth follistatin-like domain, demonstrating a functional redundancy among some follistatin-like domains of agrin. Moreover, a critical distance of the seventh follistatin-like domain to the plasma membrane appears to be required for process formation. These results demonstrate that different regions within the agrin protein are responsible for synapse formation at the neuromuscular junction and for process formation in central nervous system neurons and suggest a role for agrin's follistatin-like domains in the developing central nervous system.	[Kroeger, Stephan] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55128 Mainz, Germany; [Seliger, Beate; Schneider, Verena A.; Stangel, Daniela; Kroeger, Stephan] Univ Munich, Dept Physiol, D-80336 Munich, Germany	Johannes Gutenberg University of Mainz; University of Munich	Kroger, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55128 Mainz, Germany.	skroeger@lmu.de		Kroger, Stephan/0000-0002-4626-1690	Deutsche Forschungsgemeinschaft [KR 1039/7, KR 1039/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG Grant KR 1039/7) and the DFG Priority Program 1086 (Grant KR 1039/9).	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; Annies M, 2002, MOL CELL NEUROSCI, V20, P525, DOI 10.1006/mcne.2002.1125; Baerwald-De La Torre K, 2004, J NEUROCHEM, V90, P50, DOI 10.1111/j.1471-4159.2004.02454.x; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Bose CM, 2000, J NEUROSCI, V20, P9086; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Dailey ME, 1996, J NEUROSCI, V16, P2983; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; Dityateva G, 2003, J NEUROSCI METH, V130, P65, DOI 10.1016/S0165-0270(03)00202-4; Ferreira A, 1999, J CELL SCI, V112, P4729; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hopf C, 1996, J BIOL CHEM, V271, P5231; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; INOUYE S, 1991, BIOCHEM BIOPH RES CO, V179, P352, DOI 10.1016/0006-291X(91)91377-O; Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Knott G, 2008, BRAIN RES REV, V58, P282, DOI 10.1016/j.brainresrev.2008.01.002; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kroger S, 2009, FUTUR NEUROL, V4, P67, DOI 10.2217/14796708.4.1.67; Kroger S, 2002, NEWS PHYSIOL SCI, V17, P207, DOI 10.1152/01390.2002; Kroger S, 1996, J NEUROBIOL, V29, P165; Kroger S, 1997, MOL CELL NEUROSCI, V10, P149, DOI 10.1006/mcne.1997.0651; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; McCroskery S, 2009, NEUROSCIENCE, V163, P168, DOI 10.1016/j.neuroscience.2009.06.012; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Ramseger R, 2009, J BIOL CHEM, V284, P7697, DOI 10.1074/jbc.M806719200; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; SUMITOMO S, 1995, BIOCHEM BIOPH RES CO, V208, P1, DOI 10.1006/bbrc.1995.1297; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Ullman CG, 1997, BIOCHEM J, V326, P939, DOI 10.1042/bj3260929v; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Vannahme C, 1999, J NEUROCHEM, V73, P12, DOI 10.1046/j.1471-4159.1999.0730012.x; Wang QF, 2000, ENDOCRINOLOGY, V141, P3183, DOI 10.1210/en.141.9.3183; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zacharias U, 2002, MOL CELL NEUROSCI, V21, P626, DOI 10.1006/mcne.2002.1203; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	66	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3114	3125		10.1074/jbc.M109.039420	http://dx.doi.org/10.1074/jbc.M109.039420			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940118	hybrid, Green Published			2022-12-27	WOS:000273829000027
J	Jedidi, I; Zhang, F; Qiu, HF; Stahl, SJ; Palmer, I; Kaufman, JD; Nadaud, PS; Mukherjee, S; Wingfield, PT; Jaroniec, CP; Hinnebusch, AG				Jedidi, Iness; Zhang, Fan; Qiu, Hongfang; Stahl, Stephen J.; Palmer, Ira; Kaufman, Joshua D.; Nadaud, Philippe S.; Mukherjee, Sujoy; Wingfield, Paul T.; Jaroniec, Christopher P.; Hinnebusch, Alan G.			Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; SRB MEDIATOR; AMINO-ACIDS; YEAST; HOLOENZYME; COMPLEX; ASSOCIATION	Mediator is a multisubunit coactivator required for initiation by RNA polymerase II. The Mediator tail subdomain, containing Med15/Gal11, is a target of the activator Gcn4 in vivo, critical for recruitment of native Mediator or the Mediator tail subdomain present in sin4 Delta cells. Although several Gal11 segments were previously shown to bind Gcn4 in vitro, the importance of these interactions for recruitment of Mediator and transcriptional activation by Gcn4 in cells was unknown. We show that interaction of Gcn4 with the Mediator tail in vitro and recruitment of this subcomplex and intact Mediator to the ARG1 promoter in vivo involve additive contributions from three different segments in the N terminus of Gal11. These include the KIX domain, which is a critical target of other activators, and a region that shares a conserved motif (B-box) with mammalian coactivator SRC-1, and we establish that B-box is a critical determinant of Mediator recruitment by Gcn4. We further demonstrate that Gcn4 binds to the Gal11 KIX domain directly and, by NMR chemical shift analysis combined with mutational studies, we identify the likely binding site for Gcn4 on the KIX surface. Gcn4 is distinctive in relying on comparable contributions from multiple segments of Gal11 for efficient recruitment of Mediator in vivo.	[Jedidi, Iness; Zhang, Fan; Qiu, Hongfang; Hinnebusch, Alan G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Stahl, Stephen J.; Palmer, Ira; Kaufman, Joshua D.; Wingfield, Paul T.] NIAMS, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [Nadaud, Philippe S.; Mukherjee, Sujoy; Jaroniec, Christopher P.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University System of Ohio; Ohio State University	Hinnebusch, AG (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bldg 6A,Rm B1A-13, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov	Jaroniec, Christopher/A-4948-2008; Mukherjee, Sujoy/E-5708-2011	Jaroniec, Christopher/0000-0003-0364-2888; Wingfield, Paul/0000-0002-9515-4752; , Iness/0000-0001-8591-8782	National Institutes of Health; Ohio State University; Eli Lilly and Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); Eli Lilly and Company(Eli Lilly); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Intramural Research Program of the National Institutes of Health.; Supported by a grant from the Ohio State University and a Young Investigator Award from Eli Lilly and Company.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Balciunas D, 1999, P NATL ACAD SCI USA, V96, P376, DOI 10.1073/pnas.96.2.376; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goddard TD, 1993, SPARKY 3; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Gustafsson CM, 1998, J BIOL CHEM, V273, P30851, DOI 10.1074/jbc.273.47.30851; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; HINNEBUSCH AG, 1985, P NATL ACAD SCI USA, V82, P498, DOI 10.1073/pnas.82.2.498; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; JIANG YW, 1995, GENETICS, V140, P47; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Kim DH, 2008, MOL CELL BIOL, V28, P913, DOI 10.1128/MCB.01140-07; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu Z, 2002, P NATL ACAD SCI USA, V99, P8591, DOI 10.1073/pnas.092263499; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nishizawa M, 2001, YEAST, V18, P1099, DOI 10.1002/yea.754; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; REID GA, 1982, J BIOL CHEM, V257, P3056; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Yamazaki T, 1996, PROTEIN SCI, V5, P495; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004; Zhang F, 2008, MOL CELL BIOL, V28, P6796, DOI 10.1128/MCB.00800-08	63	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2438	2455		10.1074/jbc.M109.071589	http://dx.doi.org/10.1074/jbc.M109.071589			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940160	hybrid, Green Published			2022-12-27	WOS:000273697800023
J	Tori, K; Dassa, B; Johnson, MA; Southworth, MW; Brace, LE; Ishino, Y; Pietrokovski, S; Perler, FB				Tori, Kazuo; Dassa, Bareket; Johnson, Margaret A.; Southworth, Maurice W.; Brace, Lear E.; Ishino, Yoshizumi; Pietrokovski, Shmuel; Perler, Francine B.			Splicing of the Mycobacteriophage Bethlehem DnaB Intein IDENTIFICATION OF A NEW MECHANISTIC CLASS OF INTEINS THAT CONTAIN AN OBLIGATE BLOCK F NUCLEOPHILE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SWISS-MODEL; PROTEINS; SEQUENCES; PRECURSOR; GLUTAMINE; PROFILES; HOMOLOGY	Inteins are single turnover enzymes that splice out of protein precursors during maturation of the host protein (extein). The Cys or Ser at the N terminus of most inteins initiates a four-step protein splicing reaction by forming a (thio) ester bond at the N-terminal splice junction. Several recently identified inteins cannot perform this acyl rearrangement because they do not begin with Cys, Thr, or Ser. This study analyzes one of these, the mycobacteriophage Bethlehem DnaB intein, which we describe here as the prototype for a new class of inteins based on sequence comparisons, reactivity, and mechanism. These Class 3 inteins are characterized by a non-nucleophilic N-terminal residue that co-varies with a non-contiguous Trp, Cys, Thr triplet (WCT) and a Thr or Ser as the first C-extein residue. Several mechanistic differences were observed when compared with standard inteins or previously studied atypical KlbA Ala(1) inteins: (a) cleavage at the N-terminal splice junction in the absence of all standard N- and C-terminal splice junction nucleophiles, (b) activation of the N-terminal splice junction by a variant Block B motif that includes the WCT triplet Trp, (c) decay of the branched intermediate by thiols or Cys despite an ester linkage at the C-extein branch point, and (d) an absolute requirement for the WCT triplet Block F Cys. Based on biochemical data and confirmed by molecular modeling, we propose roles for these newly identified conserved residues, a novel protein splicing mechanism that includes a second branched intermediate, and an intein classification with three mechanistic categories.	[Tori, Kazuo; Southworth, Maurice W.; Brace, Lear E.; Perler, Francine B.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Tori, Kazuo; Ishino, Yoshizumi] Kyushu Univ, Fukuoka 8128581, Japan; [Dassa, Bareket; Pietrokovski, Shmuel] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Johnson, Margaret A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	New England Biolabs; Kyushu University; Weizmann Institute of Science; Scripps Research Institute	Perler, FB (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	perler@neb.com		Pietrokovski, Shmuel/0000-0001-8573-5863; Brace, Lear/0000-0001-6961-9758; Ishino, Yoshizumi/0000-0001-9419-0826	Israel Science Foundation [626/03]	Israel Science Foundation(Israel Science Foundation)	This work was supported in part by Israel Science Foundation Grant 626/03 (to S. P.).	Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; HODGES RA, 1992, NUCLEIC ACIDS RES, V20, P6153, DOI 10.1093/nar/20.23.6153; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mills KV, 2005, PROTEIN PEPTIDE LETT, V12, P751, DOI 10.2174/0929866054864337; Mills KV, 2004, J BIOL CHEM, V279, P20685, DOI 10.1074/jbc.M400887200; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Pearl EJ, 2007, FEBS LETT, V581, P3000, DOI 10.1016/j.febslet.2007.05.060; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	28	65	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2515	2526		10.1074/jbc.M109.069567	http://dx.doi.org/10.1074/jbc.M109.069567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940146	Green Published, hybrid			2022-12-27	WOS:000273697800030
J	Weis, MA; Hudson, DM; Kim, L; Scott, M; Wu, JJ; Eyre, DR				Weis, Mary Ann; Hudson, David M.; Kim, Lammy; Scott, Melissa; Wu, Jiann-Jiu; Eyre, David R.			Location of 3-Hydroxyproline Residues in Collagen Types I, II, III, and V/XI Implies a Role in Fibril Supramolecular Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOGEN-BROMIDE PEPTIDES; AMINO-ACID-SEQUENCE; RECESSIVE OSTEOGENESIS IMPERFECTA; BASEMENT-MEMBRANE COLLAGEN; HIGHER-ORDER STRUCTURES; TRIPLE-HELIX; CARTILAGE COLLAGEN; COVALENT STRUCTURE; PROLYL 3-HYDROXYLATION; ARTICULAR-CARTILAGE	Collagen triple helices are stabilized by 4-hydroxyproline residues. No function is known for the much less common 3-hydroxyproline (3Hyp), although genetic defects inhibiting its formation cause recessive osteogenesis imperfecta. To help understand the pathogenesis, we used mass spectrometry to identify the sites and local sequence motifs of 3Hyp residues in fibril-forming collagens from normal human and bovine tissues. The results confirm a single, essentially fully occupied 3Hyp site (A1) at Pro(986) in A-clade chains alpha 1(I), alpha 1(II), and alpha 2(V). Two partially modified sites (A2 and A3) were found at Pro(944) in alpha 1(II) and alpha 2(V) and Pro(707) in alpha 2(I) and alpha 2(V), which differed from A1 in sequence motif. Significantly, the distance between sites 2 and 3, 237 residues, is close to the collagen D-period (234 residues). A search for additional D-periodic 3Hyp sites revealed a fourth site (A4) at Pro(470) in alpha 2(V), 237 residues N-terminal to site 3. In contrast, human and bovine type III collagen contained no 3Hyp at any site, despite a candidate proline residue and recognizable A1 sequence motif. A conserved histidine in mammalian alpha 1(III) at A1 may have prevented 3-hydroxylation because this site in chicken type III was fully hydroxylated, and tyrosine replaced histidine. All three B-clade type V/XI collagen chains revealed the same three sites of 3Hyp but at different loci and sequence contexts from those in A-clade collagen chains. Two of these B-clade sites were spaced apart by 231 residues. From these and other observations we propose a fundamental role for 3Hyp residues in the ordered self-assembly of collagen supramolecular structures.	[Weis, Mary Ann; Hudson, David M.; Kim, Lammy; Scott, Melissa; Wu, Jiann-Jiu; Eyre, David R.] Univ Washington, Orthopaed Res Labs, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), 1959 NE Pacific St,HSB BB1052,Box 356500, Seattle, WA 98195 USA.	deyre@u.washington.edu			National Institutes of Health [AR37318, AR36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR036794, R01AR037318, R37AR037318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37318 and AR36794.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Burger C, 2008, BIOPHYS J, V95, P1985, DOI 10.1529/biophysj.107.128355; BURGESON RE, 1976, P NATL ACAD SCI USA, V73, P2579, DOI 10.1073/pnas.73.8.2579; BUTLER WT, 1967, BIOCHEMISTRY-US, V6, P3771, DOI 10.1021/bi00864a022; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; CLICK EM, 1970, BIOCHEMISTRY-US, V9, P4699; DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059; Dunn MP, 2009, DEV BIOL, V328, P561, DOI 10.1016/j.ydbio.2009.02.007; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2006, EUR CELLS MATER, V12, P57, DOI 10.22203/eCM.v012a07; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; EYRE DR, 1975, BIOCHEM J, V151, P595, DOI 10.1042/bj1510595; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; Garrone R., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V93, P157; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200; Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; MILLER EJ, 1973, BIOCHEMISTRY-US, V12, P3153, DOI 10.1021/bi00741a003; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; PIEZ KA, 1963, BIOCHEMISTRY-US, V2, P58, DOI 10.1021/bi00901a012; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; RHODES RK, 1979, J BIOL CHEM, V254, P2084; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; SEYER JM, 1981, BIOCHEMISTRY-US, V20, P2621, DOI 10.1021/bi00512a040; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; WOODHEADGALLOWAY J, 1980, PROC R SOC SER B-BIO, V209, P275, DOI 10.1098/rspb.1980.0095; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Young RD, 2000, J HISTOCHEM CYTOCHEM, V48, P423, DOI 10.1177/002215540004800312; Zhang XM, 2007, J BIOL CHEM, V282, P6792, DOI 10.1074/jbc.M607528200	51	102	103	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2580	2590		10.1074/jbc.M109.068726	http://dx.doi.org/10.1074/jbc.M109.068726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940144	Green Published, hybrid			2022-12-27	WOS:000273697800037
J	Wong, YY; Moon, A; Duffin, R; Barthet-Barateig, A; Meijer, HA; Clemens, MJ; de Moor, CH				Wong, Ying Ying; Moon, Alice; Duffin, Ruth; Barthet-Barateig, Adeline; Meijer, Hedda A.; Clemens, Michael J.; de Moor, Cornelia H.			Cordycepin Inhibits Protein Synthesis and Cell Adhesion through Effects on Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; TRANSLATION INITIATION; MESSENGER-RNAS; IN-VITRO; MTOR; KINASE; AKT; PHOSPHORYLATION; RAPAMYCIN; GROWTH	3'-Deoxyadenosine, also known as cordycepin, is a known polyadenylation inhibitor with a large spectrum of biological activities, including anti-proliferative, pro-apoptotic and antiinflammatory effects. In this study we confirm that cordycepin reduces the length of poly(A) tails, with some mRNAs being much more sensitive than others. The low doses of cordycepin that cause poly(A) changes also reduce the proliferation of NIH3T3 fibroblasts. At higher doses of the drug we observed inhibition of cell attachment and a reduction of focal adhesions. Furthermore, we observed a strong inhibition of total protein synthesis that correlates with an inhibition of mammalian target of rapamycin (mTOR) signaling, as observed by reductions in Akt kinase and 4E-binding protein (4EBP) phosphorylation. In 4EBP knock-out cells, the effect of cordycepin on translation is strongly reduced, confirming the role of this modification. In addition, the AMP-activated kinase (AMPK) was shown to be activated. Inhibition of AMPK prevented translation repression by cordycepin and abolished 4EBP1 dephosphorylation, indicating that the effect of cordycepin on mTOR signaling and protein synthesis is mediated by AMPK activation. We conclude that many of the reported biological effects of cordycepin are likely to be due to its effects on mTOR and AMPK signaling.	[Wong, Ying Ying; Moon, Alice; Duffin, Ruth; Barthet-Barateig, Adeline; Meijer, Hedda A.; de Moor, Cornelia H.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Clemens, Michael J.] Univ Sussex, Dept Chem & Biochem, Sch Life Sci, Brighton BN1 9QG, Sussex, England	University of Nottingham; University of Sussex	de Moor, CH (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	cornelia.demoor@nottingham.ac.uk	de Moor, Cornelia/AAE-8043-2020	de Moor, Cornelia/0000-0001-8776-0085	Wellcome Trust [076179, 082609]; Biotechnology and Biological Sciences Research Council [BB/G001847/1]; BBSRC [BB/G001847/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (Grants 076179 and 082609) and the Biotechnology and Biological Sciences Research Council (Grant BB/G001847/1).	Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Chang W, 2008, EUR J PHARMACOL, V597, P64, DOI 10.1016/j.ejphar.2008.08.030; Chen LS, 2008, BRIT J HAEMATOL, V140, P682, DOI 10.1111/j.1365-2141.2007.06955.x; Cho HJ, 2007, J MICROBIOL BIOTECHN, V17, P1134; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; CRAIG N, 1973, J CELL PHYSIOL, V82, P133, DOI 10.1002/jcp.1040820202; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Holbein S, 2008, NUCLEIC ACIDS RES, V36, P353, DOI 10.1093/nar/gkm990; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ioannidis P, 1999, ONCOGENE, V18, P117, DOI 10.1038/sj.onc.1202255; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JAGGER DV, 1961, CANCER RES, V21, P216; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; MULLER WEG, 1977, CANCER RES, V37, P3824; Nakamura K, 2006, ANTICANCER RES, V26, P43; Nakamura K, 2005, IN VIVO, V19, P137; Ng TB, 2005, J PHARM PHARMACOL, V57, P1509, DOI 10.1211/jpp.57.12.0001; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; PENMAN S, 1970, P NATL ACAD SCI USA, V67, P1878, DOI 10.1073/pnas.67.4.1878; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rhoads RE, 2007, J MAMMARY GLAND BIOL, V12, P283, DOI 10.1007/s10911-007-9058-0; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shi P, 2008, METHOD FIND EXP CLIN, V30, P347, DOI 10.1358/mf.2008.30.5.1186085; Smolewski P, 2006, ANTI-CANCER DRUG, V17, P487, DOI 10.1097/00001813-200606000-00001; Thomadaki H, 2008, CANCER CHEMOTH PHARM, V61, P251, DOI 10.1007/s00280-007-0467-y; van Gorp AGM, 2009, ONCOGENE, V28, P95, DOI 10.1038/onc.2008.367; Wehbe-Janek H, 2007, ANTICANCER RES, V27, P3143; Wei HP, 2009, EUR J MED CHEM, V44, P665, DOI 10.1016/j.ejmech.2008.05.013; Woodard J, 2008, CLIN CANCER RES, V14, P4640, DOI 10.1158/1078-0432.CCR-07-5232; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Wu WC, 2007, CANCER CHEMOTH PHARM, V60, P103, DOI 10.1007/s00280-006-0354-y; Yang FQ, 2008, J PHARMACEUT BIOMED, V48, P231, DOI 10.1016/j.jpba.2008.05.012; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	58	111	122	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2610	2621		10.1074/jbc.M109.071159	http://dx.doi.org/10.1074/jbc.M109.071159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940154	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000273697800040
J	Busillo, JM; Armando, S; Sengupta, R; Meucci, O; Bouvier, M; Benovic, JL				Busillo, John M.; Armando, Sylvain; Sengupta, Rajarshi; Meucci, Olimpia; Bouvier, Michel; Benovic, Jeffrey L.			Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MEDIATED ERK ACTIVATION; ANGIOTENSIN-II RECEPTOR; BETA-ARRESTIN; WHIM-SYNDROME; CHEMOKINE RECEPTORS; POSTTRANSLATIONAL MODIFICATIONS; DISTINCT MECHANISMS; PIVOTAL ROLE; LIGASE AIP4	The chemokine receptor CXCR4 is a widely expressed G protein-coupled receptor that has been implicated in a number of diseases including human immunodeficiency virus, cancer, and WHIM syndrome, with the latter two involving dysregulation of CXCR4 signaling. To better understand the role of phosphorylation in regulating CXCR4 signaling, tandem mass spectrometry and phospho-specific antibodies were used to identify sites of agonist-promoted phosphorylation. These studies demonstrated that Ser-321, Ser-324, Ser-325, Ser-330, Ser-339, and two sites between Ser-346 and Ser-352 were phosphorylated in HEK293 cells. We show that Ser-324/5 was rapidly phosphorylated by protein kinase C and G protein-coupled receptor kinase 6 (GRK6) upon CXCL12 treatment, whereas Ser-339 was specifically and rapidly phosphorylated by GRK6. Ser-330 was also phosphorylated by GRK6, albeit with slower kinetics. Similar results were observed in human astroglia cells, where endogenous CXCR4 was rapidly phosphorylated on Ser-324/5 by protein kinase C after CXCL12 treatment, whereas Ser-330 was slowly phosphorylated. Analysis of CXCR4 signaling in HEK293 cells revealed that calcium mobilization was primarily negatively regulated by GRK2, GRK6, and arrestin3, whereas GRK3, GRK6, and arrestin2 played a primary role in positively regulating ERK1/2 activation. In contrast, GRK2 appeared to play a negative role in ERK1/2 activation. Finally, we show that arrestin association with CXCR4 is primarily driven by the phosphorylation of far C-terminal residues on the receptor. These studies reveal that site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases resulting in both positive and negative modulation of CXCR4 signaling.	[Busillo, John M.; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Armando, Sylvain; Bouvier, Michel] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Sengupta, Rajarshi; Meucci, Olimpia] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	Jefferson University; Universite de Montreal; Drexel University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100	National Institutes of Health [GM44944, GM47417, CA129626, DA15014, DA19808]; Pennsylvania Department of Health [AB-0301]; NATIONAL CANCER INSTITUTE [R01CA129626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944, R01GM047417, R37GM047417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015014, R01DA019808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944, GM47417, and CA129626 (to J. L. B.) and DA15014 and DA19808 (to O. M.). This work was also supported by Pennsylvania Department of Health Grant AB-0301.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carr SA, 2005, METHOD ENZYMOL, V405, P82, DOI 10.1016/S0076-6879(05)05005-6; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diaz GA, 2005, CURR ALLERGY ASTHM R, V5, P350, DOI 10.1007/s11882-005-0005-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Khan MZ, 2004, AIDS RES HUM RETROV, V20, P1063, DOI 10.1089/aid.2004.20.1063; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Kuo FT, 2006, CELL SIGNAL, V18, P1914, DOI 10.1016/j.cellsig.2006.02.009; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pfleger KDG, 2007, BIOCHEM SOC T, V35, P764, DOI 10.1042/BST0350764; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Signoret N, 1998, J CELL SCI, V111, P2819; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	65	199	211	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7805	7817		10.1074/jbc.M109.091173	http://dx.doi.org/10.1074/jbc.M109.091173			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048153	Green Published, hybrid			2022-12-27	WOS:000275415600088
J	Kim, MS; Yang, YM; Son, A; Tian, YS; Lee, SI; Kang, SW; Muallem, S; Shin, DM				Kim, Min Seuk; Yang, Yu-Mi; Son, Aran; Tian, Yu Shun; Lee, Syng-Ill; Kang, Sang Won; Muallem, Shmuel; Shin, Dong Min			RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca2+ Oscillations Essential for Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPH-NODE ORGANOGENESIS; RECEPTOR ACTIVATOR; HYDROGEN-PEROXIDE; BONE HOMEOSTASIS; FREE-RADICALS; CELL-FUNCTION; DIFFERENTIATION; CALCIUM; EXPRESSION; CHANNELS	RANKL (receptor activator of NF-kappa B ligand) induces osteoclastogenesis by activating multiple signaling pathways in osteoclast precursor cells, chief among which is induction of long lasting oscillations in the intracellular concentration of Ca2+ ([Ca2+](i)). The [Ca2+](i) oscillations activate calcineurin, which activates the transcription factor NFATc1. The pathway by which RANKL induces [Ca2+](i) oscillations and osteoclastogenesis is poorly understood. Here we report the discovery of a novel pathway induced by RANKL to cause a long lasting increase in reactive oxygen species (ROS) and [Ca2+](i) oscillations that is essential for differentiation of bone marrow-derived monocytes into osteoclasts. The pathway includes RANKL-mediated stimulation of Rac1 to generate ROS, which stimulate phospholipase C gamma 1 to evoke [Ca2+](i) oscillations by stimulating Ca2+ release from the inositol 1,4,5-trisphosphate pool and STIM1-regulated Ca2+ influx. Induction and activation of the pathway is observed only after 24-h stimulation with RANKL and lasts for at least 3 days. The physiological role of the pathway is demonstrated in mice with deletion of the Peroxiredoxin II gene and results in a mark increase is ROS and, consequently, a decrease in bone density. Moreover, bone marrow-derived monocytes in PrxII(-/-) primary culture show increased ROS and spontaneous [Ca2+](i) oscillations. These findings identify the primary RANKL-stimulated pathway to trigger the late stages of osteoclastogenesis and regulate bone resorption.	[Kim, Min Seuk; Yang, Yu-Mi; Son, Aran; Tian, Yu Shun; Lee, Syng-Ill; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol,Brain Korea Project 21, Oral Sci Res Ctr,Ctr Nat Def Syst, Seoul 120752, South Korea; [Kang, Sang Won] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; [Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Yonsei University; Yonsei University Health System; Ewha Womans University; Ewha Womans University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shin, DM (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol,Brain Korea Project 21, Oral Sci Res Ctr,Ctr Nat Def Syst, 134 Shinchon Dong, Seoul 120752, South Korea.	dmshin@yuhs.ac		Shin, Dong Min/0000-0001-6042-0435	Korea Healthcare Technology R & D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084007]	Korea Healthcare Technology R & D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported by Grant A084007 from the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HARRIS ML, 1992, PHARMACOL THERAPEUT, V53, P375, DOI 10.1016/0163-7258(92)90057-7; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Marks SC, 2000, INT J DEV BIOL, V44, P309; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; MAYINGI J, 2007, C P IEEE ENG MED BIO, P5119; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thyagarajan B, 2001, J BIOL CHEM, V276, P48149, DOI 10.1074/jbc.M103977200; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	46	149	155	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6913	6921		10.1074/jbc.M109.051557	http://dx.doi.org/10.1074/jbc.M109.051557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048168	hybrid, Green Published			2022-12-27	WOS:000275415600005
J	Vora, SR; Palamakumbura, AH; Mitsi, M; Guo, Y; Pischon, N; Nugent, MA; Trackman, PC				Vora, Siddharth R.; Palamakumbura, Amitha H.; Mitsi, Maria; Guo, Ying; Pischon, Nicole; Nugent, Matthew A.; Trackman, Philip C.			Lysyl Oxidase Propeptide Inhibits FGF-2-induced Signaling and Proliferation of Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; TUMOR-SUPPRESSOR ACTIVITY; COLLAGEN GENE-EXPRESSION; CELL-GROWTH; TRANSCRIPTION FACTOR; BONE-FORMATION; CROSS-LINKS; RECEPTOR; FACTOR-2; BINDING	Pro-lysyl oxidase is secreted as a 50-kDa proenzyme and is then cleaved to a 30-kDa mature enzyme (lysyl oxidase (LOX)) and an 18-kDa propeptide ( lysyl oxidase propeptide (LOX-PP)). The presence of LOX-PP in the cell layers of phenotypically normal osteoblast cultures led us to investigate the effects of LOX-PP on osteoblast differentiation. Data indicate that LOX-PP inhibits terminal mineralization in primary calvaria osteoblast cultures when added at early stages of differentiation, with no effects seen when present at later stages. LOX-PP was found to inhibit serum-and FGF-2-stimulated DNA synthesis and FGF-2-stimulated cell growth. Enzyme-linked immunosorbent assay and Western blot analyses show that LOX-PP inhibits FGF-2-induced ERK1/2 phosphorylation, signaling events that mediate the FGF-2-induced proliferative response. LOX-PP inhibits FGF-2-stimulated phosphorylation of FRS2 alpha and FGF-2-stimulated DNA synthesis, even after inhibition of sulfation of heparan sulfate proteoglycans. These data point to a LOX-PP target at or near the level of fibroblast growth factor receptor binding or activation. Ligand binding assays on osteoblast cell layers with I-125-FGF-2 demonstrate a concentration-dependent inhibition of FGF-2 binding to osteoblasts by LOX-PP. In vitro binding assays with recombinant fibroblast growth factor receptor protein revealed that LOX-PP inhibits FGF-2 binding in an uncompetitive manner. We propose a working model for the respective roles of LOX enzyme and LOX-PP in osteoblast phenotype development in which LOX-PP may act to inhibit the proliferative response possibly to allow cells to exit from the cell cycle and progress to the next stages of differentiation.	[Trackman, Philip C.] Boston Univ, Dept Periodontol & Oral Biol, Goldman Sch Dent Med, Boston, MA 02118 USA; [Mitsi, Maria; Nugent, Matthew A.; Trackman, Philip C.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Trackman, PC (corresponding author), Boston Univ, Dept Periodontol & Oral Biol, Goldman Sch Dent Med, 700 Albany St, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021; Mitsi, Maria/S-2519-2017	Trackman, Philip C/0000-0001-5064-614X; Nugent, Matthew/0000-0002-8630-4712; Mitsi, Maria/0000-0001-8983-1983	NIDCR, National Institutes of Health [R01 DE14066]; NHLBI, National Institutes of Health [R01 HL56200]; Department of Defense [W81XWH-08-1-0349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE14066 from NIDCR and R01 HL56200 from NHLBI. This work was also supported by Department of Defense Award W81XWH-08-1-0349.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; BERRADA S, 1995, IN VITRO CELL DEV-AN, V31, P698; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; CANALIS E, 1991, ANNU REV MED, V42, P17, DOI 10.1146/annurev.med.42.1.17; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; CHEN HSV, 1992, J NEUROSCI, V12, P4427; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; De Luca F, 1999, TRENDS ENDOCRIN MET, V10, P61, DOI 10.1016/S1043-2760(98)00120-9; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Fang MA, 2001, J CELL BIOCHEM, V80, P550, DOI 10.1002/1097-4644(20010315)80:4<550::AID-JCB1009>3.3.CO;2-T; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; Feres EJ, 1996, J BIOL CHEM, V271, P6411, DOI 10.1074/jbc.271.11.6411; FRIESEL R, 1986, J BIOL CHEM, V261, P7581; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Hong HH, 1999, LAB INVEST, V79, P1655; Hsieh SC, 1998, J CELL BIOCHEM, V69, P169, DOI 10.1002/(SICI)1097-4644(19980501)69:2<169::AID-JCB7>3.0.CO;2-Q; HURLEY MM, 1993, J BIOL CHEM, V268, P5588; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Kalajzic I, 2003, J CELL BIOCHEM, V88, P1168, DOI 10.1002/jcb.10459; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Li CF, 2006, J BONE MINER RES, V21, P946, DOI 10.1359/JBMR.060309; Lian J B, 1995, Iowa Orthop J, V15, P118; Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Okazaki H, 1999, CALCIFIED TISSUE INT, V64, P542, DOI 10.1007/s002239900646; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; PALAMAKUMBURA AH, 2008, J DENT RES, V87, P854; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; RODAN SB, 1989, J BIOL CHEM, V264, P19934; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tanaka H, 1999, MOL CELL ENDOCRINOL, V150, P1, DOI 10.1016/S0303-7207(99)00046-5; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	80	38	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7384	7393		10.1074/jbc.M109.033597	http://dx.doi.org/10.1074/jbc.M109.033597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048148	Green Published, hybrid			2022-12-27	WOS:000275415600051
J	Gasmi-Seabrook, GMC; Marshall, CB; Cheung, M; Kim, B; Wang, F; Jang, YJ; Mak, TW; Stambolic, V; Ikura, M				Gasmi-Seabrook, Genevieve M. C.; Marshall, Christopher B.; Cheung, Melissa; Kim, Bryan; Wang, Feng; Jang, Ying Ju; Mak, Tak W.; Stambolic, Vuk; Ikura, Mitsuhiko			Real-time NMR Study of Guanine Nucleotide Exchange and Activation of RhoA by PDZ-RhoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PH DOMAIN; GTPASES; COMPLEX; ASSIGNMENT; PROTEINS; BINDING; LARGER; VIEW; RAS	Small guanosine triphosphatases (GTPases) become activated when GDP is replaced by GTP at the highly conserved nucleotide binding site. This process is intrinsically very slow in most GTPases but is significantly accelerated by guanine nucleotide exchange factors (GEFs). Nucleotide exchange in small GTPases has been widely studied using spectroscopy with fluorescently tagged nucleotides. However, this method suffers from effects of the bulky fluorescent moiety covalently attached to the nucleotide. Here, we have used a newly developed real-time NMR-based assay to monitor small GTPase RhoA nucleotide exchange by probing the RhoA conformation. We compared RhoA nucleotide exchange from GDP to GTP and GTP analogues in the absence and presence of the catalytic DH-PH domain of PDZ-RhoGEF (DH-PHPRG). Using the non-hydrolyzable analogue guanosine-5'-O-(3-thiotriphosphate), which we found to be a reliable mimic of GTP, we obtained an intrinsic nucleotide exchange rate of 5.5 x 10(-4) min(-1). This reaction is markedly accelerated to 1179 x 10(-4) min(-1) in the presence of DH-PHPRG at a ratio of 1: 8,000 relative to RhoA. Mutagenesis studies confirmed the importance of Arg-868 near a conserved region (CR3) of the Dbl homology (DH) domain and revealed that Glu-741 in CR1 is critical for full activity of DH-PHPRG, together suggesting that the catalytic mechanism of PDZ-RhoGEF is similar to Tiam1. Mutation of the single RhoA (E97A) residue that contacts the pleckstrin homology (PH) domain rendered the mutant 10-fold less sensitive to the activity of DH-PHPRG. Interestingly, this mutation does not affect RhoA activation by leukemia-associated RhoGEF (LARG), indicating that the PH domains of these two homologous GEFs may play different roles.	[Gasmi-Seabrook, Genevieve M. C.; Marshall, Christopher B.; Cheung, Melissa; Kim, Bryan; Wang, Feng; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Jang, Ying Ju; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada; [Gasmi-Seabrook, Genevieve M. C.; Marshall, Christopher B.; Cheung, Melissa; Kim, Bryan; Wang, Feng; Jang, Ying Ju; Mak, Tak W.; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), MaRS Toronto Med Discovery Tower,Rm 4-804,101 Col, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Marshall, Christopher/K-8943-2019; Cheung, Melissa/L-6029-2016	Marshall, Christopher/0000-0002-7571-5700; Ikura, Mitsuhiko/0000-0002-9524-1303; Cheung, Melissa/0000-0002-8076-0725; Wang, Feng/0000-0002-4322-2127; Stambolic, Vuk/0000-0001-8853-3239	Cancer Research Society (Canada); Canada Foundation for Innovation	Cancer Research Society (Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by a grant from the Cancer Research Society (Canada).; A grant from the Canada Foundation for Innovation funded the Bruker 800- and 600-MHz NMR spectrometers.	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu M, 2007, DIABETES, V56, P1363, DOI 10.2337/db06-1421; Gu J, 2006, CANCER-AM CANCER SOC, V106, P2716, DOI 10.1002/cncr.21944; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kintscher C, 2009, J MOL BIOL, V387, P270, DOI 10.1016/j.jmb.2009.01.056; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	30	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5137	5145		10.1074/jbc.M109.064691	http://dx.doi.org/10.1074/jbc.M109.064691			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018869	Green Published, hybrid			2022-12-27	WOS:000275327200005
J	Li, JP; Fu, YN; Chen, YR; Tan, TH				Li, Ju-Pi; Fu, Yu-Ning; Chen, Yi-Rong; Tan, Tse-Hua			JNK Pathway-associated Phosphatase Dephosphorylates Focal Adhesion Kinase and Suppresses Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; PROTEIN-TYROSINE PHOSPHATASES; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PHOSPHORYLATION; VHR; AUTOPHOSPHORYLATION; FIBROBLASTS; ACTIVATION; LMW-DSP2	JNK pathway-associated phosphatase (JKAP, also named DUSP22) is expressed in various tissues, indicating that JKAP may have an important biological function. We showed that JKAP localized in the actin filament-enriched region. Expression of JKAP reduced cell migration, whereas a JKAP mutant lacking catalytic activity promoted cell motility. JKAP efficiently removed tyrosine phosphorylation of several proteins. We have identified focal adhesion kinase (FAK) as a substrate of JKAP. Overexpression of JKAP, but not JKAP mutant lacking catalytic activity, decreased FAK phosphorylation at tyrosines 397, 576, and 577 in H1299 cells. Consistent with these results, decreasing JKAP expression by RNA interference promoted cell migration and Src-induced FAK phosphorylation. Taken together, this study identified a new role for JKAP in the modulation of FAK phosphorylation and cell motility.	[Li, Ju-Pi; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan; [Fu, Yu-Ning; Chen, Yi-Rong] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 35053, Miaoli County, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Baylor College of Medicine	Chen, YR (corresponding author), 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	yrchen@nhri.org.tw; ttan@nhri.org.tw	Tan, Tse-Hua/E-3983-2010; Chen, Yi-Rong/CAF-2186-2022; Li, Ju-Pi/AAS-8866-2021; Tan, Tse-Hua/ABD-7080-2021; Chen, Yi-Rong/CAH-7991-2022; Chen, Yi-Rong/E-3991-2010	Tan, Tse-Hua/0000-0003-4969-3170; Chen, Yi-Rong/0000-0002-4307-3002; Li, Ju-Pi/0000-0003-3406-4865; Tan, Tse-Hua/0000-0003-4969-3170; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002	National Institutes of Health [1R01-AI066895]; National Health Research Institutes, Taiwan [MG-097-PP-03, 98A1-IMPP01-014]; Department of Health, Taiwan [DOH97-TD-G-111-0037]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Department of Health, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-AI066895 (to T.-H. T.). This work was also supported by National Health Research Institutes, Taiwan, Grants MG-097-PP-03 (to Y.-R.C.) and 98A1-IMPP01-014 (to T.-H. T.) and Department of Health, Taiwan, Grant DOH97-TD-G-111-0037 (to Y.-R.C.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2002, J BIOL CHEM, V277, P5524, DOI 10.1074/jbc.M107653200; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Aoyama K, 2001, J BIOL CHEM, V276, P27575, DOI 10.1074/jbc.M100408200; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Hood KL, 2002, BIOCHEM BIOPH RES CO, V298, P545, DOI 10.1016/S0006-291X(02)02488-9; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang JY, 2008, J NEUROCHEM, V107, P1544, DOI 10.1111/j.1471-4159.2008.05714.x; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yokota T, 2007, PROTEINS, V66, P272, DOI 10.1002/prot.21152; Yoon TS, 2005, PROTEINS, V61, P694, DOI 10.1002/prot.20642; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	33	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5472	5478		10.1074/jbc.M109.060186	http://dx.doi.org/10.1074/jbc.M109.060186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018849	Green Published, hybrid			2022-12-27	WOS:000275327200040
J	Escamilla-Powers, JR; Daniel, CJ; Farrell, A; Taylor, K; Zhang, XL; Byers, S; Sears, R				Escamilla-Powers, Julienne R.; Daniel, Colin J.; Farrell, Amy; Taylor, Karyn; Zhang, Xiaoli; Byers, Sarah; Sears, Rosalie			The Tumor Suppressor Protein HBP1 Is a Novel c-Myc-binding Protein That Negatively Regulates c-Myc Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE BREAST-CANCER; RETINOBLASTOMA PROTEIN; ESSENTIAL COFACTOR; GENE-EXPRESSION; REPRESSOR HBP1; TARGET; TRRAP; CELL; MAX; BOX	c-Myc is an important transcription factor that regulates cellular proliferation, cell growth, and differentiation. A number of transcriptional co-factors for c-Myc have been described that have binding sites within highly conserved regions of the c-Myc transactivational domain (TAD). Given the importance of the c-Myc TAD, we set out to identify new proteins that interact with this region using a yeast two-hybrid assay. HBP1 was identified in our screen as a protein that interacts with full-length c-Myc but not a c-Myc mutant lacking the TAD. HBP1 is a transcriptional repressor and has been shown to negatively regulate the cell cycle. A correlation between HBP1 under-expression and breast cancer relapse has been described, suggesting that HBP1 may be an important tumor suppressor protein. We have found that HBP1 binds c-Myc in cells, and expression of HBP1 inhibits c-Myc transactivational activity at least partly by preventing c-Myc binding to target gene promoters. c-Myc binds to the C terminus of HBP1, a region lost in some breast tumors, and some HBP1 mutants found in breast cancer weakly interact with and/or no longer negatively regulate c-Myc. This work adds to our understanding of c-Myc regulation and mechanisms of tumor suppression by HBP1.	[Escamilla-Powers, Julienne R.; Daniel, Colin J.; Farrell, Amy; Taylor, Karyn; Zhang, Xiaoli; Byers, Sarah; Sears, Rosalie] Oregon Hlth & Sci Univ, Dept Med & Mol Genet, Portland, OR 97239 USA	Oregon Health & Science University	Sears, R (corresponding author), 3181 SW Sam Jackson Pk Rd,L103A, Portland, OR 97239 USA.	searsr@ohsu.edu			National Institutes of Health [R01 CA100855, R01 CA100855-05S1, T32-CA106195]; NATIONAL CANCER INSTITUTE [T32CA106195, R01CA100855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA100855 (to R. S.), R01 CA100855-05S1 (a minority supplement to J. R. E.-P.), and T32-CA106195 (to A. F.).	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bolognese F, 2006, GENE, V366, P109, DOI 10.1016/j.gene.2005.07.046; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Driouch K, 1998, CANCER RES, V58, P2081; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Jones RM, 1996, MOL CELL BIOL, V16, P4754; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; LESAGE F, 1994, NUCLEIC ACIDS RES, V22, P3685, DOI 10.1093/nar/22.18.3685; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mitchell KO, 2000, CANCER RES, V60, P6318; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; Park J, 2001, GENE DEV, V15, P1619, DOI 10.1101/gad.900101; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Shih HH, 1998, MOL CELL BIOL, V18, P4732, DOI 10.1128/MCB.18.8.4732; Shih HH, 2001, MOL CELL BIOL, V21, P5723, DOI 10.1128/MCB.21.17.5723-5732.2001; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06	56	31	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4847	4858		10.1074/jbc.M109.074856	http://dx.doi.org/10.1074/jbc.M109.074856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20008325	Green Published, hybrid			2022-12-27	WOS:000275274800063
J	Kim, JY; Lee, YC; Kim, C				Kim, Ji Young; Lee, Young Chul; Kim, Changsoo			Direct Inhibition of Pumilo Activity by Bam and Bgcn in Drosophila Germ Line Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNCHBACK MESSENGER-RNA; OF-MARBLES; SELF-RENEWAL; PROTEIN; NANOS; OVARY; GENE; TRANSCRIPTION; MAINTENANCE; BINDING	The fate of stem cells is intricately regulated by numerous extrinsic and intrinsic factors that promote maintenance or differentiation. The RNA-binding translational repressor Pumilio (Pum) in conjunction with Nanos (Nos) is required for self-renewal, whereas Bam (bag-of-marbles) and Bgcn (benign gonial cell neoplasm) promote differentiation of germ line stem cells in the Drosophila ovary. Genetic analysis suggests that Bam and Bgcn antagonize Pum/Nos function to promote differentiation; however, the molecular basis of this epistatic relationship is currently unknown. Here, we show that Bam and Bgcn inhibit Pum function through direct binding. We identified a ternary complex involving Bam, Bgcn, and Pum in which Bam, but not Bgcn, directly interacts with Pum, and this interaction is greatly increased by the presence of Bgcn. In a heterologous reporter assay to monitor Pum activity, Bam, but not Bgcn, inhibits Pum activity. Notably, the N-terminal region of Pum, which lacks the C-terminal RNA-binding Puf domain, mediates both the ternary protein interaction and the Bam inhibition of Pum function. These studies suggest that, in cystoblasts, Bam and Bgcn may directly inhibit Pum/Nos activity to promote differentiation of germ line stem cells.	[Kim, Ji Young; Lee, Young Chul; Kim, Changsoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Kim, C (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	changgk@chonnam.ac.kr			Korea Science and Engineering Foundation; Chonnam National University; BK21 Program; National Research Foundation [2009-0088438]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Chonnam National University; BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation	This work was supported by research grants from the Basic Research Program and National Research Laboratory of the Korea Science and Engineering Foundation, a research fund of Chonnam National University in 2004, and the BK21 Program (to C. K.) and Basic Science Research Program Grant 2009-0088438 from the National Research Foundation (to Y. C. L.).	Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Forbes A, 1998, DEVELOPMENT, V125, P679; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Gilboa L, 2003, DEVELOPMENT, V130, P6625, DOI 10.1242/dev.00853; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Lavoie CA, 1999, DEV BIOL, V212, P405, DOI 10.1006/dbio.1999.9346; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Lin HF, 1997, DEVELOPMENT, V124, P2463; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Ohlstein B, 2000, GENETICS, V155, P1809; Parisi M, 1999, GENETICS, V153, P235; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; SIKORSKI RS, 1989, GENETICS, V122, P19; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zamore PD, 1997, RNA, V3, P1421	37	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4741	4746		10.1074/jbc.M109.002014	http://dx.doi.org/10.1074/jbc.M109.002014			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018853	hybrid, Green Published			2022-12-27	WOS:000275274800052
J	Li, S; Zheng, H; Mao, AP; Zhong, B; Li, Y; Liu, Y; Gao, Y; Ran, Y; Tien, P; Shu, HB				Li, Shu; Zheng, Hao; Mao, Ai-Ping; Zhong, Bo; Li, Ying; Liu, Yu; Gao, Yan; Ran, Yong; Tien, Po; Shu, Hong-Bing			Regulation of Virus-triggered Signaling by OTUB1-and OTUB2-mediated Deubiquitination of TRAF3 and TRAF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; INNATE IMMUNE-RESPONSES; TUMOR-SUPPRESSOR CYLD; DOUBLE-STRANDED-RNA; IFN-BETA PROMOTER; INDUCIBLE GENE-I; RIG-I; ANTIVIRAL RESPONSES; NEGATIVE REGULATION	Ubiquitination and deubiquitination have emerged as critical post-translational regulatory mechanisms for activation or attenuation of the virus-triggered type I interferon (IFN)(2) induction pathways. In this study, we identified two deubiquitinating enzymes, OTUB1 and OTUB2, as negative regulators of virus-triggered type I IFN induction. Overexpression of OTUB1 and OTUB2 inhibited virus-induced activation of IRF3 and NF-kappa B, transcription of the IFNB1 gene as well as cellular antiviral response, whereas knockdown of OTUB1 and OTUB2 had opposite effects. Coimmunoprecipitations indicated OTUB1 and -2 interacted with TRAF3 and TRAF6, two E3 ubiquitin ligases required for virus-triggered IRF3 and NF-kappa B activation, respectively. Furthermore, we found that OTUB1 and OTUB2 mediated virus-triggered deubiquitination of TRAF3 and -6. These findings suggest that OTUB1 and OTUB2 negatively regulate virus-triggered type IIFN induction and cellular antiviral response by deubiquitinating TRAF3 and -6.	[Li, Shu; Zheng, Hao; Mao, Ai-Ping; Zhong, Bo; Li, Ying; Liu, Yu; Gao, Yan; Ran, Yong; Tien, Po; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Modern Virol Ctr, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Ctr, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn		, Yong/0000-0002-7005-435X	Chinese 973 Program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; Chinese 111 Project [B06018]; Chinese National Science and Technology [2008ZX10002-014]	Chinese 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); Chinese National Science and Technology(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese 973 Program (2006CB504301 and 2010CB911802), the National Natural Science Foundation of China (30630019 and 30921001), the Chinese 111 Project (B06018), and the Chinese National Science and Technology Major Project (2008ZX10002-014).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	38	129	137	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4291	4297		10.1074/jbc.M109.074971	http://dx.doi.org/10.1074/jbc.M109.074971			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996094	Green Published, hybrid			2022-12-27	WOS:000275274800005
J	Masuda, T; Goto, F; Yoshihara, T; Mikami, B				Masuda, Taro; Goto, Fumiyuki; Yoshihara, Toshihiro; Mikami, Bunzo			Crystal Structure of Plant Ferritin Reveals a Novel Metal Binding Site That Functions as a Transit Site for Metal Transfer in Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSE SPLEEN APOFERRITIN; PISUM-SATIVUM FERRITIN; PEA-SEED-FERRITIN; H-CHAIN FERRITINS; ESCHERICHIA-COLI; DIFFERENTIAL EXPRESSION; IRON INCORPORATION; HIGH-RESOLUTION; CORE-FORMATION; IN-VITRO	Ferritins are important iron storage and detoxification proteins that are widely distributed in living kingdoms. Because plant ferritin possesses both a ferroxidase site and a ferrihydrite nucleation site, it is a suitable model for studying the mechanism of iron storage in ferritin. This article presents for the first time the crystal structure of a plant ferritin from soybean at 1.8-angstrom resolution. The soybean ferritin 4 (SFER4) had a high structural similarity to vertebrate ferritin, except for the N-terminal extension region, the C-terminal short helix E, and the end of the BC-loop. Similar to the crystal structures of other ferritins, metal binding sites were observed in the iron entry channel, ferroxidase center, and nucleation site of SFER4. In addition to these conventional sites, a novel metal binding site was discovered intermediate between the iron entry channel and the ferroxidase site. This site was coordinated by the acidic side chain of Glu(173) and carbonyl oxygen of Thr(168), which correspond, respectively, to Glu(140) and Thr(135) of human H chain ferritin according to their sequences. A comparison of the ferroxidase activities of the native and the E173A mutant of SFER4 clearly showed a delay in the iron oxidation rate of the mutant. This indicated that the glutamate residue functions as a transit site of iron from the 3-fold entry channel to the ferroxidase site, which may be universal among ferritins.	[Masuda, Taro] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Food Qual Design & Dev, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan; [Goto, Fumiyuki; Yoshihara, Toshihiro] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Biotechnol Sector, Chiba 2701194, Japan	Kyoto University; Kyoto University; Central Research Institute of Electric Power Industry - Japan	Masuda, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Food Qual Design & Dev, Kyoto 6110011, Japan.	masutaro@kais.kyoto-u.ac.jp	Masuda, Taro/G-4276-2011	Masuda, Taro/0000-0002-5549-375X	Shorai Foundation for Science and Technology	Shorai Foundation for Science and Technology	This work was supported a grant from the Shorai Foundation for Science and Technology	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AROSIO P, 1978, J BIOL CHEM, V253, P4451; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Briat J. F., 1995, Iron nutrition in soils and plants. Proceedings of the Seventh International Symposium on Iron Nutrition and Interactions in Plants, Zaragoza, Spain, 27 June-2 July 1993., P265; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; CHASTEEN ND, 1982, J BIOL CHEM, V257, P7672; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Dong XB, 2007, FEBS LETT, V581, P5796, DOI 10.1016/j.febslet.2007.11.049; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOBISLOISY I, 1995, EUR J BIOCHEM, V231, P609, DOI 10.1111/j.1432-1033.1995.0609d.x; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gaymard F, 1996, BIOCHEM J, V318, P67, DOI 10.1042/bj3180067; Granier T, 1998, PROTEINS, V31, P477, DOI 10.1002/(SICI)1097-0134(19980601)31:4<477::AID-PROT13>3.3.CO;2-T; Granier T, 2003, J BIOL INORG CHEM, V8, P105, DOI 10.1007/s00775-002-0389-4; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Jiang TB, 2005, J INTEGR PLANT BIOL, V47, P477, DOI 10.1111/j.1744-7909.2005.00044.x; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; LAULHERE JP, 1993, BIOCHEM J, V290, P693, DOI 10.1042/bj2900693; LAULHERE JP, 1989, J BIOL CHEM, V264, P3629; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; LEIBOLD EA, 1984, J BIOL CHEM, V259, P4327; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Li CR, 2009, J BIOL CHEM, V284, P16743, DOI 10.1074/jbc.M109.011528; Li CR, 2009, BIOCHIMIE, V91, P230, DOI 10.1016/j.biochi.2008.09.008; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; LOBREAUX S, 1992, PLANT MOL BIOL, V19, P563, DOI 10.1007/BF00026783; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; Masuda T, 2003, BBA-PROTEINS PROTEOM, V1645, P113, DOI 10.1016/S1570-9639(02)00523-X; Masuda T, 2001, J BIOL CHEM, V276, P19575, DOI 10.1074/jbc.M011399200; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PAQUES EP, 1980, EUR J BIOCHEM, V107, P447; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RAGLAND M, 1990, J BIOL CHEM, V265, P18339; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Savino G, 1997, J BIOL CHEM, V272, P33319, DOI 10.1074/jbc.272.52.33319; STEFANINI S, 1989, BIOCHEMISTRY-US, V28, P378, DOI 10.1021/bi00427a052; Stillman TJ, 2003, J BIOL CHEM, V278, P26275, DOI 10.1074/jbc.M207354200; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Strozycki PM, 2003, PHYSIOL PLANTARUM, V118, P380, DOI 10.1034/j.1399-3054.2003.00081.x; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Toussaint L, 2007, J MOL BIOL, V365, P440, DOI 10.1016/j.jmb.2006.10.010; TREFFRY A, 1989, FEBS LETT, V247, P268, DOI 10.1016/0014-5793(89)81350-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P959, DOI 10.1042/bj3050959; Wardrop AJ, 1999, BIOCHEM J, V337, P523, DOI 10.1042/0264-6021:3370523; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; WICKS RE, 1993, BIOCHEM BIOPH RES CO, V192, P813, DOI 10.1006/bbrc.1993.1487; YABLONSKI MJ, 1992, BIOCHEMISTRY-US, V31, P9680, DOI 10.1021/bi00155a022; YANG CY, 1987, BIOCHEMISTRY-US, V26, P497, DOI 10.1021/bi00376a023; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v	69	93	103	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4049	4059		10.1074/jbc.M109.059790	http://dx.doi.org/10.1074/jbc.M109.059790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007325	Green Published, hybrid			2022-12-27	WOS:000275254000058
J	Melzer, N; Villmann, C; Becker, K; Harvey, K; Harvey, RJ; Vogel, N; Kluck, CJ; Kneussel, M; Becker, CM				Melzer, Nima; Villmann, Carmen; Becker, Kristina; Harvey, Kirsten; Harvey, Robert J.; Vogel, Nico; Kluck, Christoph J.; Kneussel, Matthias; Becker, Cord-Michael			Multifunctional Basic Motif in the Glycine Receptor Intracellular Domain Induces Subunit-specific Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; SPLICE VARIANT; PROTEIN; GEPHYRIN; DETERMINES; MODULATION; SYNAPSES; TOPOLOGY; IMPORT; NOTCH	The strychnine-sensitive glycine receptor (GlyR) is a ligand-gated ion channel that mediates fast synaptic inhibition in the vertebrate central nervous system. As a member of the family of Cys-loop receptors, it assembles from five homologous subunits (GlyR alpha 1-4 and -beta). Each subunit contains an extracellular ligand binding domain, four transmembrane domains (TM), and an intracellular domain, formed by the loop connecting TM3 and TM4(TM3-4 loop). The TM3-4 loops of the subunits GlyR alpha 1 and -alpha 3 harbor a conserved basic motif, which is part of a potential nuclear localization signal. When tested for functionality by live cell imaging of green fluorescent protein and beta-galactosidase-tagged domain constructs, the TM3-4 loops of GlyR alpha 1 and -alpha 3, but not of GlyR alpha 2 and -beta, exhibited nuclear sorting activity. Subunit specificity may be attributed to slight amino acid alterations in the basic motif. In yeast two-hybrid screening and GST pulldown assays, karyopherin alpha 3 and alpha 4 were found to interact with the TM3-4 loop, providing a molecular mechanism for the observed intracellular trafficking. These results indicate that the multifunctional basic motif of the TM3-4 loop is capable of mediating a karyopherin-dependent intracellular sorting of full-length GlyRs.	[Melzer, Nima; Villmann, Carmen; Becker, Kristina; Vogel, Nico; Kluck, Christoph J.; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Harvey, Kirsten; Harvey, Robert J.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Kneussel, Matthias] Univ Hamburg, ZMNH, D-20251 Hamburg, Germany	University of Erlangen Nuremberg; University of London; University College London; University of London School of Pharmacy; University of Hamburg	Becker, CM (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	cmb@biochem.uni-erlangen.de	Harvey, Robert/D-3994-2016	Harvey, Robert/0000-0001-5956-6664; Kneussel, Matthias/0000-0003-4900-366X	Deutsche Forschungsgemeinschaft [BE1138/5-3]; Elitenetzwerk Bayern [K-BM-200385]; Medical Research Council [G0500833, G0501258, G0601585]; European Framework Program 7 [HEALTH-F4-2008-202088]; MRC [G0501258, G0500833, G0601585] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Framework Program 7; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Deutsche Forschungsgemeinschaft (BE1138/5-3), Elitenetzwerk Bayern (Lead Structures of Cell Function, K-BM-200385), the Medical Research Council (G0500833, G0501258, and G0601585 to K. H. and R. J. H.), and European Framework Program 7 (Neuro Cypress, HEALTH-F4-2008-202088).	Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Bluem R, 2007, J BIOL CHEM, V282, P37783, DOI 10.1074/jbc.M708301200; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Croci C, 2003, J BIOL CHEM, V278, P6128, DOI 10.1074/jbc.M205162200; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Holmes KD, 2002, J NEUROCHEM, V81, P1152, DOI 10.1046/j.1471-4159.2002.00865.x; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3730	3739		10.1074/jbc.M109.030460	http://dx.doi.org/10.1074/jbc.M109.030460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959465	hybrid, Green Published			2022-12-27	WOS:000275254000025
J	Shi, WW; Cui, NR; Wu, ZY; Yang, Y; Zhang, S; Gai, HY; Zhu, DL; Jiang, C				Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Yang, Yang; Zhang, Shuang; Gai, Hongyu; Zhu, Daling; Jiang, Chun			Lipopolysaccharides Up-regulate Kir6.1/SUR2B Channel Expression and Enhance Vascular K-ATP Channel Activity via NF-kappa B-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE; POTASSIUM CHANNELS; GENE-EXPRESSION; ACTIVATION; SEPSIS; ENDOTOXEMIA; SUBUNIT; ARTERY; PHOSPHORYLATION	Sepsis is a severe medical condition causing a large number of deaths worldwide. Recent studies indicate that the septic susceptibility is attributable to the vascular ATP-sensitive K+ (K-ATP) channel. However, the mechanisms underlying the channel modulation in sepsis are still unclear. Here we show evidence for the modulation of vascular K-ATP channel by septic pathogen lipopolysaccharides (LPS). In isolated mesenteric arterial rings, phenylephrine (PE) produced concentration-dependent vasoconstriction that was relaxed by pinacidil, a selective K-ATP channel opener. The PE response was disrupted with a LPS treatment. In acutely dissociated aortic smooth myocytes the LPS treatment augmented K-ATP channel activity, and hyperpolarized the cells. Quantitative PCR analysis showed that LPS raised Kir6.1 and SUR2B transcripts in a concentration-dependent manner, which was suppressed by transcriptional inhibition. Consistently, the same LPS treatment did not affect Kir6.1/SUR2B channels in a heterologous expression system. The LPS effect on Kir6.1 and SUR2B expression was abolished in the presence of NF-kappa B inhibitors. Several other Toll-like receptor ligands also stimulated Kir6.1 and SUR2B expression to a similar degree as LPS. Thus, the effect of LPS on vasodilation involves up-regulation of K-ATP channel expression, in which the NF-kappa B-dependent signaling plays an important role.	[Zhang, Shuang; Zhu, Daling] Harbin Med Coll, Sch Pharm, Harbin 150081, Heilongjiang, Peoples R China; [Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Yang, Yang; Gai, Hongyu; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Harbin Medical University; University System of Georgia; Georgia State University	Zhu, DL (corresponding author), Harbin Med Coll, Sch Pharm, Harbin 150081, Heilongjiang, Peoples R China.	dalingz@yahoo.com; cjiang@gsu.edu	Yang, Yang/B-3440-2008; SHI, WEIWEI/B-3477-2008	Yang, Yang/0000-0003-4275-0515; SHI, WEIWEI/0000-0001-6216-712X; Yang, Yang/0000-0001-6417-3654	National Institutes of Health [HD060959]; National Natural Science Foundation of China [30470752]; American Heart Association [09GRNT2010037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Grant HD060959 (to C. J.). This work was also supported by the National Natural Science Foundation of China (Grant number 30470752, to D. L. Z.) and by the American Heart Association (Grant 09GRNT2010037, to C. J.).	Bonev AD, 1996, J GEN PHYSIOL, V108, P315, DOI 10.1085/jgp.108.4.315; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Croker B, 2007, NAT GENET, V39, P1453, DOI 10.1038/ng.2007.25; Czaika G, 2000, MUSCLE NERVE, V23, P967; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Gardiner SM, 1999, BRIT J PHARMACOL, V128, P1772, DOI 10.1038/sj.bjp.0702985; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jin XC, 2004, AM J PHYSIOL-GASTR L, V287, pG274, DOI 10.1152/ajpgi.00472.2003; KAMOUCHI M, 1994, AM J PHYSIOL, V266, pH1687, DOI 10.1152/ajpheart.1994.266.5.H1687; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; LANDRY DW, 1992, J CLIN INVEST, V89, P2071, DOI 10.1172/JCI115820; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Malm TM, 2007, J NEUROSCI, V27, P3712, DOI 10.1523/JNEUROSCI.0059-07.2007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; O'Brien AJ, 2005, BRIT J PHARMACOL, V144, P367, DOI 10.1038/sj.bjp.0706065; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; SCHEIFELE DW, 1985, AM J CLIN PATHOL, V83, P227, DOI 10.1093/ajcp/83.2.227; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Wang XR, 2003, CIRC RES, V92, P1225, DOI 10.1161/01.RES.0000075601.95738.6D; Watanabe E, 2009, CRIT CARE MED, V37, P357, DOI 10.1097/CCM.0b013e31819311c0; Wu CC, 2004, BRIT J PHARMACOL, V142, P479, DOI 10.1038/sj.bjp.0705794; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Ye D, 2005, AM J PHYSIOL-HEART C, V288, pH358, DOI 10.1152/ajpheart.00423.2004; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	36	36	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3021	10.1074/jbc.M109.058313	http://dx.doi.org/10.1074/jbc.M109.058313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19959479	Green Published, hybrid			2022-12-27	WOS:000273829000017
J	Giroud, C; Moreau, M; Mattioli, TA; Balland, V; Boucher, JL; Yun, XL; Stuehr, DJ; Santolini, J				Giroud, Claire; Moreau, Magali; Mattioli, Tony A.; Balland, Veronique; Boucher, Jean-Luc; Yun Xu-Li; Stuehr, Dennis J.; Santolini, Jerome			Role of Arginine Guanidinium Moiety in Nitric-oxide Synthase Mechanism of Oxygen Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-PROTEIN INTERACTIONS; ARYL N'-HYDROXYGUANIDINES; 2ND HALF-REACTION; NO-SYNTHASE; ELECTRON-TRANSFER; RESONANCE RAMAN; HEME ENVIRONMENT; STAPHYLOCOCCUS-AUREUS; SELECTIVE INHIBITOR; DIOXYGEN COMPLEXES	Nitric-oxide synthases (NOS) are highly regulated heme-thiolate enzymes that catalyze two oxidation reactions that sequentially convert the substrate L-Arg first to N-w-hydroxyl-L-arginine and then to L-citrulline and nitric oxide. Despite numerous investigations, the detailed molecular mechanism of NOS remains elusive and debatable. Much of the dispute in the various proposed mechanisms resides in the uncertainty concerning the number and sources of proton transfers. Although specific protonation events are key features in determining the specificity and efficiency of the two catalytic steps, little is known about the role and properties of protons from the substrate, cofactors, and H-bond network in the vicinity of the heme active site. In this study, we have investigated the role of the acidic proton from the L-Arg guanidinium moiety on the stability and reactivity of the ferrous heme-oxy complex intermediate by exploiting a series of L-Arg analogues exhibiting a wide range of guanidinium pK(a) values. Using electrochemical and vibrational spectroscopic techniques, we have analyzed the effects of the analogues on the heme, including characteristics of its proximal ligand, heme conformation, redox potential, and electrostatic properties of its distal environment. Our results indicate that the substrate guanidinium pK(a) value significantly affects the H-bond network near the heme distal pocket. Our results lead us to propose a new structural model where the properties of the guanidinium moiety finely control the proton transfer events in NOS and tune its oxidative chemistry. This model may account for the discrepancies found in previously proposed mechanisms of NOS oxidation processes.	[Mattioli, Tony A.; Santolini, Jerome] Commissariat Energie Atom Saclay, Inst Biol & Technol Saclay, Lab Stress Oxydants & Detoxicat, F-91191 Gif Sur Yvette, France; Univ Paris 05, CNRS, UMR 8601, F-75270 Paris, France; [Stuehr, Dennis J.] Lerner Res Fdn, Cleveland Clin, Cleveland, OH 44195 USA; [Balland, Veronique] Univ Paris Diderot, Electrochim Mol Lab, UMR7591, F-75205 Paris 13, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Santolini, J (corresponding author), Commissariat Energie Atom Saclay, Inst Biol & Technol Saclay, Lab Stress Oxydants & Detoxicat, F-91191 Gif Sur Yvette, France.	jerome.santolini@cea.fr	Balland, Véronique/AAD-7548-2022; Balland, Véronique/D-2479-2013	Balland, Véronique/0000-0001-9534-9659; Santolini, Jerome/0000-0001-8919-112X				ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Babu BR, 1999, J BIOL CHEM, V274, P25218, DOI 10.1074/jbc.274.36.25218; Balland V, 2008, CHEM-EUR J, V14, P7186, DOI 10.1002/chem.200800368; BERNATOWICZ MS, 1993, TETRAHEDRON LETT, V34, P3389, DOI 10.1016/S0040-4039(00)79163-5; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chartier FJM, 2006, J BIOL CHEM, V281, P9953, DOI 10.1074/jbc.M513893200; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; CHARTON M, 1965, J ORG CHEM, V30, P969, DOI 10.1021/jo01015a003; Cho KB, 2005, J PHYS CHEM B, V109, P23706, DOI 10.1021/jp054864o; Cho KB, 2007, J AM CHEM SOC, V129, P3182, DOI 10.1021/ja066662r; Cho KB, 2009, J PHYS CHEM B, V113, P336, DOI 10.1021/jp8073199; Collins JL, 1998, J MED CHEM, V41, P2858, DOI 10.1021/jm980072p; Crane BR, 2000, BIOCHEMISTRY-US, V39, P4608, DOI 10.1021/bi992409a; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Davydov R, 2002, BIOCHEMISTRY-US, V41, P10375, DOI 10.1021/bi0260637; Dawson VL, 1996, NEUROCHEM INT, V29, P97, DOI 10.1016/0197-0186(95)00149-2; de Visser SP, 2008, J AM CHEM SOC, V130, P12961, DOI 10.1021/ja8010995; Deng TJ, 1999, BIOCHEMISTRY-US, V38, P13699, DOI 10.1021/bi991287j; Dijols S, 2002, BIOCHEMISTRY-US, V41, P9286, DOI 10.1021/bi025691l; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garcin ED, 2008, NAT CHEM BIOL, V4, P700, DOI 10.1038/nchembio.115; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Huang H, 2001, J AM CHEM SOC, V123, P2674, DOI 10.1021/ja005900u; Igarashi J, 2009, J MED CHEM, V52, P2060, DOI 10.1021/jm900007a; Ingledew WJ, 2002, BIOCHEMISTRY-US, V41, P8377, DOI 10.1021/bi012101v; Jung C, 1996, BIOCHEMISTRY-US, V35, P15088, DOI 10.1021/bi961507i; Jung C, 2000, BIOCHEMISTRY-US, V39, P10163, DOI 10.1021/bi0003792; JUNG C, 1992, BIOCHEMISTRY-US, V31, P12855, DOI 10.1021/bi00166a021; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Lefevre-Groboillot D, 2005, FEBS J, V272, P3172, DOI 10.1111/j.1742-4658.2005.04736.x; LEFFEK KT, 1989, CAN J CHEM, V67, P590, DOI 10.1139/v89-089; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Li HY, 2000, J INORG BIOCHEM, V81, P133, DOI 10.1016/S0162-0134(00)00099-4; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Luzzi SD, 2005, BIOORG MED CHEM LETT, V15, P3934, DOI 10.1016/j.bmcl.2005.05.088; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Mansuy D, 2004, FREE RADICAL BIO MED, V37, P1105, DOI 10.1016/j.freeradbiomed.2004.06.031; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Martin NI, 2007, J AM CHEM SOC, V129, P12563, DOI 10.1021/ja0746159; Moreau M, 2006, BIOCHEMISTRY-US, V45, P3988, DOI 10.1021/bi051488p; MOREAU M, 2005, THESIS U PARIS DESCA; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; PACHER P, 2007, PHYSIOL REV, V315, P424; Pall ML, 2007, MED HYPOTHESES, V69, P821, DOI 10.1016/j.mehy.2007.01.070; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Perrin D.D., 1972, DISSOCIATION CONSTAN; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Renodon-Corniere A, 1999, BIOCHEMISTRY-US, V38, P4663, DOI 10.1021/bi982930p; Renodon-Corniere A, 2002, J MED CHEM, V45, P944, DOI 10.1021/jm011006h; Reynolds MR, 2007, BIOCHEMISTRY-US, V46, P7325, DOI 10.1021/bi700430y; Robinet JJ, 2008, J AM CHEM SOC, V130, P3328, DOI 10.1021/ja072650+; RodriguezCrespo I, 1997, BIOCHEMISTRY-US, V36, P8530, DOI 10.1021/bi970192j; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Schelvis JPM, 2002, BIOCHEMISTRY-US, V41, P5695, DOI 10.1021/bi0118456; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Sennequier N, 1996, BIOCHEMISTRY-US, V35, P5883, DOI 10.1021/bi952844e; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Silverman RB, 2009, ACCOUNTS CHEM RES, V42, P439, DOI 10.1021/ar800201v; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Stuehr D J, 1995, Adv Pharmacol, V34, P207; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TAYLOR PJ, 1986, J CHEM SOC PERK T 2, P1765, DOI 10.1039/p29860001765; Tejero J, 2009, FEBS J, V276, P4505, DOI 10.1111/j.1742-4658.2009.07157.x; Tosha T, 2006, BIOCHEMISTRY-US, V45, P5631, DOI 10.1021/bi060094a; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; TSUBAKI M, 1986, BIOCHEMISTRY-US, V25, P3563, DOI 10.1021/bi00360a014; Vasquez-Vivar J, 2009, FREE RADICAL BIO MED, V47, P1108, DOI 10.1016/j.freeradbiomed.2009.07.024; WANG JL, 1995, BIOCHEMISTRY-US, V34, P7080, DOI 10.1021/bi00021a020; Wang JL, 1997, BIOCHEMISTRY-US, V36, P4595, DOI 10.1021/bi962309u; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2002, J INORG BIOCHEM, V91, P618, DOI 10.1016/S0162-0134(02)00432-4; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; WELLS AV, 1992, BIOCHEMISTRY-US, V31, P4384, DOI 10.1021/bi00133a002; Woodward JJ, 2009, J AM CHEM SOC, V131, P297, DOI 10.1021/ja807299t; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; YAMAMOTO Y, 1991, CHEM AMIDINES IMIDAT, V2, P485; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	113	24	24	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7233	7245		10.1074/jbc.M109.038240	http://dx.doi.org/10.1074/jbc.M109.038240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19951943	Green Published, hybrid			2022-12-27	WOS:000275415600036
J	Samovski, D; Kalderon, B; Yehuda-Shnaidman, E; Bar-Tana, J				Samovski, Dmitri; Kalderon, Bella; Yehuda-Shnaidman, Einav; Bar-Tana, Jacob			Gating of the Mitochondrial Permeability Transition Pore by Long Chain Fatty Acyl Analogs in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BETA,BETA-METHYL-SUBSTITUTED HEXADECANEDIOIC ACID; PANCREATIC BETA-CELLS; PERFUSED-RAT-LIVER; PROTEIN-KINASE-C; ADENYLYL-CYCLASE; THYROID-HORMONE; SERINE PHOSPHORYLATION; PROTONOPHORIC ACTIVITY; PHOSPHATE POTENTIALS	The role played by long chain fatty acids (LCFA) in promoting energy expenditure is confounded by their dual function as substrates for oxidation and as putative classic uncouplers of mitochondrial oxidative phosphorylation. LCFA analogs of the MEDICA (MEthyl-substituted DICarboxylic Acids) series are neither esterified into lipids nor beta-oxidized and may thus simulate the uncoupling activity of natural LCFA in vivo, independently of their substrate role. Treatment of rats or cell lines with MEDICA analogs results in low conductance gating of the mitochondrial permeability transition pore (PTP), with 10-40% decrease in the inner mitochondrial membrane potential. PTP gating by MEDICA analogs is accounted for by inhibition of Raf1 expression and kinase activity, resulting in suppression of the MAPK/RSK1 and the adenylate cyclase/PKA transduction pathways. Suppression of RSK1 and PKA results in a decrease in phosphorylation of their respective downstream targets, Bad(Ser-112) and Bad(Ser-155). Decrease in Bad(Ser-112, Ser-155) phosphorylation results in increased binding of Bad to mitochondrial Bcl2 with concomitant displacement of Bax, followed by PTP gating induced by free mitochondrial Bax. Low conductance PTP gating by LCFA/MEDICA may account for their thyromimetic calorigenic activity in vivo.	[Samovski, Dmitri; Kalderon, Bella; Yehuda-Shnaidman, Einav; Bar-Tana, Jacob] Hebrew Univ Jerusalem, Sch Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Bar-Tana, J (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel.	bartanaj@cc.huji.ac.il	Samovski, Dmitri/AAQ-2014-2020; Samovski, Dmitri/K-3705-2019	Samovski, Dmitri/0000-0002-6860-6688; 	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Israeli Science Foundation.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; BARTANA J, 1989, J MED CHEM, V32, P2072, DOI 10.1021/jm00129a010; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; Beazely MA, 2006, EUR J PHARMACOL, V535, P1, DOI 10.1016/j.ejphar.2006.01.054; Bernardi P, 2002, VITAM HORM, V65, P97, DOI 10.1016/S0083-6729(02)65061-7; Bobyleva V, 1998, FEBS LETT, V430, P409, DOI 10.1016/S0014-5793(98)00700-5; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Choi SE, 2008, ARCH BIOCHEM BIOPHYS, V475, P109, DOI 10.1016/j.abb.2008.04.015; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Ding QM, 2004, MOL PHARMACOL, V66, P921, DOI 10.1124/mol.66.4.921; Feldman RD, 2007, LIFE SCI, V81, P267, DOI 10.1016/j.lfs.2007.05.015; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hermesh O, 2000, BBA-BIOENERGETICS, V1457, P166, DOI 10.1016/S0005-2728(00)00097-9; Hermesh O, 1998, J BIOL CHEM, V273, P3937, DOI 10.1074/jbc.273.7.3937; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; KALDERON B, 1992, ENDOCRINOLOGY, V131, P400, DOI 10.1210/en.131.1.400; KALDERON B, 1992, ENDOCRINOLOGY, V131, P1629, DOI 10.1210/en.131.4.1629; Kalderon B, 2002, J LIPID RES, V43, P1125, DOI 10.1194/jlr.M200060-JLR200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; KINGSLEYHICKMAN PB, 1990, J BIOL CHEM, V265, P1545; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Mayorek N, 1997, DIABETES, V46, P1958, DOI 10.2337/diabetes.46.12.1958; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Osawa Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1414, DOI 10.1152/ajplung.00123.2006; Russell JC, 1998, DIABETES, V47, P770, DOI 10.2337/diabetes.47.5.770; SCHOLZ R, 1984, EUR J BIOCHEM, V141, P223, DOI 10.1111/j.1432-1033.1984.tb08179.x; SCHONFELD P, 1988, BIOCHIM BIOPHYS ACTA, V936, P280, DOI 10.1016/0005-2728(88)90003-5; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shabalina IG, 2008, BBA-BIOENERGETICS, V1777, P642, DOI 10.1016/j.bbabio.2008.04.038; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; SOBOLL S, 1984, EUR J BIOCHEM, V141, P231, DOI 10.1111/j.1432-1033.1984.tb08180.x; SOBOLL S, 1993, BIOCHIM BIOPHYS ACTA, V1144, P1, DOI 10.1016/0005-2728(93)90024-A; Tan CM, 2001, BIOCHEMISTRY-US, V40, P1702, DOI 10.1021/bi0015818; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wojtczak L, 1998, ARCH BIOCHEM BIOPHYS, V357, P76, DOI 10.1006/abbi.1998.0777; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yehuda-Shnaidman E, 2005, ENDOCRINOLOGY, V146, P2462, DOI 10.1210/en.2004-1161; Yehuda-Shnaidman E, 2010, FASEB J, V24, P93, DOI 10.1096/fj.09-133538; Yue X, 2006, EUR J PHARMACOL, V540, P57, DOI 10.1016/j.ejphar.2006.04.033; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	66	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6879	6890		10.1074/jbc.M109.080416	http://dx.doi.org/10.1074/jbc.M109.080416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20037159	Green Published, hybrid			2022-12-27	WOS:000275415600002
J	Lebska, M; Ciesielski, A; Szymona, L; Godecka, L; Lewandowska-Gnatowska, E; Szczegielniak, J; Muszynska, G				Lebska, Maja; Ciesielski, Arkadiusz; Szymona, Lidia; Godecka, Luiza; Lewandowska-Gnatowska, Elzbieta; Szczegielniak, Jadwiga; Muszynska, Grazyna			Phosphorylation of Maize Eukaryotic Translation Initiation Factor 5A (eIF5A) by Casein Kinase 2 IDENTIFICATION OF PHOSPHORYLATED RESIDUE AND INFLUENCE ON INTRACELLULAR LOCALIZATION OF eIF5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; PROTEIN-KINASES; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; CK2 PHOSPHORYLATION; EIF2-BETA SUBUNIT; TERMINAL DOMAIN; PLANT-GROWTH; EXPRESSION; ARABIDOPSIS	Maize eukaryotic translation initiation factor 5A (ZmeIF5A) co-purifies with the catalytic alpha subunit of protein kinase CK2 and is phosphorylated by this enzyme. Phosphorylated ZmeIF5A was also identified after separation of maize leaf proteins by two-dimensional electrophoresis. Multiple sequence alignment of eIF5A proteins showed that in monocots, in contrast to other eukaryotes, there are two serine/threonine residues that could potentially be phosphorylated by CK2. To identify the phosphorylation site(s) of ZmeIF5A, the serine residues potentially phosphorylated by CK2 were mutated. ZmeIF5A and its mutated variants S2A and S4A were expressed in Escherichia coli and purified. Of these recombinant proteins, only ZmeIF5A-S2A was not phosphorylated by maize CK2. Also, Arabidopsis thaliana and Saccharomyces cerevisiae eIF5A-S2A mutants were not phosphorylated despite effective phosphorylation of wild-type variants. A newly developed method exploiting the specificity of thrombin cleavage was used to confirm that Ser(2) in ZmeIF5A is indeed phosphorylated. To find a role of the Ser(2) phosphorylation, ZmeIF5A and its variants mutated at Ser(2) (S2A and S2D) were transiently expressed in maize protoplasts. The expressed fluorescence labeled proteins were visualized by confocal microscopy. Although wild-type ZmeIF5A and its S2A variant were distributed evenly between the nucleus and cytoplasm, the variant with Ser(2) replaced by aspartic acid, which mimics a phosphorylated serine, was sequestered in the nucleus. These results suggests that phosphorylation of Ser(2) plays a role in regulation of nucleocytoplasmic shuttling of eIF5A in plant cells.	[Lebska, Maja; Ciesielski, Arkadiusz; Szymona, Lidia; Godecka, Luiza; Lewandowska-Gnatowska, Elzbieta; Szczegielniak, Jadwiga; Muszynska, Grazyna] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Muszynska, G (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.	muszynsk@ibb.waw.pl		Borkiewicz, Lidia/0000-0002-2834-0969	Ministry of Science and Higher Education [PBZ-MIN-014/P05/2004]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education Grant PBZ-MIN-014/P05/2004.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; BODENBACH L, 1994, EUR J BIOCHEM, V220, P263, DOI 10.1111/j.1432-1033.1994.tb18622.x; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chou WC, 2004, PHYSIOL PLANTARUM, V121, P50, DOI 10.1111/j.0031-9317.2004.00292.x; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Ciceri P, 1997, PLANT CELL, V9, P97, DOI 10.1105/tpc.9.1.97; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; DOBROWOLSKA G, 1992, EUR J BIOCHEM, V204, P299, DOI 10.1111/j.1432-1033.1992.tb16637.x; DOBROWOLSKA G, 1987, BIOCHIM BIOPHYS ACTA, V931, P188, DOI 10.1016/0167-4889(87)90206-0; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1129, P139, DOI 10.1016/0167-4781(91)90230-J; Dresselhaus T, 1999, PLANT MOL BIOL, V39, P1063, DOI 10.1023/A:1006176819213; Espunya MC, 2005, J EXP BOT, V56, P3183, DOI 10.1093/jxb/eri315; Espunya MC, 1999, PLANT J, V19, P655, DOI 10.1046/j.1365-313x.1999.00563.x; Feng HZ, 2007, PLANT PHYSIOL, V144, P1531, DOI 10.1104/pp.107.098079; French AC, 2007, J BIOL CHEM, V282, P29667, DOI 10.1074/jbc.M706457200; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Jao DLE, 2002, J CELL BIOCHEM, V86, P590, DOI 10.1002/jcb.10235; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; KANG HA, 1993, J BIOL CHEM, V268, P14750; KLIMCZAK LJ, 1995, PLANT CELL, V7, P105, DOI 10.1105/tpc.7.1.105; KLIMCZAK LJ, 1994, PLANT PHYSIOL, V105, P911, DOI 10.1104/pp.105.3.911; Lebska M, 2009, PHYSIOL PLANTARUM, V136, P251, DOI 10.1111/j.1399-3054.2009.01238.x; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu Z, 2008, J EXP BOT, V59, P939, DOI 10.1093/jxb/ern017; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Llorens F, 2005, MOL CELL BIOCHEM, V274, P53, DOI 10.1007/s11010-005-3081-5; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Martel V, 2002, ANN NY ACAD SCI, V973, P272, DOI 10.1111/j.1749-6632.2002.tb04648.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Pagano MA, 2005, MOL CELL BIOCHEM, V274, P23, DOI 10.1007/s11010-005-3116-y; Park MH, 1997, BIOL SIGNAL, V6, P115; Parreiras-E-Silva LT, 2007, BIOCHEM BIOPH RES CO, V362, P393, DOI 10.1016/j.bbrc.2007.07.185; Peracchia G, 1999, PLANT MOL BIOL, V40, P199, DOI 10.1023/A:1006196530079; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Riera M, 2001, PLANT J, V25, P365, DOI 10.1046/j.1365-313x.2001.00973.x; Sarno S, 2005, BBA-PROTEINS PROTEOM, V1754, P263, DOI 10.1016/j.bbapap.2005.07.043; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shugar D, 2005, BBA-PROTEINS PROTEOM, V1754, P1, DOI 10.1016/j.bbapap.2005.10.008; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Thompson JE, 2004, TRENDS PLANT SCI, V9, P174, DOI 10.1016/j.tplants.2004.02.008; Wang HM, 2003, J CELL BIOCHEM, V88, P812, DOI 10.1002/jcb.10438; Wang TW, 2001, J BIOL CHEM, V276, P17541, DOI 10.1074/jbc.M008544200	56	28	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6217	6226		10.1074/jbc.M109.018770	http://dx.doi.org/10.1074/jbc.M109.018770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018887	hybrid, Green Published			2022-12-27	WOS:000275367500026
J	Maillet, M; Davis, J; Auger-Messier, M; York, A; Osinska, H; Piquereau, J; Lorenz, JN; Robbins, J; Ventura-Clapier, R; Molkentin, JD				Maillet, Marjorie; Davis, Jennifer; Auger-Messier, Mannix; York, Allen; Osinska, Hanna; Piquereau, Jerome; Lorenz, John N.; Robbins, Jeffrey; Ventura-Clapier, Renee; Molkentin, Jeffery D.			Heart-specific Deletion of CnB1 Reveals Multiple Mechanisms Whereby Calcineurin Regulates Cardiac Growth and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; NF-ATC; CALCIUM; HYPERTROPHY; DEPHOSPHORYLATION; EXPRESSION; PHENOTYPES; EXCHANGER	Calcineurin is a protein phosphatase that is uniquely regulated by sustained increases in intracellular Ca2+ following signal transduction events. Calcineurin controls cellular proliferation, differentiation, apoptosis, and inducible gene expression following stress and neuroendocrine stimulation. In the adult heart, calcineurin regulates hypertrophic growth of cardiomyocytes in response to pathologic insults that are associated with altered Ca2+ handling. Here we determined that calcineurin signaling is directly linked to the proper control of cardiac contractility, rhythm, and the expression of Ca2+- handling genes in the heart. Our approach involved a cardiomyocyte-specific deletion using a CnB1-LoxP-targeted allele in mice and three different cardiac-expressing Cre alleles/transgenes. Deletion of calcineurin with the Nkx2.5-Cre knock-in allele resulted in lethality at 1 day after birth due to altered right ventricular morphogenesis, reduced ventricular trabeculation, septal defects, and valvular overgrowth. Slightly later deletion of calcineurin with the alpha-myosin heavy chain Cre transgene resulted in lethality in early mid adulthood that was characterized by substantial reductions in cardiac contractility, severe arrhythmia, and reduced myocyte content in the heart. Young calcineurin heart-deleted mice died suddenly after pressure overload stimulation or neuroendocrine agonist infusion, and telemetric monitoring of older mice showed arrhythmia leading to sudden death. Mechanistically, loss of calcineurin reduced expression of key Ca2+-handling genes that likely lead to arrhythmia and reduced contractility. Loss of calcineurin also directly impacted cellular proliferation in the postnatal developing heart. These results reveal multiple mechanisms whereby calcineurin regulates cardiac development and myocyte contractility.	[Maillet, Marjorie; Davis, Jennifer; Auger-Messier, Mannix; York, Allen; Osinska, Hanna; Robbins, Jeffrey; Molkentin, Jeffery D.] Univ Cincinnati, Med Ctr, Div Mol Cardiovasc Biol,Dept Pediat, Howard Hughes Med Inst,Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA; [Piquereau, Jerome; Ventura-Clapier, Renee] Univ Paris 11, 1FR141, F-92296 Chatenay Malabry, France; [Lorenz, John N.] Univ Cincinnati, Sch Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; UDICE-French Research Universities; Universite Paris Saclay; University System of Ohio; University of Cincinnati	Molkentin, JD (corresponding author), Univ Cincinnati, Med Ctr, Div Mol Cardiovasc Biol,Dept Pediat, Howard Hughes Med Inst,Cincinnati Childrens Hosp, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org		Ventura-Clapier, Renee/0000-0002-7488-4123; DAVIS, JENNIFER/0000-0003-2380-1321; Molkentin, Jeffery/0000-0002-3558-6529; Piquereau, Jerome/0000-0002-6019-8683	National Institutes of Health; Howard Hughes Medical Institute; Fondation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fondation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant (to J. D. M.). This work was also supported by grants from the Howard Hughes Medical Institute and an international collaborative research grant in cardiovascular disease from the Fondation Leducq (to J. D. M.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anwar A, 2005, J MOL CELL CARDIOL, V39, P911, DOI 10.1016/j.yjmcc.2005.08.001; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Coutu P, 2005, AM J PHYSIOL-HEART C, V288, pH601, DOI 10.1152/ajpheart.00424.2004; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Fewell JG, 1997, AM J PHYSIOL-HEART C, V273, pH1595, DOI 10.1152/ajpheart.1997.273.3.H1595; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Jordan MC, 2002, ANN NY ACAD SCI, V976, P259; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Schaeffer PJ, 2009, AM J PHYSIOL-HEART C, V297, pH1263, DOI 10.1152/ajpheart.00152.2009; Shigekawa M, 2007, ANN NY ACAD SCI, V1099, P53, DOI 10.1196/annals.1387.059; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang ZY, 2001, J BIOL CHEM, V276, P17706, DOI 10.1074/jbc.M100544200; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413	49	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6716	6724		10.1074/jbc.M109.056143	http://dx.doi.org/10.1074/jbc.M109.056143			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037164	Green Published, hybrid			2022-12-27	WOS:000275367500075
J	Scotto-Lavino, E; Garcia-Diaz, M; Du, GW; Frohman, MA				Scotto-Lavino, Elizabeth; Garcia-Diaz, Miguel; Du, Guangwei; Frohman, Michael A.			Basis for the Isoform-specific Interaction of Myosin Phosphatase Subunits Protein Phosphatase 1c beta and Myosin Phosphatase Targeting Subunit 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; MERLIN	Myosin II association with actin, which triggers contraction, is regulated by orchestrated waves of phosphorylation/dephosphorylation of the myosin regulatory light chain. Blocking myosin regulatory light chain phosphorylation with small molecule inhibitors alters the shape, adhesion, and migration of many types of smooth muscle and cancer cells. Dephosphorylation is mediated by myosin phosphatase (MP), a complex that consists of a catalytic subunit (protein phosphatase 1c, PP1c), a large subunit (myosin phosphatase targeting subunit, MYPT), and a small subunit of unknown function. MYPT functions by targeting PP1c onto its substrate, phosphorylated myosin II. Using RNA interference, we show here that stability of PP1c beta and MYPT1 is interdependent; knocking down one of the subunits decreases the expression level of the other. Associated changes in cell shape also occur, characterized by flattening and spreading accompanied by increased cortical actin, and cell numbers decrease secondary to apoptosis. Of the three highly conserved isoforms of PP1c, we show that MYPT1 binding is restricted to PP1c beta, and, using chimeric analysis and site-directed mutations, that the central region of PP1c beta confers the isoformspecific binding. This finding was unexpected because the MP crystal structure has been solved and was reported to identify the variable, C-terminal domain of PP1c beta as being the region key for isoform-specific interaction with MYPT1. These findings suggest a potential screening strategy for cardiovascular and cancer therapeutic agents based on destabilizing MP complex formation and function.	[Scotto-Lavino, Elizabeth; Garcia-Diaz, Miguel; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Scotto-Lavino, Elizabeth; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Du, Guangwei] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health Science Center Houston	Du, GW (corresponding author), SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA.	guangwei.du@uth.tmc.edu; michael@pharm.stonybrook.edu		Du, Guangwei/0000-0003-4193-6975	National Institutes of Health [GM071520, GM084251, GM071475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251, R01GM071520, R01GM071475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM071520 and GM084251 (to M. A. F.) and GM071475 (to G. D.).	Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jung JR, 2005, MOL CELLS, V20, P196; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025	15	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6419	6424		10.1074/jbc.M109.074773	http://dx.doi.org/10.1074/jbc.M109.074773			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042605	Green Published, hybrid			2022-12-27	WOS:000275367500046
J	Bhunia, A; Domadia, PN; Torres, J; Hallock, KJ; Ramamoorthy, A; Bhattacharjya, S				Bhunia, Anirban; Domadia, Prerna N.; Torres, Jaume; Hallock, Kevin J.; Ramamoorthy, Ayyalusamy; Bhattacharjya, Surajit			NMR Structure of Pardaxin, a Pore-forming Antimicrobial Peptide, in Lipopolysaccharide Micelles MECHANISM OF OUTER MEMBRANE PERMEABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; HOST-DEFENSE PEPTIDES; RELAXATION DISPERSION; SECONDARY STRUCTURE; BURKHOLDERIA-CENOCEPACIA; THERMODYNAMIC ANALYSIS; CORE-OLIGOSACCHARIDE; HEMOLYTIC ACTIVITIES; CHANNEL FORMATION; DESIGNED PEPTIDE	Lipopolysaccharide (LPS), the major constituent of the outer membrane of Gram-negative bacteria, is an important element against permeability of bactericidal agents, including antimicrobial peptides. However, structural determinants of antimicrobial peptides for LPS recognition are not clearly understood. Pardaxins (Pa1, Pa2, Pa3, and Pa4) are a group of pore-forming bactericidal peptides found in the mucous glands of sole fishes. Despite having a low net positive charge, pardaxins contain a broad spectrum of antibacterial activities. To elucidate the structural basis of LPS interactions of pardaxins, herein, we report the first three-dimensional structure of Pa4 bound to LPS micelles. The binding kinetics of Pa4 with LPS is estimated using [N-15-Leu-19] relaxation dispersion NMR experiments. LPS/Pa4 interactions are further characterized by a number of biophysical methods, including isothermal titration calorimetry, P-31 NMR, saturation transfer difference NMR, dynamic light scattering, and IR spectroscopy. In the LPS-Pa4 complex, Pa4 adopts a unique helix-turn-helix conformation resembling a "horseshoe." Interestingly, the LPS-bound structure of Pa4 shows striking differences with the structures determined in lipid micelles or organic solvents. Saturation transfer difference NMR identifies residues of Pa4 that are intimately associated with LPS micelles. Collectively, our results provide mechanistic insights into the outer membrane permeabilization by pardaxin.	[Hallock, Kevin J.; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Bhunia, Anirban; Domadia, Prerna N.; Torres, Jaume; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore	University of Michigan System; University of Michigan; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu; surajit@ntu.edu.sg	Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020; Bhattacharjya, SURAJIT/A-2183-2011	Torres, Jaume/0000-0002-1282-9727; Bhunia, Anirban/0000-0002-8752-2842; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	National Institutes of Health [AI 054515]; A*Star Biomedical Research Council Singapore [06/1/22/19/446]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*Star Biomedical Research Council Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 054515 (to A. R.). This work was also supported by Grant 06/1/22/19/446 from A*Star Biomedical Research Council Singapore (to S. B.).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO;2-R; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2008, BIOCHEM BIOPH RES CO, V369, P853, DOI 10.1016/j.bbrc.2008.02.105; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Hallock KJ, 2002, BIOPHYS J, V82, P2499, DOI 10.1016/S0006-3495(02)75592-6; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haselhorst T, 2001, J AM CHEM SOC, V123, P10705, DOI 10.1021/ja011156h; HOLLOWAY PW, 1989, BIOCHEMISTRY-US, V28, P931, DOI 10.1021/bi00429a002; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Lazarovici P, 1992, J NAT TOXINS, V1, P1; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Marsh D, 1999, BIOPHYS J, V77, P2630, DOI 10.1016/S0006-3495(99)77096-7; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramamoorthy A, 2004, ANNU REP NMR SPECTRO, V52, P1, DOI 10.1016/S0066-4103(04)52001-X; RAMAMOORTHY A, 2009, BIOCH BIOPH IN PRESS; Ramamoorthy A, 2006, BIOCHEMISTRY-US, V45, P6529, DOI 10.1021/bi052629q; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; SABERWAL G, 1993, J BIOL CHEM, V268, P14081; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; SHAI Y, 1990, J BIOL CHEM, V265, P20202; SHAI Y, 1991, J BIOL CHEM, V266, P22346; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; SHAI Y, 1994, TOXICOLOGY, V87, P109, DOI 10.1016/0300-483X(94)90157-0; SHAI Y, 1988, FEBS LETT, V242, P161, DOI 10.1016/0014-5793(88)81007-X; STRAIN SM, 1983, J BIOL CHEM, V258, P3466; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Thomas CJ, 2001, J BIOL CHEM, V276, P35701, DOI 10.1074/jbc.M011319200; THOMPSON SA, 1986, SCIENCE, V233, P341, DOI 10.1126/science.233.4761.341; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Tolkatchev D, 2003, J AM CHEM SOC, V125, P12432, DOI 10.1021/ja021238l; Tossi A, 2000, BIOPOLYMERS, V55, P4; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; ZAGORSKI MG, 1991, BIOCHEMISTRY-US, V30, P8009, DOI 10.1021/bi00246a019; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zintsmaster JS, 2008, J AM CHEM SOC, V130, P14060, DOI 10.1021/ja805839y	75	117	119	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3883	3895		10.1074/jbc.M109.065672	http://dx.doi.org/10.1074/jbc.M109.065672			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959835	Green Published, hybrid			2022-12-27	WOS:000275254000042
J	Higgins, WJ; Fox, DM; Kowalski, PS; Nielsen, JE; Worrall, DM				Higgins, Wayne J.; Fox, Denise M.; Kowalski, Piotr S.; Nielsen, Jens E.; Worrall, D. Margaret			Heparin Enhances Serpin Inhibition of the Cysteine Protease Cathepsin L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER PROGRESSION; INDUCED APOPTOSIS; CERVICAL-CANCER; BINDING SITE; ANTIGEN; ANTITHROMBIN; EXPRESSION; IDENTIFICATION; ANGIOGENESIS	The glycosaminoglycan heparin is known to possess anti-metastatic activity in experimental models and preclinical studies, but there is still uncertainty over its mechanism of action in this respect. As an anticoagulant, heparin enhances inhibition of thrombin by the serpin antithrombin III, but a similar cofactor role has not been previously investigated for proteases linked to metastasis. The squamous cell carcinoma antigens (serpins B3 and B4) are tumor-associated proteins that can inhibit papain-like cysteine proteases, including cathepsins L, K, and S. In this study, we show that SCCA-1 (B3) and SCCA-2 (B4) can bind heparin as demonstrated by affinity chromatography, native PAGE gel shifts, and intrinsic fluorescence quenching. Binding was specific for heparin and heparan sulfate but not other glycosaminoglycans. The presence of heparin accelerated inhibition of cathepsin L by both serpins, and in the case of SCCA-1, heparin increased the second order inhibition rate constant from 5.4 x 10(5) to> 10(8), indicating a rate enhancement of at least 180-fold. A templating mechanism was shown, consistent with ternary complex formation. Furthermore, SCCA-1 inhibition of cathepsin L-like proteolytic activity secreted from breast and melanoma cancer cell lines was significantly enhanced by heparin. This is the first example of glycosaminoglycan enhancement of B-clade serpin activity and the first report of heparin acting as a cofactor in serpin cross-class inhibition of cysteine proteases. Most importantly, this finding raises the possibility that the anticancer properties of heparin may be due, at least partly, to enhanced inhibition of prometastatic proteases.	[Higgins, Wayne J.; Fox, Denise M.; Kowalski, Piotr S.; Nielsen, Jens E.; Worrall, D. Margaret] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin	Worrall, DM (corresponding author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	mworrall@ucd.ie	Kowalski, Piotr/AAF-7450-2021	Kowalski, Piotr/0000-0001-8607-0189; Nielsen, Jens Erik/0000-0002-2831-7718	Irish Cancer Society Research [CR105WOR]; Science Foundation Ireland UREKA; University College Dublin	Irish Cancer Society Research; Science Foundation Ireland UREKA(Science Foundation Ireland); University College Dublin	This work was supported by Irish Cancer Society Research Grant CR105WOR, a Science Foundation Ireland UREKA studentship (to P. S. K.), and a University College Dublin research demonstratorship (to D. M. F.).	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; BARNES RC, 1995, FEBS LETT, V373, P61, DOI 10.1016/0014-5793(95)01015-7; Barnes RC, 2000, GYNECOL ONCOL, V78, P62, DOI 10.1006/gyno.2000.5818; BODY JJ, 1990, CANCER, V65, P1552, DOI 10.1002/1097-0142(19900401)65:7<1552::AID-CNCR2820650717>3.0.CO;2-D; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Burden RE, 2008, MOL CANCER THER, V7, P538, DOI 10.1158/1535-7163.MCT-07-0528; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Gupta VK, 2008, BIOCHIMIE, V90, P749, DOI 10.1016/j.biochi.2008.01.004; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Iwasaki M, 2004, EXP CELL RES, V299, P525, DOI 10.1016/j.yexcr.2004.06.020; Jayson GC, 1997, BRIT J CANCER, V75, P9, DOI 10.1038/bjc.1997.3; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kanaji S, 2007, FEBS LETT, V581, P4260, DOI 10.1016/j.febslet.2007.07.072; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; KATO H, 1982, CANCER, V50, P1294, DOI 10.1002/1097-0142(19821001)50:7<1294::AID-CNCR2820500712>3.0.CO;2-K; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; MOLINA R, 1990, CLIN CHEM, V36, P251; Nakashima T, 2006, HEAD NECK-J SCI SPEC, V28, P24, DOI 10.1002/hed.20293; Niers TMH, 2007, CRIT REV ONCOL HEMAT, V61, P195, DOI 10.1016/j.critrevonc.2006.07.007; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Ornstein DL, 1999, HAEMOSTASIS, V29, P48; PRATT CW, 1992, J BIOL CHEM, V267, P8795; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Richard B, 2006, THROMB HAEMOSTASIS, V95, P229, DOI 10.1160/TH05-08-0546; Rose Mark J., 2004, Current Drug Targets - Inflammation and Allergy, V3, P221, DOI 10.2174/1568010043343589; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Sakata Y, 2004, J BIOL CHEM, V279, P5081, DOI 10.1074/jbc.M311585200; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Stabuc B, 2006, NEOPLASMA, V53, P259; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; TAKEDA A, 1995, FEBS LETT, V359, P78, DOI 10.1016/0014-5793(94)01456-B; Troy AM, 2004, EUR J CANCER, V40, P1610, DOI 10.1016/j.ejca.2004.03.011; Uemura Y, 2000, INT J CANCER, V89, P368, DOI 10.1002/1097-0215(20000720)89:4<368::AID-IJC9>3.0.CO;2-6; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Yang Z, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-8; Zhang WQ, 2005, BLOOD, V106, P1621, DOI 10.1182/blood-2005-02-0547; Zheng B, 2009, BIOCHEM BIOPH RES CO, V380, P143, DOI 10.1016/j.bbrc.2009.01.057	46	44	44	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3722	3729		10.1074/jbc.M109.037358	http://dx.doi.org/10.1074/jbc.M109.037358			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959474	hybrid, Green Published			2022-12-27	WOS:000275254000024
J	Tee, AEL; Marshall, GM; Liu, PY; Xu, N; Haber, M; Norris, MD; Iismaa, SE; Liu, T				Tee, Andrew E. L.; Marshall, Glenn M.; Liu, Pei Y.; Xu, Ning; Haber, Michelle; Norris, Murray D.; Iismaa, Siiri E.; Liu, Tao			Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; SH-SY5Y CELLS; BINDING SITE; ACID; MYC; GTP; ACTIVATION; EXPRESSION; TRYPTOPHAN	We have demonstrated previously that the Myc oncoprotein blocks cancer cell differentiation by forming a novel transcriptional repressor complex with histone deacetylase and inhibiting gene transcription of tissue transglutaminase (TG2). Moreover, induction of TG2 gene transcription and transamidase activity is essential for the differentiating effects of retinoids in cancer cells. Here, we show that two structurally distinct TG2 protein isoforms, the full-length (TG2-L) and the short form (TG2-S), exert opposing effects on cell differentiation. Repression of TG2-L with small interfering RNA, which did not affect TG2-S expression, induced dramatic neuritic differentiation in neuroblastoma cells. In contrast, overexpression of TG2-S or a GTP-binding-deficient mutant of TG2-L (R580A), both of which lack the GTP-binding Arg-580 residue, induced neuroblastoma cell differentiation, which was blocked by an inhibitor of transamidase activity. Whereas N-Myc repressed and retinoid activated both TG2 isoforms, repression of TG2-L, but not simultaneous repression of TG2-L and TG2-S, enhanced neuroblastoma cell differentiation due to N-Myc small interfering RNA or retinoid. Moreover, suppression of vasoactive intestinal peptide (VIP) expression alone induced neuroblastoma cell differentiation, and VIP was up-regulated by TG2-L, but not TG2-S. Taken together, our data indicate that TG2-L and TG2-S exert opposite effects on cell differentiation due to differences in GTP binding and modulation of VIP gene transcription. Our findings highlight the potential importance of repressing the GTP binding activity of TG2-L or activating the transamidase activity of TG2-L or TG2-S for the treatment of neuroblastoma, and possibly also other Myc-induced malignancies, and for enhancing retinoid anticancer effects.	[Tee, Andrew E. L.; Marshall, Glenn M.; Liu, Pei Y.; Xu, Ning; Haber, Michelle; Norris, Murray D.; Iismaa, Siiri E.; Liu, Tao] Sydney Childrens Hosp, Childrens Canc Inst Australia, Sydney, NSW 2031, Australia; [Marshall, Glenn M.] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Sydney, NSW 2031, Australia; [Iismaa, Siiri E.] Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW 2050, Australia	Children's Cancer Institute; University of Sydney; University of Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Liu, T (corresponding author), Sydney Childrens Hosp, Childrens Canc Inst Australia, High St, Sydney, NSW 2031, Australia.	tliu@ccia.unsw.edu.au	Iismaa, Siiri/C-9300-2013; Liu, Tao/A-3922-2015	Iismaa, Siiri/0000-0003-2409-7356; Liu, Tao/0000-0001-6244-7316; Norris, Murray/0000-0002-0632-4589; Haber, Michelle/0000-0003-2036-8817	National Health and Medical Research Council of Australia [568753, 459406]; Cancer Institute of New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales	This work was supported in part by National Health and Medical Research Council of Australia Grants 568753 and 459406. The authors were also supported by the Cancer Institute of New South Wales and National Health and Medical Research Council program grants and a Cancer Institute New South Wales Career Development Fellowship. The Children's Cancer Institute Australia for Medical Research is affiliated with University of New South Wales and Sydney Children's Hospital.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Balajthy Z, 2006, BLOOD, V108, P2045, DOI 10.1182/blood-2004-02-007948; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Citron BA, 2002, NEUROCHEM INT, V40, P69, DOI 10.1016/S0197-0186(01)00062-6; FRAIJ BM, 1992, J BIOL CHEM, V267, P22616; Iismaa SE, 2003, P NATL ACAD SCI USA, V100, P12636, DOI 10.1073/pnas.1635052100; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Lee JS, 2006, FRONT BIOSCI-LANDMRK, V11, P2774, DOI 10.2741/2007; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6	25	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3561	3567		10.1074/jbc.M109.053041	http://dx.doi.org/10.1074/jbc.M109.053041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007697	Green Published, hybrid			2022-12-27	WOS:000275254000006
J	Zhang, YY; Dong, YL; Wu, X; Lu, Y; Xu, ZP; Knapp, A; Yue, Y; Xu, TJ; Xie, ZC				Zhang, Yiying; Dong, Yuanlin; Wu, Xu; Lu, Yan; Xu, Zhipeng; Knapp, Andrew; Yue, Yun; Xu, Tiejun; Xie, Zhongcong			The Mitochondrial Pathway of Anesthetic Isoflurane-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PROTEIN-LEVELS; ALZHEIMERS-DISEASE; CASPASE-3 ACTIVATION; CALCIUM HOMEOSTASIS; CELL-DEATH; SEVOFLURANE; DEMENTIA; EXPOSURE; LINK; BAX	The common inhalation anesthetic isoflurane has been shown to induce apoptosis, which then leads to accumulation of beta-amyloid protein, the hallmark feature of Alzheimer disease neuropathogenesis. The underlying molecular mechanism of the isoflurane-induced apoptosisis largely unknown. We, therefore, set out to assess whether isoflurane can induce apoptosis by regulating Bcl-2 family proteins, enhancing reactive oxygen species (ROS) accumulation, and activating the mitochondrial pathway of apoptosis. We performed these studies in cultured cells, primary neurons, and mice. Here we show for the first time that treatment with 2% isoflurane for 6 h can increase pro-apoptotic factor Bax levels, decrease antiapoptotic factor Bcl-2 levels, increase ROS accumulation, facilitate cytochrome c release from the mitochondria to the cytosol, induce activation of caspase-9 and caspase-3, and finally cause apoptosis as compared with the control condition. We have further found that isoflurane can increase the mRNA levels of Bax and reduce the mRNA levels of Bcl-2. The isoflurane-induced ROS accumulation can be attenuated by the intracellular calcium chelator BAPTA. Finally, the anesthetic desflurane does not induce activation of mitochondrial pathway of apoptosis. These results suggest that isoflurane may induce apoptosis through Bcl-2 family proteins- and ROS-associated mitochondrial pathway of apoptosis. These findings, which have identified at least partially the molecular mechanism by which isoflurane induces apoptosis, will promote more studies aimed at studying the potential neurotoxic effects of anesthetics.	[Xie, Zhongcong] Harvard Univ, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Dept Anesthesia Crit Care & Pain Med,Sch Med,Dept, Geriatr Anesthesia Res Unit,Genet & Aging Res Uni, Charlestown, MA 02129 USA; [Wu, Xu] China Med Univ, Fac Forens Med, Dept Forens Pathol, Shenyang 110001, Peoples R China; [Lu, Yan] China Med Univ, Affiliated Shengjing Hosp, Hlth Minist Congenital Malformat, Key Lab, Shenyang 110004, Liaoning, Peoples R China; Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesia, Beijing 100020, Peoples R China; [Zhang, Yiying; Xu, Tiejun] Xuzhou Med Coll, Dept Anat & Neurobiol, Xuzhou 221002, Peoples R China	Harvard University; Massachusetts General Hospital; China Medical University; China Medical University; Capital Medical University; Xuzhou Medical University	Xie, ZC (corresponding author), Harvard Univ, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Dept Anesthesia Crit Care & Pain Med,Sch Med,Dept, Geriatr Anesthesia Res Unit,Genet & Aging Res Uni, 114 16th St 3750, Charlestown, MA 02129 USA.	zxie@partners.org		Dong, Yuanlin/0000-0002-4760-0519	National Institutes of Health [K08 NS048140, R21 AG029856, R01 GM088801]; Alzheimer Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 NS048140, R21 AG029856, and R01 GM088801. This work was also supported by an American Geriatrics Society Jahnigen Award and an Investigator- initiated Research Grant from the Alzheimer Association (to Z. X.).	BOHNEN N, 1994, INT J NEUROSCI, V77, P181, DOI 10.3109/00207459408986029; Bufill E, 2009, NEUROLOGIA, V24, P108; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Gasparini M, 2002, NEUROL SCI, V23, P11, DOI 10.1007/s100720200017; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Knopman DS, 2005, NEUROLOGY, V65, P986, DOI 10.1212/01.WNL.0000171954.92119.c7; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rutter GA, 2006, BIOCHEM SOC T, V34, P351, DOI 10.1042/BST0340351; Szeto HH, 2008, ANN NY ACAD SCI, V1147, P112, DOI 10.1196/annals.1427.013; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2005, J MOL NEUROSCI, V25, P67, DOI 10.1385/JMN:25:1:067; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Zhang GH, 2008, J NEUROSCI, V28, P4551, DOI 10.1523/JNEUROSCI.5694-07.2008; Zhen Y, 2009, ANESTHESIOLOGY, V111, P741, DOI 10.1097/ALN.0b013e3181b27fd4	31	163	172	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4025	4037		10.1074/jbc.M109.065664	http://dx.doi.org/10.1074/jbc.M109.065664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007710	Green Published, hybrid			2022-12-27	WOS:000275254000056
J	Hagn, F; Klein, C; Demmer, O; Marchenko, N; Vaseva, A; Moll, UM; Kessler, H				Hagn, Franz; Klein, Christian; Demmer, Oliver; Marchenko, Natasha; Vaseva, Angelina; Moll, Ute M.; Kessler, Horst			BclxL Changes Conformation upon Binding to Wild-type but Not Mutant p53 DNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; PROTEIN STRUCTURES; CELL-DEATH; IN-VIVO; NMR; BAX; APOPTOSIS; INHIBITOR; ALIGNMENT; LIGANDS	p53 can induce apoptosis through mitochondrial membrane permeabilization by interaction of its DNA binding region with the anti-apoptotic proteins BclxL and Bcl2. However, little is known about the action of p53 at the mitochondria in molecular detail. By using NMR spectroscopy and fluorescence polarization we characterized the binding of wildtype and mutant p53 DNA binding domains to BclxL and show that the wild-type p53 DNA binding domain leads to structural changes in the BH3 binding region of BclxL, whereas mutants fail to induce such effects due to reduced affinity. This was probed by induced chemical shift and residual dipolar coupling data. These data imply that p53 partly achieves its pro-apoptotic function at the mitochondria by facilitating interaction between BclxL and BH3-only proteins in an allosteric mode of action. Furthermore, we characterize for the first time the binding behavior of Pifithrin-mu, a specific small molecule inhibitor of the p53-BclxL interaction, and present a structural model of the protein-ligand complex. A rather unusual behavior is revealed whereby Pifithrin-mu binds to both sides of the protein-protein complex. These data should facilitate the rational design of more potent specific BclxL-p53 inhibitors.	[Hagn, Franz; Demmer, Oliver; Kessler, Horst] Tech Univ Munich, Inst Adv Study, D-85747 Garching, Germany; [Kessler, Horst] CIPSM, Dept Chem, D-85747 Garching, Germany; [Klein, Christian] Roche Diagnost GmbH, Discovery Oncol, D-82372 Penzberg, Germany; [Marchenko, Natasha; Vaseva, Angelina; Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	Technical University of Munich; Roche Holding; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kessler, H (corresponding author), Lichtenbergstr 4, D-85747 Garching, Germany.	Horst.Kessler@ch.tum.de	Kessler, Horst/C-1178-2010; Hagn, Franz X/N-9553-2016; Klein, Christian/G-1336-2010	Hagn, Franz X/0000-0002-1315-459X; Klein, Christian/0000-0001-7594-7280	NCI [RO1 CA60664]; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft [SFB594]; Elite-netzwerk Bayern, CompInt; NATIONAL CANCER INSTITUTE [R01CA060664] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elite-netzwerk Bayern, CompInt; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA60664 from the NCI (to U. M. M.). This work was also supported by the Center for Integrated Protein Science Munich and Deutsche Forschungsgemeinschaft Grant SFB594 (to H. K.) and a grant from Elite-netzwerk Bayern, CompInt (to F. H.).	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; DAVEY PG, 1987, J ANTIMICROB CHEMOTH, V20, P639, DOI 10.1093/jac/20.5.639; Dehner A, 2005, ANGEW CHEM INT EDIT, V44, P5247, DOI 10.1002/anie.200501887; Dehner A, 2003, CHEMBIOCHEM, V4, P870, DOI 10.1002/cbic.200300658; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; Goddard T.D., 2004, SPARKY3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; JAHNKE W, 1995, J MAGN RESON SER B, V106, P86, DOI 10.1006/jmrb.1995.1015; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kenakin TP., 1993, PHARM ANAL DRUG RECE, V2; Klein C, 2004, BIOL CHEM, V385, P95, DOI 10.1515/BC.2004.012; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Steele AJ, 2009, BLOOD, V114, P1217, DOI 10.1182/blood-2008-11-190587; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	55	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3439	3450		10.1074/jbc.M109.065391	http://dx.doi.org/10.1074/jbc.M109.065391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955567	hybrid, Green Published			2022-12-27	WOS:000273829000058
J	Tan, M; Zhu, B; Zhou, XL; He, R; Chen, X; Eriani, G; Wang, ED				Tan, Min; Zhu, Bin; Zhou, Xiao-Long; He, Ran; Chen, Xin; Eriani, Gilbert; Wang, En-Duo			tRNA-dependent Pre-transfer Editing by Prokaryotic Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISACTIVATED AMINO-ACIDS; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; AQUIFEX-AEOLICUS; STRUCTURAL BASIS; RATIONAL DESIGN; ACTIVE-SITE; ERRORS; DISCRIMINATION; TRANSLOCATION	To prevent genetic code ambiguity due to misincorporation of amino acids into proteins, aminoacyl-tRNA synthetases have evolved editing activities to eliminate intermediate or final non-cognate products. In this work we studied the different editing pathways of class Ia leucyl-tRNA synthetase (LeuRS). Different mutations and experimental conditions were used to decipher the editing mechanism, including the recently developed compound AN2690 that targets the post-transfer editing site of LeuRS. The study emphasizes the crucial importance of tRNA for the pre- and post-transfer editing catalysis. Both reactions have comparable efficiencies in prokaryotic Aquifex aeolicus and Escherichia coli LeuRSs, although the E. coli enzyme favors post-transfer editing, whereas the A. aeolicus enzyme favors pre-transfer editing. Our results also indicate that the entry of the CCA-acceptor end of tRNA in the editing domain is strictly required for tRNA-dependent pre-transfer editing. Surprisingly, this editing reaction was resistant to AN2690, which inactivates the enzyme by forming a covalent adduct with tRNALeu in the post-transfer editing site. Taken together, these data suggest that the binding of tRNA in the post-transfer editing conformation confers to the enzyme the capacity for pre-transfer editing catalysis, regardless of its capacity to catalyze post-transfer editing.	Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Architecture & React ARN, UPR9002,Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg		edwang@sibs.ac.cn	Tan, Min/K-1780-2016	Eriani, Gilbert/0000-0002-8518-4675	Natural Science Foundation of China [30670463, 30930022]; National Key Basic Research Foundation of China [2006CB910301]; 973 Project of China [2005CB724600]; Committee of Science and Technology in Shanghai [09JC1415900]; CNRS [3606]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); 973 Project of China(National Basic Research Program of China); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Natural Science Foundation of China Grants 30670463 and 30930022, National Key Basic Research Foundation of China Grant 2006CB910301, the 973 Project of China Grant 2005CB724600, Committee of Science and Technology in Shanghai Grant 09JC1415900, and the Exchange Program and Programme International de Cooperation Scientifique from CNRS Grant 3606.	BALDWIN AN, 1966, J BIOL CHEM, V241, P831; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Mascarenhas AP, 2009, FEBS LETT, V583, P3443, DOI 10.1016/j.febslet.2009.09.039; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Seiradake E, 2009, J MOL BIOL, V390, P196, DOI 10.1016/j.jmb.2009.04.073; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	41	43	47	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3235	3244		10.1074/jbc.M109.060616	http://dx.doi.org/10.1074/jbc.M109.060616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940155	Green Published, hybrid			2022-12-27	WOS:000273829000038
J	Cloutier, N; Flamand, L				Cloutier, Nathalie; Flamand, Louis			Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen Inhibits Interferon (IFN) beta Expression by Competing with IFN Regulatory Factor-3 for Binding to IFNB Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; ANTIVIRAL RESPONSE; I INTERFERON; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATION; VIRUS-INFECTION; VIRAL PROTEIN; LANA PROTEIN	Host cells respond to viral infections by synthesizing and producing antiviral molecules such as type I interferons (IFN). The Kaposi sarcoma-associated herpesvirus (KSHV) encodes multiple proteins expressed during the lytic replication cycle that alter the antiviral response of the host. Considering that in Kaposi sarcoma lesions and primary effusion lymphoma cells KSHV is latent in the vast majority of cells, we were interested in determining whether latently expressed viral proteins have the ability to modulate IFN synthesis. The latency-associated nuclear antigen (LANA-1) is a large nuclear protein that plays a role in the establishment and maintenance of latent KSHV episome in the nucleus of infected cells. LANA-1 is also described to modulate the cellular transcription. Here, we report that LANA-1 inhibits IFN-beta transcription and synthesis by competing with the binding of interferon regulatory factor-3 (IRF3) to the IFNB promoter. Using mutants of LANA-1, we have identified the central acidic repeated region as the domain essential for interfering with the binding of IRF3 to the positive regulatory domains I-III of the IFNB promoter. In addition, the nuclear localization of LANA-1 proved essential for IFN-beta inhibition. Thus, LANA-1 interferes with the formation of IFN-beta enhanceosome by competing with the fixation of IRF3 and by inhibiting the expression of the CREB-binding protein. The ability of LANA-1 to inhibit IFNB gene expression highlights a new role for this protein in cellular gene modulation and immune evasion strategies.	[Flamand, Louis] Univ Laval, Quebec Res Ctr, Rheumat & Immunol Res Ctr, Virol Lab,CHU, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Flamand, L (corresponding author), Univ Laval, Quebec Res Ctr, Rheumat & Immunol Res Ctr, Virol Lab,CHU, 2705 Laurier Blvd,Rm T1-49, Quebec City, PQ G1V 4G2, Canada.	Louis.Flamand@crchul.ulaval.ca		Flamand, Louis/0000-0001-5010-4586	National Cancer Institute of Canada	National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported in part by a grant from the National Cancer Institute of Canada (to L. F.).	Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Bubman D, 2007, ONCOGENE, V26, P4979, DOI 10.1038/sj.onc.1210299; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Cloutier N, 2004, J VIROL METHODS, V122, P1, DOI 10.1016/j.jviromet.2004.07.004; Cloutier N, 2007, EUR J IMMUNOL, V37, P2772, DOI 10.1002/eji.200737181; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; Fakhari FD, 2002, J VIROL, V76, P6213, DOI 10.1128/JVI.76.12.6213-6223.2002; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; FUSE A, 1984, GANN, V75, P379; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Jeong JH, 2004, J BIOL CHEM, V279, P16822, DOI 10.1074/jbc.M312801200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Lefort S, 2009, J VIROL, V83, P5869, DOI 10.1128/JVI.01821-08; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Liu JY, 2007, J VIROL, V81, P4722, DOI 10.1128/JVI.02548-06; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Perry ST, 2006, J VIROL, V80, P11105, DOI 10.1128/JVI.00846-06; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Rezaee SAR, 2006, J GEN VIROL, V87, P1781, DOI 10.1099/vir.0.81919-0; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Schwam DR, 2000, J VIROL, V74, P8532, DOI 10.1128/JVI.74.18.8532-8540.2000; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Talbot SJ, 1999, VIROLOGY, V257, P84, DOI 10.1006/viro.1999.9672; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WATHELET MG, 1988, EUR J BIOCHEM, V174, P323, DOI 10.1111/j.1432-1033.1988.tb14101.x; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Zaldumbide A, 2007, MOL IMMUNOL, V44, P1352, DOI 10.1016/j.molimm.2006.05.012; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	61	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7208	7221		10.1074/jbc.M109.018838	http://dx.doi.org/10.1074/jbc.M109.018838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048166	Green Published, hybrid			2022-12-27	WOS:000275415600034
J	Inoue, K; Branigan, D; Xiong, ZG				Inoue, Koichi; Branigan, Deborah; Xiong, Zhi-Gang			Zinc-induced Neurotoxicity Mediated by Transient Receptor Potential Melastatin 7 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR FREE ZINC; SENSING ION CHANNELS; VASCULAR ENDOTHELIAL-CELLS; MILD COGNITIVE IMPAIRMENT; NEURONAL DEATH; METAL-IONS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; MG2+ HOMEOSTASIS	Transient receptor potential melastatin 7 (TRPM7) channels are novel Ca2+-permeable non-selective cation channels ubiquitously expressed. Activation of TRPM7 channels has been shown to be involved in cellular Mg2+ homeostasis, diseases caused by abnormal magnesium absorption, and in Ca2+-mediated neuronal injury under ischemic conditions. Here we show strong evidence suggesting that TRPM7 channels also play an important role in cellular Zn2+ homeostasis and in Zn2+-mediated neuronal injury. Using a combination of fluorescent Zn2+ imaging, small interfering RNA, pharmacological analysis, and cell injury assays, we show that activation of TRPM7 channels augmented Zn2+-induced injury of cultured mouse cortical neurons. The Zn2+-mediated neurotoxicity was inhibited by nonspecific TRPM7 blockers Gd3+ or 2-aminoethoxydiphenyl borate, and by knockdown of TRPM7 channels with small interfering RNA. In addition, Zn2+-mediated neuronal injury under oxygen-glucose deprivation conditions was also diminished by silencing TRPM7. Furthermore, we show that overexpression of TRPM7 channels in HEK293 cells increased intracellular Zn2+ accumulation and Zn2+-induced cell injury, while silencing TRPM7 by small interfering RNA attenuated the Zn2+-mediated cell toxicity. Thus, TRPM7 channels may represent a novel target for neurological disorders where Zn2+ toxicity plays an important role.	[Inoue, Koichi; Branigan, Deborah; Xiong, Zhi-Gang] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA		Xiong, ZG (corresponding author), 1225 NE 2nd Ave, Portland, OR 97232 USA.	zxiong@Downeurobiology.org			National Institutes of Health [R01NS47506, R01NS49470]; American Heart Association [0840132N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049470, R01NS047506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS47506 and R01NS49470 and American Heart Association Grant 0840132N.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Canzoniero LMT, 1999, J NEUROSCI, V19; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Cheng CL, 1998, J NEUROCHEM, V71, P2401; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hey JG, 2007, STROKE, V38, P670, DOI 10.1161/01.STR.0000251443.68897.99; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kitamura Y, 2006, BRAIN RES BULL, V69, P622, DOI 10.1016/j.brainresbull.2006.03.004; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PALM R, 1983, CLIN CHEM, V29, P486; Rayatzadeh H, 2009, SEIZURE-EUR J EPILEP, V18, P51, DOI 10.1016/j.seizure.2008.06.004; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sensi SL, 1997, J NEUROSCI, V17, P9554; SIMONS TJ, 1993, J BIOCHEM BIOPH METH, V270, P25; Smith JL, 2006, NEUROSCIENCE, V140, P879, DOI 10.1016/j.neuroscience.2006.02.049; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tombaugh GC, 1996, J PHYSIOL-LONDON, V493, P719, DOI 10.1113/jphysiol.1996.sp021417; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	55	108	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7430	7439		10.1074/jbc.M109.040485	http://dx.doi.org/10.1074/jbc.M109.040485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048154	hybrid, Green Published			2022-12-27	WOS:000275415600055
J	Saito, Y; Owaki, T; Matsunaga, T; Saze, M; Miura, S; Maeda, M; Eguchi, M; Tanaka, R; Taira, J; Kodama, H; Goto, S; Niitsu, Y; Terada, H; Fukai, F				Saito, Yohei; Owaki, Toshiyuki; Matsunaga, Takuya; Saze, Mizue; Miura, Shogo; Maeda, Mao; Eguchi, Mayu; Tanaka, Rika; Taira, Junichi; Kodama, Hiroaki; Goto, Sumio; Niitsu, Yoshiroh; Terada, Hiroshi; Fukai, Fumio			Apoptotic Death of Hematopoietic Tumor Cells through Potentiated and Sustained Adhesion to Fibronectin via VLA-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DRUG-RESISTANCE; BONE-MARROW MICROENVIRONMENT; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; TENASCIN-C; CAM-DR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; ACTIVATION; EXPRESSION	It has been postulated that inactivated beta 1-integrins are involved in the disordered growth of hematopoietic tumor cells. We recently found that TNIIIA2, a peptide derived from tenascin-C, strongly activates beta 1-integrins through binding with syndecan-4. We show here that Ramos Burkitt's lymphoma cells can survive and grow in suspension but undergo apoptosis when kept adhering to fibronectin by stimulation with TNIIIA2. Other integrin activators, Mg2+ and TS2/16 (an integrin-activating antibody), were also capable of inducing apoptosis. The inactivation of ERK1/2 and Akt and the subsequent activation of Bad were involved in the apoptosis. The results using other hematopoietic tumor cell lines expressing different levels of fibronectin receptors (VLA-4 and VLA-5) showed that potentiated and sustained adhesion to fibronectin via VLA-4 causally induces apoptosis also in various types of hematopoietic tumor cells in addition to Ramos cells. Because TNIIIA2 requires syndecan-4 as a membrane receptor for activation of beta 1-integrins, it induced apoptosis preferentially in hematopoietic tumor cells, which expressed both VLA-4 and syndecan-4 as membrane receptors mediating the effects of fibronectin and TNIIIA2, respectively. Therefore, normal peripheral blood cells, such as neutrophils, monocytes, and lymphocytes, which poorly expressed syndecan-4, were almost insusceptible to TNIIIA2-induced apoptosis. The TNIIIA2-related matricryptic site of TN-C could contribute, once exposed, to preventing prolonged survival of hematopoietic malignant progenitors through potentiated and sustained activation of VLA-4.	[Tanaka, Rika; Fukai, Fumio] Tokyo Univ Sci, Dept Mol Pathophysiol, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Saito, Yohei; Owaki, Toshiyuki; Terada, Hiroshi; Fukai, Fumio] Tokyo Univ Sci, Ctr Drug Delivery Res, Noda, Chiba 2788510, Japan; [Matsunaga, Takuya; Niitsu, Yoshiroh] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Chuo Ku, Sapporo, Hokkaido 060854, Japan; [Taira, Junichi; Kodama, Hiroaki] Saga Univ, Fac Sci & Engn, Saga 8490922, Japan; [Goto, Sumio] Azabu Univ, Sch Life & Environm Sci, Kanagawa 2298501, Japan	Tokyo University of Science; Tokyo University of Science; Sapporo Medical University; Saga University; Azabu University	Fukai, F (corresponding author), Tokyo Univ Sci, Dept Mol Pathophysiol, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp		Taira, Junichi/0000-0002-8438-865X	Ministry for Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation	Ministry for Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation	This work was supported in part by the High-Tech Research Center Project for Private Universities with a matching fund subsidy from Ministry for Education, Culture, Sports, Science and Technology of Japan (2004-2008) and by the Vehicle Racing Commemorative Foundation.	Atula T, 2003, ANTICANCER RES, V23, P3051; BRADSTOCK KF, 1995, LEUKEMIA LYMPHOMA, V18, P1, DOI 10.3109/10428199509064917; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; CHILOSI M, 1993, AM J PATHOL, V143, P1348; CLARK BR, 1992, BAILLIERE CLIN HAEM, V5, P619, DOI 10.1016/S0950-3536(11)80010-7; COULOMBEL L, 1988, BLOOD, V71, P329; Damiano JS, 2001, LEUKEMIA, V15, P1232, DOI 10.1038/sj.leu.2402179; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DREXLER HG, 1986, CANCER RES, V46, P6078; Fukai F, 2000, CELL MOL BIOL, V46, P145; FUKAI F, 1991, J BIOL CHEM, V266, P8807; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; JOSHI P, 1993, J CELL SCI, V106, P389; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kaneider NC, 2001, BIOCHEM BIOPH RES CO, V287, P42, DOI 10.1006/bbrc.2001.5534; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Leins A, 2003, CANCER-AM CANCER SOC, V98, P2430, DOI 10.1002/cncr.11796; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; LIGHTNER VA, 1990, ANN NY ACAD SCI, V580, P260, DOI 10.1111/j.1749-6632.1990.tb17935.x; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Molla A, 2000, CELL GROWTH DIFFER, V11, P83; Murti KG, 1996, EXP CELL RES, V226, P47, DOI 10.1006/excr.1996.0201; OCKLIND G, 1993, J HISTOCHEM CYTOCHEM, V41, P1163, DOI 10.1177/41.8.7687262; RAZ A, 1983, SCIENCE, V221, P1307, DOI 10.1126/science.6612347; SACHS L, 1995, ADV CANCER RES, V66, P1, DOI 10.1016/S0065-230X(08)60250-X; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; SANCHEZAPARICIO P, 1994, J CELL BIOL, V126, P271, DOI 10.1083/jcb.126.1.271; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Shain KH, 2000, CURR OPIN ONCOL, V12, P557, DOI 10.1097/00001622-200011000-00008; SUGAHARA H, 1994, J EXP MED, V179, P1757, DOI 10.1084/jem.179.6.1757; Takagi J, 1997, J BIOCHEM, V121, P914; Terui Y, 1996, J IMMUNOL, V156, P1981; Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Wang MWJ, 1998, CELL GROWTH DIFFER, V9, P105; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Yamashita Y, 1999, J IMMUNOL, V162, P5940	43	11	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7006	7015		10.1074/jbc.M109.027581	http://dx.doi.org/10.1074/jbc.M109.027581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20007695	Green Published, hybrid			2022-12-27	WOS:000275415600014
J	Son, BK; Akishita, M; Iijima, K; Ogawa, S; Maemura, K; Yu, J; Takeyama, K; Kato, S; Eto, M; Ouchi, Y				Son, Bo-Kyung; Akishita, Masahiro; Iijima, Katsuya; Ogawa, Sumito; Maemura, Koji; Yu, Jing; Takeyama, Kenichi; Kato, Shigeaki; Eto, Masato; Ouchi, Yasuyoshi			Androgen Receptor-dependent Transactivation of Growth Arrest-specific Gene 6 Mediates Inhibitory Effects of Testosterone on Vascular Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; PHOSPHATE-INDUCED CALCIFICATION; LOW SERUM TESTOSTERONE; MIDDLE-AGED MEN; CAROTID ATHEROSCLEROSIS; ENDOGENOUS TESTOSTERONE; REPLACEMENT THERAPY; SURVIVAL PATHWAY; ELDERLY MEN	Recent epidemiological studies have found that androgen deficiency is associated with a higher incidence of cardiovascular disease in men. However, little is known about the mechanism underlying the cardioprotective effects of androgens. Here we show the inhibitory effects of testosterone on vascular calcification and a critical role of androgen receptor (AR)-dependent transactivation of growth arrest-specific gene 6 (Gas6), a key regulator of inorganic phosphate (P-i)-induced calcification of vascular smooth muscle cells (VSMC). Testosterone and nonaromatizable androgen dihydrotestosterone inhibited P-i-induced calcification of human aortic VSMC in a concentration-dependent manner. Androgen inhibited P-i-induced VSMC apoptosis, an essential process for VSMC calcification. The effects on VSMC calcification were mediated by restoration of P-i-induced down-regulation of Gas6 expression and a subsequent reduction of Akt phosphorylation. These effects of androgen were blocked by an AR antagonist, flutamide, but not by an estrogen receptor antagonist, ICI 182,780. We then explored the mechanistic role of the AR in Gas6 expression and found an abundant expression of AR predominantly in the nucleus of VSMC and two consensus ARE sequences in the Gas6 promoter region. Dihydrotestosterone stimulated Gas6 promoter activity, and this effect was abrogated by flutamide and by AR siRNA. Site-specific mutation revealed that the proximal ARE was essential for androgen-dependent transactivation of Gas6. Furthermore, chromatin immunoprecipitation assays demonstrated ligand-dependent binding of the AR to the proximal ARE of Gas6. These results indicate that AR signaling directly regulates Gas6 transcription, which leads to inhibition of vascular calcification, and provides a mechanistic insight into the cardioprotective action of androgens.	[Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Yu, Jing] Univ Tokyo, Grad Sch Med, Dept Integrated Tradit Med, Bunkyo Ku, Tokyo 1138655, Japan; [Takeyama, Kenichi; Kato, Shigeaki] Univ Tokyo, Grad Sch Agr & Life Sci, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138655, Japan; [Maemura, Koji] Nagasaki Univ, Dept Cardiovasc Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nagasaki University	Akishita, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	akishita-tky@umin.ac.jp		Eto, Masato/0000-0002-6036-3431	Ministry of Health, Labor, and Welfare of Japan [H17-Choju-046]; Ministry of Education, Science, Culture, and Sports of Japan [21390220, 20249041]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Health and Labor Sciences Research Grant H17-Choju-046 from the Ministry of Health, Labor, and Welfare of Japan and Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture, and Sports of Japan 21390220 and 20249041.	Akishita M, 2007, HYPERTENS RES, V30, P1029, DOI 10.1291/hypres.30.1029; Alexandersen P, 2006, CLIMACTERIC, V9, P108, DOI 10.1080/13697130600647743; Alexandersen P, 1999, CIRC RES, V84, P813; Balica M, 1997, CIRCULATION, V95, P1954; Bruck B, 1997, ARTERIOSCL THROM VAS, V17, P2192, DOI 10.1161/01.ATV.17.10.2192; Emi Y, 2008, J OBSTET GYNAECOL RE, V34, P890, DOI 10.1111/j.1447-0756.2008.00857.x; Fogari R, 2005, HYPERTENS RES, V28, P625, DOI 10.1291/hypres.28.625; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Hanke H, 2001, CIRCULATION, V103, P1382, DOI 10.1161/01.CIR.103.10.1382; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hemers H, 2004, J BIOL CHEM, V279, P30880, DOI 10.1074/jbc.M401615200; Ikeda Y, 2009, ENDOCRINOLOGY, V150, P2857, DOI 10.1210/en.2008-1254; Jeppesen LL, 1996, ARTERIOSCL THROM VAS, V16, P749, DOI 10.1161/01.ATV.16.6.749; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Liu PY, 2005, J CLIN ENDOCR METAB, V90, P1041, DOI 10.1210/jc.2004-1211; Makinen J, 2005, J AM COLL CARDIOL, V45, P1603, DOI 10.1016/j.jacc.2005.01.052; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; McRobb L, 2009, ENDOCRINOLOGY, V150, P841, DOI 10.1210/en.2008-0760; Mo R, 2007, BIOCHEM BIOPH RES CO, V353, P189, DOI 10.1016/j.bbrc.2006.12.018; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Nakamura T., 2002, GERIATR GERONTOL INT, V3, P145, DOI 10.1046/j.1444-1586.2003.00077.x; NAKAO J, 1979, ATHEROSCLEROSIS, V34, P469, DOI 10.1016/0021-9150(79)90071-6; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Ong PJL, 2000, AM J CARDIOL, V85, P269, DOI 10.1016/S0002-9149(99)00630-X; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Rosano GMC, 1999, CIRCULATION, V99, P1666, DOI 10.1161/01.CIR.99.13.1666; Rzewuska-Lech E, 2005, AM J PHYSIOL-ENDOC M, V289, pE105, DOI 10.1152/ajpendo.00366.2004; Shores MM, 2006, ARCH INTERN MED, V166, P1660, DOI 10.1001/archinte.166.15.1660; Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210/jc.82.2.682; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Son BK, 2008, ENDOCRINOLOGY, V149, P1646, DOI 10.1210/en.2007-1021; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tharp DL, 2009, CARDIOVASC RES, V82, P152, DOI 10.1093/cvr/cvp038; van den Beld AW, 2003, AM J EPIDEMIOL, V157, P25, DOI 10.1093/aje/kwf160; Yaron M, 2009, EUR J ENDOCRINOL, V160, P839, DOI 10.1530/EJE-09-0052; Zhao Y, 2009, MOL CELL BIOL, V29, P1017, DOI 10.1128/MCB.02123-07; Zitzmann M, 2001, J CLIN ENDOCR METAB, V86, P4867, DOI 10.1210/jc.86.10.4867	42	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7537	7544		10.1074/jbc.M109.055087	http://dx.doi.org/10.1074/jbc.M109.055087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048160	Green Published, hybrid			2022-12-27	WOS:000275415600065
J	Berlin, S; Keren-Raifman, T; Castel, R; Rubinstein, M; Dessauer, CW; Ivanina, T; Dascal, N				Berlin, Shai; Keren-Raifman, Tal; Castel, Ruth; Rubinstein, Moran; Dessauer, Carmen W.; Ivanina, Tatiana; Dascal, Nathan			G alpha(i) and G beta gamma Jointly Regulate the Conformations of a G beta gamma Effector, the Neuronal G Protein-activated K+ Channel (GIRK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT STOICHIOMETRY; SIGNALING COMPLEXES; POTASSIUM CHANNEL; XENOPUS-OOCYTES; LIVING CELLS; BINDING; MODULATION; GPCR; G(BETA-GAMMA); RECTIFICATION	Stable complexes among G proteins and effectors are an emerging concept in cell signaling. The prototypical G beta gamma effector G protein-activated K+ channel (GIRK; Kir3) physically interacts with G beta gamma but also with G alpha(i/o). Whether and how G alpha(i/o) subunits regulate GIRK in vivo is unclear. We studied triple interactions among GIRK subunits 1 and 2, G alpha(i3) and G beta gamma. We used in vitro protein interaction assays and in vivo intramolecular Forster resonance energy transfer (i-FRET) between fluorophores attached to N and C termini of either GIRK1 or GIRK2 subunit. We demonstrate, for the first time, that G beta gamma and G alpha i3 distinctly and interdependently alter the conformational states of the heterotetrameric GIRK1/2 channel. Biochemical experiments show that G beta gamma greatly enhances the binding of GIRK1 subunit to G i3 GDP and, unexpectedly, to G alpha(GTP)(i3), i-FRET showed that both G alpha(i3) and G beta gamma induced distinct conformational changes in GIRK1 and GIRK2. Moreover, GIRK1 and GIRK2 subunits assumed unique, distinct conformations when coexpressed with a "constitutively active" G alpha(i3) mutant and G beta gamma together. These conformations differ from those assumed by GIRK1 or GIRK2 after separate coexpression of either G alpha(i3) or G beta gamma. Both biochemical and i-FRET data suggest that GIRK acts as the nucleator of the GIRK-G alpha-G beta gamma signaling complex and mediates allosteric interactions between G alpha(GTP)(i3) and G beta gamma. Our findings imply that G alpha(i/o) and the G alpha(i)beta gamma heterotrimer can regulate a G beta gamma effector both before and after activation by neurotransmitters.	[Berlin, Shai; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Berlin, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	shaiberlin@gmail.com; dascaln@post.tau.ac.il	Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Rubinstein, Moran/0000-0003-2617-2276; Dessauer, Carmen/0000-0003-1210-4280; Berlin, shai/0000-0002-5153-4876	National Institutes of Health [GM68493, GM60419]; United States Israel Binational Science Foundation [01-122]; Israel Science Foundation [49/08, 1396/05]; Segol Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419, R01GM068493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Segol Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68493 (to N.D.) and GM60419 (to C.W.D.). This work was also supported by the United States Israel Binational Science Foundation Grant 01-122 (to N.D. and C.W.D.), Israel Science Foundation Grants 49/08 and 1396/05 (to N.D.), and a Segol Fellowship (to M.R.).	Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Rishal I, 2003, J BIOL CHEM, V278, P3840, DOI 10.1074/jbc.C200605200; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Tucker SJ, 1996, AM J PHYSIOL-HEART C, V271, pH379, DOI 10.1152/ajpheart.1996.271.1.H379; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Vorobiov D, 1998, PFLUG ARCH EUR J PHY, V436, P56, DOI 10.1007/s004240050604; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yamada M, 1998, PHARMACOL REV, V50, P723; YAMADA M, 1993, J BIOL CHEM, V268, P24551; Zheng J, 2003, J NEUROSCI, V23, P8167	36	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6179	6185		10.1074/jbc.M109.085944	http://dx.doi.org/10.1074/jbc.M109.085944			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018875	Green Published, hybrid			2022-12-27	WOS:000275367500022
J	Ghosh, J; Anderson, PJ; Chandrasekaran, S; Caparon, MG				Ghosh, Joydeep; Anderson, Patricia J.; Chandrasekaran, Sukantha; Caparon, Michael G.			Characterization of Streptococcus pyogenes beta-NAD(+) Glycohydrolase RE-EVALUATION OF ENZYMATIC PROPERTIES ASSOCIATED WITH PATHOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; CYCLIC ADP-RIBOSE; CYTOLYSIN-MEDIATED TRANSLOCATION; NAD-GLYCOHYDROLASE; RIBOSYLTRANSFERASE ACTIVITY; RIBOSYLATING TOXINS; BACILLUS-SUBTILIS; HUMAN CD38; PURIFICATION; INTERMEDIATE	The Gram-positive pathogen Streptococcus pyogenes injects a beta-NAD(+) glycohydrolase (SPN) into the cytosol of an infected host cell using the cytolysin-mediated translocation pathway. In this compartment, SPN accelerates the death of the host cell by an unknown mechanism that may involve its beta-NAD(+)-dependent enzyme activities. SPN has been reported to possess the unique characteristic of not only catalyzing hydrolysis of beta-NAD(+), but also carrying out ADP-ribosyl cyclase and ADP-ribosyltransferase activities, making SPN the only beta-NAD(+) glycohydrolase that can catalyze all of these reactions. With the long term goal of understanding how these activities may contribute to pathogenesis, we have further characterized the enzymatic activity of SPN using highly purified recombinant protein. Kinetic studies of the multiple activities of SPN revealed that SPN possessed only beta-NAD(+) hydrolytic activity and lacked detectable ADP-ribosyl cyclase and ADP-ribosyltransferase activities. Similarly, SPN was unable to catalyze cyclic ADPR hydrolysis, and could not catalyze methanolysis or transglycosidation. Kinetic analysis of product inhibition by recombinant SPN demonstrated an ordered uni-bi mechanism, with ADPribose being released as a second product. SPN was unaffected by product inhibition using nicotinamide, suggesting that this moiety contributes little to the binding energy of the substrate. Upon transformation, SPN was toxic to Saccharomyces cerevisiae, whereas a glycohydrolase-inactive SPN allowed for viability. Taken together, these data suggest that SPN functions exclusively as a strict beta-NAD(+) glycohydrolase during pathogenesis.	[Ghosh, Joydeep; Chandrasekaran, Sukantha; Caparon, Michael G.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Anderson, Patricia J.] Washington Univ, Div Hematol, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Caparon, MG (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med, 660 S Euclid Ave,Box 8230, St Louis, MO 63110 USA.	caparon@borcim.wustl.edu			National Institutes of Health [AI064721]; United States Public Health Service; American Heart Association National Scientist Development Award [0530110N];  [09GRNT2220282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association National Scientist Development Award(American Heart Association); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064721 (to M. G. C.) from the United States Public Health Service. This work was also supported by an American Heart Association National Scientist Development Award (0530110N) and subsequently a Grant-in-aid (09GRNT2220282 to P. J. A.).	Ajdic D, 2000, FEMS MICROBIOL LETT, V191, P235, DOI 10.1111/j.1574-6968.2000.tb09345.x; Armstrong S, 2004, BIOCHEMISTRY-US, V43, P183, DOI 10.1021/bi034772u; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; Bricker AL, 2005, INFECT IMMUN, V73, P6562, DOI 10.1128/IAI.73.10.6562-6566.2005; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAVIS WB, 1980, ANTIMICROB AGENTS CH, V17, P663, DOI 10.1128/AAC.17.4.663; DOMENIGHINI M, 1994, MOL MICROBIOL, V14, P41, DOI 10.1111/j.1365-2958.1994.tb01265.x; EVERSE J, 1975, ARCH BIOCHEM BIOPHYS, V169, P714, DOI 10.1016/0003-9861(75)90216-7; EVERSE J, 1975, ARCH BIOCHEM BIOPHYS, V169, P702, DOI 10.1016/0003-9861(75)90215-5; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gerlach D, 1996, FEMS MICROBIOL LETT, V136, P71; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GRUSHOFF PS, 1975, J BACTERIOL, V122, P599, DOI 10.1128/JB.122.2.599-605.1975; Han S, 2002, INT J MED MICROBIOL, V291, P523; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; KANDEL J, 1974, J BIOL CHEM, V249, P2088; KAPLAN NO, 1955, METHOD ENZYMOL, V2, P551; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; Kimoto H, 2006, J BIOL CHEM, V281, P9181, DOI 10.1074/jbc.M506879200; KUSHNER S, 1978, GENETIC ENG, P173; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HC, 1999, MOL CELL BIOCHEM, V193, P89; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Love ML, 2004, STRUCTURE, V12, P477, DOI 10.1016/j.str.2004.02.006; Lund FE, 2005, ANAL BIOCHEM, V346, P336, DOI 10.1016/j.ab.2005.08.016; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MATHER IH, 1972, BIOCHEM J, V129, P141, DOI 10.1042/bj1290141; Meehl MA, 2005, PLOS PATHOG, V1, P362, DOI 10.1371/journal.ppat.0010035; Michos A, 2006, J BIOL CHEM, V281, P8216, DOI 10.1074/jbc.M511674200; MULLERSTEFFNER H, 1994, BIOCHEM BIOPH RES CO, V204, P1279, DOI 10.1006/bbrc.1994.2601; Oppenheimer N. J., 1992, ENZYMES, P453; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; SCHUBER F, 1976, EUR J BIOCHEM, V65, P247, DOI 10.1111/j.1432-1033.1976.tb10411.x; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; SEGEL IH, 1975, ENZYME KINETICS, P544; Stevens DL, 2000, J INFECT DIS, V182, P1117, DOI 10.1086/315850; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; TARNUS C, 1988, BIOORG CHEM, V16, P38, DOI 10.1016/0045-2068(88)90036-3; Tatsuno I, 2007, MICROBIOL-SGM, V153, P4253, DOI 10.1099/mic.0.2007/009555-0; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	46	36	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5683	5694		10.1074/jbc.M109.070300	http://dx.doi.org/10.1074/jbc.M109.070300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018886	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000275327200061
J	Lucero, HA; Kintsurashvili, E; Marketou, ME; Gavras, H				Lucero, Hector A.; Kintsurashvili, Ekaterina; Marketou, Maria E.; Gavras, Haralambos			Cell Signaling, Internalization, and Nuclear Localization of the Angiotensin Converting Enzyme in Smooth Muscle and Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; EXPRESSION; RECEPTORS; CANCER; GENE; INHIBITORS; PROTEINS; PATHWAYS; DOMAIN; ACE	The angiotensin converting enzyme (ACE) catalyzes the extracellular formation of angiotensin II, and degradation of bradykinin, thus regulating blood pressure and renal handling of electrolytes. We have previously shown that exogenously added ACE elicited transcriptional regulation independent of its enzymatic activity. Because transcriptional regulation generates from protein-DNA interactions within the cell nucleus we have investigated the initial cellular response to exogenous ACE and the putative internalization of the enzyme in smooth muscle cells (SMC) and endothelial cells (EC). The following phenomena were observed when ACE was added to cells in culture: 1) it bound to SMC and EC with high affinity (K-d = 361.5 +/- 60.5 pM) and with a low binding occupancy (B-max = 335.0 +/- 14.0 molecules/cell); 2) it triggered cellular signaling resulting in late activation of focal adhesion kinase and SHP2; 3) it modulated platelet-derived growth factor receptor-beta signaling; 4) it was endocytosed by SMC and EC; and 5) it transited through the early endosome, partially occupied the late endosome and the lysosome, and was localized to the nuclei. The incorporation of ACE or a fragment of it into the nuclei reached saturation at 120 min, and was preceded by a lag time of 40 min. Internalized ACE was partially cleaved into small fragments. These results revealed that extracellular ACE modulated cell signaling properties, and that SMC and EC have a pathway for delivery of extracellular ACE to the nucleus, most likely involving cell surface receptor(s) and requiring transit through late endosome/lysosome compartments.	[Lucero, Hector A.; Kintsurashvili, Ekaterina; Gavras, Haralambos] Boston Univ, Sch Med, Alapis Res Labs, Dept Med, Boston, MA 02118 USA; [Lucero, Hector A.; Kintsurashvili, Ekaterina; Marketou, Maria E.; Gavras, Haralambos] Boston Univ, Sch Med, Hypertens & Atherosclerosis Sect, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Lucero, HA (corresponding author), 715 Albany St,W508, Boston, MA 02118 USA.	hlucero@bu.edu	vardas, panos/ABF-7144-2020; Vardas, Panos/AAP-5694-2021; Vardas, Panos/AAD-5219-2022		Alapis Research Laboratories	Alapis Research Laboratories	This work was supported in part by Alapis Research Laboratories.	Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; BELDENT V, 1995, J BIOL CHEM, V270, P28962, DOI 10.1074/jbc.270.48.28962; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; de Andrade MCC, 2006, AM J PHYSIOL-RENAL, V290, pF364, DOI 10.1152/ajprenal.00110.2005; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43; GAVRAS H, 1994, HYPERTENSION, V23, P813, DOI 10.1161/01.HYP.23.6.813; HOLYCROSS BJ, 1992, HYPERTENSION, V19, P697, DOI 10.1161/01.HYP.19.6.697; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; Ignjacev-Lazich I, 2005, AM J PHYSIOL-HEART C, V289, pH1814, DOI 10.1152/ajpheart.00581.2005; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kohlstedt K, 2006, MOL PHARMACOL, V69, P1725, DOI 10.1124/mol.105.020636; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Kohlstedt K, 2009, MOL PHARMACOL, V75, P685, DOI 10.1124/mol.108.051631; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Leisle L, 2005, NAT MED, V11, P1139, DOI 10.1038/nm1105-1139; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Lindberg H, 2004, ACTA ONCOL, V43, P142, DOI 10.1080/02841860310022346; LOWENTHAL JW, 1988, J IMMUNOL, V140, P456; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Rosenthal T, 2009, J HUM HYPERTENS, V23, P623, DOI 10.1038/jhh.2009.21; RUBARTELLI A, 1995, TRENDS CELL BIOL, V5, P409, DOI 10.1016/S0962-8924(00)89093-5; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; SPRAGUE EA, 1985, AM J PATHOL, V121, P433; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Suikkanen S, 2002, J VIROL, V76, P4401, DOI 10.1128/JVI.76.9.4401-4411.2002; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; WEI L, 1991, J BIOL CHEM, V266, P9002; WEI L, 1991, J BIOL CHEM, V266, P5540; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Yoshiji H, 2004, CURR CANCER DRUG TAR, V4, P555, DOI 10.2174/1568009043332790	45	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5555	5568		10.1074/jbc.M109.074740	http://dx.doi.org/10.1074/jbc.M109.074740			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022959	hybrid, Green Published			2022-12-27	WOS:000275327200048
J	Minamide, LS; Maiti, S; Boyle, JA; Davis, RC; Coppinger, JA; Bao, Y; Huang, TY; Yates, J; Bokoch, GM; Bamburg, JR				Minamide, Laurie S.; Maiti, Sankar; Boyle, Judith A.; Davis, Richard C.; Coppinger, Judith A.; Bao, Yunhe; Huang, Timothy Y.; Yates, John; Bokoch, Gary M.; Bamburg, James R.			Isolation and Characterization of Cytoplasmic Cofilin-Actin Rods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR; F-ACTIN; ADF/COFILIN; PROTEIN; INTRANUCLEAR; EXPRESSION; MECHANISM; ATP; IDENTIFICATION; VISUALIZATION	Cofilin-actin bundles (rods), which form in axons and dendrites of stressed neurons, lead to synaptic dysfunction and may mediate cognitive deficits in dementias. Rods form abundantly in the cytoplasm of non-neuronal cells in response to many treatments that induce rods in neurons. Rods in cell lysates are not stable in detergents or with added calcium. Rods induced by ATP-depletion and released from cells by mechanical lysis were first isolated from two cell lines expressing chimeric actin-depolymerizing factor (ADF)/cofilin fluorescent proteins by differential and equilibrium sedimentation on OptiPrep gradients and then from neuronal and non-neuronal cells expressing only endogenous proteins. Rods contain ADF/cofilin and actin in a 1:1 ratio. Isolated rods are stable in dithiothreitol, EGTA, Ca2+, and ATP. Cofilin-GFP-containing rods are stable in 500 mM NaCl, whereas rods formed from endogenous proteins are significantly less stable in high salt. Proteomic analysis of rods formed from endogenous proteins identified other potential components whose presence in rods was examined by immunofluorescence staining of cells. Only actin and ADF/cofilin are in rods during all phases of their formation; furthermore, the rapid assembly of rods in vitro from these purified proteins at physiological concentration shows that they are the only proteins necessary for rod formation. Cytoplasmic rod formation is inhibited by cytochalasin D and jasplakinolide. Time lapse imaging of rod formation shows abundant small needle-shaped rods that coalesce over time. Rod filament lengths measured by ultrastructural tomography ranged from 22 to 1480 nm. These results suggest rods form by assembly of cofilin-actin subunits, followed by self-association of ADF/cofilin-saturated F-actin.	[Minamide, Laurie S.; Maiti, Sankar; Boyle, Judith A.; Davis, Richard C.; Bao, Yunhe; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Bamburg, James R.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Coppinger, Judith A.; Huang, Timothy Y.; Yates, John; Bokoch, Gary M.] Scripps Res Inst, La Jolla, CA 92037 USA	Colorado State University; Colorado State University; Scripps Research Institute	Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 1870 Campus Delivery, Ft Collins, CO 80523 USA.	jbamburg@lamar.colostate.edu		coppinger, judith/0000-0001-6813-9840	National Institutes of Health [NS40371, NS43115, HL079442, RR11823-10]; Alzheimer's Association [IIRG-01-2730]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371, T32NS043115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40371 and NS43115 (to J.R.B.) and HL079442 and RR11823-10 (to J.Y.). This work was also supported by Alzheimer's Association Grant IIRG-01-2730.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Ashworth SL, 2003, AM J PHYSIOL-RENAL, V284, pF852, DOI 10.1152/ajprenal.00210.2002; Bae SM, 2005, GYNECOL ONCOL, V99, P26, DOI 10.1016/j.ygyno.2005.05.041; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; BERSHADSKY AD, 1980, EXP CELL RES, V127, P421, DOI 10.1016/0014-4827(80)90446-2; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Davis RC, 2008, ACTA NEUROPATHOL, V115, P205, DOI 10.1007/s00401-007-0275-9; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Devineni N, 1999, BRAIN RES, V823, P129, DOI 10.1016/S0006-8993(99)01147-6; Domazetovska A, 2007, BRAIN, V130, P3275, DOI 10.1093/brain/awm247; FUKUI Y, 1979, EXP CELL RES, V120, P451, DOI 10.1016/0014-4827(79)90412-9; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P13, DOI 10.1016/S0960-8966(96)00404-X; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jang DH, 2005, P NATL ACAD SCI USA, V102, P16072, DOI 10.1073/pnas.0507675102; KOFFER A, 1988, J MUSCLE RES CELL M, V9, P320, DOI 10.1007/BF01773875; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhn TB, 2008, ADV EXP MED BIOL, V644, P232; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minamide LS, 2003, METHOD CELL BIOL, V71, P387, DOI 10.1016/S0091-679X(03)01019-7; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	46	50	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5450	5460		10.1074/jbc.M109.063768	http://dx.doi.org/10.1074/jbc.M109.063768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022956	Green Published, hybrid			2022-12-27	WOS:000275327200038
J	Thoh, M; Kumar, P; Nagarajaram, HA; Manna, SK				Thoh, Maikho; Kumar, Pankaj; Nagarajaram, Hampathalu A.; Manna, Sunil K.			Azadirachtin Interacts with the Tumor Necrosis Factor (TNF) Binding Domain of Its Receptors and Inhibits TNF-induced Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COLON-CANCER CELLS; TRANSCRIPTION; ACTIVATION; APOPTOSIS; KINASE; EXTRACT; COMPLEX; INDICA; ALPHA	The role of azadirachtin, an active component of a medicinal plant Neem (Azadirachta indica), on TNF-induced cell signaling in human cell lines was investigated. Azadirachtin blocks TNF-induced activation of nuclear factor kappa B (NF-kappa B) and also expression of NF-kappa B-dependent genes such as adhesion molecules and cyclooxygenase 2. Azadirachtin inhibits the inhibitory subunit of NF-kappa B (I kappa B alpha) phosphorylation and thereby its degradation and RelA (p65) nuclear translocation. It blocks I kappa B alpha kinase (IKK) activity ex vivo, but not in vitro. Surprisingly, azadirachtin blocks NF-kappa B DNA binding activity in transfected cells with TNF receptor-associated factor (TRAF) 2, TNF receptor-associated death domain (TRADD), IKK, or p65, but not with TNFR, suggesting its effect is at the TNFR level. Azadirachtin blocks binding of TNF, but not IL-1, IL-4, IL-8, or TNF-related apoptosis-inducing ligand (TRAIL) with its respective receptors. Anti-TNFR antibody or TNF protects azadirachtin-mediated down-regulation of TNFRs. Further, in silico data suggest that azadirachtin strongly binds in the TNF binding site of TNFR. Overall, our data suggest that azadirachtin modulates cell surface TNFRs thereby decreasing TNF-induced biological responses. Thus, azadirachtin exerts an anti-inflammatory response by a novel pathway, which may be beneficial for anti-inflammatory therapy.	[Thoh, Maikho; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Kumar, Pankaj; Nagarajaram, Hampathalu A.] Ctr DNA Fingerprinting & Diagnost, Lab Computat Biol, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in			Department of Science and Technology (DST), Government of India; Centre for DNA Fingerprinting and Diagnostics (CDFD); Council for Scientific and Industrial Research (CSIR), Government of India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics (CDFD); Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant from the Department of Science and Technology (DST), Government of India, a core grant from the Centre for DNA Fingerprinting and Diagnostics (CDFD), and fellowships (to M. T. and P. K.) from the Council for Scientific and Industrial Research (CSIR), Government of India.	Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Akudugu J, 2001, LIFE SCI, V68, P1153, DOI 10.1016/S0024-3205(00)01017-1; Anuradha A, 2007, INSECT BIOCHEM MOLEC, V37, P627, DOI 10.1016/j.ibmb.2007.03.009; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Dedrick RL, 2003, EXPERT OPIN BIOL TH, V3, P85, DOI 10.1517/eobt.3.1.85.20954; Di Ilio V, 2006, MOL CELL BIOCHEM, V287, P69, DOI 10.1007/s11010-005-9062-x; Gonzalez MS, 1999, EXP PARASITOL, V92, P100, DOI 10.1006/expr.1998.4387; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; JONES IW, 1994, FEMS MICROBIOL LETT, V120, P267, DOI 10.1111/j.1574-6968.1994.tb07044.x; Kakiuchi Y, 2002, CANCER RES, V62, P1567; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Manna SK, 1998, J BIOL CHEM, V273, P33333, DOI 10.1074/jbc.273.50.33333; Manna SX, 2006, EUR J IMMUNOL, V36, P754, DOI 10.1002/eji.200535209; MATSUSHIMA K, 1986, J IMMUNOL, V136, P4496; Nasuhara Y, 1999, J BIOL CHEM, V274, P19965, DOI 10.1074/jbc.274.28.19965; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; Ray E, 1997, CYTOKINE, V9, P587, DOI 10.1006/cyto.1997.0206; Robertson SL, 2007, ARCH INSECT BIOCHEM, V64, P200, DOI 10.1002/arch.20171; Sayah F, 2002, TISSUE CELL, V34, P53, DOI 10.1016/S0040-8166(02)00002-2; Sheng HM, 1998, CANCER RES, V58, P362; Subapriya R., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P149, DOI 10.2174/1568011053174828	25	34	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5888	5895		10.1074/jbc.M109.065847	http://dx.doi.org/10.1074/jbc.M109.065847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018848	Green Published, hybrid			2022-12-27	WOS:000275327200079
J	Jeyaraj, SC; Singh, M; Ayupova, DA; Govindaraju, S; Lee, BS				Jeyaraj, Selvi C.; Singh, Mamata; Ayupova, Dina A.; Govindaraju, Suman; Lee, Beth S.			Transcriptional Control of Human Antigen R by Bone Morphogenetic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; RNA-BINDING PROTEINS; POSTTRANSCRIPTIONAL GENE-REGULATION; MESSENGER-RNA; ALTERNATIVE PROMOTERS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; HUR; EXPRESSION; BMP-7	Human antigen R (HuR) is an RNA-binding protein with protective activities against cellular stress. This study considers the mechanisms by which HuR transcriptional regulation occurs in renal proximal tubule cells. Under basal conditions, HuRmRNA is expressed in two forms: one that contains a similar to 20-base 5'-untranslated region (UTR) sequence and one that contains a similar to 150-base, G + C-rich 5'-UTR that is inhibitory to translation. Recovery from cellular stresses such as thapsigargin and ATP depletion induced increased expression of the shorter, more translatable transcript and decreased expression of the longer form. Analysis of HuR upstream regions revealed sequences necessary for regulation of the shorter mRNA. Within the long, G + C-rich 5'-UTR exist multiple copies of the alternate Smad 1/5/8-binding motif GCCGnCGC. Recovery from ATP depletion induced increases in Smad1/5/8 levels; further, gel shift and chromatin immunoprecipitation analyses demonstrated the ability of these Smads to bind to the relevant motif in the HuR 5'-UTR. Transfection of exogenous Smad 1 increased HuR mRNA expression. Finally, HuR mRNA expression driven by the Smad-binding sites was responsive to BMP-7, a protein with known protective effects against ischemic injury in kidney. These data suggest that transcriptional induction of a readily translatable HuR mRNA may be driven by a mechanism known to protect the kidney from injury and provides a novel pathway through which administration of BMP-7 may attenuate renal damage.	[Jeyaraj, Selvi C.; Singh, Mamata; Ayupova, Dina A.; Govindaraju, Suman; Lee, Beth S.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Lee, BS (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	National Institutes of Health [RO1 DK052131, RO1 AR051515]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK052131 and RO1 AR051515 (to B. S. L.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Ashworth SL, 2003, AM J PHYSIOL-RENAL, V284, pF852, DOI 10.1152/ajprenal.00210.2002; Ayupova DA, 2009, AM J PHYSIOL-RENAL, V297, pF95, DOI 10.1152/ajprenal.90632.2008; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Cochrane J, 1999, RENAL FAILURE, V21, P135, DOI 10.3109/08860229909066978; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Martinez G, 2001, EXP NEPHROL, V9, P372; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazan-Mamczarz K, 2008, CANCER RES, V68, P7730, DOI 10.1158/0008-5472.CAN-08-2393; Meldrum KK, 2001, AM J PHYSIOL-REG I, V281, pR359, DOI 10.1152/ajpregu.2001.281.1.R359; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Nabors LB, 2001, CANCER RES, V61, P2154; NGUYEN VT, 1994, EUR J BIOCHEM, V220, P239; Okano HJ, 1997, J NEUROSCI, V17, P3024; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; Palmer BF, 1997, J INVEST MED, V45, P346; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Rasband WS, 1997, IMAGE J; Rothhammer T, 2005, CANCER RES, V65, P448; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Tsuritani K, 2007, GENOME RES, V17, P1005, DOI 10.1101/gr.6030107; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Vrljicak P, 2004, AM J PHYSIOL-RENAL, V286, pF625, DOI 10.1152/ajprenal.00152.2003; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Wang SN, 2001, J AM SOC NEPHROL, V12, P2392, DOI 10.1681/ASN.V12112392; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeng Q, 2000, J CELL SCI, V113, P471	57	21	21	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4432	4440		10.1074/jbc.M109.062216	http://dx.doi.org/10.1074/jbc.M109.062216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018854	Green Published, hybrid			2022-12-27	WOS:000275274800020
J	Yuan, HF; Wang, ZQ; Gao, CG; Chen, WG; Huang, Q; Yee, JK; Bhatia, R; Chen, WY				Yuan, Hongfeng; Wang, Zhiqiang; Gao, Chunggang; Chen, Wengang; Huang, Qin; Yee, Jiing-Kuan; Bhatia, Ravi; Chen, WenYong			BCR-ABL Gene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE DOMAIN MUTATIONS; IMATINIB RESISTANCE; POINT MUTATIONS; OLIGOMERIZATION DOMAIN; CLINICAL RESISTANCE; NILOTINIB AMN107; RNA INTERFERENCE; INHIBITOR; BCR/ABL	Acquired resistance through genetic mutations is a common phenomenon in several cancer therapies using molecularly targeted drugs, best exemplified by the BCR-ABL inhibitor imatinib in treating chronic myelogenous leukemia (CML). Overcoming acquired resistance is a daunting therapeutic challenge, and little is known about how these mutations evolve. To facilitate understanding the resistance mechanisms, we developed a novel culture model for CML acquired resistance in which the CML cell line KCL-22, following initial response to imatinib, develops resistant T315I BCR-ABL mutation. We demonstrate that the emergence of BCR-ABL mutations do not require preexisting BCR-ABL mutations derived from the original patient as the subclones of KCL-22 cells can form various BCR-ABL mutations upon imatinib treatment. BCR-ABL mutation rates vary from cell clone to clone and passages, in contrast to the relatively stable mutation rate of the hypoxanthine-guanine phosphoribosyltransferase gene. Strikingly, development of BCR-ABL mutations depends on its gene expression because BCR-ABL knockdown completely blocks KCL-22 cell relapse on imatinib and acquisition of mutations. We further show that the endogenous BCR-ABL locus has significantly higher mutagenesis potential than the transduced randomly integrated BCR-ABL cDNA. Our study suggests important roles of BCR-ABL gene expression and its native chromosomal locus for acquisition of BCR-ABL mutations and provides a new tool for further studying resistance mechanisms.	[Chen, WenYong] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Chen, Wengang; Huang, Qin] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA; [Yee, Jiing-Kuan] City Hope Natl Med Ctr, Dept Virol, Duarte, CA 91010 USA; [Bhatia, Ravi] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope	Chen, WY (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	wechen@coh.org	Chen, WenYong/D-6748-2012; yuan, hongfeng/A-3633-2012; wang, zhiqiang/D-6011-2012	Chen, WenYong/0000-0001-6913-5729	City of Hope; United States Department of Defense; STOPCANCER Foundation; V-Foundation	City of Hope; United States Department of Defense(United States Department of Defense); STOPCANCER Foundation; V-Foundation	This work was supported by start-up funds from the City of Hope, grants from the United States Department of Defense, the STOPCANCER Foundation ( to W.Y.C.), and a translational research grant from the V-Foundation ( to W.Y.C. and R. B.).	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huntly BJP, 2003, BLOOD, V102, P1160, DOI 10.1182/blood-2003-01-0123; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Karpinets TV, 2006, CURR GENOMICS, V7, P481, DOI 10.2174/138920206779315764; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kowolik CM, 2003, MOL THER, V8, P324, DOI 10.1016/S1525-0016(03)00166-7; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; La Rosee P, 2002, CANCER RES, V62, P7149; Li MJ, 2003, OLIGONUCLEOTIDES, V13, P401, DOI 10.1089/154545703322617087; Lucas CM, 2009, HAEMATOL-HEMATOL J, V94, P1362, DOI 10.3324/haematol.2009.009134; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; OSTERHOLM AM, 1995, CARCINOGENESIS, V16, P1909, DOI 10.1093/carcin/16.8.1909; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Ramaraj P, 2004, CANCER RES, V64, P5322, DOI 10.1158/0008-5472.CAN-03-3656; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ricci C, 2002, CANCER RES, V62, P5995; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Rosenhahn J, 2007, INT J ONCOL, V31, P121; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Tipping AJ, 2003, EXP HEMATOL, V31, P1073, DOI 10.1016/j.exphem.2003.08.006; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wertheim JA, 2002, BLOOD, V99, P4122, DOI 10.1182/blood.V99.11.4122; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Zhao X, 2002, NAT STRUCT BIOL, V9, P117; Zhelev Z, 2004, FEBS LETT, V570, P195, DOI 10.1016/j.febslet.2004.06.048	43	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5085	5096		10.1074/jbc.M109.039206	http://dx.doi.org/10.1074/jbc.M109.039206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007699	hybrid, Green Published			2022-12-27	WOS:000275274800084
J	Park, OJ; Kim, HJ; Woo, KM; Baek, JH; Ryoo, HM				Park, Ok-Jin; Kim, Hyun-Jung; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo			FGF2-activated ERK Mitogen-activated Protein Kinase Enhances Runx2 Acetylation and Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR BETA-1; DNA-BINDING; CELL-LINE; PHOSPHORYLATION	Runx2 is a key transcription factor regulating osteoblast differentiation and skeletal morphogenesis, and FGF2 is one of the most important regulators of skeletal development. The importance of the ERK mitogen-activated protein (MAP) kinase pathway in cranial suture development was demonstrated by the findings that the inhibition of FGF/FGF receptor (FGFR) signaling by a MEK blocker prevents the premature suture closure caused by an Fgfr2 mutation in mice. We previously demonstrated that ERK activation does not affect Runx2 gene expression but that it stimulates Runx2 transcriptional activity. However, the molecular mechanism underlying Runx2 activation by FGF/FGFR or ERK was still unclear. In this study, we found that FGF2 treatment increased the protein level of exogenously over-expressed Runx2 and that this increase is reversed by ERK inhibitors. In contrast, overexpression of constitutively active MEK strongly increased the Runx2 protein level, which paralleled an increase in Runx2 acetylation. As Runx2 protein phosphorylation mediated by ERK directly correlates with Runx2 protein stabilization, acetylation, and ubiquitination, we undertook to identify the ERK-dependent phosphorylation sites in Runx2. Analysis of two C-terminal Runx2 deletion constructs showed that the middle third of the protein is responsible for ERK-induced stabilization and activation. An in silico analysis of highly conserved ERK targets indicated that there are three relevant serine residues in this domain. Site-directed mutagenesis implicated Ser-301 in for ERK-mediated Runx2 stabilization and acetylation. In conclusion, the FGF2-induced ERK MAP kinase strongly increased the Runx2 protein level through an increase in acetylation and a decrease in ubiquitination, and these processes require the phosphorylation of Runx2 Ser-301 residue.	[Park, Ok-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Park, Ok-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [Kim, Hyun-Jung] Bone Res Inst BioRunx Co Ltd, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Genet, 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Ryoo, Hyun-Mo/D-5839-2012; Baek, Jeong-Hwa/A-8628-2012; Woo, Kyung Mi/A-2793-2009	Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189	Korea Health 21 R&D Project, Ministry of Health and Welfare [A010252, A085021]; Korean Government (MOEHRD, Basic Research Promotion Fund) [KRF-2008-532-C00018]	Korea Health 21 R&D Project, Ministry of Health and Welfare; Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (A010252 and A085021), and by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund, KRF-2008-532-C00018).	Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1; Fukuoka H, 2007, J ANAT, V211, P8, DOI 10.1111/j.1469-7580.2007.00739.x; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2006, J CELL PHYSIOL, V207, P114, DOI 10.1002/jcp.20552; Kim HJ, 2004, J CELL BIOCHEM, V91, P1239, DOI 10.1002/jcb.20038; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Li TF, 2004, EXP CELL RES, V299, P128, DOI 10.1016/j.yexcr.2004.05.025; Liang K, 1999, ENDOCRINOLOGY, V140, P5780; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naganawa T, 2008, J CELL BIOCHEM, V103, P1975, DOI 10.1002/jcb.21589; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	56	84	85	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3568	3574		10.1074/jbc.M109.055053	http://dx.doi.org/10.1074/jbc.M109.055053			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007706	hybrid, Green Published			2022-12-27	WOS:000275254000007
J	Redaelli, E; Cassulini, RR; Silva, DF; Clement, H; Schiavon, E; Zamudio, FZ; Odell, G; Arcangeli, A; Clare, JJ; Alagon, A; de la Vega, RCR; Possani, LD; Wanke, E				Redaelli, Elisa; Restano Cassulini, Rita; Fuentes Silva, Deyanira; Clement, Herlinda; Schiavon, Emanuele; Zamudio, Fernando Z.; Odell, George; Arcangeli, Annarosa; Clare, Jeffrey J.; Alagon, Alejandro; Rodriguez de la Vega, Ricardo C.; Possani, Lourival D.; Wanke, Enzo			Target Promiscuity and Heterogeneous Effects of Tarantula Venom Peptides Affecting Na+ and K+ Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATING MODIFIER TOXINS; GATED SODIUM-CHANNEL; VOLTAGE SENSORS; POTASSIUM; INHIBITOR; IDENTIFICATION; PHARMACOLOGY; SPECIFICITY; MUTATION; FEBRILE	Venom-derived peptide modulators of ion channel gating are regarded as essential tools for understanding the molecular motions that occur during the opening and closing of ion channels. In this study, we present the characterization of five spider toxins on 12 human voltage-gated ion channels, following observations about the target promiscuity of some spider toxins and the ongoing revision of their "canonical" gating-modifying mode of action. The peptides were purified de novo from the venom of Grammostola rosea tarantulas, and their sequences were confirmed by Edman degradation and mass spectrometry analysis. Their effects on seven tetrodotoxin-sensitive Na+ channels, the three human ether-a-go-go (hERG)-related K+ channels, and two human Shaker-related K+ channels were extensively characterized by electrophysiological techniques. All the peptides inhibited ion conduction through all the Na+ channels tested, although with distinctive patterns. The peptides also affected the three pharmaceutically relevant hERG isoforms differently. At higher concentrations, all peptides also modified the gating of the Na+ channels by shifting the activation to more positive potentials, whereas more complex effects were recorded on hERG channels. No effects were evident on the two Shaker-related K+ channels at concentrations well above the IC50 value for the affected channels. Given the sequence diversity of the tested peptides, we propose that tarantula toxins should be considered both as multimode and target-promiscuous ion channel modulators; both features should not be ignored when extracting mechanistic interpretations about ion channel gating. Our observations could also aid in future structure-function studies and might help the development of novel ion channel-specific drugs.	Univ Milano Bicocca, Dept Biotecnol & Biosci, I-20126 Milan, Italy; [Restano Cassulini, Rita; Clement, Herlinda; Zamudio, Fernando Z.; Odell, George; Alagon, Alejandro; Rodriguez de la Vega, Ricardo C.; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico; [Fuentes Silva, Deyanira] Univ Nacl Autonoma Mexico, Inst Quim, Coyoacan 04510, DF, Mexico; [Arcangeli, Annarosa] Univ Florence, Dipartimento Patol & Oncol Sperimentali, I-50134 Florence, Italy; [Clare, Jeffrey J.] GlaxoSmithKline, Med Res Ctr, Gene Express & Prot Biochem, Stevenage SG1 2NY, Herts, England; European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	University of Milano-Bicocca; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Florence; GlaxoSmithKline; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Wanke, E (corresponding author), Univ Milano Bicocca, Dept Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	enzo.wanke@unimib.it	Rodríguez de la Vega, Ricardo/A-4542-2008; Clement, Herlinda/AAT-1305-2021; Possani, Lourival D/J-2397-2013	Rodríguez de la Vega, Ricardo/0000-0002-9852-6654; Clement, Herlinda/0000-0001-7671-813X; milani, stefano/0000-0002-1337-9107; Schiavon, Emanuele/0000-0002-4592-6961	Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica [MIUR-PRIN2003-20052001055320, 2003052919, MIUR-FIRB2001-RBNE01XMP4-002, MIUR-FISR2001 0300179]; Universita di Milano-Bicocca [MIURPRIN2003-2005]; National Council of Science and Technology, Mexican Government; Grant Fondo Salud [014109]; Direcion General de Asuntos de Personal Academico [IN227507]	Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); Universita di Milano-Bicocca; National Council of Science and Technology, Mexican Government; Grant Fondo Salud; Direcion General de Asuntos de Personal Academico	This work was supported in part by Italian Ministero dell'Universita e della Ricerca Scientifica e Tecnologica Grants MIUR-PRIN2003-20052001055320 and 2003052919, MIUR-FIRB2001-RBNE01XMP4-002, and MIUR-FISR2001 0300179, the Universita di Milano-Bicocca Grant MIURPRIN2003-2005 (to E. W. and A. A.), the National Council of Science and Technology, Mexican Government, Grant Fondo Salud 014109, and by the Direcion General de Asuntos de Personal Academico Grant IN227507	Ackerman MJ, 2004, NAT MED, V10, P463, DOI 10.1038/nm0504-463; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Clement H, 2007, TOXICON, V50, P65, DOI 10.1016/j.toxicon.2007.02.015; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; De La Vega RCR, 2005, TOXIN REV, V24, P385, DOI [10.1080/07313830500237166, 10.3109/15569540509162660]; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; DELAVEGA RCR, 2009, ANIMAL TOXINS STATE, P194; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Diochot S, 2003, MOL PHARMACOL, V64, P59, DOI 10.1124/mol.64.1.59; Edgerton GB, 2008, TOXICON, V52, P489, DOI 10.1016/j.toxicon.2008.06.023; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Ferrat G, 2005, TOXIN REV, V24, P361, DOI 10.3109/15569540509162659; Garcia ML, 2007, TOXICON, V49, P123, DOI 10.1016/j.toxicon.2006.09.010; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Gurrola GB, 1999, FASEB J, V13, P953, DOI 10.1096/fasebj.13.8.953; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V340, P633, DOI 10.1016/j.bbrc.2005.12.046; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Lampe R.A., 1999, Analgesic Peptides from Venom of Grammostola Spatulata and Use Thereof, Patent No. [US5877026, 5877026]; LAMPE RA, 1999, Patent No. 5968838; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liao Z, 2006, BIOCHEMISTRY-US, V45, P15591, DOI 10.1021/bi061457+; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; McDonough SI, 2007, TOXICON, V49, P202, DOI 10.1016/j.toxicon.2006.09.018; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Nicholson GM, 2005, TOXIN REV, V24, P315, DOI 10.3109/15569540509162657; Oliveira JS, 2004, J BIOL CHEM, V279, P33323, DOI 10.1074/jbc.M404344200; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Restano-Cassulini R, 2006, MOL PHARMACOL, V69, P1673, DOI 10.1124/mol.105.019729; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Schonherr R, 1999, EUR J NEUROSCI, V11, P753, DOI 10.1046/j.1460-9568.1999.00493.x; SPINELLI W, 1993, CARDIOVASC RES, V27, P1580, DOI 10.1093/cvr/27.9.1580; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Wanke E, 2007, TOXICON, V49, P239, DOI 10.1016/j.toxicon.2006.09.025; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zamudio FZ, 1997, FEBS LETT, V405, P385, DOI 10.1016/S0014-5793(97)00227-5; Zhu SY, 2004, PROTEINS, V54, P361, DOI 10.1002/prot.10588; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2	59	68	76	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4130	4142		10.1074/jbc.M109.054718	http://dx.doi.org/10.1074/jbc.M109.054718			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955179	Green Published, hybrid			2022-12-27	WOS:000275254000065
J	Shigematsu, H; Sokabe, T; Danev, R; Tominaga, M; Nagayama, K				Shigematsu, Hideki; Sokabe, Takaaki; Danev, Radostin; Tominaga, Makoto; Nagayama, Kuniaki			A 3.5-nm Structure of Rat TRPV4 Cation Channel Revealed by Zernike Phase-contrast Cryoelectron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; ANKYRIN REPEAT DOMAIN; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; POTASSIUM CHANNEL; SYSTEM; LOCALIZATION; EXPRESSION; PROTEIN; OTRPC4	The transient receptor potential vanilloid 4 (TRPV4) is a nonselective cation channel responsive to various stimuli including cell swelling, warm temperatures (27-35 degrees C), and chemical compounds such as phorbol ester derivatives. Here we report the three-dimensional structure of full-length rat TRPV4 purified from baculovirus-infected Sf9 cells. Hexahistidine-tagged rat TRPV4 (His-rTRPV4) was solubilized with detergent and purified through affinity chromatography and size-exclusion chromatography. Chemical cross-linking analysis revealed that detergent-solubilized His-rTRPV4 was a tetramer. The 3.5-nm structure of rat TRPV4 was determined by cryoelectron microscopy using single-particle reconstruction from Zernike phasecontrast images. The overall structure comprises two distinct regions; a larger dense component, likely corresponding to the cytoplasmic N- and C-terminal regions, and a smaller component corresponding to the transmembrane region.	[Shigematsu, Hideki; Danev, Radostin; Nagayama, Kuniaki] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Nanostruct Physiol, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Shigematsu, Hideki; Sokabe, Takaaki; Danev, Radostin; Tominaga, Makoto; Nagayama, Kuniaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Sokabe, Takaaki; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Danev, Radostin; Tominaga, Makoto; Nagayama, Kuniaki] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Nagayama, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Nanostruct Physiol, Higashiyama Ku, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	nagayama@nips.ac.jp	Shigematsu, Hideki/E-1052-2017; Nagayama, Kuniaki/O-2522-2018	Shigematsu, Hideki/0000-0003-3951-8651; Sokabe, Takaaki/0000-0003-1280-9424	Ministry of Education, Culture, Sports, Science, and Technology of Japan [2001-2005]; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation [2006-2009]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by a grant-in-aid for creative scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (2001-2005) and by Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (2006-2009).	Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Cahalan MD, 2001, NATURE, V411, P542, DOI 10.1038/35079231; Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; Danev R, 2008, J STRUCT BIOL, V161, P211, DOI 10.1016/j.jsb.2007.10.015; Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hosokawa F, 2005, J ELECTRON MICROSC, V54, P317, DOI 10.1093/jmicro/dfi049; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	53	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11210	11218		10.1074/jbc.M109.090712	http://dx.doi.org/10.1074/jbc.M109.090712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20044482	hybrid, Green Published			2022-12-27	WOS:000276286200026
J	Wang, T; Shah, YM; Matsubara, T; Zhen, YY; Tanabe, T; Nagano, T; Fotso, S; Krausz, KW; Zabriskie, TM; Idle, JR; Gonzalez, FJ				Wang, Ting; Shah, Yatrik M.; Matsubara, Tsutomu; Zhen, Yueying; Tanabe, Tomotaka; Nagano, Tomokazu; Fotso, Serge; Krausz, Kristopher W.; Zabriskie, T. Mark; Idle, Jeffrey R.; Gonzalez, Frank J.			Control of Steroid 21-oic Acid Synthesis by Peroxisome Proliferator-activated Receptor alpha and Role of the Hypothalamic-Pituitary-Adrenal Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; ALDO-KETO REDUCTASE; NEUROPEPTIDE-Y NPY; NAKED PLASMID DNA; PPAR-ALPHA; ALDEHYDE DEHYDROGENASE; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; SUCCESSIVE REACTIONS; TISSUE DISTRIBUTION; OXIDATIVE STRESS	A previous study identified the peroxisome proliferator-activated receptor alpha (PPAR alpha) activation biomarkers 21-steroid carboxylic acids 11 beta-hydroxy-3,20-dioxopregn-4-en-21-oic acid (HDOPA) and 11 beta,20-dihydroxy-3-oxo-pregn-4-en-21-oic acid (DHOPA). In the present study, the molecular mechanism and the metabolic pathway of their production were determined. The PPAR alpha-specific time-dependent increases in HDOPA and 20 alpha-DHOPA paralleled the development of adrenal cortex hyperplasia, hypercortisolism, and spleen atrophy, which was attenuated in adrenalectomized mice. Wy-14,643 activation of PPAR alpha induced hepatic FGF21, which caused increased neuropeptide Y and agouti-related protein mRNAs in the hypothalamus, stimulation of the agouti-related protein/neuropeptide Y neurons, and activation of the hypothalamic-pituitary-adrenal (HPA) axis, resulting in increased adrenal cortex hyperplasia and corticosterone production, revealing a link between PPAR alpha and the HPA axis in controlling energy homeostasis and immune regulation. Corticosterone was demonstrated as the precursor of 21-carboxylic acids both in vivo and in vitro. Under PPAR alpha activation, the classic reductive metabolic pathway of corticosterone was suppressed, whereas an alternative oxidative path-way was uncovered that leads to the sequential oxidation on carbon 21 resulting in HDOPA. The latter was then reduced to the end product 20 alpha-DHOPA. Hepatic cytochromes P450, aldehyde dehydrogenase (ALDH3A2), and 21-hydroxysteroid dehydrogenase (AKR1C18) were found to be involved in this pathway. Activation of PPAR alpha resulted in the induction of Aldh3a2 and Akr1c18, both of which were confirmed as target genes through introduction of promoter luciferase reporter constructs into mouse livers in vivo. This study underscores the power of mass spectrometry-based metabolomics combined with genomic and physiologic analyses in identifying downstream metabolic biomarkers and the corresponding upstream molecular mechanisms.	[Wang, Ting; Shah, Yatrik M.; Matsubara, Tsutomu; Zhen, Yueying; Tanabe, Tomotaka; Nagano, Tomokazu; Krausz, Kristopher W.; Idle, Jeffrey R.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fotso, Serge; Zabriskie, T. Mark] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Idle, Jeffrey R.] Charles Univ Prague, Inst Pharmacol, Fac Med 1, Prague 12800, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon State University; Charles University Prague	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	fjgonz@helix.nih.gov	Fotso, serge/A-4396-2009; Idle, Jeff/B-1152-2012	Fotso, serge/0000-0001-7117-8568; Idle, Jeff/0000-0002-6143-1520	National Institutes of Health NCI Intramural Research; Center for Gastrointestinal Biology and Disease [P30 DK34987]; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health NCI Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Gastrointestinal Biology and Disease; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NCI Intramural Research Program. This work was also supported by Center for Gastrointestinal Biology and Disease Grant P30 DK34987.	ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Alnouti Y, 2008, TOXICOL SCI, V101, P51, DOI 10.1093/toxsci/kfm280; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BRADLOW HL, 1973, J CLIN ENDOCR METAB, V37, P811, DOI 10.1210/jcem-37-5-811; Brereton P, 2001, MOL CELL ENDOCRINOL, V171, P111, DOI 10.1016/S0303-7207(00)00417-2; Burczynski ME, 1999, CANCER RES, V59, P607; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chen L, 2005, P NATL ACAD SCI USA, V102, P15581, DOI 10.1073/pnas.0503877102; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Cunard R, 2002, J IMMUNOL, V169, P6806, DOI 10.4049/jimmunol.169.12.6806; Dai CS, 2003, J BIOL CHEM, V278, P27080, DOI 10.1074/jbc.M211947200; DELAUNOIT Y, 1992, ENDOCRINOLOGY, V130, P553, DOI 10.1210/en.130.1.553; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dhagat U, 2008, J MED CHEM, V51, P4844, DOI 10.1021/jm8003575; Fan LQ, 1998, J ENDOCRINOL, V158, P237, DOI 10.1677/joe.0.1580237; GOLDSTEIN DS, 1993, J NEUROENDOCRINOL, V5, P475, DOI 10.1111/j.1365-2826.1993.tb00511.x; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; HAN A, 1983, J BIOL CHEM, V258, P3703; HANSON ES, 1995, J NEUROENDOCRINOL, V7, P273, DOI 10.1111/j.1365-2826.1995.tb00757.x; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ishida N, 2009, PPAR RES, V2009, DOI 10.1155/2009/412949; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; LOOMIS CW, 1983, CAN J PHYSIOL PHARM, V61, P431, DOI 10.1139/y83-065; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; MONDER C, 1982, J STEROID BIOCHEM, V16, P613, DOI 10.1016/0022-4731(82)90095-4; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; PETERSON RE, 1960, J CLIN INVEST, V39, P741, DOI 10.1172/JCI104091; REISMAN D, 1995, MOL ENDOCRINOL, V9, P1500, DOI 10.1210/me.9.11.1500; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; STRICKLER RC, 1981, J BIOL CHEM, V256, P316; WAHLESTEDT C, 1987, BRAIN RES, V417, P33, DOI 10.1016/0006-8993(87)90176-4; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438; Yang Q, 2002, BIOCHEM PHARMACOL, V63, P1893, DOI 10.1016/S0006-2952(02)00923-1; Yokoi Y, 2007, FEBS J, V274, P4837, DOI 10.1111/j.1742-4658.2007.06005.x; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhen Y, 2007, MOL ENDOCRINOL, V21, P2136, DOI 10.1210/me.2007-0150	43	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7670	7685		10.1074/jbc.M109.090175	http://dx.doi.org/10.1074/jbc.M109.090175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20032461	hybrid, Green Published			2022-12-27	WOS:000275415600077
J	Zhang, R; Chen, HZ; Liu, JJ; Jia, YY; Zhang, ZQ; Yang, RF; Zhang, Y; Xu, J; Wei, YS; Liu, DP; Liang, CC				Zhang, Ran; Chen, Hou-Zao; Liu, Jin-Jing; Jia, Yu-Yan; Zhang, Zhu-Qin; Yang, Rui-Feng; Zhang, Yuan; Xu, Jing; Wei, Yu-Sheng; Liu, De-Pei; Liang, Chih-Chuan			SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; C-JUN; IN-VITRO; CHRONIC INFLAMMATION; EPITHELIAL-CELLS; DNA-BINDING; KAPPA-B; DEACETYLASE; MOLECULE; MICE	SIRT1 (Sirtuin type 1), a mammalian orthologue of yeast SIR2 (silent information regulator 2), has been shown to mediate a variety of calorie restriction (CR)-induced physiological events, such as cell fate regulation via deacetylation of the substrate proteins. However, whether SIRT1 deacetylates activator protein-1 (AP-1) to influence its transcriptional activity and target gene expression is still unknown. Here we demonstrate that SIRT1 directly interacts with the basic leucine zipper domains of c-Fos and c-Jun, the major components of AP-1, by which SIRT1 suppressed the transcriptional activity of AP-1. This process requires the deacetylase activity of SIRT1. Notably, SIRT1 reduced the expression of COX-2, a typical AP-1 target gene, and decreased prostaglandin E-2 (PGE(2)) production of peritoneal macrophages (pM Phi s). pM Phi s with SIRT1 overexpression displayed improved phagocytosis and tumoricidal functions, which are associated with depressed PGE(2). Furthermore, SIRT1 protein level was up-regulated in CR mouse pM Phi s, whereas elevated SIRT1 decreased COX-2 expression and improved PGE(2)-related macrophage functions that were reversed following inhibition of SIRT1 deacetylase activity. Thus, our results indicate that SIRT1 may be a mediator of CR-induced macrophage regulation, and its deacetylase activity contributes to the inhibition of AP-1 transcriptional activity and COX-2 expression leading to amelioration of macrophage function.	Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, DP (corresponding author), 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	liudp@pumc.edu.cn	Zhang, Ran/GZG-8709-2022	Liu, De-Pei/0000-0002-2636-4297; Chen, Hou-Zao/0000-0001-6805-3182	National Basic Research Program of China [2005CB522402, 2006CB503801]; National 863 Project [2006AA02A406]; National Natural Science Foundation of China [30721063]	National Basic Research Program of China(National Basic Research Program of China); National 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2005CB522402 and 2006CB503801, National 863 Project Grant 2006AA02A406, and National Natural Science Foundation of China Grant 30721063.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; BIRT DF, 1991, CANCER RES, V51, P1851; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castello L, 2005, FASEB J, V19, P1863, DOI 10.1096/fj.04-2864fje; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dey S, 2008, CARCINOGENESIS, V29, P1920, DOI 10.1093/carcin/bgn175; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guo YS, 2001, J BIOL CHEM, V276, P22941, DOI 10.1074/jbc.M101801200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211; Kim HJ, 2002, J AM AGING ASSOC, V25, P123, DOI 10.1007/s11357-002-0011-2; Kim YJ, 2006, LIFE SCI, V78, P2523, DOI 10.1016/j.lfs.2005.10.034; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lively TN, 2004, J BIOL CHEM, V279, P26257, DOI 10.1074/jbc.M400892200; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mai V, 2003, CANCER RES, V63, P1752; Martin ML, 1996, MOL CELL BIOL, V16, P2110; Miotto B, 2006, MOL CELL BIOL, V26, P5969, DOI 10.1128/MCB.00696-06; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Przybyszewski J, 2001, CARCINOGENESIS, V22, P1421, DOI 10.1093/carcin/22.9.1421; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; SCHULTZ RM, 1978, SCIENCE, V202, P320, DOI 10.1126/science.694537; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Stapleton PP, 2001, NUTRITION, V17, P41, DOI 10.1016/S0899-9007(00)00502-5; Sun DX, 2001, CLIN DIAGN LAB IMMUN, V8, P1003, DOI 10.1128/CDLI.8.5.1003-1011.2001; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vries RGJ, 2001, EMBO J, V20, P6095, DOI 10.1093/emboj/20.21.6095; Yakar I, 2003, ANN SURG ONCOL, V10, P469, DOI 10.1245/ASO.2003.08.017; Yamada H, 2002, CLIN EXP IMMUNOL, V128, P52, DOI 10.1046/j.1365-2249.2002.01686.x; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006	46	160	176	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7097	7110		10.1074/jbc.M109.038604	http://dx.doi.org/10.1074/jbc.M109.038604			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042607	hybrid, Green Published			2022-12-27	WOS:000275415600023
J	He, SQ; McPhaul, C; Li, JZ; Garuti, R; Kinch, L; Grishin, NV; Cohen, JC; Hobbs, HH				He, Shaoqing; McPhaul, Christopher; Li, John Zhong; Garuti, Rita; Kinch, Lisa; Grishin, Nick V.; Cohen, Jonathan C.; Hobbs, Helen H.			A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STEATOSIS; ACYL-HYDROLASE; PURIFICATION; ADIPONUTRIN; FAMILY; LIPASE; EXPRESSION; PATATIN	Obesity and insulin resistance are associated with deposition of triglycerides in tissues other than adipose tissue. Previously, we showed that a missense mutation (I148M) in PNPLA3 (patatin-like phospholipase domain-containing 3 protein) is associated with increased hepatic triglyceride content in humans. Here we examined the effect of the I148M substitution on the enzymatic activity and cellular location of PNPLA3. Structural modeling predicted that the substitution of methionine for isoleucine at residue 148 would restrict access of substrate to the catalytic serine at residue 47. In vitro assays using recombinant PNPLA3 partially purified from Sf9 cells confirmed that the wild type enzyme hydrolyzes emulsified triglyceride and that the I148M substitution abolishes this activity. Expression of PNPLA3-I148M, but not wild type PNPLA3, in cultured hepatocytes or in the livers of mice increased cellular triglyceride content. Cell fractionation studies revealed that similar to 90% of wild type PNPLA3 partitioned between membranes and lipid droplets; substitution of isoleucine for methionine at position 148 did not alter the subcellular distribution of the protein. These data are consistent with PNPLA3-I148M promoting triglyceride accumulation by limiting triglyceride hydrolysis.	[He, Shaoqing; McPhaul, Christopher; Li, John Zhong; Garuti, Rita; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nick V.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu	Li, John Zhong/S-2118-2019; Li, Zhong/U-2157-2017	Li, John Zhong/0000-0003-4991-9563; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [HL092550, UL1DE019684, PL1DK081182, HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092550, UL1DE019684, PL1DK081182, and HL20948.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2006, CURRENT PROTOCOLS CE; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; DeLano W.L, PYMOL MOL GRAPHICS S; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; GALLIARD T, 1971, BIOCHEM J, V121, P379, DOI 10.1042/bj1210379; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; SHEEHAN DC, 1980, THEORY PRACTICE HIST, P205; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; WADA I, 1991, J BIOL CHEM, V266, P19599; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904	32	449	462	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6706	6715		10.1074/jbc.M109.064501	http://dx.doi.org/10.1074/jbc.M109.064501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20034933	hybrid, Green Published			2022-12-27	WOS:000275367500074
J	Okazaki, H; Goldstein, JL; Brown, MS; Liang, GS				Okazaki, Hiroaki; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng			LXR-SREBP-1c-Phospholipid Transfer Protein Axis Controls Very Low Density Lipoprotein (VLDL) Particle Size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-TRANSFER PROTEIN; ELEMENT-BINDING PROTEIN-1C; LIVER-X-RECEPTORS; KNOCKOUT MICE; INSULIN-RESISTANCE; GENE; TRANSCRIPTION; LIPOGENESIS; ACTIVATION; SREBP-1C	Liver X receptors (LXRs) activate triglyceride synthesis in liver directly and indirectly by inducing sterol regulatory element-binding protein-1c (SREBP-1c). When administered to wild-type mice, the LXR activator T0901317 produces a mild and transient hypertriglyceridemia. Here, we show that T0901317 produces massive hypertriglyceridemia when given to mice lacking low density lipoprotein (LDL) receptors (Ldlr(-/-) mice). Triglycerides ranged from 4000 to 6000 mg/dl, and the plasma turned milky. The median diameter of VLDL particles, measured by electron microscopy, increased from 43 to 112 nm, 87% exceeding 80 nm, the size of chylomicrons. Hypertriglyceridemia was prevented in Ldlr(-/-) recipient mice that lacked SREBP-1c (Ldlr(-/-); Srebp-1c(-/-) double knock-out mice). In Ldlr(-/-) mice, T0901317 increased mRNAs not only for enzymes of fatty acid and triglyceride synthesis, but also for phospholipid transfer protein (PLTP), which transfers phospholipids into nascent VLDL, allowing particle expansion. The PLTP increase was blunted in Ldlr(-/-); Srebp-1c(-/-) animals. When Ldlr(-/-); Srebp-1c(-/-) mice received an adenovirus encoding Pltp, the hypertriglyceridemic response to T0901317 was partially restored and the VLDL size increased. We conclude that LXR agonists activate triglyceride synthesis and Pltp transcription by activating Srebp-1c. In concert with the increase in TG synthesis, the increased PLTP permits triglyceride incorporation into abnormally large VLDL, which are removed from plasma by LDL receptors. In the absence of LDL receptors, the large VLDLs accumulate and produce massive hypertriglyceridemia.	[Okazaki, Hiroaki; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu			National Institutes of Health [HL-20948]; Perot Family Foundation; Moss Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; Moss Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-20948, the Perot Family Foundation, and the Moss Heart Foundation.	Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Desrumaux C, 1999, ARTERIOSCL THROM VAS, V19, P266, DOI 10.1161/01.ATV.19.2.266; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Goldstein JL, 1983, METABOLIC BASIS INHE, P672; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JIANG XC, 1995, J BIOL CHEM, V270, P17133, DOI 10.1074/jbc.270.29.17133; Jiang XC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1634, DOI 10.2741/jiang1; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lie J, 2002, J LIPID RES, V43, P1875, DOI 10.1194/jlr.M200166-JLR200; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; Masson D, 2009, J LIPID RES, V50, pS201, DOI 10.1194/jlr.R800061-JLR200; Okazaki H, 2002, J BIOL CHEM, V277, P31893, DOI 10.1074/jbc.M204016200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598	30	70	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6801	6810		10.1074/jbc.M109.079459	http://dx.doi.org/10.1074/jbc.M109.079459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037162	Green Published, hybrid			2022-12-27	WOS:000275367500083
J	Subramanyam, M; Takahashi, N; Hasegawa, Y; Mohri, T; Okada, Y				Subramanyam, Muthangi; Takahashi, Nobuyuki; Hasegawa, Yuichi; Mohri, Tatsuma; Okada, Yasunobu			Inhibition of Protein Kinase Akt1 by Apoptosis Signal-regulating Kinase-1 (ASK1) Is Involved in Apoptotic Inhibition of Regulatory Volume Increase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMOTONIC CELL SHRINKAGE; CATION CHANNELS; B-GAMMA; ACTIVATION; STRESS; DEATH; PHOSPHORYLATION; TRANSDUCTION; PATHWAY; PREREQUISITE	Most animal cell types regulate their cell volume after an osmotic volume change. The regulatory volume increase (RVI) occurs through uptake of NaCl and osmotically obliged water after osmotic shrinkage. However, apoptotic cells undergo persistent cell shrinkage without showing signs of RVI. Persistence of the apoptotic volume decrease is a prerequisite to apoptosis induction. We previously demonstrated that volume regulation is inhibited in human epithelial HeLa cells stimulated with the apoptosis inducer. Here, we studied signaling mechanisms underlying the apoptotic inhibition of RVI in HeLa cells. Hypertonic stimulation was found to induce phosphorylation of a Ser/Thr protein kinase Akt (protein kinase B). Shrinkage-induced Akt activation was essential for RVI induction because RVI was suppressed by an Akt inhibitor, expression of a dominant negative form of Akt, or small interfering RNA-mediated knockdown of Akt1 (but not Akt2). Staurosporine, tumor necrosis factor-alpha, or a Fas ligand inhibited both RVI and hypertonicity-induced Akt activation in a manner sensitive to a scavenger for reactive oxygen species (ROS). Any of apoptosis inducers also induced phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) in a ROS-dependent manner. Suppression of (ASK1) expression blocked the effects of apoptosis, in hypertonic conditions, on both RVI induction and Akt activation. Thus, it is concluded that in human epithelial cells, shrinkage-induced activation of Akt1 is involved in the RVI process and that apoptotic inhibition of RVI is caused by inhibition of Akt activation, which results from ROS-mediated activation of ASK1.	[Subramanyam, Muthangi; Takahashi, Nobuyuki; Hasegawa, Yuichi; Mohri, Tatsuma; Okada, Yasunobu] Natl Inst Nat Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan	Okada, Y (corresponding author), Natl Inst Nat Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan.	okada@nips.ac.jp	Takahashi, Nobuyuki/AAX-8671-2021	Takahashi, Nobuyuki/0000-0002-9705-662X; Mohri, Tatsuma/0000-0002-5744-7925; Takahashi, Nobuyuki/0000-0003-0126-6292	Ministry of Education, Culture, Sports, Science, and Technology of Japa; Salt Science Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japa(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y.O. and N.T.) and from The Salt Science Research Foundation (to N.T.).	Allen RT, 2005, APOPTOSIS, V10, P525, DOI 10.1007/s10495-005-1882-3; Araki T, 2002, BIOCHEM BIOPH RES CO, V290, P1275, DOI 10.1006/bbrc.2002.6329; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Choi K, 2007, CANCER LETT, V257, P79, DOI 10.1016/j.canlet.2007.07.006; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; Gomez-Angelats M, 2002, TOXICOL PATHOL, V30, P541, DOI 10.1080/01926230290105820; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Maeno E, 2006, ACTA PHYSIOL, V187, P217, DOI 10.1111/j.1748-1716.2006.01554.x; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; McConkey David J., 1994, Trends in Cell Biology, V4, P370, DOI 10.1016/0962-8924(94)90087-6; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Nakatani K, 1999, BIOCHEM BIOPH RES CO, V257, P906, DOI 10.1006/bbrc.1999.0559; Nielsen MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1046, DOI 10.1152/ajpcell.00134.2007; Nukui M, 2006, J PHYSIOL SCI, V56, P335, DOI 10.2170/physiolsci.RP009606; Numata T, 2008, APOPTOSIS, V13, P895, DOI 10.1007/s10495-008-0220-y; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2004, CELL BIOCHEM BIOPHYS, V41, P233, DOI 10.1385/CBB:41:2:233; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; OKADA Y, 2001, J PHYSL, V523, P3; Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Shimizu T, 2008, ANTICANCER RES, V28, P75; Shimizu T, 2006, CELL PHYSIOL BIOCHEM, V18, P295, DOI 10.1159/000097607; Shimizu Takahiro, 2007, Shengli Xuebao, V59, P512; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Sugden PH, 2001, CIRC RES, V88, P975, DOI 10.1161/hh1001.091864; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Terada Y, 2001, KIDNEY INT, V60, P553, DOI 10.1046/j.1523-1755.2001.060002553.x; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Uramoto H, 2003, JPN J PHYSIOL, V53, P357, DOI 10.2170/jjphysiol.53.357; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wehner F, 2007, CELL PHYSIOL BIOCHEM, V20, P75, DOI 10.1159/000104155; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	58	26	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6109	6117		10.1074/jbc.M109.072785	http://dx.doi.org/10.1074/jbc.M109.072785			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048146	Green Published, hybrid			2022-12-27	WOS:000275367500014
J	Cheng, LL; Guo, JF; Sun, LG; Fu, J; Barnes, PF; Metzger, D; Chambon, P; Oshima, RG; Amagai, T; Su, DM				Cheng, Lili; Guo, Jianfei; Sun, Liguang; Fu, Jian; Barnes, Peter F.; Metzger, Daniel; Chambon, Pierre; Oshima, Robert G.; Amagai, Takashi; Su, Dong-Ming			Postnatal Tissue-specific Disruption of Transcription Factor FoxN1 Triggers Acute Thymic Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL DIFFERENTIATION; T-CELL; LYMPHOHEMATOPOIETIC PROGENITORS; CENTRAL TOLERANCE; TRANSGENIC MICE; NUDE PHENOTYPE; EXPRESSION; MOUSE; GENE; CRE	The transcription factor FoxN1 is essential for differentiation of thymic epithelial cell (TEC) progenitors during thymic organogenesis. However, limited information is available on the postnatal contribution of FoxN1 to thymic maintenance. To address this question, we generated a loxP-floxed FoxN1 (fx) mouse with three different promoter-driven inducible CreER(T) transgenes. Postnatal ubiquitous deletion of FoxN1 caused dramatic thymic atrophy in 5 days and more severe deterioration in medullary TECs (mTECs) than in cortical TECs (cTECs). Induction of FoxN1 deletion selectively in K5 promoter-driven somatic epithelial cells (mostly mTECs and possibly some adult epithelial stem cells) was sufficient to cause significant thymic atrophy, whereas FoxN1 deletion in K18 promoter-driven somatic epithelial cells (mostly cTECs) was not. Thymic atrophy resulted from increased apoptosis and was associated with activation of the p53 gene in mature mTECs. Although FoxN1 is required for the development of both mTECs and cTECs in thymic organogenesis, it is most important for the maintenance of mTECs in the postnatal thymus, which are in turn necessary to prevent thymic atrophy.	[Cheng, Lili; Guo, Jianfei; Sun, Liguang; Fu, Jian; Su, Dong-Ming] Univ Texas Tyler, Dept Biomed Res, Hlth Sci Ctr, Tyler, TX 75708 USA; [Barnes, Peter F.] Univ Texas Tyler, Ctr Pulm & Infect Dis Control, Hlth Sci Ctr, Tyler, TX 75708 USA; [Metzger, Daniel; Chambon, Pierre] Coll France, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; [Oshima, Robert G.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Amagai, Takashi] Meiji Univ Integrat Med, Dept Immunol & Microbiol, Kyoto 6290392, Japan	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sanford Burnham Prebys Medical Discovery Institute	Su, DM (corresponding author), Univ Texas Tyler, Dept Biomed Res, Hlth Sci Ctr, Tyler, TX 75708 USA.	dong-ming.su@uthct.edu		Metzger, Daniel/0000-0002-5555-046X	NIAID [R21AI064939, R01AI081995, R21AI079747]; University of Texas Health Science Center at Tyler; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081995, R21AI064939, R21AI079747] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas Health Science Center at Tyler; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI064939, R01AI081995, and R21AI079747 (to D.- M. S.) from NIAID. This work was also supported by the University of Texas Health Science Center at Tyler.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Amorosi S, 2008, CLIN GENET, V73, P380, DOI 10.1111/j.1399-0004.2008.00977.x; Anderson G, 2009, EUR J IMMUNOL, V39, P1694, DOI 10.1002/eji.200939379; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; FARR AG, 1985, J IMMUNOL, V134, P2971; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Goldberg GL, 2007, SEMIN IMMUNOL, V19, P289, DOI 10.1016/j.smim.2007.08.001; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hsu HC, 2005, IMMUNOL REV, V205, P130, DOI 10.1111/j.0105-2896.2005.00270.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; KOJIMA A, 1984, EXP CELL BIOL, V52, P107; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomada D, 2007, J IMMUNOL, V178, P829, DOI 10.4049/jimmunol.178.2.829; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Petrie HT, 2005, J EXP MED, V202, P11, DOI 10.1084/jem.20050990; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; SCHEIFF JM, 1978, ANAT EMBRYOL, V153, P115, DOI 10.1007/BF00343368; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Spits H, 2002, NAT REV IMMUNOL, V2, P760, DOI 10.1038/nri913; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; Swann JB, 2007, EUR J IMMUNOL, V37, P2364, DOI 10.1002/eji.200737709; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wen F, 2003, GENESIS, V35, P100, DOI 10.1002/gene.10169; Zhu X, 2007, AGING CELL, V6, P663, DOI 10.1111/j.1474-9726.2007.00325.x	57	83	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5836	5847		10.1074/jbc.M109.072124	http://dx.doi.org/10.1074/jbc.M109.072124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19955175	hybrid, Green Published			2022-12-27	WOS:000275327200074
J	Chinen, M; Morita, M; Fukumura, K; Tani, T				Chinen, Madoka; Morita, Misato; Fukumura, Kazuhiro; Tani, Tokio			Involvement of the Spliceosomal U4 Small Nuclear RNA in Heterochromatic Gene Silencing at Fission Yeast Centromeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; SPLICING MUTANTS; SACCHAROMYCES-CEREVISIAE; LYSINE-9 METHYLATION; HISTONE H3; CELL-CYCLE; TRI-SNRNP; DOMAINS; PROTEIN	prp13-1 is one of the mutants isolated in a screen for defective pre-mRNA splicing at a nonpermissive temperature in fission yeast Schizosaccharomyces pombe. We cloned the prp13(+) gene and found that it encodes U4 small nuclear RNA (snRNA) involved in the assembly of the spliceosome. The prp13-1 mutant produced elongated cells, a phenotype similar to cell division cycle mutants, and displays a high incidence of lagging chromosomes on anaphase spindles. The mutant is hypersensitive to the microtubule-destabilizing drug thiabendazole, supporting that prp13-1 has a defect in chromosomal segregation. We found that the prp13-1 mutation resulted in expression of the ura4(+) gene inserted in the pericentromeric heterochromatin region and reduced recruitment of the heterochromatin protein Swi6p to that region, indicating defects in the formation of pericentromeric heterochromatin, which is essential for the segregation of chromosomes, in prp13-1. The formation of centromeric heterochromatin is induced by the RNA interference (RNAi) system in S. pombe. Inprp13-1, the processing of centromeric noncoding RNAs to siRNAs, which direct the heterochromatin formation, was impaired and unprocessed noncoding RNAs were accumulated. These results suggest that U4 snRNA is required for the RNAi-directed heterochromatic gene silencing at the centromeres. In relation to the linkage between the spliceosomal U4 snRNA and the RNAi-directed formation of heterochromatin, we identified a mRNA-type intron in the centromeric noncoding RNAs. We propose a model in which the assembly of the spliceosome or a sub-spliceosome complex on the intron-containing centromeric noncoding RNAs facilitates the RNAi-directed formation of heterochromatin at centromeres, through interaction with the RNA-directed RNA polymerase complex.	[Chinen, Madoka; Morita, Misato; Fukumura, Kazuhiro; Tani, Tokio] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan	Kumamoto University	Tani, T (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan.	ttani@sci.kumamoto-u.ac.jp		Fukumura, Kazuhiro/0000-0002-3491-4500	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science Research Fellowships for Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to M. C.).	Alfa C., 1993, EXPT FISSION YEAST; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Beales M, 2000, YEAST, V16, P1001, DOI 10.1002/1097-0061(200008)16:11<1001::AID-YEA605>3.0.CO;2-6; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Burge CB, 1999, RNA WORLD, P525; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; HU J, 1995, MOL CELL BIOL, V15, P1274; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; LOCKHART SR, 1994, MOL CELL BIOL, V14, P3623, DOI 10.1128/MCB.14.6.3623; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Romfo CM, 1999, RNA, V5, P49, DOI 10.1017/S1355838299981323; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Weidenhammer EM, 1997, MOL CELL BIOL, V17, P3580, DOI 10.1128/MCB.17.7.3580; WERSIG C, 1990, NUCLEIC ACIDS RES, V18, P6223, DOI 10.1093/nar/18.21.6223; White SA, 2008, CURR TOP MICROBIOL, V320, P157	39	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5630	5638		10.1074/jbc.M109.074393	http://dx.doi.org/10.1074/jbc.M109.074393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018856	Green Published, hybrid			2022-12-27	WOS:000275327200055
J	Corazza, A; Rennella, E; Schanda, P; Mimmi, MC; Cutuil, T; Raimondi, S; Giorgetti, S; Fogolari, F; Viglino, P; Frydman, L; Gal, M; Bellotti, V; Brutscher, B; Esposito, G				Corazza, Alessandra; Rennella, Enrico; Schanda, Paul; Mimmi, Maria Chiara; Cutuil, Thomas; Raimondi, Sara; Giorgetti, Sofia; Fogolari, Federico; Viglino, Paolo; Frydman, Lucio; Gal, Maayan; Bellotti, Vittorio; Brutscher, Bernhard; Esposito, Gennaro			Native-unlike Long-lived Intermediates along the Folding Pathway of the Amyloidogenic Protein beta(2)-Microglobulin Revealed by Real-time Two-dimensional NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-MICROGLOBULIN; PHYSIOLOGICAL CONDITIONS; AGGREGATION; SPECTROSCOPY; SPECTRA	beta 2-microglobulin (beta 2m), the light chain of class I major histocompatibility complex, is responsible for the dialysis-related amyloidosis and, in patients undergoing long term dialysis, the full-length and chemically unmodified beta 2m converts into amyloid fibrils. The protein, belonging to the immunoglobulin superfamily, in common to other members of this family, experiences during its folding a long-lived intermediate associated to the trans-to-cis isomerization of Pro-32 that has been addressed as the precursor of the amyloid fibril formation. In this respect, previous studies on the W60G beta 2m mutant, showing that the lack of Trp-60 prevents fibril formation in mild aggregating condition, prompted us to reinvestigate the refolding kinetics of wild type and W60G beta 2m at atomic resolution by real-time NMR. The analysis, conducted at ambient temperature by the band selective flip angle short transient real-time two-dimensional NMR techniques and probing the beta 2m states every 15 s, revealed a more complex folding energy landscape than previously reported for wild type beta 2m, involving more than a single intermediate species, and shedding new light into the fibrillogenic pathway. Moreover, a significant difference in the kinetic scheme previously characterized by optical spectroscopic methods was discovered for the W60G beta 2m mutant.	[Corazza, Alessandra; Rennella, Enrico; Mimmi, Maria Chiara; Fogolari, Federico; Viglino, Paolo; Esposito, Gennaro] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Schanda, Paul; Cutuil, Thomas; Brutscher, Bernhard] Univ Grenoble 1, Ctr Etud Atom, UMR5075,CNRS, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 9, France; [Raimondi, Sara; Giorgetti, Sofia; Bellotti, Vittorio] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Raimondi, Sara; Giorgetti, Sofia; Bellotti, Vittorio] Fdn IRCCS, Biotechnol Lab, I-27100 Pavia, Italy; [Frydman, Lucio; Gal, Maayan] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	University of Udine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; Weizmann Institute of Science	Corazza, A (corresponding author), Univ Udine, Dept Biomed Sci & Technol, Piazzale Kolbe 4, I-33100 Udine, Italy.	alessandra.corazza@uniud.it; gennaro.esposito@uniud.it	Mimmi, Maria Chiara/K-3689-2014; Gal, Maayan/AAO-1171-2021; Mimmi, Maria Chiara/GYD-9155-2022; Schanda, Paul/A-5975-2010; Giorgetti, Sofia/AAD-4341-2019; Bellotti, Vittorio/A-6201-2014; Mimmi, Maria Chiara/AAA-4925-2020; Corazza, Alessandra/AGB-1457-2022	Gal, Maayan/0000-0003-3668-8647; Mimmi, Maria Chiara/0000-0002-5165-9230; Schanda, Paul/0000-0002-9350-7606; Giorgetti, Sofia/0000-0001-9438-6511; Bellotti, Vittorio/0000-0001-8678-662X; Mimmi, Maria Chiara/0000-0002-5165-9230; Corazza, Alessandra/0000-0003-2272-1928; Fogolari, Federico/0000-0001-9862-250X	Ministero dell'Istruzione, dell'Universita e della Ricerca [RBNE03PX83, RBRN07BMCT, PRIN 2007_XY59ZJ_002]; European Union (EU) [LSHM-CT-2005-037525]; EU-NMR [026145]; French Agence Nationale pour la Recherche [ANR-08-BLAN-0210]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Union (EU)(CGIAREuropean Commission); EU-NMR; French Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (FIRB Grant RBNE03PX83 and RBRN07BMCT and PRIN 2007_XY59ZJ_002), the European Union (EU) (EURAMY Project LSHM-CT-2005-037525; EU-NMR Contract 026145), and the French Agence Nationale pour la Recherche (Grant ANR-08-BLAN-0210).	CHENG HN, 1977, BIOPOLYMERS, V16, P1465, DOI 10.1002/bip.1977.360160707; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; Freeman R, 2003, J BIOMOL NMR, V27, P101, DOI 10.1023/A:1024960302926; Gal M, 2007, J AM CHEM SOC, V129, P1372, DOI 10.1021/ja066915g; Gal M, 2009, J BIOMOL NMR, V43, P1, DOI 10.1007/s10858-008-9284-9; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179; Malmodin D, 2005, PROG NUCL MAG RES SP, V46, P109, DOI 10.1016/j.pnmrs.2005.01.002; OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030; Sakata M, 2008, J MOL BIOL, V382, P1242, DOI 10.1016/j.jmb.2008.08.003; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7	27	51	51	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5827	5835		10.1074/jbc.M109.061168	http://dx.doi.org/10.1074/jbc.M109.061168			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028983	Green Published, hybrid			2022-12-27	WOS:000275327200073
J	Guo, JS; Hong, F; Loke, J; Yea, S; Lim, CL; Lee, U; Mann, DA; Walsh, MJ; Sninsky, JJ; Friedman, SL				Guo, Jinsheng; Hong, Feng; Loke, Johnny; Yea, Steven; Lim, Chooi Ling; Lee, Ursula; Mann, Derek A.; Walsh, Martin J.; Sninsky, John J.; Friedman, Scott L.			A DDX5 S480A Polymorphism Is Associated with Increased Transcription of Fibrogenic Genes in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P68 RNA HELICASE; ALPHA-2(I) COLLAGEN GENE; GROWTH-FACTOR BETA-1; TISSUE INHIBITOR; BINDING-PROTEIN; KUPFFER CELLS; PROMOTER; FIBROSIS; EXPRESSION; LIVER	We recently identified a missense single nucleotide polymorphism (SNP) in DDX5 (rs1140409, p.S480A) that enhances the risk of developing cirrhosis. DDX5 is an ATP-dependent RNA helicase and transcriptional modulator. We hypothesized that the activity of DDX5 in regulating fibrogenic gene transcription in hepatic stellate cells (HSCs) is altered by the S480A SNP. To test this, we employed two approaches: 1) transient overexpression of DDX5 cDNA or siRNA knockdown of endogenous DDX5, with replacement by either DDX5 wild type (WT) or SNP cDNA, or 2) stable expression of exogenous DDX5 WT and SNP in HSC lines. WT DDX5 mRNA in HSCs was inversely correlated with gene expression for alpha 2(I) collagen, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta 1. Stable DDX5 SNP-expressing cells had higher basal and transforming growth factor-beta 1-stimulated expression and enhanced promoter activities of fibrogenic genes. DDX5 variant-expressing cells also had higher Smad3 and AP-1-responsive reporter activities. In a one-hybrid GAL4 system, co-expression of the DDX5 SNP variant with chimeras of GAL4 DNA binding domain linked to JunD or Sp1 displayed higher transactivation of a GAL4-responsive reporter than that of DDX5 WT. Increased fibrogenic gene expression in DDX5 SNP-expressing cells was associated with reduced recruitment of DDX5 homodimers to responsive promoters, but there was no difference in the recruitment of the co-repressor HDAC1 (histone deacetylase 1). These data suggest that DDX5 is a repressor of fibrogenic genes in HSCs through interaction with transcriptional complexes. The enhanced fibrogenic activity of the DDX5 risk variant is linked to a reduced repressive function toward these target genes.	[Guo, Jinsheng; Hong, Feng; Loke, Johnny; Yea, Steven; Lim, Chooi Ling; Lee, Ursula; Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY 10029 USA; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Guo, Jinsheng] Fu Dan Univ, Shanghai Med Coll, Dept Internal Med, Div Digest Dis,Zhongshan Hosp, Shanghai 200032, Peoples R China; [Mann, Derek A.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Liver Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sninsky, John J.] Celera, Alameda, CA 94502 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Fudan University; Newcastle University - UK	Friedman, SL (corresponding author), Mt Sinai Sch Med, Div Liver Dis, Box 1123,1425 Madison Ave,Rm 1170C, New York, NY 10029 USA.	scott.friedman@mssm.edu		guo, Jinsheng/0000-0002-9980-8725; Mann, Derek/0000-0003-0950-243X	National Institutes of Health [DK65521]; Celera; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK065521, R01DK056621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celera; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK65521. This work was also supported by a research contract from Celera.	Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; Bambha K, 2008, HEPATOLOGY, V48, p815A; Bataller R, 2003, HEPATOLOGY, V37, P493, DOI 10.1053/jhep.2003.50127; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bertrand-Philippe M, 2004, J BIOL CHEM, V279, P24530, DOI 10.1074/jbc.M311804200; Camats M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002926; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; HUANG H, 2008, TXB HEPATOLOGY BASIC, P356; Huang HJ, 2006, GASTROENTEROLOGY, V130, P1679, DOI 10.1053/j.gastro.2006.02.032; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; INAGAKI Y, 1995, HEPATOLOGY, V22, P573, DOI 10.1016/0270-9139(95)90582-0; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; KIM SJ, 1989, J BIOL CHEM, V264, P7041; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Martinelli A, 2008, J GASTROEN HEPATOL, V23, P1403, DOI 10.1111/j.1440-1746.2007.05220.x; Nelson JE, 2007, HEPATOLOGY, V46, P723, DOI 10.1002/hep.21742; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Rossler OG, 2000, NUCLEIC ACIDS RES, V28, P932, DOI 10.1093/nar/28.4.932; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Wang JC, 2008, LEUKEMIA LYMPHOMA, V49, P2321, DOI 10.1080/10428190802527699; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Wasmuth HE, 2004, J MOL MED-JMM, V82, P64, DOI 10.1007/s00109-003-0505-0; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	46	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5428	5437		10.1074/jbc.M109.035295	http://dx.doi.org/10.1074/jbc.M109.035295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022962	Green Published, hybrid			2022-12-27	WOS:000275327200036
J	Matsuda, M; Hoshino, T; Yamashita, Y; Tanaka, K; Maji, D; Sato, K; Adachi, H; Sobue, G; Ihn, H; Funasaka, Y; Mizushima, T				Matsuda, Minoru; Hoshino, Tatsuya; Yamashita, Yasuhiro; Tanaka, Ken-ichiro; Maji, Daisuke; Sato, Keizo; Adachi, Hiroaki; Sobue, Gen; Ihn, Hironobu; Funasaka, Yoko; Mizushima, Tohru			Prevention of UVB Radiation-induced Epidermal Damage by Expression of Heat Shock Protein 70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INDUCED GASTRIC-LESIONS; BASE EXCISION-REPAIR; ULTRAVIOLET-B LIGHT; HUMAN SKIN; IN-VIVO; RECEPTOR ACTIVATION; LOCAL HYPERTHERMIA; INDUCED APOPTOSIS; GENETIC-EVIDENCE	Irradiation with UV light, especially UVB, causes epidermal damage via the induction of apoptosis, inflammatory responses, and DNA damage. Various stressors, including UV light, induce heat shock proteins (HSPs) and the induction, particularly that of HSP70, provides cellular resistance to such stressors. The anti-inflammatory activity of HSP70, such as its inhibition of nuclear factor kappa B (NF-kappa B), was recently revealed. These in vitro results suggest that HSP70 protects against UVB-induced epidermal damage. Here we tested this idea by using transgenic mice expressing HSP70 and cultured keratinocytes. Irradiation of wild-type mice with UVB caused epidermal damage such as induction of apoptosis, which was suppressed in transgenic mice expressing HSP70. UVB-induced apoptosis in cultured keratinocytes was suppressed by overexpression of HSP70. Irradiation of wild-type mice with UVB decreased the cutaneous level of I kappa B-alpha (an inhibitor of NF-kappa B) and increased the infiltration of leukocytes and levels of pro-inflammatory cytokines and chemokines in the epidermis. These inflammatory responses were suppressed in transgenic mice expressing HSP70. In vitro, the overexpression of HSP70 suppressed the expression of pro-inflammatory cytokines and chemokines and increased the level of I kappa B-alpha in keratinocytes irradiated with UVB. UVB induced an increase in cutaneous levels of cyclobutane pyrimidine dimers and 8-hydroxy-2'-deoxyguanosine, both of which were suppressed in transgenic mice expressing HSP70. This study provides genetic evidence that HSP70 protects the epidermis from UVB-induced radiation damage. The findings here also suggest that the protective action of HSP70 is mediated by anti-apoptotic, anti-inflammatory, and anti-DNA damage effects.	[Matsuda, Minoru; Hoshino, Tatsuya; Yamashita, Yasuhiro; Tanaka, Ken-ichiro; Sato, Keizo; Ihn, Hironobu; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Maji, Daisuke] Saishunkan Pharmaceut Co Ltd, Kumamoto 8612201, Japan; [Funasaka, Yoko] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Kumamoto University; Kobe University; Nagoya University	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Hon Machi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020; Tanaka, Ken-ichiro/J-8557-2013	Adachi, Hiroaki/0000-0002-9302-4663; 	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Health, Labour, and Welfare of Japan, as well as the Japan Science and Technology Agency, grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Bases R, 2006, CELL STRESS CHAPERON, V11, P240, DOI 10.1379/CSC-185R.1; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNET S, 1989, MUTAT RES, V219, P217, DOI 10.1016/0921-8734(89)90003-9; Budiyanto A, 2000, CARCINOGENESIS, V21, P2085, DOI 10.1093/carcin/21.11.2085; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Guo SH, 2007, CELL STRESS CHAPERON, V12, P245, DOI 10.1379/CSC-265.1; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Ishihara T, 2009, J PHARMACOL EXP THER, V328, P152, DOI 10.1124/jpet.108.144451; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jantschitsch C, 2003, PHOTOCH PHOTOBIO SCI, V2, P899, DOI 10.1039/b301253k; Jonak C., 2006, International Journal of Cosmetic Science, V28, P233, DOI 10.1111/j.1467-2494.2006.00327.x; KANE KS, 1995, J INVEST DERMATOL, V104, P62, DOI 10.1111/1523-1747.ep12613497; Kenny MK, 2001, J BIOL CHEM, V276, P9532, DOI 10.1074/jbc.M009297200; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; MAYTIN EV, 1994, J INVEST DERMATOL, V103, P547, DOI 10.1111/1523-1747.ep12396274; Mendez F, 2003, CELL STRESS CHAPERON, V8, P153, DOI 10.1379/1466-1268(2003)008<0153:HSPSOT>2.0.CO;2; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morris SD, 2002, CLIN EXP DERMATOL, V27, P220, DOI 10.1046/j.1365-2230.2002.01012.x; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Ohkawara T, 2006, INT J MOL MED, V17, P229; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Sato K, 2002, FASEB J, V16, P1713, DOI 10.1096/fj.02-0331com; SATO K, 1992, J BIOL CHEM, V267, P25371; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Takashima A, 1996, PHOTOCHEM PHOTOBIOL, V63, P397, DOI 10.1111/j.1751-1097.1996.tb03054.x; Tanaka K, 2005, J PHARMACOL EXP THER, V315, P624, DOI 10.1124/jpet.105.088674; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; TRAUTINGER F, 1993, J INVEST DERMATOL, V101, P334, DOI 10.1111/1523-1747.ep12365491; Trautinger F, 1996, J INVEST DERMATOL, V107, P442, DOI 10.1111/1523-1747.ep12365498; TRAUTINGER F, 1995, J INVEST DERMATOL, V105, P160, DOI 10.1111/1523-1747.ep12317003; Trautinger F, 1999, EXP DERMATOL, V8, P187, DOI 10.1111/j.1600-0625.1999.tb00369.x; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Zhou XW, 1998, J INVEST DERMATOL, V111, P194, DOI 10.1046/j.1523-1747.1998.00266.x; Zou Y, 1998, J BIOL CHEM, V273, P12887, DOI 10.1074/jbc.273.21.12887; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	57	56	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5848	5858		10.1074/jbc.M109.063453	http://dx.doi.org/10.1074/jbc.M109.063453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018843	hybrid, Green Published			2022-12-27	WOS:000275327200075
J	Rodionov, RN; Murry, DJ; Vaulman, SF; Stevens, JW; Lentz, SR				Rodionov, Roman N.; Murry, Daryl J.; Vaulman, Sarah F.; Stevens, Jeff W.; Lentz, Steven R.			Human Alanine-Glyoxylate Aminotransferase 2 Lowers Asymmetric Dimethylarginine and Protects from Inhibition of Nitric Oxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HYPEROXALURIA TYPE-1; RAT-KIDNEY; DIMETHYLAMINOHYDROLASE DDAH; SYNTHASE PATHWAY; HEPATIC ALANINE; MITOCHONDRIA; NG,NG-DIMETHYLARGININE; PURIFICATION; HYPERTENSION; METABOLISM	Elevated blood concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric-oxide (NO) synthase, are found in association with diabetes, hypertension, congestive heart failure, and atherosclerosis. ADMA levels are controlled by dimethylarginine dimethylaminohydrolases (DDAHs), cytosolic enzymes that hydrolyze ADMA to citrulline and dimethylamine. ADMA also has been proposed to be regulated through an alternative pathway by alanine-glyoxylate aminotransferase 2 (AGXT2), a mitochondrial aminotransferase expressed primarily in the kidney. The goal of this study was to define the subcellular localization of human AGXT2 and test the hypothesis that overexpression of human AGXT2 protects from ADMA-induced inhibition in nitric oxide (NO) production. AGXT2 was cloned from human kidney cDNA and overexpressed in COS-7 cells and human umbilical vein endothelial cells with a C-terminal FLAG epitope tag. Mitochondrial localization of human AGXT2 was demonstrated by confocal microscopy and a 41-amino acid N-terminal mitochondrial cleavage sequence was delineated by N-terminal sequencing of the mature protein. Overexpression of human AGXT2 in the liver of C57BL/6 mice using an adenoviral expression vector produced significant decreases in ADMA levels in plasma and liver. Overexpression of human AGXT2 also protected endothelial cells from ADMA-mediated inhibition of NO production. We conclude that mitochondrially localized human AGXT2 is able to effectively metabolize ADMA in vivo resulting in decreased ADMA levels and improved endothelial NO production.	[Rodionov, Roman N.; Vaulman, Sarah F.; Stevens, Jeff W.; Lentz, Steven R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Murry, Daryl J.] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Rodionov, Roman N.] Tech Univ Dresden, Univ Ctr Vasc Med, Univ Hosp Carl Gustav Carus, Div Angiol,Dept Med 3, D-01307 Dresden, Germany	University of Iowa; University of Iowa; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Lentz, SR (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	steven-lentz@uiowa.edu	Rodionov, Roman/E-1476-2012	Lentz, Steven/0000-0002-8885-4718	National Institutes of Health [HL63943, NS24621]; Office of Research and Development, United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63943 and NS24621. This work was also supported by the Office of Research and Development, United States Department of Veterans Affairs.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Boger RH, 2005, VASC MED, V10, pS1, DOI 10.1191/1358863xvm594ed; Cooper AJL, 2003, BIOCHEM J, V376, P169, DOI 10.1042/BJ20030988; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DANPURE CJ, 1989, J CELL BIOL, V108, P1345, DOI 10.1083/jcb.108.4.1345; Dayal S, 2008, AM J PHYSIOL-HEART C, V295, pH816, DOI 10.1152/ajpheart.01348.2007; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; Hartzoulakis B, 2007, BIOORG MED CHEM LETT, V17, P3953, DOI 10.1016/j.bmcl.2007.04.095; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; Jacobi J, 2008, AM J PHYSIOL-HEART C, V294, pH1058, DOI 10.1152/ajpheart.01103.2007; Kaschnitz R M, 1979, Methods Enzymol, V55, P79; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; KIMOTO M, 1995, J BIOCHEM-TOKYO, V117, P237, DOI 10.1093/jb/117.2.237; KONTANI Y, 1993, BIOCHIM BIOPHYS ACTA, V1156, P161, DOI 10.1016/0304-4165(93)90131-Q; LEE ISM, 1995, J BIOCHEM, V117, P856, DOI 10.1093/oxfordjournals.jbchem.a124787; Lee ISM, 1999, NEPHRON, V83, P184, DOI 10.1159/000045507; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Matsuguma K, 2006, J AM SOC NEPHROL, V17, P2176, DOI 10.1681/ASN.2005121379; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NOGUCHI T, 1978, BIOCHEM J, V169, P113, DOI 10.1042/bj1690113; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; OGAWA T, 1990, J BIOL CHEM, V265, P20938; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Rodionov RN, 2008, ARTERIOSCL THROM VAS, V28, P1031, DOI 10.1161/ATVBAHA.108.164830; ROWSELL EV, 1972, BIOCHEM J, V127, P155, DOI 10.1042/bj1270155; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; TAKADA Y, 1982, COMP BIOCHEM PHYS B, V72, P597, DOI 10.1016/0305-0491(82)90512-0; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vasquez EC, 1998, EXP NEUROL, V154, P353, DOI 10.1006/exnr.1998.6917; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	38	90	96	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5385	5391		10.1074/jbc.M109.091280	http://dx.doi.org/10.1074/jbc.M109.091280			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018850	Green Published, hybrid			2022-12-27	WOS:000275327200032
J	Chan, HL; Chou, HC; Duran, M; Gruenewald, J; Waterfield, MD; Ridley, A; Timms, JF				Chan, Hong-Lin; Chou, Hsiu-Chuan; Duran, MaCarmen; Gruenewald, Jana; Waterfield, Michael D.; Ridley, Anne; Timms, John F.			Major Role of Epidermal Growth Factor Receptor and Src Kinases in Promoting Oxidative Stress-dependent Loss of Adhesion and Apoptosis in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; TYROSINE PHOSPHORYLATION; C-SRC; REDOX REGULATION; PHOSPHATIDYLINOSITOL 3-KINASE; REVERSIBLE INACTIVATION; ERBB-2 OVEREXPRESSION; GEL-ELECTROPHORESIS	A growing body of evidence suggests that reactive oxygen species are critical components of cell signaling pathways, in particular regulating protein phosphorylation events. Here, we show that oxidative stress in response to hydrogen peroxide treatment of human epithelial cells induces robust tyrosine phosphorylation on multiple proteins. Using an anti-phosphotyrosine purification and liquid chromatography-tandem mass spectrometry approach, we have identified many of these H2O2-induced tyrosine-phosphorylated proteins. Importantly, we show that epidermal growth factor receptor (EGFR) and Src are the primary upstream kinases mediating these events through their redox activation. The finding that many of the identified proteins have functions in cell adhesion, cell-cell junctions, and the actin cytoskeleton prompted us to examine stress-induced changes in adhesion. Immunofluorescence analysis showed that H2O2 alters cell adhesion structures and the actin cytoskeleton causing loss of adhesion and apoptosis. Remarkably, these cellular changes could be attenuated by inhibition of EGFR and Src, identifying these kinases as targets to block oxidative damage. In summary, our data demonstrate that EGFR and Src together play a central role in oxidative stress-induced phosphorylation, which in turn results in loss of adhesion, morphological changes, and cell damage in epithelial cells. These data also provide a general model for redox signaling in other cell systems.	[Timms, John F.] UCL, Canc Prote Lab, EGA Inst Womens Hlth, London WC1E 6BT, England; [Chan, Hong-Lin] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Chan, Hong-Lin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Chou, Hsiu-Chuan; Gruenewald, Jana; Ridley, Anne] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Waterfield, Michael D.] Ludwig Inst Canc Res, London W1W 7BS, England; [Chou, Hsiu-Chuan] Ind Technol Res Inst, Hsinchu 31040, Taiwan	University of London; University College London; National Tsing Hua University; National Tsing Hua University; University of London; King's College London; Ludwig Institute for Cancer Research; Industrial Technology Research Institute - Taiwan	Timms, JF (corresponding author), UCL, Canc Prote Lab, EGA Inst Womens Hlth, Cruciform Bldg,1-1-09,Gower St, London WC1E 6BT, England.	jtimms@wibr.ucl.ac.uk	Duran, MCarmen/K-8898-2012; DURAN-RUIZ, MCarmen/N-1426-2015; Duran, Carmen M/P-4175-2017; Timms, John/A-1556-2010	DURAN-RUIZ, MCarmen/0000-0003-3954-3734; Duran, Carmen M/0000-0003-3954-3734; Timms, John/0000-0002-4507-835X; Ridley, Anne/0000-0001-8186-5708	EMF Biological Research Trust [BRT 06/28]; Association for International Cancer Research [05-426]; European Union [FP6 LSHC-CT-2003-502935]; National Science Council of Taiwan [97-2311-B-007-005]; Eve Appeal; Department of Health National Institute for Health Research Biomedical Research Centres	EMF Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Association for International Cancer Research; European Union(European Commission); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Eve Appeal; Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	This work was supported by grants from the EMF Biological Research Trust Grant BRT 06/28, the Association for International Cancer Research Grant 05-426, European Union Grants FP6 LSHC-CT-2003-502935, National Science Council of Taiwan Grant 97-2311-B-007-005, and from the Eve Appeal. This work was undertaken at University College London Hospital/University College London that received a portion of funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boardman KC, 2004, J CELL PHYSIOL, V199, P57, DOI 10.1002/jcp.10451; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chan HL, 2005, PROTEOMICS, V5, P2908, DOI 10.1002/pmic.200401300; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gharbi S, 2002, MOL CELL PROTEOMICS, V1, P91, DOI 10.1074/mcp.T100007-MCP200; Gomez S, 1999, BBA-MOL CELL RES, V1452, P121, DOI 10.1016/S0167-4889(99)00124-X; Gozin A, 1998, FREE RADICAL BIO MED, V25, P1021, DOI 10.1016/S0891-5849(98)00134-8; Guo J, 2003, NEUROSCI LETT, V345, P101, DOI 10.1016/S0304-3940(03)00483-X; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Irby RB, 2002, CANCER RES, V62, P2669; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2004, BIOCHEM SOC T, V32, P1018, DOI 10.1042/BST0321018; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pu MY, 1996, ONCOGENE, V13, P2615; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; RHEE SG, 2000, SCI STKE, pE1; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; STAMPS AC, 1994, INT J CANCER, V57, P865, DOI 10.1002/ijc.2910570616; SULLIVAN SG, 1994, FREE RADICAL BIO MED, V16, P399, DOI 10.1016/0891-5849(94)90042-6; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Timms JF, 2002, ONCOGENE, V21, P6573, DOI 10.1038/sj.onc.1205847; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; van Wetering S, 2002, J CELL SCI, V115, P1837; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; White SL, 2004, BRIT J CANCER, V90, P173, DOI 10.1038/sj.bjc.6601458; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	50	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4307	4318		10.1074/jbc.M109.047027	http://dx.doi.org/10.1074/jbc.M109.047027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996095	Green Published, hybrid			2022-12-27	WOS:000275274800007
J	Kesavan, K; Ratliff, J; Johnson, EW; Dahlberg, W; Asara, JM; Misra, P; Frangioni, JV; Jacoby, DB				Kesavan, Kamala; Ratliff, Judson; Johnson, Eric W.; Dahlberg, William; Asara, John M.; Misra, Preeti; Frangioni, John V.; Jacoby, Douglas B.			Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; HIGH-GRADE GLIOMA; PDGF-C; CANCER-CELLS; MATRIX METALLOPROTEINASE-2; HEPATOCELLULAR-CARCINOMA; ALPHA-RECEPTOR; VEGF TREATMENT; BRAIN-TUMORS; IN-VITRO	TM601 is a synthetic form of chlorotoxin, a 36-amino acid peptide derived from the venom of the Israeli scorpion, Leirius quinquestriatus, initially found to specifically bind and inhibit the migration of glioma cells in culture. Subsequent studies demonstrated specific in vitro binding to additional tumor cell lines. Recently, we demonstrated that proliferating human vascular endothelial cells are the only normal cell line tested that exhibits specific binding to TM601. Here, we identify annexin A2 as a novel binding partner for TM601 in multiple human tumor cell lines and human umbilical vein endothelial cell (HUVEC). We demonstrate that the surface binding of TM601 to the pancreatic tumor cell line Panc-1 is dependent on the expression of annexin A2. Identification of annexin A2 as a binding partner for TM601 is also consistent with the anti-angiogenic effects of TM601. Annexin A2 functions in angiogenesis by binding to tissue plasminogen activator and regulating plasminogen activation on vascular endothelial cells. We demonstrate that in HUVECs, TM601 inhibits both vascular endothelial growth factor-and basic fibroblast growth factor-induced tissue plasminogen activator activation, which is required for activation of plasminogen to plasmin. Consistent with inhibition of cell surface protease activity, TM601 also inhibits platelet-derived growth factor-C induced trans-well migration of both HUVEC and U373-MG glioma cells.	[Kesavan, Kamala; Ratliff, Judson; Johnson, Eric W.; Dahlberg, William; Jacoby, Douglas B.] TransMol Inc, Cambridge, MA 02139 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Jacoby, DB (corresponding author), TransMol Inc, Cambridge, MA 02139 USA.	jacoby@transmolecular.com						Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Diaz VM, 2004, GUT, V53, P993, DOI 10.1136/gut.2003.026831; Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; GIBBIN TE, 2009, J CLIN ONCOL, V27; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Inokuchi J, 2009, INT J CANCER, V124, P68, DOI 10.1002/ijc.23928; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; JACOBY DB, 2010, ANTICANCER IN PRESS, V30; Le DM, 2003, J NEUROSCI, V23, P4034; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lokker NA, 2002, CANCER RES, V62, P3729; Lyons SA, 2002, GLIA, V39, P162, DOI 10.1002/glia.10083; Mamelak AN, 2007, EXPERT OPIN DRUG DEL, V4, P175, DOI 10.1517/17425247.4.2.175; Mamelak AN, 2006, J CLIN ONCOL, V24, P3644, DOI 10.1200/JCO.2005.05.4569; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Misra P, 2007, J NUCL MED, V48, P1379, DOI 10.2967/jnumed.107.040303; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Nygaard SJT, 1998, J NEURO-ONCOL, V38, P11, DOI 10.1023/A:1005953000523; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; REEVES SA, 1992, CANCER RES, V52, P6871; ROSEMAN BJ, 1994, ONCOL RES, V6, P561; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Ullrich N, 1995, NEUROREPORT, V7, P343, DOI 10.1097/00001756-199512290-00082; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948; Yu GR, 2007, EXP MOL MED, V39, P641, DOI 10.1038/emm.2007.70; Zhong LP, 2009, ARCH ORAL BIOL, V54, P17, DOI 10.1016/j.archoralbio.2008.08.006; Zimmermann U, 2004, VIRCHOWS ARCH, V445, P368, DOI 10.1007/s00428-004-1103-4	39	105	114	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4366	4374		10.1074/jbc.M109.066092	http://dx.doi.org/10.1074/jbc.M109.066092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018898	Green Published, hybrid			2022-12-27	WOS:000275274800013
J	Graziani, A; Poteser, M; Heupel, WM; Schleifer, H; Krenn, M; Drenckhahn, D; Romanin, C; Baumgartner, W; Groschner, K				Graziani, Annarita; Poteser, Michael; Heupel, Wolfgang-Moritz; Schleifer, Hannes; Krenn, Martin; Drenckhahn, Detlev; Romanin, Christoph; Baumgartner, Werner; Groschner, Klaus			Cell-Cell Contact Formation Governs Ca2+ Signaling by TRPC4 in the Vascular Endothelium EVIDENCE FOR A REGULATORY TRPC4-beta-CATENIN INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; OPERATED CALCIUM-ENTRY; SURFACE EXPRESSION; ALPHA-CATENIN; VE-CADHERIN; CHANNELS; PROLIFERATION; PERMEABILITY; ADHESION; COMPLEX	TRPC4 is well recognized as a prominent cation channel in the vascular endothelium, but its contribution to agonist-induced endothelial Ca2+ entry is still a matter of controversy. Here we report that the cellular targeting and Ca2+ signaling function of TRPC4 is determined by the state of cell-cell adhesions during endothelial phenotype transitions. TRPC4 surface expression in human microvascular endothelial cells (HMEC-1) increased with the formation of cell-cell contacts. Epidermal growth factor recruited TRPC4 into the plasma membrane of proliferating cells but initiated retrieval of TRPC4 from the plasma membrane in quiescent, barrier-forming cells. Epidermal growth factor-induced Ca2+ entry was strongly promoted by the formation of cell-cell contacts, and both siRNA and dominant negative knockdown experiments revealed that TRPC4 mediates stimulated Ca2+ entry exclusively in proliferating clusters that form immature cell-cell contacts. TRPC4 co-precipitated with the junctional proteins beta-catenin and VE-cadherin. Analysis of cellular localization of fluorescent fusion proteins provided further evidence for recruitment of TRPC4 into junctional complexes. Analysis of TRPC4 function in the HEK293 expression system identified beta-catenin as a signaling molecule that enables cell-cell contact-dependent promotion of TRPC4 function. Our results place TRPC4 as a Ca2+ entry channel that is regulated by cell-cell contact formation and interaction with beta-catenin. TRPC4 is suggested to serve stimulated Ca2+ entry in a specific endothelial state during the transition from a proliferating to a quiescent phenotype. Thus, TRPC4 may adopt divergent, as yet unappreciated functions in endothelial Ca2+ homeostasis and emerges as a potential key player in endothelial phenotype switching and tuning of cellular growth factor signaling.	[Graziani, Annarita; Poteser, Michael; Schleifer, Hannes; Krenn, Martin; Groschner, Klaus] Graz Univ, Inst Pharmaceut Sci Pharmacol & Toxicol, A-8010 Graz, Austria; [Heupel, Wolfgang-Moritz; Drenckhahn, Detlev] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Baumgartner, Werner] Rhein Westfal TH Aachen, Inst Biol 2, Dept Cellular Neurobion, D-52056 Aachen, Germany	University of Graz; University of Wurzburg; Johannes Kepler University Linz; RWTH Aachen University	Groschner, K (corresponding author), Graz Univ, Inst Pharmaceut Sci Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	klaus.groschner@uni-graz.at	Groschner, Klaus/A-2550-2010; Romanin, Christoph/D-5399-2009; Baumgartner, Werner/C-5013-2012	Groschner, Klaus/0000-0002-8659-377X; Romanin, Christoph/0000-0003-3756-4136; Baumgartner, Werner/0000-0002-3160-2050; Poteser, Michael/0000-0002-9962-1098	FWF [P19820, P18475, P18169]	FWF(Austrian Science Fund (FWF))	This work was supported by FWF (Austrian Science Fund) Projects P19820 (to K. G.), P18475 (to M. P.), and P18169 (to C. R.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Flockerzi V, 2005, PFLUG ARCH EUR J PHY, V451, P81, DOI 10.1007/s00424-005-1443-1; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Giannini AL, 2000, EXP CELL RES, V255, P207, DOI 10.1006/excr.1999.4785; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; Heupel WM, 2009, J CELL SCI, V122, P1616, DOI 10.1242/jcs.040212; Kamei J, 2003, BIOCHEM BIOPH RES CO, V312, P380, DOI 10.1016/j.bbrc.2003.10.129; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kuang HB, 2009, FRONT BIOSCI-LANDMRK, V14, P2212, DOI 10.2741/3373; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Mery L, 2002, J CELL SCI, V115, P3497; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Vestweber D, 2000, J PATHOL, V190, P281; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wakabayashi I, 2006, J VASC RES, V43, P238, DOI 10.1159/000091235; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	32	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4213	4223		10.1074/jbc.M109.060301	http://dx.doi.org/10.1074/jbc.M109.060301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996314	hybrid, Green Published			2022-12-27	WOS:000275254000073
J	Guce, AI; Clark, NE; Salgado, EN; Ivanen, DR; Kulminskaya, AA; Brumer, H; Garman, SC				Guce, Abigail I.; Clark, Nathaniel E.; Salgado, Eric N.; Ivanen, Dina R.; Kulminskaya, Anna A.; Brumer, Harry, III; Garman, Scott C.			Catalytic Mechanism of Human alpha-Galactosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; CRYSTAL-STRUCTURE; TRANSITION-STATE; FABRY-DISEASE; PHANEROCHAETE-CHRYSOSPORIUM; STRUCTURAL-ANALYSIS; MOLECULAR-BASIS; MANNOSIDASE-II; GLYCOSIDASE; INSIGHTS	The enzyme alpha-galactosidase (alpha-GAL, also known as alpha-GAL A; E.C. 3.2.1.22) is responsible for the breakdown of alpha-galactosides in the lysosome. Defects in human alpha-GAL lead to the development of Fabry disease, a lysosomal storage disorder characterized by the buildup of alpha-galactosylated substrates in the tissues. alpha-GAL is an active target of clinical research: there are currently two treatment options for Fabry disease, recombinant enzyme replacement therapy (approved in the United States in 2003) and pharmacological chaperone therapy (currently in clinical trials). Previously, we have reported the structure of human alpha-GAL, which revealed the overall structure of the enzyme and established the locations of hundreds of mutations that lead to the development of Fabry disease. Here, we describe the catalytic mechanism of the enzyme derived from x-ray crystal structures of each of the four stages of the double displacement reaction mechanism. Use of a difluoro-alpha-galactopyranoside allowed trapping of a covalent intermediate. The ensemble of structures reveals distortion of the ligand into a S-1(3) skew (or twist) boat conformation in the middle of the reaction cycle. The high resolution structures of each step in the catalytic cycle will allow for improved drug design efforts on alpha-GAL and other glycoside hydrolase family 27 enzymes by developing ligands that specifically target different states of the catalytic cycle. Additionally, the structures revealed a second ligand-binding site suitable for targeting by novel pharmacological chaperones.	[Clark, Nathaniel E.; Salgado, Eric N.; Garman, Scott C.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Guce, Abigail I.; Garman, Scott C.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Ivanen, Dina R.; Kulminskaya, Anna A.] Russian Acad Sci, Petersburg Nucl Phys Inst, Mol & Radiat Biophys Div, Gatchina 188300, Russia; [Brumer, Harry, III] Royal Insitute Technol KTH, Dept Biotechnol, S-10691 Stockholm, Sweden	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Russian Academy of Sciences	Garman, SC (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	garman@biochem.umass.edu	Kulminskaya, Anna A/Q-9948-2016	Kulminskaya, Anna A/0000-0002-3481-0007	National Institutes of Health [R01 DK76877]; National Science Foundation Integrative Graduate Education and Research Traineeship [0654128]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK76877 (to S. C. G.) and by National Science Foundation Integrative Graduate Education and Research Traineeship 0654128 (to N. E. C.).	[Anonymous], 2014, METABOLIC MOL BASES; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; Brady RO, 2003, ACTA PAEDIATR, V92, P19, DOI 10.1080/08035320310000401; Brady RO, 2003, PHILOS T ROY SOC B, V358, P915, DOI 10.1098/rstb.2003.1269; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chrost B, 2007, PLANTA, V225, P311, DOI 10.1007/s00425-006-0350-9; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2007, ACTA PAEDIATR, V96, P6, DOI 10.1111/j.1651-2227.2007.00198.x; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Hart DO, 2000, BIOCHEMISTRY-US, V39, P9826, DOI 10.1021/bi0008074; Heck MP, 2004, J AM CHEM SOC, V126, P1971, DOI 10.1021/ja037822r; Holton J.B., 2000, METABOLIC MOL BASES, P1553; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawatkar SP, 2006, J AM CHEM SOC, V128, P8310, DOI 10.1021/ja061216p; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2003, J MICROBIOL BIOTECHN, V13, P313; LIEBERMAN RL, 2009, BIOCHEMISTRY; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Ly HD, 2000, CARBOHYD RES, V329, P539, DOI 10.1016/S0008-6215(00)00214-7; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Olsson ML, 2008, BRIT J HAEMATOL, V140, P3, DOI 10.1111/j.1365-2141.2007.06839.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REID JSG, 1992, BIOCHEM SOC T, V20, P23, DOI 10.1042/bst0200023; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Stoddart J.F., 1971, STEREOCHEMISTRY CARB; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wicki J, 2007, J AM CHEM SOC, V129, P4530, DOI 10.1021/ja0707254; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	52	88	92	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3625	3632		10.1074/jbc.M109.060145	http://dx.doi.org/10.1074/jbc.M109.060145			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940122	Green Published, hybrid			2022-12-27	WOS:000275254000014
J	Hirano, M; Takeuchi, Y; Aoki, T; Yanagida, T; Ide, T				Hirano, Minako; Takeuchi, Yuko; Aoki, Takaaki; Yanagida, Toshio; Ide, Toru			Rearrangements in the KcsA Cytoplasmic Domain Underlie Its Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-ION CHANNELS; FULL-LENGTH KCSA; POTASSIUM-CHANNEL; SELECTIVITY FILTER; FLUORESCENCE; CONFORMATION; CONDUCTION; PROTEINS; DYNAMICS	A change of cytosolic pH 7 to 4 opens the bacterial potassium channel KcsA. However, the overall gating mechanism leading to channel opening, especially the contribution of the cytoplasmic domain, remains unsolved. Here we report that deletion of the cytoplasmic domain resulted in changes in channel conductance and gating behavior at pH 4 without channel opening at pH 7. To probe for rearrangements in the cytoplasmic domain during channel opening, amino acid residues were substituted with cysteines and labeled with a fluorophore (tetramethylrhodamine maleimide) that exhibits increased fluorescence intensity upon transfer from a hydrophilic to hydrophobic environment. In all cases channel open probability (P-o) was similar to 1 at pH 4 and similar to 0 at pH 7. Major increases in fluorescence intensity were observed for tetramethylrhodamine maleimide-labeled residues in the cytoplasmic domain as pH changed from 7 to 4, which suggests the fluorophores shifted from a hydrophilic to hydrophobic environment. Dipicrylamide, a lipid soluble quencher, reduced the fluorescence intensities of labeled residues in the cytosolic domain at pH 4. These results reveal that a decrease in pH introduces major conformational rearrangements associated with channel opening in the KcsA cytoplasmic domain.	[Hirano, Minako; Takeuchi, Yuko; Aoki, Takaaki; Yanagida, Toshio; Ide, Toru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Ide, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	ide@phys1.med.osaka-u.ac.jp	Ide, Toru/L-7110-2015	Hirano, Minako/0000-0002-7246-0087	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Molecular and System Life Science and Innovative Nanoscience of Supermolecular Motor Proteins Working in Biomembranes) and the Hayashi Memorial Foundation for Female Natural Scientists.	Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chakrapani S, 2007, NAT STRUCT MOL BIOL, V14, P180, DOI 10.1038/nsmb0307-180; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Corvini PFX, 2000, MICROBIOL-SGM, V146, P2671, DOI 10.1099/00221287-146-10-2671; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ide T, 1999, BIOCHEM BIOPH RES CO, V265, P595, DOI 10.1006/bbrc.1999.1720; Ide T, 2002, SINGLE MOL, V3, P33, DOI 10.1002/1438-5171(200204)3:1<33::AID-SIMO33>3.0.CO;2-U; Iwamoto M, 2006, J BIOL CHEM, V281, P28379, DOI 10.1074/jbc.M602018200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106	23	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3777	3783		10.1074/jbc.M109.084368	http://dx.doi.org/10.1074/jbc.M109.084368			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959477	Green Published, hybrid			2022-12-27	WOS:000275254000030
J	Marchenko, S; Chernyavsky, AI; Arredondo, J; Gindi, V; Grando, SA				Marchenko, Steve; Chernyavsky, Alexander I.; Arredondo, Juan; Gindi, Vivian; Grando, Sergei A.			Antimitochondrial Autoantibodies in Pemphigus Vulgaris A MISSING LINK IN DISEASE PATHOPHYSIOLOGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BASAL-CELL SHRINKAGE; SIGNALING PATHWAYS; APOPTOTIC MECHANISM; DNA ANTIBODIES; MESSENGER-RNA; NITRIC-OXIDE; FAS-LIGAND; ACANTHOLYSIS; ACTIVATION	A loss of epidermal cohesion in pemphigus vulgaris (PV) results from autoantibody action on keratinocytes (KCs) activating the signaling kinases and executioner caspases that damage KCs, causing their shrinkage, detachment from neighboring cells, and rounding up (apoptolysis). In this study, we found that PV antibody binding leads to activation of epidermal growth factor receptor kinase, Src, p38 MAPK, and JNK in KCs with time pattern variations from patient to patient. Both extrinsic and intrinsic apoptotic pathways were also activated. Although Fas ligand neutralizing antibody could inhibit the former pathway, the mechanism of activation of the latter remained unknown. PV antibodies increased cytochrome c release, suggesting damage to mitochondria. The immunoblotting experiments revealed penetration of PVIgG into the subcellular mitochondrial fraction. The antimitochondrial antibodies from different PV patients recognized distinct combinations of antigens with apparent molecular sizes of 25, 30, 35, 57, 60, and 100 kDa. Antimitochondrial antibodies were pathogenic because their absorption abolished the ability of PVIgG to cause keratinocyte detachment both in vitro and in vivo. The downstream signaling of antimitochondrial antibodies involved JNK and late p38 MAPK activation, whereas the signaling of anti-desmoglein 3 (Dsg3) antibody involved JNK and biphasic p38 MAPK activation. Using KCs grown from Dsg3(-/-) mice, we determined that Dsg3 did not serve as a surrogate antigen allowing antimitochondrial antibodies to enter KCs. The PVIgG-induced activation of epidermal growth factor receptor and Src was affected neither in Dsg3(-/-) KCs nor due to absorption of antimitochondrial antibodies. These results demonstrated that apoptolysis in PV is a complex process initiated by at least three classes of autoantibodies directed against desmosomal, mitochondrial, and other keratinocyte self-antigens. These autoantibodies synergize with the proapoptotic serum and tissue factors to trigger both extrinsic and intrinsic pathways of cell death and break the epidermal cohesion, leading to blisters. Further elucidation of the primary signaling events downstream of PV autoantigens will be crucial for the development of a more successful therapy for PV patients.	[Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu			National Institutes of Health [GM62136]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62136 (to S. A. G.). A preliminary account was presented at the 69th Annual Meeting of the Society for Investigative Dermatology, Montreal, Canada, May 6-9, 2009, and published in the form of an abstract (Chernyavsky, A. I., Arredondo, J., and Grando, S. A. (2009) J. Invest. Dermatol. 129, Suppl. S11 (Abstr. 64)).	Alascon-Segovia D, 1998, J Autoimmun, V11, P509, DOI 10.1006/jaut.1998.0238; Alecu M, 1999, Roum Arch Microbiol Immunol, V58, P121; Ameglio F, 1999, J BIOL REG HOMEOS AG, V13, P220; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Baroni A, 2002, DERMATOLOGY, V205, P116, DOI 10.1159/000063895; Barwise JL, 1996, J CELL SCI, V109, P247; Bastian Boris C., 1994, Journal of Dermatological Science, V8, P194, DOI 10.1016/0923-1811(94)90054-X; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Bhol KC, 2001, CLIN IMMUNOL, V100, P172, DOI 10.1006/clim.2001.5061; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Cirillo N, 2007, J CELL PHYSIOL, V212, P563, DOI 10.1002/jcp.21111; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Fearnley Ian M, 2007, Methods Mol Biol, V357, P103; Feliciani C, 2003, EXP DERMATOL, V12, P466, DOI 10.1034/j.1600-0625.2002.120415.x; Feliciani C, 2000, J INVEST DERMATOL, V114, P71, DOI 10.1046/j.1523-1747.2000.00835.x; Frusic-Zlotkin M, 2005, ANN NY ACAD SCI, V1050, P371, DOI 10.1196/annals.1313.040; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; GEOGHEGAN W, 1992, J INVEST DERMATOL, V98, P589; Gheorghe Emma, 2005, Rom J Morphol Embryol, V46, P73; Golan TD, 1997, LUPUS, V6, P18, DOI 10.1177/096120339700600103; Golan TD, 1997, LEUKEMIA, V11, P6, DOI 10.1038/sj.leu.2400519; GOLAN TD, 1993, J INVEST DERMATOL, V100, P316, DOI 10.1111/1523-1747.ep12469994; GRANDO SA, 1989, AUTOIMMUNITY, V3, P247, DOI 10.3109/08916938908997095; GRANDO SA, 1991, CLIN EXP DERMATOL, V16, P359, DOI 10.1111/j.1365-2230.1991.tb00401.x; GRANDO SA, 1989, ARCH DERMATOL, V125, P925, DOI 10.1001/archderm.125.7.925; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando Sergei A., 1992, Journal of Dermatological Science, V4, P95, DOI 10.1016/0923-1811(92)90065-J; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Ishibashi H, 2005, SEMIN LIVER DIS, V25, P337, DOI 10.1055/s-2005-916325; Lanza A, 2007, BRIT J DERMATOL, V156, P400, DOI 10.1111/j.1365-2133.2006.07654.x; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Lim PL, 2006, IMMUNOL LETT, V103, P17, DOI 10.1016/j.imlet.2005.10.023; LOTTI RES, 2009, J INVEST DERMATO S14, V129; Marquina M, 2008, BRIT J DERMATOL, V159, P68, DOI 10.1111/j.1365-2133.2008.08582.x; Mohiti J, 1995, MOL MEMBR BIOL, V12, P321, DOI 10.3109/09687689509072434; Musante L, 2005, CLIN EXP IMMUNOL, V141, P491, DOI 10.1111/j.1365-2249.2005.02862.x; Narbutt J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/875394; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Nguyen VT, 2004, EXP CELL RES, V294, P534, DOI 10.1016/j.yexcr.2003.12.010; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Orlov MD, 2006, AUTOIMMUNITY, V39, P557, DOI 10.1080/08916930600971729; Pacheco-Tovar MG, 2009, J EUR ACAD DERMATOL, V23, P697, DOI 10.1111/j.1468-3083.2009.03162.x; Podszywalow-Bartnicka P, 2007, ACTA BIOCHIM POL, V54, P261, DOI 10.18388/abp.2007_3246; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; RAINTEAU D, 1995, FEBS LETT, V360, P80, DOI 10.1016/0014-5793(95)00087-P; Rivadeneyra-Espinoza L, 2006, J AUTOIMMUN, V26, P52, DOI 10.1016/j.jaut.2005.10.008; Ruiz-Argueelles A, 2007, J AUTOIMMUN, V29, P281, DOI 10.1016/j.jaut.2007.07.012; Sanchez-Carpintero I, 2004, BRIT J DERMATOL, V151, P565, DOI 10.1111/j.1365-2133.2004.06147.x; SAYAMA K, 1994, J INVEST DERMATOL, V103, P330, DOI 10.1111/1523-1747.ep12394858; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCHULZE K, 1989, CIRC RES, V64, P179, DOI 10.1161/01.RES.64.2.179; Seddiki N, 2001, J IMMUNOL, V166, P6423, DOI 10.4049/jimmunol.166.10.6423; Siebra MX, 2006, BRAZ J MED BIOL RES, V39, P671, DOI 10.1590/S0100-879X2006000500014; Stulik J, 2003, PROTEOMICS, V3, P951, DOI 10.1002/pmic.200300370; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; TIGALONOWA M, 1990, ACTA DERM-VENEREOL, V70, P385; TSERAIDIS G S, 1972, Arkhiv Patologii, V34, P72; TSERAIDIS G S, 1971, Vestnik Dermatologii i Venerologii, V45, P8; Wang X, 2004, FEBS LETT, V567, P281, DOI 10.1016/j.febslet.2004.04.083; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Yanase K, 1997, J CLIN INVEST, V100, P25, DOI 10.1172/JCI119517	75	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3695	3704		10.1074/jbc.M109.081570	http://dx.doi.org/10.1074/jbc.M109.081570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007702	Green Published, hybrid			2022-12-27	WOS:000275254000021
J	Sharma, MR; Donhofer, A; Barat, C; Marquez, V; Datta, PP; Fucini, P; Wilson, DN; Agrawal, RK				Sharma, Manjuli R.; Doenhoefer, Alexandra; Barat, Chandana; Marquez, Viter; Datta, Partha P.; Fucini, Paola; Wilson, Daniel N.; Agrawal, Rajendra K.			PSRP1 Is Not a Ribosomal Protein, but a Ribosome-binding Factor That Is Recycled by the Ribosome-recycling Factor (RRF) and Elongation Factor G (EF-G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI 70S RIBOSOME; 30 S SUBUNIT; CHLOROPLAST RIBOSOME; BACTERIAL RIBOSOME; STATIONARY-PHASE; STRUCTURAL BASIS; IDENTIFICATION; TRANSLATION; INITIATION; DOMAIN	Plastid-specific ribosomal proteins (PSRPs) have been proposed to play roles in the light-dependent regulation of chloroplast translation. Here we demonstrate that PSRP1 is not a bona fide ribosomal protein, but rather a functional homologue of the Escherichia coli cold-shock protein pY. Three-dimensional Cryo-electron microscopic (Cryo-EM) reconstructions reveal that, like pY, PSRP1 binds within the intersubunit space of the 70S ribosome, at a site overlapping the positions of mRNA and A-and P-site tRNAs. PSRP1 induces conformational changes within ribosomal components that comprise several intersubunit bridges, including bridge B2a, thereby stabilizes the ribosome against dissociation. We find that the presence of PSRP1/pY lowers the binding of tRNA to the ribosome. Furthermore, similarly to tRNAs, PSRP1/pY is recycled from the ribosome by the concerted action of the ribosome-recycling factor (RRF) and elongation factor G (EF-G). These results suggest a novel function for EF-G and RRF in the post-stress return of PSRP1/pY-inactivated ribosomes to the actively translating pool.	[Sharma, Manjuli R.; Barat, Chandana; Datta, Partha P.; Agrawal, Rajendra K.] New York State Dept Hlth, Wadsworth Ctr, Div Translat Med, Albany, NY 12201 USA; [Doenhoefer, Alexandra; Marquez, Viter; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Doenhoefer, Alexandra; Marquez, Viter; Wilson, Daniel N.] Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Doenhoefer, Alexandra; Marquez, Viter; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany; [Fucini, Paola] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Agrawal, Rajendra K.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wilson, DN (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	wilson@lmb.uni-muenchen.de; agrawal@wadsworth.org	Fucini, Paola/M-1118-2014; Wilson, Daniel/AAE-8504-2019	Fucini, Paola/0000-0003-1724-8507; Wilson, Daniel/0000-0003-3816-3828	National Institutes of Health [R01 GM61576]; Human Frontiers of Science Program; Deutsche Forschungsgemeinschaft [WI3285/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers of Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM61576 (to R. K. A.). This work was also supported by the Human Frontiers of Science Program (to D. N. W.) and the Deutsche Forschungsgemeinschaft Grant WI3285/1-1 (to D. N. W.).	Agafonov DE, 2001, EMBO REP, V2, P399; Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Allen JF, 2003, PHILOS T ROY SOC B, V358, P144; Barat C, 2007, MOL CELL, V27, P250, DOI 10.1016/j.molcel.2007.06.005; Barkan A, 2000, BIOCHIMIE, V82, P559, DOI 10.1016/S0300-9084(00)00602-7; Barnes D, 2003, ANTIOXID REDOX SIGN, V5, P89, DOI 10.1089/152308603321223577; Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; Bruick RK, 1999, TRENDS PLANT SCI, V4, P190, DOI 10.1016/S1360-1385(99)01402-8; BUBUNENKO MG, 1994, J BIOL CHEM, V269, P18223; CARSON M, 1991, APPL CRYSTALLOGR, V24, P103; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Daniell H, 2003, NAT BIOTECHNOL, V21, P374, DOI 10.1038/nbt0403-374; Firpo MA, 1996, J BIOL CHEM, V271, P4693; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GNIRKE A, 1989, J BIOL CHEM, V264, P7291; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Hirokawa G, 2006, TRENDS BIOCHEM SCI, V31, P143, DOI 10.1016/j.tibs.2006.01.007; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; JOHNSON CH, 1990, J BIOL CHEM, V265, P12790; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; Maki Y, 2000, GENES CELLS, V5, P965, DOI 10.1046/j.1365-2443.2000.00389.x; Manuell A, 2004, BIOCHEM SOC T, V32, P601, DOI 10.1042/BST0320601; Parsons L, 2001, BIOCHEMISTRY-US, V40, P10979, DOI 10.1021/bi011077i; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Rak A, 2002, BIOCHEM BIOPH RES CO, V299, P710, DOI 10.1016/S0006-291X(02)02721-3; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma MR, 2007, P NATL ACAD SCI USA, V104, P19315, DOI 10.1073/pnas.0709856104; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Somanchi A, 1999, CURR OPIN PLANT BIOL, V2, P404, DOI 10.1016/S1369-5266(99)00013-8; TAN XL, 1994, J BIOL CHEM, V269, P20905; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Ueta M, 2005, GENES CELLS, V10, P1103, DOI 10.1111/j.1365-2443.2005.00903.x; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Yamaguchi K, 2000, J BIOL CHEM, V275, P28455, DOI 10.1074/jbc.M004350200; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Yamaguchi K, 2002, PLANT CELL, V14, P2957, DOI 10.1105/tpc.004341; Ye KQ, 2002, EUR J BIOCHEM, V269, P5182, DOI 10.1046/j.1432-1033.2002.03222.x; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zerges W, 2000, BIOCHIMIE, V82, P583, DOI 10.1016/S0300-9084(00)00603-9	49	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4006	4014		10.1074/jbc.M109.062299	http://dx.doi.org/10.1074/jbc.M109.062299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965869	Green Published, hybrid			2022-12-27	WOS:000275254000054
J	Steichen, JM; Iyer, GH; Li, S; Saldanha, SA; Deal, MS; Woods, VL; Taylor, SS				Steichen, Jon M.; Iyer, Ganesh H.; Li, Sheng; Saldanha, S. Adrian; Deal, Michael S.; Woods, Virgil L., Jr.; Taylor, Susan S.			Global Consequences of Activation Loop Phosphorylation on Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-DEPENDENT KINASE; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; STRUCTURAL BASIS; MECHANISM; EXCHANGE; AUTOPHOSPHORYLATION; DOMAIN; CONFORMATION; THREONINE	Phosphorylation of the activation loop is one of the most common mechanisms for regulating protein kinase activity. The catalytic subunit of cAMP-dependent protein kinase autophosphorylates Thr(197) in the activation loop when expressed in Escherichia coli. Although mutation of Arg(194) to Ala prevents autophosphorylation, phosphorylation of Thr(197) can still be achieved by a heterologous protein kinase, phosphoinositide-dependent protein kinase (PDK1), in vitro. In this study, we examined the structural and functional consequences of adding a single phosphate to the activation loop of cAMP-dependent protein kinase by comparing the wild type C-subunit to the R194A mutant either in the presence or the absence of activation loopphosphorylation. Phosphorylation of Thr(197) decreased the K-m by similar to 15- and 7-fold for kemptide and ATP, respectively, increased the stability of the enzyme as measured by fluorescence and circular dichroism, and enhanced the binding between the C-subunit and IP20, a protein kinase inhibitor peptide. Additionally, deuterium exchange coupled to mass spectrometry was used to compare the structural dynamics of these proteins. All of the regions of the C-subunit analyzed underwent amide hydrogen exchange at a higher or equal rate in the unphosphorylated enzyme compared with the phosphorylated enzyme. The largest changes occurred at the C terminus of the activation segment in the p + 1 loop/APE regions and the alpha H-alpha I loop motifs and leads to the prediction of a coordinated phosphorylation-induced salt bridge between two conserved residues, Glu(208) and Arg(280).	[Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health [GM19301, CA099835, CA118595, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170, GM007752]; University of California IUCRP [UC10591]; NATIONAL CANCER INSTITUTE [R21CA099835, R33CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R01AI081982, R21AI076961, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684, R01GM020501, R01GM019301, F32GM020501, R01GM066170, R37GM019301, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California IUCRP(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM19301 (to S.S.T.) and CA099835, CA118595, AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V.L.W.). This work was also supported by National Institutes of Health Pharmacological Sciences Training Grant GM007752 (to J.M.S.) and by Discovery Grant UC10591 from the University of California IUCRP	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lee T, 2005, J MOL BIOL, V353, P600, DOI 10.1016/j.jmb.2005.08.029; LEVIN LR, 1990, MOL CELL BIOL, V10, P1066, DOI 10.1128/MCB.10.3.1066; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; ORR JW, 1994, J BIOL CHEM, V269, P27715; Pace C N, 1986, Methods Enzymol, V131, P266; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030	34	62	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3825	3832		10.1074/jbc.M109.061820	http://dx.doi.org/10.1074/jbc.M109.061820			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965870	Green Published, hybrid			2022-12-27	WOS:000275254000035
J	Sun, HQ; Li, D; Chen, S; Liu, YY; Liao, XL; Deng, WQ; Li, N; Zeng, M; Tao, DC; Ma, YX				Sun, Huaqin; Li, Dan; Chen, Shu; Liu, Yanyan; Liao, Xiaolin; Deng, Wenqian; Li, Na; Zeng, Mei; Tao, Dachang; Ma, Yongxin			Zili Inhibits Transforming Growth Factor-beta Signaling by Interacting with Smad4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIWI; ZEBRAFISH; PROTEIN; ORGANIZER; GENES	Piwi proteins are required for germ cell proliferation, differentiation, and germ line stem cell maintenance. In normal tissues, human and mouse Piwil2 are primarily expressed in testis but widely expressed in tumors. However, the underlying mechanism remains largely unknown. In vertebrates, transforming growth factor (TGF)-beta signaling plays an important role in patterning embryo and control of cell growth and differentiation. A previous study has shown a role for Zili, a Piwil2 gene in zebrafish, in germ cells in zebrafish. Here we report that zili functions in patterning the early embryo and inhibits TGF-beta signaling. Whole mount expression analysis shows that zili expresses not only in PGCs but also in axis. Ectopic expression of zili causes fusion of the eyes and reduction of mesodermal marker genes expression, suggesting that zili functions to inhibit Nodal signaling and mesoderm formation. Genetic interaction shows that zili inhibits Nodal and bone morphogenetic protein signaling. The results of protein interaction assays identify that Zili binds to Smad4 via its N-terminal domain and prevents the formation of Smad2/3/4 and Smad1/5/9/4 complexes to antagonize TGF-beta signaling. This work shows that zili plays a role in early embryogenesis beyond germ line as a novel negative regulator of TGF-beta signaling, extending the function of Piwi proteins in vertebrates.	Sichuan Univ, Dept Med Genet, W China Hosp, Chengdu 610041, Peoples R China; Sichuan Univ, Div Morbid Genom, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Ma, YX (corresponding author), 1st Keyuan 4 Lu,Gaopeng Dadao, Chengdu 610041, Peoples R China.	mayongxin@gmail.com	Deng, Wenqian/AGY-3727-2022; liu, yan/HCI-5542-2022	Li, Na/0000-0001-6163-1648	National Natural Science Foundation of China [30770812, 90919006]; National High-Tech Research and Development Program of China [2008AA02Z102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30770812 and 90919006 and National High-Tech Research and Development Program of China Grant 2008AA02Z102.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kondo M, 2007, FEBS J, V274, P2960, DOI 10.1111/j.1742-4658.2007.05838.x; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mullins MC, 1996, DEVELOPMENT, V123, P81; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Tan Cheong-Huat, 2002, Gene Expression Patterns, V2, P257, DOI 10.1016/S1567-133X(02)00052-2; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Westerfield M, 1993, ZEBRAFISH BOOK; Whitman M, 2005, DEVELOPMENT, V132, P4205, DOI 10.1242/dev.02023; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5	34	24	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4243	4250		10.1074/jbc.M109.079533	http://dx.doi.org/10.1074/jbc.M109.079533			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007318	hybrid, Green Published			2022-12-27	WOS:000275254000076
J	Guan, ZW; Haque, MM; Wei, CC; Garcin, ED; Getzoff, ED; Stuehr, DJ				Guan, Zhi-Wen; Haque, Mohammad Mahfuzul; Wei, Chin-Chuan; Garcin, Elsa D.; Getzoff, Elizabeth D.; Stuehr, Dennis J.			Lys(842) in Neuronal Nitric-oxide Synthase Enables the Autoinhibitory Insert to Antagonize Calmodulin Binding, Increase FMN Shielding, and Suppress Interflavin Electron Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NO COMPLEX-FORMATION; C-TERMINAL TAIL; CONFORMATIONAL EQUILIBRIUM; CYTOCHROME-P450 REDUCTASE; REGULATORY SITES; CONTROL ELEMENT; HEME REDUCTION; FLAVIN DOMAIN; ENZYME	Neuronal nitric-oxide synthase (nNOS) contains a unique autoinhibitory insert (AI) in its FMN subdomain that represses nNOS reductase activities and controls the calcium sensitivity of calmodulin (CaM) binding to nNOS. How the AI does this is unclear. A conserved charged residue (Lys(842)) lies within a putative CaM binding helix in the middle of the AI. We investigated its role by substituting residues that neutralize (Ala) or reverse (Glu) the charge at Lys(842). Compared with wild type nNOS, the mutant enzymes had greater cytochrome c reductase and NADPH oxidase activities in the CaM-free state, were able to bind CaM at lower calcium concentration, and had lower rates of heme reduction and NO synthesis in one case (K842A). Moreover, stopped-flow spectrophotometric experiments with the nNOS reductase domain indicate that the CaM-free mutants had faster flavin reduction kinetics and had less shielding of their FMN subdomains compared with wild type and no longer increased their level of FMN shielding in response to NADPH binding. Thus, Lys(842) is critical for the known functions of the AI and also enables two additional functions of the AI as newly identified here: suppression of electron transfer to FMN and control of the conformational equilibrium of the nNOS reductase domain. Its effect on the conformational equilibrium probably explains suppression of catalysis by the AI.	[Guan, Zhi-Wen; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Wei, Chin-Chuan] So Illinois Univ, Dept Chem, Edwardsville, IL 62026 USA; [Garcin, Elsa D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Cleveland Clinic Foundation; Southern Illinois University System; Southern Illinois University Edwardsville; University System of Maryland; University of Maryland Baltimore County; Scripps Research Institute	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Garcin, Elsa D/C-1556-2013	Garcin, Elsa D/0000-0003-0501-8421; Wei, Chin-Chuan/0000-0001-6453-9409; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM51491, CA53914, HL76491, HL5883]; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491, CA53914, and HL76491 (to D. J. S.) and HL58883 (to E. D. G.).	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Adak S, 2002, P NATL ACAD SCI USA, V99, P13516, DOI 10.1073/pnas.192283399; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; BREDT DS, 1992, J BIOL CHEM, V267, P10976; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2004, BIOCHEMISTRY-US, V43, P3929, DOI 10.1021/bi0360408; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; Guan ZW, 2003, J BIOL CHEM, V278, P30859, DOI 10.1074/jbc.M301929200; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; HEVEL JM, 1992, BIOCHEMISTRY-US, V31, P7160, DOI 10.1021/bi00146a019; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; KLATT P, 1993, J BIOL CHEM, V268, P14781; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Komeima K, 2000, J BIOL CHEM, V275, P28139; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Rozhkova EA, 2002, J BIOL CHEM, V277, P16888, DOI 10.1074/jbc.M200642200; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; SCHMIDT HHHW, 1992, BIOCHEMISTRY-US, V31, P3243, DOI 10.1021/bi00127a028; Stuehr DJ, 2005, DALTON T, P3427, DOI 10.1039/b506355h; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	55	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3064	10.1074/jbc.M109.000810	http://dx.doi.org/10.1074/jbc.M109.000810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948738	hybrid, Green Published			2022-12-27	WOS:000273829000022
J	Iizasa, E; Mitsutomi, M; Nagano, Y				Iizasa, Ei'ichi; Mitsutomi, Masaru; Nagano, Yukio			Direct Binding of a Plant LysM Receptor-like Kinase, LysM RLK1/CERK1, to Chitin in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PTERIS-RYUKYUENSIS; PROTEIN; CELLS; SITE; ARABIDOPSIS; PERCEPTION; RECOGNITION; ELICITOR; DOMAINS	Plants induce immune responses against fungal pathogens by recognition of chitin, which is a component of the fungal cell wall. Recent studies have revealed that LysM receptor-like kinase 1/chitin elicitor receptor kinase 1 (LysM RLK1/CERK1) is a critical component for the immune responses to chitin in Arabidopsis thaliana. However, the molecular mechanism of the chitin recognition by LysM RLK1 still remains unknown. Here, we present the first evidence for direct binding of LysM RLK1 to chitin. We expressed LysM RLK1 fused with yeast-enhanced green fluorescent protein (LysM RLK1-yEGFP) in yeast cells. Binding studies using the solubilized LysM RLK1-yEGFP and several insoluble polysaccharides having similar structures showed that LysM RLK1-yEGFP specifically binds to chitin. Subsequently, the fluorescence microscopic observation of the solubilized LysM RLK1-yEGFP binding to chitin beads revealed that the binding was saturable and had a high affinity, with a K-d of similar to 82 nM. This binding was competed by the addition of soluble glycol chitin or high concentration of chitin oligosaccharides having 4-8 residues of N-acetyl glucosamine. However, the competition of these chitin oligosac-charides is weaker than that of glycol chitin. These data suggest that LysM RLK1 has a higher affinity for chitin having a longer residue of N-acetyl glucosamine. We also found that LysM RLK1-yEGFP was auto phosphorylated in vitro and that chitin does not affect the phosphorylation of LysM RLK1-yEGFP. Our results provide a new dimension to chitin elicitor perception in plants.	[Iizasa, Ei'ichi] Saga Univ, Analyt Res Ctr Expt Sci, Saga 8408502, Japan; [Mitsutomi, Masaru] Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan; [Iizasa, Ei'ichi; Mitsutomi, Masaru; Nagano, Yukio] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan	Saga University; Saga University; Kagoshima University	Iizasa, E (corresponding author), Saga Univ, Analyt Res Ctr Expt Sci, 1 Honjo Machi, Saga 8408502, Japan.	k5818326@kadai.jp; nagano@cc.saga-u.ac.jp	Nagano, Yukio/H-8734-2019; Iizasa, Ei'ichi/AAE-8654-2020	Nagano, Yukio/0000-0001-5030-676X; Iizasa, Ei'ichi/0000-0002-0081-6005	Japan Society for the Promotion of Science [17580082]; Foundation for Research Fellowships of Japan Society [19-8266]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Research Fellowships of Japan Society	This work was supported in part by Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 17580082 (to Y. N.) and the Foundation for Research Fellowships of Japan Society for the Promotion of Science for Young Scientists (DC1) Grant 19-8266 (to E. I.).	Albert PK, 2006, PLANT BIOTECHNOL, V23, P459, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.23.459; BARKER SA, 1958, J CHEM SOC, P2218, DOI 10.1039/jr9580002218; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Day RB, 2001, PLANT PHYSIOL, V126, P1162, DOI 10.1104/pp.126.3.1162; GRANADO J, 1995, PLANT PHYSIOL, V107, P485, DOI 10.1104/pp.107.2.485; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Hardt M, 2004, ARCH BIOCHEM BIOPHYS, V426, P286, DOI 10.1016/j.abb.2004.03.017; Iizasa E, 2006, BIOTECHNIQUES, V40, P79, DOI 10.2144/000112041; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; JEUNIAUX C, 1958, ARCH INT PHYS BIOCH, V66, P408, DOI 10.3109/13813455809084218; Joshi MC, 2008, J BIOL CHEM, V283, P28287, DOI 10.1074/jbc.M804416200; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kim CY, 1998, PLANT MOL BIOL, V37, P523, DOI 10.1023/A:1005960313459; Kohara J, 2006, PROTEIN EXPRES PURIF, V49, P276, DOI 10.1016/j.pep.2006.05.015; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; MITSUTOMI M, 1990, AGR BIOL CHEM TOKYO, V54, P871, DOI 10.1080/00021369.1990.10870047; Mitsutomi M, 2002, CHITIN CHITOSAN RES, V8, P228; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Onaga S, 2008, GLYCOBIOLOGY, V18, P414, DOI 10.1093/glycob/cwn018; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shibuya N, 1996, PLANT CELL PHYSIOL, V37, P894, DOI 10.1093/oxfordjournals.pcp.a029030; Shimosato H, 2007, PLANT CELL, V19, P107, DOI 10.1105/tpc.105.038869; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Yabuki M, 1987, TECH B FAC HORT CHIB, V39, P23, DOI 10.1271/bbb1961.54.3341; YAMADA H, 1981, CARBOHYD RES, V92, P160, DOI 10.1016/S0008-6215(00)85993-5; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	41	135	146	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2996	10.1074/jbc.M109.027540	http://dx.doi.org/10.1074/jbc.M109.027540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19951949	hybrid, Green Published			2022-12-27	WOS:000273829000014
J	Pillai, VB; Sundaresan, NR; Kim, G; Gupta, M; Rajamohan, SB; Pillai, JB; Samant, S; Ravindra, PV; Isbatan, A; Gupta, MP				Pillai, Vinodkumar B.; Sundaresan, Nagalingam R.; Kim, Gene; Gupta, Madhu; Rajamohan, Senthilkumar B.; Pillai, Jyothish B.; Samant, Sadhana; Ravindra, P. V.; Isbatan, Ayman; Gupta, Mahesh P.			Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR SIGNALING PATHWAYS; OXIDATIVE STRESS; PROTEIN-KINASE; CALORIE RESTRICTION; NICOTINIC-ACID; HEART-FAILURE; CELL-SURVIVAL; SIR2 HOMOLOG; LIFE-SPAN; AMPK	Since the discovery of NAD-dependent deacetylases, sirtuins, it has been recognized that maintaining intracellular levels of NAD is crucial for the management of stress response of cells. Here we show that agonist-induced cardiac hypertrophy is associated with loss of intracellular levels of NAD, but not exercise-induced physiologic hypertrophy. Exogenous addition of NAD was capable of maintaining intracellular levels of NAD and blocking the agonist-induced cardiac hypertrophic response in vitro as well as in vivo. NAD treatment blocked the activation of pro-hypertrophic Akt1 signaling, and augmented the activity of anti-hypertrophic LKB1-AMPK signaling in the heart, which prevented subsequent induction of mTOR-mediated protein synthesis. By using gene knock-out and transgenic mouse models of SIRT3 and SIRT1, we showed that the anti-hypertrophic effects of exogenous NAD are mediated through activation of SIRT3, but not SIRT1. SIRT3 deacetylates and activates LKB1, thus augmenting the activity of the LKB1-AMPK pathway. These results reveal a novel role of NAD as an inhibitor of cardiac hypertrophic signaling, and suggest that prevention of NAD depletion may be critical in the treatment of cardiac hypertrophy and heart failure.	[Pillai, Jyothish B.; Samant, Sadhana; Ravindra, P. V.; Isbatan, Ayman; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Kim, Gene] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Gupta, Mahesh P.] Univ Chicago, Comm Cellular & Mol Physiol, Div Biol Sci, Chicago, IL 60637 USA; [Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu		Veeranna, Ravindra/0000-0003-4228-1843; Kim, Gene/0000-0001-6461-1992	National Institutes of Health [RO1 HL-77788, HL-83423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077788, R01HL083423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-77788 and HL-83423.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Elvehjem C A, 2002, J Biol Chem, V277, pe22; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; JACOBSON EL, 1976, ARCH BIOCHEM BIOPHYS, V175, P627, DOI 10.1016/0003-9861(76)90553-1; Kaeberlein M, 2008, CELL METAB, V8, P4, DOI 10.1016/j.cmet.2008.06.004; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morisco C, 2003, AM J PHYSIOL-HEART C, V284, pH1043, DOI 10.1152/ajpheart.00990.2002; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Neuwahl FJ, 1943, LANCET, V2, P348; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Spies TD, 1938, P SOC EXP BIOL MED, V38, P178; Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; YAMADA K, 1982, DIABETES, V31, P749, DOI 10.2337/diabetes.31.9.749; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267	52	307	321	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3133	3144		10.1074/jbc.M109.077271	http://dx.doi.org/10.1074/jbc.M109.077271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940131	Green Published, hybrid			2022-12-27	WOS:000273829000029
J	Bhattacharya, S; Dai, ZP; Li, JQ; Baxter, S; Callaway, DJE; Cowburn, D; Bu, ZM				Bhattacharya, Shibani; Dai, Zhongping; Li, Jianquan; Baxter, Sabine; Callaway, David J. E.; Cowburn, David; Bu, Zimei			A Conformational Switch in the Scaffolding Protein NHERF1 Controls Autoinhibition and Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; TORSION ANGLE DYNAMICS; X-RAY-SCATTERING; PDZ-DOMAIN; PHOSPHATE-TRANSPORT; PARATHYROID-HORMONE; ADAPTER PROTEINS; TERMINAL DOMAIN; EZRIN; NMR	The mammalian Na+/H+ exchange regulatory factor 1 (NHERF1) is a multidomain scaffolding protein essential for regulating the intracellular trafficking and macromolecular assembly of transmembrane ion channels and receptors. NHERF1 consists of tandem PDZ-1, PDZ-2 domains that interact with the cytoplasmic domains of membrane proteins and a C-terminal (CT) domain that binds the membrane-cytoskeleton linker protein ezrin. NHERF1 is held in an autoinhibited state through intramolecular interactions between PDZ2 and the CT domain that also includes a C-terminal PDZ-binding motif (-SNL). We have determined the structures of the isolated and tandem PDZ2CT domains by high resolution NMR using small angle x-ray scattering as constraints. The PDZ2CT structure shows weak intramolecular interactions between the largely disordered CT domain and the PDZ ligand binding site. The structure reveals a novel helix-turn-helix subdomain that is allosterically coupled to the putative PDZ2 domain by a network of hydrophobic interactions. This helical subdomain increases both the stability and the binding affinity of the extended PDZ structure. Using NMR and small angle neutron scattering for joint structure refinement, we demonstrate the release of intramolecular domain-domain interactions in PDZ2CT upon binding to ezrin. Based on the structural information, we show that human disease-causing mutations in PDZ2, R153Q and E225K, have significantly reduced protein stability. Loss of NHERF1 expressed in cells could result in failure to assemble membrane complexes that are important for normal physiological functions.	[Bhattacharya, Shibani; Cowburn, David] New York Struct Biol Ctr, New York, NY 10031 USA; [Callaway, David J. E.] NYU, Sch Med, New York, NY 10016 USA; [Dai, Zhongping; Li, Jianquan; Baxter, Sabine; Bu, Zimei] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Bu, Zimei] CUNY City Coll, Dept Chem, New York, NY 10031 USA	New York University; Fox Chase Cancer Center; City University of New York (CUNY) System; City College of New York (CUNY)	Callaway, DJE (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	david.callaway@nyu.edu; cowburn@nysbc.org; zimei.bu@fccc.edu	Cowburn, David/A-8448-2008	Cowburn, David/0000-0001-6770-7172	National Institutes of Health [R01 HL086496, R01 GM047021, GM-66354]; W. W. Smith Charitable Trust; Keck Foundation; New York Structural Biology Center; National Science Foundation [DMR-0454672]; National Institute of Standards and Technology, United States Department of Commerce; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047021, P41GM066354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust; Keck Foundation(W.M. Keck Foundation); New York Structural Biology Center; National Science Foundation(National Science Foundation (NSF)); National Institute of Standards and Technology, United States Department of Commerce(National Institute of Standards & Technology (NIST) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL086496 (to Z.B.), R01 GM047021 (to D. C.). This work was also supported by a grant from the W. W. Smith Charitable Trust (to Z.B.). The 900-MHz NMR system was purchased with funds from National Institutes of Health Grant GM-66354, the Keck Foundation, and the member institutions of the New York Structural Biology Center.; This work utilized facilities supported in part by the National Science Foundation under Agreement DMR-0454672. We acknowledge the support of the National Institute of Standards and Technology, United States Department of Commerce, in providing the neutron research facilities used in this work.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brenman JE, 1996, J NEUROSCI, V16, P7407; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P411; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m; Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, THESIS SWISS FEDERAL; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwon SH, 2007, CELL PHYSIOL BIOCHEM, V20, P763, DOI 10.1159/000110436; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee D, 2007, J MOL BIOL, V367, P1007, DOI 10.1016/j.jmb.2007.01.013; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lynn GW, 2005, BIOCHEMISTRY-US, V44, P565, DOI 10.1021/bi048347s; Mahon MJ, 2008, AM J PHYSIOL-RENAL, V294, pF667, DOI 10.1152/ajprenal.00276.2007; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mattinen ML, 2002, BIOPHYS J, V83, P1177, DOI 10.1016/S0006-3495(02)75241-7; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Thelin WR, 2005, J PHYSIOL-LONDON, V567, P13, DOI 10.1113/jphysiol.2005.091041; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050	69	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9981	9994		10.1074/jbc.M109.074005	http://dx.doi.org/10.1074/jbc.M109.074005			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20042604	hybrid, Green Published			2022-12-27	WOS:000276165900067
J	Bui-Nguyen, TM; Pakala, SB; Sirigiri, DR; Martin, E; Murad, F; Kumar, R				Bui-Nguyen, Tri M.; Pakala, Suresh B.; Sirigiri, Divijendranatha Reddy; Martin, Emil; Murad, Ferid; Kumar, Rakesh			Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator (Publication with Expression of Concern. See vol. 191, pg. 1198, 2016) (Withdrawn Publication. See vol. 292, pg. 4765, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; X-PROTEIN; SYNTHASE PROMOTER; GENE; EXPRESSION; ANGIOGENESIS; MICRORNAS; ACTIVATOR; GROWTH	Nitric oxide has been implicated in the pathogenesis of inflammatory disorders, including hepatitis B virus-associated hepatocellular carcinoma. Transactivator protein HBx, a major regulator of cellular responses of hepatitis B virus, is known to induce the expression of MTA1 (metastasis-associated protein 1) coregulator via NF-kappa B signaling in hepatic cells. However, the underlying mechanism of HBx regulation of the inducible nitric-oxide synthase (iNOS) pathway remains unknown. Here we provide evidence that MTA1 is a positive regulator of iNOS transcription and plays a mechanistic role in HBx stimulation of iNOS expression and activity. We found that the HBx-MTA1 complex is recruited on to the human iNOS promoter in an NF-kappa B dependent manner. Pharmacological inhibition of the NF-kappa B signaling prevented the ability of HBx to stimulate the transcription, the expression, and the activity of iNOS; nevertheless, these effects could be substantially rescued by MTA1 dysregulation. We further discovered that HBx-mediated stimulation of MTA1 is paralleled by the suppression of miR-661, a member of the small noncoding RNAs, recently shown to target MTA1. We observed that miR-661 controls of MTA1 expression contributed to the expression and activity of iNOS in HBx-expressing HepG2 cells. Accordingly, depletion of MTA1 by either miR-661 or siRNA in HBx-expressing cells severely impaired the ability of HBx to modulate the endogenous levels of iNOS and nitrite production. Together, these findings reveal an inherent role of MTA1 in HBx regulation of iNOS expression and consequently its function in the liver cancer cells.	[Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Martin, Emil; Murad, Ferid] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA	George Washington University; University of Texas System; University of Texas Health Science Center Houston	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010	Kumar, Rakesh/0000-0001-7664-0803; 	National Institutes of Health [CA98823, RO1HL088128]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 (to R. K.) and RO1HL088128 (to E. M.).	Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957; Anttila MA, 2007, GYNECOL ONCOL, V105, P97, DOI 10.1016/j.ygyno.2006.10.049; Arsura M, 2005, CANCER LETT, V229, P157, DOI 10.1016/j.canlet.2005.07.008; Azam F, 2008, ANN HEPATOL, V7, P125, DOI 10.1016/S1665-2681(19)31867-8; Bergametti F, 1999, ONCOGENE, V18, P2860, DOI 10.1038/sj.onc.1202643; Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; Ezzat S, 2005, INT J HYG ENVIR HEAL, V208, P329, DOI 10.1016/j.ijheh.2005.04.003; Gallo O, 1998, J NATL CANCER I, V90, P587, DOI 10.1093/jnci/90.8.587; Guidotti LG, 2000, J EXP MED, V191, P1247, DOI 10.1084/jem.191.7.1247; Guo JS, 2006, EUR J PHARMACOL, V536, P301, DOI 10.1016/j.ejphar.2005.12.088; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hamatsu T, 2003, ONCOL REP, V10, P599; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Hasegawa K, 1999, LIFE SCI, V64, P2199, DOI 10.1016/S0024-3205(99)00171-X; Hon WM, 2002, ANN NY ACAD SCI, V962, P275, DOI 10.1111/j.1749-6632.2002.tb04074.x; Hsieh JL, 2003, CLIN CANCER RES, V9, P338; Huo TI, 2004, GASTROENTEROLOGY, V127, P360, DOI 10.1053/j.gastro.2004.05.045; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kane JM, 1997, J SURG RES, V69, P321, DOI 10.1006/jsre.1997.5057; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Koulentaki Meri, 2004, Eur J Intern Med, V15, P35, DOI 10.1016/j.ejim.2003.11.004; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Kubicka S, 2000, LIVER, V20, P312, DOI 10.1034/j.1600-0676.2000.020004312.x; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Majano P, 2001, HEPATOLOGY, V34, P1218, DOI 10.1053/jhep.2001.29626; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Moriyama A, 1997, AM J GASTROENTEROL, V92, P1520; Ryu SH, 2008, HEPATOLOGY, V47, P929, DOI 10.1002/hep.22124; Scaria V, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-82; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SIRIGIRI DNR, 2009, CANCER RES, V69, P5639; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; Su F, 2001, J VIROL, V75, P215, DOI 10.1128/JVI.75.1.215-225.2001; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Tabor E, 2007, HEPATOL RES, V37, pS110, DOI 10.1111/j.1872-034X.2007.00172.x; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	51	41	42	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6980	6986		10.1074/jbc.M109.065987	http://dx.doi.org/10.1074/jbc.M109.065987			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022949	Green Published, hybrid			2022-12-27	WOS:000275415600011
J	Gantt, SL; Joseph, CG; Fierke, CA				Gantt, Stephanie L.; Joseph, Caleb G.; Fierke, Carol A.			Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HUMAN HDAC8; BINDING; NA+; SUBSTRATE; ENZYME; CELLS; SITE; POTASSIUM; INSIGHTS	The metal-dependent histone deacetylases (HDACs) catalyze hydrolysis of acetyl groups from acetyllysine side chains and are targets of cancer therapeutics. Two bound monovalent cations (MVCs) of unknown function have been previously observed in crystal structures of HDAC8; site 1 is near the active site, whereas site 2 is located > 20 angstrom from the catalytic metal ion. Here we demonstrate that one bound MVC activates catalytic activity (K-1/2 = 3.4 mM for K+), whereas the second, weakerbinding MVC (K-1/2 = 26 mM for K+) decreases catalytic activity by 11-fold. The weaker binding MVC also enhances the affinity of the HDAC inhibitor suberoylanilide hydroxamic acid by 5-fold. The site 1 MVC is coordinated by the side chain of Asp-176 that also forms a hydrogen bond with His-142, one of two histidines important for catalytic activity. The D176A and H142A mutants each increase the K-1/2 for potassium inhibition by >= 40-fold, demonstrating that the inhibitory cation binds to site 1. Furthermore, the MVC inhibition is mediated by His-142, suggesting that this residue is protonated for maximal HDAC8 activity. Therefore, His-142 functions either as an electrostatic catalyst or a general acid. The activating MVC binds in the distal site and causes a time-dependent increase in activity, suggesting that the site 2 MVC stabilizes an active conformation of the enzyme. Sodium binds more weakly to both sites and activates HDAC8 to a lesser extent than potassium. Therefore, it is likely that potassium is the predominant MVC bound to HDAC8 in vivo.	Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Joseph, Caleb G.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), 930 N Univ Ave, Ann Arbor, MI 48109 USA.	fierke@umich.edu			National Institutes of Health [GM40602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040602, R01GM040602, T32GM008597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40602 (to C.A.F.).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; BORIN ML, 1993, AM J PHYSIOL, V264, pC1513, DOI 10.1152/ajpcell.1993.264.6.C1513; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Hayashi H, 2002, J BIOL CHEM, V277, P11090, DOI 10.1074/jbc.M111868200; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P2412, DOI 10.1021/bi035849h; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Hughes FM, 1999, ADV ENZYME REGUL, V39, P157, DOI 10.1016/S0065-2571(98)00010-7; KASNER SE, 1992, AM J PHYSIOL, V262, pF462, DOI 10.1152/ajprenal.1992.262.3.F462; Kern S, 2007, FEBS J, V274, P3578, DOI 10.1111/j.1742-4658.2007.05887.x; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Nielsen TK, 2005, J MOL BIOL, V354, P107, DOI 10.1016/j.jmb.2005.09.065; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Sanghamitra NJM, 2008, BIOCHEMISTRY-US, V47, P1309, DOI 10.1021/bi701783x; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Wedel T, 2006, NEUROGASTROENT MOTIL, V18, P526, DOI 10.1111/j.1365-2982.2006.00781.x; WOEHL EU, 1995, COORDIN CHEM REV, V144, P147, DOI 10.1016/0010-8545(94)08001-8	32	60	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6036	6043		10.1074/jbc.M109.033399	http://dx.doi.org/10.1074/jbc.M109.033399			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20029090	hybrid, Green Published			2022-12-27	WOS:000275367500006
J	LeShane, ES; Shinde, U; Walker, JM; Barry, AN; Blackburn, NJ; Ralle, M; Lutsenko, S				LeShane, Erik S.; Shinde, Ujwal; Walker, Joel M.; Barry, Amanda N.; Blackburn, Ninian J.; Ralle, Martina; Lutsenko, Svetlana			Interactions between Copper-binding Sites Determine the Redox Status and Conformation of the Regulatory N-terminal Domain of ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; MENKES-DISEASE; DEPENDENT INTERACTION; SUPEROXIDE-DISMUTASE; TRANSPORTING ATPASE; CATALYTIC-ACTIVITY; CU(I) BINDING; CHAPERONE; DYNAMICS; ATOX1	Copper-transporting ATPase ATP7B is essential for human copper homeostasis and normal liver function. ATP7B has six N-terminal metal-binding domains (MBDs) that sense cytosolic copper levels and regulate ATP7B. The mechanism of copper sensing and signal integration from multiple MBDs is poorly understood. We show that MBDs communicate and that this communication determines the oxidation state and conformation of the entire N-terminal domain of ATP7B (N-ATP7B). Mutations of copper-coordinating Cys to Ala in any MBD (2, 3, 4, or 6) change the N-ATP7B conformation and have distinct functional consequences. Mutating MBD2 or MBD3 causes Cys oxidation in other MBDs and loss of copper binding. In contrast, mutation of MBD4 and MBD6 does not alter the redox status and function of other sites. Our results suggest that MBD2 and MBD3 work together to regulate access to other metal-binding sites, whereas MBD4 and MBD6 receive copper independently, downstream of MBD2 and MBD3. Unlike Ala substitutions, the Cys-to-Ser mutation in MBD2 preserves the conformation and reduced state of N-ATP7B, suggesting that hydrogen bonds contribute to interdomain communications. Tight coupling between MBDs suggests a mechanism by which small changes in individual sites (induced by copper binding or mutation) result in stabilization of distinct conformations of the entire N-ATP7B and altered exposure of sites for interactions with regulatory proteins.	[Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [LeShane, Erik S.; Shinde, Ujwal; Walker, Joel M.; Ralle, Martina; Lutsenko, Svetlana] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Blackburn, Ninian J.] Oregon Hlth & Sci Univ, Dept Sci & Engn, Portland, OR 97239 USA	Johns Hopkins University; Oregon Health & Science University; Oregon Health & Science University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Ralle, Martina/H-2936-2019	Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [R01 DK071865, 5-T32-HL007781]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 DK071865 (to S. L.) and Training Grant 5-T32-HL007781 (to E. S. L.).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Banci L, 2005, J MOL BIOL, V352, P409, DOI 10.1016/j.jmb.2005.07.034; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Barry AN, 2008, BIOCHEMISTRY-US, V47, P4916, DOI 10.1021/bi8001049; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Bertini I, 2008, CELL MOL LIFE SCI, V65, P89, DOI 10.1007/s00018-007-7439-6; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Ralle M, 2004, J INORG BIOCHEM, V98, P765, DOI 10.1016/j.jinorgbio.2004.02.009; Rodriguez-Granillo A, 2008, J PHYS CHEM B, V112, P4583, DOI 10.1021/jp711787x; Rodriguez-Granillo A, 2009, BIOCHEMISTRY-US, V48, P5849, DOI 10.1021/bi900235g; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	30	33	34	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6327	6336		10.1074/jbc.M109.074633	http://dx.doi.org/10.1074/jbc.M109.074633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032459	hybrid, Green Published			2022-12-27	WOS:000275367500037
J	Catalano, S; Malivindi, R; Giordano, C; Gu, GW; Panza, S; Bonofiglio, D; Lanzino, M; Sisci, D; Panno, ML; Ando, S				Catalano, Stefania; Malivindi, Rocco; Giordano, Cinzia; Gu, Guowei; Panza, Salvatore; Bonofiglio, Daniela; Lanzino, Marilena; Sisci, Diego; Panno, Maria Luisa; Ando, Sebastiano			Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID RECEPTOR; NUCLEAR RECEPTOR; BREAST-CANCER; TESTICULAR AROMATASE; HETERODIMER PARTNER; RESPONSE ELEMENT; GENE-EXPRESSION; RAT TESTIS; FACTOR-I; FXR	The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that regulates bile acid homeostasis. It is expressed in the liver and the gastrointestinal tract, but also in several non-enterohepatic tissues including testis. Recently, FXR was identified as a negative modulator of the androgen-estrogen-converting aromatase enzyme in human breast cancer cells. In the present study we detected the expression of FXR in Leydig normal and tumor cell lines and in rat testes tissue. We found, in rat Leydig tumor cells, R2C, that FXR activation by the primary bile acid chenodeoxycholic acid (CDCA) or a synthetic agonist GW4064, through a SHP-independent mechanism, down-regulates aromatase expression in terms of mRNA, protein levels, and its enzymatic activity. Transient transfection experiments, using vector containing rat aromatase promoter PII, evidenced that CDCA reduces basal aromatase promoter activity. Mutagenesis studies, electrophoretic mobility shift, and chromatin immunoprecipitation analysis reveal that FXR is able to compete with steroidogenic factor 1 in binding to a common sequence present in the aromatase promoter region interfering negatively with its activity. Finally, the FXR-mediated anti-proliferative effects exerted by CDCA on tumor Leydig cells are at least in part due to an inhibition of estrogen-dependent cell growth. In conclusion our findings identify for the first time the activators of FXR as negative modulators of the aromatase enzyme in Leydig tumor cell lines.	[Giordano, Cinzia; Ando, Sebastiano] Univ Calabria, Ctr Sanitario, I-87030 Arcavacata Di Rende, CS, Italy; [Catalano, Stefania; Malivindi, Rocco; Giordano, Cinzia; Gu, Guowei; Panza, Salvatore; Bonofiglio, Daniela; Lanzino, Marilena; Sisci, Diego] Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy; [Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87030 Arcavacata Di Rende, CS, Italy	University of Calabria; University of Calabria; University of Calabria	Ando, S (corresponding author), Univ Calabria, Ctr Sanitario, I-87030 Arcavacata Di Rende, CS, Italy.	sebastiano.ando@unical.it	Bonofiglio, Daniela/AAV-8371-2020; Malivindi, Rocco/ABB-8562-2021; /AAD-9701-2019	/0000-0001-6577-1541; CATALANO, Stefania/0000-0002-6352-9628; MALIVINDI, Rocco/0000-0002-8313-2492; BONOFIGLIO, Daniela/0000-0002-4142-0496; GIORDANO, Cinzia/0000-0003-4969-0607; Lanzino, Marilena/0000-0002-6362-5396	PRIN-MIUR (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale-Ministero dell'Istruzione dell'Universita della Ricerca); Associazione Italiana per la Ricerca sul Cancro (AIRC)	PRIN-MIUR (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale-Ministero dell'Istruzione dell'Universita della Ricerca)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by PRIN-MIUR (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale-Ministero dell'Istruzione dell'Universita della Ricerca) and Associazione Italiana per la Ricerca sul Cancro (AIRC).	Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aquila S, 2003, HUM REPROD, V18, P1650, DOI 10.1093/humrep/deg340; Bosland M C, 1996, Prog Clin Biol Res, V394, P309; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; Carpino A, 2007, EUR J ENDOCRINOL, V157, P239, DOI 10.1530/EJE-07-0029; CARROLL PR, 1987, J UROLOGY, V137, P420, DOI 10.1016/S0022-5347(17)44054-7; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Claudel T, 2002, J CLIN INVEST, V109, P961; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258; FITZPATRICK SL, 1994, MOL ENDOCRINOL, V8, P1309, DOI 10.1210/me.8.10.1309; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Fowler KA, 2000, AM J PATHOL, V156, P347, DOI 10.1016/S0002-9440(10)64736-0; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hawkins C, 1996, Oncol Nurs Forum, V23, P1203; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; INKSTER S, 1995, J CLIN ENDOCR METAB, V80, P1941, DOI 10.1210/jc.80.6.1941; JACOBS BB, 1967, J NATL CANCER I, V39, P303; Journe F, 2008, BREAST CANCER RES TR, V107, P49, DOI 10.1007/s10549-007-9535-6; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kaeding J, 2008, BIOCHEM J, V410, P245, DOI 10.1042/BJ20071136; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kocarek TA, 2002, J PHARMACOL TOXICOL, V47, P177, DOI 10.1016/S1056-8719(03)00002-9; Kovacic A, 2004, MOL ENDOCRINOL, V18, P252, DOI 10.1210/me.2003-0211; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Lanzino M, 2001, BIOL REPROD, V64, P1439, DOI 10.1095/biolreprod64.5.1439; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Miyata M, 2006, DRUG METAB PHARMACOK, V21, P315, DOI 10.2133/dmpk.21.315; Modica S, 2006, FEBS LETT, V580, P5492, DOI 10.1016/j.febslet.2006.07.082; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Nguyen A, 2008, CELL SIGNAL, V20, P2180, DOI 10.1016/j.cellsig.2008.06.014; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pezzi V, 2004, ENDOCRINOLOGY, V145, P2186, DOI 10.1210/en.2003-1366; Pircher PC, 2003, J BIOL CHEM, V278, P27703, DOI 10.1074/jbc.M302128200; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Swales KE, 2006, CANCER RES, V66, P10120, DOI 10.1158/0008-5472.CAN-06-2399; Volle DH, 2007, GENE DEV, V21, P303, DOI 10.1101/gad.409307; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Young M, 1998, ENDOCRINOLOGY, V139, P5082, DOI 10.1210/en.139.12.5082; Young M, 1997, J STEROID BIOCHEM, V63, P37, DOI 10.1016/S0960-0760(97)00069-1; Zhou J, 2005, CANCER RES, V65, P657	49	51	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5581	5593		10.1074/jbc.M109.052670	http://dx.doi.org/10.1074/jbc.M109.052670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20026603	Green Published, hybrid			2022-12-27	WOS:000275327200050
J	Hirota, N; Yasuda, D; Hashidate, T; Yamamoto, T; Yamaguchi, S; Nagamune, T; Nagase, T; Shimizu, T; Nakamura, M				Hirota, Nobuaki; Yasuda, Daisuke; Hashidate, Tomomi; Yamamoto, Teruyasu; Yamaguchi, Satoshi; Nagamune, Teruyuki; Nagase, Takahide; Shimizu, Takao; Nakamura, Motonao			Amino Acid Residues Critical for Endoplasmic Reticulum Export and Trafficking of Platelet-activating Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; V2 VASOPRESSIN; PHARMACOLOGICAL CHAPERONES; LIGAND-BINDING; TRANSMEMBRANE DOMAINS; IDENTIFICATION; MUTATIONS; RESCUE; INHIBITION; EXPRESSION	Several residues are conserved in the transmembrane domains (TMs) of G-protein coupled receptors. Here we demonstrate that a conserved proline, Pro(247), in TM6 of platelet-activating factor receptor (PAFR) is required for endoplasmic reticulum (ER) export and trafficking after agonist-induced internalization. Alanine-substituted mutants of the conserved residues of PAFRs, including P247A, were retained in the ER. Because a PAFR antagonist, Y-24180, acted as a pharmacological chaperone to rescue ER retention, this retention is due to misfolding of PAFR. Methylcarbamyl (mc)-PAF, a PAFR agonist, did not increase the cell surface expression of P247A, even though another ER-retained mutant, D63A, was effectively trafficked. Signaling and accumulation of the receptors in the early endosomes were observed in the mc-PAF-treated P247A-expressing cells, suggesting that P247A was trafficked to the cell surface by mc-PAF, and thereafter disappeared from the surface due to aberrant trafficking, e.g. enhanced internalization, deficiency in recycling, and/or accelerated degradation. The aberrant trafficking was confirmed with a sortase-A-mediated method for labeling cell surface proteins. These results demonstrate that the conserved proline in TM6 is crucial for intracellular trafficking of PAFR.	[Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Hirota, Nobuaki; Nagase, Takahide] Univ Tokyo, Dept Resp Med, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yamamoto, Teruyasu; Yamaguchi, Satoshi; Nagamune, Teruyuki] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1130033, Japan; [Yamaguchi, Satoshi; Nagamune, Teruyuki; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Nakamura, M (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moto-nakamura@umin.net	Shimizu, Takao/AAV-7052-2021; Nagamune, Teruyuki/R-7708-2017; Yamaguchi, Satoshi/V-3211-2017	Nagamune, Teruyuki/0000-0002-2435-0270; Yamaguchi, Satoshi/0000-0003-4822-7469; Yasuda, Daisuke/0000-0001-5513-0695	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Center for NanoBio Integration, the University of Tokyo	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration, the University of Tokyo	This work was supported in part by a grant-in-aid for Challenging Exploratory Research (to M. N.) and a grant-in-aid for Specially Promoted Research (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants from the Japan Society for the Promotion of Science (Global COE program) and the Center for NanoBio Integration, the University of Tokyo.	Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDA PK, 1993, MOL PHARMACOL, V43, P516; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Ishii I, 1997, J BIOL CHEM, V272, P7846, DOI 10.1074/jbc.272.12.7846; Ishii I, 1998, J BIOL CHEM, V273, P9878, DOI 10.1074/jbc.273.16.9878; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OFLAHERTY JT, 1987, BIOCHEM BIOPH RES CO, V147, P18, DOI 10.1016/S0006-291X(87)80081-5; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAN Y, 1994, J BIOL CHEM, V269, P31933; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; Parent JL, 1996, BIOCHEM BIOPH RES CO, V219, P968, DOI 10.1006/bbrc.1996.0341; Parent JL, 1996, J BIOL CHEM, V271, P23298, DOI 10.1074/jbc.271.38.23298; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; ROSE PM, 1995, FEBS LETT, V361, P243, DOI 10.1016/0014-5793(95)00164-5; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; SOUIED E, 1994, HUM MOL GENET, V3, P1433, DOI 10.1093/hmg/3.8.1433; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; TERASAWA M, 1990, PROSTAGLANDINS, V40, P553, DOI 10.1016/0090-6980(90)90001-C; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Xia S, 2004, P NATL ACAD SCI USA, V101, P15207, DOI 10.1073/pnas.0406571101; Xu W, 2001, BIOCHEMISTRY-US, V40, P8018, DOI 10.1021/bi002490d; Yamamoto T, 2009, CHEM COMMUN, P1022, DOI 10.1039/b818792d; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Zhang HFM, 2003, J BIOL CHEM, V278, P33011, DOI 10.1074/jbc.M305352200	47	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5931	5940		10.1074/jbc.M109.066282	http://dx.doi.org/10.1074/jbc.M109.066282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007715	hybrid, Green Published			2022-12-27	WOS:000275327200083
J	North, SJ; Huang, HH; Sundaram, S; Jang-Lee, J; Etienne, AT; Trollope, A; Chalabi, S; Dell, A; Stanley, P; Haslam, SM				North, Simon J.; Huang, Hung-Hsiang; Sundaram, Subha; Jang-Lee, Jihye; Etienne, A. Tony; Trollope, Alana; Chalabi, Sara; Dell, Anne; Stanley, Pamela; Haslam, Stuart M.			Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and Complexity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC-GLYCOPEPTIDE BETA-4-N-ACETYLGLUCOSAMINYLTRANSFERASE-III; SIALIC ACID TRANSPORTER; GDP-FUCOSE; MOLECULAR-CLONING; CHO MUTANT; GLYCOPROTEIN; EXPRESSION; MUTATION; MANNOSE; ALPHA-1,3-FUCOSYL-TRANSFERASE	Identifying biological roles for mammalian glycans and the pathways by which they are synthesized has been greatly facilitated by investigations of glycosylation mutants of cultured cell lines and model organisms. Chinese hamster ovary (CHO) glycosylation mutants isolated on the basis of their lectin resistance have been particularly useful for glycosylation engineering of recombinant glycoproteins. To further enhance the application of these mutants, and to obtain insights into the effects of altering one specific glycosyltransferase or glycosylation activity on the overall expression of cellular glycans, an analysis of the N-glycans and major O-glycans of a panel of CHO mutants was performed using glycomic analyses anchored by matrix-assisted laser desorption ionization-time of flight/time of flight mass spectrometry. We report here the complement of the major N-glycans and O-glycans present in nine distinct CHO glycosylation mutants. Parent CHO cells grown in monolayer versus suspension culture had similar profiles of N- and O-GalNAc glycans, although the profiles of glycosylation mutants Lec1, Lec2, Lec3.2.8.1, Lec4, LEC10, LEC11, LEC12, Lec13, and LEC30 were consistent with available genetic and biochemical data. However, the complexity of the range of N-glycans observed was unexpected. Several of the complex N-glycan profiles contained structures of m/z similar to 13,000 representing complexN-glycans with a total of 26 N-acetyllactosamine (Gal beta 1-4GlcNAc)(n) units. Importantly, the LEC11, LEC12, and LEC30 CHO mutants exhibited unique complements of fucosylated complex N-glycans terminating in Lewis(x) and sialyl-Lewis(x) determinants. This analysis reveals the larger-than-expected complexity of N-glycans in CHO cell mutants that may be used in a broad variety of functional glycomics studies and for making recombinant glycoproteins.	[Huang, Hung-Hsiang; Sundaram, Subha; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [North, Simon J.; Jang-Lee, Jihye; Etienne, A. Tony; Trollope, Alana; Chalabi, Sara; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England	Yeshiva University; Imperial College London	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	stanley@aecom.yu.edu; s.haslam@imperial.ac.uk		Huang, Hung-Hsiang/0000-0002-0157-2014; Stanley, Pamela/0000-0001-5704-3747	NCI [RO1-36434]; Consortium for Functional Glycomics [GM 62116]; Biotechnology and Biological Sciences Research Council [BBF0083091, B19088]; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Consortium for Functional Glycomics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-36434 from NCI (to P. S.). This work was also supported by Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics Grant GM 62116, Biotechnology and Biological Sciences Research Council Grants BBF0083091 and B19088, and the Wellcome Trust.; Biotechnology and Biological Sciences Research Council Professorial Research Fellow.	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Chen W, 2005, GLYCOBIOLOGY, V15, P259, DOI 10.1093/glycob/cwi011; DELL A, 1994, METHOD ENZYMOL, V230, P108; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Goldberg D, 2009, BIOINFORMATICS, V25, P365, DOI 10.1093/bioinformatics/btn636; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Kanda Y, 2006, BIOTECHNOL BIOENG, V94, P680, DOI 10.1002/bit.20880; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Lee J, 2003, BIOCHEMISTRY-US, V42, P12349, DOI 10.1021/bi0353068; Lim SF, 2008, GLYCOBIOLOGY, V18, P851, DOI 10.1093/glycob/cwn080; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2000, ARCH BIOCHEM BIOPHYS, V375, P322, DOI 10.1006/abbi.1999.1693; POTVIN B, 1991, CELL REGUL, V2, P989, DOI 10.1091/mbc.2.12.989; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; SALLUSTIO S, 1989, SOMAT CELL MOLEC GEN, V15, P387, DOI 10.1007/BF01534890; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stanley P, 2005, GLYCOBIOLOGY, V15, P43, DOI 10.1093/glycob/cwh136; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; STANLEY P, 1980, J CELL BIOL, V85, P60, DOI 10.1083/jcb.85.1.60; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	44	154	157	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5759	5775		10.1074/jbc.M109.068353	http://dx.doi.org/10.1074/jbc.M109.068353			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19951948	Green Published, hybrid			2022-12-27	WOS:000275327200068
J	Regazzetti, C; Bost, F; Le Marchand-Brustel, Y; Tanti, JF; Giorgetti-Peraldi, S				Regazzetti, Claire; Bost, Frederic; Le Marchand-Brustel, Yannick; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie			Insulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING PROTEIN; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; FACTOR-I; STRESS; TARGET; TUMOR; MTOR; GENE; RAPAMYCIN	REDD1 (regulated in development and DNA damage responses) is essential for the inhibition of mTORC1 (mammalian target of rapamycin complex) signaling pathway in response to hypoxia. REDD1 expression is regulated by many stresses such as hypoxia, oxidative stress, and energy depletion. However, the regulation of REDD1 expression in response to insulin remains unknown. In the present study, we demonstrate that in murine and in human adipocytes, insulin stimulates REDD1 expression. Insulin-induced REDD1 expression occurs through phosphoinositide 3-kinase/mTOR-dependent pathways. Moreover, using echinomycin, a hypoxia-inducible factor 1 (HIF-1) inhibitor, and HIF-1 alpha small interfering RNA, we demonstrate that insulin stimulates REDD1 expression only through the transcription factor HIF-1. In conclusion, our study shows that insulin stimulates REDD1 expression in adipocytes.	Mediterranean Res Ctr Mol Med, Team Cellular & Mol Physiopathol Obes & Diabet, INSERM, U895, F-06204 Nice, France; Univ Nice Sophia Antipolis, Inst Federatif Rech 50, F-06204 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Giorgetti-Peraldi, S (corresponding author), Ctr Mediterraneen Med Mol, INSERM, U895, Batiment Archimed,151 Route St Antoine Ginestiere, F-06204 Nice 3, France.	peraldis@unice.fr	BOST, Frederic/AAN-4691-2020	BOST, Frederic/0000-0003-4509-4701; Tanti, Jean-Francois/0000-0003-1782-1318; Regazzetti, Claire/0000-0002-8094-5885; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618	INSERM, France; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); Association for Research on Diabetes (Paris, France); Association pour la Recherche contre le Cancer [1018]; University of Nice-Sophia Antipolis, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes; European Commission [LSHM-CT-2005-018734]	INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM); Association for Research on Diabetes (Paris, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); University of Nice-Sophia Antipolis, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by INSERM, France, the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM), ALFEDIAM-Roche Diagnostics, the Association for Research on Diabetes (Paris, France), the Association pour la Recherche contre le Cancer Grant 1018, the University of Nice-Sophia Antipolis, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes. This work is part of the project "Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome" (HEPADIP), which is supported by the European Commission as an integrated Project under the 6th Framework Program, Contract LSHM-CT-2005-018734.	Aouadi M, 2007, FEBS LETT, V581, P5591, DOI 10.1016/j.febslet.2007.10.064; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Datta K, 2004, CANCER RES, V64, P456, DOI 10.1158/0008-5472.CAN-03-2706; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Eriksson JW, 2007, FEBS LETT, V581, P3734, DOI 10.1016/j.febslet.2007.06.044; Frost RA, 2009, J CELL BIOCHEM, V108, P1192, DOI 10.1002/jcb.22349; Glassford AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1590, DOI 10.1152/ajpendo.00490.2007; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Jin HO, 2009, FEBS LETT, V583, P123, DOI 10.1016/j.febslet.2008.11.035; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Lee JW, 2007, CANCER SCI, V98, P1476, DOI 10.1111/j.1349-7006.2007.00535.x; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079	30	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5157	5164		10.1074/jbc.M109.047688	http://dx.doi.org/10.1074/jbc.M109.047688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996311	hybrid, Green Published			2022-12-27	WOS:000275327200007
J	Wu, LLY; Fan, YJ; Li, SH; Li, XJ; Zhou, XF				Wu, Linda Lin-yan; Fan, Yongjun; Li, Shihua; Li, Xiao-Jiang; Zhou, Xin-Fu			Huntingtin-associated Protein-1 Interacts with Pro-brain-derived Neurotrophic Factor and Mediates Its Transport and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT SECRETION; BDNF MESSENGER-RNA; PRIMARY SENSORY NEURONS; VAL66MET POLYMORPHISM; INTRACELLULAR TRAFFICKING; HIPPOCAMPAL-NEURONS; SYNAPTIC MODULATION; ANTEROGRADE TRANSPORT; AXONAL-TRANSPORT; NERVOUS-SYSTEM	Brain-derived neurotrophic factor (BDNF) plays a pivotal role in brain development and synaptic plasticity. It is synthesized as a precursor (pro-BDNF), sorted into the secretory pathway, transported along dendrites and axons, and released in an activity-dependent manner. Mutant Huntingtin with expanded polyglutamine (polyQ) and the V66M polymorphism of BDNF reduce the dendritic distribution and axonal transport of BDNF. However, the mechanism underlying this defective transport remains unclear. Here, we report that Huntingtin-associated protein-1 (HAP1) interacts with the prodomain of BDNF and that the interaction was reduced in the presence of polyQ-expanded Huntingtin and BDNF V66M. Consistently, there was reduced coimmunoprecipitation of pro-BDNF with HAP1 in the brain homogenate of Huntington disease. Pro-BDNF distribution in the neuronal processes and its accumulation in the proximal and distal segments of crushed sciatic nerve and the activity-dependent release of pro-BDNF were abolished in HAP1(-/-) mice. These results suggest that HAP1 may participate in axonal transport and activity-dependent release of pro-BDNF by interacting with the BDNF prodomain. Accordingly, the decreased interaction between HAP1 and pro-BDNF in Huntington disease may reduce the release and transport of BDNF.	[Wu, Linda Lin-yan; Fan, Yongjun; Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Wu, Linda Lin-yan; Fan, Yongjun; Zhou, Xin-Fu] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Flinders University South Australia; Flinders University South Australia; Emory University	Zhou, XF (corresponding author), Flinders Univ S Australia, Dept Human Physiol, GPO Box 2100, Adelaide, SA 5001, Australia.	Xin-fu.zhou@flinders.edu.au	Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/F-4119-2013; zhou, xin-fu/G-6643-2011	Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175; 	National Health and Medical Research Council [375110, 480423]; Flinders University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Flinders University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Health and Medical Research Council Grants 375110 and 480423.; Supported by an International postgraduate research scholarship and Flinders University postgraduate scholarships.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Butowt R, 2001, J NEUROSCI, V21, P8915, DOI 10.1523/JNEUROSCI.21-22-08915.2001; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Conner JM, 1998, REV NEUROSCIENCE, V9, P91; del Toro D, 2006, J NEUROSCI, V26, P12748, DOI 10.1523/JNEUROSCI.3873-06.2006; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Ferrer I, 1999, REV NEUROLOGIA, V29, P515, DOI 10.33588/rn.2906.99173; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; GRAY EG, 1962, J ANAT, V96, P79; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hashimoto K, 2007, BIOESSAYS, V29, P116, DOI 10.1002/bies.20534; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; Hibbert AP, 2003, J BIOL CHEM, V278, P48129, DOI 10.1074/jbc.M300961200; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Humbert Sandrine, 2005, Journal de la Societe de Biologie, V199, P247, DOI 10.1051/jbio:2005026; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Martin EJ, 1999, J COMP NEUROL, V403, P421; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tonra JR, 1999, MICROSC RES TECHNIQ, V45, P225, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<225::AID-JEMT6>3.0.CO;2-1; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	72	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5614	5623		10.1074/jbc.M109.073197	http://dx.doi.org/10.1074/jbc.M109.073197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19996106	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000275327200053
J	Liang, Y; Zhong, ZD; Huang, YJ; Deng, W; Cao, JX; Tsao, G; Liu, QT; Pei, DQ; Kang, TB; Zeng, YX				Liang, Yi; Zhong, Zhendong; Huang, Yijun; Deng, Wen; Cao, Junxia; Tsao, George; Liu, Quentin; Pei, Duanqing; Kang, Tiebang; Zeng, Yi-Xin			Stem-like Cancer Cells Are Inducible by Increasing Genomic Instability in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE POPULATION; PROSPECTIVE IDENTIFICATION; EVOLUTION; LEUKEMIA; EFFLUX	The existence of cancer stem cells (CSCs) or stem-like cancer cells (SLCCs) is regarded as the cause of tumor formation and recurrence. However, the origin of such cells remains controversial with two competing hypotheses: CSCs are either transformed from tissue adult stem cells or dedifferentiated from transformed progenitor cells. Compelling evidence has determined the chromosomal aneuploidy to be one of the hallmarks of cancer cells, indicating genome instability plays an important role in tumorigenesis, for which CSCs are believed to be the initiator. To gain direct evidence that genomic instability is involved in the induction of SLCCs, we utilized multiple approaches to enhance genomic instability and monitored the percentage of SLCC in cultured cancer cells. Using side population (SP) cells as a marker for SLCC in human nasopharyngeal carcinoma (NPC) and CD133 for human neuroblastoma cells, we found that DNA damage inducers, UV and mitomycin C were capable of increasing SP cells in NPC CNE-2 and neuroblastoma SKN-SH cells. Likewise, either overexpression of a key regulator of cell cycle, Mad2, or knock down of Aurora B, an important kinase in mitosis, or Cdh1, a key E3 ligase in cell cycle, resulted in a significant increase of SP cells in CNE-2. More interestingly, enrichment of SP cells was observed in recurrent tumor tissues as compared with the primary tumor in the same NPC patients. Our study thus suggested that, beside transformation of tissue stem cells leading to CSC generation, genomic instability could be another potential mechanism resulting in SLCC formation, especially at tumor recurrence stage.	[Liang, Yi; Zhong, Zhendong; Cao, Junxia; Liu, Quentin; Kang, Tiebang; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China; [Liang, Yi; Zhong, Zhendong; Cao, Junxia; Liu, Quentin; Kang, Tiebang; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Huang, Yijun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510060, Guangdong, Peoples R China; [Deng, Wen; Tsao, George] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Pei, Duanqing] Guangzhou Inst Biomed, Guangzhou 510663, Guangdong, Peoples R China; [Pei, Duanqing] Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Kang, TB (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, 651 DongFeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	kangtb@mail.sysu.edu.cn; zengyix@mail.sysu.edu.cn	Deng, Wen/M-5208-2019; Deng, Wen/C-4154-2009; Zhong, Zhendong/K-5223-2013	Kang, Tiebang/0000-0001-8805-4174	Chinese National 973 Program [2006CB910104, 2010CB912201]; Chinese National 863 Program [2006AA02A404]; Guangdong Province-National Natural Science Foundation of China [u0732005]	Chinese National 973 Program(National Basic Research Program of China); Chinese National 863 Program; Guangdong Province-National Natural Science Foundation of China	The work was supported by the Chinese National 973 Program (Grants 2006CB910104 and 2010CB912201), the Chinese National 863 Program (Grant 2006AA02A404), and the Guangdong Province-National Natural Science Foundation of China Cooperation Program (Grant u0732005).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bapat SA, 2007, SEMIN CANCER BIOL, V17, P204, DOI 10.1016/j.semcancer.2006.05.001; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Deng W, 2003, CYTOM PART A, V51A, P46, DOI 10.1002/cyto.a.10004; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Houghton J, 2007, SEMIN CANCER BIOL, V17, P191, DOI 10.1016/j.semcancer.2006.04.003; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lagasse E, 2008, GENE THER, V15, P136, DOI 10.1038/sj.gt.3303068; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li LD, 2009, CELL CYCLE, V8, P1000, DOI 10.4161/cc.8.7.8041; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2003, CANCER RES, V63, P5821; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	37	91	108	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4931	4940		10.1074/jbc.M109.048397	http://dx.doi.org/10.1074/jbc.M109.048397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007324	Green Published, hybrid			2022-12-27	WOS:000275274800070
J	Rossi, A; Pisani, F; Nicchia, GP; Svelto, M; Frigeri, A				Rossi, Andrea; Pisani, Francesco; Nicchia, Grazia Paola; Svelto, Maria; Frigeri, Antonio			Evidences for a Leaky Scanning Mechanism for the Synthesis of the Shorter M23 Protein Isoform of Aquaporin-4 IMPLICATION IN ORTHOGONAL ARRAY FORMATION AND NEUROMYELITIS OPTICA ANTIBODY INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSENSITIVE WATER CHANNEL; MUSCLE PLASMA-MEMBRANE; MULTIPLE-SCLEROSIS; MESSENGER-RNA; SQUARE ARRAYS; MOUSE-BRAIN; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; FREEZE-FRACTURE; KNOCKOUT MICE	Aquaporin-4 (AQP4) exists as two major isoforms that differ in the length of the N terminus, the shorter AQP4-M23 and the longer AQP4-M1. Both isoforms form tetramers, which can further aggregate in the plasma membrane to form typical orthogonal arrays of particles (OAPs) whose dimension depends on the ratio of the M1 and M23. In this study, we tested the hypothesis that the M23 isoform can be produced directly by the M1 mRNA. In cells transiently transfected with AQP4-M1 coding sequence we observed besides AQP4-M1 the additional presence of the AQP4-M23 isoform associated with the formation of typical OAPs observable by two-dimensional blue native/SDS-PAGE and total internal reflection microscopy. The mutation of the second in-frame methionine M23 in AQP4-M1 (AQP4-M1(M23I)) prevented the expression of the M23 isoform and the formation of OAPs. We propose "leaky scanning" as a translational mechanism for the expression of AQP4-M23 protein isoform and that the formation of OAPs may occur even in the absence of AQP4-M23 mRNA. This mechanism can have important pathophysiological implications for the cell regulation of the M1/M23 ratio and thus OAP size. In this study we also provide evidence that AQP4-M1 is mobile in the plasma membrane, that it is inserted and not excluded into immobile OAPs, and that it is an important determinant of OAP structure and size.	[Frigeri, Antonio] Univ Bari, Dept Gen & Environm Physiol, I-70125 Bari, Italy; Univ Bari, Ctr Excellence Comparat Genom, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Frigeri, A (corresponding author), Univ Bari, Dept Gen & Environm Physiol, I-70125 Bari, Italy.	a.frigeri@biologia.uniba.it	PISANI, Francesco/AAC-1749-2019; frigeri, Antonio/AAC-6336-2022; Svelto, Maria/P-6186-2014	PISANI, Francesco/0000-0001-8511-117X; Frigeri, Antonio/0000-0002-5284-2934; Svelto, Maria/0000-0002-5584-9541; Rossi, Andrea/0000-0001-5863-6448	Progetto strategico regionale Neurobiotech [124]; Rete Nazionale di Proteomica, Fondo per gli Investimenti della Ricerca di Base 2008 [RBRN07BMCT]	Progetto strategico regionale Neurobiotech; Rete Nazionale di Proteomica, Fondo per gli Investimenti della Ricerca di Base 2008	This work was supported by Progetto strategico regionale Neurobiotech, Project Number 124 Regione Puglia and Rete Nazionale di Proteomica, Fondo per gli Investimenti della Ricerca di Base 2008, RBRN07BMCT.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; FRIGERI A, 1995, J CELL SCI, V108, P2993; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nicchia GP, 2008, J NEUROCHEM, V105, P2156, DOI 10.1111/j.1471-4159.2008.05302.x; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Nicchia GP, 2008, GLIA, V56, P869, DOI 10.1002/glia.20661; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2003, J CLIN PATHOL, V56, P972, DOI 10.1136/jcp.56.12.972; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Umenishi F, 1996, DNA CELL BIOL, V15, P475, DOI 10.1089/dna.1996.15.475; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; Van Hoek AN, 2000, AM J PHYSIOL-RENAL, V278, pF310, DOI 10.1152/ajprenal.2000.278.2.F310; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; WAKAYAMA Y, 1984, NEUROLOGY, V34, P1313, DOI 10.1212/WNL.34.10.1313; WAKAYAMA Y, 1986, ACTA NEUROPATHOL, V72, P130, DOI 10.1007/BF00685974; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zelenin S, 2000, PEDIATR RES, V48, P335, DOI 10.1203/00006450-200009000-00012	55	46	49	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4562	4569		10.1074/jbc.M109.069245	http://dx.doi.org/10.1074/jbc.M109.069245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007705	Green Published, hybrid			2022-12-27	WOS:000275274800033
J	Asaoka, Y; Kanai, F; Ichimura, T; Tateishi, K; Tanaka, Y; Ohta, M; Seto, M; Tada, M; Ijichi, H; Ikenoue, T; Kawabe, T; Isobe, T; Yaffe, MB; Omata, M				Asaoka, Yoshinari; Kanai, Fumihiko; Ichimura, Tohru; Tateishi, Keisuke; Tanaka, Yasuo; Ohta, Miki; Seto, Motoko; Tada, Motohisa; Ijichi, Hideaki; Ikenoue, Tsuneo; Kawabe, Takao; Isobe, Toshiaki; Yaffe, Michael B.; Omata, Masao			Identification of a Suppressive Mechanism for Hedgehog Signaling through a Novel Interaction of Gli with 14-3-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CUBITUS-INTERRUPTUS; BINDING; CANCER; PATHWAYS; 14-3-3-PROTEINS; DEGRADATION; ACTIVATION; EXPRESSION; FAMILY	Gli transcription factors are central effectors of Hedgehog signaling in development and tumorigenesis. Using a tandem affinity purification (TAP) strategy and mass spectrometry, we have found that Gli1 interacts with 14-3-3 epsilon, and that Gli2 and Gli3 also bind to 14-3-3 epsilon through homologous sites. This interaction depends on their phosphorylation, and cAMP-dependent protein kinase (PKA), a known negative regulator of Hedgehog signaling serves as a responsible kinase. A Gli2 mutant engineered to eliminate this interaction exhibited increased transcriptional activity (2 similar to 3 x). Transcriptional repression by 14-3-3 binding was also observed with Gli3, when its N-terminal repressor domain was deleted. The phosphorylation sites responsible for the binding to 14-3-3 are distinct from those required for proteolysis, the known mechanism for PKA-induced repression of Hh signaling. Our data propose a novel mechanism in which PKA down-regulates Hedgehog signaling by promoting the interaction between Gli and 14-3-3 as well as proteolysis. Given the certain neuronal or malignant disorders in human caused by the abnormality of 17p13 encompassing 14-3-3 epsilon overlap with increased Hh signaling, the Gli-14-3-3 interaction may have pathological significance for those human diseases.	[Seto, Motoko; Ijichi, Hideaki; Ikenoue, Tsuneo; Kawabe, Takao] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Kawabe, Takao] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo 1138655, Japan; [Kanai, Fumihiko; Tada, Motohisa] Chiba Univ, Grad Sch Med, Dept Med, Chiba 2608677, Japan; [Kanai, Fumihiko; Tada, Motohisa] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chiba 2608677, Japan; [Ichimura, Tohru] Natl Def Acad, Dept Appl Chem, Kanagawa 2398686, Japan; [Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Tokyo; University of Tokyo; Chiba University; Chiba University; National Defence Academy - Japan; Tokyo Metropolitan University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Asaoka, Y (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	yasa-tky@umin.ac.jp	Ijichi, Hideaki/AAE-6692-2022; Isobe, Toshiaki/Q-9279-2017; Asaoka, Yoshinari/ABC-5412-2021; IJICHI, Hideaki/AGZ-2874-2022; Ijichi, Hideaki/V-2720-2019	Ijichi, Hideaki/0000-0002-2379-7986; Asaoka, Yoshinari/0000-0002-2805-8226; IJICHI, Hideaki/0000-0002-2379-7986; Tanaka, Yasuo/0000-0002-2917-3365	National Institutes of Health [GM60594]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60594 (to M.B.Y.).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Ferretti E, 2005, TRENDS MOL MED, V11, P537, DOI 10.1016/j.molmed.2005.10.005; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lau JMC, 2006, DEV DYNAM, V235, P1761, DOI 10.1002/dvdy.20816; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Tada M, 2008, CLIN CANCER RES, V14, P3768, DOI 10.1158/1078-0432.CCR-07-1181; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tanaka Y, 2006, ONCOGENE, V25, P633, DOI 10.1038/sj.onc.1209093; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	34	31	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4185	4194		10.1074/jbc.M109.038232	http://dx.doi.org/10.1074/jbc.M109.038232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996099	Green Published, hybrid			2022-12-27	WOS:000275254000070
J	Wadhwa, R; Ryu, J; Gao, R; Choi, IK; Morrow, G; Kaur, K; Kim, I; Kaul, SC; Yun, CO; Tanguay, RM				Wadhwa, Renu; Ryu, Jihoon; Gao, Ran; Choi, Il-Kyu; Morrow, Genevieve; Kaur, Kamaljit; Kim, Inwook; Kaul, Sunil C.; Yun, Chae-Ok; Tanguay, Robert M.			Proproliferative Functions of Drosophila Small Mitochondrial Heat Shock Protein 22 in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROMUSCULAR DISORDERS; LIFE-SPAN EXTENSION; ALPHA-B-CRYSTALLIN; HSP22 HSPB8; BREAST-CANCER; P53; MORTALIN; EXPRESSION; MELANOGASTER; MEMBER	Aging is a complex process accompanied by a decreased capacity of cells to cope with random damages induced by reactive oxygen species, the natural by-products of energy metabolism, leading to protein aggregation in various components of the cell. Chaperones are important players in the aging process as they prevent protein misfolding and aggregation. Small chaperones, such as small heat shock proteins, are involved in the refolding and/or disposal of protein aggregates, a feature of many age-associated diseases. In Drosophila melanogaster, mitochondrial Hsp22 (DmHsp22), is localized in the mitochondrial matrix and is preferentially up-regulated during aging. Its overexpression results in an extension of life span (>30%) (Morrow, G., Samson, M., Michaud, S., and Tanguay, R. M. (2004) FASEB J. 18, 598-599 and Morrow, G., Battistini, S., Zhang, P., and Tanguay, R. M. (2004) J. Biol. Chem. 279, 43382-43385). Long lived flies expressing Hsp22 also have an increased resistance to oxidative stress and maintain locomotor activity longer. In the present study, the cross-species effects of Hsp22 expression were tested. DmHsp22 was found to be functionally active in human cells. It extended the life span of normal fibroblasts, slowing the aging process as evidenced by a lower level of the senescence associated beta-galactosidase. DmHsp22 expression in human cancer cells increased their malignant properties including anchorage-independent growth, tumor formation in nude mice, and resistance to a variety of anticancer drugs. We report that the DmHsp22 interacts and inactivates wild type tumor suppressor protein p53, which may be one possible way of its functioning in human cells.	[Ryu, Jihoon; Yun, Chae-Ok] Yonsei Univ, Coll Med, Inst Canc Res, Brain Korea Project Med Sci 21, Seoul, South Korea; [Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Choi, Il-Kyu; Kim, Inwook; Yun, Chae-Ok] Yonsei Univ, Grad Program Nanomed Sci, Seoul, South Korea; [Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Pav CE Marchand, PROTEO, Dept Med,Lab Genet Cellulaire & Dev, Quebec City, PQ G1V 0A6, Canada	Yonsei University; Yonsei University Health System; National Institute of Advanced Industrial Science & Technology (AIST); Yonsei University; Laval University	Yun, CO (corresponding author), Yonsei Univ, Coll Med, Inst Canc Res, Brain Korea Project Med Sci 21, 134 Shinchon Dong, Seoul, South Korea.	chaeok@yuhs.ac; Robert.tanguay@rsvs.ulaval.ca	Kaul, Sunil C/L-8671-2018; Yun, Chae-Ok/P-3698-2015; Kim, In-Wook/AAN-8123-2020; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Kim, In-Wook/0000-0002-5501-2928; Wadhwa, Renu/0000-0001-8248-5192; Yun, Chae-Ok/0000-0002-9466-4531; Gao, Ran/0000-0001-8712-429X	Canadian Institutes of Health Research [MOP-77796]; New Energy and Industrial Technology Development Organization (Japan); Ministry of Commerce Industry and Energy [10030051]; Korea Science and Engineering Foundation [R01-2006-000-10084-0, R15-2004-024-02001-0, M10416130002-04N1613-00210]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); New Energy and Industrial Technology Development Organization (Japan)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Commerce Industry and Energy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by grants from the Canadian Institutes of Health Research (MOP-77796), New Energy and Industrial Technology Development Organization (Japan), the Ministry of Commerce Industry and Energy (10030051), and the Korea Science and Engineering Foundation (R01-2006-000-10084-0, R15-2004-024-02001-0, M10416130002-04N1613-00210).	Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Besada V, 2006, PROTEOMICS, V6, P1038, DOI 10.1002/pmic.200500151; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Fichtner I, 2004, EUR J CANCER, V40, P845, DOI 10.1016/j.ejca.2003.11.030; Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Heikkila JJ, 2007, BIOTECHNOL ADV, V25, P385, DOI 10.1016/j.biotechadv.2007.03.003; Hu ZP, 2007, J NEUROSCI RES, V85, P2071, DOI 10.1002/jnr.21231; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaul SC, 2000, FEBS LETT, V474, P159, DOI 10.1016/S0014-5793(00)01594-5; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kim MV, 2006, ARCH BIOCHEM BIOPHYS, V454, P32, DOI 10.1016/j.abb.2006.07.014; King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Michaud S, 1997, CELL MOL LIFE SCI, V53, P104, DOI 10.1007/PL00000572; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Morrow Genevieve, 2008, Biotechnology Journal, V3, P728, DOI 10.1002/biot.200800015; Morselli E, 2009, CELL CYCLE, V8, P1647; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Robertson JFR, 1996, INT J BIOL MARKER, V11, P29, DOI 10.1177/172460089601100106; Shemetov AA, 2008, J NEUROSCI RES, V86, P264, DOI 10.1002/jnr.21441; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; Sun X, 2007, CELL STRESS CHAPERON, V12, P307, DOI 10.1379/CSC-276.1; Tao D, 2004, ACTA BIOCH BIOPH SIN, V36, P618, DOI 10.1093/abbs/36.9.618; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439	42	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3833	3839		10.1074/jbc.M109.080424	http://dx.doi.org/10.1074/jbc.M109.080424			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948727	hybrid, Green Published			2022-12-27	WOS:000275254000036
J	Chen, ZH; Akin, BL; Jones, LR				Chen, Zhenhui; Akin, Brandy L.; Jones, Larry R.			Ca2+ Binding to Site I of the Cardiac Ca2+ Pump Is Sufficient to Dissociate Phospholamban	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; CROSS-LINKING; FUNCTIONAL CONSEQUENCES; STRUCTURAL BASIS; ATPASE; CA2+-ATPASE; ACTIVATION; MECHANISM; CA-2+-ATPASE	Phospholamban (PLB) inhibits the activity of SERCA2a, the Ca2+-ATPase in cardiac sarcoplasmic reticulum, by decreasing the apparent affinity of the enzyme for Ca2+. Recent cross-linking studies have suggested that PLB binding and Ca2+ binding to SERCA2a are mutually exclusive. PLB binds to the E2 conformation of the Ca2+-ATPase, preventing formation of E1, the conformation that binds two Ca2+ (at sites I and II) with high affinity and is required for ATP hydrolysis. Here we determined whether Ca2+ binding to site I, site II, or both sites is sufficient to dissociate PLB from the Ca2+ pump. Seven SERCA2a mutants with amino acid substitutions at Ca2+-binding site I (E770Q, T798A, and E907Q), site II (E309Q and N795A), or both sites (D799N and E309Q/E770Q) were made, and the effects of Ca2+ on N30C-PLB cross-linking to Lys328 of SERCA2a were measured. In agreement with earlier reports with the skeletal muscle Ca2+-ATPase, none of the SERCA2a mutants (except E907Q) hydrolyzed ATP in the presence of Ca2+; however, all were phosphorylatable by Pi to form E2P. Ca2+ inhibition of E2P formation was observed only in SERCA2a mutants retaining site I. In cross-linking assays, strong cross-linking between N30C-PLB and each Ca2+-ATPase mutant was observed in the absence of Ca2+. Importantly, however, micromolar Ca2+ inhibited PLB cross-linking only to mutants retaining a functional Ca2+-binding site I. The dynamic equilibrium between Ca2+ pumps and N30C-PLB was retained by all mutants, demonstrating normal regulation of cross-linking by ATP, thapsigargin, and anti-PLB antibody. From these results we conclude that site I is the key Ca2+-binding site regulating the physical association between PLB and SERCA2a.	[Jones, Larry R.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Jones, LR (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu			National Institutes of Health [HL49428]; Showalter Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428, R01HL049428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49428 (to L.R.J.). This work was also supported by a Showalter Cardiovascular Research Grant (to Z.C.).	ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Frank K, 2000, ANN MED, V32, P572, DOI 10.3109/07853890008998837; INESI G, 1980, J BIOL CHEM, V255, P3025; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	26	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3253	3260		10.1074/jbc.M109.080820	http://dx.doi.org/10.1074/jbc.M109.080820			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948724	Green Published, hybrid			2022-12-27	WOS:000273829000040
J	Ghaemmaghami, S; Ullman, J; Ahn, M; St Martin, S; Prusiner, SB				Ghaemmaghami, Sina; Ullman, Julie; Ahn, Misol; St Martin, Susan; Prusiner, Stanley B.			Chemical Induction of Misfolded Prion Protein Conformers in Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION; BRANCHED POLYAMINES; POTENT INHIBITION; PRPSC; DISEASE; ACCUMULATION; ANTIBODIES; STRAINS; MUTANT; THERAPEUTICS	Prion-infected cells accumulate a heterogeneous population of aberrantly folded PrP conformers, including the disease-causing isoform (PrPSc). We found that specific chemicals can modulate the levels of various PrP conformers in cultured cells. Positively charged polyamidoamines (dendrimers) eliminated protease-resistant (r) PrPSc from prion-infected cells and induced the formation of insoluble, protease-sensitive PrP aggregates (designated PrPA). Larger, positively charged polyamidoamines more efficaciously induced the formation of PrPA and cleared rPrP(Sc), whereas negatively charged polyamidoamines neither induced PrPA nor cleared rPrP(Sc). Although the biochemical properties of PrPA were shown to be similar to protease-sensitive (s) PrPSc, bioassays of PrPA indicated that it is not infectious. Our studies argue that PrPA represents an aggregated PrP species that is off-pathway relative to the formation of rPrP(Sc). It remains to be established whether the formation of PrPA inhibits the formation of rPrP(Sc) by sequestering PrPC in the form of benign, insoluble aggregates.	[Ghaemmaghami, Sina; Ullman, Julie; Ahn, Misol; St Martin, Susan; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Ghaemmaghami, Sina; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), 513 Parnassus Ave,HSE 774, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu		Ghaemmaghami, Sina/0000-0002-8696-2950; Ullman, Julie/0000-0003-1325-0650; Ahn, Misol/0000-0002-6088-8481	National Institutes of Health [AG02132, AG10770, AG021601]; NATIONAL INSTITUTE ON AGING [P01AG002132, P01AG010770, P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG02132, AG10770, and AG021601 as well as by gifts from the G. Harold and Leila Y. Mathers Foundation, Hillblom Foundation, Fight for Mike Homer Program, and Mr. Robert Galvin.	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kong Qingzhong, 2004, VVolume 41, P673; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Lee IS, 2005, J AM CHEM SOC, V127, P13802, DOI 10.1021/ja055219y; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; May BCH, 2003, P NATL ACAD SCI USA, V100, P3416, DOI 10.1073/pnas.2627988100; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Prior M, 2007, J VIROL, V81, P11195, DOI 10.1128/JVI.02559-06; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631	45	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10415	10423		10.1074/jbc.M109.045112	http://dx.doi.org/10.1074/jbc.M109.045112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	19955177	Green Published, hybrid			2022-12-27	WOS:000276264600027
J	Lhee, S; Kolling, DRJ; Nair, SK; Dikanov, SA; Crofts, AR				Lhee, Sangmoon; Kolling, Derrick R. J.; Nair, Satish K.; Dikanov, Sergei A.; Crofts, Antony R.			Modifications of Protein Environment of the [2Fe-2S] Cluster of the bc(1) Complex EFFECTS ON THE BIOPHYSICAL PROPERTIES OF THE RIESKE IRON-SULFUR PROTEIN AND ON THE KINETICS OF THE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CYTOCHROME BC(1); COUPLED ELECTRON-TRANSFER; WATER-SOLUBLE FRAGMENT; FORMING HYDROGEN-BONDS; BOVINE HEART; RHODOBACTER-SPHAEROIDES; Q-CYCLE; Q(O) SITE; RHODOPSEUDOMONAS-SPHAEROIDES; UBIHYDROQUINONE OXIDATION	The rate-determining step in the overall turnover of the bc(1) complex is electron transfer from ubiquinol to the Rieske iron-sulfur protein (ISP) at the Q(o)-site. Structures of the ISP from Rhodobacter sphaeroides show that serine 154 and tyrosine 156 form H-bonds to S-1 of the [2Fe-2S] cluster and to the sulfur atom of the cysteine liganding Fe-1 of the cluster, respectively. These are responsible in part for the high potential (E-m,E-7 similar to 300 mV) and low pK(a) (7.6) of the ISP, which determine the overall reaction rate of the bc(1) complex. We have made site-directed mutations at these residues, measured thermodynamic properties using protein film voltammetry to evaluate the E-m and pK(a) values of ISPs, explored the local proton environment through two-dimensional electron spin echo envelope modulation, and characterized function in strains S154T, S154C, S154A, Y156F, and Y156W. Alterations in reaction rate were investigated under conditions in which concentration of one substrate (ubiquinol or ISPox) was saturating and the other was varied, allowing calculation of kinetic terms and relative affinities. These studies confirm that H-bonds to the cluster or its ligands are important determinants of the electrochemical characteristics of the ISP, likely through electron affinity of the interacting atom and the geometry of the H-bonding neighborhood. The calculated parameters were used in a detailed Marcus-Bronsted analysis of the dependence of rate on driving force and pH. The proton-first-then-electron model proposed accounts naturally for the effects of mutation on the overall reaction.	[Nair, Satish K.; Crofts, Antony R.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Lhee, Sangmoon; Kolling, Derrick R. J.; Nair, Satish K.; Crofts, Antony R.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Dikanov, Sergei A.] Univ Illinois, Dept Clin Vet Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Crofts, AR (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.	a-crofts@life.uiuc.edu	Nair, Satish/AAY-2510-2021	LHEE, SANGMOON/0000-0002-5395-5623	National Institutes of Health; NCRR [GM35438, GM62954, RR15878]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062954, R01GM035438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM35438 (to A. R. C.), GM62954 (to S. A. D.), and S10-RR15878 from NCRR (for instrumentation).	ANDREWS KM, 1984, THESIS U ILLINOIS UR; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; Brandt U, 1997, BIOCHEMISTRY-US, V36, P11234, DOI 10.1021/bi970968g; Brandt U, 1996, FEBS LETT, V387, P1, DOI 10.1016/0014-5793(96)00436-X; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Cape JL, 2009, BIOCHEMISTRY-US, V48, P10716, DOI 10.1021/bi901205w; Covian R, 2002, J BIOL CHEM, V277, P48449, DOI 10.1074/jbc.M208060200; Covian R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2006, BBA-BIOENERGETICS, V1757, P1019, DOI 10.1016/j.bbabio.2006.02.009; Crofts AR, 2005, RSC BIOMOLEC SCI, P123; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15791, DOI 10.1021/bi990961u; Crofts AR, 2004, PHOTOSYNTH RES, V80, P223, DOI 10.1023/B:PRES.0000030444.52579.10; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; CROFTS AR, 2002, P 12 C PHOT RES BRIS; Degli Esposti M, 1987, Biochem J, V241, P285; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; DIKANOV SA, 1982, CHEM PHYS LETT, V90, P149, DOI 10.1016/0009-2614(82)83630-0; Dikanov SA, 2006, J BIOL CHEM, V281, P27416, DOI 10.1074/jbc.M604103200; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; DUTTON PL, 1972, EUR J BIOCHEM, V30, P495, DOI 10.1111/j.1432-1033.1972.tb02121.x; Engstrom G, 2002, J BIOL CHEM, V277, P31072, DOI 10.1074/jbc.M202594200; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; Guergova-Kuras M, 2000, BIOCHEMISTRY-US, V39, P7436, DOI 10.1021/bi992491+; GURBIEL RJ, 1991, BIOCHEMISTRY-US, V30, P11579, DOI 10.1021/bi00113a013; Hammes-Schiffer S, 2008, J PHYS CHEM B, V112, P14108, DOI 10.1021/jp805876e; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; Hunsicker-Wang LM, 2003, BIOCHEMISTRY-US, V42, P7303, DOI 10.1021/bi0342719; Iwaki M, 2005, BIOCHEMISTRY-US, V44, P4230, DOI 10.1021/bi047533v; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Klingen AR, 2004, BIOCHEMISTRY-US, V43, P12383, DOI 10.1021/bi0488606; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Kolling DRJ, 2009, J PHYS CHEM A, V113, P653, DOI 10.1021/jp806789x; Konkle ME, 2009, BIOCHEMISTRY-US, V48, P9848, DOI 10.1021/bi901126u; KRAMER DM, 1993, BIOCHIM BIOPHYS ACTA, V1184, P251; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; Lin IJ, 2006, J AM CHEM SOC, V128, P10672, DOI 10.1021/ja0627388; LINK TA, 1994, BBA-BIOENERGETICS, V1185, P81, DOI 10.1016/0005-2728(94)90196-1; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LINK TA, 1992, EUR J BIOCHEM, V208, P685, DOI 10.1111/j.1432-1033.1992.tb17235.x; Manner VW, 2009, J AM CHEM SOC, V131, P9874, DOI 10.1021/ja902942g; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Miller T.M, 2007, CRC HDB CHEM PHYS, V88th; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; NOODLEMAN L, 1984, J AM CHEM SOC, V106, P2316, DOI 10.1021/ja00320a017; PRINCE RC, 1976, FEBS LETT, V65, P117, DOI 10.1016/0014-5793(76)80634-5; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; Samoilova RI, 2002, J BIOL CHEM, V277, P4605, DOI 10.1074/jbc.C100664200; Schroter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Shan SO, 1996, P NATL ACAD SCI USA, V93, P14474, DOI 10.1073/pnas.93.25.14474; SNOZZI M, 1984, BIOCHIM BIOPHYS ACTA, V766, P451, DOI 10.1016/0005-2728(84)90261-5; Suresh SJ, 2000, J CHEM PHYS, V113, P9727, DOI 10.1063/1.1320822; TAKAMIYA KI, 1979, BIOCHIM BIOPHYS ACTA, V546, P1, DOI 10.1016/0005-2728(79)90166-X; Ugulava NB, 1998, FEBS LETT, V440, P409, DOI 10.1016/S0014-5793(98)01493-8; VANDOREN SR, 1993, BIOCHEMISTRY-US, V32, P8083, DOI 10.1021/bi00083a005; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YUN CH, 1990, EUR J BIOCHEM, V194, P399, DOI 10.1111/j.1432-1033.1990.tb15633.x; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104; Zu YB, 2003, BIOCHEMISTRY-US, V42, P12400, DOI 10.1021/bi0350957; Zu YB, 2001, J AM CHEM SOC, V123, P9906, DOI 10.1021/ja016532c	80	32	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9233	9248		10.1074/jbc.M109.043505	http://dx.doi.org/10.1074/jbc.M109.043505			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20023300	Green Published, hybrid			2022-12-27	WOS:000275553700072
J	Ma, DZ; Bai, XC; Zou, HF; Lai, YM; Jiang, Y				Ma, Dongzhu; Bai, Xiaochun; Zou, Huafei; Lai, Yumei; Jiang, Yu			Rheb GTPase Controls Apoptosis by Regulating Interaction of FKBP38 with Bcl-2 and Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR; PROTEIN; TOR; COMPLEX; GROWTH; RAPTOR; ACTIVATION; INHIBITOR; TARGET; ROLES	FKBP38 is a member of the family of FK506-binding proteins that acts as an inhibitor of the mammalian target of rapamycin (mTOR). The inhibitory action of FKBP38 is antagonized by Rheb, an oncogenic small GTPase, which interacts with FKBP38 and prevents its association with mTOR. In addition to the role in mTOR regulation, FKBP38 is also involved in binding and recruiting Bcl-2 and Bcl-XL, two anti-apoptotic proteins, to mitochondria. In this study, we investigated the possibility that Rheb controls apoptosis by regulating the interaction of FKBP38 with Bcl-2 and Bcl-XL. We demonstrate in vitro that the interaction of FKBP38 with Bcl-2 is regulated by Rheb in a GTP-dependent manner. In cultured cells, the interaction is controlled by Rheb in response to changes in amino acid and growth factor conditions. Importantly, we found that the Rheb-dependent release of Bcl-XL from FKBP38 facilitates the association of this anti-apoptotic protein with the pro-apoptotic protein Bak. Consequently, when Rheb activity increases, cells become more resistant to apoptotic inducers. Our findings reveal a novel mechanism through which growth factors and amino acids control apoptosis.	[Ma, Dongzhu; Zou, Huafei; Lai, Yumei; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bai, Xiaochun] So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510510, Guangdong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China	Jiang, Y (corresponding author), W1058 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	yuj5@pitt.edu		Bai, Xiaochun/0000-0001-9631-4781	National Institutes of Health [CA129821, GM068832]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129821 and GM068832 (to Y.J.).	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Freilinger A, 2006, ONCOGENE, V25, P6467, DOI 10.1038/sj.onc.1209660; GERMAIN M, 2003, SCI STKE, pPE10; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; Mak BC, 2004, CANCER INVEST, V22, P588, DOI 10.1081/CNV-200027144; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	31	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8621	8627		10.1074/jbc.M109.092353	http://dx.doi.org/10.1074/jbc.M109.092353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20048149	Green Published, hybrid			2022-12-27	WOS:000275553700014
J	Soliman, GA; Acosta-Jaquez, HA; Dunlop, EA; Ekim, B; Maj, NE; Tee, AR; Fingar, DC				Soliman, Ghada A.; Acosta-Jaquez, Hugo A.; Dunlop, Elaine A.; Ekim, Bilgen; Maj, Nicole E.; Tee, Andrew R.; Fingar, Diane C.			mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; TUBEROUS SCLEROSIS COMPLEX-1; MAMMALIAN-CELL SIZE; GENE-PRODUCTS; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; INDUCED INHIBITION; TSC1-TSC2 COMPLEX; BINDING PARTNER; RAG GTPASES; TARGET	The mammalian target of rapamycin (mTOR) Ser/Thr kinase signals in at least two multiprotein complexes distinguished by their different partners and sensitivities to rapamycin. Acute rapamycin inhibits signaling by mTOR complex 1 (mTORC1) but not mTOR complex 2 (mTORC2), which both promote cell growth, proliferation, and survival. Although mTORC2 regulation remains poorly defined, diverse cellular mitogens activate mTORC1 signaling in a manner that requires sufficient levels of amino acids and cellular energy. Before the identification of distinct mTOR complexes, mTOR was reported to autophosphorylate on Ser-2481 in vivo in a rapamycin-and amino acid-insensitive manner. These results suggested that modulation of mTOR intrinsic catalytic activity does not universally underlie mTOR regulation. Here we re-examine the regulation of mTOR Ser-2481 autophosphorylation (Ser(P)-2481) in vivo by studying mTORC-specific Ser(P)-2481 inmTORC1 and mTORC2, with a primary focus on mTORC1. In contrast to previous work, we find that acute rapamycin and amino acid withdrawal markedly attenuate mTORC1-associated mTOR Ser(P)-2481 in cycling cells. Although insulin stimulates both mTORC1- and mTORC2-associated mTOR Ser(P)-2481 in a phosphatidylinositol 3-kinase-dependent manner, rapamycin acutely inhibits insulin-stimulated mTOR Ser(P)-2481 in mTORC1 but not mTORC2. By interrogating diverse mTORC1 regulatory input, we find that without exception mTORC1-activating signals promote, whereas mTORC1-inhibitory signals decrease mTORC1-associated mTOR Ser(P)-2481. These data suggest that mTORC1- and likely mTORC2-associated mTOR Ser-2481 autophosphorylation directly monitors intrinsic mTORC-specific catalytic activity and reveal that rapamycin inhibits mTORC1 signaling in vivo by reducing mTORC1 catalytic activity.	[Soliman, Ghada A.; Acosta-Jaquez, Hugo A.; Ekim, Bilgen; Maj, Nicole E.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Soliman, Ghada A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; [Dunlop, Elaine A.; Tee, Andrew R.] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cardiff University	Fingar, DC (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	dfingar@umich.edu	/J-6218-2019; Soliman, Ghada A/U-6472-2017	/0000-0002-9209-7561; Soliman, Ghada A/0000-0002-8629-6062; Tee, Andrew/0000-0002-5577-4631	National Institutes of Health [R01 DK-078135, K01 DK-60654]; American Diabetes Association; Michigan Diabetes Research and Training Center; American Heart Association; Worldwide Cancer Research [06-0914] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, K01DK060654, R01DK078135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; American Heart Association(American Heart Association); Worldwide Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK-078135 (to D. C. F.) and K01 DK-60654 ( to G. A. S.). This work was also supported by the American Diabetes Association, the Michigan Diabetes Research and Training Center (to D. C. F.), and the American Heart Association (to G. A. S. and B. E.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rosner M, 2009, HUM MOL GENET, V18, P3298, DOI 10.1093/hmg/ddp271; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; STAN R, 1994, J BIOL CHEM, V269, P32027; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	69	172	178	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7866	7879		10.1074/jbc.M109.096222	http://dx.doi.org/10.1074/jbc.M109.096222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20022946	Green Published, hybrid			2022-12-27	WOS:000275413800004
J	Fletcher, PL; Fletcher, MD; Weninger, K; Anderson, TE; Martin, BM				Fletcher, Paul L., Jr.; Fletcher, Maryann D.; Weninger, Keith; Anderson, Trevor E.; Martin, Brian M.			Vesicle-associated Membrane Protein (VAMP) Cleavage by a New Metalloprotease from the Brazilian Scorpion Tityus serrulatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; SNARE COMPLEX; SINGLE-MOLECULE; BOTULINUM NEUROTOXINS; REGULATED EXOCYTOSIS; SECRETORY GRANULES; GUINEA-PIG; BINDING; FUSION; VENOM	We present evidence that venom from the Brazilian scorpion Tityus serrulatus and a purified fraction selectively cleave essential SNARE proteins within exocrine pancreatic tissue. Western blotting for vesicle-associated membrane protein type v-SNARE proteins (or synaptobrevins) reveals characteristic alterations to venom-treated excised pancreatic lobules in vitro. Immunocytochemistry by electron microscopy confirms both the SNARE identity as VAMP2 and the proteolysis of VAMP2 as a marked decrease in secondary antibody-conjugated colloidal gold particles that are predominantly associated with mature zymogen granules. Studies with recombinant SNARE proteins were used to determine the specific cleavage site in VAMP2 and the susceptibility of VAMP8 (endobrevin). The VAMP2 cleavage site is between the transmembrane anchor and the SNARE motif that assembles into the ternary SNARE complex. Inclusion of divalent chelating agents ( EDTA) with fraction nu, an otherwise active purified component from venom, eliminates SNARE proteolysis, suggesting the active protein is a metalloprotease. The unique cleavages of VAMP2 and VAMP8 may be linked to pancreatitis that develops following scorpion envenomation as both of these v-SNARE proteins are associated with zymogen granule membranes in pancreatic acinar cells. We have isolated antarease, a metalloprotease from fraction nu that cleaves VAMP2, and report its amino acid sequence.	[Fletcher, Paul L., Jr.; Fletcher, Maryann D.] E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC 27834 USA; [Weninger, Keith; Anderson, Trevor E.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Martin, Brian M.] NIMH, Lab Neurotoxicol, Natl Inst Hlth, Bethesda, MD 20892 USA	University of North Carolina; East Carolina University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Fletcher, PL (corresponding author), E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC 27834 USA.	fletcherpa@ecu.edu		Fletcher, Paul/0000-0002-3200-4693	East Carolina University Center for Coastal Informatics and Modeling Funds; Burroughs Wellcome Fund; National Institutes of Health; NIMH; Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002344] Funding Source: NIH RePORTER	East Carolina University Center for Coastal Informatics and Modeling Funds; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the East Carolina University Center for Coastal Informatics and Modeling Funds ( to P. L. F.), a Career Award at the Scientific Interface from the Burroughs Wellcome Fund ( to K. W.), and by the National Institutes of Health, NIMH, Intramural Research Program (to B. M. M.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; ANGUS LDG, 1995, ANN TROP PAEDIATR, V15, P285, DOI 10.1080/02724936.1995.11747785; Antonin W, 2002, MOL CELL BIOL, V22, P1545, DOI 10.1128/MCB.22.5.1545-1554.2002; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BARTHOLOMEW C, 1970, BMJ-BRIT MED J, V1, P666, DOI 10.1136/bmj.1.5697.666; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Breidenbach MA, 2005, TRENDS MOL MED, V11, P377, DOI 10.1016/j.molmed.2005.06.012; Brunger AT, 2008, CELL MOL LIFE SCI, V65, P2296, DOI 10.1007/s00018-008-8088-0; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; FLETCHER MD, 1994, CELL TISSUE RES, V278, P255, DOI 10.1007/s004410050215; FLETCHER PL, 1992, EUR J CELL BIOL, V58, P259; Fletcher PL, 1996, TOXICON, V34, P1399, DOI 10.1016/S0041-0101(96)00093-1; FLETCHER PL, 2007, MOL BIOL CELL S, V18, pA272; FLETCHER PL, 2008, MOL BIOL CELL S, V19, pA1727; Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x; Gaisano HY, 2000, PANCREAS, V20, P217, DOI 10.1097/00006676-200004000-00001; Gwee MC, 2002, CLIN EXP PHARMACOL P, V29, P795, DOI 10.1046/j.1440-1681.2002.03726.x; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; ISMAIL M, 1995, TOXICON, V33, P825, DOI 10.1016/0041-0101(95)00005-7; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JENA BP, 1994, J CELL BIOL, V124, P43, DOI 10.1083/jcb.124.1.43; KLOPPEL G, 1986, VIRCHOWS ARCH A, V409, P791, DOI 10.1007/BF00710764; Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; MELDOLESI J, 1971, J CELL BIOL, V49, P109, DOI 10.1083/jcb.49.1.109; Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Pessini AC, 2001, TOXICON, V39, P1495, DOI 10.1016/S0041-0101(01)00122-2; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; POSSANI LD, 1991, J BIOL CHEM, V266, P3178; POSSANI LD, 1977, ARCH BIOCHEM BIOPHYS, V180, P394, DOI 10.1016/0003-9861(77)90053-4; Rosado JA, 2005, AM J PHYSIOL-CELL PH, V288, pC214, DOI 10.1152/ajpcell.00241.2004; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Valentijn JA, 1996, EUR J CELL BIOL, V70, P33; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wasle B, 2002, CELL SIGNAL, V14, P191, DOI 10.1016/S0898-6568(01)00257-1; Waterman J. A., 1938, Transactions of the Royal Society of Tropical Medicine and Hygiene, V31, P607, DOI 10.1016/S0035-9203(38)90154-3; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	55	49	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7405	7416		10.1074/jbc.M109.028365	http://dx.doi.org/10.1074/jbc.M109.028365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20026600	Green Published, hybrid			2022-12-27	WOS:000275415600053
J	Liu, BY; Yildirir, G; Wang, JY; Tolun, G; Griffith, JD; Englund, PT				Liu, Beiyu; Yildirir, Gokben; Wang, Jianyang; Tolun, Goekhan; Griffith, Jack D.; Englund, Paul T.			TbPIF1, a Trypanosoma brucei Mitochondrial DNA Helicase, Is Essential for Kinetoplast Minicircle Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERTWINED CATENATED DIMERS; CRITHIDIA-FASCICULATA; SACCHAROMYCES-CEREVISIAE; RNA INTERFERENCE; FISSION YEAST; TOPOISOMERASE; SEGREGATION; LOCALIZATION; EXPRESSION; COMPLEXES	Kinetoplast DNA, the trypanosome mitochondrial genome, is a network of interlocked DNA rings including several thousand minicircles and a few dozen maxicircles. Minicircles replicate after release from the network, and their progeny reattach. Remarkably, trypanosomes have six mitochondrial DNA helicases related to yeast PIF1 helicase. Here we report that one of the six, TbPIF1, functions in minicircle replication. RNA interference (RNAi) of TbPIF1 causes a growth defect and kinetoplast DNA loss. Minicircle replication intermediates decrease during RNAi, and there is an accumulation of multiply interlocked, covalently closed minicircle dimers (fraction U). In studying the significance of fraction U, we found that this species also accumulates during RNAi of mitochondrial topoisomerase II. These data indicate that one function of TbPIF1 is an involvement, together with topoisomerase II, in the segregation of minicircle progeny.	[Englund, Paul T.] Johns Hopkins Med Sch, Dept Biol Chem, Baltimore, MD 21205 USA; [Tolun, Goekhan; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill	Englund, PT (corresponding author), Johns Hopkins Med Sch, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	penglund@jhmi.edu	TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451	National Institutes of Health [AI058613, GM31819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058613 (to P.T.E.) and GM31819 (to J.D.G.).	Abu-Elneel K, 2001, J CELL BIOL, V153, P725, DOI 10.1083/jcb.153.4.725; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Engel ML, 1998, NUCLEIC ACIDS RES, V26, P4733, DOI 10.1093/nar/26.20.4733; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Kulikowicz T, 2006, J BIOL CHEM, V281, P3048, DOI 10.1074/jbc.M505977200; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Li CJ, 1997, J BIOL CHEM, V272, P20787, DOI 10.1074/jbc.272.33.20787; Liu BY, 2006, MOL CELL BIOL, V26, P5382, DOI 10.1128/mcb.00369-06; Liu BY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000589; Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Liu YN, 2007, MOL MICROBIOL, V64, P676, DOI 10.1111/j.1365-2958.2007.05686.x; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; PEREZMORGA DL, 1993, NUCLEIC ACIDS RES, V21, P1327, DOI 10.1093/nar/21.5.1327; RAUCH CA, 1993, EMBO J, V12, P403, DOI 10.1002/j.1460-2075.1993.tb05672.x; ROBINSON DR, 1994, J CELL BIOL, V126, P641, DOI 10.1083/jcb.126.3.641; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; RYAN KA, 1989, MOL CELL BIOL, V9, P3212, DOI 10.1128/MCB.9.8.3212; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Scocca JR, 2008, MOL MICROBIOL, V67, P820, DOI 10.1111/j.1365-2958.2007.06087.x; SHAPIRO TA, 1994, MOL CELL BIOL, V14, P3660, DOI 10.1128/MCB.14.6.3660; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Tanaka H, 2002, NUCLEIC ACIDS RES, V30, P4728, DOI 10.1093/nar/gkf590; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	42	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7056	7066		10.1074/jbc.M109.084038	http://dx.doi.org/10.1074/jbc.M109.084038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042610	Green Published, hybrid			2022-12-27	WOS:000275415600019
J	Arbel, N; Shoshan-Barmatz, V				Arbel, Nir; Shoshan-Barmatz, Varda			Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOCHROME-C RELEASE; FAMILY-MEMBERS; MEMBRANE PERMEABILIZATION; ENDOPLASMIC-RETICULUM; CANCER-THERAPY; BH3 DOMAIN; VDAC; PROTEINS	The antiapoptotic proteins of the Bcl-2 family are expressed at high levels in many types of cancer. However, the mechanism by which Bcl-2 family proteins regulate apoptosis is not fully understood. Here, we demonstrate the interaction of Bcl-2 with the outer mitochondrial membrane protein, voltage-dependent anion channel 1 (VDAC1). A direct interaction of Bcl-2 with bilayer-reconstituted purified VDAC was demonstrated, with Bcl-2 decreasing channel conductance. Expression of Bcl-2-GFP prevented apoptosis in cells expressing native but not certain VDAC1 mutants. VDAC1 sequences and amino acid residues important for interaction with Bcl-2 were defined through site-directed mutagenesis. Synthetic peptides corresponding to the VDAC1 N-terminal region and selected sequences bound specifically, in a concentration-and time-dependent manner, to immobilized Bcl-2, as revealed by the real-time surface plasmon resonance. Moreover, expression of the VDAC1-based peptides in cells over-expressing Bcl-2 prevented Bcl-2-mediated protection against staurosporine-induced apoptotic cell death. Similarly, a cell-permeable VDAC1-based synthetic peptide was also found to prevent Bcl-2-GFP-mediated protection against apoptosis. These results point to Bcl-2 as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death. Moreover, these findings suggest that interfering with the binding of Bcl-2 to mitochondria by VDAC1-based peptides may serve to potentiate the efficacy of conventional chemotherapeutic agents.	[Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il			Israel Science Foundation; Ministry of Health, Israel	Israel Science Foundation(Israel Science Foundation); Ministry of Health, Israel	This work was supported in part by grants from the Israel Science Foundation terminal region of VDAC1 constitutes a mobile component and the Chief Scientist Office of the Ministry of Health, Israel.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto Vito, 2003, Ital J Biochem, V52, P17; Dias N, 2002, MOL CANCER THER, V1, P347; Dinnen RD, 2007, J BIOL CHEM, V282, P26675, DOI 10.1074/jbc.M701864200; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Israelson A, 2008, CELL CALCIUM, V43, P196, DOI 10.1016/j.ceca.2007.05.006; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Junankar PR, 1995, J MUSCLE RES CELL M, V16, P595, DOI 10.1007/BF00130241; Kim R, 2007, CANCER GENE THER, V14, P1, DOI 10.1038/sj.cgt.7700986; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAEMMLI UK, 1970, NATURE, V227, P685; Lemasters JJ, 1999, CARDIOVASC RES, V44, P470, DOI 10.1016/S0008-6363(99)00368-5; Leone M, 2003, CANCER RES, V63, P8118; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MIYASHITA T, 1993, BLOOD, V81, P151; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Schimmer AD, 2001, CELL DEATH DIFFER, V8, P725, DOI 10.1038/sj.cdd.4400870; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vidal L, 2005, EUR J CANCER, V41, P2812, DOI 10.1016/j.ejca.2005.06.029; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	67	126	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6053	6062		10.1074/jbc.M109.082990	http://dx.doi.org/10.1074/jbc.M109.082990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037155	hybrid, Green Published			2022-12-27	WOS:000275367500008
J	Bilkovski, R; Schulte, DM; Oberhauser, F; Gomolka, M; Udelhoven, M; Hettich, MM; Roth, B; Heidenreich, A; Gutschow, C; Krone, W; Laudes, M				Bilkovski, Roman; Schulte, Dominik M.; Oberhauser, Frank; Gomolka, Matthias; Udelhoven, Michael; Hettich, Moritz M.; Roth, Bernhard; Heidenreich, Axel; Gutschow, Christian; Krone, Wilhelm; Laudes, Matthias			Role of Wnt-5a in the Determination of Human Mesenchymal Stem Cells into Preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMBILICAL-CORD BLOOD; N-TERMINAL KINASE; TRANSCRIPTION FACTOR FBI-1; HUMAN BONE-MARROW; BINDING-PROTEIN; ADIPOSE-TISSUE; SIGNALING PATHWAY; PROGENITOR CELLS; DIFFERENTIATION; ADIPOGENESIS	Increasing adipocyte size as well as numbers is important in the development of obesity and type 2 diabetes, with adipocytes being generated from mesenchymal precursor cells. This process includes the determination of mesenchymal stem cells (MSC) into preadipocytes (PA) and the differentiation of PA into mature fat cells. Although the process of differentiation has been highly investigated, the determination in humans is poorly understood. In this study, we compared human MSC and human committed PA on a cellular and molecular level to gain further insights into the regulatory mechanisms in the determination process. Both cell types showed similar morphology and expression patterns of common mesenchymal and hematopoietic surface markers. However, although MSC were able to differentiate into adipocytes and osteocytes, PA were only able to undergo adipogenesis, indicating that PA lost their multipotency during determination. WNT-5a expression showed significantly higher levels in MSC compared with PA suggesting that WNT-5a down-regulation might be important in the determination process. Indeed, incubation of human MSC in medium containing neutralizing WNT-5a antibodies abolished their ability to undergo osteogenesis, although adipogenesis was still possible. An opposite effect was achieved using recombinant WNT-5a protein. On a molecular level, WNT-5a was found to promote c-Jun N-terminal kinase-dependent intracellular signaling in MSC. Activation of this noncanonical pathway resulted in the induction of osteopontin expression further indicating pro-osteogenic effects of WNT-5a. Our data suggest that WNT-5a is necessary to maintain osteogenic potential of MSC and that inhibition of WNT-5a signaling therefore plays a role in their determination into PA in humans.	[Hettich, Moritz M.; Krone, Wilhelm] Univ Cologne, Childrens Hosp, Dept Internal Med 2, D-50937 Cologne, Germany; [Hettich, Moritz M.; Krone, Wilhelm] Univ Cologne, Childrens Hosp, Ctr Mol Med, D-50937 Cologne, Germany; [Roth, Bernhard] Univ Cologne, Childrens Hosp, Dept Neonatol, D-50937 Cologne, Germany; [Heidenreich, Axel] Univ Aachen, Dept Urol, D-52074 Aachen, Germany; [Gutschow, Christian] Univ Cologne, Dept Gen & Abdominal Surg, D-50937 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; RWTH Aachen University; University of Cologne	Laudes, M (corresponding author), Univ Cologne, Zentrum Mol Med, Klin & Poliklin Innere Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	matthias.laudes@uk-koeln.de	Laudes, Matthias/C-8885-2011; Schulte, Dominik M/G-8653-2013	Schulte, Dominik M/0000-0002-4622-6051	KollnFortune Program [KF167/2005]	KollnFortune Program	This work was supported by KollnFortune Program Grant KF167/2005 (to M.L.).	Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; GUO XJ, 1995, MOL CELL BIOL, V15, P476, DOI 10.1128/MCB.15.1.476; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim YM, 2008, INT J BIOCHEM CELL B, V40, P2482, DOI 10.1016/j.biocel.2008.04.016; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Laudes M, 2009, EXP CLIN ENDOCR DIAB, V117, P146, DOI 10.1055/s-0028-1100379; Laudes M, 2008, J MOL MED, V86, P597, DOI 10.1007/s00109-008-0326-2; Lee MW, 2005, INT J HEMATOL, V81, P126, DOI 10.1532/IJH97.A10404; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; Tchoukalova YD, 2004, AM J PHYSIOL-REG I, V287, pR1132, DOI 10.1152/ajpregu.00337.2004; Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang JF, 2004, HAEMATOLOGICA, V89, P837; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	39	81	83	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6170	6178		10.1074/jbc.M109.054338	http://dx.doi.org/10.1074/jbc.M109.054338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032469	Green Published, hybrid			2022-12-27	WOS:000275367500021
J	Guntur, KVP; Guilherme, A; Xue, LT; Chawla, A; Czech, MP				Guntur, Kalyani V. P.; Guilherme, Adilson; Xue, Liting; Chawla, Anil; Czech, Michael P.			Map4k4 Negatively Regulates Peroxisome Proliferator-activated Receptor (PPAR) gamma Protein Translation by Suppressing the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Cultured Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; AMINO-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; TNF-ALPHA; PHAS-I; C-JUN; INITIATION	The receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) is considered a master regulator of adipocyte differentiation and promotes glucose and lipid metabolism in mature adipocytes. We recently identified the yeast Sterile 20 (Ste20) protein kinase ortholog, Map4k4, in an RNA interference-based screen as an inhibitor of PPAR gamma expression in cultured adipocytes. Here, we show that RNA interference-mediated silencing of Map4k4 elevates the levels of both PPAR gamma 1 and PPAR gamma 2 proteins in 3T3-L1 adipocytes without affecting PPAR gamma mRNA levels, suggesting that Map4k4 regulates PPAR gamma at a post-transcriptional step. PPAR gamma degradation rates are remarkably rapid as measured in the presence of cycloheximide (t(1/2) = 2 h), but silencing Map4k4 had no effect on PPAR gamma degradation. However, depletion of Map4k4 significantly enhances [S-35] methionine/cysteine incorporation into proteins, suggesting that Map4k4 signaling decreases protein translation. We show a function of Map4k4 is to inhibit rapamycin-sensitive mammalian target of rapamycin ( mTOR) activity, decreasing 4E-BP1 phosphorylation. In addition, our results show mTOR and 4E-BP1 are required for the increased PPAR gamma protein expression upon Map4k4 knockdown. Consistent with this concept, adenovirus-mediated expression of Map4k4 decreased PPAR gamma protein levels and mTOR phosphorylation. These data show that Map4k4 negatively regulates PPAR gamma post-transcriptionally, by attenuating mTOR signaling and a 4E-BP1-dependent mechanism.	[Guntur, Kalyani V. P.; Guilherme, Adilson; Xue, Liting; Chawla, Anil; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Ste 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			National Institutes of Health [DK30898-25, DK030638-25]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R37DK030898, P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30898-25 and DK030638-25 (to M. P. C.).	Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Dumont F J, 1996, Life Sci, V58, P373; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Gao G, 2003, GENE THER, V10, P1926, DOI 10.1038/sj.gt.3302088; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Lin TA, 1996, J BIOL CHEM, V271, P30199, DOI 10.1074/jbc.271.47.30199; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mothe-Satney I, 2004, J BIOL CHEM, V279, P42628, DOI 10.1074/jbc.M405173200; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457	37	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6595	6603		10.1074/jbc.M109.068502	http://dx.doi.org/10.1074/jbc.M109.068502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038583	Green Published, hybrid			2022-12-27	WOS:000275367500064
J	Ogunjimi, AA; Wiesner, S; Briant, DJ; Varelas, X; Sicheri, F; Forman-Kay, J; Wrana, JL				Ogunjimi, Abiodun A.; Wiesner, Silke; Briant, Douglas J.; Varelas, Xaralabos; Sicheri, Frank; Forman-Kay, Julie; Wrana, Jeffrey L.			The Ubiquitin Binding Region of the Smurf HECT Domain Facilitates Polyubiquitylation and Binding of Ubiquitylated Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; NMR-SPECTROSCOPY; CELL POLARITY; LIGASE; DEGRADATION; PROTEINS; SYSTEM; RHOA	Mono- and polyubiquitylation of proteins are key steps in a wide range of biological processes. However, the molecular mechanisms that mediate these different events are poorly understood. Here, we employed NMR spectroscopy to map a non-covalent ubiquitin binding surface (UBS) on the Smurf ubiquitin ligase HECT domain. Analysis of mutants of the HECT UBS reveal that interfering with the UBS surface blocked Smurf-dependent degradation of its substrate RhoA in cells. In vitro analysis revealed that the UBS was not required for UbcH7-dependent charging of the HECT catalytic cysteine. Surprisingly, although the UBS was required for polyubiquitylation of both Smurf itself and the Smurf substrate RhoA, it was not required for monoubiquitylation. Furthermore, we show that mutating the UBS interfered with efficient binding of a monou-biquitylated form of RhoA to the Smurf HECT domain. Our findings suggest the UBS promotes polyubiquitylation by stabilizing ubiquitylated substrate binding to the HECT domain.	[Ogunjimi, Abiodun A.; Briant, Douglas J.; Varelas, Xaralabos; Sicheri, Frank; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Wiesner, Silke; Forman-Kay, Julie] Hosp Sick Children, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Sicheri, Frank; Wrana, Jeffrey L.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A1, Canada; [Forman-Kay, Julie] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Wrana, Jeffrey/F-8857-2013; Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541; Wiesner, Silke/0000-0003-0015-0167; Forman-Kay, Julie/0000-0001-8265-972X	Canadian Cancer Society Research Institute; Canadian Institutes of Health Research [57795, 14339]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cancer Society Research Institute grants (to J.F.-K.) and Canadian Institutes of Health Research Grants 57795 (to F.S.) and 14339 (to J.L.W.).	BARTELS H, 1995, BIOPOLYMERS, V37, P411, DOI 10.1002/bip.360370608; Bottomley MJ, 1999, J BIOMOL NMR, V13, P381, DOI 10.1023/A:1008393903034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	23	55	58	22	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6308	6315		10.1074/jbc.M109.044537	http://dx.doi.org/10.1074/jbc.M109.044537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026602	hybrid, Green Published			2022-12-27	WOS:000275367500035
J	Wang, N; Dong, QM; Li, JJ; Jangra, RK; Fan, MY; Brasier, AR; Lemon, SM; Pfeffer, LM; Li, K				Wang, Nan; Dong, Qingming; Li, Jingjing; Jangra, Rohit K.; Fan, Meiyun; Brasier, Allan R.; Lemon, Stanley M.; Pfeffer, Lawrence M.; Li, Kui			Viral Induction of the Zinc Finger Antiviral Protein Is IRF3-dependent but NF-kappa B-independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-3; HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SWINE-FEVER VIRUS; RIG-I; ADAPTER PROTEIN; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTORS; DIARRHEA VIRUS	The zinc finger antiviral protein (ZAP) is an interferon-stimulated gene that restricts the replication of retroviruses, alphaviruses, and filoviruses. Relatively little is known, however, regarding the detailed mechanism of ZAP induction during viral infections. We show that, although being inducible by either interferon or virus, expression of ZAP is more efficiently activated by virus than are several other classical interferon-stimulated genes and that viral induction of ZAP occurs under the direct control of interferon regulatory factor 3 (IRF3) independent of interferon paracrine/autocrine signaling. ZAP was up-regulated in cells unresponsive to type I and III interferons upon engagement of TLR3, retinoic inducible gene I/melanoma differentiation-associated gene 5 pathways, or ectopic expression of a constitutively active IRF3 mutant. Conversely, induction of ZAPby virus or dsRNA was severely impaired in cells expressing a dominant-negative mutant IRF3 and completely abrogated in cells lacking IRF3. In contrast to IRF3, ZAP induction was independent of NF-kappa B activity. Mutational analysis of the human ZAP promoter revealed that multiple interferon-stimulated response elements far distal to the transcription start site serve redundantly to control IRF3-dependent induction of ZAP transcription. Chromatin immunoprecipitation assays demonstrated that IRF3 selectively binds the distal interferon-stimulated response elements in human ZAP promoter following viral infection. Collectively, these data suggest that ZAP is a direct target gene of IRF3 action in cellular antiviral responses.	[Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Fan, Meiyun; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN 38163 USA; [Jangra, Rohit K.; Lemon, Stanley M.] Univ Texas Med Branch, Ctr Hepatitis Res, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Jangra, Rohit K.; Lemon, Stanley M.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Li, K (corresponding author), 858 Madison Ave,401B Mol Sci Bldg, Memphis, TN 38163 USA.	kli1@uthsc.edu	Jangra, Rohit K/B-2492-2012; Jangra, Rohit/AAT-2869-2020	Jangra, Rohit/0000-0002-3119-0869; Brasier, Allan/0000-0002-5012-4090; Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [R21-DA018054, R01-AI069285, U19-AI066316, U19-AI40035, R21-AI081058]; NATIONAL CANCER INSTITUTE [R01CA140346, R01CA133322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081058, U19AI066316, R01AI069285, U19AI040035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA018054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grants R21-DA018054 and R01-AI069285 (to K. L.), U19-AI066316 (to L. M. P.), and U19-AI40035 and R21-AI081058 (to S. M. L.).	Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Clements JL, 2003, IMMUNOL REV, V191, P211, DOI 10.1034/j.1600-065X.2003.00002.x; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Floyd-Smith G, 1999, EXP CELL RES, V246, P138, DOI 10.1006/excr.1998.4296; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fredericksen B, 2002, VIRAL IMMUNOL, V15, P29, DOI 10.1089/088282402317340215; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Langford M P, 1981, Methods Enzymol, V78, P339; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li Kui, 2009, V510, P211, DOI 10.1007/978-1-59745-394-3_16; LIN RT, 1994, J BIOL CHEM, V269, P17542; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lu Y, 2001, ONCOGENE, V20, P4777, DOI 10.1038/sj.onc.1204607; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marques J, 2008, J GEN VIROL, V89, P2767, DOI 10.1099/vir.0.2008/003558-0; Melchjorsen J, 2009, J INTERF CYTOK RES, V29, P199, DOI 10.1089/jir.2008.0050; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pitha PM, 1998, BIOCHIMIE, V80, P651, DOI 10.1016/S0300-9084(99)80018-2; Rebouillat D, 1998, EUR J BIOCHEM, V257, P319, DOI 10.1046/j.1432-1327.1998.2570319.x; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Seago J, 2007, J GEN VIROL, V88, P3002, DOI 10.1099/vir.0.82934-0; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; VERHAEGEN M, 1980, P NATL ACAD SCI-BIOL, V77, P4479, DOI 10.1073/pnas.77.8.4479; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wang Q, 1998, GENE, V222, P83, DOI 10.1016/S0378-1119(98)00476-4; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yen A, 2006, EUR J CELL BIOL, V85, P117, DOI 10.1016/j.ejcb.2005.09.020; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80	68	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6080	6090		10.1074/jbc.M109.054486	http://dx.doi.org/10.1074/jbc.M109.054486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048147	hybrid, Green Published			2022-12-27	WOS:000275367500011
J	Bublik, DR; Scolz, M; Triolo, G; Monte, M; Schneider, C				Bublik, Debora Rosa; Scolz, Massimiliano; Triolo, Gianluca; Monte, Martin; Schneider, Claudio			Human GTSE-1 Regulates p21(CIP1/WAF1) Stability Conferring Resistance to Paclitaxel Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC LOCALIZATION; MEDIATED DEGRADATION; INDUCED APOPTOSIS; UP-REGULATION; P21; PROTEIN; CELLS; GENE; P53; PHOSPHORYLATION	p21(CIP1/WAF1) belongs to the CIP/KIP family of Cdk inhibitors, and its expression is tightly controlled during the cell cycle, mainly by transcriptional and post-translational mechanisms. Fine regulation of p21(CIP1/WAF1) levels is critical for cell cycle control and for cellular response to stress. In the present work, we describe a novel mechanism to modulate p21(CIP1/WAF1) levels mediated by the human GTSE-1 (G(2) and S phase-expressed-1) protein. Our results provide evidence that hGTSE-1 protects p21(CIP1/WAF1) from proteasome-dependent degradation as part of a functional complex containing the Hsp90-binding TPR protein WISp39. We further show that the hGTSE-1 N-terminal portion is sufficient for p21(CIP1/WAF1) binding and stabilization. Finally, we demonstrate that hGTSE-1 mediated-p21(CIP1/WAF1) stabilization is clearly involved in the ability of cells to counteract cytotoxicity induced by the microtubule poison paclitaxel.	[Monte, Martin; Schneider, Claudio] Int Ctr Genet Engn & Biotechnol, Lab Nazl Consorzio Interuniv Biotecnol, I-34149 Trieste, Italy; [Triolo, Gianluca] Int Ctr Genet Engn & Biotechnol, Genome Stabil Lab, I-34149 Trieste, Italy; [Schneider, Claudio] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Schneider, C (corresponding author), Int Ctr Genet Engn & Biotechnol, Lab Nazl Consorzio Interuniv Biotecnol, Area Sci Pk,Padriciano 99, I-34149 Trieste, Italy.	schneide@lncib.it	Triolo, Gianluca/AAH-9610-2020	Monte, Martin/0000-0002-5068-563X	Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione; dell'Universitae della Ricerca (MIUR); Fondo per gli Investimenti della Ricerca di Base [RBIN04N4-003]; TRANSlational and Functional Onco-Genomics (TRANSFOG) [FP6 503438, PICT0700283]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universitae della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); TRANSlational and Functional Onco-Genomics (TRANSFOG)	This work was supported by Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Istruzione, dell'Universitae della Ricerca (MIUR) Fondo per gli Investimenti della Ricerca di Base RBIN04N4-003, TRANSlational and Functional Onco-Genomics (TRANSFOG) FP6 503438 (to C.S.), and PICT0700283 (to M.M.).	ABBAS T, 2009, NAT REV CANC; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Collavin L, 2000, FEBS LETT, V481, P57, DOI 10.1016/S0014-5793(00)01969-4; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Debernardis D, 1997, CANCER RES, V57, P870; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li WW, 1999, MOL PHARMACOL, V55, P1088, DOI 10.1124/mol.55.6.1088; LI Y, 1994, ONCOGENE, V9, P2261; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Monte M, 2000, GENE, V254, P229, DOI 10.1016/S0378-1119(00)00260-2; Monte M, 2004, J BIOL CHEM, V279, P11744, DOI 10.1074/jbc.M311123200; Monte M, 2003, J BIOL CHEM, V278, P30356, DOI 10.1074/jbc.M302902200; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pfleger CM, 2000, GENE DEV, V14, P655; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Utrera R, 1998, EMBO J, V17, P5015, DOI 10.1093/emboj/17.17.5015; Westbrook TF, 2002, MOL CELL BIOL, V22, P7041, DOI 10.1128/MCB.22.20.7041-7052.2002; Yang WT, 2003, CANCER, V98, P1123, DOI 10.1002/cncr.11625; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	34	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5274	5281		10.1074/jbc.M109.045948	http://dx.doi.org/10.1074/jbc.M109.045948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018861	Green Published, hybrid			2022-12-27	WOS:000275327200021
J	Funakoshi-Tago, M; Tago, K; Abe, M; Sonoda, Y; Kasahara, T				Funakoshi-Tago, Megumi; Tago, Kenji; Abe, Miyuki; Sonoda, Yoshiko; Kasahara, Tadashi			STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL T-CELLS; ERYTHROPOIETIN RECEPTOR; POLYCYTHEMIA-VERA; FERM DOMAIN; CYTOKINE-RECEPTOR; KINASE-ACTIVITY; NUDE-MICE; EXPRESSION; MUTATION; PROLIFERATION	It has been well established that disruption of JAK2 signaling regulation is involved in various hematopoietic disorders; however, the detailed mechanism by which abnormal activation of JAK2 exhibits transforming activity remains to be elucidated. Here, to clarify the functional role of the erythropoietin receptor (EpoR) and its downstream transcription factor STAT5 in the abnormal activation of JAK2-induced hematopoietic diseases, we generated a stable transfectant of Ba/F3 cells expressing EpoR and analyzed the molecular mechanism of how JAK2 mutation induces cell growth disorder. JAK2 V617F mutant exhibited transforming activity when EpoR was coexpressed. According to a study utilizing several truncated mutants of EpoR, the ability of EpoR to facilitate the transforming activity of JAK2 V617F mutant required the intracellular domain to interact with STAT5. Strikingly, once the truncated EpoR (EpoR-H) was mutated on Tyr-343, the phosphorylation of which is known to be important for interaction with STAT5, JAK2 V617F mutant failed to exhibit transforming activity, suggesting that STAT5 is critical for JAK2 mutant-induced hematopoietic disorder. Furthermore, the expression of the constitutively active STAT5 mutant exhibited transforming activity in Ba/F3 cells, and short hairpin RNA-mediated knockdown of STAT5 significantly inhibited the transforming activity of JAK2 V617F mutant. Taking these observations together, STAT5 plays an essential role in EpoR-JAK2 V617F mutant-induced hematopoietic disorder. Although it remains unclear why the presence of EpoR is required to activate oncogenic signaling via the JAK2 mutant and STAT5, its interacting ability is a target for the treatment of these hematopoietic diseases.	[Funakoshi-Tago, Megumi; Abe, Miyuki; Sonoda, Yoshiko; Kasahara, Tadashi] Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, Tokyo 1058512, Japan; [Tago, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Nara 6300101, Japan	Keio University; Nara Institute of Science & Technology	Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [19790071]; Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	This work was supported in part by Grant 19790071 from Ministry of Education, Culture, Sports, Science and Technology, the Research Foundation for Pharmaceutical Sciences, and the Hi-Tech Research Center Project for Private Universities in Japan.	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Chin H, 1997, BIOCHEM BIOPH RES CO, V239, P412, DOI 10.1006/bbrc.1997.7480; Chin H, 1996, BLOOD, V88, P4415, DOI 10.1182/blood.V88.12.4415.bloodjournal88124415; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Funakoshi-Tago M, 2009, J BIOL CHEM, V284, P12680, DOI 10.1074/jbc.M808879200; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; Gregory RC, 1998, BLOOD, V92, P1104, DOI 10.1182/blood.V92.4.1104.416k38_1104_1118; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Iwatsuki K, 1997, J BIOL CHEM, V272, P8149, DOI 10.1074/jbc.272.13.8149; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Sawka-Verhelle D, 2000, ENDOCRINOLOGY, V141, P1977, DOI 10.1210/en.141.6.1977; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156	36	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5296	5307		10.1074/jbc.M109.040733	http://dx.doi.org/10.1074/jbc.M109.040733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028972	Green Published, hybrid			2022-12-27	WOS:000275327200023
J	Vogel, R; Jansen, C; Roffeis, J; Reddanna, P; Forsell, P; Claesson, HE; Kuhn, H; Walther, M				Vogel, Robert; Jansen, Christian; Roffeis, Jana; Reddanna, Pallu; Forsell, Pontus; Claesson, Hans-Eric; Kuhn, Hartmut; Walther, Matthias			Applicability of the Triad Concept for the Positional Specificity of Mammalian Lipoxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULOCYTE-TYPE 15-LIPOXYGENASE; SITE-DIRECTED MUTAGENESIS; SEQUENCE DETERMINANTS; ARACHIDONIC-ACID; ACTIVE-SITE; OXYGENATION; 12-LIPOXYGENASE; EXPRESSION; CATALYSIS; CLONING	The nomenclature of lipoxygenases (LOXs) is partly based on the positional specificity of arachidonic acid oxygenation, but there is no unifying concept explaining the mechanistic basis of this enzyme property. According to the triad model, Phe-353, Ile-418, and Ile-593 of the rabbit 12/15-LOX form the bottom of the substrate-binding pocket, and introduction of less space-filling residues at either of these positions favors arachidonic acid 12-lipoxygenation. The present study was aimed at exploring the validity of the triad concept for two novel primate 12/15-LOX (Macaca mulatta and Pongo pygmaeus) and for five known members of the mammalian LOX family (human 12/15-LOX, mouse 12/15-LOX, human 15-LOX2, human platelet type 12-LOX, and mouse (12R)-LOX). The enzymes were expressed as N-terminal His tag fusion proteins in E. coli, the potential sequence determinants were mutated, and the specificity of arachidonic acid oxygenation was quantified. Taken together, our data indicate that the triad concept explains the positional specificity of all 12/15-LOXs tested (rabbit, human, M. mulatta, P. pygmaeus, and mouse). For the new enzymes of M. mulatta and P. pygmaeus, the concept had predictive value because the positional specificity predicted on the basis of the amino acid sequence was confirmed experimentally. The specificity of the platelet 12-LOX was partly explained by the triad hypothesis, but the concept was not applicable for 15-LOX2 and (12R)-LOX.	[Vogel, Robert; Jansen, Christian; Roffeis, Jana; Kuhn, Hartmut; Walther, Matthias] Charite, Inst Biochem, D-10117 Berlin, Germany; [Reddanna, Pallu] Univ Hyderabad, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Forsell, Pontus; Claesson, Hans-Eric] Orexo AB, S-10234 Stockholm, Sweden; [Forsell, Pontus; Claesson, Hans-Eric] Karolinska Inst, Dept Med Biophys & Biochem, S-17177 Stockholm, Sweden	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hyderabad; Karolinska Institutet	Kuhn, H (corresponding author), Charite, Inst Biochem, Monbijoustr 2, D-10117 Berlin, Germany.	hartmut.kuehn@charite.de		Claesson, Hans-Erik/0000-0002-1960-6542; Forsell, Pontus/0000-0002-8384-1547	European Commission [FP6, LSHMCT-2004-0050333]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by European Commission Grant FP6, LSHMCT-2004-0050333 (to H. K.).	Berger M, 1998, J MOL BIOL, V278, P935, DOI 10.1006/jmbi.1998.1737; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brash AR, 1996, J BIOL CHEM, V271, P20949, DOI 10.1074/jbc.271.34.20949; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Burger F, 2000, BIOCHEM J, V348, P329, DOI 10.1042/bj3480329; CHEN XS, 1994, J BIOL CHEM, V269, P13979; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; HAMBERG M, 1980, BIOCHEM BIOPH RES CO, V95, P1090, DOI 10.1016/0006-291X(80)91584-3; HAWKINS DJ, 1987, J BIOL CHEM, V262, P7629; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; KUHN H, 1983, FEBS LETT, V153, P353, DOI 10.1016/0014-5793(83)80641-3; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; O'Donnell Valerie B., 2009, V462, P5, DOI 10.1007/978-1-60327-115-8_1; Porta H, 2001, MICROBIOL-SGM, V147, P3199, DOI 10.1099/00221287-147-12-3199; REDDANNA P, 1990, METHOD ENZYMOL, V187, P268; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Walther M, 2009, BBA-MOL CELL BIOL L, V1791, P827, DOI 10.1016/j.bbalip.2009.05.007; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100	37	69	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5369	5376		10.1074/jbc.M109.057802	http://dx.doi.org/10.1074/jbc.M109.057802			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20026599	Green Published, hybrid			2022-12-27	WOS:000275327200030
J	Khurana, S; Jaiswal, AK; Mukhopadhyay, A				Khurana, Satish; Jaiswal, Amit K.; Mukhopadhyay, Asok			Hepatocyte Nuclear Factor-4 alpha Induces Transdifferentiation of Hematopoietic Cells into Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; STEM-CELLS; ONCOSTATIN-M; PROGENITOR CELLS; MOLECULAR-BASIS; GROWTH-FACTOR; LIVER; EXPRESSION; DIFFERENTIATION; REPAIR	Hematopoietic stem cells can directly transdifferentiate into hepatocytes because of cellular plasticity, but the molecular basis of transdifferentiation is not known. Here, we show the molecular basis using lineage-depleted oncostatin M receptor beta-expressing (Lin(-)OSMR beta(+)) mouse bone marrow cells in a hepatic differentiation culture system. Differentiation of the cells was marked by the expression of albumin. Hepatocyte nuclear factor (HNF)-4 alpha was expressed and translocated into the nuclei of the differentiating cells. Suppression of its activation in OSM-neutralized culture medium inhibited cellular differentiation. Ectopic expression of full-length HNF4 alpha in 32D myeloid cells resulted in decreased myeloid colony-forming potential and increased expression of hepatocyte-specific genes and proteins. Nevertheless, the neohepatocytes produced in culture expressed active P450 enzyme. The obligatory role of HNF4 alpha in hepatic differentiation was confirmed by transfecting Lin(-)OSMR beta(+) cells with dominant negative HNF4 alpha in the differentiation culture because its expression inhibited the transcription of the albumin and tyrosine aminotransferase genes. The loss and gain of functional activities strongly suggested that HNF4 alpha plays a central role in the transdifferentiation process. For the first time, this report demonstrates the mechanism of transdifferentiation of hematopoietic cells into hepatocytes, in which HNF4 alpha serves as a molecular switch.	[Khurana, Satish; Jaiswal, Amit K.; Mukhopadhyay, Asok] Natl Inst Immunol, Stem Cell Biol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Stem Cell Biol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	ashok@nii.res.in	Jaiswal, Amit/GRS-1053-2022; Khurana, Satish/H-9090-2016	Khurana, Satish/0000-0001-5176-1510				Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Fiegel HC, 2003, STEM CELLS, V21, P98, DOI 10.1634/stemcells.21-1-98; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Khurana S, 2007, STEM CELLS, V25, P1439, DOI 10.1634/stemcells.2006-0656; Khurana S, 2008, J HEPATOL, V49, P998, DOI 10.1016/j.jhep.2008.05.019; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Li JX, 2000, GENE DEV, V14, P464; Li WC, 2005, J CELL MOL MED, V9, P569, DOI 10.1111/j.1582-4934.2005.tb00489.x; Lian GW, 2006, EXP HEMATOL, V34, P348, DOI 10.1016/j.exphem.2005.12.004; Madhusudhan T, 2003, J HEMATOTH STEM CELL, V12, P243, DOI 10.1089/152581603321628386; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Taylor DG, 1996, NUCLEIC ACIDS RES, V24, P2930, DOI 10.1093/nar/24.15.2930; Thowfeequ S, 2007, DEV DYNAM, V236, P3208, DOI 10.1002/dvdy.21336; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434	42	22	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4725	4731		10.1074/jbc.M109.058198	http://dx.doi.org/10.1074/jbc.M109.058198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018873	Green Published, hybrid			2022-12-27	WOS:000275274800050
J	Huo, YQ; Guo, X; Li, HG; Wang, H; Zhang, WY; Wang, Y; Zhou, HJ; Gao, ZG; Telang, S; Chesney, J; Chen, YE; Ye, JP; Chapkin, RS; Wu, CD				Huo, Yuqing; Guo, Xin; Li, Honggui; Wang, Huan; Zhang, Weiyu; Wang, Ying; Zhou, Huaijun; Gao, Zhanguo; Telang, Sucheta; Chesney, Jason; Chen, Y. Eugene; Ye, Jianping; Chapkin, Robert S.; Wu, Chaodong			Disruption of Inducible 6-Phosphofructo-2-kinase Ameliorates Diet-induced Adiposity but Exacerbates Systemic Insulin Resistance and Adipose Tissue Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FAT DIET; ACTIVATED-RECEPTOR-ALPHA; AGILENT MICROARRAY; OXIDATIVE STRESS; GENE-EXPRESSION; INDUCED OBESITY; ENERGY-BALANCE; MICE LACKING; COENZYME-A; TNF-ALPHA	Adiposity is commonly associated with adipose tissue dysfunction and many overnutrition-related metabolic diseases including type 2 diabetes. Much attention has been paid to reducing adiposity as a way to improve adipose tissue function and systemic insulin sensitivity. PFKFB3/iPFK2 is a master regulator of adipocyte nutrient metabolism. Using PFKFB3(+/-) mice, the present study investigated the role of PFKFB3/iPFK2 in regulating diet-induced adiposity and systemic insulin resistance. On a high-fat diet (HFD), PFKFB3(+/-) mice gained much less body weight than did wild-type littermates. This was attributed to a smaller increase in adiposity in PFKFB3(+/-) mice than in wild-type controls. However, HFD-induced systemic insulin resistance was more severe in PFKFB3(+/-) mice than in wildtype littermates. Compared with wild-type littermates, PFKFB3(+/-) mice exhibited increased severity of HFD-induced adipose tissue dysfunction, as evidenced by increased adipose tissue lipolysis, inappropriate adipokine expression, and decreased insulin signaling, as well as increased levels of proinflammatory cytokines in both isolated adipose tissue macrophages and adipocytes. In an in vitro system, knockdown of PFKFB3/iPFK2 in 3T3-L1 adipocytes caused a decrease in the rate of glucose incorporation into lipid but an increase in the production of reactive oxygen species. Furthermore, knockdown of PFKFB3/iPFK2 in 3T3-L1 adipocytes inappropriately altered the expression of adipokines, decreased insulin signaling, increased the phosphorylation states of JNK and NF kappa B p65, and enhanced the production of proinflammatory cytokines. Together, these data suggest that PFKFB3/iPFK2, although contributing to adiposity, protects against diet-induced insulin resistance and adipose tissue inflammatory response.	[Huo, Yuqing; Wang, Huan; Zhang, Weiyu] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Guo, Xin; Li, Honggui; Chapkin, Robert S.; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, Intercoll Fac Nutr, College Stn, TX 77843 USA; [Wang, Ying; Zhou, Huaijun] Texas A&M Univ, Dept Poultry Sci, Intercoll Fac Genet, College Stn, TX 77843 USA; [Gao, Zhanguo; Ye, Jianping] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Telang, Sucheta; Chesney, Jason] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48105 USA	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Louisville; University of Michigan System; University of Michigan	Huo, YQ (corresponding author), 420 Delaware St SE,MMC508, Minneapolis, MN 55455 USA.	yuqing@umn.edu; cdwu@tamu.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X; Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health [HL78679, HL080569]; AHA [0430151N]; William W. Allen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080569, R01HL078679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); William W. Allen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78679 and HL080569 (to Y. H.). This work was also supported by AHA Grant 0430151N (to Y. H.) and the William W. Allen Foundation (to C. W. and J. L.).	Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger JJ, 1999, J APPL PHYSIOL, V87, P227, DOI 10.1152/jappl.1999.87.1.227; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Chesney J, 2005, BIOCHEM BIOPH RES CO, V331, P139, DOI 10.1016/j.bbrc.2005.02.193; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Chiang HI, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-526; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haugen F, 2007, P NUTR SOC, V66, P171, DOI 10.1017/S0029665107005423; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Krekoukia M, 2007, METABOLISM, V56, P206, DOI 10.1016/j.metabol.2006.09.014; Kusunoki M, 2000, DIABETOLOGIA, V43, P875, DOI 10.1007/s001250051464; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Llagostera E, 2009, FEBS LETT, V583, P2121, DOI 10.1016/j.febslet.2009.05.043; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Morin CL, 1997, ENDOCRINOLOGY, V138, P4665, DOI 10.1210/en.138.11.4665; Muurling M, 2003, METABOLISM, V52, P1078, DOI 10.1016/S0026-0495(03)00109-4; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Wang H, 2009, ARTERIOSCL THROM VAS, V29, P1046, DOI 10.1161/ATVBAHA.109.188839; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	56	67	68	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3713	3721		10.1074/jbc.M109.058446	http://dx.doi.org/10.1074/jbc.M109.058446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948719	hybrid, Green Published			2022-12-27	WOS:000275254000023
J	Wyatt, AR; Wilson, MR				Wyatt, Amy R.; Wilson, Mark R.			Identification of Human Plasma Proteins as Major Clients for the Extracellular Chaperone Clusterin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FORMATION; MACULAR DEGENERATION; APOLIPOPROTEIN-J; FIBRINOGEN DEPOSITION; BASEMENT-MEMBRANE; QUALITY-CONTROL; SHEAR-STRESS; VESSEL WALL; COMPLEMENT; DRUSEN	Clusterin (CLU) is an extracellular chaperone that is likely to play an important role in protein folding quality control. This study identified three deposition disease-associated proteins as major plasma clients for clusterin by studying CLU-client complexes formed in response to physiologically relevant stress (shear stress, similar to 36 dynes/cm(2) at 37 degrees C). Analysis of plasma samples by size exclusion chromatography indicated that (i) relative to control plasma, stressed plasma contained proportionally more soluble protein species of high molecular weight, and (ii) high molecular weight species were far more abundant when proteins purified by anti-CLU immunoaffinity chromatography from stressed plasma were compared with those purified from control plasma. SDS-PAGE and Western blot analyses indicated that a variety of proteins co-purified with CLU from both stressed and control plasma; however, several proteins were uniquely present or much more abundant when plasma was stressed. These proteins were identified by mass spectrometry as ceruloplasmin, fibrinogen, and albumin. Immunodot blot analysis of size exclusion chromatography fractionated plasma suggested that CLU-client complexes generated in situ are very large and may reach >= 4 x 10(7) Da. Lastly, sandwich enzyme-linked immunosorbent assay detected complexes containing CLU and ceruloplasmin, fibrinogen, or albumin in stressed but not control plasma. We have previously proposed that CLU-client complexes serve as vehicles to dispose of damaged misfolded extracellular proteins in vivo via receptor-mediated endocytosis. A better understanding of these mechanisms is likely to ultimately lead to the identification of new therapies for extracellular protein deposition disorders.	[Wyatt, Amy R.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Wyatt, Amy/0000-0002-3650-2438	Australian Research Council [DP0773555]; Australian Postgraduate Award; Australian Institute for Nuclear Science and Engineering Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Australian Institute for Nuclear Science and Engineering Postgraduate Award	This work was supported by Australian Research Council Grant DP0773555. Recipient of an Australian Postgraduate Award and an Australian Institute for Nuclear Science and Engineering Postgraduate Award.	Atmeh RF, 1997, ELECTROPHORESIS, V18, P2055, DOI 10.1002/elps.1150181130; Badimon JJ, 1999, CIRCULATION, V99, P1780, DOI 10.1161/01.CIR.99.14.1780; Barbucci R, 2003, BIOMACROMOLECULES, V4, P1506, DOI 10.1021/bm0340366; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHAVERS B, 1984, DIABETOLOGIA, V26, P415; COHN RA, 1978, LAB INVEST, V39, P13; CONNAGHAN DG, 1985, BLOOD, V65, P589; COSTANTINI V, 1991, CANCER RES, V51, P354; COSTANTINI V, 1992, J LAB CLIN MED, V119, P124; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dardik A, 2005, J VASC SURG, V41, P869, DOI 10.1016/j.jvs.2005.01.020; DUJOVNE I, 1972, KIDNEY INT, V2, P33, DOI 10.1038/ki.1972.67; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Freixes M, 2004, ACTA NEUROPATHOL, V108, P295, DOI 10.1007/s00401-004-0891-6; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; FRENCH LE, 1992, CLIN EXP IMMUNOL, V88, P389; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Gorinstein S, 2003, J AGR FOOD CHEM, V51, P822, DOI 10.1021/jf0206926; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; JENNE DE, 1991, J BIOL CHEM, V266, P11030; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Ker Y. C., 1998, Lebensmittel-Wissenschaft and Technologie, V31, P107, DOI 10.1006/fstl.1997.0306; Kim SH, 2007, LANGMUIR, V23, P5657, DOI 10.1021/la0634701; KINGSTON IB, 1977, P NATL ACAD SCI USA, V74, P5377, DOI 10.1073/pnas.74.12.5377; Klose R, 2000, J BIOL CHEM, V275, P38206, DOI 10.1074/jbc.M003640200; KOFFLER D, 1966, AM J PATHOL, V49, P383; KOFFLER D, 1965, J CLIN INVEST, V44, P1665, DOI 10.1172/JCI105273; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; MAILHAC A, 1994, CIRCULATION, V90, P988, DOI 10.1161/01.CIR.90.2.988; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; MILLER K, 1976, DIABETES, V25, P701, DOI 10.2337/diabetes.25.8.701; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; NEWSOME DA, 1986, INVEST OPHTH VIS SCI, V27, P1675; Park DC, 2008, NEOPLASIA, V10, P964, DOI 10.1593/neo.08604; Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; RAIJ L, 1981, LANCET, V1, P671; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Sakaguchi H, 2002, EXP EYE RES, V74, P547, DOI 10.1006/exer.2002.1186; Schinke T, 1997, FEBS LETT, V412, P559, DOI 10.1016/S0014-5793(97)00827-2; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Shiose S, 2004, GRAEF ARCH CLIN EXP, V242, P777, DOI 10.1007/s00417-004-0910-2; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; UEMICHI T, 1994, J CLIN INVEST, V93, P731, DOI 10.1172/JCI117027; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; WALKER FJ, 1990, J BIOL CHEM, V265, P1834; WESTBERG NG, 1972, DIABETES, V21, P163, DOI 10.2337/diab.21.3.163; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; WILSON MR, 1992, BIOCHIM BIOPHYS ACTA, V1159, P319, DOI 10.1016/0167-4838(92)90062-I; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; WILSON MR, 2008, HEAT SHOCK PROTEINS; WITTE DP, 1993, AM J PATHOL, V143, P763; WOJTUKIEWICZ MZ, 1989, THROMB RES, V55, P279, DOI 10.1016/0049-3848(89)90445-3; WOJTUKIEWICZ MZ, 1989, THROMB HAEMOSTASIS, V62, P1062; Wyatt AR, 2009, CURR MED CHEM, V16, P2855, DOI 10.2174/092986709788803187; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zakharova ET, 2000, ARCH BIOCHEM BIOPHYS, V374, P222, DOI 10.1006/abbi.1999.1559; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	80	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3532	3539		10.1074/jbc.M109.079566	http://dx.doi.org/10.1074/jbc.M109.079566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996109	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000275254000002
J	Graham, LV; Sweetwyne, MT; Pallero, MA; Murphy-Ullrich, JE				Graham, Lauren Van Duyn; Sweetwyne, Mariya T.; Pallero, Manuel A.; Murphy-Ullrich, Joanne E.			Intracellular Calreticulin Regulates Multiple Steps in Fibrillar Collagen Expression, Trafficking, and Processing into the Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE CALRETICULIN; GROWTH-FACTOR-BETA; RECEPTOR-RELATED PROTEIN; AMINO-ACID DEPRIVATION; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; SUBSTRATUM ADHESION; DERMAL FIBROBLASTS; OXIDATIVE STRESS; APOPTOTIC CELLS	Calreticulin (CRT), a chaperone and Ca2+ regulator, enhances wound healing, and its expression correlates with fibrosis in animal models, suggesting that CRT regulates production of the extracellular matrix. However, direct regulation of collagen matrix by CRT has not been previously demonstrated. We investigated the role of CRT in the regulation of fibrillar collagen expression, secretion, processing, and deposition in the extracellular matrix by fibroblasts. Mouse embryonic fibroblasts deficient in CRT (CRT-/- MEFs) have reduced transcript levels of fibrillar collagen I and III and less soluble collagen as compared with wild type MEFs. Correspondingly, fibroblasts engineered to overexpress CRT have increased collagen type I transcript and protein. Collagen expression appears to be regulated by endoplasmic reticulum (ER) calcium levels and intracellular CRT, because thapsigargin treatment reduced collagen expression, whereas addition of exogenous recombinant CRT had no effect. CRT-/- MEFs exhibited increased ER retention of collagen, and collagen and CRT were co-immunoprecipitated from isolated cell lysates, suggesting that CRT is important for trafficking of collagen through the ER. CRT-/- MEFs also have reduced type I procollagen processing and deposition into the extracellular matrix. The reduced collagen matrix deposition is partly a consequence of reduced fibronectin matrix formation in the CRT-deficient cells. Together, these data show that CRT complexes with collagen in cells and that CRT plays critical roles at multiple stages of collagen expression and processing. These data identify CRT as an important regulator of collagen and suggest that intracellular CRT signaling plays an important role in tissue remodeling and fibrosis.	[Graham, Lauren Van Duyn; Pallero, Manuel A.; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sweetwyne, Mariya T.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Murphy-Ullrich, JE (corresponding author), Volker Hall 668,1670 Univ Blvd, Birmingham, AL 35294 USA.	murphy@uab.edu	Sweetwyne, Mariya/GWR-2481-2022		National Institutes of Health [HL079644, T32 GM008361, T32 HL007918]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL079644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079644 (to J.E.M.- U.), T32 GM008361 (to L. V. G.), and T32 HL007918 (to M. T. S.) (Medical Scientist Training Program Grants, University of Alabama at Birmingham).	BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; BLANCK TJJ, 1975, ARCH BIOCHEM BIOPHYS, V171, P259, DOI 10.1016/0003-9861(75)90031-4; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; COPPOLINO M, 1995, J BIOL CHEM, V270, P23132, DOI 10.1074/jbc.270.39.23132; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Davidson JM, 1997, J BIOL CHEM, V272, P345, DOI 10.1074/jbc.272.1.345; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Elton CM, 2002, THROMB HAEMOSTASIS, V88, P648, DOI 10.1055/s-0037-1613270; Fadel MP, 1999, J BIOL CHEM, V274, P15085, DOI 10.1074/jbc.274.21.15085; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; GOLD L, 2010, FASEB J IN PRESS; GRAY AJ, 1995, J BIOL CHEM, V270, P26602, DOI 10.1074/jbc.270.44.26602; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Heal R, 1998, BIOCHEM J, V329, P389, DOI 10.1042/bj3290389; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Horino Y, 2002, LIFE SCI, V71, P3031, DOI 10.1016/S0024-3205(02)02142-2; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Knee R, 2003, BIOCHEM BIOPH RES CO, V304, P661, DOI 10.1016/S0006-291X(03)00643-0; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Midwood KS, 2002, METHOD CELL BIOL, V69, P145, DOI 10.1016/S0091-679X(02)69011-9; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; MURPHYULLRICH JE, 1993, J BIOL CHEM, V268, P26784; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Nunez MT, 2001, J CELL BIOCHEM, V82, P660, DOI 10.1002/jcb.1194; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Papp S, 2008, EXP CELL RES, V314, P1313, DOI 10.1016/j.yexcr.2008.01.008; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; PEERSCHKE EIB, 1990, J IMMUNOL, V145, P2984; PLAKIDOUDYMOCK S, 1994, CELL CALCIUM, V16, P1, DOI 10.1016/S0143-4160(05)80002-8; Poobalarahi F, 2006, AM J PHYSIOL-HEART C, V291, pH2924, DOI 10.1152/ajpheart.00153.2006; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Razzaque MS, 1998, MODERN PATHOL, V11, P1183; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Shalitin N, 2003, J CELL BIOCHEM, V90, P397, DOI 10.1002/jcb.10646; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Sugiura T, 2000, NEPHRON, V85, P71, DOI 10.1159/000045633; Taguchi T, 2007, TRENDS MOL MED, V13, P45, DOI 10.1016/j.molmed.2006.12.001; TREVES S, 1990, BIOCHEM J, V271, P473, DOI 10.1042/bj2710473; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Wu XD, 2007, SHOCK, V27, P572, DOI 10.1097/01.shk.0000246901.58068.a8; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H	74	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7067	7078		10.1074/jbc.M109.006841	http://dx.doi.org/10.1074/jbc.M109.006841			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20044481	Green Published, hybrid			2022-12-27	WOS:000275415600020
J	Williams, CA; Bell, SV; Jenkins, A				Williams, Carrie A.; Bell, Shannon V.; Jenkins, Andrew			A Residue in Loop 9 of the beta 2-Subunit Stabilizes the Closed State of the GABA(A) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE BINDING-SITE; LIGAND-INDUCED CHANGES; AGONIST BINDING; A RECEPTOR; AMINO-ACID; CHANNEL; MODULATION; PROPOFOL; PROTEIN; ETOMIDATE	In gamma-aminobutyric acid type A (GABA(A)) receptors, the structural elements that couple ligand binding to channel opening remain poorly defined. Here, site-directed mutagenesis was used to determine if Loop 9 on the non-GABA binding site interface of the beta 2-subunit may be involved in GABA(A) receptor activation. Specifically, residues Gly(170)-Gln(185) of the beta 2-subunit were mutated to alanine, co-expressed with wild-type alpha 1- and gamma 2S-subunits in human embryonic kidney (HEK) 293 cells and assayed for their activation by GABA, the intravenous anesthetic propofol and the endogenous neurosteroid pregnanolone using whole cell macroscopic recordings. Three mutants, G170A, V175A, and G177A, produced 2.5-, 6.7-, and 5.6-fold increases in GABA EC50 whereas one mutant, Q185A, produced a 5.2-fold decrease in GABA EC50. None of the mutations affected the ability of propofol or pregnanolone to potentiate a submaximal GABA response, but the Q185A mutant exhibited 8.3- and 3.5-fold increases in the percent direct activation by propofol and pregnanolone, respectively. Mutant Q185A receptors also had an increased leak current that was sensitive to picrotoxin, indicating an increased gating efficiency. Further Q185E, Q185L, and Q185W substitutions revealed a strong correlation between the hydropathy of the amino acid at this position and the GABA EC50. Taken together, these results indicate that beta 2 Loop 9 is involved in receptor activation by GABA, propofol, and pregnanolone and that beta 2(Q185) participates in hydrophilic interactions that are important for stabilizing the closed state of the GABA(A) receptor.	[Jenkins, Andrew] Emory Univ, Sch Med, Dept Anesthesiol, Rollins Res Ctr 5013, Atlanta, GA 30322 USA; [Jenkins, Andrew] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University	Jenkins, A (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, Rollins Res Ctr 5013, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	ajenki2@emory.edu	Jenkins, Andrew/E-1180-2011		NIGMS, National Institutes of Health [073959, F32 084621]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grants 073959 (to A. J.) and F32 084621 (to C. A. W.).	Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Eddins D, 2002, AM J PHYSIOL-CELL PH, V283, pC1454, DOI 10.1152/ajpcell.00204.2002; Findlay GS, 2001, NEUROSCI LETT, V305, P76, DOI 10.1016/S0304-3940(01)01879-1; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Padgett CL, 2008, J BIOL CHEM, V283, P2702, DOI 10.1074/jbc.M705699200; Paulo JA, 2009, PROTEIN EXPRES PURIF, V67, P76, DOI 10.1016/j.pep.2009.05.001; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Scheller M, 2002, J NEUROSCI, V22, P8411; Sedelnikova A, 2005, J BIOL CHEM, V280, P1535, DOI 10.1074/jbc.M409908200; Sharkey LM, 2008, MOL PHARMACOL, V74, P203, DOI 10.1124/mol.108.044891; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Wafford KA, 1996, MOL PHARMACOL, V50, P670; Williams DB, 2002, J NEUROSCI, V22, P7417; ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045; Zouridakis M, 2009, IUBMB LIFE, V61, P407, DOI 10.1002/iub.170	45	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7281	7287		10.1074/jbc.M109.050294	http://dx.doi.org/10.1074/jbc.M109.050294			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20007704	Green Published, hybrid			2022-12-27	WOS:000275415600040
J	Zhao, WQ; Santini, F; Breese, R; Ross, D; Zhang, XD; Stone, DJ; Ferrer, M; Townsend, M; Wolfe, AL; Seager, MA; Kinney, GG; Shughrue, PJ; Ray, WJ				Zhao, Wei-Qin; Santini, Francesca; Breese, Robert; Ross, Dave; Zhang, Xiaohua Douglas; Stone, David J.; Ferrer, Marc; Townsend, Matthew; Wolfe, Abigail L.; Seager, Matthew A.; Kinney, Gene G.; Shughrue, Paul J.; Ray, William J.			Inhibition of Calcineurin-mediated Endocytosis and alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid beta Oligomer-induced Synaptic Disruption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE PATHOLOGY; SCALE RNAI SCREENS; A-BETA; GLUTAMATE-RECEPTOR; TRANSGENIC MICE; ENTORHINAL CORTEX; EXCITATORY SYNAPSES; PRECURSOR PROTEIN; DENDRITIC SPINES	Synaptic degeneration, including impairment of synaptic plasticity and loss of synapses, is an important feature of Alzheimer disease pathogenesis. Increasing evidence suggests that these degenerative synaptic changes are associated with an accumulation of soluble oligomeric assemblies of amyloid beta (A beta) known as ADDLs. In primary hippocampal cultures ADDLs bind to a sub-population of neurons. However the molecular basis of this cell type-selective interaction is not understood. Here, using siRNA screening technology, we identified alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunits and calcineurin as candidate genes potentially involved in ADDL-neuron interactions. Immunocolocalization experiments confirmed that ADDL binding occurs in dendritic spines that express surface AMPA receptors, particularly the calcium-impermeable type II AMPA receptor subunit (GluR2). Pharmacological removal of the surface AMPA receptors or inhibition of AMPA receptors with antagonists reduces ADDL binding. Furthermore, using co-immunoprecipitation and photoreactive amino acid cross-linking, we found that ADDLs interact preferentially with GluR2-containing complexes. We demonstrate that calcineurin mediates an endocytotic process that is responsible for the rapid internalization of bound ADDLs along with surface AMPA receptor subunits, which then both colocalize with cpg2, a molecule localized specifically at the postsynaptic endocytic zone of excitatory synapses that plays an important role in activity-dependent glutamate receptor endocytosis. Both AMPA receptor and calcineurin inhibitors prevent oligomer-induced surface AMPAR and spine loss. These results support a model of disease pathogenesis in which A beta oligomers interact selectively with neurotransmission pathways at excitatory synapses, resulting in synaptic loss via facilitated endocytosis. Validation of this model in human disease would identify therapeutic targets for Alzheimer disease.	[Zhao, Wei-Qin; Breese, Robert; Wolfe, Abigail L.; Seager, Matthew A.; Kinney, Gene G.; Shughrue, Paul J.; Ray, William J.] Merck Res Labs, Dept Neurol, West Point, PA 19486 USA; [Santini, Francesca; Ross, Dave; Ferrer, Marc] Merck Res Labs, N Wales, PA 19454 USA; [Townsend, Matthew] Merck Res Labs, Boston, MA 02115 USA	Merck & Company; Merck & Company; Merck & Company	Zhao, WQ (corresponding author), Merck Res Labs, Dept Neurol, Mail Stop 26A-2000,770 Sunneytown Pike, West Point, PA 19486 USA.	wei-qin_zhao@merck.com	Ray, William J/E-9834-2016	Zhang, Xiaohua Douglas/0000-0002-2486-7931; Ray, William/0000-0002-4491-167X				Abraham G, 2000, BIOORGAN MED CHEM, V8, P2127, DOI 10.1016/S0968-0896(00)00133-4; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; ARMSTRONG DM, 1994, BRAIN RES, V639, P207, DOI 10.1016/0006-8993(94)91732-9; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Cha JHJ, 2001, NEUROBIOL DIS, V8, P90, DOI 10.1006/nbdi.2000.0330; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; DONEVAN SD, 1994, J PHARMACOL EXP THER, V271, P25; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; GEDDES JW, 1992, EXP NEUROL, V115, P271, DOI 10.1016/0014-4886(92)90062-U; Gladding CM, 2009, MOL CELL NEUROSCI, V40, P267, DOI 10.1016/j.mcn.2008.10.014; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hering H, 2003, J NEUROSCI, V23, P3262; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; Ikonomovic MD, 1995, HIPPOCAMPUS, V5, P469, DOI 10.1002/hipo.450050509; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1999, J NEUROSCI, V19, P1263; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shughrue PJ, 2010, NEUROBIOL AGING, V31, P189, DOI 10.1016/j.neurobiolaging.2008.04.003; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Zhang XD, 2008, NUCLEIC ACIDS RES, V36, P4667, DOI 10.1093/nar/gkn435; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2004, J NEUROCHEM, V90, P609, DOI 10.1111/j.1471-4159.2004.02509.x; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	85	139	143	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7619	7632		10.1074/jbc.M109.057182	http://dx.doi.org/10.1074/jbc.M109.057182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20032460	Green Published, hybrid			2022-12-27	WOS:000275415600073
J	Dubots, E; Audry, M; Yamaryo, Y; Bastien, O; Ohta, H; Breton, C; Marechal, E; Block, MA				Dubots, Emmanuelle; Audry, Magali; Yamaryo, Yoshiki; Bastien, Olivier; Ohta, Hiroyuki; Breton, Christelle; Marechal, Eric; Block, Maryse A.			Activation of the Chloroplast Monogalactosyldiacylglycerol Synthase MGD1 by Phosphatidic Acid and Phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE MEMBRANES; ARABIDOPSIS-THALIANA; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; KINASE-ACTIVITIES; PHOSPHOLIPASE-D; PLANT-CELLS; BIOSYNTHESIS; DIACYLGLYCEROL; GALACTOSYLTRANSFERASE; PHOSPHATIDYLCHOLINE	One of the major characteristics of chloroplast membranes is their enrichment in galactoglycerolipids, monogalactosyldiacylglycerol (MGDG), and digalactosyldiacylglycerol (DGDG), whereas phospholipids are poorly represented, mainly as phosphatidylglycerol (PG). All these lipids are synthesized in the chloroplast envelope, but galactolipid synthesis is also partially dependent on phospholipid synthesis localized in non-plastidial membranes. MGDG synthesis was previously shown essential for chloroplast development. In this report, we analyze the regulation of MGDG synthesis by phosphatidic acid (PA), which is a general precursor in the synthesis of all glycerolipids and is also a signaling molecule in plants. We demonstrate that under physiological conditions, MGDG synthesis is not active when the MGDG synthase enzyme is supplied with its substrates only, i.e. diacylglycerol and UDP-gal. In contrast, PA activates the enzyme when supplied. This is shown in leaf homogenates, in the chloroplast envelope, as well as on the recombinant MGDG synthase, MGD1. PG can also activate the enzyme, but comparison of PA and PG effects on MGD1 activity indicates that PA and PG proceed through different mechanisms, which are further differentiated by enzymatic analysis of point-mutated recombinant MGD1s. Activation of MGD1 by PA and PG is proposed as an important mechanism coupling phospholipid and galactolipid syntheses in plants.	[Block, Maryse A.] Univ Grenoble 1, CEA Grenoble, Physiol Cellulaire Vegetale Lab, IRTSV,CEA,INRA,CNRS, F-38054 Grenoble, France; [Audry, Magali; Breton, Christelle] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; [Ohta, Hiroyuki] Tokyo Inst Technol, Res Ctr Evolving Earth & Planets, Yokohama, Kanagawa 2268501, Japan; [Ohta, Hiroyuki] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Tokyo Institute of Technology; Tokyo Institute of Technology	Block, MA (corresponding author), Univ Grenoble 1, CEA Grenoble, Physiol Cellulaire Vegetale Lab, IRTSV,CEA,INRA,CNRS, 17 Rue Martyrs, F-38054 Grenoble, France.	mblock@cea.fr	Ohta, Hiroyuki/B-1840-2014; Bastien, Olivier/B-9723-2008	Ohta, Hiroyuki/0000-0002-1068-3242; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andersson MX, 2004, BBA-MOL CELL BIOL L, V1684, P46, DOI 10.1016/j.bbalip.2004.06.003; Andrews B, 2000, BIOCHEM BIOPH RES CO, V273, P302, DOI 10.1006/bbrc.2000.2938; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Babiychuk E, 2003, PLANT J, V33, P899, DOI 10.1046/j.1365-313X.2003.01680.x; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bin Y, 2004, PLANT CELL PHYSIOL, V45, P503, DOI 10.1093/pcp/pch064; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; COVES J, 1988, P NATL ACAD SCI USA, V85, P4966, DOI 10.1073/pnas.85.14.4966; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; DORNE AJ, 1982, FEBS LETT, V145, P30, DOI 10.1016/0014-5793(82)81200-3; DOUCE R, 1990, ANNU REV CELL BIOL, V6, P173, DOI 10.1146/annurev.cb.06.110190.001133; Fritz M, 2007, J BIOL CHEM, V282, P4613, DOI 10.1074/jbc.M606295200; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; JOYARD J, 2010, PROGR LIPID IN PRESS; KELLY AA, 2007, CURRENT ADV BIOCH CE; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; MALHERBE A, 1992, J BIOL CHEM, V267, P23546; MARECHAL E, 1994, J BIOL CHEM, V269, P5788; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M704385200; OHTA H, 1995, PLANT LIPID METABOLI; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Seo YS, 2009, FEBS LETT, V583, P2301, DOI 10.1016/j.febslet.2009.06.021; Siegenthaler PA, 1997, FEBS LETT, V416, P57, DOI 10.1016/S0014-5793(97)01168-X; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x; Yamaryo Y, 2008, FEBS LETT, V582, P685, DOI 10.1016/j.febslet.2008.01.039; Yamaryo Y, 2006, FEBS LETT, V580, P4086, DOI 10.1016/j.febslet.2006.06.050	41	91	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6003	6011		10.1074/jbc.M109.071928	http://dx.doi.org/10.1074/jbc.M109.071928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20023301	Green Published, hybrid			2022-12-27	WOS:000275367500003
J	Johnson, SE; Ilagan, MXG; Kopan, R; Barrick, D				Johnson, Scott E.; Ilagan, M. Xenia G.; Kopan, Raphael; Barrick, Doug			Thermodynamic Analysis of the CSL.Notch Interaction DISTRIBUTION OF BINDING ENERGY OF THE NOTCH RAM REGION TO THE CSL beta-TREFOIL DOMAIN AND THE MODE OF COMPETITION WITH THE VIRAL TRANSACTIVATOR EBNA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; ISOTHERMAL TITRATION CALORIMETRY; ACCESSIBLE SURFACE-AREAS; TRANSCRIPTIONAL ACTIVATION; INTRACELLULAR DOMAIN; NUCLEAR ANTIGEN-2; CRYSTAL-STRUCTURE; LIGAND-BINDING; HEAT-CAPACITY; PROTEIN	The Notch signaling pathway is a cell-cell communication network giving rise to cell differentiation during metazoan development. Activation of the pathway releases the intracellular portion of the Notch receptor to translocate to the nucleus, where it is able to interact with the effector transcription factor CSL, converting CSL from a transcriptional repressor to an activator. This conversion is dependent upon the high affinity binding of the RAM region of the Notch receptor to the beta-trefoil domain (BTD) of CSL. Here we probe the energetics of binding to BTD of each conserved residue of RAM through the use of isothermal titration calorimetry and single residue substitution. We find that although the highly conserved Phi W Phi P motif is the largest determinant of binding, energetically significant interactions are contributed by N-terminal residues, including a conserved Arg/Lys-rich region. Additionally, we present a thermodynamic analysis of the interaction between the Epstein-Barr virus protein EBNA2 with BTD and explore the extent to which the EBNA2- and RAM-binding sites on BTD are nonoverlapping, as proposed by Fuchs et al. ( Fuchs, K. P., Bommer, G., Dumont, E., Christoph, B., Vidal, M., Kremmer, E., and Kempkes, B. (2001) Eur. J. Biochem. 268, 4639-4646). Combining these results with displacement isothermal titration calorimetry, we propose a mechanism by which the Phi W Phi P motif of RAM and EBNA2 compete with one another for binding at the hydrophobic pocket of BTD using overlapping but specific interactions that are unique to each BTD ligand.	[Johnson, Scott E.; Barrick, Doug] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Ilagan, M. Xenia G.; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Johns Hopkins University; Washington University (WUSTL)	Barrick, D (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	barrick@jhu.edu	Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022	Ilagan, Ma Xenia/0000-0003-2888-4859; Kopan, Raphael/0000-0002-0350-2730	National Institutes of Health [GM060001, P50 CA094056]; National Science Foundation Division of Biological Infrastructure for Peptide Synthesis Instrumentation [0500580]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Biological Infrastructure for Peptide Synthesis Instrumentation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060001 (to D. B.) and P50 CA094056. This work was also supported by Instrumentation Development Grant 0500580 from the National Science Foundation Division of Biological Infrastructure for Peptide Synthesis Instrumentation.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bertagna A, 2008, BIOCHEM SOC T, V36, P157, DOI 10.1042/BST0360157; Bonde J, 2004, CURR OPIN HEMATOL, V11, P392, DOI 10.1097/01.moh.0000145672.42503.70; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Farrell CJ, 2004, P NATL ACAD SCI USA, V101, P4625, DOI 10.1073/pnas.0306482101; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuchs KP, 2001, EUR J BIOCHEM, V268, P4639, DOI 10.1046/j.1432-1327.2001.02387.x; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hayward SD, 2004, SEMIN CANCER BIOL, V14, P387, DOI 10.1016/j.semcancer.2004.04.018; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Le Gall M, 2004, J BIOL CHEM, V279, P29418, DOI 10.1074/jbc.M404589200; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; LING PD, 1995, J VIROL, V69, P1944, DOI 10.1128/JVI.69.3.1944-1950.1995; LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Pace C N, 1986, Methods Enzymol, V131, P266; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Sakai T, 1998, J VIROL, V72, P6034, DOI 10.1128/JVI.72.7.6034-6039.1998; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Velazquez-Campoy A, 2006, BIOPHYS J, V91, P1887, DOI 10.1529/biophysj.106.086561; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002	47	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6681	6692		10.1074/jbc.M109.019968	http://dx.doi.org/10.1074/jbc.M109.019968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028974	hybrid, Green Published			2022-12-27	WOS:000275367500072
J	Jung, S; Marelli, M; Rachubinski, RA; Goodlett, DR; Aitchison, JD				Jung, Sunhee; Marelli, Marcello; Rachubinski, Richard A.; Goodlett, David R.; Aitchison, John D.			Dynamic Changes in the Subcellular Distribution of Gpd1p in Response to Cell Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; TARGETING SIGNAL; LIFE-SPAN; NUCLEAR-LOCALIZATION; CALORIE RESTRICTION; MASS-SPECTROMETRY; GLOBAL ANALYSIS; OSMOTIC-STRESS; YEAST	Gpd1p is a cytosolic NAD(+)-dependent glycerol 3-phosphate dehydrogenase that also localizes to peroxisomes and plays an essential role in the cellular response to osmotic stress and a role in redox balance. Here, we show that Gpd1p is directed to peroxisomes by virtue of an N-terminal type 2 peroxisomal targeting signal (PTS2) in a Pex7p-dependent manner. Significantly, localization of Gpd1p to peroxisomes is dependent on the metabolic status of cells and the phosphorylation of aminoacyl residues adjacent to the targeting signal. Exposure of cells to osmotic stress induces changes in the subcellular distribution of Gpd1p to the cytosol and nucleus. This behavior is similar to Pnc1p, which is coordinately expressed with Gpd1p, and under conditions of cell stress changes its subcellular distribution from peroxisomes to the nucleus where it mediates chromatin silencing. Although peroxisomes are necessary for the beta-oxidation of fatty acids in yeast, the localization of Gpd1p to peroxisomes is not. Rather, shifts in the distribution of Gpd1p to different cellular compartments in response to changing cellular status suggests a role for Gpd1p in the spatial regulation of redox potential, a process critical to cell survival, especially under the complex stress conditions expected to occur in the wild.	[Aitchison, John D.] Inst Syst Biol, Seattle, WA 98103 USA; [Jung, Sunhee; Goodlett, David R.; Aitchison, John D.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Rachubinski, Richard A.; Aitchison, John D.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Alberta; University of Washington; University of Washington Seattle	Aitchison, JD (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jaitchison@systemsbiology.org		Marelli, Marcello/0000-0001-7095-8263	National Institutes of Health [GM075152, GM076547, RR022220]; Canadian Institutes for Health Research [53326]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM075152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075152, GM076547, and RR022220. This work was also supported by Canadian Institutes for Health Research Grant 53326.	AbdelRaheim SR, 2001, ARCH BIOCHEM BIOPHYS, V388, P18, DOI 10.1006/abbi.2000.2268; Aguilera J, 2005, MOL MICROBIOL, V56, P228, DOI 10.1111/j.1365-2958.2005.04533.x; Aguilera J, 2001, CURR GENET, V39, P273, DOI 10.1007/s002940100213; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brown A D, 1978, Adv Microb Physiol, V17, P181, DOI 10.1016/S0065-2911(08)60058-2; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gardocki ME, 2005, BBA-MOL CELL BIOL L, V1735, P89, DOI 10.1016/j.bbalip.2005.05.006; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Larsson C, 1998, YEAST, V14, P347, DOI 10.1002/(SICI)1097-0061(19980315)14:4<347::AID-YEA226>3.0.CO;2-9; LARSSON K, 1993, MOL MICROBIOL, V10, P1101, DOI 10.1111/j.1365-2958.1993.tb00980.x; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; Nevoigt E, 1996, YEAST, V12, P1331, DOI 10.1002/(SICI)1097-0061(199610)12:13<1331::AID-YEA28>3.3.CO;2-S; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Petriv OI, 2004, J MOL BIOL, V341, P119, DOI 10.1016/j.jmb.2004.05.064; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Rep M, 1999, MICROBIOL-UK, V145, P715, DOI 10.1099/13500872-145-3-715; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Smith JJ, 2009, CURR OPIN CELL BIOL, V21, P119, DOI 10.1016/j.ceb.2009.01.009; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; SZILARD RK, 1995, J CELL BIOL, V131, P1453, DOI 10.1083/jcb.131.6.1453; Thoms S, 2006, BBA-MOL CELL RES, V1763, P1620, DOI 10.1016/j.bbamcr.2006.08.046; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; VANDERLEIJ I, 1992, J CELL BIOL, V119, P153, DOI 10.1083/jcb.119.1.153; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204	71	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6739	6749		10.1074/jbc.M109.058552	http://dx.doi.org/10.1074/jbc.M109.058552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026609	hybrid, Green Published			2022-12-27	WOS:000275367500077
J	Schietke, R; Warnecke, C; Wacker, I; Schodel, J; Mole, DR; Campean, V; Amann, K; Goppelt-Struebe, M; Behrens, J; Eckardt, KU; Wiesener, MS				Schietke, Ruth; Warnecke, Christina; Wacker, Ingrid; Schoedel, Johannes; Mole, David R.; Campean, Valentina; Amann, Kerstin; Goppelt-Struebe, Margarete; Behrens, Juergen; Eckardt, Kai-Uwe; Wiesener, Michael S.			The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia INSIGHTS INTO CELLULAR TRANSFORMATION PROCESSES MEDIATED BY HIF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINDAU TUMOR-SUPPRESSOR; RENAL-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITIONS; INDUCIBLE FACTORS HIF-1-ALPHA; TRANSCRIPTION FACTOR SNAIL; BREAST-CANCER CELLS; GENE-EXPRESSION; UP-REGULATION; SOLID TUMORS; HIF-1	Hypoxia has been shown to promote tumor metastasis and lead to therapy resistance. Recent work has demonstrated that hypoxia represses E-cadherin expression, a hallmark of epithelial to mesenchymal transition, which is believed to amplify tumor aggressiveness. The molecular mechanism of E-cadherin repression is unknown, yet lysyl oxidases have been implicated to be involved. Gene expression of lysyl oxidase (LOX) and the related LOX-like 2 (LOXL2) is strongly induced by hypoxia. In addition to the previously demonstrated LOX, we characterize LOXL2 as a direct transcriptional target of HIF-1. We demonstrate that activation of lysyl oxidases is required and sufficient for hypoxic repression of E-cadherin, which mediates cellular transformation and takes effect in cellular invasion assays. Our data support a molecular pathway from hypoxia to cellular transformation. It includes up-regulation of HIF and subsequent transcriptional induction of LOX and LOXL2, which repress E-cadherin and induce epithelial to mesenchymal transition. Lysyl oxidases could be an attractive molecular target for cancers of epithelial origin, in particular because they are partly extracellular.	[Wiesener, Michael S.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Hypertens & Nephrol, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Warnecke, Christina; Goppelt-Struebe, Margarete; Eckardt, Kai-Uwe; Wiesener, Michael S.] Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, D-91054 Erlangen, Germany; [Campean, Valentina; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; [Schoedel, Johannes; Mole, David R.] Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Oxford	Wiesener, MS (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Hypertens & Nephrol, Interdisciplinary Ctr Clin Res, Glueckstr 6, D-91054 Erlangen, Germany.	mwiesene@molmed.uni-erlangen.de		Schodel, Johannes/0000-0002-3587-8839; Mole, David/0000-0002-0984-300X	Interdisciplinary Centre for Clinical Research; European Commission Sixth Framework Programme (Euroxy); Wellcome Trust; German Research Foundation [SFB 423]	Interdisciplinary Centre for Clinical Research; European Commission Sixth Framework Programme (Euroxy)(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the Interdisciplinary Centre for Clinical Research (to M. W. and J. B.), the European Commission Sixth Framework Programme (Euroxy) (to K. U. E.), the Wellcome Trust (to J. S.), and the German Research Foundation (SFB 423) (to M. W.).	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beavon IRG, 1999, J CLIN PATHOL-MOL PA, V52, P179, DOI 10.1136/mp.52.4.179; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Brown JM, 1998, CANCER RES, V58, P1408; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; COHEN R, 2005, CANC KIDNEY, P201; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Giampuzzi M, 2000, J BIOL CHEM, V275, P36341, DOI 10.1074/jbc.M003362200; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Jansen MK, 2007, MATRIX BIOL, V26, P136, DOI 10.1016/j.matbio.2006.09.004; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MELLO MLS, 1995, EXP CELL RES, V220, P374, DOI 10.1006/excr.1995.1328; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rofstad EK, 2000, INT J RADIAT BIOL, V76, P589, DOI 10.1080/095530000138259; RONCHETTI IP, 1986, AM J PATHOL, V124, P436; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turner KJ, 2002, CANCER RES, V62, P2957; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wiesener MS, 2007, INT J CANCER, V121, P2434, DOI 10.1002/ijc.22961; Wiesener MS, 2001, CANCER RES, V61, P5215; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhong H, 1999, CANCER RES, V59, P5830; Zimmer M, 2004, MOL CANCER RES, V2, P89	71	176	195	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6658	6669		10.1074/jbc.M109.042424	http://dx.doi.org/10.1074/jbc.M109.042424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026874	Green Published, hybrid			2022-12-27	WOS:000275367500070
J	Tsujita, K; Itoh, T; Kondo, A; Oyama, M; Kozuka-Hata, H; Irino, Y; Hasegawa, J; Takenawa, T				Tsujita, Kazuya; Itoh, Toshiki; Kondo, Akihiro; Oyama, Masaaki; Kozuka-Hata, Hiroko; Irino, Yasuhiro; Hasegawa, Junya; Takenawa, Tadaomi			Proteome of Acidic Phospholipid-binding Proteins SPATIAL AND TEMPORAL REGULATION OF CORONIN 1A BY PHOSPHOINOSITIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONIN 1B; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; PLASMA-MEMBRANE; MESSENGER-RNAS; F-ACTIN; COFILIN; PHOSPHOINOSITIDES; TRANSLATION; CELLS	Reversible interactions between acidic phospholipids in the cellular membrane and proteins in the cytosol play fundamental roles in a wide variety of physiological events. Here, we present a novel approach to the identification of acidic phospholipid-binding proteins using nano-liquid chromatography-tandem mass spectrometry. Wefound more than 400 proteins, including proteins with previously known acidic phospholipid- binding properties, and confirmed that several candidates, such as Coronin 1A, mDia1 (Diaphanous-related formin-1), PIR121/CYFIP2, EB2 (end plus binding protein-2), KIF21A (kinesin family member 21A), eEF1A1 (translation elongation factor 1 alpha 1), and TRIM2, directly bind to acidic phospholipids. Among such novel proteins, we provide evidence that Coronin 1A activity, which disassembles Arp2/3-containing actin filament branches, is spatially and temporally regulated by phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). Whereas Coronin 1A co-localizes with PI(4,5)P-2 at the plasma membrane in resting cells, it is dissociated from the plasma membrane during lamellipodia formation where the PI(4,5)P-2 signal is significantly reduced. Our in vitro experiments show that Coronin 1A preferentially binds to PI(4,5)P-2-containing liposomes and that PI(4,5)P-2 antagonizes the ability of Coronin 1A to disassemble actin filament branches, indicating a spatiotemporal regulation of Coronin 1A via a direct interaction with the plasma membrane lipid. Collectively, our proteomics data provide a list of potential acidic phospholipid- binding protein candidates ranging from the actin regulatory proteins to translational regulators.	[Takenawa, Tadaomi] Kobe Univ, Div Lipid Biochem, Dept Biochem & Mol Biol, Grad Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Itoh, Toshiki; Kondo, Akihiro; Hasegawa, Junya] Kobe Univ, Div Membrane Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Med Prote Lab, Inst Med Sci, Tokyo 1088639, Japan	Kobe University; Kobe University; University of Tokyo	Takenawa, T (corresponding author), Kobe Univ, Div Lipid Biochem, Dept Biochem & Mol Biol, Grad Sch Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Hasegawa, Junya/AAR-1009-2021; Hasegawa, Junya/F-7007-2015; Hasegawa, Junya/I-5282-2019	Hasegawa, Junya/0000-0002-7041-890X; Hasegawa, Junya/0000-0002-7041-890X; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Hasegawa, Junya/0000-0003-1216-7468; Oyama, Masaaki/0000-0001-6478-3735	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for creative scientific research from the Japan Society for the Promotion of Science (to T.T.), grants-in-aid for young scientists from the Japan Society for the Promotion of Science (to K.T. and T.I.), grants-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.I. and T.T.), and the Global Centers of Excellence Program from the Japan Society for the Promotion of Science (to T.I., J.H., and T.T.).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; Oyama M, 2007, MOL CELL PROTEOMICS, V6, P1000, DOI 10.1074/mcp.M600297-MCP200; Park SJ, 2007, GENES CELLS, V12, P611, DOI 10.1111/j.1365-2443.2007.01081.x; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	35	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6781	6789		10.1074/jbc.M109.057018	http://dx.doi.org/10.1074/jbc.M109.057018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032464	hybrid, Green Published			2022-12-27	WOS:000275367500081
J	Arragain, S; Garcia-Serres, R; Blondin, G; Douki, T; Clemancey, M; Latour, JM; Forouhar, F; Neely, H; Montelione, GT; Hunt, JF; Mulliez, E; Fontecave, M; Atta, M				Arragain, Simon; Garcia-Serres, Ricardo; Blondin, Genevieve; Douki, Thierry; Clemancey, Martin; Latour, Jean-Marc; Forouhar, Farhad; Neely, Helen; Montelione, Gaetano T.; Hunt, John F.; Mulliez, Etienne; Fontecave, Marc; Atta, Mohamed			Post-translational Modification of Ribosomal Proteins STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF RimO FROM THERMOTOGA MARITIMA, A RADICAL S-ADENOSYLMETHIONINE METHYLTHIOTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRANSFER-RNA; ESCHERICHIA-COLI; CATALYTIC MECHANISM; ENZYME; METHYLATION; INSIGHTS; CLUSTER; BINDING; SULFUR	Post-translational modifications of ribosomal proteins are important for the accuracy of the decoding machinery. A recent in vivo study has shown that the rimO gene is involved in generation of the 3-methylthio derivative of residue Asp-89 in ribosomal protein S12 (Anton, B. P., Saleh, L., Benner, J. S., Raleigh, E. A., Kasif, S., and Roberts, R. J. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 1826-1831). This reaction is formally identical to that catalyzed by MiaB on the C2 of adenosine 37 near the anticodon of several tRNAs. Wepresent spectroscopic evidence that Thermotoga maritima RimO, like MiaB, contains two [4Fe-4S] centers, one presumably bound to three invariant cysteines in the central radical S-adenosylmethionine (AdoMet) domain and the other to three invariant cysteines in the N-terminal UPF0004 domain. We demonstrate that holo-RimO can specifically methylthiolate the aspartate residue of a 20-mer peptide derived from S12, yielding a mixture of mono-and bismethyl-thio derivatives. Finally, we present the 2.0 angstrom crystal structure of the central radical AdoMet and the C-terminal TRAM (tRNA methyltransferase 2 and MiaB) domains in apo-RimO. Although the core of the open triose-phosphate isomerase (TIM) barrel of the radical AdoMet domain was conserved, RimO showed differences in domain organization compared with other radical AdoMet enzymes. The unusually acidic TRAM domain, likely to bind the basic S12 protein, is located at the distal edge of the radical AdoMet domain. The basic S12 protein substrate is likely to bind RimO through interactions with both the TRAM domain and the concave surface of the incomplete TIM barrel. These biophysical results provide a foundation for understanding the mechanism of methylthioation by radical AdoMet enzymes in the MiaB/RimO family.	[Forouhar, Farhad; Neely, Helen; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Arragain, Simon; Garcia-Serres, Ricardo; Blondin, Genevieve; Clemancey, Martin; Latour, Jean-Marc; Mulliez, Etienne; Fontecave, Marc; Atta, Mohamed] CEA CNRS UJF, Commissariat Energie Atom Grenoble, iRTSV LCBM, UMR 5249, F-38054 Grenoble 09, France; [Douki, Thierry] CEA UJF, Lab Les Acides Nucl, Commissariat Energie Atom Grenoble, DSM INaC SCIB,UMR E3, F-38054 Grenoble 09, France; [Forouhar, Farhad; Neely, Helen; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Dept Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Fontecave, Marc] Coll France, F-75005 Paris, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; UDICE-French Research Universities; PSL Research University Paris; College de France	Hunt, JF (corresponding author), Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA.	jfhunt@biology.columbia.edu; mohamed.atta@cea.fr	Arragain, Simon/AAA-6356-2019; Thierry, Douki/H-2108-2018; García-Serres, Ricardo/E-4344-2012	Arragain, Simon/0000-0002-6500-0066; Thierry, Douki/0000-0002-5022-071X; García-Serres, Ricardo/0000-0001-5203-0568; Montelione, Gaetano/0000-0002-9440-3059	Northeast Structural Genomics Consortium [GM074958, GM062413]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, P50GM062413] Funding Source: NIH RePORTER	Northeast Structural Genomics Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sylvie Kieffer-Jaquinod (CEA-iRTSV-EDyP-Grenoble) for MS2 analysis, Bernard Dublet for matrix-assisted laser desorption ionization time-of-flight experiments, and Fabien Pierrel for cloning the rimO gene from T. maritima. The crystallographic work was supported by National Institutes of Health Protein Structure Initiative Grants GM074958 and GM062413 to the Northeast Structural Genomics Consortium.	Anantharaman V, 2001, FEMS MICROBIOL LETT, V197, P215, DOI 10.1111/j.1574-6968.2001.tb10606.x; Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Bai Y, 2007, ACTA CRYSTALLOGR F, V63, P135, DOI 10.1107/S1744309107002904; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chandor-Proust A, 2008, J BIOL CHEM, V283, P36361, DOI 10.1074/jbc.M806503200; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; DONG HJ, 1995, J MOL BIOL, V248, P551, DOI 10.1006/jmbi.1995.0242; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2008, CHEM BIOL, V15, P209, DOI 10.1016/j.chembiol.2008.02.011; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Forouhar F, 2006, J BIOL CHEM, V281, P7533, DOI 10.1074/jbc.M507996200; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Kowalak JA, 1996, PROTEIN SCI, V5, P1625, DOI 10.1002/pro.5560050816; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller R, 2007, J APPL CRYSTALLOGR, V40, P938, DOI 10.1107/S0021889807034565; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Seemann M, 2009, J AM CHEM SOC, V131, P13184, DOI 10.1021/ja9012408; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q; Yang J, 2009, BIOCHEMISTRY-US, V48, P9234, DOI 10.1021/bi9010286; Zarembinski TI, 2003, PROTEINS, V50, P177, DOI 10.1002/prot.10311	41	53	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5792	5801		10.1074/jbc.M109.065516	http://dx.doi.org/10.1074/jbc.M109.065516			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007320	Green Published, hybrid			2022-12-27	WOS:000275327200070
J	Khair, L; Subramanian, L; Moser, BA; Nakamura, TM				Khair, Lyne; Subramanian, Lakxmi; Moser, Bettina A.; Nakamura, Toru M.			Roles of Heterochromatin and Telomere Proteins in Regulation of Fission Yeast Telomere Recombination and Telomerase Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEIN; TAZ1 PROTEIN; RNA SUBUNIT; MAINTENANCE; LENGTH; KU; REPLICATION; BINDING; PROTECTION; REQUIRES	When the telomerase catalytic subunit (Trt1/TERT) is deleted, a majority of fission yeast cells survives by circularizing chromosomes. Alternatively, a small minority survives by maintaining telomeric repeats through recombination among telomeres. The recombination-based telomere maintenance in trt1 Delta cells is inhibited by the telomere protein Taz1. In addition, catalytically inactive full-length Trt1 (Trt1-CI) and truncated Trt1 lacking the T-motif and reverse transcriptase (RT) domain (Trt1-Delta T/RT) can strongly inhibit recombination-based survival. Here, we investigated the effects of deleting the heterochromatin proteins Swi6 (HP1 ortholog) and Clr4 (Suv39 family of histone methyltransferases) and the telomere capping complex subunits Poz1 and Ccq1 on Taz1- and Trt1-dependent telomere recombination inhibition. The ability of Taz1 to inhibit telomere recombination did not require Swi6, Clr4, Poz1, or Ccq1. Although Swi6, Clr4, and Poz1 were dispensable for the inhibition of telomere recombination by Trt1-CI, Ccq1 was required for efficient telomere recruitment of Trt1 and Trt1-CI-dependent inhibition of telomere recombination. We also found that Swi6, Clr4, Ccq1, the checkpoint kinase Rad3 (ATR ortholog), and the telomerase regulatory subunit Est1 are all required for Trt1-Delta T/RT to inhibit telomere recombination. However, because loss of Swi6, Clr4, Rad3, Ccq1, or Est1 did not significantly alter the recruitment efficiency of Trt1-Delta T/RT to telomeres, these factors are likely to enhance the ability of Trt1-Delta T/RT to inhibit recombination-based survival by contributing to the negative regulation of telomere recombination.	[Khair, Lyne; Subramanian, Lakxmi; Moser, Bettina A.; Nakamura, Toru M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nakamura, TM (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MC669, Chicago, IL 60607 USA.	nakamut@uic.edu	Nakamura, Toru M/B-2055-2008	Nakamura, Toru M/0000-0001-5752-0814	National Institutes of Health [GM078253]; University of Illinois at Chicago (UIC); UIC Campus Research Board; Sidney Kimmel Scholar program; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago (UIC); UIC Campus Research Board; Sidney Kimmel Scholar program; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078253 (to T.M.N.). This work was also supported by a University of Illinois at Chicago (UIC) start-up fund, UIC Campus Research Board, a Sidney Kimmel Scholar program (to T.M.N.), and a predoctoral fellowship from the American Heart Association (to L. S.).	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Alfa C., 1993, EXPT FISSION YEAST; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Beernink HTH, 2003, CURR BIOL, V13, P575, DOI 10.1016/S0960-9822(03)00169-6; Bisht KK, 2008, YEAST, V25, P537, DOI 10.1002/yea.1603; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Ekwall K, 1996, J CELL SCI, V109, P2637; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 1997, GENETICS, V146, P1221; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kibe T, 2003, NUCLEIC ACIDS RES, V31, P5054, DOI 10.1093/nar/gkg718; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lansdorp PM, 2009, EMBO J, V28, P2532, DOI 10.1038/emboj.2009.172; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 2002, GENETICS, V161, P1437; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Royle NJ, 2008, CYTOGENET GENOME RES, V122, P281, DOI 10.1159/000167814; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Subramanian L, 2008, MOL CELL BIOL, V28, P1443, DOI 10.1128/MCB.01614-07; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354	46	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5327	5337		10.1074/jbc.M109.078840	http://dx.doi.org/10.1074/jbc.M109.078840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20040595	Green Published, hybrid			2022-12-27	WOS:000275327200026
J	Lee, Y; Park, J; Kweon, S; Choe, M				Lee, YongChan; Park, JongChan; Kweon, SoonWook; Choe, MuHyeon			Enhanced Formation of Disulfide-bridged Dimer (Fab-PE38)(2) Utilizing Repeats of the Fab Binding Domain of Protein G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY B3; PSEUDOMONAS EXOTOXIN; RECOMBINANT IMMUNOTOXIN; ESCHERICHIA-COLI; FRAGMENT; RENATURATION; PURIFICATION; GLUTATHIONE; BOND	Fab-PE38 used in this study is B3(Fab)-ext-PE38, and it is an antibody toxin that is made by fusing the Pseudomonas exotoxin to the Fab domain of B3 antibody. This antibody toxin selectively binds to cancer cells and kills the target cancer cells. B3(Fab)-ext-PE38 has a cysteine residue on the ext sequence, and (B3(Fab)-ext-PE38)(2) is the disulfide-bridged dimer of the B3(Fab)-ext-PE38 monomer. (B3(Fab)-ext-PE38)(2) has been found to have 11-fold higher cytotoxicity on the CRL-1739 cell line than monomeric B3(scFv)-PE38. We made a recombinant tandem repeat of the domain III of Streptococcal protein G that has Fab binding property up to seven repeats. Multiple monomers were found to form non-covalent complexes with this tandem repeat. Complexes were purified by size-exclusion chromatography, and we could enhance the production of the disulfide-bridged dimer by reduction and oxidation of the complexes. The tandem repeat makes close intermolecular interactions between monomers possible, and the use of it greatly enhances the yield of the disulfide-bridged dimer.	Korea Univ, Coll Life Sci, Seoul 136701, South Korea; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea	Korea University; Korea University	Choe, M (corresponding author), SeongbugGu AnamDong 5Ga, Seoul 136701, South Korea.	choemh@korea.ac.kr			Korean government (Ministry of Education, Science and Technology) [R01-2006-000-10125-0]	Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a Korea University Grant and Korea Science and Engineering Foundation Grant R01-2006-000-10125-0 funded by the Korean government (Ministry of Education, Science and Technology).	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; BJORCK L, 1984, J IMMUNOL, V133, P969; BUCHNER J, 1992, BIO-TECHNOL, V10, P682, DOI 10.1038/nbt0692-682; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; CHAUDHARY VK, 1990, J BIOL CHEM, V265, P16306; CHOE M, 1994, CANCER RES, V54, P3460; Choi SH, 2001, B KOREAN CHEM SOC, V22, P1361; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; KONISHI K, 1991, ARCH BIOCHEM BIOPHYS, V289, P90, DOI 10.1016/0003-9861(91)90446-P; PAI LH, 1991, P NATL ACAD SCI USA, V88, P3358, DOI 10.1073/pnas.88.8.3358; Park JH, 2001, MOL CELLS, V12, P398; PASTAN I, 1991, CANCER RES, V51, P3781; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Rabenstein DL, 1996, J ORG CHEM, V61, P7391, DOI 10.1021/jo960917+; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; SJOBRING U, 1991, J BIOL CHEM, V266, P399; Swaisgood HE, 2005, BIOTECHNOL ADV, V23, P71, DOI 10.1016/j.biotechadv.2004.09.004; Yoo M, 2006, J MICROBIOL BIOTECHN, V16, P1097	19	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5127	5131		10.1074/jbc.C109.006395	http://dx.doi.org/10.1074/jbc.C109.006395			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022943	Green Published, hybrid			2022-12-27	WOS:000275327200003
J	McRae, S; Pagliai, FA; Mohapatra, NP; Gener, A; Mahmou, ASA; Gunn, JS; Lorca, GL; Gonzalez, CF				McRae, Steven; Pagliai, Fernando A.; Mohapatra, Nrusingh P.; Gener, Alejandro; Mahmou, Asma Sayed Abdelgeliel; Gunn, John S.; Lorca, Graciela L.; Gonzalez, Claudio F.			Inhibition of AcpA Phosphatase Activity with Ascorbate Attenuates Francisella tularensis Intramacrophage Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-PHOSPHATASE; VIRULENCE DETERMINANTS; EXPRESSION; TULAREMIA; PROTEINS; NOVICIDA	Acid phosphatase activity in the highly infectious intracellular pathogen Francisella tularensis is directly related with the ability of these bacteria to survive inside host cells. Pharmacological inactivation of acid phosphatases could potentially help in the treatment of tularemia or even be utilized to neutralize the infection. In the present work, we report inhibitory compounds for three of the four major acid phosphatases produced by F. tularensis SCHU4: AcpA, AcpB, and AcpC. The inhibitors were identified using a catalytic screen from a library of chemicals approved for use in humans. The best results were obtained against AcpA. The two compounds identified, ascorbate (K-i = 380 +/- 160 mu M) and 2-phosphoascorbate (K-i = 3.2 +/- 0.85 mu M) inhibit AcpA in a noncompetitive, nonreversible fashion. A potential ascorbylation site in the proximity of the catalytic pocket of AcpA was identified using site-directed mutagenesis. The effects of the inhibitors identified in vitro were evaluated using bioassays determining the ability of F. tularensis to survive inside infected cells. The presence of ascorbate or 2-phosphoascorbate impaired the intramacrophage survival of F. tularensis in an AcpA-dependent manner as it was probed using knockout strains. The evidence presented herein indicated that ascorbate could be a good alternative to be used clinically to improve treatments against tularemia.	[McRae, Steven; Pagliai, Fernando A.; Gener, Alejandro; Mahmou, Asma Sayed Abdelgeliel; Lorca, Graciela L.; Gonzalez, Claudio F.] Univ Florida, Dept Microbiol & Cell Sci, Inst Food & Agr Sci, Gainesville, FL 32610 USA; [Mohapatra, Nrusingh P.; Gunn, John S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Mohapatra, Nrusingh P.; Gunn, John S.] Ohio State Univ, Div Infect Dis, Dept Internal Med, Columbus, OH 43210 USA	State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gonzalez, CF (corresponding author), Univ Florida, Genet Inst, Rm 306, Gainesville, FL 32610 USA.	cfgonzalez@ufl.edu	Gener, Alejandro Rafael/AAC-1139-2020; Pagliai, Fernando A./J-9921-2019; Gunn, John/E-3167-2011	Gener, Alejandro Rafael/0000-0001-7875-2358; Pagliai, Fernando A./0000-0002-0434-4594				Aragon V, 2001, INFECT IMMUN, V69, P177, DOI 10.1128/IAI.69.1.177-185.2001; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Baron GS, 1999, FEMS MICROBIOL LETT, V176, P85, DOI 10.1111/j.1574-6968.1999.tb13646.x; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Chhatwal GS, 1997, MICROB PATHOGENESIS, V22, P257, DOI 10.1006/mpat.1996.0118; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Felts RL, 2006, J BIOL CHEM, V281, P30289, DOI 10.1074/jbc.M606391200; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Hasenkopf K, 2002, J AGR FOOD CHEM, V50, P5697, DOI 10.1021/jf020411u; Hernychova L, 2001, PROTEOMICS, V1, P508, DOI 10.1002/1615-9861(200104)1:4<508::AID-PROT508>3.3.CO;2-B; Khan AS, 2000, LANCET, V356, P1179, DOI 10.1016/S0140-6736(00)02769-0; KLENNER F R, 1951, South Med Surg, V113, P101; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Nobeli I, 2003, J MOL BIOL, V334, P697, DOI 10.1016/j.jmb.2003.10.008; ORTWERTH B, 1980, BIOCHIM BIOPHYS ACTA, V956, P10; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PAULING L, 1971, AM J CLIN NUTR, V24, P1294; PAULING L, 1989, SCIENCE, V24, P1535; Reilly TJ, 2006, PROTEIN EXPRES PURIF, V45, P132, DOI 10.1016/j.pep.2005.05.001; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; SAHA AK, 1985, ARCH BIOCHEM BIOPHYS, V243, P150, DOI 10.1016/0003-9861(85)90783-0; Shoju H, 2006, ANAL BIOCHEM, V353, P290, DOI 10.1016/j.ab.2006.02.024; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; Sjostedt A, 2003, CURR OPIN MICROBIOL, V6, P66, DOI 10.1016/S1369-5274(03)00002-X; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	30	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5171	5177		10.1074/jbc.M109.039511	http://dx.doi.org/10.1074/jbc.M109.039511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028980	hybrid, Green Published			2022-12-27	WOS:000275327200009
J	Ogihara, T; Chuang, JC; Vestermark, GL; Garmey, JC; Ketchum, RJ; Huang, XL; Brayman, KL; Thorner, MO; Repa, JJ; Mirmira, RG; Evans-Molina, C				Ogihara, Takeshi; Chuang, Jen-Chieh; Vestermark, George L.; Garmey, James C.; Ketchum, Robert J.; Huang, Xiaolun; Brayman, Kenneth L.; Thorner, Michael O.; Repa, Joyce J.; Mirmira, Raghavendra G.; Evans-Molina, Carmella			Liver X Receptor Agonists Augment Human Islet Function through Activation of Anaplerotic Pathways and Glycerolipid/Free Fatty Acid Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRANSCRIPTION FACTOR; INSULIN GENE-TRANSCRIPTION; GLUCOSE-HOMEOSTASIS; BETA-CELLS; LIPID-METABOLISM; SECRETION; EXPRESSION; RAT; BIOSYNTHESIS; SUPPRESSION	Recent studies in rodent models suggest that liver X receptors (LXRs) may play an important role in the maintenance of glucose homeostasis and islet function. To date, however, no studies have comprehensively examined the role of LXRs in human islet biology. Human islets were isolated from non-diabetic donors and incubated in the presence or absence of two synthetic LXR agonists, TO-901317 and GW3965, under conditions of low and high glucose. LXR agonist treatment enhanced both basal and stimulated insulin secretion, which corresponded to an increase in the expression of genes involved in anaplerosis and reverse cholesterol transport. Furthermore, enzyme activity of pyruvate carboxylase, a key regulator of pyruvate cycling and anaplerotic flux, was also increased. Whereas LXR agonist treatment up-regulated known downstream targets involved in lipogenesis, we observed no increase in the accumulation of intra-islet triglyceride at the dose of agonist used in our study. Moreover, LXR activation increased expression of the genes encoding hormone-sensitive lipase and adipose triglyceride lipase, two enzymes involved in lipolysis and glycerolipid/free fatty acid cycling. Chronically, insulin gene expression was increased after treatment with TO-901317, and this was accompanied by increased Pdx-1 nuclear protein levels and enhanced Pdx-1 binding to the insulin promoter. In conclusion, our data suggest that LXR agonists have a direct effect on the islet to augment insulin secretion and expression, actions that should be considered either as therapeutic or unintended side effects, as these agents are developed for clinical use.	[Vestermark, George L.; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Ogihara, Takeshi; Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ogihara, Takeshi; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Chuang, Jen-Chieh; Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Garmey, James C.; Thorner, Michael O.] Univ Virginia, Dept Med, Charlottesville, VA 22904 USA; [Huang, Xiaolun; Brayman, Kenneth L.] Univ Virginia, Dept Surg, Charlottesville, VA 22904 USA; [Ketchum, Robert J.] Rocky Vista Univ, Dept Struct Med, Parker, CO 80134 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Virginia	Evans-Molina, C (corresponding author), Indiana Univ, Sch Med, Dept Med, 635 Barnhill Dr,MS 2031A, Indianapolis, IN 46202 USA.	cevansmo@iupui.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Repa, Joyce/0000-0001-5740-1954	National Institutes of Health [R01DK60581, K08 DK080225]; Manpei Suzuki Diabetes Foundation; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK060581, K08DK080225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK60581 (to R. G. M.) and K08 DK080225 (to C. E.-M.). This work was also supported by a Manpei Suzuki Diabetes Foundation Grant (to T.O.), an American Diabetes Association mentor-based post-doctoral fellowship (to R. G. M.), and an American Diabetes Association Research Award (to J.J.R.).	Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; Gravena C, 2002, J ENDOCRINOL, V173, P73, DOI 10.1677/joe.0.1730073; Green CD, 2009, ENDOCRINOLOGY, V150, P2637, DOI 10.1210/en.2008-1039; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Leibiger B, 2000, J BIOL CHEM, V275, P30153, DOI 10.1074/jbc.M005216200; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Liu YQ, 1999, DIABETES, V48, P1747, DOI 10.2337/diabetes.48.9.1747; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Mallini N, 2008, CHEM BIOL DRUG DES, V71, P140, DOI 10.1111/j.1747-0285.2007.00620.x; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Ogihara T, 2003, J BIOL CHEM, V278, P21693, DOI 10.1074/jbc.M302684200; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz H, 2009, DIABETOLOGIA, V52, P1352, DOI 10.1007/s00125-009-1366-z; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wente W, 2007, ENDOCRINOLOGY, V148, P1843, DOI 10.1210/en.2006-1247; Yeom SY, 2006, MOL CELL BIOL, V26, P4553, DOI 10.1128/MCB.01412-05; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	57	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5392	5404		10.1074/jbc.M109.064659	http://dx.doi.org/10.1074/jbc.M109.064659			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007976	Green Published, hybrid			2022-12-27	WOS:000275327200033
J	Rasmussen, T; Edwards, MD; Black, SS; Rasmussen, A; Miller, S; Booth, IR				Rasmussen, Tim; Edwards, Michelle D.; Black, Susan S.; Rasmussen, Akiko; Miller, Samantha; Booth, Ian R.			Tryptophan in the Pore of the Mechanosensitive Channel MscS ASSESSMENT OF PORE CONFORMATIONS BY FLUORESCENCE SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRONIC-ENERGY TRANSFER; POLARIZATION SPECTRUM; MEMBRANE-PROTEIN; ION CHANNELS; TRANSITIONS; MECHANISM; RESIDUES; DYNAMICS; HELIX	Structural changes in channel proteins give critical insights required for understanding the gating transitions that underpin function. Tryptophan (Trp) is uniquely sensitive to its environment and can be used as a reporter of conformational changes. Here, we have used site-directed Trp insertion within the pore helices of the small mechanosensitive channel protein, MscS, to monitor conformational transitions. We show that Trp can be inserted in place of Leu at the two pore seal positions, Leu(105) and Leu(109), resulting in functional channels. Using Trp(105) as a probe, we demonstrate that the A106V mutation causes a modified conformation in the purified channel protein consistent with a more open state in solution. Moreover, we show that solubilized MscS changes to a more open conformation in the presence of phospholipids or their lysoforms.	[Rasmussen, Tim] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Rasmussen, T (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	t.rasmussen@abdn.ac.uk	Rasmussen, Tim/E-8268-2011; Miller, Samantha/A-4799-2010; Rasmussen, Tim/P-7566-2019	Rasmussen, Tim/0000-0003-1126-846X; Rasmussen, Tim/0000-0003-1126-846X; Miller, Samantha/0000-0002-8223-9693	Wellcome Trust [040174, 086903]; MRC [G0400277] Funding Source: UKRI; Medical Research Council [G0400277] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Wellcome Trust (Grant 040174 and 086903).	Adams PD, 2002, J AM CHEM SOC, V124, P9278, DOI 10.1021/ja0167710; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Alston RW, 2008, BIOPHYS J, V94, P2280, DOI 10.1529/biophysj.107.116921; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Booth IR, 2007, METHOD ENZYMOL, V428, P47, DOI 10.1016/S0076-6879(07)28003-6; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Clark EH, 2003, BIOCHEMISTRY-US, V42, P11065, DOI 10.1021/bi034607e; Coker G., 1994, RESONANCE ENERGY TRA, p[148, 44]; Deitrich CL, 2007, ANAL CHEM, V79, P8381, DOI 10.1021/ac071397t; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; KIRBY EP, 1970, J BIOL CHEM, V245, P6300; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P530; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Pan CP, 2004, BIOPHYS J, V86, P3828, DOI 10.1529/biophysj.103.038901; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Rasmussen A, 2007, BIOCHEMISTRY-US, V46, P10899, DOI 10.1021/bi701056k; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Shapovalov G, 2004, J GEN PHYSIOL, V124, P151, DOI 10.1085/jgp.200409087; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; WEBER G, 1960, BIOCHEM J, V75, P345, DOI 10.1042/bj0750345; WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335; WILSON ML, 1985, BIOCHEMISTRY-US, V24, P1920, DOI 10.1021/bi00329a018	40	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5377	5384		10.1074/jbc.M109.071472	http://dx.doi.org/10.1074/jbc.M109.071472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20037156	Green Published, hybrid			2022-12-27	WOS:000275327200031
J	Ahmed, KM; Tsai, CY; Lee, WH				Ahmed, Kazi Mokim; Tsai, Connie Y.; Lee, Wen-Hwa			Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE CULTURES; BREAST-CANCER; EPITHELIAL ACINI; CDNA INTEGRATION; BRCA1; CELLS; EXPRESSION; PROTEINS; LET-7; MORPHOGENESIS	The high mobility group AT-hook 2 (HMGA2), a DNA architectural protein, is highly regulated during development and plays an important role in tumorigenesis. Indeed, HMGA2 was overexpressed in many different kinds of tumors. However, the mechanisms regulating HMGA2 expression remain elusive. Using microarray analysis, we found that HMGA2, along with a dozen of other genes, was co-repressed by ZBRK1, BRCA1, and CtIP. BRCA1 exerts its transcriptional repression activity through interaction with the transcriptional repressor ZBRK1 in the central domain, and with CtIP in the C-terminal BRCT domain. Here, we show that ZBRK1, BRCA1, and CtIP form a repression complex that coordinately regulates HMGA2 expression via a ZBRK1 recognition site in the HMGA2 promoter. Depletion of any of the proteins in this complex via adenoviral RNA interference in MCF10A mammary epithelial cells activates HMGA2 expression, resulting in increased colony formation in soft agar. Similarly, depletion of ZBRK1, or ectopic overexpression of HMGA2, in MCF10A cells induces abnormal acinar size with increased cell number and inhibits normal acinar formation. Consistently, many BRCA1-deficient mouse breast tumors express higher levels of HMGA2 than BRCA1-proficient tumors. These results suggest that activation of HMGA2 gene expression through derepression of the ZBRK1/BRCA1/CtIP complex is a significant step in accelerating breast tumorigenesis.	[Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014		National Institutes of Health [CA94170]; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94170 ( to W. H. L.).	Ashar HR, 1996, GENOMICS, V31, P207, DOI 10.1006/geno.1996.0033; Buckley NE, 2007, MOL CANCER RES, V5, P261, DOI 10.1158/1541-7786.MCR-06-0250; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Droge P, 2008, CELL STEM CELL, V2, P8, DOI 10.1016/j.stem.2007.12.003; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Langelotz C, 2003, BRIT J CANCER, V88, P1406, DOI 10.1038/sj.bjc.6600935; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li AYJ, 2009, CANCER RES, V69, P5699, DOI 10.1158/0008-5472.CAN-08-4833; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Zhang HT, 2000, DNA CELL BIOL, V19, P253, DOI 10.1089/10445490050021168; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zheng L, 2000, ONCOGENE, V19, P6159, DOI 10.1038/sj.onc.1203968; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	42	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4464	4471		10.1074/jbc.M109.062265	http://dx.doi.org/10.1074/jbc.M109.062265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007691	hybrid, Green Published			2022-12-27	WOS:000275274800024
J	Duit, S; Mayer, H; Blake, SM; Schneider, WJ; Nimpf, J				Duit, Sarah; Mayer, Harald; Blake, Sophia M.; Schneider, Wolfgang J.; Nimpf, Johannes			Differential Functions of ApoER2 and Very Low Density Lipoprotein Receptor in Reelin Signaling Depend on Differential Sorting of the Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; CORTICAL PLATE DEVELOPMENT; BRAIN-DEVELOPMENT; NEURONAL MIGRATION; SYNAPTIC PLASTICITY; GAMMA-SECRETASE; BINDING DOMAIN; VLDL RECEPTOR; LIPID RAFTS; GENE FAMILY	ApoER2 and very low density lipoprotein (VLDL) receptor transmit the Reelin signal into target cells of the central nervous system. To a certain extent, both receptors can compensate for each other, and only the loss of both receptors results in the reeler phenotype, which is characterized by a gross defect in the architecture of laminated brain structures. Nevertheless, both receptors also have specific distinct functions, as corroborated by analyses of the subtle phenotypes displayed in mice lacking either ApoER2 or VLDL receptor. The differences in their function( s), however, have not been defined at the cellular level. Here, using a panel of chimeric receptors, we demonstrate that endocytosis of Reelin and the fate of the individual receptors upon stimulation are linked to their specific sorting to raft versus non-raft domains of the plasma membrane. VLDL receptor residing in the non-raft domain endocytoses and destines Reelin for degradation via the clathrin-coated pit/clathrin-coated vesicle/endosome pathway without being degraded to a significant extent. Binding of Reelin to ApoER2, a resident of rafts, leads to the production of specific receptor fragments with specific functions of their own and to degradation of ApoER2 via lysosomes. These features contribute to a receptor-specific fine tuning of the Reelin signal, leading to a novel model that emphasizes negative feedback loops specifically mediated by ApoER2 and VLDL receptor, respectively.	[Duit, Sarah; Mayer, Harald; Blake, Sophia M.; Schneider, Wolfgang J.; Nimpf, Johannes] Med Univ Vienna, Max F Perutz Labs, Univ Dept, Dept Med Biochem,Vienna Bioctr, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Nimpf, J (corresponding author), Med Univ Vienna, Max F Perutz Labs, Univ Dept, Dept Med Biochem,Vienna Bioctr, Dr Bohrgasse 9-2, A-1030 Vienna, Austria.	johannes.nimpf@meduniwien.ac.at		Nimpf, Johannes/0000-0002-9273-3492	"Fonds zur Forderung der Wissenschaftlichen Forschung, FWF," Austria [P16872-B09, P19611-B09]; Herzfelder'sche Familienstiftung	"Fonds zur Forderung der Wissenschaftlichen Forschung, FWF," Austria(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung	This work was supported by the "Fonds zur Forderung der Wissenschaftlichen Forschung, FWF," Austria, Grants P16872-B09 and P19611-B09 and the Herzfelder'sche Familienstiftung.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Brandes C, 1997, GENOMICS, V42, P185, DOI 10.1006/geno.1997.4702; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Forster E, 2006, EUR J NEUROSCI, V23, P901, DOI 10.1111/j.1460-9568.2006.04612.x; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Jossin Y, 2003, J NEUROSCI, V23, P9953; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Masiulis I, 2009, BIOL CHEM, V390, P67, DOI 10.1515/BC.2009.011; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; NANDI PK, 1982, P NATL ACAD SCI-BIOL, V79, P5881, DOI 10.1073/pnas.79.19.5881; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Perez-Garcia CG, 2004, EUR J NEUROSCI, V20, P2827, DOI 10.1111/j.1460-9568.2004.03733.x; Pol A, 2000, J BIOL CHEM, V275, P30566, DOI 10.1074/jbc.M001131200; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Riddell DR, 2001, J LIPID RES, V42, P998; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Stockinger W, 1998, J BIOL CHEM, V273, P32213, DOI 10.1074/jbc.273.48.32213; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200	52	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4896	4908		10.1074/jbc.M109.025973	http://dx.doi.org/10.1074/jbc.M109.025973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948739	Green Published, hybrid			2022-12-27	WOS:000275274800067
J	Feliciangeli, S; Tardy, MP; Sandoz, G; Chatelain, FC; Warth, R; Barhanin, J; Bendahhou, S; Lesage, F				Feliciangeli, Sylvain; Tardy, Magalie P.; Sandoz, Guillaume; Chatelain, Franck C.; Warth, Richard; Barhanin, Jacques; Bendahhou, Said; Lesage, Florian			Potassium Channel Silencing by Constitutive Endocytosis and Intracellular Sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; MEMBRANE; ENDOSOMES; TREK-1; LOCALIZATION; PHARMACOLOGY; CONDUCTANCE; MODULATION; RECEPTORS; PROTEINS	Tandem of P domains in a weak inwardly rectifying K+ channel 1 (TWIK1) is a K+ channel that produces unusually low levels of current. Replacement of lysine 274 by a glutamic acid (K274E) is associated with stronger currents. This mutation would prevent conjugation of a small ubiquitin modifier peptide to Lys-274, a mechanism proposed to be responsible for channel silencing. However, we found no biochemical evidence of TWIK1 sumoylation, and we showed that the conservative change K274R did not increase current, suggesting that K274E modifies TWIK1 gating through a charge effect. Now we rule out an eventual effect of K274E on TWIK1 trafficking, and we provide convincing evidence that TWIK1 silencing results from its rapid retrieval from the cell surface. TWIK1 is internalized via a dynamin-dependent mechanism and addressed to the recycling endosomal compartment. Mutation of a diisoleucine repeat located in its cytoplasmic C terminus (I293A, I294A) stabilizes TWIK1 at the plasma membrane, resulting in robust currents. The effects of I293A, I294A on channel trafficking and of K274E on channel activity are cumulative, promoting even more currents. Activation of serotoninergic receptor 5-HT1R or adrenoreceptor alpha 2A-AR stimulates TWIK1 but has no effect on TWIK1I293A, I294A, suggesting that G(i) protein activation is a physiological signal for increasing the number of active channels at the plasma membrane.	[Feliciangeli, Sylvain; Tardy, Magalie P.; Sandoz, Guillaume; Chatelain, Franck C.; Lesage, Florian] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Feliciangeli, Sylvain; Tardy, Magalie P.; Sandoz, Guillaume; Chatelain, Franck C.; Lesage, Florian] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Warth, Richard] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Barhanin, Jacques; Bendahhou, Said] TIANP, CNRS, F-06103 Nice 2, France; [Barhanin, Jacques; Bendahhou, Said] Univ Nice Sophia Antipolis, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Regensburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lesage, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Lesage, Florian/P-9780-2019; Warth, Richard/N-7119-2014; Lesage, Florian/D-5097-2011; Feliciangeli, Sylvain/Q-1292-2016; sandoz, guillaume/AAI-9236-2020	Lesage, Florian/0000-0002-4406-7106; Warth, Richard/0000-0001-6084-0659; Lesage, Florian/0000-0002-4406-7106; Feliciangeli, Sylvain/0000-0003-3358-3719; sandoz, guillaume/0000-0003-1251-0852; CHATELAIN, Franck C./0000-0002-8426-8893	Fondation pour la Recherche Me dicale	Fondation pour la Recherche Me dicale(Fondation pour la Recherche Medicale)	This work was supported by the Fondation pour la Recherche Me dicale (Equipe labellise e to F. L.).	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Cain SM, 2008, MOL CELL NEUROSCI, V37, P32, DOI 10.1016/j.mcn.2007.08.009; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Gounon P, 2002, METHOD MICROBIOL, V31, P531, DOI 10.1016/S0580-9517(02)31029-8; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LIPKOWITZ MS, 1992, AM J PHYSIOL, V263, pF144, DOI 10.1152/ajprenal.1992.263.1.F144; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; NEWMAN GR, 2001, RESIN MICROSCOPY ONE; OKUSA MD, 1994, AM J PHYSIOL, V267, pF347, DOI 10.1152/ajprenal.1994.267.3.F347; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2000, J BIOL CHEM, V275, P28722, DOI 10.1074/jbc.M003755200; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; WILSON VG, 2005, SCI STKE, pPE32, DOI DOI 10.1126/STKE.2902005PE32	47	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4798	4805		10.1074/jbc.M109.078535	http://dx.doi.org/10.1074/jbc.M109.078535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19959478	Green Published, hybrid			2022-12-27	WOS:000275274800058
J	Kondrikov, D; Fonseca, FV; Elms, S; Fulton, D; Black, SM; Block, ER; Su, Y				Kondrikov, Dmitry; Fonseca, Fabio V.; Elms, Shawn; Fulton, David; Black, Steven M.; Block, Edward R.; Su, Yunchao			beta-Actin Association with Endothelial Nitric-oxide Synthase Modulates Nitric Oxide and Superoxide Generation from the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL REGULATION; PROTEIN TRANSDUCTION; BINDING; TETRAHYDROBIOPTERIN; IDENTIFICATION; MECHANISMS; DOMAIN; ARTERY; CELLS	Protein-protein interactions represent an important post-translational mechanism for endothelial nitric-oxide synthase (eNOS) regulation. We have previously reported that beta-actin is associated with eNOS oxygenase domain and that association of eNOS with beta-actin increases eNOS activity and nitric oxide (NO) production. In the present study, we found that beta-actin-induced increase in NO production was accompanied by decrease in superoxide formation. A synthetic actin-binding sequence (ABS) peptide 326 with amino acid sequence corresponding to residues 326-333 of human eNOS, one of the putative ABSs, specifically bound to beta-actin and prevented eNOS association with beta-actin in vitro. Peptide 326 also prevented beta-actin-induced decrease in superoxide formation and increase in NO and L-citrulline production. A modified peptide 326 replacing hydrophobic amino acids leucine and tryptophan with neutral alanine was unable to interfere with eNOS-beta-actin binding and to prevent beta-actin-induced changes in NO and superoxide formation. Site-directed mutagenesis of the actin-binding domain of eNOS replacing leucine and tryptophan with alanine yielded an eNOS mutant that exhibited reduced eNOS-beta-actin association, decreased NO production, and increased superoxide formation in COS-7 cells. Disruption of eNOS-beta-actin interaction in endothelial cells using ABS peptide 326 resulted in decreased NO production, increased superoxide formation, and decreased endothelial monolayer wound repair, which was prevented by PEG-SOD and NO donor NOC-18. Taken together, this novel finding indicates that beta-actin binding to eNOS through residues 326-333 in the eNOS protein results in shifting the enzymatic activity from superoxide formation toward NO production. Modulation of NO and superoxide formation from eNOS by beta-actin plays an important role in endothelial function.	[Kondrikov, Dmitry; Fulton, David; Su, Yunchao] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Fonseca, Fabio V.; Elms, Shawn; Fulton, David; Black, Steven M.; Su, Yunchao] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Block, Edward R.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; State University System of Florida; University of Florida	Su, Y (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.	ysu@mcg.edu			National Institutes of Health [R01HL088261]; Flight Attendants Medical Research Institute [032040, 072104]; American Heart Association [0555322B, 0855338E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL088261. This work was also supported by Flight Attendants Medical Research Institute Grants 032040 and 072104 and American Heart Association Greater Southeast Affiliate Grants 0555322B and 0855338E.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P17349, DOI 10.1074/jbc.M000050200; BRESNICK AR, 1990, J BIOL CHEM, V265, P9236; CHEITLIN R, 1981, J BIOL CHEM, V256, P3156; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Gustafsson AB, 2005, METH MOLEC MED, V112, P81; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ji Y, 2007, P NATL ACAD SCI USA, V104, P8839, DOI 10.1073/pnas.0611416104; Keep NH, 2000, NEUROL SCI, V21, pS929, DOI 10.1007/s100720070006; Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004; Kondrikov D, 2004, FASEB J, V18, pA1026; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lakshminrusimha S, 2007, AM J PHYSIOL-HEART C, V293, pH1491, DOI 10.1152/ajpheart.00185.2007; Le Cras TD, 2001, AM J PHYSIOL-LUNG C, V280, pL575, DOI 10.1152/ajplung.2001.280.4.L575; Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; SU Y, 2007, SCI STKE; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Su YC, 2003, AM J PHYSIOL-CELL PH, V284, pC1542, DOI 10.1152/ajpcell.00248.2002; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Venema VJ, 1996, BIOCHEM BIOPH RES CO, V226, P703, DOI 10.1006/bbrc.1996.1417; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804	34	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4319	4327		10.1074/jbc.M109.063172	http://dx.doi.org/10.1074/jbc.M109.063172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19946124	hybrid, Green Published			2022-12-27	WOS:000275274800008
J	Maita, N; Nyirenda, J; Igura, M; Kamishikiryo, J; Kohda, D				Maita, Nobuo; Nyirenda, James; Igura, Mayumi; Kamishikiryo, Jun; Kohda, Daisuke			Comparative Structural Biology of Eubacterial and Archaeal Oligosaccharyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; X-RAY-DIFFRACTION; PROTEIN GLYCOSYLATION; STT3 SUBUNIT; COMPLEX; TRANSFERASE; IDENTIFICATION; GLYCOPROTEIN; GLYCAN; OST3P	Oligosaccharyltransferase (OST) catalyzes the transfer of an oligosaccharide from a lipid donor to an asparagine residue in nascent polypeptide chains. In the bacterium Campylobacter jejuni, a single-subunit membrane protein, PglB, catalyzes N-glycosylation. We report the 2.8 angstrom resolution crystal structure of the C-terminal globular domain of PglB and its comparison with the previously determined structure from the archaeon Pyrococcus AglB. The two distantly related oligosaccharyltransferases share unexpected structural similarity beyond that expected from the sequence comparison. The common architecture of the putative catalytic sites revealed a new catalytic motif in PglB. Site-directed mutagenesis analyses confirmed the contribution of this motif to the catalytic function. Bacterial PglB and archaeal AglB constitute a protein family of the catalytic subunit of OST along with STT3 from eukaryotes. A structure-aided multiple sequence alignment of the STT3/PglB/AglB protein family revealed three types of OST catalytic centers. This novel classification will provide a useful framework for understanding the enzymatic properties of the OST enzymes from Eukarya, Archaea, and Bacteria.	[Maita, Nobuo; Nyirenda, James; Igura, Mayumi; Kamishikiryo, Jun; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Kohda, D (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kohda@bioreg.kyushu-u.ac.jp	Maita, Nobuo/J-1443-2012; Kohda, Daisuke/I-4990-2019; Nyirenda, James/AAP-4432-2020	Maita, Nobuo/0000-0003-2260-5783; Kohda, Daisuke/0000-0001-8234-3776; Nyirenda, James/0000-0001-7122-3189; Kamishikiryo, Jun/0000-0002-7505-7429	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by a Japanese government scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.; Supported by Grants-in-Aid for Scientific Research on Priority Areas and the Targeted Proteins Research Program from MEXT of Japan.	Abu-Qarn Mehtap, 2007, Archaea, V2, P73; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Eichler J, 2003, MICROBIOL-SGM, V149, P3347, DOI 10.1099/mic.0.26591-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2007, ACTA CRYSTALLOGR F, V63, P798, DOI 10.1107/S1744309107040134; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Standley DM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-221; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200	44	73	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4941	4950		10.1074/jbc.M109.081752	http://dx.doi.org/10.1074/jbc.M109.081752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007322	hybrid, Green Published			2022-12-27	WOS:000275274800071
J	Su, B; Bu, YH; Engelberg, D; Gelman, IH				Su, Bing; Bu, Yahao; Engelberg, David; Gelman, Irwin H.			SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C-Raf/MEK/ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CYTOSKELETAL ARCHITECTURE; MATRIX METALLOPROTEINASES; TYROSINE PHOSPHORYLATION; BINDING PROTEIN; HUMAN BREAST; SUBSTRATE; SSECKS; SRC; ACTIVATION	SSeCKS/Gravin/AKAP12 ("SSeCKS") encodes a cytoskeletal protein that regulatesG(1)-> S progression by scaffolding cyclins, protein kinase C (PKC) and PKA. SSeCKS is down-regulated in many tumor types including prostate, and when re-expressed in MAT-LyLu (MLL) prostate cancer cells, SSeCKS selectively inhibits metastasis by suppressing neovascularization at distal sites, correlating with its ability to down-regulate proangiogenic genes including Vegfa. However, the forced re-expression of VEGF only rescues partial lung metastasis formation. Here, we show that SSeCKS potently inhibits chemotaxis and Matrigel invasion, motility parameters contributing to metastasis formation. SSeCKS suppressed serum-induced activation of the Raf/MEK/ERK pathway, resulting in down-regulation of matrix metalloproteinase-2 expression. In contrast, SSeCKS had no effect on serum-induced phosphorylation of the Src substrate, Shc, in agreement with our previous data that SSeCKS does not inhibit Src kinase activity in cells. Invasiveness and chemotaxis could be restored by the forced expression of constitutively active MEK1, MEK2, ERK1, or PKC alpha. SSeCKS suppressed phorbol ester-induced ERK1/2 activity only if it encoded its PKC binding domain (amino acids 553-900), suggesting that SSeCKS attenuates ERK activation through a direct scaffolding of conventional and/or novel PKC isozymes. Finally, control of MLL invasiveness by SSeCKS is influenced by the actin cytoskeleton: the ability of SSeCKS to inhibit podosome formation is unaffected by cytochalasin D or jasplakinolide, whereas its ability to inhibit MEK1/2 and ERK1/2 activation is nullified by jasplakinolide. Our findings suggest that SSeCKS suppresses metastatic motility by disengaging activated Src and then inhibiting the PKC-Raf/MEK/ERK pathways controlling matrix metalloproteinase-2 expression and podosome formation.	[Su, Bing; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Bu, Yahao] Kinex Pharmaceut LLC, Buffalo, NY 14203 USA; [Engelberg, David] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Roswell Park Cancer Institute; Hebrew University of Jerusalem	Gelman, IH (corresponding author), Elm & Carlton Sts, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org			NCI NIH HHS [2P30 CA016056, R01 CA094108, CA94108, P30 CA016056, R55 CA094108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA094108, R55CA094108] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Boissier S, 2000, CANCER RES, V60, P2949; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Chapline C, 1996, J BIOL CHEM, V271, P6417, DOI 10.1074/jbc.271.11.6417; Chapline C, 1998, J BIOL CHEM, V273, P19482, DOI 10.1074/jbc.273.31.19482; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gelman IH, 2006, MOL CANCER RES, V4, P151, DOI 10.1158/1541-7786.MCR-05-0252; Gelman IH, 1998, CELL MOTIL CYTOSKEL, V41, P1; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Guvakova MA, 2002, J CELL SCI, V115, P4149, DOI 10.1242/jcs.00104; Heuertz RM, 1997, AM J RESP CELL MOL, V17, P456, DOI 10.1165/ajrcmb.17.4.2702; HYATT SL, 1994, CELL GROWTH DIFFER, V5, P495; Itoh T, 1998, CANCER RES, V58, P1048; Kim BS, 1998, J NEUROCHEM, V71, P1333; KLEINMAN HK, 2007, CURRENT PROTOCOLS CE; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Lin XY, 1997, CANCER RES, V57, P2304; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; LIN XY, 1995, MOL CELL BIOL, V15, P2754; Lokeshwar BL, 1999, ANN NY ACAD SCI, V878, P271, DOI 10.1111/j.1749-6632.1999.tb07690.x; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nelson PJ, 1999, J CELL SCI, V112, P361; Nelson PJ, 1997, MOL CELL BIOCHEM, V175, P233, DOI 10.1023/A:1006836003758; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkas J, 2002, CANCER RES, V62, P4781; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Suthiphongchai T, 2003, ONCOL RES, V13, P253, DOI 10.3727/096504003108748302; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tao JC, 2007, J BIOL CHEM, V282, P6597, DOI 10.1074/jbc.M608927200; van der Voort CR, 2000, J NEUROIMMUNOL, V108, P82, DOI 10.1016/S0165-5728(00)00253-8; Vayalil PK, 2004, CARCINOGENESIS, V25, P987, DOI 10.1093/carcin/bgh095; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Xia W, 2001, CANCER RES, V61, P5644; Xia W, 2002, EXP CELL RES, V277, P139, DOI 10.1006/excr.2002.5560; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	47	64	65	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4578	4586		10.1074/jbc.M109.073494	http://dx.doi.org/10.1074/jbc.M109.073494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018890	hybrid, Green Published			2022-12-27	WOS:000275274800035
J	Zhu, H; Shuman, S				Zhu, Hui; Shuman, Stewart			Gap Filling Activities of Pseudomonas DNA Ligase D (LigD) Polymerase and Functional Interactions of LigD with the DNA End-binding Ku Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; JOINING FUNCTION; REPAIR; COMPONENT; PRIMASE; LAMBDA; COMPLEX; MYCOBACTERIA; MECHANISM; BACTERIA	Many bacterial pathogens, including Pseudomonas aeruginosa, have a nonhomologous end joining (NHEJ) system of DNA double strand break (DSB) repair driven by Ku and DNA ligase D(LigD). LigD is a multifunctional enzyme composed of a ligase domain fused to an autonomous polymerase module (POL) that adds ribonucleotides or deoxyribonucleotides to DSB ends and primer-templates. LigD POL and the eukaryal NHEJ polymerase lambda are thought to bridge broken DNA ends via contacts with a duplex DNA segment downstream of the primer terminus, a scenario analogous to gap repair. Here, we characterized the gap repair activity of Pseudomonas LigD POL, which is more efficient than simple templated primer extension and relies on a 5'-phosphate group on the distal gap strand end to confer apparent processivity in filling gaps of 3 or 4 nucleotides. Mutations of the His-553, Arg-556, and Lys-566 side chains implicated in DNA 5'-phosphate binding eliminate the preferential filling of 5'-phosphate gaps. Mutating Phe-603, which is imputed to stack on the nucleobase of the template strand that includes the 1st bp of the downstream gap duplex segment, selectively affects incorporation of the final gap-closing nucleotide. We find that Pseudomonas Ku stimulates POL-catalyzed ribonucleotide addition to a plasmid DSB end and promotes plasmid end joining by full-length Pseudomonas LigD. A series of incremental truncations from the C terminus of the 293-amino acid Ku polypeptide identifies Ku-(1-229) as sufficient for homodimerization and LigD stimulation. The slightly longer Ku-(1-253) homodimer forms stable complexes at both ends of linear plasmid DNA that protect the DSBs from digestion by 5'- and 3'-exonucleases.	[Zhu, Hui; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611.	Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; Brissett NC, 2007, SCIENCE, V318, P456, DOI 10.1126/science.1145112; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Garcia-Diaz M, 2006, CELL, V124, P331, DOI [10.1016/j.cell.2005.10.039, 10.1016/j.cel.2005.10.039]; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Ito N, 2003, GENES CELLS, V8, P913, DOI 10.1111/j.1365-2443.2003.00693.x; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Lipps G, 2004, NAT STRUCT MOL BIOL, V11, P157, DOI 10.1038/nsmb723; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Yakovleva L, 2006, J BIOL CHEM, V281, P25026, DOI 10.1074/jbc.M603302200; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2005, J BIOL CHEM, V280, P33707, DOI 10.1074/jbc.M506838200; Zhu H, 2005, J BIOL CHEM, V280, P25973, DOI 10.1074/jbc.M504002200; Zhu H, 2005, J BIOL CHEM, V280, P418, DOI 10.1074/jbc.M410110200; Zhu H, 2008, J BIOL CHEM, V283, P8331, DOI 10.1074/jbc.M705476200; Zhu H, 2007, NUCLEIC ACIDS RES, V35, P3631, DOI 10.1093/nar/gkm145; Zhu H, 2006, J BIOL CHEM, V281, P13873, DOI 10.1074/jbc.M600055200	30	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4815	4825		10.1074/jbc.M109.073874	http://dx.doi.org/10.1074/jbc.M109.073874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018881	Green Published, hybrid			2022-12-27	WOS:000275274800060
J	Bellemare, J; Rouleau, M; Harvey, M; Guillemette, C				Bellemare, Judith; Rouleau, Melanie; Harvey, Mario; Guillemette, Chantal			Modulation of the Human Glucuronosyltransferase UGT1A Pathway by Splice Isoform Polypeptides Is Mediated through Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCE; HUMAN BILIRUBIN; COMPLEX LOCUS; METABOLISM; HOMODIMERIZATION; EXPRESSION; REGULATORS; VARIANTS	This study investigated the molecular mechanisms underlying the regulatory effect of the newly discovered 45-kDa enzymatically inactive UGT1A spliced polypeptides, named isoform i2, upon UGT1A-mediated glucuronidation. Initially, using an inducible system that mimics the relative abundance of isoforms 1 and 2 of UGT1A1 in human tissues, the rates of formation of glucuronides were significantly reduced. We then used a heterologous system constitutively expressing both isoforms i1 and i2 for an in- depth investigation of the presence of spliced i2 on glucuronidation kinetics. UGT1A1, UGT1A7, and UGT1A8 were selected as candidates for these studies. In all cases, co-expression of i1 and i2 in HEK293 cells leads to a significant reduction of the velocity of the glucuronidation reaction without affecting the affinity (K-m (app)) for all substrates tested and the K-m for the co-substrate, UDP-glucuronic acid. The data are consistent with a dominant-negative model of inhibition but do not sustain with an UGT1A_i2-mediated inhibition by competitive binding for substrate or the co-substrate. In contrast, the data from the co-immunoprecipitation experiments are indicative of the existence of a mixture homo-oligomeric (i1-i1 or i2-i2) and hetero-oligomeric (i1-i2) complexes in which the i2-i2 and i1-i2 subunits would be inactive. Thus, protein-protein interactions are likely responsible for the inhibition of active UGT1A_i1 by i2 spliced polypeptides. This new regulatory mechanism may alternatively modulate cellular response to endo/xeno stimulus.	[Guillemette, Chantal] Univ Laval, CHU Laval, Res Ctr, Pharmacogenom Lab, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Guillemette, C (corresponding author), Univ Laval, CHU Laval, Res Ctr, Pharmacogenom Lab, 2705 Boul Laurier,T3-48, Quebec City, PQ G1V 4G2, Canada.	Chantal.Guillemette@crchul.ulaval.ca	Guillemette, Chantal/AAT-6246-2020; Guillemette, Chantal/J-6463-2012	Guillemette, Chantal/0000-0002-1113-1212; Rouleau, Melanie/0000-0003-4154-3127; Rouleau, Michele/0000-0002-2357-1848	Canadian Institutes of Health Research; Canada Research Chair Program; Fonds de la Recherche en Sante du Quebec; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funds from the Canadian Institutes of Health Research and the Canada Research Chair Program ( to C. G.).; Recipient of a Canadian Institutes of Health Research Frederick Banting and Charles Best studentship award.; Recipient of a graduate studentship award from the Fonds de la Recherche en Sante du Quebec and National Sciences and Engineering Research Council of Canada.	BELLEMARE J, 2009, PHARMACOGEN IN PRESS; Bernard O, 2004, DRUG METAB DISPOS, V32, P775, DOI 10.1124/dmd.32.8.775; Ciotti M, 1998, BIOCHEMISTRY-US, V37, P11018, DOI 10.1021/bi980747q; Finel M, 2008, CURR DRUG METAB, V9, P70, DOI 10.2174/138920008783331158; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P1781, DOI 10.1124/dmd.107.016402; Fujiwara R, 2010, J PHARM SCI-US, V99, P442, DOI 10.1002/jps.21830; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Ghosh SS, 2001, J BIOL CHEM, V276, P42108, DOI 10.1074/jbc.M106742200; Girard H, 2007, PHARMACOGENET GENOM, V17, P1077, DOI 10.1097/FPC.0b013e3282f1f118; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Kern A, 2008, ENDOCRINOLOGY, V149, P1277, DOI 10.1210/en.2007-1348; Kurkela M, 2007, PHARMACOGENET GENOM, V17, P115, DOI 10.1097/FPC.0b013e328011b598; Lepine J, 2004, J CLIN ENDOCR METAB, V89, P5222, DOI 10.1210/jc.2004-0331; Levesque E, 2007, HEPATOLOGY, V45, P128, DOI 10.1002/hep.21464; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; Operana TN, 2007, J BIOL CHEM, V282, P4821, DOI 10.1074/jbc.M609417200; Ouzzine M, 1999, FEBS LETT, V454, P187, DOI 10.1016/S0014-5793(99)00797-8; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; PETERS WHM, 1984, J BIOL CHEM, V259, P1701; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stasiv Y, 2001, J BIOL CHEM, V276, P42241, DOI 10.1074/jbc.M105066200; Venkatakrishnan K, 2001, J CLIN PHARMACOL, V41, P1149, DOI 10.1177/00912700122012724; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	25	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3600	3607		10.1074/jbc.M109.083139	http://dx.doi.org/10.1074/jbc.M109.083139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996319	Green Published, hybrid			2022-12-27	WOS:000275254000011
J	Wu, Y; Song, SW; Sun, JY; Bruner, JM; Fuller, GN; Zhang, W				Wu, Ying; Song, Sonya W.; Sun, Jiyuan; Bruner, Janet M.; Fuller, Gregory N.; Zhang, Wei			IIp45 Inhibits Cell Migration through Inhibition of HDAC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASES; MOLECULAR CHAPERONE; BINDING-PROTEIN; ACETYLATION; HSP90; CORTACTIN; INVASION; CANCER; CYTOSKELETON; ACTIVATION	IIp45 (aka MIIP) is a newly discovered gene whose protein product inhibits cell migration. HDAC6 is a class IIb deacetylase that specifically deacetylates alpha-tubulin, modulates microtubule dynamics, and promotes cell migration. A yeast two-hybrid assay using IIp45 as bait identified HDAC6 protein as a binding partner of IIp45. This physical interaction of the two functionally antagonistic proteins was confirmed by glutathione S-transferase pulldown assay and co-immunoprecipitation assay in human cells. Serial deletion constructs of HDAC6 were used to characterize the interaction of HDAC6 and IIp45, and this analysis found that the two catalytic domains of HDAC6 protein are required for IIp45 binding. We examined the protein expression patterns of IIp45 and HDAC6 in glioma tissues. Elevated protein levels of HDAC6 were found in high grade glioma samples, in contrast to the decreased protein expression of IIp45. The potential negative regulation of HDAC6 expression by IIp45 was confirmed in cell lines with altered IIp45 expression by constitutive overexpression or small interfering RNA knockdown. Protein turnover study revealed that overexpression of IIp45 significantly reduces the intracellular protein stability of endogenous HDAC6, indicating a possible mechanism for the negative regulation of HDAC6 by IIp45. Results from the HDAC activity assay demonstrated that overexpressed IIp45 effectively decreases HDAC6 activity, increases acetylated alpha-tubulin, and reduces cell migration. The increased cell migration resulting from siIIp45 knockdown was significantly reversed by co-transfection of siHDAC6. Thus, we report here for the first time a novel mechanism by which IIp45 inhibits cell motility through inhibition of HDAC6.	[Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, Houston, TX 77030 USA; [Song, Sonya W.] Capital Med Univ, Beijing Shijitan Hosp, Beijing 100069, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Capital Medical University	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, 1515 Holcombe Blvd, Houston, TX 77030 USA.	wzhang@mdanderson.org	sun, jiyuan/B-3828-2010	Fuller, Gregory/0000-0001-9447-2647	James S. McDonnell Foundation	James S. McDonnell Foundation	This work was supported by a grant from the James S. McDonnell Foundation.	Aoyagi S, 2005, TRENDS CELL BIOL, V15, P565, DOI 10.1016/j.tcb.2005.09.003; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Moser C, 2009, ANTICANCER RES, V29, P2031; Ohoka Y, 1998, GENES CELLS, V3, P603, DOI 10.1046/j.1365-2443.1998.00216.x; Rao R, 2008, BLOOD, V112, P1886, DOI 10.1182/blood-2008-03-143644; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Song SW, 2005, CANCER RES, V65, P3562, DOI 10.1158/0008-5472.CAN-04-3392; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Witt O, 2009, CURR PHARM DESIGN, V15, P436, DOI 10.2174/138161209787315774; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200	31	41	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3554	3560		10.1074/jbc.M109.063354	http://dx.doi.org/10.1074/jbc.M109.063354			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20008322	hybrid, Green Published			2022-12-27	WOS:000275254000005
J	Drag, M; Bogyo, M; Ellman, JA; Salvesen, GS				Drag, Marcin; Bogyo, Matthew; Ellman, Jonathan A.; Salvesen, Guy S.			Aminopeptidase Fingerprints, an Integrated Approach for Identification of Good Substrates and Optimal Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE AMINOPEPTIDASES; SPECIFICITY DETERMINANTS; LEUCINE AMINOPEPTIDASE; UNEXPECTED SPECIFICITY; LEUCYL AMINOPEPTIDASE; ANALOG INHIBITORS; BINDING-ENERGY; LIBRARIES; POTENT; METALLOPROTEASES	Aminopeptidases process the N-terminal amino acids of target substrates by sequential cleavage of one residue at a time. They are found in all cell compartments of prokaryotes and eukaryotes, being implicated in the major proteolytic events of cell survival, defense, growth, and development. We present a new approach for the fast and reliable evaluation of the substrate specificity of individual aminopeptidases. Using solid phase chemistry with the 7-amino-4-carbamoylmethylcoumarin fluorophore, we have synthesized a library of 61 individual natural and unnatural amino acids substrates, chosen to cover a broad spectrum of the possible interactions in the S1 pocket of this type of protease. As proof of concept, we determined the substrate specificity of human, pig, and rat orthologs of aminopeptidase N (CD13), a highly conserved cell surface protease that inactivates enkephalins and other bioactive peptides. Our data reveal a large and hydrophobic character for the S1 pocket of aminopeptidase N that is conserved with aminopeptidase Ns. Our approach, which can be applied in principle to all aminopeptidases, yields useful information for the design of specific inhibitors, and more importantly, reveals a relationship between the kinetics of substrate hydrolysis and the kinetics of enzyme inhibition.	[Drag, Marcin] Wroclaw Univ Technol, Fac Chem, Div Med Chem & Microbiol, PL-50370 Wroclaw, Poland; Burnham Inst Med Res, Apoptosis & Cell Death Res Program, La Jolla, CA 92037 USA; [Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Ellman, Jonathan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Wroclaw University of Science & Technology; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; University of California System; University of California Berkeley	Drag, M (corresponding author), Wroclaw Univ Technol, Fac Chem, Div Med Chem & Microbiol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	mdrag@burnham.org; gsalvesen@burnham.org	Ellman, Jonathan A/C-7732-2013	Bogyo, Matthew/0000-0003-3753-4412	National Institutes of Health [AIG1139, RR20843, GM054051, EB005011]; State for Scientific Research in Poland [2 P05A 013 30]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State for Scientific Research in Poland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AIG1139 and RR20843 (to G.S.S.), GM054051 (to J.A.E.), and EB005011 (to M.B.). This work was also supported by State for Scientific Research Grant 2 P05A 013 30 in Poland.	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; BARTLETT PA, 1995, J ORG CHEM, V60, P3107, DOI 10.1021/jo00115a028; Bogyo M, 2006, NAT CHEM BIOL, V2, P229, DOI 10.1038/nchembio0506-229; Bradshaw RA, 2002, ESSAYS BIOCHEM, V38, P65, DOI 10.1042/bse0380065; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Chen HX, 1999, BIOORG MED CHEM LETT, V9, P1511; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Coombs GS, 1999, J BIOL CHEM, V274, P24074, DOI 10.1074/jbc.274.34.24074; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dive V, 2004, CELL MOL LIFE SCI, V61, P2010, DOI 10.1007/s00018-004-4050-y; Drag M, 2005, EUR J MED CHEM, V40, P764, DOI 10.1016/j.ejmech.2005.02.011; Drag M, 2005, TETRAHEDRON LETT, V46, P3359, DOI 10.1016/j.tetlet.2005.03.083; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Drag M, 2007, BIOORG MED CHEM LETT, V17, P1516, DOI 10.1016/j.bmcl.2007.01.028; Drag M, 2006, SYNTHETIC COMMUN, V36, P2787, DOI 10.1080/00397910600767330; FOURNIEZALUSKI MC, 1992, J MED CHEM, V35, P1259, DOI 10.1021/jm00085a013; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; GIANNOUSIS PP, 1987, J MED CHEM, V30, P1603, DOI 10.1021/jm00392a014; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; LEJCZAK B, 1989, BIOCHEMISTRY-US, V28, P3549, DOI 10.1021/bi00434a060; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o; MORGAN BP, 1991, J AM CHEM SOC, V113, P297, DOI 10.1021/ja00001a043; Patterson AW, 2007, NAT PROTOC, V2, P424, DOI 10.1038/nprot.2007.28; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; RANDO RR, 1974, SCIENCE, V185, P320, DOI 10.1126/science.185.4148.320; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Schneider Eric L., 2009, V539, P59, DOI 10.1007/978-1-60327-003-8_4; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Skinner-Adams TS, 2007, J MED CHEM, V50, P6024, DOI 10.1021/jm070733v; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Vassiliou S, 2007, BIOORGAN MED CHEM, V15, P3187, DOI 10.1016/j.bmc.2007.02.042; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	45	87	87	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3310	3318		10.1074/jbc.M109.060418	http://dx.doi.org/10.1074/jbc.M109.060418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948737	Green Published, hybrid			2022-12-27	WOS:000273829000046
J	Tung, JY; Yang, CW; Chou, SW; Lin, CC; Sun, YJ				Tung, Jung-Yu; Yang, Chih-Wei; Chou, Shao-Wen; Lin, Chien-Chih; Sun, Yuh-Ju			Calcium Binds to LipL32, a Lipoprotein from Pathogenic Leptospira, and Modulates Fibronectin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN LIPL32; MOLECULAR-CLONING; SURFACE PROTEIN; EXPRESSION; GENE; DYE; INFECTION; SOFTWARE; DISEASE; GROWTH	Tubulointerstitial nephritis is a cardinal renal manifestation of leptospirosis. LipL32, a major lipoprotein and a virulence factor, locates on the outer membrane of the pathogen Leptospira. It evades immune response by recognizing and adhering to extracellular matrix components of the host cell. The crystal structure of Ca2+-bound LipL32 was determined at 2.3A resolution. LipL32 has a novel polyD sequence of seven aspartates that forms a continuous acidic surface patch for Ca2+ binding. A significant conformational change was observed for the Ca2+ bound form of LipL32. Calcium binding to LipL32 was determined by isothermal titration calorimetry. The binding of fibronectin to LipL32 was observed by Stains-all CD and enzyme-linked immunosorbent assay experiments. The interaction between LipL32 and fibronectin might be associated with Ca2+ binding. Based on the crystal structure of Ca2+-bound LipL32 and the Stains-all results, fibronectin probably binds near the polyD region on LipL32. Ca2+ binding to LipL32 might be important for Leptospira to interact with the extracellular matrix of the host cell.	Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Yang, Chih-Wei] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital		yjsun@life.nthu.edu.tw			National Science Council of Taiwan [97-2311B-007-014]; National Tsing Hua University [98N2424E1]; Taiwan Ministry of Economic Affairs [98EC17A17S20101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University; Taiwan Ministry of Economic Affairs(Ministry of Economic Affairs, Taiwan)	This work was supported by National Science Council of Taiwan Grant 97-2311B-007-014 (to Y.-J.S.), National Tsing Hua University Grant 98N2424E1 (to Y.-J.S.), and Taiwan Ministry of Economic Affairs Grant 98EC17A17S20101 (to Y.-J.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Biegel E, 1995, Ugeskr Laeger, V157, P157; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; HOFMANN SL, 1989, J BIOL CHEM, V264, P18083; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; IVEY DM, 1993, J BIOL CHEM, V268, P11296; JOHNSON RC, 1963, J BACTERIOL, V85, P983, DOI 10.1128/JB.85.5.983-985.1963; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1982, PREPARATION ANAL PRO, P94; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; SHENBERG E, 1967, J BACTERIOL, V93, P1598, DOI 10.1128/JB.93.5.1598-1606.1967; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2000, J AM SOC NEPHROL, V11, P2017, DOI 10.1681/ASN.V11112017; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73	46	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3245	3252		10.1074/jbc.M109.006320	http://dx.doi.org/10.1074/jbc.M109.006320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948735	Green Published, hybrid			2022-12-27	WOS:000273829000039
J	Whittaker, GC; Orr, SJ; Quigley, L; Hughes, L; Francischetti, IMB; Zhang, WG; McVicar, DW				Whittaker, Gillian C.; Orr, Selinda J.; Quigley, Laura; Hughes, Laurel; Francischetti, Ivo M. B.; Zhang, Weigou; McVicar, Daniel W.			The Linker for Activation of B Cells (LAB)/Non-T Cell Activation Linker (NTAL) Regulates Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Signaling and Macrophage Inflammatory Responses Independently of the Linker for Activation of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; NEGATIVE REGULATION; CUTTING EDGE; AMPLIFIES INFLAMMATION; CYTOKINE PRODUCTION; TRANSDUCTION; DAP12; LAT; TREM-2; MONOCYTES	Triggering receptor expressed on myeloid cells-2 (TREM-2) is rapidly emerging as a key regulator of the innate immune response via its regulation of macrophage inflammatory responses. Here we demonstrate that proximal TREM-2 signaling parallels other DAP12-based receptor systems in its use of Syk and Src-family kinases. However, we find that the linker for activation of T cells (LAT) is severely reduced as monocytes differentiate into macrophages and that TREM-2 exclusively uses the linker for activation of B cells (LAB encoded by the gene Lat2(-/-)) to mediate downstream signaling. LAB is required for TREM-2-mediated activation of Erk1/2 and dampens proximal TREM-2 signals through a novel LAT-independent mechanism resulting in macrophages with proinflammatory properties. Thus, Lat2(-/-) macrophages have increased TREM-2-induced proximal phosphorylation, and lipopolysaccharide stimulation of these cells leads to increased interleukin-10 (IL-10) and decreased IL-12p40 production relative to wild type cells. Together these data identify LAB as a critical, LAT-independent regulator of TREM-2 signaling and macrophage development capable of controlling subsequent inflammatory responses.	[Whittaker, Gillian C.; Orr, Selinda J.; Quigley, Laura; Hughes, Laurel; McVicar, Daniel W.] NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Francischetti, Ivo M. B.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA; [Zhang, Weigou] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University	McVicar, DW (corresponding author), NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Bldg 560,Rms 31-46, Frederick, MD 21702 USA.	mcvicard@mail.nih.gov	McVicar, Daniel/G-1970-2015	McVicar, Daniel/0000-0002-1112-5111; Orr, Selinda/0000-0001-8539-7825	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048674, R01AI056156, ZIAAI000810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health (Intramural Research Programs, NCI, Center for Cancer Research, and NIAID).	Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Chen H, 2002, J BIOL CHEM, V277, P3011, DOI 10.1074/jbc.M109714200; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Janssen E, 2004, J IMMUNOL, V172, P6810, DOI 10.4049/jimmunol.172.11.6810; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mason LH, 1998, J IMMUNOL, V160, P4148; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tessarz AS, 2007, J IMMUNOL, V178, P1991, DOI 10.4049/jimmunol.178.4.1991; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; WHITTAKER GC, UCSD NATURE MOL, DOI DOI 10.1038/MP.A000750.01; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng YM, 2001, J BIOL CHEM, V276, P12999, DOI 10.1074/jbc.M009344200; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	41	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2976	10.1074/jbc.M109.038398	http://dx.doi.org/10.1074/jbc.M109.038398			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948717	Green Published, hybrid			2022-12-27	WOS:000273829000012
J	Gallardo, O; Pastor, FIJ; Polaina, J; Diaz, P; Lysek, R; Vogel, P; Isorna, P; Gonzalez, B; Sanz-Aparicio, J				Gallardo, Oscar; Javier Pastor, F. I.; Polaina, Julio; Diaz, Pilar; Lysek, Robert; Vogel, Pierre; Isorna, Pablo; Gonzalez, Beatriz; Sanz-Aparicio, Julia			Structural Insights into the Specificity of Xyn10B from Paenibacillus barcinonensis and Its Improved Stability by Forced Protein Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDE HYDROLASE FAMILY-5; SITE-DIRECTED MUTAGENESIS; XYLAN-DEGRADING ENZYMES; IN-VITRO RECOMBINATION; AEROMONAS-CAVIAE ME-1; COLD-SHOCK PROTEIN; BETA-GLUCOSIDASE; BACILLUS SP; GEOBACILLUS-STEAROTHERMOPHILUS; CATALYTIC-PROPERTIES	Paenibacillus barcinonensis is a soil bacterium bearing a complex set of enzymes for xylan degradation, including several secreted enzymes and Xyn10B, one of the few intracellular xylanases reported to date. The crystal structure of Xyn10B has been determined by x-ray analysis. The enzyme folds into the typical (beta/alpha)(8) barrel of family 10 glycosyl hydrolases (GH10), with additional secondary structure elements within the beta/alpha motifs. One of these loops-L7-located at the beta 7 C terminus, was essential for xylanase activity as its partial deletion yielded an inactive enzyme. The loop contains residues His(249)-Glu(250), which shape a pocket opened to solvent in close proximity to the + 2 subsite, which has not been described in other GH10 enzymes. This wide cavity at the + 2 subsite, where methyl-2,4-pentanediol from the crystallization medium was found, is a noteworthy feature of Xyn10B, as compared with the narrow crevice described for other GH10 xylanases. Docking analysis showed that this open cavity can accommodate glucuronic acid decorations of xylo-oligosaccharides. Co-crystallization experiments with conduramine derivative inhibitors supported the importance of this open cavity at the + 2 subsite for Xyn10B activity. Several mutant derivatives of Xyn10B with improved thermal stability were obtained by forced evolution. Among them, mutant xylanases S15L and M93V showed increased half-life, whereas the double mutant S15L/M93V exhibited a further increase in stability, showing a 20-fold higher heat resistance than the wild type xylanase. All the mutations obtained were located on the surface of Xyn10B. Replacement of a Ser by a Leu residue in mutant xylanase S15L can increase hydrophobic packing efficiency and fill a superficial indentation of the protein, giving rise to a more compact structure of the enzyme.	[Gallardo, Oscar; Javier Pastor, F. I.; Diaz, Pilar] Univ Barcelona, Dept Microbiol, Fac Biol, E-08028 Barcelona, Spain; [Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Lysek, Robert; Vogel, Pierre] Ecole Polytech Fed Lausanne, Lab Glycochim & Synth Asymetr, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Isorna, Pablo; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Pastor, FIJ (corresponding author), Univ Barcelona, Dept Microbiol, Fac Biol, Av Diagonal 645, E-08028 Barcelona, Spain.	fpastor@ub.edu	Sanz-Aparicio, Julia/F-6201-2013; saso, luciano/F-6306-2012; Román, Óscar Gallardo/B-3924-2010; Polaina, Julio/H-4498-2012; Gonzalez, Beatriz/M-1219-2014; Diaz, Pilar/I-2465-2014	Sanz-Aparicio, Julia/0000-0002-6849-8621; saso, luciano/0000-0003-4530-8706; Román, Óscar Gallardo/0000-0003-0537-2498; Gonzalez, Beatriz/0000-0002-0710-0202; Polaina, Julio/0000-0001-9912-0640; Pastor, Francisco/0000-0003-0326-2527; Diaz, Pilar/0000-0003-4008-0669	Spanish Ministry of Education and Science [BIO2007-67708-C04-04]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Spanish Ministry of Education and Science Grant BIO2007-67708-C04-04.	Arrizubieta MJ, 2000, J BIOL CHEM, V275, P28843, DOI 10.1074/jbc.M003036200; BABA T, 1994, APPL ENVIRON MICROB, V60, P2252, DOI 10.1128/AEM.60.7.2252-2258.1994; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Blanco A, 1996, FEMS MICROBIOL LETT, V137, P285, DOI 10.1016/0378-1097(96)00074-2; BLANCO A, 1995, APPL ENVIRON MICROB, V61, P4468, DOI 10.1128/AEM.61.12.4468-4470.1995; Blanco A, 1999, MICROBIOL-SGM, V145, P2163, DOI 10.1099/13500872-145-8-2163; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Connerton I, 1999, BBA-PROTEIN STRUCT M, V1433, P110, DOI 10.1016/S0167-4838(99)00151-X; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; ESTELL DA, 1985, J BIOL CHEM, V260, P6518; Fontes CMGA, 2000, MICROBIOL-SGM, V146, P1959, DOI 10.1099/00221287-146-8-1959; Frigerio F, 1996, PROTEIN ENG, V9, P439, DOI 10.1093/protein/9.5.439; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Fujimoto Z, 2004, J BIOL CHEM, V279, P9606, DOI 10.1074/jbc.M312293200; FUKUMURA M, 1995, BIOSCI BIOTECH BIOCH, V59, P40, DOI 10.1271/bbb.59.40; Gallardo O, 2003, APPL MICROBIOL BIOT, V61, P226, DOI 10.1007/s00253-003-1239-1; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolenova K, 2006, J BIOTECHNOL, V121, P338, DOI 10.1016/j.jbiotec.2005.08.001; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIAO XB, 1990, GENE, V88, P107, DOI 10.1016/0378-1119(90)90066-Z; Lo Leggio L, 1999, PROTEINS, V36, P295; LOPEZCAMACHO C, 1993, MUTAT RES, V301, P73, DOI 10.1016/0165-7992(93)90027-S; LopezCamacho C, 1996, BIOCHEM J, V314, P833, DOI 10.1042/bj3140833; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P1017; Lysek R, 2005, BIOORG MED CHEM LETT, V15, P3071, DOI 10.1016/j.bmcl.2005.04.023; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Martin A, 2002, J MOL BIOL, V318, P1341, DOI 10.1016/S0022-2836(02)00243-7; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; TABERNERO C, 1995, APPL ENVIRON MICROB, V61, P2420, DOI 10.1128/AEM.61.6.2420-2424.1995; Tabka MG, 2006, ENZYME MICROB TECH, V39, P897, DOI 10.1016/j.enzmictec.2006.01.021; Torres AL, 2000, BIORESOURCE TECHNOL, V74, P135, DOI 10.1016/S0960-8524(99)00178-9; Tsujibo H, 2004, J BACTERIOL, V186, P1029, DOI 10.1128/JB.186.4.1029-1037.2004; Usui K, 2003, J BIOSCI BIOENG, V95, P488, DOI 10.1016/S1389-1723(03)80050-6; Usui K, 1999, BIOSCI BIOTECH BIOCH, V63, P1346, DOI 10.1271/bbb.63.1346; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Van Petegem F, 2003, J BIOL CHEM, V278, P7531, DOI 10.1074/jbc.M206862200; Vardakou M, 2005, J MOL BIOL, V352, P1060, DOI 10.1016/j.jmb.2005.07.051; VIIKARI L, 1994, FEMS MICROBIOL REV, V13, P335, DOI 10.1016/0168-6445(94)90090-6; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Yasukawa K, 2007, BBA-PROTEINS PROTEOM, V1774, P1281, DOI 10.1016/j.bbapap.2007.08.002	68	43	46	0	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2721	2733		10.1074/jbc.M109.064394	http://dx.doi.org/10.1074/jbc.M109.064394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940147	hybrid, Green Published			2022-12-27	WOS:000273697800050
J	Kodadek, T				Kodadek, Thomas			No Splicing, No Dicing: Non-proteolytic Roles of the Ubiquitin-Proteasome System in Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVATION DOMAIN; REGULATORY PARTICLE; BINDING PROTEIN; GAL4 TURNOVER; YEAST; ASSOCIATION; SUG1; COACTIVATOR; ELONGATION; SUBUNIT	The ubiquitin-proteasome pathway (UPP) is responsible for most programmed turnover of proteins in eukaryotic cells, and this activity has been known for some time to be involved in transcriptional regulation. More recently, intersections of the UPP and transcription have been discovered that are not proteolytic in nature and appear to revolve around the chaperonin-like activities of the ATPases in the 19 S regulatory subunit of the proteasome. Moreover, monoubiquitylation, which does not signal degradation, has been found to be a key modification of many transcription factors and histones. These various non-proteolytic roles of the UPP in transcription are reviewed here, and plausible mechanistic models are discussed.	[Kodadek, Thomas] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Kodadek, Thomas] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Kodadek, T (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA.	kodadek@scripps.edu		Kodadek, Thomas/0000-0003-1930-4795	National Institutes of Health [GM087283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087283. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; Brooks CL, 2004, CELL CYCLE, V3, P436; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Collins GA, 2009, NATURE, V461, pE7, DOI 10.1038/nature08406; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferdous A, 2008, MOL BIOSYST, V4, P1116, DOI 10.1039/b809291e; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Makino Y, 1999, GENES CELLS, V4, P529, DOI 10.1046/j.1365-2443.1999.00277.x; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; XU QL, 1995, MOL CELL BIOL, V15, P6025; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	49	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2221	2226		10.1074/jbc.R109.077883	http://dx.doi.org/10.1074/jbc.R109.077883			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19955182	Green Published, hybrid			2022-12-27	WOS:000273697800001
J	Matsuyama, T; Yamashita, T; Imai, H; Shichida, Y				Matsuyama, Take; Yamashita, Takahiro; Imai, Hiroo; Shichida, Yoshinori			Covalent Bond between Ligand and Receptor Required for Efficient Activation in Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL SCHIFF-BASE; METARHODOPSIN-II; VISUAL PIGMENTS; CHROMOPHORE CONFIGURATION; CONSTITUTIVE ACTIVATION; COMPLEX-FORMATION; BOVINE RHODOPSIN; 1ST STEP; BINDING; PROTEIN	Rhodopsin is an extensively studied member of the G-protein coupled receptors (GPCRs). Although rhodopsin shares many features with the other GPCRs, it exhibits unique features as a photoreceptor molecule. A hallmark in the molecular structure of rhodopsin is the covalently bound chromophore that regulates the activity of the receptor acting as an agonist or inverse agonist. Here we show the pivotal role of the covalent bond between the retinal chromophore and the lysine residue at position 296 in the activation pathway of bovine rhodopsin, by use of a rhodopsin mutant K296G reconstituted with retinylidene Schiff bases. Our results show that photoreceptive functions of rhodopsin, such as regiospecific photoisomerization of the ligand, and its quantum yield were not affected by the absence of the covalent bond, whereas the activation mechanism triggered by photoisomerization of the retinal was severely affected. Furthermore, our results show that an active state similar to the Meta-II intermediate of wild-type rhodopsin did not form in the bleaching process of this mutant, although it exhibited relatively weak G protein activity after light irradiation because of an increased basal activity of the receptor. We propose that the covalent bond is required for transmitting structural changes from the photoisomerized agonist to the receptor and that the covalent bond forcibly keeps the low affinity agonist in the receptor, resulting in a more efficient G protein activation.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Kyoto Univ, CREST JST, Kyoto 6068502, Japan; [Imai, Hiroo] Kyoto Univ, Primates Res Inst, Dept Mol Cell Biol, Aichi 4848506, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University		shichida@rh.biophys.kyoto-u.ac.jp		Imai, Hiroo/0000-0003-0729-0322; Matsuyama Hoyos, Takesi/0000-0003-2092-7519	Japanese Ministry of Education, Culture, Sports, Science, and Technology [A06]; Honjo International Scholarship Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This work was supported in part by a grant-in-aid for scientific research and the Global Center of Excellence Program (A06) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology ( to Y.S.).; Supported by the Honjo International Scholarship Foundation.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; IMAI H, 1994, BIOCHEMISTRY-US, V33, P14351, DOI 10.1021/bi00251a049; Imai H, 2000, METHOD ENZYMOL, V315, P293; Imamoto Y, 1996, BIOCHEMISTRY-US, V35, P14599, DOI 10.1021/bi9614850; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Kandori H, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1197, DOI 10.1023/A:1013123016803; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; MATUOKA S, 1984, BIOCHIM BIOPHYS ACTA, V765, P38, DOI 10.1016/0005-2728(84)90154-3; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; PITT GAJ, 1955, BIOCHEM J, V59, P122, DOI 10.1042/bj0590122; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SHICHIDA Y, 1988, BIOCHEMISTRY-US, V27, P6495, DOI 10.1021/bi00417a044; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Surya A, 1998, EXP EYE RES, V66, P599, DOI 10.1006/exer.1997.0453; SUZUKI H, 1973, J PHYS SOC JPN, V34, P156, DOI 10.1143/JPSJ.34.156; Terakita A, 1998, FEBS LETT, V439, P110, DOI 10.1016/S0014-5793(98)01340-4; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; TREHAN A, 1990, BIOORG CHEM, V18, P30, DOI 10.1016/0045-2068(90)90013-U; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431	41	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8114	8121		10.1074/jbc.M109.063875	http://dx.doi.org/10.1074/jbc.M109.063875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20042594	Green Published, hybrid			2022-12-27	WOS:000275413800029
J	Edwards, MM; Mammadova-Bach, E; Alpy, F; Klein, A; Hicks, WL; Roux, M; Simon-Assmann, P; Smith, RS; Orend, G; Wu, J; Peachey, NS; Naggert, JK; Lefebvre, O; Nishina, PM				Edwards, Malia M.; Mammadova-Bach, Elmina; Alpy, Fabien; Klein, Annick; Hicks, Wanda L.; Roux, Michel; Simon-Assmann, Patricia; Smith, Richard S.; Orend, Gertraud; Wu, Jiang; Peachey, Neal S.; Naggert, Juergen K.; Lefebvre, Olivier; Nishina, Patsy M.			Mutations in Lama1 Disrupt Retinal Vascular Development and Inner Limiting Membrane Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL GLOBULAR DOMAIN; LAMININ ALPHA-1 CHAIN; COLLAGEN-XVIII; BASEMENT-MEMBRANES; EYE ABNORMALITIES; KNOBLOCH-SYNDROME; GLIAL-CELLS; ENDOSTATIN; EXPRESSION; ZEBRAFISH	The Neuromutagenesis Facility at the Jackson Laboratory generated a mouse model of retinal vasculopathy, nmf223, which is characterized clinically by vitreal fibroplasia and vessel tortuosity. nmf223 homozygotes also have reduced electroretinogram responses, which are coupled histologically with a thinning of the inner nuclear layer. The nmf223 locus was mapped to chromosome 17, and a missense mutation was identified in Lama1 that leads to the substitution of cysteine for a tyrosine at amino acid 265 of laminin alpha 1, a basement membrane protein. Despite normal localization of laminin alpha 1 and other components of the inner limiting membrane, a reduced integrity of this structure was suggested by ectopic cells and blood vessels within the vitreous. Immunohistochemical characterization of nmf223 homozygous retinas demonstrated the abnormal migration of retinal astrocytes into the vitreous along with the persistence of hyaloid vasculature. The Y265C mutation significantly reduced laminin N-terminal domain (LN) interactions in a bacterial two-hybrid system. Therefore, this mutation could affect interactions between laminin alpha 1 and other laminin chains. To expand upon these findings, a Lama1 null mutant, Lama1(tm1.1Olf), was generated that exhibits a similar but more severe retinal phenotype than that seen in nmf223 homozygotes. The increased severity of the Lama1 null mutant phenotype is probably due to the complete loss of the inner limiting membrane in these mice. This first report of viable Lama1 mouse mutants emphasizes the importance of this gene in retinal development. The data presented herein suggest that hypomorphic mutations in human LAMA1 could lead to retinal disease.	[Mammadova-Bach, Elmina; Alpy, Fabien; Klein, Annick; Simon-Assmann, Patricia; Orend, Gertraud; Lefebvre, Olivier] INSERM, U682, F-67200 Strasbourg, France; [Smith, Richard S.; Naggert, Juergen K.] Jackson Lab, Bar Harbor, ME 04609 USA; [Mammadova-Bach, Elmina; Alpy, Fabien; Klein, Annick; Simon-Assmann, Patricia; Orend, Gertraud; Lefebvre, Olivier] Univ Strasbourg, F-67081 Strasbourg, France; [Roux, Michel] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [Wu, Jiang; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland, OH 44195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Jackson Laboratory; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Lefebvre, O (corresponding author), INSERM, U682, 3 Ave Moliere, F-67200 Strasbourg, France.	olivier.lefebvre@inserm.fr; patsy.nishina@jax.org	Peachey, Neal/G-5533-2010; Lefebvre, Olivier/S-6436-2019; Orend, Gertraud/E-8446-2015; Lefebvre, Olivier/I-2388-2016; Roux, Michel J/A-3213-2009; Alpy, Fabien/H-8941-2016; Alpy, Fabien/ABD-5893-2020	Peachey, Neal/0000-0002-4419-7226; Lefebvre, Olivier/0000-0001-9130-9174; Orend, Gertraud/0000-0003-2522-1195; Lefebvre, Olivier/0000-0001-9130-9174; Roux, Michel J/0000-0002-5812-5215; Alpy, Fabien/0000-0002-0526-0720; Alpy, Fabien/0000-0002-0526-0720	National Institutes of Health [EY011996, EY016501, R24EY16538, CA34196]; Department of Veterans Affairs; Foundation Fighting Blindness; Research to Prevent Blindness; Association pour la Recherche sur le Cancer [3666]; Institut National du Cancer and Canceropole Grand-Est; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016501, R01EY011996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer and Canceropole Grand-Est; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011996, EY016501, and R24EY16538 and Grant CA34196 (to The Jackson Laboratory). This work was also supported by the Department of Veterans Affairs, Foundation Fighting Blindness, Research to Prevent Blindness, Association pour la Recherche sur le Cancer Grant 3666, Institut National du Cancer and Canceropole Grand-Est.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Alpy F, 2005, GENESIS, V43, P59, DOI 10.1002/gene.20154; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Biehlmaier O, 2007, INVEST OPHTH VIS SCI, V48, P2887, DOI 10.1167/iovs.06-1212; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; De Arcangelis A, 1996, J CELL BIOL, V133, P417, DOI 10.1083/jcb.133.2.417; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Dixelius J, 2004, J BIOL CHEM, V279, P23766, DOI 10.1074/jbc.M311675200; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Duh EJ, 2004, OPHTHALMOLOGY, V111, P1885, DOI 10.1016/j.ophtha.2004.03.030; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; Ekblom M, 1998, ANN NY ACAD SCI, V857, P194, DOI 10.1111/j.1749-6632.1998.tb10117.x; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; Falk M, 1999, MATRIX BIOL, V18, P557, DOI 10.1016/S0945-053X(99)00047-5; Feldkamper M, 2003, DEV OPHTHALMOL, V37, P34; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P1000, DOI 10.1167/iovs.04-1185; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hurskainen M, 2005, FASEB J, V19, P1564, DOI 10.1096/fj.04-3101fje; Javaherian K, 2002, J BIOL CHEM, V277, P45211, DOI 10.1074/jbc.M206358200; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Kumagai C, 1997, FEBS LETT, V412, P211, DOI 10.1016/S0014-5793(97)00780-1; Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; LUTTY GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P267, DOI 10.1001/archopht.1992.01080140123039; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Mascarenhas JB, 2005, MATRIX BIOL, V23, P507, DOI 10.1016/j.matbio.2004.11.003; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mehes E, 2002, CELL MOTIL CYTOSKEL, V53, P203, DOI 10.1002/cm.10062; Menzel O, 2004, HUM MUTAT, V23, P77, DOI 10.1002/humu.10284; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Ohlmann AV, 2004, INVEST OPHTH VIS SCI, V45, P2384, DOI 10.1167/iovs.03-1214; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; Paulus JD, 2006, DEV DYNAM, V235, P213, DOI 10.1002/dvdy.20604; Peachey NS, 2003, EXP EYE RES, V77, P477, DOI 10.1016/S0014-4835(03)00149-0; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Scavello GS, 2005, MOL VIS, V11, P97; Schittny JC, 1989, CURR OPIN CELL BIOL, V1, P983, DOI 10.1016/0955-0674(89)90069-0; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Semina EV, 2006, DEV BIOL, V299, P63, DOI 10.1016/j.ydbio.2006.07.005; Shichiri M, 2001, FASEB J, V15, P1044, DOI 10.1096/fj.99-1083com; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; SOROKIN LM, 1992, EXP CELL RES, V201, P137, DOI 10.1016/0014-4827(92)90357-E; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zinkevich NS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-13	56	60	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7697	7711		10.1074/jbc.M109.069575	http://dx.doi.org/10.1074/jbc.M109.069575			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048158	Green Published, hybrid			2022-12-27	WOS:000275415600079
J	Ronen, D; Rosenberg, MM; Shalev, DE; Rosenberg, M; Rotem, S; Friedler, A; Ravid, S				Ronen, Daniel; Rosenberg, Masha M.; Shalev, Deborah E.; Rosenberg, Michael; Rotem, Shahar; Friedler, Assaf; Ravid, Shoshana			The Positively Charged Region of the Myosin IIC Non-helical Tailpiece Promotes Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ISOFORMS; CASEIN KINASE-II; NONMUSCLE MYOSIN; SMOOTH-MUSCLE; CELLULAR-LOCALIZATION; COILED-COIL; NMR-SPECTROSCOPY; PHOSPHORYLATION; ROD; CYTOKINESIS	The motor protein, non-muscle myosin II (NMII), must undergo dynamic oligomerization into filaments to participate in cellular processes such as cell migration and cytokinesis. A small non-helical region at the tail of the long coiled-coil region (tailpiece) is a common feature of all dynamically assembling myosin II proteins. In this study, we investigated the role of the tailpiece in NMII-C self-assembly. We show that the tailpiece is natively unfolded, as seen by circular dichroism and NMR experiments, and is divided into two regions of opposite charge. The positively charged region (Tailpiece(1946-1967)) starts at residue 1946 and is extended by seven amino acids at its N terminus from the traditional coiled-coil ending proline (Tailpiece(1953-1967)). Pull-down and sedimentation assays showed that the positive Tailpiece(1946-1967) binds to assembly incompetent NMII-C fragments inducing filament assembly. The negative region, residues 1968-2000, is responsible for NMII paracrystal morphology as determined by chimeras in which the negative region was swapped between the NMII isoforms. Mixing the positive and negative peptides had no effect on the ability of the positive peptide to bind and induce filament assembly. This study provides molecular insight into the role of the structurally disordered tailpiece of NMII-C in shifting the oligomeric equilibrium of NMII-C toward filament assembly and determining its morphology.	[Rosenberg, Masha M.; Rotem, Shahar; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ravid, Shoshana] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Friedler, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Safra Campus, IL-91904 Jerusalem, Israel.	assaf@chem.ch.huji.ac.il; shoshr@ekmd.huji.ac.il	Shalev, Deborah E/AAY-2873-2021		Israel Ministry of Health [3114]; European Research Council	Israel Ministry of Health; European Research Council(European Research Council (ERC)European Commission)	This work was supported in part by Israel Ministry of Health Grant 3114 (to S. R.) and a starting grant from the European Research Council (to A. F.).	ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; ATKINSON SJ, 1991, J CELL SCI, V99, P823; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KELLEY CA, 1990, J BIOL CHEM, V265, P17876; KENDRICKJONES J, 1971, J MOL BIOL, V59, P527, DOI 10.1016/0022-2836(71)90316-0; Kolega J, 1999, CELL MOTIL CYTOSKEL, V43, P255, DOI 10.1002/(SICI)1097-0169(1999)43:3<255::AID-CM8>3.0.CO;2-T; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rovner AS, 2002, J CELL BIOL, V156, P113, DOI 10.1083/jcb.200107131; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; SINARD JH, 1990, J CELL BIOL, V111, P2417, DOI 10.1083/jcb.111.6.2417; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Straussman R, 2001, J CELL SCI, V114, P3047; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744	51	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7079	7086		10.1074/jbc.M109.049221	http://dx.doi.org/10.1074/jbc.M109.049221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19959848	Green Published, hybrid			2022-12-27	WOS:000275415600021
J	Hou, SW; Vigeland, LE; Zhang, GP; Xu, R; Li, M; Heinemann, SH; Hoshi, T				Hou, Shangwei; Vigeland, Leif E.; Zhang, Guangping; Xu, Rong; Li, Min; Heinemann, Stefan H.; Hoshi, Toshinori			Zn2+ Activates Large Conductance Ca2+-activated K+ Channel via an Intracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; SLO1 BK CHANNELS; CRYSTAL-STRUCTURE; RAT HIPPOCAMPUS; ION CHANNELS; ZINC-BINDING; METAL IONS; VOLTAGE; CA2+; SITES	Zinc is an essential trace element and plays crucial roles in normal development, often as an integral structural component of transcription factors and enzymes. Recent evidence suggests that intracellular Zn2+ functions as a signaling molecule, mediating a variety of important physiological phenomena. However, the immediate effectors of intracellular Zn2+ signaling are not well known. We show here that intracellular Zn2+ potently and reversibly activates large-conductance voltage-and Ca2+-activated Slo1 K+ (BK) channels. The full effect of Zn2+ requires His(365) in the RCK1 (regulator of conductance for K+) domain of the channel. Furthermore, mutation of two nearby acidic residues, Asp(367) and Glu(399), also reduced activation of the channel by Zn2+, suggesting a possible structural arrangement for Zn2+ binding by the aforementioned residues. Extracellular Zn2+ activated Slo1 BK channels when coexpressed with Zn2+-permeable TRPM7 (transient receptor potential melastatin 7) channels. The results thus demonstrate that Slo1 BK channels represent a positive and direct effector of Zn2+ signaling and may participate in sculpting cellular response to an increase in intracellular Zn2+ concentration.	[Hou, Shangwei; Hoshi, Toshinori] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Vigeland, Leif E.] Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Zhang, Guangping] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Li, Min] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Heinemann, Stefan H.] Univ Jena, Dept Biophys, Ctr Mol Biomed, D-07745 Jena, Germany	University of Pennsylvania; University of Pennsylvania; University of Chicago; Johns Hopkins University; Johns Hopkins University; Friedrich Schiller University of Jena	Hou, SW (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	shangwei@mail.med.upenn.edu	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221; Hou, Shangwei/0000-0002-5958-7198; Heinemann, Stefan H./0000-0002-4144-0251	National Institutes of Health [GM057654, MH084691, GM078579]; Deutsche Forschungsgemeinschaft [HE2993/8]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517, R01GM078579, R01GM057654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants GM057654 (to T. H.), MH084691 (to M. L.), and GM078579 (to M. L. and T. H.). This work was also supported by Deutsche Forschungsgemeinschaft (HE2993/8).	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Chanoit G, 2008, AM J PHYSIOL-HEART C, V295, pH1227, DOI 10.1152/ajpheart.00610.2008; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Hou SW, 2009, CHANNELS, V3, P249; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Karagulova G, 2007, J PHARMACOL EXP THER, V321, P517, DOI 10.1124/jpet.107.119644; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Lee S, 2009, AM J PHYSIOL-HEART C, V297, pH569, DOI 10.1152/ajpheart.00293.2009; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Miles E W, 1977, Methods Enzymol, V47, P431; Mills DA, 2002, J BIOL CHEM, V277, P14894, DOI 10.1074/jbc.M111922200; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; Ostendorp T, 2005, ACTA CRYSTALLOGR F, V61, P673, DOI 10.1107/S1744309105018014; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; PERMYAKOV E, 2009, METALLOPROTEOMICS, P283; POWELL SR, 1994, AM J PHYSIOL, V266, pH2497, DOI 10.1152/ajpheart.1994.266.6.H2497; Prost AL, 2004, J PHYSIOL-LONDON, V559, P157, DOI 10.1113/jphysiol.2004.065094; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sandstead HH, 2000, J NUTR, V130, p347S, DOI 10.1093/jn/130.2.347S; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sharpley MS, 2006, J BIOL CHEM, V281, P34803, DOI 10.1074/jbc.M607389200; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Volbeda A, 1996, CURR OPIN STRUC BIOL, V6, P804, DOI 10.1016/S0959-440X(96)80011-X; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239	72	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6434	6442		10.1074/jbc.M109.069211	http://dx.doi.org/10.1074/jbc.M109.069211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037152	Green Published, hybrid			2022-12-27	WOS:000275367500048
J	Zimmermann, L; Paster, W; Weghuber, J; Eckerstorfer, P; Stockinger, H; Schutz, GJ				Zimmermann, Lars; Paster, Wolfgang; Weghuber, Julian; Eckerstorfer, Paul; Stockinger, Hannes; Schuetz, Gerhard J.			Direct Observation and Quantitative Analysis of Lck Exchange between Plasma Membrane and Cytosol in Living T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE MICROSCOPY; ACYL-PROTEIN THIOESTERASE; TYROSINE KINASE; DIFFUSION; PALMITOYLATION; MICRODOMAINS; BINDING; RAS; FLUORESCENCE; DYNAMICS	Palmitoylation represents a common motif for anchorage of cytosolic proteins to the plasma membrane. Being reversible, it allows for controlled exchange between cytosolic and plasma membrane-bound subpopulations. In this study, we present a live cell single molecule approach for quantifying the exchange kinetics of plasma membrane and cytosolic populations of fluorescently labeled Lck, the key Src family kinase involved in early T cell signaling. Total internal reflection (TIR) fluorescence microscopy was employed for confining the analysis to membrane-proximal molecules. Upon photobleaching Lck-YFP in TIR configuration, fluorescence recovery proceeds first via the cytosol outside of the evanescent field, so that in the early phase fluorescence signal arises predominantly from membrane-proximal cytosolic Lck. The diffusion constant of each molecule allowed us to distinguish whether the molecule has already associated with the plasma membrane or was still freely diffusing in the cytosol. From the number of molecules that inserted during the recovery time we quantified the insertion kinetics: on average, membrane-proximal molecules within the evanescent field needed similar to 400 ms to be inserted. The average lifetime of Lck in the plasma membrane was estimated at 50 s; together with the mobility of 0.26 mu m(2)/s this provides sufficient time to explore the surface of the whole T cell before dissociation into the cytosol. Experiments on palmitoylation-deficient Lck mutants yielded similar on-rates, but substantially increased off-rates. We discuss our findings based on a model for the plasma membrane association and dissociation kinetics of Lck, which accounts for reversible palmitoylation on cysteine 3 and 5.	[Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Paster, Wolfgang; Eckerstorfer, Paul; Stockinger, Hannes] Med Univ Vienna, Mol Immunol Unit, Inst Hyg & Appl Immunol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria	Johannes Kepler University Linz; Medical University of Vienna	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Stockinger, Hannes/E-5173-2011; Schuetz, Gerhard/B-1243-2008	Stockinger, Hannes/0000-0001-6404-4430; Schuetz, Gerhard/0000-0003-1542-1089; Paster, Wolfgang/0000-0002-5537-2886; Weghuber, Julian/0000-0001-6312-4666	Austrian Science Fund [Y250B10]; Austrian Federal Ministry for Science and Research; European Union [202272]; Austrian Science Fund (FWF) [Y 250] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF Project Y250B10), the GEN-AU Project of the Austrian Federal Ministry for Science and Research, and the European Union Project LipidomicNet (Grant 202272).	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Anton O, 2008, J EXP MED, V205, P3201, DOI 10.1084/jem.20080552; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Haughn L, 1998, J EXP MED, V188, P1575, DOI 10.1084/jem.188.9.1575; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Ohsugi Y, 2006, BIOPHYS J, V91, P3456, DOI 10.1529/biophysj.105.074625; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 2004, MICROSC RES TECHNIQ, V63, P159, DOI 10.1002/jemt.20016; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Wieser S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822890; Wieser S, 2008, BIOPHYS J, V95, P5988, DOI 10.1529/biophysj.108.141655; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6063	6070		10.1074/jbc.M109.025981	http://dx.doi.org/10.1074/jbc.M109.025981			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040600	hybrid, Green Published			2022-12-27	WOS:000275367500009
J	Carroll, SM; Hampton, RY				Carroll, Sarah M.; Hampton, Randolph Y.			Usa1p Is Required for Optimal Function and Regulation of the Hrd1p Endoplasmic Reticulum-associated Degradation Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; UNFOLDED PROTEIN RESPONSE; QUALITY-CONTROL; MEMBRANE-PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; MISFOLDED GLYCOPROTEINS; MEDIATED REGULATION; COMPLEX; YEAST	Usa1p is a recently discovered member of the HRD ubiquitin ligase complex. The HRD pathway is a conserved route of ubiquitin-dependent, endoplasmic reticulum (ER)-associated degradation (ERAD) of numerous lumenal (ERAD-L) and membrane-anchored (ERAD-M) substrates. We have investigated Usa1p to understand its importance in HRD complex action. Usa1p was required for the optimal function of the Hrd1p E3 ubiquitin ligase; its loss caused deficient degradation of both membrane-associated and lumenal proteins. Furthermore, Usa1p functioned in regulation of Hrd1p by two mechanisms. First, Hrd1p self-degradation, which serves to limit the levels of uncomplexed E3, is absolutely dependent on Usa1p and the ubiquitin-like (Ubl) domain of Usa1p. We found that Usa1p allows Hrd1p degradation by promoting trans interactions between Hrd1p molecules. The Ubl domain of Usa1p was required specifically for Hrd1p self-ubiquitination but not for degradation of either ERAD-L or ERAD-M substrates. In addition, Usa1p was able to attenuate the activity-dependent toxicity of Hrd1p without compromising substrate degradation, indicating a separate role in ligase regulation that operates in parallel to stability control. Many of the described actions of Usa1p are distinct from those of Der1p, which is recruited to the HRD complex by Usa1p. Thus, this novel, conserved factor is broadly involved in the function and regulation of the HRD pathway of ERAD.	[Carroll, Sarah M.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health, NIDDK [GM51996-06]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051996] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51996-06 (NIDDK, to R.Y.H.). This work was also supported by the American Heart Association (an Established Investigator award ( to R.Y.H.)).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Kim I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007604; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, FEBS LETT, V443, P241, DOI 10.1016/S0014-5793(98)01724-4; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	33	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5146	5156		10.1074/jbc.M109.067876	http://dx.doi.org/10.1074/jbc.M109.067876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19940128	Green Published, hybrid			2022-12-27	WOS:000275327200006
J	Kraushaar, DC; Yamaguchi, Y; Wang, LC				Kraushaar, Daniel C.; Yamaguchi, Yu; Wang, Lianchun			Heparan Sulfate Is Required for Embryonic Stem Cells to Exit from Self-renewal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLYPICAN DALLY-LIKE; MOUSE EMBRYOS; ES CELLS; DIFFERENTIATION; DROSOPHILA; PLURIPOTENCY; PROTEOGLYCANS; BIOSYNTHESIS; WINGLESS	Pluripotent embryonic stem cells (ESCs) must select between alternative fates of self-renewal and lineage commitment at each division during continuous proliferation. Heparan sulfate (HS) is a highly sulfated polysaccharide and is present abundantly on the ESC surface. In this study, we investigated the role of HS in ESC self-renewal by examining Ext1(-/-) ESCs that are deficient in HS. We found that Ext1(-/-) ESCs retained their self-renewal potential but failed to transit from self-renewal to differentiation upon removal of leukemia inhibitory factor. Furthermore, we found that the aberrant cell fate commitment is caused by defects in fibroblast growth factor signaling, which directly retained high expression of the pluripotency gene Nanog in Ext1(-/-) ESCs. Therefore, our studies identified and defined HS as a novel factor that controls ESC fate commitment and also delineates that HS facilitates fibroblast growth factor signaling, which, in turn, inhibits Nanog expression and commits ESCs to lineage differentiation.	[Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yamaguchi, Yu] Burnham Inst Med Res, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Sanford Burnham Prebys Medical Discovery Institute	Wang, LC (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	Lwang@ccrc.uga.edu			National Institutes of Health [P01 HD25936]; University of Georgia Research Foundation; Georgia Cancer Coalition; Cousin fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD025936, R01HD025936] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Foundation; Georgia Cancer Coalition; Cousin fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HD25936 (to Y. Y.). This work was also supported in part by the University of Georgia Research Foundation and Georgia Cancer Coalition (to L. W.) and a Cousin fellowship (to D. C. K.).	Baeg GH, 2001, DEVELOPMENT, V128, P87; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Binari RC, 1997, DEVELOPMENT, V124, P2623; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LI QG, 1990, BIOCHEM BIOPH RES CO, V166, P557, DOI 10.1016/0006-291X(90)90844-D; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Milne CD, 2008, J IMMUNOL, V180, P2839, DOI 10.4049/jimmunol.180.5.2839; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nguyen TT, 2007, REPRODUCTION, V134, P41, DOI 10.1530/REP-06-0087; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Yan D, 2007, DEV BIOL, V312, P203, DOI 10.1016/j.ydbio.2007.09.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	42	69	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5907	5916		10.1074/jbc.M109.066837	http://dx.doi.org/10.1074/jbc.M109.066837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022960	Green Published, hybrid			2022-12-27	WOS:000275327200081
J	Ly, TK; Wang, JB; Pereira, R; Rojas, KS; Peng, X; Feng, QY; Cerione, RA; Wilson, KF				Ly, Thi K.; Wang, Jianbin; Pereira, Ryan; Rojas, Katherine S.; Peng, Xu; Feng, Qiyu; Cerione, Richard A.; Wilson, Kristin F.			Activation of the Ran GTPase Is Subject to Growth Factor Regulation and Can Give Rise to Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING-PROTEIN; U-SNRNA EXPORT; MESSENGER-RNA; NUCLEAR-PROTEIN; MALIGNANT TRANSFORMATION; COMPLEX; CANCER; CYCLE; MECHANISM; RECEPTOR	Although the small GTPase Ran is best known for its roles in nucleocytoplasmic transport, mitotic spindle assembly, and nuclear envelope formation, recent studies have demonstrated the overexpression of Ran in multiple tumor types and that its expression is correlated with a poor patient prognosis, providing evidence for the importance of this GTPase in cell growth regulation. Here we show that Ran is subject to growth factor regulation by demonstrating that it is activated in a serum-dependent manner in human breast cancer cells and, in particular, in response to heregulin, a growth factor that activates the Neu/ErbB2 tyrosine kinase. The heregulin-dependent activation of Ran requires mTOR (mammalian target of rapamycin) and stimulates the capped RNA binding capability of the cap-binding complex in the nucleus, thus influencing gene expression at the level of mRNA processing. We further demonstrate that the excessive activation of Ran has important consequences for cell growth by showing that a novel, activated Ran mutant is sufficient to transform NIH-3T3 cells in an mTOR-and epidermal growth factor receptor-dependent manner and that Ran-transformed cells form tumors in mice.	[Ly, Thi K.; Wang, Jianbin; Rojas, Katherine S.; Peng, Xu; Feng, Qiyu; Cerione, Richard A.; Wilson, Kristin F.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Pereira, Ryan; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Rojas, Katherine/GRJ-2722-2022		National Institutes of Health [GM040654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM040654.	Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; CLARKE PR, 1995, J CELL SCI, V108, P1217; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KATAOKA N, 1994, NUCLEIC ACIDS RES, V22, P3861, DOI 10.1093/nar/22.19.3861; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Lewis JD, 1996, NUCLEIC ACIDS RES, V24, P3332, DOI 10.1093/nar/24.17.3332; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; OHNO M, 1987, P NATL ACAD SCI USA, V84, P5187, DOI 10.1073/pnas.84.15.5187; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; REN MD, 1994, MOL CELL BIOL, V14, P4216, DOI 10.1128/MCB.14.6.4216; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; SMITH M R, 1990, New Biologist, V2, P648; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wilson KF, 2000, J BIOL CHEM, V275, P37307, DOI 10.1074/jbc.C000482200; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	40	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5815	5826		10.1074/jbc.M109.071886	http://dx.doi.org/10.1074/jbc.M109.071886			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028979	Green Published, hybrid			2022-12-27	WOS:000275327200072
J	Saxena, M; Singh, S; Zzaman, S; Bastia, D				Saxena, Mukesh; Singh, Samarendra; Zzaman, Shamsu; Bastia, Deepak			Investigations of pi Initiator Protein-mediated Interaction between Replication Origins alpha and gamma of the Plasmid R6K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; COPY-NUMBER CONTROL; ESCHERICHIA-COLI; DNA-REPLICATION; BINDING-SITES; IN-VITRO; CONFORMATIONAL-CHANGES; FUNCTIONAL-ANALYSIS; PURIFIED PROTEINS; RK2 REPLICATION	A typical plasmid replicon of Escherichia coli, such as ori gamma of R6K, contains tandem iterons (iterated initiator protein binding sites), an AT-rich region that melts upon initiator-iteron interaction, two binding sites for the bacterial initiator protein DnaA, and a binding site for the DNA-bending protein IHF. R6K also contains two structurally atypical origins called gamma and beta that are located on either side of gamma and contain a single and a half-iteron, respectively. Individually, these sites do not bind to initiator protein pi but access it by DNA looping-mediated interaction with the seven pi-bound gamma iterons. The pi protein exists in 2 interconvertible forms: inert dimers and active monomers. Initiator dimers generally function as negative regulators of replication by promoting iteron pairing ("handcuffing") between pairs of replicons that turn off both origins. Contrary to this existing paradigm, here we show that both the dimeric and the monomeric pi are necessary for ori alpha-driven plasmid maintenance. Furthermore, efficient looping interaction between alpha and gamma or between 2 gamma iterons in vitro also required both forms of pi. Why does alpha-gamma iteron pairing promote alpha activation rather than repression? We show that a weak, transitory alpha-gamma interaction at the iteron pairs was essential for alpha-driven plasmid maintenance. Swapping the alpha iteron with one of gamma without changing the original sequence context that caused enhanced looping in vitro caused a significant inhibition of alpha-mediated plasmid maintenance. Therefore, the affinity of alpha iteron for pi-bound gamma and not the sequence context determined whether the origin was activated or repressed.	[Saxena, Mukesh; Singh, Samarendra; Zzaman, Shamsu; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	bastia@musc.edu			National Institutes of Health [GM049264]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM049264 from the National Institutes of Health (to D. B.).	Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; Abhyankar MM, 2003, J BIOL CHEM, V278, P45476, DOI 10.1074/jbc.M308516200; ABLES AL, 1991, P NATL ACAD SCI USA, V88, P9011; BASTIA D, 1996, DNA REPLICATION EUKA; Blasina A, 1996, P NATL ACAD SCI USA, V93, P3559, DOI 10.1073/pnas.93.8.3559; BUSHMAN FD, 1986, P NATL ACAD SCI USA, V83, P9353, DOI 10.1073/pnas.83.24.9353; CHATTORAJ DK, 1985, P NATL ACAD SCI USA, V82, P2588, DOI 10.1073/pnas.82.9.2588; Choy HE, 1997, J MOL BIOL, V272, P293, DOI 10.1006/jmbi.1997.1221; CROSA JH, 1978, J MOL BIOL, V124, P443, DOI 10.1016/0022-2836(78)90181-X; CROSA JH, 1976, J BACTERIOL, V126, P454, DOI 10.1128/JB.126.1.454-466.1976; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; FILUTOWICZ M, 1985, NUCLEIC ACIDS RES, V13, P103, DOI 10.1093/nar/13.1.103; FILUTOWICZ M, 1988, NUCLEIC ACIDS RES, V16, P3829, DOI 10.1093/nar/16.9.3829; FILUTOWICZ M, 1987, J CELL SCI, P15; GERMINO J, 1983, CELL, V34, P125, DOI 10.1016/0092-8674(83)90142-3; HELINSKI DR, 1996, ESCHERICHIA COLI SAL; INUZUKA N, 1980, J BIOL CHEM, V255, P1071; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; KELLEY W, 1985, P NATL ACAD SCI USA, V82, P2574, DOI 10.1073/pnas.82.9.2574; KELLEY WL, 1991, J BIOL CHEM, V266, P15924; KELLEY WL, 1992, P NATL ACAD SCI USA, V89, P5078, DOI 10.1073/pnas.89.11.5078; KHAN SA, 1988, BIOCHIM BIOPHYS ACTA, V951, P375, DOI 10.1016/0167-4781(88)90109-1; Koudelka GB, 2000, CURR BIOL, V10, pR704, DOI 10.1016/S0960-9822(00)00710-7; Kruger R, 2001, J MOL BIOL, V306, P945, DOI 10.1006/jmbi.2000.4426; Kunnimalaiyaan S, 2004, J BIOL CHEM, V279, P41058, DOI 10.1074/jbc.M403151200; Kunnimalaiyaan S, 2007, J BACTERIOL, V189, P4953, DOI 10.1128/JB.00109-07; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; LOVETT MA, 1975, P NATL ACAD SCI USA, V72, P2905, DOI 10.1073/pnas.72.8.2905; Lu YB, 1998, EMBO J, V17, P5192, DOI 10.1093/emboj/17.17.5192; MCEACHERN MJ, 1989, P NATL ACAD SCI USA, V86, P7942, DOI 10.1073/pnas.86.20.7942; MIRON A, 1994, P NATL ACAD SCI USA, V91, P6438, DOI 10.1073/pnas.91.14.6438; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; MUKHERJEE S, 1988, P NATL ACAD SCI USA, V85, P6287, DOI 10.1073/pnas.85.17.6287; MUKHERJEE S, 1985, CELL, V43, P189, DOI 10.1016/0092-8674(85)90023-6; MUKHERJEE S, 1988, CELL, V52, P375, DOI 10.1016/S0092-8674(88)80030-8; Ohlsson R, 2007, CURR OPIN CELL BIOL, V19, P321, DOI 10.1016/j.ceb.2007.04.008; PAL SK, 1988, J BACTERIOL, V170, P3554, DOI 10.1128/jb.170.8.3554-3560.1988; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 2004, GENETIC SWITCH; Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522; STENZEL TT, 1991, GENE DEV, V5, P1453, DOI 10.1101/gad.5.8.1453; Swan MK, 2006, P NATL ACAD SCI USA, V103, P18481, DOI 10.1073/pnas.0609046103; TOMIZAWA J, 1990, J MOL BIOL, V212, P683, DOI 10.1016/0022-2836(90)90230-J; Toukdarian AE, 1998, GENE, V223, P205, DOI 10.1016/S0378-1119(98)00370-9; Zzaman S, 2005, MOL CELL, V20, P833, DOI 10.1016/j.molcel.2005.10.037; Zzaman S, 2004, J BIOL CHEM, V279, P50886, DOI 10.1074/jbc.M407531200; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	47	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5695	5704		10.1074/jbc.M109.067439	http://dx.doi.org/10.1074/jbc.M109.067439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20029091	hybrid, Green Published			2022-12-27	WOS:000275327200062
J	Hamasaki-Katagiri, N; Ames, JB				Hamasaki-Katagiri, Nobuko; Ames, James B.			Neuronal Calcium Sensor-1 (Ncs1p) Is Up-regulated by Calcineurin to Promote Ca2+ Tolerance in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-HAND PROTEINS; P-TYPE ATPASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 4-KINASE; CA2+-BINDING PROTEINS; CRYSTAL-STRUCTURE; GUANYLYL CYCLASE; TRANSCRIPTIONAL REPRESSOR; 3-DIMENSIONAL STRUCTURE	Neuronal calcium sensor (NCS) proteins regulate signal transduction and are highly conserved from yeast to humans. NCS homolog in fission yeast (Ncs1p) is essential for cell growth under extreme Ca2+ conditions. Ncs1p expression increases similar to 100-fold when fission yeast grows in high extracellular Ca2+ (>0.1 M). Here, we show that Ca2+-induced expression of Ncs1p is controlled at the level of transcription. Transcriptional reporter assays show that ncs1 promoter activity increased 30-fold when extracellular Ca2+ was raised to 0.1 M and was highly Ca2+-specific. Ca2+-dependent transcription of ncs1 is abolished by the calcineurin inhibitor (FK506) and by knocking out the calcineurin target, prz1. Thus, Ca2+-induced expression of Ncs1p is linked to the calcineurin/prz1 stress response. The Ca2+-responsive ncs1 promoter region consists of 130 nucleotides directly upstream from the start codon and contains tandem repeats of the sequence, 5'-caact-3', that binds to Prz1p. The Ca2+-sensitive ncs1 Delta phenotype is rescued by a yam8 null mutation, suggesting a possible interaction between Ncs1p and the Ca2+ channel, Yam8p. Ca2+ uptake and Ncs1p binding to yeast membranes are both decreased in yam8 Delta, suggesting Ca2+-induced binding of Ncs1p to Yam8p results in channel closure. We propose that Ncs1p promotes Ca2+ tolerance in fission yeast, in part by cytosolic Ca2+ buffering and perhaps by negatively regulating the Yam8p Ca2+ channel.	[Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Hamasaki-Katagiri, Nobuko] Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA	University of California System; University of California Davis; University System of Maryland; University of Maryland Baltimore	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu			National Institutes of Health [EY012347, NS059969]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS059969 (to J. B. A.).	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Carnero E, 2000, MOL GEN GENET, V264, P173, DOI 10.1007/s004380000318; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Catty P, 1996, BIOSCIENCE REP, V16, P75, DOI 10.1007/BF01206198; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; DAVIS TN, 1995, ADV SEC MESS PHOSPH, V30, P339; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; EILAM Y, 1987, J GEN MICROBIOL, V133, P1641; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; ESCHER A, 1989, P NATL ACAD SCI USA, V86, P6528, DOI 10.1073/pnas.86.17.6528; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Furune T, 2008, GENES GENET SYST, V83, P373, DOI 10.1266/ggs.83.373; GHISLAIN M, 1990, J BIOL CHEM, V265, P18400; HALACHMI D, 1992, EUR J BIOCHEM, V207, P1003, DOI 10.1111/j.1432-1033.1992.tb17136.x; Hamasaki-Katagiri N, 2004, J BIOL CHEM, V279, P12744, DOI 10.1074/jbc.M311895200; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HIDAKA H, 1993, NEUROSCI RES, V16, P73, DOI 10.1016/0168-0102(93)90074-Z; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; IIDA H, 1990, J BIOL CHEM, V265, P13391; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Maeda T, 2004, GENES CELLS, V9, P71, DOI 10.1111/j.1356-9597.2004.00699.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser MJ, 1997, J CELL SCI, V110, P1805; Moser NJ, 1996, MOL CELL BIOL, V16, P4824; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Okorokov LA, 2001, FEBS LETT, V505, P321, DOI 10.1016/S0014-5793(01)02852-6; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Tasaka Y, 2000, BIOCHEM BIOPH RES CO, V269, P265, DOI 10.1006/bbrc.2000.2278; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	76	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4405	4414		10.1074/jbc.M109.058594	http://dx.doi.org/10.1074/jbc.M109.058594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018864	Green Published, hybrid			2022-12-27	WOS:000275274800017
J	Hines, RM; Kang, RJ; Goytain, A; Quamme, GA				Hines, Rochelle M.; Kang, Rujun; Goytain, Angela; Quamme, Gary A.			Golgi-specific DHHC Zinc Finger Protein GODZ Mediates Membrane Ca2+ Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; PALMITOYLATION; CHANNEL; TRAFFICKING; SUBUNIT; IDENTIFICATION; HUNTINGTIN; HIP14; DOMAIN; STABILITY	The Golgi-specific zinc finger protein GODZ (palmitoyl acyltransferase/DHHC-3) mediates the palmitoylation and post-translational modification of many protein substrates that regulate membrane-protein interactions. Here, we show that GODZ also mediates Ca2+ transport in expressing Xenopus laevis oocytes. Two-electrode voltage-clamp, fluorescence, and Ca-45(2+) isotopic uptake determinations demonstrated voltage-and concentration-dependent, saturable, and substrate-inhibitable Ca2+ transport in oocytes expressing GODZ cRNA but not in oocytes injected with water alone. Moreover, we show that GODZ-mediated Ca2+ transport is regulated by palmitoylation, as the palmitoyl acyltransferase inhibitor 2-bromopalmitate or alteration of the acyltransferase DHHC motif (GODZ-DHHS) diminished GODZ-mediated Ca2+ transport by similar to 80%. The GODZ mutation V61R abolished Ca2+ transport but did not affect palmitoyl acyltransferase activity. Coexpression of GODZ-V61R with GODZ-DHHS restored GODZ-DHHS-mediated Ca2+ uptake to values observed with wild-type GODZ, excluding an endogenous effect of palmitoylation. Coexpression of an independent palmitoyl acyltransferase (HIP14) with the GODZ-DHHS mutant also rescued Ca2+ transport. HIP14 did not mediate Ca2+ transport when expressed alone. Immunocytochemistry studies showed that GODZ and HIP14 co-localized to the Golgi and the same post-Golgi vesicles, suggesting that heteropalmitoylation might play a physiological role in addition to a biochemical function. We conclude that GODZ encodes a Ca2+ transport protein in addition to its ability to palmitoylate protein substrates.	[Hines, Rochelle M.; Kang, Rujun] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Goytain, Angela; Quamme, Gary A.] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Quamme, GA (corresponding author), Vancouver Hosp, Dept Med, Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	quamme@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020	Hines, Rochelle/0000-0002-0459-7911	Canadian Institutes of Health Research [MOP-53288] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Chan AW, 2007, CELL CALCIUM, V42, P419, DOI 10.1016/j.ceca.2007.04.009; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Goytain A, 2008, J BIOL CHEM, V283, P33365, DOI 10.1074/jbc.M801469200; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mies F, 2007, J BIOL CHEM, V282, P18339, DOI 10.1074/jbc.M611160200; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Varner AS, 2003, BIOCHEM J, V373, P91, DOI 10.1042/BJ20021598; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	31	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4621	4628		10.1074/jbc.M109.069849	http://dx.doi.org/10.1074/jbc.M109.069849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19955568	hybrid, Green Published			2022-12-27	WOS:000275274800040
J	Ooshio, T; Kobayashi, R; Ikeda, W; Miyata, M; Fukumoto, Y; Matsuzawa, N; Ogita, H; Takai, Y				Ooshio, Takako; Kobayashi, Reiko; Ikeda, Wataru; Miyata, Muneaki; Fukumoto, Yuri; Matsuzawa, Naomi; Ogita, Hisakazu; Takai, Yoshimi			Involvement of the Interaction of Afadin with ZO-1 in the Formation of Tight Junctions in Madin-Darby Canine Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; EPITHELIAL-CELLS; ADHESION MOLECULE; E-CADHERIN; DIRECT BINDING; ALPHA-CATENIN; MDCK CELLS; NECTIN; ORGANIZATION; PROTEIN	Tight junctions (TJs) and adherens junctions (AJs) are major junctional apparatuses in epithelial cells. Claudins and junctional adhesion molecules (JAMs) are major cell adhesion molecules (CAMs) at TJs, whereas cadherins and nectins are major CAMs at AJs. Claudins and JAMs are associated with ZO proteins, whereas cadherins are associated with beta-and alpha-catenins, and nectins are associated with afadin. We previously showed that nectins first form cell-cell adhesions where the cadherin-catenin complex is recruited to form AJs, followed by the recruitment of the JAM-ZO and claudin-ZO complexes to the apical side of AJs to form TJs. It is not fully understood how TJ components are recruited to the apical side of AJs. We studied the roles of afadin and ZO-1 in the formation of TJs in Madin-Darby canine kidney (MDCK) cells. Before the formation of TJs, ZO-1 interacted with afadin through the two proline-rich regions of afadin and the SH3 domain of ZO-1. During and after the formation of TJs, ZO-1 dissociated from afadin and associated with JAM-A. Knockdown of afadin impaired the formation of both AJs and TJs in MDCK cells, whereas knockdown of ZO-1 impaired the formation of TJs, but not AJs. Re-expression of full-length afadin restored the formation of both AJs and TJs in afadin-knockdown MDCK cells, whereas re-expression of afadin-Delta PR1-2, which is incapable of binding to ZO-1, restored the formation of AJs, but not TJs. These results indicate that the transient interaction of afadin with ZO-1 is necessary for the formation of TJs in MDCK cells.	[Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ooshio, Takako] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Kobe University; Osaka University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020; Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058; Ooshio, Takako/0000-0001-6508-8152; Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Hyogo Science and Technology Association	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association	This work was supported by a grant-in-aid for scientific research and for Cancer Research and by Targeted Proteins Research Program ( TPRP) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2007-2009), and by Hyogo Science and Technology Association.	Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Okamoto R, 2005, GENES CELLS, V10, P435, DOI 10.1111/j.1365-2443.2005.00846.x; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Yagi T, 2000, GENE DEV, V14, P1169; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yamada A, 2005, J BIOL CHEM, V280, P6016, DOI 10.1074/jbc.M408215200; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; YONEMURA S, 1995, J CELL SCI, V108, P127	44	86	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5003	5012		10.1074/jbc.M109.043760	http://dx.doi.org/10.1074/jbc.M109.043760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20008323	Green Published, hybrid			2022-12-27	WOS:000275274800077
J	Abulrob, A; Lu, ZF; Baumann, E; Vobornik, D; Taylor, R; Stanimirovic, D; Johnston, LJ				Abulrob, Abedelnasser; Lu, Zhengfang; Baumann, Ewa; Vobornik, Dusan; Taylor, Rod; Stanimirovic, Danica; Johnston, Linda J.			Nanoscale Imaging of Epidermal Growth Factor Receptor Clustering EFFECTS OF INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCANNING OPTICAL MICROSCOPY; EGF RECEPTOR; CELL-SURFACE; FLUORESCENCE MICROSCOPY; LIPID RAFTS; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; FIELD; ORGANIZATION; ACTIVATION	The development of some solid tumors is associated with overexpression of the epidermal growth factor receptor (EGFR) and often correlates with poor prognosis. Near field scanning optical microscopy, a technique with subdiffraction-limited optical resolution, was used to examine the influence of two inhibitors (the chimeric 225 antibody and tyrosine phosphorylation inhibitor AG1478) on the nanoscale clustering of EGFR in HeLa cells. The EGFR is organized in small clusters, average diameter of 150 nm, on the plasma membrane for both control and EGF-treated cells. The numbers of receptors in individual clusters vary from as few as one or two proteins to greater than 100. Both inhibitors yield an increased cluster density and an increase in the fraction of clusters with smaller diameters and fewer receptors. Exposure to AG1478 also decreases the fraction of EGFR that colocalizes with both rafts and caveolae. EGF stimulation results in a significant loss of the full-length EGFR from the plasma membrane with the concomitant appearance of low molecular mass proteolytic products. By contrast, AG1478 reduces the level of EGFR degradation. Changes in receptor clustering provide one mechanism for regulating EGFR signaling and are relevant to the design of strategies for therapeutic interventions based on modulating EGFR signaling.	[Abulrob, Abedelnasser; Baumann, Ewa; Stanimirovic, Danica] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R5, Canada; [Lu, Zhengfang; Vobornik, Dusan; Taylor, Rod; Johnston, Linda J.] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R5, Canada	National Research Council Canada; National Research Council Canada	Abulrob, A (corresponding author), Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R5, Canada.	Abedelnasser.Abulrob@nrc.gc.ca; Linda.Johnston@nrc-cnrc.gc.ca		Johnston, Linda/0000-0002-9136-4920	Canadian Institute for Photonics Innovation	Canadian Institute for Photonics Innovation	This work was supported in part by a grant from the Canadian Institute for Photonics Innovation (to L.J.J., D.V., and R.T.).	Abulrob A, 2008, J MICROSC-OXFORD, V232, P225, DOI 10.1111/j.1365-2818.2008.02093.x; Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Alexander A., 1998, FRONT BIOSCI-LANDMRK, V3, pD729, DOI [10.1101/cshperspect.a017459, DOI 10.1101/CSHPERSPECT.A017459]; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Ciardiello F, 1998, CLIN CANCER RES, V4, P821; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; de Bakker BI, 2007, CHEMPHYSCHEM, V8, P1473, DOI 10.1002/cphc.200700169; de Bakker BI, 2008, J CELL SCI, V121, P627, DOI 10.1242/jcs.019513; Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; El-Rayes BF, 2004, BRIT J CANCER, V91, P418, DOI 10.1038/sj.bjc.6601921; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; GULLICK WJ, 1986, CANCER RES, V46, P285; Gumbleton M, 2000, PHARM RES-DORDR, V17, P1035, DOI 10.1023/A:1026464526074; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Hoppener C, 2005, BIOPHYS J, V88, P3681, DOI 10.1529/biophysj.104.051458; Hoppener C, 2008, NANO LETT, V8, P642, DOI 10.1021/nl073057t; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Ianoul A, 2004, BIOPHYS J, V87, P3525, DOI [10.1529/biophysj.104.046383, 10.1529/biophysj.104.046393]; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Jia CL, 2007, BIOELECTROMAGNETICS, V28, P197, DOI 10.1002/bem.20293; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; MURAKAMI Y, 1994, BIOCHEM J, V301, P63, DOI 10.1042/bj3010063; Nagy P, 1999, J CELL SCI, V112, P1733; Ness GO, 1996, INT J CANCER, V65, P161, DOI 10.1002/(SICI)1097-0215(19960117)65:2<161::AID-IJC6>3.0.CO;2-X; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yu CX, 2009, BIOCHEM BIOPH RES CO, V378, P376, DOI 10.1016/j.bbrc.2008.11.018	52	71	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3145	3156		10.1074/jbc.M109.073338	http://dx.doi.org/10.1074/jbc.M109.073338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19959837	Green Published, hybrid			2022-12-27	WOS:000273829000030
J	Weng, JW; Fan, KN; Wang, WN				Weng, Jing-Wei; Fan, Kang-Nian; Wang, Wen-Ning			The Conformational Transition Pathway of ATP Binding Cassette Transporter MsbA Revealed by Atomistic Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; RESTING-STATE CONFORMATION; ESCHERICHIA-COLI MSBA; ABC TRANSPORTER; NUCLEOTIDE-BINDING; MULTIDRUG TRANSPORTER; MALTOSE TRANSPORTER; ALTERNATING ACCESS; STRUCTURAL BASIS; P-GLYCOPROTEIN	ATP binding cassette transporters are integral membrane proteins that use the energy released from ATP hydrolysis at the two nucleotide binding domains (NBDs) to translocate a wide variety of substrates through a channel at the two transmembrane domains (TMDs) across the cell membranes. MsbA from Gram-negative bacteria is a lipid and multidrug resistance ATP binding cassette exporter that can undergo large scale conformational changes between the outward-facing and the inward-facing conformations revealed by crystal structures in different states. Here, we use targeted molecular dynamics simulation methods to explore the atomic details of the conformational transition from the outward-facing to the inward-facing states of MsbA. The molecular dynamics trajectories revealed a clear spatiotemporal order of the conformational movements. The disruption of the nucleotide binding sites at the NBD dimer interface is the very first event that initiates the following conformational changes, verifying the assumption that the conformational conversion is triggered by ATP hydrolysis. The conserved x-loops of the NBDs were identified to participate in the interaction network that stabilizes the cytoplasmic tetrahelix bundle of the TMDs and play an important role in mediating the cross-talk between the NBD and TMD. The movement of the NBD dimer is transmitted through x-loops to break the tetrahelix bundle, inducing the packing rearrangements of the transmembrane helices at the cytoplasmic side and the periplasmic side sequentially. The packing rearrangement within each periplasmic wing of TMD that results in exposure of the substrate binding sites occurred at the end stage of the trajectory, preventing the wrong timing of the binding site accessibility.	[Wang, Wen-Ning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Key Lab Mol Catalysis & Innovat Mat, Dept Chem, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, WN (corresponding author), 220 Handan Rd, Shanghai 200433, Peoples R China.	wnwang@fudan.edu.cn	Fan, K/GXH-3734-2022		National High Technology Research Program of China [2006AA02A320]; National Major Basic Research Program of China [2009CB918600, 2009ZX09301-011]; National Science Foundation of China [20973040]; Science and Technology Commission of Shanghai Municipality [08DZ2270500]; Shanghai Leading Academic Discipline [B108]	National High Technology Research Program of China(National High Technology Research and Development Program of China); National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	This work was supported by National High Technology Research Program of China Grant 2006AA02A320, National Major Basic Research Program of China Grants 2009CB918600 and 2009ZX09301-011, National Science Foundation of China Grant 20973040, Science and Technology Commission of Shanghai Municipality Grant 08DZ2270500, and Shanghai Leading Academic Discipline Project B108.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Apostolakis J, 1999, J CHEM PHYS, V110, P2099, DOI 10.1063/1.477819; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Buchaklian AH, 2006, BIOCHEMISTRY-US, V45, P12539, DOI 10.1021/bi060830a; Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Choe S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940048; Compoint M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1869413; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kong YF, 2002, P NATL ACAD SCI USA, V99, P5999, DOI 10.1073/pnas.092051099; Law RJ, 2008, BIOPHYS J, V95, P2739, DOI 10.1529/biophysj.107.128025; Law RJ, 2003, BIOPHYS J, V84, P14, DOI 10.1016/S0006-3495(03)74829-2; LING V, 1992, CANCER-AM CANCER SOC, V69, P2603, DOI 10.1002/1097-0142(19920515)69:10<2603::AID-CNCR2820691034>3.0.CO;2-E; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; Swift RV, 2008, BIOCHEMISTRY-US, V47, P4102, DOI 10.1021/bi8000209; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; van der Vaart A, 2004, BIOPHYS J, V87, P562, DOI 10.1529/biophysj.103.037333; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2008, BIOPHYS J, V95, P5100, DOI 10.1529/biophysj.108.139444; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	64	48	49	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3053	10.1074/jbc.M109.056432	http://dx.doi.org/10.1074/jbc.M109.056432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996093	Green Published, hybrid			2022-12-27	WOS:000273829000021
J	Tchen, CR; Martins, JRS; Paktiawal, N; Perelli, R; Saklatvala, J; Clark, AR				Tchen, Carmen R.; Martins, Joana R. S.; Paktiawal, Nasren; Perelli, Roberta; Saklatvala, Jeremy; Clark, Andrew R.			Glucocorticoid Regulation of Mouse and Human Dual Specificity Phosphatase 1 (DUSP1) Genes UNUSUAL CIS-ACTING ELEMENTS AND UNEXPECTED EVOLUTIONARY DIVERGENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; MAP KINASE; INFLAMMATORY RESPONSES; DNA-BINDING; MOLECULAR-MECHANISMS; RECEPTOR; EXPRESSION; INHIBITION; DEXAMETHASONE	Anti-inflammatory effects of glucocorticoids (GCs) are partly mediated by up-regulation of DUSP1 (dual specificity phosphatase 1), which dephosphorylates and inactivates mitogen-activated protein kinases. We identified putative GC-responsive regions containing GC receptor (GR) binding site consensus sequences that are well conserved between human and mouse DUSP1 loci in position, orientation, and sequence (at least 11 of 15 positions identical) and lie within regions of extended sequence conservation (minimum 65% identity over at least 100 bp). These were located similar to 29, 28, 24, 4.6, and 1.3 kb upstream of the DUSP1 transcription start site. The homology-based approach successfully identified four cis-acting regions that mediated transcriptional responses to dexamethasone. However, there was surprising interspecies divergence in site usage. This could not be explained by variations of the GR binding sites themselves. Instead, variations in flanking sequences appear to have driven the evolutionary divergence in mechanisms of regulation of mouse and human DUSP1 genes. There was a good correlation between the ability of cis-acting elements to respond to GC in transiently transfected reporter constructs and their ability to recruit GR in the context of intact chromatin. We propose that divergence of gene regulation has involved the loss or gain of binding sites for accessory transcription factors that assist in GR recruitment. Finally, a novel GC-responsive region of the human DUSP1 gene contains a highly unusual element, in which three closely spaced GR half-sites are required for potent transcriptional activation by GC.	[Tchen, Carmen R.; Martins, Joana R. S.; Paktiawal, Nasren; Perelli, Roberta; Saklatvala, Jeremy; Clark, Andrew R.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Clark, AR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	andy.clark@imperial.ac.uk	Clark, Andrew/AAN-4043-2021	Clark, Andy/0000-0003-4996-8322	Medical Research Council (United Kingdom); Arthritis Research Campaign (United Kingdom); MRC [G8623776] Funding Source: UKRI; Medical Research Council [G8623776] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research Campaign (United Kingdom)(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom) and the Arthritis Research Campaign (United Kingdom).	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2003, J ENDOCRINOL, V178, P5, DOI 10.1677/joe.0.1780005; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; Dewannieux M, 2005, CYTOGENET GENOME RES, V110, P35, DOI 10.1159/000084936; Dorfman K, 1996, ONCOGENE, V13, P925; Fan WJ, 2009, LIFE SCI, V84, P838, DOI 10.1016/j.lfs.2009.03.014; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Jang BC, 2007, FEMS IMMUNOL MED MIC, V51, P171, DOI 10.1111/j.1574-695X.2007.00293.x; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kang BN, 2008, AM J PHYSIOL-LUNG C, V295, pL186, DOI 10.1152/ajplung.00352.2007; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Schacke Heike, 2005, Curr Opin Investig Drugs, V6, P503; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sousa AR, 1999, J ALLERGY CLIN IMMUN, V104, P565, DOI 10.1016/S0091-6749(99)70325-8; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	67	57	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2642	2652		10.1074/jbc.M109.037309	http://dx.doi.org/10.1074/jbc.M109.037309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940143	Green Published, hybrid			2022-12-27	WOS:000273697800043
J	Aloia, L; Parisi, S; Fusco, L; Pastore, L; Russo, T				Aloia, Luigi; Parisi, Silvia; Fusco, Ludovico; Pastore, Lucio; Russo, Tommaso			Differentiation of Embryonic Stem Cells 1 (Dies1) Is a Component of Bone Morphogenetic Protein 4 (BMP4) Signaling Pathway Required for Proper Differentiation of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; PLURIPOTENCY; STAT3; ACTIVATION; EXPRESSION; SMAD	Embryonic stem cells (ESCs) are pluripotent cells able to grow indefinitely in culture and to differentiate into all cell types of embryos upon specific stimuli. Molecular mechanisms controlling the unique characteristics of ESCs are still largely unknown. We identified Dies1 (Differentiation of ESCs 1), an unpublished gene, that encodes a type I membrane protein. ESCs stably transfected with Dies1 small hairpin RNAs failed to properly differentiate toward neural and cardiac cell fate upon appropriate stimuli and continued to express markers of undifferentiated cells, such as the membrane-associated alkaline phosphatase, and transcription factors, like Oct3/4 and Nanog, when grown under conditions promoting differentiation. Our results demonstrated that Dies1 is required for BMP4/Smad1 signaling cascade; in undifferentiated ESCs Dies1 knockdown did not affect the expression of leukemia inhibitory factor downstream targets, whereas it resulted in a strong decrease of BMP4 signaling, as demonstrated by the decrease of Id1, -2, and -3 mRNAs, the decreased activity of Id1 gene promoter, and the reduced phospho-Smad1 levels. Dies1 knockdown had no effect in murine ESCs when the expression of the BMP4 receptor Alk3 was suppressed. The phenotype induced by Dies1 suppression in ESCs is due to the indirect activation of the Nodal/Activin pathway, which is a consequence of the BMP4 pathway inhibition and is sufficient to support the mESC undifferentiated state in the absence of leukemia inhibitory factor.	[Fusco, Ludovico; Pastore, Lucio; Russo, Tommaso] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Aloia, Luigi; Parisi, Silvia; Fusco, Ludovico; Pastore, Lucio; Russo, Tommaso] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Aloia, Luigi; Parisi, Silvia] European Sch Mol Med SEMM, I-80145 Milan, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate	Russo, T (corresponding author), Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	tommaso.russo@unina.it	Pastore, Lucio/F-4668-2010; Pastore, Lucio/AAF-3487-2019; Russo, Tommaso/K-1331-2016	Pastore, Lucio/0000-0001-6894-9317; Russo, Tommaso/0000-0003-4426-0106; Aloia, Luigi/0000-0003-4509-2730	EC-Sirocco Consortium; Associazione Italiana Ricerca sul Cancro; Italian Ministry of Health	EC-Sirocco Consortium; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from EC-Sirocco Consortium, Associazione Italiana Ricerca sul Cancro, and Italian Ministry of Health.	Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	26	40	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7776	7783		10.1074/jbc.M109.077156	http://dx.doi.org/10.1074/jbc.M109.077156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042595	Green Published, hybrid			2022-12-27	WOS:000275415600085
J	Bamberg, CE; Mackay, CR; Lee, H; Zahra, D; Jackson, J; Lim, YS; Whitfeld, PL; Craig, S; Corsini, E; Lu, B; Gerard, C; Gerard, NP				Bamberg, Claire E.; Mackay, Charles R.; Lee, Hyun; Zahra, David; Jackson, Jenny; Lim, Yun Si; Whitfeld, Peter L.; Craig, Stewart; Corsini, Erin; Lu, Bao; Gerard, Craig; Gerard, Norma P.			The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYLATION-STIMULATING PROTEIN; BETA-ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; CHEMOATTRACTANT RECEPTOR; HUMAN NEUTROPHILS; COUPLED RECEPTOR; COMPLEMENT C5A; ENDOCYTOSIS; ANAPHYLATOXIN; ACTIVATION	The complement anaphylatoxin C5a is a proinflammatory component of host defense that functions through two identified receptors, C5a receptor (C5aR) and C5L2. C5aR is a classical G protein-coupled receptor, whereas C5L2 is structurally homologous but deficient in G protein coupling. In human neutrophils, we show C5L2 is predominantly intracellular, whereas C5aR is expressed on the plasma membrane. Confocal analysis shows internalized C5aR following ligand binding is co-localized with both C5L2 and beta-arrestin. Antibody blockade of C5L2 results in a dramatic increase in C5a-mediated chemotaxis and ERK1/2 phosphorylation but does not alter C5a-mediated calcium mobilization, supporting its role in modulation of the beta-arrestin pathway. Association of C5L2 with beta-arrestin is confirmed by cellular co-immunoprecipitation assays. C5L2 blockade also has no effect on ligand uptake or C5aR endocytosis in human polymorphonuclear leukocytes, distinguishing its role from that of a rapid recycling or scavenging receptor in this cell type. This is thus the first example of a naturally occurring seven-transmembrane segment receptor that is both obligately uncoupled from G proteins and a negative modulator of signal transduction through the beta-arrestin pathway. Physiologically, these properties provide the possibility for additional fine-tuning of host defense.	[Craig, Stewart; Corsini, Erin; Lu, Bao; Gerard, Craig; Gerard, Norma P.] Harvard Univ, Sch Med, Div Pulm, Dept Pediat,Childrens Hosp, Boston, MA 02115 USA; [Gerard, Norma P.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Mackay, Charles R.; Lee, Hyun; Zahra, David; Jackson, Jenny; Lim, Yun Si] Garvan Inst Med Res, Immunol & Inflammat Dept, Darlinghurst, NSW 2010, Australia; [Mackay, Charles R.; Whitfeld, Peter L.] G2 Inflammat Pty Ltd, Darlinghurst, NSW 2010, Australia	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Garvan Institute of Medical Research	Gerard, C (corresponding author), 320 Longwood Ave, Boston, MA 02115 USA.	craig.gerard@childrens.harvard.edu; norma.gerard@childrens.harvard.edu	Mackay, Charles R/A-9673-2008; Corsini, Erin/AAG-6248-2020	Mackay, Charles R/0000-0002-6338-7340; Bayley, Erin/0000-0003-4715-0244	National Institutes of Health [HL36162, HL51366]; Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051366, R01HL036162, R37HL036162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL36162 ( to N.P.G.) and HL51366 ( to C. G.). This work was also supported by funding from the Medical Research Council ( to C. R. M.).	BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cui W, 2007, AM J PHYSIOL-ENDOC M, V293, pE1482, DOI 10.1152/ajpendo.00565.2006; Cui W, 2009, MOL IMMUNOL, V46, P3086, DOI 10.1016/j.molimm.2009.06.007; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Johswich K, 2007, ADV EXP MED BIOL, V598, P159; Johswich K, 2006, J BIOL CHEM, V281, P39088, DOI 10.1074/jbc.M609734200; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MALECH HL, 1977, J CELL BIOL, V75, P666, DOI 10.1083/jcb.75.3.666; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; NOBLE LJ, 1994, J NEUROSCI RES, V38, P654, DOI 10.1002/jnr.490380608; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tsuji RF, 2000, J IMMUNOL, V165, P1588, DOI 10.4049/jimmunol.165.3.1588; Tzafriri AR, 2004, J THEOR BIOL, V229, P127, DOI 10.1016/j.jtbi.2004.03.009; van Lith LHC, 2009, J BIOMOL SCREEN, V14, P1067, DOI 10.1177/1087057109341407; Videm V, 2004, SCAND J IMMUNOL, V59, P25, DOI 10.1111/j.0300-9475.2004.01351.x; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whistler JL, 2002, TRAFFIC, V3, P866, DOI 10.1034/j.1600-0854.2002.31203.x	41	179	183	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7633	7644		10.1074/jbc.M109.092106	http://dx.doi.org/10.1074/jbc.M109.092106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20044484	Green Published, hybrid			2022-12-27	WOS:000275415600074
J	Kloer, DP; Rojas, R; Ivan, V; Moriyama, K; van Vlijmen, T; Murthy, N; Ghirlando, R; van der Sluijs, P; Hurley, JH; Bonifacino, JS				Kloer, Daniel P.; Rojas, Raul; Ivan, Viorica; Moriyama, Kengo; van Vlijmen, Thijs; Murthy, Namita; Ghirlando, Rodolfo; van der Sluijs, Peter; Hurley, James H.; Bonifacino, Juan S.			Assembly of the Biogenesis of Lysosome-related Organelles Complex-3 (BLOC-3) and Its Interaction with Rab9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; MYOSIN-VA; VESICLE TRAFFICKING; GUNMETAL MOUSE; PROTEIN; GENE; FAMILY; HPS1; MELANOSOMES; TRANSPORT	The Hermansky-Pudlak syndrome (HPS) is a genetic hypopigmentation and bleeding disorder caused by defective biogenesis of lysosome-related organelles (LROs) such as melanosomes and platelet dense bodies. HPS arises from mutations in any of 8 genes in humans and 16 genes in mice. Two of these genes, HPS1 and HPS4, encode components of the biogenesis of lysosome-related organelles complex-3 (BLOC-3). Herein we show that recombinant HPS1-HPS4 produced in insect cells can be efficiently isolated as a 1:1 heterodimer. Analytical ultracentrifugation reveals that this complex has a molecular mass of 146 kDa, equivalent to that of the native complex and to the sum of the predicted molecular masses of HPS1 and HPS4. This indicates that HPS1 and HPS4 interact directly in the absence of any other protein as part of BLOC-3. Limited proteolysis and deletion analyses show that both subunits interact with one another throughout most of their lengths with the sole exception of a long, unstructured loop in the central part of HPS4. An interaction screen reveals a specific and strong interaction of BLOC-3 with the GTP-bound form of the endosomal GTPase, Rab9. This interaction is mediated by HPS4 and the switch I and II regions of Rab9. These characteristics indicate that BLOC-3 might function as a Rab9 effector in the biogenesis of LROs.	[Ghirlando, Rodolfo; Hurley, James H.] NIDDK, NIH, Mol Biol Lab, Bethesda, MD 20892 USA; [Rojas, Raul; Moriyama, Kengo; Murthy, Namita; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Ivan, Viorica; van Vlijmen, Thijs; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utrecht University; Utrecht University Medical Center	Hurley, JH (corresponding author), NIDDK, NIH, Mol Biol Lab, Bldg 50 Rm 4517, Bethesda, MD 20892 USA.	hurley@helix.nih.gov; juan@helix.nih.gov	何, 敏仪/E-6352-2015; van Vlijmen, Thijs/B-4069-2009; Ghirlando, Rodolfo/A-8880-2009	van Vlijmen, Thijs/0000-0002-5882-6660; Bonifacino, Juan S./0000-0002-5673-6370	NICHD; NIDDK; Netherlands' Proteomics Center; DFG-NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK036130] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Netherlands' Proteomics Center; DFG-NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Programs of NICHD (to J. S. B.) and NIDDK (to J. H. H.), the Netherlands' Proteomics Center (to P. v. d. S.), and the DFG-NIH program (to D. P. K.).	Bachli EB, 2004, AM J MED GENET A, V127A, P201, DOI 10.1002/ajmg.a.20683; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Chiang PW, 2003, J BIOL CHEM, V278, P20332, DOI 10.1074/jbc.M300090200; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Hoffman-Sommer M, 2005, TRAFFIC, V6, P534, DOI 10.1111/j.1600-0854.2005.00301.x; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Ito S, 2005, J INVEST DERMATOL, V125, P715, DOI 10.1111/j.0022-202X.2005.23884.x; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Li Wei, 2007, Journal of Genetics and Genomics, V34, P669, DOI 10.1016/S1673-8527(07)60076-9; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Martina JA, 2003, J BIOL CHEM, V278, P29376, DOI 10.1074/jbc.M301294200; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Nazarian R, 2008, MOL GENET METAB, V93, P134, DOI 10.1016/j.ymgme.2007.09.001; Oh J, 2000, HUM MOL GENET, V9, P375, DOI 10.1093/hmg/9.3.375; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seki N, 2000, J HUM GENET, V45, P318, DOI 10.1007/s100380070025; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; van der Sluijs P, 2008, METHOD ENZYMOL, V438, P185, DOI 10.1016/S0076-6879(07)38013-0; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Zhang Q, 2002, BRIT J HAEMATOL, V117, P414, DOI 10.1046/j.1365-2141.2002.03444.x	45	62	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7794	7804		10.1074/jbc.M109.069088	http://dx.doi.org/10.1074/jbc.M109.069088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048159	hybrid, Green Published			2022-12-27	WOS:000275415600087
J	Radner, FPW; Streith, IE; Schoiswohl, G; Schweiger, M; Kumari, M; Eichmann, TO; Rechberger, G; Koefeler, HC; Eder, S; Schauer, S; Theussl, HC; Preiss-Landl, K; Lass, A; Zimmermann, R; Hoefler, G; Zechner, R; Haemmerle, G				Radner, Franz P. W.; Streith, Ingo E.; Schoiswohl, Gabriele; Schweiger, Martina; Kumari, Manju; Eichmann, Thomas O.; Rechberger, Gerald; Koefeler, Harald C.; Eder, Sandra; Schauer, Silvia; Theussl, H. Christian; Preiss-Landl, Karina; Lass, Achim; Zimmermann, Robert; Hoefler, Gerald; Zechner, Rudolf; Haemmerle, Guenter			Growth Retardation, Impaired Triacylglycerol Catabolism, Hepatic Steatosis, and Lethal Skin Barrier Defect in Mice Lacking Comparative Gene Identification-58 (CGI-58)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID STORAGE DISEASE; ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; INSULIN-RESISTANCE; PROTEIN; OBESITY; MOBILIZATION; EXPRESSION; LIPOLYSIS	Comparative gene identification-58 (CGI-58), also designated as alpha/beta-hydrolase domain containing-5 (ABHD-5), is a lipid droplet-associated protein that activates adipose triglyceride lipase (ATGL) and acylates lysophosphatidic acid. Activation of ATGL initiates the hydrolytic catabolism of cellular triacylglycerol (TG) stores to glycerol and nonesterified fatty acids. Mutations in both ATGL and CGI-58 cause "neutral lipid storage disease" characterized by massive accumulation of TG in various tissues. The analysis of CGI-58-deficient (Cgi-58(-/-)) mice, presented in this study, reveals a dual function of CGI-58 in lipid metabolism. First, systemic TG accumulation and severe hepatic steatosis in newborn Cgi-58(-/-) mice establish a limiting role for CGI-58 in ATGL-mediated TG hydrolysis and supply of nonesterified fatty acids as energy substrate. Second, a severe skin permeability barrier defect uncovers an essential ATGL-independent role of CGI-58 in skin lipid metabolism. The neonatal lethal skin barrier defect is linked to an impaired hydrolysis of epidermal TG. As a consequence, sequestration of fatty acids in TG prevents the synthesis of acylceramides, which are essential lipid precursors for the formation of a functional skin permeability barrier. This mechanism may also underlie the pathogenesis of ichthyosis in neutral lipid storage disease patients lacking functional CGI-58.	[Radner, Franz P. W.; Streith, Ingo E.; Schoiswohl, Gabriele; Schweiger, Martina; Kumari, Manju; Eichmann, Thomas O.; Rechberger, Gerald; Eder, Sandra; Preiss-Landl, Karina; Lass, Achim; Zimmermann, Robert; Zechner, Rudolf; Haemmerle, Guenter] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Koefeler, Harald C.] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Schauer, Silvia; Hoefler, Gerald] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Theussl, H. Christian] Inst Mol Pathol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Medical University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; guenter.haemmerle@uni-graz.at	Lass, Achim/C-3332-2008; Hoefler, Gerald/B-7006-2008; Hoefler, Gerald/H-1796-2016	Lass, Achim/0000-0002-8190-7151; Eichmann, Thomas O./0000-0002-8521-2795; Radner, Franz/0000-0003-3466-0181; Schoiswohl, Gabriele/0000-0002-7346-2834; Haemmerle, Guenter/0000-0001-9900-5896; Hoefler, Gerald/0000-0002-9056-3063; Zimmermann, Robert/0000-0002-7354-870X; Schweiger, Martina/0000-0002-3419-1007; Zechner, Rudolf/0000-0001-5483-1182; Rechberger, Gerald N./0000-0002-0071-317X; Kofeler, Harald/0000-0002-2725-9616	Austrian Ministry for Science and Research; SFB LIPOTOX [F30-B05]; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P20602-B05]; Austrian Science Fund (FWF) [F 3002, Z 136, P 20602, W 901] Funding Source: researchfish	Austrian Ministry for Science and Research; SFB LIPOTOX(German Research Foundation (DFG)); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant "GOLD-Genomics of Lipid-associated Disorders" (which is part of the Austrian Genome Project "GEN-AU Genome Research in Austria") funded by the Austrian Ministry for Science and Research and by Grant SFB LIPOTOX F30-B05 and FWF Project P20602-B05 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; AUSUBEL FM, 2004, CURRENT PROTOCOLS MO, V2; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caviglia JM, 2009, BBA-MOL CELL BIOL L, V1791, P198, DOI 10.1016/j.bbalip.2008.12.018; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GUERCIOLINI R, 1997, INT J OBES S3, V21, P12; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HILAIRE N, 1995, J BIOL CHEM, V270, P27027, DOI 10.1074/jbc.270.45.27027; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JORDANS GHW, 1953, ACTA MED SCAND, V145, P419; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; McMahon A, 2007, MOL VIS, V13, P258; MONTEROMORAN G, 2010, J LIPID RES IN PRESS; NAVARRO JM, 1995, J BIOL CHEM, V270, P21362, DOI 10.1074/jbc.270.36.21362; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Raben DM, 2005, TRENDS ENDOCRIN MET, V16, P35, DOI 10.1016/j.tem.2005.01.009; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WERTZ PW, 1985, J INVEST DERMATOL, V84, P410, DOI 10.1111/1523-1747.ep12265510; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	47	147	147	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7300	7311		10.1074/jbc.M109.081877	http://dx.doi.org/10.1074/jbc.M109.081877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20023287	Green Published, hybrid			2022-12-27	WOS:000275415600042
J	Daly, AC; Vizan, P; Hill, CS				Daly, Amanda C.; Vizan, Pedro; Hill, Caroline S.			Smad3 Protein Levels Are Modulated by Ras Activity and during the Cell Cycle to Dictate Transforming Growth Factor-beta Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; SIGNALING PATHWAYS; PROSTATE-CANCER; TARGETED DISRUPTION; DEPENDENT KINASES; UBIQUITIN LIGASE; DOWN-REGULATION; TUMOR-CELLS; EXPRESSION	Transforming growth factor beta (TGF-beta) regulates many biological processes, and aberrant TGF-beta signaling is implicated in tumor development. Smad3 is a central component of the TGF-beta signaling pathway, and once activated, Smad3 forms complexes with Smad4 or other receptor-regulated Smads, which accumulate in the nucleus to transcriptionally regulate TGF-beta target genes. Because Smad3 plays a significant role in mediating the activities of TGF-beta, we examined its regulation during tumor development using a well characterized tumor model. We demonstrate that Smad3 levels are dramatically reduced in the tumorigenic cell line transformed with activated H-Ras compared with the normal parental epithelial cells. Interestingly, we also observe a cell cycle-dependent regulation of Smad3 in both cell types, with high Smad3 levels in quiescent cells and a significant drop in Smad3 protein levels in proliferating cells. Smad3 is regulated at the mRNA level and at the level of protein stability. In addition, functional analysis indicates that down-regulation of Smad3 levels is required for the tumor cells to proliferate in the presence of TGF-beta, because ectopic expression of Smad3 in the tumorigenic cell line restores the growth inhibitory response to TGF-beta. In contrast, expression of high levels of Smad3 did not interfere with the ability of these cells to undergo epithelial to mesenchymal transition upon TGF-beta stimulation. Altogether, our results suggest that the level of Smad3 protein is an important determinant of the progression of tumorigenesis. High levels of Smad3 are required for the tumor suppressor activities of TGF-beta, whereas lower levels are sufficient for the tumor promoting functions.	[Daly, Amanda C.; Vizan, Pedro; Hill, Caroline S.] Canc Res UK London Res Inst, Lab Dev Signalling, London WC2A 3PX, England	Cancer Research UK	Hill, CS (corresponding author), 44 Lincolns Inn Fields, London WC2A 3PX, England.	caroline.hill@cancer.org.uk	; Vizan, Pedro/K-5555-2015	Hill, Caroline/0000-0002-8632-0480; Vizan, Pedro/0000-0002-6787-9940	Cancer Research UK; European Union [MRTN-CT-2004-005428]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-235995]	Cancer Research UK(Cancer Research UK); European Union(European Commission); Marie Curie Intra-European Fellowship(European Commission)	This work was supported by Cancer Research UK, a European Union Research Training Network Grant (MRTN-CT-2004-005428), and a Marie Curie Intra-European Fellowship PIEF-GA-2009-235995 (to P. V.).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Howell M, 1997, EMBO J, V16, P7411, DOI 10.1093/emboj/16.24.7411; Inman GJ, 2002, J BIOL CHEM, V277, P51008, DOI 10.1074/jbc.M208532200; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jeruss JS, 2003, MOL CELL ENDOCRINOL, V203, P185, DOI 10.1016/S0303-7207(02)00291-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Ku JL, 2007, CANCER LETT, V247, P283, DOI 10.1016/j.canlet.2006.05.008; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian F, 2003, CANCER RES, V63, P8284; Vijayachandra K, 2003, CANCER RES, V63, P3447; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welsh JB, 2001, CANCER RES, V61, P5974; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YA, 2006, CANCER CELL, V9, P445, DOI 10.1016/j.ccr.2006.04.025; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	56	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6489	6497		10.1074/jbc.M109.043877	http://dx.doi.org/10.1074/jbc.M109.043877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037158	Green Published, hybrid			2022-12-27	WOS:000275367500053
J	Wang, ZX; Thurmond, DC				Wang, Zhanxiang; Thurmond, Debbie C.			Differential Phosphorylation of RhoGDI Mediates the Distinct Cycling of Cdc42 and Rac1 to Regulate Second- phase Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; GTP-BINDING PROTEINS; NUCLEOTIDE DISSOCIATION INHIBITOR; FACTOR ATTACHMENT PROTEIN; 1ST PHASE; B-CELLS; GLUCOSE; RELEASE; EXOCYTOSIS; ISLETS	Cdc42 cycling through GTP/GDP states is critical for its function in the second/granule mobilization phase of insulin granule exocytosis in pancreatic islet beta cells, although the identities of the Cdc42 cycling proteins involved remain incomplete. Using a tandem affinity purification-based mass spectrometry screen for Cdc42 cycling factors in beta cells, RhoGDI was identified. RNA interference-mediated depletion of RhoGDI from isolated islets selectively amplified the second phase of insulin release, consistent with the role of RhoGDI as a Cdc42 cycling factor. Replenishment of RhoGDI to RNA interference-depleted cells normalized secretion, confirming the action of RhoGDI to be that of a negative regulator of Cdc42 activation. Given that RhoGDI also regulates Rac1 activation in beta cells, and that Rac1 activation occurs in a Cdc42-dependent manner, the question as to how the beta cell utilized RhoGDI for differential Cdc42 and Rac1 cycling was explored. Co-immunoprecipitation was used to determine that RhoGDI-Cdc42 complexes dissociated upon stimulation of beta cells with glucose for 3 min, correlating with the timing of glucose-induced Cdc42 activation and the onset of RhoGDI tyrosine phosphorylation. Glucose-induced disruption of RhoGDI-Rac1 complexes occurred subsequent to this, coincident with Rac1 activation, which followed the onset of RhoGDI serine phosphorylation. RhoGDI-Cdc42 complex dissociation was blocked by mutation of RhoGDI residue Tyr-156, whereas RhoGDI-Rac1 dissociation was blocked by RhoGDI mutations Y156F and S101A/S174A. Finally, expression of a triple Y156F/S101A/S174A-RhoGDI mutant specifically inhibited only the second/granule mobilization phase of glucose-stimulated insulin secretion, overall supporting the integration of RhoGDI into the activation cycling mechanism of glucose-responsive small GTPases.	[Wang, Zhanxiang; Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Pediat, Basic Diabet Res Grp, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Thurmond, DC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Basic Diabet Res Grp, Herman B Wells Ctr Pediat Res, Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu			National Institutes of Health [DK076614]; American Diabetes Association Career Development Award [1-03-CD-10]; Indiana University Research Support Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development Award(American Diabetes Association); Indiana University Research Support Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076614 (to D. C. T.). This work was also supported by American Diabetes Association Career Development Award 1-03-CD-10 and an Indiana University Research Support Fund Grant.	Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Gasman S, 2003, CELL SIGNAL, V15, P893, DOI 10.1016/S0898-6568(03)00052-4; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Guerrera IC, 2007, J PROTEOME RES, V6, P2623, DOI 10.1021/pr070078f; Hatlapatka K, 2009, AM J PHYSIOL-ENDOC M, V297, pE315, DOI 10.1152/ajpendo.90981.2008; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Horie M, 2001, CARDIOVASC DRUG THER, V15, P31, DOI 10.1023/A:1011106701063; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; KiralyBorri CE, 1996, BIOCHEM J, V314, P199, DOI 10.1042/bj3140199; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kowluru A, 1997, BIOCHEM PHARMACOL, V54, P1097, DOI 10.1016/S0006-2952(97)00314-6; Kowluru A, 2008, J CELL MOL MED, V12, P164, DOI 10.1111/j.1582-4934.2007.00168.x; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Lim Y, 2003, BIOCHEM BIOPH RES CO, V305, P292, DOI 10.1016/S0006-291X(03)00733-2; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; NESHER R, 1987, ENDOCRINOLOGY, V121, P1017, DOI 10.1210/endo-121-3-1017; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Park KH, 2000, J BIOMAT SCI-POLYM E, V11, P903, DOI 10.1163/156856200744093; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Rhodes CJ., 2000, DIABETES MELLITUS FU, P20; ROGERS S, 1985, ARCH DIS CHILD, V60, P200, DOI 10.1136/adc.60.3.200; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; Shigeto M, 2006, J PHARMACOL SCI, V101, P293, DOI 10.1254/jphs.FP0060057; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Straub SG, 2004, DIABETES, V53, P3179, DOI 10.2337/diabetes.53.12.3179; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Zhao Y, 2008, J BIOL CHEM, V283, P5306, DOI 10.1074/jbc.M707695200	55	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6186	6197		10.1074/jbc.M109.072421	http://dx.doi.org/10.1074/jbc.M109.072421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028975	Green Published, hybrid			2022-12-27	WOS:000275367500023
J	Shokeer, A; Mannervik, B				Shokeer, Abeer; Mannervik, Bengt			Minor Modifications of the C-terminal Helix Reschedule the Favored Chemical Reactions Catalyzed by Theta Class Glutathione Transferase T1-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; PROTEIN-STRUCTURE; ENZYME EVOLUTION; STRUCTURAL BASIS; EFFICIENCY; PRODUCTS; ISOTHIOCYANATES; DETOXICATION; PROMISCUITY; CONJUGATION	Adaptive responses to novel toxic challenges provide selective advantages to organisms in evolution. Glutathione transferases (GSTs) play a pivotal role in the cellular defense because they are main contributors to the inactivation of genotoxic compounds of exogenous as well as of endogenous origins. GSTs are promiscuous enzymes catalyzing a variety of chemical reactions with numerous alternative substrates. Despite broad substrate acceptance, individual GSTs display pronounced selectivities such that only a limited number of substrates are transformed with high catalytic efficiency. The present study shows that minor structural changes in the C-terminal helix of mouse GST T1-1 induce major changes in the substrate-activity profile of the enzyme to favor novel chemical reactions and to suppress other reactions catalyzed by the parental enzyme.	[Shokeer, Abeer; Mannervik, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, SE-75123 Uppsala, Sweden	Uppsala University	Mannervik, B (corresponding author), Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, Box 576, SE-75123 Uppsala, Sweden.	bengt.mannervik@biorg.uu.se	Shokeer, Abeer/ABA-4836-2020	Shokeer, Abeer/0000-0001-8919-9658	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Swedish Research Council and the Swedish Cancer Society.	BJORNESTEDT R, 1992, BIOCHEM J, V282, P505; Board PG, 2005, METHOD ENZYMOL, V401, P61, DOI 10.1016/S0076-6879(05)01004-9; Broo K, 2002, J MOL BIOL, V318, P59, DOI 10.1016/S0022-2836(02)00032-3; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Dagnino-Subiabre A, 2000, BIOCHEM BIOPH RES CO, V274, P32, DOI 10.1006/bbrc.2000.3087; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Griswold KE, 2006, J MOL BIOL, V364, P400, DOI 10.1016/j.jmb.2006.09.012; Habig W H, 1981, Methods Enzymol, V77, P398; HOROVITZ A, 1996, FOLDING DESIGN, V1, P121, DOI DOI 10.1016/S1359-0278(96)00056-9; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Jemth P, 1997, ARCH BIOCHEM BIOPHYS, V348, P247, DOI 10.1006/abbi.1997.0357; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Josephy PD, 2006, MOL TOXICOLOGY, P333; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Kurtovic S, 2009, BIOCHEMISTRY-US, V48, P9330, DOI 10.1021/bi901168q; LAEMMLI UK, 1970, NATURE, V227, P685; Larsson AK, 2004, PROTEIN ENG DES SEL, V17, P49, DOI 10.1093/protein/gzh005; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lien S, 2002, BIOCHEM PHARMACOL, V63, P191, DOI 10.1016/S0006-2952(01)00846-2; Mannervik B., 1978, CONJUGATION REACTION, P101; Matzkin LM, 2008, GENETICS, V178, P1073, DOI 10.1534/genetics.107.083287; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Norrgard MA, 2006, P NATL ACAD SCI USA, V103, P4876, DOI 10.1073/pnas.0600849103; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Shokeer A, 2005, BIOCHEM J, V388, P387, DOI 10.1042/BJ20042064; Tars K, 2006, J MOL BIOL, V355, P96, DOI 10.1016/j.jmb.2005.10.049; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472	35	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5639	5645		10.1074/jbc.M109.074757	http://dx.doi.org/10.1074/jbc.M109.074757			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022951	Green Published, hybrid			2022-12-27	WOS:000275327200056
J	Butt, T; Mufti, T; Humayun, A; Rosenthal, PB; Khan, S; Khan, S; Molloy, JE				Butt, Tariq; Mufti, Tabish; Humayun, Ahmad; Rosenthal, Peter B.; Khan, Sohaib; Khan, Shahid; Molloy, Justin E.			Myosin Motors Drive Long Range Alignment of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR MOTILITY; PROTEINS; MUSCLE; CYTOSKELETON; FIBROBLASTS; ADAPTATIONS; NETWORKS; DYNAMICS; TRACKING; MOTION	The bulk alignment of actin filament sliding movement, powered by randomly oriented myosin molecules, has been observed and studied using an in vitro motility assay. The well established, actin filament gliding assay is a minimal experimental system for studying actomyosin motility. Here, we show that when the assay is performed at densities of actin filaments approaching those found in living cells, filament gliding takes up a preferred orientation. The oriented patterns of movement that we have observed extend over a length scale of 10-100 mu m, similar to the size of a mammalian cell. We studied the process of filament alignment and found that it depends critically upon filament length and density. We developed a simple quantitative measure of filament sliding orientation and this enabled us to follow the time course of alignment and the formation and disappearance of oriented domains. Domains of oriented filaments formed spontaneously and were separated by distinct boundaries. The pattern of the domain structures changed on the time scale of several seconds and the collision of neighboring domains led to emergence of new patterns. Our results indicate that actin filament crowding may play an important role in structuring the leading edge of migrating cells. Filament alignment due to near-neighbor mechanical interactions can propagate over a length scale of several microns; much greater than the size of individual filaments and analogous to a log drive. Self-alignment of actin filaments may make an important contribution to cell polarity and provide a mechanism by which cell migration direction responds to chemical cues.	[Butt, Tariq; Khan, Shahid] LUMS Sch Sci & Engn, Sector U DHA, Dept Life Sci, Lahore 54792, Pakistan; [Mufti, Tabish; Humayun, Ahmad; Khan, Sohaib] LUMS Sch Sci & Engn, Sector U DHA, Dept Comp Sci, Lahore 54792, Pakistan; [Rosenthal, Peter B.; Molloy, Justin E.] Natl Inst Med Res, Div Phys Biochem, MRC, London NW7 1AA, England	Lahore University of Management Sciences; Lahore University of Management Sciences; MRC National Institute for Medical Research	Khan, S (corresponding author), LUMS Sch Sci & Engn, Sector U DHA, Dept Life Sci, Lahore 54792, Pakistan.	shahidkh@lums.edu.pk; jmolloy@nimr.mrc.ac.uk		Molloy, Justin/0000-0002-8307-2450; Khan, Shahid/0000-0002-0361-6068; Butt, Tariq/0000-0002-8789-9543; Butt, Tariq/0000-0001-7532-1747	Higher Education Commission-British Council Link; Lahore University of Management Sciences; School of Science and Engineering; Computer Science Department; Medical Research Council, UK; Medical Research Council [MC_U117570592, MC_U117581334] Funding Source: researchfish; MRC [MC_U117581334, MC_U117570592] Funding Source: UKRI	Higher Education Commission-British Council Link; Lahore University of Management Sciences; School of Science and Engineering; Computer Science Department; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a Higher Education Commission-British Council Link grant in "Bionanotechnology" (to Sh. K.), Lahore University of Management Sciences, School of Science and Engineering, Computer Science Department for research assistant stipends (to A. H. and T. M.), and a Medical Research Council, UK, grant-in-aid (to J. E. M. and P. B. R.).	Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Bunk R, 2003, BIOCHEM BIOPH RES CO, V301, P783, DOI 10.1016/S0006-291X(03)00027-5; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; KUIPER NH, 1962, P KON NED AK WET A, V63, P38; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SHEETZ MP, 1986, METHOD ENZYMOL, V134, P531; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Takenawa T, 2001, J CELL SCI, V114, P1801; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Uttenweiler D, 2000, BIOPHYS J, V78, P2709, DOI 10.1016/S0006-3495(00)76815-9; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wiggins CH, 1998, BIOPHYS J, V74, P1043, DOI 10.1016/S0006-3495(98)74029-9; WORK SS, 1992, ANAL BIOCHEM, V202, P275, DOI 10.1016/0003-2697(92)90106-H; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	32	81	82	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4964	4974		10.1074/jbc.M109.044792	http://dx.doi.org/10.1074/jbc.M109.044792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19940124	Green Published, hybrid			2022-12-27	WOS:000275274800073
J	Gao, DT; Ashraf, MZ; Kar, NS; Lin, D; Sayre, LM; Podrez, EA				Gao, Detao; Ashraf, Mohammad Z.; Kar, Niladri S.; Lin, De; Sayre, Lawrence M.; Podrez, Eugene A.			Structural Basis for the Recognition of Oxidized Phospholipids in Oxidized Low Density Lipoproteins by Class B Scavenger Receptors CD36 and SR-BI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; MEMBRANE; ESTERS; FAMILY; LDL	Specific oxidized phospholipids (oxPC(CD36)) accumulate in vivo at sites of oxidative stress and serve as high affinity ligands for scavenger receptors class B (CD36 and SR-BI). Recognition of oxPC(CD36) by scavenger receptors plays a role in several pathophysiological processes. The structural basis for the recognition of oxPC(CD36) by CD36 and SR-BI is poorly understood. A characteristic feature of oxPC(CD36) is an sn-2 acyl group that incorporates a terminal gamma-hydroxy (or oxo)-alpha,beta-unsaturated carbonyl. In the present study, a series of model oxidized phospholipids were designed, synthesized, and tested for their ability to serve as ligands for CD36 and SR-BI. We demonstrated that intact the sn-1 hydrophobic chain, the sn-3 hydrophilic phosphocholine or phosphatidic acid group, and the polar sn-2 tail are absolutely essential for high affinity binding. We further found that a terminal negatively charged carboxylate at the sn-2 position suffices to generate high binding affinity to class B scavenger receptors. In addition, factors such as polarity, rigidity, optimal chain length of sn-2, and sn-3 positions and negative charge at the sn-3 position of phospholipids further modulate the binding affinity. We conclude that all three positions of oxidized phospholipids are essential for the effective recognition by scavenger receptors class B. Furthermore, the structure of residues in these positions controls the affinity of the binding. The present studies suggest that, in addition to oxPC(CD36), other oxidized phospholipids observed in vivo may represent novel ligands for scavenger receptors class B.	[Ashraf, Mohammad Z.; Kar, Niladri S.; Podrez, Eugene A.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Gao, Detao; Lin, De; Sayre, Lawrence M.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Podrez, EA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,ND50, Cleveland, OH 44195 USA.	podreze@ccf.org	LIN, DE/F-2522-2010		National Institutes of Health [HL053315, HL077213, 2P01HL073311-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL077213, R01HL053315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL053315, HL077213 and 2P01HL073311-06 (to E. A. P.) and HL053315 (to L. M. S.).	Ashraf MZ, 2008, J BIOL CHEM, V283, P10408, DOI 10.1074/jbc.M710474200; GOLDSTEIN JL, 1974, P NATL ACAD SCI USA, V71, P4288, DOI 10.1073/pnas.71.11.4288; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; HOPPE G, 1994, J CLIN INVEST, V94, P1506, DOI 10.1172/JCI117490; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597	15	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4447	4454		10.1074/jbc.M109.082800	http://dx.doi.org/10.1074/jbc.M109.082800			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996318	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000275274800022
J	Taira, N; Yamamoto, H; Yamaguchi, T; Miki, Y; Yoshida, K				Taira, Naoe; Yamamoto, Hiroyuki; Yamaguchi, Tomoko; Miki, Yoshio; Yoshida, Kiyotsugu			ATM Augments Nuclear Stabilization of DYRK2 by Inhibiting MDM2 in the Apoptotic Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; TOPOISOMERASE-II-ALPHA; P53 TUMOR-SUPPRESSOR; LYN TYROSINE KINASE; OXIDATIVE STRESS; P53-DEPENDENT APOPTOSIS; PROTEIN-KINASES; FAMILY KINASES; PHOSPHORYLATION; ABL	The tumor suppressor p53 is a transcription factor that regulates cell cycle, DNA repair, senescence, and apoptosis in response to DNA damage. Phosphorylation of p53 at Ser-46 is indispensable for the commitment to apoptotic cell death. A previous study has shown that upon exposure to genotoxic stress, DYRK2 translocates into the nucleus and phosphorylates p53 at Ser-46, thereby inducing apoptosis. However, less is known about mechanisms responsible for intracellular control of DYRK2. Here we show the functional nuclear localization signal at N-terminal domain of DYRK2. Under normal conditions, nuclear and not cytoplasmic DYRK2 is ubiquitinated by MDM2, resulting in its constitutive degradation. In the presence of proteasome inhibitors, we detected a stable complex of DYRK2 with MDM2 at the nucleus. Upon exposure to genotoxic stress, ATM phosphorylates DYRK2 at Thr-33 and Ser-369, which enables DYRK2 to escape from degradation by dissociation from MDM2 and to induce the kinase activity toward p53 at Ser-46 in the nucleus. These findings indicate that ATM controls stability and pro-apoptotic function of DYRK2 in response to DNA damage.	[Taira, Naoe; Yamamoto, Hiroyuki; Yamaguchi, Tomoko; Miki, Yoshio; Yoshida, Kiyotsugu] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Miki, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.	miki.mgen@mri.tmd.ac.jp; yos.mgen@mri.tmd.ac.jp			Ministry of Education, Science, and Culture of Japan; Uehara Memorial Foundation; Senri Life Science Foundation; Takeda Science Foundation; Kowa Life Science Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senri Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kowa Life Science Foundation	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (to K. Y. and Y. M.), Uehara Memorial Foundation (to K. Y.), Senri Life Science Foundation (to K. Y.), Takeda Science Foundation (to K. Y.), and Kowa Life Science Foundation (to K. Y.).	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kimura J, 2008, NUCLEIC ACIDS RES, V36, P5250, DOI 10.1093/nar/gkn506; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Nihira K, 2008, ONCOGENE, V27, P7285, DOI 10.1038/onc.2008.334; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Peretz S, 2001, P NATL ACAD SCI USA, V98, P1676, DOI 10.1073/pnas.041416598; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Shinagawa H, 2008, ANTIOXID REDOX SIGN, V10, P939, DOI 10.1089/ars.2007.1851; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Yamaguchi T, 2007, CELL SIGNAL, V19, P2088, DOI 10.1016/j.cellsig.2007.06.002; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Yoshida K, 2001, MOL PHARMACOL, V60, P1431, DOI 10.1124/mol.60.6.1431; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021	29	51	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4909	4919		10.1074/jbc.M109.042341	http://dx.doi.org/10.1074/jbc.M109.042341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19965871	Green Published, hybrid			2022-12-27	WOS:000275274800068
J	Sinning, S; Musgaard, M; Jensen, M; Severinsen, K; Celik, L; Koldso, H; Meyer, T; Bols, M; Jensen, HH; Schiott, B; Wiborg, O				Sinning, Steffen; Musgaard, Maria; Jensen, Marie; Severinsen, Kasper; Celik, Leyla; Koldso, Heidi; Meyer, Tine; Bols, Mikael; Jensen, Henrik Helligso; Schiott, Birgit; Wiborg, Ove			Binding and Orientation of Tricyclic Antidepressants within the Central Substrate Site of the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; REUPTAKE INHIBITORS; BACTERIAL HOMOLOG; NEUROTRANSMITTER; IMIPRAMINE; MECHANISM; LEUT; 5-HYDROXYTRYPTAMINE; DOPAMINE; SYNAPTOSOMES	Tricyclic antidepressants (TCAs) have been used for decades, but their orientation within and molecular interactions with their primary target is yet unsettled. The recent finding of a TCA binding site in the extracellular vestibule of the bacterial leucine transporter 11 angstrom above the central site has prompted debate about whether this vestibular site in the bacterial transporter is applicable to binding of antidepressants to their relevant physiological target, the human serotonin transporter (hSERT). We present an experimentally validated structural model of imipramine and analogous TCAs in the central substrate binding site of hSERT. Two possible binding modes were observed from induced fit docking calculations. We experimentally validated a single binding mode by combining mutagenesis of hSERT with uptake inhibition studies of different TCA analogs according to the paired mutation ligand analog complementation paradigm. Using this experimental method, we identify a salt bridge between the tertiary aliphatic amine and Asp(98). Furthermore, the 7-position of the imipramine ring is found vicinal to Phe(335), and the pocket lined by Ala(173) and Thr(439) is utilized by 3-substituents. These protein-ligand contact points unambiguously orient the TCA within the central binding site and reveal differences between substrate binding and inhibitor binding, giving important clues to the inhibition mechanism. Consonant with the well established competitive inhibition of uptake by TCAs, the resulting binding site for TCAs in hSERT is fully overlapping with the serotonin binding site in hSERT and dissimilar to the low affinity noncompetitive TCA site reported in the leucine transporter (LeuT).	[Musgaard, Maria; Jensen, Marie; Celik, Leyla; Koldso, Heidi; Meyer, Tine; Bols, Mikael; Jensen, Henrik Helligso; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Celik, Leyla; Schiott, Birgit] Aarhus Univ, iNANO Ctr, DK-8000 Aarhus C, Denmark; [Celik, Leyla; Schiott, Birgit] Aarhus Univ, InSPIN Ctr, DK-8000 Aarhus C, Denmark; [Sinning, Steffen; Severinsen, Kasper; Wiborg, Ove] Aarhus Univ Hosp, Mol Neurobiol Lab, Ctr Psychiat Res, DK-8240 Risskov, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Schiott, B (corresponding author), Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark.	birgit@chem.au.dk; owiborg@post.tele.dk	Schiott, Birgit/F-5067-2011; Bols, Mikael/F-6882-2014	Schiott, Birgit/0000-0001-9937-1562; Bols, Mikael/0000-0002-6561-6952; Musgaard, Maria/0000-0001-6096-9014; Sinning, Steffen/0000-0001-6971-6929	iNANO Center; Danish Center for Scientific Computing; Danish National Research Foundation; Danish Natural Science Research Council; Carlsberg, Novo Nordisk; Lundbeck Foundations	iNANO Center; Danish Center for Scientific Computing; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg, Novo Nordisk(Novo NordiskCarlsberg Foundation); Lundbeck Foundations	This work was supported by the iNANO Center, the Danish Center for Scientific Computing, the Danish National Research Foundation, the Danish Natural Science Research Council, and the Carlsberg, Novo Nordisk, and Lundbeck Foundations.	Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Bauer Michael, 2002, World J Biol Psychiatry, V3, P5, DOI 10.3109/15622970209150599; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; HORN AS, 1974, BRIT J PHARMACOL, V51, P399, DOI 10.1111/j.1476-5381.1974.tb10675.x; HORN AS, 1971, MOL PHARMACOL, V7, P66; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Larsen MB, 2004, J BIOL CHEM, V279, P42147, DOI 10.1074/jbc.M405579200; LEE CM, 1982, J NEUROSCI, V2, P1515; LEE CM, 1981, P NATL ACAD SCI-BIOL, V78, P5250, DOI 10.1073/pnas.78.8.5250; LINGJAERDE O, 1971, ACTA PHYSIOL SCAND, V83, P257, DOI 10.1111/j.1748-1716.1971.tb05075.x; Masson J, 1999, PHARMACOL REV, V51, P439; Nelson N, 1998, J NEUROCHEM, V71, P1785; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; PLENGE P, 1985, EUR J PHARMACOL, V119, P1, DOI 10.1016/0014-2999(85)90314-0; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; Rudnick G, 2007, ACS CHEM BIOL, V2, P606, DOI 10.1021/cb7001818; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Schildkraut J. J., 1965, J NEUROPSYCHIATRY CL, V7, P524; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	45	83	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8363	8374		10.1074/jbc.M109.045401	http://dx.doi.org/10.1074/jbc.M109.045401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	19948720	Green Published, hybrid			2022-12-27	WOS:000275413800052
J	Cardoso, LEM; Little, PJ; Ballinger, ML; Chan, CK; Braun, KR; Potter-Perigo, S; Bornfeldt, KE; Kinsella, MG; Wight, TN				Cardoso, Luiz E. M.; Little, Peter J.; Ballinger, Mandy L.; Chan, Christina K.; Braun, Kathleen R.; Potter-Perigo, Susan; Bornfeldt, Karin E.; Kinsella, Michael G.; Wight, Thomas N.			Platelet-derived Growth Factor Differentially Regulates the Expression and Post-translational Modification of Versican by Arterial Smooth Muscle Cells through Distinct Protein Kinase C and Extracellular Signal-regulated Kinase Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; TRANSFORMING GROWTH-FACTOR-BETA-1; PHENOTYPIC MODULATION; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; II DECORIN; BIGLYCAN; ACTIVATION; MIGRATION; ATHEROSCLEROSIS	The synthesis of proteoglycans involves steps that regulate both protein and glycosaminoglycan (GAG) synthesis, but it is unclear whether these two pathways are regulated by the same or different signaling pathways. We therefore investigated signaling pathways involved in platelet-derived growth factor (PDGF)-mediated increases in versican core protein and GAG chain synthesis in arterial smooth muscle cells (ASMCs). PDGF treatment of ASMCs resulted in increased versican core protein synthesis and elongation of GAG chains attached to the versican core protein. The effects of PDGF on versican mRNA were blocked by inhibiting either protein kinase C (PKC) or the ERK pathways, whereas the GAG elongation effect of PDGF was blocked by PKC inhibition but not by ERK inhibition. Interestingly, blocking protein synthesis in the presence of cycloheximide abolished the PDGF effect, but not in the presence of xyloside, indicating that GAG synthesis that results from PKC activation is independent from de novo protein synthesis. PDGF also stimulated an increase in the chondroitin-6-sulfate to chondroitin-4-sulfate ratio of GAG chains on versican, and this effect was blocked by PKC inhibitors. These data show that PKC activation is sufficient to cause GAG chain elongation, but both PKC and ERK activation are required for versican mRNA core protein expression. These results indicate that different signaling pathways control different aspects of PDGF-stimulated versican biosynthesis by ASMCs. These data will be useful in designing strategies to interfere with the synthesis of this proteoglycan in various disease states.	[Cardoso, Luiz E. M.; Chan, Christina K.; Braun, Kathleen R.; Potter-Perigo, Susan; Kinsella, Michael G.; Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA; [Little, Peter J.; Ballinger, Mandy L.] Baker IDI Heart & Diabet Inst, Cell Biol Diabet Lab, Melbourne, Vic 3004, Australia; [Little, Peter J.] Monash Univ, Sch Med, Dept Med, Alfred Hosp, Prahran, Vic 3004, Australia; [Little, Peter J.] Monash Univ, Sch Med, Dept Immunol, Alfred Hosp, Prahran, Vic 3004, Australia; [Bornfeldt, Karin E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Washington; University of Washington Seattle	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Hope Heart Program, 1201 9th Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Bornfeldt, Karin/AAI-2241-2019; Little, Peter J./F-9865-2015	Bornfeldt, Karin/0000-0001-9208-6523; Little, Peter J./0000-0002-0335-3835; Ballinger, Mandy/0000-0002-9706-0514	National Institutes of Health [HL18645, HL62887, HL88627]; National Health and Medical Research Council of Australia Research Project [268928]; Diabetes Australia Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL062887, R01HL088627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia Research Project(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL18645 (to T.N.W.) and HL62887 and HL88627 (to K. E. B.). This work was also supported by National Health and Medical Research Council of Australia Research Project Grant 268928 and by funds from the Diabetes Australia Research Trust (to P.J.L.).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; ASANO T, 1984, J PHARMACOL EXP THER, V231, P141; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; BALLINGER ML, 2009, J CELL MOL IN PRESS; BERENSON GS, 1988, ARCH PATHOL LAB MED, V112, P1002; BERGSTRAND H, 1992, J PHARMACOL EXP THER, V263, P1334; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; CAMEJO G, 1980, ATHEROSCLEROSIS, V35, P307, DOI 10.1016/0021-9150(80)90129-X; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Cartel NJ, 2001, AM J PHYSIOL-LUNG C, V281, pL786, DOI 10.1152/ajplung.2001.281.4.L786; CHANG Y, 1983, J BIOL CHEM, V258, P5679; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dadlani H, 2008, J BIOL CHEM, V283, P7844, DOI 10.1074/jbc.M703125200; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Hascall V.C., 1991, CELL BIOL EXTRACELLU, P149; Hedin U, 1997, J CELL PHYSIOL, V172, P109, DOI 10.1002/(SICI)1097-4652(199707)172:1<109::AID-JCP12>3.0.CO;2-7; HIDAKA Y, 1992, ATHEROSCLEROSIS, V95, P87, DOI 10.1016/0021-9150(92)90179-K; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; KOBAYASHI S, 1985, BIOCHIM BIOPHYS ACTA, V841, P71, DOI 10.1016/0304-4165(85)90275-2; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAHY JC, 1991, NEUROSCIENCE, V44, P361, DOI 10.1016/0306-4522(91)90061-R; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Liu J, 1998, AM J PHYSIOL-LUNG C, V274, pL702, DOI 10.1152/ajplung.1998.274.5.L702; Maniatis T, 1982, MOL CLONING LABORATO, P433; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Prydz K, 2000, J CELL SCI, V113, P193; ROSS R, 1990, PHILOS T ROY SOC B, V327, P155, DOI 10.1098/rstb.1990.0051; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; WIGHT TN, 1983, J CELL BIOL, V96, P167, DOI 10.1083/jcb.96.1.167; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	52	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6987	6995		10.1074/jbc.M109.088674	http://dx.doi.org/10.1074/jbc.M109.088674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042606	Green Published, hybrid			2022-12-27	WOS:000275415600012
J	Selvi, BR; Batta, K; Kishore, AH; Mantelingu, K; Varier, RA; Balasubramanyam, K; Pradhan, SK; Dasgupta, D; Sriram, S; Agrawal, S; Kundu, TK				Selvi, B. Ruthrotha; Batta, Kiran; Kishore, A. Hari; Mantelingu, Kempegowda; Varier, Radhika A.; Balasubramanyam, Karanam; Pradhan, Suman Kalyan; Dasgupta, Dipak; Sriram, Sokalingam; Agrawal, Shipra; Kundu, Tapas K.			Identification of a Novel Inhibitor of Coactivator-associated Arginine Methyltransferase 1 (CARM1)-mediated Methylation of Histone H3 Arg-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN METHYLATION; TRANSCRIPTIONAL COACTIVATOR; ANDROGEN RECEPTOR; GENE-EXPRESSION; CARM1; REGULATOR; DIFFERENTIATION; ACTIVATION; INSIGHTS; PRMT1	Methylation of the arginine residues of histones by methyl-transferases has important consequences for chromatin structure and gene regulation; however, the molecular mechanism(s) of methyltransferase regulation is still unclear, as is the biological significance of methylation at particular arginine residues. Here, we report a novel specific inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1; also known as PRMT4) that selectively inhibits methylation at arginine 17 of histone H3 (H3R17). Remarkably, this plant-derived inhibitor, called TBBD (ellagic acid), binds to the substrate (histone) preferentially at the signature motif, "KAPRK," where the proline residue (Pro-16) plays a critical role for interaction and subsequent enzyme inhibition. In a promoter-specific context, inhibition of H3R17 methylation represses expression of p21, a p53-responsive gene, thus implicating a possible role for H3 Arg-17 methylation in tumor suppressor function. These data establish TBBD as a novel specific inhibitor of arginine methylation and demonstrate substrate sequence-directed inhibition of enzyme activity by a small molecule and its physiological consequence.	[Selvi, B. Ruthrotha; Batta, Kiran; Kishore, A. Hari; Mantelingu, Kempegowda; Varier, Radhika A.; Balasubramanyam, Karanam; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Pradhan, Suman Kalyan; Dasgupta, Dipak] IAF, Div Biophys, Saha Inst Nucl Phys, Kolkata 700064, W Bengal, India; [Sriram, Sokalingam; Agrawal, Shipra] Inst Bioinformat & Appl Biotechnol, Bangalore 560066, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Saha Institute of Nuclear Physics	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Pradhan, Suman/O-4518-2015	Varier, Radhika/0000-0003-1302-3159; Kempegowda, Mantelingu/0000-0003-1114-8003; Bharathavikru, Ruthrotha Selvi/0000-0002-3096-7461; Kundu, Tapas/0000-0001-7790-214X	Jawaharlal Nehru Centre for Advanced Scientific Research; Department of Biotechnology, Government of India	Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Jawaharlal Nehru Centre for Advanced Scientific Research and the Department of Biotechnology, Government of India.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Jurenka J, 2008, ALTERN MED REV, V13, P128; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Kim S, 1998, AMINO ACIDS, V15, P291, DOI 10.1007/BF01320895; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Losso JN, 2004, J NUTR BIOCHEM, V15, P672, DOI 10.1016/j.jnutbio.2004.06.004; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Osborne T, 2008, J AM CHEM SOC, V130, P4574, DOI 10.1021/ja077104v; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Spannhoff A, 2007, BIOORG MED CHEM LETT, V17, P4150, DOI 10.1016/j.bmcl.2007.05.088; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; SWAMINATHAN V, 2007, CHROMATIN DIS, P397; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856	40	65	69	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7143	7152		10.1074/jbc.M109.063933	http://dx.doi.org/10.1074/jbc.M109.063933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022955	Green Published, hybrid			2022-12-27	WOS:000275415600028
J	Ohashi, K; Parker, JL; Ouchi, N; Higuchi, A; Vita, JA; Gokce, N; Pedersen, AA; Kalthoff, C; Tullin, S; Sams, A; Summer, R; Walsh, K				Ohashi, Koji; Parker, Jennifer L.; Ouchi, Noriyuki; Higuchi, Akiko; Vita, Joseph A.; Gokce, Noyan; Pedersen, Anette Amstrup; Kalthoff, Christoph; Tullin, Soren; Sams, Anette; Summer, Ross; Walsh, Kenneth			Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATORY MARKERS; T-CELLS; OBESE; PROTEIN; FAT; ASSOCIATION; RECRUITMENT; MODULATION	It is established that the adipocyte-derived cytokine adiponectin protects against cardiovascular and metabolic diseases, but the effect of this adipokine on macrophage polarization, an important mediator of disease progression, has never been assessed. We hypothesized that adiponectin modulates macrophage polarization from that resembling a classically activated M1 phenotype to that resembling alternatively-activated M2cells. Peritoneal macrophages and the stromal vascular fraction (SVF) cells of adipose tissue isolated from adiponectin knock-out mice displayed increased M1 markers, including tumor necrosis factor-alpha, interleukin-6, and monocyte chemoattractant protein-1 and decreased M2 markers, including arginase-1, macrophage galactose N-acetyl-galactosamine specific lectin-1, and interleukin-10. The systemic delivery of adenovirus expressing adiponectin significantly augmented arginase-1 expression in peritoneal macrophages and SVF cells in both wild-type and adiponectin knock-out mice. In culture, the treatment of macrophages with recombinant adiponectin protein led to an increase in the levels of M2 markers and a reduction of reactive oxygen species and reactive oxygen species-related gene expression. Adiponectin also stimulated the expression of M2 markers and attenuated the expression of M1 markers in human monocyte-derived macrophages and SVF cells isolated from human adipose tissue. These data show that adiponectin functions as a regulator of macrophage polarization, and they indicate that conditions of high adiponectin expression may deter metabolic and cardiovascular disease progression by favoring an anti-inflammatory phenotype in macrophages.	Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Vita, Joseph A.; Gokce, Noyan] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Evans Dept Med, Boston, MA 02118 USA; [Tullin, Soren; Sams, Anette] Novo Nordisk, Diabet Biol & Pharmacol, DK-2760 Malov, Denmark; [Summer, Ross] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kalthoff, Christoph] Novo Nordisk, Prot Chem, DK-2760 Malov, Denmark; [Pedersen, Anette Amstrup] Novo Nordisk, Mammalian Cell Technol, DK-2760 Malov, Denmark	Boston University; Boston University; Novo Nordisk; Boston University; Novo Nordisk; Novo Nordisk	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Mol Cardiol Sect, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	王, 强/F-4212-2011; OHASHI, Koji/I-7307-2014; Sams, Anette/R-1764-2016; OUCHI, Noriyuki/I-7306-2014	Sams, Anette/0000-0002-9203-4333; Walsh, Kenneth/0000-0001-7580-2276; Gokce, Noyan/0000-0003-2920-3445; Vita, Joseph/0000-0001-5607-1797	National Institutes of Health [HL81587, AG15052, HL91949]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091949, P01HL081587, K08HL077138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052, R37AG015052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81587, AG15052, and HL91949.	Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Endo M, 2003, AM J PHYSIOL-LUNG C, V285, pL313, DOI 10.1152/ajplung.00434.2002; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007; Summer R, 2007, AM J RESP CELL MOL, V37, P152, DOI 10.1165/rcmb.2006-0386OC; Takaoka M, 2009, CIRC RES, V105, P906, DOI 10.1161/CIRCRESAHA.109.199653; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	43	429	447	4	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6153	6160		10.1074/jbc.M109.088708	http://dx.doi.org/10.1074/jbc.M109.088708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028977	Green Published, hybrid			2022-12-27	WOS:000275367500019
J	Hundsrucker, C; Skroblin, P; Christian, F; Zenn, HM; Popara, V; Joshi, M; Eichhorst, J; Wiesner, B; Herberg, FW; Reif, B; Rosenthal, W; Klussmann, E				Hundsrucker, Christian; Skroblin, Philipp; Christian, Frank; Zenn, Hans-Michael; Popara, Viola; Joshi, Mangesh; Eichhorst, Jenny; Wiesner, Burkhard; Herberg, Friedrich W.; Reif, Bernd; Rosenthal, Walter; Klussmann, Enno			Glycogen Synthase Kinase 3 beta Interaction Protein Functions as an A-kinase Anchoring Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PRINCIPAL CELLS; PKA REGULATORY SUBUNITS; PHASE PEPTIDE-SYNTHESIS; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; SCAFFOLDING PROTEINS; DIFFICULT SEQUENCES; AKAP BINDING; PHOSPHORYLATION; GSK-3-BETA	A-kinase anchoring proteins (AKAPs) include a family of scaffolding proteins that target protein kinase A (PKA) and other signaling proteins to cellular compartments and thereby confine the activities of the associated proteins to distinct regions within cells. AKAPs bind PKA directly. The interaction is mediated by the dimerization and docking domain of regulatory subunits of PKA and the PKA-binding domain of AKAPs. Analysis of the interactions between the dimerization and docking domain and various PKA-binding domains yielded a generalized motif allowing the identification of AKAPs. Our bioinformatics and peptide array screening approaches based on this signature motif identified GSKIP (glycogen synthase kinase 3 beta interaction protein) as an AKAP. GSKIP directly interacts with PKA and GSK3 beta (glycogen synthase kinase 3 beta). It is widely expressed and facilitates phosphorylation and thus inactivation of GSK3 beta by PKA. GSKIP contains the evolutionarily conserved domain of unknown function 727. We show here that this domain of GSKIP and its vertebrate orthologues binds both PKA and GSK3 beta and thereby provides a mechanism for the integration of PKA and GSK3 beta signaling pathways.	[Hundsrucker, Christian; Skroblin, Philipp; Christian, Frank; Popara, Viola; Joshi, Mangesh; Eichhorst, Jenny; Wiesner, Burkhard; Reif, Bernd; Klussmann, Enno] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Zenn, Hans-Michael; Herberg, Friedrich W.] Univ Kassel, Inst Biol, D-34134 Kassel, Germany; [Rosenthal, Walter] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rosenthal, Walter] Charite, Dept Mol Pharmacol & Cell Biol, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Universitat Kassel; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klussmann, E (corresponding author), Leibniz Inst Mol Pharmacol, Campus Berlin Buch,Robert Rossle Str 10, D-13125 Berlin, Germany.	klussmann@fmp-berlin.de	Herberg, Friedrich W/B-5572-2015	Herberg, Friedrich W/0000-0001-7117-7653; Skroblin, Philipp/0000-0003-0321-3493; Reif, Bernd/0000-0001-7368-7198; Christian, Frank/0000-0001-8208-5930	Deutsche Forschungsgemeinschaft Forschergruppe 806 [KL1415/4-1]; European Union [037189]; German Ministry of Education and Science [FKZ 0315097, 0315516]	Deutsche Forschungsgemeinschaft Forschergruppe 806(German Research Foundation (DFG)); European Union(European Commission); German Ministry of Education and Science	This work was supported by Deutsche Forschungsgemeinschaft Forschergruppe 806, Project KL1415/4-1, the European Union Project Thera cAMP, Proposal 037189, and the GoBio Program of the German Ministry of Education and Science Grants FKZ 0315097 and 0315516.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Billadeau DD, 2007, PANCREATOLOGY, V7, P398, DOI 10.1159/000108955; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Dodge-Kafka K. L., 2008, V186, P3, DOI 10.1007/978-3-540-72843-6_1; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; HOUSLAY MD, 2006, SCI STKE, pE32; Hundsrucker C., 2008, V186, P483, DOI 10.1007/978-3-540-72843-6_20; HUNDSRUCKER C, 2007, THESIS FREE U BERLIN; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; HYDE C, 1994, INT J PEPT PROT RES, V43, P431; Jensen J, 2007, CELL SIGNAL, V19, P204, DOI 10.1016/j.cellsig.2006.06.006; Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McCahill A. C., 2008, V186, P125, DOI 10.1007/978-3-540-72843-6_6; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; Schmidt A, 2009, TRAFFIC, V10, P2, DOI 10.1111/j.1600-0854.2008.00843.x; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; Vijayaraghavan S, 1999, MOL ENDOCRINOL, V13, P705, DOI 10.1210/me.13.5.705; Wang XL, 2000, J NEUROSCI, V20, P8551; Wojtal KA, 2006, MOL BIOL CELL, V17, P3638, DOI 10.1091/mbc.E06-03-0230; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	55	43	47	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5507	5521		10.1074/jbc.M109.047944	http://dx.doi.org/10.1074/jbc.M109.047944			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007971	hybrid, Green Published			2022-12-27	WOS:000275327200044
J	Lausen, J; Pless, O; Leonard, F; Kuvardina, ON; Koch, B; Leutz, A				Lausen, Joern; Pless, Ole; Leonard, Fransisca; Kuvardina, Olga N.; Koch, Benjamin; Leutz, Achim			Targets of the Tal1 Transcription Factor in Erythrocytes E2 UBIQUITIN CONJUGASE REGULATION BY Tal1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; VASCULAR DEVELOPMENT; DNA-BINDING; PROTEOLYTIC PATHWAY; MYELOID PROGENITORS; CRITICAL REGULATOR; ESCHERICHIA-COLI; SCL/TAL-1 GENE	The Tal1 transcription factor is essential for the development of the hematopoietic system and plays a role during definitive erythropoiesis in the adult. Despite the importance of Tal1 in erythropoiesis, only a small number of erythroid differentiation target genes are known. A chromatin precipitation and cloning approach was established to uncover novel Tal1 target genes in erythropoiesis. The BirA tag/BirA ligase biotinylation system in combination with streptavidin chromatin precipitation (Strep-CP) was used to co-precipitate genomic DNA bound to Tal1. Tal1 was found to bind in the vicinity of 31 genes including the E2-ubiquitin conjugase UBE2H gene. Binding of Tal1 to UBE2H was confirmed by chromatin immunoprecipitation. UBE2H expression is increased during erythroid differentiation of hCD34(+) cells. Tal1 expression activated UBE2H expression, whereas Tal1 knock-down reduced UBE2H expression and ubiquitin transfer activity. This study identifies parts of the ubiquitinylation machinery as a cellular target downstream of the transcription factor Tal1 and provides novel insights into Tal1-regulated erythropoiesis.	[Lausen, Joern; Kuvardina, Olga N.; Koch, Benjamin] Inst Biomed Res, D-60596 Frankfurt, Main, Germany; [Pless, Ole; Leonard, Fransisca; Leutz, Achim] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Leutz, Achim] Humboldt Univ, Inst Biol, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Lausen, J (corresponding author), Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Main, Germany.	lausen@em.uni-frankfurt.de	Pless, Ole/E-8348-2016; Leutz, Achim/K-9643-2013	Pless, Ole/0000-0002-1468-316X; Leutz, Achim/0000-0001-8259-927X; Koch, Benjamin/0000-0002-3253-8396	Deutsche Forschungsgemeinschaft [LA 1389/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant LA 1389/3-1 from the Deutsche Forschungsgemeinschaft.	Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Barton LM, 1999, INT J BIOCHEM CELL B, V31, P1193, DOI 10.1016/S1357-2725(99)00082-5; BASH RO, 1995, BLOOD, V86, P666, DOI 10.1182/blood.V86.2.666.bloodjournal862666; BOCHES FS, 1982, SCIENCE, V215, P978, DOI 10.1126/science.7156977; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen CY, 2002, EXP HEMATOL, V30, P634, DOI 10.1016/S0301-472X(02)00826-3; de la Grange PB, 2008, STEM CELLS, V26, P1658, DOI 10.1634/stemcells.2007-0952; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ema M, 2003, TRENDS CARDIOVAS MED, V13, P254, DOI 10.1016/S1050-1738(03)00105-1; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gottgens B, 2004, VOX SANG, V87, P15, DOI 10.1111/j.1741-6892.2004.00423.x; Grebenova D, 2006, BLOOD CELL MOL DIS, V37, P210, DOI 10.1016/j.bcmd.2006.08.001; HAAS AL, 1991, ADV EXP MED BIOL, V307, P191; HALDEMAN MT, 1995, J BIOL CHEM, V270, P9507, DOI 10.1074/jbc.270.16.9507; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; HENSOLD JO, 1988, BLOOD, V71, P1153; Hoang T, 1996, BLOOD, V87, P102; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; HOWARD PK, 1985, GENE, V35, P321, DOI 10.1016/0378-1119(85)90011-3; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; KAISER P, 1994, J BIOL CHEM, V269, P8797; Kaiser P, 1995, FEBS LETT, V377, P193, DOI 10.1016/0014-5793(95)01323-7; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Keller MA, 2006, PHYSIOL GENOMICS, V28, P114, DOI 10.1152/physiolgenomics.00055.2006; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Li BH, 2007, BLOOD, V110, P2704, DOI 10.1182/blood-2006-12-064154; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Mahajan MC, 2009, EXP HEMATOL, V37, P1143, DOI 10.1016/j.exphem.2009.07.001; Marteijn JAF, 2006, LEUKEMIA, V20, P1511, DOI 10.1038/sj.leu.2404319; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Okamoto Y, 2003, CANCER RES, V63, P4167; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Porcher C, 1999, DEVELOPMENT, V126, P4603; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tang T, 2002, J BIOL CHEM, V277, P18365, DOI 10.1074/jbc.M109812200; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WEFES I, 1995, P NATL ACAD SCI USA, V92, P4982, DOI 10.1073/pnas.92.11.4982; Wen J, 2005, J BIOL CHEM, V280, P12956, DOI 10.1074/jbc.M412721200; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Xu ZX, 2006, BIOCHEM J, V399, P297, DOI 10.1042/BJ20060873	71	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5338	5346		10.1074/jbc.M109.030296	http://dx.doi.org/10.1074/jbc.M109.030296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028976	Green Published, hybrid			2022-12-27	WOS:000275327200027
J	Parkhurst, CN; Zampieri, N; Chao, MV				Parkhurst, Christopher N.; Zampieri, Niccolo; Chao, Moses V.			Nuclear Localization of the p75 Neurotrophin Receptor Intracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; INHIBIT NEURITE OUTGROWTH; AFFINITY NGF RECEPTOR; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; CELL-DEATH; NOGO RECEPTOR; TRANSLOCATION	The p75 neurotrophin receptor, a member of the tumor necrosis factor superfamily of receptors, undergoes an alpha-secretase-mediated release of its extracellular domain, followed by a gamma-secretase-mediated intramembrane cleavage. Like amyloid precursor protein and Notch, gamma-secretase cleavage of the p75 receptor releases an intracellular domain (ICD). However, it has been experimentally challenging to determine the precise subcellular localization and functional consequences of the p75 ICD. Here, we utilized a nuclear translocation assay and biochemical fractionation approaches to follow the fate of the ICD. We found that the p75 ICD can translocate to the nucleus to activate a green fluorescent protein reporter gene. Furthermore, the p75 ICD was localized in nuclear fractions. Chromatin immunoprecipitation experiments indicated that nerve growth factor induced the association of endogenous p75 with the cyclin E-1 promoter. Expression of the p75 ICD resulted in modulation of gene expression from this locus. These results suggest that the p75 ICD generated by gamma-secretase cleavage is capable of modulating transcriptional events in the nucleus.	[Parkhurst, Christopher N.; Zampieri, Niccolo; Chao, Moses V.] NYU, Sch Med, Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Physiol & Neurobiol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Chao, MV (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	chao@saturn.med.nyu.edu		Zampieri, Niccolo/0000-0002-2228-9453; Chao, Moses/0000-0002-6969-3744	National Institutes of Health [AG025970]; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025970 (to M. V. C.).	Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Bengoechea TG, 2009, P NATL ACAD SCI USA, V106, P7870, DOI 10.1073/pnas.0901533106; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; FORNEROD M, 1997, CELL, V90, P1052; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Frade JM, 1996, NATURE, V383, P166; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2007, CELL STRESS CHAPERON, V12, P186, DOI 10.1379/CSC-264R.1; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Majdan M, 1997, J NEUROSCI, V17, P6988; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Podlesniy P, 2006, AM J PATHOL, V169, P119, DOI 10.2353/ajpath.2006.050787; Powell JC, 2009, J NEUROCHEM, V108, P216, DOI 10.1111/j.1471-4159.2008.05763.x; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Takahashi Y, 2000, GENE DEV, V14, P804; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang LM, 2008, PLOS BIOL, V6, P2496, DOI 10.1371/journal.pbio.0060289; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	49	56	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5361	5368		10.1074/jbc.M109.045054	http://dx.doi.org/10.1074/jbc.M109.045054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022966	hybrid, Green Published			2022-12-27	WOS:000275327200029
J	Andersen, JT; Daba, MB; Berntzen, G; Michaelsen, TE; Sandlie, I				Andersen, Jan Terje; Daba, Muluneh Bekele; Berntzen, Goril; Michaelsen, Terje E.; Sandlie, Inger			Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED RECEPTOR; CHRONIC HEPATITIS-C; FAMILIAL HYPERCATABOLIC HYPOPROTEINEMIA; GLUTATHIONE-S-TRANSFERASE; ALPHA FUSION PROTEIN; PH-DEPENDENT BINDING; SERUM HALF-LIFE; CRYSTAL-STRUCTURE; HUMAN IGG1; THERAPEUTIC ANTIBODIES	The neonatal Fc receptor (FcRn) regulates the serum half-life of both IgG and albumin through a pH-dependent mechanism that involves salvage from intracellular degradation. Therapeutics and diagnostics built on IgG, Fc, and albumin fusions are frequently evaluated in rodents regarding biodistribution and pharmacokinetics. Thus, it is important to address cross-species ligand reactivity with FcRn, because in vivo testing of such molecules is done in the presence of competing murine ligands, both in wild type (WT) and human FcRn (hFcRn) transgenic mice. Here, binding studies were performed in vitro using enzyme-linked immunosorbent assay and surface plasmon resonance with recombinant soluble forms of human (shFcRn(WT)) and mouse (smFcRn(WT)) receptors. No binding of albumin from either species was observed at physiological pH to either receptor. At acidic pH, a 100-fold difference in binding affinity was observed. Specifically, smFcRn(WT) bound human serum albumin with a K-D of similar to 90 mu M, whereas shFcRn(WT) bound mouse serum albumin with a K-D of 0.8 mu M. shFcRn(WT) ignored mouse IgG1, and smFcRn(WT) bound strongly to human IgG1. The latter pair also interacted at physiological pH with calculated affinity in the micromolar range. In all cases, binding of albumin and IgG from either species to both receptors were additive. Cross-species albumin binding differences could partly be explained by non-conserved amino acids found within the alpha 2-domain of the receptor. Such distinct cross-species FcRn binding differences must be taken into consideration when IgG- and albumin-based therapeutics and diagnostics are evaluated in rodents for their pharmacokinetics.	[Andersen, Jan Terje; Daba, Muluneh Bekele; Berntzen, Goril; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, N-0371 Oslo, Norway; [Andersen, Jan Terje; Daba, Muluneh Bekele; Berntzen, Goril; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0371 Oslo, Norway; [Michaelsen, Terje E.] Univ Oslo, Inst Pharm, N-0371 Oslo, Norway; [Michaelsen, Terje E.] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Andersen, JT (corresponding author), Univ Oslo, Dept Mol Biosci, POB 1041, N-0371 Oslo, Norway.	janta@imbv.uio.no; sandlie@imbv.uio.no	Andersen, Jan Terje/AAB-6209-2020	Michaelsen, Terje Einar/0000-0001-8877-8519; Andersen, Jan Terje/0000-0003-1710-1628	Steering Board for Research in Molecular Biology; Biotechnology and Bioinformatics at the University of Oslo; Norwegian Research Council [179573]; Norwegian Cancer Society [B95078]	Steering Board for Research in Molecular Biology; Biotechnology and Bioinformatics at the University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics at the University of Oslo (to J. T. A.), The Norwegian Research Council (Grant 179573), and the Norwegian Cancer Society (Grant B95078).	Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Bain VG, 2006, J HEPATOL, V44, P671, DOI 10.1016/j.jhep.2005.12.011; Balan V, 2006, ANTIVIR THER, V11, P35; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cox GN, 2004, EXP HEMATOL, V32, P441, DOI 10.1016/j.exphem.2004.01.012; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; ESUMI H, 1979, BIOCHEM BIOPH RES CO, V87, P1191, DOI 10.1016/S0006-291X(79)80033-9; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Kaplan W, 1997, PROTEIN SCI, V6, P399; Kenanova V, 2005, CANCER RES, V65, P622; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; MACKENZIE N, 1984, IMMUNOL TODAY, V5, P364, DOI 10.1016/0167-5699(84)90080-X; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Medesan C, 1997, J IMMUNOL, V158, P2211; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Norderhaug L, 1997, J IMMUNOL METHODS, V204, P77, DOI 10.1016/S0022-1759(97)00034-3; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; WALDMANN TA, 1990, J CLIN INVEST, V86, P2093, DOI 10.1172/JCI114947; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wunder A, 2003, J IMMUNOL, V170, P4793, DOI 10.4049/jimmunol.170.9.4793; Yazaki PJ, 2008, NUCL MED BIOL, V35, P151, DOI 10.1016/j.nucmedbio.2007.10.010; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014; Zhu XP, 2002, BIOCHEM J, V367, P703, DOI 10.1042/BJ20020200	58	134	151	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4826	4836		10.1074/jbc.M109.081828	http://dx.doi.org/10.1074/jbc.M109.081828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018855	hybrid, Green Published			2022-12-27	WOS:000275274800061
J	Maritzen, T; Schmidt, MR; Kukhtina, V; Higman, VA; Strauss, H; Volkmer, R; Oschkinat, H; Dotti, CG; Haucke, V				Maritzen, Tanja; Schmidt, Michael R.; Kukhtina, Viktoria; Higman, Victoria A.; Strauss, Holger; Volkmer, Rudolf; Oschkinat, Hartmut; Dotti, Carlos G.; Haucke, Volker			A Novel Subtype of AP-1-binding Motif within the Palmitoylated trans-Golgi Network/Endosomal Accessory Protein Gadkin/gamma-BAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EAR-BINDING MOTIF; CLATHRIN; MEMBRANE; AP-1; TRAFFICKING; COMPLEX; CELLS; ENTHOPROTIN; ENDOSOMES; DOMAINS	Membrane traffic between the trans-Golgi network (TGN) and endosomes is mediated in part by the assembly of clathrin-AP-1 adaptor complex-coated vesicles. This process involves multiple accessory proteins that directly bind to the ear domain of AP-1 gamma via degenerate peptide motifs that conform to the consensus sequence empty setG(P/D/E)(empty set/L/M) (with empty set being a large hydrophobic amino acid). Recently, gamma-BAR (hereafter referred to as Gadkin for reasons explained below) has been identified as a novel AP-1 recruitment factor involved in AP-1-dependent endosomal trafficking of lysosomal enzymes. How precisely Gadkin interacts with membranes and with AP-1 gamma has remained unclear. Here we show that Gadkin is an S-palmitoylated peripheral membrane protein that lacks stable tertiary structure. S-Palmitoylation is required for the recruitment of Gadkin to TGN/endosomal membranes but not for binding to AP-1. Furthermore, we identify a novel subtype of AP-1-binding motif within Gadkin that specifically associates with the gamma 1-adaptin ear domain. Mutational inactivation of this novel type of motif, either alone or in combination with three more conventional AP-1 gamma binding peptides, causes Gadkin to mislocalize to the plasma membrane and interferes with its ability to render AP-1 brefeldin A-resistant, indicating its physiological importance. Our studies thus unravel the molecular basis for Gadkin-mediated AP-1 recruitment to TGN/endosomal membranes and identify a novel subtype of the AP-1-binding motif.	[Maritzen, Tanja; Schmidt, Michael R.; Kukhtina, Viktoria; Haucke, Volker] Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, D-14195 Berlin, Germany; [Maritzen, Tanja; Schmidt, Michael R.; Kukhtina, Viktoria; Haucke, Volker] Charite Univ Med Berlin, D-14195 Berlin, Germany; [Higman, Victoria A.; Strauss, Holger; Oschkinat, Hartmut; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Dotti, Carlos G.] Univ Louvain, Sch Med, Mol & Dev Genet Program, Vlanders Inst Biotechnol, B-3000 Louvain, Belgium; [Dotti, Carlos G.] Univ Louvain, Sch Med, Dept Human Genet, B-3000 Louvain, Belgium; [Volkmer, Rudolf] Charite Univ Med Berlin, Inst Med Immunol, D-10115 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haucke, V (corresponding author), Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	volker.haucke@fu-berlin.de	Dotti, Carlos G/I-5533-2015; Higman, Victoria/H-3795-2011; Strauss, Holger Martin/I-8403-2012	Dotti, Carlos G/0000-0003-4052-1719; Higman, Victoria/0000-0002-3204-2665; Haucke, Volker/0000-0003-3119-6993; Volkmer, Rudolf/0000-0003-4710-1143; Oschkinat, Hartmut/0000-0002-4384-9544; Maritzen, Tanja/0000-0003-4993-0340	Deutsche Forschungsgemeinschaft (DFG) [HA2686/1-3, 1-4, SFB 449/TP A11]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG Grants HA2686/1-3 and 1-4 to V. H. and T. M.), SFB 449/TP A11 (to V. H.) and Z1 (to R. V.), and DFG Exc 257-Neurocure.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Dittie AS, 1996, J CELL BIOL, V132, P523, DOI 10.1083/jcb.132.4.523; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Neubrand VE, 2005, EMBO J, V24, P1122, DOI 10.1038/sj.emboj.7600600; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wasiak S, 2003, FEBS LETT, V555, P437, DOI 10.1016/S0014-5793(03)01299-7; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T	26	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4074	4086		10.1074/jbc.M109.049197	http://dx.doi.org/10.1074/jbc.M109.049197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965873	Green Published, hybrid			2022-12-27	WOS:000275254000060
J	Sakuma, R; Ohmine, S; Ikeda, Y				Sakuma, Ryuta; Ohmine, Seiga; Ikeda, Yasuhiro			Determinants for the Rhesus Monkey TRIM5 alpha-mediated Block of the Late Phase of HIV-1 Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-BOX 2; CYTOPLASMIC BODIES; RESTRICTION FACTOR; RETROVIRUS RESTRICTION; CAPSID-BINDING; OLD-WORLD; DOMAINS; ASSOCIATION; INFECTION	Rhesus monkey TRIM5 alpha (TRIM5 alpha rh) includes RING, B-box, coiled-coil, and B30.2(PRYSPRY) domains and blocks HIV-1 infection by targeting HIV-1 core through a B30.2(PRYSPRY) domain. Previously, we reported that TRIM5 alpha rh also blocks HIV-1 production in a B30.2(PRYSPRY)-independent manner. Efficient encapsidation of TRIM5 alpha rh, but not human TRIM5 alpha (TRIM5 alpha hu), in HIV-1 virus-like particles suggests the interaction between Gag and TRIM5 alpha rh during viral assembly. Here, we determined responsible regions for late restriction activity of TRIM5 alpha rh. The RING disruption, but not the replacement with human TRIM21 RING, ablated the efficient encapsidation and the late restriction, suggesting that a RING structure was essential for the late restriction and efficient interaction with HIV-1 Gag. The prominent cytoplasmic body formation of TRIM5 alpha rh, which depended on the coiled-coil domain and the ensuing linker 2 region, was not required for the encapsidation. Intriguingly, TRIM5 alpha rh coiled-coil domain mutants (M133T and/or T146A) showed impaired late restriction activity, despite the efficient encapsidation and cytoplasmic body formation. Our results suggest that the TRIM5 alpha rh-mediated late restriction involves at least two distinct activities as follows: (i) interaction with HIV-1 Gag polyprotein through the N-terminal, RING, and B-box 2 regions of a TRIM5 alpha rh monomer, and (ii) an effector function(s) that depends upon the coiled-coil and linker 2 domains of TRIM5 alpha rh. We speculate that the TRIM5 alpha rh coiled coil region recruits additional factor(s), such as other TRIM family proteins or a cellular protease, during the late restriction. RBCC domains of TRIM family proteins may play a role in sensing newly synthesized viral proteins as a part of innate immunity against viral infection.	[Sakuma, Ryuta; Ohmine, Seiga; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA	Mayo Clinic	Ikeda, Y (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu			National Institutes of Health [1R56AI074363-01A1]; Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI074363-01A1 (to Y.I.). This work was also supported by the Mayo Foundation (to Y.I.) and Siebens Ph. D. training fellowship (to S. O.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Diaz-Griffero F, 2006, VIROLOGY, V351, P404, DOI 10.1016/j.virol.2006.03.023; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Morner A, 1999, J VIROL, V73, P2343; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Richardson MW, 2008, J VIROL, V82, P11117, DOI 10.1128/JVI.01046-08; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sakuma R, 2008, NAT MED, V14, P236, DOI 10.1038/nm0308-236; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235	32	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3784	3793		10.1074/jbc.M109.059063	http://dx.doi.org/10.1074/jbc.M109.059063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951947	Green Published, hybrid			2022-12-27	WOS:000275254000031
J	Park, YK; Park, H				Park, Young-Kwon; Park, Hyunsung			Prevention of CCAAT/Enhancer-binding Protein beta DNA Binding by Hypoxia during Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; ACTIVATED RECEPTOR-GAMMA; STEM-CELL FUNCTION; ADIPOCYTE DIFFERENTIATION; C/EBP-BETA; INDUCIBLE FACTOR; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; DOWN-REGULATION; CYCLE ARREST	Upon exposure to adipogenesis-inducing hormones, confluent 3T3-L1 preadipocytes express C/EBP beta (CCAAT/enhancer binding protein beta). Early induced C/EBP beta is inactive but, after a lag period, acquires its DNA-binding capability by sequential phosphorylation. During this period, preadipocytes pass the G(1)/S checkpoint synchronously. Thr(188) of C/EBP beta is phosphorylated initially to prime the factor for subsequent phosphorylation at Ser(184) or Thr(179) by GSK3 beta, which translocates into the nuclei during the G(1)/S transition. Many events take place during the G(1)/S transition, including reduction in p27(Kip1) protein levels, retinoblastoma (Rb) phosphorylation, GSK3 beta nuclear translocation, and C/EBP beta binding to target promoters. During hypoxia, hypoxia-inducible factor-1 alpha (HIF-1 alpha) is stabilized, thus maintaining expression of p27(Kip1), which inhibits Rb phosphorylation. Even under normoxic conditions, constitutive expression of p27(Kip1) blocks the nuclear translocation of GSK3 beta and DNA binding capability of C/EBP beta. Hypoxia also blocks nuclear translocation of GSK3 beta and DNA binding capability of C/EBP beta in HIF-1 alpha knockdown 3T3-L1 cells that fail to induce p27(Kip1). Nonetheless, under hypoxia, these cells can block Rb phosphorylation and the G(1)/S transition. Altogether, these findings suggest that hypoxia prevents the nuclear translocation of GSK3 beta and the DNA binding capability of C/EBP beta by blocking the G(1)/S transition through HIF-1 alpha-dependent induction of p27(Kip1) and an HIF-1 alpha/p27-independent mechanism.	[Park, Young-Kwon; Park, Hyunsung] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Park, H (corresponding author), Univ Seoul, Dept Life Sci, Siripdae Gil 13, Seoul 130743, South Korea.	hspark@uos.ac.kr		Park, Young-Kwon/0000-0002-3473-7233	Korea Healthcare Technology RD Project [A090616]; Seoul Science Fellowship	Korea Healthcare Technology RD Project; Seoul Science Fellowship	This work was supported by Korea Healthcare Technology R&D Project Grant A090616 (to H.P.).; Supported by a Seoul Science Fellowship.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Choi SM, 2006, J BIOL CHEM, V281, P34056, DOI 10.1074/jbc.M603913200; Cole KA, 2004, AM J PHYSIOL-CELL PH, V286, pC349, DOI 10.1152/ajpcell.00255.2003; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hackenbeck T, 2009, CELL CYCLE, V8, P1386, DOI 10.4161/cc.8.9.8306; Hammer S, 2007, CELL CYCLE, V6, P1919, DOI 10.4161/cc.6.15.4515; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Krtolica A, 1998, ONCOGENE, V17, P2295, DOI 10.1038/sj.onc.1202159; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Okada M, 2009, BIOCHEM BIOPH RES CO, V379, P249, DOI 10.1016/j.bbrc.2008.12.069; OLASHAW N, 2002, SCI STKE, pRE7; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; PIWIENPILIPUK G, 2003, J BIOL CHEM, V278, P35668; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yim S, 2004, BIOCHEM BIOPH RES CO, V322, P9, DOI 10.1016/j.bbrc.2004.07.072; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	53	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3289	3299		10.1074/jbc.M109.059212	http://dx.doi.org/10.1074/jbc.M109.059212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940121	Green Published, hybrid			2022-12-27	WOS:000273829000044
J	Pieslinger, AM; Hoepflinger, MC; Tenhaken, R				Pieslinger, Anja Maria; Hoepflinger, Marion Christine; Tenhaken, Raimund			Cloning of Glucuronokinase from Arabidopsis thaliana, the Last Missing Enzyme of the myo-Inositol Oxygenase Pathway to Nucleotide Sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCURONATE 4-EPIMERASE; L-ARABINOSE; D-XYLOSE; FUNCTIONAL CLONING; DEFICIENT MUTANT; GHMP KINASE; GENE FAMILY; D-GALACTOSE; CELL-WALLS; BIOSYNTHESIS	Nucleotide sugars are building blocks for carbohydrate polymers in plant cell walls. They are synthesized from sugar-1-phosphates or epimerized as nucleotide sugars. The main precursor for primary cell walls is UDP-glucuronic acid, which can be synthesized via two independent pathways. One starts with the ring cleavage of myo-inositol into glucuronic acid, which requires a glucuronokinase and a pyrophosphorylase for activation into UDP-glucuronate. Here we report on the purification of glucuronokinase from Lilium pollen. A 40-kDa protein was purified combining six chromatographic steps and peptides were de novo sequenced. This allowed the cloning of the gene from Arabidopsis thaliana and the expression of the recombinant protein in Escherichia coli for biochemical characterization. Glucuronokinase is a novel member of the GHMP-kinase superfamily having an unique substrate specificity for D-glucuronic acid with a K-m of 0.7 mM. It requires ATP as phosphate donor (K-m 0.56 mM). In Arabidopsis, the gene is expressed in all plant tissues with a preference for pollen. Genes for glucuronokinase are present in (all) plants, some algae, and a few bacteria as well as in some lower animals.	[Pieslinger, Anja Maria; Hoepflinger, Marion Christine; Tenhaken, Raimund] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria	Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Dept Cell Biol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019	Tenhaken, Raimund/0000-0002-6764-4826	German Research Foundation; Austrian Science Fund [FWF P20297-B16]; Austrian Science Fund (FWF) [P 20297] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants of the German Research Foundation (Deutsche Forschungsgemeinschaft, Bonn) and Austrian Science Fund Grant FWF P20297-B16 (Vienna).	ANDERSON RL, 1962, J BIOL CHEM, V237, P1029; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; BORK P, 1993, PROTEIN SCI, V2, P31; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; CHAN PH, 1975, ANAL BIOCHEM, V64, P372, DOI 10.1016/0003-2697(75)90445-5; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Davey MW, 1999, PLANT PHYSIOL, V121, P535, DOI 10.1104/pp.121.2.535; DICKINSON DB, 1982, PHYTOCHEMISTRY, V21, P843, DOI 10.1016/0031-9422(82)80076-9; DOLEZAL O, 1991, PLANT PHYSIOL, V96, P1255, DOI 10.1104/pp.96.4.1255; DYBALLA N, 2008, LABORJOURNAL, V4, P44; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; FEINGOLD DS, 1982, ENCY PLANT PHYSL; FEINGOLD DS, 1980, BIOCH PLANTS; GIBEAUT DM, 1994, FASEB J, V8, P904, DOI 10.1096/fasebj.8.12.8088456; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Hinterberg B, 2002, PLANT PHYSIOL BIOCH, V40, P1011, DOI 10.1016/S0981-9428(02)01465-1; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kaplan CP, 1997, PLANT MOL BIOL, V34, P497, DOI 10.1023/A:1005816104743; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; KROH M, 1970, PLANT PHYSIOL, V45, P92, DOI 10.1104/pp.45.1.92; LEIBOWITZ MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P559, DOI 10.1016/0003-9861(77)90144-8; LOEWUS FA, 1962, P NATL ACAD SCI USA, V48, P421, DOI 10.1073/pnas.48.3.421; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; NEUFELD EF, 1961, J BIOL CHEM, V236, P3102; NEUFELD EF, 1960, J BIOL CHEM, V235, P906; Pieslinger AM, 2009, ANAL BIOCHEM, V388, P254, DOI 10.1016/j.ab.2009.03.002; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Schneider S, 2006, PLANT PHYSIOL, V141, P565, DOI 10.1104/pp.106.077123; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Sherson S, 1999, PLANT MOL BIOL, V39, P1003, DOI 10.1023/A:1006181908753; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Usadel B, 2004, FEBS LETT, V569, P327, DOI 10.1016/j.febslet.2004.06.005; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	40	31	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2902	10.1074/jbc.M109.069369	http://dx.doi.org/10.1074/jbc.M109.069369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19951951	Green Published, hybrid			2022-12-27	WOS:000273829000004
J	Tseng, IC; Xu, H; Chou, FP; Li, G; Vazzano, AP; Kao, JPY; Johnson, MD; Lin, CY				Tseng, I-Chu; Xu, Han; Chou, Feng-Pai; Li, Gong; Vazzano, Alexander P.; Kao, Joseph P. Y.; Johnson, Michael D.; Lin, Chen-Yong			Matriptase Activation, an Early Cellular Response to Acidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE; EPITHELIAL-CELLS; NA+/H+ EXCHANGER; INTRACELLULAR PH; TUMOR INVASION; IN-VITRO; INHIBITOR; CLONING	Extracellular acidosis often rapidly causes intracellular acidification, alters ion channel activities, and activates G protein-coupled receptors. In this report, we demonstrated a novel cellular response to acidosis: induction of the zymogen activation of matriptase. Acid-induced matriptase activation is ubiquitous among epithelial and carcinoma cells and is characterized by rapid onset, fast kinetics, and the magnitude of activation seen. Trace amounts of activated matriptase can be detected 1 min after cells are exposed to pH 6.0 buffer, and the vast majority of latent matriptase within the cells is converted to activated matriptase within 20 min. Matriptase activation may be a direct response to proton exposure because acid-induced matriptase activation also occurs in an in vitro, cell-free setting in which intracellular signaling molecules and ion channel activities are largely absent. Acid-induced matriptase activation takes place both on the cell surface and inside the cells, likely due to the parallel intracellular acidification that activates intracellular matriptase. Following matriptase activation, the active enzyme is immediately inhibited by binding to hepatocyte growth factor activator inhibitor 1, resulting in stable matriptase-hepatocyte growth factor activator inhibitor 1 complexes that are rapidly secreted. As an early response to acidosis, matriptase activation can also be induced by perturbation of intracellular pH homeostasis by 5-(N-methyl-N-isobutyl)-amiloride and 5-(N-ethyl-Nisopropyl)-amiloride, both of which inhibit Na+/H+ exchangers, and diisothiocyanostilbene-2,2'-disulfonic acid, which can inhibit other acid-base ion channels. This study uncovers a novel mechanism regulating proteolysis in epithelial and carcinoma cells, and also demonstrates that a likely function of matriptase is as an early response to acidosis.	[Tseng, I-Chu; Xu, Han; Chou, Feng-Pai; Vazzano, Alexander P.; Lin, Chen-Yong] Univ Maryland, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Li, Gong; Kao, Joseph P. Y.] Univ Maryland, Inst Biotechnol, Ctr Biomed Engn & Technol, Ctr Med Biotechnol, Baltimore, MD 21201 USA; [Johnson, Michael D.] Georgetown Univ, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20057 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Georgetown University	Lin, CY (corresponding author), BRB 10-027,655 W Baltimore St, Baltimore, MD 21201 USA.	cylin@som.umaryland.edu	Tseng, I-Chu/C-1936-2013; Feng-Pai, Chou/AGS-4250-2022	Tseng, I-Chu/0000-0001-8522-6524; johnson, Michael/0000-0001-6260-7586; Kao, Joseph/0000-0002-8875-2180	National Institutes of Health [R01CA096851, R01CA104944]; Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE [R01CA123223, R01CA096851, R01CA104944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA096851 and R01CA104944 (to C.Y.L.) and the Maryland Cigarette Restitution Fund Program.	Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Bernardo AA, 1999, J CLIN INVEST, V104, P195, DOI 10.1172/JCI5344; Bertog M, 1999, J PHYSIOL-LONDON, V521, P3, DOI 10.1111/j.1469-7793.1999.00003.x; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; CHERNEW I, 1962, J CLIN INVEST, V41, P1945, DOI 10.1172/JCI104652; Cox T, 1997, J EXP BIOL, V200, P3055; Drummond HA, 2008, HYPERTENSION, V51, P1265, DOI 10.1161/HYPERTENSIONAHA.107.093401; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; Hachem JP, 2003, J INVEST DERMATOL, V121, P345, DOI 10.1046/j.1523-1747.2003.12365.x; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Hunter RC, 2005, APPL ENVIRON MICROB, V71, P2501, DOI 10.1128/AEM.71.5.2501-2510.2005; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; KORTING HC, 1990, ACTA DERM-VENEREOL, V70, P429; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Marcotte N, 2005, J PHYS CHEM B, V109, P11819, DOI 10.1021/jp0510138; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Mauro T, 1998, ARCH DERMATOL RES, V290, P215, DOI 10.1007/s004030050293; MUALLEM S, 1990, J BIOL CHEM, V265, P12813; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Press AG, 1998, ALIMENT PHARM THER, V12, P673; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Soleimani M, 2001, J MEMBRANE BIOL, V183, P71, DOI 10.1007/s00232-001-0055-8; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; TAGGART M, 1994, J PHYSIOL-LONDON, V475, P285, DOI 10.1113/jphysiol.1994.sp020069; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Taylor CJ, 2006, J PHYSIOL-LONDON, V576, P769, DOI 10.1113/jphysiol.2006.117374; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009	58	59	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3261	3270		10.1074/jbc.M109.055640	http://dx.doi.org/10.1074/jbc.M109.055640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940125	Green Published, hybrid			2022-12-27	WOS:000273829000041
J	Broglie, P; Matsumoto, K; Akira, S; Brautigan, DL; Ninomiya-Tsuji, J				Broglie, Peter; Matsumoto, Kunihiro; Akira, Shizuo; Brautigan, David L.; Ninomiya-Tsuji, Jun			Transforming Growth Factor beta-activated Kinase 1 (TAK1) Kinase Adaptor, TAK1-binding Protein 2, Plays Dual Roles in TAK1 Signaling by Recruiting Both an Activator and an Inhibitor of TAK1 Kinase in Tumor Necrosis Factor Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TNF-ALPHA; POLYUBIQUITIN CHAINS; CELL-DEATH; TAB2; IL-1; UBIQUITIN; IKK; APOPTOSIS; COMPLEX	Transforming growth factor beta-activated kinase 1 (TAK1) kinase is an indispensable signaling intermediate in tumor necrosis factor (TNF), interleukin 1, and Toll-like receptor signaling pathways. TAK1-binding protein 2 (TAB2) and its closely related protein, TAB3, are binding partners of TAK1 and have previously been identified as adaptors of TAK1 that recruit TAK1 to a TNF receptor signaling complex. TAB2 and TAB3 redundantly mediate activation of TAK1. In this study, we investigated the role of TAB2 by analyzing fibroblasts having targeted deletion of the tab2 gene. In TAB2-deficient fibroblasts, TAK1 was associated with TAB3 and was activated following TNF stimulation. However, TAB2-deficient fibroblasts displayed a significantly prolonged activation of TAK1 compared with wild type control cells. This suggests that TAB2 mediates deactivation of TAK1. We found that a TAK1-negative regulator, protein phosphatase 6 (PP6), was recruited to the TAK1 complex in wild type but not in TAB2-deficient fibroblasts. Furthermore, we demonstrated that both PP6 and TAB2 interacted with the polyubiquitin chains and this interaction mediated the assembly with TAK1. Our results indicate that TAB2 not only activates TAK1 but also plays an essential role in the deactivation of TAK1 by recruiting PP6 through a polyubiquitin chain-dependent mechanism.	[Broglie, Peter; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of North Carolina; North Carolina State University; Nagoya University; Osaka University; University of Virginia	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	jun_tsuji@ncsu.edu	Akira, Shizuo/C-3134-2009	Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084406, R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068812 (to J.N.-T.).	Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zabrocki P, 2002, MOL MICROBIOL, V43, P835, DOI 10.1046/j.1365-2958.2002.02786.x	37	53	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2333	2339		10.1074/jbc.M109.090522	http://dx.doi.org/10.1074/jbc.M109.090522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19955178	hybrid, Green Published			2022-12-27	WOS:000273697800013
J	Xiong, SQ; Salazar, G; San Martin, A; Ahmad, M; Patrushev, N; Hilenski, L; Nazarewicz, RR; Ma, MH; Ushio-Fukai, M; Alexander, RW				Xiong, Shiqin; Salazar, Gloria; San Martin, Alejandra; Ahmad, Mushtaq; Patrushev, Nikolay; Hilenski, Lula; Nazarewicz, Rafal Robert; Ma, Minhui; Ushio-Fukai, Masuko; Alexander, R. Wayne			PGC-1 alpha Serine 570 Phosphorylation and GCN5-mediated Acetylation by Angiotensin II Drive Catalase Down-regulation and Vascular Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ACTIVATED PROTEIN-KINASE; SENSITIVE SIGNALING PATHWAYS; INDUCED AKT ACTIVATION; ENERGY-METABOLISM; OXIDATIVE STRESS; CARDIOMYOCYTE HYPERTROPHY; GAMMA COACTIVATOR-1; CARDIAC-HYPERTROPHY	Angiotensin II (Ang II) is a pleuripotential hormone that is important in the pathophysiology of multiple conditions including aging, cardiovascular and renal diseases, and insulin resistance. Reactive oxygen species (ROS) are important mediators of Ang II-induced signaling generally and have a well defined role in vascular hypertrophy, which is inhibited by overexpression of catalase, inferring a specific role of H2O2. The molecular mechanisms are understood incompletely. The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a key regulator of energy metabolism and ROS-scavenging enzymes including catalase. We show that Ang II stimulates Akt-dependent PGC-1 alpha serine 570 phosphorylation, which is required for the binding of the histone acetyltransferase GCN5 (general control nonderepressible 5) to PGC-1 alpha and for its lysine acetylation. These sequential post-translational modifications suppress PGC-1 alpha activity and prevent its binding to the catalase promoter through the forkhead box O1 transcription factor, thus decreasing catalase expression. We demonstrate that overexpression of the phosphorylation-defective mutant PGC-1 alpha (S570A) prevents Ang II-induced increases in H2O2 levels and hypertrophy ([H-3]leucine incorporation). Knockdown of PGC-1 alpha by small interfering RNA promotes basal and Ang II-stimulated ROS and hypertrophy, which is reversed by polyethylene glycol-conjugated catalase. Thus, endogenous PGC-1 alpha is a negative regulator of vascular hypertrophy by up-regulating catalase expression and thus reducing ROS levels. We provide novel mechanistic insights by which Ang II may mediate its ROS-dependent pathophysiologic effects on multiple cardiometabolic diseases.	[Alexander, R. Wayne] Emory Univ Hosp, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Alexander, R. Wayne] Emory Univ, Sch Med, Emory Univ Hosp, Atlanta, GA 30322 USA; [Ushio-Fukai, Masuko] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	Emory University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, RW (corresponding author), Emory Univ Hosp, Div Cardiol, Dept Med, Suite H-153,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	ralexan@emory.edu	San Martin, Alejandra/HDN-0012-2022	San Martin, Alejandra/0000-0002-4620-1591	National Institutes of Health [UO1 HL80711, HL60728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077524, R01HL060728, U01HL080711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1 HL80711 and HL60728.	Anilkumar N, 2009, FRONT BIOSCI-LANDMRK, V14, P3168, DOI 10.2741/3443; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Ferrario CM, 2002, AM J HYPERTENS, V15, p9S, DOI 10.1016/S0895-7061(01)02274-9; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hoo WS, 2004, CYTOM PART A, V58A, P140, DOI 10.1002/cyto.a.10097; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim EJ, 2008, YONSEI MED J, V49, P811, DOI 10.3349/ymj.2008.49.5.811; Kim MJ, 2008, MOL CANCER RES, V6, P1872, DOI 10.1158/1541-7786.MCR-08-0084; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lapante MA, 2005, FREE RADICAL BIO MED, V38, P589, DOI 10.1016/j.freeradbiomed.2004.11.026; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763; Li F, 2005, J PHARMACOL EXP THER, V312, P1043, DOI 10.1124/jpet.104.076588; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Rocic P, 2003, J BIOL CHEM, V278, P36973, DOI 10.1074/jbc.M302099200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953; Wu R, 2005, HYPERTENSION, V45, P1139, DOI 10.1161/01.HYP.0000164572.92049.29; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhang Y, 2005, HYPERTENSION, V46, P732, DOI 10.1161/01.HYP.0000182660.74266.6d	52	65	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2474	2487		10.1074/jbc.M109.065235	http://dx.doi.org/10.1074/jbc.M109.065235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940161	Green Published, hybrid			2022-12-27	WOS:000273697800026
J	Sethi, MK; Buettner, FFR; Krylov, VB; Takeuchi, H; Nifantiev, NE; Haltiwanger, RS; Gerardy-Schahn, R; Bakker, H				Sethi, Maya K.; Buettner, Falk F. R.; Krylov, Vadim B.; Takeuchi, Hideyuki; Nifantiev, Nikolay E.; Haltiwanger, Robert S.; Gerardy-Schahn, Rita; Bakker, Hans			Identification of Glycosyltransferase 8 Family Members as Xylosyltransferases Acting on O-Glucosylated Notch Epidermal Growth Factor Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LINE HEPG2; PROTEIN O-FUCOSYL-TRANSFERASE-1; LIGAND-BINDING; MODIFIES NOTCH; FRINGE; DOMAIN; GLUCOSYLTRANSFERASE; GLYCOSYLATION; BIOSYNTHESIS; SPECIFICITY	The epidermal growth factor repeats of the Notch receptor are extensively glycosylated with three different O-glycans. O-Fucosylation and elongation by the glycosyltransferase Fringe have been well studied and shown to be essential for proper Notch signaling. In contrast, biosynthesis of O-glucose and O-N-acetylglucosamine is less well understood. Recently, the isolation of the Drosophila mutant rumi has shown that absence of O-glucose impairs Notch function. O-Glucose is further extended by two contiguous alpha 1,3-linked xylose residues. We have identified two enzymes of the human glycosyltransferase 8 family, now named GXYLT1 and GXYLT2 (glucoside xylosyltransferase), as UDP-D-xylose:beta D-glucoside alpha 1,3-D-xylosyltransferases adding the first xylose. The enzymes are specific for beta-glucose-terminating acceptors and UDP-xylose as donor substrate. Generation of the alpha 1,3-linkage was confirmed by nuclear magnetic resonance. Activity on a natural acceptor could be shown by in vitro xylosylation of a Notch fragment expressed in a UDP-xylose-deficient cell line and in vivo by co-expression of the enzymes and the Notch fragment in insect cells followed by mass spectrometric analysis of peptide fragments.	[Sethi, Maya K.; Buettner, Falk F. R.; Gerardy-Schahn, Rita; Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany; [Buettner, Falk F. R.] Univ Vet Med Hannover, Dept Infect Dis, Inst Microbiol, D-30173 Hannover, Germany; [Krylov, Vadim B.; Nifantiev, Nikolay E.] Russian Acad Sci, Lab Glycoconjugate Chem, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bakker, H (corresponding author), Hannover Med Sch, Dept Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/AAA-1623-2020; Nifantiev, Nikolay E/O-6579-2015; Takeuchi, Hideyuki/AAZ-9210-2020; Krylov, Vadim B./AAE-9936-2022; Bakker, Hans/A-1787-2017; Krylov, Vadim B./AES-8666-2022	Bakker, Hans/0000-0002-1364-9154; Nifantiev, Nikolay E/0000-0002-0727-4050; Krylov, Vadim B./0000-0001-9477-4610; Bakker, Hans/0000-0002-1364-9154; Krylov, Vadim B./0000-0001-9477-4610	National Institutes of Health [GM061126]; Deutsche Forschungsgemeinschaft (DFG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grown in Insect-Xpress medium (Lonza) by baculovirus Grant GM061126 (to R. S. H.). This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) (to R. G.-S.) for the Junior Research Group "Stem Cell Glycans" established under the roof of REBIRTH, a DFG cluster of Excellence at Hannover Medical School.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; BJOERN S, 1991, J BIOL CHEM, V266, P11051; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; HASE S, 1990, J BIOL CHEM, V265, P1858; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Krylov V, 2007, SYNTHESIS-STUTTGART, P3147, DOI 10.1055/s-2007-990784; Luther KB, 2009, INT J BIOCHEM CELL B, V41, P1011, DOI 10.1016/j.biocel.2008.10.001; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Omichi K, 1997, EUR J BIOCHEM, V245, P143, DOI 10.1111/j.1432-1033.1997.00143.x; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200	29	79	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1582	1586		10.1074/jbc.C109.065409	http://dx.doi.org/10.1074/jbc.C109.065409			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19940119	Green Published, hybrid			2022-12-27	WOS:000273429100003
J	Luttichau, HR				Luttichau, Hans R.			The Cytomegalovirus UL146 Gene Product vCXCL1 Targets Both CXCR1 and CXCR2 as an Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; HUMAN ENDOTHELIAL-CELLS; SEQUENCE VARIABILITY; FUNCTIONAL EXPRESSION; CHEMOKINE RECEPTORS; GRO-ALPHA; VMIP-II; INTERLEUKIN-8; IL-8; BROAD	Large DNA viruses, such as herpesvirus and poxvirus, encode proteins that target and exploit the chemokine system of their host. UL146 and UL147 in the cytomegalovirus (CMV) genome encode the two CXC chemokines vCXCL1 and vCXCL2. In this study, vCXCL1 was probed against a panel of the 18 classified human chemokine receptors. In calcium mobilization assays vCXCL1 acted as an agonist on both CXCR1 and CXCR2 but did not activate or block any of the other 16 chemokine receptors. vCXCL1 was characterized and compared with CXCL1/GRO alpha, CXCL2/GRO beta, CXCL3/GRO gamma, CXCL5/ENA-78, CXCL6/GCP2, CXCL7/NAP-2 and CXCL8/IL-8 in competition binding, calcium mobilization, inositol triphosphate turnover, and chemotaxis assays using CXCR1- and CXCR2-expressing Chinese hamster ovary, 300.19, COS7, and L1.2 cells. The affinities of vCXCL1 for the CXCR1 and CXCR2 receptors were 44 and 5.6 nM, respectively, as determined in competition binding against radioactively labeled CXCL8. In calcium mobilization, phosphatidylinositol turnover, and chemotaxis assays, vCXCL1 acted as a highly efficacious activator of both receptors, with a rather low potency for the CXCR1 receptor but comparable with CXCL5 and CXCL7. It is suggested that CMV uses the UL146 gene product expressed in infected endothelial cells to attract neutrophils by activating their CXCR1 and CXCR2 receptors, whereby neutrophils can act as carriers of the virus to uninfected endothelial cells. In that way a lasting pool of CMV-infected endothelial cells could be maintained.	[Luttichau, Hans R.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Luttichau, Hans R.] Univ Copenhagen, Herlev Hosp, Dept Med O107, Infect Dis Unit, DK-2730 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Luttichau, HR (corresponding author), Univ Copenhagen, Panum Inst 18 6, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	LUTTICHAU@sund.ku.dk		Luttichau, Hans Rudolf/0000-0002-5428-4075	Danish Medical Research Council; Foundation of A. P. Moller and Chastine McKinney Moller; Foundation of Arvid Nilsson; Augustinus Foundation; Beckett-Foundation; Foundation of Bent Bogh and Wife; Foundation of Carl and Ellen Hertz; Foundation of Christian Larsen and Ellen Larsen; Foundation of Frode V. Nyegaard and Wife; Foundation of E. Danielsen and Wife; Foundation of Einar Hansen and Wife; Foundation of Michael Hermann Nielsen; Foundation of Else and Mogens Wedell-Wedellsborg; Foundation of Karl G Andersen; Harboe-Foundation; Foundation of Holger Hjortenberg and Wife; Illum Foundation; Foundation of Johan Boserup and Lise Boserup; Foundation of Niels Hansen and Wife; Foundation of Werner Richter and Wife; Foundation of Ove William Buhl Olesen and Wife; Foundation of Meta and HAkon Bagger; Foundation of Jakob Madsen and Wife	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Foundation of A. P. Moller and Chastine McKinney Moller; Foundation of Arvid Nilsson; Augustinus Foundation; Beckett-Foundation; Foundation of Bent Bogh and Wife; Foundation of Carl and Ellen Hertz; Foundation of Christian Larsen and Ellen Larsen; Foundation of Frode V. Nyegaard and Wife; Foundation of E. Danielsen and Wife; Foundation of Einar Hansen and Wife; Foundation of Michael Hermann Nielsen; Foundation of Else and Mogens Wedell-Wedellsborg; Foundation of Karl G Andersen; Harboe-Foundation; Foundation of Holger Hjortenberg and Wife; Illum Foundation; Foundation of Johan Boserup and Lise Boserup; Foundation of Niels Hansen and Wife; Foundation of Werner Richter and Wife; Foundation of Ove William Buhl Olesen and Wife; Foundation of Meta and HAkon Bagger; Foundation of Jakob Madsen and Wife	This work was supported by grants from the Danish Medical Research Council, the Foundation of A. P. Moller and Chastine McKinney Moller, the Foundation of Arvid Nilsson, the Augustinus Foundation, the Beckett-Foundation, the Foundation of Bent Bogh and Wife, the Foundation of Carl and Ellen Hertz, the Foundation of Christian Larsen and Ellen Larsen, the Foundation of Frode V. Nyegaard and Wife, the Foundation of E. Danielsen and Wife, the Foundation of Einar Hansen and Wife, the Foundation of Michael Hermann Nielsen, the Foundation of Else and Mogens Wedell-Wedellsborg, the Foundation of Karl G Andersen, the Harboe-Foundation, the Foundation of Holger Hjortenberg and Wife, the Illum Foundation, the Foundation of Johan Boserup and Lise Boserup, the Foundation of Niels Hansen and Wife, the Foundation of Werner Richter and Wife, the Foundation of Ove William Buhl Olesen and Wife, the Foundation of Meta and HAkon Bagger, and the Foundation of Jakob Madsen and Wife.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; BenBaruch A, 1997, CYTOKINE, V9, P37, DOI 10.1006/cyto.1996.0133; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Coulin F, 1997, EUR J BIOCHEM, V248, P507, DOI 10.1111/j.1432-1033.1997.00507.x; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Dewin DR, 2006, J IMMUNOL, V176, P544, DOI 10.4049/jimmunol.176.1.544; Dong C, 2005, J IMMUNOL METHODS, V302, P136, DOI 10.1016/j.jim.2005.05.008; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Hassan-Walker AF, 2004, J MED VIROL, V74, P573, DOI 10.1002/jmv.20210; He R, 2006, INTERVIROLOGY, V49, P215, DOI 10.1159/000091468; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lindow M, 2003, TRENDS PHARMACOL SCI, V24, P126, DOI 10.1016/S0165-6147(03)00033-6; Liu Y, 1997, J IMMUNOL, V158, P604; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Lurain NS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-4; Luttichau HR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-50; Luttichau HR, 2007, J BIOL CHEM, V282, P17794, DOI 10.1074/jbc.M702001200; Luttichau HR, 2003, J BIOL CHEM, V278, P10928, DOI 10.1074/jbc.M211329200; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Luttichau HR, 2001, EUR J IMMUNOL, V31, P1217; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Osborne J, 1999, HUM IMMUNOL, V60, P921, DOI 10.1016/S0198-8859(99)00083-X; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; PETZELBAUER P, 1995, CYTOKINE, V7, P267, DOI 10.1006/cyto.1995.0031; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Rosenkilde MM, 2001, ONCOGENE, V20, P1582, DOI 10.1038/sj.onc.1204191; SCHONBECK U, 1995, J IMMUNOL, V154, P2375; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; SMITH MG, 1956, P SOC EXP BIOL MED, V92, P424, DOI 10.3181/00379727-92-22498; Stine J T, 1999, Chem Immunol, V72, P161, DOI 10.1159/000058732; Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948; Wolf M, 1998, EUR J IMMUNOL, V28, P164, DOI 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S; Wuyts A, 1998, EUR J BIOCHEM, V255, P67, DOI 10.1046/j.1432-1327.1998.2550067.x; Yang W, 1997, BIOCHEMISTRY-US, V36, P15193, DOI 10.1021/bi971594u	52	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9137	9146		10.1074/jbc.M109.002774	http://dx.doi.org/10.1074/jbc.M109.002774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20044480	Green Published, hybrid			2022-12-27	WOS:000275553700063
J	Sousa, KM; Villaescusa, JC; Cajanek, L; Ondr, JK; Castelo-Branco, G; Hofstra, W; Bryja, V; Palmberg, C; Bergman, T; Wainwright, B; Lang, RA; Arenas, E				Sousa, Kyle M.; Villaescusa, J. Carlos; Cajanek, Lukas; Ondr, Jennifer K.; Castelo-Branco, Goncalo; Hofstra, Wytske; Bryja, Vitezslav; Palmberg, Carina; Bergman, Tomas; Wainwright, Brandon; Lang, Richard A.; Arenas, Ernest			Wnt2 Regulates Progenitor Proliferation in the Developing Ventral Midbrain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; BETA-CATENIN; DOPAMINERGIC CELLS; DISHEVELLED PHOSPHORYLATION; INCREASES DIFFERENTIATION; NEURONAL DIFFERENTIATION; SIGNALING COMPONENTS; TARGETED DISRUPTION; INT-1 PROTOONCOGENE; MURINE INT-1	Wnts are secreted, lipidated proteins that regulate multiple aspects of brain development, including dopaminergic neuron development. In this study, we perform the first purification and signaling analysis of Wnt2 and define the function of Wnt2 in ventral midbrain precursor cultures, as well as in Wnt2-null mice in vivo. We found that purified Wnt2 induces the phosphorylation of both Lrp5/6 and Dvl-2/3, and activates beta-catenin in SN4741 dopaminergic cells. Moreover, purified Wnt2 increases progenitor proliferation, and the number of dopaminergic neurons in ventral midbrain precursor cultures. In agreement with these findings, analysis of the ventral midbrain of developing Wnt2-null mice revealed a decrease in progenitor proliferation and neurogenesis that lead to a decrease in the number of postmitotic precursors and dopaminergic neurons. Collectively, our observations identify Wnt2 as a novel regulator of dopaminergic progenitors and dopaminergic neuron development.	[Hofstra, Wytske; Bryja, Vitezslav; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; [Ondr, Jennifer K.; Lang, Richard A.] Childrens Hosp Res Fdn, Dev Biol Div, Cincinnati, OH 45229 USA; [Ondr, Jennifer K.; Lang, Richard A.] Childrens Hosp Res Fdn, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno 61107, Czech Republic; [Bryja, Vitezslav] Inst Biophys AS CR, Brno 61107, Czech Republic; [Palmberg, Carina; Bergman, Tomas] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 1, SE-17177 Stockholm, Sweden; [Sousa, Kyle M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wainwright, Brandon] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	Karolinska Institutet; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Karolinska Institutet; University of Michigan System; University of Michigan; University of Queensland	Arenas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Scheeles Vag 1,A1 2, S-17177 Stockholm, Sweden.	ernest.arenas@ki.se	Lang, Richard/E-5578-2011; Castelo-Branco, Gonçalo/B-1635-2009; Bryja, Vítězslav/P-4217-2019; Castelo-Branco, Goncalo/A-8357-2015; Castelo-Branco, Gonçalo/O-9162-2019; Bryja, Vít?zslav/H-1925-2014; Cajanek, Lukas/ABG-6559-2020; Arenas, Ernest/AAO-5231-2020	Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vítězslav/0000-0002-9136-5085; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vít?zslav/0000-0002-9136-5085; Cajanek, Lukas/0000-0003-2914-8589; Arenas, Ernest/0000-0003-0197-6577; Lang, Richard/0000-0002-5212-254X; Wainwright, Brandon/0000-0003-0406-2092; Villaescusa, J. Carlos/0000-0001-9456-9828	Swedish Foundation for Strategic Research; Swedish Research Council [VR2008:2811]; Norwegian Research Council; European Commission; Karolinska Institute; FEBS; Portuguese Fundacao para a Ciencia e Tecnologia; Calouste Gulbenkian Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Karolinska Institute(Karolinska Institutet); FEBS; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Calouste Gulbenkian Foundation	This work was supported in part by the Swedish Foundation for Strategic Research (INGVAR and CEDB), Swedish Research Council (VR2008:2811 and DBRM), Norwegian Research Council, European Commission (Euro-StemCell), and Karolinska Institute.; Supported by a FEBS Long-Term fellowship.; Supported by the Portuguese Fundacao para a Ciencia e Tecnologia, Karolinksa Institute, and the Calouste Gulbenkian Foundation. Present address: The Wellcome Trust/CRUK, Gurdon Inst., University of Cambridge, Cambridge CB2 1QN, UK.	Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Bellusci S, 1997, DEVELOPMENT, V124, P53; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743, DOI 10.1002/j.1460-2075.1988.tb03003.x; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	41	61	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7246	7253		10.1074/jbc.M109.079822	http://dx.doi.org/10.1074/jbc.M109.079822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20018874	hybrid, Green Published			2022-12-27	WOS:000275415600037
J	Deng, WY; de Hoog, CL; Yu, HB; Li, YL; Croxen, MA; Thomas, NA; Puente, JL; Foster, LJ; Finlay, BB				Deng, Wanyin; de Hoog, Carmen L.; Yu, Hong B.; Li, Yuling; Croxen, Matthew A.; Thomas, Nikhil A.; Puente, Jose L.; Foster, Leonard J.; Finlay, B. Brett			A Comprehensive Proteomic Analysis of the Type III Secretome of Citrobacter rodentium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; EFFECTOR PROTEIN; ENTEROCYTE EFFACEMENT; VIRULENCE FACTOR; IDENTIFICATION; SYSTEM; TRANSLOCATION; COLONIZATION; LOCUS; SPECIFICITY	Enteropathogenic Escherichia coli, enterohemorrhagic E. coli, and Citrobacter rodentium belong to the family of attaching and effacing (A/E) bacterial pathogens. They intimately attach to host intestinal epithelial cells, trigger the effacement of intestinal microvilli, and cause diarrheal disease. Central to their pathogenesis is a type III secretion system (T3SS) encoded by a pathogenicity island called the locus of enterocyte effacement (LEE). The T3SS is used to inject both LEE- and non-LEE-encoded effector proteins into the host cell, where these effectors modulate host signaling pathways and immune responses. Identifying the effectors and elucidating their functions are central to understanding the molecular pathogenesis of these pathogens. Here we analyzed the type III secretome of C. rodentium using the highly sensitive and quantitative SILAC (stable isotope labeling with amino acids in cell culture)-based mass spectrometry. This approach not only confirmed nearly all known secreted proteins and effectors previously identified by conventional biochemical and proteomic techniques, but also identified several new secreted proteins. The T3SS-dependent secretion of these new proteins was validated, and five of them were translocated into cultured cells, representing new or additional effectors. Deletion mutants for genes encoding these effectors were generated in C. rodentium and tested in a murine infection model. This study comprehensively characterizes the type III secretome of C. rodentium, expands the repertoire of type III secreted proteins and effectors for the A/E pathogens, and demonstrates the simplicity and sensitivity of using SILAC-based quantitative proteomics as a tool for identifying substrates for protein secretion systems.	[Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Foster, Leonard J.; Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Thomas, Nikhil A.] Dalhousie Univ, Dept Microbiol & Immunol Med, Halifax, NS B3X 1H5, Canada; [Puente, Jose L.] Univ Nacl Autonoma Mexico, Dept Mol Microbiol, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico	University of British Columbia; University of British Columbia; University of British Columbia; Dalhousie University; Universidad Nacional Autonoma de Mexico	Finlay, BB (corresponding author), 301,2815 East Mall, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca		Thomas, Nikhil/0000-0003-3037-425X; Puente, Jose/0000-0002-8411-4974; Croxen, Matthew/0000-0002-9564-7952	Canadian Institutes of Health Research; Genome Canada/Genome BC; Howard Hughes Medical Institute; Canadian Institutes of Health Research/Canadian Association of Gastroenterology/Ferring Pharmaceuticals; Canadian Foundation for Innovation; British Columbia (BC) Knowledge Development Fund; Michael Smith Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Genome BC(Genome Canada); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research/Canadian Association of Gastroenterology/Ferring Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia (BC) Knowledge Development Fund; Michael Smith Foundation(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research grants, a Genome Canada/Genome BC through the PRoteomics for Emerging PAthogen REsponse project (to L.J.F. and B.B.F.), and a Howard Hughes Medical Institute operating grant (to B.B.F.).; <SUP>2</SUP>Supported by a Canadian Institutes of Health Research postdoctoral fellowship.; <SUP>3</SUP>Supported by a Canadian Institutes of Health Research/Canadian Association of Gastroenterology/Ferring Pharmaceuticals postdoctoral fellowship.; We thank Nikolay Stoynov for technical assistance, and Kristie Keeney and Stephanie Shames for critical reading of the manuscript. Infrastructure used in this project was funded by the Canadian Foundation for Innovation, the British Columbia (BC) Knowledge Development Fund, and the Michael Smith Foundation through the BC Proteomics Network.	Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Bulgin RR, 2009, CELL MICROBIOL, V11, P217, DOI 10.1111/j.1462-5822.2008.01248.x; Buss C, 2009, CELL MICROBIOL, V11, P661, DOI 10.1111/j.1462-5822.2009.01284.x; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dahan S, 2005, INFECT IMMUN, V73, P679, DOI 10.1128/IAI.73.2.679-686.2005; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Deng WY, 2003, MOL MICROBIOL, V48, P95, DOI 10.1046/j.1365-2958.2003.03429.x; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; LEVINE MM, 1978, LANCET, V1, P1119; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ogura Y, 2008, J BACTERIOL, V190, P6948, DOI 10.1128/JB.00625-08; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Thomas NA, 2007, J BIOL CHEM, V282, P29634, DOI 10.1074/jbc.M706019200; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Vlisidou I, 2006, FEMS MICROBIOL LETT, V263, P32, DOI 10.1111/j.1574-6968.2006.00410.x; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wilson RK, 2001, CELL MICROBIOL, V3, P753, DOI 10.1046/j.1462-5822.2001.00159.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	56	56	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6790	6800		10.1074/jbc.M109.086603	http://dx.doi.org/10.1074/jbc.M109.086603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20034934	Green Published, hybrid			2022-12-27	WOS:000275367500082
J	De Jonge, N; Hohlweg, W; Garcia-Pino, A; Respondek, M; Buts, L; Haesaerts, S; Lah, J; Zangger, K; Loris, R				De Jonge, Natalie; Hohlweg, Walter; Garcia-Pino, Abel; Respondek, Michal; Buts, Lieven; Haesaerts, Sarah; Lah, Jurij; Zangger, Klaus; Loris, Remy			Structural and Thermodynamic Characterization of Vibrio fischeri CcdB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PROTEIN-STRUCTURE; KILLER PROTEIN; DNA CLEAVAGE; GYRASE; ENERGETICS; BINDING; REJUVENATION; RECOGNITION; INDUCTION	CcdB(Vfi) from Vibrio fischeri is a member of the CcdB family of toxins that poison covalent gyrase-DNA complexes. In solution CcdB(Vfi) is a dimer that unfolds to the corresponding monomeric components in a two-state fashion. In the unfolded state, the monomer retains a partial secondary structure. This observation correlates well with the crystal and NMR structures of the protein, which show a dimer with a hydrophobic core crossing the dimer interface. In contrast to its F plasmid homologue, CcdB(Vfi) possesses a rigid dimer interface, and the apparent relative rotations of the two subunits are due to structural plasticity of the monomer. CcdB(Vfi) shows a number of non-conservative substitutions compared with the F plasmid protein in both the CcdA and the gyrase binding sites. Although variation in the CcdA interaction site likely determines toxin-antitoxin specificity, substitutions in the gyrase-interacting region may have more profound functional implications.	[De Jonge, Natalie; Garcia-Pino, Abel; Buts, Lieven; Haesaerts, Sarah; Loris, Remy] Vrije Univ Brussel, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Hohlweg, Walter; Respondek, Michal; Zangger, Klaus] Graz Univ, Inst Chem, A-8010 Graz, Austria; [Lah, Jurij] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	Vrije Universiteit Brussel; University of Graz; University of Ljubljana	Loris, R (corresponding author), Vrije Univ Brussel, Dept Mol & Cellular Interact, Pl Laan 2, B-1050 Brussels, Belgium.	Remy.Loris@VIB-VUB.be	Loris, Remy/GPG-0894-2022	Haesaerts, Sarah/0000-0003-3913-9125; Zangger, Klaus/0000-0003-1682-1594; Loris, Remy/0000-0002-8862-3338; Garcia-Pino, Abel/0000-0002-0634-0300	Vlaams Interuniversitair Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Ministry of Higher Education, Science and Technology; Agency for Research of Republic of Slovenia [P1-0201, J1-6653]; Instituut voor Wetenschap en Technologie; Belgian Federal Science Policy Office (DWTC); European Space Agency [AO2004]; FWO; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Vlaams Interuniversitair Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Ministry of Higher Education, Science and Technology; Agency for Research of Republic of Slovenia(Slovenian Research Agency - Slovenia); Instituut voor Wetenschap en Technologie; Belgian Federal Science Policy Office (DWTC)(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); FWO(FWO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Vlaams Interuniversitair Instituut voor Biotechnologie, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), and the Onderzoeksraad of the Vrije Universiteit Brussel. The work was also supported by the Ministry of Higher Education, Science and Technology and by the Agency for Research of Republic of Slovenia (Grants P1-0201 and J1-6653).; Recipient of a predoctoral grant from the Instituut voor Wetenschap en Technologie. Present address: arGEN-X BVBA, Technologiepark 30, 9052 Zwijnaarde, Belgium.; Supported by the Belgian Federal Science Policy Office (DWTC) and the European Space Agency in the context of Prodex project AO2004.; Recipient of a postdoctoral fellowship from the FWO.; Supported by the Austrian Science Foundation (Project 19902).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; BAHASSI EM, 1995, MOL MICROBIOL, V15, P1031, DOI 10.1111/j.1365-2958.1995.tb02278.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchlow SE, 1997, J MOL BIOL, V273, P826, DOI 10.1006/jmbi.1997.1357; Dao-Thi MH, 2000, J MOL BIOL, V299, P1373, DOI 10.1006/jmbi.2000.3815; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; De Jonge N, 2007, ACTA CRYSTALLOGR F, V63, P356, DOI 10.1107/S1744309107012092; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drobnak I, 2009, J MOL BIOL, V392, P63, DOI 10.1016/j.jmb.2009.05.086; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Ladbury J.E., 1998, BIOCALORIMETRY APPL; Lah J, 2005, J BIOL CHEM, V280, P17397, DOI 10.1074/jbc.M501128200; Lah J, 2003, J BIOL CHEM, V278, P14101, DOI 10.1074/jbc.M209855200; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Maki S, 1996, J MOL BIOL, V256, P473, DOI 10.1006/jmbi.1996.0102; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Oberer M, 1999, BIOL CHEM, V380, P1413, DOI 10.1515/BC.1999.181; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; PRESS WH, 1992, NUMERICAL RECIPES; Respondek M, 2009, BIOMOL NMR ASSIGN, V3, P145, DOI 10.1007/s12104-009-9161-9; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; SantosSierra S, 1997, FEMS MICROBIOL LETT, V152, P51, DOI 10.1016/S0378-1097(97)00177-8; Simic M, 2009, ACTA CHIM SLOV, V56, P139; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wilbaux M, 2007, J BACTERIOL, V189, P2712, DOI 10.1128/JB.01679-06; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305	51	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5606	5613		10.1074/jbc.M109.068429	http://dx.doi.org/10.1074/jbc.M109.068429			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19959472	Green Published, hybrid			2022-12-27	WOS:000275327200052
J	Nishimura, YV; Sekine, K; Chihama, K; Nakajima, K; Hoshino, M; Nabeshima, Y; Kawauchi, T				Nishimura, Yoshiaki V.; Sekine, Katsutoshi; Chihama, Kaori; Nakajima, Kazunori; Hoshino, Mikio; Nabeshima, Yo-ichi; Kawauchi, Takeshi			Dissecting the Factors Involved in the Locomotion Mode of Neuronal Migration in the Developing Cerebral Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RADIAL MIGRATION; RNA INTERFERENCE; GENE-TRANSFER; SAD KINASES; CDK5; PHOSPHORYLATION; BRAIN; ORGANIZATION; DOUBLECORTIN	Neuronal migration is essential for proper cortical layer formation and brain function, because migration defects result in neurological disorders such as mental retardation and epilepsy. Neuronal migration is divided into several contiguous steps: early phase (multipolar mode), locomotion mode, and terminal translocation mode. The locomotion mode covers most of the migration route and thereby is the main contributor to cortical layer formation. However, analysis of the molecular mechanisms regulating this mode is difficult due to the secondary effects of defects at the early phase of migration. In this study, we established an ex vivo chemical inhibitor screening, allowing us to directly analyze the locomotion mode of migration. Roscovitine and PP2, inhibitors for Cdk5 and Src family kinases, respectively, suppressed the locomotion mode of migration. In line with this, a small percentage of Cdk5- or Src family kinase (Fyn)-knockdown cells exhibited locomoting morphology but retarded migration, although the majority of cells were stalled at the early phase of migration. We also showed that rottlerin, widely used as a specific inhibitor for protein kinase C delta (PKC delta), suppressed the locomotion mode. Unexpectedly, however, the dominant-negative form as well as RNA interference for PKC delta hardly affected the locomotion, whereas they may disturb terminal translocation. In addition, we found JNK to be a potential downstream target of rottlerin. Taken together, our novel chemical inhibitor screening provides evidence that Cdk5 and Src family kinases regulate the locomotion mode of neuronal migration. It also uncovered roles for Fyn and PKC delta in the early and final phases of migration, respectively.	[Nishimura, Yoshiaki V.; Chihama, Kaori; Hoshino, Mikio; Nabeshima, Yo-ichi; Kawauchi, Takeshi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kawauchi, Takeshi] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; [Hoshino, Mikio] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo 1878502, Japan; [Kawauchi, Takeshi] JST, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Nabeshima, Yo-ichi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Kyoto University; Keio University; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Hoshino, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hoshino@ncnp.go.jp; kawauchi@sc.itc.keio.ac.jp	Nakajima, Kazunori/L-3396-2013; Kawauchi, Takeshi/L-4770-2013	Nakajima, Kazunori/0000-0003-1864-9425; Kawauchi, Takeshi/0000-0002-8650-4474				Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; Chen Y, 2005, J NEUROSCI, V25, P507, DOI 10.1523/JNEUROSCI.4089-04.2005; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; des Portes V, 1998, CELL, V92, P51; Fan JH, 2006, J INVEST DERMATOL, V126, P1233, DOI 10.1038/sj.jid.5700149; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jossin Y, 2003, J NEUROSCI, V23, P9953; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; LoTurco J, 2009, CEREB CORTEX, V19, pI120, DOI 10.1093/cercor/bhp033; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Miyata T, 2002, J NEUROSCI RES, V69, P861, DOI 10.1002/jnr.10335; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; SACHS CW, 1995, J BIOL CHEM, V270, P26639, DOI 10.1074/jbc.270.44.26639; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	66	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5878	5887		10.1074/jbc.M109.033761	http://dx.doi.org/10.1074/jbc.M109.033761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022952	Green Published, hybrid			2022-12-27	WOS:000275327200078
J	Windhorst, S; Fliegert, R; Blechner, C; Mollmann, K; Hosseini, Z; Gunther, T; Eiben, M; Chang, L; Lin, HY; Fanick, W; Schumacher, U; Brandt, B; Mayr, GW				Windhorst, Sabine; Fliegert, Ralf; Blechner, Christine; Moellmann, Katharina; Hosseini, Zara; Guenther, Thomas; Eiben, Maike; Chang, Lydia; Lin, Hong-Ying; Fanick, Werner; Schumacher, Udo; Brandt, Burkhard; Mayr, Georg W.			Inositol 1,4,5-Trisphosphate 3-Kinase-A Is a New Cell Motility-promoting Protein That Increases the Metastatic Potential of Tumor Cells by Two Functional Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ACTIN; EXPRESSION; MICE; REORGANIZATION; MIGRATION; ONCOGENE; GROWTH	Cellular migration is an essential prerequisite for metastatic dissemination of cancer cells. This study demonstrates that the neuron/testis-specific F-actin-targeted inositol 1,4,5-trisphosphate 3-kinase-A (ITPKA) is ectopically expressed in different human tumor cell lines and during tumor progression in the metastatic tumor model Balb-neuT. High expression of ITPKA increases invasive migration in vitro and metastasis in a xenograft SCID mouse model. Mechanistic studies show that ITPKA promotes migration of tumor cells by two different mechanisms as follows: growth factor independently high levels of ITPKA induce the formation of large cellular protrusions by directly modulating the actin cytoskeleton. The F-actin binding activity of ITPKA stabilizes and bundles actin filaments and thus increases the levels of cellular F-actin. In growth factor-stimulated cells, the catalytically active domain enhances basal ITPKA-induced migration by activating store-operated calcium entry through production of inositol 1,3,4,5-tetrakisphosphate and subsequent inhibition of inositol phosphate 5-phosphatase. These two functional activities of ITPKA stimulating tumor cell migration place the enzyme among the potential targets of anti-metastatic therapy.	[Windhorst, Sabine; Fliegert, Ralf; Blechner, Christine; Hosseini, Zara; Guenther, Thomas; Chang, Lydia; Lin, Hong-Ying; Fanick, Werner; Mayr, Georg W.] Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol 1, D-20246 Hamburg, Germany; [Moellmann, Katharina; Eiben, Maike; Brandt, Burkhard] Univ Klinikum Hamburg Eppendorf, Inst Tumorbiol, D-20246 Hamburg, Germany; [Schumacher, Udo] Univ Klinikum Hamburg Eppendorf, Inst Anat Expt Morphol 2, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Windhorst, S (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol 1, Martinistr 52, D-20246 Hamburg, Germany.	s.windhorst@uke.uni-hamburg.de		Brandt, Burkhard/0000-0003-3681-3049; Gunther, Thomas/0000-0001-9650-0218	Roggenbuck-Stiftung Hamburg	Roggenbuck-Stiftung Hamburg	This work was supported by the Roggenbuck-Stiftung Hamburg.	BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Brandt B, 2005, SEMIN CANCER BIOL, V15, P387, DOI 10.1016/j.semcancer.2005.06.006; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Feldner JC, 2002, EXP CELL RES, V272, P93, DOI 10.1006/excr.2001.5385; Gremm D, 2000, EUR J BIOCHEM, V267, P4339, DOI 10.1046/j.1432-1327.2000.01463.x; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Jojovic M, 2000, CANCER LETT, V152, P151, DOI 10.1016/S0304-3835(99)00443-7; Jun KS, 1998, LEARN MEMORY, V5, P317; KATSANTONIS J, 1994, CELL BIOCHEM FUNCT, V12, P267, DOI 10.1002/cbf.290120407; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; KROM YD, 2006, BMC BIOTECHNOL, V28, P6; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Roesch A, 2003, MELANOMA RES, V13, P503, DOI 10.1097/00008390-200310000-00009; SAUER K, 2009, CURRENT PROTOCOLS IM; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Windhorst S, 2008, BIOCHEM J, V414, P407, DOI 10.1042/BJ20080630; Woodring PJ, 1996, BIOCHEM J, V319, P73, DOI 10.1042/bj3190073; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	31	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5541	5554		10.1074/jbc.M109.047050	http://dx.doi.org/10.1074/jbc.M109.047050			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022963	Green Published, hybrid			2022-12-27	WOS:000275327200047
J	Robart, AR; Collins, K				Robart, Aaron R.; Collins, Kathleen			Investigation of Human Telomerase Holoenzyme Assembly, Activity, and Processivity Using Disease-linked Subunit Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW FAILURE; DOMINANT DYSKERATOSIS-CONGENITA; FUNCTIONAL-CHARACTERIZATION; REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; HEMATOLOGIC DISORDERS; CLINICAL PRESENTATION; MAMMALIAN TELOMERASE; PULMONARY-FIBROSIS; GENE TERC	After the initial discovery of human telomerase deficiency in the X-linked form of the bone marrow failure syndrome dyskeratosis congenita, mutations in genes encoding telomerase subunits have been identified in patients with a wide spectrum of disorders. Structure/function studies of disease-linked variants of human telomerase RNA (hTR) or telomerase reverse transcriptase (TERT) have exploited in vitro reconstitution of the enzyme catalytic core and/or a PCR-amplified activity assay readout that would not reflect alterations of cellular RNP assembly efficiency, telomeric primer recognition, and/or repeat addition processivity. Here we used telomerase reconstitution in vivo and direct telomeric-repeat primer extension activity assays to compare the ribonucleoprotein (RNP) assembly and activity properties of disease-linked subunit variants in holoenzyme context. Analysis of a large panel of hTR variants revealed numerous biochemical mechanisms for telomerase loss of function, including reduced association of hTR with TERT, reduced RNP catalytic activity, or loss in fidelity of telomeric repeat synthesis. An absolute correlation exists between hTR loss of function and hematopoietic deficiency, but there is no readily apparent telomerase deficiency imposed by an hTR variant linked to pulmonary fibrosis. Some disease-linked TERT variants have altered properties of holoenzyme assembly or repeat addition processivity, but other TERT variants linked to either pulmonary fibrosis or hematopoietic deficiency retained normal hTR interaction and RNP catalytic activity. Combined with additional hTR structure/function studies, our results establish a new resolution of insight into hTR structural requirements for hTR-TERT interaction and for the catalytic cycle of human telomerase holoenzyme.	[Robart, Aaron R.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu		Robart, Aaron/0000-0002-0518-3972	National Institutes of Health [HL079585]; American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL079585, R01HL079585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL079585. This work was also supported by a Breakthroughs in Gerontology Award from the American Federation for Aging Research.	Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Collins Kathleen, 2009, V13, P285, DOI 10.1007/978-3-540-70840-7_14; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Errington TM, 2008, MOL CELL BIOL, V28, P6510, DOI 10.1128/MCB.00777-08; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Ly H, 2005, BLOOD, V106, P1246, DOI 10.1182/blood-2005-01-0247; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Marrone A, 2007, HAEMATOLOGICA, V92, P1013, DOI 10.3324/haematol.11407; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; ROBART AR, 2010, RNA IN PRESS; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wilson DB, 2003, LANCET, V361, P1993, DOI 10.1016/S0140-6736(03)13575-1; Wong JMY, 2004, HUM GENET, V115, P448, DOI 10.1007/s00439-004-1178-7; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Xie MY, 2008, J BIOL CHEM, V283, P2049, DOI 10.1074/jbc.M708032200; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	46	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4375	4386		10.1074/jbc.M109.088575	http://dx.doi.org/10.1074/jbc.M109.088575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20022961	hybrid, Green Published			2022-12-27	WOS:000275274800014
J	Nabuurs, SM; van Mierlo, CPM				Nabuurs, Sanne M.; van Mierlo, Carlo P. M.			Interrupted Hydrogen/Deuterium Exchange Reveals the Stable Core of the Remarkably Helical Molten Globule of alpha-beta Parallel Protein Flavodoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII APOFLAVODOXIN; FOLDING INTERMEDIATE; HYDROGEN-EXCHANGE; UNFOLDED MOLECULES; ENERGY LANDSCAPE; ON-PATHWAY; AGGREGATION; EQUILIBRIUM; LACTALBUMIN; APOMYOGLOBIN	Kinetic intermediates that appear early during protein folding often resemble the relatively stable molten globule intermediates formed by several proteins under mildly denaturing conditions. Molten globules have a substantial amount of secondary structure but lack virtually all tertiary side-chain packing characteristics of natively folded proteins. Due to exposed hydrophobic groups, molten globules are prone to aggregation, which can have detrimental effects on organisms. The molten globule that is observed during folding of alpha-beta parallel flavodoxin from Azotobacter vinelandii is a remarkably non-native species. This folding intermediate is helical and contains no beta-sheet and is kinetically off-pathway to the native state. It can be trapped under native-like conditions by substituting residue Phe(44) for Tyr(44). To characterize this species at the residue level, in this study, use is made of interrupted hydrogen/deuterium exchange detected by NMR spectroscopy. In the molten globule of flavodoxin, the helical region comprising residues Leu(110)-Val(125) is shown to be better protected against exchange than the other ordered parts of the folding intermediate. This helical region is better buried than the other helices, causing its context-dependent stabilization against unfolding. Residues Leu(110)-Val(125) thus form the stable core of the helical molten globule of alpha-beta parallel flavodoxin, which is almost entirely structured. Non-native docking of helices in the molten globule of flavodoxin prevents formation of the parallel beta-sheet of native flavodoxin. Hence, to produce native alpha-beta parallel protein molecules, the off-pathway species needs to unfold.	[Nabuurs, Sanne M.; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	vanMierlo, Carlo p/B-4491-2016	vanMierlo, Carlo p/0000-0002-5358-8392				Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; Arai M, 2002, J MOL BIOL, V321, P121, DOI 10.1016/S0022-2836(02)00566-1; Arai M, 1996, FOLD DES, V1, P275, DOI 10.1016/S1359-0278(96)00041-7; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BALDWIN RL, 1994, NATURE, V369, P183, DOI 10.1038/369183a0; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Fernandez-Recio J, 2001, BIOCHEMISTRY-US, V40, P15234, DOI 10.1021/bi010216t; Forge V, 1999, J MOL BIOL, V288, P673, DOI 10.1006/jmbi.1999.2687; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Kato H, 2007, J MOL BIOL, V365, P870, DOI 10.1016/j.jmb.2006.10.047; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Melo EP, 2003, BIOCHEMISTRY-US, V42, P7611, DOI 10.1021/bi034267x; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nishimura C, 2005, P NATL ACAD SCI USA, V102, P4765, DOI 10.1073/pnas.0409538102; Nishimura C, 2008, J MOL BIOL, V378, P715, DOI 10.1016/j.jmb.2008.03.025; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Otzen DE, 2007, BBA-PROTEINS PROTEOM, V1774, P323, DOI 10.1016/j.bbapap.2006.11.012; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Spence GR, 2004, J MOL BIOL, V341, P215, DOI 10.1016/j.jmb.2004.05.049; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Yamasaki K, 2003, BIOPOLYMERS, V69, P176, DOI 10.1002/bip.10351	44	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4165	4172		10.1074/jbc.M109.087932	http://dx.doi.org/10.1074/jbc.M109.087932			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959481	Green Published, hybrid			2022-12-27	WOS:000275254000068
J	Alkhouri, N; Gornicka, A; Berk, MP; Thapaliya, S; Dixon, LJ; Kashyap, S; Schauer, PR; Feldstein, AE				Alkhouri, Naim; Gornicka, Agnieszka; Berk, Michael P.; Thapaliya, Samjhana; Dixon, Laura J.; Kashyap, Sangeeta; Schauer, Philip R.; Feldstein, Ariel E.			Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; ADIPOSE-TISSUE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; MICE; INFLAMMATION; SENSITIVITY; DEATH; EXPRESSION; PATHWAYS	Adipocyte death has been reported in both obese humans and rodents. However, its role in metabolic disorders, including insulin resistance, hepatic steatosis, and inflammation associated with obesity has not been studied. We now show using real-time reverse transcription-PCR arrays that adipose tissue of obese mice display a pro-apoptotic phenotype. Moreover, caspase activation and adipocyte apoptosis were markedly increased in adipose tissue from both mice with diet-induced obesity and obese humans. These changes were associated with activation of both the extrinsic, death receptor-mediated, and intrinsic, mitochondrial-mediated pathways of apoptosis. Genetic inactivation of Bid, a key pro-apoptotic molecule that serves as a link between these two cell death pathways, significantly reduced caspase activation, adipocyte apoptosis, prevented adipose tissue macrophage infiltration, and protected against the development of systemic insulin resistance and hepatic steatosis independent of body weight. These data strongly suggest that adipocyte apoptosis is a key initial event that contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis associated with obesity in both mice and humans. Inhibition of adipocyte apoptosis may be a new therapeutic strategy for the treatment of obesity-associated metabolic complications.	[Feldstein, Ariel E.] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Schauer, Philip R.] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Alkhouri, Naim; Feldstein, Ariel E.] Cleveland Clin, Dept Pediat Gastroenterol, Cleveland, OH 44195 USA; [Kashyap, Sangeeta] Cleveland Clin, Dept Endocrinol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Feldstein, AE (corresponding author), Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cell Biol, NE10,9500 Euclid Ave, Cleveland, OH 44195 USA.	feldsta@ccf.org	Berk, Michael/M-3585-2019; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Kashyap, Sangeeta/0000-0002-7489-6650; Schauer, Philip/0000-0002-4029-7537	National Institutes of Health [DK076852, DK082451]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451, R01DK076852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK076852 and DK082451 (to A. E. F.).	Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cosson E, 2005, DIABETES METAB, V31, P47, DOI 10.1016/S1262-3636(07)70166-0; Diehl Anna Mae, 2003, Endocr Pract, V9 Suppl 2, P93; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nanji Amin A, 2004, Clin Liver Dis, V8, P559, DOI 10.1016/j.cld.2004.04.002; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nolsoe RL, 2006, GENES IMMUN, V7, P316, DOI 10.1038/sj.gene.6364300; PANG C, 2008, J AM J PHYSL ENDOCRI, V295, pE313; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Syn WK, 2009, CLIN LIVER DIS, V13, P565, DOI 10.1016/j.cld.2009.07.003; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; YE J, 2007, Q AM J PHYSL ENDOCRI, V293, pE1118; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625	39	249	255	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3428	3438		10.1074/jbc.M109.074252	http://dx.doi.org/10.1074/jbc.M109.074252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940134	hybrid, Green Published			2022-12-27	WOS:000273829000057
J	Kang, HW; Vitko, I; Lee, SS; Perez-Reyes, E; Lee, JH				Kang, Ho-Won; Vitko, Iuliia; Lee, Sang-Soo; Perez-Reyes, Edward; Lee, Jung-Ha			Structural Determinants of the High Affinity Extracellular Zinc Binding Site on Ca(v)3.2 T-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-DEPENDENT ACTIVATION; K+ CHANNEL; TRANSMEMBRANE SEGMENTS; POTASSIUM CHANNELS; CA2+ CHANNELS; ELECTROSTATIC INTERACTIONS; MOLECULAR DETERMINANTS; CHARGED RESIDUES; SENSORY NEURONS; INHIBITION	Ca(v)3.2 T-type channels contain a high affinity metal binding site for trace metals such as copper and zinc. This site is occupied at physiologically relevant concentrations of these metals, leading to decreased channel activity and pain transmission. A histidine at position 191 was recently identified as a critical determinant for both trace metal block of Ca(v)3.2 and modulation by redox agents. His(191) is found on the extracellular face of the Ca(v)3.2 channel on the IS3-S4 linker and is not conserved in other Ca(v)3 channels. Mutation of the corresponding residue in Ca(v)3.1 to histidine, Gln(172), significantly enhances trace metal inhibition, but not to the level observed in wild-type Ca(v)3.2, implying that other residues also contribute to the metal binding site. The goal of the present study is to identify these other residues using a series of chimeric channels. The key findings of the study are that the metal binding site is composed of a Asp-Gly-His motif in IS3-S4 and a second aspartate residue in IS2. These results suggest that metal binding stabilizes the closed conformation of the voltage-sensor paddle in repeat I, and thereby inhibits channel opening. These studies provide insight into the structure of T-type channels, and identify an extracellular motif that could be targeted for drug development.	Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Kang, Ho-Won; Lee, Sang-Soo; Lee, Jung-Ha] Sogang Univ, Basic Sci Inst Cell Damage Control, Seoul 121742, South Korea; [Vitko, Iuliia; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22911 USA; [Perez-Reyes, Edward] Univ Virginia, Grad Program Neurosci, Charlottesville, VA 22911 USA	Sogang University; Sogang University; University of Virginia; University of Virginia	Lee, JH (corresponding author), Shinsu Dong 1, Seoul 121742, South Korea.	jhleem@sogang.ac.kr		Lee, Sang Soo/0000-0003-0467-9025	Korea Science and Engineering Foundation [R11-2009-036-01003-0]; National Research Foundation of Korea [2009-0093822, 2009-0087964]; University of Virginia	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); University of Virginia	This work was supported by Korea Science and Engineering Foundation Grant R11-2009-036-01003-0, Priority Research Centers Program 2009-0093822, and Basic Science Research Program 2009-0087964 through the National Research Foundation of Korea, and a grant from the University of Virginia (to E.P.R.).	Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chen HJ, 2000, PFLUG ARCH EUR J PHY, V439, P423, DOI 10.1007/s004240050959; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gomora JC, 2002, BIOPHYS J, V83, P229, DOI 10.1016/S0006-3495(02)75164-3; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Jeong SW, 2003, NEUROREPORT, V14, P1537, DOI 10.1097/00001756-200308060-00028; Kang HW, 2007, FEBS LETT, V581, P5774, DOI 10.1016/j.febslet.2007.11.045; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; LAUSSAC JP, 1980, J BIOL CHEM, V255, P7563; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Obejero-Paz CA, 2004, J GEN PHYSIOL, V124, P631, DOI 10.1085/jgp.200409167; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; TANABE T, 1991, NATURE, V352, P800, DOI 10.1038/352800a0; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Traboulsie A, 2007, J PHYSIOL-LONDON, V578, P159, DOI 10.1113/jphysiol.2006.114496; TSIEN RW, 1987, ANNU REV BIOPHYS BIO, V16, P265; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Vitko I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003560; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104	41	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3271	3281		10.1074/jbc.M109.067660	http://dx.doi.org/10.1074/jbc.M109.067660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940152	Green Published, hybrid			2022-12-27	WOS:000273829000042
J	Kassavetis, GA; Prakash, P; Shim, E				Kassavetis, George A.; Prakash, Prachee; Shim, Eunjung			The C53/C37 Subcomplex of RNA Polymerase III Lies Near the Active Site and Participates in Promoter Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-IIIB; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; ELONGATION COMPLEX; CROSS-LINKING; DNA CONTACTS; SUBSTRATE-SPECIFICITY; PREINITIATION COMPLEX; CHAIN ELONGATION	The C53 and C37 subunits of RNA polymerase III (pol III) form a subassembly that is required for efficient termination; pol III lacking this subcomplex displays increased processivity of RNA chain elongation. We show that the C53/C37 subcomplex additionally plays a role in formation of the initiation-ready open promoter complex similar to that of the Brf1 N-terminal zinc ribbon domain. In the absence of C53 and C37, the transcription bubble fails to stably propagate to and beyond the transcriptional start site even when the DNA template is supercoiled. The C53/C37 subcomplex also stimulates the formation of an artificially assembled elongation complex from its component DNA and RNA strands. Protein-RNA and protein-DNA photochemical cross-linking analysis places a segment of C53 close to the RNA 3' end and transcribed DNA strand at the catalytic center of the pol III elongation complex. We discuss the implications of these findings for the mechanism of transcriptional termination by pol III and propose a structural as well as functional correspondence between the C53/C37 subcomplex and the RNA polymerase II initiation factor TFIIF.	[Kassavetis, George A.] Univ Calif San Diego, Ctr Mol Genet, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kassavetis, GA (corresponding author), Univ Calif San Diego, Ctr Mol Genet, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gak@ucsd.edu			National Institutes of Health (NIGMS) [GM18386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018386, R01GM018386, F32GM018386] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM18386 (NIGMS).	AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; BARDELEBEN C, 1994, J MOL BIOL, V235, P1193, DOI 10.1006/jmbi.1994.1073; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Bartholomew B, 1995, METHOD ENZYMOL, V262, P476; BARTHOLOMEW B, 1994, J BIOL CHEM, V269, P18090; Bobkova EV, 1997, J BIOL CHEM, V272, P22832, DOI 10.1074/jbc.272.36.22832; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CAMPBELL FE, 1992, MOL CELL BIOL, V12, P2260, DOI 10.1128/MCB.12.5.2260; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen BS, 2004, BIOCHEMISTRY-US, V43, P12741, DOI 10.1021/bi048993r; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; HANNA MM, 1993, NUCLEIC ACIDS RES, V21, P2073, DOI 10.1093/nar/21.9.2073; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Joazeiro CAP, 1996, GENE DEV, V10, P725, DOI 10.1101/gad.10.6.725; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KASSAVETIS GA, 1995, P NATL ACAD SCI USA, V92, P9786, DOI 10.1073/pnas.92.21.9786; KASSAVETIS GA, 1992, J MOL BIOL, V226, P47, DOI 10.1016/0022-2836(92)90123-2; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kassavetis GA, 2002, EMBO J, V21, P5508, DOI 10.1093/emboj/cdf533; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; KASSAVETIS GA, 1986, J BIOL CHEM, V261, P14256; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Micorescu M, 2008, J BACTERIOL, V190, P157, DOI 10.1128/JB.01498-07; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SHAABAN SA, 1995, MOL CELL BIOL, V15, P1467; Shaaban SA, 1996, MOL CELL BIOL, V16, P6468; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soragni E, 2008, J BIOL CHEM, V283, P26568, DOI 10.1074/jbc.M803769200; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; Thompson NE, 2009, J BIOL CHEM, V284, P24754, DOI 10.1074/jbc.M109.030486; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; WERNER M, 1993, J BIOL CHEM, V268, P20721; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Wooddell CI, 2000, BIOCHEMISTRY-US, V39, P13405, DOI 10.1021/bi0014249; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Ziegler LM, 2003, J BIOL CHEM, V278, P48950, DOI 10.1074/jbc.M309656200	69	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2695	2706		10.1074/jbc.M109.074013	http://dx.doi.org/10.1074/jbc.M109.074013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940126	Green Published, hybrid			2022-12-27	WOS:000273697800048
J	Wang, TT; Dabbas, B; Laperriere, D; Bitton, AJ; Soualhine, H; Tavera-Mendoza, LE; Dionne, S; Servant, MJ; Bitton, A; Seidman, EG; Mader, S; Behr, MA; White, JH				Wang, Tian-Tian; Dabbas, Basel; Laperriere, David; Bitton, Ari J.; Soualhine, Hafid; Tavera-Mendoza, Luz E.; Dionne, Serge; Servant, Marc J.; Bitton, Alain; Seidman, Ernest G.; Mader, Sylvie; Behr, Marcel A.; White, John H.			Direct and Indirect Induction by 1,25-Dihydroxyvitamin D-3 of the NOD2/CARD15-Defensin beta 2 Innate Immune Pathway Defective in Crohn Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; CUTTING EDGE; GENE; DIPEPTIDE; EPIDEMIOLOGY; POLYMORPHISM; SYMPTOMS; TARGET; CELLS; NOD2	Vitamin D signaling through its nuclear vitamin D receptor has emerged as a key regulator of innate immunity in humans. Here we show that hormonal vitamin D, 1,25-dihydroxyvitamin D-3, robustly stimulates expression of pattern recognition receptor NOD2/CARD15/IBD1 gene and protein in primary human monocytic and epithelial cells. The vitamin D receptor signals through distal enhancers in the NOD2 gene, whose function was validated by chromatin immunoprecipitation and chromatin conformation capture assays. A key downstream signaling consequence of NOD2 activation by agonist muramyl dipeptide is stimulation of NF-kappa B transcription factor function, which induces expression of the gene encoding antimicrobial peptide defensin beta 2 (DEFB2/HBD2). Pretreatment with 1,25-dihydroxyvitamin D-3 synergistically induced NF-kappa B function and expression of genes encoding DEFB2/HBD2 and antimicrobial peptide cathelicidin in the presence of muramyl dipeptide. Importantly, this synergistic response was also seen in macrophages from a donor wild type for NOD2 but was absent in macrophages from patients with Crohn disease homozygous for non-functional NOD2 variants. These studies provide strong molecular links between vitamin D deficiency and the genetics of Crohn disease, a chronic incurable inflammatory bowel condition, as Crohn's pathogenesis is associated with attenuated NOD2 or DEFB2/HBD2 function.	[Wang, Tian-Tian; Dabbas, Basel; Bitton, Ari J.; Tavera-Mendoza, Luz E.; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Dionne, Serge; Bitton, Alain; Seidman, Ernest G.; Behr, Marcel A.; White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Soualhine, Hafid; Seidman, Ernest G.; Behr, Marcel A.] McGill Univ, Montreal Gen Hosp, Montreal, PQ H3G 1Y6, Canada; [Soualhine, Hafid; Behr, Marcel A.] McGill Univ, Div Infect Dis & Med Microbiol, Montreal, PQ H3G 1Y6, Canada; [Dionne, Serge; Seidman, Ernest G.] McGill Univ, Div Gastroenterol, Montreal, PQ H3G 1Y6, Canada; [Laperriere, David; Mader, Sylvie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Laperriere, David; Mader, Sylvie] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Servant, Marc J.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	White, JH (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	john.white@mcgill.ca	white, john h/N-9782-2013; Soualhine, Hafid/AAH-3735-2019	white, john h/0000-0002-4785-2687; Soualhine, Hafid/0000-0002-5526-6741	McGill University	McGill University	This work was supported by a nutrition grant from McGill University (to J.H.W. and M.B.).	Aratari A, 2006, DIGEST LIVER DIS, V38, P319, DOI 10.1016/j.dld.2005.10.002; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jia HP, 2001, GENE, V263, P211; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Levy E, 2000, J LIPID RES, V41, P12; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; Lim WC, 2005, NAT CLIN PRACT GASTR, V2, P308, DOI 10.1038/ncpgasthep0215; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Martin K, 2002, DIGESTION, V66, P121, DOI 10.1159/000065592; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Simmons JD, 2000, GUT, V47, P211, DOI 10.1136/gut.47.2.211; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weber G, 2005, J INVEST DERMATOL, V124, P1080, DOI 10.1111/j.0022-202X.2005.23687.x; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Zeng L, 1996, SCAND J GASTROENTERO, V31, P79, DOI 10.3109/00365529609031631	38	266	275	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2237	2241		10.1074/jbc.C109.071225	http://dx.doi.org/10.1074/jbc.C109.071225			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948723	Green Published, hybrid			2022-12-27	WOS:000273697800003
J	Fang, QM; Kanugula, S; Tubbs, JL; Tainer, JA; Pegg, AE				Fang, Qingming; Kanugula, Sreenivas; Tubbs, Julie L.; Tainer, John A.; Pegg, Anthony E.			Repair of O-4-Alkylthymine by O-6-Alkylguanine-DNA Alkyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-BINDING MECHANISM; ESCHERICHIA-COLI ADA; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O(6)-ALKYLGUANINE-DNA ALKYLTRANSFERASE; O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; DIFFERENTIAL INACTIVATION; DAMAGE RECOGNITION; CRYSTAL-STRUCTURE; GENE-PRODUCT	O-6-Alkylguanine-DNA alkyltransferase (AGT) plays a major role in repair of the cytotoxic and mutagenic lesion O-6-methylguanine (m(6)G) in DNA. Unlike the Escherichia coli alkyltransferase Ogt that also repairs O-4-methylthymine (m(4)T) efficiently, the human AGT (hAGT) acts poorly on m(4)T. Here we made several hAGT mutants in which residues near the cysteine acceptor site were replaced by corresponding residues from Ogt to investigate the basis for the inefficiency of hAGT in repair of m(4)T. Construct hAGT-03 (where hAGT sequence-V(149)CSSGAVGN(157)- was replaced with the corresponding Ogt - I(143)GRNGTMTG(151)-) exhibited enhanced m(4)T repair activity in vitro compared with hAGT. Three AGT proteins (hAGT, hAGT-03, and Ogt) exhibited similar protection from killing by N-methyl-N'-nitro-N-nitrosoguanidine and caused a reduction in m(6)G-induced G: C to A: T mutations in both nucleotide excision repair (NER)-proficient and -deficient Escherichia coli strains that lack endogenous AGTs. hAGT-03 resembled Ogt in totally reducing the m(4)T-induced T: A to C: G mutations in NER proficient and -deficient strains. Surprisingly, wild type hAGT expression caused a significant but incomplete decrease in NER-deficient strains but a slight increase in T: A to C: G mutation frequency in NER-proficient strains. The T: A to C: G mutations due to O-4-alkylthymine formed by ethylating and propylating agents were also efficiently reduced by either hAGT-03 or Ogt, whereas hAGT had little effect irrespective of NER status. These results show that specific alterations in the hAGT active site facilitate efficient recognition and repair of O-4-alkylthymines and reveal damage-dependent interactions of base and nucleotide excision repair.	[Fang, Qingming] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fang, QM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	quf2@psu.edu; aep1@psu.edu	Tainer, John/GWQ-4878-2022; Fang, Qingming/B-6839-2008	Tainer, John/0000-0003-1659-2429; Fang, Qingming/0000-0002-4006-0636	National Institutes of Health United States Public Health Service [R01-CA018137, CA-097209, CA-071976]; NATIONAL CANCER INSTITUTE [R01CA097209, R01CA071976, R01CA018137] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants R01-CA018137, CA-097209, and CA-071976.	BASU AK, 1990, MUTAT RES, V233, P189, DOI 10.1016/0027-5107(90)90162-W; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; BRONSTEIN SM, 1991, CANCER RES, V51, P5188; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CRUZEIROHANSSON L, 1994, CARCINOGENESIS, V15, P1525, DOI 10.1093/carcin/15.8.1525; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DENENGELSE L, 1986, CARCINOGENESIS, V7, P393; DEVEREUX TR, 1991, CARCINOGENESIS, V12, P299, DOI 10.1093/carcin/12.2.299; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P7027, DOI 10.1021/bi00242a031; DOSANJH MK, 1990, BIOCHEMISTRY-US, V29, P4698, DOI 10.1021/bi00471a026; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; ELDER RH, 1994, BIOCHEM J, V298, P231, DOI 10.1042/bj2980231; Encell LP, 1999, BIOCHEMISTRY-US, V38, P12097, DOI 10.1021/bi9913606; Encell LP, 2000, CARCINOGENESIS, V21, P1397, DOI 10.1093/carcin/21.7.1397; Engelbergs J, 1998, P NATL ACAD SCI USA, V95, P1635, DOI 10.1073/pnas.95.4.1635; Fang QM, 2008, BIOCHEMISTRY-US, V47, P10892, DOI 10.1021/bi8008664; Fang QM, 2008, BIOCHEM PHARMACOL, V75, P618, DOI 10.1016/j.bcp.2007.09.022; Fang QM, 2005, BIOCHEMISTRY-US, V44, P15396, DOI 10.1021/bi051460d; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; Goodtzova K, 1997, J BIOL CHEM, V272, P8332, DOI 10.1074/jbc.272.13.8332; GRAVES RJ, 1989, CARCINOGENESIS, V10, P661, DOI 10.1093/carcin/10.4.661; Guengerich FP, 2003, BIOCHEMISTRY-US, V42, P10965, DOI 10.1021/bi034937z; HARRIS LC, 1993, BRIT J CANCER, V67, P1196, DOI 10.1038/bjc.1993.225; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KAWATE H, 1995, CARCINOGENESIS, V16, P1595, DOI 10.1093/carcin/16.7.1595; Kooistra R, 1999, NUCLEIC ACIDS RES, V27, P1795, DOI 10.1093/nar/27.8.1795; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lawley P. D., 1976, CHEM CARCINOGENS AM, V173, P83; Liu LP, 2002, CANCER RES, V62, P3037; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Luu KX, 2002, BIOCHEMISTRY-US, V41, P8689, DOI 10.1021/bi025857i; MACKAY WJ, 1994, J BACTERIOL, V176, P3224, DOI 10.1128/jb.176.11.3224-3230.1994; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; Mazon G, 2009, DNA REPAIR, V8, P697, DOI 10.1016/j.dnarep.2009.01.022; Melikishvili M, 2008, BIOCHEMISTRY-US, V47, P13754, DOI 10.1021/bi801666c; Milsom MD, 2008, CANCER RES, V68, P6171, DOI 10.1158/0008-5472.CAN-08-0320; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; MOORE MH, 1994, EMBO J, V13, P1495, DOI 10.1002/j.1460-2075.1994.tb06410.x; OTOOLE SM, 1993, CANCER RES, V53, P3895; Paalman SR, 1997, NUCLEIC ACIDS RES, V25, P1795, DOI 10.1093/nar/25.9.1795; PAULY GT, 1995, BIOCHEMISTRY-US, V34, P8924, DOI 10.1021/bi00027a045; Pauly GT, 1998, CARCINOGENESIS, V19, P457, DOI 10.1093/carcin/19.3.457; Pauly GT, 2001, CHEM RES TOXICOL, V14, P894, DOI 10.1021/tx010032f; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; PEGG AE, 1993, BIOCHEMISTRY-US, V32, P11998, DOI 10.1021/bi00096a009; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; PRESTON BD, 1986, P NATL ACAD SCI USA, V83, P8501, DOI 10.1073/pnas.83.22.8501; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Rasimas JJ, 2007, J BIOL CHEM, V282, P3357, DOI 10.1074/jbc.M608876200; Reese JS, 2008, STEM CELLS, V26, P675, DOI 10.1634/stemcells.2007-0803; SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; Samson L, 1997, CARCINOGENESIS, V18, P919, DOI 10.1093/carcin/18.5.919; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SASSANFAR M, 1991, J BIOL CHEM, V266, P2767; SINGER B, 1990, MUTAT RES, V233, P45, DOI 10.1016/0027-5107(90)90150-3; SINGER B, 1991, CARCINOGENESIS, V12, P949; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; VOIGT JM, 1989, J BIOL CHEM, V264, P5172; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393; WILKINSON MC, 1989, NUCLEIC ACIDS RES, V17, P8475, DOI 10.1093/nar/17.21.8475; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200; Zhao HF, 2009, BLOOD, V113, P5747, DOI 10.1182/blood-2008-10-186684	74	24	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8185	8195		10.1074/jbc.M109.045518	http://dx.doi.org/10.1074/jbc.M109.045518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20026607	Green Published, hybrid			2022-12-27	WOS:000275413800037
J	Robertson, S; Allie-Reid, F; Vanden Berghe, W; Visser, K; Binder, A; Africander, D; Vismer, M; De Bosscher, K; Hapgood, J; Haegeman, G; Louw, A				Robertson, Steven; Allie-Reid, Fatima; Vanden Berghe, Wim; Visser, Koch; Binder, Anke; Africander, Donita; Vismer, Michael; De Bosscher, Karolien; Hapgood, Janet; Haegeman, Guy; Louw, Ann			Abrogation of Glucocorticoid Receptor Dimerization Correlates with Dissociated Glucocorticoid Behavior of Compound A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOSTEROID-BINDING GLOBULIN; GONADOTROPIN-RELEASING-HORMONE; FACTOR-KAPPA-B; AZIRIDINE PRECURSOR; IN-VIVO; MOLECULAR-MECHANISMS; ANDROGEN RECEPTOR; PLANT-ORIGIN; LIVING CELLS; DNA-BINDING	Compound A (CpdA), a dissociated glucocorticoid receptor modulator, decreases corticosteroid-binding globulin (CBG), adrenocorticotropic hormone (ACTH), and luteneinizing hormone levels in rats. Whether this is due to transcriptional regulation by CpdA is not known. Using promoter reporter assays we show that CpdA, like dexamethasone (Dex), directly transrepresses these genes. Results using a rat Cbg proximal-promoter reporter construct in BWTG3 and HepG2 cell lines support a glucocorticoid receptor (GR)-dependent transrepression mechanism for CpdA. However, CpdA, unlike Dex, does not result in transactivation via glucocorticoid-responsive elements within a promoter reporter construct even when GR is co-transfected. The inability of CpdA to result in transactivation via glucocorticoid-responsive elements is confirmed on the endogenous tyrosine aminotransferase gene, whereas transrepression ability is confirmed on the endogenous CBG gene. Consistent with a role for CpdA in modulating GR activity, whole cell binding assays revealed that CpdA binds reversibly to the GR, but with lower affinity than Dex, and influences association of [H-3] Dex, but has no effect on dissociation. In addition, like Dex, CpdA causes nuclear translocation of the GR, albeit to a lesser degree. Several lines of evidence, including fluorescence resonance energy transfer, co-immunoprecipitation, and nuclear immunofluorescence studies of nuclear localization-deficient GR show that CpdA, unlike Dex, does not elicit ligand-induced GR dimerization. Comparison of the behavior of CpdA in the presence of wild type GR to that of Dex with a dimerization-deficient GR mutant (GR(dim)) strongly supports the conclusion that loss of dimerization is responsible for the dissociated behavior of CpdA.	[Robertson, Steven; Allie-Reid, Fatima; Visser, Koch; Binder, Anke; Africander, Donita; Vismer, Michael; Louw, Ann] Univ Stellenbosch, Dept Biochem, ZA-7602 Stellenbosch, South Africa; [Vanden Berghe, Wim; De Bosscher, Karolien; Haegeman, Guy] Univ Ghent, Dept Physiol, LEGEST, B-9000 Ghent, Belgium; [Hapgood, Janet] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa	Stellenbosch University; Ghent University; University of Cape Town	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7602 Stellenbosch, South Africa.		Berghe, Wim Vanden/S-6425-2018; Hapgood, Janet P/P-2549-2018; Vanden Berghe, Wim/HGE-4696-2022; Louw, Ann/A-7620-2012	Berghe, Wim Vanden/0000-0003-0161-7355; Hapgood, Janet P/0000-0002-4414-4861; Louw, Ann/0000-0002-1021-6732; Africander, Donita/0000-0002-3429-7100; De Bosscher, Karolien/0000-0001-5059-9718	Flemish-South African bilateral [BIL99/39]; Medical Research Council; National Research Foundation; Stellenbosch University (South Africa)	Flemish-South African bilateral; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Stellenbosch University (South Africa)	This work was supported in part by Flemish-South African bilateral agreement BIL99/39 and grants from the Medical Research Council, National Research Foundation, and Stellenbosch University (South Africa) (to A.L. and J.H.).	Adcock IM, 2000, PULM PHARMACOL THER, V13, P115, DOI 10.1006/pupt.2000.0243; ADELMAN JP, 1986, P NATL ACAD SCI USA, V83, P179, DOI 10.1073/pnas.83.1.179; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Beato M, 1996, ANN NY ACAD SCI, V784, P93, DOI 10.1111/j.1749-6632.1996.tb16231.x; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Deak T, 1997, AM J PHYSIOL-REG I, V273, pR1998; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Hayashi R, 2004, EUR J PHARMACOL, V500, P51, DOI 10.1016/j.ejphar.2004.07.011; Ingenbleek Y, 1999, NUTRITION, V15, P305, DOI 10.1016/S0899-9007(99)00009-X; Jacobsen BM, 2009, MOL ENDOCRINOL, V23, P989, DOI 10.1210/me.2009-0048; KASTNER P, 1990, J BIOL CHEM, V265, P12163; Louw A, 1999, ENDOCRINOLOGY, V140, P2044, DOI 10.1210/en.140.5.2044; Louw A, 2000, BIOCHEM PHARMACOL, V59, P167, DOI 10.1016/S0006-2952(99)00302-0; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Louw A, 2000, ENDOCR RES, V26, P729, DOI 10.3109/07435800009048593; Martens C, 2005, MOL ENDOCRINOL, V19, P885, DOI 10.1210/me.2004-0333; McEwan IJ, 1997, BIOESSAYS, V19, P153, DOI 10.1002/bies.950190210; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Reichardt HM, 2000, Z RHEUMATOL, V59, P1; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schacke H, 2002, E SCHERING RES FDN W, V40, P357; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schacke Heike, 2004, Curr Opin Investig Drugs, V5, P524; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; SMITH CL, 1992, ENDOCRINOLOGY, V130, P2245, DOI 10.1210/en.130.4.2245; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Sui XM, 1999, J BIOL CHEM, V274, P9449, DOI 10.1074/jbc.274.14.9449; Swart P, 2003, BIOESSAYS, V25, P612, DOI 10.1002/bies.10285; Tanner TM, 2003, MOL CELL ENDOCRINOL, V201, P155, DOI 10.1016/S0303-7207(02)00411-2; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; UNDERHILL DA, 1995, GENE, V162, P205, DOI 10.1016/0378-1119(95)00337-6; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Webster JC, 1999, TRENDS ENDOCRIN MET, V10, P396, DOI 10.1016/S1043-2760(99)00186-1; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	68	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8061	8075		10.1074/jbc.M109.087866	http://dx.doi.org/10.1074/jbc.M109.087866			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20037160	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000275413800024
J	Hattori, T; Umetsu, M; Nakanishi, T; Togashi, T; Yokoo, N; Abe, H; Ohara, S; Adschiri, T; Kumagai, I				Hattori, Takamitsu; Umetsu, Mitsuo; Nakanishi, Takeshi; Togashi, Takanari; Yokoo, Nozomi; Abe, Hiroya; Ohara, Satoshi; Adschiri, Tadafumi; Kumagai, Izumi			High Affinity Anti-inorganic Material Antibody Generation by Integrating Graft and Evolution Technologies POTENTIAL OF ANTIBODIES AS BIOINTERFACE MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PANCREAS RIBONUCLEASE; GOLD-BINDING POLYPEPTIDE; HUMAN-PLASMA ALBUMIN; MONOCLONAL-ANTIBODY; PROTEIN; DOMAIN; ADSORPTION; NANOPARTICLES; SELECTION; SURFACES	Recent advances in molecular evolution technology enabled us to identify peptides and antibodies with affinity for inorganic materials. In the field of nanotechnology, the use of the functional peptides and antibodies should aid the construction of interface molecules designed to spontaneously link different nanomaterials; however, few material-binding antibodies, which have much higher affinity than short peptides, have been identified. Here, we generated high affinity antibodies from material-binding peptides by integrating peptide-grafting and phage-display techniques. Amaterial-binding peptide sequence was first grafted into an appropriate loop of the complementarity determining region (CDR) of a camel-type single variable antibody fragment to create a low affinity material-binding antibody. Application of a combinatorial library approach to another CDR loop in the low affinity antibody then clearly and steadily promoted affinity for a specific material surface. Thermodynamic analysis demonstrated that the enthalpy synergistic effect from grafted and selected CDR loops drastically increased the affinity for material surface, indicating the potential of antibody scaffold for creating high affinity small interface units. We show the availability of the construction of antibodies by integrating graft and evolution technology for various inorganic materials and the potential of high affinity material-binding antibodies in biointerface applications.	[Hattori, Takamitsu; Umetsu, Mitsuo; Nakanishi, Takeshi; Kumagai, Izumi] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Umetsu, Mitsuo] Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808578, Japan; [Togashi, Takanari; Yokoo, Nozomi; Adschiri, Tadafumi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Abe, Hiroya; Ohara, Satoshi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University	Umetsu, M (corresponding author), Aoba 6-6-11-608,Aoba Ku, Sendai, Miyagi 9808579, Japan.	mitsuo@kuma.che.tohoku.ac.jp; kmiz@kuma.che.tohoku.ac.jp	Adschiri, Tadafumi/E-4867-2010; Ohara, Satoshi/ABA-4925-2020	Hattori, Takamitsu/0000-0002-5502-2595; Togashi, Takanari/0000-0001-9559-7791	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization of Japan; Japan Science and Technology of Japan; Japan Society for the Promotion of Science research; Hosokawa Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology of Japan; Japan Society for the Promotion of Science research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hosokawa Foundation	This work was supported by a scientific research grant from the Ministry of Education, Science, Sports and Culture of Japan (to M. U. and I. K.), the Industrial Technology Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan (to M. U.), proposal-oriented research promotion program of Japan Science and Technology of Japan (to M. U.), Japan Society for the Promotion of Science research fellowships for young scientists (to T. H.), and in part by The Hosokawa Foundation (to M. U.).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P6385, DOI 10.1073/pnas.90.14.6385; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Brown S, 2001, NANO LETT, V1, P391, DOI 10.1021/nl0155173; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Frederickson S, 2006, P NATL ACAD SCI USA, V103, P14307, DOI 10.1073/pnas.0602658103; Geva M, 2003, J AM CHEM SOC, V125, P696, DOI 10.1021/ja027942j; Habermuller L, 2000, FRESEN J ANAL CHEM, V366, P560; Hattori T, 2008, BIOCHEM BIOPH RES CO, V365, P751, DOI 10.1016/j.bbrc.2007.11.062; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kessler N, 1996, FASEB J, V10, P1435, DOI 10.1096/fasebj.10.12.8903514; Kramer RM, 2004, J AM CHEM SOC, V126, P13282, DOI 10.1021/ja046735b; Krauland EM, 2007, BIOTECHNOL BIOENG, V97, P1009, DOI 10.1002/bit.21341; Maenaka K, 1996, BIOCHEM BIOPH RES CO, V218, P682, DOI 10.1006/bbrc.1996.0122; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, J Biotechnol, V74, P277; Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758; NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5; NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X; Park TJ, 2006, ANAL CHEM, V78, P7197, DOI 10.1021/ac060976f; Peelle BR, 2005, LANGMUIR, V21, P6929, DOI 10.1021/la050261s; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Sano K, 2005, SMALL, V1, P826, DOI 10.1002/smll.200500010; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; SATO K, 1994, MOL IMMUNOL, V31, P371; Schembri MA, 1999, FEMS MICROBIOL LETT, V170, P363, DOI 10.1111/j.1574-6968.1999.tb13396.x; Schnirman AA, 2006, NANO LETT, V6, P1870, DOI 10.1021/nl0607636; Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070; Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897; Thai CK, 2004, BIOTECHNOL BIOENG, V87, P129, DOI 10.1002/bit.20149; Umetsu M, 2005, ADV MATER, V17, P2571, DOI 10.1002/adma.200500863; Umetsu M, 2008, J MATER RES, V23, P3241, DOI 10.1557/JMR.2008.0401; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Watanabe H, 2007, BIOCONJUGATE CHEM, V18, P645, DOI 10.1021/bc060203y; Watanabe H, 2008, J BIOL CHEM, V283, P36031, DOI 10.1074/jbc.M805547200; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Woodbury RG, 1998, BIOSENS BIOELECTRON, V13, P1117, DOI 10.1016/S0956-5663(98)00060-8	46	23	28	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7784	7793		10.1074/jbc.M109.020156	http://dx.doi.org/10.1074/jbc.M109.020156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20044483	Green Published, hybrid			2022-12-27	WOS:000275415600086
J	Umehara, T; Nakamura, Y; Jang, MK; Nakano, K; Tanaka, A; Ozato, K; Padmanabhan, B; Yokoyama, S				Umehara, Takashi; Nakamura, Yoshihiro; Jang, Moon Kyoo; Nakano, Kazumi; Tanaka, Akiko; Ozato, Keiko; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki			Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CHROMATIN; BINDING; PROTEIN; CHROMOSOMES; NUCLEOSOME; INSIGHTS; PARTICLE	Recognition of acetylated chromatin by the bromodomains and extra-terminal domain (BET) family proteins is a hallmark for transcriptional activation and anchoring viral genomes to mitotic chromosomes of the host. One of the BET family proteins BRD2 interacts with acetylated chromatin during mitosis and leads to transcriptional activation in culture cells. Here, we report the crystal structures of the N-terminal bromodomain of human BRD2 (BRD2-BD1; residues 74-194) in complex with each of three different Lys-12-acetylated H4 peptides. The BRD2-BD1 recognizes the H4 tail acetylated at Lys-12 (H4K12ac), whereas the side chain of hypoacetylated Lys-8 of H4 binds at the cavity of the dimer interface of BRD2-BD1. From binding studies, we identified the BRD2-BD1 residues that are responsible for recognition of the Lys-12-acetylated H4 tail. In addition, mutationto Lys-8 in the Lys-12-acetylated H4 tail decreased the binding to BRD2-BD1, implicating the critical role of Lys-8 in the Lys-12-acetylated H4 tail for the recognition by BRD2-BD1. Our findings provide a structural basis for deciphering the histone code by the BET bromodomain through the binding with a long segment of the histone H4 tail, which presumably prevents erasure of the histone code during the cell cycle.	[Padmanabhan, Balasundaram; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Jang, Moon Kyoo; Ozato, Keiko] NICHHD, Dept Mol Growth Regulat, Natl Inst Hlth, Bethesda, MD 20892 USA; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Tokyo	Padmanabhan, B (corresponding author), Aptuit Laurus Pvt, ICICI Knowledge Pk, Hyderabad 500078, Andhra Pradesh, India.	paddy.b@aptuitlaurus.com; yokoyama@biochem.s.u-tokyo.ac.jp	Umehara, Takashi/AHB-1730-2022; Umehara, Takashi/N-5683-2015; Yokoyama, Shigeyuki/N-6911-2015	Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960; Yokoyama, Shigeyuki/0000-0003-3133-7338; Jang, Moon Kyoo/0000-0002-1657-2877	National Institutes of Health; National Institute of Biomedical Innovation; RIKEN Structural Genomics/Proteomics Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); RIKEN Structural Genomics/Proteomics Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, by the RIKEN Structural Genomics/Proteomics Initiative, and the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Denis GV, 2001, FRONT BIOSCI, V6, pD1065; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	41	85	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7610	7618		10.1074/jbc.M109.062422	http://dx.doi.org/10.1074/jbc.M109.062422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048151	Green Published, hybrid			2022-12-27	WOS:000275415600072
J	Ahmed, SM; Daulat, AM; Meunier, A; Angers, S				Ahmed, Syed M.; Daulat, Avais M.; Meunier, Alexandre; Angers, Stephane			G Protein beta gamma Subunits Regulate Cell Adhesion through Rap1a and Its Effector Radil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN CONFORMATION; SIGNALING PATHWAYS; PROSTATE-CANCER; SMALL GTPASE; ACTIVATION; RECEPTORS; MIGRATION; ROLES; INFLAMMATION; POLARIZATION	The activation of several G protein-coupled receptors is known to regulate the adhesive properties of cells in different contexts. Here, we reveal that G beta gamma subunits of heterotrimeric G proteins regulate cell-matrix adhesiveness by activating Rap1a-dependent inside-out signals and integrin activation. We show that G beta gamma subunits enter in a protein complex with activated Rap1a and its effector Radil and establish that this complex is required downstream of receptor stimulation for the activation of integrins and the positive modulation of cell-matrix adhesiveness. Moreover, we demonstrate that G beta gamma and activated Rap1a promote the translocation of Radil to the plasma membrane at sites of cell-matrix contacts. These results add to the molecular understanding of how G protein-coupled receptors impinge on cell adhesion and suggest that the G beta gamma.Rap1.Radil complex plays important roles in this process.	[Ahmed, Syed M.; Daulat, Avais M.; Meunier, Alexandre; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Angers, Stephane] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON M5S 3M2, Canada	University of Toronto; University of Toronto	Angers, S (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St, Toronto, ON M5S 3M2, Canada.	stephane.angers@utoronto.ca	Ahmed, Mukhtar/ABE-8477-2020; Ahmed, Mukhtar/HIR-3483-2022; Angers, Stephane/E-1432-2014	Angers, Stephane/0000-0001-7241-9044; Daulat, Avais/0000-0002-3076-2132; Ahmed, Syed Mukhtar/0000-0002-9183-9957	Natural Sciences and Engineering Research Council; Ontario Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship in Science and Technology	Supported by an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council and recipient of an Ontario Graduate Scholarship in Science and Technology.	Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 1997, FEBS LETT, V410, P59, DOI 10.1016/S0014-5793(97)00324-4; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Etzioni A, 2004, CURR OPIN ALLERGY CL, V4, P485, DOI 10.1097/00130832-200412000-00003; Faivre S, 2001, MOL PHARMACOL, V60, P363, DOI 10.1124/mol.60.2.363; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hao JJ, 2008, J PROTEOME RES, V7, P2911, DOI 10.1021/pr800016a; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Itoh M, 2007, CANCER RES, V67, P4759, DOI 10.1158/0008-5472.CAN-06-4246; Jeon TJ, 2007, J CELL BIOL, V179, P833, DOI 10.1083/jcb.200705068; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lafuente EM, 2007, LEUKEMIA LYMPHOMA, V48, P987, DOI 10.1080/10428190701242341; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; N'Diaye EN, 2003, J CELL BIOL, V163, P1157, DOI 10.1083/jcb.200307155; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Niggli V, 2009, BIOCHEM BIOPH RES CO, V386, P688, DOI 10.1016/j.bbrc.2009.06.098; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Savli H, 2008, EXP MOL MED, V40, P176, DOI 10.3858/emm.2008.40.2.176; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; SNYDERMAN R, 1981, SCIENCE, V213, P830, DOI 10.1126/science.6266014; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Till KJ, 2008, CANCER RES, V68, P8429, DOI 10.1158/0008-5472.CAN-08-1758; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	79	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6538	6551		10.1074/jbc.M109.069948	http://dx.doi.org/10.1074/jbc.M109.069948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048162	Green Published, hybrid			2022-12-27	WOS:000275367500059
J	Nilsson, SC; Nita, I; Mansson, L; Groeneveld, TWL; Trouw, LA; Villoutreix, BO; Blom, AM				Nilsson, Sara C.; Nita, Izabela; Mansson, Lisa; Groeneveld, Tom W. L.; Trouw, Leendert A.; Villoutreix, Bruno O.; Blom, Anna M.			Analysis of Binding Sites on Complement Factor I That Are Required for Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; CONFORMATIONAL-CHANGES; C4B-BINDING PROTEIN; C-3 CONVERTASE; X-RAY; CLEAVAGE; COFACTOR; C3B; SUSCEPTIBILITY; PURIFICATION	The central complement inhibitor factor I (FI) degrades activated complement factors C4b and C3b in the presence of cofactors such as C4b-binding protein, factor H, complement receptor 1, and membrane cofactor protein. FI is a serine protease composed of two chains. The light chain comprises the serine protease domain, whereas the heavy chain contains several domains; that is, the FI and membrane attack complex domain (FIMAC), CD5, low density lipoprotein receptor 1 (LDLr1) and LDLr2 domains. To understand better how FI acts as a complement inhibitor, we used homology-based models of FI domains to predict potential binding sites. Specific amino acids were then mutated to yield 16 well expressed mutants, which were then purified from media of eukaryotic cells for functional analyses. The Michaelis constant (K-m) of all FI mutants toward a small substrate was not altered, whereas some mutants showed increased maximum initial velocity (V-max). All the mutations in the FIMAC domain affected the ability of FI to degrade C4b and C3b irrespective of the cofactor used, whereas only some mutations in the CD5 and LDLr1/2 domains had a similar effect. These same mutants also showed impaired binding to C3met. In conclusion, the FIMAC domain appears to harbor the main binding sites important for the ability of FI to degrade C4b and C3b.	[Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden; [Trouw, Leendert A.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Villoutreix, Bruno O.] Univ Paris Diderot, INSERM, MTi U973, F-75205 Paris, France	Lund University; Skane University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blom, AM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Villoutreix, Bruno/I-4565-2015; Blom, Anna/AFS-7369-2022; Trouw, Leendert/AGK-5202-2022; Blom, Anna/B-9607-2009	Villoutreix, Bruno/0000-0002-6456-7730; Trouw, Leendert/0000-0001-5186-2290; Blom, Anna/0000-0002-1348-1734; Groeneveld, Tom/0000-0002-9095-3280	United States Immunodeficiency Network; Swedish Research Council; Soderberg Foundation; Swedish Foundation for Strategic Research; Foundations of Osterlund	United States Immunodeficiency Network; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundations of Osterlund	This work was supported by the United States Immunodeficiency Network, the Swedish Research Council, the Soderberg Foundation, the Swedish Foundation for Strategic Research, and the Foundations of Osterlund, Greta and Johan Kock, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg.	ADAMS EM, 1991, J IMMUNOL, V147, P3005; Amadei N, 2001, SCAND J IMMUNOL, V53, P615, DOI 10.1046/j.1365-3083.2001.00931.x; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Chamberlain D, 1998, BIOCHEMISTRY-US, V37, P13918, DOI 10.1021/bi9805184; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; EKDAHL KN, 1990, J IMMUNOL, V144, P4269; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; ISENMAN DE, 1983, J BIOL CHEM, V258, P4238; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; MEDOF ME, 1984, J EXP MED, V159, P1669, DOI 10.1084/jem.159.6.1669; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Nilsson SC, 2007, MOL IMMUNOL, V44, P1835, DOI 10.1016/j.molimm.2006.10.005; Nilsson SC, 2010, EUR J IMMUNOL, V40, P172, DOI 10.1002/eji.200939280; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; PERKINS SJ, 1993, BIOCHEM J, V295, P101, DOI 10.1042/bj2950101; Sadallah S, 1999, AM J KIDNEY DIS, V33, P1153, DOI 10.1016/S0272-6386(99)70155-1; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Tsiftsoglou SA, 2005, BIOCHEMISTRY-US, V44, P6239, DOI 10.1021/bi047680t; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Vyse TJ, 1996, J CLIN INVEST, V97, P925, DOI 10.1172/JCI118515; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6235	6245		10.1074/jbc.M109.097212	http://dx.doi.org/10.1074/jbc.M109.097212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20044478	Green Published, hybrid			2022-12-27	WOS:000275367500028
J	Sensken, SC; Graler, MH				Sensken, Sven-Christian; Graeler, Markus H.			Down- regulation of S1P(1) Receptor Surface Expression by Protein Kinase C Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; LYMPHOCYTE EGRESS; COUPLED RECEPTORS; RENAL-TRANSPLANTATION; THYMOCYTE EMIGRATION; DRUG FTY720; T-CELLS; IN-VIVO; SPHINGOSINE-1-PHOSPHATE; AGONISTS	The sphingosine 1-phosphate receptor type 1 (S1P(1)) is important for the maintenance of lymphocyte circulation. S1P(1) receptor surface expression on lymphocytes is critical for their egress from thymus and lymph nodes. Premature activation-induced internalization of the S1P(1) receptor in lymphoid organs, mediated either by pharmacological agonists or by inhibition of the S1P degrading enzyme S1P-lyase, blocks lymphocyte egress and induces lymphopenia in blood and lymph. Regulation of S1P(1) receptor surface expression is therefore a promising way to control adaptive immunity. Hence, we analyzed potential cellular targets for their ability to alter S1P(1) receptor surface expression without stimulation. The initial observation that preincubation of mouse splenocytes with its natural analog sphingosine was sufficient to block Transwell(TM) chemotaxis to S1P directed subsequent investigations to the underlying mechanism. Sphingosine is known to inhibit protein kinase C (PKC), and PKC inhibition with nanomolar concentrations of staurosporine, calphostin C, and GF109203X down-regulated surface expression of S1P(1) but not S1P(4) in transfected rat hepatoma HTC4 cells. The PKC activator phorbol 12-myristate 13-acetate partially rescued FTY720-induced down-regulation of the S1P(1) receptor, linking PKC activation with S1P(1) receptor surface expression. FTY720, but not FTY720 phosphate, efficiently inhibited PKC. Cell-based efficacy was obvious with 10 nM FTY720, and in vivo treatment of mice with 0.3-3 mg/kg/day FTY720 showed increasing concentration-dependent effectiveness. PKC inhibition therefore may contribute to lymphopenia by down-regulating S1P(1) receptor cell surface expression independently from its activation.	[Sensken, Sven-Christian; Graeler, Markus H.] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Hannover Medical School	Graler, MH (corresponding author), Hannover Med Sch, Inst Immunol, Bldg K11,OE 9422,Carl Neuberg Str 1, D-30625 Hannover, Germany.	graeler.markus@mh-hannover.de	Gräler, Markus/ABH-1905-2021	Gräler, Markus/0000-0001-6650-7849	Deutsche Forschungsgemeinschaft [1943/1-4]; Priority Program 1267 [GR-1943/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Program 1267	This work was supported by Deutsche Forschungsgemeinschaft Grants GR-1943/1-4 of the Emmy Noether Program and GR-1943/2-1 of Priority Program 1267 "Sphingolipids: Signal and Disease."	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; BAZZI MD, 1987, BIOCHEM BIOPH RES CO, V146, P203, DOI 10.1016/0006-291X(87)90711-X; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Budde K, 2006, CLIN TRANSPLANT, V20, P17, DOI 10.1111/j.1399-0012.2006.00596.x; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Graeler MH, 2003, J BIOL CHEM, V278, P27737, DOI 10.1074/jbc.C300147200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Liao JJ, 2007, J BIOL CHEM, V282, P1964, DOI 10.1074/jbc.M608597200; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Peest U, 2008, J CELL BIOCHEM, V104, P756, DOI 10.1002/jcb.21665; Premenko-Lanier M, 2008, NATURE, V454, P894, DOI 10.1038/nature07199; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Tedesco-Silva H, 2007, TRANSPLANTATION, V84, P885, DOI 10.1097/01.tp.0000281385.26500.3b; Vessey DA, 2007, J BIOCHEM MOL TOXIC, V21, P273, DOI 10.1002/jbt.20193; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; WALTON GM, 1987, ANAL BIOCHEM, V161, P425, DOI 10.1016/0003-2697(87)90471-4; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; 2009, NAT REV DRUG DISCOV, V8, P98	46	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6298	6307		10.1074/jbc.M109.049692	http://dx.doi.org/10.1074/jbc.M109.049692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032465	hybrid, Green Published			2022-12-27	WOS:000275367500034
J	Manna, PT; Smith, AJ; Taneja, TK; Howell, GJ; Lippiat, JD; Sivaprasadarao, A				Manna, Paul T.; Smith, Andrew J.; Taneja, Tarvinder K.; Howell, Gareth J.; Lippiat, Jonathan D.; Sivaprasadarao, Asipu			Constitutive Endocytic Recycling and Protein Kinase C-mediated Lysosomal Degradation Control K-ATP Channel Surface Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; SENSITIVE POTASSIUM CHANNELS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; ACTIVATING MUTATIONS; TRAFFICKING; GLUCOSE; RAT; MODULATION	Pancreatic ATP-sensitive potassium (K-ATP) channels control insulin secretion by coupling the excitability of the pancreatic beta-cell to glucose metabolism. Little is currently known about how the plasma membrane density of these channels is regulated. We therefore set out to examine in detail the endocytosis and recycling of these channels and how these processes are regulated. To achieve this goal, we expressed K-ATP channels bearing an extracellular hemagglutinin epitope in human embryonic kidney cells and followed their fate along the endocytic pathway. Our results show that K-ATP channels undergo multiple rounds of endocytosis and recycling. Further, activation of protein kinase C (PKC) with phorbol 12-myristate 13-acetate significantly decreases K-ATP channel surface density by reducing channel recycling and diverting the channel to lysosomal degradation. These findings were recapitulated in the model pancreatic beta-cell line INS1e, where activation of PKC leads to a decrease in the surface density of native K-ATP channels. Because sorting of internalized channels between lysosomal and recycling pathways could have opposite effects on the excitability of pancreatic beta-cells, we propose that PKC-regulated K-ATP channel trafficking may play a role in the regulation of insulin secretion.	[Manna, Paul T.; Smith, Andrew J.; Taneja, Tarvinder K.; Howell, Gareth J.; Lippiat, Jonathan D.; Sivaprasadarao, Asipu] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England.	a.sivaprasadarao@leeds.ac.uk		Lippiat, Jonathan/0000-0003-3748-7345; Sivaprasadarao, Asipu/0000-0002-6755-3502; Manna, Paul Thomas/0000-0002-2260-2075	Medical Research Council, United Kingdom; BBSRC [BB/D524875/1] Funding Source: UKRI; MRC [G0802050] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish; Medical Research Council [G0802050] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, United Kingdom.	ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Garg V, 2007, AM J PHYSIOL-HEART C, V293, pH322, DOI 10.1152/ajpheart.01035.2006; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nesher R, 2002, DIABETES, V51, pS68, DOI 10.2337/diabetes.51.2007.S68; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Partridge CJ, 2001, J BIOL CHEM, V276, P35947, DOI 10.1074/jbc.M104762200; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Sivaprasadarao A, 2007, BIOCHEM SOC T, V35, P1055, DOI 10.1042/BST0351055; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Warwar N, 2008, BBA-MOL CELL RES, V1783, P1929, DOI 10.1016/j.bbamcr.2008.04.007; WILEMAN T, 1984, BIOCHEM J, V220, P665, DOI 10.1042/bj2200665; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241	45	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5963	5973		10.1074/jbc.M109.066902	http://dx.doi.org/10.1074/jbc.M109.066902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20026601	Green Published, hybrid			2022-12-27	WOS:000275327200086
J	Gerashchenko, MV; Su, D; Gladyshev, VN				Gerashchenko, Maxim V.; Su, Dan; Gladyshev, Vadim N.			CUG Start Codon Generates Thioredoxin/Glutathione Reductase Isoforms in Mouse Testes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL THIOREDOXIN REDUCTASE; ALTERNATIVE SPLICING VARIANT; TRANSLATION INITIATION; GLUTATHIONE-REDUCTASE; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; SPERM MATURATION; SELENOCYSTEINE; MECHANISM; GENE	Mammalian cytosolic and mitochondrial thioredoxin reductases are essential selenocysteine-containing enzymes that control thioredoxin functions. Thioredoxin/glutathione reductase (TGR) is a third member of this enzyme family. It has an additional glutaredoxin domain and shows highest expression in testes. Herein, we found that human and several other mammalian TGR genes lack any AUG codons that could function in translation initiation. Although mouse and rat TGRs have such codons, we detected protein sequences upstream of them by immunoblot assays and direct proteomic analyses. Further gene engineering and expression analyses demonstrated that a CUG codon, located upstream of the sequences previously thought to initiate translation, is the actual start codon in mouse TGR. The use of this codon relies on the Kozak consensus sequence and ribosome-scanning mechanism. However, CUG serves as an inefficient start codon that allows downstream initiation, thus generating two isoforms of the enzyme in vivo and in vitro. The use of CUG evolved in mammalian TGRs, and in some of these organisms, GUG is used instead. The newly discovered longer TGR form shows cytosolic localization in cultured cells and is expressed in spermatids in mouse testes. This study shows that CUG codon is used as an inefficient start codon to generate protein isoforms in mouse.	[Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gerashchenko, Maxim V.; Su, Dan; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Gerashchenko, Maxim V.; Su, Dan; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Div Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Su, Dan/B-1972-2010; Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Gladyshev, Vadim/0000-0002-0372-7016; Gerashchenko, Maxim/0000-0001-8396-2202	NIGMS NIH HHS [R37 GM065204, GM065204, R01 GM065204] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065204, R37GM065204] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Andersson M, 1996, J BIOL CHEM, V271, P10116, DOI 10.1074/jbc.271.17.10116; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Chang EY, 2005, FREE RADICAL BIO MED, V39, P1666, DOI 10.1016/j.freeradbiomed.2005.08.008; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; FALVEY E, 1995, EMBO J, V14, P4307, DOI 10.1002/j.1460-2075.1995.tb00105.x; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Imataka H, 1997, EMBO J, V16, P817, DOI 10.1093/emboj/16.4.817; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kehr S, 2009, J MOL BIOL, V389, P808, DOI 10.1016/j.jmb.2009.04.024; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Miranda-Vizuete A, 2002, MOL CELLS, V13, P488; Mokrejs M, 2006, NUCLEIC ACIDS RES, V34, pD125, DOI 10.1093/nar/gkj081; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; Rundlof AK, 2007, DIFFERENTIATION, V75, P123, DOI 10.1111/j.1432-0436.2006.00121.x; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; TAIRA M, 1990, J BIOL CHEM, V265, P16491; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	47	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4595	4602		10.1074/jbc.M109.070532	http://dx.doi.org/10.1074/jbc.M109.070532			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018845	Green Published, hybrid			2022-12-27	WOS:000275274800037
J	Palmer, SJ; Santucci, N; Widagdo, J; Bontempo, SJ; Taylor, KM; Tay, ESE; Hook, J; Lemckert, F; Gunning, PW; Hardeman, EC				Palmer, Stephen J.; Santucci, Nicole; Widagdo, Jocelyn; Bontempo, Sara J.; Taylor, Kylie M.; Tay, Enoch S. E.; Hook, Jeff; Lemckert, Frances; Gunning, Peter W.; Hardeman, Edna C.			Negative Autoregulation of GTF2IRD1 in Williams-Beuren Syndrome via a Novel DNA Binding Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; GENERAL TRANSCRIPTION FACTOR-3; TFII-I GENES; EXPRESSION; DELETION; MICE; ENHANCER; REPEATS; 7Q11.23; PROTEIN	The GTF2IRD1 gene is of principal interest to the study of Williams-Beuren syndrome (WBS). This neurodevelopmental disorder results from the hemizygous deletion of a region of chromosome 7q11.23 containing 28 genes including GTF2IRD1. WBS is thought to be caused by haploinsufficiency of certain dosage-sensitive genes within the deleted region, and the feature of supravalvular aortic stenosis (SVAS) has been attributed to reduced elastin caused by deletion of ELN. Human genetic mapping data have implicated two related genes GTF2IRD1 and GTF2I in the cause of some the key features of WBS, including craniofacial dysmorphology, hypersociability, and visuospatial deficits. Mice with mutations of the Gtf2ird1 allele show evidence of craniofacial abnormalities and behavioral changes. Here we show the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. The affinity for this protein-DNA interaction is critically dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This autoregulatory mechanism leads to dosage compensation of GTF2IRD1 transcription in WBS patients. The GTF2IRD1 promoter represents the first established in vivo gene target of the GTF2IRD1 protein, and we use it to model its DNA interaction capabilities.	[Palmer, Stephen J.] Univ New S Wales, Dept Anat, Sch Med Sci, Sydney, NSW 2052, Australia; [Hook, Jeff; Gunning, Peter W.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Santucci, Nicole; Bontempo, Sara J.; Tay, Enoch S. E.] Childrens Hosp, Muscle Dev Unit, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Lemckert, Frances; Gunning, Peter W.] Childrens Hosp, Oncol Res Unit, Westmead, NSW 2145, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Children's Medical Research Institute - Australia; University of Sydney; University of Sydney	Palmer, SJ (corresponding author), Univ New S Wales, Dept Anat, Sch Med Sci, Rm 502,Wallace Wurth C27, Sydney, NSW 2052, Australia.	s.palmer@unsw.edu.au	Gunning, Peter W/E-9058-2010; Palmer, Stephen/F-2822-2013; Hardeman, Edna C/F-8872-2012; Widagdo, Jocelyn/J-6316-2013	Palmer, Stephen/0000-0002-4907-4719; Widagdo, Jocelyn/0000-0001-9667-9203; Hardeman, Edna/0000-0003-1649-7712; Gunning, Peter/0000-0003-0833-3128	Australian National Health and Medical Research Council (NHMRC) [423401]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Project Grant 423401 from the Australian National Health and Medical Research Council (NHMRC).	ANTONELL A, 2009, J MED GENET; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Collette JC, 2009, J HUM GENET, V54, P193, DOI 10.1038/jhg.2009.5; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Durkin ME, 2001, GENOMICS, V73, P20, DOI 10.1006/geno.2001.6507; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Karmiloff-Smith A, 2003, J MED GENET, V40, P136, DOI 10.1136/jmg.40.2.136; Li HH, 2009, EMBO MOL MED, V1, P50, DOI 10.1002/emmm.200900003; Makeyev AV, 2009, GENE, V433, P16, DOI 10.1016/j.gene.2008.11.027; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Palmer SJ, 2007, GENE EXPR PATTERNS, V7, P396, DOI 10.1016/j.modgep.2006.11.008; Polly P, 2003, J BIOL CHEM, V278, P36603, DOI 10.1074/jbc.M212814200; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Stekel DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-6; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tay ESE, 2003, BIOCHEM J, V374, P359, DOI 10.1042/BJ20030189; Thompson PD, 2007, FEBS LETT, V581, P1233, DOI 10.1016/j.febslet.2007.02.040; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; van Hagen JM, 2007, NEUROBIOL DIS, V26, P112, DOI 10.1016/j.nbd.2006.12.009; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x	33	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4715	4724		10.1074/jbc.M109.086660	http://dx.doi.org/10.1074/jbc.M109.086660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007321	hybrid, Green Published			2022-12-27	WOS:000275274800049
J	Pike, ST; Rajendra, R; Artzt, K; Appling, DR				Pike, Schuyler T.; Rajendra, Rashmi; Artzt, Karen; Appling, Dean R.			Mitochondrial C-1-Tetrahydrofolate Synthase (MTHFD1L) Supports the Flow of Mitochondrial One-carbon Units into the Methyl Cycle in Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; DEPENDENT METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NEURAL-TUBE DEFECTS; SERINE HYDROXYMETHYLTRANSFERASE ISOZYMES; C-13 NMR ANALYSIS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; C1-TETRAHYDROFOLATE SYNTHASE; HOMOCYSTEINE REMETHYLATION; CELLS	Mitochondrial folate-dependent one-carbon (1-C) metabolism converts 1-C donors such as serine and glycine to formate, which is exported and incorporated into the cytoplasmic tetrahydrofolate (THF) 1-C pool. Developing embryos depend on this mitochondrial pathway to provide 1-C units for cytoplasmic process such as de novo purine biosynthesis and the methyl cycle. This pathway is composed of sequential methylene-THF dehydrogenase, methenyl-THF cyclohydrolase, and 10-formyl-THF synthetase activities. In embryonic mitochondria, the bifunctional MTHFD2 enzyme catalyzes the dehydrogenase and cyclohydrolase reactions, but the enzyme responsible for the mitochondrial synthetase reaction has not been identified in embryos. A monofunctional 10-formyl-THF synthetase (MTHFD1L gene product) functions in adult mitochondria and is a likely candidate for the embryonic activity. Here we show that the MTHFD1L enzyme is present in mitochondria from normal embryonic tissues and embryonic fibroblast cell lines, and embryonic mitochondria possess the ability to synthesize formate from glycine. The MTHFD1L transcript was detected at all stages of mouse embryogenesis examined. In situ hybridizations showed that MTHFD1L was expressed ubiquitously throughout the embryo but with localized regions of higher expression. The spatial pattern of MTHFD1L expression was virtually indistinguishable from that of MTHFD2 and MTHFD1 (cytoplasmic C-1-THF synthase) in embryonic day 9.5 mouse embryos, suggesting coordinated regulation. Finally, we show using stable isotope labeling that in an embryonic mouse cell line, greater than 75% of 1-C units entering the cytoplasmic methyl cycle are mitochondrially derived. Thus, a complete pathway of enzymes for supplying 1-C units from the mitochondria to the methyl cycle in embryonic tissues is established.	[Pike, Schuyler T.; Appling, Dean R.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Rajendra, Rashmi; Artzt, Karen] Univ Texas Austin, Mol Genet Sect, Austin, TX 78712 USA; [Rajendra, Rashmi; Artzt, Karen] Univ Texas Austin, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn,A5300, Austin, TX 78712 USA.	dappling@mail.utexas.edu		Pike, Schuyler/0000-0003-1366-9486	NICHD NIH HHS [HD10668, R01 HD010668] Funding Source: Medline; NIDDK NIH HHS [R01 DK061425, DK61425] Funding Source: Medline; NIGMS NIH HHS [R01 GM086856, GM086856] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086856] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Antony AC, 2000, TERATOLOGY, V62, P42, DOI 10.1002/1096-9926(200007)62:1&lt;42::AID-TERA9&gt;3.0.CO;2-U; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Atkinson DE, 1977, CELLULAR ENERGY META, DOI DOI 10.1016/C2009-0-03136-5; Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; BARLOWE C K, 1988, Biofactors, V1, P171; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; BELANGER C, 1989, J BIOL CHEM, V264, P4837; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Carter M, 1999, HUM MOL GENET, V8, P2199, DOI 10.1093/hmg/8.12.2199; Chen J, 1996, CANCER RES, V56, P4862; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; CONLON RA, 1992, DEVELOPMENT, V116, P357; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Greene NDE, 2005, AM J MED GENET C, V135C, P31, DOI 10.1002/ajmg.c.30051; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003; Howard KM, 2003, GENE, V319, P85, DOI 10.1016/S0378-1119(03)00796-0; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; HUM DW, 1988, J BIOL CHEM, V263, P15946; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kawakami K, 2003, CLIN CANCER RES, V9, P5860; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; Parle-McDermott A, 2009, HUM MUTAT, V30, P1650, DOI 10.1002/humu.21109; Pasternack LB, 1996, ARCH BIOCHEM BIOPHYS, V326, P158, DOI 10.1006/abbi.1996.0060; PASTERNACK LB, 1994, BIOCHEMISTRY-US, V33, P74, DOI 10.1021/bi00167a010; Patel H, 2005, ARCH BIOCHEM BIOPHYS, V442, P133, DOI 10.1016/j.abb.2005.07.022; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; Sies H., 1982, METABOLIC COMPARTMEN, P205; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; Spiegelstein O, 2004, DEV DYNAM, V231, P221, DOI 10.1002/dvdy.20107; STORCH KJ, 1988, AM J PHYSIOL, V255, pE322, DOI 10.1152/ajpendo.1988.255.3.E322; Sugiura T, 2004, BIOCHEM BIOPH RES CO, V315, P204, DOI 10.1016/j.bbrc.2004.01.035; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; VATANKHAH M, 1994, BIOL MASS SPECTROM, V23, P277, DOI 10.1002/bms.1200230507; Veech R. L., 1987, PYRIDINE NUCLEOTIDE, P79; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	58	93	94	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4612	4620		10.1074/jbc.M109.079855	http://dx.doi.org/10.1074/jbc.M109.079855			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948730	hybrid, Green Published			2022-12-27	WOS:000275274800039
J	Ishikawa, HO; Ayukawa, T; Nakayama, M; Higashi, S; Kamiyama, S; Nishihara, S; Aoki, K; Ishida, N; Sanai, Y; Matsuno, K				Ishikawa, Hiroyuki O.; Ayukawa, Tomonori; Nakayama, Minoru; Higashi, Shunsuke; Kamiyama, Shin; Nishihara, Shoko; Aoki, Kazuhisa; Ishida, Nobuhiro; Sanai, Yutaka; Matsuno, Kenji			Two Pathways for Importing GDP-fucose into the Endoplasmic Reticulum Lumen Function Redundantly in the O-Fucosylation of Notch in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE SUGAR TRANSPORTERS; DEFICIENCY TYPE-II; CONGENITAL DISORDER; MOLECULAR-CLONING; GLYCOSYLATION; GENE; CELL; GLYCOSYLTRANSFERASE; ENCODES; FRINGE	Notch is a transmembrane receptor that shares homology with proteins containing epidermal growth factor-like repeats and mediates the cell-cell interactions necessary for many cell fate decisions. In Drosophila, O-fucosyltransferase 1 catalyzes the O-fucosylation of these epidermal growth factor-like repeats. This O-fucose elongates, resulting in an O-linked tetrasaccharide that regulates the signaling activities of Notch. Fucosyltransferases utilize GDP-fucose, which is synthesized in the cytosol, but fucosylation occurs in the lumen of the endoplasmic reticulum (ER) and Golgi. Therefore, GDP-fucose uptake into the ER and Golgi is essential for fucosylation. However, although GDP-fucose biosynthesis is well understood, the mechanisms and intracellular routes of GDP-fucose transportation remain unclear. Our previous study on the Drosophila Golgi GDP-fucose transporter (Gfr), which specifically localizes to the Golgi, suggested that another GDP-fucose transporter(s) exists in Drosophila. Here, we identified Efr (ER GDP-fucose transporter), a GDP-fucose transporter that localizes specifically to the ER. Efr is a multifunctional nucleotide sugar transporter involved in the biosynthesis of heparan sulfate-glycosaminoglycan chains and the O-fucosylation of Notch. Comparison of the fucosylation defects in the N-glycans in Gfr and Efr mutants revealed that Gfr and Efr made distinct contributions to this modification; Gfr but not Efr was crucial for the fucosylation of N-glycans. We also found that Gfr and Efr function redundantly in the O-fucosylation of Notch, although they had different localizations and nucleotide sugar transportation specificities. These results indicate that two pathways for the nucleotide sugar supply, involving two nucleotide sugar transporters with distinct characteristics and distributions, contribute to the O-fucosylation of Notch.	[Ishikawa, Hiroyuki O.; Nakayama, Minoru; Matsuno, Kenji] Tokyo Univ Sci, Res Inst Sci & Technol, Genome & Drug Res Ctr, Chiba 2788510, Japan; [Ayukawa, Tomonori; Higashi, Shunsuke; Matsuno, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Kamiyama, Shin; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Tokyo 1928577, Japan; [Aoki, Kazuhisa; Ishida, Nobuhiro; Sanai, Yutaka] Tokyo Metropolitan Inst Med Sci, Dept Biochem Cell Res, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo University of Science; Tokyo University of Science; Soka University; Tokyo Metropolitan Institute of Medical Science	Matsuno, K (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Genome & Drug Res Ctr, 2641 Yamazaki, Chiba 2788510, Japan.	matsuno@rs.noda.tus.ac.jp		Nishihara, Shoko/0000-0002-1668-2603	Japanese Ministry of Education, Culture, Sports and Science; Proposal-oriented Research Promotion Program, Japan Science and Technology Agency	Japanese Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Proposal-oriented Research Promotion Program, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports and Science (to K. M.) and grants from the Proposal-oriented Research Promotion Program, Japan Science and Technology Agency (to K. M.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bakker H, 2005, GLYCOBIOLOGY, V15, P193, DOI 10.1093/glycob/cwh159; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hidalgo A, 2003, BLOOD, V101, P1705, DOI 10.1182/blood-2002-09-2840; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2004, EXP CELL RES, V301, P242, DOI 10.1016/j.yexcr.2004.08.043; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035	47	36	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4122	4129		10.1074/jbc.M109.016964	http://dx.doi.org/10.1074/jbc.M109.016964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948734	Green Published, hybrid			2022-12-27	WOS:000275254000064
J	Li, BH; Zhao, L; Wang, C; Guo, HZ; Wu, L; Zhang, XM; Qian, WZ; Wang, H; Guo, YJ				Li, Bohua; Zhao, Lei; Wang, Chong; Guo, Huaizu; Wu, Lan; Zhang, Xunming; Qian, Weizhu; Wang, Hao; Guo, Yajun			The Protein-Protein Interface Evolution Acts in a Similar Way to Antibody Affinity Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC HYPERMUTATION; STRUCTURAL BASIS; RATIONAL DESIGN; RECOGNITION; INTERLEUKIN-2; REPERTOIRE; ANTIGEN	Understanding the evolutionary mechanism that acts at the interfaces of protein-protein complexes is a fundamental issue with high interest for delineating the macromolecular complexes and networks responsible for regulation and complexity in biological systems. To investigate whether the evolution of protein-protein interface acts in a similar way as antibody affinity maturation, we incorporated evolutionary information derived from antibody affinity maturation with common simulation techniques to evaluate prediction success rates of the computational method in affinity improvement in four different systems: antibody-receptor, antibody-peptide, receptor-membrane ligand, and receptor-soluble ligand. It was interesting to find that the same evolutionary information could improve the prediction success rates in all the four protein-protein complexes with an exceptional high accuracy (>57%). One of the most striking findings in our present study is that not only in the antibody-combining site but in other protein-protein interfaces almost all of the affinity-enhancing mutations are located at the germline hotspot sequences (RGYW or WA), indicating that DNA hot spot mechanisms may be widely used in the evolution of protein-protein interfaces. Our data suggest that the evolution of distinct protein-protein interfaces may use the same basic strategy under selection pressure to maintain interactions. Additionally, our data indicate that classical simulation techniques incorporating the evolutionary information derived from in vivo antibody affinity maturation can be utilized as a powerful tool to improve the binding affinity of protein-protein complex with a high accuracy.	[Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Guo, Yajun] Second Mil Med Univ, Gen Hosp 301, Ctr Canc, Shanghai 200433, Peoples R China; [Li, Bohua; Qian, Weizhu; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Li, Bohua; Qian, Weizhu; Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Wang, Chong; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China; [Wang, Chong; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, New Lib Bldg,10-11th Floor,800 Xiang Yin Rd, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888; Zhao, Lei/0000-0002-5884-2708	National Natural Science Foundation of China; Ministry of Science and Technology of China; National Key Project for Infectious Diseases; National Key Project for New Drug Development and Manufacture; Shanghai Commission of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Project for Infectious Diseases; National Key Project for New Drug Development and Manufacture; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by grants from the National Natural Science Foundation of China, Ministry of Science and Technology of China (973 and 863 program projects), National Key Project for Infectious Diseases, National Key Project for New Drug Development and Manufacture, and Shanghai Commission of Science and Technology.	BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Clark LA, 2006, J IMMUNOL, V177, P333, DOI 10.4049/jimmunol.177.1.333; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Du JM, 2007, J BIOL CHEM, V282, P15073, DOI 10.1074/jbc.M701654200; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Gemma S, 2006, J MED CHEM, V49, P3421, DOI 10.1021/jm060257t; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5; Kabat E. A., 1991, NIH PUBLICATION; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9	37	20	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3865	3871		10.1074/jbc.M109.076547	http://dx.doi.org/10.1074/jbc.M109.076547			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007707	hybrid, Green Published			2022-12-27	WOS:000275254000040
J	Rahman, MA; Senga, T; Ito, S; Hyodo, T; Hasegawa, H; Hamaguchi, M				Rahman, Mohammad Aminur; Senga, Takeshi; Ito, Satoko; Hyodo, Toshinori; Hasegawa, Hitoki; Hamaguchi, Michinari			S-Nitrosylation at Cysteine 498 of c-Src Tyrosine Kinase Regulates Nitric Oxide-mediated Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUSTER MOTIF; E-CADHERIN; CANCER; TRANSFORMATION; MEMBRANE; MYRISTYLATION; ACTIVATION; SYNTHASES; PROTEINS; RESIDUES	Nitric oxide (NO) plays a pivotal role in tumorigenesis, particularly with relation to cancer cell invasion and metastasis. NO can reversibly couple to cysteine thiols to form an S-nitrosothiol, which regulates the enzymatic activities of target proteins. c-Src is a tyrosine kinase that promotes cancer cell invasion and metastasis. Interestingly, c-Src can be activated by NO stimulation. However, mechanisms by which NO stimulates Src kinase activity have not been elucidated. We report here that NO causes S-nitrosylation of c-Src at cysteine 498 (Cys(498)) to stimulate its kinase activity. Cys(498) is conserved among Src family kinases, and Cys(506) of c-Yes, which corresponds to Cys(498) of c-Src, was also important for the NO-mediated activation of c-Yes. Estrogens may work synergistically with NO to induce the proliferation and migration of many kinds of breast cancer cells. For example, beta-estradiol induces the expression of endothelial nitric synthase and production of NO in MCF7 cells. We found that activation of c-Src in MCF7 cells by beta-estradiol stimulation was mediated by the S-nitrosylation of Cys(498). In addition, we report that disruption of E-cadherin junctions and enhancement of cell invasion by beta-estradiol stimulation was mediated by NO-dependent activation of c-Src. These results identify a novel signaling pathway that links NO and Src family kinases to cancer cell invasion and metastasis.	[Rahman, Mohammad Aminur; Senga, Takeshi; Ito, Satoko; Hyodo, Toshinori; Hasegawa, Hitoki; Hamaguchi, Michinari] Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan	Nagoya University	Senga, T (corresponding author), Nagoya Univ, Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp; mhamagu@med.nagoya-u.ac.jp		Hyodo, Toshinori/0000-0003-3046-5338	Ministry of Education, Science, Culture and Technology of Japan	Ministry of Education, Science, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Culture and Technology of Japan.	Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; ALBINI A, 1986, P NATL ACAD SCI USA, V83, P8182, DOI 10.1073/pnas.83.21.8182; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; Chiarugi P, 2008, MOL CELLS, V26, P329; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JOVE R, 1989, ONCOGENE RES, V5, P49; JOVE R, 1987, CELL, V50, P937, DOI 10.1016/0092-8674(87)90520-4; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Loibl S, 2006, PATHOL RES PRACT, V202, P1, DOI 10.1016/j.prp.2005.10.003; Mayer BJ, 1998, CURR TOP MICROBIOL, V228, P1; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Oesterreich S, 2003, CANCER RES, V63, P5203; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Oo ML, 2003, ONCOGENE, V22, P1411, DOI 10.1038/sj.onc.1206286; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; Rahman MA, 2008, ONCOL REP, V19, P975; Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296; Senga T, 2008, CANCER SCI, V99, P571, DOI 10.1111/j.1349-7006.2007.00714.x; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Ying L, 2005, CANCER RES, V65, P9132, DOI 10.1158/0008-5472.CAN-05-1358	34	85	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3806	3814		10.1074/jbc.M109.059782	http://dx.doi.org/10.1074/jbc.M109.059782			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948721	Green Published, hybrid			2022-12-27	WOS:000275254000033
J	Yang, TB; Chaudhuri, S; Yang, LH; Du, LQ; Poovaiah, BW				Yang, Tianbao; Chaudhuri, Shubho; Yang, Lihua; Du, Liqun; Poovaiah, B. W.			A Calcium/Calmodulin-regulated Member of the Receptor-like Kinase Family Confers Cold Tolerance in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL REGION; FREEZING TOLERANCE; PROTEIN-PHOSPHORYLATION; GENE-EXPRESSION; CALCIUM; ARABIDOPSIS; CALMODULIN; CA2+/CALMODULIN; TRANSCRIPTOME; ACCLIMATION	Cold is a limiting environmental factor that adversely affects plant growth and productivity. Calcium/calmodulin-mediated signaling is believed to play a pivotal role in plant response to cold stress, but its exact role is not clearly understood. Here, we report that CRLK1, a novel calcium/calmodulin-regulated receptor-like kinase, is crucial for cold tolerance in plants. CRLK1 has two calmodulin-binding sites with different affinities as follows: one located at residues 369-390 with a K-d of 25 nM, and the other located at residues 28-112 with a K-d of 160 nM. Calcium/calmodulin stimulated the kinase activity, but the addition of chlorpromazine, a calmodulin antagonist, blocked its stimulation. CRLK1 is mainly localized in the plasma membrane, and its expression is stimulated by cold and hydrogen peroxide treatments. Under normal growth conditions, there is no noticeable phenotypic difference between wild-type and crlk1 knock-out mutant plants. However, as compared with wild-type plants, the crlk1 knock-out mutants exhibited an increased sensitivity to chilling and freezing temperatures. Northern analysis showed that the induction of cold-responsive genes, including CBF1, RD29A, COR15a, and KIN1 in crlk1 mutants, is delayed as compared with wild-type plants. These results indicate that CRLK1 is a positive regulator of cold tolerance in plants. Furthermore, our results suggest that CRLK1 plays a role in bridging calcium/calmodulin signaling and cold signaling.	[Poovaiah, B. W.] Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA; Washington State Univ, Dept Hort, Pullman, WA 99164 USA	Washington State University; Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA.	poovaiah@wsu.edu			United States Department of Agriculture [2008-35100-04566]; National Institute of Food and Agriculture; National Science Foundation [ISO-0642146]; Washington State University Agricultural Research Center	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); Washington State University Agricultural Research Center	This work was supported by the National Research Initiative Competitive Grant 2008-35100-04566 from the United States Department of Agriculture, the National Institute of Food and Agriculture, Grant ISO-0642146 from the National Science Foundation, and the Washington State University Agricultural Research Center.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Browse J, 2001, CURR OPIN PLANT BIOL, V4, P241, DOI 10.1016/S1369-5266(00)00167-9; Charpenteau M, 2004, BIOCHEM J, V379, P841, DOI 10.1042/BJ20031045; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; MONROY AF, 1993, PLANT PHYSIOL, V102, P1227, DOI 10.1104/pp.102.4.1227; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Polisensky DH, 1996, PLANT PHYSIOL, V111, P1271, DOI 10.1104/pp.111.4.1271; POOVAIAH BW, 1973, PLANT PHYSIOL, V52, P236, DOI 10.1104/pp.52.3.236; POOVAIAH BW, 1987, CRC CR REV PLANT SCI, V6, P47, DOI 10.1080/07352688709382247; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; Tahtiharju S, 1997, PLANTA, V203, P442, DOI 10.1007/s004250050212; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Townley HE, 2002, PLANT PHYSIOL, V128, P1169, DOI 10.1104/pp.010814; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; VELUTHAMBI K, 1984, SCIENCE, V223, P167, DOI 10.1126/science.223.4632.167; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yang TB, 2007, FUNCT PLANT BIOL, V34, P343, DOI 10.1071/FP06293; Zhang L, 2003, TRENDS PLANT SCI, V8, P123, DOI 10.1016/S1360-1385(03)00013-X	41	124	150	9	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7119	7126		10.1074/jbc.M109.035659	http://dx.doi.org/10.1074/jbc.M109.035659			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20026608	Green Published, hybrid			2022-12-27	WOS:000275415600025
J	Armstrong, JL; Flockhart, R; Veal, GJ; Lovat, PE; Redfern, CPF				Armstrong, Jane L.; Flockhart, Ross; Veal, Gareth J.; Lovat, Penny E.; Redfern, Christopher P. F.			Regulation of Endoplasmic Reticulum Stress-induced Cell Death by ATF4 in Neuroectodermal Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FENRETINIDE-INDUCED APOPTOSIS; MELANOMA-CELLS; PROTEASOME INHIBITORS; GROWTH ARREST; ALPHA-SUBUNIT; ER STRESS; IN-VITRO; PROTEIN; TRANSLATION; NOXA	The neuroectodermal tumors neuroblastoma and melanoma represent biologically aggressive and chemoresistant cancers. The chemotherapeutic agents fenretinide and bortezomib induce apoptosis through endoplasmic reticulum (ER) stress in these tumor types. The aim of this study was to test the hypothesis that the early events of ER stress signaling and response pathways induced by fenretinide and bortezomib are mediated by the eukaryotic initiation factor 2 alpha (eIF2 alpha)-ATF4 signaling pathway. Treatment of neuroblastoma and melanoma cell lines with fenretinide, bortezomib, or thapsigargin resulted in induction of eIF2 alpha signaling, characterized by increased expression of phosphorylated eIF2 alpha, ATF4, ATF3, and GADD34. These events correlated with induction of the pro-apoptotic protein Noxa. The cytotoxic response, characterized by up-regulation of Noxa and cell death, was dependent on ATF4, but not the ER-related pro-death signaling pathways involving GADD153 or IRE1. Although PERK-dependent phosphorylation of eIF2 alpha enhanced ATF4 protein levels during ER stress, cell death in response to fenretinide, bortezomib, or thapsigargin was not abrogated by inhibition of eIF2 alpha phosphorylation through PERK knockdown or overexpression of wild-type eIF2 alpha. Furthermore, ATF4 induction in response to ER stress was dependent primarily on transcriptional activation, which occurred in a PERK-and phosphorylated eIF2 alpha-independent manner. These results demonstrate that ATF4 mediates ER stress-induced cell death of neuroectodermal tumor cells in response to fenretinide or bortezomib. Understanding the complex regulation of cell death pathways in response to ER stress-inducing drugs has the potential to reveal novel therapeutic targets, thus allowing the development of improved treatment strategies to overcome chemoresistance.	[Armstrong, Jane L.; Flockhart, Ross; Lovat, Penny E.] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Armstrong, JL (corresponding author), Univ Newcastle, Sch Med, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	J.L.Armstrong@ncl.ac.uk	Longo, Kenneth A/A-5631-2010	Veal, Gareth/0000-0002-1897-8678; Redfern, Christopher/0000-0002-1833-8048; Armstrong, Jane/0000-0002-5822-0597; Lovat, Penny/0000-0002-6657-6825	Cancer Research UK; Newcastle Healthcare Charity; British Skin Foundation; Engineering and Physical Sciences Research Council [EP/C509005/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Newcastle Healthcare Charity; British Skin Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Cancer Research UK, the Newcastle Healthcare Charity, and the British Skin Foundation.	Adams J, 1999, CANCER RES, V59, P2615; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Carracedo A, 2006, CANCER RES, V66, P6748, DOI 10.1158/0008-5472.CAN-06-0169; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Hill DS, 2009, CLIN CANCER RES, V15, P1192, DOI 10.1158/1078-0432.CCR-08-2150; Iovanna JL, 2002, J GASTROINTEST CANC, V31, P89; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Linder S, 2005, DRUG RESIST UPDATE, V8, P199, DOI 10.1016/j.drup.2005.06.004; Lovat PE, 2000, EXP CELL RES, V260, P50, DOI 10.1006/excr.2000.4988; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Raffaghello L, 2003, INT J CANCER, V104, P559, DOI 10.1002/ijc.10991; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zu K, 2006, ONCOGENE, V25, P546, DOI 10.1038/sj.onc.1209071	41	118	121	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6091	6100		10.1074/jbc.M109.014092	http://dx.doi.org/10.1074/jbc.M109.014092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022965	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000275367500012
J	Butler, PL; Mallampalli, RK				Butler, Phillip L.; Mallampalli, Rama K.			Cross-talk between Remodeling and de Novo Pathways Maintains Phospholipid Balance through Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; PLATELET-ACTIVATING-FACTOR; ADULT-RAT LUNG; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; II CELLS; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; ACYL-COA; CHOLINEPHOSPHATE CYTIDYLYLTRANSFERASE; MOLECULAR DETERMINANTS	Phosphatidylcholine (PtdCho), the major phospholipid of animal membranes, is generated by its remodeling and de novo synthesis. Overexpression of the remodeling enzyme, LPCAT1 (acyl-CoA: lysophosphatidylcholine acyltransferase) in epithelia decreased de novo PtdCho synthesis without significantly altering cellular PtdCho mass. Overexpression of LPCAT1 increased degradation of CPT1 (cholinephosphotransferase), a resident Golgi enzyme that catalyzes the terminal step for de novo PtdCho synthesis. CPT1 degradation involved its multiubiquitination and processing via the lysosomal pathway. CPT1 mutants harboring arginine substitutions at multiple carboxyl-terminal lysines exhibited proteolytic resistance to effects of LPCAT1 overexpression in cells and restored de novo PtdCho synthesis. Thus, cross-talk between phospholipid remodeling and de novo pathways involves ubiquitin-lysosomal processing of a key molecular target that mechanistically provides homeostatic control of cellular PtdCho content.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Internal Med, Pittsburgh, PA 15213 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mallampalli, RK (corresponding author), UPMC Montefiore, NW628,3459 5th Ave, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			National Institutes of Health R01 [HL097376, HL096376, HL098174, HL081784, HL068135]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081784, R01HL098174, R01HL096376, R01HL068135, R01HL097376] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL097376, HL096376, HL098174, HL081784, and HL068135 (to R. K. M.). This work was also supported by a Merit Review Award from the Department of Veterans Affairs.	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Agassandian M, 2007, BIOCHEM J, V403, P409, DOI 10.1042/BJ20061364; Bladergroen BA, 1999, EUR J BIOCHEM, V264, P152, DOI 10.1046/j.1432-1327.1999.00589.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; CHEN M, 1990, AM J PHYSIOL, V258, pL195, DOI 10.1152/ajplung.1990.258.4.L195; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cui Z, 1995, BIOCHEM J, V312, P939, DOI 10.1042/bj3120939; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; Dietl P, 2004, BIOL NEONATE, V85, P299, DOI 10.1159/000078176; Fisher AB, 1997, AM J PHYSIOL-LUNG C, V272, pL238, DOI 10.1152/ajplung.1997.272.2.L238; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MALLAMPALLI RK, 1993, PEDIATR RES, V34, P502, DOI 10.1203/00006450-199310000-00024; MALLAMPALLI RK, 1994, AM J RESP CELL MOL, V10, P48, DOI 10.1165/ajrcmb.10.1.8292380; Mallampalli RK, 1996, BIOCHEM J, V318, P333, DOI 10.1042/bj3180333; MALLAMPALLI RK, 1994, AM J PHYSIOL-LUNG C, V267, pL641, DOI 10.1152/ajplung.1994.267.6.L641; MASON RJ, 1984, BIOCHIM BIOPHYS ACTA, V794, P392, DOI 10.1016/0005-2760(84)90005-5; McCoy DM, 2006, AM J RESP CELL MOL, V35, P394, DOI 10.1165/rcmb.2005-0401OC; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; McMaster CR, 1997, BBA-LIPID LIPID MET, V1348, P100, DOI 10.1016/S0005-2760(97)00097-0; MILLER JC, 1981, J BIOL CHEM, V256, P2662; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NICHOLAS TE, 1982, RESP PHYSIOL, V49, P315, DOI 10.1016/0034-5687(82)90119-0; Pelham HRB, 2004, CURR BIOL, V14, pR357, DOI 10.1016/j.cub.2004.04.027; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Salome RG, 2000, J APPL PHYSIOL, V88, P10, DOI 10.1152/jappl.2000.88.1.10; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; TERCE F, 1991, BIOCHIM BIOPHYS ACTA, V1084, P69, DOI 10.1016/0005-2760(91)90057-O; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P167, DOI 10.1016/0005-2760(91)90091-U; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; WRIGHT JR, 1990, AM J PHYSIOL, V259, pL1, DOI 10.1152/ajplung.1990.259.2.L1; Wright MM, 2001, J BIOL CHEM, V276, P25254, DOI 10.1074/jbc.M011552200; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746	55	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6246	6258		10.1074/jbc.M109.017350	http://dx.doi.org/10.1074/jbc.M109.017350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018880	hybrid, Green Published			2022-12-27	WOS:000275367500029
J	Machutta, CA; Bommineni, GR; Luckner, SR; Kapilashrami, K; Ruzsicska, B; Simmerling, C; Kisker, C; Tonge, PJ				Machutta, Carl A.; Bommineni, Gopal R.; Luckner, Sylvia R.; Kapilashrami, Kanishk; Ruzsicska, Bela; Simmerling, Carlos; Kisker, Caroline; Tonge, Peter J.			Slow Onset Inhibition of Bacterial beta-Ketoacyl-acyl Carrier Protein Synthases by Thiolactomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS KASA; ESCHERICHIA-COLI; RESIDENCE TIME; BIOLOGICAL PROPERTIES; CRYSTAL-STRUCTURE; ENOYL REDUCTASE; DRUG-TARGET; CELL-WALL; ENZYMES	Thiolactomycin (TLM), a natural product thiolactone antibiotic produced by species of Nocardia and Streptomyces, is an inhibitor of the beta-ketoacyl-acyl carrier protein synthase (KAS) enzymes in the bacterial fatty acid synthase pathway. Using enzyme kinetics and direct binding studies, TLM has been shown to bind preferentially to the acyl-enzyme intermediates of the KASI and KASII enzymes from Mycobacterium tuberculosis and Escherichia coli. These studies, which utilized acylenzyme mimics in which the active site cysteine was replaced by a glutamine, also revealed that TLM is a slow onset inhibitor of the KASI enzymes KasA and ecFabB but not of the KASII enzymes KasB and ecFabF. The differential affinity of TLM for the acyl-KAS enzymes is proposed to result from structural change involving the movement of helices alpha 5 and alpha 6 that prepare the enzyme to bind malonyl-AcpM or TLM and that is initiated by formation of hydrogen bonds between the acyl-enzyme thioester and the oxyanion hole. The finding that TLM is a slow onset inhibitor of ecFabB supports the proposal that the long residence time of TLM on the ecFabB homologues in Serratia marcescens and Klebsiella pneumonia is an important factor for the in vivo antibacterial activity of TLM against these two organisms despite the fact that the in vitro MIC values are only 100-200 mu g/ml. The mechanistic data on the interaction of TLM with KasA will provide an important foundation for the rational development of high affinity KasA inhibitors based on the thiolactone skeleton.	[Simmerling, Carlos; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Luckner, Sylvia R.; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	peter.tonge@sunysb.edu	Tonge, Peter J/A-7443-2009; Kisker, Caroline/T-1724-2019	Tonge, Peter J/0000-0003-1606-3471; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [R01AI044639]; Deutsche Forschungsgemeinschaft [SFB 630]; Forschungszentrum [FZ82]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI044639 (to P.J.T.). This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB 630 and Forschungszentrum FZ82 (to C.K.).	Argyrou A, 2006, BIOCHEMISTRY-US, V45, P13947, DOI 10.1021/bi061874m; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brown MS, 2003, J AM CHEM SOC, V125, P10166, DOI 10.1021/ja034540i; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; DeLano W.L, PYMOL MOL GRAPHICS S; Edwards P, 1997, FEBS LETT, V402, P62, DOI 10.1016/S0014-5793(96)01437-8; HAMADA S, 1990, ORAL MICROBIOL IMMUN, V5, P340, DOI 10.1111/j.1399-302X.1990.tb00438.x; HAYASHI T, 1983, BIOCHEM BIOPH RES CO, V115, P1108, DOI 10.1016/S0006-291X(83)80050-3; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Jackowski S, 2002, ANTIMICROB AGENTS CH, V46, P1246, DOI 10.1128/AAC.46.5.1246-1252.2002; Jones AL, 2003, PLANTA, V216, P752, DOI 10.1007/s00425-002-0925-z; Kim P, 2006, J MED CHEM, V49, P159, DOI 10.1021/jm050825p; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Liu XY, 2008, P NATL ACAD SCI USA, V105, P13321, DOI 10.1073/pnas.0806873105; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; McFadden JM, 2002, ORG LETT, V4, P3859, DOI 10.1021/ol026685k; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; NISHIDA I, 1986, J BIOCHEM-TOKYO, V99, P1447, DOI 10.1093/oxfordjournals.jbchem.a135614; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; OISHI H, 1982, J ANTIBIOT, V35, P391, DOI 10.7164/antibiotics.35.391; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; SATO T, 1989, J ANTIBIOT, V42, P890, DOI 10.7164/antibiotics.42.890; Schaeffer ML, 2004, TUBERCULOSIS, V84, P353, DOI 10.1016/j.tube.2004.03.001; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; Sridharan S, 2007, J MOL BIOL, V366, P469, DOI 10.1016/j.jmb.2006.11.006; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; TSAY JT, 1992, J BACTERIOL, V174, P508, DOI 10.1128/jb.174.2.508-513.1992; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Walsh C., 2003, ANTIBIOTICS ACTIONS, P23, DOI DOI 10.1128/9781555817886; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Zhang YM, 2006, J BIOL CHEM, V281, P17390, DOI 10.1074/jbc.M513199200	51	30	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6161	6169		10.1074/jbc.M109.077909	http://dx.doi.org/10.1074/jbc.M109.077909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018879	hybrid, Green Published			2022-12-27	WOS:000275367500020
J	Ding, BJ; LeJeune, D; Li, SS				Ding, Baojin; LeJeune, Danielle; Li, Shisheng			The C-terminal Repeat Domain of Spt5 Plays an Important Role in Suppression of Rad26-independent Transcription Coupled Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; GLOBAL GENOMIC REPAIR; DNA-DEPENDENT ATPASE; SACCHAROMYCES-CEREVISIAE; COCKAYNE-SYNDROME; ELONGATION-FACTOR; IN-VIVO; PREFERENTIAL REPAIR	In eukaryotic cells, transcription coupled nucleotide excision repair (TCR) is believed to be initiated by RNA polymerase II (Pol II) stalled at a lesion in the transcribed strand of a gene. Rad26, the yeast homolog of the human Cockayne syndrome group B (CSB) protein, plays an important role in TCR. Spt4, a transcription elongation factor that forms a complex with Spt5, has been shown to suppress TCR in rad26 Delta cells. Here we present evidence that Spt4 indirectly suppresses Rad26-independent TCR by protecting Spt5 from degradation and stabilizing the interaction of Spt5 with Pol II. We further found that the C-terminal repeat (CTR) domain of Spt5, which is dispensable for cell viability and is not involved in interactions with Spt4 and Pol II, plays an important role in the suppression. The Spt5 CTR is phosphorylated by the Bur kinase. Inactivation of the Bur kinase partially alleviates TCR in rad26 Delta cells. We propose that the Spt5 CTR suppresses Rad26-independent TCR by serving as a platform for assembly of a multiple protein suppressor complex that is associated with Pol II. Phosphorylation of the Spt5 CTR by the Bur kinase may facilitate the assembly of the suppressor complex.	[Ding, Baojin; LeJeune, Danielle; Li, Shisheng] Louisiana State Univ, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Ding, Baojin/J-5479-2015; Li, Shisheng/H-9126-2012	Ding, Baojin/0000-0002-2149-2599; Tatum, Danielle/0000-0002-3281-3853	National Science Foundation [MCB-0745229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0745229.	Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; COLLART MA, 2004, CURRENT PROTOCOLS MO; Ding BJ, 2007, DNA REPAIR, V6, P1661, DOI 10.1016/j.dnarep.2007.06.001; ELLENBERGER T, 2006, DNA REPAIR MUTAGENES; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jansen LET, 2002, NUCLEIC ACIDS RES, V30, P3532, DOI 10.1093/nar/gkf475; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; LeJeune D, 2009, DNA REPAIR, V8, P40, DOI 10.1016/j.dnarep.2008.08.010; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Li SH, 2006, J BIOL CHEM, V281, P36643, DOI 10.1074/jbc.M604885200; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 1997, J MOL BIOL, V271, P31, DOI 10.1006/jmbi.1997.1154; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LOMMEL L, 1991, MUTAT RES, V255, P183, DOI 10.1016/0921-8777(91)90052-Q; LUNDBLAD V, 2004, CURRENT PROTOCOLS MO; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1999, J BIOL CHEM, V274, P27823, DOI 10.1074/jbc.274.39.27823; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Ramsey KL, 2004, MOL CELL BIOL, V24, P6362, DOI 10.1128/MCB.24.14.6362-6378.2004; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Sambrook J., 2001, MOL CLONING LAB MANU; Schindler D, 1975, Methods Cell Biol, V12, P17; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SIKORSKI RS, 1989, GENETICS, V122, P19; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; SWANSON MS, 1992, GENETICS, V132, P325; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; WINSTON F, 1984, GENETICS, V107, P179; Winston F, 2001, GENOME BIOL, V2; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	74	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5317	5326		10.1074/jbc.M109.082818	http://dx.doi.org/10.1074/jbc.M109.082818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20042611	Green Published, hybrid			2022-12-27	WOS:000275327200025
J	Li, GR; Luna, C; Qiu, JM; Epstein, DL; Gonzalez, P				Li, Guorong; Luna, Coralia; Qiu, Jianming; Epstein, David L.; Gonzalez, Pedro			Targeting of Integrin beta 1 and Kinesin 2 alpha by MicroRNA 183	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRABECULAR MESHWORK CELLS; KINASE EXPRESSION INCREASES; RETINAL GANGLION-CELLS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; CELLULAR SENESCENCE; MALIGNANT PHENOTYPE; SIGNALING PATHWAYS; COLORECTAL-CANCER; MOUSE MODEL	MicroRNA 183 (miR-183) has been reported to inhibit tumor invasiveness and is believed to be involved in the development and function of ciliated neurosensory organs. We have recently found that expression of miR-183 increased after the induction of cellular senescence by exposure to H2O2. To gain insight into the biological roles of miR-183 we investigated two potential novel targets: integrin beta 1 (ITGB1) and kinesin 2 alpha (KIF2A). miR-183 significantly decreased the expression of ITGB1 and KIF2A measured by Western blot. Targeting of the 3'-untranslated region (3'-UTR) of ITGB1 and KIF2A by miR-183 was confirmed by luciferase assay. Transfection with miR-183 led to a significant decrease in cell invasion and migration capacities of HeLa cells that could be rescued by expression of ITGB1 lacking the 3'-UTR. Although miR-183 had no effects on cell adhesion in HeLa cells, it significantly decreased adhesion to laminin, gelatin, and collagen type I in normal human diploid fibroblasts and human trabecular meshwork cells. These effects were also rescued by expression of ITGB1 lacking the 3'-UTR. Targeting of KIF2A by miR-183 resulted in some increase in the formation of cells with monopolar spindles in HeLa cells but not in human diploid fibroblast or human trabecular meshwork cells. The regulation of ITGB1 expression by miR-183 provides a new mechanism for the anti-metastatic role of miR-183 and suggests that this miRNA could influence the development and function in neurosensory organs, and contribute to functional alterations associated with cellular senescence in human diploid fibroblasts and human trabecular meshwork cells.	[Li, Guorong; Luna, Coralia; Qiu, Jianming; Epstein, David L.; Gonzalez, Pedro] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA	Duke University	Gonzalez, P (corresponding author), 4002 AERI Bldg,2351 Erwin Rd, Durham, NC 27710 USA.	gonza012@mc.duke.edu	Ariel, Pablo/AGJ-4118-2022		NEI [EY01894, EY016228, EY019137, EY05722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY016228, R01EY001894, R21EY019137, P30EY005722] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY01894, EY016228, EY019137, and EY05722 from the NEI, and Research to Prevent Blindness.	Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; Bradley JMB, 2003, INVEST OPHTH VIS SCI, V44, P5174, DOI 10.1167/iovs.03-0213; Cann GM, 1996, DEV BIOL, V180, P82, DOI 10.1006/dbio.1996.0286; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Chow J, 2007, MOL VIS, V13, P1926; Clegg D O, 2000, Results Probl Cell Differ, V31, P141; Davies D, 2002, J COMP NEUROL, V445, P122, DOI 10.1002/cne.10161; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Fais S, 2007, CANCER LETT, V258, P155, DOI 10.1016/j.canlet.2007.09.014; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; Filla MS, 2006, INVEST OPHTH VIS SCI, V47, P1956, DOI 10.1167/iovs.05-0626; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jang CY, 2008, J CELL BIOL, V181, P255, DOI 10.1083/jcb.200711032; Johnstone MA, 2004, J GLAUCOMA, V13, P421, DOI 10.1097/01.ijg.0000131757.63542.24; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; KEMPERMAN H, 1994, INVAS METAST, V14, P98; Leu ST, 2004, DEV BIOL, V276, P416, DOI 10.1016/j.ydbio.2004.09.003; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Lugini L, 2003, LAB INVEST, V83, P1555, DOI 10.1097/01.LAB.0000098425.03006.42; Luna C, 2009, MOL VIS, V15, P534; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Marrs GS, 2006, MOL CELL NEUROSCI, V32, P230, DOI 10.1016/j.mcn.2006.04.005; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Skeith A, 1999, DEV BRAIN RES, V116, P123, DOI 10.1016/S0165-3806(99)00070-X; Soukup GA, 2009, BRAIN RES, V1277, P104, DOI 10.1016/j.brainres.2009.02.027; STEPHENS LE, 1993, J CELL BIOL, V123, P1607, DOI 10.1083/jcb.123.6.1607; Toyama K, 2005, HEARING RES, V201, P21, DOI 10.1016/j.heares.2004.04.019; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; White DE, 2007, J MAMMARY GLAND BIOL, V12, P135, DOI 10.1007/s10911-007-9045-5; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b	51	83	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5461	5471		10.1074/jbc.M109.037127	http://dx.doi.org/10.1074/jbc.M109.037127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19940135	Green Published, hybrid			2022-12-27	WOS:000275327200039
J	Fritton, JC; Kawashima, Y; Mejia, W; Courtland, HW; Elis, S; Sun, H; Wu, YG; Rosen, CJ; Clemmons, D; Yakar, S				Fritton, J. Christopher; Kawashima, Yuki; Mejia, Wilson; Courtland, Hayden-Williams; Elis, Sebastien; Sun, Hui; Wu, Yinjgie; Rosen, Clifford J.; Clemmons, David; Yakar, Shoshana			The Insulin-like Growth Factor-1 Binding Protein Acid-labile Subunit Alters Mesenchymal Stromal Cell Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY-COMPOSITION; ADIPOCYTE DIFFERENTIATION; RECEPTOR DEFICIENCY; BONE-MARROW; PPAR-GAMMA; HORMONE; SERUM; ROSIGLITAZONE; OSTEOPOROSIS; DENSITY	Age-related osteoporosis is accompanied by an increase in marrow adiposity and a reduction in serum insulin-like growth factor-1 (IGF-1) and the binding proteins that stabilize IGF-1. To determine the relationship between these proteins and bone marrow adiposity, we evaluated the adipogenic potential of marrow-derived mesenchymal stromal cells (MSCs) from mice with decreased serum IGF-1 due to knockdown of IGF-1 production by the liver or knock-out of the binding proteins. We employed 10-16-week-old, liver-specific IGF-1-deficient, IGFBP-3 knockout (BP3KO) and acid-labile subunit knock-out (ALSKO) mice. We found that expression of the late adipocyte differentiation marker peroxisome proliferator-activated receptor gamma was increased in marrow isolated from ALSKO mice. When induced with adipogenic media, MSC cultures from ALSKO mice revealed a significantly greater number of differentiated adipocytes compared with controls. MSCs from ALSKO mice also exhibited decreased alkaline-phosphatase positive colony size in cultures that were stimulated with osteoblast differentiation media. These osteoblast-like cells from ALSKO mice failed to induce osteoclastogenesis of control cells in co-culture assays, indicating that impairment of IGF-1 complex formation with ALS in bone marrow alters cell fate, leading to increased adipogenesis.	[Fritton, J. Christopher] Univ Med & Dent New Jersey, Dept Orthopaed, Newark, NJ 07103 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA; [Clemmons, David] Univ N Carolina, Div Endocrinol, Chapel Hill, NC 27599 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Maine Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Yakar, S (corresponding author), 1 Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	shoshana.yakar@mssm.edu	Elis, Sebastien/K-6158-2019	Fritton, James/0000-0002-6475-7622	National Institutes of Health [AR054919, AR055141, AR045433, AR053853, AR054604]; Charles H. Revson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054604, R01AR054919, R01AR055141, R01AR053853, R01AR045433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Revson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR054919 and AR055141 (to S. Y.), AG02331 (to D. C.), and AR045433, AR053853, and AR054604 (to C. J. R.). This work was also supported by a Charles H. Revson Foundation Fellowship (to J. C. F.).	Ackert-Bicknell CL, 2009, ENDOCRINOLOGY, V150, P1330, DOI 10.1210/en.2008-0936; Ali AT, 2005, CLIN CHIM ACTA, V354, P101, DOI 10.1016/j.cccn.2004.11.026; Bachrach LK, 1998, J BONE MINER RES, V13, P415, DOI 10.1359/jbmr.1998.13.3.415; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chan SSY, 2009, AM J PHYSIOL-ENDOC M, V296, pE654, DOI 10.1152/ajpendo.90846.2008; Di Iorgi N, 2008, J CLIN ENDOCR METAB, V93, P2281, DOI 10.1210/jc.2007-2691; Domene H M, 2005, J Endocrinol Invest, V28, P43; Domene HM, 2009, HORM RES, V72, P129, DOI 10.1159/000232486; FRITTON JC, 2010, J BONE MINE IN PRESS; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Garnero P, 2000, LANCET, V355, P898, DOI 10.1016/S0140-6736(99)05463-X; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Kasukawa Y, 2004, CURR PHARM DESIGN, V10, P2577, DOI 10.2174/1381612043383764; Labarta JI, 1997, CLIN ENDOCRINOL, V47, P657, DOI 10.1046/j.1365-2265.1997.2581078.x; Laron Z, 2006, CLIN ENDOCRINOL, V65, P114, DOI 10.1111/j.1365-2265.2006.02558.x; Lecka-Czernik B, 2007, ENDOCRINOLOGY, V148, P903, DOI 10.1210/en.2006-1121; Liney GP, 2007, J MAGN RESON IMAGING, V26, P787, DOI 10.1002/jmri.21072; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Misra M, 2008, AM J PHYSIOL-ENDOC M, V295, pE385, DOI 10.1152/ajpendo.00052.2008; Nam S Y, 2000, Obes Rev, V1, P73, DOI 10.1046/j.1467-789x.2000.00015.x; Niu TH, 2005, GENE, V361, P38, DOI 10.1016/j.gene.2005.07.016; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Ogawa S, 1999, BIOCHEM BIOPH RES CO, V260, P122, DOI 10.1006/bbrc.1999.0896; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; RUDLING M, 1992, P NATL ACAD SCI USA, V89, P6983, DOI 10.1073/pnas.89.15.6983; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Shang CA, 2003, MOL ENDOCRINOL, V17, P2494, DOI 10.1210/me.2003-0139; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Sztefko K, 2009, ADV MED SCI-POLAND, V54, P51, DOI 10.2478/v10039-009-0017-4; Ueland T, 2004, GROWTH HORM IGF RES, V14, P404, DOI 10.1016/j.ghir.2004.06.002; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2006, J ENDOCRINOL, V189, P289, DOI 10.1677/joe.1.06657; Yakar S, 2009, FASEB J, V23, P709, DOI 10.1096/fj.08-118976	37	15	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4709	4714		10.1074/jbc.M109.041913	http://dx.doi.org/10.1074/jbc.M109.041913			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007694	Green Published, hybrid			2022-12-27	WOS:000275274800048
J	Govindan, MV				Govindan, Manjapra Variath			Recruitment of cAMP-response Element-binding Protein and Histone Deacetylase Has Opposite Effects on Glucocorticoid Receptor Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; CORTICOTROPIN-RELEASING FACTOR; NUCLEAR FACTOR-I; CYCLIC-AMP; COREPRESSOR COMPLEX; PHOSPHORYLATED CREB; NEGATIVE REGULATION; TRANSGENIC MICE; ATT-20 CELLS; DNA-BINDING	Glucocorticoids control the synthesis of the glucocorticoid receptor (GR) in various tissues through a negative feedback regulation of the mRNA. In this study, we have identified feedback regulatory domains in the human GR gene promoter and examined the roles of GR, the cAMP-response element-binding protein (CREB), and HDAC-6 in association with promoter elements of the human GR gene. Using breast cancer T47D and HeLa-GR cells, we identify specific negative glucocorticoid-response elements in the GR gene. The feedback regulatory domains were also involved in interactions with CREB. GR-bound negative glucocorticoid-response elements recruited HDAC-6, and this was dependent on treatment with dexamethasone. Both CREB and HDAC-6 formed complexes with GR-dexamethasone. The HDAC-6 LXXLL motif between amino acids 313 and 418 made direct contact with the GR AF-1 domain. Interestingly enough, although the level of GR decreased in CREB knockdown cells, it was elevated in HDAC-6 knockdown cells. Our results suggest that CREB-P is dephosphorylated and that HDAC-6 is recruited by the GR, and they play opposite roles in the negative feedback regulation of the GR gene.	[Govindan, Manjapra Variath] Univ Laval, Ctr Rech Cancerol, Ctr Hosp Univ Quebec, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; [Govindan, Manjapra Variath] Univ Laval, Fac Med, Dept Mol Biol Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Govindan, MV (corresponding author), Univ Laval, Ctr Rech Cancerol, Ctr Hosp Univ Quebec, Hotel Dieu Quebec, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	mgovindanv@gmail.com						AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnes PJ, 1995, BIOCHEM SOC T, V23, P940, DOI 10.1042/bst0230940; BLACK EJ, 1991, ONCOGENE, V6, P1949; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; Bodwell JE, 1998, J STEROID BIOCHEM, V65, P91, DOI 10.1016/S0960-0760(97)00185-4; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Burke ZD, 1997, NEUROSCIENCE, V78, P1177, DOI 10.1016/S0306-4522(96)00603-3; CAIRNS C, 1993, DNA CELL BIOL, V12, P695, DOI 10.1089/dna.1993.12.695; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CHROUSOS GP, 1982, J CLIN INVEST, V69, P1261, DOI 10.1172/JCI110565; DALLMAN M F, 1972, Endocrinology, V91, P961; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; EBERWINE JH, 1984, J BIOL CHEM, V259, P2166; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Govindan M, 2009, P NATL ACAD SCI USA, V106, P19854, DOI 10.1073/pnas.0910134106; GOVINDAN MV, 1991, J STEROID BIOCHEM, V40, P317, DOI 10.1016/0960-0760(91)90197-D; GOVINDAN MV, 1980, EXP CELL RES, V127, P293, DOI 10.1016/0014-4827(80)90435-8; GuardiolaDiaz HM, 1996, MOL ENDOCRINOL, V10, P317, DOI 10.1210/me.10.3.317; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2003, METHOD ENZYMOL, V364, P246; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; JONES MT, 1976, J ENDOCRINOL, V69, P1, DOI 10.1677/joe.0.0690001; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kovacs KJ, 2000, J NEUROSCI, V20, P3843, DOI 10.1523/JNEUROSCI.20-10-03843.2000; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Kuwahara S, 2003, J NEUROSCI, V23, P10231; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LaRochelle O, 2008, J BIOL CHEM, V283, P8190, DOI 10.1074/jbc.M800640200; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; LECLERC S, 1991, J BIOL CHEM, V266, P17333; LECLERC S, 1991, J BIOL CHEM, V266, P8711; Levine SJ, 1996, AM J RESP CELL MOL, V15, P245, DOI 10.1165/ajrcmb.15.2.8703481; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PEPIN MC, 1992, MOL PHARMACOL, V41, P1016; PERRY M, 1982, J BIOL CHEM, V257, P7336; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; ROCHE PJ, 1988, GENE, V71, P421, DOI 10.1016/0378-1119(88)90059-5; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; ROSEN LB, 1992, ENDOCRINOLOGY, V130, P2237, DOI 10.1210/en.130.4.2237; SASAKI K, 1984, J BIOL CHEM, V259, P15424; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SCHILLING K, 1991, NEUROENDOCRINOLOGY, V53, P528, DOI 10.1159/000125768; SCHLECHTE JA, 1982, J STEROID BIOCHEM, V16, P69, DOI 10.1016/0022-4731(82)90145-5; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; TREMBLAY Y, 1988, P NATL ACAD SCI USA, V85, P8890, DOI 10.1073/pnas.85.23.8890; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VERBEECK MAE, 1990, FEBS LETT, V272, P89, DOI 10.1016/0014-5793(90)80455-R; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Warriar N, 1996, J BIOL CHEM, V271, P18662, DOI 10.1074/jbc.271.31.18662; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; Webster JC, 1997, J BIOL CHEM, V272, P9287; Werner S, 1996, STEROIDS, V61, P216, DOI 10.1016/0039-128X(96)00017-7; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	68	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4489	4510		10.1074/jbc.M109.072728	http://dx.doi.org/10.1074/jbc.M109.072728			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018896	Green Published, hybrid			2022-12-27	WOS:000275274800027
J	Zhao, YB; Shen, Y; Yang, SL; Wang, JY; Hu, QW; Wang, Y; He, Q				Zhao, Yuanbiao; Shen, Ye; Yang, Silu; Wang, Jiyong; Hu, Qiwen; Wang, Ying; He, Qun			Ubiquitin Ligase Components Cullin4 and DDB1 Are Essential for DNA Methylation in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLTRANSFERASE; CIRCADIAN CLOCK; EPIGENETIC INHERITANCE; LYSINE-9 METHYLATION; PROTEINS; HP1; HETEROCHROMATIN; ARABIDOPSIS; FREQUENCY; COMPLEX	DNA methylation and H3K9 trimethylation are involved in gene silencing and heterochromatin assembly in mammals and fungi. In the filamentous fungus Neurospora crassa, it has been demonstrated that H3K9 trimethylation catalyzed by histone methyltransferase DIM-5 is essential for DNA methylation. Trimethylated H3K9 is recognized by HP1, which then recruits the DNA methyltransferase DIM-2 to methylate the DNA. Here, we show that in Neurospora, ubiquitin ligase components Cullin4 and DDB1 are essential for DNA methylation. These proteins regulate DNA methylation through their effects on the trimethylation of histone H3K9. In addition, we showed that the E3 ligase activity of the Cul4-based ubiquitin ligase is required for its function in histone H3K9 trimethylation in Neurospora. Furthermore, we demonstrated that Cul4 and DDB1 are associated with the histone methyltransferase DIM-5 protein in vivo. Together, these results suggest a mechanism for DNA methylation control that may be applicable in other eukaryotic organisms.	[Zhao, Yuanbiao; Shen, Ye; Yang, Silu; Wang, Jiyong; Hu, Qiwen; Wang, Ying; He, Qun] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China	China Agricultural University	He, Q (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China.	qunhe@cau.edu.cn	zhao, yuanbiao/I-2990-2019		State Key Laboratory of Agrobiotechnology [2008SKLAB03-02]; Program for New Century Excellent Talents in University [NCET-06-0104]; Doctoral Program of Higher Education of China [20070019020]	State Key Laboratory of Agrobiotechnology; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by State Key Laboratory of Agrobiotechnology Grant 2008SKLAB03-02 (to Q. H.), Program for New Century Excellent Talents in University Grant NCET-06-0104, and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20070019020.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Honda S, 2008, MOL CELL BIOL, V28, P6044, DOI 10.1128/MCB.00823-08; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; REIS A, 1994, AM J HUM GENET, V54, P741; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035	51	47	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4355	4365		10.1074/jbc.M109.034710	http://dx.doi.org/10.1074/jbc.M109.034710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948733	Green Published, hybrid			2022-12-27	WOS:000275274800012
J	Peterfy, M; Harris, TE; Fujita, N; Reue, K				Peterfy, Miklos; Harris, Thurl E.; Fujita, Naoya; Reue, Karen			Insulin-stimulated Interaction with 14-3-3 Promotes Cytoplasmic Localization of Lipin-1 in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; SUBCELLULAR-LOCALIZATION; RAT HEPATOCYTES; DEPENDENT ACTIVATION; MAMMALIAN TARGET; KINASE-ACTIVITY; RAF-1 KINASE; FATTY-ACIDS; PHOSPHORYLATION; PROTEINS	Lipin-1 is a bifunctional protein involved in lipid metabolism and adipogenesis. Lipin-1 plays a role in the biosynthesis of triacylglycerol through its phosphatidate phosphatase activity and also acts as a transcriptional co-activator of genes involved in oxidative metabolism. Lipin-1 resides in the cytoplasm and translocates to the endoplasmic reticulum membrane to catalyze the phosphatidate phosphatase reaction. It also possesses a nuclear localization signal, which is required for its translocation to the nucleus and may therefore be important for lipin-1 co- activator function. Thus, subcellular localization may be an important factor in the regulation of this protein. Here, we show that the nuclear localization signal alone is not sufficient for lipin-1 nuclear localization, and identify lipin-1 interaction with 14-3-3 as a determinant of its subcellular localization. We demonstrate that lipin-1 interacts with 14-3-3 proteins and that overexpression of 14-3-3 promotes the cytoplasmic localization of lipin-1 in 3T3-L1 adipocytes. The effect of 14-3-3 is mediated through a serine-rich domain in lipin-1. Functional mapping of the 14-3-3-interacting region within the serine-rich domain indicates redundancy and cooperativity among several sites, including five phosphorylated serine and threonine residues. Insulin stimulation of 3T3-L1 adipocytes results in increased lipin-1 phosphorylation, enhanced interaction with 14-3-3, and predominantly cytoplasmic localization. In summary, our studies suggest that insulin may modulate the cellular function of lipin-1 by regulating its subcellular localization through interactions with 14-3-3 proteins.	[Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Peterfy, Miklos] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Peterfy, Miklos] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center; University of Virginia; Japanese Foundation for Cancer Research	Reue, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda 6506A,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu			National Institutes of Health [HL28481, DK28312]; American Diabetes Association [23018]; Cedars-Sinai Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Cedars-Sinai Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL28481 (to M. P. and K. R.) and DK28312 (to T. E. H.). This work was also supported by American Diabetes Association Grant 23018 (to M. P.) and the Cedars-Sinai Medical Center (to M. P.).	Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; BRINDLEY DN, 1988, PHOSPHATIDATE PHOSPH; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; DIGGLE TA, 1991, BIOCHEM J, V279, P545, DOI 10.1042/bj2790545; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Pierrat B, 2000, EUR J BIOCHEM, V267, P2680, DOI 10.1046/j.1432-1327.2000.01285.x; PITTNER RA, 1985, BIOCHEM J, V230, P525, DOI 10.1042/bj2300525; Porras A, 1996, INT J OBESITY, V20, pS43; Reue K, 2000, J LIPID RES, V41, P1067; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; WITTERS LA, 1983, J BIOL CHEM, V258, P5643; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	47	60	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3857	3864		10.1074/jbc.M109.072488	http://dx.doi.org/10.1074/jbc.M109.072488			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955570	hybrid, Green Published			2022-12-27	WOS:000275254000039
J	Rai, K; Jafri, IF; Chidester, S; James, SR; Karpf, AR; Cairns, BR; Jones, DA				Rai, Kunal; Jafri, Itrat F.; Chidester, Stephanie; James, Smitha R.; Karpf, Adam R.; Cairns, Bradley R.; Jones, David A.			Dnmt3 and G9a Cooperate for Tissue-specific Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG-BINDING-PROTEIN; DNA METHYLATION; EXPRESSION PATTERN; BHLH GENES; LIVER; BRAIN; METHYLTRANSFERASE; DIFFERENTIATION; REPLICATION; HOMEOBOX	Although DNA methylation is critical for proper embryonic and tissue-specific development, how different DNA methyltransferases affect tissue-specific development and their targets remains unknown. We address this issue in zebrafish through antisense-based morpholino knockdown of Dnmt3 and Dnmt1. Our data reveal that Dnmt3 is required for proper neurogenesis, and its absence results in profound defects in brain and retina. Interestingly, other organs such as intestine remain unaffected suggesting tissue-specific requirements of Dnmt3. Further, comparison of Dnmt1 knockdown phenotypes with those of Dnmt3suggested that these two families have distinct functions. Consistent with this idea, Dnmt1 failed to complement Dnmt3 deficiency, and Dnmt3 failed to complement Dnmt1 deficiency. Downstream of Dnmt3 we identify a neurogenesis regulator, lef1, as a Dnmt3-specific target gene that is demethylated and up-regulated in dnmt3 morphants. Knockdown of lef1 rescued neurogenesis defects resulting from Dnmt3 absence. Mechanistically, we show cooperation between Dnmt3 and an H3K9 methyltransferase G9a in regulating lef1. Further, like Dnmt1Suv39h1 cooperativity, Dnmt3 and G9a seemed to function together for tissue-specific development. G9a knockdown, but not Suv39h1 loss, phenocopied dnmt3 morphants and G9a overexpression provided a striking rescue of dnmt3 morphant phenotypes, whereas Suv39h1 overexpression failed, supporting the notion of specific DNMT-histone methyltransferase networks. Consistent with this model, H3K9me3 levels on the lef1 promoter were reduced in both dnmt3 and g9a morphants, and its knockdown rescued neurogenesis defects in g9a morphants. We propose a model wherein specific DNMT-histone methyltransferase networks are utilized to silence critical regulators of cell fate in a tissue-specific manner.	[Rai, Kunal; Jafri, Itrat F.; Chidester, Stephanie; Cairns, Bradley R.; Jones, David A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rai, Kunal; Jafri, Itrat F.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [James, Smitha R.; Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharm & Therapeut, Buffalo, NY 14263 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Roswell Park Cancer Institute	Cairns, BR (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu; david.jones@hci.utah.edu		Chidester, Stephanie/0000-0003-4163-3480; Karpf, Adam/0000-0002-0866-0666; Rai, Kunal/0000-0003-2321-6894	National Institutes of Health [R01 HD058506]; NCI [R01 CA116468, R01 CA11674]; Howard Hughes Medical Institute; HuntsmanCancer Foundation; Cancer Center [CA042014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA116468, R01CA116674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); HuntsmanCancer Foundation; Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD058506 (to D. A. J. and B. R. C.) and by NCI Grants R01 CA116468 and R01 CA11674 (to D. A. J. and A. R. K.). This work was also supported by the Howard Hughes Medical Institute (to B. R. C.), the HuntsmanCancer Foundation (to D. A. J. and B. R. C.), and Cancer Center Support Grant CA042014.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Anderson RM, 2009, DEV BIOL, V334, P213, DOI 10.1016/j.ydbio.2009.07.017; Beri S, 2007, J NEUROCHEM, V101, P1380, DOI 10.1111/j.1471-4159.2007.04539.x; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blader P, 1997, DEVELOPMENT, V124, P4557; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Denovan-Wright EM, 2000, BBA-GENE STRUCT EXPR, V1492, P227, DOI 10.1016/S0167-4781(00)00102-0; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Forsell J, 2001, J EXP BIOL, V204, P2517; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Hsu M, 2007, MOL CELL BIOL, V27, P5047, DOI 10.1128/MCB.02234-06; JACKSONGRUSBY L, 2001, NAT GENET, V39, P27; Kim CH, 1997, NEUROSCI LETT, V239, P113, DOI 10.1016/S0304-3940(97)00908-7; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; LI HS, 1994, DEV BIOL, V162, P181, DOI 10.1006/dbio.1994.1077; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PUSCHEL AW, 1992, MECH DEVELOP, V38, P197, DOI 10.1016/0925-4773(92)90053-M; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Stenkamp D L, 1998, Mol Vis, V4, P26; Tatematsu K, 2000, GENES CELLS, V5, P677, DOI 10.1046/j.1365-2443.2000.00359.x; Thomas T, 1998, DEVELOPMENT, V125, P3005; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	48	95	97	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4110	4121		10.1074/jbc.M109.073676	http://dx.doi.org/10.1074/jbc.M109.073676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19946145	Green Published, hybrid			2022-12-27	WOS:000275254000063
J	Takahashi, E; Nagano, O; Ishimoto, T; Yae, T; Suzuki, Y; Shinoda, T; Nakamura, S; Niwa, S; Ikeda, S; Koga, H; Tanihara, H; Saya, H				Takahashi, Eri; Nagano, Osamu; Ishimoto, Takatsugu; Yae, Toshifumi; Suzuki, Yoshimi; Shinoda, Takeshi; Nakamura, Satoshi; Niwa, Shinichiro; Ikeda, Shun; Koga, Hisashi; Tanihara, Hidenobu; Saya, Hideyuki			Tumor Necrosis Factor-alpha Regulates Transforming Growth Factor-beta-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; ANCHORAGE-INDEPENDENT GROWTH; PROTEIN-KINASE-C; IN-VIVO; FIBROBLAST MIGRATION; ADHESION MOLECULES; HYALURONAN-BINDING; ENDOTHELIAL-CELLS; MICROARRAY DATA; UP-REGULATION	Aberrant epithelial-mesenchymal transition (EMT) is involved in development of fibrotic disorders and cancer invasion. Alterations of cell-extracellular matrix interaction also contribute to those pathological conditions. However, the functional interplay between EMT and cell-extracellular matrix interactions remains poorly understood. We now show that the inflammatory mediator tumor necrosis factor-alpha (TNF-alpha) induces the formation of fibrotic foci by cultured retinal pigment epithelial cells through activation of transforming growth factor-beta (TGF-beta) signaling in a manner dependent on hyaluronan-CD44- moesin interaction. TNF-alpha promoted CD44 expression and moesin phosphorylation by protein kinase C, leading to the pericellular interaction of hyaluronan and CD44. Formation of the hyaluronan-CD44-moesin complex resulted in both cell-cell dissociation and increased cellular motility through actin remodeling. Furthermore, this complex was found to be associated with TGF-beta receptor II and clathrin at actin microdomains, leading to activation of TGF-beta signaling. We established an in vivo model of TNF-alpha-induced fibrosis in the mouse eye, and such ocular fibrosis was attenuated in CD44-null mice. The production of hyaluronan and its interaction with CD44, thus, play an essential role in TNF-alpha-inducedEMTand are potential therapeutic targets in fibrotic disorders.	[Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo 1608582, Japan; [Takahashi, Eri; Tanihara, Hidenobu] Kumamoto Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Kumamoto 8608556, Japan; [Nagano, Osamu; Saya, Hideyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Suzuki, Yoshimi; Shinoda, Takeshi; Nakamura, Satoshi; Niwa, Shinichiro] Link Genom Inc, Dept Biomed Res & Dev, Tokyo 1030024, Japan; [Ikeda, Shun; Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Genome Res, Lab Med Genom, Chiba 2920818, Japan	Keio University; Kumamoto University; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	hsaya@a5.keio.jp	Saya, Hideyuki/J-4325-2013; Ishimoto, Takatsugu/AAP-1356-2020; Nagano, Osamu/J-5874-2013	Ishimoto, Takatsugu/0000-0003-1852-1835; Nagano, Osamu/0000-0002-7630-142X; Saya, Hideyuki/0000-0001-6610-1902	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to O.N. and H.S.) and by a grant from the National Institute of Biomedical Innovation, Japan (to H.S.).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; Anggiansah CL, 2003, J PHYSIOL-LONDON, V550, P631, DOI 10.1113/jphysiol.2003.038943; Armstrong D, 1998, OPHTHALMOLOGICA, V212, P410, DOI 10.1159/000027378; Banh A, 2007, MOL VIS, V13, P2248; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dureau P, 2000, GRAEF ARCH CLIN EXP, V238, P608, DOI 10.1007/s004170000156; Florquin S, 2002, AM J KIDNEY DIS, V39, P407, DOI 10.1053/ajkd.2002.30563; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; HAYNES BF, 1991, ARTHRITIS RHEUM, V34, P1434; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Kaida M, 2000, INVEST OPHTH VIS SCI, V41, P3215; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KAN FWK, 1990, ANAT REC, V228, P370, DOI 10.1002/ar.1092280403; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kosaki R, 1999, CANCER RES, V59, P1141; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; KUPPNER MC, 1993, CURR EYE RES, V12, P923, DOI 10.3109/02713689309020399; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Limb GA, 1996, GRAEF ARCH CLIN EXP, V234, P213, DOI 10.1007/BF00430412; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; Mitsuda S, 2005, DEV BIOL, V280, P122, DOI 10.1016/j.ydbio.2005.01.009; Mrass P, 2008, IMMUNITY, V29, P971, DOI 10.1016/j.immuni.2008.10.015; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Okamoto I, 1998, J NATL CANCER I, V90, P307, DOI 10.1093/jnci/90.4.307; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WIEDEMANN P, 1992, SURV OPHTHALMOL, V36, P373, DOI 10.1016/0039-6257(92)90115-A; Wyatt TA, 1997, AM J PHYSIOL-LUNG C, V273, pL1007, DOI 10.1152/ajplung.1997.273.5.L1007; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeng CX, 1998, INT J CANCER, V77, P396; ZUK A, 1989, J CELL BIOL, V108, P903, DOI 10.1083/jcb.108.3.903	65	127	133	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4060	4073		10.1074/jbc.M109.056523	http://dx.doi.org/10.1074/jbc.M109.056523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19965872	Green Published, hybrid			2022-12-27	WOS:000275254000059
J	Wan, T; Liu, T; Zhang, HF; Tang, SB; Min, W				Wan, Ting; Liu, Ting; Zhang, Haifeng; Tang, Shibo; Min, Wang			AIP1 Functions as Arf6-GAP to Negatively Regulate TLR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; ADAPTER MOLECULE; INTERFERON-BETA; PLASMA-MEMBRANE; PROTEIN; PATHWAY; FAMILY; ACTIVATION; TIRAP; TOLL-LIKE-RECEPTOR-4	Toll-like receptor 4 (TLR4) is unique among the Toll-like receptors in its ability to utilize TLR/IL1R-domain-containing adaptor protein (TIRAP), which recruits TLR4-MyD88 to phosphatidylinositol 4,5-bisphosphate (PIP2)-rich sites on the plasma membrane, to activate NF-kappa B and MAPK pathways. Here, we show that AIP1 disrupts formation of the TLR4-TIRAP-MyD88 complex without directly binding to any of the complex components. AIP1 via its pleckstrin homology and C2 domains binds to phosphatidylinositol 4-phosphate, a lipid precursor of PIP2. Knock-out of AIP1 in cells increases and overexpression of AIP1 reduces cellular PIP2 levels. We further show that AIP1 is a novel GTPase-activating protein (GAP) for Arf6, a small GTPase regulating cellular PIP2 production and formation of the TLR4-TIRAP-MyD88 complex. Thus, deletion of the GAPdomain on AIP1 results in a loss of its ability to mediate the inhibition of Arf6- and TLR4-induced signaling events. We conclude that AIP1 functions as a novel Arf6- GAP to negatively regulate PIP2-dependent TLR4-TIRAP-MyD88 signaling.	[Wan, Ting; Tang, Shibo; Min, Wang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; Yale Univ, Sch Med, Dept Pathol, Interdepartmental Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	Sun Yat Sen University; Yale University	Tang, SB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.	tangsb@mail.sysu.edu.cn; wang.min@yale.edu	TANG, Shi/GXH-5719-2022		National Institutes of Health [R01 HL-65978-5, P01HL070295-6]; National Nature Science Foundation of China [30828032]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065978, P01HL070295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-65978-5 and P01HL070295-6. This work was also supported by National Nature Science Foundation of China Grant 30828032 (to W. M.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200	26	24	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3750	3757		10.1074/jbc.M109.069385	http://dx.doi.org/10.1074/jbc.M109.069385			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948740	Green Published, hybrid			2022-12-27	WOS:000275254000027
J	Falae, A; Combe, A; Amaladoss, A; Carvalho, T; Menard, R; Bhanot, P				Falae, Adebola; Combe, Audrey; Amaladoss, Anburaj; Carvalho, Teresa; Menard, Robert; Bhanot, Purnima			Role of Plasmodium berghei cGMP-dependent Protein Kinase in Late Liver Stage Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; PROTECTIVE IMMUNITY; SPOROZOITES; CELLS; VACCINATION	The liver is the first organ infected by Plasmodium sporozoites during malaria infection. In the infected hepatocytes, sporozoites undergo a complex developmental program to eventually generate hepatic merozoites that are released into the bloodstream in membrane-bound vesicles termed merosomes. Parasites blocked at an early developmental stage inside hepatocytes elicit a protective host immune response, making them attractive targets in the effort to develop a pre-erythrocytic stage vaccine. Here, we generated parasites blocked at a late developmental stage inside hepatocytes by conditionally disrupting the Plasmodium berghei cGMP-dependent protein kinase in sporozoites. Mutant sporozoites are able to invade hepatocytes and undergo intracellular development. However, they remain blocked as late liver stages that do not release merosomes into the medium. These late arrested liver stages induce protection in immunized animals. This suggests that, similar to the well studied early liver stages, late stage liver stages too can confer protection from sporozoite challenge.	[Bhanot, Purnima] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Combe, Audrey; Carvalho, Teresa; Menard, Robert] Inst Pasteur, Unite Biol & Genet Paludisme, F-75724 Paris 15, France	Rutgers State University New Brunswick; Rutgers State University Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bhanot, P (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, 225 Warren St,E450D, Newark, NJ 07103 USA.	bhanotpu@umdnj.edu	Carvalho, Teresa/F-6414-2013; Carvalho, Teresa/P-4333-2019	Carvalho, Teresa/0000-0002-4947-371X; Carvalho, Teresa/0000-0002-4947-371X	American Heart Association [0735036N]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant 0735036N (to P.B.).	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Baker DA, 2004, TRENDS PARASITOL, V20, P227, DOI 10.1016/j.pt.2004.02.007; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; Deng WS, 2002, MOL MICROBIOL, V44, P1141, DOI 10.1046/j.1365-2958.2002.02948.x; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumar KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004480; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Renia L, 2008, PARASITE, V15, P379, DOI 10.1051/parasite/2008153379; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001	27	73	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3282	3288		10.1074/jbc.M109.070367	http://dx.doi.org/10.1074/jbc.M109.070367			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940133	hybrid, Green Published			2022-12-27	WOS:000273829000043
J	Norambuena, A; Palma, F; Poblete, MI; Donoso, MV; Pardo, E; Gonzalez, A; Huidobro-Toro, JP				Norambuena, Andres; Palma, Francisco; Poblete, M. Ines; Donoso, M. Veronica; Pardo, Evelyn; Gonzalez, Alfonso; Huidobro-Toro, J. Pablo			UTP Controls Cell Surface Distribution and Vasomotor Activity of the Human P2Y(2) Receptor through an Epidermal Growth Factor Receptor-transregulated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; PROMOTES CARDIOMYOCYTE HYPERTROPHY; ADHESION MOLECULE-1 EXPRESSION; GREEN FLUORESCENT PROTEIN; NUCLEOTIDE RECEPTOR; LIPID RAFTS; TYROSINE KINASE; ACTIN CYTOSKELETON; EGF RECEPTOR	Extracellular nucleotides transmit signals into the cells through the P2 family of cell surface receptors. These receptors are amply expressed in human blood vessels and participate in vascular tone control; however, their signaling mechanisms remain unknown. Here we show that in smooth muscle cells of isolated human chorionic arteries, the activation of the P2Y(2) receptor (P2Y(2)R) induces not only its partition into membrane rafts but also its rapid internalization. Cholesterol depletion with methyl-beta-cyclodextrin reduced the association of the agonist-activated receptor into membrane rafts but did not affect either the UTP-mediated vasoconstrictions or the vasomotor responses elicited by both serotonin and KCl. Ex vivo perfusion of human chorionic artery segments with 1-10 mu M UTP, a selective P2Y(2)R agonist, displaced the P2Y(2)R localization into membrane rafts within 1 min, a process preceded by the activation of both RhoA and Rac1 GTPases. AG1478, a selective and potent inhibitor of the epidermal growth factor receptor tyrosine kinase activity, not only blocked the UTP-induced vasomotor activity but also abrogated both RhoA and Rac1 activation, the P2Y(2)R association with membrane rafts, and its internalization. Altogether, these results show for the first time that the plasma membrane distribution of the P2Y(2)R is transregulated by the epidermal growth factor receptor, revealing an unsuspected functional interplay that controls both the membrane distribution and the vasomotor activity of the P2Y(2)R in intact human blood vessels.	Pontificia Univ Catolica Chile, Inst Milenio Biol Fundamental & Aplicada, Ctr Regulac Celular & Patol JV Luco, Santiago 7780344, Chile; [Norambuena, Andres] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Ciencias Fisiol, Fac Ciencias Biol, Charlottesville, VA 22908 USA; [Pardo, Evelyn; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Escuela Med, Santiago 7780344, Chile	Pontificia Universidad Catolica de Chile; University of Virginia; Pontificia Universidad Catolica de Chile	Norambuena, A (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Dept Ciencias Fisiol, Fac Ciencias Biol, Charlottesville, VA 22908 USA.	an2r@virginia.edu			Fondo Nacional de Areas Prioritarias [13980001]; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia [PFB12/2007]; Ministerio de Planificacion y Cooperacion de Chile; Center for Cell Regulation and Pathology; General Secretariat of the Organization of American States; Center for Cell Regulation and Pathology training; Comision Nacional de Investigacion Cientifica y Tecnologica graduate student	Fondo Nacional de Areas Prioritarias; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Ministerio de Planificacion y Cooperacion de Chile; Center for Cell Regulation and Pathology; General Secretariat of the Organization of American States; Center for Cell Regulation and Pathology training; Comision Nacional de Investigacion Cientifica y Tecnologica graduate student	This work was supported by Fondo Nacional de Areas Prioritarias Grant 13980001, Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia Grant PFB12/2007, and the Millenium Institute for Fundamental and Applied Biology, which is financed in part by the Ministerio de Planificacion y Cooperacion de Chile.; Supported in part by a postdoctoral training fellowship from the Center for Cell Regulation and Pathology and from the General Secretariat of the Organization of American States, Scholarship Program for Academic Studies. To whom correspondence should be addressed: Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908. E-mail: an2r@virginia.edu.; Supported by a Center for Cell Regulation and Pathology training fellowship.; Recipient of a Comision Nacional de Investigacion Cientifica y Tecnologica graduate student fellowship.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Benard V, 2002, METHOD ENZYMOL, V345, P349; BERK BC, 1985, J CLIN INVEST, V75, P1083, DOI 10.1172/JCI111772; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Buvinic S, 2006, J PHYSIOL-LONDON, V573, P427, DOI 10.1113/jphysiol.2006.105882; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Donoso MV, 2005, AM J PHYSIOL-HEART C, V288, pH2439, DOI 10.1152/ajpheart.00548.2004; Ecke D, 2008, BIOCHEM J, V409, P107, DOI 10.1042/BJ20070671; Elia MG, 2005, CELL SIGNAL, V17, P739, DOI 10.1016/j.cellsig.2004.10.013; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hailstones D, 1998, J LIPID RES, V39, P369; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; HOLLENBERG MD, 1995, MOL CELL BIOCHEM, V149, P77, DOI 10.1007/BF01076566; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lemarie CA, 2006, CIRC RES, V99, P434, DOI 10.1161/01.RES.0000237388.89261.47; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Loirand G, 1999, J PHYSIOL-LONDON, V516, P825, DOI 10.1111/j.1469-7793.1999.0825u.x; Maguire JJ, 2005, TRENDS PHARMACOL SCI, V26, P448, DOI 10.1016/j.tips.2005.07.007; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Morris JB, 2004, J BIOL CHEM, V279, P8740, DOI 10.1074/jbc.M310012200; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; MURAMATSU I, 1985, Canadian Journal of Physiology and Pharmacology, V63, P994; Murasawa S, 1998, HYPERTENSION, V32, P668, DOI 10.1161/01.HYP.32.4.668; Norambuena A, 2008, MOL PHARMACOL, V74, P1666, DOI 10.1124/mol.108.048496; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751, DOI 10.1152/ajpheart.2000.278.6.H1751; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Ushio-Fukai M, 2005, CIRC RES, V97, P829, DOI 10.1161/01.RES.0000185322.46009.F5; Valdecantos P, 2003, PLACENTA, V24, P17, DOI 10.1053/plac.2002.0862; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; WALTERS WAW, 1991, REPROD FERT DEVELOP, V3, P475, DOI 10.1071/RD9910475; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; YLIKORKALA O, 1985, AM J OBSTET GYNECOL, V152, P318, DOI 10.1016/S0002-9378(85)80221-0; Yu N, 2008, CIRC RES, V102, P581, DOI 10.1161/CIRCRESAHA.107.162271; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb	80	16	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2940	10.1074/jbc.M109.081166	http://dx.doi.org/10.1074/jbc.M109.081166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996104	Green Published, hybrid			2022-12-27	WOS:000273829000008
J	Paleskava, A; Konevega, AL; Rodnina, MV				Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.			Thermodynamic and Kinetic Framework of Selenocysteyl-tRNA(Sec) Recognition by Elongation Factor SelB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; FACTOR-TU; TRANSLATION FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TERNARY COMPLEX; SELENOCYSTEINE; BINDING; PURIFICATION	SelB is a specialized translation elongation factor that delivers selenocysteyl-tRNA(Sec) (Sec-tRNA(Sec)) to the ribosome. Here we show that Sec-tRNA(Sec) binds to SelB.GTP with an extraordinary high affinity (K-d = 0.2 pM). The tight binding is driven enthalpically and involves the net formation of four ion pairs, three of which may involve the Sec residue. The dissociation of tRNA from the ternary complex SelB.GTP.Sec-tRNA(Sec) is very slow (0.3 h(-1)), and GTP hydrolysis accelerates the release of Sect-RNA(Sec) by more than a million-fold (to 240 s(-1)). The affinities of Sec-tRNA(Sec) to SelB in the GDP or apoforms, or Ser-tRNA(Sec) and tRNA(Sec) to SelB in any form, are similar (K-d = 0.5 mu M). Thermodynamic coupling in binding of Sec-tRNA(Sec) and GTP to SelB ensures at the same time the specificity of Sec-versus Ser-tRNA(Sec) selection and rapid release of Sec-tRNA(Sec) from SelB after GTP cleavage on the ribosome. SelB provides an example for the evolution of a highly specialized protein-RNA complex toward recognition of unique set of identity elements. The mode of tRNA recognition by SelB is reminiscent of another specialized factor, eIF2, rather than of EF-Tu, the common delivery factor for all other aminoacyl-tRNAs, in line with a common evolutionary ancestry of SelB and eIF2.	[Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008; Paleskava, Alena/AAO-7332-2020	Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150; Paleskava, Alena/0000-0001-8623-8404	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	ABRAHAMSON JK, 1985, BIOCHEMISTRY-US, V24, P692, DOI 10.1021/bi00324a023; Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; Atkins JF, 2000, NATURE, V407, P463, DOI 10.1038/35035189; AXLEY MJ, 1991, P NATL ACAD SCI USA, V88, P8450, DOI 10.1073/pnas.88.19.8450; BARON C, 1991, J BIOL CHEM, V266, P20375; Baron Christian, 1995, P529; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Fischer N, 2007, BIOL CHEM, V388, P1061, DOI 10.1515/BC.2007.108; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hilgenfeld R, 1996, BIOCHIMIE, V78, P971, DOI 10.1016/S0300-9084(97)86719-3; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Huttenhofer A, 1998, COLD SPRING HARBOR M, P603; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Keeling PJ, 1998, J MOL EVOL, V47, P649, DOI 10.1007/PL00006422; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Kothe U, 2006, ANAL BIOCHEM, V356, P148, DOI 10.1016/j.ab.2006.04.038; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ose T, 2007, STRUCTURE, V15, P577, DOI 10.1016/j.str.2007.03.007; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; Rudinger J, 1996, EMBO J, V15, P650, DOI 10.1002/j.1460-2075.1996.tb00397.x; Selmer M, 2002, EMBO J, V21, P4145, DOI 10.1093/emboj/cdf408; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Thanbichler M, 2003, PROTEIN EXPRES PURIF, V31, P265, DOI 10.1016/S1046-5928(03)00167-0; Thanbichler M, 2002, METHOD ENZYMOL, V347, P3; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wintermeyer W, 1974, Methods Enzymol, V29, P667; Yoshizawa S, 2005, NAT STRUCT MOL BIOL, V12, P198, DOI 10.1038/nsmb890	40	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3014	10.1074/jbc.M109.081380	http://dx.doi.org/10.1074/jbc.M109.081380			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940162	Green Published, hybrid			2022-12-27	WOS:000273829000016
J	Skerget, K; Taler-Vercic, A; Bavdek, A; Hodnik, V; Ceru, S; Tusek-Znidaric, M; Kumm, T; Pitsi, D; Pompe-Novak, M; Palumaa, P; Soriano, S; Kopitar-Jerala, N; Turk, V; Anderluh, G; Zerovnik, E				Skerget, Katja; Taler-Vercic, Ajda; Bavdek, Andrej; Hodnik, Vesna; Ceru, Slavko; Tusek-Znidaric, Magda; Kumm, Tiina; Pitsi, Didier; Pompe-Novak, Marusa; Palumaa, Peep; Soriano, Salvador; Kopitar-Jerala, Natasa; Turk, Vito; Anderluh, Gregor; Zerovnik, Eva			Interaction between Oligomers of Stefin B and Amyloid-beta in Vitro and in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; HEAT-SHOCK PROTEINS; HUMAN CYSTATIN-C; FIBRIL FORMATION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; EPM1; COMPLEX; CONFORMATION; AGGREGATION	To contribute to the question of the putative role of cystatins in Alzheimer disease and in neuroprotection in general, we studied the interaction between human stefin B (cystatin B) and amyloid-beta-(1-40) peptide (A beta). Using surface plasmon resonance and electrospray mass spectrometry we were able to show a direct interaction between the two proteins. As an interesting new fact, we show that stefin B binding to A beta is oligomer specific. The dimers and tetramers of stefin B, which bind A beta, are domain-swapped as judged from structural studies. Consistent with the binding results, the same oligomers of stefin B inhibit A beta fibril formation. When expressed in cultured cells, stefin B co-localizes with A beta intracellular inclusions. It also co-immunoprecipitates with the APP fragment containing the A beta epitope. Thus, stefin B is another APP/A beta-binding protein in vitro and likely in cells.	[Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia; [Bavdek, Andrej; Hodnik, Vesna; Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; [Tusek-Znidaric, Magda; Pompe-Novak, Marusa] Natl Inst Biol, Dept Plant Physiol & Biotechnol, Ljubljana 1000, Slovenia; [Kumm, Tiina; Palumaa, Peep] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia; [Pitsi, Didier; Soriano, Salvador] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Dept Neurosci, London SE5 8AF, England; [Soriano, Salvador] Loma Linda Univ & Med Ctr, Div Human Anat, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; National Institute of Biology - Slovenia; Tallinn University of Technology; University of London; King's College London; Loma Linda University		eva.zerovnik@ijs.si	Zerovnik, Eva/AAB-6498-2022; Anderluh, Gregor/C-6905-2014; Palumaa, Peep/AAF-7617-2020; Palumaa, Peep/B-4668-2019; soriano, salvador/AAB-5595-2022	Anderluh, Gregor/0000-0002-9916-8465; Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; Kirsipuu, Tiina/0000-0002-2462-5617; Pompe Novak, Marusa/0000-0003-4176-849X	Slovenian Research Agency (ARRS) [P1-0140]; Estonian Science Foundation [9171]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Estonian Science Foundation	This work was supported by Program P1-0140 (proteolysis and its regulation, led by B. Turk) via the Slovenian Research Agency (ARRS) and Estonian Science Foundation Grant 9171 (to P.P.).	Anderluh G, 2005, FEBS J, V272, P3042, DOI 10.1111/j.1742-4658.2005.04717.x; BENUSSI L, 2006, HUMAN STEFINS CYSTAT, P115; Bernstein HG, 1996, MOL CHEM NEUROPATHOL, V27, P225, DOI 10.1007/BF02815106; BERNSTEIN HG, 1994, BRAIN RES BULL, V33, P477, DOI 10.1016/0361-9230(94)90071-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buckig A, 2002, HISTOCHEM CELL BIOL, V118, P353, DOI 10.1007/s00418-002-0459-2; Ceru S, 2008, AMYLOID, V15, P147, DOI 10.1080/13506120802193555; Cipollini E, 2008, BBA-MOL CELL RES, V1783, P312, DOI 10.1016/j.bbamcr.2007.08.007; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; ENGH RA, 1993, J MOL BIOL, V234, P1060, DOI 10.1006/jmbi.1993.1659; II K, 1993, VIRCHOWS ARCH A, V423, P185, DOI 10.1007/BF01614769; IVERFELDT K, 1993, P NATL ACAD SCI USA, V90, P4146, DOI 10.1073/pnas.90.9.4146; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jenko S, 2004, PROTEINS, V55, P417, DOI 10.1002/prot.20041; JERALA R, 1988, FEBS LETT, V239, P41, DOI 10.1016/0014-5793(88)80541-6; Jerala R, 1999, J MOL BIOL, V291, P1079, DOI 10.1006/jmbi.1999.3045; Joensuu T, 2008, EPILEPSIA, V49, P557, DOI 10.1111/j.1528-1167.2007.01422.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; KOPITARJERALA N, 1993, BIOCHIM BIOPHYS ACTA, V1164, P75, DOI 10.1016/0167-4838(93)90114-7; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; MARTIN JR, 1995, J MOL BIOL, V246, P331, DOI 10.1006/jmbi.1994.0088; MARUYAMA K, 1992, NEUROSCI LETT, V144, P38, DOI 10.1016/0304-3940(92)90710-O; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Morgan GJ, 2008, J MOL BIOL, V375, P487, DOI 10.1016/j.jmb.2007.10.033; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Rabzelj S, 2005, PROTEIN SCI, V14, P2713, DOI 10.1110/ps.051609705; Rabzelj S, 2008, FEBS J, V275, P2455, DOI 10.1111/j.1742-4658.2008.06390.x; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Skerget K, 2009, PROTEINS, V74, P425, DOI 10.1002/prot.22156; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235; Zerovnik E, 2002, BBA-PROTEIN STRUCT M, V1594, P1, DOI 10.1016/S0167-4838(01)00295-3; Zerovnik E, 1997, EUR J BIOCHEM, V245, P364, DOI 10.1111/j.1432-1033.1997.t01-1-00364.x; ZEROVNIK E, 2005, AMYLOID AMYLOIDOSIS, P21	50	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3201	3210		10.1074/jbc.M109.024620	http://dx.doi.org/10.1074/jbc.M109.024620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955183	Green Published, hybrid			2022-12-27	WOS:000273829000035
J	Attia, RR; Connnaughton, S; Boone, LR; Wang, F; Elam, MB; Ness, GC; Cook, GA; Park, EA				Attia, Ramy R.; Connnaughton, Sara; Boone, Lindsey R.; Wang, Fang; Elam, Marshall B.; Ness, Gene C.; Cook, George A.; Park, Edwards A.			Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone ROLE OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma COACTIVATOR (PGC-1 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FATTY-ACIDS; IN-VIVO; HEPATIC GLUCONEOGENESIS; OXIDATIVE-METABOLISM; PROTEIN EXPRESSION; ALPHA; INDUCTION; ISOFORM-4; MECHANISM	PDK4 (pyruvate dehydrogenase kinase 4) regulates pyruvate oxidation through the phosphorylation and inhibition of the pyruvate dehydrogenase complex (PDC). PDC catalyzes the conversion of pyruvate to acetyl-CoA and is an important control point in glucose and pyruvate metabolism. PDK4 gene expression is stimulated by thyroid hormone (T-3), glucocorticoids, and long chain fatty acids. The effects of T-3 on gene expression in the liver are mediated via the thyroid hormone receptor. Here, we have identified two binding sites for thyroid hormone receptor beta in the promoter of the rat PDK4 (rPDK4) gene. In addition, we have investigated the role of transcriptional coactivators and found that the PGC-1 alpha (peroxisome proliferator-activated receptor gamma coactivator) enhances the T-3 induction of rPDK4. Following T-3 administration, there is an increase in the association of PGC-1 alpha with the rPDK4 promoter. Interestingly, this increased association is with the proximal rPDK4 promoter rather than the distal region of the gene that contains the T-3 response elements. Administration of T-3 to hypothyroid rats elevated the abundance of PGC-1 alpha mRNA and protein in the liver. In addition, we observed greater association of PGC-1 alpha not only with the rPDK4 gene but also with phosphoenolpyruvate carboxykinase and CPT-1a (carnitine palmitoyltransferase 1a) genes. Knockdown of PGC-1 alpha in rat hepatocytes reduced the T-3 induction of PDK4, PEPCK, and CPT-1a genes. Our results indicate that T-3 regulates PGC-1 alpha abundance and association with hepatic genes, and in turn PGC-1 alpha is an important participant in the T-3 induction of selected genes.	[Attia, Ramy R.; Connnaughton, Sara; Wang, Fang; Elam, Marshall B.; Cook, George A.; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Boone, Lindsey R.; Ness, Gene C.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; State University System of Florida; University of South Florida	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [DK0059368, DK075504, DK075414]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368, R01DK075414, R01DK075504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK0059368 (to E.A.P.), DK075504 (to M.B.E.), and DK075414 (to G.C.N.).	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V265, P97, DOI 10.1023/B:MCBI.0000044321.17680.a2; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; HEIMBERG M, 1985, ENDOCR REV, V6, P590, DOI 10.1210/edrv-6-4-590; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Lagor WR, 2007, EXP BIOL MED, V232, P353; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Lopez D, 2006, BBA-MOL CELL BIOL L, V1761, P492, DOI 10.1016/j.bbalip.2006.03.012; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; MYNATT RL, 1994, BIOCHEM BIOPH RES CO, V201, P932, DOI 10.1006/bbrc.1994.1791; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Priestman DA, 1997, FEBS LETT, V419, P55, DOI 10.1016/S0014-5793(97)01430-0; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sugden MC, 1996, MOL CELL ENDOCRINOL, V119, P219, DOI 10.1016/0303-7207(96)03817-8; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Sugden MC, 2000, BIOCHEM J, V352, P731, DOI 10.1042/0264-6021:3520731; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wulf A, 2007, MOL CELL ENDOCRINOL, V270, P57, DOI 10.1016/j.mce.2007.02.008; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	54	52	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2375	2385		10.1074/jbc.M109.039081	http://dx.doi.org/10.1074/jbc.M109.039081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948729	Green Published, hybrid			2022-12-27	WOS:000273697800018
J	Song, KN; Krause, C; Shi, ST; Patterson, M; Suto, R; Grgurevic, L; Vukicevic, S; van Dinther, M; Falb, D; ten Dijke, P; Alaoui-Ismaili, MH				Song, Kening; Krause, Carola; Shi, Songting; Patterson, Marilyn; Suto, Robert; Grgurevic, Lovorka; Vukicevic, Slobodan; van Dinther, Maarten; Falb, Dean; ten Dijke, Peter; Alaoui-Ismaili, Moulay Hicham			Identification of a Key Residue Mediating Bone Morphogenetic Protein (BMP)-6 Resistance to Noggin Inhibition Allows for Engineered BMPs with Superior Agonist Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENIC PROTEIN-1; I RECEPTORS; EXPRESSION; COMPONENTS; BINDING; INDUCE	Bone morphogenetic proteins (BMPs) are used clinically to induce new bone formation in spinal fusions and long bone nonunion fractures. However, large amounts of BMPs are needed to achieve these effects. BMPs were found to increase the expression of antagonists, which potentially limit their therapeutic efficacy. However, the relative susceptibility of osteoinductive BMPs to different antagonists is not well characterized. Here we show that BMP-6 is more resistant to noggin inhibition and more potent in promoting osteoblast differentiation in vitro and inducing bone regeneration in vivo when compared with its closely related BMP-7 paralog. Noggin was found to play a critical role as a negative feedback regulator of BMP-7 but not BMP6-induced biological responses. Using BMP-6/7 chimeras, we identified lysine 60 as a key residue conferring noggin resistance within the BMP-6 protein. A remarkable correlation was found between the presence of a lysine at this position and noggin resistance among a panel of osteoinductive BMPs. Introduction of a lysine residue at the corresponding positions of BMP-2 and BMP-7 allowed for molecular engineering of recombinant BMPs with increased resistance to noggin antagonism.	[Krause, Carola; Shi, Songting; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Krause, Carola; Shi, Songting; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Ctr Biomed Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Song, Kening; Patterson, Marilyn; Falb, Dean; Alaoui-Ismaili, Moulay Hicham] Stryker Biotech, Hopkinton, MA 01748 USA; [Suto, Robert] Xtal BioStruct Inc, Natick, MA 01760 USA; [Grgurevic, Lovorka; Vukicevic, Slobodan] Univ Zagreb, Lab Mineralized Tissues, Sch Med, Zagreb 10000, Croatia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zagreb	ten Dijke, P (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands.	p.ten_dijke@lumc.nl; Hicham.Alaoui@stryker.com	Vukicevic, Slobodan/AEG-2646-2022; Dijke, Peter ten/AAG-4660-2021	Vukicevic, Slobodan/0000-0003-4076-0285; Dijke, Peter ten/0000-0002-7234-342X; van Dinther, Maarten/0000-0002-9451-8884	Netherlands Organization for Scientific Research [918.66.606]; Innovation-oriented Research Program Genomics [IGE07001]; Center for Biomedical Genetics; Croatian Ministry of Science, Education, and Sports	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Innovation-oriented Research Program Genomics; Center for Biomedical Genetics; Croatian Ministry of Science, Education, and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported in part by Netherlands Organization for Scientific Research Grant 918.66.606, Innovation-oriented Research Program Genomics Grant IGE07001, and a grant from the Center for Biomedical Genetics (to P. D.). This work was also supported by a grant from the Croatian Ministry of Science, Education, and Sports (to S. V.).	Alaoui-Ismaili MH, 2009, CYTOKINE GROWTH F R, V20, P501, DOI 10.1016/j.cytogfr.2009.10.001; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Burkus J. Kenneth, 2008, P71; COOK SD, 1994, CLIN ORTHOP RELAT R, P302; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Friedlaender GE, 2004, PROG INFLAM RES, P157; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; GERHART TN, 1993, CLIN ORTHOP RELAT R, P317; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Kaplan FS, 2009, CYTOKINE GROWTH F R, V20, P399, DOI 10.1016/j.cytogfr.2009.10.006; Kloen P, 2002, J BONE JOINT SURG AM, V84A, P1909, DOI 10.2106/00004623-200211000-00001; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korchynskyi O, 2003, J BONE MINER RES, V18, P1177, DOI 10.1359/jbmr.2003.18.7.1177; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Meyer R A, 2001, BMC Musculoskelet Disord, V2, P2, DOI 10.1186/1471-2474-2-2; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Reddi AH, 2009, CYTOKINE GROWTH F R, V20, P341, DOI 10.1016/j.cytogfr.2009.10.015; Ripamonti U, 2005, CYTOKINE GROWTH F R, V16, P357, DOI 10.1016/j.cytogfr.2005.02.006; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Tylzanowski P, 2006, DEV DYNAM, V235, P1599, DOI 10.1002/dvdy.20782; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vukicevic S, 2008, BONE MORPHOGENETIC P; Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yonemori K, 1997, AM J PATHOL, V150, P1335	38	92	101	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12169	12180		10.1074/jbc.M109.087197	http://dx.doi.org/10.1074/jbc.M109.087197			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20048150	Green Published, hybrid			2022-12-27	WOS:000276787100047
J	Sunters, A; Armstrong, VJ; Zaman, G; Kypta, RM; Kawano, Y; Lanyon, LE; Price, JS				Sunters, Andrew; Armstrong, Victoria J.; Zaman, Gul; Kypta, Robert M.; Kawano, Yoshiaki; Lanyon, Lance E.; Price, Joanna S.			Mechano-transduction in Osteoblastic Cells Involves Strain-regulated Estrogen Receptor alpha-mediated Control of Insulin-like Growth Factor (IGF) I Receptor Sensitivity to Ambient IGF, Leading to Phosphatidylinositol 3-Kinase/AKT-dependent Wnt/LRP5 Receptor-independent Activation of beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOSTEAL BONE-FORMATION; MECHANICAL STRAIN; NITRIC-OXIDE; ER-ALPHA; ANABOLIC RESPONSE; ADAPTIVE RESPONSE; INDUCED APOPTOSIS; MESSENGER-RNA; BREAST-CANCER; T-ANTIGEN	The capacity of bones to adjust their mass and architecture to withstand the loads of everyday activity derives from the ability of their resident cells to respond appropriately to the strains engendered. To elucidate the mechanisms of strain responsiveness in bone cells, we investigated in vitro the responses of primary mouse osteoblasts and UMR-106 osteoblast-like cells to a single period of dynamic strain. This stimulates a cascade of events, including activation of insulin-like growth factor I receptor (IGF-IR), phosphatidylinositol 3-kinase-mediated phosphorylation of AKT, inhibition of GSK-3 beta, increased activation of beta-catenin, and associated lymphoid-enhancing factor/T cell factor-mediated transcription. Initiation of this pathway does not involve the Wnt/LRP5/Frizzled receptor and does not culminate in increased IGF transcription. The effect of strain on IGF-IR is mimicked by exogenous des-(1-3)IGF-I and is blocked by the IGF-IR inhibitor H1356. Inhibition of strain-related prostanoid and nitric oxide production inhibits strain-related (and basal) AKT activity, but their separate ectopic administration does not mimic it. Strain-related IGF-IR activation of AKT requires estrogen receptor alpha (ER alpha) with which IGF-1R physically associates. The ER blocker ICI 182,780 increases the concentration of des-(1-3) IGF-I necessary to activate this cascade, whereas estrogen inhibits both basal AKT activity and its activation by des-(1-3) IGF-I. These data suggest an initial cascade of strain-related events in osteoblasts in which strain activates IGF-IR, in association with ER alpha, so initiating phosphatidylinositol 3-kinase/AKT-dependent activation of beta-catenin and altered lymphoid-enhancing factor/T cell factor transcription. This cascade requires prostanoid/nitric oxide production and is independent of Wnt/LRP5.	[Sunters, Andrew; Armstrong, Victoria J.; Zaman, Gul; Lanyon, Lance E.; Price, Joanna S.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England; [Kypta, Robert M.; Kawano, Yoshiaki] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W12 0NN, England; [Kypta, Robert M.] CIC bioGUNE, Ctr Cooperat Res Biosci, Derio 48160, Spain	University of London; University of London Royal Veterinary College; Imperial College London; CIC bioGUNE	Sunters, A (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Royal Coll St, London NW1 0TU, England.	asunters@rvc.ac.uk	cancer, biogune/H-7276-2012; Kypta, Robert/F-7699-2011	Kypta, Robert/0000-0002-2389-310X	Wellcome Trust; BBSRC [BB/D524883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524883/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alexaki VI, 2004, FASEB J, V18, P1594, DOI 10.1096/fj.04-1495fje; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bikle D, 2001, J BONE MINER RES, V16, P2320, DOI 10.1359/jbmr.2001.16.12.2320; BINDERMAN I, 1988, CALCIFIED TISSUE INT, V42, P261, DOI 10.1007/BF02553753; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Campana WM, 1999, J NEUROSCI RES, V57, P332; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Chambers TJ, 1999, OSTEOARTHR CARTILAGE, V7, P422, DOI 10.1053/joca.1998.0231; Cheng MZ, 1999, J BONE MINER RES, V14, P1742, DOI 10.1359/jbmr.1999.14.10.1742; Cheng MZ, 2002, J BONE MINER RES, V17, P593, DOI 10.1359/jbmr.2002.17.4.593; Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617; COLSTON KW, 1989, J BONE MINER RES, V4, P625; Costessi A, 2005, BONE, V36, P418, DOI 10.1016/j.bone.2004.10.016; DALLAS SL, 1993, J BONE MINER RES, V8, P251; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7; Ferrari SL, 2005, CURR OPIN LIPIDOL, V16, P207, DOI 10.1097/01.mol.0000162326.62419.e4; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K; Hoyland JA, 1997, BONE, V20, P87, DOI 10.1016/S8756-3282(96)00346-8; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jessop HL, 2004, J BONE MINER RES, V19, P938, DOI 10.1359/jbmr.2004.19.6.938; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Johnson DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE205, DOI 10.1152/ajpendo.1996.271.1.E205; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kamata A, 1998, BIOCHEM BIOPH RES CO, V246, P404, DOI 10.1006/bbrc.1998.8632; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kispert A, 1998, DEVELOPMENT, V125, P4225; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Kodama Y, 2000, CALCIFIED TISSUE INT, V66, P298, DOI 10.1007/s002230010060; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lanyon L, 2004, J ENDOCRINOL, V182, P183, DOI 10.1677/joe.0.1820183; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318, DOI 10.1152/ajpendo.1995.268.2.E318; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu JM, 2008, J BONE MINER METAB, V26, P159, DOI 10.1007/s00774-007-0799-z; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mendez P, 2003, MOL BRAIN RES, V112, P170, DOI 10.1016/S0169-328X(03)00088-3; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Monroe JJ, 1996, BIOCHEM BIOPH RES CO, V225, P320, DOI 10.1006/bbrc.1996.1173; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nakamura E, 2000, AM J PHYSIOL-CELL PH, V279, pC510, DOI 10.1152/ajpcell.2000.279.2.C510; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; NOBLE M, 1995, TRANSGENIC RES, V4, P215, DOI 10.1007/BF01969114; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; RAWLINSON SCF, 1991, J BONE MINER RES, V6, P1345; Reijnders CMA, 2007, J ENDOCRINOL, V192, P131, DOI 10.1677/joe.1.06880; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2006, BONE, V39, P1261, DOI 10.1016/j.bone.2006.06.030; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Song RXD, 2006, ENDOCR-RELAT CANCER, V13, pS3, DOI 10.1677/erc.1.01322; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Sun M, 2001, CANCER RES, V61, P5985; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Tang LY, 1997, J BONE MINER RES, V12, P276, DOI 10.1359/jbmr.1997.12.2.276; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; Visconti LA, 2004, ARCH ORAL BIOL, V49, P485, DOI 10.1016/j.archoralbio.2004.01.006; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; Wang YM, 2006, ENDOCRINOLOGY, V147, P4753, DOI 10.1210/en.2006-0196; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang S, 2005, J MOL ENDOCRINOL, V35, P433, DOI 10.1677/jme.1.01858	104	96	101	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8743	8758		10.1074/jbc.M109.027086	http://dx.doi.org/10.1074/jbc.M109.027086			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20042609	hybrid, Green Published			2022-12-27	WOS:000275553700027
J	Horibata, Y; Sugimoto, H				Horibata, Yasuhiro; Sugimoto, Hiroyuki			StarD7 Mediates the Intracellular Trafficking of Phosphatidylcholine to Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER PROTEIN; MAMMALIAN-CELLS; LIPID TRANSFER; PHOSPHATIDYLSERINE; TRANSPORT; DOMAIN; MICE	Steroidogenic acute regulatory protein-related lipid transfer (START) domains, found in 15 mammalian proteins termed StarD1-StarD15, are lipid-binding domains implicated in the intracellular lipid transport systems. In the present study, we analyzed the lipid ligand and function of StarD7. We found two variable forms of mammalian StarD7, termed StarD7-I and StarD7-II. Unlike StarD7-II, StarD7-I contained a mitochondrial-targeting sequence in its N terminus. Overexpressed StarD7-I tagged with V5/His in HEPA-1 cells was mainly observed in the mitochondria of cells prepared at low cellular density, but it was distributed in the cytoplasm of high density cells. StarD7-II was constantly distributed in the cytoplasm at any cellular density. Endogenous StarD7 in HEPA-1 cells and rat liver was also distributed in both the cytoplasm and the mitochondria. A protease K protection assay indicated that the mitochondrial StarD7 was associated with the outer mitochondrial membrane. The purified recombinant StarD7 specifically catalyzed the transfer of PC between lipid vesicles in vitro. Furthermore, the intracellular transport of fluorescent PC that was exogenously incorporated into the mitochondria was increased in cells that overexpressed StarD7-I. These results suggest that StarD7 facilitates the delivery of PC to mitochondria in non-vesicular system.	[Horibata, Yasuhiro; Sugimoto, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Biochem, Mibu, Tochigi 3210293, Japan	Dokkyo Medical University	Sugimoto, H (corresponding author), Dokkyo Med Univ, Sch Med, Dept Biochem, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	h-sugi@dokkyomed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japanese Government [20770091]	Ministry of Education, Culture, Sports, Science and Technology, Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Young Scientists (B) 20770091 from the Ministry of Education, Culture, Sports, Science and Technology, Japanese Government.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Brouwer APM, 2002, EXP CELL RES, V274, P100, DOI 10.1006/excr.2001.5460; Durand S, 2004, PLACENTA, V25, P37, DOI 10.1016/S0143-4004(03)00214-5; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuge O, 2003, J BIOCHEM, V133, P397, DOI 10.1093/jb/mvg052; Morita T, 2004, J CELL SCI, V117, P5759, DOI 10.1242/jcs.01499; NICHOLS JW, 1983, J BIOL CHEM, V258, P5368; NICOLAY K, 1990, BIOCHIM BIOPHYS ACTA, V1025, P49, DOI 10.1016/0005-2736(90)90189-U; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; SLEIGHT RG, 1989, J CELL SCI, V93, P363; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Zhou LY, 2008, J CELL SCI, V121, P2186, DOI 10.1242/jcs.024703; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	27	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7358	7365		10.1074/jbc.M109.056960	http://dx.doi.org/10.1074/jbc.M109.056960			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042613	Green Published, hybrid			2022-12-27	WOS:000275415600048
J	Sephton, CF; Good, SK; Atkin, S; Dewey, CM; Mayer, P; Herz, J; Yu, G				Sephton, Chantelle F.; Good, Shannon K.; Atkin, Stan; Dewey, Colleen M.; Mayer, Paul, III; Herz, Joachim; Yu, Gang			TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA; EXPRESSION; DEPLETION; GENE; SPECIFICATION; DROSOPHILA; SCLEROSIS; DISEASE; FAMILY	TDP-43 is a DNA/RNA-binding protein implicated in multiple steps of transcriptional and post-transcriptional regulation of gene expression. Alteration of this multifunctional protein is associated with a number of neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin positive inclusions. Whereas a pathological link to neurodegenerative disorders has been established, the cellular and physiological functions of TDP-43 remain unknown. In this study, we show that TDP-43 is a nuclear protein with persistent high-level expression during embryonic development and with progressively decreased protein levels during postnatal development. In mice where the TDP-43 gene (Tardbp) was disrupted using a gene trap that carries a beta-galactosidase marker gene, heterozygous (Tardbp(+/-)) mice are fertile and healthy, but intercrosses of Tardbp(+/-) mice yielded no viable homozygotic null (Tardbp(-/-)) mice. Indeed, Tardbp(-/-) embryos die between 3.5 and 8.5 days of development. Tardbp(-/-) blastocysts grown in cell culture display abnormal expansion of their inner cell mass. The pattern of beta-galactosidase staining at E9.5 Tardbp(+/-) embryos is predominantly restricted to the neuroepithelium and remains prominent in neural progenitors at E10.5-12.5. TDP-43 is detected in spinal cord progenitors and in differentiated motor neurons as well as in the dorsal root ganglia at E12.5. beta-Galactosidase staining of tissues from adult Tardbp(+/-) mice shows widespread expression of TDP-43, including prominent levels in various regions of the central nervous system afflicted in neurodegenerative disorders. These results indicate that TDP-43 is developmentally regulated and indispensible for early embryonic development.	[Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Atkin, Stan] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, G (corresponding author), 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu			National Institutes of Health [R01 AG029547, AG023104]; Welch Foundation [I-1566]; Ted Nash Longlife Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023104, R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Ted Nash Longlife Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG029547 and AG023104, Welch Foundation Grant I-1566, the Ted Nash Longlife Foundation, and the Consortium for Frontotemporal Dementia Research.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Casafont I, 2009, J STRUCT BIOL, V167, P235, DOI 10.1016/j.jsb.2009.06.006; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	31	265	269	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6826	6834		10.1074/jbc.M109.061846	http://dx.doi.org/10.1074/jbc.M109.061846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040602	Green Published, hybrid			2022-12-27	WOS:000275367500085
J	Zhang, NS; Oliver, SG				Zhang, Nianshu; Oliver, Stephen G.			The Transcription Activity of Gis1 Is Negatively Modulated by Proteasome-mediated Limited Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER PROTEIN GIS1; SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; GENE-EXPRESSION; BUDDING YEAST; NUCLEAR-LOCALIZATION; GLUCOSE STARVATION; STRESS-RESPONSE; KINASE RIM15; LIFE-SPAN	The transcriptional response to environmental changes has to be prompt but appropriate. Previously, it has been shown that the Gis1 transcription factor is responsible for regulating the expression of postdiauxic shift genes in response to nutrient starvation, and this transcription regulation is dependent upon the Rim15 kinase. Here we demonstrate that the activity of Gis1 is negatively modulated by proteasome-mediated limited proteolysis. Limited degradation of Gis1 by the proteasome leads to the production of smaller variants, which have weaker transcription activities than the full-length protein. The coiled-coil domain, absent from the smaller variants, is part of the second transcription activation domain in Gis1 and is essential for both the limited proteolysis of Gis1 and its full activity. Endogenous Gis1 and its variants, regardless of their transcription capabilities, activate transcription in a Rim15-dependent manner. However, when the full-length Gis1 accumulates in cells due to overexpression or inhibition of the proteasome function, transcription activation by Gis1 is no longer solely controlled by Rim15. Together, these data strongly indicate that the function of the limited degradation is to ensure that Gis1-dependent transcription is strictly regulated by the Rim15 kinase. Furthermore, we have revealed that the kinase activity of Rim15 is essential for this regulation.	[Zhang, Nianshu] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Zhang, NS (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Sanger Bldg,80 Tennis Court Rd, Cambridge CB2 1GA, England.	nz228@cam.ac.uk	Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; Zhang, Nianshu/0000-0002-2690-7554	Biotechnology and Biological Sciences Research Council [BB/C505140/2]; Biotechnology and Biological Sciences Research Council [BB/C505140/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/C505140/2 ( to S. G. O.).	AMBERG DC, 2005, METHODS YEAST GENETI, P200; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brown AJP, 2001, EMBO J, V20, P3177, DOI 10.1093/emboj/20.12.3177; Cameroni E, 2004, CELL CYCLE, V3, P462; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Fujimuro M, 1998, BIOCHEM BIOPH RES CO, V251, P818, DOI 10.1006/bbrc.1998.9560; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Ogiso Y, 1999, BIOCHEM BIOPH RES CO, V258, P448, DOI 10.1006/bbrc.1999.0635; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; SIKORSKI RS, 1989, GENETICS, V122, P19; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Tronnersjo S, 2007, MOL GENET GENOMICS, V277, P57, DOI 10.1007/s00438-006-0171-3; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; WACH A, 1994, YEAST, V10, P1808; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wishart JA, 2006, YEAST, V23, P325, DOI 10.1002/yea.1348; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen KY, 2003, YEAST, V20, P1255, DOI 10.1002/yea.1037; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3	53	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6465	6476		10.1074/jbc.M109.073288	http://dx.doi.org/10.1074/jbc.M109.073288			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022953	Green Published, hybrid			2022-12-27	WOS:000275367500051
J	Zhang, WC; Peng, YJ; Zhang, GS; He, WQ; Qiao, YN; Dong, YY; Gao, YQ; Chen, C; Zhang, CH; Li, W; Shen, HH; Ning, W; Kamm, KE; Stull, JT; Gao, X; Zhu, MS				Zhang, Wen-Cheng; Peng, Ya-Jing; Zhang, Gen-Sheng; He, Wei-Qi; Qiao, Yan-Ning; Dong, Ying-Ying; Gao, Yun-Qian; Chen, Chen; Zhang, Cheng-Hai; Li, Wen; Shen, Hua-Hao; Ning, Wen; Kamm, Kristine E.; Stull, James T.; Gao, Xiang; Zhu, Min-Sheng			Myosin Light Chain Kinase Is Necessary for Tonic Airway Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CA2+ SENSITIZATION; NONMUSCLE MYOSIN; RHOA/RHO-KINASE; II INHIBITOR; G-PROTEINS; MICE; PHOSPHORYLATION; PHOSPHATASE; ASTHMA	Different interacting signaling modules involving Ca2+/calmodulin-dependent myosin light chain kinase, Ca2+-independent regulatory light chain phosphorylation, myosin phosphatase inhibition, and actin filament-based proteins are proposed as specific cellular mechanisms involved in the regulation of smooth muscle contraction. However, the relative importance of specific modules is not well defined. By using tamoxifen-activated and smooth muscle-specific knock-out of myosin light chain kinase in mice, we analyzed its role in tonic airway smooth muscle contraction. Knock-out of the kinase in both tracheal and bronchial smooth muscle significantly reduced contraction and myosin phosphorylation responses to K+-depolarization and acetylcholine. Kinase-deficient mice lacked bronchial constrictions in normal and asthmatic airways, whereas the asthmatic inflammation response was not affected. These results indicate that myosin light chain kinase acts as a central participant in the contractile signaling module of tonic smooth muscle. Importantly, contractile airway smooth muscles are necessary for physiological and asthmatic airway resistance.	[Zhang, Wen-Cheng; Peng, Ya-Jing; He, Wei-Qi; Qiao, Yan-Ning; Dong, Ying-Ying; Gao, Yun-Qian; Chen, Chen; Zhang, Cheng-Hai; Gao, Xiang; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Zhang, Wen-Cheng; Peng, Ya-Jing; He, Wei-Qi; Qiao, Yan-Ning; Dong, Ying-Ying; Gao, Yun-Qian; Chen, Chen; Zhang, Cheng-Hai; Gao, Xiang; Zhu, Min-Sheng] MOE Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Zhang, Gen-Sheng; Li, Wen; Shen, Hua-Hao] Zhejiang Univ, Sch Med, Hosp 2, Dept Resp Dis, Hangzhou 310009, Zhejiang, Peoples R China; [Ning, Wen] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Nanjing University; Zhejiang University; Nankai University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, MS (corresponding author), 12 Xue Fu Rd, Nanjing 210061, Peoples R China.	zhums@nju.edu.cn	He, Weiqi/I-7935-2013; Zhang, Wencheng/AAO-8445-2020; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Qiao, Yanning/0000-0002-8092-4662; Chen, Chen/0000-0001-7075-8501	National Basic Research Program of China [973 2009CB942602, 2005CB522501, 2007CB947100, 2009CB522101]; National Institutes of Health [HL26043]; National Natural Science Funding of China [30570911]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Basic Research Program of China Grants 973 2009CB942602, 2005CB522501, 2007CB947100, and 2009CB522101, National Institutes of Health Grant HL26043, and National Natural Science Funding of China Grant 30570911.	Ammit AJ, 2000, AM J RESP CRIT CARE, V161, P257, DOI 10.1164/ajrccm.161.1.9901005; BARNES PJ, 1992, AIRWAY SMOOTH MUSCLE, P59; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Diamant Z, 2007, RESP MED, V101, P378, DOI 10.1016/j.rmed.2006.12.004; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; GOLENHOFEN K, 1991, DIGEST DIS, V9, P341, DOI 10.1159/000171321; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Harnett KM, 2005, AM J PHYSIOL-GASTR L, V288, pG407, DOI 10.1152/ajpgi.00398.2004; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; HIMPENS B, 1988, J GEN PHYSIOL, V92, P713, DOI 10.1085/jgp.92.6.713; Hirota S, 2007, EUR RESPIR J, V30, P114, DOI 10.1183/09031936.00147706; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; JIANG H, 1992, AM J RESP CELL MOL, V7, P567, DOI 10.1165/ajrcmb/7.6.567; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kume H, 2008, CURR MED CHEM, V15, P2876, DOI 10.2174/092986708786242831; LINDER ME, 1992, SCI AM, V267, P56; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V291, pL281, DOI 10.1152/ajplung.00320.2005; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Patel CA, 2006, AM J PHYSIOL-GASTR L, V291, pG830, DOI 10.1152/ajpgi.00130.2006; Rattan S, 2008, AM J PHYSIOL-GASTR L, V294, pG687, DOI 10.1152/ajpgi.00501.2007; Sausbier M, 2007, FASEB J, V21, P812, DOI 10.1096/fj.06-7167com; Schaafsma D, 2004, BRIT J PHARMACOL, V143, P477, DOI 10.1038/sj.bjp.0705903; Schelegle ES, 2003, ANAT REC PART A, V270A, P11, DOI 10.1002/ar.a.10004; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1968, J PHARMACOL EXP THER, V159, P129; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Wu Y, 2008, AM J PHYSIOL-LUNG C, V295, pL988, DOI 10.1152/ajplung.90202.2008; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009	47	49	50	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5522	5531		10.1074/jbc.M109.062836	http://dx.doi.org/10.1074/jbc.M109.062836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018858	Green Published, hybrid			2022-12-27	WOS:000275327200045
J	Balakrishnan, L; Stewart, J; Polaczek, P; Campbell, JL; Bambara, RA				Balakrishnan, Lata; Stewart, Jason; Polaczek, Piotr; Campbell, Judith L.; Bambara, Robert A.			Acetylation of Dna2 Endonuclease/Helicase and Flap Endonuclease 1 by p300 Promotes DNA Stability by Creating Long Flap Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR P300; OKAZAKI FRAGMENT MATURATION; BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; POLYMERASE-DELTA; REPLICATION FORK; HUMAN FEN1; YEAST; GLYCOSYLASE; CLEAVAGE	Flap endonuclease 1 (FEN1) and Dna2 endonuclease/helicase (Dna2) sequentially coordinate their nuclease activities for efficient resolution of flap structures that are created during the maturation of Okazaki fragments and repair of DNA damage. Acetylation of FEN1 by p300 inhibits its endonuclease activity, impairing flap cleavage, a seemingly undesirable effect. We now show that p300 also acetylates Dna2, stimulating its 5'-3' endonuclease, the 5'-3' helicase, and DNA-dependent ATPase activities. Furthermore, acetylated Dna2 binds its DNA substrates with higher affinity. Differential regulation of the activities of the two endonucleases by p300 indicates a mechanism in which the acetylase promotes formation of longer flaps in the cell at the same time as ensuring correct processing. Intentional formation of longer flaps mediated by p300 in an active chromatin environment would increase the resynthesis patch size, providing increased opportunity for incorrect nucleotide removal during DNA replication and damaged nucleotide removal during DNA repair. For example, altering the ratio between short and long flap Okazaki fragment processing would be a mechanism for better correction of the error-prone synthesis catalyzed by DNA polymerase alpha.	[Balakrishnan, Lata; Stewart, Jason; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Polaczek, Piotr; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM024441 (to R. A. B.) and GM087666 (to J. L. C.).	Alexiadis V, 1997, CHROMOSOMA, V105, P324; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kim MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004864; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SLIJEPCEVIC P, 1994, MUTAT RES, V323, P113, DOI 10.1016/0165-7992(94)90084-1; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	31	46	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4398	4404		10.1074/jbc.M109.086397	http://dx.doi.org/10.1074/jbc.M109.086397			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20019387	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000275274800016
J	Giraldo, AMV; Medus, ML; Lebrero, MG; Pagano, RS; Labriola, CA; Landolfo, L; Delfino, JM; Parodi, AJ; Caramelo, JJ				Villamil Giraldo, Ana Maria; Lopez Medus, Maximo; Gonzalez Lebrero, Mariano; Pagano, Rodrigo S.; Labriola, Carlos A.; Landolfo, Lucas; Delfino, Jose M.; Parodi, Armando J.; Caramelo, Julio J.			The Structure of Calreticulin C-terminal Domain Is Modulated by Physiological Variations of Calcium Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR CHAPERONE; QUALITY-CONTROL; P-DOMAIN; BINDING; CALNEXIN; PROTEIN; LECTIN; CONFORMATION	Calreticulin is an abundant endoplasmic reticulum resident protein that fulfills at least two basic functions. Firstly, due to its ability to bind monoglucosylated high mannose oligosaccharides, calreticulin is a central component of the folding quality control system of glycoproteins. On the other hand, thanks to its capacity to bind high amounts of calcium, calreticulin is one of the main calcium buffers in the endoplasmic reticulum. This last activity resides on a highly negatively charged domain located at the C terminus. Interestingly, this domain has been proposed to regulate the intracellular localization of calreticulin. Structural information for this domain is currently scarce. Here we address this issue by employing a combination of biophysical techniques and molecular dynamics simulation. We found that calreticulin C-terminal domain at low calcium concentration displays a disordered structure, whereas calcium addition induces a more rigid and compact conformation. Remarkably, this change develops when calcium concentration varies within a range similar to that taking place in the endoplasmic reticulum upon physiological fluctuations. In addition, a much higher calcium concentration is necessary to attain similar responses in a peptide displaying a randomized sequence of calreticulin C-terminal domain, illustrating the sequence specificity of this effect. Molecular dynamics simulation reveals that this ordering effect is a consequence of the ability of calcium to bring into close proximity residues that lie apart in the primary structure. These results place calreticulin in a new setting in which the protein behaves not only as a calcium-binding protein but as a finely tuned calcium sensor.	[Villamil Giraldo, Ana Maria; Lopez Medus, Maximo; Pagano, Rodrigo S.; Landolfo, Lucas; Caramelo, Julio J.] Fdn Inst Leloir, Lab Struct Cell Biol, Buenos Aires, DF, Argentina; [Labriola, Carlos A.; Parodi, Armando J.] Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina; [Labriola, Carlos A.; Parodi, Armando J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Villamil Giraldo, Ana Maria; Gonzalez Lebrero, Mariano; Delfino, Jose M.] Univ Buenos Aires, Dept Biol Chem, Buenos Aires, DF, Argentina; [Villamil Giraldo, Ana Maria; Gonzalez Lebrero, Mariano; Delfino, Jose M.] Univ Buenos Aires, Inst Biochem & Biophys, Sch Pharm & Biochem, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Dept Biol Chem, Sch Sci, RA-1428 Buenos Aires, DF, Argentina	Leloir Institute; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Caramelo, JJ (corresponding author), Fdn Inst Leloir, Lab Struct Cell Biol, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	jcaramelo@leloir.org.ar		Gonzalez Lebrero, Mariano/0000-0003-4327-1735	National Institutes of Health [GM044500]; Howard Hughes Medical Institute; University of Buenos Aires; National Agency for the Promotion of Science and Technology (Argentina); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Buenos Aires(University of Buenos Aires); National Agency for the Promotion of Science and Technology (Argentina)(ANPCyT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044500. This work was also supported by the Howard Hughes Medical Institute, by the University of Buenos Aires, and by the National Agency for the Promotion of Science and Technology (Argentina).	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bouvier M, 2000, BIOCHEMISTRY-US, V39, P14950, DOI 10.1021/bi0019545; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gunsteren W. F., 1990, ANGEW CHEM INT EDIT, V29, P992; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Labriola C, 1999, MOL BIOL CELL, V10, P1381, DOI 10.1091/mbc.10.5.1381; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Mukhopadhyay K, 1998, BIOPHYS CHEM, V74, P175, DOI 10.1016/S0301-4622(98)00177-X; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; STORRS RW, 1992, BIOPOLYMERS, V32, P1695, DOI 10.1002/bip.360321211; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Toft KN, 2008, BBA-PROTEINS PROTEOM, V1784, P1265, DOI 10.1016/j.bbapap.2008.05.005; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van der Wal FJ, 1998, EUR J BIOCHEM, V256, P51, DOI 10.1046/j.1432-1327.1998.2560051.x; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200	45	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4544	4553		10.1074/jbc.M109.034512	http://dx.doi.org/10.1074/jbc.M109.034512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018892	Green Published, hybrid			2022-12-27	WOS:000275274800031
J	Bruni, F; Polosa, PL; Gadaleta, MN; Cantatore, P; Roberti, M				Bruni, Francesco; Polosa, Paola Loguercio; Gadaleta, Maria Nicola; Cantatore, Palmiro; Roberti, Marina			Nuclear Respiratory Factor 2 Induces the Expression of Many but Not All Human Proteins Acting in Mitochondrial DNA Transcription and Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING SITES; GENE-EXPRESSION; POLYMERASE GAMMA; MTDNA TRANSCRIPTION; ACCESSORY SUBUNIT; BIOGENESIS; PROMOTER; GABP; IDENTIFICATION; TERMINATION	In mammals, NRF-2 (nuclear respiratory factor 2), also named GA-binding protein, is an Ets family transcription factor that controls many genes involved in cell cycle progression and protein synthesis as well as in mitochondrial biogenesis. In this paper, we analyzed the role of NRF-2 in the regulation of human genes involved in mitochondrial DNA transcription and replication. By a combination of bioinformatic and biochemical approaches, we found that the factor binds in vitro and in vivo to the proximal promoter region of the genes coding for the transcription termination factor mTERF, the RNA polymerase POLRMT, the B subunit of the DNA polymerase-gamma, the DNA helicase TWINKLE, and the single-stranded DNA-binding protein mtSSB. The role of NRF-2 in modulating the expression of those genes was further established by RNA interference and overexpression strategies. On the contrary, we found that NRF-2 does not control the genes for the subunit A of DNA polymerase-gamma and for the transcription repressor MTERF3; we suggest that these genes are under regulatory mechanisms that do not involve NRF proteins. Since NRFs are known to positively control the expression of transcription-activating proteins, the novelty emerging from our data is that proteins playing antithetical roles in mitochondrial DNA transcription, namely activators and repressors, are under different regulatory pathways. Finally, we developed a more stringent consensus with respect to the general consensus of NRF-2/GA-binding protein when searching for NRF-2 binding sites in the promoter of mitochondrial proteins.	[Bruni, Francesco; Polosa, Paola Loguercio; Gadaleta, Maria Nicola; Cantatore, Palmiro; Roberti, Marina] Univ Bari, Dept Biochem & Mol Biol Ernesto Quagliariello, I-70125 Bari, Italy; [Gadaleta, Maria Nicola; Cantatore, Palmiro] CNR, Inst Biomembrane & Bioenerget, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Roberti, M (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	marina.roberti@biologia.uniba.it	Loguercio Polosa, Paola/I-5633-2012; Bruni, Francesco/I-4074-2018	Bruni, Francesco/0000-0001-5120-5936	Universita di Bari; Progetto di Ricerca di Ateneo; Telethon-Italy [GGP06233]	Universita di Bari; Progetto di Ricerca di Ateneo; Telethon-Italy(Fondazione Telethon)	This work was supported by grants from Universita di Bari, Progetto di Ricerca di Ateneo, and Telethon-Italy (Grant GGP06233).	Blesa JR, 2007, GENE, V391, P198, DOI 10.1016/j.gene.2006.12.024; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Moreno MA, 2009, BIOCHEM J, V418, P453, DOI 10.1042/BJ20081174; GASTON K, 1995, GENE, V157, P257, DOI 10.1016/0378-1119(95)00120-U; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gong QM, 2000, J BIOL CHEM, V275, P38012, DOI 10.1074/jbc.M004078200; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Kropotov A, 2007, FEBS J, V274, P5804, DOI 10.1111/j.1742-4658.2007.06103.x; Lefai E, 2000, J BIOL CHEM, V275, P33123, DOI 10.1074/jbc.M003024200; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447; Takahashi K, 2008, J BIOL CHEM, V283, P15134, DOI 10.1074/jbc.M800498200; Takahashi Y, 2002, BBA-GENE STRUCT EXPR, V1574, P359, DOI 10.1016/S0167-4781(01)00374-8; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Ye F, 1996, NUCLEIC ACIDS RES, V24, P1481, DOI 10.1093/nar/24.8.1481	37	54	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3939	3948		10.1074/jbc.M109.044305	http://dx.doi.org/10.1074/jbc.M109.044305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19951946	hybrid, Green Published			2022-12-27	WOS:000275254000047
J	Yuan, ZQ; Kim, D; Shu, SK; Wu, JB; Guo, JP; Xiao, L; Kaneko, S; Coppola, D; Cheng, JQ				Yuan, Zengqiang; Kim, Donghwa; Shu, Shaokun; Wu, Junbing; Guo, Jianping; Xiao, Lei; Kaneko, Satoshi; Coppola, Domenico; Cheng, Jin Q.			Phosphoinositide 3-Kinase/Akt Inhibits MST1-Mediated Pro-apoptotic Signaling through Phosphorylation of Threonine 120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN STERILE20-LIKE KINASE-1; STE20-LIKE PROTEIN-KINASE; PROMOTES CELL-SURVIVAL; PROTEOLYTIC ACTIVATION; REGULATING KINASE-1; AKT PHOSPHORYLATION; STERILE-20 KINASE; HIPPO PATHWAY; HUMAN CANCER; HISTONE H2B	The protein kinase mammalian sterile 20-like kinase 1 (MST1) is a mammalian homologue of the Drosophila hippo and plays a critical role in regulation of programmed cell death. MST1 exerts pro-apoptotic function through cleavage, autophosphorylation-Thr(183) and subsequent translocation to the nucleus where it phosphorylates a number of molecules, including LATS1/2, FOXO, JNK, and histone H2B. Here, we show that the cleavage of MST1 is inhibited by the phosphatidylinositol 3-kinase/Akt pathway. Akt interacts with MST1 and phosphorylates a highly conserved residue threonine 120 of MST1, which leads to inhibition of its kinase activity and nuclear translocation as well as the autophosphorylation of Thr(183). Phospho-MST1-Thr(120) failed to activate downstream targets FOXO3a and JNK. Further, inverse correlation between pMST1-Thr(120) and pMST1-Thr(183) was observed in human ovarian tumors. These findings indicate that the phosphorylation of MST1-Thr(120) by Akt could be a major mechanism of regulation of the Hippo/MST1 pathway by cell survival signaling.	[Yuan, Zengqiang; Wu, Junbing; Xiao, Lei; Cheng, Jin Q.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Kim, Donghwa; Shu, Shaokun; Guo, Jianping; Kaneko, Satoshi; Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; H Lee Moffitt Cancer Center & Research Institute	Yuan, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zqyuan@ibp.ac.cn; jin.cheng@moffitt.org	xiao, Lei/J-4217-2017; Xiao, Lei/I-3655-2017		National Institutes of Health Grants [CA107078, CA137041, P50 CA119997]; Department of Defense [OC073222]; Bankhead-Coley [09BB-05]; National Science Foundation [30870792]; Ministry of Science and Technology [973-2009CB918704]; NATIONAL CANCER INSTITUTE [R01CA107078, R01CA137041, P50CA119997] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley; National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA107078, CA137041, and P50 CA119997 and by Department of Defense Grant OC073222 and Bankhead-Coley Grant 09BB-05 (to J.Q.C.). This work was also supported by National Science Foundation Grant 30870792 and Ministry of Science and Technology Grant 973-2009CB918704 (to Z.Y.).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Minoo P, 2007, MODERN PATHOL, V20, P331, DOI 10.1038/modpathol.3800740; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ozes ON, 1999, NATURE, V401, P82; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	47	70	75	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3815	3824		10.1074/jbc.M109.059675	http://dx.doi.org/10.1074/jbc.M109.059675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940129	Green Published, hybrid			2022-12-27	WOS:000275254000034
J	Zhu, HL; Fernandez, C; Fan, JB; Shewmaker, F; Chen, J; Minton, AP; Liang, Y				Zhu, Hai-Li; Fernandez, Cristina; Fan, Jun-Bao; Shewmaker, Frank; Chen, Jie; Minton, Allen P.; Liang, Yi			Quantitative Characterization of Heparin Binding to Tau Protein IMPLICATION FOR INDUCER-MEDIATED TAU FILAMENT FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; FULL-LENGTH TAU; LIGHT-SCATTERING; ALZHEIMER; AGGREGATION; POLYMERIZATION; FLUORESCENCE; PATHOGENESIS; DIMERIZATION; MECHANISM	Neurofibrillary tangles, principally composed of bundles of filaments formed by the microtubule-associated protein Tau, are a hallmark of a group of neurodegenerative diseases such as Alzheimer disease. Polyanionic cofactors such as heparin can induce Tau filament formation in vitro. Here we quantitatively characterize the interaction between recombinant human Tau fragment Tau(244-372) and heparin (average molecular mass = 7 kDa) as well as heparin-induced fibril formation by using static light scattering, isothermal titration calorimetry, turbidity assays, and transmission electron microscopy. Our data clearly show that at physiological pH, heparin 7K, and human Tau(244-372) form a tight 1:1 complex with an equilibrium association constant exceeding 10(6) M-1 under reducing conditions, triggering Tau fibrillization. In the absence of dithiothreitol, heparin shows a moderate binding affinity (10(5) M-1) to Tau(244-372), similarly triggering Tau fibrillization. Further fibrillization kinetics analyses show that the lag time appears to be approximately invariant up to a molar ratio of 2:1 and then increases at larger ratios of heparin/Tau. The maximum slope representing the apparent rate constant for fibril growth increases sharply with substoichiometric ratios of heparin/Tau and then decreases to some extent with ratios of >1:1. The retarding effect of heparin in excess is attributed to the large increase in ionic strength of the medium arising from free heparin. Together, these results suggest that the formation of the 1:1 complex of Tau monomer and heparin plays an important role in the inducer-mediated Tau filament formation, providing clues to understanding the pathogenesis of neurodegenerative diseases.	[Zhu, Hai-Li; Fan, Jun-Bao; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Fernandez, Cristina; Shewmaker, Frank; Minton, Allen P.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Fernandez, Cristina/G-2269-2015; Fan, Jun-bao/E-7155-2012; Liang, Yi/V-1396-2017	Fernandez, Cristina/0000-0003-3792-4015; Liang, Yi/0000-0002-7349-8300; Fan, Junbao/0000-0002-1709-3659; Minton, Allen/0000-0001-8459-1247	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30770421, 30970599]; Chinese 111 Project [B06018]; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024956] Funding Source: NIH RePORTER	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301, National Natural Science Foundation of China Grants 30770421 and 30970599, and Chinese 111 Project Grant B06018. This work was also supported in part by National Institutes of Health grants through the Intramural Research Program of the NIDDK.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Attri AK, 2005, ANAL BIOCHEM, V346, P132, DOI 10.1016/j.ab.2005.08.013; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Kameyama K, 2006, BIOPHYS J, V90, P2164, DOI 10.1529/biophysj.105.074310; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Perez M, 1996, J NEUROCHEM, V67, P1183; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stacey K. A., 1956, LIGHT SCATTERING PHY; THEISEN A, 2000, REFRACTIVE INCREMENT, P55; van Holde K.E., 2006, PRINCIPLES PHYS BIOC, P91; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wilson DM, 1997, AM J PATHOL, V150, P2181; Xu H, 2005, J BIOL INORG CHEM, V10, P529, DOI 10.1007/s00775-005-0007-3	40	76	75	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3592	3599		10.1074/jbc.M109.035691	http://dx.doi.org/10.1074/jbc.M109.035691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959468	hybrid, Green Published			2022-12-27	WOS:000275254000010
J	Maerz, S; Funakoshi, Y; Negishi, Y; Suzuki, T; Seiler, S				Maerz, Sabine; Funakoshi, Yoko; Negishi, Yuki; Suzuki, Tadashi; Seiler, Stephan			The Neurospora Peptide:N-Glycanase Ortholog PNG1 Is Essential for Cell Polarity despite Its Lack of Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RESTRICTED EPITOPE; N-GLYCANASE; CYTOPLASMIC PEPTIDE; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN TURNOVER; YEAST; DEGLYCOSYLATION; DEGRADATION; PROTEIN; CYTOSOL	Secretory proteins are subjected to a stringent endoplasmic reticulum-based quality control system that distinguishes aberrant from correctly folded proteins. The cytoplasmic peptide: N-glycanase cleaves oligosaccharides from misfolded glycoproteins and prepares them for degradation by the 26 S proteasome. In contrast to abundant in vitro data on its enzymatic function, the in vivo relevance of peptide: N-glycanase activity remains unclear. Here we show that the PNG1 ortholog from the filamentous ascomycete Neurospora crassa is an essential protein, and its deletion results in strong polarity defects. PNG1 and its predicted binding partner RAD23 have distinct functions in N. crassa and are involved in cell wall integrity and DNA repair, respectively. Moreover, wild type PNG1 has substitutions in essential catalytic amino acids, and its deglycosylation activity is lost. These substitutions are conserved in many PNG1 orthologs of the fungal kingdom, implying a so far unrecognized enzyme-independent function of PNG1 that may only become apparent in highly polar cells such as fungal hyphae.	[Maerz, Sabine; Seiler, Stephan] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Maerz, Sabine; Seiler, Stephan] DFG Res Ctr Mol Physiol Brain CMPB, D-37073 Gottingen, Germany; [Funakoshi, Yoko; Negishi, Yuki; Suzuki, Tadashi] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama 3510198, Japan	University of Gottingen; German Research Foundation (DFG); RIKEN	Seiler, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Grisebachstr 8, D-37077 Gottingen, Germany.	sseiler@gwdg.de	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021	Suzuki, Tadashi/0000-0003-1030-7631	CREST; JST; Global COE Program (Osaka University); Deutsche Forschungsgemeinschaft (DFG); DFG [SP1111]	CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); Global COE Program (Osaka University)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by grants from the CREST, JST, and Global COE Program (Osaka University) (to T. S.) and by the Deutsche Forschungsgemeinschaft (DFG) through the DFG Research Center of Molecular Physiology of the Brain and the DFG Priority Program Cell Polarity (Grant SP1111) (to S. S.).	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; FtouhiPaquin N, 1997, J BIOL CHEM, V272, P22960, DOI 10.1074/jbc.272.36.22960; Hagihara S, 2007, GLYCOBIOLOGY, V17, P1070, DOI 10.1093/glycob/cwm079; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Joshi S, 2005, FEBS LETT, V579, P823, DOI 10.1016/j.febslet.2004.12.060; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; Kato T, 2007, J BIOCHEM, V142, P175, DOI 10.1093/jb/mvm117; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Miyazaki A, 2009, GLYCOCONJUGATE J, V26, P133, DOI 10.1007/s10719-008-9171-3; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2005, METHODS, V35, P360, DOI 10.1016/j.ymeth.2004.10.008; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	43	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2326	2332		10.1074/jbc.M109.045302	http://dx.doi.org/10.1074/jbc.M109.045302			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940117	Green Published, hybrid			2022-12-27	WOS:000273697800012
J	Delaroche, D; Cantrelle, FX; Subra, F; Van Heijenoort, C; Guittet, E; Jiao, CY; Blanchoin, L; Chassaing, G; Lavielle, S; Auclair, C; Sagan, S				Delaroche, Diane; Cantrelle, Francois-Xavier; Subra, Frederic; Van Heijenoort, Carine; Guittet, Eric; Jiao, Chen-Yu; Blanchoin, Laurent; Chassaing, Gerard; Lavielle, Solange; Auclair, Christian; Sagan, Sandrine			Cell-penetrating Peptides with Intracellular Actin-remodeling Activity in Malignant Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTENNAPEDIA HOMEOBOX PEPTIDE; MARCKS-RELATED PROTEIN; MASS-SPECTROMETRY; F-ACTIN; POLYMERIZATION; BINDING; DELIVERY; PYRENE; DOMAIN; ACID	Cell-penetrating peptides can cross cell membranes and are commonly seen as biologically inert molecules. However, we found that some cell-penetrating peptides could remodel actin cytoskeleton in oncogene-transformed NIH3T3/EWS-Fli cells. These cells have profound actin disorganization related to their tumoral transformation. These arginine- and/or tryptophan-rich peptides could cross cell membrane and induce stress fiber formation in these malignant cells, whereas they had no perceptible effect in non-tumoral fibroblasts. In addition, motility (migration speed, random motility coefficient, wound healing) of the tumor cells could be decreased by the cell-permeant peptides. Although the peptides differently influenced actin polymerization in vitro, they could directly bind monomeric actin as determined by NMR and calorimetry studies. Therefore, cell-penetrating peptides might interact with intracellular protein partners, such as actin. In addition, the fact that they could reverse the tumoral phenotype is of interest for therapeutic purposes.	[Jiao, Chen-Yu; Chassaing, Gerard; Lavielle, Solange; Sagan, Sandrine] Univ Paris 06, CNRS, Lab Biomol, F-75005 Paris, France; [Delaroche, Diane; Cantrelle, Francois-Xavier; Van Heijenoort, Carine; Guittet, Eric] CNRS, Inst Chim Subst Nat, Lab Chim & Biol Struct, F-91198 Gif Sur Yvette, France; [Subra, Frederic; Auclair, Christian] Ecole Normale Super, CNRS, Lab Biotechnol & Pharmacol Genet Appl, F-94235 Cachan, France; [Blanchoin, Laurent] Commissariat Energie Atom Grenoble, Inst Rech Technol & Sci Vivant, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Sagan, S (corresponding author), Univ Paris 06, CNRS, Lab Biomol, 4 Pl Jussieu, F-75005 Paris, France.	sandrine.sagan@upmc.fr	VAN HEIJENOORT, Carine/N-1986-2016; SAGAN, Sandrine/AAA-8537-2022; s, s/GYR-2278-2022; s, s/HHD-0404-2022; S, SAGAN/I-8132-2013; s, s/GVS-3323-2022; QI, DANDAN/GVR-9324-2022; s, s/HIK-1178-2022; van Heijenoort, Carine/AAX-1041-2021	VAN HEIJENOORT, Carine/0000-0002-2839-1037; S, SAGAN/0000-0003-0083-4411; van Heijenoort, Carine/0000-0002-2839-1037; cantrelle, francois-xavier/0000-0002-3413-5443; Guittet, Eric/0000-0002-8368-6719	Agence Nationale pour la Recherche [05-BLAN0269]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche Grant 05-BLAN0269.	Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; ENCINAS MV, 1986, PHOTOCHEM PHOTOBIOL, V44, P579, DOI 10.1111/j.1751-1097.1986.tb04712.x; Fotin-Mleczek M, 2005, J CELL SCI, V118, P3339, DOI 10.1242/jcs.02460; Goddard T. D, 2007, SPARKY 3; Hansen M, 2008, ADV DRUG DELIVER REV, V60, P572, DOI 10.1016/j.addr.2007.09.003; Hari SP, 2000, BIOCHEMISTRY-US, V39, P3763, DOI 10.1021/bi9926734; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; JOLIOT AH, 1991, NEW BIOL, V3, P1121; Jones AT, 2008, INT J PHARMACEUT, V354, P34, DOI 10.1016/j.ijpharm.2007.10.046; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lanzetti L, 2001, EXP CELL RES, V271, P45, DOI 10.1006/excr.2001.5369; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; ORIOLAUDIT C, 1978, EUR J BIOCHEM, V87, P371, DOI 10.1111/j.1432-1033.1978.tb12386.x; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; SAAR K, 2007, HDB CELL PENETRATING, P553; Shikinaka K, 2008, BIOMACROMOLECULES, V9, P537, DOI 10.1021/bm701068n; Spaz JA, 2007, ANAL BIOCHEM, V367, P95, DOI 10.1016/j.ab.2007.04.001; Sroka TC, 2006, CARCINOGENESIS, V27, P1748, DOI 10.1093/carcin/bgl005; Sugiyama S, 2009, DEV GROWTH DIFFER, V51, P369, DOI 10.1111/j.1440-169X.2009.01093.x; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Turner JJ, 2007, BLOOD CELL MOL DIS, V38, P1, DOI 10.1016/j.bcmd.2006.10.003; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wohnsland F, 2000, J STRUCT BIOL, V131, P217, DOI 10.1006/jsbi.2000.4299; Wohnsland F, 2000, BIOPHYS CHEM, V85, P169, DOI 10.1016/S0301-4622(00)00113-7; Yang H, 1996, J PHYS CHEM-US, V100, P14533, DOI 10.1021/jp9607531	46	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7712	7721		10.1074/jbc.M109.045872	http://dx.doi.org/10.1074/jbc.M109.045872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20037163	hybrid, Green Published			2022-12-27	WOS:000275415600080
J	Massignan, T; Stewart, RS; Biasini, E; Solomon, IH; Bonetto, V; Chiesa, R; Harris, DA				Massignan, Tania; Stewart, Richard S.; Biasini, Emiliano; Solomon, Isaac H.; Bonetto, Valentina; Chiesa, Roberto; Harris, David A.			A Novel, Drug-based, Cellular Assay for the Activity of Neurotoxic Mutants of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SCRAPIE; CELLS; PRP; GENTAMICIN; ANTIBODIES; BLEOMYCIN; DISEASE; ATAXIA; MICE	In prion diseases, the infectious isoform of the prion protein (PrPSc) may subvert a normal, physiological activity of the cellular isoform (PrPC). A deletion mutant of the prion protein (Delta 105-125) that produces a neonatal lethal phenotype when expressed in transgenic mice provides a window into the normal function of PrPC and how it can be corrupted to produce neurotoxic effects. We report here the surprising and unexpected observation that cells expressing Delta 105-125 PrP and related mutants are hypersensitive to the toxic effects of two classes of antibiotics (aminoglycosides and bleomycin analogues) that are commonly used for selection of stably transfected cell lines. This unusual phenomenon mimics several essential features of Delta 105-125 PrP toxicity seen in transgenic mice, including rescue by co-expression of wild type PrP. Cells expressing Delta 105-125 PrP are susceptible to drug toxicity within minutes, suggesting that the mutant protein enhances cellular accumulation of these cationic compounds. Our results establish a screenable cellular phenotype for the activity of neurotoxic forms of PrP, and they suggest possible mechanisms by which these molecules could produce their pathological effects in vivo.	[Harris, David A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Massignan, Tania; Biasini, Emiliano; Bonetto, Valentina; Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, I-20156 Milan, Italy; [Massignan, Tania; Bonetto, Valentina] Ist Ric Farmacol Mario Negri, Dept Mol Pharmacol & Biochem, I-20156 Milan, Italy; [Biasini, Emiliano; Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy	Washington University (WUSTL); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Chiesa, Roberto/G-1561-2017; Bonetto, Valentina/ABB-6383-2020; Biasini, Emiliano/A-3147-2011; Bonetto, Valentina/I-4694-2018	Chiesa, Roberto/0000-0002-3842-3733; Bonetto, Valentina/0000-0003-0456-2054; Biasini, Emiliano/0000-0002-3927-6341; Bonetto, Valentina/0000-0003-0456-2054; massignan, tania/0000-0002-6176-2696; Harris, David/0000-0002-6985-5790	National Institutes of Health [NS052526, NS040975]; Department of Defense [DAMD17-03-1-0531]; Telethon Foundation [GFP04007, TCR08002, TCR08005]; National Institutes of Health Neuroscience Blueprint Core [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040975, P30NS057105, R01NS052526, R01NS065244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Telethon Foundation(Fondazione Telethon); National Institutes of Health Neuroscience Blueprint Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS052526 and NS040975 (to D. A. H.). This work was also supported by Department of Defense Grant DAMD17-03-1-0531 (to R. S. S.) and Telethon Foundation Grants GFP04007 (to E. B.), TCR08002 (to V. B.), and TCR08005 (to R.C.). The Hope Center Viral Vectors Core is supported by National Institutes of Health Neuroscience Blueprint Core Grant P30 NS057105 (to Washington University).	Abraham AT, 2003, CHEM BIOL, V10, P45, DOI 10.1016/S1074-5521(02)00306-X; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hobbie SN, 2007, NUCLEIC ACIDS RES, V35, P6086, DOI 10.1093/nar/gkm658; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Li MJ, 2005, METH MOL B, V309, P261; Louis Sharon A, 2005, Methods Mol Biol, V290, P265; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Matucci A, 2005, BRAIN RES BULL, V65, P155, DOI 10.1016/j.brainresbull.2004.12.008; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sandoval RM, 2000, AM J PHYSIOL-RENAL, V279, pF884, DOI 10.1152/ajprenal.2000.279.5.F884; SCHURR E, 1989, CANCER RES, V49, P2729; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Thornton G, 2005, GENES CELLS, V10, P941, DOI 10.1111/j.1365-2443.2005.00891.x; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	44	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7752	7765		10.1074/jbc.M109.064949	http://dx.doi.org/10.1074/jbc.M109.064949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19940127	Green Published, hybrid			2022-12-27	WOS:000275415600083
J	Hayashihara, K; Uchiyama, S; Shimamoto, S; Kobayashi, S; Tomschik, M; Wakamatsu, H; No, D; Sugahara, H; Hori, N; Noda, M; Ohkubo, T; Zlatanova, J; Matsunaga, S; Fukui, K				Hayashihara, Kayoko; Uchiyama, Susumu; Shimamoto, Shigeru; Kobayashi, Shouhei; Tomschik, Miroslav; Wakamatsu, Hidekazu; No, Daisuke; Sugahara, Hiroki; Hori, Naoto; Noda, Masanori; Ohkubo, Tadayasu; Zlatanova, Jordanka; Matsunaga, Sachihiro; Fukui, Kiichi			The Middle Region of an HP1-binding Protein, HP1-BP74, Associates with Linker DNA at the Entry/Exit Site of Nucleosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METAPHASE CHROMOSOMES; HISTONE H1-LIKE PROTEIN; TOPOISOMERASE-II-ALPHA; HETEROCHROMATIN PROTEIN-1; MITOTIC CHROMOSOMES; TERTIARY STRUCTURE; GLOBULAR DOMAIN; IN-VIVO; H1; CHROMATIN	In higher eukaryotic cells, DNA molecules are present as chromatin fibers, complexes of DNA with various types of proteins; chromatin fibers are highly condensed in metaphase chromosomes during mitosis. Although the formation of the metaphase chromosome structure is essential for the equal segregation of replicated chromosomal DNA into the daughter cells, the mechanism involved in the organization of metaphase chromosomes is poorly understood. To identify proteins involved in the formation and/or maintenance of metaphase chromosomes, we examined proteins that dissociated from isolated human metaphase chromosomes by 0.4 M NaCl treatment; this treatment led to significant chromosome decondensation, but the structure retained the core histones. One of the proteins identified, HP1-BP74 (heterochromatin protein 1-binding protein 74), composed of 553 amino acid residues, was further characterized. HP1-BP74 middle region (BP74Md), composed of 178 amino acid residues (Lys(97)-Lys(274)), formed a chromatosome-like structure with reconstituted mononucleosomes and protected the linker DNA from micrococcal nuclease digestion by similar to 25 bp. The solution structure determined by NMR revealed that the globular domain (Met(153)-Thr(237)) located within BP74Md possesses a structure similar to that of the globular domain of linker histones, which underlies its nucleosome binding properties. Moreover, we confirmed that BP74Md and full-length HP1-BP74 directly binds to HP1 (heterochromatin protein 1) and identified the exact sites responsible for this interaction. Thus, we discovered that HP1-BP74 directly binds to HP1, and its middle region associates with linker DNA at the entry/exit site of nucleosomal DNA in vitro.	[Hayashihara, Kayoko; Uchiyama, Susumu; Kobayashi, Shouhei; Wakamatsu, Hidekazu; No, Daisuke; Hori, Naoto; Noda, Masanori; Matsunaga, Sachihiro; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Shimamoto, Shigeru; Sugahara, Hiroki; Ohkubo, Tadayasu] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Tomschik, Miroslav; Zlatanova, Jordanka] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Osaka University; Osaka University; University of Wyoming	Fukui, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan.	kfukui@bio.eng.osaka-u.ac.jp	UCHIYAMA, Susumu/F-9590-2017; Matsunaga, Sachihiro/F-8689-2010; Zlatanova, Jordanka/B-3273-2009; , Miroslav/AAD-9416-2020	UCHIYAMA, Susumu/0000-0002-5181-179X; Matsunaga, Sachihiro/0000-0003-3024-3559; , Miroslav/0000-0002-0758-6169	Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by special coordination funds (to K. F. and S. U.) and grants-in-aid for scientific research (to S. U., S. M., and K. F.) from the Ministry of Education, Culture, Sports, Science, and Technology and by the Japan Science and Technology Agency (Bioinformatics Research and Development to S. M. and Sentan to K. F.).	BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1978, NUCLEIC ACIDS RES, V5, P3643, DOI 10.1093/nar/5.10.3643; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Cherukuri S, 2008, MOL BIOL CELL, V19, P1816, DOI 10.1091/mbc.E07-10-1018; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fan JY, 2007, METHODS, V41, P286, DOI 10.1016/j.ymeth.2006.11.001; FLEMMING W, 1982, ZELLSUBSTANZ KERN ZE; Fukui K, 2007, CHEM REC, V7, P230, DOI 10.1002/tcr.20120; Gambe AE, 2007, CYTOM PART A, V71A, P286, DOI 10.1002/cyto.a.20378; GASSER SM, 1987, EXP CELL RES, V173, P85, DOI 10.1016/0014-4827(87)90334-X; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GEORGEL P, 1993, J BIOL CHEM, V268, P1947; GOULD H, 1998, CHROMATIN PRACTICAL, P22; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HAYASHIHARA K, 2008, PROTOCOLS NETWORK, DOI DOI 10.1038/NPROT.2008.166; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LE DB, 1996, EMBO J, V15, P6701; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Luger K, 1999, METH MOL B, V119, P1; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PARSEGHIAN MH, 1994, PROTEIN SCI, V3, P575; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; RASHEED BKA, 1989, J CELL SCI, V94, P61; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; SEYEDIN SM, 1981, EXP CELL RES, V136, P399, DOI 10.1016/0014-4827(81)90019-7; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Sumner AT, 2003, CHROMOSOMES ORG FUNC, P5; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Takata H, 2007, GENES CELLS, V12, P269, DOI 10.1111/j.1365-2443.2007.01051.x; Tanaka H, 2006, INT J ANDROL, V29, P353, DOI 10.1111/j.1365-2605.2005.00600.x; Tanaka M, 2001, DEVELOPMENT, V128, P655; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; WUTHRCH K, 1986, NMR PROTEINS NUCL AC; Yamamoto T, 1996, GENE, V173, P281, DOI 10.1016/0378-1119(96)00020-0; Yan W, 2003, P NATL ACAD SCI USA, V100, P10546, DOI 10.1073/pnas.1837812100; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Zlatanova J, 2008, TRENDS BIOCHEM SCI, V33, P247, DOI 10.1016/j.tibs.2008.04.001	62	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6498	6507		10.1074/jbc.M109.092833	http://dx.doi.org/10.1074/jbc.M109.092833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042602	Green Published, hybrid			2022-12-27	WOS:000275367500054
J	Lebaudy, A; Pascaud, F; Very, AA; Alcon, C; Dreyer, I; Thibaud, JB; Lacombe, B				Lebaudy, Anne; Pascaud, Francois; Very, Anne-Alienor; Alcon, Carine; Dreyer, Ingo; Thibaud, Jean-Baptiste; Lacombe, Benoit			Preferential KAT1-KAT2 Heteromerization Determines Inward K+ Current Properties in Arabidopsis Guard Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT POTASSIUM CHANNEL; KAT1; SUBUNIT; AKT2; STOICHIOMETRY; CARROT; KDC1; ION; COOPERATIVITY; RECTIFICATION	Guard cells adjust their volume by changing their ion content due to intense fluxes that, for K+, are believed to flow through inward or outward Shaker channels. Because Shaker channels can be homo-or heterotetramers and Arabidopsis guard cells express at least five genes encoding inward Shaker subunits, including the two major ones, KAT1 and KAT2, the molecular identity of inward Shaker channels operating therein is not yet completely elucidated. Here, we first addressed the properties of KAT1-KAT2 heteromers by expressing KAT1-KAT2 tandems in Xenopus oocytes. Then, computer analyses of the data suggested that coexpression of free KAT1 and KAT2 subunits resulted mainly in heteromeric channels made of two subunits of each type due to some preferential association of KAT1-KAT2 heterodimers at the first step of channel assembly. This was further supported by the analysis of KAT2 effect on KAT1 targeting in tobacco cells. Finally, patch-clamp recordings of native inward channels in wild-type and mutant genotypes strongly suggested that this preferential heteromerization occurs in planta and that Arabidopsis guard cell inward Shaker channels are mainly heteromers of KAT1 and KAT2 subunits.	[Lacombe, Benoit] Univ Montpellier 2, Montpellier SupAgro, INRA, CNRS,UMR 5004,U386, F-34060 Montpellier, France; [Dreyer, Ingo] Univ Potsdam, Inst Biochem & Biol, Heisenberg Grp Biophys & Mol Pflanzenbiol, D-14476 Potsdam, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; University of Potsdam	Lacombe, B (corresponding author), BPMP, Batiment 7,Campus INRA SupAgro,Pl Viala, F-34060 Montpellier, France.	benoit.lacombe@supagro.inra.fr	Lacombe, Benoit/B-1202-2013; Dreyer, Ingo/N-4747-2014	Dreyer, Ingo/0000-0002-2781-0359; Lacombe, Benoit/0000-0001-9924-3093; THIBAUD, Jean-Baptiste/0000-0002-0824-6465; VERY, Anne-Alienor/0000-0003-1961-5243	Institut National de la Recherche Agronomique/Region Languedoc-Roussillon; CNRS; Heisenberg fellowship from the Deutsche Forschungsgemeinschaft; Agence National de la Recherche Genoplante [GPLA06041G]; Agropolis Foundation [0803-022]	Institut National de la Recherche Agronomique/Region Languedoc-Roussillon(Region Occitanie); CNRS(Centre National de la Recherche Scientifique (CNRS)); Heisenberg fellowship from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence National de la Recherche Genoplante(French National Research Agency (ANR)); Agropolis Foundation	This work was supported in part by doctoral fellowship grants from the Institut National de la Recherche Agronomique/Region Languedoc-Roussillon (to A. L.) and CNRS (to F. P.), a Heisenberg fellowship from the Deutsche Forschungsgemeinschaft (to I. D.), Agence National de la Recherche Genoplante Grant GPLA06041G (to B. L. and J.-B.T.), and Agropolis Foundation Grant 0803-022 (to J.-B.T.).	Ache P, 2001, PLANT J, V27, P571, DOI 10.1046/j.1365-313X.2001.t01-1-01116.x; Baizabal-Aguirre VM, 1999, J MEMBRANE BIOL, V167, P119, DOI 10.1007/s002329900476; Bregante M, 2008, PLANT MOL BIOL, V66, P61, DOI 10.1007/s11103-007-9252-x; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; Duby G, 2008, PLANT J, V53, P115, DOI 10.1111/j.1365-313X.2007.03324.x; Ehrhardt T, 1997, FEBS LETT, V409, P166, DOI 10.1016/S0014-5793(97)00502-4; Formentin E, 2004, FEBS LETT, V573, P61, DOI 10.1016/j.febslet.2004.07.052; Gaymard F, 1996, J BIOL CHEM, V271, P22863, DOI 10.1074/jbc.271.37.22863; Geiger D, 2009, J BIOL CHEM, V284, P21288, DOI 10.1074/jbc.M109.017574; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hosy E, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-14; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Jeanguenin L, 2008, PLANT SIGNAL BEHAV, V3, P622, DOI 10.4161/psb.3.9.6209; Kwak JM, 2001, PLANT PHYSIOL, V127, P473, DOI 10.1104/pp.010428; Lacombe B, 1998, J MEMBRANE BIOL, V166, P91, DOI 10.1007/s002329900451; Lacombe B, 2000, FEBS LETT, V466, P351, DOI 10.1016/S0014-5793(00)01093-0; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lebaudy A, 2008, PLANT J, V54, P1076, DOI 10.1111/j.1365-313X.2008.03479.x; Lebaudy A, 2008, P NATL ACAD SCI USA, V105, P5271, DOI 10.1073/pnas.0709732105; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Marten I, 1998, BIOPHYS J, V74, P2953, DOI 10.1016/S0006-3495(98)78002-6; Marten I, 1997, P NATL ACAD SCI USA, V94, P3448, DOI 10.1073/pnas.94.7.3448; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Michard E, 2005, J GEN PHYSIOL, V126, P605, DOI 10.1085/jgp.200509413; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Mikosch M, 2006, PLANT PHYSIOL, V142, P923, DOI 10.1104/pp.106.087064; Naso A, 2006, BIOPHYS J, V91, P3673, DOI 10.1529/biophysj.106.091777; Naso A, 2009, BIOPHYS J, V96, P4063, DOI 10.1016/j.bpj.2009.02.055; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; Picco C, 2004, BIOPHYS J, V86, P224, DOI 10.1016/S0006-3495(04)74098-9; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Sutter JU, 2006, PLANT CELL, V18, P935, DOI 10.1105/tpc.105.038950; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Urbach S, 2000, PLANT J, V23, P527, DOI 10.1046/j.1365-313x.2000.00828.x; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Xicluna J, 2007, J BIOL CHEM, V282, P486, DOI 10.1074/jbc.M607607200; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	57	44	46	8	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6265	6274		10.1074/jbc.M109.068445	http://dx.doi.org/10.1074/jbc.M109.068445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040603	Green Published, hybrid			2022-12-27	WOS:000275367500031
J	Mehta, S; Sibley, LD				Mehta, Simren; Sibley, L. David			Toxoplasma gondii Actin Depolymerizing Factor Acts Primarily to Sequester G-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACANTHAMOEBA ACTOPHORIN ADF/COFILIN; REFLECTION FLUORESCENCE MICROSCOPY; CHICKEN SKELETAL-MUSCLE; F-ACTIN; FILAMENT TURNOVER; CAENORHABDITIS-ELEGANS; BINDING SITE; FACTOR/COFILIN PROTEINS; APICOMPLEXAN PARASITES; MICROFILAMENT DYNAMICS	Toxoplasma gondii is a protozoan parasite belonging to the phylum Apicomplexa. Parasites in this phylum utilize a unique process of motility termed gliding, which is dependent on parasite actin filaments. Surprisingly, 98% of parasite actin is maintained as G-actin, suggesting that filaments are rapidly assembled and turned over. Little is known about the regulated disassembly of filaments in the Apicomplexa. In higher eukaryotes, the related actin depolymerizing factor (ADF) and cofilin proteins are essential regulators of actin filament turnover. ADF is one of the few actin-binding proteins conserved in apicomplexan parasites. In this study we examined the mechanism by which T. gondii ADF (TgADF) regulates actin filament turnover. Unlike other members of the ADF/cofilin (AC) family, apicomplexan ADFs lack key F-actin binding sites. Surprisingly, this promotes their enhanced disassembly of actin filaments. Restoration of the C-terminal F-actin binding site to TgADF stabilized its interaction with filaments but reduced its net filament disassembly activity. Analysis of severing activity revealed that TgADF is a weak severing protein, requiring much higher concentrations than typical AC proteins. Investigation of TgADF interaction with T. gondii actin (TgACT) revealed that TgADF disassembled short TgACT oligomers. Kinetic and steady-state polymerization assays demonstrated that TgADF has strong monomer-sequestering activity, inhibiting TgACT polymerization at very low concentrations. Collectively these data indicate that TgADF promoted the efficient turnover of actin filaments via weak severing of filaments and strong sequestering of monomers. This suggests a dual role for TgADF in maintaining high G-actin concentrations and effecting rapid filament turnover.	[Mehta, Simren; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	sibley@wustl.edu	Mehta, Simren/AAE-8738-2019	Mehta, Simren/0000-0003-0163-5510	National Institutes of Health [AI073155]; Washington University Morse/Berg Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036, R01AI073155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Morse/Berg Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI073155 (to L.D.S.). This work was also supported by a Washington University Morse/Berg Fellowship (to S.M.).	ABE H, 1989, J BIOCHEM-TOKYO, V106, P172, DOI 10.1093/oxfordjournals.jbchem.a122810; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Allen ML, 1997, MOL BIOCHEM PARASIT, V88, P43, DOI 10.1016/S0166-6851(97)00069-8; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Gordon Jennifer L., 2007, P555; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; HARRIS HE, 1980, FEBS LETT, V121, P175, DOI 10.1016/0014-5793(80)81291-9; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Joynson DH, 2001, TOXOPLASMOSIS COMPRE; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard SA, 1997, NAT STRUCT BIOL, V4, P369, DOI 10.1038/nsb0597-369; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Maciver SK, 1998, CURR OPIN CELL BIOL, V10, P140, DOI 10.1016/S0955-0674(98)80097-5; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; MORIYAMA K, 1992, J BIOL CHEM, V267, P7240; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nachmias VT, 1993, CURR OPIN CELL BIOL, V5, P56, DOI 10.1016/S0955-0674(05)80008-0; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P6624, DOI 10.1021/bi00344a049; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pope BJ, 2000, J MOL BIOL, V298, P649, DOI 10.1006/jmbi.2000.3688; Poupel O, 1999, MICROBES INFECT, V1, P653, DOI 10.1016/S1286-4579(99)80066-5; QUIRK S, 1993, BIOCHEMISTRY-US, V32, P8525, DOI 10.1021/bi00084a019; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; SHIMIZU N, 1986, J BIOCHEM-TOKYO, V99, P751, DOI 10.1093/oxfordjournals.jbchem.a135534; Shiozaki N, 2009, BIOCHEM BIOPH RES CO, V390, P54, DOI 10.1016/j.bbrc.2009.09.063; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Smertenko AP, 1998, PLANT J, V14, P187, DOI 10.1046/j.1365-313X.1998.00107.x; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Xu JH, 2008, PARASITOL RES, V103, P263, DOI 10.1007/s00436-008-0961-0; Yamashiro S, 2005, BIOCHEMISTRY-US, V44, P14238, DOI 10.1021/bi050933d; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; YONEZAWA N, 1991, J BIOL CHEM, V266, P10485	73	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6835	6847		10.1074/jbc.M109.068155	http://dx.doi.org/10.1074/jbc.M109.068155			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042603	Green Published, hybrid			2022-12-27	WOS:000275367500086
J	Okamoto, M; Liu, WM; Luo, YC; Tanaka, A; Cai, XN; Norris, DA; Dinarello, CA; Fujita, M				Okamoto, Miyako; Liu, Weimin; Luo, Yuchun; Tanaka, Aki; Cai, Xiangna; Norris, David A.; Dinarello, Charles A.; Fujita, Mayumi			Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TUMOR-GROWTH; IN-VIVO; MOLECULAR PLATFORM; PERIODIC SYNDROMES; IMMUNE-RESPONSES; CARCINOMA-CELLS; CANCER CELLS; ACTIVATION; METASTASIS	Interleukin-1 beta (IL-1 beta) is a pleiotropic cytokine promoting inflammation, angiogenesis, and tissue remodeling as well as regulation of immune responses. Although IL-1 beta contributes to growth and metastatic spread in experimental and human cancers, the molecular mechanisms regulating the conversion of the inactive IL-1 beta precursor to a secreted and active cytokine remains unclear. Here we demonstrate that NALP3 inflammasome is constitutively assembled and activated with cleavage of caspase-1 in human melanoma cells. Late stage human melanoma cells spontaneously secrete active IL-1 beta via constitutive activation of the NALP3 inflammasome and IL-1 receptor signaling, exhibiting a feature of autoinflammatory diseases. Unlike human blood monocytes, these melanoma cells require no exogenous stimulation. In contrast, NALP3 functionality in intermediate stage melanoma cells requires activation of the IL-1 receptor to secrete active IL-1 beta; cells from an early stage of melanoma require stimulation of the IL-1 receptor plus the co-stimulant muramyl dipeptide. The spontaneous secretion of IL-1 beta from melanoma cells was reduced by inhibition of caspase-1 or the use of small interfering RNA directed against ASC. Supernatants from melanoma cell cultures enhanced macrophage chemotaxis and promoted in vitro angiogenesis, both prevented by pretreating melanoma cells with inhibitors of caspases-1 and -5 or IL-1 receptor blockade. These findings implicate IL-1-mediated autoinflammation as contributing to the development and progression of human melanoma and suggest that inhibiting the inflammasome pathway or reducing IL-1 activity can be a therapeutic option for melanoma patients.	[Okamoto, Miyako; Liu, Weimin; Luo, Yuchun; Tanaka, Aki; Cai, Xiangna; Norris, David A.; Fujita, Mayumi] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Fujita, M (corresponding author), Univ Colorado Denver, Dept Dermatol, Mail Stop 8127,12801 E 17th Ave,Rm 4124, Aurora, CO 80045 USA.	mayumi.fujita@ucdenver.edu	Luo, Yuchun/B-8683-2014; Dinarello, Charles/C-8524-2013		National Institutes of Health [CA125833, AI-15614, 5T32AR007411]; Dermatology Foundation; Tadamitsu Cancer Research Fund; NATIONAL CANCER INSTITUTE [R03CA125833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015614, R01AI015614, R37AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Tadamitsu Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA125833 (to M. F.) and AI-15614 (to C. A. D.). This work was also supported by grants from the Dermatology Foundation (to M. F.) and the Tadamitsu Cancer Research Fund (to M. F.).; Supported by National Institutes of Health Training Grant 5T32AR007411.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Arlt A, 2002, CANCER RES, V62, P910; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; den Broeder AA, 2006, ANN RHEUM DIS, V65, P760, DOI 10.1136/ard.2004.033662; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jin L, 1997, CANCER-AM CANCER SOC, V80, P421, DOI 10.1002/(SICI)1097-0142(19970801)80:3<421::AID-CNCR10>3.0.CO;2-Z; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Muerkoster SS, 2006, ONCOGENE, V25, P3973, DOI 10.1038/sj.onc.1209423; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Sanz C, 2004, BIOCHEM J, V384, P281, DOI 10.1042/BJ20040867; Sawai H, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-8; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; SUN WH, 1992, CANCER RES, V52, P5412; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; VidalVanaclocha F, 1996, JNCI-J NATL CANCER I, V88, P198, DOI 10.1093/jnci/88.3-4.198; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Yang JM, 2001, CANCER RES, V61, P4901; Yano S, 2003, CANCER SCI, V94, P244, DOI 10.1111/j.1349-7006.2003.tb01428.x	56	228	241	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6477	6488		10.1074/jbc.M109.064907	http://dx.doi.org/10.1074/jbc.M109.064907			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038581	Green Published, hybrid			2022-12-27	WOS:000275367500052
J	Takemura, T; Nakamura, S; Yokota, D; Hirano, I; Ono, T; Shigeno, K; Fujisawa, S; Ohnishi, K				Takemura, Tomonari; Nakamura, Satoki; Yokota, Daisuke; Hirano, Isao; Ono, Takaaki; Shigeno, Kazuyuki; Fujisawa, Shinya; Ohnishi, Kazunori			Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; LIVER-REGENERATION; COLORECTAL-CANCER; TRANSFORMATION; FOXM1; BCR/ABL; PATHWAY; SUPPRESSION	Chronic myelogenous leukemia (CML) is characterized by a reciprocal chromosomal translocation ( 9; 22) that generates the Bcr-Abl fusion gene. The Ras/Raf-1/MEK/ERK pathway is constitutively activated in Bcr-Abl-transformed cells, and Ras activity enhances the oncogenic ability of Bcr-Abl. However, the mechanism by which Bcr-Abl activates the Ras pathway is not completely understood. Raf kinase inhibitor protein (RKIP) inhibits activation of MEK by Raf-1 and its downstream signal transduction, resulting in blocking the MAP kinase pathway. In the present study, we found that RKIP was depleted in CML cells. We investigated the interaction between RKIP and Bcr-Abl in CML cell lines and Bcr-Abl(+) progenitor cells from CML patients. The Abl kinase inhibitors and depletion of Bcr-Abl induced the expression of RKIP and reduced the pERK1/2 status, resulting in inhibited proliferation of CML cells. Moreover, RKIP up-regulated cell cycle regulator FoxM1 expression, resulting in G(1) arrest via p27(Kip1) and p21(Cip1) accumulation. In colony-forming unit granulocyte, erythroid, macrophage, megakaryocyte, colony-forming unit-granulocyte macrophage, and burst-forming unit erythroid, treatment with the Abl kinase inhibitors and depletion of Bcr-Abl induced RKIP and reduced FoxM1 expressions, and inhibited colony formation of Bcr-Abl(+) progenitor cells, whereas depletion of RKIP weakened the inhibition of colony formation activity by the Abl kinase inhibitors in Bcr-Abl(+) progenitor cells. Thus, Bcr-Abl represses the expression of RKIP, continuously activates pERK1/2, and suppresses FoxM1 expression, resulting in proliferation of CML cells.	[Takemura, Tomonari; Nakamura, Satoki; Yokota, Daisuke; Hirano, Isao; Ono, Takaaki; Shigeno, Kazuyuki; Fujisawa, Shinya; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Takemura, Tomonari; Yokota, Daisuke; Hirano, Isao; Ono, Takaaki; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Canc, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Fujisawa, Shinya] Hamamatsu Med Ctr, Div Hematol, Naka Ku, Shizuoka 4328580, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Nakamura, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	satonaka@hama-med.ac.jp		Ono, Takaaki/0000-0003-3922-7432	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590987]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 17590987 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akaishi J, 2006, ANTICANCER RES, V26, P4437; Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; Houben Roland, 2007, J Carcinog, V6, P16, DOI 10.1186/1477-3163-6-16; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Nottage M, 2002, CURR PHARM DESIGN, V8, P2231, DOI 10.2174/1381612023393107; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; RUDKIN GT, 1964, SCIENCE, V144, P1229, DOI 10.1126/science.144.3623.1229; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schuierer MM, 2006, ONCOL REP, V16, P451; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Teh MT, 2002, CANCER RES, V62, P4773; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zlobec I, 2008, CLIN CANCER RES, V14, P143, DOI 10.1158/1078-0432.CCR-07-1380	50	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6585	6594		10.1074/jbc.M109.075788	http://dx.doi.org/10.1074/jbc.M109.075788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028985	Green Published, hybrid			2022-12-27	WOS:000275367500063
J	Tan, SX; Greetham, D; Raeth, S; Grant, CM; Dawes, IW; Perrone, GG				Tan, Shi-Xiong; Greetham, Darren; Raeth, Sebastian; Grant, Chris M.; Dawes, Ian W.; Perrone, Gabriel G.			The Thioredoxin-Thioredoxin Reductase System Can Function in Vivo as an Alternative System to Reduce Oxidized Glutathione in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; HYDROGEN-PEROXIDE; REDOX STATE; MONOTHIOL GLUTAREDOXINS; GAMMA-GLUTAMYLCYSTEINE; ENDOPLASMIC-RETICULUM; GENETIC-ANALYSIS; CELL-CYCLE; YEAST; PROTECTION	Cellular mechanisms that maintain redox homeostasis are crucial, providing buffering against oxidative stress. Glutathione, the most abundant low molecular weight thiol, is considered the major cellular redox buffer in most cells. To better understand how cells maintain glutathione redox homeostasis, cells of Saccharomyces cerevisiae were treated with extracellular oxidized glutathione (GSSG), and the effect on intracellular reduced glutathione (GSH) and GSSG were monitored over time. Intriguingly cells lacking GLR1 encoding the GSSG reductase in S. cerevisiae accumulated increased levels of GSH via a mechanism independent of the GSH biosynthetic pathway. Furthermore, residual NADPH-dependent GSSG reductase activity was found in lysate derived from glr1 cell. The cytosolic thioredoxin-thioredoxin reductase system and not the glutaredoxins (Grx1p, Grx2p, Grx6p, and Grx7p) contributes to the reduction of GSSG. Overexpression of the thioredoxins TRX1 or TRX2 in glr1 cells reduced GSSG accumulation, increased GSH levels, and reduced cellular glutathione E-h'. Conversely, deletion of TRX1 or TRX2 in the glr1 strain led to increased accumulation of GSSG, reduced GSH levels, and increased cellular E-h'. Furthermore, it was found that purified thioredoxins can reduce GSSG to GSH in the presence of thioredoxin reductase and NADPH in a reconstituted in vitro system. Collectively, these data indicate that the thioredoxin-thioredoxin reductase system can function as an alternative system to reduce GSSG in S. cerevisiae in vivo.	[Tan, Shi-Xiong; Dawes, Ian W.; Perrone, Gabriel G.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Tan, Shi-Xiong; Raeth, Sebastian; Dawes, Ian W.; Perrone, Gabriel G.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Greetham, Darren; Grant, Chris M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of New South Wales Sydney; University of New South Wales Sydney; University of Manchester	Dawes, IW (corresponding author), Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Tan, Shi-Xiong/Y-3728-2019	Grant, Chris/0000-0002-0616-6576; Tan, Shi-Xiong/0000-0002-0020-2572	Australian Research Council; Cancer Institute New South Wales	Australian Research Council(Australian Research Council); Cancer Institute New South Wales	This work was supported by grants from the Australian Research Council and the Cancer Institute New South Wales.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inoue Y, 1998, BBA-GENE STRUCT EXPR, V1395, P315, DOI 10.1016/S0167-4781(97)00199-1; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IZAWA S, 1995, FEBS LETT, V368, P73, DOI 10.1016/0014-5793(95)00603-7; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Machado AK, 1997, J BIOL CHEM, V272, P17045, DOI 10.1074/jbc.272.27.17045; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; OHTAKE Y, 1991, YEAST, V7, P953, DOI 10.1002/yea.320070907; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Stephen DWS, 1996, FEMS MICROBIOL LETT, V141, P207, DOI 10.1111/j.1574-6968.1996.tb08386.x; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; WHEALS AE, 1982, MOL CELL BIOL, V2, P361, DOI 10.1128/MCB.2.4.361; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	54	71	74	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6118	6126		10.1074/jbc.M109.062844	http://dx.doi.org/10.1074/jbc.M109.062844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	19951944	Green Published, hybrid			2022-12-27	WOS:000275367500015
J	Chatterjee, A; Wang, L; Armstrong, DL; Rossie, S				Chatterjee, Anindya; Wang, Ling; Armstrong, David L.; Rossie, Sandra			Activated Rac1 GTPase Translocates Protein Phosphatase 5 to the Cell Membrane and Stimulates Phosphatase Activity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; HUMAN BREAST-CANCER; SERINE/THREONINE PHOSPHATASE; EPITHELIAL-CELLS; RHO-GTPASES; TPR DOMAIN; NUCLEAR-LOCALIZATION; CARDIAC-ARRHYTHMIA; TERMINAL REGION; MOLECULAR-BASIS	Physiological studies of ion channel regulation have implicated the Ser/Thr protein phosphatase 5 (PP5) as an effector of Rac1 GTPase signaling, but direct biochemical evidence for PP5 regulation by Rac1 is lacking. In this study we used immunoprecipitation, in vitro binding, cellular fractionation, and immunofluorescence techniques to show that the tetratricopeptide repeat domain of PP5 interacts specifically and directly with active Rac1. Consequently, activation of Rac1 promoted PP5 translocation to the plasma membrane in intact cells and stimulated PP5 phosphatase activity in vitro. In contrast, neither constitutively active RhoA-V14 nor dominant negative Rac1N17, which preferentially binds GDP and retains an inactive conformation, bound PP5 or stimulated its activity. In addition, Rac1N17 and Rac1(PBRM), a mutant lacking the C-terminal polybasic region required for Rac1 association with the membrane, both failed to cause membrane translocation of PP5. Mutation of predicted contact residues in the PP5 tetratricopeptide repeat domain or within Rac1 also disrupted co-immunoprecipitation of Rac1-PP5 complexes and membrane translocation of PP5. Specific binding of PP5 to activated Rac1 provides a direct mechanism by which PP5 can be stimulated and recruited to participate in Rac1-mediated signaling pathways.	[Chatterjee, Anindya; Wang, Ling; Rossie, Sandra] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Chatterjee, Anindya; Wang, Ling; Rossie, Sandra] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Armstrong, David L.] NIEHS, Environm Biol Program, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Rossie, S (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	rossie@purdue.edu			National Institutes of Health [NS031221, NCI-2P30CA23168]; National Institutes of Health Intramural Research Program at NIEHS [Z01-ES080043]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080043, ZIAES102285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031221, R29NS031221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Program at NIEHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS031221 (to S.R.). This work was also supported in part by Purdue Cancer Center NCI Core Grant NCI-2P30CA23168 from the National Institutes of Health and the National Institutes of Health Intramural Research Program at NIEHS through Grant Z01-ES080043 (to D. L. A.).	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Bahl R, 2001, MOL BRAIN RES, V90, P101, DOI 10.1016/S0169-328X(01)00089-4; BECKER W, 1994, J BIOL CHEM, V269, P22586; Borthwick EB, 2001, FEBS LETT, V491, P279, DOI 10.1016/S0014-5793(01)02177-9; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gentile S, 2006, P NATL ACAD SCI USA, V103, P5202, DOI 10.1073/pnas.0600080103; Gentile S, 2008, P NATL ACAD SCI USA, V105, P14704, DOI 10.1073/pnas.0802250105; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Manser Edward J, 2002, Methods Mol Biol, V189, P3; Messner DJ, 2006, J CELL BIOCHEM, V99, P241, DOI 10.1002/jcb.20919; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Patil S, 2004, AM J PHYSIOL-LUNG C, V287, pL1314, DOI 10.1152/ajplung.00383.2003; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sanchez-Ortiz E, 2009, J NEUROCHEM, V111, P391, DOI 10.1111/j.1471-4159.2009.06337.x; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schuster MK, 2004, BIOL REPROD, V70, P1493, DOI 10.1095/biolreprod.103.024331; Schwarz JR, 2004, J CELL MOL MED, V8, P22, DOI 10.1111/j.1582-4934.2004.tb00256.x; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sinclair C, 1999, J BIOL CHEM, V274, P23666, DOI 10.1074/jbc.274.33.23666; Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	57	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3872	3882		10.1074/jbc.M109.088427	http://dx.doi.org/10.1074/jbc.M109.088427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19948726	hybrid, Green Published			2022-12-27	WOS:000275254000041
J	Chung, CW; Zhang, QL; Qiao, LY				Chung, Chul-Won; Zhang, Qing L.; Qiao, Li-Ya			Endogenous Nerve Growth Factor Regulates Collagen Expression and Bladder Hypertrophy through Akt and MAPK Pathways during Cystitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; NEUROTROPHIC FACTOR; URINARY-BLADDER; HEMORRHAGIC CYSTITIS; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; UP-REGULATION; SUBSTANCE-P; C-JUN; ACTIVATION	Type I collagen forms the main constituent of the extracellular matrix in visceral organs. We reported here that cyclophosphamide (CYP)-induced cystitis significantly increased the production of type I collagen in the inflamed bladder leading to increases in the bladder weight and the thickness of the bladder wall. The endogenous nerve growth factor (NGF) in the urinary bladder regulated type I collagen expression because the neutralizing NGF antibody attenuated cystitis-induced type I collagen up-regulation in the inflamed bladder. Neutralizing NGF antibody also subsequently reversed cystitis-induced increases in bladder weight. Further studies on the intermediate signaling pathways mediating NGF-induced type I collagen expression in the inflamed bladder during cystitis revealed that Akt, JNK, and ERK1/2 activities were increased in the inflamed bladder, whereas p38 MAPK remained unchanged. Suppression of endogenous NGF level with neutralizing NGF antibody significantly blocked the increased activity of Akt, JNK, and ERK1/2 in the inflamed bladder during cystitis. These results indicate that endogenous NGF plays an important role in the activation of Akt and MAPK in the urinary bladder and in bladder hypertrophy during cystitis.	[Chung, Chul-Won; Zhang, Qing L.; Qiao, Li-Ya] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Virginia Commonwealth University	Qiao, LY (corresponding author), MMRB 5038,Box 980551, Richmond, VA 23298 USA.	lqiao2@vcu.edu			National Institutes of Health [DK077917]; Interstitial Cystitis Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interstitial Cystitis Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK077917 (to L.-Y.Q.). This work was also supported by a grant from the Interstitial Cystitis Association (to L.-Y.Q.).	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Batler RA, 2002, J UROLOGY, V168, P819, DOI 10.1016/S0022-5347(05)64750-7; Chen MW, 1995, WORLD J UROL, V13, P344; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; DEVRIES CR, 1990, J UROLOGY, V143, P1; DONNERER J, 1992, ANN NY ACAD SCI, V657, P505, DOI 10.1111/j.1749-6632.1992.tb22814.x; DONNERER J, 1992, NEUROSCIENCE, V49, P693, DOI 10.1016/0306-4522(92)90237-V; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; FLEISCHMAJER R, 1990, ANN NY ACAD SCI, V580, P161, DOI 10.1111/j.1749-6632.1990.tb17927.x; GABELLA G, 1990, ANAT EMBRYOL, V182, P409; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; GOMES TNA, 1995, BRAZ J MED BIOL RES, V28, P1103; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Howard PS, 2005, UROLOGY, V66, P1349, DOI 10.1016/j.urology.2005.06.124; Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Klinger MB, 2008, AM J PHYSIOL-RENAL, V295, pF1778, DOI 10.1152/ajprenal.90501.2008; Lee Sang Don, 2006, J Pediatr Urol, V2, P225, DOI 10.1016/j.jpurol.2006.03.011; LEVINE LA, 1989, J UROLOGY, V141, P1063, DOI 10.1016/S0022-5347(17)41173-6; Li FF, 2009, BIOCHEM BIOPH RES CO, V386, P289, DOI 10.1016/j.bbrc.2009.05.084; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Lutz M, 2004, EUR J BIOCHEM, V271, P920, DOI 10.1111/j.1432-1033.2004.03994.x; Madduri S, 2009, NEUROSCI RES, V65, P88, DOI 10.1016/j.neures.2009.06.003; Majumdar P, 2009, DIABETES-METAB RES, V25, P452, DOI 10.1002/dmrr.964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Murray E, 2004, J UROLOGY, V172, P2434, DOI 10.1097/01.ju.0000143549.29867.4e; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Oka M, 2009, J UROLOGY, V182, P382, DOI 10.1016/j.juro.2009.02.104; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Papakrivopoulou J, 2004, CARDIOVASC RES, V61, P736, DOI 10.1016/j.cardiores.2003.12.018; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; Qiao LY, 2007, AM J PHYSIOL-REG I, V292, pR1368, DOI 10.1152/ajpregu.00570.2006; Reunanen N, 2000, J BIOL CHEM, V275, P34634, DOI 10.1074/jbc.C000175200; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; Saini Rajiv, 2008, Curr Urol Rep, V9, P314, DOI 10.1007/s11934-008-0054-8; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Skaper SD, 2001, MOL BRAIN RES, V97, P177, DOI 10.1016/S0169-328X(01)00314-X; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Stanzel RDP, 2008, EXP NEUROL, V211, P203, DOI 10.1016/j.expneurol.2008.01.028; STILLWELL TJ, 1988, CANCER, V61, P451, DOI 10.1002/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Tekgul S, 1996, J UROLOGY, V156, P582, DOI 10.1016/S0022-5347(01)65757-4; Theiss AL, 2004, INFLAMM BOWEL DIS, V10, P871, DOI 10.1097/00054725-200411000-00021; Tonra JR, 1998, J NEUROSCI, V18, P4374; TUTTLE JB, 1994, J AUTONOM NERV SYST, V49, P147, DOI 10.1016/0165-1838(94)90134-1; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; WU BY, 1989, J BIOL CHEM, V264, P9000; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731	57	33	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4206	4212		10.1074/jbc.M109.040444	http://dx.doi.org/10.1074/jbc.M109.040444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19996110	Green Published, hybrid			2022-12-27	WOS:000275254000072
J	Xu, H; Dhanasekaran, DN; Lee, CM; Reddy, EP				Xu, Hua; Dhanasekaran, Danny N.; Lee, Clement M.; Reddy, E. Premkumar			Regulation of Neurite Outgrowth by Interactions between the Scaffolding Protein, JNK-associated Leucine Zipper Protein, and Neuronal Growth-associated Protein Superior Cervical Ganglia Clone 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCG10 MESSENGER-RNA; MICROTUBULE DYNAMICS; MAP-KINASE; STATHMIN; FAMILY; DIFFERENTIATION; LOCALIZATION; INDUCTION; MODULES; JLP	JLP (JNK-associated leucine zipper protein) is a novel scaffolding protein involved in JNK signaling. Although it is known that JLP is highly expressed in brain, the biological function of JLP in neuronal systems remains unknown. Here, we report a novel interaction between JLP and SCG10 (superior cervical ganglia clone 10), which is a microtubule-destabilizing factor that is essential for neurite outgrowth. Inhibition of endogenous JLP expression using small interference RNA methodology strongly enhanced nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Our results show that JLP negatively regulates NGF-induced neurite outgrowth by decreasing the level of phosphorylated SCG10. Furthermore, inhibition of JNK phosphorylation by a small molecule inhibitor, SP600125, resulted in inhibition of SCG10 phosphorylation and inhibition of neurite growth. Taken together, our results suggest that JLP negatively regulates NGF-induced neurite outgrowth through a sequestering mechanism that results in an attenuation of NGF-induced SCG10 phosphorylation.	[Xu, Hua; Dhanasekaran, Danny N.; Lee, Clement M.; Reddy, E. Premkumar] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lee, CM (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, 3307 N Broad St, Philadelphia, PA 19140 USA.	clement@temple.edu; reddy@temple.edu	Lee, Clement M./E-7104-2012; Reddy, E. Premkumar/F-6233-2011	Lee, Clement M./0000-0003-3486-8492; 	NATIONAL CANCER INSTITUTE [R01CA123233] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123233-02, R01 CA123233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; Gantulga D, 2008, J BIOCHEM, V144, P693, DOI 10.1093/jb/mvn123; Gelderblom M, 2004, INT J DEV NEUROSCI, V22, P559, DOI 10.1016/j.ijdevneu.2004.07.014; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Hannan AJ, 1996, NEUROSCIENCE, V72, P889, DOI 10.1016/0306-4522(95)00593-5; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mori N, 2002, J NEUROSCI RES, V70, P264, DOI 10.1002/jnr.10353; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Ozon S, 1998, J NEUROCHEM, V70, P2386; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828	22	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3548	3553		10.1074/jbc.M109.064113	http://dx.doi.org/10.1074/jbc.M109.064113			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19959466	Green Published, hybrid			2022-12-27	WOS:000275254000004
J	Jang, ER; Ryu, M; Park, JE; Kim, JH; Lee, JS; Song, K				Jang, Eun Ryoung; Ryu, Minsook; Park, Jeong Eun; Kim, Jung-Ho; Lee, Jong-Soo; Song, Kiwon			A New Isoquinolinium Derivative, Cadein1, Preferentially Induces Apoptosis in p53-defective Cancer Cells with Functional Mismatch Repair via a p38-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; COLON-CANCER; MICROSATELLITE INSTABILITY; METHYLATING AGENTS; DNA METHYLATION; G(2) CHECKPOINT; CARCINOMA-CELLS; DEFICIENT CELLS; CYCLE ARREST; G2/M ARREST	We screened a protoberberine backbone derivative library for compounds with anti-proliferative effects on p53-defective cancer cells. A compound identified from this small molecule library, cadein1 (cancer-selective death inducer 1), an isoquinolinium derivative, effectively leads to a G(2)/M delay and caspase-dependent apoptosis in various carcinoma cells with nonfunctional p53. The ability of cadein1 to induce apoptosis in p53-defective colon cancer cells was tightly linked to the presence of a functional DNA mismatch repair(MMR) system, which is an important determinant in chemosensitivity. Cadein1 was very effective in MMR+/p53(-) cells, whereas it was not effective in p53(+) cells regardless of the MMR status. Consistently, when the function of MMR was blocked with short hairpin RNA in SW620 (MMR+/p53(-)) cells, cadein1 was no longer effective in inducing apoptosis. Besides, the inhibition of p53 increased the pro-apoptotic effect of cadein1 in HEK293(MMR+/p53(+)) cells, whereas it did not affect the response to cadein1 in RKO (MMR-/p53(+)) cells. The apoptotic effects of cadein1 depended on the activation of p38 but not on the activation of Chk2 or other stress-activated kinases in p53-defective cells. Taken together, our results show that cadein1 may have a potential to be an anticancer chemotherapeutic agent that is preferentially effective on p53-mutant colon cancer cells with functional MMR.	[Jang, Eun Ryoung; Park, Jeong Eun; Song, Kiwon] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Ryu, Minsook; Lee, Jong-Soo] Ajou Univ, Dept Mol Sci & Technol, Coll Nat Sci, Suwon 443749, South Korea; [Kim, Jung-Ho] Hanwha Chem Res & Dev Ctr, Taejon 305345, South Korea	Yonsei University; Ajou University	Song, K (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	bc5012@yonsei.ac.kr			National Research and Development; Ministry of Health and Welfare, Republic of Korea [NCCR-0920300]; Korea Health Industry Development Institute [B05-0016-AM0815-07A3-00030B]; Korean Government Ministry of Education (Ministry of Education and Human Resources Development) [KRF-2006-8-1284]	National Research and Development; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korean Government Ministry of Education (Ministry of Education and Human Resources Development)(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research and Development Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea Grant NCCR-0920300 and in part by Korea Health Industry Development Institute (Grant B05-0016-AM0815-07A3-00030B).; Supported by Korea Research Foundation Grant KRF-2006-8-1284 funded by the Korean Government Ministry of Education (Ministry of Education and Human Resources Development).	BOYER JC, 1995, CANCER RES, V55, P6063; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Corazzari M, 2005, BIOCHEM BIOPH RES CO, V331, P810, DOI 10.1016/j.bbrc.2005.03.184; Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7; Craig WJ, 1999, AM J CLIN NUTR, V70, p491S, DOI 10.1093/ajcn/70.3.491s; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Fink D, 1996, CANCER RES, V56, P4881; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Franchitto A, 2003, ONCOGENE, V22, P2110, DOI 10.1038/sj.onc.1206254; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; Gudkov AV, 2003, CANCER BIOL THER, V2, P444, DOI 10.4161/cbt.2.4.480; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Iizuka N, 2003, INT J CANCER, V107, P666, DOI 10.1002/ijc.11452; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kim HJ, 2006, CHEM BIOL, V13, P881, DOI 10.1016/j.chembiol.2006.06.012; KOI M, 1994, CANCER RES, V54, P4308; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lin XJ, 2001, CANCER RES, V61, P1508; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Liu LL, 1996, CANCER RES, V56, P5375; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Orfila L, 2000, J ETHNOPHARMACOL, V71, P449, DOI 10.1016/S0378-8741(00)00177-X; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; SAYA H, 2007, 19 FED AS OC BIOCH M; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yamane K, 2004, BIOCHEM BIOPH RES CO, V318, P297, DOI 10.1016/j.bbrc.2004.04.030; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	44	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2986	10.1074/jbc.M109.070466	http://dx.doi.org/10.1074/jbc.M109.070466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19948725	Green Published, hybrid			2022-12-27	WOS:000273829000013
J	Qian, Y; Lee, I; Lee, WS; Qian, MQ; Kudo, M; Canfield, WM; Lobel, P; Kornfeld, S				Qian, Yi; Lee, Intaek; Lee, Wang-Sik; Qian, Meiqian; Kudo, Mariko; Canfield, William M.; Lobel, Peter; Kornfeld, Stuart			Functions of the alpha, beta, and gamma Subunits of UDP-GlcNAc:Lysosomal Enzyme N-Acetylglucosamine-1-phosphotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; NEURONAL CEROID-LIPOFUSCINOSIS; ASN-LINKED OLIGOSACCHARIDES; PSEUDO-HURLER POLYDYSTROPHY; SITE-DIRECTED MUTAGENESIS; LYSINE-BASED STRUCTURE; LYSOSOMAL-ENZYME; N-ACETYLGLUCOSAMINE; CATHEPSIN-D; DNASE I	UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is an alpha(2)beta(2)gamma(2) hexamer that mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases. Using a multifaceted approach, including analysis of acid hydrolase phosphorylation in mice and fibroblasts lacking the gamma subunit along with kinetic studies of recombinant alpha(2)beta(2)gamma(2) and alpha(2)beta(2) forms of the transferase, we have explored the function of the alpha/beta and gamma subunits. The findings demonstrate that the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase. In mouse brain, the alpha/beta subunits phosphorylate about one-third of the acid hydrolases at close to wild-type levels but require the gamma subunit for optimal phosphorylation of the rest of the acid hydrolases. In addition to enhancing the activity of the alpha/beta subunits toward a subset of the acid hydrolases, the gamma subunit facilitates the addition of the second GlcNAc-P to high mannose oligosaccharides of these substrates. We postulate that the mannose 6-phosphate receptor homology domain of the gamma subunit binds and presents the high mannose glycans of the acceptor to the alpha/beta catalytic site in a favorable manner.	[Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Kudo, Mariko; Kornfeld, Stuart] Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Piscataway, NJ 08851 USA; [Qian, Meiqian; Lobel, Peter] Univ Med & Dent New Jersey, Dept Pharmacol, Piscataway, NJ 08851 USA; [Canfield, William M.; Lobel, Peter] Genzyme Corp, Oklahoma City, OK 73104 USA	Washington University (WUSTL); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sanofi-Aventis; Genzyme Corporation	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu		Lee, Intaek/0000-0003-1084-674X	National Institutes of Health [CA08759, DK054317]; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA08759 (to S. K.) and DK054317 (to P. L.).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; Bargal R, 2007, MOL GENET METAB, V91, P299, DOI 10.1016/j.ymgme.2007.04.007; Bargal R, 2006, MOL GENET METAB, V88, P359, DOI 10.1016/j.ymgme.2006.03.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Cacia J, 1998, BIOCHEMISTRY-US, V37, P15154, DOI 10.1021/bi981465t; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; CATHEY SS, 2009, J MED GENET IN PRESS; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CUOZZO JW, 1994, J BIOL CHEM, V269, P14490; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; CUOZZO JW, 1995, J BIOL CHEM, V270, P15611, DOI 10.1074/jbc.270.26.15611; Dittmer F, 1997, J BIOL CHEM, V272, P852, DOI 10.1074/jbc.272.2.852; DUBOIS M, 1956, ANAL CHEM, V28, P356; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; Gelfman CM, 2007, INVEST OPHTH VIS SCI, V48, P5221, DOI 10.1167/iovs.07-0452; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; KORNFELD S, 2000, METABOLIC MOL BASES, P3469; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; LANG L, 1984, J BIOL CHEM, V259, P4663; LANG L, 1985, J CLIN INVEST, V76, P2191, DOI 10.1172/JCI112227; LAZZARINO DA, 1988, J BIOL CHEM, V263, P10118; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sohar I, 2000, CLIN CHEM, V46, P1005; SONDERFELDFRESKO S, 1989, J BIOL CHEM, V264, P7692; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tikkanen R, 1997, EMBO J, V16, P6684, DOI 10.1093/emboj/16.22.6684; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; VARKI AP, 1981, P NATL ACAD SCI-BIOL, V78, P7773, DOI 10.1073/pnas.78.12.7773; Vogel P, 2009, VET PATHOL, V46, P313, DOI 10.1354/vp.46-2-313; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; Watanabe T, 2009, GLYCOBIOLOGY, V19, P834, DOI 10.1093/glycob/cwp061; WEITZ G, 1992, J BIOL CHEM, V267, P10039; Yaghootfam A, 2003, J BIOL CHEM, V278, P32653, DOI 10.1074/jbc.M304865200	50	51	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3360	3370		10.1074/jbc.M109.068650	http://dx.doi.org/10.1074/jbc.M109.068650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19955174	Green Published, hybrid			2022-12-27	WOS:000273829000051
J	Zhang, YQ; Yin, LY; Anderson, J; Ma, HY; Gonzalez, FJ; Willson, TM; Edwards, PA				Zhang, Yanqiao; Yin, Liya; Anderson, Jody; Ma, Huiyan; Gonzalez, Frank J.; Willson, Timothy M.; Edwards, Peter A.			Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; ORPHAN NUCLEAR RECEPTOR; N-TERMINAL KINASE; BILE-ACIDS; SR-BI; IN-VIVO; ESSENTIAL REGULATOR; LIPID HOMEOSTASIS; GENE-EXPRESSION	Farnesoid X receptor (FXR) plays important regulatory roles in bile acid, lipoprotein, and glucose homeostasis. Here, we have utilized Fxr(-/-) mice and mice deficient in scavenger receptor class B type I (SR-BI), together with an FXR-specific agonist and adenovirus expressing hepatocyte nuclear factor 4 alpha or constitutively active FXR, to identify the mechanisms by which activation of FXR results in hypocholesterolemia. We identify a novel pathway linking FXR to changes in hepatic p-JNK, hepatocyte nuclear factor 4 alpha, and finally SR-BI. Importantly, we demonstrate that the FXR-dependent increase in SR-BI results in both hypocholesterolemia and an increase in reverse cholesterol transport, a process involving the transport of cholesterol from peripheral macrophages to the liver for excretion into the feces. In addition, we demonstrate that FXR activation also induces an SR-BI-independent increase in reverse cholesterol transport and reduces intestinal cholesterol absorption. Together, these data indicate that FXR is a promising therapeutic target for treatment of hypercholesterolemia and coronary heart disease.	[Zhang, Yanqiao] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Anderson, Jody; Edwards, Peter A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Edwards, Peter A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Edwards, Peter A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Willson, Timothy M.] GlaxoSmithKline Inc, Discovery Med Chem, Res Triangle Pk, NC 27709 USA	Northeast Ohio Medical University (NEOMED); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); GlaxoSmithKline	Zhang, YQ (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, 4209 State Route 44, Rootstown, OH 44272 USA.	yzhang@neoucom.edu	feinstein, doug/M-9414-2019		National Institutes of Health [HL30568, HL68445]; American Heart Association Beginning [0565173Y]; Scientist Development [0830255N]; Laubisch Fund; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL068445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Beginning(American Heart Association); Scientist Development; Laubisch Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by National Institutes of Health Grants HL30568 and HL68445 (to P. A. E.). This work was also supported by American Heart Association Beginning Grant-in-aid 0565173Y (to Y. Z.), Scientist Development Grant 0830255N (to Y. Z.), and a grant from the Laubisch Fund (to Y. Z.).	Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calpe-Berdiel L, 2008, J LIPID RES, V49, P1904, DOI 10.1194/jlr.M700470-JLR200; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Drewes T, 1996, MOL CELL BIOL, V16, P925; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hubbert ML, 2007, MOL ENDOCRINOL, V21, P1359, DOI 10.1210/me.2007-0089; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Jiang Shuying, 2003, Nucl Recept, V1, P5, DOI 10.1186/1478-1336-1-5; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee H, 2006, J LIPID RES, V47, P201, DOI 10.1194/jlr.M500417-JLR200; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; TURLEY SD, 1994, J LIPID RES, V35, P328; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	51	81	84	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3035	10.1074/jbc.M109.083899	http://dx.doi.org/10.1074/jbc.M109.083899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996107	Green Published, hybrid			2022-12-27	WOS:000273829000019
J	Yan, LP; Holleran, BJ; Lavigne, P; Escher, E; Guillemette, G; Leduc, R				Yan, Liping; Holleran, Brian J.; Lavigne, Pierre; Escher, Emanuel; Guillemette, Gaetan; Leduc, Richard			Analysis of Transmembrane Domains 1 and 4 of the Human Angiotensin II AT(1) Receptor by Cysteine-scanning Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; SITE-DIRECTED MUTAGENESIS; LIGAND-BINDING POCKET; TYPE-1 RECEPTOR; CONSTITUTIVE ACTIVATION; ACCESSIBILITY METHOD; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; IDENTIFICATION	The octapeptide hormone angiotensin II (AngII) exerts a wide variety of cardiovascular effects through the activation of the AT(1) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT(1) receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand- binding pocket. Here, we investigated the role of the first and fourth transmembrane domains (TMDs) in the formation of the binding pocket of the human AT(1) receptor using the substituted-cysteine accessibility method. Each residue within the Phe-28((1.32))-Ile-53((1.57)) fragment of TMD1 and Leu-143((4.40))-Phe-170((4.67)) fragment of TMD4 was mutated, one at a time, to a cysteine. The resulting mutant receptors were expressed in COS-7 cells, which were subsequently treated with the charged sulfhydryl-specific alkylating agent methanethiosulfonate ethylammonium (MTSEA). This treatment led to a significant reduction in the binding affinity of TMD1 mutants M30C((1.34))-AT(1) and T33C((1.37))-AT(1) and TMD4 mutant V169C((4.66))-AT(1). Although this reduction in binding of the TMD1 mutants was maintained when examined in a constitutively active receptor (N111G-AT(1)) background, we found that V169C((4.66))-AT(1) remained unaffected when treated with MTSEA compared with untreated in this context. Moreover, the complete loss of binding observed for R167C((4.64))-AT(1) was restored upon treatment with MTSEA. Our results suggest that the extracellular portion of TMD1, particularly residues Met-30((1.34)) and Thr-33((1.37)), aswellasresiduesArg-167((4.64)) andVal-169((4.66)) at the junction of TMD4 and the second extracellular loop, are important binding determinants within the AT1 receptor binding pocket but that these TMDs undergo very little movement, if at all, during the activation process.	[Yan, Liping; Holleran, Brian J.; Lavigne, Pierre; Escher, Emanuel; Guillemette, Gaetan; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Leduc, R (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.	Richard.Leduc@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alberts GL, 1998, MOL PHARMACOL, V54, P379, DOI 10.1124/mol.54.2.379; BALLESTEROS JA, 1995, INTEGRATED METHODS C; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Domazet I, 2009, J BIOL CHEM, V284, P31953, DOI 10.1074/jbc.M109.051839; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Feng YH, 1999, J BIOL CHEM, V274, P35546, DOI 10.1074/jbc.274.50.35546; FONG TM, 1994, J BIOL CHEM, V269, P14957; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HUANG RRC, 1995, BIOCHEMISTRY-US, V34, P10048, DOI 10.1021/bi00031a029; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 2000, BIOCHEMISTRY-US, V39, P12190, DOI 10.1021/bi001069m; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; MATSUI H, 1989, BIOCHEMISTRY-US, V28, P4125, DOI 10.1021/bi00435a075; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAN Y, 1994, J BIOL CHEM, V269, P31933; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Santos EL, 2004, REGUL PEPTIDES, V119, P183, DOI 10.1016/j.regpep.2004.02.009; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Ulloa-Aguirre A, 2009, FRONT BIOSCI-LANDMRK, V14, P973, DOI 10.2741/3290; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Waugh DJJ, 2000, J BIOL CHEM, V275, P11698, DOI 10.1074/jbc.275.16.11698; WERGE TM, 1994, J BIOL CHEM, V269, P22054; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S	51	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2227	2236		10.1074/jbc.M109.077180	http://dx.doi.org/10.1074/jbc.M109.077180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940150	Green Published, hybrid			2022-12-27	WOS:000273697800002
J	Deligny, A; Denys, A; Marcant, A; Melchior, A; Mazurier, J; van Kuppevelt, TH; Allain, F				Deligny, Audrey; Denys, Agnes; Marcant, Adeline; Melchior, Aurelie; Mazurier, Joel; van Kuppevelt, Toin H.; Allain, Fabrice			Synthesis of Heparan Sulfate with Cyclophilin B-binding Properties Is Determined by Cell Type-specific Expression of Sulfotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSUBSTITUTED GLUCOSAMINE RESIDUES; MOLECULAR-CLONING; PROTEIN-KINASE; N-SULFATION; ADHESION; MICE; BIOSYNTHESIS; LACTOFERRIN; ACTIVATION; ANTIBODIES	Cyclophilin B (CyPB) induces migration and adhesion of T lymphocytes via a mechanism that requires interaction with 3-O-sulfated heparan sulfate (HS). HS biosynthesis is a complex process with many sulfotransferases involved. N-Deacetylases/N-sulfotransferases are responsible for N-sulfation, which is essential for subsequent modification steps, whereas 3-O-sulfotransferases (3-OSTs) catalyze the least abundant modification. These enzymes are represented by several isoforms, which differ in term of distribution pattern, suggesting their involvement in making tissue-specific HS. To elucidate how the specificity of CyPB binding is determined, we explored the relationships between the expression of these sulfotransferases and the generation of HS motifs with CyPB-binding properties. We demonstrated that high N-sulfate density and the presence of 2-O- and 3-O-sulfates determine binding of CyPB, as evidenced by competitive experiments with heparin derivatives, soluble HS, and anti-HS antibodies. We then showed that target cells, i.e. CD4(+) lymphocyte subsets, monocytes/macrophages, and related cell lines, specifically expressed high levels of NDST2 and 3-OST3 isoforms. Silencing the expression of NDST1, NDST2, 2-OST, and 3-OST3 by RNA interference efficiently decreased binding and activity of CyPB, thus confirming their involvement in the biosynthesis of binding sequences for CyPB. Moreover, we demonstrated that NDST1 was able to partially sulfate exogenous substrate in the absence of NDST2 but not vice versa, suggesting that both isoenzymes do not have redundant activities but do have rather complementary activities in making N-sulfated sequences with CyPB-binding properties. Altogether, these results suggest a regulatory mechanism in which cell type-specific expression of certain HS sulfotransferases determines the specific binding of CyPB to target cells.	[Deligny, Audrey; Denys, Agnes; Marcant, Adeline; Melchior, Aurelie; Mazurier, Joel; Allain, Fabrice] Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonctionnelle, CNRS, UMR 8576,Inst Rech Federatif 147, F-59655 Villeneuve Dascq, France; [van Kuppevelt, Toin H.] Nijmegen Ctr Mol Life Sci, Dept Matrix Biochem, NL-6500 HB Nijmegen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Radboud University Nijmegen	Allain, F (corresponding author), Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonctionnelle, CNRS, UMR 8576,Inst Rech Federatif 147, F-59655 Villeneuve Dascq, France.	fabrice.allain@univ-lille1.fr	van Kuppevelt, A.H.M.S.M./L-4463-2015	Allain, Fabrice/0000-0002-4484-6302	CNRS; Universite des Sciences et Technologies de Lille, France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite des Sciences et Technologies de Lille, France	This work was supported by the CNRS and the Universite des Sciences et Technologies de Lille, France.	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; BAME KJ, 1991, J BIOL CHEM, V266, P12461; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Carpentier M, 2002, BIOCHEMISTRY-US, V41, P5222, DOI 10.1021/bi015951j; Damiens E, 1998, EUR J CELL BIOL, V77, P344, DOI 10.1016/S0171-9335(98)80093-9; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Denys A, 1998, BIOCHEM J, V336, P689, DOI 10.1042/bj3360689; Dhennin-Duthille I, 2000, J CELL BIOCHEM, V79, P583, DOI 10.1002/1097-4644(20001215)79:4<583::AID-JCB70>3.0.CO;2-9; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forster-Horvath C, 2001, EUR J IMMUNOL, V31, P600, DOI 10.1002/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Melchior A, 2008, EXP CELL RES, V314, P616, DOI 10.1016/j.yexcr.2007.11.007; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pejler G, 1996, BIOCHEM J, V320, P897, DOI 10.1042/bj3200897; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Rong JH, 2000, BIOCHEM J, V346, P463, DOI 10.1042/0264-6021:3460463; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; SPIK G, 1991, J BIOL CHEM, V266, P10735; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; Tiwari V, 2007, FEBS LETT, V581, P4468, DOI 10.1016/j.febslet.2007.08.029; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; van den Born J, 2003, GLYCOBIOLOGY, V13, P1, DOI 10.1093/glycob/cwg011; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Vanpouille C, 2004, BIOCHEM J, V382, P733, DOI 10.1042/BJ20031453; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wegrowski Y, 2006, CLIN EXP IMMUNOL, V144, P485, DOI 10.1111/j.1365-2249.2006.03059.x; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2001, BIOCHEM BIOPH RES CO, V288, P786, DOI 10.1006/bbrc.2001.5847	57	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1701	1715		10.1074/jbc.M109.018184	http://dx.doi.org/10.1074/jbc.M109.018184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19940140	Green Published, hybrid			2022-12-27	WOS:000273429100016
J	Ahn, JE; Guarino, LA; Zhu-Salzman, K				Ahn, Ji-Eun; Guarino, Linda A.; Zhu-Salzman, Keyan			Coordination of Hepatocyte Nuclear Factor 4 and Seven-up Controls Insect Counter-defense Cathepsin B Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER-TRANSCRIPTION FACTOR; COLORADO POTATO BEETLES; LIGAND-BINDING DOMAIN; GENE-EXPRESSION; PROTEINASE-INHIBITORS; PROTEASE INHIBITOR; VISCERAL ENDODERM; STRUCTURAL BASIS; FACTOR 4-ALPHA; FACTOR HNF-4	CmCatB, a cathepsin B-type cysteine protease, is insensitive to inhibition by the soybean cysteine protease inhibitor (scN). Cowpea bruchids dramatically induce CmCatB expression when major digestive proteases are inactivated by dietary scN, which is presumably an adaptive strategy that insects use to minimize effects of nutrient deficiency. In this study, we cloned the cowpea bruchid hepatocyte nuclear factor 4 (CmHNF-4) and demonstrated its involvement in transcriptional activation of CmCatB in the digestive tract of scN-adapted bruchids. Electrophoretic mobility shift assays demonstrated that CmHNF-4 binds to a CmCatB promoter region containing two tandem chicken ovalbumin upstream promoter (COUP) sites, which is also the cis-element for Seven-up (CmSvp), a previously identified transcriptional repressor of CmCatB. Although CmSvp is predominantly expressed in unadapted insect midgut, CmHNF-4 is more abundant in adapted bruchids. When transiently expressed in Drosophila S2 cells, CmHNF-4 substantially increased CmCatB expression through COUP binding. CmSvp inhibited CmHNF-4-mediated transcriptional activation even in the absence of its DNA-binding domain. Thus antagonism resulted, at least in part, from protein-protein interactions between CmSvp and CmHNF-4. Association of the two transcription factors was subsequently confirmed by glutathione S-transferase pulldown assays. Interestingly, anti-CmHNF-4 serum caused a supershift not only with nuclear extracts of scN-adapted insect midgut but with that of unadapted control insects as well. The presence of CmHNF-4 in unadapted insects further supported the idea that interplay between CmSvp and CmHNF-4 controls CmCatB transcription activation. Together, these results suggest that coordination between CmHNF-4 and CmSvp is important in counter-defense gene regulation in insects.	[Ahn, Ji-Eun; Guarino, Linda A.; Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Zhu-Salzman, Keyan] Texas A&M Univ, Vegetable& Fruit Improvement Ctr, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Zhu-Salzman, K (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ksalzman@tamu.edu			National Research Initiative; U. S. Department of Agriculture Cooperative State Research, Education, and Extension Service [2005-35604-15438, 2007-35607-17887, 2008-34402-19195]	National Research Initiative(United States Department of Agriculture (USDA)); U. S. Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the National Research Initiative and special grants of the U. S. Department of Agriculture Cooperative State Research, Education, and Extension Service (Grants 2005-35604-15438, 2007-35607-17887, and 2008-34402-19195).	Ahn JE, 2004, INSECT MOL BIOL, V13, P649, DOI 10.1111/j.0962-1075.2004.00523.x; Ahn JE, 2007, FEBS J, V274, P2800, DOI 10.1111/j.1472-4658.2007.05816.x; [Anonymous], 2001, NUCL RECEPTORS GENET; BOLTER CJ, 1995, J INSECT PHYSIOL, V41, P1071, DOI 10.1016/0022-1910(95)00073-4; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Broadway RM, 1997, J INSECT PHYSIOL, V43, P855, DOI 10.1016/S0022-1910(97)00028-0; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; Drewes T, 1996, MOL CELL BIOL, V16, P925; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Duncan SA, 1997, DEVELOPMENT, V124, P279; Eeckhoute J, 2003, NUCLEIC ACIDS RES, V31, P6640, DOI 10.1093/nar/gkg850; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GUARINO LA, 1991, J VIROL, V65, P3676, DOI 10.1128/JVI.65.7.3676-3680.1991; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Iordanidou P, 2005, J BIOL CHEM, V280, P21810, DOI 10.1074/jbc.M501221200; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kapitskaya MZ, 1998, J BIOL CHEM, V273, P29801, DOI 10.1074/jbc.273.45.29801; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Kistanova E, 2001, BIOCHEM J, V356, P635, DOI 10.1042/0264-6021:3560635; Koo YD, 2008, INSECT MOL BIOL, V17, P235, DOI 10.1111/j.1365-2583.2008.00799.x; Ktistaki E, 1997, MOL CELL BIOL, V17, P2790, DOI 10.1128/MCB.17.5.2790; Lee SB, 2007, PESTIC BIOCHEM PHYS, V88, P237, DOI 10.1016/j.pestbp.2006.12.001; Li TG, 2006, DRUG METAB DISPOS, V34, P756, DOI 10.1124/dmd.105.007575; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; McNair A, 2000, BIOCHEM J, V352, P557, DOI 10.1042/0264-6021:3520557; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Moon J, 2004, INSECT MOL BIOL, V13, P283, DOI 10.1111/j.0962-1075.2004.00485.x; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Palanker L, 2006, DEVELOPMENT, V133, P3549, DOI 10.1242/dev.02512; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Swevers L, 1998, MECH DEVELOP, V72, P3, DOI 10.1016/S0925-4773(97)00180-9; Ungaro P, 2008, J BIOL CHEM, V283, P30970, DOI 10.1074/jbc.M803895200; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu Q, 2004, J MOL ENDOCRINOL, V32, P947, DOI 10.1677/jme.0.0320947; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; You M, 2002, ARCH BIOCHEM BIOPHYS, V398, P79, DOI 10.1006/abbi.2001.2713; ZHONG WM, 1993, EMBO J, V12, P537, DOI 10.1002/j.1460-2075.1993.tb05685.x; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x	44	4	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6573	6584		10.1074/jbc.M109.095596	http://dx.doi.org/10.1074/jbc.M109.095596			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048156	Green Published, hybrid			2022-12-27	WOS:000275367500062
J	Aouida, M; Poulin, R; Ramotar, D				Aouida, Mustapha; Poulin, Richard; Ramotar, Dindial			The Human Carnitine Transporter SLC22A16 Mediates High Affinity Uptake of the Anticancer Polyamine Analogue Bleomycin-A5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTERS; ANTITUMOR AGENT BLEOMYCIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; MAMMALIAN-CELLS; DRUG BLEOMYCIN; IDENTIFICATION; MECHANISM; RESISTANCE; CLEAVAGE	Bleomycin is used in combination with other antineoplastic agents to effectively treat lymphomas, testicular carcinomas, and squamous cell carcinomas of the cervix, head, and neck. However, resistance to bleomycin remains a persistent limitation in exploiting the full therapeutic benefit of the drug with other types of cancers. Previously, we documented that the Saccharomyces cerevisiae L-carnitine transporter Agp2 is responsible for the high affinity uptake of polyamines and of the polyamine analogue bleomycin-A5. Herein, we document that the human L-carnitine transporter hCT2 encoded by the SLC22A16 gene is involved in bleomycin-A5 uptake, as well as polyamines. We show that NT2/D1 human testicular cancer cells, which highly express hCT2, are extremely sensitive to bleomycin-A5, whereas HCT116 human colon carcinoma cells devoid of detectable hCT2 expression or MCF-7 human breast cancer cells that only weakly express the permease showed striking resistance to the drug. NT2/D1 cells accumulated fluorescein-labeled bleomycin-A5 to substantially higher levels than HCT116 cells. Moreover, L-carnitine protected NT2/D1 cells from the lethal effects of bleomycin-A5 by preventing its influx, and siRNA targeted to hCT2 induced resistance to bleomycin-A5-dependent genotoxicity. Furthermore, hCT2 overexpression induced by transient transfection of a functional hCT2-GFP fusion protein sensitized HCT116 cells to bleomycin-A5. Collectively, our data strongly suggest that hCT2 can mediate bleomycin-A5 and polyamine uptake, and that the rate of bleomycin-A5 accumulation may account for the differential response to the drug in patients.	[Aouida, Mustapha; Ramotar, Dindial] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Poulin, Richard] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Montreal, PQ G1V 0A6, Canada	Universite de Montreal; Laval University	Aouida, M (corresponding author), 5415 Assompt, Montreal, PQ H1T 2M4, Canada.	aouidamustapha@yahoo.fr; dramotar.hmr@ssss.gouv.qc.ca	Aouida, Mustapha/AEJ-4513-2022	Aouida, Mustapha/0000-0001-7945-5320	Canadian Institutes of Health Research [MOP-67196]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-67196 (to D. R.) from the Canadian Institutes of Health Research.	Alnouti Y, 2006, DRUG METAB DISPOS, V34, P477, DOI 10.1121/dmd.105.006932; Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2003, ANTIMICROB AGENTS CH, V47, P2012, DOI 10.1128/AAC.47.6.2012-2014.2003; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Azam S, 2007, APOPTOSIS, V12, P1243, DOI 10.1007/s10495-006-0050-8; BENNETT RAO, 1993, BIOCHEMISTRY-US, V32, P3188, DOI 10.1021/bi00063a034; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burger RM, 1998, CHEM REV, V98, P1153, DOI 10.1021/cr960438a; Canellos GP, 2004, SEMIN HEMATOL, V41, P26, DOI 10.1053/j.seminhematol.2004.09.005; Daigle ND, 2009, J CELL PHYSIOL, V220, P680, DOI 10.1002/jcp.21814; DAR ME, 1995, NUCLEIC ACIDS RES, V23, P3224, DOI 10.1093/nar/23.16.3224; Dorr RT, 1998, CANCER CHEMOTH PHARM, V42, P149, DOI 10.1007/s002800050798; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Eraly SA, 2002, BIOCHEM BIOPH RES CO, V297, P1159, DOI 10.1016/S0006-291X(02)02343-4; GILONI L, 1981, J BIOL CHEM, V256, P8608; Gong SM, 2002, EXP HEMATOL, V30, P1162, DOI 10.1016/S0301-472X(02)00901-3; GORDONSMITH RH, 1983, BIOCHEM PHARMACOL, V32, P3701, DOI 10.1016/0006-2952(83)90138-7; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; JANI JP, 1992, CANCER RES, V52, P2931; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lamhonwah AM, 2005, BIOCHEM BIOPH RES CO, V338, P1966, DOI 10.1016/j.bbrc.2005.10.170; Lazo J S, 1996, Cancer Chemother Biol Response Modif, V16, P39; LESSARD M, 1995, J BIOL CHEM, V270, P1685, DOI 10.1074/jbc.270.4.1685; MIYAKI M, 1975, CANCER RES, V35, P2015; NICHOLS CR, 1994, SEMIN ONCOL, V21, P102; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; PODDEVIN B, 1991, BIOCHEM PHARMACOL, V42, pS67, DOI 10.1016/0006-2952(91)90394-K; PRON G, 1993, BIOCHEM BIOPH RES CO, V194, P333, DOI 10.1006/bbrc.1993.1824; Ramotar D, 2003, CURR GENET, V43, P213, DOI 10.1007/s00294-003-0396-1; Robertson KA, 2001, CANCER RES, V61, P2220; Sanz G, 2002, CANCER RES, V62, P4453; Sato N, 2007, INT J GYNECOL PATHOL, V26, P53, DOI 10.1097/01.pgp.0000225845.67245.b3; SEBTI SM, 1991, CANCER RES, V51, P227; Seiler N, 2003, CURR DRUG TARGETS, V4, P565, DOI 10.2174/1389450033490876; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Song IS, 2004, MOL CANCER THER, V3, P1543; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; STEIGHNER RJ, 1990, MUTAT RES, V240, P93, DOI 10.1016/0165-1218(90)90012-Q; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; TATES AD, 1994, MUTAT RES, V307, P293, DOI 10.1016/0027-5107(94)90303-4; TOUNEKTI O, 1993, CANCER RES, V53, P5462; UMEZAWA H, 1971, Pure and Applied Chemistry, V28, P665, DOI 10.1351/pac197128040665; Umezawa H, 1965, Antimicrob Agents Chemother (Bethesda), V5, P1079; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; WORTH L, 1993, BIOCHEMISTRY-US, V32, P2601, DOI 10.1021/bi00061a018	51	78	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6275	6284		10.1074/jbc.M109.046151	http://dx.doi.org/10.1074/jbc.M109.046151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037140	Green Published, hybrid			2022-12-27	WOS:000275367500032
J	Arendt, CS; Ullman, B				Arendt, Cassandra S.; Ullman, Buddy			Role of Transmembrane Domain 4 in Ligand Permeation by Crithidia fasciculata Equilibrative Nucleoside Transporter 2 (CfNT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; SITE-SATURATION MUTAGENESIS; CONFER DRUG-RESISTANCE; LEISHMANIA-DONOVANI; SACCHAROMYCES-CEREVISIAE; S-6-(4-NITROBENZYL)-MERCAPTOPURINE RIBOSIDE; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; POINT MUTATIONS; ALPHA-SUBUNIT	Equilibrative nucleoside transporters play essential roles in nutrient uptake, cardiovascular and renal function, and purine analog drug chemotherapies. Limited structural information is available for this family of transporters; however, residues in transmembrane domains 1, 2, 4, and 5 appear to be important for ligand and inhibitor binding. In order to identify regions of the transporter that are important for ligand specificity, a genetic selection for mutants of the inosine-guanosine-specific Crithidia fasciculata nucleoside transporter 2 (CfNT2) that had gained the ability to transport adenosine was carried out in the yeast Saccharomyces cerevisiae. Nearly all positive clones from the genetic selection carried mutations at lysine 155 in transmembrane domain 4, highlighting lysine 155 as a pivotal residue governing the ligand specificity of CfNT2. Mutation of lysine 155 to asparagine conferred affinity for adenosine on the mutant transporter at the expense of inosine and guanosine affinity due to weakened contacts to the purine ring of the ligand. Following systematic cysteine-scanning mutagenesis, thiol-specific modification of several positions within transmembrane domain 4 was found to interfere with inosine transport capability, indicating that this helix lines the water-filled ligand translocation channel. Additionally, the pattern of modification of transmembrane domain 4 suggested that it may deviate from helicity in the vicinity of residue 155. Position 155 was also protected from modification in the presence of ligand, suggesting that lysine 155 is in or near the ligand binding site. Transmembrane domain 4 and particularly lysine 155 appear to play key roles in ligand discrimination and translocation by CfNT2.	[Arendt, Cassandra S.] Pacific Univ Oregon, Sch Pharm, Hillsboro, OR 97123 USA; [Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Arendt, CS (corresponding author), Pacific Univ Oregon, Sch Pharm, 222 SE 8th Ave,Suite 451, Hillsboro, OR 97123 USA.	csarendt@pacificu.edu			National Institutes of Health [AI023682, AI044138]; American Cancer Society [PF-02-097-01-CSM]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023682, R37AI023682, R01AI044138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI023682 and AI044138. This work was also supported by American Cancer Society Grant PF-02-097-01-CSM (to C.S.A.).	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Arendt CS, 2007, ANAL BIOCHEM, V365, P185, DOI 10.1016/j.ab.2007.03.030; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Endres CJ, 2005, MOL PHARMACOL, V67, P837, DOI 10.1124/mol.104.008102; Endres CJ, 2004, BIOCHEM J, V380, P131, DOI 10.1042/BJ20031880; Galazka J, 2006, INT J BIOCHEM CELL B, V38, P1221, DOI 10.1016/j.biocel.2005.12.016; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guerra CF, 1998, THEOR CHEM ACC, V99, P391, DOI 10.1007/s002140050021; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; LABAN A, 1990, NATURE, V343, P572, DOI 10.1038/343572a0; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu T, 2008, AM J PHYSIOL-CELL PH, V295, pC64, DOI 10.1152/ajpcell.90602.2007; Liu W, 2005, MOL BIOCHEM PARASIT, V140, P1, DOI 10.1016/j.molbiopara.2004.11.018; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Paproski RJ, 2008, BIOCHEM J, V414, P291, DOI 10.1042/BJ20080074; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rodriguez JI, 2009, J COMPUT CHEM, V30, P1082, DOI 10.1002/jcc.21134; Rodriguez JI, 2009, CHEM PHYS LETT, V472, P149, DOI 10.1016/j.cplett.2009.02.081; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SIKORSKI RS, 1989, GENETICS, V122, P19; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	56	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6024	6035		10.1074/jbc.M109.074351	http://dx.doi.org/10.1074/jbc.M109.074351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037157	hybrid, Green Published			2022-12-27	WOS:000275367500005
J	Bhatnagar, S; Kumar, A; Makonchuk, DY; Li, H; Kumar, A				Bhatnagar, Shephali; Kumar, Akhilesh; Makonchuk, Denys Y.; Li, Hong; Kumar, Ashok			Transforming Growth Factor-beta-activated Kinase 1 Is an Essential Regulator of Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; SKELETAL-MUSCLE DIFFERENTIATION; P38 MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; P38-ALPHA/BETA MAPK; MESSENGER-RNA; WEAK INDUCER	Satellite cells/myoblasts account for the majority of muscle regenerative potential in response to injury and muscular adaptation to exercise. Although the ability to influence this process would provide valuable benefits for treating a variety of patients suffering from muscle loss, the regulatory mechanisms of myogenesis are not completely understood. We have tested the hypothesis that transforming growth factor-beta-activated kinase 1 (TAK1) is an important regulator of skeletal muscle formation. TAK1 is expressed in proliferating C2C12 myoblasts, and its levels are reduced upon differentiation of myoblasts into myotubes. In vivo, TAK1 is predominantly expressed in developing skeletal muscle of young mice. However, the expression of TAK1 was significantly up-regulated in regenerating skeletal muscle of adult mice. Overexpression of a dominant negative mutant of TAK1 or knockdown of TAK1 inhibited the proliferation and differentiation of C2C12 myoblasts. TAK1 was required for the expression of myogenic regulatory factors in differentiating myoblasts. Genetic ablation of TAK1 also inhibited the MyoD-driven transformation of mouse embryonic fibroblasts into myotubes. Inhibition of TAK1 suppressed the differentiation-associated activation of p38 mitogen-activated protein kinase (MAPK) and Akt kinase. Overexpression of a constitutively active mutant of MAPK kinase 6 (MKK6, an upstream activator of p38 MAPK) but not constitutive active Akt restored the myogenic differentiation in TAK1-deficient mouse embryonic fibroblasts. Insulin growth factor 1-induced myogenic differentiation was also found to involve TAK1. Collectively, our results suggest that TAK1 is an important upstream regulator of skeletal muscle cell differentiation.	[Bhatnagar, Shephali; Kumar, Akhilesh; Makonchuk, Denys Y.; Li, Hong; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 S Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	LI, HONG/A-7133-2013	Kumar, Ashok/0000-0001-8571-2848; Kumar, Ashok/0000-0002-2444-9529	National Institutes of Health [RO1 AG129623]; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG129623 (to A. K.).	Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li YQ, 2000, CELL SIGNAL, V12, P751, DOI 10.1016/S0898-6568(00)00120-0; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Puri PL, 2000, GENE DEV, V14, P574; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wald D, 2001, EUR J IMMUNOL, V31, P3747, DOI 10.1002/1521-4141(200112)31:12<3747::AID-IMMU3747>3.0.CO;2-E; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	69	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6401	6411		10.1074/jbc.M109.064063	http://dx.doi.org/10.1074/jbc.M109.064063			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037161	Green Published, hybrid			2022-12-27	WOS:000275367500044
J	Voss, JE; Scally, SW; Taylor, NL; Atkinson, SC; Griffin, MDW; Hutton, CA; Parker, MW; Alderton, MR; Gerrard, JA; Dobson, RCJ; Dogovski, C; Perugini, MA				Voss, Jarrod E.; Scally, Stephen W.; Taylor, Nicole L.; Atkinson, Sarah C.; Griffin, Michael D. W.; Hutton, Craig A.; Parker, Michael W.; Alderton, Malcolm R.; Gerrard, Juliet A.; Dobson, Renwick C. J.; Dogovski, Con; Perugini, Matthew A.			Substrate-mediated Stabilization of a Tetrameric Drug Target Reveals Achilles Heel in Anthrax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; SIZE-DISTRIBUTION ANALYSIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BACILLUS-ANTHRACIS; LYSINE BIOSYNTHESIS; SELF-ASSOCIATION; PURIFICATION; ULTRACENTRIFUGATION; EVOLUTION	Bacillus anthracis is a Gram-positive spore-forming bacterium that causes anthrax. With the increased threat of anthrax in biowarfare, there is an urgent need to characterize new antimicrobial targets from B. anthracis. One such target is dihydrodipicolinate synthase (DHDPS), which catalyzes the committed step in the pathway yielding meso-diaminopimelate and lysine. In this study, we employed CD spectroscopy to demonstrate that the thermostability of DHDPS from B. anthracis (Ba-DHDPS) is significantly enhanced in the presence of the substrate, pyruvate. Analytical ultracentrifugation studies show that the tetramer-dimer dissociation constant of the enzyme is 3-fold tighter in the presence of pyruvate compared with the apo form. To examine the significance of this substrate-mediated stabilization phenomenon, a dimeric mutant of Ba-DHDPS (L170E/G191E) was generated and shown to have markedly reduced activity compared with the wild-type tetramer. This demonstrates that the substrate, pyruvate, stabilizes the active form of the enzyme. We next determined the high resolution (2.15 angstrom) crystal structure of Ba-DHDPS in complex with pyruvate (3HIJ) and compared this to the apo structure (1XL9). Structural analyses show that there is a significant (91 angstrom(2)) increase in buried surface area at the tetramerization interface of the pyruvate-bound structure. This study describes a new mechanism for stabilization of the active oligomeric form of an antibiotic target from B. anthracis and reveals an "Achilles heel" that can be exploited in structure-based drug design.	[Voss, Jarrod E.; Scally, Stephen W.; Taylor, Nicole L.; Atkinson, Sarah C.; Griffin, Michael D. W.; Parker, Michael W.; Dobson, Renwick C. J.; Dogovski, Con; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hutton, Craig A.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Alderton, Malcolm R.] Def Sci & Technol Org, Human Protect & Performance Div, Fishermans Bend, Vic 3207, Australia; [Gerrard, Juliet A.] Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand	University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research; Defence Science & Technology; University of Canterbury	Perugini, MA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	perugini@unimelb.edu.au	Dobson, Renwick/AAZ-7020-2021; Hutton, Craig/M-2442-2013; Parker, Michael W/F-9069-2013; Dobson, Renwick/A-9188-2011	Dobson, Renwick/0000-0002-5506-4939; Hutton, Craig/0000-0002-2353-9258; Parker, Michael W/0000-0002-3101-1138; Atkinson, Sarah/0000-0002-3518-9785; Griffin, Michael/0000-0001-9845-7735; Perugini, Matthew/0000-0001-8052-5584; Scally, Stephen/0000-0002-4264-7772	Defense Threat Reduction Agency [AB07CBT004]; Australian Research Council Future Fellowship; Federation Fellowship	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Australian Research Council Future Fellowship(Australian Research Council); Federation Fellowship	This work was supported in part by the Defense Threat Reduction Agency (Project ID AB07CBT004) and by an Australian Research Council Future Fellowship ( to M. A. P.) and a Federation Fellowship ( to M. W. P.).	Athamna A, 2004, J ANTIMICROB CHEMOTH, V53, P247, DOI 10.1093/jac/dkh016; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Brey RN, 2005, ADV DRUG DELIVER REV, V57, P1266, DOI 10.1016/j.addr.2005.01.028; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; CREMER J, 1988, J GEN MICROBIOL, V134, P3221; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DEREPPE C, 1992, PLANT PHYSIOL, V98, P813, DOI 10.1104/pp.98.3.813; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Domigan LJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1510, DOI 10.1016/j.bbapap.2009.06.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; FRISCH DA, 1991, PLANT PHYSIOL, V96, P444, DOI 10.1104/pp.96.2.444; Girish TS, 2008, FEBS LETT, V582, P2923, DOI 10.1016/j.febslet.2008.07.035; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LABER B, 1992, BIOCHEM J, V288, P691, DOI 10.1042/bj2880691; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; MATSUMURA M, 1984, BIOCHIM BIOPHYS ACTA, V786, P9, DOI 10.1016/0167-4838(84)90147-X; Melo RC, 2007, GENET MOL RES, V6, P946; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Pedone E, 2003, BIOCHEM J, V373, P875, DOI 10.1042/BJ20021747; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SMITH H, 1956, NATURE, V178, P865, DOI 10.1038/178865a0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2009, ACTA CRYSTALLOGR F, V65, P188, DOI 10.1107/S1744309109000670; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolterink-van Loo S, 2008, EXTREMOPHILES, V12, P461, DOI 10.1007/s00792-008-0152-z; YUGARI YASUMI, 1965, J BIOL CHEM, V240, P4710	45	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5188	5195		10.1074/jbc.M109.038166	http://dx.doi.org/10.1074/jbc.M109.038166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19948665	hybrid, Green Published			2022-12-27	WOS:000275327200011
J	Zhai, DY; Yu, E; Jin, CF; Welsh, K; Shiau, CW; Chen, LL; Salvesen, GS; Liddington, R; Reed, JC				Zhai, Dayong; Yu, Eric; Jin, Chaofang; Welsh, Kate; Shiau, Chung-wei; Chen, Lili; Salvesen, Guy S.; Liddington, Robert; Reed, John C.			Vaccinia Virus Protein F1L Is a Caspase-9 Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH PROTEASE; CYTOCHROME-C; ACTIVATION; APOPTOSIS; APAF-1; BCL-2; MITOCHONDRIA; DOMAIN; BAK; RECRUITMENT	Apoptosis plays important roles in host defense, including the elimination of virus-infected cells. The executioners of apoptosis are caspase family proteases. We report that vaccinia virus-encoded F1L protein, previously recognized as anti-apoptotic viral Bcl-2 family protein, is a caspase-9 inhibitor. F1L binds to and specifically inhibits caspase-9, the apical protease in the mitochondrial cell death pathway while failing to inhibit other caspases. In cells, F1L inhibits apoptosis and proteolytic processing of caspases induced by overexpression of caspase-9 but not caspase-8. An N-terminal region of F1L preceding the Bcl-2-like fold accounts for caspase-9 inhibition and significantly contributes to the anti-apoptotic activity of F1L. Viral F1L thus provides the first example of caspase inhibition by a Bcl-2 family member; it functions both as a suppressor of proapoptotic Bcl-2 family proteins and as an inhibitor of caspase-9, thereby neutralizing two sequential steps in the mitochondrial cell death pathway.	[Zhai, Dayong; Yu, Eric; Jin, Chaofang; Welsh, Kate; Shiau, Chung-wei; Chen, Lili; Salvesen, Guy S.; Liddington, Robert; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanford-burnham.org		Yu, Eric/0000-0001-7026-7008	National Institutes of Health [P01AI055789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AI055789.	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Costantini P, 2002, CELL DEATH DIFFER, V9, P82, DOI 10.1038/sj.cdd.4400932; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deveraux QL, 2000, METHOD ENZYMOL, V322, P154; Everett H, 2002, CURR OPIN MICROBIOL, V5, P395, DOI 10.1016/S1369-5274(02)00340-5; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Krajewska M, 1997, CANCER RES, V57, P1605; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhai DY, 2003, BIOCHEM J, V376, P229, DOI 10.1042/BJ20030374; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	53	34	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5569	5580		10.1074/jbc.M109.078113	http://dx.doi.org/10.1074/jbc.M109.078113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022954	Green Published, hybrid			2022-12-27	WOS:000275327200049
J	Arao, Y; Carpenter, K; Hewitt, S; Korach, KS				Arao, Yukitomo; Carpenter, Karen; Hewitt, Sylvia; Korach, Kenneth S.			Estrogen Down-regulation of the Scx Gene Is Mediated by the Opposing Strand-overlapping Gene Bop1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX TRANSCRIPTION FACTOR; SENSE-ANTISENSE PAIRS; RIBOSOME BIOGENESIS; X-CHROMOSOME; IN-VIVO; RNA; EXPRESSION; SCLERAXIS; INACTIVATION; TENDON	Recent genome-wide transcriptome studies suggest the presence of numerous bidirectional overlapping coding gene pairs in mammalian genomes. Various antisense RNAs are reported as non-coding RNAs that regulate the expression of sense RNA. However, it is still unclear whether the expression of bidirectional overlapping coding genes are regulated by the opposite strand gene transcript acting as a non-coding RNA. Bop1 and Scx are a pair of bidirectional overlapping coding genes related to cellular proliferation and differentiation, respectively. Scx gene is localized in the intron 3 region of the Bop1 gene. The expression of these genes is reciprocally regulated by estrogen (E2) in the mouse uterus. In situ hybridization indicated that both genes are expressed in the uterine endometrial epithelial cells and that the antisense RNA of Scx (Bop1 intronic RNA) accumulates as a stable RNA in these cells. The existence of Bop1 intronic RNA was confirmed by reverse transcription-PCR and was increased after E2 treatment, coinciding with a decrease in Scx mRNA. Murine myoblasts expressing doxycycline-inducible endogenous Bop1 gene showed an increase in Bop1 intronic RNA and a simultaneous decrease in Scx mRNA. Murine fibroblasts expressing Scx mRNA from an exogenous Scx mini-gene indicated that the accumulation of Bop1 intronic RNA impairs the Scx gene expression in a trans-acting manner, which resulted in the reduction of the Scx mRNA level. This study demonstrates a novel example of hormone-stimulated intronic noncoding RNA down-regulating the expression of an opposing strand-overlapping coding gene.	[Arao, Yukitomo; Carpenter, Karen; Hewitt, Sylvia; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021; Hewitt, Sylvia/W-8752-2019	Hewitt, Sylvia/0000-0001-7713-0805; Arao, Yukitomo/0000-0003-1560-351X; Korach, Kenneth/0000-0002-7765-418X	NIEHS [Z01ES70065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01ES70065 (to K. S. K.) through the Division of Intramural Research of the NIEHS.	Brown D, 1999, DEVELOPMENT, V126, P4317; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Deroo BJ, 2004, ENDOCRINOLOGY, V145, P5485, DOI 10.1210/en.2004-0471; Faghihi MA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r38; Galante PAF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r40; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hyder SM, 1997, CANCER RES, V57, P2547; Jakymiw A, 2007, J CELL SCI, V120, P1317, DOI 10.1242/jcs.03429; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawa-uchi T, 1998, J CELL BIOCHEM, V70, P468, DOI 10.1002/(SICI)1097-4644(19980915)70:4<468::AID-JCB4>3.0.CO;2-H; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liu Y, 1997, J CELL BIOCHEM, V67, P66, DOI 10.1002/(SICI)1097-4644(19971001)67:1<66::AID-JCB7>3.0.CO;2-U; Liu Y, 1997, J BIOL CHEM, V272, P29880, DOI 10.1074/jbc.272.47.29880; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; NOGUCHI M, 1994, J BIOL CHEM, V269, P29161; Numata K, 2007, GENE, V392, P134, DOI 10.1016/j.gene.2006.12.005; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Perez AV, 2003, MECH DEVELOP, V120, P1153, DOI 10.1016/j.mod.2003.08.003; Pestov DG, 1998, ONCOGENE, V17, P3187, DOI 10.1038/sj.onc.1202260; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLLARD JW, 1987, CELL TISSUE RES, V249, P533; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; SILVERMAN TA, 1992, J BIOL CHEM, V267, P9738; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Werner Andreas, 2005, RNA Biol, V2, P53, DOI 10.4161/rna.2.2.1852	41	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4806	4814		10.1074/jbc.M109.036681	http://dx.doi.org/10.1074/jbc.M109.036681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19996321	Green Published, hybrid			2022-12-27	WOS:000275274800059
J	Shinohara, M; Adachi, Y; Mitsushita, J; Kuwabara, M; Nagasawa, A; Harada, S; Furuta, S; Zhang, Y; Seheli, K; Miyazaki, H; Kamata, T				Shinohara, Masahiro; Adachi, Yoshifumi; Mitsushita, Junji; Kuwabara, Mitsuhiro; Nagasawa, Atsushi; Harada, Saori; Furuta, Shuichi; Zhang, Yugen; Seheli, Kajla; Miyazaki, Hitoshi; Kamata, Tohru			Reactive Oxygen Generated by NADPH Oxidase 1 (Nox1) Contributes to Cell Invasion by Regulating Matrix Metalloprotease-9 Production and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SUPEROXIDE-PRODUCTION; EPITHELIAL-CELLS; GENE-EXPRESSION; TUMOR-CELLS; RAS; CANCER; TRANSFORMATION; PHOSPHORYLATION; INVOLVEMENT	A mediating role of the reactive oxygen species-generating enzyme Nox1 has been suggested for Ras oncogene transformation phenotypes including anchorage-independent cell growth, augmented angiogenesis, and tumorigenesis. However, little is known about whether Nox1 signaling regulates cell invasiveness. Here, we report that the cell invasion activity was augmented in K-Ras-transformed normal rat kidney cells and attenuated by transfection of Nox1 small interference RNAs(siRNAs) into the cells. Diphenyleneiodonium (DPI) or Nox1 siRNAs blocked up-regulation of matrix metalloprotease-9 at both protein and mRNA levels in K-Ras-transformed normal rat kidney cells. Furthermore, DPI and Nox1 siRNAs inhibited the activation of IKK alpha kinase and the degradation of I kappa B alpha, suppressing the NF kappa B-dependent matrix metalloprotease-9 promoter activity. Additionally, epidermal growth factor-stimulated migration of CaCO-2 cells was abolished by DPI and Nox1 siRNAs, indicating the requirement of Nox1 activity for the motogenic effect of epidermal growth factor. This Nox1 action was mediated by down-regulation of the Rho activity through the low molecular weight protein-tyrosine phosphatase-p190RhoGAP-dependent mechanism. Taken together, our findings define a mediating role of Nox1-generated reactive oxygen species in cell invasion processes, most notably metalloprotease production and cell motile activity.	[Shinohara, Masahiro; Adachi, Yoshifumi; Mitsushita, Junji; Kuwabara, Mitsuhiro; Nagasawa, Atsushi; Harada, Saori; Furuta, Shuichi; Zhang, Yugen; Seheli, Kajla; Kamata, Tohru] Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, Nagano 3908621, Japan; [Miyazaki, Hitoshi] Univ Tsukuba, Ctr Gene Res, Ibaraki 3058572, Japan	Shinshu University; University of Tsukuba	Kamata, T (corresponding author), Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, 3-1-1 Asahi, Nagano 3908621, Japan.	kamatat@shinshu-u.ac.jp	Mitsushita, Junji/D-7688-2016	Mitsushita, Junji/0000-0001-9402-4318; Shinohara, Masahiro/0000-0002-5532-1042	Ministry of Science and Culture of Japan	Ministry of Science and Culture of Japan	This work was supported by a grant on Cancer Research in Applied Areas from the Ministry of Science and Culture of Japan (to T. K.).	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Aguirre-Ghiso JA, 1999, ONCOGENE, V18, P4718, DOI 10.1038/sj.onc.1202850; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; BERNHARD EJ, 1990, CANCER RES, V50, P3872; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Komatsu D, 2008, ONCOGENE, V27, P4724, DOI 10.1038/onc.2008.102; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; LIOTTA LA, 1990, JAMA-J AM MED ASSOC, V263, P1123, DOI 10.1001/jama.263.8.1123; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; SATO H, 1993, ONCOGENE, V8, P395; Shimizu H, 2001, BIOCHEM BIOPH RES CO, V289, P602, DOI 10.1006/bbrc.2001.6007; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Shirai H, 1995, ANTICANCER RES, V15, P2889; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Steinbrenner H, 2005, FREE RADICAL RES, V39, P245, DOI 10.1080/10715760500053487; Wilson AJ, 1999, EXP CELL RES, V250, P187, DOI 10.1006/excr.1999.4496; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745	35	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4481	4488		10.1074/jbc.M109.071779	http://dx.doi.org/10.1074/jbc.M109.071779			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018867	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000275274800026
J	Ellisdon, AM; Jani, D; Kohler, A; Hurt, E; Stewart, M				Ellisdon, Andrew M.; Jani, Divyang; Koehler, Alwin; Hurt, Ed; Stewart, Murray			Structural Basis for the Interaction between Yeast Spt-Ada-Gcn5 Acetyltransferase (SAGA) Complex Components Sgf11 and Sus1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE COMPLEX; HISTONE H2B; TRANSCRIPTION ELONGATION; FUNCTIONAL COMPONENT; DEUBIQUITINATION; MACHINERY; ACETYLATION; ASSOCIATION; DROSOPHILA	Sus1 is a central component of the yeast gene gating machinery, the process by which actively transcribing genes such as GAL1 become associated with nuclear pore complexes. Sus1 is a component of both the SAGA transcriptional co-activator complex and the TREX-2 complex that binds to nuclear pore complexes. TREX-2 contains two Sus1 chains that have an articulated helical hairpin fold, enabling them to wrap around an extended alpha-helix in Sac3, following a helical hydrophobic stripe. In SAGA, Sus1 binds to Sgf11 and has been proposed to provide a link between SAGA and TREX-2. We present here the crystal structure of the complex between Sus1 and the N-terminal region of Sgf11 that forms an extended alpha-helix around which Sus1 wraps in a manner that shares some similarities with the Sus1-Sac3 interface in TREX-2. However, the Sus1-binding site on Sgf11 is somewhat shorter than on Sac3 and is based on a narrower hydrophobic stripe. Engineered mutants that disrupt the Sgf11-Sus1 interaction in vitro confirm the importance of the hydrophobic helical stripe in molecular recognition. Helix alpha 1 of the Sus1-articulated hairpin does not bind directly to Sgf11 and adopts a wide range of conformations within and between crystal forms, consistent with the presence of a flexible hinge and also with results from previous extensive mutagenesis studies (Klockner, C., Schneider, M., Lutz, S., Jani, D., Kressler, D., Stewart, M., Hurt, E., and Kohler, A. (2009) J. Biol. Chem. 284, 12049-12056). A single Sus1 molecule cannot bind Sgf11 and Sac3 simultaneously and this, combined with the structure of the Sus1-Sgf11 complex, indicates that Sus1 forms separate subcomplexes within SAGA and TREX-2.	[Ellisdon, Andrew M.; Jani, Divyang; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Koehler, Alwin; Hurt, Ed] Univ Heidelberg, Zentrum Biochem, INF328, D-69120 Heidelberg, Germany	MRC Laboratory Molecular Biology; Ruprecht Karls University Heidelberg	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Ellisdon, Andrew/0000-0002-2248-9914	Wellcome Trust; Deutsche Forschungsgemeinschaft [SBF638]; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Wellcome Trust Program Grant ( to M. S.) and by grants from the Deutsche Forschungsgemeinschaft (SBF638, B3 to E. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Faza MB, 2009, J CELL BIOL, V184, P833, DOI 10.1083/jcb.200810059; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Klockner C, 2009, J BIOL CHEM, V284, P12049, DOI 10.1074/jbc.M900502200; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kurshakova M, 2007, MOL CELL, V27, P332, DOI 10.1016/j.molcel.2007.05.035; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Luna R, 2009, RNA BIOL, V6, P145, DOI 10.4161/rna.6.2.7803; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Montigiani S, 1996, J MOL BIOL, V258, P6, DOI 10.1006/jmbi.1996.0229; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Wilmes GM, 2009, MOL CELL, V33, P671, DOI 10.1016/j.molcel.2009.03.003; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	39	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3850	3856		10.1074/jbc.M109.070839	http://dx.doi.org/10.1074/jbc.M109.070839			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007317	Green Published, hybrid			2022-12-27	WOS:000275254000038
J	Gutman, O; Walliser, C; Piechulek, T; Gierschik, P; Henis, YI				Gutman, Orit; Walliser, Claudia; Piechulek, Thomas; Gierschik, Peter; Henis, Yoav I.			Differential Regulation of Phospholipase C-beta(2) Activity and Membrane Interaction by G alpha(q), G beta(1)gamma(2), and Rac2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ISOZYME-SPECIFIC STIMULATION; NUCLEOTIDE-BINDING PROTEIN; RHO GTPASES; C-BETA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HUMAN NEUTROPHILS; PLASMA-MEMBRANE; CLEAVAGE FURROW; ACTIVATION	We combined fluorescence recovery after photobleaching (FRAP) beam-size analysis with biochemical assays to investigate the mechanisms of membrane recruitment and activation of phospholipase C-beta(2) (PLC beta(2)) by G protein alpha(q) and beta gamma dimers. We show that activation by alpha(q) and beta gamma differ from activation by Rac2 and from each other. Stimulation by alpha(q) enhanced the plasma membrane association of PLC beta(2), but not of PLC beta(2)Delta, which lacks the alpha(q)-interacting region. Although alpha(q) resembled Rac2 in increasing the contribution of exchange to the FRAP of PLC beta(2) and in enhancing its membrane association, the latter effect was weaker than with Rac2. Moreover, the membrane recruitment of PLC beta(2) by alpha(q) occurred by enhancing PLC beta(2) association with fast-diffusing (lipid-like) membrane components, whereas stimulation by Rac2 led to interactions with slow diffusing membrane sites. On the other hand, activation by beta gamma shifted the FRAP of PLC beta(2) and PLC beta(2)Delta to pure lateral diffusion 3- to 5-fold faster than lipids, suggesting surfing-like diffusion along the membrane. We propose that these different modes of PLC beta(2) membrane recruitment may accommodate contrasting functional needs to hydrolyze phosphatidylinositol 4,5-bisphosphate (PtdInsP(2)) in localized versus dispersed populations. PLC beta(2) activation by Rac2, which leads to slow lateral diffusion and much faster exchange, recruits PLC beta(2) to act locally on PtdInsP2 at specific domains. Activation by alpha(q) leads to lipid-like diffusion of PLC beta(2) accompanied by exchange, enabling the sampling of larger, yet limited, areas prior to dissociation. Finally, activation by beta gamma recruits PLC beta(2) to the membrane by transient interactions, leading to fast "surfing" diffusion along the membrane, sampling large regions for dispersed PtdInsP(2) populations.	[Walliser, Claudia; Piechulek, Thomas; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89081 Ulm, Germany; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Ulm University; Tel Aviv University	Gierschik, P (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.gierschik@uni-ulm.de; henis@tauex.tau.ac.il		Henis, Yoav/0000-0002-1408-3877	German-Israeli Foundation [I-730-46.13/2002]; Deutsche Forschungsgemeinschaft [SFB 497]	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Grant I-730-46.13/2002 from the German-Israeli Foundation for Scientific Research and Development (to Y.I.H. and P. G.) and by the Deutsche Forschungsgemeinschaft (Grant SFB 497, TP C10, to P. G.).	Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ARKINSTALL S, 1995, FEBS LETT, V364, P45, DOI 10.1016/0014-5793(95)00351-9; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulinski JC, 2001, J CELL SCI, V114, P3885; CAMPS M, 1990, BIOCHEM J, V271, P743, DOI 10.1042/bj2710743; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Coburn RF, 1997, J CELL PHYSIOL, V171, P271, DOI 10.1002/(SICI)1097-4652(199706)171:3<271::AID-JCP5>3.0.CO;2-L; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Efron B, 1993, INTRO BOOTSTRAP, P124; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1997, EUR J BIOCHEM, V246, P71, DOI 10.1111/j.1432-1033.1997.t01-1-00071.x; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; LEE SB, 1993, J BIOL CHEM, V268, P25952; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; de Jesus ML, 2006, NEUROCHEM INT, V49, P72, DOI 10.1016/j.neuint.2005.12.015; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Mason D, 2007, J GEN PHYSIOL, V129, P267, DOI 10.1085/jgp.200609656; Matsuoka S, 2006, J CELL SCI, V119, P1071, DOI 10.1242/jcs.02824; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; PATERSON A, 1995, CELL SIGNAL, V7, P709, DOI 10.1016/0898-6568(95)00039-R; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Rabiet MJ, 2002, BLOOD, V100, P1835, DOI 10.1182/blood-2001-12-0193; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; de Azua IR, 2006, J NEUROSCI RES, V84, P13, DOI 10.1002/jnr.20858; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Yaradanakul A, 2007, J MEMBRANE BIOL, V220, P53, DOI 10.1007/s00232-007-9074-4	65	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3905	3915		10.1074/jbc.M109.085100	http://dx.doi.org/10.1074/jbc.M109.085100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20007712	hybrid, Green Published			2022-12-27	WOS:000275254000044
J	Paratkar, S; Patel, SS				Paratkar, Swaroopa; Patel, Smita S.			Mitochondrial Transcription Factor Mtf1 Traps the Unwound Non-template Strand to Facilitate Open Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; YEAST MITOCHONDRIAL; PROMOTER DNA; SACCHAROMYCES-CEREVISIAE; INITIATION COMPLEX; SPECIFICITY FACTOR; STRUCTURE PREDICTION; PROTEIN STRUCTURES; STRUCTURAL BASIS; MISMATCH BUBBLE	The catalytic subunit of the mitochondrial (mt) RNA polymerase ( RNAP) is highly homologous to the bacteriophage T7/T3 RNAP. Unlike the phage RNAP, however, the mtRNAP relies on accessory proteins to initiate promoter-specific transcription. Rpo41, the catalytic subunit of the Saccharomyces cerevisiae mtRNAP, requires Mtf1 for opening the duplex promoter. To elucidate the role of Mtf1 in promoter-specific DNA opening, we have mapped the structural organization of the mtRNAP using site-specific protein-DNA photo-cross-linking studies. Both Mtf1 and Rpo41 cross-linked to distinct sites on the promoter DNA, but the dominant cross-links were those of the Mtf1, which indicates a direct role of Mtf1 in promoter-specific binding and initiation. Strikingly, Mtf1 cross-linked with a high efficiency to the melted region of the promoter DNA, based on which we suggest that Mtf1 facilitates DNA melting by trapping the non-template strand in the unwound conformation. Additional strong cross-links of the Mtf1 were observed with the -8 to -10 base-paired region of the promoter. The cross-linking results were incorporated into a structural model of the mtRNAP-DNA, created from a homology model of the C-terminal domain of Rpo41 and the available structure of Mtf1. The promoterDNAis sandwiched between Mtf1 and Rpo41 in the structural model, and Mtf1 closely associates mainly with one face of the promoter across the entire nona-nucleotide consensus sequence. Overall, the studies reveal that in many ways the role of Mtf1 is analogous to the transcription factors of the multisubunit RNAPs, which provides an intriguing link between single- and multisubunit RNAPs.	[Paratkar, Swaroopa; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051966, R01GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51966 (to S. S. P.).	AIYAR SE, 1994, BIOCHEMISTRY-US, V33, P11501, DOI 10.1021/bi00204a012; AIYAR SE, 1994, J BIOL CHEM, V269, P13179; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Brieba LG, 2001, BIOCHEMISTRY-US, V40, P3882, DOI 10.1021/bi002716c; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen BS, 2004, BIOCHEMISTRY-US, V43, P12741, DOI 10.1021/bi048993r; CHEN Y, 1993, J MOL BIOL, V230, P453, DOI 10.1006/jmbi.1993.1162; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Guo Q, 2006, J MOL BIOL, V358, P241, DOI 10.1016/j.jmb.2006.02.001; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mangus D A, 1996, Methods Enzymol, V264, P57, DOI 10.1016/S0076-6879(96)64009-9; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P7993, DOI 10.1093/nar/10.24.7993; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Rykunov Dmitry, 2009, Journal of Structural and Functional Genomics, V10, P95, DOI 10.1007/s10969-008-9044-9; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1987, J BIOL CHEM, V262, P12785; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Stano NM, 2002, J BIOL CHEM, V277, P37292, DOI 10.1074/jbc.M201600200; Stano NM, 2002, J MOL BIOL, V315, P1009, DOI 10.1006/jmbi.2001.5313; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; TICHO BS, 1988, J BIOL CHEM, V263, P10096; Ujvari A, 2000, J MOL BIOL, V295, P1173, DOI 10.1006/jmbi.1999.3418; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINKLEY CS, 1985, J BIOL CHEM, V260, P4214; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053	65	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3949	3956		10.1074/jbc.M109.050732	http://dx.doi.org/10.1074/jbc.M109.050732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20008320	Green Published, hybrid			2022-12-27	WOS:000275254000048
J	Chen, JF; Chen, CL; Rawale, S; Chen, CA; Zweier, JL; Kaumaya, PTP; Chen, YR				Chen, Jingfeng; Chen, Chwen-Lih; Rawale, Sharad; Chen, Chun-An; Zweier, Jay L.; Kaumaya, Pravin T. P.; Chen, Yeong-Renn			Peptide-based Antibodies against Glutathione-binding Domains Suppress Superoxide Production Mediated by Mitochondrial Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; NITRIC-OXIDE; POSTISCHEMIC HEART; RADICAL FORMATION; OXIDATIVE STRESS; S-NITROSYLATION; GENERATION; PROTEINS; SITE	Complex I (NQR) is a critical site of superoxide (O-2(radical anion)) production and the major host of redox protein thiols in mitochondria. In response to oxidative stress, NQR-derived protein thiols at the 51- and 75-kDa subunits are known to be reversibly S-glutathionylated. Although several glutathionylated domains from NQR 51 and 75 kDa have been identified, their roles in the regulatory functions remain to be explored. To gain further insights into protein S-glutathionylation of complex I, we used two peptides of S-glutathionylated domain ((200)GAGAYI (C) under bar GEETALIESIEGK(219) of 51-kDa protein and (VDSDTL)-V-361 (C) under bar TEEVFPTAGAGTDLR(382) of 75-kDa protein) as chimeric epitopes incorporating a "promiscuous" T-cell epitope to generate two polyclonal antibodies, AbGSCA206 and AbGSCB367. Binding of AbGSCA206 and AbGSCB367 inhibited NQR-mediated O-2(radical anion). generation by 37 and 57%, as measured by EPR spin-trapping. To further provide an appropriate control, two peptides of non-glutathionylated domain ((21)SGDTTAPKKTSFGSLKDFDR(40) of 51-kDa peptide and (100)WNILTNSEKTKKAREGVMEFL(120) of 75-kDa peptide) were synthesized as chimeric epitopes to generate two polyclonal antibodies, Ab51 and Ab75. Binding of A51 did not affect NQR-mediated O-2(radical anion) generation to a significant level. However, binding of Ab75 inhibited NQR- mediated O-2(radical anion) generation by 35%. None of AbGSCA206, AbGSCB367, Ab51, or Ab75 showed an inhibitory effect on the electron transfer activity of NQR, suggesting that antibody binding to the glutathione-binding domain decreased electron leakage from the hydrophilic domain of NQR. When heart tissue homogenates were immunoprecipitated with Ab51 or Ab75 and probed with an antibody against glutathione, protein S-glutathionylation was enhanced in post-ischemic myocardium at the NQR 51-kDa subunit, but not at the 75-kDa subunit, indicating that the 51-kDa subunit of flavin subcomplex is more sensitive to oxidative stress resulting from myocardial infarction.	[Chen, Jingfeng; Chen, Chwen-Lih; Chen, Chun-An; Zweier, Jay L.; Chen, Yeong-Renn] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med,Dept Internal Med, Columbus, OH 43210 USA; [Rawale, Sharad; Kaumaya, Pravin T. P.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, YR (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, 4209 State Route 44, Rootstown, OH 44272 USA.	ychen1@neoucom.edu	Kaumaya, Pravin T. P/E-3354-2011		National Institutes of Health [HL83237, HL63744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL063744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL83237 (to Y.-R.C.) and HL63744 (to J.L.Z.).	Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; GALANTE YM, 1979, ARCH BIOCHEM BIOPHYS, V192, P559, DOI 10.1016/0003-9861(79)90126-7; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Hatefi Y, 1978, Methods Enzymol, V53, P11; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; KOBSCONRAD S, 1993, J BIOL CHEM, V268, P25285; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; REDFEARN ER, 1966, BIOCHIM BIOPHYS ACTA, V118, P413, DOI 10.1016/S0926-6593(66)80050-4; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vinogradov A D, 1979, Methods Enzymol, V55, P118; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	36	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3168	3180		10.1074/jbc.M109.056846	http://dx.doi.org/10.1074/jbc.M109.056846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940158	Green Published, hybrid			2022-12-27	WOS:000273829000032
J	Ham, HJ; Rho, HJ; Shin, SK; Yoon, HJ				Ham, Hye Jin; Rho, Hyun Joo; Shin, Seung Koo; Yoon, Hye-Joo			The TGL2 Gene of Saccharomyces cerevisiae Encodes an Active Acylglycerol Lipase Located in the Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIACYLGLYCEROL LIPASE; DIACYLGLYCEROL KINASE; ESCHERICHIA-COLI; LIPID PARTICLES; YEAST; PURIFICATION; PROTEIN; LIPOLYSIS; MOVEMENT; CLONING	The Saccharomyces cerevisiae Tgl2 protein shows sequence homology to Pseudomonas triacylglycerol (TAG) lipases, but its role in the yeast lipid metabolism is not known. Using hemagglutinin-tagged Tgl2p purified from yeast, we report that this protein carries a significant lipolytic activity toward long-chain TAG. Importantly, mutant hemagglutinin-Tgl2p(S144A), which contains alanine 144 in place of serine 144 in the lipase consensus sequence (G/A)XSXG exhibits no such activity. Although cellular TAG hydrolysis is reduced in the tgl2 deletion mutant, overproduction of Tgl2p in this mutant leads to an increase in TAG degradation in the presence of fatty acid synthesis inhibitor cerulenin, but that of Tgl2p(S144A) does not. This result demonstrates the lipolytic function of Tgl2p in yeast. Although other yeast TAG lipases are localized to lipid particles, Tgl2p is enriched in the mitochondria. The mitochondrial fraction purified from the TGL2-overexpressing yeast shows a strong lipolytic activity, which was absent in the tgl2 deletion mutant. Therefore, we conclude that Tgl2p is a functional lipase of the yeast mitochondria. By analyzing phenotypic effects of TGL2-deficient yeast, we also find that lipolysis-competent Tgl2p is required for the viability of cells treated with antimitotic drug. The addition of oleic acid, the product of Tgl2p-catalyzed lipolysis, fully complements the antimitotic drug sensitivity of the tgl2 null mutation. Thus, we propose that the mitochondrial Tgl2p-dependent lipolysis is crucial for the survival of cells under antimitotic drug treatment.	[Ham, Hye Jin; Rho, Hyun Joo; Shin, Seung Koo; Yoon, Hye-Joo] Pohang Univ Sci & Technol, Dept Chem, Bionanotechnol Ctr, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Shin, SK (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Bionanotechnol Ctr, Pohang 790784, South Korea.	skshin@postech.ac.kr; hjyoon@postech.ac.kr	Shin, Seung Koo/D-2670-2012; Yoon, Hye-Joo/D-4007-2012	Shin, Seung Koo/0000-0002-8294-2119; 	Ministry of Education, Science, and Technology of the Republic of Korea [FPR08A1-040]	Ministry of Education, Science, and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Functional Proteomics Center Grant FPR08A1-040 established by the Ministry of Education, Science, and Technology of the Republic of Korea.	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Caron JM, 1997, MOL BIOL CELL, V8, P621, DOI 10.1091/mbc.8.4.621; CLAYCOMB WC, 1971, J BIOL CHEM, V246, P7139; DARTOIS V, 1992, BIOCHIM BIOPHYS ACTA, V1131, P253, DOI 10.1016/0167-4781(92)90023-S; DAUM G, 1982, J BIOL CHEM, V257, P3028; DESNUELLE P, 1963, J LIPID RES, V4, P369; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; MANN JT, 1966, J BIOL CHEM, V241, P3595; Matsufuji Y, 2008, YEAST, V25, P825, DOI 10.1002/yea.1637; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; SchmidtDannert C, 1997, METHOD ENZYMOL, V284, P194; SCHOUSBOE I, 1976, BIOCHIM BIOPHYS ACTA, V450, P165, DOI 10.1016/0005-2760(76)90088-6; SCHOUSBOE I, 1976, BIOCHIM BIOPHYS ACTA, V424, P366, DOI 10.1016/0005-2760(76)90026-6; Seo J, 2008, ANAL CHEM, V80, P6145, DOI 10.1021/ac801007y; SIKORSKI RS, 1989, GENETICS, V122, P19; SOLOMON F, 1991, ANNU REV CELL BIOL, V7, P633, DOI 10.1146/annurev.cellbio.7.1.633; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Van Heusden GPH, 1998, YEAST, V14, P225, DOI 10.1002/(SICI)1097-0061(199802)14:3<225::AID-YEA215>3.0.CO;2-#; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	39	23	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3005	10.1074/jbc.M109.046946	http://dx.doi.org/10.1074/jbc.M109.046946			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19959834	Green Published, hybrid			2022-12-27	WOS:000273829000015
J	Liang, CC; Wang, CR; Peng, X; Gan, BY; Guan, JL				Liang, Chun-Chi; Wang, Chenran; Peng, Xu; Gan, Boyi; Guan, Jun-Lin			Neural-specific Deletion of FIP200 Leads to Cerebellar Degeneration Caused by Increased Neuronal Death and Axon Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; INTRACELLULAR PROTEIN-DEGRADATION; AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; AUTOPHAGOSOME FORMATION; MOLECULAR MACHINERY; MOUSE MODELS; DISEASE; CELLS; MICE	FIP200 (FAK family-interacting protein of 200 kDa) is a conserved protein recently identified as a potential mammalian counterpart of yeast autophagy protein Atg17. However, it remains unknown whether mammalian FIP200 regulates autophagy in vivo. Here we show that neural-specific deletion of FIP200 resulted in cerebellar degeneration accompanied by progressive neuronal loss, spongiosis, and neurite degeneration in the cerebellum. Furthermore, deletion of FIP200 led to increased apoptosis in cerebellum as well as accumulation of ubiquitinated protein aggregates without any deficiency in proteasome catalytic functions. We also observed an increased p62/SQSTM1 accumulation in the cerebellum and reduced autophagosome formation as well as accumulation of damaged mitochondria in the mutant mice. Lastly, analysis of cerebellar neurons in vitro showed reduced JNK activation and increased susceptibility to serum deprivation-induced apoptosis in cerebellar neurons from the mutant mice. Taken together, these results provide strong genetic evidence for a role of FIP200 in the regulation of neuronal homeostasis through its function in autophagy in vivo.	[Liang, Chun-Chi; Wang, Chenran; Peng, Xu; Gan, Boyi; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 109 Zina Pitcher,Rm 3027 BSRB, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Gan, Boyi/HDM-4206-2022; wang, chenran/N-6629-2013; Liang, Chun-Chi/D-7986-2016; Liang, Richard Chun-Chi/C-6989-2013	Liang, Chun-Chi/0000-0002-8345-8564; 	National Institutes of Health [GM52890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52890 (to J.- L. G.).	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Chano T, 2006, INT J MOL MED, V18, P425; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Ciechanover Aaron, 2006, Hematology Am Soc Hematol Educ Program, P1; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fortun J, 2003, J NEUROSCI, V23, P10672; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hooper NM, 2003, TRENDS BIOTECHNOL, V21, P144, DOI 10.1016/S0167-7799(03)00026-X; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Matalon R, 2000, J GENE MED, V2, P165; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200	54	153	155	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3499	3509		10.1074/jbc.M109.072389	http://dx.doi.org/10.1074/jbc.M109.072389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940130	hybrid, Green Published			2022-12-27	WOS:000273829000064
J	Li, Q; Li, G; Lan, XM; Zheng, M; Chen, KH; Cao, CM; Xiao, RP				Li, Qian; Li, Geng; Lan, Xiaomei; Zheng, Ming; Chen, Kuang-Hueih; Cao, Chun-Mei; Xiao, Rui-Ping			Receptor Interacting Protein 3 Suppresses Vascular Smooth Muscle Cell Growth by Inhibition of the Phosphoinositide 3-Kinase-Akt Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANGIOTENSIN-CONVERTING ENZYME; RIP-LIKE KINASE; NEOINTIMAL HYPERPLASIA; BALLOON ANGIOPLASTY; DEATH DOMAIN; APOPTOSIS; AKT; PROLIFERATION; RESTENOSIS	Proliferation of vascular smooth muscle cells (VSMCs) is a primary mechanism underlying cardiovascular proliferative disorders. Phosphoinositide 3-kinase (PI3K)-Akt (or protein kinase B) axis has been assigned at the center of pathways that regulate cell proliferation. Here we demonstrate that enhanced PI3K-Akt signaling by mitogenic stimulation or arterial injury profoundly elevates expression of receptor interacting protein 3 (RIP3) in primary cultured rat VSMCs and in vivo and that the up-regulation of RIP3 leads toVSMCgrowth arrest and apoptosis via inhibiting the PI3K-Akt signaling pathway, thereby alleviating balloon injury-induced neointimal formation. Specifically, mitogenic stimulation with platelet-derived growth factor-BB or angiotensin II leads to a profound increase in RIP3 expression, which is abolished by inhibition of PI3K or Akt, and increased PI3K-Akt signaling by expression of a constitutively active PI3K mutant also elevates RIP3 expression. Importantly, adenoviral overexpression of RIP3 not only triggers apoptosis but also causes cell cycle arrest at G(1)/G(0) phases that is associated with suppressed Akt activation. In sharp contrast, RIP3 gene silencing enhances serum- and platelet-derived growth factor-induced cell proliferation and Akt activation. In vivo adenoviral gene delivery of rat RIP3 (rRIP3) increased apoptosis and reduced VSMC proliferation, thus, effectively alleviating balloon injury-induced neointimal formation. The growth-suppressive and pro-apoptotic effects are independent of rRIP3 Ser/Thr kinase activity, because overexpression of a kinase-in-active mutant of rRIP3, similar to its wild type, is sufficient to induce growth arrest and apoptosis. These findings reveal a novel growth-suppressive action of RIP3, marking RIP3 as an important factor to prevent excessive mitogenic stimulation- or injury-induced vascular smooth muscle cells hyperplasia.	[Li, Qian; Lan, Xiaomei; Zheng, Ming; Cao, Chun-Mei; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Beijing 100083, Peoples R China; [Li, Qian; Li, Geng; Lan, Xiaomei; Xiao, Rui-Ping] Peking Univ, Inst Cardiovasc Sci, Beijing 100083, Peoples R China; [Chen, Kuang-Hueih; Xiao, Rui-Ping] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA	Peking University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cao, CM (corresponding author), Peking Univ, Inst Mol Med, Beijing 100083, Peoples R China.	Caochunmei@pku.edu.cn; Xiaor@grc.nia.nih.gov	Xiao, Rui-Ping/AAE-2629-2019; Yimei, Wang/AAE-4083-2019		National Institutes of Health Intramural Research Program, NIA; Peking University; Chinese 973 Program [2007CB512100]	National Institutes of Health Intramural Research Program, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Peking University(Peking University); Chinese 973 Program(National Basic Research Program of China)	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIA (to K.-H.C. and R.-P.X.). This work was also supported by Peking University 985 Project and Chinese 973 Program (2007CB512100) (to Q.Li, G.Li, X.L., M.Z., C.-M.C, and R.-P.X).	Banai S, 1998, CIRCULATION, V97, P1960, DOI 10.1161/01.CIR.97.19.1960; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bennett MR, 1999, CARDIOVASC RES, V41, P361, DOI 10.1016/S0008-6363(98)00212-0; Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Durand E, 2002, J AM COLL CARDIOL, V39, P1680, DOI 10.1016/S0735-1097(02)01831-4; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Guthikonda S, 1999, CURR OPIN CARDIOL, V14, P283, DOI 10.1097/00001573-199907000-00002; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kenagy RD, 1997, CIRCULATION, V96, P3555; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Meder D, 2005, SCIENCE, V307, P1731, DOI 10.1126/science.1110551; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Novak K, 1998, NAT MED, V4, P989, DOI 10.1038/1965; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Shigematsu K, 2000, ARTERIOSCL THROM VAS, V20, P2373, DOI 10.1161/01.ATV.20.11.2373; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; VISWANATHAN M, 1992, J CLIN INVEST, V90, P1707, DOI 10.1172/JCI116043; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou RH, 2003, ARTERIOSCL THROM VAS, V23, P2015, DOI 10.1161/01.ATV.0000095161.06906.ED	53	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9535	9544		10.1074/jbc.M109.071332	http://dx.doi.org/10.1074/jbc.M109.071332			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20042608	Green Published, hybrid			2022-12-27	WOS:000276165900027
J	Agarwal, S; Mishra, NK; Bhatnagar, S; Bhatnagar, R				Agarwal, Shivangi; Mishra, Neeraj Kumar; Bhatnagar, Sonika; Bhatnagar, Rakesh			PemK Toxin of Bacillus anthracis Is a Ribonuclease AN INSIGHT INTO ITS ACTIVE SITE, STRUCTURE, AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA INTERFERASE; ESCHERICHIA-COLI; STRESSFUL CONDITIONS; ANTITOXIN SYSTEMS; CATALYTIC SITE; CELL-DEATH; PROTEIN; MAZEF; ENDORIBONUCLEASE; GENOME	Bacillus anthracis genome harbors a toxin-antitoxin (TA) module encoding pemI (antitoxin) and pemK (toxin). This study describes the rPemK as a potent ribonuclease with a preference for pyrimidines (C/U), which is consistent with our previous study that demonstrated it as a translational attenuator. The in silico structural modeling of the PemK in conjunction with the site-directed mutagenesis confirmed the role of His-59 and Glu-78 as an acid-base couple in mediating the ribonuclease activity. The rPemK is shown to form a complex with the rPemI, which is in line with its function as a TA module. This rPemI-rPemK complex becomes catalytically inactive when both the proteins interact in a molar stoichiometry of 1. The rPemI displays vulnerability to proteolysis but attains conformational stability only upon rPemK interaction. The pemI-pemK transcript is shown to be up-regulated upon stress induction with a concomitant increase in the amount of PemK and a decline in the PemI levels, establishing the role of these modules in stress. The artificial perturbation of TA interaction could unleash the toxin, executing bacterial cell death. Toward this end, synthetic peptides are designed to disrupt the TA interaction. The peptides are shown to be effective in abrogating TA interaction in micromolar range in vitro. This approach can be harnessed as a potential antibacterial strategy against anthrax in the future.	[Agarwal, Shivangi; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India; [Mishra, Neeraj Kumar] Jawaharlal Nehru Univ, Biophys Chem Lab, Sch Biotechnol, New Delhi 110067, India; [Bhatnagar, Sonika] Netaji Subhas Inst Technol, Div Biotechnol, New Delhi 110078, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Netaji Subhas University of Technology	Bhatnagar, R (corresponding author), Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India.	rakbhat01@yahoo.com		Agarwal, Shivangi/0000-0002-2406-7678; Bhatnagar, Sonika/0000-0002-8818-4240; Mishra, Neeraj/0000-0002-6762-1747	Department of Biotechnology, Delhi, India	Department of Biotechnology, Delhi, India	This work was supported by the Department of Biotechnology, Delhi, India.	Agarwal S, 2007, FEBS LETT, V581, P1727, DOI 10.1016/j.febslet.2007.03.051; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemos JAC, 2005, FEMS MICROBIOL LETT, V253, P251, DOI 10.1016/j.femsle.2005.09.045; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Melvin I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S2; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Park S, 2008, ARCH MICROBIOL, V189, P541, DOI 10.1007/s00203-007-0341-7; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Pimentel B, 2005, EMBO J, V24, P3459, DOI 10.1038/sj.emboj.7600815; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Tachdjian S, 2006, J BACTERIOL, V188, P4553, DOI 10.1128/JB.00080-06; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; Vetter SM, 2005, ANTIMICROB AGENTS CH, V49, P1302, DOI 10.1128/AAC.49.4.1302-1305.2005; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	43	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7254	7270		10.1074/jbc.M109.073387	http://dx.doi.org/10.1074/jbc.M109.073387			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022964	Green Published, hybrid			2022-12-27	WOS:000275415600038
J	Simao, AMS; Yadav, MC; Narisawa, S; Bolean, M; Pizauro, JM; Hoylaerts, MF; Ciancaglini, P; Millan, JL				Simao, Ana Maria S.; Yadav, Manisha C.; Narisawa, Sonoko; Bolean, Mayte; Pizauro, Joao Martins; Hoylaerts, Marc F.; Ciancaglini, Pietro; Millan, Jose Luis			Proteoliposomes Harboring Alkaline Phosphatase and Nucleotide Pyrophosphatase as Matrix Vesicle Biomimetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT OSSEOUS PLATE; CELL MEMBRANE GLYCOPROTEIN-1; GPI-ANCHORED PROTEIN; MOTILITY-STIMULATING PROTEIN; ATP-INITIATED CALCIFICATION; AIR-WATER-INTERFACE; INORGANIC PYROPHOSPHATE; GROWTH-PLATE; CALCIUM PYROPHOSPHATE; EPIPHYSEAL CARTILAGE	We have established a proteoliposome system as an osteoblast-derived matrix vesicle (MV) biomimetic to facilitate the study of the interplay of tissue-nonspecific alkaline phosphatase (TNAP) and NPP1 (nucleotide pyrophosphatase/phosphodiesterase-1) during catalysis of biomineralization substrates. First, we studied the incorporation of TNAP into liposomes of various lipid compositions (i.e. in pure dipalmitoyl phosphatidylcholine (DPPC), DPPC/dipalmitoyl phosphatidylserine (9:1 and 8:2), and DPPC/dioctadecyl-dimethylammonium bromide (9:1 and 8:2) mixtures. TNAP reconstitution proved virtually complete in DPPC liposomes. Next, proteoliposomes containing either recombinant TNAP, recombinant NPP1, or both together were reconstituted in DPPC, and the hydrolysis of ATP, ADP, AMP, pyridoxal-5'-phosphate (PLP), p-nitrophenyl phosphate, p-nitrophenylthymidine 5'-monophosphate, and PPi by these proteoliposomes was studied at physiological pH. p-Nitrophenylthymidine 5'-monophosphate and PLP were exclusively hydrolyzed by NPP1-containing and TNAP-containing proteoliposomes, respectively. In contrast, ATP, ADP, AMP, PLP, p-nitrophenyl phosphate, and PPi were hydrolyzed by TNAP-, NPP1-, and TNAP plus NPP1- containing proteoliposomes. NPP1 plus TNAP additively hydrolyzed ATP, but TNAP appeared more active in AMP formation than NPP1. Hydrolysis of PPi by TNAP-, and TNAP plus NPP1- containing proteoliposomes occurred with catalytic efficiencies and mild cooperativity, effects comparable with those manifested by murine osteoblast-derived MVs. The reconstitution of TNAP and NPP1 into proteoliposome membranes generates a phospholipid microenvironment that allows the kinetic study of phosphosubstrate catabolism in a manner that recapitulates the native MV microenvironment.	[Simao, Ana Maria S.; Yadav, Manisha C.; Narisawa, Sonoko; Hoylaerts, Marc F.; Ciancaglini, Pietro; Millan, Jose Luis] Sanford Childrens Hlth Res Ctr, Burnham Inst Med Res, La Jolla, CA 92037 USA; [Ciancaglini, Pietro] Univ Sao Paulo, Dept Chem, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14040901 Ribeirao Preto, SP, Brazil; [Pizauro, Joao Martins] Univ Estadual Paulista, Dept Technol, Fac Ciencias Agrarias & Vet Jaboticabal, BR-14884900 Jaboticabal, SP, Brazil; [Hoylaerts, Marc F.] Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium	Sanford Burnham Prebys Medical Discovery Institute; Universidade de Sao Paulo; Universidade Estadual Paulista; KU Leuven	Millan, JL (corresponding author), Sanford Childrens Hlth Res Ctr, Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	millan@burnham.org	Pizauro, João/D-3171-2012; CIANCAGLINI, PIETRO/X-7410-2019; Ciancaglini, Pietro/C-4842-2012; Bolean, Mayte/A-1484-2014	Pizauro, João/0000-0002-0911-5053; CIANCAGLINI, PIETRO/0000-0002-2785-1345; Ciancaglini, Pietro/0000-0002-2785-1345; Bolean, Mayte/0000-0002-8307-1298; Hoylaerts, Marc/0000-0002-6474-3933	National Institutes of Health [DE12889, AR47908, AR53102]; Thrasher Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Excellentie Financiering KULeuven [EF/05/013]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047908, R01AR053102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Excellentie Financiering KULeuven(KU Leuven); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE12889, AR47908, and AR53102, by a grant from the Thrasher Research Fund, and by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The Center for Molecular and Vascular Biology is supported by the "Excellentie Financiering KULeuven" (EF/05/013).	ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; Anderson HC, 1997, AM J PATHOL, V151, P1555; Anderson HC, 2005, AM J PATHOL, V166, P1711, DOI 10.1016/S0002-9440(10)62481-9; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Andoh K, 1999, BBA-GENE STRUCT EXPR, V1446, P213, DOI 10.1016/S0167-4781(99)00090-1; Arien A, 1997, J MICROENCAPSUL, V14, P753, DOI 10.3109/02652049709006825; Balcerzak M, 2007, ANAL BIOCHEM, V361, P176, DOI 10.1016/j.ab.2006.10.001; Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; Benatti CR, 2007, CHEM PHYS LIPIDS, V145, P27, DOI 10.1016/j.chemphyslip.2006.10.002; Benatti CR, 2001, CHEM PHYS LIPIDS, V111, P93, DOI 10.1016/S0009-3084(01)00134-7; BERNARD GW, 1978, CLIN ORTHOP RELAT R, P218; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Boskey A. L., 2006, DYNAMICS BONE CARTIL, P201; Camolezi FL, 2002, INT J BIOCHEM CELL B, V1282, P1; CARRUTHERS A, 1986, TRENDS BIOCHEM SCI, V11, P331, DOI 10.1016/0968-0004(86)90292-6; Ciancaglini P, 2006, BRAZ J MED BIOL RES, V39, P603, DOI 10.1590/S0100-879X2006000500006; CIANCAGLINI P, 1990, INT J BIOCHEM, V22, P385, DOI 10.1016/0020-711X(90)90141-O; CIANCAGLINI P, 2010, J BONE MINER RES, DOI DOI 10.1359/JBMR.091023; CURTI C, 1986, CELL MOL BIOL, V32, P55; Damek-Poprawa M, 2006, BIOCHEMISTRY-US, V45, P3325, DOI 10.1021/bi0515927; Demenis MA, 2000, IUBMB LIFE, V49, P113; Di Mauro S, 2002, J BONE MINER RES, V17, P1383, DOI 10.1359/jbmr.2002.17.8.1383; EANES ED, 1989, ANAT REC, V224, P220, DOI 10.1002/ar.1092240211; EANES ED, 1985, CALCIFIED TISSUE INT, V37, P390, DOI 10.1007/BF02553708; FALLON MD, 1980, LAB INVEST, V43, P489; Frittitta L, 1999, J CLIN ENDOCR METAB, V84, P3620, DOI 10.1210/jc.84.10.3620; Gijsbers R, 2003, BIOCHEM J, V371, P321, DOI 10.1042/BJ20021943; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hashimoto S, 1998, P NATL ACAD SCI USA, V95, P3094, DOI 10.1073/pnas.95.6.3094; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hosoda N, 1999, EUR J BIOCHEM, V265, P763, DOI 10.1046/j.1432-1327.1999.00779.x; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; Hsu HHT, 1996, J BIOL CHEM, V271, P26383, DOI 10.1074/jbc.271.42.26383; Hsu HHT, 1999, BBA-BIOMEMBRANES, V1416, P320, DOI 10.1016/S0005-2736(98)00235-1; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; Ierardi DF, 2002, BBA-BIOMEMBRANES, V1567, P183, DOI 10.1016/S0005-2736(02)00615-6; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Johnson K, 1999, J BONE MINER RES, V14, P883, DOI 10.1359/jbmr.1999.14.6.883; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Kirsch T, 2003, J BONE MINER RES, V18, P1872, DOI 10.1359/jbmr.2003.18.10.1872; KUNITAKE T, 1977, CHEM LETT, P387, DOI 10.1246/cl.1977.387; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P1398, DOI 10.1021/bi011579w; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P8368, DOI 10.1021/bi012038+; Leone F.A., 1997, TRENDS COMP BIOCH PH, V3, P57; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Leone FA, 1998, INT J BIOCHEM CELL B, V30, P89, DOI 10.1016/S1357-2725(97)00077-0; Letho MT, 1998, BIOCHEM J, V332, P101, DOI 10.1042/bj3320101; Liu C, 1999, BLOOD, V93, P2297, DOI 10.1182/blood.V93.7.2297.407k19_2297_2301; MAJESKA RJ, 1975, BIOCHIM BIOPHYS ACTA, V391, P51, DOI 10.1016/0005-2744(75)90151-5; Meerson NR, 1998, HEPATOLOGY, V27, P563, DOI 10.1002/hep.510270234; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MilluYn JL., 2006, MAMMALIAN ALKALINE P, DOI 10.1002/3527608060; MORRIS DC, 1992, BONE MINER, V19, P287, DOI 10.1016/0169-6009(92)90877-G; MOSS DW, 1967, BIOCHEM J, V102, P53, DOI 10.1042/bj1020053; MURATA J, 1994, J BIOL CHEM, V269, P30479; Murphy WL, 2000, POLYHEDRON, V19, P357, DOI 10.1016/S0277-5387(99)00366-6; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; New R.R., 1990, LIPOSOMES PRACTICAL; PIZAURO JM, 1987, COMP BIOCHEM PHYS B, V87, P921, DOI 10.1016/0305-0491(87)90413-5; Pizauro JM, 1995, MOL CELL BIOCHEM, V152, P121, DOI 10.1007/BF01076074; PRASAD R, 1996, MANUAL MEMBRANE LIPI; REZENDE AA, 1994, BIOCHEM J, V301, P517, DOI 10.1042/bj3010517; Rezende LA, 1998, CELL MOL BIOL, V44, P293; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; Ronzon F, 2002, BBA-BIOMEMBRANES, V1560, P1, DOI 10.1016/S0005-2736(01)00405-9; SAY JC, 1991, BIOCHIM BIOPHYS ACTA, V1074, P256, DOI 10.1016/0304-4165(91)90161-9; Sela J, 2000, CRIT REV ORAL BIOL M, V11, P423, DOI 10.1177/10454411000110040301; Sergienko E, 2009, J BIOMOL SCREEN, V14, P824, DOI 10.1177/1087057109338517; Sesana S, 2008, BIOCHEMISTRY-US, V47, P5433, DOI 10.1021/bi800005s; Sharom FJ, 1996, BIOCHEM CELL BIOL, V74, P701, DOI 10.1139/o96-077; Simao AMS, 2007, COMP BIOCHEM PHYS A, V146, P679, DOI 10.1016/j.cbpa.2006.05.008; STORCH J, 1985, TRENDS BIOCHEM SCI, V10, P418, DOI 10.1016/0968-0004(85)90021-0; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826	84	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7598	7609		10.1074/jbc.M109.079830	http://dx.doi.org/10.1074/jbc.M109.079830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048161	Green Published, hybrid			2022-12-27	WOS:000275415600071
J	Lei, XY; Zhang, S; Barbour, SE; Bohrer, A; Ford, EL; Koizumi, A; Papa, FR; Ramanadham, S				Lei, Xiaoyong; Zhang, Sheng; Barbour, Suzanne E.; Bohrer, Alan; Ford, Eric L.; Koizumi, Akio; Papa, Feroz R.; Ramanadham, Sasanka			Spontaneous Development of Endoplasmic Reticulum Stress That Can Lead to Diabetes Mellitus Is Associated with Higher Calcium-independent Phospholipase A(2) Expression A ROLE FOR REGULATION BY SREBP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; NITRIC-OXIDE SYNTHASE; ELEMENT-BINDING PROTEIN-1; CYTOCHROME-C RELEASE; FATTY-ACID SYNTHASE; ER STRESS; INSULINOMA CELLS; CERAMIDE GENERATION; INDUCED APOPTOSIS; MOUSE MODEL	Our recent studies indicate that endoplasmic reticulum (ER) stress causes INS-1 cell apoptosis by a Ca2+-independent phospholipase A(2) (iPLA(2)beta)-mediated mechanism that promotes ceramide generation via sphingomyelin hydrolysis and subsequent activation of the intrinsic pathway. To elucidate the association between iPLA(2)beta and ER stress, we compared beta-cell lines generated from wild type (WT) and Akita mice. The Akita mouse is a spontaneous model of ER stress that develops hyperglycemia/diabetes due to ER stress-induced beta-cell apoptosis. Consistent with a predisposition to developing ER stress, basal phosphorylated PERK and activated caspase-3 are higher in the Akita cells than WT cells. Interestingly, basal iPLA(2)beta, mature SREBP-1 (mSREBP-1), phosphorylated Akt, and neutral sphingomyelinase (NSMase) are higher, relative abundances of sphingomyelins are lower, and mitochondrial membrane potential (Delta Psi) is compromised in Akita cells, in comparison with WT cells. Exposure to thapsigargin accelerates Delta Psi loss and apoptosis of Akita cells and is associated with increases in iPLA(2)beta, mSREBP-1, and NSMase in both WT and Akita cells. Transfection of Akita cells with iPLA(2)beta small interfering RNA, however, suppresses NSMase message, Delta Psi loss, and apoptosis. The iPLA(2)beta gene contains a sterol-regulatory element, and transfection with a dominant negative SREBP-1 reduces basal mSREBP-1 and iPLA(2)beta in the Akita cells and suppresses increases in mSREBP-1 and iPLA(2)beta due to thapsigargin. These findings suggest that ER stress leads to generation of mSREBP-1, which can bind to the sterol-regulatory element in the iPLA(2)beta gene to promote its transcription. Consistent with this, SREBP-1, iPLA(2)beta, and NSMase messages in Akita mouse islets are higher than in WT islets.	[Lei, Xiaoyong; Zhang, Sheng; Bohrer, Alan; Ford, Eric L.; Ramanadham, Sasanka] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Barbour, Suzanne E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Koizumi, Akio] Kyoto Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan; [Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	Washington University (WUSTL); Virginia Commonwealth University; Kyoto University; University of California System; University of California San Francisco	Ramanadham, S (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	sramanad@dom.wustl.edu		Papa, Feroz/0000-0002-3684-9108	National Institutes of Health [R01-DK69455, P41-RR00954, P60-DK20579, P30-DK56341, DK065671]; American Diabetes Association; National Science Foundation [NSFMCB-0544068]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069455, K08DK065671, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK69455, P41-RR00954, P60-DK20579, P30-DK56341, and DK065671. This work was also supported by a grant from the American Diabetes Association (to S. R.) and National Science Foundation Grant NSFMCB-0544068 (to S. E. B.).	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Boilard E, 2001, J BIOL CHEM, V276, P17568, DOI 10.1074/jbc.M006152200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; CORBETT JA, 1992, DIABETES, V41, P897, DOI 10.2337/diabetes.41.8.897; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Diaz-Horta O, 2002, DIABETES, V51, P1815, DOI 10.2337/diabetes.51.6.1815; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Isenovic E, 2000, HYPERTENSION, V35, P249, DOI 10.1161/01.HYP.35.1.249; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRONCKE KD, 1993, BIOCHIM BIOPHYS ACTA, V1182, P221, DOI 10.1016/0925-4439(93)90144-P; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Maggi LB, 2002, J BIOL CHEM, V277, P38449, DOI 10.1074/jbc.M206247200; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathews CE, 2002, TRANSPLANTATION, V73, P1333, DOI 10.1097/00007890-200204270-00024; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; SATO R, 1994, J BIOL CHEM, V269, P17267; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schmidt RE, 2009, EXP NEUROL, V216, P207, DOI 10.1016/j.expneurol.2008.11.019; Seashols SJ, 2004, BBA-MOL CELL BIOL L, V1684, P29, DOI 10.1016/j.bbalip.2004.05.003; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Tithof PK, 2000, TOXICOL SCI, V53, P40, DOI 10.1093/toxsci/53.1.40; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Williams SD, 2001, AM J PHYSIOL-HEART C, V281, pH168, DOI 10.1152/ajpheart.2001.281.1.H168; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	70	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6693	6705		10.1074/jbc.M109.084293	http://dx.doi.org/10.1074/jbc.M109.084293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032468	hybrid, Green Published			2022-12-27	WOS:000275367500073
J	Bhatt, TK; Yogavel, M; Wydau, S; Berwal, R; Sharma, A				Bhatt, Tarun Kumar; Yogavel, Manickam; Wydau, Sandra; Berwal, Ritu; Sharma, Amit			Ligand-bound Structures Provide Atomic Snapshots for the Catalytic Mechanism of D-Amino Acid Deacylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA DEACYLASE; D-TYR-TRNA(TYR) DEACYLASE; ESCHERICHIA-COLI; PLASMODIUM-FALCIPARUM; SACCHAROMYCES-CEREVISIAE; BACILLUS SUBTILIS; CRYSTAL-STRUCTURE; ARCHAEA; IDENTIFICATION; SYNTHETASES	D-tyrosyl-tRNATyr deacylase (DTD) is an editing enzyme that removes D-amino acids from mischarged tRNAs. We describe an in-depth analysis of the malaria parasite Plasmodium falciparum DTD here. Our data provide structural insights into DTD complexes with adenosine and D-amino acids. Bound adenosine is proximal to the DTD catalysis site, and it represents the authentic terminal adenosine of charged tRNA. DTD-bound D-amino acids cluster at three different subsites within the overall active site pocket. These subsites, called transition, active, and exit subsites allow docking, re-orientation, chiral selection, catalysis, and exit of the free D-amino acid from DTD. Our studies reveal variable modes of D-amino acid recognition by DTDs, suggesting an inherent plasticity that can accommodate all D-amino acids. An in-depth analysis of native, ADP-bound, and D-amino acid-complexed DTD structures provide the first atomic snapshots of ligand recognition and subsequent catalysis by this enzyme family. We have mapped sites for the deacylation reaction and mark possible routes for entry and egress of all substrates and products. We have also performed structure-based inhibitor discovery and tested lead compounds against the malaria parasite P. falciparum using growth inhibition assays. Our studies provide a comprehensive structural basis for the catalytic mechanism of DTD enzymes and have implications for inhibition of this enzyme in P. falciparum as a route to inhibiting the parasite.	[Bhatt, Tarun Kumar; Yogavel, Manickam; Berwal, Ritu; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Wydau, Sandra] Ecole Polytech, CNRS, UMR7654, Biochim Lab, F-91128 Palaiseau, France	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com	Bhatt, Tarun Kumar/AFD-8503-2022; Manickam, Yogavel/O-4570-2015	Manickam, Yogavel/0000-0002-2119-062X; Wydau-Dematteis, Sandra/0000-0003-2023-3656	European Commission [HEALTH-F3-2009-223024]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been conducted as part of the MEPHITIS project and was supported in part by the European Commission (Grant Agreement HEALTH-F3-2009-223024).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1681, DOI 10.1021/bi00869a033; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; Dwivedi S, 2005, NAT STRUCT MOL BIOL, V12, P556, DOI 10.1038/nsmb943; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferri-Fioni ML, 2006, J BIOL CHEM, V281, P27575, DOI 10.1074/jbc.M605860200; Ferri-Fioni ML, 2001, J BIOL CHEM, V276, P47285, DOI 10.1074/jbc.M106550200; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim K, 2003, J BIOL CHEM, V278, P13496, DOI 10.1074/jbc.M213150200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 1999, J BIOL CHEM, V274, P19109, DOI 10.1074/jbc.274.27.19109; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wydau S, 2007, NUCLEIC ACIDS RES, V35, P930, DOI 10.1093/nar/gkl1145; Zheng G, 2009, BIOCHEM J, V417, P85, DOI 10.1042/BJ20080617	28	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5917	5930		10.1074/jbc.M109.038562	http://dx.doi.org/10.1074/jbc.M109.038562			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007323	Green Published, hybrid			2022-12-27	WOS:000275327200082
J	Brzeska, H; Guag, J; Remmert, K; Chacko, S; Korn, ED				Brzeska, Hanna; Guag, Jake; Remmert, Kirsten; Chacko, Susan; Korn, Edward D.			An Experimentally Based Computer Search Identifies Unstructured Membrane-binding Sites in Proteins APPLICATION TO CLASS I MYOSINS, PAKS, AND CARMIL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN KINASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; ACANTHAMOEBA-CASTELLANII; CAPPING PROTEIN; EFFECTOR DOMAIN; LIPID-BINDING; LOCALIZATION; ACTIN; SEQUENCE	Programs exist for searching protein sequences for potential membrane-penetrating segments (hydrophobic regions) and for lipid-binding sites with highly defined tertiary structures, such as PH, FERM, C2, ENTH, and other domains. However, a rapidly growing number of membrane-associated proteins (including cytoskeletal proteins, kinases, GTP-binding proteins, and their effectors) bind lipids through less structured regions. Here, we describe the development and testing of a simple computer search program that identifies unstructured potential membrane-binding sites. Initially, we found that both basic and hydrophobic amino acids, irrespective of sequence, contribute to the binding to acidic phospholipid vesicles of synthetic peptides that correspond to the putative membrane-binding domains of Acanthamoeba class I myosins. Based on these results, we modified a hydrophobicity scale giving Arg- and Lys-positive, rather than negative, values. Using this basic and hydrophobic scale with a standard search algorithm, we successfully identified previously determined unstructured membrane-binding sites in all 16 proteins tested. Importantly, basic and hydrophobic searches identified previously unknown potential membrane-binding sites in class I myosins, PAKs and CARMIL (capping protein, Arp2/3, myosin I linker; a membrane-associated cytoskeletal scaffold protein), and synthetic peptides and protein domains containing these newly identified sites bound to acidic phospholipids in vitro.	[Brzeska, Hanna; Guag, Jake; Remmert, Kirsten; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Chacko, Susan] NIH, Sci Comp Branch, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50,Rm 2515, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; BAINES IC, 1990, J CELL BIOL, V111, P1895, DOI 10.1083/jcb.111.5.1895; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; BRZESKA H, 1990, J BIOL CHEM, V265, P16138; BRZESKA H, 1992, J BIOL CHEM, V267, P23870; BRZESKA H, 1990, J BIOL CHEM, V265, P3591; Brzeska H, 1999, P NATL ACAD SCI USA, V96, P394, DOI 10.1073/pnas.96.2.394; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; DOBERSTEIN SK, 1993, NATURE, V365, P841, DOI 10.1038/365841a0; Feng L, 2001, BIOCHEMISTRY-US, V40, P904, DOI 10.1021/bi000996q; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Ishikawa T, 2004, P NATL ACAD SCI USA, V101, P12189, DOI 10.1073/pnas.0404835101; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1993, J BIOL CHEM, V268, P14981; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; KULESZALIPKA D, 1991, J CELL BIOL, V115, P109, DOI 10.1083/jcb.115.1.109; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee SF, 1998, J BIOL CHEM, V273, P27911, DOI 10.1074/jbc.273.43.27911; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu X, 2000, J BIOL CHEM, V275, P24886, DOI 10.1074/jbc.M004287200; LYNCH TJ, 1989, J BIOL CHEM, V264, P19333; McKenna JMD, 2009, J BIOL CHEM, V284, P28650, DOI 10.1074/jbc.M109.049791; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Morita YS, 1996, EUR J CELL BIOL, V71, P371; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Ostap EM, 2003, CELL MOTIL CYTOSKEL, V54, P29, DOI 10.1002/cm.10081; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Scott DL, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-17; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274; Swanljung-Collins H, 1994, Adv Exp Med Biol, V358, P205; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Van Troys M, 2000, BIOCHEMISTRY-US, V39, P12181, DOI 10.1021/bi000816c; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; WANG ZY, 1995, J BIOL CHEM, V270, P27969, DOI 10.1074/jbc.270.46.27969; Wang ZY, 1997, J MUSCLE RES CELL M, V18, P395, DOI 10.1023/A:1018686428955; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winteroll S, 2005, TRANSFUS MED HEMOTH, V32, P20, DOI 10.1159/000082126; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; YU FX, 1992, J BIOL CHEM, V267, P14616	56	43	43	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5738	5747		10.1074/jbc.M109.066910	http://dx.doi.org/10.1074/jbc.M109.066910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018884	hybrid, Green Published			2022-12-27	WOS:000275327200066
J	Masuho, I; Celver, J; Kovoor, A; Martemyanov, KA				Masuho, Ikuo; Celver, Jeremy; Kovoor, Abraham; Martemyanov, Kirill A.			Membrane Anchor R9AP Potentiates GTPase-accelerating Protein Activity of RGS11.G beta(5) Complex and Accelerates Inactivation of the mGluR6-G(o) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON-BIPOLAR CELLS; RGS PROTEINS; K+ CHANNELS; R7BP; EXPRESSION; REGULATOR; AFFINITY; SUBUNITS; PHOTORECEPTORS; KINETICS	The R7 subfamily of RGS proteins critically regulates neuronal G protein-signaling pathways that are essential for vision, nociception, motor coordination, and reward processing. A member of the R7 RGS family, RGS11, is a GTPase-accelerating protein specifically expressed in retinal ON-bipolar cells where it forms complexes with the atypical G protein beta subunit, G beta(5), and transmembrane protein R9AP. Association with R9AP has been shown to be critical for the proteolytic stability of the complex in the retina. In this study we report that R9AP can in addition stimulate the GTPase-accelerating protein activity of the RGS11.G beta(5) complex at G alpha(o). Single turnover GTPase assays reveal that R9AP co-localizes RGS11.G beta(5) and G alpha(o) on the membrane and allosterically potentiates the GTPase-accelerating function of RGS11.G beta(5). Reconstitution of mGluR6-G alpha(o) signaling in Xenopus oocytes indicates that RGS11.G beta(5)-mediated GTPase acceleration in this system requires co-expression of R9AP. The results provide new insight into the regulation of mGluR6-G alpha(o) signaling by the RGS11.G beta(5).R9AP complex and establish R9AP as a general GTPase-accelerating protein activity regulator of R7 RGS complexes.	[Masuho, Ikuo; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Celver, Jeremy; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Rhode Island	Kovoor, A (corresponding author), 57 Fogarty Hall,41 Lower Coll Rd, Kingston, RI 02881 USA.	abekovoor@uri.edu; martemyanov@umn.edu	Masuho, Ikuo/J-6115-2014		National Institutes of Health [EY018139, DA026405, R41MH078570]; McKnight Land; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH078570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Land; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants EY018139 (to K. A. M.), DA026405 (to K. A. M.), and R41MH078570 (to J. C. and A. K.). This work was also supported by a McKnight Land Grant award (to K. A. M.).	Andernacht M, 2009, ATW-INT J NUCL POWER, V54, P33; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Cao Y, 2008, J NEUROSCI, V28, P10443, DOI 10.1523/JNEUROSCI.3282-08.2008; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Garzon J, 2003, NEUROPSYCHOPHARMACOL, V28, P1983, DOI 10.1038/sj.npp.1300263; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Keresztes G, 2003, MOL CELL NEUROSCI, V24, P687, DOI 10.1016/S1044-7431(03)00231-8; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2004, METHOD ENZYMOL, V390, P196; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Vardi Noga, 2002, Keio Journal of Medicine, V51, P154; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	43	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4781	4787		10.1074/jbc.M109.058511	http://dx.doi.org/10.1074/jbc.M109.058511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007977	Green Published, hybrid			2022-12-27	WOS:000275274800056
J	Nishi, H; Ono, K; Iwanaga, Y; Horie, T; Nagao, K; Takemura, G; Kinoshita, M; Kuwabara, Y; Mori, RT; Hasegawa, K; Kita, T; Kimura, T				Nishi, Hitoo; Ono, Koh; Iwanaga, Yoshitaka; Horie, Takahiro; Nagao, Kazuya; Takemura, Genzou; Kinoshita, Minako; Kuwabara, Yasuhide; Mori, Rieko Takanabe; Hasegawa, Koji; Kita, Toru; Kimura, Takeshi			MicroRNA-15b Modulates Cellular ATP Levels and Degenerates Mitochondria via Arl2 in Neonatal Rat Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; HEART; EXPRESSION; HYPERTROPHY; ISOFORM; MUSCLE; ABNORMALITIES; DEFICIENCY; TISSUES; MODELS	MicroRNAs (miRNAs or miRs) are small, non-coding RNAs that modulate mRNA stability and post-transcriptional translation. A growing body of evidence indicates that specific miRNAs can affect the cellular function of cardiomyocytes. In the present study, miRNAs that are highly expressed in the heart were over-expressed in neonatal rat ventricular myocytes, and cellular ATP levels were assessed. As a result, miR-15b, -16, -195, and -424, which have the same seed sequence, the most critical determinant of miRNA targeting, decreased cellular ATP levels. These results suggest that these miRNAs could specifically down-regulate the same target genes and consequently decrease cellular ATP levels. Through a bioinformatics approach, ADP-ribosylation factor-like 2 (Arl2) was identified as a potential target of miR-15b. It has already been shown that Arl2 localizes to adenine nucleotide transporter 1, the exchanger of ADP/ATP in mitochondria. Overexpression of miR-15b, -16, -195, and -424 suppressed the activity of a luciferase reporter construct fused with the 3'-untranslated region of Arl2. In addition, miR-15b overexpression decreased Arl2 mRNA and protein expression levels. The effects of Arl2 siRNA on cellular ATP levels were the same as those of miR-15b, and the expression of Arl2 could restore ATP levels reduced by miR-15b. A loss-of-function study of miR-15b resulted in increased Arl2 protein and cellular ATP levels. Electron microscopic analysis revealed that mitochondria became degenerated in cardiomyocytes that had been transduced with miR-15b and Arl2 siRNA. The present results suggest that miR-15b may decrease mitochondrial integrity by targeting Arl2 in the heart.	[Ono, Koh] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Iwanaga, Yoshitaka] Kinki Univ, Sch Med, Dept Internal Med, Div Cardiol, Osakasayama 5898511, Japan; [Takemura, Genzou] Gifu Univ, Grad Sch Med, Div Cardiol, Gifu 5011194, Japan; [Mori, Rieko Takanabe; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto 6128555, Japan	Kyoto University; Kindai University (Kinki University); Gifu University	Ono, K (corresponding author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	kohono@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Science, and Technology [R31-10069]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. O., K. H., T. K., and T. K.) and by Grant R31-10069 (WCU Program) from the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology.	BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Chen XM, 1999, J BIOL CHEM, V274, P37750, DOI 10.1074/jbc.274.53.37750; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DAS AM, 1990, BIOCHEM J, V266, P355, DOI 10.1042/bj2660355; Dorner A, 2007, TRENDS CARDIOVAS MED, V17, P284, DOI 10.1016/j.tcm.2007.10.001; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Dorner A, 1999, BBA-BIOMEMBRANES, V1417, P16, DOI 10.1016/S0005-2736(98)00245-4; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; HEYLIGER C E, 1985, Canadian Journal of Cardiology, V1, P401; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Murdock DG, 1999, J BIOL CHEM, V274, P14429, DOI 10.1074/jbc.274.20.14429; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Ning XH, 2000, J AM COLL CARDIOL, V36, P282, DOI 10.1016/S0735-1097(00)00689-6; PASSARELLA S, 1988, BIOCHEM BIOPH RES CO, V156, P978, DOI 10.1016/S0006-291X(88)80940-9; RUPP H, 1992, FASEB J, V6, P2349, DOI 10.1096/fasebj.6.6.1531968; SABBAH HN, 1992, J MOL CELL CARDIOL, V24, P1333, DOI 10.1016/0022-2828(92)93098-5; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; SCHEUER J, 1982, J CLIN INVEST, V70, P1300, DOI 10.1172/JCI110729; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; SORDAHL LA, 1973, AM J PHYSIOL, V224, P497, DOI 10.1152/ajplegacy.1973.224.3.497; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	38	115	121	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4920	4930		10.1074/jbc.M109.082610	http://dx.doi.org/10.1074/jbc.M109.082610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007690	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000275274800069
J	Altmayr, F; Jusek, G; Holzmann, B				Altmayr, Felicitas; Jusek, Gabriela; Holzmann, Bernhard			The Neuropeptide Calcitonin Gene-related Peptide Causes Repression of Tumor Necrosis Factor-alpha Transcription and Suppression of ATF-2 Promoter Recruitment in Toll-like Receptor-stimulated Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP EARLY REPRESSOR; SIGNAL-TRANSDUCTION; INNATE IMMUNITY; NEGATIVE REGULATION; BINDING-PROTEIN; SENSORY NERVES; MAST-CELLS; T-CELLS; C-JUN; EXPRESSION	Sensory nerves may dampen inflammatory processes through the release of the neuropeptide calcitonin gene-related peptide (CGRP). CGRP mediates immunosuppressive activities through up-regulation of interleukin-10 or, alternatively, through an interleukin-10-independent pathway that is associated with rapid induction of the transcriptional inducible cAMP early repressor (ICER). In this work, we further investigated the molecular mechanisms of immune modulation by CGRP. Using TLR2-stimulated dendritic cells, we show that inhibition of tumor necrosis factor-alpha production by CGRP is dependent on up-regulation of endogenous ICER. Dendritic cell expression of ICER was selectively induced by CGRP and elevation of cellular cAMP levels but not by numerous pro- and anti-inflammatory cytokines. Treatment of dendritic cells with CGRP did not interfere with the induction of Tnfa gene expression but caused premature repression of TLR2-induced transcriptional activity. ATF-2 was rapidly phosphorylated and recruited to the Tnfa promoter following ligation of TLR2. Concomitant administration of CGRP completely prevented binding of ATF-2 to the Tnfa promoter, whereas recruitment of ICER was markedly elevated. In contrast, CGRP did not influence TLR2-stimulated binding of NF-kappa B p65. Together, these results are consistent with a model suggesting that CGRP causes rapid up-regulation of ICER, which in turn competes with ATF-2 for binding to the Tnfa promoter, leading to repression of gene expression.	[Altmayr, Felicitas; Jusek, Gabriela; Holzmann, Bernhard] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany	Technical University of Munich	Holzmann, B (corresponding author), Tech Univ Munich, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	holzmann@chir.med.tu-muenchen.de						Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; ASAHINA A, 1995, J IMMUNOL, V154, P3056; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Bodor J, 1998, J BIOL CHEM, V273, P9544, DOI 10.1074/jbc.273.16.9544; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Carucci JA, 2000, J IMMUNOL, V164, P3494, DOI 10.4049/jimmunol.164.7.3494; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Drissi H, 1998, J BIOL CHEM, V273, P20168, DOI 10.1074/jbc.273.32.20168; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Fox FE, 1997, J INVEST DERMATOL, V108, P43, DOI 10.1111/1523-1747.ep12285627; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Kameda T, 1999, BBA-GENE STRUCT EXPR, V1445, P31, DOI 10.1016/S0167-4781(99)00018-4; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Levite M, 1998, J IMMUNOL, V160, P993; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mead JR, 2003, J BIOL CHEM, V278, P17741, DOI 10.1074/jbc.M301602200; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Monaco L, 1997, ONCOGENE, V15, P2493, DOI 10.1038/sj.onc.1201636; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Naukkarinen A, 1996, J PATHOL, V180, P200, DOI 10.1002/(SICI)1096-9896(199610)180:2<200::AID-PATH632>3.0.CO;2-Z; NUMAO T, 1992, J IMMUNOL, V149, P3309; Reinshagen M, 2000, GASTROENTEROLOGY, V119, P368, DOI 10.1053/gast.2000.9307; Reinshagen M, 1998, J PHARMACOL EXP THER, V286, P657; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; Thonberg H, 2001, BIOCHEM J, V354, P169, DOI 10.1042/bj3540169; Torii H, 1997, J LEUKOCYTE BIOL, V61, P216, DOI 10.1002/jlb.61.2.216; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Uyttersprot N, 1999, EUR J BIOCHEM, V259, P370, DOI 10.1046/j.1432-1327.1999.00049.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	49	30	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3525	3531		10.1074/jbc.M109.066787	http://dx.doi.org/10.1074/jbc.M109.066787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	20018859	Green Published, hybrid			2022-12-27	WOS:000275254000001
J	Callahan, KP; Butler, JS				Callahan, Kevin P.; Butler, J. Scott			TRAMP Complex Enhances RNA Degradation by the Nuclear Exosome Component Rrp6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; SUBUNIT; CORE; POLYADENYLATION; SURVEILLANCE; TRANSCRIPTS; INTERACTS	The RNA-processing exosome contains ribonucleases that degrade aberrant RNAs in archael and eukaryotic cells. In Saccharomyces cerevisiae, the nuclear/nucleolar 3'-5' exoribonuclease Rrp6 distinguishes the nuclear exosome from the cytoplasmic exosome. In vivo, the TRAMP complex enhances the ability of the nuclear exosome to destroy some aberrant RNAs. Previous reports showed that purified TRAMP enhanced RNA degradation by the nuclear exosome in vitro. However, the exoribonucleolytic component(s) of the nuclear exosome enhanced by TRAMP remain unidentified. We show that TRAMP does not significantly enhance RNA degradation by purified exosomes lacking Rrp6 in vitro, suggesting that TRAMP activation experiments with nuclear exosome preparations reflect, in part, effects on the activity of Rrp6. Consistent with this, we show that incubation of purified TRAMP with recombinant Rrp6 results in a 10-fold enhancement of the rate of RNA degradation. This increased activity results from enhancement of the hydrolytic activity of Rrp6 because TRAMP cannot enhance the activity of an Rrp6 mutant lacking a key amino acid side chain in its active site. We observed no ATP or polyadenylation dependence for the enhancement of Rrp6 activity by TRAMP, suggesting that neither the poly(A) polymerase activity of Trf4 nor the helicase activity of Mtr4 plays a role in the enhancement. These findings identify TRAMP as an exosome-independent enhancer of Rrp6 activity.	[Callahan, Kevin P.; Butler, J. Scott] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Butler, J. Scott] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Butler, J. Scott] Univ Rochester, Med Ctr, Ctr RNA Biol Genome Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Butler, JS (corresponding author), Box 672,601 Elmwood Ave, Rochester, NY 14642 USA.	scott_butler@urmc.rochester.edu			National Institutes of Health [GM-59898]; National Science Foundation [MCB-0817324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-59898. This work was also supported by National Science Foundation Grant MCB-0817324.	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bayne EH, 2007, CELL, V129, P651, DOI 10.1016/j.cell.2007.05.004; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; BUTLER JS, 1990, MOL CELL BIOL, V10, P2599, DOI 10.1128/MCB.10.6.2599; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	34	76	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3540	3547		10.1074/jbc.M109.058396	http://dx.doi.org/10.1074/jbc.M109.058396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955569	Green Published, hybrid			2022-12-27	WOS:000275254000003
J	Yang, XM; Wood, PA; Hrushesky, WJM				Yang, Xiaoming; Wood, Patricia A.; Hrushesky, William J. M.			Mammalian TIMELESS Is Required for ATM-dependent CHK2 Activation and G(2)/M Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HISTONE H3; SERINE 10; PHOSPHORYLATION; KINASES; CANCER; P53; PROTEIN; REPAIR	Timeless (Tim), a core circadian clock gene in Drosophila, is retained in mammals but has no apparent mammalian circadian clock function. Mammalian TIM is essential for ATR-dependent Chk1 activation and S-phase arrest. We report that TIM is likewise essential for ATM-dependent Chk2-mediated signaling of doxorubicin-induced DNA double strand breaks. TIM depletion attenuates doxorubicin-induced G(2)/M cell cycle arrest and sensitizes cancer cells to doxorubicin-induced cytotoxicity. TIM is, thereby, a potential novel anticancer drug target whose inhibition may enhance the therapeutic cytotoxicity of agents that activate DNA damage pathways as part of their mechanism.	[Hrushesky, William J. M.] Wm Jennings Bryan Dorn Vet Affairs Med Ctr, Med Chronobiol Lab, Columbia, SC 29209 USA; [Wood, Patricia A.; Hrushesky, William J. M.] Univ S Carolina, Sch Med, Columbia, SC 29209 USA; [Hrushesky, William J. M.] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29209 USA; [Hrushesky, William J. M.] Univ S Carolina, Sch Engn & Comp Sci, Columbia, SC 29209 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hrushesky, WJM (corresponding author), Wm Jennings Bryan Dorn Vet Affairs Med Ctr, Med Chronobiol Lab, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	williamhrushesky@gmail.com		Hrushesky, William/0000-0002-0955-3192				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gotter AL, 2006, NEUROREPORT, V17, P1229, DOI 10.1097/01.wnr.0000233092.90160.92; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kennedy DR, 2007, P NATL ACAD SCI USA, V104, P17632, DOI 10.1073/pnas.0708274104; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perona R, 2008, CLIN TRANSL ONCOL, V10, P538, DOI 10.1007/s12094-008-0248-5; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Prives C, 1999, J PATHOL, V187, P112; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shieh SY, 2000, GENE DEV, V14, P289; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	50	80	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3030	10.1074/jbc.M109.050237	http://dx.doi.org/10.1074/jbc.M109.050237			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19996108	hybrid, Green Published			2022-12-27	WOS:000273829000018
J	Bhattacharya, S; HuangFu, WC; Liu, JH; Veeranki, S; Baker, DP; Koumenis, C; Diehl, JA; Fuchs, SY				Bhattacharya, Sabyasachi; HuangFu, Wei-Chun; Liu, Jianghuai; Veeranki, Sudhakar; Baker, Darren P.; Koumenis, Constantinos; Diehl, J. Alan; Fuchs, Serge Y.			Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; CDC25A PROTEIN PHOSPHATASE; DOWN-REGULATION; ALPHA RECEPTOR; BETA-CATENIN; DEPENDENT DEGRADATION; UBIQUITIN LIGASE; HEPATITIS-C; PATHWAY; VIRUSES	Phosphorylation-dependent ubiquitination and ensuing down-regulation and lysosomal degradation of the interferon alpha/beta receptor chain 1 (IFNAR1) of the receptor for Type I interferons play important roles in limiting the cellular responses to these cytokines. These events could be stimulated either by the ligands (in a Janus kinase-dependent manner) or by unfolded protein response (UPR) inducers including viral infection (in a manner dependent on the activity of pancreatic endoplasmic reticulum kinase). Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation. Casein kinase 1 alpha (CK1 alpha) was shown to directly phosphorylate Ser535 within the ligand-independent pathway. Yet given the constitutive activity of CK1 alpha, it remained unclear how this pathway is stimulated by UPR. Here we report that induction of UPR promotes the phosphorylation of a proximal residue, Ser(532), in a pancreatic endoplasmic reticulum kinase-dependent manner. This serine serves as a priming site that promotes subsequent phosphorylation of IFNAR1 within its degron by CK1 alpha. These events play an important role in regulating ubiquitination and degradation of IFNAR1 as well as the extent of Type I interferon signaling.	[Bhattacharya, Sabyasachi; HuangFu, Wei-Chun; Liu, Jianghuai; Veeranki, Sudhakar; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bhattacharya, Sabyasachi; HuangFu, Wei-Chun; Liu, Jianghuai; Veeranki, Sudhakar; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Koumenis, Constantinos] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Biogen	Fuchs, SY (corresponding author), 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Koumenis, Constantinos/B-2002-2008	Liu, Jianghuai/0000-0002-2382-9140; Koumenis, Costas/0000-0001-5945-4726	National Institutes of Health [CA92900, CA104838]; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA092900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92900 (to S. Y. F.) and CA104838 (to J. A. D.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; BILLARD C, 1986, BLOOD, V67, P821; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; CONSTANTINESCU SN, 1995, P NATL ACAD SCI USA, V92, P10487, DOI 10.1073/pnas.92.23.10487; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; DONELLADEANA A, 1985, BIOCHIM BIOPHYS ACTA, V829, P180, DOI 10.1016/0167-4838(85)90187-6; Donzelli M, 2004, CELL CYCLE, V3, P469; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hagen T, 2002, BIOCHEM BIOPH RES CO, V294, P324, DOI 10.1016/S0006-291X(02)00485-0; Hartwell D, 2009, INT J TECHNOL ASSESS, V25, P56, DOI 10.1017/S0266462309090084; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; HuangFu WC, 2008, FEBS LETT, V582, P3206, DOI 10.1016/j.febslet.2008.08.013; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jin J, 2008, J BIOL CHEM, V283, P19322, DOI 10.1074/jbc.M802474200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Lang K, 2008, EXPERT REV VACCINES, V7, P915, DOI 10.1586/14760584.7.7.915; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Luquin E, 2007, ANTIVIR RES, V76, P194, DOI 10.1016/j.antiviral.2007.06.004; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; MAXWELL BL, 1985, INT J CANCER, V36, P23, DOI 10.1002/ijc.2910360105; MEGGIO F, 1979, FEBS LETT, V106, P76, DOI 10.1016/0014-5793(79)80698-5; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; UMPHRESS JL, 1992, EUR J BIOCHEM, V203, P239, DOI 10.1111/j.1432-1033.1992.tb19852.x; WALLACH DFH, 1987, FUNDAMENTALS RECEPTO; Waris G, 2002, BIOCHEM PHARMACOL, V64, P1425, DOI 10.1016/S0006-2952(02)01300-X	48	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2318	2325		10.1074/jbc.M109.071498	http://dx.doi.org/10.1074/jbc.M109.071498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19948722	Green Published, hybrid			2022-12-27	WOS:000273697800011
J	Schoenwaelder, SM; Ono, A; Nesbitt, WS; Lim, J; Jarman, K; Jackson, SP				Schoenwaelder, Simone M.; Ono, Akiko; Nesbitt, Warwick S.; Lim, Joanna; Jarman, Kate; Jackson, Shaun P.			Phosphoinositide 3-Kinase p110 beta Regulates Integrin alpha(IIb)beta(3) Avidity and the Cellular Transmission of Contractile Forces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-2; THROMBUS FORMATION; FOCAL ADHESIONS; SECRETED ADP; ACTIVATION; HEMOSTASIS; MECHANISM; RAP1B	Phosphoinositide (PI) 3-kinase (PI3K) signaling processes play an important role in regulating the adhesive function of integrin alpha(IIb)beta(3), necessary for platelet spreading and sustained platelet aggregation. PI3K inhibitors are effective at reducing platelet aggregation and thrombus formation in vivo and as a consequence are currently being evaluated as novel antithrombotic agents. PI3K regulation of integrin alpha(IIb)beta(3) activation (affinity modulation) primarily occurs downstream of G(i)-coupled and tyrosine kinase-linked receptors linked to the activation of Rap1b, AKT, and phospholipase C. In the present study, we demonstrate an important role for PI3Ks in regulating the avidity (strength of adhesion) of high affinity integrin alpha(IIb)beta(3) bonds, necessary for the cellular transmission of contractile forces. Using knock-out mouse models and isoform-selective PI3K inhibitors, we demonstrate that the Type Ia p110 beta isoform plays a major role in regulating thrombin-stimulated fibrin clot retraction in vitro. Reduced clot retraction induced by PI3K inhibitors was not associated with defects in integrin alpha(IIb)beta(3) activation, actin polymerization, or actomyosin contractility but was associated with a defect in integrin alpha(IIb)beta(3) association with the contractile cytoskeleton. Analysis of integrin alpha(IIb)beta(3) adhesion contacts using total internal reflection fluorescence microscopy revealed an important role for PI3Ks in regulating the stability of high affinity integrin alpha(IIb)beta(3) bonds. These studies demonstrate an important role for PI3K p110 beta in regulating the avidity of high affinity integrin alpha(IIb)beta(3) receptors, necessary for the cellular transmission of contractile forces. These findings may provide new insight into the potential antithrombotic properties of PI3K p110 beta inhibitors.	[Schoenwaelder, Simone M.; Ono, Akiko; Nesbitt, Warwick S.; Lim, Joanna; Jarman, Kate; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Monash University	Schoenwaelder, SM (corresponding author), Monash Univ, Australian Ctr Blood Dis, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	Simone.Schoenwaelder@med.monash.edu.au	Schoenwaelder, Simone/E-9506-2011; Jackson, Shaun P/E-9633-2011	Nesbitt, Warwick/0000-0001-5644-7053; Schoenwaelder, Simone/0000-0003-0465-5840; Jackson, Shaun/0000-0002-4750-1991	National Heart Foundation of Australia; National Health and Medical Research Council of Australia.	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia.(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Heart Foundation of Australia and the National Health and Medical Research Council of Australia.	Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; BROMBERG ME, 1985, AM J PHYSIOL, V249, pC297, DOI 10.1152/ajpcell.1985.249.3.C297; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; COHEN I, 1989, BLOOD, V73, P1880; COHEN I, 1982, J CELL BIOL, V93, P775, DOI 10.1083/jcb.93.3.775; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; FOX JEB, 1993, ADV EXP MED BIOL, V344, P175; Gilcrease MZ, 2004, CANCER RES, V64, P7395, DOI 10.1158/0008-5472.CAN-04-1809; Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314; GUINEBAULT C, 1993, BIOCHEM J, V292, P851, DOI 10.1042/bj2920851; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HARTWIG JH, 2007, PLATELETS; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; JAKOBSEN E, 1973, Thrombosis Research, V3, P145, DOI 10.1016/0049-3848(73)90065-0; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Lynch L, 2005, MOL BIOL CELL, V16, P51, DOI 10.1091/mbc.E04-05-0399; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ono A, 2008, BLOOD, V112, P90, DOI 10.1182/blood-2007-12-127001; Osdoit S, 2001, J BIOL CHEM, V276, P6703, DOI 10.1074/jbc.M008945200; Pasquet JM, 1999, BIOCHEM J, V342, P171, DOI 10.1042/0264-6021:3420171; Payrastre B, 2000, BIOCHEM PHARMACOL, V60, P1069, DOI 10.1016/S0006-2952(00)00417-2; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P24876, DOI 10.1074/jbc.272.40.24876; Selheim F, 1999, BIOCHEM BIOPH RES CO, V263, P780, DOI 10.1006/bbrc.1999.1450; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; TRUSKEY GA, 1992, J CELL SCI, V103, P491; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	57	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2886	2896		10.1074/jbc.M109.029132	http://dx.doi.org/10.1074/jbc.M109.029132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940148	Green Published, hybrid			2022-12-27	WOS:000273697800064
J	Schuh, NR; Guerrero, MS; Schrecengost, RS; Bouton, AH				Schuh, Natasha R.; Guerrero, Michael S.; Schrecengost, Randy S.; Bouton, Amy H.			BCAR3 Regulates Src/p130(Cas) Association, Src Kinase Activity, and Breast Cancer Adhesion Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CRK-ASSOCIATED SUBSTRATE; MEDIATED CELL-ADHESION; C-SRC; TYROSINE PHOSPHORYLATION; ANTIESTROGEN RESISTANCE; TAMOXIFEN RESISTANCE; COMPLEX-FORMATION; ADAPTER PROTEINS; DEPENDENT MANNER	The nonreceptor protein-tyrosine kinase c-Src is frequently overexpressed and/or activated in a variety of cancers, including those of the breast. Several heterologous binding partners of c-Src have been shown to regulate its catalytic activity by relieving intramolecular autoinhibitory interactions. One such protein, p130(Cas) (Cas), is expressed at high levels in both breast cancer cell lines and breast tumors, providing a potential mechanism for c-Src activation in breast cancers. The Cas-binding protein BCAR3 (breast cancer antiestrogen resistance-3) is expressed at high levels in invasive breast cancer cell lines, and this molecule has previously been shown to coordinate with Cas to increase c-Src activity in COS-1 cells. In this study, we show for the first time using gain- and loss-of-function approaches that BCAR3 regulates c-Src activity in the endogenous setting of breast cancer cells. We further show that BCAR3 regulates the interaction between Cas and c-Src, both qualitatively as well as quantitatively. Finally, we present evidence that the coordinated activity of these proteins contributes to breast cancer cell adhesion signaling and spreading. Based on these data, we propose that the c-Src/Cas/BCAR3 signaling axis is a prominent regulator of c-Src activity, which in turn controls cell behaviors that lead to aggressive and invasive breast tumor phenotypes.	[Schuh, Natasha R.; Guerrero, Michael S.; Schrecengost, Randy S.; Bouton, Amy H.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Bouton, AH (corresponding author), Univ Virginia, Dept Microbiol, Box 800734, Charlottesville, VA 22908 USA.	ahb8y@virginia.edu			National Institutes of Health Training [T32 CA009109]; Department of Defense Breast Cancer Research [BC043365, BC050339]; Ruth L. Kirschstein National Research Service [CA130168];  [R01 CA096846]; NATIONAL CANCER INSTITUTE [T32CA009109, F31CA130168, R01CA096846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 CA009109 (to N. R. S., M. S. G., and R. S. S.) and Research Grant R01 CA096846 (to A. H. B.). This work was also supported by Department of Defense Breast Cancer Research Program Grants BC043365 (to N. R. S.) and BC050339 (to R. S. S.) and Ruth L. Kirschstein National Research Service Award CA130168 (to M. S. G.).	Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bouton AH, 1997, HYBRIDOMA, V16, P403, DOI 10.1089/hyb.1997.16.403; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Burnham MR, 1999, MOL CARCINOGEN, V26, P20, DOI 10.1002/(SICI)1098-2744(199909)26:1<20::AID-MC3>3.0.CO;2-M; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cai DP, 1999, J IMMUNOL, V163, P2104; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Dail M, 2004, J BIOL CHEM, V279, P41892, DOI 10.1074/jbc.M402929200; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dorssers LCJ, 2005, BREAST CANCER RES, V7, pR82, DOI 10.1186/bcr954; Felekkis KN, 2005, MOL CANCER RES, V3, P32; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Shah AN, 2007, ANTI-CANCER DRUG, V18, P371, DOI 10.1097/CAD.0b013e32801265d7; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; van der Flier S, 2000, INT J CANCER, V89, P465, DOI 10.1002/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000	44	21	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2309	2317		10.1074/jbc.M109.046631	http://dx.doi.org/10.1074/jbc.M109.046631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940159	Green Published, hybrid			2022-12-27	WOS:000273697800010
J	Chen, HB; Giri, NC; Zhang, RH; Yamane, K; Zhang, Y; Maroney, M; Costa, M				Chen, Haobin; Giri, Nitai Charan; Zhang, Ronghe; Yamane, Kenichi; Zhang, Yi; Maroney, Michael; Costa, Max			Nickel Ions Inhibit Histone Demethylase JMJD1A and DNA Repair Enzyme ABH2 by Replacing the Ferrous Iron in the Catalytic Centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LYSINE METHYLATION; ALKYLATION DAMAGE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; TISSUE-CULTURE; A549 CELLS; ACTIVATION; COMPLEXES; JHDM2A	Iron- and 2-oxoglutarate-dependent dioxygenases are a diverse family of non-heme iron enzymes that catalyze various important oxidations in cells. A key structural motif of these dioxygenases is a facial triad of 2-histidines-1-carboxylate that coordinates the Fe(II) at the catalytic site. Using histone demethylase JMJD1A and DNA repair enzyme ABH2 as examples, we show that this family of dioxygenases is highly sensitive to inhibition by carcinogenic nickel ions. We find that, with iron, the 50% inhibitory concentrations of nickel (IC50 [Ni(II)]) are 25 mu M for JMJD1A and 7.5 mu M for ABH2. Without iron, JMJD1A is 10 times more sensitive to nickel inhibition with an IC50 [Ni(II)] of 2.5 mu M, and approximately one molecule of Ni(II) inhibits one molecule of JMJD1A, suggesting that nickel causes inhibition by replacing the iron. Furthermore, nickel-bound JMJD1A is not reactivated by excessive iron even up to a 2 mM concentration. Using x-ray absorption spectroscopy, we demonstrate that nickel binds to the same site in ABH2 as iron, and replacement of the iron by nickel does not prevent the binding of the cofactor 2-oxoglutarate. Finally, we show that nickel ions target and inhibit JMJD1A in intact cells, and disruption of the iron-binding site decreases binding of nickel ions to ABH2 in intact cells. Together, our results reveal that the members of this dioxygenase family are specific targets for nickel ions in cells. Inhibition of these dioxygenases by nickel is likely to have widespread impacts on cells (e.g. impaired epigenetic programs and DNA repair) and may eventually lead to cancer development.	[Chen, Haobin; Zhang, Ronghe; Costa, Max] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Giri, Nitai Charan; Maroney, Michael] Univ Massachusetts, Dept Chem, Amherst, MA 01002 USA; [Yamane, Kenichi; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	New York University; University of Massachusetts System; University of Massachusetts Amherst; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Chen, HB (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA.	haobin.chen@nyumc.org; max.costa@nyumc.org	costa, max/H-1754-2012	Maroney, Michael/0000-0002-5598-3038; Giri, Nitai/0000-0002-0476-840X; Zhang, Yi/0000-0002-2789-0811	NIEHS [ES000260, ES014454, ES005512]; NCI [CA16087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005512, R01ES014454, P30ES000260] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES000260, ES014454, and ES005512 from NIEHS and Grant CA16087 from NCI.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Bal W, 2000, CHEM RES TOXICOL, V13, P616, DOI 10.1021/tx000044l; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2005, TOXICOL APPL PHARM, V206, P275, DOI 10.1016/j.taap.2004.11.011; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; COLPAS GJ, 1991, INORG CHEM, V30, P920, DOI 10.1021/ic00005a010; COSTA M, 1981, TOXICOL APPL PHARM, V60, P313, DOI 10.1016/0041-008X(91)90234-6; COSTA M, 1981, CANCER RES, V41, P2868; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; Davidson TL, 2006, MOL CARCINOGEN, V45, P479, DOI 10.1002/mc.20176; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Govindarajan B, 2002, MOL MED, V8, P1; GRANDJEAN P, 1988, AM J IND MED, V13, P193; *INT ASS STUD PAIN, 1990, MONOGRAPH IASP, P1; Ju TT, 2006, J MOL BIOL, V363, P823, DOI 10.1016/j.jmb.2006.08.060; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Karaczyn A, 2006, J CELL BIOCHEM, V97, P1025, DOI 10.1002/jcb.20705; Karaczyn AA, 2005, CHEM RES TOXICOL, V18, P1934, DOI 10.1021/tx050122a; Karaczyn AA, 2006, EXP CELL RES, V312, P3252, DOI 10.1016/j.yexcr.2006.06.025; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Ke QD, 2008, TOXICOL APPL PHARM, V228, P190, DOI 10.1016/j.taap.2007.12.015; Ke QD, 2007, TOXICOL APPL PHARM, V219, P18, DOI 10.1016/j.taap.2006.08.013; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134; Kowara R, 2004, MOL CELL BIOCHEM, V255, P195, DOI 10.1023/B:MCBI.0000007275.22785.91; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Padden KM, 2001, J AM CHEM SOC, V123, P1072, DOI 10.1021/ja003282b; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; RANDALL CR, 1995, INORG CHEM, V34, P1036, DOI 10.1021/ic00109a007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Sutherland JE, 2001, MUTAT RES-FUND MOL M, V479, P225, DOI 10.1016/S0027-5107(01)00163-4; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Topol IA, 2006, J PHYS CHEM A, V110, P4223, DOI 10.1021/jp055633k; Webb SM, 2005, PHYS SCRIPTA, VT115, P1011; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yan Y, 2003, TOXICOL APPL PHARM, V190, P272, DOI 10.1016/S0041-008X(03)00169-8; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009	53	105	108	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7374	7383		10.1074/jbc.M109.058503	http://dx.doi.org/10.1074/jbc.M109.058503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042601	Green Published, hybrid			2022-12-27	WOS:000275415600050
J	Papasergi, S; Garibaldi, M; Tuscano, G; Signorino, G; Ricci, S; Peppoloni, S; Pernice, I; Lo Passo, C; Teti, G; Felici, F; Beninati, C				Papasergi, Salvatore; Garibaldi, Manuela; Tuscano, Giovanna; Signorino, Giacomo; Ricci, Susanna; Peppoloni, Samuele; Pernice, Ida; Lo Passo, Carla; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Plasminogen- and Fibronectin-binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; PYOGENES CHALLENGE; HOST-CELLS; SURFACE; MICE; TRANSMIGRATION; VACCINATION; PNEUMOCOCCI; VIRULENCE; RESPONSES	Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. The ability of this bacterium to adhere to epithelial cells is considered as an essential early step in colonization and infection. By screening a whole genome phage display library with sera from infected patients, we previously identified three antigenic fragments matching open reading frame spr0075 of the strain R6 genome. This locus encodes for an similar to 120-kDa protein, herein referred to as plasminogen- and fibronectin-binding protein B (PfbB), which displays an LPXTG cell wall anchoring motif and six repetitive domains. In this study, by using isogenic pfbB-deleted mutants of the encapsulated D39 and of the unencapsulated DP1004 type 2 pneumococcal strains, we show that PfbB is involved in S. pneumoniae adherence to various epithelial respiratory tract cell lines. Our data suggest that PfbB directly mediates bacterial adhesion, because fluorescent beads coated with the recombinant PfbB sp17 fragment ( encompassing one of the six repetitive domains and the C-terminal region) efficiently bound to epithelial cells. Mutants lacking PfbB bound to fibronectin and plasminogen considerably less efficiently than wild type bacteria, whereas sp17-coated beads specifically bound to both of these substrates. Taken together, our data suggest that, by directly interacting with fibronectin, PfbB significantly increases the ability of S. pneumoniae to adhere to human epithelial cells.	[Papasergi, Salvatore; Garibaldi, Manuela; Tuscano, Giovanna; Signorino, Giacomo; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Elie Metchnikoff Dept, I-98125 Messina, Italy; [Ricci, Susanna] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy; [Peppoloni, Samuele] Univ Modena & Reggio Emilia, Dipartimento Sci Sanita Pubbl, I-41125 Modena, Italy; [Pernice, Ida; Lo Passo, Carla] Univ Messina, Dipartimento Sci Vita M Malpighi, I-98165 Messina, Italy; [Felici, Franco] Univ Molise, Dipartimento Sci Tecnol Ambiente & Terr, I-86090 Pesche, IS, Italy	University of Messina; University of Siena; Universita di Modena e Reggio Emilia; University of Messina; University of Molise	Beninati, C (corresponding author), Policlin Univ, Elie Metchnikoff Dept, Torre Biol IIp, Via Consolare Valeria SNC, I-98125 Messina, Italy.	cbeninati@unime.it	ricci, susanna/R-4184-2018; Peppoloni, Samuele/L-2177-2016; Felici, Franco/H-5693-2012; papasergi, salvatore/AAE-8818-2021	ricci, susanna/0000-0002-2279-6391; Peppoloni, Samuele/0000-0003-4191-6974; Felici, Franco/0000-0003-2205-5195; Lo Passo, Carla/0000-0001-5531-6748; BENINATI, Concetta/0000-0001-8305-1337; Signorino, Giacomo/0000-0002-5366-6020; Pernice, Ida/0000-0001-8328-2776	MIUR PRIN/COFIN	MIUR PRIN/COFIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported in part by grants from the MIUR PRIN/COFIN 2005 Research Program of Italy.	Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Guzman CA, 1999, J INFECT DIS, V179, P901, DOI 10.1086/314655; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Knodler LA, 2001, NAT REV MOL CELL BIO, V2, P578, DOI 10.1038/35085062; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SHOEMAKER NB, 1974, MOL GEN GENET, V128, P283, DOI 10.1007/BF00268516; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	30	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7517	7524		10.1074/jbc.M109.062075	http://dx.doi.org/10.1074/jbc.M109.062075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048164	hybrid, Green Published			2022-12-27	WOS:000275415600063
J	Bullmann, L; Haarmann, R; Mirus, O; Bredemeier, R; Hempel, F; Maier, UG; Schleiff, E				Bullmann, Lars; Haarmann, Raimund; Mirus, Oliver; Bredemeier, Rolf; Hempel, Franziska; Maier, Uwe G.; Schleiff, Enrico			Filling the Gap, Evolutionarily Conserved Omp85 in Plastids of Chromalveolates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE BIOGENESIS; PROTEIN TRANSLOCATION; IMPORT; COMPLEX; COMPONENTS; PREDICTION; APICOPLAST; TOC75; MITOCHONDRIAL; TRANSPORTERS	Chromalveolates are a diverse group of protists that include many ecologically and medically relevant organisms such as diatoms and apicomplexan parasites. They possess plastids generally surrounded by four membranes, which evolved by engulfment of a red alga. Today, most plastid proteins must be imported, but many aspects of protein import into complex plastids are still cryptic. In particular, how proteins cross the third outermost membrane has remained unexplained. We identified a protein in the third outermost membrane of the diatom Phaeodactylum tricornutum with properties comparable to those of the Omp85 family. We demonstrate that the targeting route of P. tricornutum Omp85 parallels that of the translocation channel of the outer envelope membrane of chloroplasts, Toc75. In addition, the electrophysiological properties are similar to those of the Omp85 proteins involved in protein translocation. This supports the hypothesis that P. tricornutum Omp85 is involved in precursor protein translocation, which would close a gap in the fundamental understanding of the evolutionary origin and function of protein import in secondary plastids.	Univ Marburg, D-35032 Marburg, Germany; [Haarmann, Raimund; Mirus, Oliver; Bredemeier, Rolf; Schleiff, Enrico] Goethe Univ Frankfurt, Cluster Excellence Frankfurt, D-60438 Frankfurt, Germany; [Haarmann, Raimund; Mirus, Oliver; Bredemeier, Rolf; Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, Dept Biosci, D-60438 Frankfurt, Germany	Philipps University Marburg; Goethe University Frankfurt; Goethe University Frankfurt		maier@staff.uni-marburg.de; schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489	Deutsche Forschungsgemeinschaft [SFB TR1/A10, SFB807/P17]; Volkswagenstiftung; Graduate School [1216, SFB 593]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen); Graduate School	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TR1/A10 (to O.M. and E.S.) and SFB807/P17 (to R.H. and E.S.)), the Volkswagenstiftung (to R.B. and E.S.), Graduate School 1216 (to L.B. and U.G.M.), and SFB 593 (to F.H. and U.G.M.).	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Baldwin AJ, 2006, FEBS J, V273, P1547, DOI 10.1111/j.1742-4658.2006.05175.x; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bolte K, 2009, J EUKARYOT MICROBIOL, V56, P9, DOI 10.1111/j.1550-7408.2008.00370.x; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; Gould SB, 2006, J MOL EVOL, V62, P674, DOI 10.1007/s00239-005-0099-y; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Hust B, 2006, PLANT BIOLOGY, V8, P18, DOI 10.1055/s-2005-873044; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kilian O, 2004, J MOL EVOL, V58, P712, DOI 10.1007/s00239-004-2593-z; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Loffelhardt W, 2007, SYMBIOSIS, V44, P33; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; Mirus O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-254; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Ruffolo CG, 1996, INFECT IMMUN, V64, P3161, DOI 10.1128/IAI.64.8.3161-3167.1996; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; THOMAS WR, 1986, INFECT IMMUN, V52, P812, DOI 10.1128/IAI.52.3.812-817.1986; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wunder T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-236	59	63	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6848	6856		10.1074/jbc.M109.074807	http://dx.doi.org/10.1074/jbc.M109.074807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042599	hybrid, Green Published			2022-12-27	WOS:000275367500087
J	Collins, JM; Neville, MJ; Hoppa, MB; Frayn, KN				Collins, Jennifer M.; Neville, Matt J.; Hoppa, Michael B.; Frayn, Keith N.			De Novo Lipogenesis and Stearoyl-CoA Desaturase Are Coordinately Regulated in the Human Adipocyte and Protect against Palmitate-induced Cell Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOUNSATURATED FATTY-ACIDS; INSULIN SENSITIVITY; ADIPOSE-TISSUE; GLYCERIDE SYNTHESIS; ECTOPIC FAT; BETA-CELLS; MICE; DIFFERENTIATION; DISRUPTION; INHIBITION	De novo lipogenesis (DNL) is paradoxically up-regulated by its end product, saturated fatty acids (SAFAs). We tested the hypothesis that SAFA-induced up-regulation of DNL reflects coordinate up-regulation of elongation and desaturation pathways for disposal of SAFAs and production of monounsaturated fatty acids to protect cells from SAFA toxicity. Human preadipocytes were differentiated in vitro for 14 days with [U-C-13] palmitate (0-200 mu M) to distinguish exogenous fatty acids from those synthesized by DNL. Exogenous palmitate up-regulated DNL (p < 0.001) concomitantly with SCD and elongation (each p < 0.001). Adipocytes from some donors were intolerant to high palmitate concentrations (400 mu M). Palmitate-intolerant cells showed lower TG accumulation. They had lower expression of SCD mRNA and less monounsaturated fatty acids in TG, emphasizing the importance of desaturation for dealing with exogenous SAFAs. There was greater [U-C-13] palmitate incorporation in phospholipids. SCD knockdown with small interfering RNA caused down-regulation of DNL and of expression of DNL-related genes, with reduced membrane fluidity (p < 0.02) and insulin sensitivity (p < 0.01), compared with scrambled small interfering RNA controls. There was preferential channeling of DNL-derived versus exogenous palmitate into elongation and of DNL-derived versus exogenous stearate into desaturation. DNL may not act primarily to increase fat stores but may serve as a key regulator, in tandem with elongation and desaturation, to maintain cell membrane fluidity and insulin sensitivity within the human adipocyte.	[Collins, Jennifer M.; Neville, Matt J.; Hoppa, Michael B.; Frayn, Keith N.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford	Frayn, KN (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	keith.frayn@oxlip.ox.ac.uk			Humane Research Trust	Humane Research Trust	This work was supported by the Humane Research Trust.	AMRI EZ, 1994, J LIPID RES, V35, P930; AMRI EZ, 1991, J LIPID RES, V32, P1449; Arsov T, 2006, BIOCHEM BIOPH RES CO, V342, P1152, DOI 10.1016/j.bbrc.2006.02.032; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022; Dey D, 2007, MOL CELL BIOCHEM, V300, P149, DOI 10.1007/s11010-006-9378-1; Diraison F, 2003, J LIPID RES, V44, P846, DOI 10.1194/jlr.M200461-JLR200; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Gomez FE, 2002, BIOCHEMISTRY-US, V41, P5473, DOI 10.1021/bi012177r; GRUNFELD C, 1981, BIOCHEM BIOPH RES CO, V103, P219, DOI 10.1016/0006-291X(81)91682-X; Hauner H, 2000, METH MOL B, V155, P239; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Major CA, 2008, J LIPID RES, V49, P1456, DOI 10.1194/jlr.M700596-JLR200; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OLEFSKY JM, 1975, J CLIN INVEST, V56, P1499, DOI 10.1172/JCI108231; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; SAGGERSON ED, 1972, BIOCHEM J, V128, P1069, DOI 10.1042/bj1281069; SAGGERSON ED, 1971, EUR J BIOCHEM, V23, P109, DOI 10.1111/j.1432-1033.1971.tb01597.x; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Tanti JF, 2000, METH MOL B, V155, P157; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Warensjo E, 2008, NUTR METAB CARDIOVAS, V18, P683, DOI 10.1016/j.numecd.2007.11.002; Yee JK, 2008, J LIPID RES, V49, P2124, DOI 10.1194/jlr.M700600-JLR200	45	78	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6044	6052		10.1074/jbc.M109.053280	http://dx.doi.org/10.1074/jbc.M109.053280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032470	hybrid, Green Published			2022-12-27	WOS:000275367500007
J	Fouladkou, F; Lu, C; Jiang, C; Zhou, LM; She, YM; Walls, JR; Kawabe, H; Brose, N; Henkelman, RM; Huang, A; Bruneau, BG; Rotin, D				Fouladkou, Fatemeh; Lu, Chen; Jiang, Chong; Zhou, Limei; She, Yimin; Walls, Jonathon R.; Kawabe, Hiroshi; Brose, Nils; Henkelman, R. M.; Huang, Annie; Bruneau, Benoit G.; Rotin, Daniela			The Ubiquitin Ligase Nedd4-1 Is Required for Heart Development and Is a Suppressor of Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; VIRUS-LIKE PARTICLES; FACTOR MULTIMER SIZE; GROWTH-FACTOR; EBOLA-VIRUS; STABILITY; DOMAINS; PROTEIN; MOTIF; GENE	Nedd4 (Nedd4-1) is a Hect domain E3 ubiquitin ligase that also contains a C2 domain and three WW domains. Despite numerous in vitro studies, its biological function in vivo is not well understood. Here we show that disruption of Nedd4-1 in mice (leaving Nedd4-2 intact) caused embryonic lethality at mid gestation, with pronounced heart defects (double-outlet right ventricle and atrioventricular cushion defects) and vasculature abnormalities. Quantitative mass spectrometry and immunoblot analyses of lysates from the wild type and knock-out mouse embryonic fibroblasts to identify Nedd4-1 in vivo targets revealed dramatically increased amounts of thrombospondin-1 (Tsp-1) in the knock-out mouse embryonic fibroblasts and embryos. Tsp-1 is an inhibitor of angiogenesis, and its elevated level was mediated primarily by enhanced transcription. Interestingly, the administration of aspirin (an inhibitor of Tsp-1) to the pregnant heterozygote mothers led to a reduction in Tsp-1 levels and a substantial rescue of the embryonic lethality. These results suggest that Nedd4-1 is a suppressor of Tsp1 and that increased levels of Tsp-1 in the Nedd4-1 knock-out mice may have contributed to the developmental defect observed in the embryos.	[Rotin, Daniela] Hosp Sick Children, Cell Biol Program, MaRS TMDT, Toronto, ON M5G 1L7, Canada; [Henkelman, R. M.; Huang, Annie; Rotin, Daniela] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1L7, Canada; [Kawabe, Hiroshi; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Bruneau, Benoit G.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pediat, San Francisco, CA 94158 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Max Planck Society; University of California System; University of California San Francisco; The J David Gladstone Institutes	Rotin, D (corresponding author), Hosp Sick Children, Cell Biol Program, MaRS TMDT, Rm 11-305,101 Coll St, Toronto, ON M5G 1L7, Canada.	drotin@sickkids.ca	amsalu, ribka/G-8780-2019; Kawabe, Hiroshi/U-7325-2018; HENKELMAN, MARK/W-6847-2019	Bruneau, Benoit/0000-0002-0804-7597; Kawabe, Hiroshi/0000-0001-5650-8696; She, Yi-Min/0000-0002-0571-4630	Canadian Institute of Health Research [MOP 13494]; National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Deutsche Forschungsgemeinschaft [SFB271/B11]; European Union; Canadian Foundation for Innovation; Ontario Research and Development Challenge Fund; Japan Society for the Promotion of Science for Research Abroad; Canada Research Chair award	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research and Development Challenge Fund(General Electric); Japan Society for the Promotion of Science for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institute of Health Research Grant MOP 13494 (to D.R.), by the National Cancer Institute of Canada/Canadian Cancer Society Research Institute (to D.R.), by Deutsche Forschungsgemeinschaft Grant SFB271/B11 (to N.B.), and by the European Union (EUSynapse) (to N.B.). This work was also supported in part by the Canadian Foundation for Innovation and the Ontario Research and Development Challenge Fund.; <SUP>1</SUP>Supported by a Fellowship from the Japan Society for the Promotion of Science for Research Abroad.; <SUP>2</SUP>Recipient of a Canada Research Chair award.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dussart S, 2005, J MOL BIOL, V345, P547, DOI 10.1016/j.jmb.2004.10.067; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Guo NH, 1997, CANCER RES, V57, P1735; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Obler D, 2008, J MED GENET, V45, P481, DOI 10.1136/jmg.2008.057984; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Pimanda JE, 2004, J BIOL CHEM, V279, P21439, DOI 10.1074/jbc.M313560200; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Serebruany VL, 2004, THROMB RES, V113, P197, DOI 10.1016/j.thromres.2004.03.002; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Urata S, 2007, J VIROL, V81, P4895, DOI 10.1128/JVI.02829-06; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yang QW, 2003, CANCER RES, V63, P6299; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	67	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6770	6780		10.1074/jbc.M109.082347	http://dx.doi.org/10.1074/jbc.M109.082347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026598	hybrid, Green Published			2022-12-27	WOS:000275367500080
J	Pourcet, B; Pineda-Torra, I; Derudas, B; Staels, B; Glineur, C				Pourcet, Benoit; Pineda-Torra, Ines; Derudas, Bruno; Staels, Bart; Glineur, Corine			SUMOylation of Human Peroxisome Proliferator-activated Receptor alpha Inhibits Its Trans-activity through the Recruitment of the Nuclear Corepressor NCoR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-ALPHA; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAYS; RESPONSE ELEMENT; FATTY-ACIDS; CROSS-TALK; GAMMA; GENE; METABOLISM	The nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR alpha) is a key regulator of genes implicated in lipid homeostasis and inflammation. PPAR alpha trans-activity is enhanced by recruitment of coactivators such as SRC1 and CBP/p300 and is inhibited by binding of corepressors such as NCoR and SMRT. In addition to ligand binding, PPAR alpha activity is regulated by post-translational modifications such as phosphorylation and ubiquitination. In this report, we demonstrate that hPPAR alpha is SUMOylated by SUMO-1 on lysine 185 in the hinge region. The E2-conjugating enzyme Ubc9 and the SUMO E3-ligase PIASy are implicated in this process. In addition, ligand treatment decreases the SUMOylation rate of hPPAR alpha. Finally, our results demonstrate that SUMO-1 modification of hPPAR alpha down-regulates its trans-activity through the specific recruitment of corepressor NCoR but not SMRT leading to the differential expression of a subset of PPAR alpha target genes. In conclusion, hPPAR alpha SUMOylation on lysine 185 down-regulates its trans-activity through the selective recruitment of NCoR.	[Glineur, Corine] Inst Pasteur, UR545, INSERM, F-59019 Lille, France; [Pourcet, Benoit; Derudas, Bruno; Staels, Bart; Glineur, Corine] UDSL, F-59000 Lille, France; [Pourcet, Benoit; Derudas, Bruno; Staels, Bart; Glineur, Corine] INSERM, U545, F-59000 Lille, France; [Pourcet, Benoit; Derudas, Bruno; Staels, Bart; Glineur, Corine] Univ Lille Nord France, F-59000 Lille, France; [Pineda-Torra, Ines] UCL, Div Med, London WC1 E6JJ, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of London; University College London	Glineur, C (corresponding author), Inst Pasteur, UR545, INSERM, 01 Rue Prof Calmette,BP 245, F-59019 Lille, France.	Corine.Glineur@pasteur-lille.fr	Pourcet, Benoit/ABF-4625-2020; Staels, Bart/N-9497-2016	Pourcet, Benoit/0000-0002-6758-5467; Staels, Bart/0000-0002-3784-1503; Pineda Torra, Ines/0000-0002-7349-2208	Region Nord-Pas de Calais/FEDER; Fondation Coeur et Arteres; European Vascular Genomics Network	Region Nord-Pas de Calais/FEDER(Region Hauts-de-FranceEuropean Commission); Fondation Coeur et Arteres; European Vascular Genomics Network	This work was supported by grants from the Region Nord-Pas de Calais/FEDER, Fondation Coeur et Arteres, and European Vascular Genomics Network.	Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; Davignon J, 2001, ADV EXP MED BIOL, V498, P49; Degerny C, 2005, J BIOL CHEM, V280, P24330, DOI 10.1074/jbc.M411250200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Liu MH, 2008, MOL ENDOCRINOL, V22, P1078, DOI 10.1210/me.2007-0547; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; VUDAC N, 1994, J BIOL CHEM, V269, P31012; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	34	68	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					5983	5992		10.1074/jbc.M109.078311	http://dx.doi.org/10.1074/jbc.M109.078311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	19955185	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-27	WOS:000275367500001
J	Tan, YF; You, HH; Wu, C; Altomare, DA; Testa, JR				Tan, Yinfei; You, Huihong; Wu, Chao; Altomare, Deborah A.; Testa, Joseph R.			Appl1 Is Dispensable for Mouse Development, and Loss of Appl1 Has Growth Factor-selective Effects on Akt Signaling in Murine Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN RECEPTORS; PROTEIN APPL1; MICE LACKING; KINASE AKT2; CELL-DEATH; BAR-PH; PATHWAY; TRANSDUCTION; ACTIVATION; APOPTOSIS	The adaptor protein APPL1 (adaptor protein containing pleckstrin homology (PH), phosphotyrosine binding (PTB), and leucine zipper motifs) was first identified as a binding protein of AKT2 by yeast two-hybrid screening. APPL1 was subsequently found to bind to several membrane-bound receptors and was implicated in their signal transduction through AKT and/or MAPK pathways. To determine the unambiguous role of Appl1 in vivo, we generated Appl1 knock-out mice. Here we report that Appl1 knock-out mice are viable and fertile. Appl1-null mice were born at expected Mendelian ratios, without obvious phenotypic abnormalities. Moreover, Akt activity in various fetal tissues was unchanged compared with that observed in wildtype littermates. Studies of isolated Appl1(-/-) murine embryonic fibroblasts (MEFs) showed that Akt activation by epidermal growth factor, insulin, or fetal bovine serum was similar to that observed in wild-type MEFs, although Akt activation by HGF was diminished in Appl1(-/-) MEFs. To rule out a possible redundant role played by the related Appl2, we used small interfering RNA to knock down Appl2 expression in Appl1(-/-) MEFs. Unexpectedly, cell survival was unaffected under normal culture conditions, and activation of Akt was unaltered following epidermal growth factor stimulation, although Akt activity did decrease further after HGF stimulation. Furthermore, we found that Appl proteins are required for HGF-induced cell survival and migration via activation of Akt. Our studies suggest that Appl1 is dispensable for development and only participate in Akt signaling under certain conditions.	[Tan, Yinfei; You, Huihong; Altomare, Deborah A.; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Genet & Signaling Program, Philadelphia, PA 19111 USA; [Wu, Chao] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Testa, JR (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Joseph.Testa@fccc.edu			National Institutes of Health [CA77429, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA077429, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77429 (to J.R.T.) and CA06927 (to Fox Chase Cancer Center) from the NCI and an appropriation from the Commonwealth of Pennsylvania.	Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cox DM, 2002, BIOTECHNIQUES, V33, P267, DOI 10.2144/02332bm02; Dooher JE, 2004, J VIROL, V78, P1645, DOI 10.1128/JVI.78.4.1645-1656.2004; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Ko ML, 2009, J NEUROCHEM, V108, P1607, DOI 10.1111/j.1471-4159.2009.05931.x; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McCrea HJ, 2008, BIOCHEM BIOPH RES CO, V369, P493, DOI 10.1016/j.bbrc.2008.02.067; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Staiger H, 2007, DIABETIC MED, V24, P817, DOI 10.1111/j.1464-5491.2007.02166.x; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	31	41	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6377	6389		10.1074/jbc.M109.068452	http://dx.doi.org/10.1074/jbc.M109.068452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040596	Green Published, hybrid			2022-12-27	WOS:000275367500042
J	Chang, AN; Chen, GH; Gerard, RD; Kamm, KE; Stull, JT				Chang, Audrey N.; Chen, Guohua; Gerard, Robert D.; Kamm, Kristine E.; Stull, James T.			Cardiac Myosin Is a Substrate for Zipper-interacting Protein Kinase (ZIPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; PHOSPHATASE-ASSOCIATED KINASE; SKELETAL-MUSCLE CONTRACTION; SMOOTH-MUSCLE; IDENTIFICATION; HEART; HYPERTROPHY; MYOCARDIUM; ACTIVATION; APOPTOSIS	Zipper-interacting protein kinase (ZIPK) is a member of the death-associated protein kinase family associated with apoptosis in nonmuscle cells where it phosphorylates myosin regulatory light chain (RLC) to promote membrane blebbing. ZIPK mRNA and protein are abundant in heart tissue and isolated ventricular neonatal rat cardiac myocytes. An unbiased substrate search performed with purified ZIPK on heart homogenates led to the discovery of a prominent 20-kDa protein substrate identified as RLC of ventricular myosin. Biochemical analyses showed ZIPK phosphorylated cardiac RLC at Ser-15 with a V-max value 2-fold greater than the value for smooth/non-muscle RLC; cardiac RLC is a favorable biochemical substrate. Knockdown of ZIPK in cardiac myocytes by small interfering RNA significantly decreased the extent of RLC Ser-15 phosphorylation. Thus, ZIPK may act as a cardiac RLC kinase and thereby affect contractility.	[Chang, Audrey N.; Chen, Guohua; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [HL080536, HL026043]; Moss Heart Fund; Fouad A. and Val Imm Bashour; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360, R01HL026043, R37HL026043, R01HL080536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 and HL026043 ( to J.T.S.). This work was also supported by grants from the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology.	Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Ihara E, 2007, AM J PHYSIOL-CELL PH, V292, pC1951, DOI 10.1152/ajpcell.00434.2006; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Morley SJ, 2008, DEV CELL, V15, P639, DOI 10.1016/j.devcel.2008.10.007; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; MURAKAMI U, 1976, J BIOCHEM, V80, P611, DOI 10.1093/oxfordjournals.jbchem.a131316; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; STULL JT, 1986, ENZYMES, V17, P113; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Wu XD, 1999, J BIOL CHEM, V274, P20328, DOI 10.1074/jbc.274.29.20328; Yang YH, 1998, J STRUCT BIOL, V122, P139, DOI 10.1006/jsbi.1998.3979; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	36	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5122	5126		10.1074/jbc.C109.076489	http://dx.doi.org/10.1074/jbc.C109.076489			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20038585	hybrid, Green Published			2022-12-27	WOS:000275327200002
J	Hung, CH; Hwang, HJ; Chen, YH; Chiu, YF; Ke, SC; Burnap, RL; Chu, HA				Hung, Chung-Hsien; Hwang, Hong Jin; Chen, Yung-Han; Chiu, Yi-Fang; Ke, Shyue-Chu; Burnap, Robert L.; Chu, Hsiu-An			Spectroscopic and Functional Characterizations of Cyanobacterium Synechocystis PCC 6803 Mutants on and near the Heme Axial Ligand of Cytochrome b(559) in Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING PROPERTIES; SITE-DIRECTED MUTAGENESIS; MOLECULAR-MASS SUBUNITS; DELETION MUTAGENESIS; PLASTOQUINONE-POOL; REDOX PROPERTIES; POTENTIAL FORM; LESS MUTANT; IN-VIVO; PROTEIN	The functional role of cytochrome (cyt) b(559) in photosystem II (PSII) was investigated in H22K alpha and Y18S alpha cyt b(559) mutants of the cyanobacterium Synechocystis sp. PCC6803. H22K alpha and Y18S alpha cyt b(559) mutant carries one amino acid substitution on and near one of heme axial ligands of cyt b(559) in PSII, respectively. Both mutants grew photoautotrophically, assembled stable PSII, and exhibited the normal period-four oscillation in oxygen yield. However, both mutants showed several distinct chlorophyll a fluorescence properties and were more susceptible to photoinhibition than wild type. EPR results indicated the displacement of one of the two axial ligands to the heme of cyt b(559) in H22K alpha mutant reaction centers, at least in isolated reaction centers. The maximum absorption of cyt b(559) in Y18S alpha mutant PSII core complexes was shifted to 561 nm. Y18S alpha and H22K alpha mutant PSII core complexes contained predominately the low potential form of cyt b(559). The findings lend support to the concept that the redox properties of cyt b(559) are strongly influenced by the hydrophobicity and ligation environment of the heme. When the cyt b(559) mutations placed in a D1-D170A genetic background that prevents assembly of the manganese cluster, accumulation of PSII is almost completely abolished. Overall, our data support a functional role of cyt b(559) in protection of PSII under photoinhibition conditions in vivo.	[Hung, Chung-Hsien; Chiu, Yi-Fang; Chu, Hsiu-An] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Chiu, Yi-Fang] Acad Sinica, Mol & Biol Agr Sci Program, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Hung, Chung-Hsien] Natl Taiwan Univ, Coll Life Sci, Inst Plant Biol, Taipei 10617, Taiwan; [Hwang, Hong Jin; Burnap, Robert L.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74075 USA; [Chen, Yung-Han; Ke, Shyue-Chu] Natl Dong Hwa Univ, Dept Phys, Hualien 97401, Taiwan; [Chiu, Yi-Fang] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 402, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Oklahoma State University System; Oklahoma State University - Stillwater; National Dong Hwa University; National Chung Hsing University	Chu, HA (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	chuha@gate.sinica.edu.tw	Chu, Hsiu-An/H-1237-2011	Chu, Hsiu-An/0000-0001-8018-4492	National Science Council [NSC 97-2627-M-001-001, NSC 96-2311-B-001-040-MY3]; Academia Sinica; National Science Foundation [MCB-0818371]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Council Grants NSC 97-2627-M-001-001 and NSC 96-2311-B-001-040-MY3 and by Academia Sinica (to H.-A. C.). Work in the Burnap laboratory was supported by the National Science Foundation Grant MCB-0818371.	AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; BABCOCK GT, 1985, BIOCHEMISTRY-US, V24, P3638, DOI 10.1021/bi00335a036; BARBER J, 1993, P NATL ACAD SCI USA, V90, P10942, DOI 10.1073/pnas.90.23.10942; Bondarava N, 2003, J BIOL CHEM, V278, P13554, DOI 10.1074/jbc.M212842200; BRUCE D, 1989, BIOCHIM BIOPHYS ACTA, V974, P66, DOI 10.1016/S0005-2728(89)80166-5; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; BUSER CA, 1992, BIOCHEMISTRY-US, V31, P11449, DOI 10.1021/bi00161a025; Chiu YF, 2009, BBA-BIOENERGETICS, V1787, P1179, DOI 10.1016/j.bbabio.2009.05.007; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6150, DOI 10.1021/bi00186a014; DZELZKALNS VA, 1989, PLANT PHYSIOL, V90, P617, DOI 10.1104/pp.90.2.617; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HAAG E, 1993, BIOCHEMISTRY-US, V32, P4444, DOI 10.1021/bi00067a037; Hung CH, 2007, BBA-BIOENERGETICS, V1767, P686, DOI 10.1016/j.bbabio.2007.02.016; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Kaminskaya O, 2005, BBA-BIOENERGETICS, V1708, P333, DOI 10.1016/j.bbabio.2005.05.002; Kaminskaya O, 2007, BBA-BIOENERGETICS, V1767, P550, DOI 10.1016/j.bbabio.2007.02.005; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Kondo K, 2009, PHOTOSYNTH RES, V99, P217, DOI 10.1007/s11120-008-9399-6; Kropacheva TN, 2003, CHEM PHYS, V294, P471, DOI 10.1016/S0301-0104(03)00327-6; Kruk J, 2001, J BIOL CHEM, V276, P86, DOI 10.1074/jbc.M003602200; Kruk J, 1999, PHOTOSYNTH RES, V62, P273, DOI 10.1023/A:1006374319191; LAEMMLI UK, 1970, NATURE, V227, P685; LAVOREL J, 1976, J THEOR BIOL, V57, P171, DOI 10.1016/S0022-5193(76)80011-2; Li J, 2002, BBA-BIOENERGETICS, V1556, P175, DOI 10.1016/S0005-2728(02)00360-2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MEUNIER PC, 1995, PHOTOSYNTH RES, V47, P61; Morais F, 2001, J BIOL CHEM, V276, P31986, DOI 10.1074/jbc.M103935200; Morais F, 1998, J BIOL CHEM, V273, P29315, DOI 10.1074/jbc.273.45.29315; Napoli E, 2007, BBA-MOL BASIS DIS, V1772, P773, DOI 10.1016/j.bbadis.2007.04.001; Ohad I, 2004, BIOCHEMISTRY-US, V43, P2297, DOI 10.1021/bi0348260; PAKRASI HB, 1991, EMBO J, V10, P1619, DOI 10.1002/j.1460-2075.1991.tb07684.x; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; PAKRASI HB, 1990, Z NATURFORSCH C, V45, P423; Qian M, 1999, BIOCHEMISTRY-US, V38, P6070, DOI 10.1021/bi982331i; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; Roncel M, 2001, EUR J BIOCHEM, V268, P4961, DOI 10.1046/j.0014-2956.2001.02427.x; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; Swiatek M, 2003, MOL GENET GENOMICS, V268, P699, DOI 10.1007/s00438-002-0791-1; THOMPSON LK, 1988, BIOCHEMISTRY-US, V27, P6653, DOI 10.1021/bi00418a002; THOMPSON LK, 1989, BIOCHEMISTRY-US, V28, P8048, DOI 10.1021/bi00446a012; WADA K, 1971, P NATL ACAD SCI USA, V68, P3064, DOI 10.1073/pnas.68.12.3064	48	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5653	5663		10.1074/jbc.M109.044719	http://dx.doi.org/10.1074/jbc.M109.044719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20007972	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000275327200058
J	Hurskainen, M; Ruggiero, F; Hagg, P; Pihlajaniemi, T; Huhtala, P				Hurskainen, Merja; Ruggiero, Florence; Hagg, Pasi; Pihlajaniemi, Taina; Huhtala, Pirkko			Recombinant Human Collagen XV Regulates Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE ZONES; EXON-INTRON ORGANIZATION; HUMAN TISSUES; XVIII COLLAGEN; ALPHA-1 CHAIN; PROLYL 4-HYDROXYLASE; SULFATE PROTEOGLYCAN; CORRESPONDING GENE; ENDOSTATIN; DOMAIN	The C-terminal end of collagen XV, restin, has been the focus of several studies, but the functions of full-length collagen XV have remained unknown. We describe here studies on the production, purification, and function of collagen XV and the production of a monoclonal N-terminal antibody to it. Full-length human collagen XV was produced in insect cells using baculo-viruses and purified from the cell culture medium. The yield was 15 mg/liter of cell culture medium. The collagen XV was shown to be trimeric, with disulfide bonds in the collagenous region. Rotary shadowing electron microscopy revealed rod-like molecules with a mean length of 241.8 nm and with a globular domain at one end. The globular domain was verified to be the N-terminal end by N-terminal antibody binding. The molecules show flexibility in their conformation, presumably due to the many interruptions in their collagenous domains. The ability of collagen XV to serve as a substrate for cells was tested in cell adhesion assays, and it was shown that cells did not bind to collagen XV coated surfaces. When added to the culture medium of fibroblasts and fibrosarcoma cells, however, collagen XV rapidly bound to their fibronectin network. Solid phase assays showed that collagen XV binds to fibronectin, laminin, and vitronectin and that it binds to the collagen/gelatin-binding domain of fibronectin. No binding was detected to fibrillar collagens, fibril-associated collagens, or decorin. Interestingly, collagen XV was found to inhibit the adhesion and migration of fibrosarcoma cells when present in fibronectin-containing matrices.	[Hurskainen, Merja; Hagg, Pasi; Pihlajaniemi, Taina; Huhtala, Pirkko] Univ Oulu, Inst Biomed, Oulu Ctr Cell Matrix Res, Bioctr Oulu,Dept Med Biochem & Mol Biol, Oulu 90014, Finland; [Ruggiero, Florence] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69361 Lyon 07, France	University of Oulu; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Huhtala, P (corresponding author), Univ Oulu, Inst Biomed, Oulu Ctr Cell Matrix Res, Bioctr Oulu,Dept Med Biochem & Mol Biol, Aapistie 7, Oulu 90014, Finland.	pirkko.huhtala@oulu.fi		RUGGIERO, Florence/0000-0003-2915-5359; Pihlajaniemi, Taina/0000-0002-1664-9045; Hurskainen, Merja/0000-0001-8270-8974	European Commission [504 743]; Research Council for Health of the Academy of Finland [115237, 114784]; Sigrid Juselius Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council for Health of the Academy of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by European Commission Grant 504 743, Research Council for Health of the Academy of Finland Grants 115237 and 114784, and a grant from the Sigrid Juselius Foundation.	Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Amenta PS, 2000, HUM PATHOL, V31, P359, DOI 10.1016/S0046-8177(00)80251-8; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Amenta PS, 2003, J PATHOL, V199, P298, DOI 10.1002/path.1303; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Eklund L, 2001, P NATL ACAD SCI USA, V98, P1194, DOI 10.1073/pnas.031444798; Eriksson K, 2003, FEBS LETT, V536, P19, DOI 10.1016/S0014-5793(03)00003-6; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; Fukushige T, 2005, J DERMATOL, V32, P74; Hagg PM, 1997, AM J PATHOL, V150, P2075; Hagg PM, 1998, J BIOL CHEM, V273, P17824, DOI 10.1074/jbc.273.28.17824; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; Harris A, 2007, MOL CANCER RES, V5, P1241, DOI 10.1158/1541-7786.MCR-07-0200; Hurskainen M, 2005, FASEB J, V19, P1564, DOI 10.1096/fj.04-3101fje; *INV CORP, 2008, BAC TO BAC BAC EXPR; Jin XM, 2001, CANCER GENE THER, V8, P982, DOI 10.1038/sj.cgt.7700396; John H, 2005, BBA-PROTEINS PROTEOM, V1747, P161, DOI 10.1016/j.bbapap.2004.10.013; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; KIVIRIKKO S, 1994, J BIOL CHEM, V269, P4773; KIVIRIKKO S, 1995, AM J PATHOL, V147, P1500; Li DQ, 2000, J BIOL CHEM, V275, P22339, DOI 10.1074/jbc.M000519200; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; MURAGAKI Y, 1994, J BIOL CHEM, V269, P4042; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Musso O, 1998, HEPATOLOGY, V28, P98, DOI 10.1002/hep.510280115; Myers JC, 1996, CELL TISSUE RES, V286, P493, DOI 10.1007/s004410050719; Myers JC, 2007, BIOCHEM J, V404, P535, DOI 10.1042/BJ20070201; Nyberg P, 2003, J BIOL CHEM, V278, P22404, DOI 10.1074/jbc.M210325200; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Olsson AK, 2004, CANCER RES, V64, P9012, DOI 10.1158/0008-5472.CAN-04-2172; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; REHN M, 1994, J BIOL CHEM, V269, P13929; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; SARRET Y, 1992, J INVEST DERMATOL, V99, P656, DOI 10.1111/1523-1747.ep12668151; Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996; Snellman A, 2000, J BIOL CHEM, V275, P8936, DOI 10.1074/jbc.275.12.8936; Tomono Y, 2002, CELL STRUCT FUNCT, V27, P9, DOI 10.1247/csf.27.9; Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Wilson RF, 2003, ANTICANCER RES, V23, P1289; XU R, 2002, XUE YU SHENG WU WU L, V34, P138; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414	43	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5258	5265		10.1074/jbc.M109.033787	http://dx.doi.org/10.1074/jbc.M109.033787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20040604	Green Published, hybrid			2022-12-27	WOS:000275327200019
J	Schnaufer, A; Wu, MT; Park, YJ; Nakai, T; Deng, JP; Proff, R; Hol, WGJ; Stuart, KD				Schnaufer, Achim; Wu, Meiting; Park, Young-Jun; Nakai, Tadashi; Deng, Junpeng; Proff, Rose; Hol, Wim G. J.; Stuart, Kenneth D.			A Protein-Protein Interaction Map of Trypanosome similar to 20S Editosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EDITING COMPLEX; STRANDED-DNA-BINDING; ZINC-FINGER MOTIFS; OB-FOLD; STRUCTURAL INTEGRITY; MESSENGER-RNAS; BRUCEI; MITOCHONDRIA; SURVIVAL; GENOME	Mitochondrial mRNA editing in trypanosomatid parasites involves several multiprotein assemblies, including three very similar complexes that contain the key enzymatic editing activities and sediment at similar to 20S on glycerol gradients. These similar to 20S editosomes have a common set of 12 proteins, including enzymes for uridylyl (U) removal and addition, 2 RNA ligases, 2 proteins with RNase III-like domains, and 6 proteins with predicted oligonucleotide binding (OB) folds. In addition, each of the 3 distinct similar to 20S editosomes contains a different RNase III-type endonuclease, 1 of 3 related proteins and, in one case, an additional exonuclease. Here we present a protein-protein interaction map that was obtained through a combination of yeast two-hybrid analysis and subcomplex reconstitution with recombinant protein. This map inter-links ten of the proteins and in several cases localizes the protein region mediating the interaction, which often includes the predicted OB-fold domain. The results indicate that the OB-fold proteins form an extensive protein-protein interaction network that connects the two trimeric subcomplexes that catalyze U removal or addition and RNA ligation. One of these proteins, KREPA6, interacts with the OB-fold zinc finger protein in each subcomplex that interconnects their two catalytic proteins. Another OB-fold protein, KREPA3, appears to link to the putative endonuclease subcomplex. These results reveal a physical organization that underlies the coordination of the various catalytic and substrate binding activities within the similar to 20S editosomes during the editing process.	[Hol, Wim G. J.] Univ Washington, Dept Biochem, Biomol Struct Ctr, Seattle, WA 98195 USA; [Stuart, Kenneth D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Schnaufer, Achim; Wu, Meiting; Proff, Rose; Stuart, Kenneth D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research	Hol, WGJ (corresponding author), Univ Washington, Dept Biochem, Biomol Struct Ctr, 1959 Pacific Ave NE,Box 357742, Seattle, WA 98195 USA.	wghol@u.washington.edu; ken.stuart@sbri.org	Nakai, Tadashi/F-8047-2010; Park, Young-Jun/AAF-6249-2021	Nakai, Tadashi/0000-0001-9770-8168; Park, Young-Jun/0000-0003-2901-6949; Schnaufer, Achim/0000-0003-2132-5560	National Institutes of Health [GM042188, GM077418]; Economic Development Administration; United States Department of Commerce; Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042188, R01GM077418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic Development Administration; United States Department of Commerce; Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM042188 (to K.S.) and GM077418 (to W.H.). Research was conducted using equipment made possible by support from the Economic Development Administration, United States Department of Commerce, and the M. J. Murdock Charitable Trust.	ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, P NATL ACAD SCI USA, V100, P10617, DOI 10.1073/pnas.1833120100; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Babbarwal VK, 2007, RNA, V13, P737, DOI 10.1261/rna.327707; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Deng JP, 2005, EMBO J, V24, P4007, DOI 10.1038/sj.emboj.7600861; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Gao GH, 2005, P NATL ACAD SCI USA, V102, P4712, DOI 10.1073/pnas.0500553102; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; James P, 1996, GENETICS, V144, P1425; Kang XD, 2004, J BIOL CHEM, V279, P3893, DOI 10.1074/jbc.M310185200; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; Law JA, 2007, MOL CELL BIOL, V27, P777, DOI 10.1128/MCB.01460-06; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Zikova A, 2008, INT J PARASITOL, V38, P901, DOI 10.1016/j.ijpara.2007.12.009	57	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5282	5295		10.1074/jbc.M109.059378	http://dx.doi.org/10.1074/jbc.M109.059378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20018860	Green Published, hybrid			2022-12-27	WOS:000275327200022
J	Seifert, EL; Estey, C; Xuan, JY; Harper, ME				Seifert, Erin L.; Estey, Carmen; Xuan, Jian Y.; Harper, Mary-Ellen			Electron Transport Chain-dependent and -independent Mechanisms of Mitochondrial H2O2 Emission during Long-chain Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; NICOTINAMIDE-NUCLEOTIDE TRANSHYDROGENASE; ALPHA-KETOGLUTARATE DEHYDROGENASE; INSULIN-RESISTANCE; RAT-HEART; COMPLEX-III; SUPEROXIDE-PRODUCTION; MUSCLE MITOCHONDRIA; LIVER-MITOCHONDRIA; ENERGY-METABOLISM	Oxidative stress in skeletal muscle is a hallmark of various pathophysiologic states that also feature increased reliance on long-chain fatty acid (LCFA) substrate, such as insulin resistance and exercise. However, little is known about the mechanistic basis of the LCFA-induced reactive oxygen species (ROS) burden in intact mitochondria, and elucidation of this mechanistic basis was the goal of this study. Specific aims were to determine the extent to which LCFA catabolism is associated with ROS production and to gain mechanistic insights into the associated ROS production. Because intermediates and by-products of LCFA catabolism may interfere with antioxidant mechanisms, we predicted that ROS formation during LCFA catabolism reflects a complex process involving multiple sites of ROS production as well as modified mitochondrial function. Thus, we utilized several complementary approaches to probe the underlying mechanism(s). Using skeletal muscle mitochondria, our findings indicate that even a low supply of LCFA is associated with ROS formation in excess of that generated by NADH-linked substrates. Moreover, ROS production was evident across the physiologic range of membrane potential and was relatively insensitive to membrane potential changes. Determinations of topology and membrane potential as well as use of inhibitors revealed complex III and the electron transfer flavoprotein (ETF) and ETF-oxidoreductase, as likely sites of ROS production. Finally, ROS production was sensitive to matrix levels of LCFA catabolic intermediates, indicating that mitochondrial export of LCFA catabolic intermediates can play a role in determining ROS levels.	[Seifert, Erin L.; Estey, Carmen; Xuan, Jian Y.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	Maryellen.Harper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009	Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by the Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes) (to M.- E. H.) and by a fellowship from the Canadian Diabetes Association (to E. L. S.). Part of this work was presented at the Obesity Society Meeting, 2007.	Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4; Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; BROWN GC, 2002, BIOENERGETICS PRACTI, P49; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chinopoulos C, 2000, NEUROCHEM INT, V36, P483, DOI 10.1016/S0197-0186(99)00161-8; Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; JOCELYN PC, 1985, BIOCHEM PHARMACOL, V34, P1588, DOI 10.1016/0006-2952(85)90706-3; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; LYSIAK W, 1988, J BIOL CHEM, V263, P1151; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Pedersen A, 2008, J BIOENERG BIOMEMBR, V40, P463, DOI 10.1007/s10863-008-9170-x; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Ramsay RR, 1999, AM J MED SCI, V318, P28, DOI 10.1097/00000441-199907000-00005; RAMSAY RR, 1987, BIOCHEM J, V241, P883, DOI 10.1042/bj2410883; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RYDSTROM J, 1972, EUR J BIOCHEM, V31, P496, DOI 10.1111/j.1432-1033.1972.tb02557.x; Sauer SW, 2008, BBA-BIOENERGETICS, V1777, P1276, DOI 10.1016/j.bbabio.2008.05.447; Savitha S, 2007, MECH AGEING DEV, V128, P206, DOI 10.1016/j.mad.2006.11.029; Savitha S, 2007, EUR J PHARMACOL, V574, P61, DOI 10.1016/j.ejphar.2007.07.016; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Schonfeld P, 2009, FREE RADICAL BIO MED, V47, P503, DOI 10.1016/j.freeradbiomed.2009.05.006; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Sipos I, 2003, NEUROCHEM RES, V28, P1575, DOI 10.1023/A:1025634728227; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STANLEY KK, 1975, BIOCHEM J, V150, P77, DOI 10.1042/bj1500077; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tretter L, 2007, NEUROCHEM RES, V32, P569, DOI 10.1007/s11064-006-9130-y; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043; Wieckowski MR, 2000, FEBS LETT, V484, P61, DOI 10.1016/S0014-5793(00)02127-X; WOLDEGIORGIS G, 1982, J BIOL CHEM, V257, P4783; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	73	184	188	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5748	5758		10.1074/jbc.M109.026203	http://dx.doi.org/10.1074/jbc.M109.026203			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20032466	Green Published, hybrid			2022-12-27	WOS:000275327200067
J	Gu, FF; Jones, MK; Chen, JG; Patterson, JC; Catte, A; Jerome, WG; Li, L; Segrest, JP				Gu, Feifei; Jones, Martin K.; Chen, Jianguo; Patterson, James C.; Catte, Andrea; Jerome, W. Gray; Li, Ling; Segrest, Jere P.			Structures of Discoidal High Density Lipoproteins A COMBINED COMPUTATIONAL-EXPERIMENTAL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRAINED MOLECULAR-DYNAMICS; HDL PARTICLES; APOA-I; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; APOLIPOPROTEIN AI; LIPID-BINDING; BELT MODEL; CONFORMATION; DOMAIN	Conversion of discoidal phospholipid (PL)-rich high density lipoprotein (HDL) to spheroidal cholesteryl ester-rich HDL is a central step in reverse cholesterol transport. A detailed understanding of this process and the atheroprotective role of apolipoprotein A-I (apoA-I) requires knowledge of the structure and dynamics of these various particles. This study, combining computation with experimentation, illuminates structural features of apoA-I allowing it to incorporate varying amounts of PL. Molecular dynamics simulated annealing of PL-rich HDL models containing unesterified cholesterol results in double belt structures with the same general saddle-shaped conformation of both our previous molecular dynamics simulations at 310 K and the x-ray structure of lipid-free apoA-I. Conversion from a discoidal to a saddle-shaped particle involves loss of helicity and formation of loops in opposing antiparallel parts of the double belt. During surface expansion caused by the temperature-jump step, the curved palmitoyloleoylphosphatidylcholine bilayer surfaces approach planarity. Relaxation back into saddle-shaped structures after cool down and equilibration further supports the saddle-shaped particle model. Our kinetic analyses of reconstituted particles demonstrate that PL-rich particles exist in discrete sizes corresponding to local energetic minima. Agreement of experimental and computational determinations of particle size/shape and apoA-I helicity provide additional support for the saddle-shaped particle model. Truncation experiments combined with simulations suggest that the N-terminal proline-rich domain of apoA-I influences the stability of PL-rich HDL particles. We propose that apoA-I incorporates increasing PL in the form of minimal surface bilayers through the incremental unwinding of an initially twisted saddle-shaped apoA-I double belt structure.	[Gu, Feifei; Jones, Martin K.; Chen, Jianguo; Patterson, James C.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gu, Feifei; Jones, Martin K.; Chen, Jianguo; Patterson, James C.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Jones, Martin K.; Patterson, James C.; Catte, Andrea; Segrest, Jere P.] Univ Alabama Birmingham, Ctr Computat & Struct Dynam, Birmingham, AL 35294 USA; [Patterson, James C.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Jerome, W. Gray] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Li, L (corresponding author), 1808 7th Ave S,BDB 630, Birmingham, AL 35294 USA.	lili@uab.edu; segrest@uab.edu		Catte, Andrea/0000-0002-1124-1788; Li, Ling/0000-0002-9245-7387	National Institutes of Health [DK20539, CA68485, DK58404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Vinod Mishra and Michael J. Jablonsky for their assistance in proton NMR and CD spectroscopy. We also thank the University of Alabama at Birmingham Information Technology and the Department of Mechanical Engineering for use of the IBM Blue Gene/L rack that they jointly maintain. EM analysis was performed in part through the use of the Vanderbilt University Medical Center Research EM Resource (supported by National Institutes of Health Grants DK20539, CA68485, and DK58404).	Anantharamaiah GM, 1996, METHOD ENZYMOL, V263, P267; BassolinoKlimas D, 1996, PROTEIN SCI, V5, P593; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; BROUILLETTE CG, 1982, J BIOL CHEM, V257, P12; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Feller S E, 1997, Pac Symp Biocomput, P142; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KERR ID, 1994, BIOPHYS J, V67, P1501, DOI 10.1016/S0006-3495(94)80624-1; Klon AE, 2002, J MOL BIOL, V324, P703, DOI 10.1016/S0022-2836(02)01143-9; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Li H, 1997, PROTEIN SCI, V6, P956, DOI 10.1002/pro.5560060502; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; Miyazaki M, 2009, BIOCHEMISTRY-US, V48, P7756, DOI 10.1021/bi900785x; Panagotopulos SE, 2001, J BIOL CHEM, V276, P42965, DOI 10.1074/jbc.M106462200; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; SANKARARAMAKRISHNAN R, 1995, BIOPHYS CHEM, V55, P215, DOI 10.1016/0301-4622(95)00006-J; Schlenkrich Michael, 1996, P31; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1994, CURR OPIN CARDIOL, V9, P404; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; SorciThomas MG, 1997, J BIOL CHEM, V272, P7278, DOI 10.1074/jbc.272.11.7278; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P4240, DOI 10.1021/bi060023b; TANFORD C, 1980, HYDROPHOBIC EFFECT, P112; vanAntwerpen R, 1997, J LIPID RES, V38, P659; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	52	66	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4652	4665		10.1074/jbc.M109.069914	http://dx.doi.org/10.1074/jbc.M109.069914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19948731	Green Published, hybrid			2022-12-27	WOS:000275274800044
J	Walker, MR; Brown, SL; Riehl, TE; Stenson, WF; Stappenbeck, TS				Walker, Monica R.; Brown, Sarah L.; Riehl, Terrence E.; Stenson, William F.; Stappenbeck, Thaddeus S.			Growth Factor Regulation of Prostaglandin-Endoperoxide Synthase 2 (Ptgs2) Expression in Colonic Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; CYCLOOXYGENASE-2 EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; STROMAL CELLS; GASTROINTESTINAL-TRACT; MICROBIAL ECOLOGY; RADIATION-INJURY; COX-2 EXPRESSION; EPITHELIAL-CELLS	We previously found that a population of colonic stromal cells that constitutively express high levels of prostaglandin-endoperoxide synthase 2 (Ptgs2, also known as Cox-2) altered their location in the lamina propria in response to injury in a Myd88-dependent manner (Brown, S. L., Riehl, T. E., Walker, M. R., Geske, M. J., Doherty, J. M., Stenson, W. F., and Stappenbeck, T. S. (2007) J. Clin. Invest. 117, 258-269). At the time of this study, the identity of these cells and the mechanism by which they expressed high levels of Ptgs2 were unknown. Here we found that these colonic stromal cells were mesenchymal stem cells (MSCs). These colonic MSCs expressed high Ptgs2 levels not through interaction with bacterial products but instead as a consequence of mRNA stabilization downstream of Fgf9 (fibroblast growth factor 9), a growth factor that is constitutively expressed by the intestinal epithelium. This stabilization was mediated partially through a mechanism involving endogenous CUG-binding protein 2 (CUGbp2). These studies suggest that Fgf9 is an important factor in the regulation of Ptgs2 in colonic MSCs and may be a factor involved in its constitutive expression in vivo.	[Walker, Monica R.; Brown, Sarah L.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Ctr Canc & Stem Cell Biol, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Riehl, Terrence E.; Stenson, William F.] Washington Univ, Sch Med, Ctr Canc & Stem Cell Biol, Div Gastroenterol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stappenbeck, TS (corresponding author), 660 S Euclid,Box 8118, St Louis, MO 63110 USA.	stappenb@wustl.edu			National Institutes of Health [DK071619, DK07161-90251, DK33165, DK55753, P30-DK52574]; Crohn's Colitis Foundation of America; Pew Scholars Foundation; Cancer Research Institute Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007161, P30DK052574, R01DK071619, R01DK055753, R37DK033165, R01DK033165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's Colitis Foundation of America; Pew Scholars Foundation; Cancer Research Institute Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071619 (to T. S.), DK07161-90251 (to T. S. S.), DK33165 (to W. S.), DK55753 (to W. S.), and P30-DK52574 (to the Washington University Digestive Disease Research Core). This work was also supported by the Crohn's Colitis Foundation of America (to T. S.), the Pew Scholars Foundation (to T. S.), and a Cancer Research Institute Training Grant (Predoctoral Emphasis Pathway in Tumor Immunology) (to M. W.).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ALLGAYER H, 1989, GASTROENTEROLOGY, V96, P1290, DOI 10.1016/S0016-5085(89)80016-2; Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; BONNEY RJ, 1978, BIOCHEM J, V176, P433, DOI 10.1042/bj1760433; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Cao ZX, 2007, CELL SIGNAL, V19, P1542, DOI 10.1016/j.cellsig.2007.01.028; CHANG WWL, 1971, AM J ANAT, V131, P73, DOI 10.1002/aja.1001310105; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Doherty JM, 2008, STEM CELLS, V26, P2124, DOI 10.1634/stemcells.2008-0380; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Estivariz CF, 2000, DIGEST DIS SCI, V45, P736, DOI 10.1023/A:1005447827579; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ishikawa TO, 2006, MOL IMAGING BIOL, V8, P171, DOI 10.1007/s11307-006-0034-7; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kage K, 1999, BIOCHEM BIOPH RES CO, V254, P259, DOI 10.1006/bbrc.1998.9875; Kiba T, 2006, DIGESTION, V74, P215, DOI 10.1159/000100512; Kim Chang H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P343, DOI 10.2174/1568008043339712; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; LOFTIN CD, 2002, PROTAGLANDINS OTHER, P177; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Pham H, 2008, J CELL PHYSIOL, V214, P96, DOI 10.1002/jcp.21167; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Sala FG, 2006, DEV BIOL, V299, P373, DOI 10.1016/j.ydbio.2006.08.001; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schadt EE, 2000, J CELL BIOCHEM, V80, P192; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; STANLEY ER, 1976, J EXP MED, V143, P631, DOI 10.1084/jem.143.3.631; Stoeltzing O, 2007, CANCER LETT, V258, P291, DOI 10.1016/j.canlet.2007.09.009; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Walker MR, 2008, CURR OPIN GASTROEN, V24, P115, DOI 10.1097/MOG.0b013e3282f4954f; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wang J, 2007, BRIT J RADIOL, V80, pS41, DOI 10.1259/bjr/33057885; Weaver M, 2000, DEVELOPMENT, V127, P2695; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xu K, 2009, ONCOGENE, V28, P1410, DOI 10.1038/onc.2008.500; Xu K, 2007, J BIOL CHEM, V282, P32699, DOI 10.1074/jbc.M705272200; Yaksh TL, 2001, J NEUROSCI, V21, P5847, DOI 10.1523/JNEUROSCI.21-16-05847.2001; Zhang XQ, 2006, DEVELOPMENT, V133, P173, DOI 10.1242/dev.02175; Zimmermann KC, 1998, MOL PHARMACOL, V54, P536, DOI 10.1124/mol.54.3.536	72	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					5026	5039		10.1074/jbc.M109.032672	http://dx.doi.org/10.1074/jbc.M109.032672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20018844	Green Published, hybrid			2022-12-27	WOS:000275274800079
J	Sun, SC; Hsu, PJ; Wu, FJ; Li, SH; Lu, CH; Luo, CW				Sun, Su-Chin; Hsu, Pei-Jen; Wu, Fang-Ju; Li, Sheng-Hsiang; Lu, Chung-Hao; Luo, Ching-Wei			Thyrostimulin, but Not Thyroid-stimulating Hormone (TSH), Acts as a Paracrine Regulator to Activate the TSH Receptor in Mammalian Ovary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN RECEPTOR; BETA SUBUNIT; EXPRESSION; DIFFERENTIATION; MUTATIONS; PROTEIN; CLONING; BROWN; GENE	The thyroid-stimulating hormone receptor (TSHR), activated by either TSH or the newly discovered glycoprotein hormone thyrostimulin, plays a central role in the control of body metabolism. Interestingly, in addition to its thyroid expression, we discovered that the mRNA level of TSHR is periodically regulated in rat ovary by gonadotropins. Ovarian microdissection followed by real-time PCR analysis indicated that granulosa cells show the highest level of TSHR expression. Cultures of follicles and primary granulosa cells demonstrated that the level of TSHR is up-regulated and decreased by the gonadotropin-driven cAMP cascade and estradiol production, respectively. Furthermore, in contrast to the negligible expression of TSH in the ovary, we also found by real-time PCR and immunohistochemical analysis that thyrostimulin is expressed mainly in oocytes. Evolving before the appearance of gonadotropins, thyrostimulin is considered the most ancestral glycoprotein hormone. Therefore, the presence of thyrostimulin in the ovary suggests that it may have a primitive function in reproduction when it activates ovarian TSHR. Next, we generated recombinant thyrostimulin protein and characterized its non-covalent heterodimeric nature. Using purified recombinant thyrostimulin, we show that the human ovarian cell line NIH:OVCAR-3 also expresses endogenous and functional TSHR. Using cultured rat granulosa cells isolated from different ovarian stages, we found that treatments with thyrostimulin significantly increase cAMP production and the c-fos gene response in the presence of gonadotropins. Thus, this study demonstrates that oocyte-derived thyrostimulin and granulosa cell-expressed TSHR compose a novel paracrine system in the ovary, where the activity is tightly controlled by gonadotropins.	[Sun, Su-Chin; Hsu, Pei-Jen; Wu, Fang-Ju; Luo, Ching-Wei] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Sun, Su-Chin; Hsu, Pei-Jen; Wu, Fang-Ju; Luo, Ching-Wei] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Li, Sheng-Hsiang; Lu, Chung-Hao] Mackay Mem Hosp, Dept Med Res, Tamsui 251, Taipei Country, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital	Luo, CW (corresponding author), Natl Yang Ming Univ, Dept Life Sci, 155 Li Nong St,Sect 2, Taipei 112, Taiwan.	cwluo@ym.edu.tw			Yen Tjing Ling Medical Foundation [CI-97-1]; National Science Council [NSC97-2311-B-010-001-MY3]; Ministry of Education Aim for the Top University Plan in Taiwan	Yen Tjing Ling Medical Foundation; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education Aim for the Top University Plan in Taiwan	This work was supported by Yen Tjing Ling Medical Foundation Grant CI-97-1, National Science Council Grant NSC97-2311-B-010-001-MY3, and the Ministry of Education Aim for the Top University Plan in Taiwan.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Aghajanova L, 2009, REPROD BIOMED ONLINE, V18, P337, DOI 10.1016/S1472-6483(10)60091-0; Balzan S, 2009, CELL BIOCHEM FUNCT, V27, P259, DOI 10.1002/cbf.1567; Brokken LJS, 2005, EXP CLIN ENDOCR DIAB, V113, P13, DOI 10.1055/s-2004-830516; Crisanti P, 2001, ENDOCRINOLOGY, V142, P812, DOI 10.1210/en.142.2.812; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; Dutton CM, 1997, THYROID, V7, P879, DOI 10.1089/thy.1997.7.879; Endo T, 2008, AM J PHYSIOL-ENDOC M, V295, pE514, DOI 10.1152/ajpendo.90433.2008; Francis T, 1991, Thyroid, V1, P223, DOI 10.1089/thy.1991.1.223; Goto-Kazeto R, 2009, GEN COMP ENDOCR, V161, P313, DOI 10.1016/j.ygcen.2009.01.009; HAMILTON TC, 1983, CANCER RES, V43, P5379; Heinrichs C, 2000, THYROID, V10, P387, DOI 10.1089/thy.2000.10.387; HSUEH AJW, 1992, TRENDS ENDOCRIN MET, V3, P164, DOI 10.1016/1043-2760(92)90166-X; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kumar RS, 2000, MOL CELL ENDOCRINOL, V167, P1, DOI 10.1016/S0303-7207(00)00304-X; Li Chang, 2004, Endocr Regul, V38, P131; Ludgate M, 1999, ONCOGENE, V18, P4798, DOI 10.1038/sj.onc.1202864; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; Macdonald LE, 2005, P NATL ACAD SCI USA, V102, P2496, DOI 10.1073/pnas.0409849102; MENGISTU M, 1994, J ENDOCRINOL INVEST, V17, P437, DOI 10.1007/BF03347732; MIYAI K, 1971, NEW ENGL J MED, V285, P1043, DOI 10.1056/NEJM197111042851902; Mutinati M, 2010, ANIM REPROD SCI, V118, P1, DOI 10.1016/j.anireprosci.2009.05.019; Nagasaki H, 2006, J MOL ENDOCRINOL, V37, P39, DOI 10.1677/jme.1.01932; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Okada SL, 2006, MOL ENDOCRINOL, V20, P414, DOI 10.1210/me.2005-0270; Rocha A, 2007, GEN COMP ENDOCR, V152, P89, DOI 10.1016/j.ygcen.2007.03.001; ROSELLIREHFUSS L, 1992, ENDOCRINOLOGY, V130, P1857, DOI 10.1210/en.130.4.1857; SAIARDI A, 1995, BIOCHEM J, V310, P491, DOI 10.1042/bj3100491; Strauss J F 3rd, 1988, Prog Clin Biol Res, V267, P177; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Tando Y, 2009, GEN COMP ENDOCR, V162, P329, DOI 10.1016/j.ygcen.2009.04.015; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Trudeau VL, 2009, ENDOCRINOLOGY, V150, P3446, DOI 10.1210/en.2009-0465; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vischer HF, 2003, J MOL ENDOCRINOL, V30, P227, DOI 10.1677/jme.0.0300227; Zhang W, 2009, J CELL MOL MED, V13, P4636, DOI 10.1111/j.1582-4934.2008.00670.x	37	56	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3758	3765		10.1074/jbc.M109.066266	http://dx.doi.org/10.1074/jbc.M109.066266			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955180	Green Published, hybrid			2022-12-27	WOS:000275254000028
J	Vinas-Castells, R; Beltran, M; Valls, G; Gomez, I; Garcia, JM; Montserrat-Sentis, B; Baulida, J; Bonilla, F; de Herreros, AG; Diaz, VM				Vinas-Castells, Rosa; Beltran, Manuel; Valls, Gabriela; Gomez, Irene; Miguel Garcia, Jose; Montserrat-Sentis, Barbara; Baulida, Josep; Bonilla, Felix; Garcia de Herreros, Antonio; Diaz, Victor M.			The Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BETA-TRCP; TRANSCRIPTION FACTOR; CELL-MIGRATION; TUMOR; EXPRESSION; TWIST; PHOSPHORYLATION; REPRESSOR; PROTEINS	The transcription factor SNAIL1 is a master regulator of epithelial to mesenchymal transition. SNAIL1 is a very unstable protein, and its levels are regulated by the E3 ubiquitin ligase beta-TrCP1 that interacts with SNAIL1 upon its phosphorylation by GSK-3 beta. Here we show that SNAIL1 polyubiquitylation and degradation may occur in conditions precluding SNAIL1 phosphorylation by GSK-3 beta, suggesting that additional E3 ligases participate in the control of SNAIL1 protein stability. In particular, we demonstrate that the F-box E3 ubiquitin ligase FBXl14 interacts with SNAIL1 and promotes its ubiquitylation and proteasome degradation independently of phosphorylation by GSK-3 beta. In vivo, inhibition of FBXl14 using short hairpin RNA stabilizes both ectopically expressed and endogenous SNAIL1. Moreover, the expression of FBXl14 is potently down-regulated during hypoxia, a condition that increases the levels of SNAIL1 protein but not SNAIL1 mRNA. FBXL14 mRNA is decreased in tumors with a high expression of two proteins up-regulated in hypoxia, carbonic anhydrase 9 and TWIST1. In addition, Twist1 small interfering RNA prevents hypoxia-induced Fbxl14 downregulation and SNAIL1 stabilization in NMuMG cells. Altogether, these results demonstrate the existence of an alternative mechanism controlling SNAIL1 protein levels relevant for the induction of SNAIL1 during hypoxia.	[Montserrat-Sentis, Barbara; Baulida, Josep; Garcia de Herreros, Antonio; Diaz, Victor M.] Hosp Mar, Inst Municipal Invest Med, Programa Recerca Canc, E-08003 Barcelona, Spain; [Gomez, Irene; Miguel Garcia, Jose; Bonilla, Felix] Hosp Univ Puerta Hierro, Med Oncol Serv, E-28222 Majadahonda, Spain; [Garcia de Herreros, Antonio; Diaz, Victor M.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Puerta de Hierro-Majadahonda; Pompeu Fabra University	de Herreros, AG (corresponding author), Hosp Mar, Inst Municipal Invest Med, Programa Recerca Canc, Parc Recerca Biomed Barcelona,Doctor Aiguader 88, E-08003 Barcelona, Spain.	agarcia@imim.es; vdiaz@imim.es	de Herreros, A Garcia/H-3104-2014; Díaz, Víctor Manuel/F-5013-2016; Viñas-Castells, Rosa/J-7722-2017	de Herreros, A Garcia/0000-0001-5270-0808; Díaz, Víctor Manuel/0000-0001-8561-7576; Viñas-Castells, Rosa/0000-0003-0610-4495	Ministerio de Ciencia y Tecnologia [SAF2006-00339]; Fundacio La Marato de TV3; Instituto Carlos III [RD06/0020/0040, RD06/0020/0020]; Generalitat de Catalunya [2005SGR00970]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3; Instituto Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Ministerio de Ciencia y Tecnologia Grant SAF2006-00339 and by a grant from the Fundacio La Marato de TV3 (to A. G. H.). This work was also supported in part by Instituto Carlos III Grants RD06/0020/0040 and RD06/0020/0020 and by Generalitat de Catalunya Grant 2005SGR00970.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, NAT CELL BIOL, V10, P253, DOI 10.1038/ncb0308-253; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	30	126	130	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3794	3805		10.1074/jbc.M109.065995	http://dx.doi.org/10.1074/jbc.M109.065995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19955572	hybrid, Green Published			2022-12-27	WOS:000275254000032
J	Freschauf, GK; Mani, RS; Mereniuk, TR; Fanta, M; Virgen, CA; Dianov, GL; Grassot, JM; Hall, DG; Weinfeld, M				Freschauf, Gary K.; Mani, Rajam S.; Mereniuk, Todd R.; Fanta, Mesfin; Virgen, Caesar A.; Dianov, Grigory L.; Grassot, Jean-Marie; Hall, Dennis G.; Weinfeld, Michael			Mechanism of Action of an Imidopiperidine Inhibitor of Human Polynucleotide Kinase/Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; IONIZING-RADIATION; DNA; KINASE; XRCC1; BINDING; 3'-PHOSPHATASE; PROTEIN; DAMAGE; CELLS	The small molecule, 2-(1-hydroxyundecyl)-1-(4-nitrophenylamino)-6-phenyl-6,7a-dihydro-1H-pyrrolo[3,4-b] pyridine5,7(2H,4aH)-dione (A12B4C3), is a potent inhibitor of the phosphatase activity of human polynucleotide kinase/phosphatase (PNKP) in vitro. Kinetic analysis revealed that A12B4C3 acts as a noncompetitive inhibitor, and this was confirmed by fluorescence quenching, which showed that the inhibitor can form a ternary complex with PNKP and a DNA substrate, i.e. A12B4C3 does not prevent DNA from binding to the phosphatase DNA binding site. Conformational analysis using circular dichroism, UV difference spectroscopy, and fluorescence resonance energy transfer all indicate that A12B4C3 disrupts the secondary structure of PNKP. Investigation of the potential site of binding of A12B4C3 to PNKP using site-directed mutagenesis pointed to interaction between Trp(402) of PNKP and the inhibitor. Cellular studies revealed that A12B4C3 sensitizes A549 human lung cancer cells to the topoisomerase I poison, camptothecin, but not the topoisomerase II poison, etoposide, in a manner similar to small interfering RNA against PNKP. A12B4C3 also inhibits the repair of DNA single and double strand breaks following exposure of cells to ionizing radiation, but does not inhibit two other key strand-break repair enzymes, DNA polymerase beta or DNA ligase III, providing additional evidence that PNKP is the cellular target of the inhibitor.	[Freschauf, Gary K.; Mani, Rajam S.; Mereniuk, Todd R.; Fanta, Mesfin; Virgen, Caesar A.; Weinfeld, Michael] Cross Canc Inst, Dept Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Dianov, Grigory L.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England; [Grassot, Jean-Marie; Hall, Dennis G.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Oxford; University of Alberta	Weinfeld, M (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB BT6G 1Z2, Canada.	michaelw@cancerboard.ab.ca	Hall, Dennis/E-6865-2016	Hall, Dennis/0000-0001-8555-6400	Canadian Institutes of Health Research and Alberta Cancer Foundation; Canadian Institutes of Health Research Drug Development Initiative; Natural Sciences and Engineering Research Council of Canada; MRC [G0700730] Funding Source: UKRI; Medical Research Council [G0700730] Funding Source: researchfish	Canadian Institutes of Health Research and Alberta Cancer Foundation(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Drug Development Initiative(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Canadian Institutes of Health Research and Alberta Cancer Foundation (to M.W.), the Canadian Institutes of Health Research Drug Development Initiative, and Natural Sciences and Engineering Research Council of Canada (to D.G.H.).	Bernstein NK, 2008, ANTI-CANCER AGENT ME, V8, P358, DOI 10.2174/187152008784220311; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Donovan J W, 1973, Methods Enzymol, V27, P497; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Freschauf GK, 2009, CANCER RES, V69, P7739, DOI 10.1158/0008-5472.CAN-09-1805; Ismail IH, 2004, ONCOGENE, V23, P873, DOI 10.1038/sj.onc.1207303; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; LEACH SJ, 1969, PHYS PRINCIPLES TECH, P101; Mani RS, 2007, J BIOL CHEM, V282, P28004, DOI 10.1074/jbc.M704867200; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Mani RS, 2003, BIOCHEMISTRY-US, V42, P12077, DOI 10.1021/bi030127b; MANI RS, 1983, BIOCHEMISTRY-US, V22, P1734, DOI 10.1021/bi00276a033; Mani RS, 2001, BIOCHEMISTRY-US, V40, P12967, DOI 10.1021/bi011383w; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Ulaczyk-Lesanko A, 2007, J COMB CHEM, V9, P695, DOI 10.1021/cc0700344; Wells GJ, 2006, BIOORG MED CHEM LETT, V16, P1151, DOI 10.1016/j.bmcl.2005.11.086; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003	27	35	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2351	2360		10.1074/jbc.M109.055764	http://dx.doi.org/10.1074/jbc.M109.055764			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19940137	Green Published, hybrid			2022-12-27	WOS:000273697800015
J	Cooper, EM; Boeke, JD; Cohen, RE				Cooper, Eric M.; Boeke, Jef D.; Cohen, Robert E.			Specificity of the BRISC Deubiquitinating Enzyme Is Not Due to Selective Binding to Lys(63)-linked Polyubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-BINDING; STRUCTURAL BASIS; DNA; COMPLEX; BRCA1; CHAIN; REVEALS; IDENTIFICATION; DETERMINANTS; DEGRADATION	BRISC (Brcc36-containing isopeptidase complex) is a four-subunit deubiquitinating (DUB) enzyme that has a catalytic subunit, called Brcc36, that is a member of the JAMM/MPN+ family of zinc metalloproteases. A notable feature of BRISC is its high specificity for cleaving Lys(63)-linked polyubiquitin. Here, we show that BRISC selectivity is not due to preferential binding to Lys(63)-linked polyubiquitin but is instead dictated by how the substrate isopeptide linkage is oriented within the enzyme active site. BRISC possesses a high affinity binding site for the ubiquitin hydrophobic surface patch that accounts for the bulk of the affinity between enzyme and substrate. Although BRISC can interact with either subunit of a diubiquitin conjugate, substrate cleavage occurs only when BRISC is bound to the hydrophobic patch of the distal (i.e. the "S1") ubiquitin at a ubiquitin-ubiquitin cleavage site. The importance of the Lys(63)-linked proximal (S1') ubiquitin was underscored by our finding that BRISC could not cleave the isopeptide bond joining a ubiquitin to a non-ubiquitin substrate. Finally, we also show that Abro1, another BRISC subunit, binds directly to Brcc36 and that the Brcc36-Abro1 heterodimer includes a minimal complex with Lys(63)-specific DUB activity.	[Cooper, Eric M.; Cohen, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Cooper, Eric M.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cooper, Eric M.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Cooper, EM (corresponding author), 733 N Broadway,320 BRB, Baltimore, MD 21205 USA.	emcooper@jhsph.edu; bob.cohen@colostate.edu		Boeke, Jef/0000-0001-5322-4946	National Institutes of Health Roadmap [RR020839]; Ruth Kirschstein Postdoctoral Fellowship [5F32GM075712]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075712] Funding Source: NIH RePORTER	National Institutes of Health Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant RR020839 (to R. E. C. and J. D. B.). This work was also supported by Ruth Kirschstein Postdoctoral Fellowship 5F32GM075712 (to E. M. C.).	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PICKART CM, 1986, J BIOL CHEM, V261, P210; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	42	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10344	10352		10.1074/jbc.M109.059667	http://dx.doi.org/10.1074/jbc.M109.059667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20032457	Green Published, hybrid			2022-12-27	WOS:000276264600019
J	Petrovic, N; Walden, TB; Shabalina, IG; Timmons, JA; Cannon, B; Nedergaard, J				Petrovic, Natasa; Walden, Tomas B.; Shabalina, Irina G.; Timmons, James A.; Cannon, Barbara; Nedergaard, Jan			Chronic Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; FAT-CELLS; MITOCHONDRIAL BIOGENESIS; ADULT HUMANS; NONSHIVERING THERMOGENESIS; TRANSCRIPTIONAL CONTROL; UNCOUPLING PROTEIN-1; COLD-ACCLIMATION; SKELETAL-MUSCLE; GENE-EXPRESSION	The recent insight that brown adipocytes and muscle cells share a common origin and in this respect are distinct from white adipocytes has spurred questions concerning the origin and molecular characteristics of the UCP1-expressing cells observed in classic white adipose tissue depots under certain physiological or pharmacological conditions. Examining precursors from the purest white adipose tissue depot (epididymal), we report here that chronic treatment with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone promotes not only the expression of PGC-1 alpha and mitochondriogenesis in these cells but also a norepinephrine-augmentable UCP1 gene expression in a significant subset of the cells, providing these cells with a genuine thermogenic capacity. However, although functional thermogenic genes are expressed, the cells are devoid of transcripts for the novel transcription factors now associated with classic brown adipocytes (Zic1, Lhx8, Meox2, and characteristically PRDM16) or for myocyte-associated genes (myogenin and myomirs (muscle-specific microRNAs)) and retain white fat characteristics such as Hoxc9 expression. Co-culture experiments verify that the UCP1-expressing cells are not proliferating classic brown adipocytes (adipomyocytes), and these cells therefore constitute a subset of adipocytes ("brite" adipocytes) with a developmental origin and molecular characteristics distinguishing them as a separate class of cells.	[Petrovic, Natasa; Walden, Tomas B.; Shabalina, Irina G.; Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Arrhenius Labs, SE-10691 Stockholm, Sweden; [Timmons, James A.; Cannon, Barbara] Univ London Royal Vet Coll, Life Style Res Grp, London NW1 0TU, England	Stockholm University; University of London; University of London Royal Veterinary College	Petrovic, N (corresponding author), Stockholm Univ, Wenner Gren Inst, Arrhenius Labs, F3, SE-10691 Stockholm, Sweden.	natasa.petrovic@wgi.su.se	Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Timmons, James A/M-6350-2019; Shabalina, Irina/AAC-3720-2019; Shabalina, Irina G/A-4225-2011; Timmons, James A/J-4698-2014; Cannon, Barbara/B-3089-2016	Timmons, James A/0000-0002-2255-1220; Shabalina, Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450; Timmons, James A/0000-0002-2255-1220; Nedergaard, Jan/0000-0003-2070-1587; Cannon, Barbara/0000-0001-6594-2363	Swedish Research Council; European Union Collaborative Project ADAPT [201100]; Jeansson Foundation; COST Action Mitofood; Biotechnology and Biological Sciences Research Council [BB/G013128/1] Funding Source: researchfish; BBSRC [BB/G013128/1] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union Collaborative Project ADAPT(European Commission); Jeansson Foundation; COST Action Mitofood(European Cooperation in Science and Technology (COST)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Swedish Research Council, the European Union Collaborative Project ADAPT(contract 201100), the Jeansson Foundation, and the COST Action Mitofood.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2008, NATURE, V454, P947, DOI 10.1038/454947a; Carmona MC, 2007, DIABETES, V56, P2797, DOI 10.2337/db06-1734; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; COUSIN B, 1992, J CELL SCI, V103, P931; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esser V, 1996, J BIOL CHEM, V271, P6972, DOI 10.1074/jbc.271.12.6972; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Moulin K, 2001, BIOCHEM J, V356, P659, DOI 10.1042/bj3560659; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Shabalina IG, 2008, BBA-BIOENERGETICS, V1777, P642, DOI 10.1016/j.bbabio.2008.04.038; SKALA J, 1970, COMP BIOCHEM PHYSIOL, V33, P509, DOI 10.1016/0010-406X(70)90368-3; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Timmons JA, 2009, NEW ENGL J MED, V361, P415, DOI 10.1056/NEJMc091009; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	60	973	1023	4	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7153	7164		10.1074/jbc.M109.053942	http://dx.doi.org/10.1074/jbc.M109.053942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20028987	Green Published, hybrid			2022-12-27	WOS:000275415600029
J	Kajava, AV; Vasselon, T				Kajava, Andrey V.; Vasselon, Thierry			A Network of Hydrogen Bonds on the Surface of TLR2 Controls Ligand Positioning and Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; LEUCINE-RICH REPEAT; MICROBIAL LIPOPROTEINS; BACTERIAL LIPOPROTEINS; PATHOGEN RECOGNITION; CRYSTAL-STRUCTURE; INNATE IMMUNITY; LIPOPEPTIDE; ACTIVATION; BINDING	TLR2 is a pattern recognition receptor that functions in association with TLR1 or TLR6 to mediate innate immune responses to a variety of conserved microbial products. In the present study, the ectodomain of TLR2 was extensively mutated, and the mutants were assessed for their ability to bind and to mediate cellular responses to triacylated lipopeptide Pam(3)CSK(4). This analysis provides evidence that the recently published crystal structure of the TLR2-TLR1-Pam(3)CSK(4) complex represents a functional signal-inducing complex. Furthermore, we report that extended H-bond networks on the surface of TLR2 are critical for signaling in response to Pam(3)CSK(4) and to other di- and tri-acylated TLR2-TLR6 and TLR2-TLR1 ligands. Based on this finding, we suggest a dynamic model for TLR2-mediated recognition of these ligands in which TLR2 fluctuates between a conformation that is more suitable for binding of the fatty acyl moieties of the ligands and a conformation that favors, via a specific orientation of the ligand head group, formation of a signal-inducing ternary complex.	[Vasselon, Thierry] Univ Montpellier 1, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Vasselon, Thierry] Univ Montpellier 1, CNRS, Inst Mol Genet, F-34293 Montpellier 5, France; Univ Montpellier 2, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Vasselon, Thierry] Univ Montpellier 2, CNRS, Inst Mol Genet Montpellier, F-34293 Montpellier 5, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Vasselon, T (corresponding author), Univ Montpellier 1, Ctr Rech Biochim Macromol, 1919 Route Mende, F-34293 Montpellier 5, France.	thierry.vasselon@igmm.cnrs.fr	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886	Agence Nationale de Recherche sur le Sida et les Hepatites Virales	Agence Nationale de Recherche sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This work was supported in part by the Agence Nationale de Recherche sur le Sida et les Hepatites Virales (to T. V.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Vasselon T, 2002, J LEUKOCYTE BIOL, V71, P503	28	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6227	6234		10.1074/jbc.M109.063669	http://dx.doi.org/10.1074/jbc.M109.063669			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20007698	hybrid, Green Published			2022-12-27	WOS:000275367500027
J	Sun, JL; Li, R				Sun, Jianlong; Li, Rong			Human Negative Elongation Factor Activates Transcription and Regulates Alternative Transcription Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; IMMUNODEFICIENCY-VIRUS TRANSCRIPTION; BREAST-CANCER CELLS; GENE-EXPRESSION; NELF; PROMOTER; DROSOPHILA; COFACTOR; COMPLEX; GENOME	The human negative elongation factor (NELF) is a four-subunit protein complex that inhibits the movement of RNA polymerase II (RNAPII) at an early elongation stage in vitro. NELF-mediated stalling of RNAPII also attenuates transcription of a number of inducible genes in human cells. To obtain a genome-wide understanding of human NELF-mediated transcriptional regulation in vivo, we carried out an exon array study in T47D breast cancer cells with transient small interfering RNA knockdown of individual NELF subunits. Upon depletion of NELF-A, -C, or -E, the vast majority of NELF-regulated genes were downregulated. Many of the down-regulated genes encode proteins that play key roles in cell cycle progression. Consequently, NELF knockdown resulted in significant reduction in DNA synthesis and cell proliferation. Chromatin immunoprecipitation showed that NELF knockdown led to dissociation of RNAPII from the promoter-proximal region of the cell cycle-regulating genes. This was accompanied by decreased histone modifications associated with active transcription initiation (H3K9Ac) and elongation (H3K36Me3), as well as reduced recruitment of the general transcription factor TFIIB and increased overall histone occupancy at a subset of the down-regulated promoters. Lastly, our study indicates that NELF regulates alternative transcription initiation of BSG (Basigin) gene by differentially influencing RNAPII density at the two neighboring exons at the 5' end of the gene. Taken together, our data suggest a diverse transcriptional consequence of NELF-mediated RNAPII pausing in the human genome.	[Sun, Jianlong; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Li, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, 15355 Lambda Dr, San Antonio, TX 78245 USA.	lir3@uthscsa.edu			National Institutes of Health [DK064604]; Max and Minnie Tomerlin Voelcker Scholar; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max and Minnie Tomerlin Voelcker Scholar; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK064604. This work was also supported by a Max and Minnie Tomerlin Voelcker Scholar Award (to R. L.).	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, ONCOGENE, V26, P2543, DOI 10.1038/sj.onc.1210047; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200	32	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6443	6452		10.1074/jbc.M109.084285	http://dx.doi.org/10.1074/jbc.M109.084285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028984	Green Published, hybrid			2022-12-27	WOS:000275367500049
J	Tateno, H; Ohnishi, K; Yabe, R; Hayatsu, N; Sato, T; Takeya, M; Narimatsu, H; Hirabayashi, J				Tateno, Hiroaki; Ohnishi, Koji; Yabe, Rikio; Hayatsu, Norihito; Sato, Takashi; Takeya, Motohiro; Narimatsu, Hisashi; Hirabayashi, Jun			Dual Specificity of Langerin to Sulfated and Mannosylated Glycans via a Single C-type Carbohydrate Recognition Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; MANNAN-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; KERATAN SULFATE; DENDRITIC CELLS; DC-SIGN; BIRBECK GRANULES; LECTIN; EXPRESSION; LIGANDS	Langerin is categorized as a C-type lectin selectively expressed in Langerhans cells, playing roles in the first line of defense against pathogens and in Birbeck granule formation. Although these functions are thought to be exerted through glycan-binding activity of the C-type carbohydrate recognition domain, sugar-binding properties of Langerin have not been fully elucidated in relation to its biological functions. Here, we investigated the glycan-binding specificity of Langerin using comprehensive glycoconjugate microarray, quantitative frontal affinity chromatography, and conventional cell biological analyses. Langerin showed outstanding affinity to galactose-6-sulfated oligosaccharides, including keratan sulfate, while it preserved binding activity to mannose, as a common feature of the C-type lectins with an EPN motif. By a mutagenesis study, Lys-299 and Lys-313 were found to form extended binding sites for sulfated glycans. Consistent with the former observation, the sulfated Langerin ligands were found to be expressed in brain and spleen, where the transcript of keratan sulfate 6-O-sulfotransferase is expressed. Moreover, such sulfated ligands were up-regulated in glioblastoma relative to normal brain tissues, and Langerin-expressing cells were localized in malignant brain tissues. Langerin also recognized pathogenic fungi, such as Candida and Malassezia, expressing heavily mannosylated glycans. These observations provide strong evidence that Langerin mediates diverse functions on Langerhans cells through dual recognition of sulfated as well as mannosylated glycans by its uniquely evolved C-type carbohydrate-recognition domain.	[Tateno, Hiroaki; Yabe, Rikio; Hayatsu, Norihito; Sato, Takashi; Narimatsu, Hisashi; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Ohnishi, Koji; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Kumamoto University	Hirabayashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jun-hirabayashi@aist.go.jp	Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018; Sato, Takashi/M-2577-2018; Narimatsu, Hisashi/M-4757-2018	Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659; Sato, Takashi/0000-0002-9973-8923; Narimatsu, Hisashi/0000-0002-8402-133X; Ohnishi, Koji/0000-0002-6790-6902	New Energy and Industrial Technology Development Organization; Ministry of Education, Science and Culture of Japan; National BioResource Project in Japan	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National BioResource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the New Energy and Industrial Technology Development Organization, grants-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan (to H. T.), and the National BioResource Project in Japan.	Akama TO, 2001, J BIOL CHEM, V276, P16271, DOI 10.1074/jbc.M009995200; Bertolotto A, 1998, J NEUROIMMUNOL, V85, P69, DOI 10.1016/S0165-5728(97)00251-8; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V368, P217, DOI 10.1016/j.bbrc.2008.01.058; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Jander S, 1996, GLIA, V18, P255, DOI 10.1002/(SICI)1098-1136(199611)18:3<255::AID-GLIA9>3.0.CO;2-Y; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Kato Y, 2008, BIOCHEM BIOPH RES CO, V369, P1041, DOI 10.1016/j.bbrc.2008.02.130; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; MEYER K, 1953, J BIOL CHEM, V205, P611; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; NELSON RD, 1991, CLIN MICROBIOL REV, V4, P1; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Terada M, 2005, J BIOL CHEM, V280, P10897, DOI 10.1074/jbc.M413092200; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2003, IMMUNOL RES, V28, P93, DOI 10.1385/IR:28:2:93; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x	44	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6390	6400		10.1074/jbc.M109.041863	http://dx.doi.org/10.1074/jbc.M109.041863			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026605	Green Published, hybrid			2022-12-27	WOS:000275367500043
J	Wu, JW; Breydo, L; Isas, JM; Lee, J; Kuznetsov, YG; Langen, R; Glabe, C				Wu, Jessica W.; Breydo, Leonid; Isas, J. Mario; Lee, Jerome; Kuznetsov, Yurii G.; Langen, Ralf; Glabe, Charles			Fibrillar Oligomers Nucleate the Oligomerization of Monomeric Amyloid beta but Do Not Seed Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MISFOLDING DISEASES; A-BETA; ALZHEIMERS-DISEASE; MEMBRANE DISRUPTION; COMMON MECHANISM; MEMORY; BRAIN; NEURODEGENERATION; CONFORMATIONS; NEUROTOXICITY	Soluble amyloid oligomers are potent neurotoxins that are involved in a wide range of human degenerative diseases, including Alzheimer disease. In Alzheimer disease, amyloid beta (A beta) oligomers bind to neuronal synapses, inhibit long term potentiation, and induce cell death. Recent evidence indicates that several immunologically distinct structural variants exist as follows: prefibrillar oligomers (PFOs), fibrillar oligomers (FOs), and annular protofibrils. Despite widespread interest, amyloid oligomers are poorly characterized in terms of structural differences and pathological significance. FOs are immunologically related to fibrils because they react with OC, a conformation-dependent, fibril-specific antibody and do not react with antibodies specific for other types of oligomers. However, fibrillar oligomers are much smaller than fibrils. FOs are soluble at 100,000 x g, rich in beta-sheet structures, but yet bind weakly to thioflavin T. EPR spectroscopy indicates that FOs display significantly more spin-spin interaction at multiple labeled sites than PFOs and are more structurally similar to fibrils. Atomic force microscopy indicates that FOs are approximately one-half to one-third the height of mature fibrils. We found that A beta FOs do not seed the formation of thioflavin T-positive fibrils from A beta monomers but instead seed the formation of FOs from A beta monomers that are positive for the OC anti-fibril antibody. These results indicate that the lattice of FOs is distinct from the fibril lattice even though the polypeptide chains are organized in an immunologically identical conformation. The FOs resulting from seeded reactions have the same dimensions and morphology as the initial seeds, suggesting that the seeds replicate by growing to a limiting size and then splitting, indicating that their lattice is less stable than fibrils. We suggest that FOs may represent small pieces of single fibril protofilament and that the addition of monomers to the ends of FOs is kinetically more favorable than the assembly of the oligomers into fibrils via sheet stacking interaction. These studies provide novel structural insight into the relationship between fibrils and FOs and suggest that the increased toxicity of FOs may be due to their ability to replicate and the exposure of hydrophobic sheet surfaces that are otherwise obscured by sheet-sheet interactions between protofilaments in a fibril.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Isas, J. Mario; Langen, Ralf] Univ So Calif, Zilhka Neurogenet Inst, Los Angeles, CA 90033 USA	University of California System; University of California Irvine; University of Southern California		cglabe@uci.edu	Breydo, Leo/AAJ-7996-2020; Breydo, Leonid/E-6119-2010	Breydo, Leonid/0000-0003-4666-2301	National Institutes of Health [38298, AG00538, AG027936]; Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027936, P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 38298 and AG00538 and Grant AG027936 (to R. L.). This work was also supported by the Cure Alzheimer Fund (to C. G.) and a grant from the Larry L. Hillblom Foundation (to C. G. and R. L.).	Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1999, METHOD ENZYMOL, V309, P467; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Vincent VAM, 2002, J NEUROSCI RES, V69, P578, DOI 10.1002/jnr.10329; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	42	123	123	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6071	6079		10.1074/jbc.M109.069542	http://dx.doi.org/10.1074/jbc.M109.069542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20018889	Green Published, hybrid			2022-12-27	WOS:000275367500010
J	Chang, PC; Izumiya, Y; Wu, CY; Fitzgerald, LD; Campbell, M; Ellison, TJ; Lam, KS; Luciw, PA; Kung, HJ				Chang, Pei-Ching; Izumiya, Yoshihiro; Wu, Chun-Yi; Fitzgerald, Latricia D.; Campbell, Mel; Ellison, Thomas J.; Lam, Kit S.; Luciw, Paul A.; Kung, Hsing-Jien			Kaposi's Sarcoma-associated Herpesvirus (KSHV) Encodes a SUMO E3 ligase That Is SIM-dependent and SUMO-2/3-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-ASSOCIATED PROTEIN; EPSTEIN-BARR-VIRUS; CELL-CYCLE ARREST; K-BZIP; TRANSCRIPTIONAL REPRESSION; HUMAN CYTOMEGALOVIRUS; LYTIC REPLICATION; TUMOR-SUPPRESSOR; GROWTH ARREST; SUMOYLATION	Sumoylation has emerged as a major post-translational modification of cellular proteins, affecting a variety of cellular processes. Viruses have exploited the sumoylation pathway to advance their own replication by evolving several ways to perturb the host sumoylation apparatus. However, there has been no report of virally encoded enzymes directly involved in catalyzing the sumoylation reaction. Here, we report that the K-bZIP protein encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) is a SUMO E3 ligase with specificity toward SUMO2/3. K-bZIP is a nuclear factor that functions to modulate viral gene expression and to prolong the G1 phase, allowing viral transcription and translation to proceed at the early stage of infection. In addition to functioning as a transcriptional factor, we show that K-bZIP carries a SIM (SUMO-interacting motif), which specifically binds to SUMO-2/3 but not SUMO-1. K-bZIP catalyzes its own SUMO modification as well as that of its interacting partners such as the cellular tumor suppressor proteins p53 and Rb, both in vitro and in vivo. This reaction depends on an intact SIM. Sumoylation of p53 leads to its activation and K-bZIP is recruited to several p53 target chromatin sites in a SIM-dependent manner. In addition to the identification of a viral SUMO-2/3 E3 ligase, our results provide additional insights into the mechanisms whereby K-bZIP induces cell cycle arrest.	[Chang, Pei-Ching; Fitzgerald, Latricia D.; Campbell, Mel; Ellison, Thomas J.; Kung, Hsing-Jien] Univ Calif Davis, Dept Biol Chem & Mol Med, Davis, CA 95616 USA; [Chang, Pei-Ching; Izumiya, Yoshihiro; Wu, Chun-Yi; Fitzgerald, Latricia D.; Campbell, Mel; Ellison, Thomas J.; Lam, Kit S.; Kung, Hsing-Jien] Univ Calif Davis, UC Davis Canc Ctr, Davis, CA 95616 USA; [Izumiya, Yoshihiro] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA; [Wu, Chun-Yi; Lam, Kit S.] Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kung, HJ (corresponding author), UC Davis Canc Ctr, Res 3 Rm 2400,4645 2nd Ave, Sacramento, CA 95817 USA.	hkung@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013	Ellison, Thomas/0000-0001-9231-918X; Izumiya, Yoshihiro/0000-0002-9184-2603	National Institutes of Health [R01 CA114575, DE019085]; NATIONAL CANCER INSTITUTE [R01CA114575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported, in whole or in part, by National Institutes of Health Grants R01 CA114575 and DE019085.	Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; AuCoin DP, 2004, VIROLOGY, V318, P542, DOI 10.1016/j.virol.2003.10.016; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Huh YH, 2008, J VIROL, V82, P10444, DOI 10.1128/JVI.00833-08; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; Izumiya Y, 2007, J VIROL, V81, P1072, DOI 10.1128/JVI.01473-06; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Katano H, 2001, VIROLOGY, V286, P446, DOI 10.1006/viro.2001.1005; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Lin SF, 1999, J VIROL, V73, P1909, DOI 10.1128/JVI.73.3.1909-1917.1999; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muller S, 1999, J VIROL, V73, P5137; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Park J, 2000, J VIROL, V74, P11977, DOI 10.1128/JVI.74.24.11977-11982.2000; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rosas-Acosta G, 2005, VIROLOGY, V331, P190, DOI 10.1016/j.virol.2004.10.025; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wilson VG, 2001, VIRUS RES, V81, P17, DOI 10.1016/S0168-1702(01)00365-3; Wu FY, 2003, J VIROL, V77, P8893, DOI 10.1128/JVI.77.16.8893-8914.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Wu YC, 2007, BIOCHEM SOC T, V35, P1433, DOI 10.1042/BST0351433; Wu YC, 2009, VIROLOGY, V387, P176, DOI 10.1016/j.virol.2009.02.002; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005	50	72	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5266	5273		10.1074/jbc.M109.088088	http://dx.doi.org/10.1074/jbc.M109.088088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20034935	Green Published, hybrid			2022-12-27	WOS:000275327200020
J	Qiao, XY; Pham, DNT; Luo, HY; Wu, JP				Qiao, Xiaoying; Pham, Diep Ngoc Thi; Luo, Hongyu; Wu, Jiangping			Ran Overexpression Leads to Diminished T Cell Responses and Selectively Modulates Nuclear Levels of c-Jun and c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; RAN/TC4; IMPORT; MOUSE; TRANSCRIPTION; TRANSPORT; MITOSIS; MEMBERS	Ras-related nuclear protein (Ran) is a Ras family GTPase, and its documented functions are the regulation of DNA replication, cell cycle progression, nuclear structure formation, RNA processing and exportation, and nuclear protein importation. In this study, we performed detailed mapping of Ran expression during mouse ontogeny using in situ hybridization. High Ran expression was found in various organs and tissues including the thymus cortex and spleen white pulp. Ran was induced in T cells 24 h after their activation. The function of Ran in the immune system was investigated using Ran transgenic (Tg) mice. In Ran Tg T cells, there was compromised activation marker expression, lymphokine secretion, and proliferation upon T cell receptor activation in vitro when compared with wild type T cells. Tg mice also manifested defective delayed type hypersensitivity in vivo. Upon PMA and ionomycin stimulation, Tg T cells were defective in nuclear accumulation of AP-1 factors (c-Jun and c-Fos) but not NF-kappa B family members. Our experiments showed that Ran had important regulatory function in T cell activation. One of the possible mechanisms is that intracellular Ran protein levels control the nuclear retention for selective transcription factors such as c-Jun and c-Fos of AP-1, which is known to be critical in T cell activation and proliferation and lymphokine secretion.	[Qiao, Xiaoying; Pham, Diep Ngoc Thi; Luo, Hongyu; Wu, Jiangping] Notre Dame Hosp, CRCHUM, Immunol Lab, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] Notre Dame Hosp, CRCHUM, Serv Nephrol, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; Universite de Montreal	Wu, JP (corresponding author), Notre Dame Hosp, CRCHUM, Immunol Lab, 1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP57697, MOP69089, PPP86159, IMH- 79565, MOP97829]; Kidney Foundation of Canada; Heart and Stroke Foundation of Quebec; J.- Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Heart and Stroke Foundation of Quebec; J.- Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	This work was supported by grants from the Canadian Institutes of Health Research (Grants MOP57697, MOP69089, and PPP86159 to J. W. and Grants IMH- 79565 and MOP97829 to H. L.), the Kidney Foundation of Canada, the Heart and Stroke Foundation of Quebec, and the J.- Louis Levesque Foundation (to J. W.). It was also supported by a group grant from Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research.	Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; COUTAVAS EE, 1994, MAMM GENOME, V5, P623, DOI 10.1007/BF00411457; DRIVAS G, 1991, MAMM GENOME, V1, P112, DOI 10.1007/BF02443787; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; LEDERER JA, 1994, J IMMUNOL, V152, P77; Lopez-Casas PP, 2002, MECH DEVELOP, V113, P103, DOI 10.1016/S0925-4773(02)00007-2; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; Marusina AI, 2008, J IMMUNOL, V180, P409, DOI 10.4049/jimmunol.180.1.409; MATSUMOTO T, 1993, MOL BIOL CELL, V4, P337, DOI 10.1091/mbc.4.3.337; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; Mondino A, 1996, J IMMUNOL, V157, P2048; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Nieland JD, 1998, CANCER GENE THER, V5, P259; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200	23	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5488	5496		10.1074/jbc.M109.058024	http://dx.doi.org/10.1074/jbc.M109.058024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028981	hybrid, Green Published			2022-12-27	WOS:000275327200042
J	Yamamoto, T; Shimizu, Y; Ueda, T; Shiro, Y				Yamamoto, Tatsuya; Shimizu, Yoshihiro; Ueda, Takuya; Shiro, Yoshitsugu			Mg2+ Dependence of 70 S Ribosomal Protein Flexibility Revealed by Hydrogen/Deuterium Exchange and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOMES; HYDROGEN-EXCHANGE; ANGSTROM RESOLUTION; ASSEMBLY MAP; TRANSFER-RNA; SUBUNIT; 50S; RIBONUCLEOPROTEIN; DISSOCIATION; ACTIVATION	The ribosome from Escherichia coli requires a specific concentration of Mg2+ to maintain the 70 S complex formation and allow protein synthesis, and then the structure must be stable and flexible. How does the ribosome acquire these conflicting factors at the same time? Here, we investigated the hydrogen/deuterium exchange of 52 proteins in the 70 S ribosome, which controlled stability and flexibility under various Mg2+ concentrations, using mass spectrometry. Many proteins exhibited a sigmoidal curve for Mg2+ concentration dependence, incorporating more deuterium at lower Mg2+ concentration. By comparing deuterium incorporation with assembly, we have discovered a typical mechanism of complexes for acquiring both stability and flexibility at the same time. In addition, we got information of the localization of flexibility in ribosomal function by the analysis of related proteins with stalk protein, tRNA, mRNA, and nascent peptide, and demonstrate the relationship between structure, assembly, flexibility, and function of the ribosome.	[Yamamoto, Tatsuya; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Biometal Sci Lab, Sayo, Hongo 6795148, Japan; [Shimizu, Yoshihiro; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan	RIKEN; University of Tokyo	Yamamoto, T (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Biometal Sci Lab, 1-1-1 Kouto, Sayo, Hongo 6795148, Japan.	tyamamot@spring8.or.jp	Shiro, Yoshitsugu Y/J-3757-2014; Shimizu, Yoshihiro/A-6472-2016; Ueda, Takuya/K-5217-2014	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Shimizu, Yoshihiro/0000-0003-3499-1394; Ueda, Takuya/0000-0002-7760-8271; Yamamoto, Tatsuya/0000-0001-8356-8248	Ministry of Education, Culture, Sports Science, and Technology of Japan [20770129]	Ministry of Education, Culture, Sports Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Young Scientist (B) 20770129 from the Ministry of Education, Culture, Sports Science, and Technology of Japan.	Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Blaha G, 2002, BIOPHYS CHEM, V96, P153, DOI 10.1016/S0301-4622(02)00021-2; BONNET D, 1980, NUCLEIC ACIDS RES, V8, P2489, DOI 10.1093/nar/8.11.2489; CHAO FC, 1957, ARCH BIOCHEM BIOPHYS, V70, P426, DOI 10.1016/0003-9861(57)90130-3; COTTER RI, 1971, EUR J BIOCHEM, V23, P468, DOI 10.1111/j.1432-1033.1971.tb01642.x; GESTELAND RF, 1966, J MOL BIOL, V18, P356, DOI 10.1016/S0022-2836(66)80253-X; Grondek JF, 2004, RNA, V10, P1861, DOI 10.1261/rna.7130504; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Liiv A, 2006, J BIOL CHEM, V281, P29850, DOI 10.1074/jbc.M603013200; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; LUCASLENARD J, 1967, P NATL ACAD SCI USA, V57, P1050, DOI 10.1073/pnas.57.4.1050; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; O'Connor M, 2004, NUCLEIC ACIDS RES, V32, P5750, DOI 10.1093/nar/gkh913; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Recht MI, 2004, J MOL BIOL, V344, P395, DOI 10.1016/j.jmb.2004.09.009; ROHL R, 1982, P NATL ACAD SCI-BIOL, V79, P729, DOI 10.1073/pnas.79.3.729; Rostom AA, 2000, P NATL ACAD SCI USA, V97, P5185, DOI 10.1073/pnas.97.10.5185; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SPIERER P, 1979, NUCLEIC ACIDS RES, V6, P1669, DOI 10.1093/nar/6.4.1669; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yamamoto T, 2004, J BIOCHEM, V135, P17, DOI 10.1093/jb/mvh002; Yamamoto T, 2006, FEBS LETT, V580, P3638, DOI 10.1016/j.febslet.2006.05.049; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	30	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5646	5652		10.1074/jbc.M109.081836	http://dx.doi.org/10.1074/jbc.M109.081836			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022945	hybrid, Green Published			2022-12-27	WOS:000275327200057
J	Blamowska, M; Sichting, M; Mapa, K; Mokranjac, D; Neupert, W; Hell, K				Blamowska, Marta; Sichting, Martin; Mapa, Koyeli; Mokranjac, Dejana; Neupert, Walter; Hell, Kai			ATPase Domain and Interdomain Linker Play a Key Role in Aggregation of Mitochondrial Hsp70 Chaperone Ssc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; STRUCTURAL BASIS; PROTEIN IMPORT; BIOCHEMICAL-PROPERTIES; COCHAPERONE BINDING; PRECURSOR PROTEINS; ESCHERICHIA-COLI; TRANSLOCATION; DNAK	The co-chaperone Hep1 is required to prevent the aggregation of mitochondrial Hsp70 proteins. We have analyzed the interaction of Hep1 with mitochondrial Hsp70 (Ssc1) and the determinants in Ssc1 that make it prone to aggregation. The ATPase and peptide binding domain (PBD) of Hsp70 proteins are connected by a linker segment that mediates interdomain communication between the domains. We show here that the minimal Hep1 binding entity of Ssc1 consists of the ATPase domain and the interdomain linker. In the absence of Hep1, the ATPase domain with the interdomain linker had the tendency to aggregate, in contrast to the ATPase domain with the mutated linker segment or without linker, and in contrast to the PBD. The closest homolog of Ssc1, bacterial DnaK, and a Ssc1 chimera, in which a segment of the ATPase domain of Ssc1 was replaced by the corresponding segment from DnaK, did not aggregate in Delta hep1 mitochondria. The propensity to aggregate appears to be a specific property of the mitochondrial Hsp70 proteins. The ATPase domain in combination with the interdomain linker is crucial for aggregation of Ssc1. In conclusion, our results suggest that interdomain communication makes Ssc1 prone to aggregation. Hep1 counteracts aggregation by binding to this aggregation-prone conformer.	[Blamowska, Marta; Sichting, Martin; Mapa, Koyeli; Mokranjac, Dejana; Neupert, Walter; Hell, Kai] Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Hell, K (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de		Mokranjac, Dejana/0000-0002-4005-6979	Deutsche Forschungsgemeinschaft [SFB 594 (B13, B3)]; Center for Integrated Protein Science Munich; Elite Netzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Elite Netzwerk Bayern	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 594 (B13, B3), the Center for Integrated Protein Science Munich, and a predoctoral fellowship from the Elite Netzwerk Bayern (to M. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; Becker D, 2009, J BIOL CHEM, V284, P2934, DOI 10.1074/jbc.M803557200; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Deloche O, 1997, J BIOL CHEM, V272, P28539, DOI 10.1074/jbc.272.45.28539; Deloche O, 1996, J BIOL CHEM, V271, P23960, DOI 10.1074/jbc.271.39.23960; Deloche O, 1997, J BACTERIOL, V179, P6066, DOI 10.1128/jb.179.19.6066-6075.1997; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Sherman F., 1986, METHODS YEAST GENETI; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200	44	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4423	4431		10.1074/jbc.M109.061697	http://dx.doi.org/10.1074/jbc.M109.061697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007714	Green Published, hybrid			2022-12-27	WOS:000275274800019
J	Goldman, SDB; Krise, JP				Goldman, Stephen D. B.; Krise, Jeffrey P.			Niemann-Pick C1 Functions Independently of Niemann-Pick C2 in the Initial Stage of Retrograde Transport of Membrane-impermeable Lysosomal Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ISOLATED RAT HEPATOCYTES; DISEASE TYPE-C; LATE ENDOSOMES; CHOLESTEROL HOMEOSTASIS; HYBRID ORGANELLES; LIPID TRANSPORT; ALDEHYDE LOAD; PROTEIN; CELLS	The rare neurodegenerative disease Niemann-Pick Type C (NPC) results from mutations in either NPC1 or NPC2, which are membrane-bound and soluble lysosomal proteins, respectively. Previous studies have shown that mutations in either protein result in biochemically indistinguishable phenotypes, most notably the hyper-accumulation of cholesterol and other cargo in lysosomes. We comparatively evaluated the kinetics of [H-3] dextran release from lysosomes of wild type, NPC1, NPC2, and NPC1/NPC2 pseudo-double mutant cells and found significant differences between all cell types examined. Specifically, NPC1 or NPC2 mutant fibroblasts treated with NPC1 or NPC2 siRNA (to create NPC1/NPC2pseudo-double mutants) secreted dextran less efficiently than did either NPC1 or NPC2 single mutant cell lines, suggesting that the two proteins may work independently of one another in the egress of membrane-impermeable lysosomal cargo. To investigate the basis for these differences, we examined the role of NPC1 and NPC2 in the retrograde fusion of lysosomes with late endosomes to create so-called hybrid organelles, which is believed to be the initial step in the egress of cargo from lysosomes. We show here that cells with mutated NPC1 have significantly reduced rates of late endosome/lysosome fusion relative to wild type cells, whereas cells with mutations in NPC2 have rates that are similar to those observed in wild type cells. Instead of being involved in hybrid organelle formation, we show that NPC2 is required for efficient membrane fission events from nascent hybrid organelles, which is thought to be required for the reformation of lysosomes and the release of lysosomal cargo-containing membrane vesicles. Collectively, these results suggest that NPC1 and NPC2 can function independently of one another in the egress of certain membrane-impermeable lysosomal cargo.	[Goldman, Stephen D. B.; Krise, Jeffrey P.] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	University of Kansas	Krise, JP (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, 2095 Constant Ave, Lawrence, KS 66047 USA.	krise@ku.edu			National Institutes of Health [RO1 CA106655]; NATIONAL CANCER INSTITUTE [R01CA106655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA106655.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BOLHUIS PA, 1987, NEUROLOGY, V37, P75, DOI 10.1212/WNL.37.1.75; Bright NA, 1997, J CELL SCI, V110, P2027; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; JAHRAUS A, 1994, J CELL SCI, V107, P145; JATZKEWI.H, 1965, J NEUROCHEM, V12, P135, DOI 10.1111/j.1471-4159.1965.tb06749.x; Kaufmann AM, 2009, ANAL BIOCHEM, V386, P91, DOI 10.1016/j.ab.2008.11.036; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; KRIEGER M, 1978, J BIOL CHEM, V253, P4093; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Luzio JP, 2005, BIOCHEM SOC SYMP, V72, P77, DOI 10.1042/bss0720077; Luzio JP, 2000, J CELL SCI, V113, P1515; McNeil PL, 2002, J CELL SCI, V115, P873; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; SOLHEIM AE, 1983, BIOCHIM BIOPHYS ACTA, V763, P284, DOI 10.1016/0167-4889(83)90136-2; SOLHEIM AE, 1983, BIOCHEM J, V210, P929, DOI 10.1042/bj2100929; Subramanian K, 2008, P NATL ACAD SCI USA, V105, P15223, DOI 10.1073/pnas.0808256105; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Virgili M, 2006, NEUROCHEM INT, V48, P201, DOI 10.1016/j.neuint.2005.10.004; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Zervas M, 2001, J NEUROPATH EXP NEUR, V60, P49, DOI 10.1093/jnen/60.1.49; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	46	52	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4983	4994		10.1074/jbc.M109.037622	http://dx.doi.org/10.1074/jbc.M109.037622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007703	Green Published, hybrid			2022-12-27	WOS:000275274800075
J	Haweker, H; Rips, S; Koiwa, H; Salomon, S; Saijo, Y; Chinchilla, D; Robatzek, S; von Schaewen, A				Haeweker, Heidrun; Rips, Stephan; Koiwa, Hisashi; Salomon, Susanne; Saijo, Yusuke; Chinchilla, Delphine; Robatzek, Silke; von Schaewen, Antje			Pattern Recognition Receptors Require N-Glycosylation to Mediate Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; ENDOPLASMIC-RETICULUM; INNATE IMMUNITY; FLAGELLIN PERCEPTION; MOLECULAR-PATTERNS; QUALITY-CONTROL; LINKED GLYCANS; ARABIDOPSIS; PROTEIN; KINASE	N-Glycans attached to the ectodomains of plasma membrane pattern recognition receptors constitute likely initial contact sites between plant cells and invading pathogens. To assess the role of N-glycans in receptor-mediated immune responses, we investigated the functionality of Arabidopsis receptor kinases EFR and FLS2, sensing bacterial translation elongation factor Tu (elf18) and flagellin (flg22), respectively, in N-glycosylation mutants. As revealed by binding and responses to elf18 or flg22, both receptors tolerated immature N-glycans induced by mutations in various Golgi modification steps. EFR was specifically impaired by loss-of-function mutations in STT3A, a subunit of the endoplasmic reticulum resident oligosaccharyltransferase complex. FLS2 tolerated mild underglycosylation occurring in stt3a but was sensitive to severe underglycosylation induced by tunicamycin treatment. EFR accumulation was significantly reduced when synthesized without N-glycans but to lesser extent when underglycosylated in stt3a or mutated in single amino acid positions. Interestingly, EFRN143Q lacking a single conserved N-glycosylation site from the EFR ectodomain accumulated to reduced levels and lost the ability to bind its ligand and to mediate elf18-elicited oxidative burst. However, EFR-YFP protein localization and peptide: N-glycosidase F digestion assays support that both EFR produced in stt3a and EFRN143Q in wild type cells correctly targeted to the plasma membrane via the Golgi apparatus. These results indicate that a single N-glycan plays a critical role for receptor abundance and ligand recognition during plant-pathogen interactions at the cell surface.	[Haeweker, Heidrun; Salomon, Susanne; Saijo, Yusuke; Robatzek, Silke; von Schaewen, Antje] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Rips, Stephan] Univ Munster, Inst Bot, D-48149 Munster, Germany; [Koiwa, Hisashi] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, Dept Hort Sci, College Stn, TX 77843 USA; [Koiwa, Hisashi] Texas A&M Univ, Mol & Environm Plant Sci Program, College Stn, TX 77843 USA; [Chinchilla, Delphine] Univ Basel, Basel Zurich Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland	Max Planck Society; University of Munster; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Basel	von Schaewen, A (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	Schaewen@uni-muenster.de	Koiwa, Hisashi/AAO-6512-2020; Koiwa, Hisashi/AAA-8182-2019; Robatzek, Silke/B-6844-2013	Koiwa, Hisashi/0000-0002-7421-340X; 				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Germain H, 2008, PLANTA, V228, P851, DOI 10.1007/s00425-008-0787-0; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kajiura H, 2010, GLYCOBIOLOGY, V20, P235, DOI 10.1093/glycob/cwp170; Kamikubo Y, 2008, BIOCHEM J, V410, P595, DOI 10.1042/BJ20071137; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Lerouxel O, 2005, PLANT J, V42, P455, DOI 10.1111/j.1365-313X.2005.02392.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schob H, 1997, MOL GEN GENET, V256, P581, DOI 10.1007/s004380050604; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; Zhu JZ, 2009, MOL IMMUNOL, V46, P978, DOI 10.1016/j.molimm.2008.09.024; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	43	143	147	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4629	4636		10.1074/jbc.M109.063073	http://dx.doi.org/10.1074/jbc.M109.063073			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20007973	hybrid, Green Published			2022-12-27	WOS:000275274800041
J	Mashanov, GI; Nobles, M; Harmer, SC; Molloy, JE; Tinker, A				Mashanov, Gregory I.; Nobles, Muriel; Harmer, Stephen C.; Molloy, Justin E.; Tinker, Andrew			Direct Observation of Individual KCNQ1 Potassium Channels Reveals Their Distinctive Diffusive Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; REGULATORY VOLUME DECREASE; GREEN FLUORESCENT PROTEIN; CELL-SURFACE MICRODOMAINS; SINGLE-MOLECULE TRACKING; PLASMA-MEMBRANE; LIVING CELLS; TRANSIENT CONFINEMENT; CRYSTAL-STRUCTURE; SUBUNIT	We have directly observed the trafficking and fusion of ion channel containing vesicles and monitored the release of individual ion channels at the plasma membrane of live mammalian cells using total internal reflection fluorescence microscopy. Proteins were fused in-frame with green or red fluorescent proteins and expressed at low level in HL-1 and HEK293 cells. Dual color imaging revealed that vesicle trafficking involved motorized movement along microtubules followed by stalling, fusion, and subsequent release of individual ion channels at the plasma membrane. We found that KCNQ1-KCNE1 complexes were released in batches of about 5 molecules per vesicle. Toelucidate the properties of ion channel complexes at the cell membrane we tracked the movement of individual molecules and compared the diffusive behavior of two types of potassium channel complex (KCNQ1-KCNE1 and Kir6.2-SUR2A) to that of a G-protein coupled receptor, the A1 adenosine receptor. Plots of mean squared displacement against time intervals showed that mobility depended on channel type, cell type, and temperature. Analysis of the mobility of wild type KCNQ1-KCNE1 complexes showed the existence of a significant immobile subpopulation and also a significant number of molecules that demonstrated periodic stalling of diffusive movements. This behavior was enhanced in cells treated with jasplakinolide and was abrogated in a C-terminal truncated form (KCNQ1(R518X)-KCNE1) of the protein. This mutant has been identified in patients with the long QT syndrome. We propose that KCNQ1-KCNE1 complexes interact intermittently with the actin cytoskeleton via the C-terminal region and this interaction may have a functional role.	[Mashanov, Gregory I.; Molloy, Justin E.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Nobles, Muriel; Harmer, Stephen C.; Tinker, Andrew] UCL, BHF Labs, London WC1E 6JJ, England; [Nobles, Muriel; Harmer, Stephen C.; Tinker, Andrew] UCL, Dept Med, London WC1E 6JJ, England	MRC National Institute for Medical Research; University of London; University College London; University of London; University College London	Molloy, JE (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jmolloy@nimr.mrc.ac.uk; a.tinker@ucl.ac.uk	Harmer, Stephen/D-5512-2015	Harmer, Stephen/0000-0003-3909-6698; Molloy, Justin/0000-0002-8307-2450	Medical Research Council, UK; British Heart Foundation; Medical Research Council [MC_U117570592] Funding Source: researchfish; MRC [MC_U117570592] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Grant-in-aid from the Medical Research Council, UK (to G. M. and J. M.) and a grant from the British Heart Foundation (to M. N., S. H., and A. T.).	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Briddon SJ, 2004, P NATL ACAD SCI USA, V101, P4673, DOI 10.1073/pnas.0400420101; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Calloe K, 2007, BBA-MOL CELL RES, V1773, P764, DOI 10.1016/j.bbamcr.2007.02.008; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Ciruela F, 1995, J NEUROSCI RES, V42, P818, DOI 10.1002/jnr.490420610; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Nechyporuk-Zloy V, 2008, AM J PHYSIOL-CELL PH, V294, pC1096, DOI 10.1152/ajpcell.00252.2007; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sako Y, 2003, J PHARMACOL SCI, V93, P253, DOI 10.1254/jphs.93.253; SALKOFF L, 1995, NEURON, V15, P489, DOI 10.1016/0896-6273(95)90137-X; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tinker A., 2002, ASSEMBLY TARGETING I, P28; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; vanTol BL, 2007, AM J PHYSIOL-CELL PH, V293, pC1010, DOI 10.1152/ajpcell.00071.2007; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Zhao S, 2006, DRUG METAB REV, V38, P141	52	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3664	3675		10.1074/jbc.M109.039974	http://dx.doi.org/10.1074/jbc.M109.039974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940153	Green Published, hybrid			2022-12-27	WOS:000275254000018
J	Orelli, B; McClendon, TB; Tsodikov, OV; Ellenberger, T; Niedernhofer, LJ; Scharer, OD				Orelli, Barbara; McClendon, T. Brooke; Tsodikov, Oleg V.; Ellenberger, Tom; Niedernhofer, Laura J.; Schaerer, Orlando D.			The XPA-binding domain of ERCC1 Is Required for Nucleotide Excision Repair but Not Other DNA Repair Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; INTERSTRAND CROSS-LINKS; XERODERMA-PIGMENTOSUM; DUAL-INCISION; NUCLEAR ABNORMALITIES; DROSOPHILA MUS312; CRYSTAL-STRUCTURE; COCKAYNE-SYNDROME; ENDONUCLEASE; CISPLATIN	The endonuclease ERCC1-XPF incises the damaged strand of DNA 5' to a lesion during nucleotide excision repair (NER) and has additional, poorly characterized functions in interstrand cross-link repair, double-strand break repair, and homologous recombination. XPA, another key factor in NER, interacts with ERCC1 and recruits it to sites of damage. We identified ERCC1 residues that are critical for the interaction with XPA and assessed their importance for NER in vitro and in vivo. Mutation of two conserved residues (Asn-110 and Tyr-145) located in the XPA-binding site of ERCC1 dramatically affected NER but not nuclease activity on model DNA substrates. In ERCC1-deficient cells expressing ERCC1(N110A/Y145A), the nuclease was not recruited to sites of UV damage. The repair of UV-induced (6-4) photoproducts was severely impaired in these cells, and they were hypersensitive to UV irradiation. Remarkably, the ERCC1(N110A/Y145A) protein rescues the sensitivity of ERCC1-deficient cells to cross-linking agents. Our studies suggest that ERCC1-XPF engages in different repair pathways through specific protein-protein interactions and that these functions can be separated through the selective disruption of these interactions. We discuss the impact of these findings for understanding how ERCC1 contributes to resistance of tumor cells to therapeutic agents such as cisplatin.	[Orelli, Barbara; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci & Chem, Stony Brook, NY 11794 USA; [McClendon, T. Brooke; Niedernhofer, Laura J.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [McClendon, T. Brooke; Niedernhofer, Laura J.] Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15213 USA; [Tsodikov, Oleg V.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Washington University (WUSTL)	Scharer, OD (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci & Chem, Chem 619, Stony Brook, NY 11794 USA.	orlando@pharm.stonybrook.edu	Schärer, Orlando D./AAF-8613-2021; Classen, Scott/AAY-8176-2020; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715	National Institutes of Health [GM080454, CA092584, ES016114]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080454, R01GM052504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080454 (to O. D. S.), CA092584 (to O. D. S. and T. E.), and ES016114 (to L. J. N.).	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; Cummings M, 2006, BIOCHEM PHARMACOL, V72, P166, DOI 10.1016/j.bcp.2006.04.025; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; De Silva IU, 2002, NUCLEIC ACIDS RES, V30, P3848, DOI 10.1093/nar/gkf479; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Guggenheim ER, 2009, CHEMBIOCHEM, V10, P141, DOI 10.1002/cbic.200800471; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LI L, 1995, MOL CELL BIOL, V15, P1993; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nishino T, 2005, STRUCTURE, V13, P1183, DOI 10.1016/j.str.2005.04.024; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Olaussen KA, 2007, NEW ENGL J MED, V357, P1559, DOI 10.1056/NEJMc072007; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rolig RL, 1998, MUTAGENESIS, V13, P357, DOI 10.1093/mutage/13.4.357; Salmon P, 2000, BLOOD, V96, P3392; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Sgouros J, 1999, TRENDS BIOCHEM SCI, V24, P95, DOI 10.1016/S0968-0004(99)01355-9; Shivji MKK, 1999, METH MOL B, V113, P373; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wu Q, 2005, EMBO REP, V6, P551, DOI 10.1038/sj.embor.7400418; Yagi T, 1997, MUTAGENESIS, V12, P41, DOI 10.1093/mutage/12.1.41; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhu GY, 2009, BIOCHEMISTRY-US, V48, P4916, DOI 10.1021/bi900389b; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	72	71	74	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3705	3712		10.1074/jbc.M109.067538	http://dx.doi.org/10.1074/jbc.M109.067538			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19940136	Green Published, hybrid			2022-12-27	WOS:000275254000022
J	Chen, HL; Libertini, SJ; Wang, Y; Kung, HJ; Ghosh, P; Mudryj, M				Chen, Honglin; Libertini, Stephen J.; Wang, Yu; Kung, Hsing-Jien; Ghosh, Paramita; Mudryj, Maria			ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT FORMS; CYCLIN-E; CANCER XENOGRAFT; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAY; STEROID-BINDING; KINASE; ACTIVATION; PROGRESSION; GROWTH	Androgen ablation therapy is effective in treating androgen-dependent prostate tumors; however, tumors that can proliferate in castrate levels of androgen eventually arise. We previously reported that in CWR22Rv1 (Rv1) cells, the protease calpain 2 can cleave the androgen receptor (AR) into a constitutively active similar to 80,000 low molecular weight(LMW) form. In this study, we further dissect the mechanisms that produce the AR LMW forms using Rv1 cells and the related CWR22-R1 (R1) cells. The 39-amino acid insertional mutation in the Rv1-AR (E3DM-AR) sensitizes this AR to calpain 2 proteolysis. R1 cells encode the same AR molecule as the parental CWR22 xenograft. Using calpain 2 small interfering RNA and calpeptin, we find that calpain 2 plays a role in the generation of the LMW-AR in R1 cells. Furthermore, LMW-AR expression is regulated by the activation of calpain 2 by ERK 1 and 2. Inhibition of ERK phosphorylation or small interfering RNA-mediated decrease of ERK expression reduces LMW-AR levels in R1 cells. Conversely, activation of the MAPK pathway results in increased ERK phosphorylation and increased levels of LMW-AR. Finally, analyses of human tumor samples found that LMW-AR levels are higher in tumors that have an increased calpain/calpastatin ratio and/or increased levels of phospho-ERK (pERK). This suggests that a higher calpain/calpastatin ratio collaborates with activated ERK to promote the generation of the LMW-AR.	[Chen, Honglin; Libertini, Stephen J.; Mudryj, Maria] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 19616 USA; [Wang, Yu; Ghosh, Paramita] Univ Calif Davis, Dept Urol, Davis, CA 95616 USA; [Kung, Hsing-Jien] Univ Calif Davis, Div Basic Sci, Ctr Canc, Davis, CA 95616 USA; [Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ghosh, Paramita; Mudryj, Maria] Vet Affairs No Calif Hlth Care Syst, Mather, CA 95655 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mudryj, M (corresponding author), Univ Calif Davis, Dept Med Microbiol, 3147 Tupper Hall, Davis, CA 95616 USA.	mmudryj@ucdavis.edu	WANG, YU/E-4655-2013; Kung, Hsing-Jien/C-7651-2013		Department of Defense [PC051049]; Veterans Affairs Merit Award; Department of Defense Predoctoral Award [PC073557]; NATIONAL CANCER INSTITUTE [R01CA133209] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Veterans Affairs Merit Award(US Department of Veterans Affairs); Department of Defense Predoctoral Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Department of Defense Grant PC051049 (to M. M.), Veterans Affairs Merit Award (to M. M.), and Department of Defense Predoctoral Award PC073557 (to H. C.).	Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Berrevoets CA, 2002, MOL CELL ENDOCRINOL, V198, P97, DOI 10.1016/S0303-7207(02)00373-8; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; DEBOER W, 1987, J STEROID BIOCHEM, V28, P9, DOI 10.1016/0022-4731(87)90117-8; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Delk NA, 2009, CANCER RES, V69, P2817, DOI 10.1158/0008-5472.CAN-08-4182; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gregory CW, 1999, ENDOCRINOLOGY, V140, P2372, DOI 10.1210/en.140.5.2372; Gregory CW, 2001, J MOL ENDOCRINOL, V27, P309, DOI 10.1677/jme.0.0270309; Gregory CW, 2001, CANCER RES, V61, P4315; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Linja MJ, 2001, CANCER RES, V61, P3550; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Marcelli M, 2000, CANCER RES, V60, P944; Pelley RP, 2006, CANCER RES, V66, P11754, DOI 10.1158/0008-5472.CAN-06-2918; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Porter DC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.23.e101; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tepper CG, 2002, CANCER RES, V62, P6606; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang XD, 2003, ONCOGENE, V22, P769, DOI 10.1038/sj.onc.1206166; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Xia L, 2002, J BIOL CHEM, V277, P35422, DOI 10.1074/jbc.M203940200; Yang HJ, 2008, J CELL PHYSIOL, V217, P569, DOI 10.1002/jcp.21565; Zhang WL, 1996, J BIOL CHEM, V271, P18825, DOI 10.1074/jbc.271.31.18825	41	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2368	2374		10.1074/jbc.M109.049379	http://dx.doi.org/10.1074/jbc.M109.049379			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19946123	hybrid, Green Published			2022-12-27	WOS:000273697800017
